<div id="yui_3_15_0_3_1445544180031_5257"><div id="q18" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">1</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_173"><input type="hidden" name="q20803:18_:flagged" value="0"><input type="hidden" value="qaid=910902&amp;qubaid=20803&amp;qid=4627&amp;slot=18&amp;checksum=4aa1cb67f0b95f52358a91f30dbcb425&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:18_:flaggedcheckbox" name="q20803:18_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23&id=4627"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content" id="yui_3_15_0_3_1445544180031_5256"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:18_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old man presents with a&nbsp;4-week history of progressive abdominal and back pain. In addition, he has lost his appetite and lacks energy. He had an uncomplicated endovascular abdominal aortic aneurysm repair (EVAR) 18 months ago. He is afebrile and hemodynamically stable but has mild upper abdominal tenderness. His sedimentation rate is elevated at 45. A representative cut of his CT scan is shown below. Regarding this clinical scenario, which of the following statements is the most accurate?</p>
<p><a href="./VESAP3_files/20728.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/20728.jpg" alt="Img" width="67" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:18_answer" disabled="disabled" value="0" id="q20803:18_answer0"><label for="q20803:18_answer0">a. the duodenum can usually be repaired primarily</label> </div>
<div class="r1"><input type="radio" name="q20803:18_answer" disabled="disabled" value="1" id="q20803:18_answer1"><label for="q20803:18_answer1">b. aortoenteric erosion is excluded by the history of EVAR</label> </div>
<div class="r0"><input type="radio" name="q20803:18_answer" disabled="disabled" value="2" id="q20803:18_answer2"><label for="q20803:18_answer2">c. broad spectrum antibiotics are curative</label> </div>
<div class="r1"><input type="radio" name="q20803:18_answer" disabled="disabled" value="3" id="q20803:18_answer3"><label for="q20803:18_answer3">d. this condition can usually be diagnosed by esophagogastroduodenoscopy</label> </div>
<div class="r0"><input type="radio" name="q20803:18_answer" disabled="disabled" value="4" id="q20803:18_answer4"><label for="q20803:18_answer4">e. the endograft can usually be preserved</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:18_-submit" name="q20803:18_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome" id="yui_3_15_0_3_1445544180031_5255"><h4 class="accesshide">Feedback</h4><div class="feedback" id="yui_3_15_0_3_1445544180031_5254"><div class="generalfeedback" id="yui_3_15_0_3_1445544180031_5253"><p id="yui_3_15_0_3_1445544180031_5252">The CT scan shown demonstrates air within the aneurysm sac which, this far out from his EVAR, is indicative of infection with a gas-forming organism or a communication with the gastrointestinal tract. While it is not uncommon to see air in the aneurysm sac within the first few weeks of EVAR, typically being introduced by the endograft delivery system, 18 months post-procedure is well beyond expected. This man likely has an aortoenteric erosion or fistula following EVAR. There have been numerous reports of both endograft infections and graft enteric erosions over the past several years. Esophagogastroduodenoscopy is frequently non-diagnostic because of the inability to adequately examine the fourth portion of the duodenum. A variety of mechanisms have been offered to explain the development of graft infection after EVAR. In some cases, it appears that pre-existent inflammation between the aortic aneurysm and the duodenum may have been present, though unsuspected, at the time of the initial aneurysm repair. In other cases there is evidence of erosion of the graft through the aortic wall into the duodenum. Alternatively, the endograft may be contaminated at the time of implantation, or become so as a result of a bacteremic episode from a remote source such as an infected central line or urinary tract infection. The principles of management include removal of the infected graft, meticulous repair of the bowel, and revascularization. In the photograph shown below, taken from the left side of the table, the duodenum is retracted by the surgeon. The duodenotomy has been temporarily closed to prevent additional contamination. The tip of the suction catheter is inserted into the erosion in the anterior wall of the aorta. Inadequate repair of the bowel injury is associated with a high likelihood of treatment failure. Many surgeons currently employ an in- situ reconstruction with Rifampin-bonded polyester, autogenous deep vein, or cryopreserved allograft, although the evidence supporting one technique over another is lacking. The mortality appears to be higher in patients with an aorto-enteric fistula compared&nbsp;to patients without bowel involvement. The bowel can usually be repaired primarily but it is critical to adequately mobilize the duodenum and debride devitalized tissue before attempting closure. Hasty attempts to close the bowel without adequate visualization of the entire circumference of the enterotomy can lead to early leak-which carries an excessive risk of persistent, and usually, fatal infection.</p>
<p><img src="./VESAP3_files/AssetProxy_276.jpg" alt="" width="150" height="112"><br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Back%20MR.%20Graft%20infections.%20In:%20Rutherford%20RB,%20ed.%20Vascular%20Surgery%207th%20Edition.%20Philadelphia,%20PA:%20Saunders%20Elsevier;%202010:643-662" target="_blank">Back MR. Graft infections. In: Rutherford RB, ed. Vascular Surgery 7th Edition. Philadelphia, PA: Saunders Elsevier 2010:643-62.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Antoniou%20GA,%20Koutsias%20S,%20Antoniou%20SA%20et%20al.%20Outcome%20after%20endovascular%20stent%20graft%20repair%20of%20aortoenteric%20fistula:%20A%20systematic%20review.%20J%20Vasc%20Surg;%202009;%2049%20(3):782-9" target="_blank">Antoniou GA, Koutsias S, Antoniou SA, Georgiakakis A, Lazarides MK, Giannoukas AD. Outcome after endovascular stent graft repair of aortoenteric fistula: A systematic review. J Vasc Surg 2009; 49 (3):782-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Laser%20A,%20Baker%20N,%20Rectenwald%20J,%20et%20al.%20Graft%20infection%20after%20endovascular%20abdominal%20aortic%20aneurysm%20repair.%20J%20Vasc%20Surg;%202011;%2053%20(4):Online" target="_blank">Laser A, Baker N, Rectenwald J, Eliason JL, Criado-Pallares E, Upchurch GR Jr. Graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg 2011; 53 (4):Online</a>.</p>
<p>QID: 30019</p></div><div class="rightanswer">The correct answer is: the duodenum can usually be repaired primarily</div></div></div></div></div><div id="q419" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">2</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_182"><input type="hidden" name="q20803:419_:flagged" value="0"><input type="hidden" value="qaid=911303&amp;qubaid=20803&amp;qid=4793&amp;slot=419&amp;checksum=5760d9fbb24b82363efcf3258f013890&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:419_:flaggedcheckbox" name="q20803:419_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q419&id=4793"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:419_:sequencecheck" value="2"><div class="qtext"><p>A 19-year-old woman has presented for cosmetic treatment of varicose veins in her left leg. She is asymptomatic. On examination, varicose veins are present in her lateral thigh and calf and a large skin hemangioma is present in the popliteal area of the same leg (see below). Her left foot is 1 inch longer than her right. This patient's pre-treatment workup should include which of the following?</p>
<p><img src="./VESAP3_files/LURIE test1.jpg" alt="" width="447" height="322"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:419_answer" disabled="disabled" value="0" id="q20803:419_answer0"><label for="q20803:419_answer0">1. venous reflux study</label> </div>
<div class="r1"><input type="radio" name="q20803:419_answer" disabled="disabled" value="1" id="q20803:419_answer1"><label for="q20803:419_answer1">2. MRI of left leg</label> </div>
<div class="r0"><input type="radio" name="q20803:419_answer" disabled="disabled" value="2" id="q20803:419_answer2"><label for="q20803:419_answer2">3. biopsy of hemangioma</label> </div>
<div class="r1"><input type="radio" name="q20803:419_answer" disabled="disabled" value="3" id="q20803:419_answer3"><label for="q20803:419_answer3">4. x-ray of left foot</label> </div>
<div class="r0"><input type="radio" name="q20803:419_answer" disabled="disabled" value="4" id="q20803:419_answer4"><label for="q20803:419_answer4">5. ultrasound scan or venography of deep veins</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:419_-submit" name="q20803:419_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Klippel-Trenaunay Syndrome (KTS) includes a triad of port-wine stains (capillary hemangiomas), limb hypertrophy, and lateral varicose veins (vena marginalis lateralis). Approximately 10% of patients with KTS have either atresia or hypoplasia of the deep venous system. The vena marginalis lateralis serves as one of the main outflow tracts because it drains either into the pelvic veins or directly into the external iliac vein. Treatment of superficial veins in the absence of a normal deep system can result in severe venous insufficiency and should be avoided.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>Lee BB, Villavicencio L. Congenital vascular malformations: general considerations. In: Rutherford’s Vascular Surgery 7<sup>th</sup> edition. 2010, chapter 68, pp. 1046-64.</p>
<p>QID: 30740</p></div><div class="rightanswer">The correct answer is: ultrasound scan or venography of deep veins</div></div></div></div></div><div id="q184" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">3</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_191"><input type="hidden" name="q20803:184_:flagged" value="0"><input type="hidden" value="qaid=911068&amp;qubaid=20803&amp;qid=4551&amp;slot=184&amp;checksum=80bcf98d2fdb096deb68b527a63c6367&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:184_:flaggedcheckbox" name="q20803:184_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q184&id=4551"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:184_:sequencecheck" value="2"><div class="qtext"><p>A&nbsp;77 year old man presents with an asymptomatic 70% right internal carotid artery stenosis. Based on a published randomized trial in a population of similar patients, the estimated five year aggregate risk of ipsilateral stroke or death with medical management is</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:184_answer" disabled="disabled" value="0" id="q20803:184_answer0"><label for="q20803:184_answer0">a. 1%</label> </div>
<div class="r1"><input type="radio" name="q20803:184_answer" disabled="disabled" value="1" id="q20803:184_answer1"><label for="q20803:184_answer1">b. 11%</label> </div>
<div class="r0"><input type="radio" name="q20803:184_answer" disabled="disabled" value="2" id="q20803:184_answer2"><label for="q20803:184_answer2">c. 40%</label> </div>
<div class="r1"><input type="radio" name="q20803:184_answer" disabled="disabled" value="3" id="q20803:184_answer3"><label for="q20803:184_answer3">d. 5%</label> </div>
<div class="r0"><input type="radio" name="q20803:184_answer" disabled="disabled" value="4" id="q20803:184_answer4"><label for="q20803:184_answer4">e. 17%</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:184_-submit" name="q20803:184_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The Asymptomatic Carotid Atherosclerosis (ACAS) Study randomized 1662 patients with a &gt; 60% asymptomatic carotid stenosis into a surgical (carotid endarterectomy) arm and a medical management arm (mainly aspirin therapy). After a mean of 2.7 years of follow up, the 5-year Kaplan-Meier projected risk for any stroke or death with medical management alone was 11% compared to a 5.1% risk in those who underwent carotid endarterectomy. This large study concluded that all good surgical risk patients with this type of carotid lesion be considered for carotid endarterectomy. It has been suggested that the current widespread use of statins, ACE inhibitors and advanced antiplatelet drugs (e.g. clopidogrel) may have likely lowered that risk of stroke in asymptomatic patients with carotid stenosis. At the present time, carotid endarterectomy remains both indicated and the gold standard for stroke reduction in good surgical risk patients.<br><br>References:</p>
<p>The Executive Committee for the Asymptomatic Carotid Atherosclerosis (ACAS). Endarterectomy for asymptomatic carotid artery stenosis. JAMA; 1995; 273 (18):1421-1428. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7723155">http://www.ncbi.nlm.nih.gov/pubmed/7723155</a></p>
<p>QID: 30328</p></div><div class="rightanswer">The correct answer is: 11%</div></div></div></div></div><div id="q185" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">4</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_200"><input type="hidden" name="q20803:185_:flagged" value="0"><input type="hidden" value="qaid=911069&amp;qubaid=20803&amp;qid=4552&amp;slot=185&amp;checksum=49bdb740bc3df154a0d0ecd5fb984677&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:185_:flaggedcheckbox" name="q20803:185_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q185&id=4552"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:185_:sequencecheck" value="2"><div class="qtext"><p>A 76 yo man presents with a left hemisphere stroke. Initial symptoms resolved after 24hrs with no residual deficit. He has an ipsilateral 80% internal carotid stenosis suitable for endarterectomy. &nbsp; &nbsp;When is the best timing of carotid endarterectomy after acute stroke?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:185_answer" disabled="disabled" value="0" id="q20803:185_answer0"><label for="q20803:185_answer0">a. 48 to 72 hours</label> </div>
<div class="r1"><input type="radio" name="q20803:185_answer" disabled="disabled" value="1" id="q20803:185_answer1"><label for="q20803:185_answer1">b. &lt; 6 months</label> </div>
<div class="r0"><input type="radio" name="q20803:185_answer" disabled="disabled" value="2" id="q20803:185_answer2"><label for="q20803:185_answer2">c. &lt; 2 weeks</label> </div>
<div class="r1"><input type="radio" name="q20803:185_answer" disabled="disabled" value="3" id="q20803:185_answer3"><label for="q20803:185_answer3">d. &lt; 4 weeks</label> </div>
<div class="r0"><input type="radio" name="q20803:185_answer" disabled="disabled" value="4" id="q20803:185_answer4"><label for="q20803:185_answer4">e. &lt; 48 hours</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:185_-submit" name="q20803:185_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The timing of&nbsp;carotid endarterecomty (CEA)&nbsp;after a stroke has been defined by several guidelines on symptomatic carotid surgery based on pooled analysis of data from NASCET and ECST. The benefit of carotid endarterectomy decreases inversely with the time from the initial cerebrovascular event. To achieve the greatest benefit, carotid endarterectomy should be performed within two weeks of the the index event. &nbsp;Many surgeons avoid urgent surgery (&lt;48 hours) in patients with stroke. &nbsp;A Swedish prospective study involving 2596 patients found that surgery within 24 hours&nbsp;had a mortality and stroke rate of 11.5% compared to that of approximately&nbsp;4.0% in those&nbsp;treated 3-14 days after their event.&nbsp; Further multivariate analysis showed that time to intervention was the strongest determinant of risk of stroke or death.&nbsp; (odds ratio 4.24, 95% CI 2.07-8.70, P&lt;0.001). In summary, the timing of carotid endarterectomy for patients presenting with stroke must be individualized based on the clinical magnitude of the stoke, the size of the stroke on brain imaging, assessment of patient-specific co-morbidities, anatomic features of the carotid lesion, as well as surgeon experience and preference. Based on current evidence it appears that carotid endarterectomy between 48 hours and two weeks after the index neurological event is a prudent strategy to reduce the risk of recurrent stroke and yet avoid the risks associated with urgent reperfusion of vulnerable brain.</p>
<p>References:</p>
<p>1. Stromberg S, Gellin J, Osterberg T, et al. Very urgent carotid endarterectomy confers increased procedural risk. Stroke 2012; 43: 1331-1335. <a href="http://www.ncbi.nlm.nih.gov/pubmed/22426315">http://www.ncbi.nlm.nih.gov/pubmed/22426315</a></p>
<p>2. Rerkasem K and Rothwell PM. Systematic review of the operative risks of carotid endarterectomy for recently symptomatic stenosis in relation to the timing of surgery. Stroke 2009; 40: e564-e572. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19661467">http://www.ncbi.nlm.nih.gov/pubmed/19661467</a></p>
<p>3. Barnett HJ, Taylor DW, Eliasziw M, et a. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-1425. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9811916">http://www.ncbi.nlm.nih.gov/pubmed/9811916</a></p>
<p>4. Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST). Lancet 1998; 351: 379-1987. <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=randomised+trial+of+endarterectomy+for+recently%2C+1998%2C+lancet">http://www.ncbi.nlm.nih.gov/pubmed/?term=randomised+trial+of+endarterectomy+for+recently%2C+1998%2C+lancet</a></p>
<p>5. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004;&nbsp;363: 915-924. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15043958">http://www.ncbi.nlm.nih.gov/pubmed/15043958</a></p>
<p>QID: 30329</p></div><div class="rightanswer">The correct answer is: &lt; 2 weeks</div></div></div></div></div><div id="q338" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">5</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_209"><input type="hidden" name="q20803:338_:flagged" value="0"><input type="hidden" value="qaid=911222&amp;qubaid=20803&amp;qid=4399&amp;slot=338&amp;checksum=6c49c77d841bcd327424d96561a4ed37&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:338_:flaggedcheckbox" name="q20803:338_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q338&id=4399"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:338_:sequencecheck" value="2"><div class="qtext"><p>A 67 year old male with three-drug hypertension is referred to you with the results of a renal artery duplex scan, including resistive indices. A Renal Resistive Index (1-End Diastolic Velocity/Peak Systolic Velocity) obtained at the time of renal artery duplex scanning may be useful in predicting the presence of</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:338_answer" disabled="disabled" value="0" id="q20803:338_answer0"><label for="q20803:338_answer0">a. &gt; 70% ipsilateral renal artery stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:338_answer" disabled="disabled" value="1" id="q20803:338_answer1"><label for="q20803:338_answer1">b. &gt; 30% ipsilateral renal artery stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:338_answer" disabled="disabled" value="2" id="q20803:338_answer2"><label for="q20803:338_answer2">c. &gt; 70% contralateral renal artery stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:338_answer" disabled="disabled" value="3" id="q20803:338_answer3"><label for="q20803:338_answer3">d. ipsilateral renal artery occlusion</label> </div>
<div class="r0"><input type="radio" name="q20803:338_answer" disabled="disabled" value="4" id="q20803:338_answer4"><label for="q20803:338_answer4">e. ipsilateral renal parenchymal sclerosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:338_-submit" name="q20803:338_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The Renal Resistive Index (RI) is calculated from hilar peak systolic velocity and end diastolic velocity in the kidney at the time of renal artery duplex scanning. It is not derived from main renal artery velocity profiles and thus is of limited utility in predicting the existence of main renal artery disease. There is evidence that a RI &gt; 0.8 is associated with intrarenal parenchymal sclerosis. There is also evidence that a RI &lt; 0.8 may predict blood pressure and renal function responses to renal revascularization and reduced long-term mortality. In the example provided below, the RI is 0.75, which would not be a contraindication to proceeding with renal artery revascularization.<br><br><a href="./VESAP3_files/AssetProxy_108.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_108.jpg" alt="img" width="100" height="74" border="0" hspace="10" vspace="10"></a><br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Garovic%20VD,%20Textor%20SC.%20Renovascular%20hypertension%20and%20ischemic%20nephropathy.%20Circulation;%202005;%20112%20(9):1362-1374" target="_blank">Garovic VD, Textor SC. Renovascular hypertension and ischemic nephropathy. Circulation; 2005; 112 (9):1362-1374.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Crutchley%20T,%20Pearce%20J,%20Craven%20T%20et.%20al.%20Clinical%20utility%20of%20the%20resistive%20index%20in%20atherosclerotic%20renovascular%20disease.%20J%20Vasc%20Surg;%202009;%2049%20(1):148-55" target="_blank">Crutchley T, Pearce J, Craven T et. al. Clinical utility of the resistive index in atherosclerotic renovascular disease. J Vasc Surg; 2009; 49 (1):148-55</a>.</p>
<p>QID: 30604</p></div><div class="rightanswer">The correct answer is: ipsilateral renal parenchymal sclerosis</div></div></div></div></div><div id="q353" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">6</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_218"><input type="hidden" name="q20803:353_:flagged" value="0"><input type="hidden" value="qaid=911237&amp;qubaid=20803&amp;qid=5147&amp;slot=353&amp;checksum=e45aba7d24291e33e5081680498edef6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:353_:flaggedcheckbox" name="q20803:353_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q353&id=5147"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:353_:sequencecheck" value="2"><div class="qtext"><p>A 45-year-old man presents with a 1.5 cm aneurysm of the left renal artery (image shown below) discovered incidentally on a CT scan. The patient is asymptomatic, has no other significant medical history, and has a benign physical examination. Which of the following is the most appropriate management option for the patient?</p>
<p><a href="./VESAP3_files/Left renal artery aneurysm-CTA for Chung-3.jpg" target="images"><img src="./VESAP3_files/Left renal artery aneurysm-CTA for Chung-3.jpg" alt="Left renal artery aneurysm visible on CT angiogram." width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:353_answer" disabled="disabled" value="0" id="q20803:353_answer0"><label for="q20803:353_answer0">a. ex-vivo aneurysm resection and reconstruction</label> </div>
<div class="r1"><input type="radio" name="q20803:353_answer" disabled="disabled" value="1" id="q20803:353_answer1"><label for="q20803:353_answer1">b. in situ bypass with aneurysm exclusion</label> </div>
<div class="r0"><input type="radio" name="q20803:353_answer" disabled="disabled" value="2" id="q20803:353_answer2"><label for="q20803:353_answer2">c. endovascular exclusion with a combination of coils</label> </div>
<div class="r1"><input type="radio" name="q20803:353_answer" disabled="disabled" value="3" id="q20803:353_answer3"><label for="q20803:353_answer3">d. open aneurysmectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:353_answer" disabled="disabled" value="4" id="q20803:353_answer4"><label for="q20803:353_answer4">e. non-operative management</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:353_-submit" name="q20803:353_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Indications for the repair of renal artery aneurysms have evolved from series of open renal artery aneurysm reconstructions.&nbsp;The most frequently employed criterion is a renal artery aneurysm in a female of reproductive age who is currently pregnant or plans&nbsp;to become pregnant.&nbsp; While the natural history of renal aneurysms in this subpopulation is not well defined, many surgeons are reluctant to recommend surveillance for these women due to the association between rupture and maternal / fetal mortality.&nbsp; Symptoms of renal aneurysms may include frank rupture with hypotension and pain, flank pain,&nbsp;evidence of embolization into the renal parenchyma, and hematuria.&nbsp;Renal artery aneurysms believed to be symptomatic merit repair. For asymptomatic aneurysms, most authors have utilized a threshold of <span style="text-decoration: underline;">&gt;</span> 2.0 cm in maximal diameter.&nbsp;Saccular morphology and lack of calcification of&nbsp;renal artery&nbsp;aneurysms have not been associated with rupture, so these should not influence the decision to operate.&nbsp;Hypertension has been cited as a possible indication for repair, though this association is also inconsistent in the literature.&nbsp;Multiple methods have evolved for repair, with the most appropriate method varying mostly upon the operator’s experience and the anatomy of the aneurysm. Since most renal artery aneurysms occur at the renal artery bifurcation and involve multiple branches, open repair may necessitate ex vivo techniques to minimize the risk of prolonged warm ischemia times that would produce irreversible renal parenchymal damage. In the case above, the&nbsp;diameter of the aneurysm would not merit repair in the absence of symptoms.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2004%3B40%3A53-60." target="_blank">English WP, Pearce JD, Craven TE, Wilson DB, Edwards MS, Ayerdi J, et al.&nbsp; Surgical management of renal artery aneurysms.&nbsp; J Vasc Surg 2004;40:53-60.</a></p>
<p>QID: 30621</p></div><div class="rightanswer">The correct answer is: non-operative management</div></div></div></div></div><div id="q12" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">7</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_227"><input type="hidden" name="q20803:12_:flagged" value="0"><input type="hidden" value="qaid=910896&amp;qubaid=20803&amp;qid=4622&amp;slot=12&amp;checksum=61282f47db55c53562dc462c7aa86bd3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:12_:flaggedcheckbox" name="q20803:12_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q12&id=4622"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:12_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old man undergoes an endovascular aneurysm repair with open femoral artery exposure. At the completion of the procedure he has a strong pulse in both femoral arteries and palpable dorsalis pedis pulses bilaterally.&nbsp;A short time later, while in the recovery room, he loses his pulse and Doppler signal in the right foot. His left foot exam is normal. Which of the following is the appropriate next step?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:12_answer" disabled="disabled" value="0" id="q20803:12_answer0"><label for="q20803:12_answer0">a. start intravenous heparin and observe</label> </div>
<div class="r1"><input type="radio" name="q20803:12_answer" disabled="disabled" value="1" id="q20803:12_answer1"><label for="q20803:12_answer1">b. order a CTA of the abdomen with runoff</label> </div>
<div class="r0"><input type="radio" name="q20803:12_answer" disabled="disabled" value="2" id="q20803:12_answer2"><label for="q20803:12_answer2">c. perform a left-to-right femoral-femoral bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:12_answer" disabled="disabled" value="3" id="q20803:12_answer3"><label for="q20803:12_answer3">d. perform diagnostic angiography from the left brachial artery</label> </div>
<div class="r0"><input type="radio" name="q20803:12_answer" disabled="disabled" value="4" id="q20803:12_answer4"><label for="q20803:12_answer4">e. re-explore the right common femoral artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:12_-submit" name="q20803:12_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Arterial complications after endovascular aneurysm repair (EVAR) have decreased as experience with&nbsp;the technique&nbsp;and devices has grown. Furthermore, device delivery systems have become more flexible and smaller in profile, both of which have contributed to reduced trauma to the arteries that serve as the pathway to the aorta. Endograft limb thrombosis, common or external iliac artery dissection, intimal flaps, access vessel dissection, and embolic events can all lead to an ischemic leg after endovascular aneurysm repair. The appropriate step is to return immediately to the operating room where any of these issues can be addressed. None of the other four options should be considered when dealing with this pulse exam change after EVAR.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Maldonado%20TS,%20Rockman%20CB,%20Riles%20E,%20et%20al.%20Ischemic%20complications%20after%20endovascular%20abdominal%20aortic%20aneurysm%20repair.%20J%20Vasc%20Surg;%202004;%2040%20(4):703-710" target="_blank">Maldonado TS, Rockman CB, Riles E, Douglas D, Adelman MA, Jacobowitz GR, et al. Ischemic complications after endovascular abdominal aortic aneurysm repair. J Vasc Surg 2004; 40 (4):703-10.</a></p>
<p>QID: 30013</p></div><div class="rightanswer">The correct answer is: re-explore the right common femoral artery</div></div></div></div></div><div id="q357" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">8</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_236"><input type="hidden" name="q20803:357_:flagged" value="0"><input type="hidden" value="qaid=911241&amp;qubaid=20803&amp;qid=5150&amp;slot=357&amp;checksum=7e0fa9eebc74dd84bed140c4c1d994c5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:357_:flaggedcheckbox" name="q20803:357_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q357&id=5150"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:357_:sequencecheck" value="2"><div class="qtext"><p><span>A 55-year-old woman presents to the clinic with a renal artery duplex ultrasound showing peak systolic velocity of 232 cm/sec and a renal:aortic peak systolic velocity ratio of 4.0 (image shown below).&nbsp;This lesion in the main renal artery is&nbsp;likely to produce which of the following&nbsp;intrarenal&nbsp;changes?</span></p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/Chung-1.jpg" target="images"><img src="./VESAP3_files/Chung-1.jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:357_answer" disabled="disabled" value="0" id="q20803:357_answer0"><label for="q20803:357_answer0">a. <span>angiotensin II-mediated vasoconstriction of the efferent arterioles to&nbsp;increase&nbsp;glomerular filtration rate</span></label> </div>
<div class="r1"><input type="radio" name="q20803:357_answer" disabled="disabled" value="1" id="q20803:357_answer1"><label for="q20803:357_answer1">b. <span>no intra-renal effects</span></label> </div>
<div class="r0"><input type="radio" name="q20803:357_answer" disabled="disabled" value="2" id="q20803:357_answer2"><label for="q20803:357_answer2">c. <span>angiotensin II-mediated vasodilation of the afferent arterioles to&nbsp;decrease glomerular filtration rate</span></label> </div>
<div class="r1"><input type="radio" name="q20803:357_answer" disabled="disabled" value="3" id="q20803:357_answer3"><label for="q20803:357_answer3">d. <span>angiotensin II-mediated vasodilation of the afferent arterioles to&nbsp;increase&nbsp;glomerular filtration rate</span></label> </div>
<div class="r0"><input type="radio" name="q20803:357_answer" disabled="disabled" value="4" id="q20803:357_answer4"><label for="q20803:357_answer4">e. <span>angiotensin II-mediated vasoconstriction of the afferent arterioles to&nbsp;increase glomerular filtration rate</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:357_-submit" name="q20803:357_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The duplex findings presented above represent a hemodynamically significant (&gt;60%) renal artery stenosis since the peak systolic velocity&nbsp;exceeds 180 cm/sec and, more importantly, the renal:aortic peak systolic velocity ratio is more than 3.5. Hemodynamically significant renal artery stenosis results in a decrease in the perfusion of the juxta-glomerular apparatus.&nbsp;This results in an increase in renin secretion. Renin is an enzyme that cleaves&nbsp;angiotensinogen produced by the liver to generate&nbsp;angiotensin I.&nbsp;&nbsp;Angiotensin I&nbsp;then circulates to the lungs, where it is cleaved by angiotensin-converting enzyme into the active peptide&nbsp;angiotensin II.&nbsp;Within the&nbsp;kidney, angiotensin II produces&nbsp;vasoconstriction&nbsp;of the efferent tubules, thereby increasing glomerular filtration rate.&nbsp;Angiotensin II also&nbsp;upregulates several transporters and co-transporters within the kidney to increase sodium reabsorption, increase volume, and augment blood pressure. Outside of the kidney, angiotensin II is&nbsp;a powerful vascoconstrictor and stimulates release of aldosterone from the adrenal cortex. The sum of all of these effects is to augment blood pressure.&nbsp;In a patient with renal artery stenosis, the net sum is hypertension that is often severe and difficult to control.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/2022413" target="_blank">Martinez-Maldonado, M.&nbsp; Pathophysiology of renovascular hypertension. Hypertension &nbsp;1991;17:&nbsp;707-19.</a></p>
<p>QID: 30627</p></div><div class="rightanswer">The correct answer is: <span>angiotensin II-mediated vasoconstriction of the efferent arterioles to&nbsp;increase&nbsp;glomerular filtration rate</span></div></div></div></div></div><div id="q34" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">9</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_245"><input type="hidden" name="q20803:34_:flagged" value="0"><input type="hidden" value="qaid=910918&amp;qubaid=20803&amp;qid=4643&amp;slot=34&amp;checksum=83e46861c2508448615c9c056f939233&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:34_:flaggedcheckbox" name="q20803:34_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q34&id=4643"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:34_:sequencecheck" value="2"><div class="qtext"><p>A 28-year-old man is referred for a chronic, nonhealing wound on&nbsp;his left anterior shin. His past medical history is significant for&nbsp;3 episodes of deep venous thrombosis involving both lower extremities and recurrent oral ulcerations. He has been treated with indefinite anticoagulation and compression therapy with wound care. Your ultrasound technician examines the extremity and identifies a 4 cm popliteal artery aneurysm and an incidental 4.5 cm abdominal aortic aneurysm, in addition to findings consistent with remote femoral vein thrombosis. Which of the following is the most probable diagnosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:34_answer" disabled="disabled" value="0" id="q20803:34_answer0"><label for="q20803:34_answer0">a. Klippel-Trenaunay syndrome</label> </div>
<div class="r1"><input type="radio" name="q20803:34_answer" disabled="disabled" value="1" id="q20803:34_answer1"><label for="q20803:34_answer1">b. Marfan’s syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:34_answer" disabled="disabled" value="2" id="q20803:34_answer2"><label for="q20803:34_answer2">c. Behcet’s syndrome</label> </div>
<div class="r1"><input type="radio" name="q20803:34_answer" disabled="disabled" value="3" id="q20803:34_answer3"><label for="q20803:34_answer3">d. Ehlers-Danlos syndrome type IV</label> </div>
<div class="r0"><input type="radio" name="q20803:34_answer" disabled="disabled" value="4" id="q20803:34_answer4"><label for="q20803:34_answer4">e. Loeys-Dietz syndrome</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:34_-submit" name="q20803:34_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>With the exception of Klippel-Trenaunay syndrome, all of the conditions listed are associated with early-onset aneurysmal disease.&nbsp;Both Marfan’s and Loeys-Dietz syndromes are dominated by aortic aneurysm or aortic dissection formation, pectus excavatum, long bone structure, and bicuspid aortic valve.&nbsp;EDS type IV is characterized&nbsp;with small stature, translucent skin, and susceptiblty to easy bruising. The most common presentation of vascular-Behcet’s syndrome is recurrent deep venous thrombosis (4:1 compared to arterial presentation).&nbsp;The mechanism of recurrent thrombosis is related to the inflammatory reaction within the vessel wall. The cutaneous ulcerations typically occur on the lower limbs in a distribution that is inconsistent with chronic venous insufficiency.&nbsp;Oral ulcerations are common. Patients that present with Behcet’s are also prone to infrarenal aortic aneurysm formation and are also&nbsp;susceptible to coronary artery aneurysms, pulmonary artery aneurysms, visceral aneurysms, and peripheral aneurysms.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Alpagut+U%2C+Ugurlucan+M%2C+Dayioglu+E.+Major+arterial+involvement+and+review+of+Behcet%E2%80%99s+disease.+Annals+of+Vascular+Surgery%3B+2007%3B+21(2)%3A+232-9." target="_blank">Alpagut U, Ugurlucan M, Dayioglu E. Major arterial involvement and review of Behcet’s disease. Annals of Vascular Surgery 2007; 21(2): 232-9.</a></p>
<p>QID: 30037</p></div><div class="rightanswer">The correct answer is: Behcet’s syndrome</div></div></div></div></div><div id="q520" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">10</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_254"><input type="hidden" name="q20803:520_:flagged" value="0"><input type="hidden" value="qaid=911404&amp;qubaid=20803&amp;qid=5256&amp;slot=520&amp;checksum=aa7d7f410cfdd8a29c3f518e217a4c74&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:520_:flaggedcheckbox" name="q20803:520_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q520&id=5256"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:520_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is the most common&nbsp;major source of radiation exposure to interventionalists and hospital personnel?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:520_answer" disabled="disabled" value="0" id="q20803:520_answer0"><label for="q20803:520_answer0">a. natural background radiation</label> </div>
<div class="r1"><input type="radio" name="q20803:520_answer" disabled="disabled" value="1" id="q20803:520_answer1"><label for="q20803:520_answer1">b. defective sheilding</label> </div>
<div class="r0"><input type="radio" name="q20803:520_answer" disabled="disabled" value="2" id="q20803:520_answer2"><label for="q20803:520_answer2">c. patient</label> </div>
<div class="r1"><input type="radio" name="q20803:520_answer" disabled="disabled" value="3" id="q20803:520_answer3"><label for="q20803:520_answer3">d. inadvertent exposure to the primary X-ray beam</label> </div>
<div class="r0"><input type="radio" name="q20803:520_answer" disabled="disabled" value="4" id="q20803:520_answer4"><label for="q20803:520_answer4">e. x-ray tube housing</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:520_-submit" name="q20803:520_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>For hospital personel and endovascular interventionalists, scatter radiation from the target (patient) represents the greatest source of x-ray exposure on a routine basis. While there is a small amount of radiation that is emmitted through the shielded x-ray tube, which is called leakage, it is very small compared to the radiation that is emitted from the patient when they are exposed to the primary x-ray beam.&nbsp; A portion of the radiation to which the patient is exposed is deflected in all directions; this is called primary scatter.&nbsp; It can interact with other objects and be deflected again, which is called secondary scatter.&nbsp; While extremely poor technique by&nbsp;an interventionalist leading to self-exposure to the primary beam could certainly cause substantial exposure, this is unusual.&nbsp; Shields are routinely monitered by radiation safety officers for defects.&nbsp; Natural background exposure typically represents minimal naturally occuring radiation to which we are all exposed.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics+1999%3B+19(4)%3A1037-55." target="_blank">Brateman L. Radiation safety considerations for diagnostic radiology personell. Radiographics 1999;19(4):1037-55. </a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53(1S)%3A22S-27S." target="_blank">Mitchell EL, Furey P. Prevention of radiation injury from medical imaging. J Vasc Surg 2011;53(1S):22S-27S. </a>&nbsp;</p>
<p>QID: 30924</p></div><div class="rightanswer">The correct answer is: patient</div></div></div></div></div><div id="q54" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">11</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_263"><input type="hidden" name="q20803:54_:flagged" value="0"><input type="hidden" value="qaid=910938&amp;qubaid=20803&amp;qid=4310&amp;slot=54&amp;checksum=50667fbcac1302b5658e339da337c1f2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:54_:flaggedcheckbox" name="q20803:54_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q54&id=4310"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:54_:sequencecheck" value="2"><div class="qtext"><p>A 55 year old man is undergoing open repair of a ruptured abdominal aortic aneurysm.&nbsp; Following opening of the aneurysm sac, there is noted to be severe, dark red bleeding from the right posterior aspect of the aorta, into the aneurysm sac.&nbsp; What is the next best step in management?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:54_answer" disabled="disabled" value="0" id="q20803:54_answer0"><label for="q20803:54_answer0">a. Vena cava moblization and ligation</label> </div>
<div class="r1"><input type="radio" name="q20803:54_answer" disabled="disabled" value="1" id="q20803:54_answer1"><label for="q20803:54_answer1">b. Circumferential control of the vena cava followed by excision of the diseased segment with interposition graft reconstruction</label> </div>
<div class="r0"><input type="radio" name="q20803:54_answer" disabled="disabled" value="2" id="q20803:54_answer2"><label for="q20803:54_answer2">c. Mobilization of the aneurysm followed by primary repair of the bleeding vessel</label> </div>
<div class="r1"><input type="radio" name="q20803:54_answer" disabled="disabled" value="3" id="q20803:54_answer3"><label for="q20803:54_answer3">d. Primary repair of the bleeding hole from within the aneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:54_answer" disabled="disabled" value="4" id="q20803:54_answer4"><label for="q20803:54_answer4">e. Aortic ligation followed by axillo-bifemoral bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:54_-submit" name="q20803:54_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The scenario presented is consistent with an aorto-caval arteriovenous fistula.&nbsp; It arises as a result of contained aneurysm rupture into the vena cava.&nbsp; No attempts should be made to mobilize the vena cava or other structures.&nbsp; Rather, the hole in the aortic wall should be fixed primarily from within the aneurysm.&nbsp; Temporary balloon control with a foley may be beneficial in select cases.&nbsp; If diagnosed prior to open exploration, endovascular repair has been reported with superior results.</p>
<p>Alexander JJ, Imbembo AL. Aorta-vena cava fistula. Surgery 1989; 105: 1-12.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/2643193">http://www.ncbi.nlm.nih.gov/pubmed/2643193</a></p>
<p>Schmidt R, Bruns C, Walter M, Erasmi H. Aorto-caval fistula - an uncommon complication of infrarenal aortic aneurysms. Thorac. Cardiovasc. Surg. 1994; 42: 208-11.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/7825158">http://www.ncbi.nlm.nih.gov/pubmed/7825158</a></p>
<p>Woolley DS, Spence RK. Aortocaval fistula treated by aortic exclusion. J. Vasc. Surg. 1995; 22: 639-42.</p>
<p>&nbsp;</p>
<p>&nbsp;QID: 30059</p></div><div class="rightanswer">The correct answer is: Primary repair of the bleeding hole from within the aneurysm</div></div></div></div></div><div id="q404" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">12</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_272"><input type="hidden" name="q20803:404_:flagged" value="0"><input type="hidden" value="qaid=911288&amp;qubaid=20803&amp;qid=4945&amp;slot=404&amp;checksum=576954b6b0571ce30e5546456496efa2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:404_:flaggedcheckbox" name="q20803:404_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q404&id=4945"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:404_:sequencecheck" value="2"><div class="qtext"><p>A 45-year-old woman complains of pelvic pain, heaviness in her left leg, dyspareunia, and varicose veins. Her symptoms have worsened over the past year and her gynecologic evaluation is normal. Duplex ultrasound revealed reflux in the great saphenous vein with a valve closure time of 2.5 seconds. A magnetic resonance venogram (MRV) was performed and is shown below. Which of the following is the most appropriate next step in the management of this patient?<br><br><a href="./VESAP3_files/AssetProxy_007.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_007.jpg" alt="img" width="100" height="100" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:404_answer" disabled="disabled" value="0" id="q20803:404_answer0"><label for="q20803:404_answer0">a. foam sclerotherapy of the great saphenous vein</label> </div>
<div class="r1"><input type="radio" name="q20803:404_answer" disabled="disabled" value="1" id="q20803:404_answer1"><label for="q20803:404_answer1">b. prescribe 20-30 mmHg compression stockings</label> </div>
<div class="r0"><input type="radio" name="q20803:404_answer" disabled="disabled" value="2" id="q20803:404_answer2"><label for="q20803:404_answer2">c. ligation and stripping of the great saphenous vein</label> </div>
<div class="r1"><input type="radio" name="q20803:404_answer" disabled="disabled" value="3" id="q20803:404_answer3"><label for="q20803:404_answer3">d. repeat ultrasound in 3 months to evaluate for progression</label> </div>
<div class="r0"><input type="radio" name="q20803:404_answer" disabled="disabled" value="4" id="q20803:404_answer4"><label for="q20803:404_answer4">e. left renal vein venography with left ovarian vein embolization</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:404_-submit" name="q20803:404_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The patient has a classic presentation for pelvic venous congestion syndrome, which is a pelvic venous disorder seen in females. Patient symptoms often include pelvic pain, pain occurring during sexual intercourse (dyspareunia), and, in some patients, leg heaviness. Varicose veins can also be associated and can be located in the extremity and vulvar region. The MRV demonstrates a large left ovarian vein, which is commonly the side affected. When this vein refluxes to the pelvic veins it causes congestion. Given that the patient has a central venous problem, treating only the varicose vein in the leg will not help her symptoms; it is imperative to address the pelvic venous pathology. The most important next step is venography with left ovarian vein embolization (see below venographic image demonstrating left ovarian vein reflux into the pelvic veins).<br><br><a href="./VESAP3_files/AssetProxy_006.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_006.jpg" alt="img" width="100" height="132" border="0" hspace="10" vspace="10"></a><br><br>Compression is important for patients with venous disease in the extremities. Repeat ultrasound will not be very useful in further assessment of this patient. Foam sclerotherapy or ligation and stripping of the great saphenous vein will not address the patient's central venous problem nor correct her pelvic congestion.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol%3B+2002%3B+13+(2+Part+1)%3A171-8." target="_blank">Venbrux AC, Chang AH, Kim HS, Montague BJ<span>,&nbsp;</span>Hebert JB<span>,&nbsp;</span>Arepally A<span>,&nbsp;</span>et al. Pelvic congestion syndrome (pelvic venous incompetence): Impact of ovarian and internal iliac vein embolotherapy on menstrual cycle and chronic pelvic pain. J Vasc Interv Radiol; 2002; 13 (2 Part 1):171-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cardiovasc+Intervent+Radiol%3B+2007%3B+30+(4)%3A655-61." target="_blank">Kwon SH, Oh JH, Ko KR, Park HC<span>,&nbsp;</span>Huh JY. Transcatheter ovarian vein embolization using coils for the treatment of pelvic congestion syndrome. Cardiovasc Intervent Radiol; 2007; 30 (4):655-61.</a></p>
<p>QID: 30722</p></div><div class="rightanswer">The correct answer is: left renal vein venography with left ovarian vein embolization</div></div></div></div></div><div id="q155" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">13</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_281"><input type="hidden" name="q20803:155_:flagged" value="0"><input type="hidden" value="qaid=911039&amp;qubaid=20803&amp;qid=4773&amp;slot=155&amp;checksum=aebbe6e97025f6bcc3cffa1e2f9c596c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:155_:flaggedcheckbox" name="q20803:155_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q155&id=4773"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:155_:sequencecheck" value="2"><div class="qtext"><p>A 52-year-old man is referred with swelling and discomfort in his right arm that is exacerbated by activity. It has been progressive for several years and is limiting his productivity. Venous duplex shows normal compression and augmentation throughout both upper extremities. Upper extremity venography with the arm in adduction is normal. Regarding this situation, which of the following statements is most accurate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:155_answer" disabled="disabled" value="0" id="q20803:155_answer0"><label for="q20803:155_answer0">a. venous plethysmography (1-second outflow fraction) with the arm in abduction is abnormal in patients likely to benefit from rib resection</label> </div>
<div class="r1"><input type="radio" name="q20803:155_answer" disabled="disabled" value="1" id="q20803:155_answer1"><label for="q20803:155_answer1">b. a normal venous duplex effectively eliminates a vascular etiology for the symptoms</label> </div>
<div class="r0"><input type="radio" name="q20803:155_answer" disabled="disabled" value="2" id="q20803:155_answer2"><label for="q20803:155_answer2">c. the presence of venous stenosis with the arm abducted is abnormal</label> </div>
<div class="r1"><input type="radio" name="q20803:155_answer" disabled="disabled" value="3" id="q20803:155_answer3"><label for="q20803:155_answer3">d. venous balloon dilation is the initial treatment of choice</label> </div>
<div class="r0"><input type="radio" name="q20803:155_answer" disabled="disabled" value="4" id="q20803:155_answer4"><label for="q20803:155_answer4">e. first rib resection is not indicated in the absence of thrombosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:155_-submit" name="q20803:155_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Most patients with venous thoracic outlet syndrome (TOS) present with acute thrombosis of the axillo-subclavian veins. However, up to 25% of venous TOS patients have symptoms of pain and swelling due to compression of the subclavian vein in the absence of thrombosis. &nbsp;Thrombosis is not a requirement for diagnosis or treatment. Diagnostic studies will often be normal with the arm in a neutral position and will show signs of venous outflow obstruction only with provocative abduction of the affected arm.&nbsp;It should be noted that the presence of venous stenosis with the arm abducted may be present in normal, asymptomatic patients and this finding in isolation is not an indication for treatment. Pathological venous compression is invariably associated with the development of collateral pathways. Positional venous outflow obstruction can also be detected with physiological tests, such as venous plethysmography.&nbsp;In non-thrombotic venous thoracic outlet syndrome, an abnormal 1-second venous outflow fraction measured with venous plethysmography with the arm in abduction may be predictive of symptomatic relief with first rib resection. &nbsp;As with Paget-Shroetter syndrome, the mainstay of treatment is decompression of the vein with first rib resection; adjuvant intervention can be performed on the subclavian vein as needed.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+15768011" target="_blank">Sanders RJ, Hammond SL. Subclavian vein obstruction without thrombosis. J Vasc Surg 2005; 41(2):285-90.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+20434295" target="_blank">Thakur S, Comerota AJ. Bilateral nonthrombotic subclavian vein obstruction causing upper extremity venous claudication. J Vasc Surg 2010; 52(1):208-11.</a></p>
<p>QID: 30249</p></div><div class="rightanswer">The correct answer is: venous plethysmography (1-second outflow fraction) with the arm in abduction is abnormal in patients likely to benefit from rib resection</div></div></div></div></div><div id="q377" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">14</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_290"><input type="hidden" name="q20803:377_:flagged" value="0"><input type="hidden" value="qaid=911261&amp;qubaid=20803&amp;qid=5107&amp;slot=377&amp;checksum=920dac06636782d6c122ba8e8db563cf&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:377_:flaggedcheckbox" name="q20803:377_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q377&id=5107"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:377_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old female smoker with a&nbsp;2-month&nbsp;history of post-prandial abdominal pain and weight loss presents to the emergency department with a&nbsp;4-hour history of constant, severe abdominal pain.&nbsp;Her abdominal exam is relatively benign and without peritoneal signs.&nbsp;Her white blood cell count is 18.9 K/uL and her serum lactate is 2 mmol/L.&nbsp;A lateral abdominal aortogram is obtained (image is shown below). Which of the following is the most likely cause of this patient’s acute mesenteric ischemia?</p>
<p><img src="./VESAP3_files/Rectenwald-5.jpg" alt="" width="650" height="647"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:377_answer" disabled="disabled" value="0" id="q20803:377_answer0"><label for="q20803:377_answer0">a. aortic dissection</label> </div>
<div class="r1"><input type="radio" name="q20803:377_answer" disabled="disabled" value="1" id="q20803:377_answer1"><label for="q20803:377_answer1">b. mesenteric venous thrombosis</label> </div>
<div class="r0"><input type="radio" name="q20803:377_answer" disabled="disabled" value="2" id="q20803:377_answer2"><label for="q20803:377_answer2">c. arterial thrombosis</label> </div>
<div class="r1"><input type="radio" name="q20803:377_answer" disabled="disabled" value="3" id="q20803:377_answer3"><label for="q20803:377_answer3">d. nonocclusive mesenteric ischemia</label> </div>
<div class="r0"><input type="radio" name="q20803:377_answer" disabled="disabled" value="4" id="q20803:377_answer4"><label for="q20803:377_answer4">e. arterial embolism</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:377_-submit" name="q20803:377_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Traditionally, arterial embolization was thought to be the most common cause of acute mesenteric ischemia. More&nbsp;recent data has suggested that arterial thrombosis is the most common cause in the contemporary period.&nbsp;In the current case, the antecedent history of post-prandial abdominal pain suggests a prior history of chronic mesenteric ischemia. Presently, the patient has constant abdominal pain, which suggests the patient has progressed to acute mesenteric ischemia. The lack of abdominal findings is common in the early stages of acute mesenteric ischemia. Only after there is frank bowel necrosis or perforation will local or generalized peritoneal signs develop. Leukocytosis is the most common laboratory finding. Lactic acidosis may develop over time, but it is often a relatively late finding that is not required for the diagnosis of acute mesenteric ischemia. The most common location for mesenteric arterial occlusive disease is at the origin of the mesenteric arteries. At arteriography, a lateral or oblique projections&nbsp;are necessary to visualize the origins of the mesenteric arteries since the origins will overlie the aorta on AP projections.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2012%3B55%3A1682-9." target="_blank">Ryer EJ, KalraM, Oderich GS, Duncan AA, Gloviczki P, Cha, S. et al. Revascularization for acute mesenteric ischemia.&nbsp; J Vasc Surg 2012;55:1682-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=A+comparison+of+endovascular+revascularization+with+traditional+therapy+for+the+treatment+of+acute+mesenteric+ischemia." target="_blank">Arthurs ZM, Titus J, Bannazadeh M, Eagleton MJ, Srivastava S, Sarac TP, et al.&nbsp; A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia.&nbsp; J Vasc Surg 2011;53:698-705.</a></p>
<p>QID: 30662</p></div><div class="rightanswer">The correct answer is: arterial thrombosis</div></div></div></div></div><div id="q369" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">15</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_299"><input type="hidden" name="q20803:369_:flagged" value="0"><input type="hidden" value="qaid=911253&amp;qubaid=20803&amp;qid=5115&amp;slot=369&amp;checksum=cc6b5d0d1e09862a65b446a4f449f602&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:369_:flaggedcheckbox" name="q20803:369_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q369&id=5115"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:369_:sequencecheck" value="2"><div class="qtext"><p><span>A 64-year-old man with a single functioning kidney and serum Cr of 2.6 mg/dL undergoes an MRA with gadolinium (image shown below). The patient returns to the clinic with joint stiffness in the elbows and skin darkening and itching. &nbsp;Which of the following is the next appropriate step in the management of this patient?</span></p>
<p><span><img src="./VESAP3_files/renal stenosis.jpg" alt="" width="380" height="409"></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:369_answer" disabled="disabled" value="0" id="q20803:369_answer0"><label for="q20803:369_answer0">a. <span>skin biopsy</span></label> </div>
<div class="r1"><input type="radio" name="q20803:369_answer" disabled="disabled" value="1" id="q20803:369_answer1"><label for="q20803:369_answer1">b. <span>hemodialysis</span></label> </div>
<div class="r0"><input type="radio" name="q20803:369_answer" disabled="disabled" value="2" id="q20803:369_answer2"><label for="q20803:369_answer2">c. <span>renal artery stenting</span></label> </div>
<div class="r1"><input type="radio" name="q20803:369_answer" disabled="disabled" value="3" id="q20803:369_answer3"><label for="q20803:369_answer3">d. <span>repeat MRA&nbsp;</span></label> </div>
<div class="r0"><input type="radio" name="q20803:369_answer" disabled="disabled" value="4" id="q20803:369_answer4"><label for="q20803:369_answer4">e. <span>renal artery bypass</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:369_-submit" name="q20803:369_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Nephrogenic systemic fibrosis (NSF) is a rare condition caused by gadolinium exposure in patients with renal dysfunction.&nbsp;The pathophysiology&nbsp;remains unclear.&nbsp;Patients present with skin darkening, skin fibrosis, joint contracture, and even internal organ fibrosis.&nbsp;Skin biopsy can confirm gadolinium in cutaneous specimens; however, there is no&nbsp;treatment that can reverse&nbsp;this condition. Avoiding gadolinium in patients with renal dysfunction appears to be critical to decreasing NSF incidence.&nbsp;The FDA has issued warnings against the use of gadolinium in patients with significant renal dysfunction.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+Radiol+2013%3B23%3A307-18." target="_blank">Thomsen HS, Morcos SK, Almén T, Bellin MF, Bertolotto M, Bongartz G, et al. Nephrogenic systemic fibrosis and gadolinium-based contrast media: updated ESUR Contrast Medium Safety Committee guidelines.&nbsp;Eur Radiol 2013;23:307-18.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+J+Am+Soc+Nephrol+2007%3B+2(2)%3A264-7." target="_blank">Deo A, Fogel M, Cowper SE. Nephrogenic systemic fibrosis: a population study examining the relationship of disease development to gadolinium exposure.&nbsp;Clin J Am Soc Nephrol 2007; 2(2):264-7.</a></p>
<p>QID: 30651</p></div><div class="rightanswer">The correct answer is: <span>skin biopsy</span></div></div></div></div></div><div id="q452" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">16</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_308"><input type="hidden" name="q20803:452_:flagged" value="0"><input type="hidden" value="qaid=911336&amp;qubaid=20803&amp;qid=5170&amp;slot=452&amp;checksum=b6a7c63707b064af7fec1a6c735cc463&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:452_:flaggedcheckbox" name="q20803:452_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q452&id=5170"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:452_:sequencecheck" value="2"><div class="qtext"><p>What are the pharmacologic effects of cilostazol?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:452_answer" disabled="disabled" value="0" id="q20803:452_answer0"><label for="q20803:452_answer0">a. plasminogen activation, with thrombolytic action in the microcirculation and vasodilatory effects</label> </div>
<div class="r1"><input type="radio" name="q20803:452_answer" disabled="disabled" value="1" id="q20803:452_answer1"><label for="q20803:452_answer1">b. inhibition of ADP receptors, with antiplatelet and vasodilatory effects</label> </div>
<div class="r0"><input type="radio" name="q20803:452_answer" disabled="disabled" value="2" id="q20803:452_answer2"><label for="q20803:452_answer2">c. inhibition of IIb/IIIa receptors, with antiplatelet and vasodilatory effects</label> </div>
<div class="r1"><input type="radio" name="q20803:452_answer" disabled="disabled" value="3" id="q20803:452_answer3"><label for="q20803:452_answer3">d. inhibition of factor Xa, with inhibition of thrombosis in the microcirculation and vasodilatory effects</label> </div>
<div class="r0"><input type="radio" name="q20803:452_answer" disabled="disabled" value="4" id="q20803:452_answer4"><label for="q20803:452_answer4">e. inhibition of phosphodiesterase type 3, with antiplatelet and vasodilatory effects</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:452_-submit" name="q20803:452_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Cilostazol and pentoxifylline are the only two medications approved by the FDA for the treatment of intermittent claudication.</p>
<p>Cilostazol is a phosphodiesterase type 3 inhibitor that has antiplatelet and vasodilatory effects. Multiple placebo-controlled clinical trials&nbsp;demonstrated&nbsp;increases in walking distance in patients with intermittent claudication treated with cilostazol, but the studies did not&nbsp;correlate a known mechanism of action of the drug to the functional and quality-of-life benefits observed in the trials.</p>
<p>Cilostazol is considered first line pharmacologic therapy in the treatment of intermittent claudication. In contrast, studies evaluating pentoxifylline have not consistently demonstrated improvements in walking distance in patients with intermittent claudication and in a direct comparison with cilostazol, pentoxifylline was not found to have&nbsp;benefit.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Dobesh%20PP,%20Stacy%20ZA,%20Persson%20EL.%20Pharmacologic%20therapy%20for%20intermittent%20claudication.%20Pharmacotherapy;%202009;%2029%20(5):526-553" target="_blank">Dobesh PP, Stacy ZA, Persson EL. Pharmacologic therapy for intermittent claudication. Pharmacotherapy; 2009; 29 (5):526-553.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/18254032" target="_blank">Robless P Mikhailidis DP, Stansby GP. Cilostazol for peripheral arterial disease. Cochrane Database of Systemat Rev 2008; (1):CD003748.</a></p>
<p>QID: 30810</p></div><div class="rightanswer">The correct answer is: inhibition of phosphodiesterase type 3, with antiplatelet and vasodilatory effects</div></div></div></div></div><div id="q244" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">17</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_317"><input type="hidden" name="q20803:244_:flagged" value="0"><input type="hidden" value="qaid=911128&amp;qubaid=20803&amp;qid=4976&amp;slot=244&amp;checksum=3db9e51d9a4f195ea06dccf408a3b43e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:244_:flaggedcheckbox" name="q20803:244_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q244&id=4976"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:244_:sequencecheck" value="2"><div class="qtext"><p>A diagnosis of arterial steal with ischemic pain but no digital breakdown has been established in a 51-year-old diabetic man on hemodialysis. He has a functioning brachio-axillary graft in his non-dominant arm and no useable autogenous vein. Which of the following options is the <strong>least</strong> optimal next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:244_answer" disabled="disabled" value="0" id="q20803:244_answer0"><label for="q20803:244_answer0">a. <p>proximalization of the graft with a PTFE graft from the axillary artery and ligation of the current graft&nbsp; arterial anastomosis</p></label> </div>
<div class="r1"><input type="radio" name="q20803:244_answer" disabled="disabled" value="1" id="q20803:244_answer1"><label for="q20803:244_answer1">b. conversion to peritoneal dialysis with ligation of the graft</label> </div>
<div class="r0"><input type="radio" name="q20803:244_answer" disabled="disabled" value="2" id="q20803:244_answer2"><label for="q20803:244_answer2">c. brachial artery ligation below the anastomosis, with saphenous vein bypass from the axillary to distal brachial artery</label> </div>
<div class="r1"><input type="radio" name="q20803:244_answer" disabled="disabled" value="3" id="q20803:244_answer3"><label for="q20803:244_answer3">d. ligation of the graft with placement of a graft in the dominant arm</label> </div>
<div class="r0"><input type="radio" name="q20803:244_answer" disabled="disabled" value="4" id="q20803:244_answer4"><label for="q20803:244_answer4">e. banding of the graft near the arterial anastomosis guided by digital plethysmography</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:244_-submit" name="q20803:244_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The case presented is a patient with arterial steal without breakdown. While distal revascularization and interval ligation (DRIL) is widely accepted as a reliable access-salvaging method for such patients, other approaches have been successful in patients with steal who do not have tissue breakdown, such as banding and proximalization. Ligation of the access is a reasonable and definitive option if peritoneal dialysis is feasible. Ligation and placement of a similar access in the contralateral extremity would be the least attractive option here, as the likelihood of steal developing on the contralateral side is significant, with potential persistant functional compromise of both upper extremities.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1988%3B+7%3A770%E2%80%933." target="_blank">Schanzer H, Schwartz M, Harrington E, Haimov M. Treatment of ischemia due to “steal” by arteriovenous fistula with distal artery ligation and revascularization. J Vasc Surg&nbsp;1988; 7:770–3.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc.+Surg++2011%3B+54%3A554-82." target="_blank">Jennings, WC, Brown RE, Ruiz C. Primary arteriovenous fistula inflow proximalization for patients at high risk for dialysis access-associated ischemic steal syndrome. J Vasc. Surg&nbsp; 2011; 54:554-82.&nbsp;&nbsp;</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+57+Using+distal" target="_blank">Aimaq R, Katz SG. Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation. J Vasc Surg 2013; 57:1073-83.&nbsp;&nbsp;</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc.+Surg+2007%3B+20%3A184-8" target="_blank">Suding PN, Wilson SE. Strategies for management of ischemic steal syndrome.&nbsp; Semin Vasc Surg 2007; 20:184-8</a>.</p>
<p>QID: 30426</p></div><div class="rightanswer">The correct answer is: ligation of the graft with placement of a graft in the dominant arm</div></div></div></div></div><div id="q25" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">18</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_326"><input type="hidden" name="q20803:25_:flagged" value="0"><input type="hidden" value="qaid=910909&amp;qubaid=20803&amp;qid=4635&amp;slot=25&amp;checksum=8a0f0c2ae468d41c1e5dfe990f4a6540&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:25_:flaggedcheckbox" name="q20803:25_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q25&id=4635"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:25_:sequencecheck" value="2"><div class="qtext"><p>Following endovascular repair of an abdominal aortic aneurysm, a 63-year-old&nbsp;woman is found to have a gangrenous left colon during emergent re-operative exploration for abdominal pain, distension, and bloody diarrhea. Which&nbsp;of the following is the&nbsp;most appropriate&nbsp;management option&nbsp;for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:25_answer" disabled="disabled" value="0" id="q20803:25_answer0"><label for="q20803:25_answer0">a. colectomy and end colostomy</label> </div>
<div class="r1"><input type="radio" name="q20803:25_answer" disabled="disabled" value="1" id="q20803:25_answer1"><label for="q20803:25_answer1">b. bypass graft to inferior mesenteric artery (IMA)</label> </div>
<div class="r0"><input type="radio" name="q20803:25_answer" disabled="disabled" value="2" id="q20803:25_answer2"><label for="q20803:25_answer2">c. colectomy and primary bowel anastomosis</label> </div>
<div class="r1"><input type="radio" name="q20803:25_answer" disabled="disabled" value="3" id="q20803:25_answer3"><label for="q20803:25_answer3">d. endarterectomy and patch angioplasty of the IMA</label> </div>
<div class="r0"><input type="radio" name="q20803:25_answer" disabled="disabled" value="4" id="q20803:25_answer4"><label for="q20803:25_answer4">e. reimplantation of the IMA into the graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:25_-submit" name="q20803:25_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Though no large, multi-center randomized trials or meta-analysis are available to investigate this topic, it remains an important message. Whereas attempts at revascularization or ensuring antegrade flow to the colon would be appropriate at the time of initial surgery to avoid the onset of ischemic colitis or for chronic ischemia, once the development of acute ischemic changes occur these maneuvers should be avoided. While colectomy with primary bowel anastomosis is possible, in the setting of an emergent takeback and resultant high mortality&nbsp;like&nbsp;this clinical scenario, the most appropriate management would be a colectomy of the ischemic segment of colon and end stoma.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Schneider%20DB,%20Nelken%20NA,%20Messina%20LM,%20et%20al.%20Isolated%20inferior%20mesenteric%20artery%20revascularization%20for%20chronic%20visceral%20ischemia.%20J%20Vasc%20Surg;%201999;%2030%20(1):51-58" target="_blank">Schneider DB, Nelken NA, Messina LM, Ehrenfeld WK. Isolated inferior mesenteric artery revascularization for chronic visceral ischemia. J Vasc Surg 1999; 30 (1):51-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Rapp%20JH,%20Reilly%20LM,%20Qvarfordt%20PG,%20et%20al.%20Durability%20of%20endarterectomy%20and%20antegrade%20grafts%20in%20the%20treatment%20of%20chronic%20visceral%20ischemia.%20J%20Vasc%20Surg;%201986;%203%20(5):799-806" target="_blank">Rapp JH, Reilly LM, Qvarfordt PG, Goldstone J, Ehrenfeld WK, Stoney RJ. Durability of endarterectomy and antegrade grafts in the treatment of chronic visceral ischemia. J Vasc Surg 1986; 3 (5):799-806.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Van%20Vroonhoven%20TJ,%20Verhagen%20HJ,%20Broker%20WF,%20et%20al.%20Transmural%20ischaemic%20colitis%20following%20operation%20for%20ruptured%20abdominal%20aortic%20aneurysm.%20Neth%20J%20Surg;%201991;%2043%20(3):56-59" target="_blank">Van Vroonhoven TJ, Verhagen HJ, Broker WF, Janssen IM. Transmural ischaemic colitis following operation for ruptured abdominal aortic aneurysm. Neth J Surg 1991; 43 (3):56-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Longo%20WE,%20Ward%20D,%20Vernava%20AM%20III,%20et%20al.%20Outcome%20of%20patients%20with%20total%20colonic%20ischemia.%20Dis%20Colon%20Rectum;%201996;%2039%20(1):88-100" target="_blank">Longo WE, Ward D, Vernava AM III, Kaminski DL. Outcome of patients with total colonic ischemia. Dis Colon Rectum 1996; 39 (1):88-100.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Valentine%20RJ,%20Hagino%20RT,%20Jackson%20MR,%20et%20al.%20Gastrointestinal%20complications%20after%20aortic%20surgery.%20J%20Vasc%20Surg;%201998;%2028%20(3):404-411" target="_blank">Valentine RJ, Hagino RT, Jackson MR, Kakish HB, Bengtson TD, Glagett GP. Gastrointestinal complications after aortic surgery. J Vasc Surg 1998; 28 (3):404-11.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Antolovic%20D,%20Koch%20M,%20Hinz%20U,%20et%20al.%20Ischemic%20colitis:%20Analysis%20of%20risk%20factors%20for%20postoperative%20mortality.%20Langenbecks%20Arch%20Surg;%202008;%20393%20(4):507-512" target="_blank">Antolovic D, Koch M, Hinz U, Schottler D, Schmidt T, Heger U, et al. Ischemic colitis: Analysis of risk factors for postoperative mortality. Langenbecks Arch Surg 2008; 393 (4):507-12.</a></p>
<p>QID: 30027</p></div><div class="rightanswer">The correct answer is: colectomy and end colostomy</div></div></div></div></div><div id="q378" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">19</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_335"><input type="hidden" name="q20803:378_:flagged" value="0"><input type="hidden" value="qaid=911262&amp;qubaid=20803&amp;qid=5106&amp;slot=378&amp;checksum=35a3746654db8b7ee42eb5961a17c9cc&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:378_:flaggedcheckbox" name="q20803:378_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q378&id=5106"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:378_:sequencecheck" value="2"><div class="qtext"><p>When performing an angiogram for suspected chronic mesenteric ischemia, which of the following arteriographic findings is most consistent with that diagnosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:378_answer" disabled="disabled" value="0" id="q20803:378_answer0"><label for="q20803:378_answer0">a. dissection of the proximal superior mesenteric artery</label> </div>
<div class="r1"><input type="radio" name="q20803:378_answer" disabled="disabled" value="1" id="q20803:378_answer1"><label for="q20803:378_answer1">b. non-visualization of&nbsp;mesenteric arterial occlusive disease without selective catheterization</label> </div>
<div class="r0"><input type="radio" name="q20803:378_answer" disabled="disabled" value="2" id="q20803:378_answer2"><label for="q20803:378_answer2">c. distal tapering of the superior mesenteric artery on AP aortogram</label> </div>
<div class="r1"><input type="radio" name="q20803:378_answer" disabled="disabled" value="3" id="q20803:378_answer3"><label for="q20803:378_answer3">d. absence of mesenteric collaterals</label> </div>
<div class="r0"><input type="radio" name="q20803:378_answer" disabled="disabled" value="4" id="q20803:378_answer4"><label for="q20803:378_answer4">e. stenosis or occlusion&nbsp;at the origin of multiple mesenteric arteries on lateral aortogram</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:378_-submit" name="q20803:378_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Although computed tomographic imaging is generally felt to be more useful in acute mesenteric ischemia, traditional catheter based angiography has remained the gold standard for the diagnosis of chronic mesenteric ischemia. Arteriography&nbsp;is essential for both diagnosis and operative planning.&nbsp;Mesenteric arterial disease represents&nbsp;"aortic spillover disease," which explains the&nbsp;frequency of disease at the&nbsp;origins of the celiac and superior mesenteric arteries. Because of this, selective catheterization of the mesenteric vessel is rarely needed to make the diagnosis.&nbsp;Angiographic evidence of disease within the distal vasculature generally suggests a nonatherosclerotic disease process such as nonocclusive mesenteric ischemia or cocaine/ergot ingestion.&nbsp;Given the orientation of the origins of the celiac and superior mesenteric arteries relative to the aorta, a “cross-table” or lateral aortogram is considered an essential view for the diagnosis of mesenteric disease (Fig. 1).&nbsp;The AP view can be useful for visualizing key collaterals that confirm the presence of a proximal mesenteric stenosis, such the Arc of Riolan and the Marginal Artery of Drummond (Fig. 2).</p>
<p><img src="./VESAP3_files/Rectenwald-6 (Figure 1 for Discussion).jpg" alt="" width="270" height="288"></p>
<p><img src="./VESAP3_files/Rectenwald-6 (Figure 2 for Discussion).jpg" alt="" width="559" height="419"></p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Huber TS, Lee WA.&nbsp; Mesenteric Vascular Disease: Chronic Ischemia. Chapter 148 in Rutherford’s Vascular Surgery. 7<sup>th</sup> Edition. Eds: Cronenwett and Johnston. Saunder Elsevier, Philadelphia, PA. 2010.</p>
<p>QID: 30664</p></div><div class="rightanswer">The correct answer is: stenosis or occlusion&nbsp;at the origin of multiple mesenteric arteries on lateral aortogram</div></div></div></div></div><div id="q531" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">20</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_344"><input type="hidden" name="q20803:531_:flagged" value="0"><input type="hidden" value="qaid=911415&amp;qubaid=20803&amp;qid=5267&amp;slot=531&amp;checksum=cd5a9f3c9bdf5535dc1a3a46a056c0b7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:531_:flaggedcheckbox" name="q20803:531_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q531&id=5267"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:531_:sequencecheck" value="2"><div class="qtext"><p>Direct fluoroscopy can deliver high doses of radiation during a single procedure. A standard chest radiograph can deliver 0.02 R. How much radiation would be delivered in 30 minutes of fluoroscopy time?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:531_answer" disabled="disabled" value="0" id="q20803:531_answer0"><label for="q20803:531_answer0">a. 1000-1500 R</label> </div>
<div class="r1"><input type="radio" name="q20803:531_answer" disabled="disabled" value="1" id="q20803:531_answer1"><label for="q20803:531_answer1">b. 2 - 5 R</label> </div>
<div class="r0"><input type="radio" name="q20803:531_answer" disabled="disabled" value="2" id="q20803:531_answer2"><label for="q20803:531_answer2">c. 3000-3600 R</label> </div>
<div class="r1"><input type="radio" name="q20803:531_answer" disabled="disabled" value="3" id="q20803:531_answer3"><label for="q20803:531_answer3">d. 15 - 30 R</label> </div>
<div class="r0"><input type="radio" name="q20803:531_answer" disabled="disabled" value="4" id="q20803:531_answer4"><label for="q20803:531_answer4">e. 60 - 600 R</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:531_-submit" name="q20803:531_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In fluoroscopy the rate of radiation delivered to the skin entrance generally ranges from 2 to 20 R/min. Therefore, 30 minutes of fluoroscopy can deliver 60 to 600 R of entrance skin exposure. &nbsp;One minute of fluoroscopy is therefore equivalent to 100 to 1000 chest radiographs.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<div class="column">
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2003%3B14%3A+977-90." target="_blank">Miller DL, Balter S, Cole PE, Lu HT, Berenstein A, Albert R, et al. Radiation doses in interventional radiology procedures: the RAD-IR study: part II: skin dose. J Vasc Interv Radiol 2003;14: 977-90. </a></p>
<p>Committee to Assess Health Risks from Exposure to Low Levels of Ionizing Radiation NRC. Health risks from exposure to low levels of ionizing radiation: BEIR VII Phase 2. Washington, DC: National Academies Press; 2006.&nbsp;</p>
<p>QID: 30935</p>
</div></div><div class="rightanswer">The correct answer is: 60 - 600 R</div></div></div></div></div><div id="q455" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">21</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_353"><input type="hidden" name="q20803:455_:flagged" value="0"><input type="hidden" value="qaid=911339&amp;qubaid=20803&amp;qid=5173&amp;slot=455&amp;checksum=f8fe84c9fc68b008401bc3fb344eb418&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:455_:flaggedcheckbox" name="q20803:455_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q455&id=5173"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:455_:sequencecheck" value="2"><div class="qtext"><p>Laboratory monitoring of anticoagulation is essential to ensure therapeutic efficacy and to minimize the risk of bleeding complications. Which of the following anticoagulants is correctly paired with its monitoring laboratory test?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:455_answer" disabled="disabled" value="0" id="q20803:455_answer0"><label for="q20803:455_answer0">a. warfarin - Activated Partial Thromboplastin Time</label> </div>
<div class="r1"><input type="radio" name="q20803:455_answer" disabled="disabled" value="1" id="q20803:455_answer1"><label for="q20803:455_answer1">b. heparin - International Normalized Ratio</label> </div>
<div class="r0"><input type="radio" name="q20803:455_answer" disabled="disabled" value="2" id="q20803:455_answer2"><label for="q20803:455_answer2">c. fondaparinux - Bleeding Time</label> </div>
<div class="r1"><input type="radio" name="q20803:455_answer" disabled="disabled" value="3" id="q20803:455_answer3"><label for="q20803:455_answer3">d. dalteparin - Anti-Factor Xa Level</label> </div>
<div class="r0"><input type="radio" name="q20803:455_answer" disabled="disabled" value="4" id="q20803:455_answer4"><label for="q20803:455_answer4">e. bivalirudin - Fibrinogen Level</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:455_-submit" name="q20803:455_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Dalteparin is a low molecular weight heparin anticoagulant. Laboratory monitoring of low molecular weight heparin therapy is usually not necessary. However, in certain clinical situations, such as morbid obesity and renal failure, the dose can be difficult to determine. The chromogenic anti-Xa level assay is the anticoagulation monitoring laboratory test recommended by the College of American Pathologists. Bivalirudin is a direct thrombin inhibitor. When used clinically, the activated clotting time (ACT) is useful in monitoring its anticoagulant effects. Heparin anticoagulation is monitored by measurement of the activated partial thromboplastin time (APTT) that is sensitive to the inhibitory effects of heparin on thrombin, factor Xa, and factor IXa. Fondaparinux is a direct factor Xa inhibitor anticoagulant. There is no recommended standard monitoring test available. Warfarin is an orally active vitamin K antagonist anticoagulant. Laboratory monitoring of warfarin anticoagulation is via prothrombin time (PT) or International Normalized Ratio (INR).<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest+2001%3B+119+(1+Suppl)%3A64S-94S." target="_blank">Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS,&nbsp;Halperin JL,&nbsp;Raschke R,&nbsp;et al. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119 (1 Suppl):64S-94S.</a></p>
<p>QID: 30813</p></div><div class="rightanswer">The correct answer is: dalteparin - Anti-Factor Xa Level</div></div></div></div></div><div id="q62" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">22</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_362"><input type="hidden" name="q20803:62_:flagged" value="0"><input type="hidden" value="qaid=910946&amp;qubaid=20803&amp;qid=4657&amp;slot=62&amp;checksum=73d1e92669fdc0c73d638e9def0c025e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:62_:flaggedcheckbox" name="q20803:62_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q62&id=4657"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:62_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old woman develops back pain and hypotension immediately following placement of a balloon expandable bare metal stent in her left common iliac artery. Extravasation of contrast is visible on retrograde injection of the access sheath. Which of the following is the appropriate first step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:62_answer" disabled="disabled" value="0" id="q20803:62_answer0"><label for="q20803:62_answer0">a. reversal of anticoagulation</label> </div>
<div class="r1"><input type="radio" name="q20803:62_answer" disabled="disabled" value="1" id="q20803:62_answer1"><label for="q20803:62_answer1">b. open retroperitoneal repair the artery</label> </div>
<div class="r0"><input type="radio" name="q20803:62_answer" disabled="disabled" value="2" id="q20803:62_answer2"><label for="q20803:62_answer2">c. administration of blood products</label> </div>
<div class="r1"><input type="radio" name="q20803:62_answer" disabled="disabled" value="3" id="q20803:62_answer3"><label for="q20803:62_answer3">d. re-inflation of the angioplasty balloon</label> </div>
<div class="r0"><input type="radio" name="q20803:62_answer" disabled="disabled" value="4" id="q20803:62_answer4"><label for="q20803:62_answer4">e. placement of a covered stent</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:62_-submit" name="q20803:62_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Iliac artery percutaneous transluminal angioplasty is associated with a less than 1% risk of vessel rupture. This risk is increased in patients who have highly calcified or occluded vessels, along with the use of oversized balloons or recent intervention on the artery. Patients with a past medical history of diabetes or steroid use are also at particular risk. Patients who develop rupture of the iliac artery should have immediate balloon tamponade with reversal of anticoagulation. A covered stent should be placed if possible.</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Allaire+E%2C+Melliere+D%2C+Poussier+B%2C+et+al.+Iliac+artery+rupture+during+balloon+dilatation%3A+what+treatment%3F+Ann+Vasc+Surg.+2003%3B17%3A306-314." target="_blank">Allaire E, Melliere D<span>,&nbsp;</span>Poussier B<span>,&nbsp;</span>Kobeiter H<span>,&nbsp;</span>Desgranges P<span>,&nbsp;</span>Becquemin JP<span>.</span>&nbsp;Iliac artery rupture during balloon dilatation: what treatment? Ann Vasc Surg 2003;17:306-14.</a></p>
<p><a href="http://evtoday.com/2005/05/EVT0505_F9_Ahamed.html/" target="_blank">Ahmed H,&nbsp; Nanjundappa A, Laird JR.&nbsp; Complications After Iliac Artery Interventions.&nbsp; Endovascular Today, May 2005.</a></p>
<p>QID: 30072</p></div><div class="rightanswer">The correct answer is: re-inflation of the angioplasty balloon</div></div></div></div></div><div id="q180" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">23</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_371"><input type="hidden" name="q20803:180_:flagged" value="0"><input type="hidden" value="qaid=911064&amp;qubaid=20803&amp;qid=4685&amp;slot=180&amp;checksum=613bd060f34e3ae22c1d70c3252e56dd&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:180_:flaggedcheckbox" name="q20803:180_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q180&id=4685"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:180_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old man presents with a 1-week history of 2 episodes of right arm weakness lasting 30 minutes with complete recovery. Carotid duplex demonstrates a 70% stenosis of the left internal carotid artery. With regards to men with high-grade symptomatic carotid stenosis, which of the following statements is true?&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:180_answer" disabled="disabled" value="0" id="q20803:180_answer0"><label for="q20803:180_answer0">a. risk of any stroke or death at 2 years with medical management is 11%</label> </div>
<div class="r1"><input type="radio" name="q20803:180_answer" disabled="disabled" value="1" id="q20803:180_answer1"><label for="q20803:180_answer1">b. risk of any stroke or death at 5 years with carotid endarterectomy is greater than 50%</label> </div>
<div class="r0"><input type="radio" name="q20803:180_answer" disabled="disabled" value="2" id="q20803:180_answer2"><label for="q20803:180_answer2">c. risk of stroke or death is independent of treatment strategy</label> </div>
<div class="r1"><input type="radio" name="q20803:180_answer" disabled="disabled" value="3" id="q20803:180_answer3"><label for="q20803:180_answer3">d. risk of ipsilateral stroke at 2 years with carotid endarterectomy is less than 2%</label> </div>
<div class="r0"><input type="radio" name="q20803:180_answer" disabled="disabled" value="4" id="q20803:180_answer4"><label for="q20803:180_answer4">e. risk of ipsilateral stroke at 2 years with medical management is 26%</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:180_-submit" name="q20803:180_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The North American Symptomatic Carotid Endarterectomy Trial (NASCET) randomized 659 patients with symptomatic carotid stenosis &gt; 70% into a medical treatment (aspirin, blood pressure control) arm and a surgical (carotid endarterectomy) arm. The risk for ipsilateral stroke at 2 years with medical management was 26% and the risk for any stroke or death was 32%. For carotid endarterectomy, the risk for ipsilateral stroke was 9% at 2 years.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=north+american+symptomatic+carotid+endarterectomy+trial+collaborators%2C+1991" target="_blank">North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325 (7):445-53. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=north+american+symptomatic+carotid+endarterectomy+trial+collaborators%2C+1991"><br></a></p>
<p>QID: 30323</p></div><div class="rightanswer">The correct answer is: risk of ipsilateral stroke at 2 years with medical management is 26%</div></div></div></div></div><div id="q379" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">24</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_380"><input type="hidden" name="q20803:379_:flagged" value="0"><input type="hidden" value="qaid=911263&amp;qubaid=20803&amp;qid=5117&amp;slot=379&amp;checksum=3b9440786f7c70805bc8dff533f1b8a4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:379_:flaggedcheckbox" name="q20803:379_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q379&id=5117"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:379_:sequencecheck" value="2"><div class="qtext"><p>A 38-year-old man admitted to the medical intensive care unit for acute heart failure and cardiac arrhythmias from viral myocarditis develops diffuse, severe abdominal pain out of proportion to&nbsp;abdominal exam findings.&nbsp;The serum lactate is elevated.&nbsp;A current left ventricular ejection fraction is &lt; 15% despite inotropes.&nbsp;He has palpable femoral pulses.&nbsp;The patient is presumed to have&nbsp;nonocclusive mesenteric ischemia (NOMI). Which of the following is the most appropriate first&nbsp;step in the management of this patient?</p>
<p><img src="./VESAP3_files/Rectenwald-7.jpg" alt="" width="549" height="548"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:379_answer" disabled="disabled" value="0" id="q20803:379_answer0"><label for="q20803:379_answer0">a. initiate systemic intravenous thrombolysis</label> </div>
<div class="r1"><input type="radio" name="q20803:379_answer" disabled="disabled" value="1" id="q20803:379_answer1"><label for="q20803:379_answer1">b. wean vasopressors</label> </div>
<div class="r0"><input type="radio" name="q20803:379_answer" disabled="disabled" value="2" id="q20803:379_answer2"><label for="q20803:379_answer2">c. mesenteric arteriogram with selective catheter infusion of papaverine</label> </div>
<div class="r1"><input type="radio" name="q20803:379_answer" disabled="disabled" value="3" id="q20803:379_answer3"><label for="q20803:379_answer3">d. balloon angioplasty of the superior mesenteric artery origin</label> </div>
<div class="r0"><input type="radio" name="q20803:379_answer" disabled="disabled" value="4" id="q20803:379_answer4"><label for="q20803:379_answer4">e. exploratory laparotomy with bowel resection</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:379_-submit" name="q20803:379_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Nonocclusive mesenteric ischemia (NOMI) may be difficult to distinguish from thromboembolic occlusion of the mesenteric vasculature without mesenteric angiography.&nbsp;The typical patient is critically ill, with&nbsp;severe cardiac disease or sepsis and requires inotropic support.&nbsp;Fatal NOMI has been associated with severe cardiac failure (Odds Ratio&nbsp;2.9), a history of atrial fibrillation (Odds Ratio&nbsp;2.2), and recent surgery (Odds Ratio 3.4).&nbsp;Treatment of NOMI first involves a careful review of the patient’s history and current medications.&nbsp;Any recent use of cocaine or ergots should be noted, as these may be inciting agents whose effects diminish over time after discontinuation. Optimization of cardiac function and avoiding vasopressor agents is recommended.&nbsp;Failure to improve with best medical treatment is an indication to proceed with &nbsp;mesenteric angiography for confirmation of NOMI and initiation of catheter-based vasodilators such as papaverine, nigroglycerine, or glucagon.&nbsp;Administration of broad spectrum antibiotics is appropriate.&nbsp; Although many patients with NOMI do indeed have associated proximal mesenteric artery stenosis, balloon angioplasty of these vessels to treat vasospasm is not recommended.&nbsp;Laparotomy with bowel resection is reserved for patients with NOMI who have necrotic bowel or signs of perforation.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sem+Vasc+Surg+2010%3B23%3A54-64." target="_blank">Bjorck M, Wanhainen A. Nonocclusive mesenteric hypoperfusion syndromes: recognition and treatment.&nbsp; Sem Vasc Surg 2010;23:54-64.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sem+Vasc+Surg+2010%3B+23%3A4-8." target="_blank">Acosta S. Epidemiology of mesenteric vascular disease: clinical implications. Sem Vasc Surg 2010; 23:4-8.</a></p>
<p>QID: 30665</p></div><div class="rightanswer">The correct answer is: wean vasopressors</div></div></div></div></div><div id="q293" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">25</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_389"><input type="hidden" name="q20803:293_:flagged" value="0"><input type="hidden" value="qaid=911177&amp;qubaid=20803&amp;qid=5032&amp;slot=293&amp;checksum=de775f5ed060e306812407d30f690915&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:293_:flaggedcheckbox" name="q20803:293_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q293&id=5032"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:293_:sequencecheck" value="2"><div class="qtext"><p>A&nbsp;56-year-old man with an elevated creatinine and hypertension refractory to a 4-medication anti-hypertensive regimen is referred to you for evaluation of renovascular hypertension. A renal&nbsp;duplex ultrasound is performed and reveals findings&nbsp;consistent with a greater than 60% right renal artery stenosis. Which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:293_answer" disabled="disabled" value="0" id="q20803:293_answer0"><label for="q20803:293_answer0">a. CT angiography and duplex ultrasound have comparable diagnostic accuracy for renal artery stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:293_answer" disabled="disabled" value="1" id="q20803:293_answer1"><label for="q20803:293_answer1">b. duplex ultrasound is more accurate than CT angiography in patients with calcified atherosclerotic plaque within the renal arteries</label> </div>
<div class="r0"><input type="radio" name="q20803:293_answer" disabled="disabled" value="2" id="q20803:293_answer2"><label for="q20803:293_answer2">c. duplex ultrasound is accurate for predicting a stenosis in the renal arteries at levels of 50% and 80%</label> </div>
<div class="r1"><input type="radio" name="q20803:293_answer" disabled="disabled" value="3" id="q20803:293_answer3"><label for="q20803:293_answer3">d. CT angiogram is not useful for determining fibromuscular dysplasia within renal arteries</label> </div>
<div class="r0"><input type="radio" name="q20803:293_answer" disabled="disabled" value="4" id="q20803:293_answer4"><label for="q20803:293_answer4">e. CT angiography is poor for the evaluation of renal artery stenosis due to the small size of the renal arteries</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:293_-submit" name="q20803:293_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The reported accuracy for duplex ultrasound scanning for predicting renal artery stenosis is based on accuracy of predicting a &gt; 60% stenosis or occlusion of the renal artery. Accuracy of duplex scanning for that degree of stenosis is in the 85-98% range, and is dependent on both user experience and the duplex criteria utilized. Calcification of the renal arteries makes evaluation more difficult if a window through the plaque cannot be found; it decreases the accuracy of the study. In multiple studies, CTA has been shown to have a diagnostic accuracy that is equivalent to duplex ultrasound scanning by using modern spiral CTA and multi-detector CTA. Some studies even suggest CTA (and MR angiogram) are superior to renal duplex scanning, though often with a comparison using a vascular laboratory that has an accuracy below the standard 85%.<br><br>Criteria for &gt;60% renal artery (RA) stenosis include RA peak systolic velocity (PSV) 180-200cm/sec or post-stenotic turbulance and renal aortic ratio (RAR) (highest RA PSV/aorta PSV greater or equal to 3.5).</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1986%3B+4+(5)%3A450-6." target="_blank">Kohler TR, Zierler RE, Martin RL, Nicholls SC<span>,&nbsp;</span>Bergelin RO<span>,&nbsp;</span>Kazmers A<span>,&nbsp;</span>et al. Noninvasive diagnosis of renal artery stenosis by ultrasonic duplex scanning. J Vasc Surg 1986; 4 (5):450-6.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1988%3B+7+(2)%3A363-9." target="_blank">Taylor DC, Kettler MD, Moneta GL, Kohler TR,&nbsp;Kazmers A,&nbsp;Beach KW,&nbsp;et al. Duplex ultrasound scanning in the diagnosis of renal artery stenosis: A prospective evaluation. J Vasc Surg 1988; 7 (2):363-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1990%3B+12+(3)%3A227-36." target="_blank">Hansen KJ, Tribble RW, Reavis SW, Canzanello VJ,&nbsp;Craven TE,&nbsp;Plonk GW Jr,&nbsp;et al. Renal duplex sonography: Evaluation of clinical utility. J Vasc Surg 1990; 12 (3):227-36.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology+1997%3B+205+(1)%3A121-7." target="_blank">Kaatee R, Beek FJ, de Lange EE, van Leeuwen MS,&nbsp;Smits HF,&nbsp;van der Ven PJ,&nbsp;et al. Renal artery stenosis: Detection and quantification with spiral CT angiography versus optimized digital subtraction angiography. Radiology 1997; 205 (1):121-7.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Acta+Radiol+2006%3B+47+(8)%3A764-74." target="_blank">Eklof H, Ahlstrom H, Magnusson A, Andersson LG<span>,&nbsp;</span>Andrén B<span>,&nbsp;</span>Hägg A<span>,&nbsp;</span>et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol 2006; 47 (8):764-74.</a></p>
<p>QID: 30513</p></div><div class="rightanswer">The correct answer is: CT angiography and duplex ultrasound have comparable diagnostic accuracy for renal artery stenosis</div></div></div></div></div><div id="q453" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">26</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_398"><input type="hidden" name="q20803:453_:flagged" value="0"><input type="hidden" value="qaid=911337&amp;qubaid=20803&amp;qid=5171&amp;slot=453&amp;checksum=f4e5526a35cc952e582a00cf6b53e2be&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:453_:flaggedcheckbox" name="q20803:453_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q453&id=5171"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:453_:sequencecheck" value="2"><div class="qtext"><p>Which medication is contraindicated in patients with congestive heart failure?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:453_answer" disabled="disabled" value="0" id="q20803:453_answer0"><label for="q20803:453_answer0">a. abciximab</label> </div>
<div class="r1"><input type="radio" name="q20803:453_answer" disabled="disabled" value="1" id="q20803:453_answer1"><label for="q20803:453_answer1">b. cilostazol</label> </div>
<div class="r0"><input type="radio" name="q20803:453_answer" disabled="disabled" value="2" id="q20803:453_answer2"><label for="q20803:453_answer2">c. atorvastatin</label> </div>
<div class="r1"><input type="radio" name="q20803:453_answer" disabled="disabled" value="3" id="q20803:453_answer3"><label for="q20803:453_answer3">d. clopidogrel</label> </div>
<div class="r0"><input type="radio" name="q20803:453_answer" disabled="disabled" value="4" id="q20803:453_answer4"><label for="q20803:453_answer4">e. amlodipine</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:453_-submit" name="q20803:453_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Cilostazol is a phosphodiesterase type 3 inhibitor that has antiplatelet and vasodilatory effects. It improves walking distance in some patients with intermittent claudication.</p>
<p>Cilostazol has a "black box warning," mandated by the FDA, indicating that it is contraindicated for use in patients with heart failure of any severity. However, this is not because of any observed adverse effects of cilostazol. Cilostazol has not been implicated in increased cardiovascular mortality in clinical trials. It had been noted however, that use of some other phosophodiesterase inhibitors (milrinone, in particular) were associated with increased mortality in patients with severe heart failure. The proscription of cilostazol use in patients with congestive heart failure is based on this observed class effect.</p>
<p>Atorvastatin is a cholesterol lowering statin medication. Clopidogrel and abciximab are antiplatelet medications and are used for the treatment of coronary artery disease. Amlodipine is a calcium channel blocker used for the treatment of hypertension. All of these medications are safe to use in patients with a history of congestive heart failure.<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Pharmacologic+therapy+for+intermittent+claudication.+Pharmacotherapy%3B+2009%3B+29+(5)%3A526-53." target="_blank">Dobesh PP, Stacy ZA, Persson EL. Pharmacologic therapy for intermittent claudication. Pharmacotherapy 2009; 29 (5):526-53.</a></p>
<p>QID: 30811</p></div><div class="rightanswer">The correct answer is: cilostazol</div></div></div></div></div><div id="q175" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">27</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_407"><input type="hidden" name="q20803:175_:flagged" value="0"><input type="hidden" value="qaid=911059&amp;qubaid=20803&amp;qid=4678&amp;slot=175&amp;checksum=65e6fa310c65a81abe5b9756967db1ad&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:175_:flaggedcheckbox" name="q20803:175_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q175&id=4678"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:175_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old woman is scheduled to undergo carotid stent placement for a symptomatic high-grade left ICA stenosis. Which of the following is the recommended antithrombotic management?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:175_answer" disabled="disabled" value="0" id="q20803:175_answer0"><label for="q20803:175_answer0">a. begin warfarin to maintain at INR of 2.0 to 3.0 immediately following the procedure; the use of additional anti-platelet agents is unnecessary</label> </div>
<div class="r1"><input type="radio" name="q20803:175_answer" disabled="disabled" value="1" id="q20803:175_answer1"><label for="q20803:175_answer1">b. hold antiplatelet therapy before the procedure because use of an anti-embolic device (filter) makes this unnecessary</label> </div>
<div class="r0"><input type="radio" name="q20803:175_answer" disabled="disabled" value="2" id="q20803:175_answer2"><label for="q20803:175_answer2">c. low dose aspirin (81 mg) daily initiated before, and continued after, is sufficient anti-platelet therapy in this scenario</label> </div>
<div class="r1"><input type="radio" name="q20803:175_answer" disabled="disabled" value="3" id="q20803:175_answer3"><label for="q20803:175_answer3">d. hold antiplatelet therapy before the procedure to decrease the risk of bleeding then begin aspirin 325 mg&nbsp;daily</label> </div>
<div class="r0"><input type="radio" name="q20803:175_answer" disabled="disabled" value="4" id="q20803:175_answer4"><label for="q20803:175_answer4">e. <p>dual antiplatelet therapy with aspirin and clopidogrel beginning at least 3 days before the procedure&nbsp; and continued for at least 1 month, followed by aspirin indefinitely</p></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:175_-submit" name="q20803:175_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Recently updated guidelines from the Society&nbsp;for Vascular Surgery recommend initiation of dual antiplatelet therapy at least 3 days before carotid stenting.&nbsp;It is recommended that dual agents be continued for at least 1 month, followed by aspirin indefinitely. This is admittedly based on low quality evidence (Category C), but the writers of the guidelines felt sufficiently certain of the benefits to make it a Grade 1 recommendation, which is meant to identify practices where the benefit clearly outweighs the risk and where there is a high degree of confidence. Individualization of antithrombotic management strategies will be needed for patients with other risk factors and comorbid conditions, including coronary stents and intracranial pathologies.&nbsp;The routine use of anticoagulants, such as warfarin, is not recommended.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p class="EndNoteBibliography"><a href="http://www.ncbi.nlm.nih.gov/pubmed/21889705" target="_blank">Ricotta JJ, Aburahma A<span>,&nbsp;</span>Ascher E<span>,&nbsp;</span>Eskandari M<span>,&nbsp;</span>Faries P<span>,&nbsp;</span>Lal BK,&nbsp;et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease<em>.</em> J Vasc Surg 2011; 54(3): e1-e31</a>. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21889705"><br></a></p>
<p class="EndNoteBibliography"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23281092" target="_blank">Brott TG, Halperin JL<span>,&nbsp;</span>Abbara S<span>,&nbsp;</span>Bacharach JM<span>,&nbsp;</span>Barr JD<span>,&nbsp;</span>Bush RL,&nbsp;et al.&nbsp;2011 ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American Stroke Association, American Association of Neuroscience Nurses, American Association of Neurological Surgeons, American College of Radiology, American Society of Neuroradiology, Congress of Neurological Surgeons, Society of Atherosclerosis Imaging and Prevention, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of NeuroInterventional Surgery, Society for Vascular Medicine, and Society for Vascular Surgery. Developed in collaboration with the American Academy of Neurology and Society of Cardiovascular Computed Tomography. Catheter Cardiovasc Interv 2013; 81(1): E76-123. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/23281092"><br></a></p>
<p class="EndNoteBibliography">QID: 30316</p></div><div class="rightanswer">The correct answer is: <p>dual antiplatelet therapy with aspirin and clopidogrel beginning at least 3 days before the procedure&nbsp; and continued for at least 1 month, followed by aspirin indefinitely</p></div></div></div></div></div><div id="q449" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">28</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_416"><input type="hidden" name="q20803:449_:flagged" value="0"><input type="hidden" value="qaid=911333&amp;qubaid=20803&amp;qid=5166&amp;slot=449&amp;checksum=b8e363bc219e230ad72affa3786274d9&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:449_:flaggedcheckbox" name="q20803:449_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q449&id=5166"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:449_:sequencecheck" value="2"><div class="qtext"><p>When treating patients with symptomatic peripheral arterial disease, what serum HDL level&nbsp;is the targeted goal of therapy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:449_answer" disabled="disabled" value="0" id="q20803:449_answer0"><label for="q20803:449_answer0">a. &lt; 100 mg/dL</label> </div>
<div class="r1"><input type="radio" name="q20803:449_answer" disabled="disabled" value="1" id="q20803:449_answer1"><label for="q20803:449_answer1">b. &lt; 60 mg/dL</label> </div>
<div class="r0"><input type="radio" name="q20803:449_answer" disabled="disabled" value="2" id="q20803:449_answer2"><label for="q20803:449_answer2">c. &gt; 100 mg/dL</label> </div>
<div class="r1"><input type="radio" name="q20803:449_answer" disabled="disabled" value="3" id="q20803:449_answer3"><label for="q20803:449_answer3">d. &gt; 60 mg/dL</label> </div>
<div class="r0"><input type="radio" name="q20803:449_answer" disabled="disabled" value="4" id="q20803:449_answer4"><label for="q20803:449_answer4">e. &gt; 40 mg/dL</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:449_-submit" name="q20803:449_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Elevated HDL &gt; 40 mg/dL and elevated apolipoprotein (a-1) levels have been found to be 2 factors that are protective for the development of peripheral arterial disease (PAD). Raising the HDL levels should be a secondary goal of lipid management after lowering LDL levels. TASC II recommends using fibrates and/or niacin to raise HDL levels and lower triglyceride levels in patients with PAD. <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Liapis%20CS,%20Avgerinos%20ED,%20Kadoglou%20NP,%20and%20Kakisis%20JD.%20What%20a%20vascular%20surgeon%20should%20know%20and%20do%20about%20atherosclerotic%20risk%20factors.%20J%20Vasc%20Surg;%202009;%2049%20(5):1348-1354" target="_blank">Liapis CS, Avgerinos ED, Kadoglou NP, Kakisis JD. What a vascular surgeon should know and do about atherosclerotic risk factors. J Vasc Surg 2009; 49 (5):1348-54.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/17140820" target="_blank">Norgren L, Hiatt WR, Dormandy JA, Nehler MR<span>,&nbsp;</span>Harris KA<span>,&nbsp;</span>Fowkes FG,&nbsp;et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg; 2007; 33 (Suppl 1):S1-75.</a></p>
<p>QID: 30806</p></div><div class="rightanswer">The correct answer is: &gt; 40 mg/dL</div></div></div></div></div><div id="q307" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">29</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_425"><input type="hidden" name="q20803:307_:flagged" value="0"><input type="hidden" value="qaid=911191&amp;qubaid=20803&amp;qid=5066&amp;slot=307&amp;checksum=7309df2cecca7c92684a1b1e6f480204&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:307_:flaggedcheckbox" name="q20803:307_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q307&id=5066"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:307_:sequencecheck" value="2"><div class="qtext"><p>While completing a duplex ultrasound, you desire to increase the sensitivity and penetration of the beam while visualizing an external iliac artery stent in a morbidly obese patient located approximately 5 cm from the end of the probe. Which of the following is the best method to achieve improved visualization?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:307_answer" disabled="disabled" value="0" id="q20803:307_answer0"><label for="q20803:307_answer0">a. use the lowest possible operating frequency</label> </div>
<div class="r1"><input type="radio" name="q20803:307_answer" disabled="disabled" value="1" id="q20803:307_answer1"><label for="q20803:307_answer1">b. decrease roundtrip time</label> </div>
<div class="r0"><input type="radio" name="q20803:307_answer" disabled="disabled" value="2" id="q20803:307_answer2"><label for="q20803:307_answer2">c. increase the incident angle from 0 degrees to 40 degrees</label> </div>
<div class="r1"><input type="radio" name="q20803:307_answer" disabled="disabled" value="3" id="q20803:307_answer3"><label for="q20803:307_answer3">d. increase percentage reflection</label> </div>
<div class="r0"><input type="radio" name="q20803:307_answer" disabled="disabled" value="4" id="q20803:307_answer4"><label for="q20803:307_answer4">e. decrease propagation velocity</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:307_-submit" name="q20803:307_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The appropriate frequency for color Doppler operation is highly depth dependent. When shallower than 1 to 2 cm, higher frequencies result in stronger color Doppler signals. If deeper than 3 cm, especially when sensitivity is an issue, the lowest possible operating frequency should be used to ensure adequate sensitivity. Using too high an operating frequency at deeper depths can result in loss of color filling. Decreasing the propagation velocity or roundtrip time, and increasing the percentage reflection are tissue-specific factors that cannot be controlled by the ultrasonographer. Increasing the incident angle, or the angle of the probe with respect to the skin, would further increase the distance to the target and decrease the number of reflected signals coming back to the probe, thereby further decreasing the resolution. The image below demonstrates the ideal Doppler operating frequency as a function of tissue depth.</p>
<p><img src="./VESAP3_files/2.jpg" alt="" width="598" height="598"></p>
<p class="FigureLegend">Ideal Doppler operating frequency based on depth. Reprinted from “Ultrasound Physics &amp; Instrumentation,” by F. R. Miele, p. 534. Copyright 2006 by Miele Enterprises, LLC. Reprinted with permission.</p>
<p>Content adapted from the Clinical Review of Phlebology and Venous Ultrasound, Eds Eric Mowatt-Larssen, MD, Sapan S. Desai, MD, PhD, MBA, and Cynthia Shortell, MD. “Ultrasound Physics” by Frank Miele. Copyright 2013 Surgisphere Corporation. Content and figure used with permission.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>“Ultrasound Physics &amp; Instrumentation 4th Edition." F. R. Miele. 2006 Meile Enterprises Inc. pg. 534.</p>
<p>QID: 30528</p></div><div class="rightanswer">The correct answer is: use the lowest possible operating frequency</div></div></div></div></div><div id="q182" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">30</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_434"><input type="hidden" name="q20803:182_:flagged" value="0"><input type="hidden" value="qaid=911066&amp;qubaid=20803&amp;qid=4549&amp;slot=182&amp;checksum=b9f8a120e750a81bf4450cc82174403a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:182_:flaggedcheckbox" name="q20803:182_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q182&id=4549"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:182_:sequencecheck" value="2"><div class="qtext"><p>A 75yo female is undergoing carotid endarterectomy for an asymptomatic lesion.&nbsp; Patch closure has become the&nbsp;standard of care when compared to primary repair due to which of the following results?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:182_answer" disabled="disabled" value="0" id="q20803:182_answer0"><label for="q20803:182_answer0">a. Women have lower restenosis rates than men.</label> </div>
<div class="r1"><input type="radio" name="q20803:182_answer" disabled="disabled" value="1" id="q20803:182_answer1"><label for="q20803:182_answer1">b. The risk of restenosis is reduced with patch closure.</label> </div>
<div class="r0"><input type="radio" name="q20803:182_answer" disabled="disabled" value="2" id="q20803:182_answer2"><label for="q20803:182_answer2">c. Patch closure has a similar rate or perioperiatve stroke compared to primary repair.</label> </div>
<div class="r1"><input type="radio" name="q20803:182_answer" disabled="disabled" value="3" id="q20803:182_answer3"><label for="q20803:182_answer3">d. Primary repair has a lower risk of peri-operative thrombosis.</label> </div>
<div class="r0"><input type="radio" name="q20803:182_answer" disabled="disabled" value="4" id="q20803:182_answer4"><label for="q20803:182_answer4">e. All of the above.</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:182_-submit" name="q20803:182_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>While patch closure versus primary closure has&nbsp;historically been&nbsp;a controversial subject, there is evidence that patching produces improved results when compared to primary repair.&nbsp; There is no significant difference in the type of patch used.&nbsp; Comparative&nbsp;randomized controls trial&nbsp;of&nbsp;carotid endarterectomy&nbsp;has found that there was a higher risk of stroke,&nbsp;and restenosis rates&nbsp;among patients that did not undergo patch closure.&nbsp; Meta-analysis showed the following reductions for patch vs no patch respectively:&nbsp; At &lt;30days the risk of any stroke:&nbsp;1.9% vs 3.% (OR 0.57, 95% CI 0.31-1.03), P&lt;0.06; &nbsp;and ipsilateral stroke 1.5% vs 4.5% (OR 0.31, 95% CI 0.15-0.63, 0&lt;0.0001).&nbsp; Rate of occlusion at 30 days was 0.5% vs 3.1% (OR 0.18, 95% CI 0.08-0.4, p&lt;0.0001) and&nbsp;rate of&nbsp;restenosis&nbsp;at 1yr was 4.3% vs 13.8% (OR 0.24, 95% CI 0.17-0.34, p&lt;0.00001).&nbsp; There is also some evidence that women have a higher restonsis rate due to the smaller average size of the vessel lumen when compared to men however this has not always born out in subgroup analysis.&nbsp; The US center for Medicare and Medicaid has adopted patching as a physician quality measure.</p>
<p>&nbsp;</p>
<p>References:</p>
<p>1. Katz D, Snyder SO, Gandhi RH, et al. Long-term follow-up for recurrent stenosis: a prospective randomized study of expanded PTFE patch angioplasty vs primary closure after carotid endarterectomy J Vasc Surg1994; 19:198-203. <a href="http://www.ncbi.nlm.nih.gov/pubmed/8114181">http://www.ncbi.nlm.nih.gov/pubmed/8114181</a></p>
<p>2. Bond R, Rerkasem K, Naylor AR, et al. Systematic review of randomized controlled trials of patch angioplasty versus primary closure and different types of patch materials during carotid endarterectomy.&nbsp; J Vasc Surg 2004; 40:1126-1135. <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=bond+r%2C+2004%2C+j+vasc+surg">http://www.ncbi.nlm.nih.gov/pubmed/?term=bond+r%2C+2004%2C+j+vasc+surg</a></p>
<p>3. Aburahma AF, Robinson PA, Saiedy S et al. Prospective randomized trial fo bilateral carotid endarterectomies: primary closure versus patching. Stroke 1999; 30: 1185-1189. <a href="http://www.ncbi.nlm.nih.gov/pubmed/10356097">http://www.ncbi.nlm.nih.gov/pubmed/10356097</a></p>
<p>4. Rerkasem K and Rothwell PM. Patch angioplasty versus primary closure for carotid endarterectomy.&nbsp; Cochrane database System Rev. 2009; &nbsp;Oct 7;(4):CD000160. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19821267">http://www.ncbi.nlm.nih.gov/pubmed/19821267</a></p>
<p>QID: 30326</p></div><div class="rightanswer">The correct answer is: The risk of restenosis is reduced with patch closure.</div></div></div></div></div><div id="q349" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">31</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_443"><input type="hidden" name="q20803:349_:flagged" value="0"><input type="hidden" value="qaid=911233&amp;qubaid=20803&amp;qid=5142&amp;slot=349&amp;checksum=d13941de29be902050282e4511fe2531&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:349_:flaggedcheckbox" name="q20803:349_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q349&id=5142"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:349_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old woman presents with 2-drug hypertension and a serum creatinine that has increased from a baseline of 1.4 mg/dL to 2.4 mg/dL over 4 months. CT angiography reveals bilateral 80% renal artery stenoses. Which of the following statements best describes the role of bilateral renal artery stenoses in producing ischemic nephropathy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:349_answer" disabled="disabled" value="0" id="q20803:349_answer0"><label for="q20803:349_answer0">a. bilateral renal artery stenoses reduce renal perfusion below a critical perfusion pressure, thereby reducing glomerular filtration</label> </div>
<div class="r1"><input type="radio" name="q20803:349_answer" disabled="disabled" value="1" id="q20803:349_answer1"><label for="q20803:349_answer1">b. bilateral renal artery stenoses cause repetitive episodes of ischemia-reperfusion with generation of toxic oxygen radicals</label> </div>
<div class="r0"><input type="radio" name="q20803:349_answer" disabled="disabled" value="2" id="q20803:349_answer2"><label for="q20803:349_answer2">c. bilateral renal artery stenoses produce atheroemboli to the renal parenchyma to induce nephrosclerosis</label> </div>
<div class="r1"><input type="radio" name="q20803:349_answer" disabled="disabled" value="3" id="q20803:349_answer3"><label for="q20803:349_answer3">d. bilateral renal artery stenoses activate the renin-angiotensin and cholinergic systems to decrease renal perfusion pressure</label> </div>
<div class="r0"><input type="radio" name="q20803:349_answer" disabled="disabled" value="4" id="q20803:349_answer4"><label for="q20803:349_answer4">e. bilateral renal artery stenoses cause repetitive episodes of renal hyperperfusion that induces renal fibrosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:349_-submit" name="q20803:349_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Atherosclerotic occlusive disease of the renal arteries has been associated with renovascular hypertension for some time. More recently, renal arterial occlusive disease has been linked to progressive nephropathy. Ischemic nephropathy needs to be considered in patients who are azotemic due to the fact that reversal of the ischemic condition may lead to retrieval of renal function. The etiology is a reduction of renal perfusion to a level below which the kidney has adequate perfusion. Hemodynamic studies across stenotic lesions indicate that pressure gradients and changes in blood flow can be detected only when lumen occlusion exceeds nearly 70-80% of luminal area and not lesser degrees of narrowing. This reduction of perfusion pressure to the kidney invariably activates pressor mechanisms to restore renal perfusion, including activation of the renin-angiotensin system, adrenergic stimuli, and other mechanisms. These mechanisms are triggered in order to elevate the perfusion pressure to the kidneys. The cholinergic system would not aid in this function. The exact pathophysiology of the renal injury with atherosclerotic renal artery occlusive disease is not completely understood, but it is most certainly multi-factorial. In addition, the loss of glomerular filtration develops in these patients superimposed on other vascular changes related to aging, essential hypertension, smoking, and diabetes. This results in renal parenchymal pathology, such as nephrosclerosis, atheroembolic disease, or glomerulosclerosis. The final pathological process is interstitial fibrosis and scarring of the renal parenchyma, such that renal function is impaired.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Textor,%20SC.%20Ischemic%20nephropathy:%20Where%20are%20we%20now?%20J%20Am%20Soc%20Nephrol;%202004;%2015%20(8):1974-1982" target="_blank">Textor, SC. Ischemic nephropathy: Where are we now? J Am Soc Nephrol 2004; 15(8):1974-82.</a><br><br>Pohl MA, Wilcox CS. Renal artery stenosis, renal vascular hypertension and ischemic nephropathy. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract, 8th ed. Media, PA: Lippincott, Williams &amp; Wilkins; 2006:1272-1326.</p>
<p>QID: 30616</p></div><div class="rightanswer">The correct answer is: bilateral renal artery stenoses reduce renal perfusion below a critical perfusion pressure, thereby reducing glomerular filtration</div></div></div></div></div><div id="q114" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">32</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_452"><input type="hidden" name="q20803:114_:flagged" value="0"><input type="hidden" value="qaid=910998&amp;qubaid=20803&amp;qid=4726&amp;slot=114&amp;checksum=62dbc79fe7e76b5f102e977c864fc51a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:114_:flaggedcheckbox" name="q20803:114_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q114&id=4726"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:114_:sequencecheck" value="2"><div class="qtext"><p>A 46-year-old woman presents with a thrombosed, left prosthetic brachial-axillary upper arm straight access. The prosthetic access was placed 2 years ago and was working well until dialysis earlier today. On physical examination of her left arm, she has no thrill or bruit in her graft or arteriovenous (AV) access outflow, no edema, and palpable radial, ulnar, and brachial arteries. Which of the following is the most likely cause of this patient's AV access thrombosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:114_answer" disabled="disabled" value="0" id="q20803:114_answer0"><label for="q20803:114_answer0">a. intra prosthetic graft stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:114_answer" disabled="disabled" value="1" id="q20803:114_answer1"><label for="q20803:114_answer1">b. poor arterial inflow</label> </div>
<div class="r0"><input type="radio" name="q20803:114_answer" disabled="disabled" value="2" id="q20803:114_answer2"><label for="q20803:114_answer2">c. stenosis of the graft-arterial anastomosis</label> </div>
<div class="r1"><input type="radio" name="q20803:114_answer" disabled="disabled" value="3" id="q20803:114_answer3"><label for="q20803:114_answer3">d. central venous stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:114_answer" disabled="disabled" value="4" id="q20803:114_answer4"><label for="q20803:114_answer4">e. stenosis of the graft-venous anastomosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:114_-submit" name="q20803:114_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Access thrombosis that occurs 1-2 years after access placement is most commonly due to intimal hyperplasia, which, in a prosthetic access, occurs most commonly at the graft-venous anastomosis. Central venous stenosis related to previous dialysis catheters is the second common cause of late AV access failure. In this patient, however, with no arm edema, no central lines for over 1 year, and a normal pulse examination, the most likely cause is intimal hyperplasia at the graft-venous anastomosis.</p>
<p>&nbsp;</p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vas+Surg+2008%3B+48%3A55S-80S." target="_blank"> Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg 2008; 48:55S-80S.</a><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%20Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank"> <br></a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vas+Surg+2008+48%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarb A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vas Surg 2008 48:2S-25S.</a></p>
<p>QID: 30201</p></div><div class="rightanswer">The correct answer is: stenosis of the graft-venous anastomosis</div></div></div></div></div><div id="q382" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">33</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_461"><input type="hidden" name="q20803:382_:flagged" value="0"><input type="hidden" value="qaid=911266&amp;qubaid=20803&amp;qid=5102&amp;slot=382&amp;checksum=f9c0fb6a15ea34d761608aadec8dba66&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:382_:flaggedcheckbox" name="q20803:382_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q382&id=5102"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:382_:sequencecheck" value="2"><div class="qtext"><p>A 77-year-old woman with a history of ovarian cancer and heparin induced thrombocytopenia (HITT) presents to the emergency room with a 4-day history of progressively worsening diffuse abdominal pain. She is hemodynamically stable and the abdomen is diffusely tender; there are no peritoneal signs. The CT scan reveals acute mesenteric venous thrombosis (image is shown below). Which of the following is the most appropriate initial management for this patient?</p>
<p><img src="./VESAP3_files/Rowe-7.jpg" alt="" width="657" height="585"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:382_answer" disabled="disabled" value="0" id="q20803:382_answer0"><label for="q20803:382_answer0">a. anticoagulation with unfractionated heparin</label> </div>
<div class="r1"><input type="radio" name="q20803:382_answer" disabled="disabled" value="1" id="q20803:382_answer1"><label for="q20803:382_answer1">b. anticoagulation with Argatroban</label> </div>
<div class="r0"><input type="radio" name="q20803:382_answer" disabled="disabled" value="2" id="q20803:382_answer2"><label for="q20803:382_answer2">c. exploratory laparotomy with bowel resection</label> </div>
<div class="r1"><input type="radio" name="q20803:382_answer" disabled="disabled" value="3" id="q20803:382_answer3"><label for="q20803:382_answer3">d. anticoagulation with low molecular weight heparin</label> </div>
<div class="r0"><input type="radio" name="q20803:382_answer" disabled="disabled" value="4" id="q20803:382_answer4"><label for="q20803:382_answer4">e. catheter-directed thrombolytic therapy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:382_-submit" name="q20803:382_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Once the diagnosis of mesenteric venous thrombosis (MVT) is confirmed, medical therapy with anticoagulation should be instituted in patients without peritonitis. After initial anticoagulation, continued treatment with low-molecular-weight heparin (LMWH) or Warfarin is advocated. In this case, heparin and&nbsp;LMWH are contraindicated because of the heparin-induced thrombocytopenia, so a direct thrombin inhibitor&nbsp;(Argatroban or a Hirudin derivative) should be&nbsp;administered intravenously. If bowel ischemia is suspected, an exploratory laparotomy or laparoscopy is indicated. Bowel resection should be performed in cases of severe ischemic or frank necrotic intestinal segments.&nbsp;Systemic thrombolysis in MVT has not been evaluated systematically, however, catheter directed thrombolysis (transhepatic, operatively placed, or via superior mesenteric artery)&nbsp;has been&nbsp;described. Catheter-directed thrombolysis has not been proven to be superior to anticoagulation alone and should be reserved for patients with clinical deterioration despite resuscitation and anticoagulation. Patients with abdominal pain for more than 48 hours without signs of peritonitis are unlikely to progress to venous infarction if treated with anticoagulants.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vascular+2007%3B15%3A41-5." target="_blank">Zhou W, Choi L, Liu P, Dardik A<span>,&nbsp;</span>Eraso A<span>,&nbsp;</span>Lumsden AB<span>.</span>&nbsp;Percutaneous transhepatic thrombectomy and pharmacologic thrombolysis of mesenteric venous thrombosis. Vascular&nbsp;2007;15:41-5.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2005%3B16%3A651-61." target="_blank">Hollingshead M, Burke C, Mauro M, Weeks SM<span>,&nbsp;</span>Dixon RG<span>,&nbsp;</span>Jaques PF<span>.</span>&nbsp;Transcatheter thrombolytic therapy for acute mesenteric and portal vein thrombosis. J Vasc Interv Radiol&nbsp;2005;16:651-61.</a></p>
<p>QID: 30669</p></div><div class="rightanswer">The correct answer is: anticoagulation with Argatroban</div></div></div></div></div><div id="q304" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">34</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_470"><input type="hidden" name="q20803:304_:flagged" value="0"><input type="hidden" value="qaid=911188&amp;qubaid=20803&amp;qid=5062&amp;slot=304&amp;checksum=7f67446b4ddddbac1d9aa6ad5e9111e6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:304_:flaggedcheckbox" name="q20803:304_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q304&id=5062"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:304_:sequencecheck" value="2"><div class="qtext"><p>You are referred a patient who has an asymptomatic cervical bruit. The image depicts vertebral velocities and waveforms obtained as a routine part of carotid duplex evaluation. Which of the following statements is <strong>true</strong>?</p>
<p><a href="./VESAP3_files/12242.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/12242.jpg" alt="Img" width="72" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:304_answer" disabled="disabled" value="0" id="q20803:304_answer0"><label for="q20803:304_answer0">a. the study labeled "A" suggests distal arteriovenous malformation and "B" is normal</label> </div>
<div class="r1"><input type="radio" name="q20803:304_answer" disabled="disabled" value="1" id="q20803:304_answer1"><label for="q20803:304_answer1">b. the study labeled "A" suggests reperfusion hyperemia and "B" suggests distal stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:304_answer" disabled="disabled" value="2" id="q20803:304_answer2"><label for="q20803:304_answer2">c. the study labeled "A" is normal and "B" suggests a proximal stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:304_answer" disabled="disabled" value="3" id="q20803:304_answer3"><label for="q20803:304_answer3">d. the study labeled "A" suggests subarachnoid hemorrhage and "B" suggests subclavian steal syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:304_answer" disabled="disabled" value="4" id="q20803:304_answer4"><label for="q20803:304_answer4">e. both studies are normal</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:304_-submit" name="q20803:304_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Evaluation of the vertebral arteries is a routine component of cerebrovascular duplex scanning. Ultrasonographic evaluation of the&nbsp;cervical vertebral arteries&nbsp;is limited as&nbsp;the&nbsp;vertebral foramen&nbsp;produce an acoustic shadow on B-mode and color Doppler imaging, as seen in the accompanying image. Once identified, the vertebral artery can be followed to its origin with the subclavian artery. Diagnostic accuracy in predicting greater than 50% vertebral artery stenosis is not as good as it is in the cervical internal carotid artery. Classification of vertebral artery flow into 3 categories (normal, abnormal, occluded) has good correlation with angiography. Retrograde vertebral artery flow is indicative of a proximal subclavian or innominate artery stenosis or occlusion. Flow reversal may occur only during diastole (ie, "to-and-fro" flow), but if seen after upper-extremity exercise, flow reversal throughout the pulse cycle is diagnostic of subclavian steal syndrome. The effect of vertebral steal on basilar artery flow can be assessed by transcranial Doppler at rest and after arm exercise. The size of the vertebral arteries varies. Arterial hypoplasia is not uncommon and can decrease the diagnostic accuracy of occlusion. Damped, low-velocity spectra indicate a proximal stenosis, whereas a high-resistance spectral waveform suggests the presence of a downstream (more distal) occlusive lesion or arterial dissection. In this image, the portion labeled A represents a normal vertebral artery waveform and velocity, while B represents a blunted, notched waveform with low velocities characteristic of a proximal stenosis.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Bendick%20PJ,%20Jackson%20VP.%20Evaluation%20of%20the%20vertebral%20arteries%20with%20duplex%20sonography.%20J%20Vasc%20Surg;%201986;%203%20(3):523-530" target="_blank">Bendick PJ, Jackson VP. Evaluation of the vertebral arteries with duplex sonography. J Vasc Surg 1986; 3 (3):523-30.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Bartels%20E,%20Flugel%20KA.%20Evaluation%20of%20extracranial%20vertebral%20artery%20dissection%20with%20duplex%20color-flow%20imaging.%20Stroke;%201996;%2027%20(2):290-295" target="_blank">Bartels E, Flugel KA. Evaluation of extracranial vertebral artery dissection with duplex color-flow imaging. Stroke 1996; 27 (2):290-5.</a><br><br>Armstrong PA, Bandyk DF. Arterial duplex scanning. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. Philadelphia, PA: Saunders Elsevier; 2010:235-56.</p>
<p>QID: 30524</p></div><div class="rightanswer">The correct answer is: the study labeled "A" is normal and "B" suggests a proximal stenosis</div></div></div></div></div><div id="q248" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">35</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_479"><input type="hidden" name="q20803:248_:flagged" value="0"><input type="hidden" value="qaid=911132&amp;qubaid=20803&amp;qid=2349&amp;slot=248&amp;checksum=293fd4fb59ab434d16b6c5aa8e3c0c4e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:248_:flaggedcheckbox" name="q20803:248_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q248&id=2349"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:248_:sequencecheck" value="2"><div class="qtext"><p><span>A 47 year old male with diabetic neuropathy is currently dialyzing via a left brachio-axillary AV graft constructed 3 months ago after vein mapping showed no veins useable for autogenous access in either arm.&nbsp; After the access placement he gradually developed ulceration of the left 5th finger. &nbsp;Left 5</span><sup>th</sup><span>&nbsp;digit interphalyngeal amputation was performed by a hand surgeon one month prior, who referred the patient for vascular evaluation because of poor wound healing. Radial pulse is not palpable in either wrist. Digital pulse volume recordings are obtained.&nbsp; When the graft is compressed, waveforms in the left digits augment and are symmetrical with those of the right side.&nbsp;<span>Which of the following would be LEAST appropriate?</span></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:248_answer" disabled="disabled" value="0" id="q20803:248_answer0"><label for="q20803:248_answer0">a. <span>Brachial artery ligation below the anastomosis, with saphenous vein bypass from the axillary to distal brachial artery (DRIL procedure)</span></label> </div>
<div class="r1"><input type="radio" name="q20803:248_answer" disabled="disabled" value="1" id="q20803:248_answer1"><label for="q20803:248_answer1">b. <span>Broad spectrum antibiotics and hyperbaric therapy</span></label> </div>
<div class="r0"><input type="radio" name="q20803:248_answer" disabled="disabled" value="2" id="q20803:248_answer2"><label for="q20803:248_answer2">c. <span>Banding of the graft near the arterial anastomosis guided by digital plethysmography</span></label> </div>
<div class="r1"><input type="radio" name="q20803:248_answer" disabled="disabled" value="3" id="q20803:248_answer3"><label for="q20803:248_answer3">d. <span>Proximalization of the graft with a 3mm PTFE graft from the axillary artery and ligation of the current graft arterial anastomosis</span></label> </div>
<div class="r0"><input type="radio" name="q20803:248_answer" disabled="disabled" value="4" id="q20803:248_answer4"><label for="q20803:248_answer4">e. <span>Ligation of the graft with placement of a graft in the dominant arm</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:248_-submit" name="q20803:248_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>&nbsp;Hyperbaric therapy is unlikely to be of any benefit. All of the other procedures may be appropriate in selected patients to treat severe steal&nbsp;with digital gangrene.&nbsp;</p>
<p>REFS</p>
<ol>
<li>Schanzer H, Schwartz M, Harrington E, Haimov M: Treatment of ischemia due to "steal” by arteriovenous fistula with distal artery ligation and revascularization.&nbsp;<em>J Vasc Surg</em>&nbsp;7:770-773, 1988</li>
<li>Jennings, WC, Brown RE, Ruiz C. Primary arteriovenous fistula inflow proximalization for patients at high risk for dialysis access-associated ischemic steal syndrome<em>. J Vasc. Surg</em>&nbsp; 2011; 54:554-8</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Aimaq%20R%5BAuthor%5D&cauthor=true&cauthor_uid=23375137">Aimaq R</a>,&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Katz%20SG%5BAuthor%5D&cauthor=true&cauthor_uid=23375137">Katz SG</a>.&nbsp;Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation<em>. J Vasc Surg</em>&nbsp;2013 57:1073-</li>
<li>Suding PN, Wilson SE. Strategies for management of ischemic steal syndrome.&nbsp;&nbsp;<em>Semin Vasc. Surg</em>&nbsp;2007; 20:184-8</li></ol>
<p><span>QID: 30432</span></p></div><div class="rightanswer">The correct answer is: <span>Broad spectrum antibiotics and hyperbaric therapy</span></div></div></div></div></div><div id="q99" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">36</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_488"><input type="hidden" name="q20803:99_:flagged" value="0"><input type="hidden" value="qaid=910983&amp;qubaid=20803&amp;qid=4920&amp;slot=99&amp;checksum=783ca50288a81366e1afa6964da7bd5c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:99_:flaggedcheckbox" name="q20803:99_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q99&id=4920"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:99_:sequencecheck" value="2"><div class="qtext"><p>A 43-year-old male triathlete presents to clinic with unilateral calf and thigh pain during maximal effort; the pain is relieved with rest. Duplex and CT examination of the involved extremity would be most likely to yield which of the following findings?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:99_answer" disabled="disabled" value="0" id="q20803:99_answer0"><label for="q20803:99_answer0">a. popliteal entrapment syndrome</label> </div>
<div class="r1"><input type="radio" name="q20803:99_answer" disabled="disabled" value="1" id="q20803:99_answer1"><label for="q20803:99_answer1">b. external iliac artery vasospasm and endofibrosis</label> </div>
<div class="r0"><input type="radio" name="q20803:99_answer" disabled="disabled" value="2" id="q20803:99_answer2"><label for="q20803:99_answer2">c. aortoiliac atherosclerotic disease</label> </div>
<div class="r1"><input type="radio" name="q20803:99_answer" disabled="disabled" value="3" id="q20803:99_answer3"><label for="q20803:99_answer3">d. a Baker’s cyst in the popliteal space</label> </div>
<div class="r0"><input type="radio" name="q20803:99_answer" disabled="disabled" value="4" id="q20803:99_answer4"><label for="q20803:99_answer4">e. adventitial cystic disease</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:99_-submit" name="q20803:99_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Exercise-induced external iliac artery endofibrosis is uncommon, however it may manifest as claudication and loss of power with maximal effort in high-endurance athletes lacking traditional PAD risk factors. &nbsp;While advential cystic disease and popliteal entrapment syndrome may be seen in young patients presenting with claudication, symptoms would be confined to the calf/lower leg.&nbsp; Given the patient’s young age and athleticism, atherosclerotic disease is highly unlikely.&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+58%3A105-11." target="_blank">Shalhub S, Zierler R, Smith W, Olmsted K<span>,&nbsp;</span>Clowes AW<span>.</span>&nbsp;Vasospasm as a cause for claudication in athletes with external iliac artery endofibrosis.&nbsp; J Vasc Surg 2013; 58:105-11.</a></p>
<p>QID: 30150</p></div><div class="rightanswer">The correct answer is: external iliac artery vasospasm and endofibrosis</div></div></div></div></div><div id="q451" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">37</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_497"><input type="hidden" name="q20803:451_:flagged" value="0"><input type="hidden" value="qaid=911335&amp;qubaid=20803&amp;qid=5168&amp;slot=451&amp;checksum=b278bedc9979c314b2695bb326905333&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:451_:flaggedcheckbox" name="q20803:451_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q451&id=5168"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:451_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man is referred for management of mild intermittent claudication due to infrainguinal occlusive disease. He stopped smoking 5 years ago and participates regularly in an exercise program. He does not have hypertension, diabetes, or known heart disease. What is the recommended treatment goal of LDL in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:451_answer" disabled="disabled" value="0" id="q20803:451_answer0"><label for="q20803:451_answer0">a. &lt; 150 mg/dL</label> </div>
<div class="r1"><input type="radio" name="q20803:451_answer" disabled="disabled" value="1" id="q20803:451_answer1"><label for="q20803:451_answer1">b. &lt; 100 mg/dL</label> </div>
<div class="r0"><input type="radio" name="q20803:451_answer" disabled="disabled" value="2" id="q20803:451_answer2"><label for="q20803:451_answer2">c. &lt; 70 mg/dL</label> </div>
<div class="r1"><input type="radio" name="q20803:451_answer" disabled="disabled" value="3" id="q20803:451_answer3"><label for="q20803:451_answer3">d. &lt; 40 mg/dL</label> </div>
<div class="r0"><input type="radio" name="q20803:451_answer" disabled="disabled" value="4" id="q20803:451_answer4"><label for="q20803:451_answer4">e. there is no recommended goal of LDL in this patient without known heart disease</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:451_-submit" name="q20803:451_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>According to ACC/AHA guidelines for the management of patients with PAD, treatment with a hydroxymethyl glutaryl coenzyme-A reductase inhibitor (statin) is indicated to achieve a target low-density lipoprotein (LDL) cholesterol level of less than 100 mg/dL. In patients considered to be at very high risk, a therapeutic target of 70 mg/dL has been recommended. Among the factors that define very high risk in individuals with PAD are: 1) multiple major risk factors (especially diabetes), 2) poorly controlled risk factors (especially smoking), 3) components of the metabolic syndrome (especially elevated triglycerides), and 4) individuals with acute coronary syndromes. In short, the recommended goal is 100 mg/dL in patients with disease confined to one vascular bed and 70 mg/dL in patients with disease in more than one vascular bed.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/16702489" target="_blank">Smith SC Jr, Allen J, Blair SN, Bonow RO<span>,&nbsp;</span>Brass LM<span>,&nbsp;</span>Fonarow GC<span>,&nbsp;</span>et al. AHA/ACC Guidelines for secondary prevention of patients with coronary and other atherosclerotic vascular disease: 2006 update. Endorsed by the National Heart, Lung, and Blood Institute. Circulation 2006; 113 (19):2363-72.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=ACC%2FAHA+Guidelines+for+the+Management+of+Patients+With+Peripheral+Arterial+Disease+(Lower+Extremity%2C+Renal%2C+Mesenteric%2C+and+Abdominal+Aortic)%3A+Executive+Summary." target="_blank">Hirsch A, Haskal Z, Hertzer N, Bakal CW<span>,&nbsp;</span>Creager MA<span>,&nbsp;</span>Halperin JL<span>,</span>&nbsp;et al. ACC/AHA Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic): Executive Summary. J Am Coll Cardiol 2006; 47(6): 1239-312.</a></p>
<p>QID: 30808</p></div><div class="rightanswer">The correct answer is: &lt; 100 mg/dL</div></div></div></div></div><div id="q148" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">38</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_506"><input type="hidden" name="q20803:148_:flagged" value="0"><input type="hidden" value="qaid=911032&amp;qubaid=20803&amp;qid=4766&amp;slot=148&amp;checksum=9cb865e24cde0d47de9cbd27f4ea9528&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:148_:flaggedcheckbox" name="q20803:148_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q148&id=4766"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:148_:sequencecheck" value="2"><div class="qtext"><p class="desc">Which of the following statements regarding aberrant LEFT subclavian artery is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:148_answer" disabled="disabled" value="0" id="q20803:148_answer0"><label for="q20803:148_answer0">a. most patients are symptomatic</label> </div>
<div class="r1"><input type="radio" name="q20803:148_answer" disabled="disabled" value="1" id="q20803:148_answer1"><label for="q20803:148_answer1">b. more common in men than women</label> </div>
<div class="r0"><input type="radio" name="q20803:148_answer" disabled="disabled" value="2" id="q20803:148_answer2"><label for="q20803:148_answer2">c. more likely to have congenital heart disease than aberrant right subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:148_answer" disabled="disabled" value="3" id="q20803:148_answer3"><label for="q20803:148_answer3">d. thromboembolism is the most common presentation</label> </div>
<div class="r0"><input type="radio" name="q20803:148_answer" disabled="disabled" value="4" id="q20803:148_answer4"><label for="q20803:148_answer4">e. more common than aberrant right subclavian artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:148_-submit" name="q20803:148_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p class="desc">Patients with aberrant left subclavian arteries commonly have an associated right-sided aortic arch.&nbsp; Additionally, they have a 6-fold greater incidence of congenital heart anomalies compared to aberrant right subclavian arteries. Most patients are asymptomatic, however, a greater proportion have symptoms compared with aberrant right SCA. Aberrant left subclavian artery is less common than aberrant right subclavian artery. There is a slight preponderance of females. Most cases are discovered as an incidental finding on crossectional imaging obtained for other indications. The indications for intervention are similar to aberrant right subclavian artery and are related to compression of the&nbsp;aero-digestive tract or aneurysmal degeneration.</p>
<p class="desc">&nbsp;</p>
<h2 class="desc">References:</h2>
<p class="desc"><a href="http://www.sciencedirect.com/science/article/pii/S074152141102129X" target="_blank">Farhang B, Garg N,Stone WM, Ricotta JJ, Bower TC.&nbsp; Aberrant subclavian artery: presentation and outcomes.&nbsp; J Vasc Surg. 2011; 54(5):1542</a></p>
<p class="desc"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Thorac+Cardiovasc+Surg+2010%3B+139(5)%3Ae97-8." target="_blank">Wu JY, Chen HY, Shu CC, Yu CJ.&nbsp;Kommerell diverticulum, right-sided aorta, and left aberrant subclavian artery in a patient with dysphagia.&nbsp;J Thorac Cardiovasc Surg 2010; 139(5):e97-8.</a></p>
<p class="desc">QID: 30242</p></div><div class="rightanswer">The correct answer is: more likely to have congenital heart disease than aberrant right subclavian artery</div></div></div></div></div><div id="q44" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">39</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_515"><input type="hidden" name="q20803:44_:flagged" value="0"><input type="hidden" value="qaid=910928&amp;qubaid=20803&amp;qid=4721&amp;slot=44&amp;checksum=8717e9f3d69e45a054040cb933c172c2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:44_:flaggedcheckbox" name="q20803:44_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q44&id=4721"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:44_:sequencecheck" value="2"><div class="qtext"><p>A 53-year-old man undergoes uneventful endovascular repair of a 5.8 cm asymptomatic infrarenal abdominal aortic aneurysm (EVAR). &nbsp;The evening of his surgery, he complains of crampy abdominal pain followed by a bloody bowel movement. &nbsp;His temperature is 38.8C and he does not have peritonitis. White count is 19k and lactate is 2.8 (normal &lt;2.0). Which of the following is the most appropriate next step of care for this patient?</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:44_answer" disabled="disabled" value="0" id="q20803:44_answer0"><label for="q20803:44_answer0">a. exploratory laparotomy</label> </div>
<div class="r1"><input type="radio" name="q20803:44_answer" disabled="disabled" value="1" id="q20803:44_answer1"><label for="q20803:44_answer1">b. flat and upright abdominal x-rays</label> </div>
<div class="r0"><input type="radio" name="q20803:44_answer" disabled="disabled" value="2" id="q20803:44_answer2"><label for="q20803:44_answer2">c. aggressive IV fluid resuscitation and serial abdominal exams</label> </div>
<div class="r1"><input type="radio" name="q20803:44_answer" disabled="disabled" value="3" id="q20803:44_answer3"><label for="q20803:44_answer3">d. CT scan of the abdomen and pelvis</label> </div>
<div class="r0"><input type="radio" name="q20803:44_answer" disabled="disabled" value="4" id="q20803:44_answer4"><label for="q20803:44_answer4">e. sigmoidoscopy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:44_-submit" name="q20803:44_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This is a classic presentation of colon ischemia following aneurysm surgery. While the incidence of colon ischemia following EVAR is probably less than open repair, it should always be considered in the differential diagnosis of postoperative abdominal pain, especially if associated with early bowel function. Blood mixed with stool is pathognomonic for ischemic colitis. Diagnostic sigmoidoscopy is recommended to assess the viability of the colonic mucosa. If the mucosa is normal, other explanations for abdominal pain should be considered. If the mucosa is abnormal, the severity of ischemia should be graded. In the presence of full thickness ischemia, urgent colectomy and end colostomy is appropriate. &nbsp;If only mucosal ischemia is detected, antibiotics and fluid resuscitation are indicated. In selected cases, late re-implantation of the inferior mesenteric artery has been reported to restore colonic perfusion and prevent acute perforation or the late development of stricture.</p>
<p>&nbsp;<img src="./VESAP3_files/colon ischemia.jpg" alt="" width="579" height="434"></p>
<h2>References:&nbsp;&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vasc+Endovascular+Surg+2010%3B44%3A+597%E2%80%93600" target="_blank">Sfyroeras GS, Koutsias S, Karathanos C, Stamoulis K, Giannoukas AD. Colonic ischemia after endovascular exclusion of an aortoiliac aneurysm using an iliac branch device. Vasc Endovascular Surg 2010; 44:597–600</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+48%3A272%E2%80%937." target="_parent">Perry RJ, Martin MJ, Eckert MJ, Sohn VY, Steele SR. Colonic ischemia complicating open vs endovascular abdominal aortic aneurysm repair. J Vasc Surg 2008; 48:272–7.</a></p>
<p>QID: 30048</p></div><div class="rightanswer">The correct answer is: sigmoidoscopy</div></div></div></div></div><div id="q339" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">40</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_524"><input type="hidden" name="q20803:339_:flagged" value="0"><input type="hidden" value="qaid=911223&amp;qubaid=20803&amp;qid=5131&amp;slot=339&amp;checksum=262f14838aefb631ecd31df01e15e63c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:339_:flaggedcheckbox" name="q20803:339_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q339&id=5131"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:339_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old woman with poorly controlled 4-drug hypertension, severe bilateral lower extremity claudication, and postprandial abdominal pain has the angiographic findings shown below. Which of the following is the most appropriate management option for this patient?<br><br><a href="./VESAP3_files/AssetProxy_040.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_040.jpg" alt="img" width="100" height="85" border="0" hspace="10" vspace="10"></a><a href="./VESAP3_files/AssetProxy_126.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_126.jpg" alt="img" width="100" height="85" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:339_answer" disabled="disabled" value="0" id="q20803:339_answer0"><label for="q20803:339_answer0">a. aortic and superior mesenteric artery angioplasty and stenting</label> </div>
<div class="r1"><input type="radio" name="q20803:339_answer" disabled="disabled" value="1" id="q20803:339_answer1"><label for="q20803:339_answer1">b. axillary-bifemoral bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:339_answer" disabled="disabled" value="2" id="q20803:339_answer2"><label for="q20803:339_answer2">c. trans-aortic visceral and renal endarterectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:339_answer" disabled="disabled" value="3" id="q20803:339_answer3"><label for="q20803:339_answer3">d. thoraco-femoral bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:339_answer" disabled="disabled" value="4" id="q20803:339_answer4"><label for="q20803:339_answer4">e. infrarenal aorta to renal artery and superior mesenteric artery bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:339_-submit" name="q20803:339_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Complex aortic disease that involves the visceral and renal arteries is a challenging clinical problem. This patient has a so-called "coral reef" type lesion in the para-visceral, para-renal aorta, with extension into the superior mesenteric artery (SMA). The primary pathology is aortic with extension of aortic atherosclerosis into branch vessels. To globally address the patient's symptoms requires a direct surgical approach. The only procedure that addresses all 3 of her symptomatic complaints is trans-aortic visceral and renal endarterectomy.<br><br><a href="./VESAP3_files/AssetProxy_077.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_077.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a><a href="./VESAP3_files/AssetProxy_146.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_146.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a><a href="./VESAP3_files/AssetProxy_091.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_091.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a><a href="./VESAP3_files/AssetProxy_157.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_157.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a><br><br>The University of California-San Francisco group has written several reports on their experience with this technique (operative photographs are shown above). In one of the reports, they observed a 3% mortality rate and a 3% incidence of recurrent mesenteric symptoms in 67 patients. They concluded that it may be an invaluable option in patients with appropriate anatomy.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1986%3B+3+(5)%3A799-806." target="_blank">Rapp JH, Reilly LM, Qvarfordt PG, Goldstone J<span>,&nbsp;</span>Ehrenfeld WK<span>,&nbsp;</span>Stoney RJ<span>.</span>&nbsp;Durability of endarterectomy and antegrade grafts in the treatment of chronic visceral ischemia. J Vasc Surg 1986; 3 (5):799-806.</a><br><br>Huber TS, Lee WA, Seeger JM. Chronic mesenteric ischemia. In: Rutherford RB, ed. Vascular Surgery. 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1739-45.</p>
<p>QID: 30605</p></div><div class="rightanswer">The correct answer is: trans-aortic visceral and renal endarterectomy</div></div></div></div></div><div id="q242" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">41</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_533"><input type="hidden" name="q20803:242_:flagged" value="0"><input type="hidden" value="qaid=911126&amp;qubaid=20803&amp;qid=4973&amp;slot=242&amp;checksum=0cfd36a249a6943af2ba92ec8d19eb59&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:242_:flaggedcheckbox" name="q20803:242_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q242&id=4973"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:242_:sequencecheck" value="2"><div class="qtext"><p>A 67-year-old man with end-stage renal disease (ESRD) presents with complaints of increasing edema of the right upper extremity 2 years after placement of a right brachial-cephalic upper arm direct access. On physical examination of his right arm, he has a prominent pulse overlying his arteriovenous (AV) access, moderate edema, and palpable radial, ulnar, and brachial artery pulses. Venography of the right upper extremity shows an 80% subclavian vein stenosis, a patent internal jugular vein with no stenosis, and a patent innominate vein with no stenosis. Which of the following is the best management option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:242_answer" disabled="disabled" value="0" id="q20803:242_answer0"><label for="q20803:242_answer0">a. right subclavian vein angioplasty with covered stent placement</label> </div>
<div class="r1"><input type="radio" name="q20803:242_answer" disabled="disabled" value="1" id="q20803:242_answer1"><label for="q20803:242_answer1">b. right subclavian vein angioplasty with bare metal stent placement</label> </div>
<div class="r0"><input type="radio" name="q20803:242_answer" disabled="disabled" value="2" id="q20803:242_answer2"><label for="q20803:242_answer2">c. right subclavian vein angioplasty</label> </div>
<div class="r1"><input type="radio" name="q20803:242_answer" disabled="disabled" value="3" id="q20803:242_answer3"><label for="q20803:242_answer3">d. ligation of the AV access</label> </div>
<div class="r0"><input type="radio" name="q20803:242_answer" disabled="disabled" value="4" id="q20803:242_answer4"><label for="q20803:242_answer4">e. right subclavian to internal jugular venous bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:242_-submit" name="q20803:242_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Venous hypertension occurs secondary to venous outflow stenosis, with or without venous valvular incompetence. The outflow obstruction is commonly located in the subclavian vein due to intimal hyperplasia associated with central venous catheters, but it may also be located anywhere along the venous outflow tract. Clinical presentation ranges from asymptomatic, with only increased dialysis venous pressures, to symptomatic, including prolonged puncture site bleeding, extremity edema, varicosities, pigmentation, dermatosclerosis, and venous ulceration. Patients with clinically symptomatic venous hypertension should be evaluated further with venography. Subclavian vein stenosis may be treated by a number of either endovascular or open surgical methods, but, due to their minimally invasive nature, endovascular techniques should be attempted first. Successful central venous angioplasty, which may require high pressure balloons, will alleviate symptoms. There is no proven benefit to placement of either bare metal or covered stents post-angioplasty; these should be reserved for either suboptimal results with angioplasty alone or recurrent stenosis. If endovascular methods of treatment fail, open surgical methods include subclavian to internal jugular bypass and jugular turndown. Ligation of the AV access should only be used as a last resort, such as instances when the subclavian stenosis is not amenable to treatment options described above or with occlusions of the innominate vein.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Brown%20L,%20McLarent%20JT.%20Subclavian%20to%20jugular%20bypass%20for%20relief%20of%20intractable%20venous%20hypertension%20and%20salvage%20of%20hemodialysis%20access.%20J%20Vasc%20Surg;%201993;%2018%20():537" target="_blank">Brown L, McLarent JT. Subclavian to jugular bypass for relief of intractable venous hypertension and salvage of hemodialysis access. J Vasc Surg; 1993; 18:537.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/3726757" target="_blank">Currier CB, Widder S, Ali A, Kuusisto E<span>,&nbsp;</span>Sidawy A. Surgical management of subclavian and axillary vein thrombosis in patients with a functioning arteriovenous fistula. Surgery 1986; 100 (1):25-8.</a></p>
<p>QID: 30423</p></div><div class="rightanswer">The correct answer is: right subclavian vein angioplasty</div></div></div></div></div><div id="q348" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">42</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_542"><input type="hidden" name="q20803:348_:flagged" value="0"><input type="hidden" value="qaid=911232&amp;qubaid=20803&amp;qid=5141&amp;slot=348&amp;checksum=c93755c4de217bf8e12a06f1a04fbb71&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:348_:flaggedcheckbox" name="q20803:348_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q348&id=5141"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:348_:sequencecheck" value="2"><div class="qtext"><p>A 53-year-old woman with a history of chronic mesenteric ischemia and a retrograde right common iliac to superior mesenteric artery bypass presents with recurrence of her post-prandial abdominal pain. Her abdomen is non-tender. CT arteriography demonstrates a flush occlusion of both the celiac axis and superior mesenteric artery and an occluded retrograde bypass. Which of the following is the best treatment option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:348_answer" disabled="disabled" value="0" id="q20803:348_answer0"><label for="q20803:348_answer0">a. thrombectomy of the retrograde bypass with revision of the proximal anastomosis by re-siting on the left common iliac artery</label> </div>
<div class="r1"><input type="radio" name="q20803:348_answer" disabled="disabled" value="1" id="q20803:348_answer1"><label for="q20803:348_answer1">b. thrombolysis of the retrograde bypass with stenting of any stenoses that are revealed</label> </div>
<div class="r0"><input type="radio" name="q20803:348_answer" disabled="disabled" value="2" id="q20803:348_answer2"><label for="q20803:348_answer2">c. thrombectomy of the retrograde bypass and long-term anticoagulation with a target PT INR of 2.5 - 3.5</label> </div>
<div class="r1"><input type="radio" name="q20803:348_answer" disabled="disabled" value="3" id="q20803:348_answer3"><label for="q20803:348_answer3">d. antegrade aortoceliac/aortosuperior mesenteric artery bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:348_answer" disabled="disabled" value="4" id="q20803:348_answer4"><label for="q20803:348_answer4">e. retrograde bypass to the celiac axis from the left common iliac artery with 6 mm PTFE</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:348_-submit" name="q20803:348_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Remedial, open surgical revascularization for recurrent symptoms of chronic mesenteric ischemia is occasionally necessary, although quite rare, given the excellent graft patency rates for mesenteric bypass. The surgical options include both antegrade and retrograde bypasses, with the choice being contingent upon the distribution of any aortoiliac occlusive disease and the original procedure. A failed retrograde bypass from the infrarenal aorta to the superior mesenteric artery (SMA) can usually be remediated with the traditional antegrade bypass from the supraceliac aorta to both the celiac axis and the SMA. This usually requires siting the SMA anastomosis distal to the original one and obviates the concern about the course of the retrograde graft that may have contributed to the initial failure. A failed antegrade bypass can usually be redone or converted to a retrograde bypass. Clearly the latter option is much simpler, but the overriding principle in this setting should be to optimize the potential long-term graft patency and clinical success, rather than minimizing the operative procedure. It is distinctly unusual for both limbs of an antegrade bypass to fail, and this scenario would suggest a problem at the proximal aortic anastomosis. In the more common scenario, in which a single graft limb occludes, it is usually due to a stenosis at the distal anastomosis from intimal hyperplasia or a technical problem from tunneling or kinking of the graft. The anastomotic problem can be corrected by graft thrombectomy and revision of the anastomosis with a vein patch or a new interposition graft. Problems related to tunneling the graft usually require excising the redundant segment and/or replacing the limb. Redo mesenteric bypass, and particularly a redo ante grade bypass, may be technically challenging due to the previous dissection and the interval adhesions. Giswold et al reported an impressive series of 22 patients that underwent 33 repeat (or redo) mesenteric bypasses with a 6% mortality rate and a 62% primary patency rate at 4 years.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Giswold%20ME,%20Landry%20GJ,%20Taylor%20LM,%20Jr,%20et%20al.%20Outcomes%20after%20redo%20procedures%20for%20failed%20mesenteric%20revascularization.%20Eur%20J%20Vasc%20Endovasc%20Surg;%202004;%2038%20(4):315-319" target="_blank">Giswold ME, Landry GJ, Taylor LM, Jr, Moneta GL<span>.</span>&nbsp;Outcomes after redo procedures for failed mesenteric revascularization. Eur J Vasc Endovasc Surg 2004; 38(4):315-9.</a><br><br>Huber TS, Lee WA. Mesenteric vascular disease: Chronic ischemia. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:2273-88.</p>
<p>QID: 30615</p></div><div class="rightanswer">The correct answer is: antegrade aortoceliac/aortosuperior mesenteric artery bypass</div></div></div></div></div><div id="q55" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">43</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_551"><input type="hidden" name="q20803:55_:flagged" value="0"><input type="hidden" value="qaid=910939&amp;qubaid=20803&amp;qid=4311&amp;slot=55&amp;checksum=03f28ebfdd3e2d97779783a9b1edf9d4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:55_:flaggedcheckbox" name="q20803:55_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q55&id=4311"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:55_:sequencecheck" value="2"><div class="qtext"><p>A 70 year old female undergoes successful open repair of an infrarenal abdominal aortic aneurysm.&nbsp; She has previously required a partial colectomy.&nbsp; On postoperative day number two, she has an episode of dark, bloody stool.&nbsp; Sigmoidoscopy demonstrates mild duskiness of the colon mucosa with no frank infarction.&nbsp; She is hemodynamically stable without any further episodes of blood per rectum.&nbsp; Which of the following is NOT part of her further management?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:55_answer" disabled="disabled" value="0" id="q20803:55_answer0"><label for="q20803:55_answer0">a. Invasive monitoring</label> </div>
<div class="r1"><input type="radio" name="q20803:55_answer" disabled="disabled" value="1" id="q20803:55_answer1"><label for="q20803:55_answer1">b. Total abdominal colectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:55_answer" disabled="disabled" value="2" id="q20803:55_answer2"><label for="q20803:55_answer2">c. Bowel rest</label> </div>
<div class="r1"><input type="radio" name="q20803:55_answer" disabled="disabled" value="3" id="q20803:55_answer3"><label for="q20803:55_answer3">d. Intravenous fluid resuscitation</label> </div>
<div class="r0"><input type="radio" name="q20803:55_answer" disabled="disabled" value="4" id="q20803:55_answer4"><label for="q20803:55_answer4">e. Broad spectrum antibiotics</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:55_-submit" name="q20803:55_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Colon ischemia following aortic surgery is a potentially life-threatening complication.&nbsp; Prompt diagnosis and management is essential.&nbsp; Emergent flexible sigmoidoscopy is the initial diagnostic test of choice, and has been shown to be reliable in making the diagnosis.&nbsp; Patients with evidence of frank infarction or septic shock should be evaluated for emergent exploration with colectomy.&nbsp; Mucosal ischemic changes alone can be managed supportively, with very few patients progressing to frank necrosis.</p>
<p>Ernst CB, Hagihara PF, Daughtery ME, et al.&nbsp; Ischemic colitis incidence following abdominal aortic reconstruction: a prospective study.&nbsp; Surgery 1976 Oct; 80(4): 417-21.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/968729">http://www.ncbi.nlm.nih.gov/pubmed/968729</a></p>
<p>Brandt CP, Piotrowski JJ, Alexander JJ.&nbsp; Flexible sigmoidoscopy - a reliable determinant of colonic ischemia following ruptured abdominal aortic aneurysm.&nbsp; Surg Endosc.&nbsp; 1997 Feb; 11(2): 113-5.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/9069138">http://www.ncbi.nlm.nih.gov/pubmed/9069138</a></p>
<p>Brewster DC, Franlin DP, Cambria RP, et al.&nbsp; Intestinal ischemia complicating abdominal aortic surgery.&nbsp; Surgery. 1991 Apr; 109(4): 447-54.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/1844392">http://www.ncbi.nlm.nih.gov/pubmed/1844392</a></p>
<p>&nbsp;QID: 30060</p></div><div class="rightanswer">The correct answer is: Total abdominal colectomy</div></div></div></div></div><div id="q358" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">44</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_560"><input type="hidden" name="q20803:358_:flagged" value="0"><input type="hidden" value="qaid=911242&amp;qubaid=20803&amp;qid=5151&amp;slot=358&amp;checksum=30a3b813bd9fadc10ee6cec68b8771f6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:358_:flaggedcheckbox" name="q20803:358_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q358&id=5151"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:358_:sequencecheck" value="2"><div class="qtext"><p><span>Which of the following intraoperative maneuvers would&nbsp;facilitate&nbsp;exposure of the superior mesenteric artery (SMA)&nbsp;at the typical location for SMA embolectomy?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:358_answer" disabled="disabled" value="0" id="q20803:358_answer0"><label for="q20803:358_answer0">a. <span>caudal&nbsp;retraction of the transverse mesocolon</span></label> </div>
<div class="r1"><input type="radio" name="q20803:358_answer" disabled="disabled" value="1" id="q20803:358_answer1"><label for="q20803:358_answer1">b. <span>division of the inferior mesenteric vein</span></label> </div>
<div class="r0"><input type="radio" name="q20803:358_answer" disabled="disabled" value="2" id="q20803:358_answer2"><label for="q20803:358_answer2">c. <span>cephalad&nbsp;retraction of the&nbsp;left renal vein</span></label> </div>
<div class="r1"><input type="radio" name="q20803:358_answer" disabled="disabled" value="3" id="q20803:358_answer3"><label for="q20803:358_answer3">d. <span>retraction of the superior mesenteric vein to the patient's left</span></label> </div>
<div class="r0"><input type="radio" name="q20803:358_answer" disabled="disabled" value="4" id="q20803:358_answer4"><label for="q20803:358_answer4">e. <span>mobilization of the 4th portion of the duodenum to allow&nbsp;the root of the mesentery to be grasped</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:358_-submit" name="q20803:358_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The anatomy of the superior mesenteric artery (SMA) and its relationship to surrounding structures is vital to exposing the SMA for the open surgical treatment of both acute and chronic&nbsp;mesenteric ischemia.&nbsp;To perform SMA embolectomy, most surgeons expose the SMA&nbsp;in the root of the small bowel mesentery inferior to transverse mesocolon.&nbsp;Infra-mesocolic exposure of the SMA requires cephalad displacement of the transverse colon.&nbsp;For most open exposures of the SMA from an anterior, trans-abdominal approach (ie, not via a left flank or retroperitoneal approach),&nbsp;the artery is exposed near the root of the mesentery at a location&nbsp;inferior to the pancreas&nbsp;and distal to the point at which the SMA crosses over the duodenum. At this location, the SMA can be palpated in the mesentery in most cases, even if it is pulseless. A longitudinal incision in the anterior leaflet of the mesentery in this location will allow exposure of the SMA in the vicinity of the middle colic artery branch.&nbsp;If the superior mesenteric vein is encountered, dissection should proceed to the&nbsp;patient's left to identify the proximal superior mesenteric artery.</p>
<p>Many surgeons&nbsp;find it helpful to mobilize the 4th portion of the duodenum to allow the root of the mesentery to be grasped between the&nbsp;palm of the hand (posterior to the root of the mesentery) and the thumb (rolling over the SMA anteriorly). Although this maneuver can be helpful, it&nbsp;is not universally required for exposure of the SMA in that location.&nbsp;Of the choices available in this question, none of the maneuvers would facilitate exposure, except for mobilization of the 4th portion of the duodenum.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Lin PL. Treatment of acute visceral artery occlusive disease. in Mastery of Vascular and Endovascular Surgery, ed. Zelenock GB.</p>
<p>QID: 30628</p></div><div class="rightanswer">The correct answer is: <span>mobilization of the 4th portion of the duodenum to allow&nbsp;the root of the mesentery to be grasped</span></div></div></div></div></div><div id="q120" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">45</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_569"><input type="hidden" name="q20803:120_:flagged" value="0"><input type="hidden" value="qaid=911004&amp;qubaid=20803&amp;qid=4737&amp;slot=120&amp;checksum=0d042360fcde5de89a8a4cefc8495929&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:120_:flaggedcheckbox" name="q20803:120_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q120&id=4737"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:120_:sequencecheck" value="2"><div class="qtext"><p>A 26-year-old woman with a recent history of cocaine-induced anterior myocardial infarction (MI) presents with 6 hours of numbness and coolness of the right hand. Her right radial and ulnar pulses are not palpable, but her right axillary and left upper extremity pulses are easily palpable. The motor function of her right hand is diminished. &nbsp;Which of the following is the most probable diagnosis?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:120_answer" disabled="disabled" value="0" id="q20803:120_answer0"><label for="q20803:120_answer0">a. cocaine-induced vasculitis</label> </div>
<div class="r1"><input type="radio" name="q20803:120_answer" disabled="disabled" value="1" id="q20803:120_answer1"><label for="q20803:120_answer1">b. thrombosed aneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:120_answer" disabled="disabled" value="2" id="q20803:120_answer2"><label for="q20803:120_answer2">c. paradoxical embolus</label> </div>
<div class="r1"><input type="radio" name="q20803:120_answer" disabled="disabled" value="3" id="q20803:120_answer3"><label for="q20803:120_answer3">d. arterial dissection</label> </div>
<div class="r0"><input type="radio" name="q20803:120_answer" disabled="disabled" value="4" id="q20803:120_answer4"><label for="q20803:120_answer4">e. cardiogenic embolus</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:120_-submit" name="q20803:120_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Even though each of the available answers are possible sources for acute limb ischemia, the most likely diagnosis in&nbsp;this young patient is a brachial embolus from a&nbsp;cardiogenic source. The additional history of recent MI supports cardiogenic embolus as the best choice. Reports indicate that cardiac thrombus formation occurs in up to 40% of cases after myocardial infarction and is more&nbsp;common following&nbsp;anterior wall infarctions. The&nbsp;risk of embolism associated with myocardial thrombus approximates 5%.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Int+Medicine+1986%3B+146%3A593-7." target="_blank">Kaplan K. Prophylactic anticoagulation following acute myocardial infarction. Arch Int Medicine 1986; 146:593-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/3516044" target="_blank">Meltzer RS, Visser CA, Fuster V. Intracardiac thrombi and systemic embolization. Ann Int Med 1986;104:689-98.</a></p>
<p>QID: 30213</p></div><div class="rightanswer">The correct answer is: cardiogenic embolus</div></div></div></div></div><div id="q507" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">46</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_578"><input type="hidden" name="q20803:507_:flagged" value="0"><input type="hidden" value="qaid=911391&amp;qubaid=20803&amp;qid=5238&amp;slot=507&amp;checksum=fa3f9aadbe749cf96d077471235d7f62&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:507_:flaggedcheckbox" name="q20803:507_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q507&id=5238"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:507_:sequencecheck" value="2"><div class="qtext"><p>You are performing an urgent thoracic endovascular aneurysm repair (TEVAR) and a CT or 3D reconstruction is unavailable. The pathology requires distal coverage near &nbsp;the celiac artery. Of the following options, which C-arm gantry angle will likely provide the best image of the origin of the celiac artery ?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:507_answer" disabled="disabled" value="0" id="q20803:507_answer0"><label for="q20803:507_answer0">a. 30 degrees left anterior oblique (LAO)</label> </div>
<div class="r1"><input type="radio" name="q20803:507_answer" disabled="disabled" value="1" id="q20803:507_answer1"><label for="q20803:507_answer1">b. straight anterior-posterior (AP)</label> </div>
<div class="r0"><input type="radio" name="q20803:507_answer" disabled="disabled" value="2" id="q20803:507_answer2"><label for="q20803:507_answer2">c. 45 degrees right anterior oblique (RAO)</label> </div>
<div class="r1"><input type="radio" name="q20803:507_answer" disabled="disabled" value="3" id="q20803:507_answer3"><label for="q20803:507_answer3">d. 45 degrees left anterior oblique (LAO)</label> </div>
<div class="r0"><input type="radio" name="q20803:507_answer" disabled="disabled" value="4" id="q20803:507_answer4"><label for="q20803:507_answer4">e. 75 degrees left anterior oblique (LAO)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:507_-submit" name="q20803:507_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Visualization of the celiac artery origin is often important for placement of a thoracic endograft when attempting to achieve an adequate distal landing zone. The most common optimal gantry angle for the celiac origin is between 75 degrees LAO and straight lateral 90 degrees, with 75 degrees generally easier to obtain. However, in patients with tortuous, distorted anatomy from aneurysmal disease, this angle may not be ideal. Preoperative 3D reconstruction and measurements from CT scan reformats (in at least the axial plane) are necessary to determine the optimal C-arm gantry angle to visualize the celiac artery origin. CT and 3D reconstruction as part of preoperative planning can save fluoroscopy time and contrast intraoperatively, as well as avoid inadvertent branch vessel coverage or inadequate distal apposition resulting in a distal Type 1 endoleak.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Thorac+Cardiovasc+Surg%3B+2008%3B+20+(4)%3A348-357." target="_blank">Ueda T, Fleischmann D, Rubin GD, Dake MD<span>,&nbsp;</span>Sze DY. Imaging of the thoracic aorta before and after stent-graft repair of aneurysms and dissections. Semin Thorac Cardiovasc Surg 2008; 20(4):348-57.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2003%3B+38+(4)%3A730-738." target="_blank">Wyers MC, Fillinger MF, Schermerhorn ML, Powell RJ<span>,&nbsp;</span>Rzucidlo EM<span>,&nbsp;</span>Walsh DB,&nbsp;et al. Endovascular repair of abdominal aortic aneurysm without preoperative arteriography. J Vasc Surg 2003; 38(4):730-8.</a></p>
<p>QID: 30906</p></div><div class="rightanswer">The correct answer is: 75 degrees left anterior oblique (LAO)</div></div></div></div></div><div id="q139" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">47</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_587"><input type="hidden" name="q20803:139_:flagged" value="0"><input type="hidden" value="qaid=911023&amp;qubaid=20803&amp;qid=4756&amp;slot=139&amp;checksum=0320e7d8995fafbc40ac5f846f2b4951&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:139_:flaggedcheckbox" name="q20803:139_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q139&id=4756"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:139_:sequencecheck" value="2"><div class="qtext"><p>A 56-year-old man presents 2 hours after his left arm was trapped in a conveyor belt. There are skin abrasions on the medial surface of his left arm and forearm. The axillary pulse is present, but the brachial and radial pulses are absent. There is decreased sensation of the hand and forearm, but motor function is preserved. X-rays are negative for fractures and the CT angiogram obtained is below. Which of the following is the most appropriate management option for this patient?</p>
<p>&nbsp;</p>
<p><img alt="brachial artery injury" src="./VESAP3_files/brachial artery injury.jpg" width="400" height="400"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:139_answer" disabled="disabled" value="0" id="q20803:139_answer0"><label for="q20803:139_answer0">a. <p>catheter-directed thrombectomy and balloon angioplasty</p></label> </div>
<div class="r1"><input type="radio" name="q20803:139_answer" disabled="disabled" value="1" id="q20803:139_answer1"><label for="q20803:139_answer1">b. exploration with debridement and primary repair of the artery</label> </div>
<div class="r0"><input type="radio" name="q20803:139_answer" disabled="disabled" value="2" id="q20803:139_answer2"><label for="q20803:139_answer2">c. catheter-directed thrombectomy and stent placement</label> </div>
<div class="r1"><input type="radio" name="q20803:139_answer" disabled="disabled" value="3" id="q20803:139_answer3"><label for="q20803:139_answer3">d. saphenous vein interposition graft</label> </div>
<div class="r0"><input type="radio" name="q20803:139_answer" disabled="disabled" value="4" id="q20803:139_answer4"><label for="q20803:139_answer4">e. brachial thrombectomy from antecubital incision</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:139_-submit" name="q20803:139_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has acute left upper extremity ischemia resulting from blunt trauma, with demonstration of a segmental occlusion of the brachial artery in the distal upper arm. &nbsp;Although penetrating injuries can frequently be managed successfully with local debridement and primary repair, blunt injuries are usually associated with more severe intimal damage&nbsp;that extends beyond the segment that appears grossly injured on external arterial inspection.&nbsp;In this case, the relatively lengthy segment of thrombosis and injury would be better managed with interposition graft rather than primary repair. Reversed saphenous vein is the conduit of choice. Given the relatively short duration of ischemia, fasciotomies may not be necessary and can be selectively performed if symptoms persist or worsen following vascular repair. &nbsp;</p>
<p>Permanent disability occurs more frequently after blunt versus penetrating upper extremity injuries, and the risk is increased by associated orthopedic, nerve, and vein injuries. In comparison to lower extremity injuries, amputation of the arm is required less often.</p>
<p>&nbsp;</p>
<h2 style="TEXT-ALIGN: left" align="center">References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Curr+Opin+Crit+Care.+2010%3B16(6)%3A602-8." target="_blank">Feliciano DV. Management of peripheral arterial injury. Curr Opin Crit Care 2010;16(6):602-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2012%3B+26(5)%3A655-64." target="_blank">Franz RW, Skytta CK, Shah KJ, Hartman JF, Wright ML. A five-year review of management of upper-extremity arterial injuries at an urban level I trauma center. Ann Vasc Surg 2012; 26(5):655-64.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2001%3B15(1)%3A43-8." target="_blank">Brown KR, Jean-Claude J, Seabrook GR, Towne JB, Cambria RA. Determinates of functional disability after complex upper extremity trauma. Ann Vasc Surg 2001;15(1):43-8.</a></p>
<p>QID: 30232</p></div><div class="rightanswer">The correct answer is: saphenous vein interposition graft</div></div></div></div></div><div id="q340" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">48</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_596"><input type="hidden" name="q20803:340_:flagged" value="0"><input type="hidden" value="qaid=911224&amp;qubaid=20803&amp;qid=5132&amp;slot=340&amp;checksum=063e17fdb61950e7117e00ecc6926385&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:340_:flaggedcheckbox" name="q20803:340_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q340&id=5132"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:340_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old woman is taken urgently to the operating room by the colorectal surgeons for presumed ischemic colitis. At exploration, ischemia of the small bowel from the mid jejunum to the ileocecal valve and the ascending colon is detected (image is shown below). The transverse, descending, and sigmoid colon appear to be spared. You are asked to provide an intraoperative consultation. Which of the following is the most probable diagnosis?<br><br><a href="./VESAP3_files/AssetProxy_094.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_094.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:340_answer" disabled="disabled" value="0" id="q20803:340_answer0"><label for="q20803:340_answer0">a. thrombotic occlusion of the iliocolic artery with sparing of the main superior mesenteric artery</label> </div>
<div class="r1"><input type="radio" name="q20803:340_answer" disabled="disabled" value="1" id="q20803:340_answer1"><label for="q20803:340_answer1">b. embolus to the proximal superior mesenteric artery</label> </div>
<div class="r0"><input type="radio" name="q20803:340_answer" disabled="disabled" value="2" id="q20803:340_answer2"><label for="q20803:340_answer2">c. embolus to the superior mesenteric artery lodging immediately distal to the middle colic artery</label> </div>
<div class="r1"><input type="radio" name="q20803:340_answer" disabled="disabled" value="3" id="q20803:340_answer3"><label for="q20803:340_answer3">d. non-occlusive mesenteric ischemia</label> </div>
<div class="r0"><input type="radio" name="q20803:340_answer" disabled="disabled" value="4" id="q20803:340_answer4"><label for="q20803:340_answer4">e. thrombotic occlusion of the superior mesenteric artery at its origin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:340_-submit" name="q20803:340_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Cardiac emboli to the superior mesenteric artery (SMA) typically lodge at major branch points in the SMA where the caliber of the artery diminishes. <br><br><a href="./VESAP3_files/AssetProxy_148.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_148.jpg" alt="img" width="124" height="92" border="0" hspace="10" vspace="10"></a><a href="./VESAP3_files/AssetProxy_064.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_064.jpg" alt="img" width="100" height="93" border="0" hspace="10" vspace="10"></a><br><br>The most common site is immediately distal to the takeoff of the middle colic artery. An embolus at this site typically spares the proximal jejunal branches and proximal jejunum and produces ischemia of the mid and distal jejunum and ileum. This is in contrast to a thrombotic occlusion of the SMA, which produces intestinal ischemia involving the small intestine from the ligament of Treitz to the ascending colon. With thrombotic occlusion of the SMA, the transverse and descending colon are often less ischemic or spared altogether due to collaterals from the inferior mesenteric artery to these segments of colon. Visualization of a meandering artery is also an indication of longstanding mesenteric occlusive disease that would point towards thrombotic mesenteric ischemia.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Bergan%20JJ.%20Recognition%20and%20treatment%20of%20intestinal%20ischemia.%20Surg%20Clin%20North%20Am;%201968;%2047%20(1):109" target="_blank">Bergan JJ. Recognition and treatment of intestinal ischemia. Surg Clin North Am 1968; 47 (1):109-26.</a><br><br>Wyers MC, Zwolak RM. Physiology and diagnosis of splanchnic arterial occlusion. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1707-17.</p>
<p>QID: 30606</p></div><div class="rightanswer">The correct answer is: embolus to the superior mesenteric artery lodging immediately distal to the middle colic artery</div></div></div></div></div><div id="q177" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">49</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_605"><input type="hidden" name="q20803:177_:flagged" value="0"><input type="hidden" value="qaid=911061&amp;qubaid=20803&amp;qid=4681&amp;slot=177&amp;checksum=85952ae4c95a1f83a334414ae9b4cd0d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:177_:flaggedcheckbox" name="q20803:177_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q177&id=4681"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:177_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding clopidogrel resistance in patients undergoing carotid stenting is true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:177_answer" disabled="disabled" value="0" id="q20803:177_answer0"><label for="q20803:177_answer0">a. Clopidogrel resistance does not occur, it is a myth</label> </div>
<div class="r1"><input type="radio" name="q20803:177_answer" disabled="disabled" value="1" id="q20803:177_answer1"><label for="q20803:177_answer1">b. certain medications, such as omeprazole and calcium channel blockers, increase the effects of clopidogrel</label> </div>
<div class="r0"><input type="radio" name="q20803:177_answer" disabled="disabled" value="2" id="q20803:177_answer2"><label for="q20803:177_answer2">c. resistance is associated with mutations in the CYP2C19 gene</label> </div>
<div class="r1"><input type="radio" name="q20803:177_answer" disabled="disabled" value="3" id="q20803:177_answer3"><label for="q20803:177_answer3">d. individualized dosing based on platelet function testing improves outcomes in large randomized trials</label> </div>
<div class="r0"><input type="radio" name="q20803:177_answer" disabled="disabled" value="4" id="q20803:177_answer4"><label for="q20803:177_answer4">e. at present, clopidiogrel is the only antiplatelet agent appropriate for patients undergoing carotid stenting</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:177_-submit" name="q20803:177_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The response to clopidogrel has been widely examined, as it is thought that up to one third of patients are poor responders. Resistance is associated with mutations in the CYP2C19 gene. This gene encodes for a member of the cytochrome P450 superfamily of enzymes. Clopidogrel is given orally as an inactive pro-drug that requires bioactivation via several enzymes, including CYP2C19. Genetic testing for mutations in the CYP2C19 gene is available, and higher dosing strategies have been recommended in such patients. Strong data confirming a benefit from these dosing modifications is currently unavailable. Another strategy, involving the use of bedside platelet function testing using the VerifyNow system, has been recently evaluated. Unfortunately, clinical trials have not shown a benefit of individualized clopidogrel dosing based on such tests. Proton pump inhibitors are thought to decrease, not increase, the effects of clopidogrel by interacting with cytochrome P450 enzymes that metabolize it to its active form. Other anti-platelet agents that work through P2Y12 receptor inhibition (ticlopidine, prasugrel, and ticagrelor) are available and some have recommended the use of these agents in patients with clopidogrel resistance.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23026654" target="_blank">Cattaneo M, Mechanisms of variability in antiplatelet agents response. Thrombosis Research 2012; 130, Supplement 1: S27-8.</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/23026654"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/16772608" target="_blank">Hulot JS, Bura A,&nbsp;Villard E,&nbsp;Azizi M,&nbsp;Remones V,&nbsp;Goyenvalle C,&nbsp;et al. Cytochrome P450 2C19 loss-of-function polymorphism is a major determinant of clopidogrel responsiveness in healthy subjects. Blood 2006; 108(7): 2244-7. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/16772608"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24030523" target="_blank">D'Ugo E, Rossi S, De Caterina R. Proton pump inhibitors and clopidogrel: an association to avoid? Intern Emerg Med 2013; 9(1):11-22.</a><a href="http://www.ncbi.nlm.nih.gov/pubmed/24030523"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Brilakis+ES%2C+Patel+VG%2C+Banerjee+S.+Medical+management+after+coronary+stent+implantation%3A+a+review.+Jama+2013%3B+310(2)%3A+189-98." target="_blank">Brilakis ES, Patel VG, Banerjee S. Medical management after coronary stent implantation: a review. Jama 2013; 310(2): 189-98.</a></p>
<p>QID: 30318</p></div><div class="rightanswer">The correct answer is: resistance is associated with mutations in the CYP2C19 gene</div></div></div></div></div><div id="q287" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">50</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_614"><input type="hidden" name="q20803:287_:flagged" value="0"><input type="hidden" value="qaid=911171&amp;qubaid=20803&amp;qid=5087&amp;slot=287&amp;checksum=8cf71f8e00470546c0428ed105bc538c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:287_:flaggedcheckbox" name="q20803:287_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q287&id=5087"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:287_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man with sudden onset of a severe headache was found to have an intracranial hemorrhage. He underwent successful clipping of an intracranial aneurysm. However, 3 days post-operatively he had neurologic deterioration. The following transcranial Doppler waveform was obtained from a depth of 70 mm through a trans-temporal window. The below waveform indicates which of the following?</p>
<p><a href="./VESAP3_files/10987.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/10987.jpg" alt="Img" width="100" height="55"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:287_answer" disabled="disabled" value="0" id="q20803:287_answer0"><label for="q20803:287_answer0">a. vasospasm of the middle cerebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:287_answer" disabled="disabled" value="1" id="q20803:287_answer1"><label for="q20803:287_answer1">b. normal flow pattern of the middle cerebral artery</label> </div>
<div class="r0"><input type="radio" name="q20803:287_answer" disabled="disabled" value="2" id="q20803:287_answer2"><label for="q20803:287_answer2">c. normal flow pattern of the posterior cerebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:287_answer" disabled="disabled" value="3" id="q20803:287_answer3"><label for="q20803:287_answer3">d. normal flow pattern of the anterior cerebral artery</label> </div>
<div class="r0"><input type="radio" name="q20803:287_answer" disabled="disabled" value="4" id="q20803:287_answer4"><label for="q20803:287_answer4">e. vasospasm of the anterior cerebral artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:287_-submit" name="q20803:287_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Interpretation of transcranial Doppler studies is dependent upon knowledge of the window used for obtaining the Doppler waveform, the depth from which the waveform was obtained, and the expected direction of flow within the particular artery. The transtemporal window is used to examine the middle cerebral, anterior cerebral, and posterior cerebral arteries, as well as the terminal intracranial internal carotid artery. The middle cerebral artery is imaged at a depth of 30-60 mm and demonstrates antegrade flow towards the probe. The terminal internal carotid artery is imaged at a depth of 55-65 mm and normally demonstrates bidirectional flow. The anterior cerebral artery is imaged at a depth of 60-80 mm and normally demonstrates retrograde flow away from the probe. The posterior cerebral artery is imaged at a depth of 60-70 mm and demonstrates antegrade flow towards the probe. Vasospasm is defined as elevations of mean velocities. Normal mean velocities in the vessels visible through the trans temporal window are less than 60 cm/second. Vasospasm of the middle cerebral artery is defined as a mean velocity greater than 120 cm/second. Vasospasm of the anterior cerebral artery is described as a mean velocity greater than 130 cm/second without evidence of vasospasm in the middle cerebral artery. A mean velocity of greater than 110 cm/second in the posterior cerebral artery indicates vasospasm. When there is vasospasm in the middle cerebral artery, elevated mean velocities in the anterior cerebral and posterior cerebral artery may indicate vasospasm or collateral flow. The waveform shown, obtained from a depth appropriate for the anterior cerebral artery, demonstrates flow away from the probe and the mean velocity would not approach criteria for vasospasm; thus, it is a normal flow pattern for the anterior cerebral artery.<br><br></p>
<h3>Reference:</h3>
<p>Byrd-Raynor SM, Smith WB. Transcranial duplex imaging. In: Strandness's Duplex Scanning in Vascular Disorders, 4th ed. Zierler RE, ed. Lippincott Williams &amp; Wilkins, Philadelphia, PA; 2010:101-13.</p>
<p>QID: 30507</p></div><div class="rightanswer">The correct answer is: normal flow pattern of the anterior cerebral artery</div></div></div></div></div><div id="q143" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">51</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_623"><input type="hidden" name="q20803:143_:flagged" value="0"><input type="hidden" value="qaid=911027&amp;qubaid=20803&amp;qid=4761&amp;slot=143&amp;checksum=e66a5b911026334d8f62aaa7f28665be&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:143_:flaggedcheckbox" name="q20803:143_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q143&id=4761"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:143_:sequencecheck" value="2"><div class="qtext"><p>A 41-year-old non-smoking woman presents with a 3-month history of severe cramping pain in her left forearm with moderate arm activity. On physical examination, her left radial and ulnar pulses are not palpable, but the Doppler signals are present. The ESR is normal. The MRI did not reveal increased signal in the arterial wall of her aorta or branches. Angiography was performed to determine the anatomy of her upper extremity circulation; selected images obtained are shown below (Figs 1 &amp; 2). Based on the images, which of the following is the best, most durable treatment option to alleviate this patient's symptoms?<br></p><p><img src="./VESAP3_files/Cull - 10 image1.jpg" alt="Cull - 10 image1" width="349" height="362">&nbsp;</p>
<p><img src="./VESAP3_files/Cull - 10 image2.jpg" alt="Cull - 10 image2" width="471" height="471"></p>
<p><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:143_answer" disabled="disabled" value="0" id="q20803:143_answer0"><label for="q20803:143_answer0">a. subclavian to brachial bypass with polytetrafluoroethylene (PTFE)</label> </div>
<div class="r1"><input type="radio" name="q20803:143_answer" disabled="disabled" value="1" id="q20803:143_answer1"><label for="q20803:143_answer1">b. angiography with re-canalization and angioplasty/stenting of the subclavian/axillary artery</label> </div>
<div class="r0"><input type="radio" name="q20803:143_answer" disabled="disabled" value="2" id="q20803:143_answer2"><label for="q20803:143_answer2">c. left carotid to brachial artery bypass with reversed saphenous vein</label> </div>
<div class="r1"><input type="radio" name="q20803:143_answer" disabled="disabled" value="3" id="q20803:143_answer3"><label for="q20803:143_answer3">d. angiography, re-canalization, and atherectomy of the subclavian/axillary artery</label> </div>
<div class="r0"><input type="radio" name="q20803:143_answer" disabled="disabled" value="4" id="q20803:143_answer4"><label for="q20803:143_answer4">e. hospitalization and aggressive treatment with intravenous high-dose corticosteroids</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:143_-submit" name="q20803:143_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The patient likely suffers from long-term sequelae of Takayasu’s arteritis. Surgery is generally contraindicated during the active inflammatory phase of the disease, except to save life or limb. The presence of a normal ESR suggests that the disease is currently quiescent. She has severe symptoms and treatment is warranted. Given the patient’s excellent health and the long segment of occlusion, an open revascularization is likely to be most durable. In the absence of signs of active disease, treatment with aggressive immunosuppression is unlikely to give significant improvement. Percutaneous treatment of any modality in the case of a long occlusion such as this is not likely to be as durable as open repair. As in the case of the lower extremity, a good quality saphenous vein conduit will likely provide more durable results than PTFE.</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2000%3B+14(2)%3A125-9." target="_blank">Sparks SR, Chock A, Seslar S, Bergan JJ<span>,&nbsp;</span>Owens EL. Surgical treatment of Takayasu’s arteritis: case report and literature review. Ann Vasc Surg&nbsp;2000; 14(2):125-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Vasc+Surg+1994%3B8(4)%3A401-7." target="_blank">Robbs JV, Abdool-Carrim AT, Kadwa AM. Arterial reconstruction for non-specific arteritis (Takayasu’s disease) medium to long-term results. Eur J Vasc Surg&nbsp;1994;8(4):401-7.</a></p>
<p><a style="line-height: 1.5;" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1990%3B+12(4)%3A429-37." target="_blank">Weaver FA, Yellin AE, Campen DH, Oberg J,&nbsp;Foran J,&nbsp;Kitridou RC,&nbsp;et al. Surgical procedures in the management of Takayasu’s arteritis. J Vasc Surg&nbsp;1990; 12(4):429-37.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2012%3B+125%3A813-9." target="_blank">Saadoun D, Lambert M, Mirault T, Resche-Rigon M<span>,&nbsp;</span>Koskas F<span>,&nbsp;</span>Cluzel P,&nbsp;et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu's arteritis: a multicenter experience. Circulation&nbsp;2012; 125:813-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2006%3B+43%3A64-71." target="_blank">Fields CE, Bower TC, Cooper LT, Hoskin T<span>,&nbsp;</span>Noel AA<span>,&nbsp;</span>Panneton JM, et al. Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg 2006; 43:64-71.</a></p>
<p>QID: 30237</p></div><div class="rightanswer">The correct answer is: left carotid to brachial artery bypass with reversed saphenous vein</div></div></div></div></div><div id="q506" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">52</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_632"><input type="hidden" name="q20803:506_:flagged" value="0"><input type="hidden" value="qaid=911390&amp;qubaid=20803&amp;qid=5237&amp;slot=506&amp;checksum=b5d39c8f55516c93bde604a738f23eea&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:506_:flaggedcheckbox" name="q20803:506_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q506&id=5237"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:506_:sequencecheck" value="2"><div class="qtext"><p>When performing thoracic endovascular aneurysm repair (TEVAR), the approximate gantry angle for best visualization of the brachiocephalic vessel origins is which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:506_answer" disabled="disabled" value="0" id="q20803:506_answer0"><label for="q20803:506_answer0">a. 45 degrees left anterior oblique (LAO)</label> </div>
<div class="r1"><input type="radio" name="q20803:506_answer" disabled="disabled" value="1" id="q20803:506_answer1"><label for="q20803:506_answer1">b. 45 degrees right anterior oblique (RAO)</label> </div>
<div class="r0"><input type="radio" name="q20803:506_answer" disabled="disabled" value="2" id="q20803:506_answer2"><label for="q20803:506_answer2">c. 0 degrees, straight anterior-posterior (AP)</label> </div>
<div class="r1"><input type="radio" name="q20803:506_answer" disabled="disabled" value="3" id="q20803:506_answer3"><label for="q20803:506_answer3">d. 15 degrees right anterior oblique (RAO)</label> </div>
<div class="r0"><input type="radio" name="q20803:506_answer" disabled="disabled" value="4" id="q20803:506_answer4"><label for="q20803:506_answer4">e. 90 degrees (full lateral position)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:506_-submit" name="q20803:506_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>When imaging the thoracic aorta for endovascular aneurysm repair it is important to obtain an image that is in a perpendicular plane (orthogonal) to the aorta so that the aortic branch origins are seen at their true location, all of the proximal landing zone is utilized, and no unintentional coverage of the vessels occurs (in this case the arch vessels). In general, 45 degrees of LAO is a good starting point for imaging the arch. However, with age, the arch tends to lengthen and steeper oblique angles may be necessary to appropriately visualize the brachiocephalic vessels. For an accurate determination of the optimal gantry angle, measurements from CT and/or preoperative 3D reconstruction is recommended. An angle measurement can be made in an axial CT image using almost any of the available software programs. For many surgeons, 3D reconstruction is more intuitive in planning the gantry angle and other aspects of the case. In either case, using the CT data to plan the case can save fluoroscopy time, reduce contrast load (avoiding multiple acquisitions trying to get an accurate impression of the anatomy), and minimize the risk of endoleak or inadvertent branch vessel coverage. In the absence of prior CT or MR imaging, gantry angle can be adjusted after the pigtail catheter has been positioned, using the course of the pigtail catheter to indicate the anatomy of the arch. As seen in the images below, 45 degrees is accurate for the younger patient, but this angle would be misleading for the older patient.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Thorac+Cardiovasc+Surg%3B+2008%3B+20+(4)%3A348-357" target="_blank">Ueda T, Fleischmann D, Rubin GD, Dake MD<span>,&nbsp;</span>Sze DY. Imaging of the thoracic aorta before and after stent-graft repair of aneurysms and dissections. Semin Thorac Cardiovasc Surg 2008; 20(4):348-57.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg.%3B+2003%3B+38+(4)%3A730-8" target="_blank">Wyers MC, Fillinger MF, Schermerhorn ML, Powell RJ<span>,&nbsp;</span>Rzucidlo EM<span>,&nbsp;</span>Walsh DB,&nbsp;et al. Endovascular repair of abdominal aortic aneurysm without preoperative arteriography. J Vasc Surg 2003; 38(4):730-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2000%3B+13+(4)%3A247-63." target="_blank">Fillinger MF. Imaging of the thoracic and thoracoabdominal aorta. Semin Vasc Surg 2000; 13 (4):247-63.</a></p>
<p>QID: 30905</p></div><div class="rightanswer">The correct answer is: 45 degrees left anterior oblique (LAO)</div></div></div></div></div><div id="q164" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">53</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_641"><input type="hidden" name="q20803:164_:flagged" value="0"><input type="hidden" value="qaid=911048&amp;qubaid=20803&amp;qid=4664&amp;slot=164&amp;checksum=eff157632c162e68a5211778ab77d22c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:164_:flaggedcheckbox" name="q20803:164_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q164&id=4664"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:164_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old, asymptomatic woman is sent to you urgently by a local ophthalmologist with a photograph showing her ocular findings. The image obtained is shown below. Which of the following statements regarding the ocular findings is most accurate?<br><br><a href="./VESAP3_files/AssetProxy_046.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_046.jpg" alt="img" width="100" height="98" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:164_answer" disabled="disabled" value="0" id="q20803:164_answer0"><label for="q20803:164_answer0">a. she has negligible stroke risk</label> </div>
<div class="r1"><input type="radio" name="q20803:164_answer" disabled="disabled" value="1" id="q20803:164_answer1"><label for="q20803:164_answer1">b. she should undergo urgent evaluation and carotid endarterectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:164_answer" disabled="disabled" value="2" id="q20803:164_answer2"><label for="q20803:164_answer2">c. she will have marked progression of carotid plaque</label> </div>
<div class="r1"><input type="radio" name="q20803:164_answer" disabled="disabled" value="3" id="q20803:164_answer3"><label for="q20803:164_answer3">d. she should undergo angiography</label> </div>
<div class="r0"><input type="radio" name="q20803:164_answer" disabled="disabled" value="4" id="q20803:164_answer4"><label for="q20803:164_answer4">e. she has a 10-20% stroke risk in the next 6 months</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:164_-submit" name="q20803:164_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The term "Hollenhorst plaque" is used to describe cholesterol crystal&nbsp;embolization&nbsp;to the retinal circulation. This can be an incidental finding on an ocular exam. It is an age-indeterminate microatheroembolus from any proximal cardiovascular structure. Thus, they are not specifically associated with severe carotid disease. In a study of 130 patients with a Hollenhorst plaque or a retinal artery occlusion, asymptomatic patients rarely had simultaneous carotid stenosis; only 6 patients required carotid intervention. No stroke or transient ischemic attack was identified in follow-up of patients with this condition and serial carotid Duplex scans failed to identify progression of carotid stenoses. Stroke-free survival rates were high. Patients with a Hollenhorst plaque should undergo evaluation; however, the decision to treat a carotid stenosis can be made independent of the ocular finding.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Dunlap%20AB,%20Kosmorsky%20GS,%20Kashyap%20VS.%20The%20fate%20of%20patients%20with%20retinal%20artery%20occlusion%20and%20Hollenhorst%20plaque.%20J%20Vasc%20Surg;%202007;%2046%20(6):1125-1129" target="_blank">Dunlap AB, Kosmorsky GS, Kashyap VS. The fate of patients with retinal artery occlusion and Hollenhorst plaque. J Vasc Surg 2007; 46 (6):1125-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Hollenhorst%20RW.%20Significance%20of%20bright%20plaques%20in%20the%20retinal%20arterioles.%20JAMA;%201961;%20178%20(1):23-29" target="_blank">Hollenhorst RW. Significance of bright plaques in the retinal arterioles. JAMA 1961; 178 (1):23-9</a>.</p>
<p>QID: 30301</p></div><div class="rightanswer">The correct answer is: she has negligible stroke risk</div></div></div></div></div><div id="q152" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">54</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_650"><input type="hidden" name="q20803:152_:flagged" value="0"><input type="hidden" value="qaid=911036&amp;qubaid=20803&amp;qid=4770&amp;slot=152&amp;checksum=0f137279e92a621f9a349b4a20ae0226&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:152_:flaggedcheckbox" name="q20803:152_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q152&id=4770"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:152_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old woman presents 10 years after a coronary artery bypass graft (CABG) with a left internal mammary artery (LIMA) graft with chest pain and left arm fatigue during upper extremity exertion. Angiography of the aortic arch was performed and is shown below. Regarding this patient's condition, which of the following statements is&nbsp;<strong>true</strong>?<br></p><p><img src="./VESAP3_files/Cull - 7 image.jpg" alt="Cull - 7 image" width="389" height="443"></p>
<p><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:152_answer" disabled="disabled" value="0" id="q20803:152_answer0"><label for="q20803:152_answer0">a. subclavian angioplasty and stent placement is the most durable treatment&nbsp;option for this condition</label> </div>
<div class="r1"><input type="radio" name="q20803:152_answer" disabled="disabled" value="1" id="q20803:152_answer1"><label for="q20803:152_answer1">b. a carotid to subclavian bypass will not effectively treat both sets of symptoms</label> </div>
<div class="r0"><input type="radio" name="q20803:152_answer" disabled="disabled" value="2" id="q20803:152_answer2"><label for="q20803:152_answer2">c. repeat CABG using a saphenous vein graft to replace the LIMA graft is indicated</label> </div>
<div class="r1"><input type="radio" name="q20803:152_answer" disabled="disabled" value="3" id="q20803:152_answer3"><label for="q20803:152_answer3">d. Duplex evaluation of her left subclavian and carotid arteries would be expected to demonstrate retrograde flow in the left vertebral artery</label> </div>
<div class="r0"><input type="radio" name="q20803:152_answer" disabled="disabled" value="4" id="q20803:152_answer4"><label for="q20803:152_answer4">e. placement of a vertebral artery stent will eliminate the neurologic symptoms</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:152_-submit" name="q20803:152_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient presents with subclavian steal syndrome affecting the vertebral and left internal mammary artery (LIMA) circulation. Restoration of flow to the subclavian artery beyond the occlusion will result in normal flow to the vertebral and LIMA. Angioplasty and stent placement are useful techniques but are probably not as durable as open bypass, especially because the lesion is a total occlusion. Duplex evaluation of the left vertebral would be expected to demonstrate reversal of flow because the vertebral artery is providing collateral flow to the arm and mammary artery.</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cardiovasc+Intervent+Radiol+2006%3B+29(6)%3A348-53." target="_blank">Filippo F, Francesco M, Francesco R, Corrado A<span>,&nbsp;</span>Chiara M<span>,&nbsp;</span>Valentina C,&nbsp;et al. Percutaneous angioplasty and stenting of left subclavian artery lesions for the treatment of patients with concomitant vertebral and coronary subclavian steal syndrome. Cardiovasc Intervent Radiol&nbsp;2006; 29(6):348-53.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2004%3B+18(5)%3A566-71." target="_blank">Ferrara F, Meli F, Raimondi F, Milio G,&nbsp;Amato C,&nbsp;Cospite V,&nbsp;et al. Subclavian stenosis/occlusion in patients with subclavian steal syndrome and previous bypass of internal mammary artery: medical or surgical treatment? Ann Vasc Surg&nbsp;2004; 18(5):566-71.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chirurgia+2013%3B+108%3A264-7." target="_blank">Bindea D, Todoran A, Mihai T, Ober C<span>,&nbsp;</span>Iancu A. Coronary-subclavian steal syndrome treated with carotid to subclavian artery bypass. Chirurgia 2013; 108:264-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B+38%3A699-704." target="_blank">Westerband A, Rodriguez JA, Ramaiah VG, Diethrich EB<span>.</span>&nbsp;Endovascular therapy in prevention and management of coronary-subclavian steal. J Vasc Surg 2003; 38:699-704.</a></p>
<p>QID: 30246</p></div><div class="rightanswer">The correct answer is: Duplex evaluation of her left subclavian and carotid arteries would be expected to demonstrate retrograde flow in the left vertebral artery</div></div></div></div></div><div id="q418" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">55</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_659"><input type="hidden" name="q20803:418_:flagged" value="0"><input type="hidden" value="qaid=911302&amp;qubaid=20803&amp;qid=4792&amp;slot=418&amp;checksum=3f08954589410e56aaf353b17900ce15&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:418_:flaggedcheckbox" name="q20803:418_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q418&id=4792"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:418_:sequencecheck" value="2"><div class="qtext"><p>A 36-year-old woman has a routine follow-up duplex ultrasound 5 days after thermal ablation of her left great saphenous vein. She is asymptomatic, has resumed her routine physical activities, and is satisfied with the treatment results. Based on the ultrasounds below, her management should include which of the following?</p>
<p>&nbsp;<img src="./VESAP3_files/LURIE fig 01.jpg" alt="" width="240" height="322"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:418_answer" disabled="disabled" value="0" id="q20803:418_answer0"><label for="q20803:418_answer0">1. surgical ligation of the saphenofemoral junction</label> </div>
<div class="r1"><input type="radio" name="q20803:418_answer" disabled="disabled" value="1" id="q20803:418_answer1"><label for="q20803:418_answer1">2. rest and leg elevation</label> </div>
<div class="r0"><input type="radio" name="q20803:418_answer" disabled="disabled" value="2" id="q20803:418_answer2"><label for="q20803:418_answer2">3. 3 months of coumadin</label> </div>
<div class="r1"><input type="radio" name="q20803:418_answer" disabled="disabled" value="3" id="q20803:418_answer3"><label for="q20803:418_answer3">4. no treatment is necessary</label> </div>
<div class="r0"><input type="radio" name="q20803:418_answer" disabled="disabled" value="4" id="q20803:418_answer4"><label for="q20803:418_answer4">5. low-molecular-weight heparin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:418_-submit" name="q20803:418_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Endovenous heat-induced thrombosis (EHIT) is a complication of thermal ablation of the superficial veins, which occurs in .5-2% of cases. Current classification divides all occurrences of EHIT into 4 classes:</p>
<ol>
<li>At the level of the deep vein without protrusion into the common femoral vein (CFV)</li>
<li>Projecting less than 50% into the CFV</li>
<li>Protruding more than 50% into the CFV</li>
<li>Occlusion of the CFV</li>
</ol>
<p>In this patient, the ultrasound images<strong>&nbsp;</strong>demonstrate that EHIT should be classified as class 2. EHIT class 2 should be treated with 1 to 2 weeks of low-molecular-weight-heparin, which usually results in complete resolution. For classes 3 to 4, full DVT treatment is recommended.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+54%3A10S-17S." target="_blank">Haqqani OP, Vasiliu C, O'Donnell TF, Iafrati MD. Great saphenous vein patency and endovenous heat-induced thrombosis after endovenous thermal ablation with modified catheter tip positioning. J Vasc Surg 2011; 54:10S-17S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2010%3B+52%3A388-93." target="_blank">Lawrence PF, Chandra A, Wu M, Rigberg D<span>,&nbsp;</span>DeRubertis B<span>,&nbsp;</span>Gelabert H,&nbsp;et al. Classification of proximal endovenous closure levels and treatment algorithm. J Vasc Surg 2010; 52:388-93.</a></p>
<p>QID: 30739</p></div><div class="rightanswer">The correct answer is: low-molecular-weight heparin</div></div></div></div></div><div id="q132" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">56</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_668"><input type="hidden" name="q20803:132_:flagged" value="0"><input type="hidden" value="qaid=911016&amp;qubaid=20803&amp;qid=4749&amp;slot=132&amp;checksum=d108f496b1009c5ecba36383414af9ba&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:132_:flaggedcheckbox" name="q20803:132_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q132&id=4749"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:132_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is the most appropriate management strategy for a patient who sustains a low velocity gun shot wound (GSW) to the mid-right subclavian artery?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:132_answer" disabled="disabled" value="0" id="q20803:132_answer0"><label for="q20803:132_answer0">a. 4<sup>th</sup> intercostal space anterior thoracotomy for control</label> </div>
<div class="r1"><input type="radio" name="q20803:132_answer" disabled="disabled" value="1" id="q20803:132_answer1"><label for="q20803:132_answer1">b. right posterolateral thoracotomy</label> </div>
<div class="r0"><input type="radio" name="q20803:132_answer" disabled="disabled" value="2" id="q20803:132_answer2"><label for="q20803:132_answer2">c. infraclavicular incision for control</label> </div>
<div class="r1"><input type="radio" name="q20803:132_answer" disabled="disabled" value="3" id="q20803:132_answer3"><label for="q20803:132_answer3">d. admission to the ICU for serial exam and intensive surveillance</label> </div>
<div class="r0"><input type="radio" name="q20803:132_answer" disabled="disabled" value="4" id="q20803:132_answer4"><label for="q20803:132_answer4">e. femoral access, innominate, subclavian selective arteriography with endovascular covered stent-graft repair</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:132_-submit" name="q20803:132_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Similar to other vascular injury patterns, the approach to axillosubclavian arterial injury has evolved with the development of endovascular technology. The ability to perform arteriography in a hybrid operating room has been transformative, allowing for the application of covered stent-grafting in unstable patients, regardless of mechanism. This requires institutional and surgical coordination and capability. Combined brachial/femoral access may be facilitative. Balloon guidance and cross-access snaring techniques to assist wire placement are described. Open control of right subclavian injury is via a median sternotomy with clavicular extension. Left subclavian artery control may require 4<sup>th</sup> ICS anterior thoracotomy. Selective use of a supraclavicular incision, with or without clavicular resection, or combined supraclavicular and infraclavicular incisions are also possible, depending on injury location. These may be facilitated by percutaneous, proximal inflow balloon occlusion. While no mortality benefit has been appreciated comparing the endovascular and open approach, low-level literature does suggest endovascular management takes less time, requires less intravenous fluid, and reduces blood loss. Reasonable mid-term outcomes of stent-grafting for injury in this location are now appreciated. Reintervention, mostly percutaneous, appears to be needed in less than 10% of endovascular repairs. &nbsp;Collectively, stroke and amputation with axillosubclavian arterial injury occur in less than 2% of patients, with an all-cause mortality of 10-20%.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Trauma+2011%3B+71(5)%3AE114-21." target="_blank">Shalhub S, Starnes BW, Hatsukami TS, Karmy-Jones R, Tran NT. Repair of blunt thoracic arterial injuries: an evolution from open to endovascular approach. J Trauma 2011;71(5):E114-21.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Injury+2012%3B+43%3A1785-92" target="_blank">DuBose JJ, Rajani R, Gilani R, Arthurs ZA, Morrison JJ, Clouse WD, et al. Endovascular management of axillo-subclavian arterial injury: a review of published experience. Injury 2012; 43:1785-92.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+57%3A547-67." target="_blank">Sinha W, Patterson BO, Ma J, Holt PJ, Thompson MM, Carrell T, et al. Sytematic review and meta-analysis of open surgical and endovascular management of thoracic outlet vascular injuries. J Vasc Surg 2013; 57:547-67.</a></p>
<p>QID: 30225</p></div><div class="rightanswer">The correct answer is: femoral access, innominate, subclavian selective arteriography with endovascular covered stent-graft repair</div></div></div></div></div><div id="q356" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">57</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_677"><input type="hidden" name="q20803:356_:flagged" value="0"><input type="hidden" value="qaid=911240&amp;qubaid=20803&amp;qid=4421&amp;slot=356&amp;checksum=1828271be4e6095744ced39c9a4681e2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:356_:flaggedcheckbox" name="q20803:356_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q356&id=4421"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:356_:sequencecheck" value="2"><div class="qtext"><p>A 22 year old woman is referred to your clinic for evaluation of idiopathic thrombocytopenic purpura (ITP), refractory to medical management.&nbsp;On CTA, the patient’s spleen is enlarged, with a maximum length of 17cm.&nbsp;The expected result of preoperative splenic artery embolization is:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:356_answer" disabled="disabled" value="0" id="q20803:356_answer0"><label for="q20803:356_answer0">a. Reduction in&nbsp;splenic size and blood loss&nbsp;at subsequent splenectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:356_answer" disabled="disabled" value="1" id="q20803:356_answer1"><label for="q20803:356_answer1">b. Splenic infarction, avoiding the need for&nbsp;operative splenectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:356_answer" disabled="disabled" value="2" id="q20803:356_answer2"><label for="q20803:356_answer2">c. No&nbsp;effect upon the splenic size or function</label> </div>
<div class="r1"><input type="radio" name="q20803:356_answer" disabled="disabled" value="3" id="q20803:356_answer3"><label for="q20803:356_answer3">d. Pancreatitis if&nbsp;liquid embolization agents are utilized</label> </div>
<div class="r0"><input type="radio" name="q20803:356_answer" disabled="disabled" value="4" id="q20803:356_answer4"><label for="q20803:356_answer4">e. Excessive arterial access site&nbsp;bleeding that is a contraindication to embolization</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:356_-submit" name="q20803:356_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Splenic artery embolization for hematologic diseases, such as ITP, hereditary spherocytosis, or myelofibrosis, has become a popular adjunct in the surgical management prior to splenectomy (especially laparoscopic splenectomy). In small series,&nbsp;preoperative embolization&nbsp;has been shown to reduce splenic size and&nbsp;decrease blood loss.&nbsp;In small case reports, embolization&nbsp;alone has been utilized.&nbsp;However, these series are small,&nbsp;so embolic therapy alone should be reserved for patients who are otherwise poor operative risks.&nbsp;</p>
<p><strong>References:</strong></p>
<p>1. <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Naoum%20JJ%5BAuthor%5D&cauthor=true&cauthor_uid=17512282">Naoum JJ</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Silberfein%20EJ%5BAuthor%5D&cauthor=true&cauthor_uid=17512282">Silberfein EJ</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Zhou%20W%5BAuthor%5D&cauthor=true&cauthor_uid=17512282">Zhou W</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Sweeney%20JF%5BAuthor%5D&cauthor=true&cauthor_uid=17512282">Sweeney JF</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Albo%20D%5BAuthor%5D&cauthor=true&cauthor_uid=17512282">Albo D</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Brunicardi%20FC%5BAuthor%5D&cauthor=true&cauthor_uid=17512282">Brunicardi FC</a>, et al.&nbsp; Concomitant intraoperative splenic artery embolization and laparoscopic splenectomy versus laparoscopic splenectomy: comparison of treatment outcome.&nbsp; Am J Surg&nbsp; 2007;193:713-718.</p>
<p>QID: 30626</p></div><div class="rightanswer">The correct answer is: Reduction in&nbsp;splenic size and blood loss&nbsp;at subsequent splenectomy</div></div></div></div></div><div id="q421" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">58</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_686"><input type="hidden" name="q20803:421_:flagged" value="0"><input type="hidden" value="qaid=911305&amp;qubaid=20803&amp;qid=4796&amp;slot=421&amp;checksum=aa2a3bf25c9a2774929bf095188a9e8d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:421_:flaggedcheckbox" name="q20803:421_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q421&id=4796"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:421_:sequencecheck" value="2"><div class="qtext"><p>A 56-year-old man presents with a chronic wound in his right leg (see image below). He is symptomatic, with heaviness and aching while standing. He has no history of deep venous thrombosis. On examination, varicose veins are present in his medial thigh and calf, and the skin in his lower leg is discolored with brownish pigment. The area of skin surrounding the ulcer appears sclerotic. Pitting edema is present in his foot and lower calf. A duplex ultrasound scan shows patent deep and superficial veins and reflux &gt;1 second in the femoral, popliteal, and great saphenous veins. His CEAP classification is which of the following?</p>
<p><img src="./VESAP3_files/Picture5ok.jpg" alt="" width="243" height="396"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:421_answer" disabled="disabled" value="0" id="q20803:421_answer0"><label for="q20803:421_answer0">1. C<sub>4a</sub>, E<sub>p</sub>, A<sub>s,</sub>, P<sub>o</sub></label> </div>
<div class="r1"><input type="radio" name="q20803:421_answer" disabled="disabled" value="1" id="q20803:421_answer1"><label for="q20803:421_answer1">2. C<sub>6s</sub>, E<sub>p</sub>, A<sub>s,d</sub>, P<sub>r</sub></label> </div>
<div class="r0"><input type="radio" name="q20803:421_answer" disabled="disabled" value="2" id="q20803:421_answer2"><label for="q20803:421_answer2">3. C<sub>2s</sub>, E<sub>s</sub>, A<sub>s</sub>, P<sub>o</sub></label> </div>
<div class="r1"><input type="radio" name="q20803:421_answer" disabled="disabled" value="3" id="q20803:421_answer3"><label for="q20803:421_answer3">4. C<sub>6</sub>, E<sub>p</sub>, A<sub>d</sub>, P<sub>r</sub></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:421_-submit" name="q20803:421_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The CEAP classification includes Clinical Class (C), Etiology (E), Anatomy (A), and Pathophysiology (P).</p>
<p>Clinical classes are defined as:</p>
<p>C0:&nbsp;&nbsp;&nbsnbsp;&nbsp;&nbsp;&nbsp; No visible or palpable signs of venous disease</p>
<p>C1:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Telangiectasies or reticular veins</p>
<p>C2:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Varicose veins</p>
<p>C3:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Edema</p>
<p>C4a:&nbsp;&nbsp;&nbsp;&nbsp; Pigmentation or eczema</p>
<p>C4b:&nbsp;&nbsp;&nbsp;&nbsp; Lipodermatosclerosis or atrophie blanche</p>
<p>C5:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Healed venous ulcer</p>
<p>C6:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Active venous ulcer</p>
<p>Each case may be described as symptomatic (s), or asymptomatic (a). A basic CEAP evaluation includes only the highest clinical class, which in the described patient is C<sub>6s</sub> (ulcer, symptomatic). A complete CEAP evaluation lists all classes that are present, which in this case are varicose veins, swelling, skin changes, and recurrent ulcer – C<sub>2,3,4b,5,6,s</sub>.</p>
<p>Etiologic classification includes:</p>
<p>Ec:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Congenital</p>
<p>Ep:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Primary</p>
<p>Es:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Secondary (postthrombotic)</p>
<p>En:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No venous cause identified</p>
<p>Anatomic classification indicates involvement of:</p>
<p>As:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Superficial veins</p>
<p>Ap:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Perforator veins</p>
<p>Ad:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deep veins</p>
<p>Pathophysiologic classification includes:</p>
<p>Pr:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Reflux</p>
<p>Po:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Obstruction</p>
<p>Pr,o:&nbsp;&nbsp;&nbsp;&nbsp; Reflux and obstruction</p>
<p>It is recommended to include the <em>l</em>evel of investigation (L)</p>
<p>Level I: &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;Office visit, with history and clinical examination, which may include use of a hand-held Doppler scanner.</p>
<p>Level II: &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Noninvasive vascular laboratory testing.</p>
<p>Level III:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Invasive investigations or more complex imaging</p>
<p>The described patient should be classified as C<sub>6s</sub>, E<sub>p</sub>, A<sub>s,d</sub>, P<sub> r</sub> (LII)</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2004%3B+40(6)%3A1248-52." target="_blank">Eklöf B, Rutherford RB, Bergan JJ, Carpentier PH, Gloviczki P, Kistner RL, et al; American Venous Forum International Ad Hoc Committee for Revision of the CEAP Classification.&nbsp; Revision of the CEAP classification for chronic venous disorders: consensus statement.&nbsp; J Vasc Surg 2004; 40(6):1248-52.</a></p>
<p>QID: 30743</p></div><div class="rightanswer">The correct answer is: C<sub>6s</sub>, E<sub>p</sub>, A<sub>s,d</sub>, P<sub>r</sub></div></div></div></div></div><div id="q186" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">59</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_695"><input type="hidden" name="q20803:186_:flagged" value="0"><input type="hidden" value="qaid=911070&amp;qubaid=20803&amp;qid=4553&amp;slot=186&amp;checksum=4f686fdbda3653a8bfb3fad21e4f9875&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:186_:flaggedcheckbox" name="q20803:186_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q186&id=4553"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:186_:sequencecheck" value="2"><div class="qtext"><p>The use of a carotid shunt is used to maintain cerebral perfusion during endarterectomy.&nbsp; Which of the following scenerios would a shunt not be indicated: &nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:186_answer" disabled="disabled" value="0" id="q20803:186_answer0"><label for="q20803:186_answer0">a. 65yo M with stump pressures &lt;40 mm Hg and contralateral ICA occlusion</label> </div>
<div class="r1"><input type="radio" name="q20803:186_answer" disabled="disabled" value="1" id="q20803:186_answer1"><label for="q20803:186_answer1">b. 82yo F with stump pressures &gt;40 mm Hg who under local anesthesia develops new agitation</label> </div>
<div class="r0"><input type="radio" name="q20803:186_answer" disabled="disabled" value="2" id="q20803:186_answer2"><label for="q20803:186_answer2">c. 55yo M with stump pressure &lt; 40mm Hg and EEG monitoring with decreased amplitude and rhythm<br><ol>
</ol></label> </div>
<div class="r1"><input type="radio" name="q20803:186_answer" disabled="disabled" value="3" id="q20803:186_answer3"><label for="q20803:186_answer3">d. 62yo F with stump pressures &gt; 40 mm Hg and acute resolved ipsilateral stroke<br><ol>
</ol></label> </div>
<div class="r0"><input type="radio" name="q20803:186_answer" disabled="disabled" value="4" id="q20803:186_answer4"><label for="q20803:186_answer4">e. 75yo F with stump pressures &gt;40mm Hg and history of contralateral stroke</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:186_-submit" name="q20803:186_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>There are several markers of adequate cerebral&nbsp;perfusion during carotid endarterectomy.&nbsp; One marker is carotid stump back pressure, with pressures&nbsp;over 40mmHg suggesting adequate cerebral perfusion.&nbsp;Awake neurologic observation is also a marker.&nbsp;Neurologic changes during clamping can occur at the time of clamping or delayed several minutes.&nbsp; Any neurologic changes in mental status of the awake patient or changes of suppression in EEG monitoring are both signs of cerebral compromise.&nbsp; Cases&nbsp;in&nbsp;which&nbsp;the circle of Willis is not intact, including a contralateral carotid artery occlusion, is often an indication for shunting.&nbsp; Patients with recent ischemic event will have an area of ischemic penumbra which will benefit from increased perfusion pressure.&nbsp; Additional methods that can be used to evaluate the role of shunting include: TCD and SEP and cerebral oximetery.&nbsp; The history of a contralateral stroke alone is not a general indication for shunt placement.</p>
<p>References:</p>
<ol>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/5087279">Hays RJ, Levinson SA, Wylie EJ. Intraoperative measurement of carotid back pressure as a guide to operative management for carotid endarterectomy.&nbsp; Surgery 72:953, 1972. &nbsp;PMID: 5087279</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/4696724">Moore WS, Yee JM, Hall AD; Collateral cerebral blood pressure: An index of tolerance to temporary carotid occlusion.&nbsp; Arch Surg 106:520, 1973. PMID: 4696724</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/21906905">AbuRahama, AF, Albeir YM, Stone PA. Shunting during carotid endarterectomy. J Vasc Surg54: 1502-10, 2011. PMID 21906905</a></li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed/22051863">Goodney PP, Wallaert JB, Scali S, et al. Impact of practice patterns in shunt use during carotid endarterectomy with contralateral carotid occlusion. J Vasc Surg. 55(1):61-71, 2012. PMID: 22051863</a></li>
</ol>
<p>&nbsp;</p>
<p>The correct answer is: 75yo F with stump pressures &gt; 40 mm Hg and a history of contralateral stroke.</p>
<p>&nbsp;QID: 30330</p></div><div class="rightanswer">The correct answer is: 75yo F with stump pressures &gt;40mm Hg and history of contralateral stroke</div></div></div></div></div><div id="q95" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">60</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_704"><input type="hidden" name="q20803:95_:flagged" value="0"><input type="hidden" value="qaid=910979&amp;qubaid=20803&amp;qid=4915&amp;slot=95&amp;checksum=cc8d1ac17e0280c5330dbd7ffe4d187f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:95_:flaggedcheckbox" name="q20803:95_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q95&id=4915"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:95_:sequencecheck" value="2"><div class="qtext"><p>A 56-year-old man presents with complaints of intermittent right hip and buttock claudication and erectile dysfunction. On examination he has absent femoral pulses. The penile brachial index is 0.38 with a penile systolic pressure of 60 mmHg. The ankle brachial index and segmental blood pressures showed:</p>
<ul>
<li>Rt: Severely decreased right ankle pressure indices: 0.57/0.51.</li>
<li>Moderately decreased right great toe pressure 45mmHg (0.28).</li>
<li>Decrease of the right high thigh pressure.</li>
<li>Lt: Severely decreased left ankle pressure indices: 0.46/0.54.</li>
<li>Moderately decreased left great toe pressure 51mmHg (0.32).</li>
<li id="yui_3_13_0_2_1387905860765_90">Decrease of the left high thigh pressure.</li>
</ul>
<p><img src="./VESAP3_files/Q3 CTA coronal.jpg" alt="" width="240" height="446"></p>
<p>&nbsp;Based on published data, which of the following represents the appropriate intervention option for this patient?&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:95_answer" disabled="disabled" value="0" id="q20803:95_answer0"><label for="q20803:95_answer0">a. <span>percutaneous transluminal balloon angioplasty of the aorta and bilateral iliac arteries</span></label> </div>
<div class="r1"><input type="radio" name="q20803:95_answer" disabled="disabled" value="1" id="q20803:95_answer1"><label for="q20803:95_answer1">b. <span>open aortobifemoral bypass grafting</span></label> </div>
<div class="r0"><input type="radio" name="q20803:95_answer" disabled="disabled" value="2" id="q20803:95_answer2"><label for="q20803:95_answer2">c. <span>axillobifemoral bypass grafting</span></label> </div>
<div class="r1"><input type="radio" name="q20803:95_answer" disabled="disabled" value="3" id="q20803:95_answer3"><label for="q20803:95_answer3">d. <span>femoro-femoral bypass grafting</span></label> </div>
<div class="r0"><input type="radio" name="q20803:95_answer" disabled="disabled" value="4" id="q20803:95_answer4"><label for="q20803:95_answer4">e. <span>open cutdown of both groins and transluminal balloon angioplasty of the aorta and bilateral iliac arteries</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:95_-submit" name="q20803:95_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Leriche syndrome refers to a combination of dimished or absent femoral pulses, thigh and buttock claudication, and erectile dysfunction (ED) in men. &nbsp;Percutaneous balloon therapy with or without stenting has supplanted surgical reconstruction as the most common therapy for aortoiliac occlusive disease. The recent TransAtlantic Intersociety Consensus (TASC II) states that TASC types A and B lesions are best treated with endovascular techniques.&nbsp; Intermediate TASC type C lesions can be treated appropriately with either percutaneous or open techniques. TASC type D disease, as is present in this patient, is best treated with open surgery. The 5-year cumulative graft patency for aortobifemoral bypass is 86%. Axillofemoral bypass graft is associated with 4-year cumulative patency of 29-74%.&nbsp; A femoro-femoral bypass graft would not address this patient’s disease.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2007%3B+45+(Suppl+S)%3AS5-67." target="_blank">Norgren L, Hiatt WR, Dormandy JA, Nehler MR<span>,&nbsp;</span>Harris KA<span>,&nbsp;</span>Fowkes FG;&nbsp;TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Treatment strategy for intermittent claudication. J Vasc Surg; 2007; 45 (Suppl S):S5-67.</a></p>
<p>DePalma RG. Vasculogenic Erectile Dysfunction. In: Moore WS, ed. Vascular and Endovascular Surgery: A Comprehensive Review. 8th ed.&nbsp; Elsevier Saunders: Philadelphia; 2013. p. 147-155.</p>
<p>QID: 30145</p></div><div class="rightanswer">The correct answer is: <span>open aortobifemoral bypass grafting</span></div></div></div></div></div><div id="q376" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">61</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_713"><input type="hidden" name="q20803:376_:flagged" value="0"><input type="hidden" value="qaid=911260&amp;qubaid=20803&amp;qid=5108&amp;slot=376&amp;checksum=1dcbcbef09c7e0432dcd08ef39aaa870&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:376_:flaggedcheckbox" name="q20803:376_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q376&id=5108"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:376_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is the current, most common cause of acute mesenteric ischemia?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:376_answer" disabled="disabled" value="0" id="q20803:376_answer0"><label for="q20803:376_answer0">a. mesenteric venous thrombosis</label> </div>
<div class="r1"><input type="radio" name="q20803:376_answer" disabled="disabled" value="1" id="q20803:376_answer1"><label for="q20803:376_answer1">b. nonocclusive mesenteric ischemia</label> </div>
<div class="r0"><input type="radio" name="q20803:376_answer" disabled="disabled" value="2" id="q20803:376_answer2"><label for="q20803:376_answer2">c. aortic dissection</label> </div>
<div class="r1"><input type="radio" name="q20803:376_answer" disabled="disabled" value="3" id="q20803:376_answer3"><label for="q20803:376_answer3">d. arterial embolism</label> </div>
<div class="r0"><input type="radio" name="q20803:376_answer" disabled="disabled" value="4" id="q20803:376_answer4"><label for="q20803:376_answer4">e. arterial thrombosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:376_-submit" name="q20803:376_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Traditionally, arterial embolization was thought to be the most common cause of acute mesenteric ischemia. However, more recent data has suggested that arterial thrombosis is the most common cause at this time.&nbsp;This paradigm shift may be secondary to more effective and aggressive anticoagulation in patients with atrial fibrillation.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2012%3B+55%3A1682-9." target="_blank">Ryer EJ, KalraM, Oderich GS, Duncan AA, Gloviczki P, Cha, S. et al. Revascularization for acute mesenteric ischemia. J Vasc Surg 2012; 55:1682-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surg+Clin+N+Am+2013%3B+93%3A925-40." target="_blank">Bobadilla JL. Mesenteric Ischemia. Surg Clin N Am 2013; 93:925-40.</a></p>
<p>QID: 30661</p></div><div class="rightanswer">The correct answer is: arterial thrombosis</div></div></div></div></div><div id="q76" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">62</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_722"><input type="hidden" name="q20803:76_:flagged" value="0"><input type="hidden" value="qaid=910960&amp;qubaid=20803&amp;qid=4988&amp;slot=76&amp;checksum=7a8e58061ad6b4c4a984b8547ef57217&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:76_:flaggedcheckbox" name="q20803:76_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q76&id=4988"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:76_:sequencecheck" value="2"><div class="qtext"><p>An 80-year-old woman with atrial fibrillation stopped her warfarin therapy in order to undergo a colonoscopy. She presents to the emergency department with acute pain in the left leg. On physical examination, the leg is severely ischemic with impaired motor and sensory function. Which of the following is the best indication to perform a prophylactic fasciotomy following successful embolectomy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:76_answer" disabled="disabled" value="0" id="q20803:76_answer0"><label for="q20803:76_answer0">a. a preoperative serum potassium level of 4.0 mEq/ Liter</label> </div>
<div class="r1"><input type="radio" name="q20803:76_answer" disabled="disabled" value="1" id="q20803:76_answer1"><label for="q20803:76_answer1">b. a preoperative ischemia time of more than 6 hours</label> </div>
<div class="r0"><input type="radio" name="q20803:76_answer" disabled="disabled" value="2" id="q20803:76_answer2"><label for="q20803:76_answer2">c. a preoperative serum bicarbonate level of 22 mEq/ Liter</label> </div>
<div class="r1"><input type="radio" name="q20803:76_answer" disabled="disabled" value="3" id="q20803:76_answer3"><label for="q20803:76_answer3">d. a preoperative finding of severe sensory impairment in the foot</label> </div>
<div class="r0"><input type="radio" name="q20803:76_answer" disabled="disabled" value="4" id="q20803:76_answer4"><label for="q20803:76_answer4">e. a preoperative serum creatinine phosphokinase level of 500 IU/ Liter</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:76_-submit" name="q20803:76_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>While ultimately the decision to perform a prophylactic fasciotomy following revascularization for acute arterial ischemia is a clinical decision, the most commonly accepted indication is prolonged preoperative ischemia. Other factors present in this case that would also favor fasciotomy are the impairments seen in motor and sensory function, which correlate with inadequacy of collateral perfusion. If prolonged severe ischemia has existed prior to embolectomy, the surgeon may elect to perform a fasciotomy empirically in conjunction with the embolectomy. If the surgeon elects not to perform a fasciotomy at the time of initial embolectomy, the patient will need close post-operative monitoring for worsening neurologic or ischemic sypmtoms. Failure to see improvement in these parameters after reperfusion may also indicate the development of compartment syndrome. When in doubt, bedside measurement of compartment pressures can be performed, with pressures exceeding 30 - 40 mmHg being considered an indication for fasciotomy.</p>
<p>While fasciotomy can be a somewhat morbid operation which increases hospital length of stay and has cosmetic consequences, failure to prevent or treat compartment syndrome reduces the patient's chances for limb salvage and for a functional limb afterwards, and it has historically been a major point of litigation. The serum potassium level and serum bicarbonate levels listed are within normal range, and the CPK level is only mildly elevated. A finding of preoperative sensory impairment is indicative of severe ischemia, but, in and of itself, it is not an indication for prophylactic fasciotomy.<br><br></p>
<h3>Reference:</h3>
<p>Greenberg RK, Ouriel K. Arterial thromboembolism. In: Rutherford RB, ed. Vascular Surgery. 5th ed. Philadelphia, PA: WB Saunders; 2000:822-35.</p>
<p>QID: 30119</p></div><div class="rightanswer">The correct answer is: a preoperative ischemia time of more than 6 hours</div></div></div></div></div><div id="q336" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">63</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_731"><input type="hidden" name="q20803:336_:flagged" value="0"><input type="hidden" value="qaid=911220&amp;qubaid=20803&amp;qid=5291&amp;slot=336&amp;checksum=561267ff78ad018267d47a1299602d21&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:336_:flaggedcheckbox" name="q20803:336_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q336&id=5291"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:336_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old woman presents with a serum creatinine of 2.2 mg/dL, which has increased from 1.5 mg/dL 12 months prior. Duplex imaging revealed unilateral renal artery stenosis with the ipsilateral kidney measuring 6 cm and the contralateral kidney measuring 9 cm. Resistive indices were measured. Angiography confirmed unilateral renal artery ostial stenosis. Which of the following pole to pole length and resistive index (RI) pairs&nbsp;most supports a decision to perform renal revascularization?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:336_answer" disabled="disabled" value="0" id="q20803:336_answer0"><label for="q20803:336_answer0">a. kidney length &gt; 9c m and RI &gt; 0.8</label> </div>
<div class="r1"><input type="radio" name="q20803:336_answer" disabled="disabled" value="1" id="q20803:336_answer1"><label for="q20803:336_answer1">b. kidney length &lt; 9 cm and RI &lt; 0.8</label> </div>
<div class="r0"><input type="radio" name="q20803:336_answer" disabled="disabled" value="2" id="q20803:336_answer2"><label for="q20803:336_answer2">c. kidney length &lt; 9 cm and RI &gt; 1.0</label> </div>
<div class="r1"><input type="radio" name="q20803:336_answer" disabled="disabled" value="3" id="q20803:336_answer3"><label for="q20803:336_answer3">d. kidney length &gt; 9 cm and RI &lt; 0.8</label> </div>
<div class="r0"><input type="radio" name="q20803:336_answer" disabled="disabled" value="4" id="q20803:336_answer4"><label for="q20803:336_answer4">e. kidney length &gt; 9 cm and RI &gt; 1.0</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:336_-submit" name="q20803:336_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Decreased renal parenchymal perfusion leads to ischemic nephropathy, which has as its hallmarks: glomerular atrophy, tubulo-interstitial lesions, and fibrosis. It is now recognized that the severity of histopathologic damage is an important determinant and predictor of renal functional outcome after revascularization. The classification of chronic renal disease stresses the importance of proteinuria as a marker of renal disease. Proteinuria increases with declining renal function and reflects the severity of parenchymal damage. Proteinuria, and a high renal resistive index, are associated with glomerular damage and altered intrarenal perfusion. Loss of parenchyma leads to renal atrophy. The risk of renal atrophy is highest in patients who have an elevated systolic blood pressure, high-grade renal artery atherosclerotic disease, and low renal cortical blood flow velocity, as assessed by renal duplex scanning. Renal atrophy correlates with changes in the serum creatinine concentration. With progressive renal atrophy, the likelihood of any retrieval of any meaningful renal function from the atrophied kidney with revascularization declines. Normal kidney length is 10-12 cm, so a 6 cm kidney is quite atrophic and probably irreversibly sclerotic. A renal resistive index value &gt; 0.8 can reliably identify patients in whom intervention will not improve renal function (negative predictive value). There remains some controversy on whether a resistive index &lt; 0.8 can reliably predict a positive response to intervention (positive predictive value). As such, a larger kidney with a resistive index &lt; 0.8 is more likely to respond to therapy with an improvement in renal function.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Meyrier%20A.%20Renal%20vascular%20lesions%20in%20the%20elderly:%20Nephrosclerosis%20or%20atheromatous%20renal%20disease?%20Nephrol%20Dial%20Transplant;%201996;%2011%20(Suppl%209):45-52" target="_blank">Meyrier A. Renal vascular lesions in the elderly: Nephrosclerosis or atheromatous renal disease? Nephrol Dial Transplant 1996;11 (Suppl 9):45-52.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Surg+1991%3B+213(5)%3A446-55." target="_blank">Dean RH, Tribble RW, Hansen KJ, O'Neil E<span>,&nbsp;</span>Craven TE<span>,&nbsp;</span>Redding JF 2nd. Evolution of renal insufficiency in ischaemic nephropathy. Ann Surg 1991; 213(5):446-55.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Pol+Merkur+Lekarski+2005%3B+19+(110)%3A206-10." target="_blank">Flisiski M, Manitius J. Predictors of successful renal artery revascularization in atherosclerotic renovascular disease. Pol Merkur Lekarski 2005; 19 (110):206-10.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kidney+Int%3B+1998%3B+53+(3)%3A735-42." target="_blank">Caps MT, Zierler RE, Polissar NL, Bergelin RO<span>,&nbsp;</span>Beach KW<span>,&nbsp;</span>Cantwell-Gab K<span>,&nbsp;</span>et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998; 53 (3):735-42.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/11172177" target="_blank">Radermacher J, Chavan A, Bleck J, Vitzthum A,&nbsp;Stoess B,&nbsp;Gebel MJ,&nbsp;et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001; 344(6):410-17.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Ultrasound+Med+2005%3B+24(12)%3A1641-7." target="_blank">Garci­a-Criado A, Gilabert R, Nicolau C, Real MI,&nbsp;Muntañá X,&nbsp;Blasco J,&nbsp;et al. Value of Doppler sonography for predicting clinical outcome after renal artery revascularization in atherosclerotic renal artery stenosis. J Ultrasound Med 2005; 24(12):1641-7.</a></p>
<p>QID: 30602</p></div><div class="rightanswer">The correct answer is: kidney length &gt; 9 cm and RI &lt; 0.8</div></div></div></div></div><div id="q322" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">64</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_740"><input type="hidden" name="q20803:322_:flagged" value="0"><input type="hidden" value="qaid=911206&amp;qubaid=20803&amp;qid=4853&amp;slot=322&amp;checksum=43cfb16f958210f9b3c59ceef3c7e52d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:322_:flaggedcheckbox" name="q20803:322_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q322&id=4853"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:322_:sequencecheck" value="2"><div class="qtext"><p>Based on&nbsp;the described renal duplex ultrasound findings, renal artery intervention may&nbsp;be considered in&nbsp;which of the following patients with refractory hypertension?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:322_answer" disabled="disabled" value="0" id="q20803:322_answer0"><label for="q20803:322_answer0">a. Proximal renal artery PSV 185 cm/sec, aortic velocity 125 cm/sec</label> </div>
<div class="r1"><input type="radio" name="q20803:322_answer" disabled="disabled" value="1" id="q20803:322_answer1"><label for="q20803:322_answer1">b. Proximal renal artery PSV 200 cm/sec, aortic velocity&nbsp; 50 cm/sec</label> </div>
<div class="r0"><input type="radio" name="q20803:322_answer" disabled="disabled" value="2" id="q20803:322_answer2"><label for="q20803:322_answer2">c. Proximal renal artery PSV 125 cm/sec, aortic velocity 60 cm/sec</label> </div>
<div class="r1"><input type="radio" name="q20803:322_answer" disabled="disabled" value="3" id="q20803:322_answer3"><label for="q20803:322_answer3">d. Proximal renal artery PSV 185 cm/sec, aortic velocity 35 cm/sec</label> </div>
<div class="r0"><input type="radio" name="q20803:322_answer" disabled="disabled" value="4" id="q20803:322_answer4"><label for="q20803:322_answer4">e. Proximal renal artery PSV 185 cm/sec, aortic velocity within an aneurysmal segment of suprarenal aorta 50 cm/sec</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:322_-submit" name="q20803:322_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>At the current time, when cost-effectiveness is crucial, the most important characteristic of any screening test for renal artery stenosis (RAS) is to provide sufficient sensitivity and to guide the need for additional diagnostic and therapeutic modalities. Renal duplex ultrasound (RDU) imaging is a relatively less costly and effective anatomic screening tool to evaluate RAS. Also, RDU imaging can evaluate the hemodynamic status of renal arteries at the hilum, including tardus/parvus, acceleration time, acceleration index, resistance index, and pulsatility index.&nbsp; Several Doppler parameters have been proposed for the diagnosis of &gt;60% RAS.&nbsp; Currently the recommendations are PSV higher than 200cm/sec and renal aortic ratio greater than 3.5.&nbsp; Important to remember that the renal artery ratio will be inaccurate if suprarenal aortic velocities are less than 45cm/sec or measured with an aneurysmal segment of the aorta.&nbsp; In this instance, PSV greater than 200 cm/sec alone would be the criteria for renal artery stenosis greater than 60%.</p>
<p>&nbsp;</p>
<p>White CJ. Circulation. 2006;113:1464-1473. Hirsch AT et al. Circulation 2006;113;463-654</p>
<p>&nbsp;</p>
<p>Olin&nbsp;JW, Piedmonte&nbsp;MR, Young&nbsp;JR, DeAnna&nbsp;S, Grubb&nbsp;M, Childs&nbsp;MB. The utility of duplex ultrasound scanning of the renal arteries for diagnosing significant renal artery stenosis. <em>Ann Intern Med</em>. 1995;122:833–838</p>
<p>QID: 30556</p></div><div class="rightanswer">The correct answer is: Proximal renal artery PSV 200 cm/sec, aortic velocity&nbsp; 50 cm/sec</div></div></div></div></div><div id="q312" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">65</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_749"><input type="hidden" name="q20803:312_:flagged" value="0"><input type="hidden" value="qaid=911196&amp;qubaid=20803&amp;qid=5077&amp;slot=312&amp;checksum=7f1c045d8ef0f20f0ac72e5f4817a70c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:312_:flaggedcheckbox" name="q20803:312_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q312&id=5077"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:312_:sequencecheck" value="2"><div class="qtext"><p>Which statement concerning intervals for conducting vascular laboratory ultrasound surveillance examinations of small (&lt;5.5 cm) abdominal aortic aneurysms (AAAs)<strong>&nbsp;</strong>in men&nbsp;is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:312_answer" disabled="disabled" value="0" id="q20803:312_answer0"><label for="q20803:312_answer0">a. a &lt;l% risk of rupture should be possible with a surveillance interval of 4 years for AAAs 3.0 - 3.9cm</label> </div>
<div class="r1"><input type="radio" name="q20803:312_answer" disabled="disabled" value="1" id="q20803:312_answer1"><label for="q20803:312_answer1">b. a&nbsp;<span style="text-decoration: underline;">&lt;</span>l% risk of rupture should be possible with a surveillance interval of 3 years for AAAs 4.0 - 4.4cm</label> </div>
<div class="r0"><input type="radio" name="q20803:312_answer" disabled="disabled" value="2" id="q20803:312_answer2"><label for="q20803:312_answer2">c. a&nbsp;<span style="text-decoration: underline;">&lt;</span>l% risk of rupture should be possible with a surveillance interval of 2 years for AAAs 4.0 - 4.4cm</label> </div>
<div class="r1"><input type="radio" name="q20803:312_answer" disabled="disabled" value="3" id="q20803:312_answer3"><label for="q20803:312_answer3">d. a &lt;l% risk of rupture should be possible with a surveillance interval of 5 years for AAAs 3.0 - 3.9cm</label> </div>
<div class="r0"><input type="radio" name="q20803:312_answer" disabled="disabled" value="4" id="q20803:312_answer4"><label for="q20803:312_answer4">e. a&nbsp;<span style="text-decoration: underline;">&lt;</span>l% risk of rupture should be possible with a surveillance interval of 2 years for AAAs 4.5 - 5.4cm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:312_-submit" name="q20803:312_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The Rescan Investigators performed a systematic literature review and meta-analysis of the available literature through December of 2010 of studies with repeat measurements over time of AAAs &lt; 5cm. Eighteen data sets encompassing 15,471 patients were included in the meta-analysis. The goals were to develop risk predictions of an AAA growing to exceed 5.5 cm in diameter for given time intervals and to develop suggestions for surveillance intervals so that the risk of rupture of the AAA between surveillance studies would be &lt; 1%.&nbsp; Based on the analysis, the investigators concluded it should be possible to maintain a &lt;1% risk of rupture with surveillance intervals of 3 years for AAAs 3.0 - 3.9 cm, 2 years for AAAs 4.0 - 4.4 cm, and 1 year for AAAs 4.5 - 5.4cm in diameter.&nbsp;The analysis applies only to men and differs from earlier recommendations of surveillance intervals from the Society for Vascular Surgery, which recommends reimaging in 3 years for AAAs 3.0 to 3.4cm, in 1 year for aortas 3.5 to 4.4cm, and in 6 months for aortas 4.5 to 5.4 cm in diameter.</p>
<p>&nbsp;&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2013%3B+309%3A+806-13." target="_blank">Rescan Collaborators; Bown MJ,&nbsp;Sweeting MJ,&nbsp;Brown LC,&nbsp;Powell JT,&nbsp;Thompson SG. Surveillance intervals for small abdominal aortic aneurysms: A meta-analysis. JAMA 2013; 309: 806-13.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2009%3B+50%3A+S2-49." target="_blank">Chaikof EL, Brewster DC, Dalman RL, Makaroun MS,&nbsp;Illig KA,&nbsp;Sicard GA,&nbsp;et al.&nbsp; The care of patients with abdominal aortic aneurysm:&nbsp; The Society for Vascular Surgery practice guidelines. J Vasc Surg 2009; 50: S2-49.</a></p>
<p>QID: 30539</p></div><div class="rightanswer">The correct answer is: a&nbsp;<span style="text-decoration: underline;">&lt;</span>l% risk of rupture should be possible with a surveillance interval of 2 years for AAAs 4.0 - 4.4cm</div></div></div></div></div><div id="q77" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">66</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_758"><input type="hidden" name="q20803:77_:flagged" value="0"><input type="hidden" value="qaid=910961&amp;qubaid=20803&amp;qid=4990&amp;slot=77&amp;checksum=69cd62deb8834250a2fd766779a598d7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:77_:flaggedcheckbox" name="q20803:77_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q77&id=4990"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:77_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old male cigarette smoker has intermittent calf claudication of the right lower extremity at 3 blocks. He has a palpable femoral pulse, nonpalpable distal pulses on the right, and a normal appearing foot. His ankle brachial index is 0.7 on the right and 1.1 on the left. By CTA, he has a 3 cm occlusion of the right superficial femoral artery. Which of the following is the appropriate first step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:77_answer" disabled="disabled" value="0" id="q20803:77_answer0"><label for="q20803:77_answer0">a. femoropopliteal bypass with saphenous vein if endovascular treatment is unsuccessful</label> </div>
<div class="r1"><input type="radio" name="q20803:77_answer" disabled="disabled" value="1" id="q20803:77_answer1"><label for="q20803:77_answer1">b. angiography with endovascular atherectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:77_answer" disabled="disabled" value="2" id="q20803:77_answer2"><label for="q20803:77_answer2">c. smoking cessation, exercise, and medical management alone</label> </div>
<div class="r1"><input type="radio" name="q20803:77_answer" disabled="disabled" value="3" id="q20803:77_answer3"><label for="q20803:77_answer3">d. femoropopliteal bypass with saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:77_answer" disabled="disabled" value="4" id="q20803:77_answer4"><label for="q20803:77_answer4">e. angiography with subintimal recanalization and stent placement</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:77_-submit" name="q20803:77_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The initial treatment of a patient with moderate intermittent claudication should include a progressive exercise program and risk factor modification including management of smoking, hyperlipidemia, hypertension, and diabetes. Statins and anti-platelet agents are appropriate in most patients with peripheral artery disease. Consideration of pharmacologic treatment of claudication (ie, cilostazol) would be appropriate as well. Endovascular or open surgical revascularization are typically considered only if initial medical management is insufficient and the claudication is severe enough to be considered lifestyle or work limiting. Only if exercise and risk factor modification are unsuccessful in achieving satisfactory symptom relief should direct arterial revascularization be considered. The short arterial occlusion in this patient is classified as a TASC II A, for which endovascular treatment is recommended over surgery.<br><br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B+45+(Suppl+S)%3AS5-67." target="_blank">Norgren L, Hiatt WR, Dormandy JA, Nehler MR<span>,&nbsp;</span>Harris KA<span>,&nbsp;</span>Fowkes FG<span>;</span>&nbsp;TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Treatment strategy for intermiitent claudication. J Vasc Surg 2007; 45 (Suppl S):S5-67.</a></p>
<p>QID: 30121</p></div><div class="rightanswer">The correct answer is: smoking cessation, exercise, and medical management alone</div></div></div></div></div><div id="q231" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">67</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_767"><input type="hidden" name="q20803:231_:flagged" value="0"><input type="hidden" value="qaid=911115&amp;qubaid=20803&amp;qid=4963&amp;slot=231&amp;checksum=0fb1cf60eb712ab0ea600153b2d9b853&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:231_:flaggedcheckbox" name="q20803:231_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q231&id=4963"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:231_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding patency rates of arteriovenous (AV) access is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:231_answer" disabled="disabled" value="0" id="q20803:231_answer0"><label for="q20803:231_answer0">a. secondary patency rates of autogenous and prosthetic AV accesses are equivalent</label> </div>
<div class="r1"><input type="radio" name="q20803:231_answer" disabled="disabled" value="1" id="q20803:231_answer1"><label for="q20803:231_answer1">b. prosthetic accesses require fewer revisions than autogenous accesses in order to maintain equivalent secondary patency rates</label> </div>
<div class="r0"><input type="radio" name="q20803:231_answer" disabled="disabled" value="2" id="q20803:231_answer2"><label for="q20803:231_answer2">c. diabetes mellitus positively impacts maturation and primary patency rates for autogenous AV accesses</label> </div>
<div class="r1"><input type="radio" name="q20803:231_answer" disabled="disabled" value="3" id="q20803:231_answer3"><label for="q20803:231_answer3">d. The primary potency of one-stage transposed autogenous access is better than a two-stage procedure</label> </div>
<div class="r0"><input type="radio" name="q20803:231_answer" disabled="disabled" value="4" id="q20803:231_answer4"><label for="q20803:231_answer4">e. primary patency rates of autogenous and prosthetic AV accesses are equivalent</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:231_-submit" name="q20803:231_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>One-year and two-year primary patency rates for autogenous AV accesses have consistently been shown to be higher than prosthetic AV accesses. The secondary patency rates are equivalent at the expense of an increased number of procedures to maintain patency of the prosthetic grafts.These superior patency rates include autogenous transpositions, which have demonstrated similar primary and secondary patency rates to direct access. Furthermore, to maintain secondary patency rates, prosthetic accesses require more revisions than autogenous accesses. Diabetes mellitus negatively impacts maturation and primary patency rates for all autogenous AV accesses.<br><br></p>
<h3>References:</h3><p><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephrol+Dial+Transplant+2005%3B+20+(10)%3A2168-71." target="_blank">Keuter XH, van der Sande FM, Kessels AG, de Haan MW<span>,&nbsp;</span>Hoeks AP<span>,&nbsp;</span>Tordoir JH. Excellent performance of one-stage brachial-basilic arteriovenous fistula. Nephrol Dial Transplant 2005; 20 (10):2168-71.</a></p>
<p>QID: 30409</p></div><div class="rightanswer">The correct answer is: secondary patency rates of autogenous and prosthetic AV accesses are equivalent</div></div></div></div></div><div id="q246" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">68</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_776"><input type="hidden" name="q20803:246_:flagged" value="0"><input type="hidden" value="qaid=911130&amp;qubaid=20803&amp;qid=1957&amp;slot=246&amp;checksum=9396f4f2cb5d9614067fbda136cc04e3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:246_:flaggedcheckbox" name="q20803:246_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q246&id=1957"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:246_:sequencecheck" value="2"><div class="qtext"><p>A 67 year old patient with end stage renal disease is dialyzing via a left arm brachio-axillary ePTFE graft.&nbsp;&nbsp; Blood cultures had been drawn at her dialysis unit 48 hours ago when she had a fever to 102, and grew out methicillin resistant staph. aureus from 4 of 4 bottles. On examination, she is currently afebrile, normotensive with a heart rate of 90. &nbsp;There is no audible heart murmur. The graft has a good thrill.&nbsp; There is erythema at a mid-graft puncture site, but no fluctuance or cellulitis elsewhere. Optimal management would be</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:246_answer" disabled="disabled" value="0" id="q20803:246_answer0"><label for="q20803:246_answer0">a. Complete graft excision with conversion to a brachio-basilic fistula if feasible, with placement of a temporary trans-jugular dialysis catheter after 48 hours</label> </div>
<div class="r1"><input type="radio" name="q20803:246_answer" disabled="disabled" value="1" id="q20803:246_answer1"><label for="q20803:246_answer1">b. immediate complete graft excision with concomitant tunneled jugular catheter placement</label> </div>
<div class="r0"><input type="radio" name="q20803:246_answer" disabled="disabled" value="2" id="q20803:246_answer2"><label for="q20803:246_answer2">c. Antibiotic therapy with avoidance of use of the graft for 4 to 6 weeks, with placement of a tunneled dialysis catheter for temporary use</label> </div>
<div class="r1"><input type="radio" name="q20803:246_answer" disabled="disabled" value="3" id="q20803:246_answer3"><label for="q20803:246_answer3">d. partial excision of the graft segment at the site of puncture site erythema, followed by interposition ePTFE graft tunneled well lateral to the infection site</label> </div>
<div class="r0"><input type="radio" name="q20803:246_answer" disabled="disabled" value="4" id="q20803:246_answer4"><label for="q20803:246_answer4">e. Intravenous antibiotic therapy for six weeks, continued use of the graft in sites away from the area of erythema, with surgery only if blood culures remain positive on antibiotic therapy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:246_-submit" name="q20803:246_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span style="font-family: arial,helvetica,sans-serif; font-size: small;">Prosthetic dialysis graft infection occurs in about 4% of grafts implanted and is a cause of major morbidity and mortality. The patient in this question has a graft infection manifest by fever and bacteremia.&nbsp; While intravenous antibiotics are appropriate initial therapy, in the presence of graft infection this is not definitive therapy.&nbsp; Placement of central intravenous catheters should be avoided in the setting of bacteremia, but if needed for temporary dialysis a non-tunneled catheter would be appropriate.&nbsp; Partial graft excision and preservation of the access is appropriate in some cases, but MRSA septicemia would be a contraindication to this approach.&nbsp;</span></p>
<p><span style="font-family: arial,helvetica,sans-serif; font-size: small; color: #888888;">&nbsp;</span></p>
<p><span style="font-family: arial,helvetica,sans-serif; font-size: small; color: #888888;">REFS</span></p>
<p><span style="font-family: arial,helvetica,sans-serif; font-size: small; color: #888888;"><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Ryan%20SV%5BAuthor%5D&cauthor=true&cauthor_uid=14718819"><span style="color: #888888;">Ryan SV</span></a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Calligaro%20KD%5BAuthor%5D&cauthor=true&cauthor_uid=14718819"><span style="color: #888888;">Calligaro KD</span></a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Scharff%20J%5BAuthor%5D&cauthor=true&cauthor_uid=14718819"><span style="color: #888888;">Scharff J</span></a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Dougherty%20MJ%5BAuthor%5D&cauthor=true&cauthor_uid=14718819"><span style="color: #888888;">Dougherty MJ</span></a>. Management of infected prosthetic dialysis arteriovenous grafts.&nbsp; <em>J Vasc Surg</em> 2004; 39:73-8</span></p>
<h1><span style="font-size: small; color: #888888;"><span style="font-family: arial,helvetica,sans-serif;"><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Minga%20TE%5BAuthor%5D&cauthor=true&cauthor_uid=11684549"><span style="color: #888888;">Minga TE</span></a>,</span> <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Flanagan%20KH%5BAuthor%5D&cauthor=true&cauthor_uid=11684549"><span style="color: #888888;">Flanagan KH</span></a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Allon%20M%5BAuthor%5D&cauthor=true&cauthor_uid=11684549"><span style="color: #888888;">Allon M</span></a>.&nbsp; Clinical consequences of infected arteriovenous grafts in hemodialysis patients. &nbsp;<em>Am J Kidney Disease</em> 2001 38:975-8</span></h1>
<p><span style="font-size: small; color: #888888;">QID: 30429</span></p></div><div class="rightanswer">The correct answer is: partial excision of the graft segment at the site of puncture site erythema, followed by interposition ePTFE graft tunneled well lateral to the infection site</div></div></div></div></div><div id="q40" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">69</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_785"><input type="hidden" name="q20803:40_:flagged" value="0"><input type="hidden" value="qaid=910924&amp;qubaid=20803&amp;qid=4651&amp;slot=40&amp;checksum=811fc0b21525091bf6e9e384b1394474&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:40_:flaggedcheckbox" name="q20803:40_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q40&id=4651"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:40_:sequencecheck" value="2"><div class="qtext"><p>A 66-year-old man with a past medical history of hypertension, hyperlipidemia, and tobacco use presents to the emergency room with a 6 hour history of acute chest, back, and abdominal pain. The pain is sharp in character and rates 8/10 in intensity. The patient reports pain and numbness in his right lower extremity since arrival. On physical examination the patient is visibly uncomfortable. His blood pressure is 170/110, heart rate 98, respiratory rate 24, temperature 98.8. His lungs are clear to auscultation, his heart has a regular rhythm, and his abdomen is tender out of proportion to the exam. His right femoral pulse is absent and he has decreased motor function&nbsp;and sensation in his right foot. His left femoral and pedal pulses are palpable. He has a right femoral Doppler signal. There are no Doppler signals in the right foot. Initial work up included an EKG and a chest x-ray; both were unremarkable. The CTA obtained is shown below. Which of the following is the best management option for this patient?</p><p><a href="./VESAP3_files/1.jpg" target="images"><img src="./VESAP3_files/1.jpg" alt="" width="100" role="presentation" style="vertical-align:text-bottom; margin: 0 .5em;" class="img-responsive"></a><br></p><p><br></p><p><a href="./VESAP3_files/2(1).jpg" target="images"><img src="./VESAP3_files/2(1).jpg" alt="" width="100" role="presentation" style="vertical-align:text-bottom; margin: 0 .5em;" class="img-responsive"></a><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:40_answer" disabled="disabled" value="0" id="q20803:40_answer0"><label for="q20803:40_answer0">a. initiate medical therapy with IV beta blockers followed by TEVAR</label> </div>
<div class="r1"><input type="radio" name="q20803:40_answer" disabled="disabled" value="1" id="q20803:40_answer1"><label for="q20803:40_answer1">b. initiate medical therapy with IV beta blockers</label> </div>
<div class="r0"><input type="radio" name="q20803:40_answer" disabled="disabled" value="2" id="q20803:40_answer2"><label for="q20803:40_answer2">c. initiate medical therapy with IV beta blockers followed by TEVAR with right common iliac artery stenting</label> </div>
<div class="r1"><input type="radio" name="q20803:40_answer" disabled="disabled" value="3" id="q20803:40_answer3"><label for="q20803:40_answer3">d. initiate medical therapy with IV beta blockers followed by TEVAR with perioperative cerebrospinal fluid drainage</label> </div>
<div class="r0"><input type="radio" name="q20803:40_answer" disabled="disabled" value="4" id="q20803:40_answer4"><label for="q20803:40_answer4">e. initiate medical therapy with IV beta blockers followed by right axillo-femoral bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:40_-submit" name="q20803:40_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient presents with an acute complicated type B aortic dissection. There is clinical and radiographic evidence of malperfusion to the mesenteric, renal, and right common iliac arteries. The most optimal management option for this patient is to initiate medical therapy followed by TEVAR with right common iliac artery stenting. The purpose of the TEVAR procedure is to seal the proximal entry tear and redirect flow into the true lumen; this will likely improve the blood flow to the mesenteric and renal vessels. The CTA also shows evidence of significant right common iliac artery compression; this will likely require a right common iliac artery angioplasty and stent placement. Although a right axillo-femoral bypass will likely restore flow to the right lower extremity, it is unlikely to improve the flow to the mesenteric and renal vessels.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Fattori+R%2C+Montgomery+D%2C+Lovato+L%2C+Kische+S%2C+Di+Eusanio+M%2C+Ince+H%2C+et+al.+Survival+after+endovascular+therapy+in+patients+with+type+B+aortic+dissection%3A+a+report+from+the+International+Registry+of+Acute+Aortic+Dissection+(IRAD).+JACC+Cardiovasc+Interv.+2013+Aug%3B6(8)%3A876-82.+doi%3A+10.1016%2Fj.jcin.2013.05.003." target="_blank">Fattori R, Montgomery D, Lovato L, Kische S, Di Eusanio M, Ince H, et al.&nbsp;Survival after endovascular therapy in patients with type B aortic dissection: a report from the International Registry of Acute Aortic Dissection (IRAD).&nbsp;JACC Cardiovasc Interv 2013; 6(8):876-82.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=attori+R%2C+Cao+P%2C+De+Rango+P%2C+Czerny+M%2C+Evangelista+A%2C+Nienaber+C%2C+et+al.+Interdisciplinary+expert+consensus+document+on+management+of+type+B+aortic+dissection.+J+Am+Coll+Cardiol.+2013+Apr+23%3B61(16)%3A1661-78." target="_blank">Fattori R, Cao P, De Rango P, Czerny M, Evangelista A, Nienaber C, et al.&nbsp;Interdisciplinary expert consensus document on management of type B aortic dissection.&nbsp;J Am Coll Cardiol 2013; 61(16):1661-78.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=White+RA%2C+Miller+DC%2C+Criado+FJ%2C+Dake+MD%2C+Diethrich+EB%2C+Greenberg+RK%2C+et+al.+Report+on+the+results+of+thoracic+endovascular+aortic+repair+for+acute%2C+complicated%2C+type+B+aortic+dissection+at+30+days+and+1+year+from+a+multidisciplinary+subcommittee+of+the+Society+for+Vascular+Surgery+Outcomes+Committee.+J+Vasc+Surg.+2011+Apr%3B53(4)%3A1082-90." target="_blank">White RA, Miller DC, Criado FJ, Dake MD, Diethrich EB, Greenberg RK, et al.&nbsp;Report on the results of thoracic endovascular aortic repair for acute, complicated, type B aortic dissection at 30 days and 1 year from a multidisciplinary subcommittee of the Society for Vascular Surgery Outcomes Committee.&nbsp;J Vasc Surg 2011; 53(4):1082-90.&nbsp;</a></p>
<p>QID: 30044</p></div><div class="rightanswer">The correct answer is: initiate medical therapy with IV beta blockers followed by TEVAR with right common iliac artery stenting</div></div></div></div></div><div id="q24" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">70</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_794"><input type="hidden" name="q20803:24_:flagged" value="0"><input type="hidden" value="qaid=910908&amp;qubaid=20803&amp;qid=4634&amp;slot=24&amp;checksum=63991ae5bfdb9b0fefb4decd0d7db7a5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:24_:flaggedcheckbox" name="q20803:24_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q24&id=4634"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:24_:sequencecheck" value="2"><div class="qtext"><p>One year after endovascular repair of a 5 cm abdominal aortic aneurysm (AAA), a 65-year-old woman develops new onset atrial fibrillation. She has been receiving warfarin for 3 months. A follow-up computed tomographic (CT) scan indicates both adequate endograft apposition zones and&nbsp;a persistent Type II endoleak from a pair of lumbar arteries. The aneurysm remains 5 cm in maximal diameter and there is no evidence of migration. She has no other symptoms.&nbsp;Which of the following is the&nbsp;best treatment option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:24_answer" disabled="disabled" value="0" id="q20803:24_answer0"><label for="q20803:24_answer0">a. translumbar embolization of endoleak</label> </div>
<div class="r1"><input type="radio" name="q20803:24_answer" disabled="disabled" value="1" id="q20803:24_answer1"><label for="q20803:24_answer1">b. transfemoral arteriogram</label> </div>
<div class="r0"><input type="radio" name="q20803:24_answer" disabled="disabled" value="2" id="q20803:24_answer2"><label for="q20803:24_answer2">c. cessation of warfarin therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:24_answer" disabled="disabled" value="3" id="q20803:24_answer3"><label for="q20803:24_answer3">d. transfemoral embolization of endoleak</label> </div>
<div class="r0"><input type="radio" name="q20803:24_answer" disabled="disabled" value="4" id="q20803:24_answer4"><label for="q20803:24_answer4">e. continued conservative management and routine follow-up with CT scan</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:24_-submit" name="q20803:24_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Anticoagulation with warfarin after endovascular aneurysm repair does not significantly increase mortality, the incidence of re-intervention, or the risk for aneurysm rupture. There is a trend toward detection of early endoleaks in anticoagulated patients, but anticoagulation does not preclude spontaneous endoleak resolution, nor does it increase late endoleak rates. Warfarin therapy is associated with slower reduction in the size of the aneurysm sac. Observing Type II endoleaks appears to be safe in the absence of aneurysm enlargement regardless of whether the patient receives warfarin therapy. Although there is some suggestion that persistent Type II endoleaks may lead to increased risks for aneurysm sac growth and re-intervention, persistent Type II endoleaks have not been shown to increase the risks for AAA-related death.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Fairman%20RM,%20Carpenter%20JP,%20Baum%20RA,%20et%20al.%20Potential%20impact%20of%20therapeutic%20warfarin%20treatment%20on%20type%20II%20endoleaks%20and%20sac%20shrinkage%20rates%20on%20midterm%20follow-up%20examination.%20J%20Vasc%20Surg;%202002;%2035%20(4):679-685" target="_blank">Fairman RM, Carpenter JP, Baum RA, Larson RA, Golden MA, Barker CF, et al. Potential impact of therapeutic warfarin treatment on type II endoleaks and sac shrinkage rates on midterm follow-up examination. J Vasc Surge 2002; 35 (4):679-85.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Biebl%20M,%20Hakaim%20AG,%20Oldenbrug%20WA,%20et%20al.%20Does%20chronic%20oral%20anticoagulation%20with%20warfarin%20affect%20durability%20of%20endovascular%20aortic%20aneurysm%20exclusion%20in%20a%20midterm%20follow-up?.%20J%20Endovasc%20Ther;%202005;%2012%20(1):58-65" target="_blank">Biebl M, Hakaim AG, Oldenbrug WA, Klocker J, Lau LL, Neuhauser B, et al. Does chronic oral anticoagulation with warfarin affect durability of endovascular aortic aneurysm exclusion in a midterm follow-up?. J Endovasc Ther 2005; 12 (1):58-65.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Jones%20JE,%20Atkins%20MD,%20Brewater%20DC,%20et%20al.%20Persistent%20type%202%20endoleak%20after%20endovascular%20repair%20of%20abdominal%20aortic%20aneurysm%20is%20associated%20with%20adverse%20late%20outcomes.%20J%20Vasc%20Surg;%202007;%2046%20(1):1-8" target="_blank">Jones JE, Atkins MD, Brewster DC, Chung TK, Kwolek CL, LaMuraglia GM, et al. Persistent type 2 endoleak after endovascular repair of abdominal aortic aneurysm is associated with adverse late outcomes. J Vasc Surg 2007; 46 (1):1-8</a>.</p>
<p>QID: 30026</p></div><div class="rightanswer">The correct answer is: continued conservative management and routine follow-up with CT scan</div></div></div></div></div><div id="q521" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">71</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_803"><input type="hidden" name="q20803:521_:flagged" value="0"><input type="hidden" value="qaid=911405&amp;qubaid=20803&amp;qid=5257&amp;slot=521&amp;checksum=d33ad85531a22ec6ad4056319df045fb&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:521_:flaggedcheckbox" name="q20803:521_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q521&id=5257"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:521_:sequencecheck" value="2"><div class="qtext"><p>Compared to other areas of&nbsp;an interventionalist's&nbsp;body, which of the following best describes the annual radiation dose allowed to the lens of the eye?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:521_answer" disabled="disabled" value="0" id="q20803:521_answer0"><label for="q20803:521_answer0">a. it is not monitored</label> </div>
<div class="r1"><input type="radio" name="q20803:521_answer" disabled="disabled" value="1" id="q20803:521_answer1"><label for="q20803:521_answer1">b. it requires the use of special&nbsp;badges to moniter</label> </div>
<div class="r0"><input type="radio" name="q20803:521_answer" disabled="disabled" value="2" id="q20803:521_answer2"><label for="q20803:521_answer2">c. it is approximately 30% of the allowable exposure for the rest of the body</label> </div>
<div class="r1"><input type="radio" name="q20803:521_answer" disabled="disabled" value="3" id="q20803:521_answer3"><label for="q20803:521_answer3">d. it is twice the allowable exposure for the rest of the body</label> </div>
<div class="r0"><input type="radio" name="q20803:521_answer" disabled="disabled" value="4" id="q20803:521_answer4"><label for="q20803:521_answer4">e. it is the same as the allowable exposure for the rest of the body</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:521_-submit" name="q20803:521_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The lens of the eye is more sensitive to radiation than the skin and other organs. While high doses of radiation can cause deterministic damage and result in rapid cataract formation, there is also evidence that radiation exerts a stocastic effect that can result in the delayed formation of cataracts. It is for this reason the the current annual exposure limit for the lens of the eye is&nbsp;0.15 Sv (15 rem), while any other organ or tissue is 0.50 Sv (50 rem). &nbsp;Because of this sensitivity, it is recommended that flouroscopists utilize leaded eyeglasses with side shields to limit lens exposure. The dose to the lens is calculated from the exposure reported by&nbsp;the standard collar badge.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics+1999%3B+19(4)%3A1037-55." target="_blank"><span style="font-size: 10pt;">Brateman L. Radiation safety considerations for diagnostic radiology personell. Radiographics 1999;19(4):1037-55.</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2010%3B+21%3A607-15." target="_blank"><span style="font-size: 10pt;">Miller DL, Vañó E<span>,&nbsp;</span>Bartal G<span>,&nbsp;</span>Balter S<span>,&nbsp;</span>Dixon R<span>,&nbsp;</span>Padovani R<span>,&nbsp;</span>et al. Occupational Radiation Protection in Interventional Radiology: A Joint Guideline of the Cardiovascular and Interventional Radiology Society of Europe and the Society of Interventional Radiology. J Vasc Interv Radiol 2010; 21:607-15.</span></a></p>
<p><span style="font-size: 10pt;">QID: 30925</span></p></div><div class="rightanswer">The correct answer is: it is approximately 30% of the allowable exposure for the rest of the body</div></div></div></div></div><div id="q370" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">72</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_812"><input type="hidden" name="q20803:370_:flagged" value="0"><input type="hidden" value="qaid=911254&amp;qubaid=20803&amp;qid=5294&amp;slot=370&amp;checksum=c7999d58226e467a9f055676bc2c51cf&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:370_:flaggedcheckbox" name="q20803:370_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q370&id=5294"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:370_:sequencecheck" value="2"><div class="qtext"><p>A 30-year-old woman&nbsp;is diagnosed with a right renal artery aneurysm (image shown below). Which of the following parameters is&nbsp;the most compelling indication for&nbsp;surgical repair of the aneurysm?</p>
<p>&nbsp;</p>
<p>&nbsp;<img src="./VESAP3_files/Kougias-2.jpg" alt="" width="593" height="418"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:370_answer" disabled="disabled" value="0" id="q20803:370_answer0"><label for="q20803:370_answer0">a. anticipated pregnancy</label> </div>
<div class="r1"><input type="radio" name="q20803:370_answer" disabled="disabled" value="1" id="q20803:370_answer1"><label for="q20803:370_answer1">b. anatomic location at the bifurcation of the main renal artery</label> </div>
<div class="r0"><input type="radio" name="q20803:370_answer" disabled="disabled" value="2" id="q20803:370_answer2"><label for="q20803:370_answer2">c. diameter of 1.8 cm</label> </div>
<div class="r1"><input type="radio" name="q20803:370_answer" disabled="disabled" value="3" id="q20803:370_answer3"><label for="q20803:370_answer3">d. concurrent polycystic kidney disease</label> </div>
<div class="r0"><input type="radio" name="q20803:370_answer" disabled="disabled" value="4" id="q20803:370_answer4"><label for="q20803:370_answer4">e. associated fibromuscular dysplasia of the renal artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:370_-submit" name="q20803:370_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Renal artery aneurysms&nbsp;are rare. A renal aneurysm was present in only 12 of 100,421&nbsp;patients in an autopsy series. A recent publication based on a 2-year sample at a single institution reported a prevalence of 0.7%&nbsp;out of&nbsp;more than 800 abdominal CTAs. Most renal aneurysms are related to atherosclerosis and fibromuscular dysplasia.&nbsp;Less common etiologies include&nbsp;collagen&nbsp;vascular disease (eg, polyarteritis nodosa, pseudoxanthoma elasticum) and connective tissue disorders such as Ehlers-Danlos and Marfan’s syndromes. The most common anatomic location for renal artery aneurysms is at the primary or secondary branching point of the main renal artery, making surgical or endovascular treatment more challenging.</p>
<p>The risk of rupture is&nbsp;believed to be increased during pregnanacy. Therefore, most authors recommend treatment of renal artery aneurysms in women of childbearing age. The significance of calcification in the wall of renal aneurysms is uncertain.&nbsp;While it&nbsp;has been suggested that the presence of calcification&nbsp;is associated with a reduced rupture risk, rupture has been described for calcified renal&nbsp;artery aneurysms. The decision to intervene in these aneurysms is a complex. Size of the aneurysm (2 cm and greater), patient age, presence of symptoms, and the presence of hypertension are factors that are taken into consideration in treating this entity. Although controversial, treatment of renal artery aneurysms in hypertensive patients may result in improved blood pressure control and reduction in the use of antihypertensive medications in some patients.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Urol+Cutaneous+Rev+1951%3B55%3A451-63." target="_blank">Abeshouse BS. Aneurysm of the renal artery; report of two cases and review of the literature. Urol Cutaneous Rev 1951;55:451-63.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Renal+artery+aneurysms%3A+A+35-year+clinical+experience+with+252+aneurysms+in+168+patients." target="_blank">Henke PK, Cardneau JD, Welling TH, 3rd, Upchurch GR, Jr., Wakefield TW, Jacobs LA, et al.Renal artery aneurysms: A 35-year clinical experience with 252 aneurysms in 168 patients. Ann Surg 2001;234:454-62.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2004%3B40%3A53-60." target="_blank">English WP, Pearce JD, Craven TE, Wilson DB, Edwards MS, Ayerdi J, et al. Surgical management of renal artery aneurysms. J Vasc Surg 2004;40:53-60.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B37%3A293-300." target="_blank">Pfeiffer T, Reiher L, Grabitz K, Grunhage B, Hafele S, Voiculescu A. Reconstruction for renal artery aneurysm: Operative techniques and long-term results. J Vasc Surg 2003;37:293-300.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Acta+Radiol++2007%3B+48%3A274." target="_blank">Zhang&nbsp;LJ,&nbsp;Yang&nbsp;GF,&nbsp;Qi&nbsp;J,&nbsp;Shen&nbsp;W.&nbsp;Renal artery aneurysm: diagnosis and surveillance with multidetector-row computed tomography.&nbsp;Acta Radiol&nbsp;&nbsp;2007;&nbsp;48:274.&nbsp;</a></p>
<p>QID: 30652</p></div><div class="rightanswer">The correct answer is: anticipated pregnancy</div></div></div></div></div><div id="q259" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">73</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_821"><input type="hidden" name="q20803:259_:flagged" value="0"><input type="hidden" value="qaid=911143&amp;qubaid=20803&amp;qid=4996&amp;slot=259&amp;checksum=308915b8331b38bacc6855fc44d0ca4c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:259_:flaggedcheckbox" name="q20803:259_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q259&id=4996"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:259_:sequencecheck" value="2"><div class="qtext"><p>A 46-year-old man with end-stage renal disease presents to the office from dialysis for evaluation of a right forearm prosthetic radial antecubital arteriovenous access, which is currently being used for dialysis (see image below). On physical examination of his right arm, he has a thrill and bruit overlying his graft, no edema, and palpable radial and brachial artery pulses. A duplex scan of the masses is performed and turbulent graft flow is noted. Which of the following is the most probable diagnosis?</p>
<p>&nbsp;</p>
<p><img style="vertical-align: bottom;" src="./VESAP3_files/Question 1 image.jpg" alt="" width="414" height="288"></p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:259_answer" disabled="disabled" value="0" id="q20803:259_answer0"><label for="q20803:259_answer0">a. abscess&nbsp;formation</label> </div>
<div class="r1"><input type="radio" name="q20803:259_answer" disabled="disabled" value="1" id="q20803:259_answer1"><label for="q20803:259_answer1">b. true aneurysms</label> </div>
<div class="r0"><input type="radio" name="q20803:259_answer" disabled="disabled" value="2" id="q20803:259_answer2"><label for="q20803:259_answer2">c. perigraft seromas</label> </div>
<div class="r1"><input type="radio" name="q20803:259_answer" disabled="disabled" value="3" id="q20803:259_answer3"><label for="q20803:259_answer3">d. pseudoaneurysm formation</label> </div>
<div class="r0"><input type="radio" name="q20803:259_answer" disabled="disabled" value="4" id="q20803:259_answer4"><label for="q20803:259_answer4">e. graft hematoma</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:259_-submit" name="q20803:259_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Pseudoaneurysms are defects in the wall of the AV fistula or graft due to the trauma of repeated puncture for dialysis. They are more commonly seen in prosthetic than autogenous arteriovenous accesses, occurring in 2-10% of all prosthetic grafts. They may be seen anywhere along the length of the access and occur due to continuous puncturing of the AV access in the same location by dialysis personnel.&nbsp; Commonly occurring in pairs, due to an arterial and venous puncture with each dialysis session, they can lead to skin erosion. The diagnosis is made by clinical examination, but it may be confirmed with duplex imaging demonstrating a classic "yin-yang" sign on color-flow imaging created by the turbulent flow.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank">Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg 2008; 48 (S):55S-80S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2008%3B+48+(5S)%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg; 2008; 48 (5S):2S-25S.</a></p>
<p>QID: 30443</p></div><div class="rightanswer">The correct answer is: pseudoaneurysm formation</div></div></div></div></div><div id="q318" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">74</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_830"><input type="hidden" name="q20803:318_:flagged" value="0"><input type="hidden" value="qaid=911202&amp;qubaid=20803&amp;qid=5083&amp;slot=318&amp;checksum=d898624c1e23f82c5f4bf3474e3b71b0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:318_:flaggedcheckbox" name="q20803:318_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q318&id=5083"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:318_:sequencecheck" value="2"><div class="qtext"><p>A 28-year-old healthy woman presents to your clinic with a 6-month history of right lower extremity claudication. On physical exam she has normal pedal pulses at rest. She undergoes treadmill testing (with pre- and post-exercise ankle brachial indices) that demonstrates a&nbsp;30% drop in the right leg ABI after 1 minute of exercise that remains sustained and has a slow return to baseline. The left leg is normal. She undergoes an arterial duplex study of the right leg. Which of the following ultrasound findings are suggestive of the etiology of her claudication?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:318_answer" disabled="disabled" value="0" id="q20803:318_answer0"><label for="q20803:318_answer0">a. loss of a normal tri-phasic waveform in the pedal vessels with active plantar flexion</label> </div>
<div class="r1"><input type="radio" name="q20803:318_answer" disabled="disabled" value="1" id="q20803:318_answer1"><label for="q20803:318_answer1">b. atherosclerotic changes to the superficial femoral, popliteal, and tibial runoff vessels</label> </div>
<div class="r0"><input type="radio" name="q20803:318_answer" disabled="disabled" value="2" id="q20803:318_answer2"><label for="q20803:318_answer2">c. normal tri-phasic waveforms in the pedal vessels at rest and with active plantar flexion</label> </div>
<div class="r1"><input type="radio" name="q20803:318_answer" disabled="disabled" value="3" id="q20803:318_answer3"><label for="q20803:318_answer3">d. aneurysmal dilation of the popliteal artery with intraluminal thrombus</label> </div>
<div class="r0"><input type="radio" name="q20803:318_answer" disabled="disabled" value="4" id="q20803:318_answer4"><label for="q20803:318_answer4">e. external compression of the popliteal artery by a cystic mass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:318_-submit" name="q20803:318_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Popliteal artery entrapment syndrome is a rare cause of arterial claudication; it typically affects younger patients who do not have the usual cardiovascular risk factors for development of atherosclerosis. It is caused by an embryological anomaly in the development of the popliteal fossa, resulting in repetitive external compression of the popliteal artery. There are 4 described variants of the popliteal artery fossa that have been described in relation to popliteal artery entrapment syndrome: (Type 1) the medial head of the gastrocnemius muscle attachment more laterally than normal, (Type 2) anomalous muscle band of the medial head of the gastrocnemius compresses the popliteal artery, (Type 3) the popliteal artery takes a more medial course to a normally attached medial head of the gastrocnemius muscle, (Type 4) the popliteal artery and gastrocnemius muscle are normal but an abnormal fibrous band compresses the popliteal artery (see Image 1 below).</p>
<p>On physical exam, the affected limb has normal pedal pulses at rest and may have a loss or weakening of the pulse exam with active plantar flexion. An exercise ABI study may show a drop in the ABI in the affected limb with exercise. Duplex ultrasonography will show normal waveforms across the popliteal artery in the neutral position. With active plantar flexion, there can be a doubling of flow velocity suggestive of stenosis or in severe cases complete loss of flow (see Image 2 below).</p>
<p><img src="./VESAP3_files/Slide1.jpg" alt="" width="380" height="395"></p>
<p>Image 1: (<a style="line-height: 1.5;" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Popliteal+artery+disease%3A+diagnosis+and+treatment.+Radiographics.+2004+Mar-Apr%3B24(2)%3A467-79.)" target="_blank">Wright LB,&nbsp;Matchett WJ,&nbsp;Cruz CP,&nbsp;James CA,&nbsp;Culp WC,&nbsp;Eidt JF,&nbsp;et al. Popliteal artery disease: diagnosis and treatment. Radiographics 2004; 24(2):467-79</a>.)</p>
<p><img style="line-height: 1.5;" src="./VESAP3_files/Slide1.jpg" alt="" width="560" height="415"></p>
<p>Image 2: (A) Duplex US of popliteal artery at rest. (B) Duplex US of popliteal artery with active plantar flexion. Complete loss of flow through the popliteal artery.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/14573416" target="_blank">Macedo TM,&nbsp; Johnson CM Hallet JW,&nbsp;Breen JF.&nbsp;Popliteal artery entrapment syndrome: Role of imaging in the diagnosis. Am J Roentgenol 2003;181: 1259-65.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Popliteal+artery+disease%3A+diagnosis+and+treatment.+Radiographics.+2004+Mar-Apr%3B24(2)%3A467-79.)" target="_blank">Wright LB, Matchett WJ, Cruz CP, James CA,&nbsp;Culp WC,&nbsp;Eidt JF,&nbsp;et al. Popliteal artery disease: diagnosis and treatment. Radiographics 2004; 24(2):467-79.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23853226" target="_blank">Altintas U, Helgstrand UV, Hansen MA, Stentzer KF,&nbsp;Schroeder TV,&nbsp;Eiberg JP. Popliteal artery entrapment syndrome: ultrasound imaging, intraoperative findings, and clinical outcome. Vasc Endovascular Surg 2013; 47(7):513-8.</a></p>
<p>QID: 30552</p></div><div class="rightanswer">The correct answer is: loss of a normal tri-phasic waveform in the pedal vessels with active plantar flexion</div></div></div></div></div><div id="q477" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">75</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_839"><input type="hidden" name="q20803:477_:flagged" value="0"><input type="hidden" value="qaid=911361&amp;qubaid=20803&amp;qid=5202&amp;slot=477&amp;checksum=389808854d424b8ceb14e7b3f6eca528&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:477_:flaggedcheckbox" name="q20803:477_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q477&id=5202"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:477_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements about temporal arteritis (TA) is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:477_answer" disabled="disabled" value="0" id="q20803:477_answer0"><label for="q20803:477_answer0">a. the disease is limited to branches of the carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:477_answer" disabled="disabled" value="1" id="q20803:477_answer1"><label for="q20803:477_answer1">b. the diagnosis is confirmed by an elevated C-reactive protein level</label> </div>
<div class="r0"><input type="radio" name="q20803:477_answer" disabled="disabled" value="2" id="q20803:477_answer2"><label for="q20803:477_answer2">c. it is most common in women in their fifth decade of life</label> </div>
<div class="r1"><input type="radio" name="q20803:477_answer" disabled="disabled" value="3" id="q20803:477_answer3"><label for="q20803:477_answer3">d. imaging is not useful for diagnosis of TA</label> </div>
<div class="r0"><input type="radio" name="q20803:477_answer" disabled="disabled" value="4" id="q20803:477_answer4"><label for="q20803:477_answer4">e. arterial biospies may be obtained after starting therapy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:477_-submit" name="q20803:477_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Giant cell arteritis (GCA), also know as temporal arteritis (TA), is one of the most common indications for long-term steroid therapy, often administered at high doses. Vasculitis due to GCA should be treated as a medical emergency, as the visual loss that occurs in up to a fifth of patients may be prevented by prompt recognition and treatment. Also, a specific diagnosis is important, as treatment with high-dose corticosteroid therapy is associated with serious side effects. Patient harm occurs if treatment for GCA is provided for a false-positive diagnosis.</p>
<p>The diagnosis of GCA or TA is made if 3 of these 5 criteria are present:</p>
<ul>
<li>Age at disease onset ≥ 50 years</li>
<li>New headache</li>
<li>Temporal artery abnormality</li>
<li>Elevated erythrocyte sedimentation rate &gt; 50 mm/hr</li>
<li>Biopsy specimen demonstrating vasculitis characterized by predominance of mononuclear infiltration or granulomatous inflammation, usually with multinucleated giant cells</li>
</ul>
<p>Temporal artery biopsy (TAB) is the gold standard for GCA diagnosis and often remains positive for 2-6 weeks after the start of treatment. Biopsy specimens should include at least a 2 cm segment of artery. Contralateral biopsies are rarely indicated. TAB may be negative in some patients with GCA, however, due to the presence of skip lesions or because of an inadequate specimen (&lt; 1 cm) being obtained, C-reactive protein levels may be elevated with GCA, but this finding is not specific.</p>
<p>Duplex ultrasonography can detect a characteristic appearance superficial temporal artery abnormalities, including a hypoechoic “halo” sign, occlusions, and arterial stenoses. Positron emission tomography scanning is used to evaluate aortic and large vessel disease. Magnetic resonance imaging has shown mural enhancement in inflamed temporal and occipital arteries. These techniques show promise for the diagnosis and monitoring of large vessel disease, but do not replace TAB for cranial GCA.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surg+Clin+North+Am+2013%3B+93(4)%3A833-75%2C+viii." target="_blank">Wu W, Chaer RA. Nonarteriosclerotic vascular disease. Surg Clin North Am 2013; 93(4):833-75, viii.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Autoimmun+Rev.+2011%3B11(6-7)%3AA544-54." target="_blank">Borchers AT, Gershwin ME. Giant cell arteritis: a review of classification, pathophysiology, geoepidemiology and treatment. Autoimmun Rev 2012;11(6-7):A544-54.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Curr+Opin+Ophthalmol+2010%3B+21(6)%3A417-22." target="_blank">Kale N, Eggenberger E. Diagnosis and management of giant cell arteritis: a review. Curr Opin Ophthalmol 2010; 21(6):417-22.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+Med+2010%3B10(4)%3A381-6." target="_blank">Dasgupta B. Giant Cell Arteritis Guideline Development Group. Concise guidance: diagnosis and management of giant cell arteritis. Clin Med 2010;10(4):381-6.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=BMC+Musculoskelet+Disord+2010%3B+11%3A44." target="_blank">Arida A, Kyprianou M, Kanakis M, Sfikakis PP. The diagnostic value of ultrasonography-derived edema of the temporal artery wall in giant cell arteritis: a second meta-analysis. BMC Musculoskelet Disord 2010; 11:44.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arthritis+Rheum+1990%3B+33(8)%3A1065-7." target="_blank">Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990; 33(8):1065-7.&nbsp;</a></p>
<p>QID: 30841</p></div><div class="rightanswer">The correct answer is: arterial biospies may be obtained after starting therapy</div></div></div></div></div><div id="q187" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">76</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_848"><input type="hidden" name="q20803:187_:flagged" value="0"><input type="hidden" value="qaid=911071&amp;qubaid=20803&amp;qid=4554&amp;slot=187&amp;checksum=df1110764546f015eb811bc844ee1b38&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:187_:flaggedcheckbox" name="q20803:187_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q187&id=4554"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:187_:sequencecheck" value="2"><div class="qtext"><p>A 65 year old man with a history of AAA repaired with EVAR presents to the ER as the unrestrained driver in a motor vehicle accident. Upon presentation to the ER, he is hemodynamically stable but complaining of difficulty breathing, and is immediately intubated. Workup reveals a sternal fracture and flail chest, as well as a small subdural hematoma.&nbsp; His chest CT is shown below. The best management of this patient is:</p>
<p><img src="./VESAP3_files/Picture1.jpg" alt="" width="490" height="272"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:187_answer" disabled="disabled" value="0" id="q20803:187_answer0"><label for="q20803:187_answer0">a. Initial observation in the ICU with blood pressure control, and follow-up chest CT in 6 months.</label> </div>
<div class="r1"><input type="radio" name="q20803:187_answer" disabled="disabled" value="1" id="q20803:187_answer1"><label for="q20803:187_answer1">b. Placement of thoracic endograft distal to the origin of the left subclavian artery, coiling of the right subclavian artery and carotid subclavian bypass on the right.</label> </div>
<div class="r0"><input type="radio" name="q20803:187_answer" disabled="disabled" value="2" id="q20803:187_answer2"><label for="q20803:187_answer2">c. Open repair of the thoracic aorta with a tube graft and re-implantation of all identifiable intercostal arteries.</label> </div>
<div class="r1"><input type="radio" name="q20803:187_answer" disabled="disabled" value="3" id="q20803:187_answer3"><label for="q20803:187_answer3">d. Placement of thoracic endograft distal to the left common carotid artery without coiling or bypass to either subclavian artery unless hand ischemia develops.</label> </div>
<div class="r0"><input type="radio" name="q20803:187_answer" disabled="disabled" value="4" id="q20803:187_answer4"><label for="q20803:187_answer4">e. Placement of thoracic endograft distal to the origin of the left subclavian artery, coiling of the right subclavian artery, without carotid subclavian bypass on the right</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:187_-submit" name="q20803:187_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The CT scan demonstrates injury to the descending thoracic aorta at the origin of an aberrant right subclavian artery. &nbsp;Management with an endograft is the best surgical option in this patient whose respiratory compromise from the flail chest is likely to be significant. In a recent analysis of TEVAR versus open repair for blunt thoracic aortic trauma, complications and in hospital death were less in patients managed with TEVAR (48% vs. 70%).&nbsp; Furthermore, over the study period, TEVAR essentially replaced open repair in the setting of blunt thoracic aortic trauma. <sup>1</sup> Coiling of the right subclavian artery is required to prevent endoleak. Revascularization of the right subclavian artery with bypass or transposition would be prudent in this patient with an abdominal endograft, not only to continue to perfuse his upper extremity, but also to maintain collateral flow to the spinal cord, and decrease the risk of paraplegia. <sup>2-4</sup> The patient is stable and would likely be able to tolerate the increased operative time added by the bypass.</p>
<p>References:</p>
<p>Azizzadeh A, Charlton-Ouw KM, Chen Z, et al. An outcome analysis of endovascular versus open repair of blunt traumatic aortic injuries. J Vasc Surg 2013;&nbsp;57: 108-15. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23141678">http://www.ncbi.nlm.nih.gov/pubmed/23141678</a></p>
<p>Rizvi AZ, Murad MH, Fairman RM, et al.&nbsp;The effect of left subclavian artery coverage on morbidity and mortality in patients undergoing endovascular thoracic aortic interventions: a systematic review and meta-analysis.&nbsp;J Vasc Surg 2009; 50: 1159–1169. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19878792">http://www.ncbi.nlm.nih.gov/pubmed/19878792</a></p>
<p>Holt PJ, Johnson C, Hinchliffe RJ, et al. Outcomes of the endovascular management of aortic arch aneurysm: Implications for management of the left subclavian artery, J Vasc Surg 2010; 51: 1329-1338.&nbsp;&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/20303695">http://www.ncbi.nlm.nih.gov/pubmed/20303695</a>&nbsp;</p>
<p>Matsumura JS, Lee WA, Mitchell RS, et al.&nbsp;Management of the left subclavian artery with TEVAR: clinical practice guidelines of the Society for Vascular Surgery, J Vasc Surg 2009; 50: 1155–1158. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19878791">http://www.ncbi.nlm.nih.gov/pubmed/19878791</a></p>
<p>QID: 30331</p></div><div class="rightanswer">The correct answer is: Placement of thoracic endograft distal to the origin of the left subclavian artery, coiling of the right subclavian artery and carotid subclavian bypass on the right.</div></div></div></div></div><div id="q247" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">77</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_857"><input type="hidden" name="q20803:247_:flagged" value="0"><input type="hidden" value="qaid=911131&amp;qubaid=20803&amp;qid=2350&amp;slot=247&amp;checksum=8557cd264450c3940d0c28b273dd6ada&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:247_:flaggedcheckbox" name="q20803:247_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q247&id=2350"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:247_:sequencecheck" value="2"><div class="qtext"><p><span>A 50 year old man with end stage renal disease had a&nbsp; right brachio-axillary prosthetic bridge graft in placed 6 weeks ago, and has persistent edema throughout the right arm.&nbsp; Fistulography shows patency of the graft with no stenoses within the arm.&nbsp; Central venography is shown below.&nbsp; The most appropriate management would be:</span></p><p><span><img src="./VESAP3_files/dougherty 8 .jpg" alt="" width="986" height="839" role="presentation" style="vertical-align:text-bottom; margin: 0 .5em;" class="img-responsive"><br></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:247_answer" disabled="disabled" value="0" id="q20803:247_answer0"><label for="q20803:247_answer0">a. <span>Ligation of the graft and construction of contralateral access</span></label> </div>
<div class="r1"><input type="radio" name="q20803:247_answer" disabled="disabled" value="1" id="q20803:247_answer1"><label for="q20803:247_answer1">b. <span>Cross-sternal axillo-axillary venous bypass</span></label> </div>
<div class="r0"><input type="radio" name="q20803:247_answer" disabled="disabled" value="2" id="q20803:247_answer2"><label for="q20803:247_answer2">c. <span>Transluminal angioplasty of the venous occlusion with primary stenting</span></label> </div>
<div class="r1"><input type="radio" name="q20803:247_answer" disabled="disabled" value="3" id="q20803:247_answer3"><label for="q20803:247_answer3">d. <span>Ace wrapping and observation</span></label> </div>
<div class="r0"><input type="radio" name="q20803:247_answer" disabled="disabled" value="4" id="q20803:247_answer4"><label for="q20803:247_answer4">e. <span>Transluminal angioplasty of the venous occlusion with selective stenting</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:247_-submit" name="q20803:247_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The venogram shows a segmental occlusion of the right subclavian vein.&nbsp; Pacemaker wires are present on the left side with patency of the superior vena cava.&nbsp; Ace wrapping and observation alone may help control edema, but central venous obtsruction will compromise dialysis efficiency and should not be ignored. While cross sternal bypass has been described, it would not be a first line treatment, and the presence of pacemaker leads would make this suboptimal.&nbsp; Ligating and abandoning the graft would be inappropriate, particularly given the likely presence of contralateral venous compromise.&nbsp; Angioplasty of the subclavian occlusion is the correct approach.&nbsp; Stenting can be utilized if needed to produce an acceptable techinical result, but the presence of the lesion at the thoracic inlet is a relative contraindication for a stent, which will be prone to fracture at that location.</p>
<p>&nbsp;</p>
<p><span>References</span></p>
<div class="cit"><span><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Illig%20KA%5BAuthor%5D&cauthor=true&cauthor_uid=21889100"><span>Illig KA</span></a>.</span>&nbsp; Management of central vein stenoses and occlusions:&nbsp; the critical importance of the costoclavicular junction. Semin Vasc Surg. 2011;24:113-8</div>
<div class="cit">&nbsp;</div>
<div class="cit">
<p><span><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Bakken%20AM%5BAuthor%5D&cauthor=true&cauthor_uid=17398386"><span>Bakken AM</span></a>,&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Protack%20CD%5BAuthor%5D&cauthor=true&cauthor_uid=17398386"><span>Protack CD</span></a>,&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Saad%20WE%5BAuthor%5D&cauthor=true&cauthor_uid=17398386"><span>Saad WE</span></a>,&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Lee%20DE%5BAuthor%5D&cauthor=true&cauthor_uid=17398386"><span>Lee DE</span></a>,&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Waldman%20DL%5BAuthor%5D&cauthor=true&cauthor_uid=17398386"><span>Waldman DL</span></a>,&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Davies%20MG%5BAuthor%5D&cauthor=true&cauthor_uid=17398386"><span>Davies MG</span></a><strong>.&nbsp;&nbsp;</strong>Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients.&nbsp;<a title="Journal of vascular surgery." href="http://www.ncbi.nlm.nih.gov/pubmed/17398386"><span><em>J Vasc Surg.</em></span></a>2007;45:776-83.</span></p>
<span>Teruya TH, Abou-Zamzam AM Jr, Limm W, Wong L, Wong L&nbsp; Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers.&nbsp;&nbsp;<em>Ann Vasc Surg</em>. 2003;17:526</span></div>
<div class="cit"><span><span>QID: 30431</span></span></div></div><div class="rightanswer">The correct answer is: <span>Transluminal angioplasty of the venous occlusion with selective stenting</span></div></div></div></div></div><div id="q150" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">78</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_866"><input type="hidden" name="q20803:150_:flagged" value="0"><input type="hidden" value="qaid=911034&amp;qubaid=20803&amp;qid=4768&amp;slot=150&amp;checksum=5894904d2d6c1baf58ab27844a28e487&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:150_:flaggedcheckbox" name="q20803:150_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q150&id=4768"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:150_:sequencecheck" value="2"><div class="qtext"><p>&nbsp;A 32-year-old woman who currently smokes presents with a 6-month history of low-grade fever, weight loss, and progressive exertional fatigue of both upper extremities. Clinical examination reveals diminished pulses in both arms and bilateral supraclavicular bruits. Her erythrocyte sedimentation rate and C reactive protein are elevated. Regarding this patient, which of the following statements is most accurate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:150_answer" disabled="disabled" value="0" id="q20803:150_answer0"><label for="q20803:150_answer0">a. long-term outcome of surgical revascularization is improved if it is delayed until the disease is quiescent</label> </div>
<div class="r1"><input type="radio" name="q20803:150_answer" disabled="disabled" value="1" id="q20803:150_answer1"><label for="q20803:150_answer1">b. Buerger’s disease is the most likely diagnosis</label> </div>
<div class="r0"><input type="radio" name="q20803:150_answer" disabled="disabled" value="2" id="q20803:150_answer2"><label for="q20803:150_answer2">c. a normal erythrocyte sedimentation rate and the absence of fever and vessel tenderness are reliable indicators that the disease is in the quiescent phase</label> </div>
<div class="r1"><input type="radio" name="q20803:150_answer" disabled="disabled" value="3" id="q20803:150_answer3"><label for="q20803:150_answer3">d. conservative management may produce initial improvement, but surgical revascularization will likely be required for sustained symptom relief</label> </div>
<div class="r0"><input type="radio" name="q20803:150_answer" disabled="disabled" value="4" id="q20803:150_answer4"><label for="q20803:150_answer4">e. her 10-year survival will likely be significantly less than matched controls</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:150_-submit" name="q20803:150_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Despite her smoking, this patient’s clinical picture is more representative of Takayasu’s arteritis than of Buerger’s disease or of atherosclerosis involving the aortic branches. Takayasu’s arteritis is marked by systemic inflammatory signs, elevated markers of inflammation, and involvement of subclavian arteries. Patients with Buerger’s disease have more distal involvement of small - and medium-sized vessels, with symptoms of rest pain and/or gangrene. The erythrocyte sedimentation rate is usually elevated during the active phase of Takayasu’s arteritis and may normalize once the disease becomes quiescent.&nbsp; However, the absence of an elevated sed rate, fever, and vessel tenderness are not reliable indicators of disease quiescence.</p>
<p>Surgical revascularization is required in only a minority of patients and is associated with improved long-term outcomes when performed when the disease is quiescent. Long-term survival (10 years) is not significantly affected, regardless of the status of disease activity or steroid therapy.</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2000%3B14%3A125-9." target="_blank">Sparks SR, Chock A, Seslar S, Bergan JJ<span>,&nbsp;</span>Owens EL<span>.</span>&nbsp;Surgical treatment of Takayasu’s arteritis: case report and literature review. Ann Vasc Surg 2000;14:125-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Rheum+Dis+Clin+N+Am+2007%3B33%3A691-739." target="_blank">Stone JH. Vasculitis: a collection of pearls and myths. Rheum Dis Clin N Am 2007;33:691-739.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1990%3B+12%3A429-37." target="_blank">Weaver FA, Yellin AE, Campen DH, Oberg J<span>,&nbsp;</span>Foran J<span>,&nbsp;</span>Kitridou RC,&nbsp;et al. Surgical procedures in the management of Takayasu's arteritis. J Vasc Surg 1990;12:429-37.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2006%3B+43(1)%3A64-71." target="_blank">Fields CE, Bower TC, Cooper LT, Hoskin T, Noel AA, Panneton JM, et al. Takayasu's arteritis: operative results and influence of disease activity. J Vasc Surg 2006; 43(1):64-71.</a></p>
<p>QID: 30244</p></div><div class="rightanswer">The correct answer is: long-term outcome of surgical revascularization is improved if it is delayed until the disease is quiescent</div></div></div></div></div><div id="q519" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">79</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_875"><input type="hidden" name="q20803:519_:flagged" value="0"><input type="hidden" value="qaid=911403&amp;qubaid=20803&amp;qid=5255&amp;slot=519&amp;checksum=174bc14f50ddf0fe2618b37be4bc5b58&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:519_:flaggedcheckbox" name="q20803:519_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q519&id=5255"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:519_:sequencecheck" value="2"><div class="qtext"><p>Which of the following principles best summarize the basic tenets of radiation safety used to limit occupational exposure of interventionists?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:519_answer" disabled="disabled" value="0" id="q20803:519_answer0"><label for="q20803:519_answer0">a. wide angle collimation, exposure surface, beam energy</label> </div>
<div class="r1"><input type="radio" name="q20803:519_answer" disabled="disabled" value="1" id="q20803:519_answer1"><label for="q20803:519_answer1">b. pulse width, exposure angle, beam filtration</label> </div>
<div class="r0"><input type="radio" name="q20803:519_answer" disabled="disabled" value="2" id="q20803:519_answer2"><label for="q20803:519_answer2">c. time, distance, and shielding</label> </div>
<div class="r1"><input type="radio" name="q20803:519_answer" disabled="disabled" value="3" id="q20803:519_answer3"><label for="q20803:519_answer3">d. dose modulation, noise reduction, scatter control</label> </div>
<div class="r0"><input type="radio" name="q20803:519_answer" disabled="disabled" value="4" id="q20803:519_answer4"><label for="q20803:519_answer4">e. frame rate, increased magnification, tube height</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:519_-submit" name="q20803:519_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>While many modalities can be used to limit both operator exposure as well as patient exposure, they all typically fall into one of three basic principals: limiting exposure time, maximizing distance from the radiation source, and using shielding to prevent unnecessary exposure to primary, as well as scatter, radiation. Modalities such as frame rate and pulse width are functions of radiation time. Collimation and beam filtration represent types of shielding, while tube height and exposure angle are functions of distance.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics+1999%3B+19(4)%3A1037-55." target="_blank">Brateman L. Radiation safety considerations for diagnostic radiology personell. Radiographics 1999; 19(4):1037-55. &nbsp;</a> &nbsp; &nbsp; &nbsp;&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53(1S)%3A22S-27S." target="_blank">Mitchell EL, Furey P. Prevention of radiation injury from medical imaging. J Vasc Surg 2011; 53(1S):22S-27S.&nbsp;</a></p>
<p>QID: 30923</p></div><div class="rightanswer">The correct answer is: time, distance, and shielding</div></div></div></div></div><div id="q359" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">80</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_884"><input type="hidden" name="q20803:359_:flagged" value="0"><input type="hidden" value="qaid=911243&amp;qubaid=20803&amp;qid=5154&amp;slot=359&amp;checksum=d851bb676a7b48bfcba229293fcb2e94&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:359_:flaggedcheckbox" name="q20803:359_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q359&id=5154"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:359_:sequencecheck" value="2"><div class="qtext"><p>At laparotomy for&nbsp;acute mesenteric ischemia, the terminal 20 cm of ileum and the right colon are frankly necrotic with overt perforation. There is no pulse in the superior mesenteric artery (SMA), celiac artery, or inferior mesenteric artery (IMA). Which of the following is the most appropriate first step&nbsp;at laparotomy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:359_answer" disabled="disabled" value="0" id="q20803:359_answer0"><label for="q20803:359_answer0">a. resection of&nbsp;only&nbsp;frankly necrotic or perforated bowel</label> </div>
<div class="r1"><input type="radio" name="q20803:359_answer" disabled="disabled" value="1" id="q20803:359_answer1"><label for="q20803:359_answer1">b. retrograde aorta-SMA bypass using saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:359_answer" disabled="disabled" value="2" id="q20803:359_answer2"><label for="q20803:359_answer2">c. antegrade aorto-SMA bypass using ringed PTFE</label> </div>
<div class="r1"><input type="radio" name="q20803:359_answer" disabled="disabled" value="3" id="q20803:359_answer3"><label for="q20803:359_answer3">d. direct puncture of the SMA with infusion of thrombolytic agent</label> </div>
<div class="r0"><input type="radio" name="q20803:359_answer" disabled="disabled" value="4" id="q20803:359_answer4"><label for="q20803:359_answer4">e. resection of all bowel that is not normal in appearance</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:359_-submit" name="q20803:359_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Initial treatment of acute mesenteric ischemia requires volume&nbsp;resuscitation and attempted correction of metabolic derrangments with expeditious operative management. In the last decade, diagnostic imaging has shifted from catheter angiography to CT angiography.&nbsp;Surgical management is indicated universally when bowel is threatened; the&nbsp;surgeon should have a functional knowledge of mesenteric anatomy and revascularization techniques.&nbsp;</p>
<p>At laparotomy, the first priority is to prevent any further contamination of the periteonal cavity. Overtly necrotic or leaking bowel should be resected upon entry into the abdomen to prevent spill of enteric contents. Bowel that is not overtly necrotic or perforated&nbsp;should not be resected initially, as revascularization may preserve the viability of the bowel. Moreover,&nbsp;predicting viability of bowel can be difficult at the initial exploration. In most cases, the non-viable bowel should be resected and the stapled ends of the bowel left in the abdomen for anastomosis at a later time.</p>
<p>The next priority is revascularization of the gut. The SMA lies to the (patient's) left of the superior mesenteric vein when&nbsp;approached at the base of the mesentery.&nbsp;It is &nbsp;recommended for either embolectomy or bypass to isolate the artery between the middle and right&nbsp;colic branches.&nbsp;If embolism is the suspected cause, a transverse arteriotomy is&nbsp;preferred. When bypass is anticipated, a single bypass (usually to the SMA) is all that is required in these urgent situations. The choice of conduit for a bypass is dictated, in part, by the&nbsp;amount of contamination that is present. With&nbsp;significant contamination, a vein conduit&nbsp;(greater saphenous or femoral vein) is preferred, unless the&nbsp;patient is too unstable to tolerate the additional&nbsp;time required for vein harvest. Both antegrade and retrograde configurations&nbsp;may be used for a bypass to the SMA. Antegrade bypass&nbsp;involves a bypass from the supre-celiac aorta to the SMA, tunneling behind the tail/body of the pancreas to the&nbsp;SMA.&nbsp;A retrograde bypass may be constructed using either the infrarenal aorta or the iliac artery as&nbsp;the inflow artery.&nbsp;In the acute setting, a long extra-anatomic iliomesenteric bypass originating on the common iliac artery is a good option. The antegrade approach&nbsp;avoids kinking of a vein conduit, but it requires supra-celiac&nbsp;aortic cross-clamping that may not be&nbsp;tolerated in an ill patient. The retrograde approach originating from the infrarenal aorta avoids supra-celiac aortic cross-clamping, but it is prone to&nbsp;kinking when a vein conduit is used. After&nbsp;a bypass, the bowel should be reassessed. Since it may be difficult to determine bowel viability, a&nbsp;second look&nbsp;laparotomy in 24 hours is indicated in most cases to assess bowel viability. At second-look laparotomy, bowel viability is assessed using a combination of direct inspection, palpation of the mesenteric pulses, interrogation of the anti-mesenteric surface of the bowel for arterial flow using&nbsp;a continuous wave Doppler, and, occasionally, the use of a UV source (Wood's lamp) after&nbsp;intravenous injection of sodium fluorescein.&nbsp;If significant lengths of bowel are nonviable or questionable and short gut syndrome is a possibility, a third-look&nbsp;laparotomy may be indicated.&nbsp;&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+1998%3B12%3A187-97." target="_blank">Kazmers A. Operative management of acute mesenteric ischemia. &nbsp;Ann Vasc Surg 1998;12:187-97.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17681712" target="_blank">Kougias P, LauD, El Sayed HF, Zhou W<span>,&nbsp;</span>Huynh TT<span>,&nbsp;</span>Lin PH<span>.</span>&nbsp; Determinants of mortality and treament outcome following surgical interventions for acute&nbsp;mesenteric&nbsp;ischemia. J Vas Surg 2007;46:467-74.&nbsp;&nbsp;&nbsp;</a></p>
<p>QID: 30630</p></div><div class="rightanswer">The correct answer is: resection of&nbsp;only&nbsp;frankly necrotic or perforated bowel</div></div></div></div></div><div id="q428" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">81</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_893"><input type="hidden" name="q20803:428_:flagged" value="0"><input type="hidden" value="qaid=911312&amp;qubaid=20803&amp;qid=4872&amp;slot=428&amp;checksum=fdcdc60b2bb2c6fb631a5dbdc34d522c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:428_:flaggedcheckbox" name="q20803:428_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q428&id=4872"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:428_:sequencecheck" value="2"><div class="qtext"><p>A 49-year-old man is recovering from an open reduction and internal fixation of a right ankle fracture. On postoperative day 5, he develops acute right lower extremity swelling associated with moderate pain. Pulse examination and motor function are normal. Duplex ultrasound demonstrates acute deep venous thrombosis of the popliteal and femoral veins. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:428_answer" disabled="disabled" value="0" id="q20803:428_answer0"><label for="q20803:428_answer0">a. open surgical venous thrombectomy, followed by full anticoagulation</label> </div>
<div class="r1"><input type="radio" name="q20803:428_answer" disabled="disabled" value="1" id="q20803:428_answer1"><label for="q20803:428_answer1">b. intravenous unfractionated heparin for partial thromboplastin time in the range of 60-80 seconds, combined with pharmacomechanical thrombolysis</label> </div>
<div class="r0"><input type="radio" name="q20803:428_answer" disabled="disabled" value="2" id="q20803:428_answer2"><label for="q20803:428_answer2">c. placement of an inferior vena cava filter and a compression stocking</label> </div>
<div class="r1"><input type="radio" name="q20803:428_answer" disabled="disabled" value="3" id="q20803:428_answer3"><label for="q20803:428_answer3">d. subcutaneous fractionated heparin (1 mg/kg twice a day) with transition to warfarin for an INR of 2-3, and compression stocking</label> </div>
<div class="r0"><input type="radio" name="q20803:428_answer" disabled="disabled" value="4" id="q20803:428_answer4"><label for="q20803:428_answer4">e. aspirin (325 mg/day), clopidogril (75 mg/day), and a compression stocking</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:428_-submit" name="q20803:428_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>While ongoing study continues, there is no conclusive evidence that removal of acute clot for deep venous thrombosis inferior to the inguinal ligament is superior in the prevention of post-thrombotic syndrome, when compared to anticoagulation alone. Immediate full anticoagulation remains paramount to prevent pulmonary embolism. Compression hose, as well as early ambulation (as per orthopedic surgery recommendation), is important in recovery and minimizing development of post-thrombotic syndrome.</p>
<p>In patients at increased risk of bleeding from full anticoagulation, an inferior vena cava filter may be considered. When anticoagulation risks are small, such as in this patient who is 5 days post-op, overall bleeding risk is significantly lower with subcutaneous fractionated heparin, compared to unfractionated heparin. Aspirin and clopidogril are not effective treatments for acute deep venous thrombosis, and open venous thrombectomy would be rarely indicated, and only in patients with phlegmasia cerulean dolens (venous gangrene).</p>
<p>&nbsp;</p>
<h2><strong>References</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Med+2005%3B5%3A276-84." target="_blank">Huisman MV, Bounameaux H. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention. Semin Vasc Med 2005;5:276-84.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Becattini+C.+Treatment+of+DVT%3A+how+long+is+enough+and+how+do+you+predict+recurrence." target="_blank">Agnelli G, Becattini C. Treatment of DVT: how long is enough and how do you predict recurrence. J Throm Thrombolysis 2008;25:37-44.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2012%3B55%3A1449-62." target="_blank">Meissner MH, Gloviczki P, Comerota AJ, Dalsing MC,&nbsp;Eklof BG,&nbsp;Gillespie DL,&nbsp;et al. Early thrombus removal strategies for acute deep venous thrombosis: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2012;55:1449-62.</a></p>
<p>QID: 30753</p></div><div class="rightanswer">The correct answer is: subcutaneous fractionated heparin (1 mg/kg twice a day) with transition to warfarin for an INR of 2-3, and compression stocking</div></div></div></div></div><div id="q21" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">82</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_902"><input type="hidden" name="q20803:21_:flagged" value="0"><input type="hidden" value="qaid=910905&amp;qubaid=20803&amp;qid=4631&amp;slot=21&amp;checksum=9fd7332f09d7779970da9a31a60d3a56&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:21_:flaggedcheckbox" name="q20803:21_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q21&id=4631"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:21_:sequencecheck" value="2"><div class="qtext"><p>Aorto-iliac occlusive disease is best treated with surgical revascularization in a patient with:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:21_answer" disabled="disabled" value="0" id="q20803:21_answer0"><label for="q20803:21_answer0">a. TASC D disease</label> </div>
<div class="r1"><input type="radio" name="q20803:21_answer" disabled="disabled" value="1" id="q20803:21_answer1"><label for="q20803:21_answer1">b. TASC A disease</label> </div>
<div class="r0"><input type="radio" name="q20803:21_answer" disabled="disabled" value="2" id="q20803:21_answer2"><label for="q20803:21_answer2">c. TASC B disease</label> </div>
<div class="r1"><input type="radio" name="q20803:21_answer" disabled="disabled" value="3" id="q20803:21_answer3"><label for="q20803:21_answer3">d. TASC C disease</label> </div>
<div class="r0"><input type="radio" name="q20803:21_answer" disabled="disabled" value="4" id="q20803:21_answer4"><label for="q20803:21_answer4">e. TASC E disease</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:21_-submit" name="q20803:21_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC), originally published in January 2000, was a series of recommendations on the management of peripheral vascular disease produced as a result of cooperation between&nbsp;14 medical and surgical vascular, cardiovascular, vascular radiology, and cardiology societies in Europe and North America. Most recently updated in January 2007, and now referred to as the TASC II guidelines, these recommendations assimilate input from 18 societies or organizations with even broader international representation, including Europe, North America, Asia, Africa, and Australia. The TASC classification of atherosclerotic lesions spans from mild disease (TASC A) to severe disease (TASC D); there is no TASC E classification. In general, the TASC classification worsens as lesions increase in severity (occlusions being worse than stenoses), length, and multiplicity. Current guidelines for endovascular treatment of aorto-iliac disease show highly favorable early and late outcomes for patients with TASC A and B lesions. As techniques have advanced, TASC C lesions are also being treated successfully using endovascular approaches. Although durability for endovascular treatment of TASC C lesions may be reduced, such treatment may be appropriate in patients at higher surgical risk or by operators with a history of favorable long-term success. It is still currently recommended that patients with TASC D disease be treated with surgical revascularization. Ipsilateral superficial artery obstruction is an independent factor for predicting failure for both surgical and endovascular treatment. <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Timaran%20CH,%20Prault%20TL,%20Stevens%20SL,%20et%20al.%20Iliac%20artery%20stenting%20versus%20surgical%20reconstruction%20for%20TASC%20(TransAtlantic%20Inter-Society%20Consensus)%20type%20B%20and%20type%20C%20iliac%20lesions.%20J%20Vasc%20Surg;%202003;%2038%20(2):272-278" target="_blank">Timaran CH, Prault TL, Stevens SL, Freeman MB, Goldman MH. Iliac artery stenting versus surgical reconstruction for TASC (TransAtlantic Inter-Society Consensus) type B and type C iliac lesions. J Vasc Surg 2003; 38 (2):272-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Dormandy%20JA,%20Rutherford%20RB,%20TASC%20Working%20Group.%20TransAtlantic%20InterSociety%20Consensus%20(TASC)%20Management%20of%20peripheral%20arterial%20disease%20(PAD).%20J%20Vasc%20Surg;%202000;%2031%20(1%20pt%202):S1-S296" target="_blank">Dormandy JA, Rutherford RB, TASC Working Group. TransAtlantic InterSociety Consensus (TASC) Management of peripheral arterial disease (PAD). J Vasc Surg 2000; 31 (1 pt 2):S1-S296.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Ballard%20JL,%20Bergan%20JJ,%20Singh%20P,%20et%20al.%20Aortoiliac%20stent%20deployment%20versus%20surgical%20reconstruction:%20analysis%20of%20outcome%20and%20cost.%20J%20Vasc%20Surg;%201998;%2028%20(1):94-101%20Discussion:%20101-103" target="_blank">Ballard JL, Bergan JJ, Singh P, Yonemoto H, Killeen JD. Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. J Vasc Surg 1998; 28 (1):94-10</a>1.</p>
<p>QID: 30023</p></div><div class="rightanswer">The correct answer is: TASC D disease</div></div></div></div></div><div id="q156" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">83</span></h3><div class="state">Not answered</div><div class="grade">Points out of 3.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_911"><input type="hidden" name="q20803:156_:flagged" value="0"><input type="hidden" value="qaid=911040&amp;qubaid=20803&amp;qid=4777&amp;slot=156&amp;checksum=df4358e1562e95606adaa521aec0eddf&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:156_:flaggedcheckbox" name="q20803:156_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q156&id=4777"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:156_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding radial arterial lines is <strong>not true</strong>?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:156_answer" disabled="disabled" value="0" id="q20803:156_answer0"><label for="q20803:156_answer0">a. mortality in patients requiring radial artery thrombectomy is high</label> </div>
<div class="r1"><input type="radio" name="q20803:156_answer" disabled="disabled" value="1" id="q20803:156_answer1"><label for="q20803:156_answer1">b. the incidence of permanent ischemic complications is .09%</label> </div>
<div class="r0"><input type="radio" name="q20803:156_answer" disabled="disabled" value="2" id="q20803:156_answer2"><label for="q20803:156_answer2">c. pseudoaneurysms from radial arterial lines are almost always mycotic and require excision</label> </div>
<div class="r1"><input type="radio" name="q20803:156_answer" disabled="disabled" value="3" id="q20803:156_answer3"><label for="q20803:156_answer3">d. the Allen test should be avoided prior to arterial catheterization of the radial artery due to an excessive false positive rate</label> </div>
<div class="r0"><input type="radio" name="q20803:156_answer" disabled="disabled" value="4" id="q20803:156_answer4"><label for="q20803:156_answer4">e. radial artery thrombosis occurs in up to 20%</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:156_-submit" name="q20803:156_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Radial arterial lines are ubiquitous in ICU’s across the United States. Generally regarded as safe and necessary, they are not without potential serious complications. Temporary artery occlusion has been noted in up to 20% of patients, although permanent ischemic complications are reported as being rare at .09%. Prior to radial artery catheterization, the adequacy of collateral circulation to the hand should be tested. The most common test is the so-called modified Allen test, in which the color of the hand is subjectively assessed following compression of the radial artery. Placement of a pulse oximeter on the thumb, combined with radial artery compression, has also been described. A normal Allen's test is not completely protective because ischemic complications can also result from embolization related to the catheter.&nbsp;</p>
<p>Radial artery pseudoaneurysms following arterial line placement are usually due to arterial infection and should be treated with resection. &nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Anesth+Analg+2009%3B+109%3A1763-81." target="_blank">Brzezinski M, Luisetti T, London MJ. Radial artery cannulation: a comprehensive review of recent anatomic and physiologic investigations. Anesth Analg 2009; 109:1763-81.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Crit+Care+2002%3B+6%3A199-204." target="_blank">Scheer B, Perel A, Pfeiffer UJ. Clinical review: complications and risk factors of peripheral arterial catheters used for haemodynamic monitoring in anaesthesia and intensive care medicine. Crit Care 2002; 6:199-204.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Open+surgical+management+of+complications+from+indwelling+radial+artery+catheters." target="_blank">Garg K, Howell BW, Saltzberg SS, Berland TL<span>,&nbsp;</span>Mussa FF<span>,&nbsp;</span>Maldonado TS,&nbsp;et al. Open surgical management of complications from indwelling radial artery catheters. J Vasc Surg 2013; 58:1325-30.</a></p>
<p>QID: 30250</p></div><div class="rightanswer">The correct answer is: the Allen test should be avoided prior to arterial catheterization of the radial artery due to an excessive false positive rate</div></div></div></div></div><div id="q328" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">84</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_920"><input type="hidden" name="q20803:328_:flagged" value="0"><input type="hidden" value="qaid=911212&amp;qubaid=20803&amp;qid=5092&amp;slot=328&amp;checksum=d0502cb06d16cf043414ebf47fcbcaf0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:328_:flaggedcheckbox" name="q20803:328_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q328&id=5092"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:328_:sequencecheck" value="2"><div class="qtext"><p>According to the Doppler equation, the frequency shift of reflected ultrasound is inversely related to which of the following parameters?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:328_answer" disabled="disabled" value="0" id="q20803:328_answer0"><label for="q20803:328_answer0">a. speed of the red blood cells</label> </div>
<div class="r1"><input type="radio" name="q20803:328_answer" disabled="disabled" value="1" id="q20803:328_answer1"><label for="q20803:328_answer1">b. propagation speed of ultrasound in the tissue</label> </div>
<div class="r0"><input type="radio" name="q20803:328_answer" disabled="disabled" value="2" id="q20803:328_answer2"><label for="q20803:328_answer2">c. frequency of the transmitted ultrasound</label> </div>
<div class="r1"><input type="radio" name="q20803:328_answer" disabled="disabled" value="3" id="q20803:328_answer3"><label for="q20803:328_answer3">d. Doppler pulse repetition frequency</label> </div>
<div class="r0"><input type="radio" name="q20803:328_answer" disabled="disabled" value="4" id="q20803:328_answer4"><label for="q20803:328_answer4">e. cosine of the Doppler angle</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:328_-submit" name="q20803:328_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The Doppler shift refers to the change in frequency of sound waves as a result of relative motion between the sound source and a reflector. The moving reflectors in diagnostic vascular ultrasound are predominantly the red blood cells. According to the Doppler equation, this shift or change in frequency is directly proportional to the frequency of the transmitted ultrasound (transducer frequency), the speed of the red blood cells, and the cosine of the Doppler angle; however, it is inversely proportional to the propagation speed of ultrasound in the tissue. Therefore, the Doppler frequency shift increases if the transducer frequency is increased, as well as when the red blood cell velocity increases. The cosine of the Doppler angle (conventionally defined as the angle between the ultrasound beam and the vessel wall) is maximal at 0 degrees (ie, parallel to flow, which is rarely possible in vascular applications) and minimal at 90 degrees (perpendicular to the vessel wall). The propagation speed of ultrasound is determined by the medium or tissue through which it travels. All ultrasound travels at the same speed through a particular tissue. When the Doppler equation is solved for the frequency shift, the propagation speed of ultrasound in the tissue is in the denominator; so as the propagation speed increases, the Doppler shift decreases. The number of transmitted ultrasound pulses that occur in 1 second is referred to as the "pulse repetition frequency" or PRF. The PRF is not a factor in the Doppler equation.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Kremkau FW. Chapter 5 Doppler Principles. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:125-75.</p>
<p>QID: 30562</p></div><div class="rightanswer">The correct answer is: propagation speed of ultrasound in the tissue</div></div></div></div></div><div id="q523" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">85</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_929"><input type="hidden" name="q20803:523_:flagged" value="0"><input type="hidden" value="qaid=911407&amp;qubaid=20803&amp;qid=5259&amp;slot=523&amp;checksum=eeaa9ee0cfa6c848921bffc0f6b379f5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:523_:flaggedcheckbox" name="q20803:523_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q523&id=5259"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:523_:sequencecheck" value="2"><div class="qtext"><p>Of the following options, which area of skin is most sensitive to radiation effects?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:523_answer" disabled="disabled" value="0" id="q20803:523_answer0"><label for="q20803:523_answer0">a. abdomen</label> </div>
<div class="r1"><input type="radio" name="q20803:523_answer" disabled="disabled" value="1" id="q20803:523_answer1"><label for="q20803:523_answer1">b. chest</label> </div>
<div class="r0"><input type="radio" name="q20803:523_answer" disabled="disabled" value="2" id="q20803:523_answer2"><label for="q20803:523_answer2">c. back</label> </div>
<div class="r1"><input type="radio" name="q20803:523_answer" disabled="disabled" value="3" id="q20803:523_answer3"><label for="q20803:523_answer3">d. anterior neck</label> </div>
<div class="r0"><input type="radio" name="q20803:523_answer" disabled="disabled" value="4" id="q20803:523_answer4"><label for="q20803:523_answer4">e. palms</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:523_-submit" name="q20803:523_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The skin of the body has differential sensitivity to radiation effects, with the thinner areas of skin and extremities are usually most affected. From most to least sensitive, the rank is:&nbsp;anterior neck, antecubital and popliteal spaces, flexor surfaces of extremities, chest and abdomen, face, back, extensor sur- faces, nape of neck, scalp, palms, and soles.</p>
<p>It should be noted that the eye is more sensitive to the damaging effects of radiation than skin. The answer in this question is restricted to the relative sensitivities of the skin.</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<div class="column">
<p>Kalz F. Theoretical considerations and clinical use of grenz rays in dermatology. Arch Dermatol Syph 1941;43:447-72.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Int+Cardiol+2004%3B17%3A131-42." target="_blank">Vlietstra RE, Wagner LK, Koenig TR, Mettler FA. Radiation burns as a severe complication of fluoroscopically guided cardiological interven- tions. J Int Cardiol 2004; 17:131-42.&nbsp;</a></p>
<p>QID: 30927</p>
</div></div><div class="rightanswer">The correct answer is: anterior neck</div></div></div></div></div><div id="q268" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">86</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_938"><input type="hidden" name="q20803:268_:flagged" value="0"><input type="hidden" value="qaid=911152&amp;qubaid=20803&amp;qid=5005&amp;slot=268&amp;checksum=2381b41761050a746e9387da094cebfe&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:268_:flaggedcheckbox" name="q20803:268_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q268&id=5005"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:268_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old man is referred for hemodialysis access. The patient is right handed and his glomerular filtration rate (GFR) is&nbsp;22 ml/min. Duplex vein mapping demonstrates thickened, recanalized cephalic veins in both upper extremities not suitable for use. His basilic veins are less than 2 mm in diameter bilaterally. Which of the following is the optimal procedure for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:268_answer" disabled="disabled" value="0" id="q20803:268_answer0"><label for="q20803:268_answer0">a. upper arm basilic vein transposition</label> </div>
<div class="r1"><input type="radio" name="q20803:268_answer" disabled="disabled" value="1" id="q20803:268_answer1"><label for="q20803:268_answer1">b. defer access placement until GFR is &lt; 10 ml/min</label> </div>
<div class="r0"><input type="radio" name="q20803:268_answer" disabled="disabled" value="2" id="q20803:268_answer2"><label for="q20803:268_answer2">c. defer access placement until GFR is &lt; 20 ml/min</label> </div>
<div class="r1"><input type="radio" name="q20803:268_answer" disabled="disabled" value="3" id="q20803:268_answer3"><label for="q20803:268_answer3">d. placement of an upper arm arteriovenous prosthetic access</label> </div>
<div class="r0"><input type="radio" name="q20803:268_answer" disabled="disabled" value="4" id="q20803:268_answer4"><label for="q20803:268_answer4">e. placement of a forearm loop arteriovenous prosthetic access</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:268_-submit" name="q20803:268_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Both KDOQI and SVS guidelines for placement of hemodialysis access recommend placement of autogenous access, if feasible, in patients with GFR &lt; 25 ml/min.&nbsp; However, if autogenous access is not feasible and prosthetic access is required, placement should be delayed until 4 to 6 weeks before the initiation of hemodialysis. Patency of prosthetic grafts is limited by the time of access placement and not the time of access use, mandating graft placement only when dialysis is imminent.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>National Kidney Foundation KDOQI 2006 Vascular Access Guidelines.&nbsp; Am J Kidney Disease 2006;48(suppl 1):S177-322.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B48%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintainance of arteriovenous hemodialysis access. J Vasc Surg 2008;48:2S-25S.</a></p>
<p>QID: 30452</p></div><div class="rightanswer">The correct answer is: defer access placement until GFR is &lt; 10 ml/min</div></div></div></div></div><div id="q100" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">87</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_947"><input type="hidden" name="q20803:100_:flagged" value="0"><input type="hidden" value="qaid=910984&amp;qubaid=20803&amp;qid=4922&amp;slot=100&amp;checksum=5f8f541937ff9d3af4e31000b7efde6c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:100_:flaggedcheckbox" name="q20803:100_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q100&id=4922"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:100_:sequencecheck" value="2"><div class="qtext"><p>A patient who sustained a gunshot wound to his left popliteal fossa presents to the emergency department 4 hours later with an expanding hematoma and a cold left lower extremity. He is taken directly to the operating room and, upon open exposure, both the popliteal artery and vein are transected. Vascular control is obtained, and both arterial and venous reconstructions are performed successfully after an additional 3 hours of operative time.&nbsp; Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:100_answer" disabled="disabled" value="0" id="q20803:100_answer0"><label for="q20803:100_answer0">a. initiate antiplatelet therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:100_answer" disabled="disabled" value="1" id="q20803:100_answer1"><label for="q20803:100_answer1">b. start a heparin drip</label> </div>
<div class="r0"><input type="radio" name="q20803:100_answer" disabled="disabled" value="2" id="q20803:100_answer2"><label for="q20803:100_answer2">c. perform a four-compartment fasciotomy</label> </div>
<div class="r1"><input type="radio" name="q20803:100_answer" disabled="disabled" value="3" id="q20803:100_answer3"><label for="q20803:100_answer3">d. create an arteriovenous fistula to maintain patency of the venous reconstruction</label> </div>
<div class="r0"><input type="radio" name="q20803:100_answer" disabled="disabled" value="4" id="q20803:100_answer4"><label for="q20803:100_answer4">e. observation, leg elevation, and serial CPK measurements</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:100_-submit" name="q20803:100_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In the setting of combined arterial and venous injuries, particularly with a prolonged ischemia time, four-compartment fasciotomy should be used liberally for limb salvage. This is especially true in the popliteal fossa where concomitant arterial and venous reconstruction should be performed whenever feasible. Outcomes analysis from the National Trauma Databank demonstrates an amputation rate of 9% in patients who sustain injuries to the popliteal vasculature, and as high as 30% historically.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+47(6)%3A1259-64." target="_blank">Woodward EB, Clouse WD, Eliason JL, Peck MA, Bowser AN, Cox MW, et al. Penetrating femoropopliteal injury during modern warfare: experience of the Balad Vascular Registry. J Vasc Surg 2008; 47(6):1259-64.</a></p>
<p>QID: 30152</p></div><div class="rightanswer">The correct answer is: perform a four-compartment fasciotomy</div></div></div></div></div><div id="q122" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">88</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_956"><input type="hidden" name="q20803:122_:flagged" value="0"><input type="hidden" value="qaid=911006&amp;qubaid=20803&amp;qid=4739&amp;slot=122&amp;checksum=d315d6875c72304ce8d9ead16a80dee0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:122_:flaggedcheckbox" name="q20803:122_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q122&id=4739"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:122_:sequencecheck" value="2"><div class="qtext"><p>A 32-year-old woman presents with an ischemic right hand caused by an embolus to the distal right brachial artery. Selected CT angiography images are shown below. Which of the following is the best option and will provide the most durable treatment for this patient's condition?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/CTA TOS.jpg" target="images"><img src="./VESAP3_files/CTA TOS.jpg" alt="CTA arterial TOS" width="100"></a></p>
<p><a href="./VESAP3_files/3D recon.jpg" target="images"><img src="./VESAP3_files/3D recon.jpg" alt="Arterial TOS 3D" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:122_answer" disabled="disabled" value="0" id="q20803:122_answer0"><label for="q20803:122_answer0">a. angioplasty and long-term anticoagulation</label> </div>
<div class="r1"><input type="radio" name="q20803:122_answer" disabled="disabled" value="1" id="q20803:122_answer1"><label for="q20803:122_answer1">b. cervical sympathectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:122_answer" disabled="disabled" value="2" id="q20803:122_answer2"><label for="q20803:122_answer2">c. covered stent placement after transaxillary first rib resection</label> </div>
<div class="r1"><input type="radio" name="q20803:122_answer" disabled="disabled" value="3" id="q20803:122_answer3"><label for="q20803:122_answer3">d. cervical rib resection, arterial reconstruction, and distal thromboembolectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:122_answer" disabled="disabled" value="4" id="q20803:122_answer4"><label for="q20803:122_answer4">e. first rib resection and arterial reconstruction</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:122_-submit" name="q20803:122_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>CT angiography of the right chest shows a cervical rib&nbsp;and a stenosis of the&nbsp;distal subclavian artery. First rib resection&nbsp;will not completely relieve compression&nbsp; of the cephalad aspect of the artery. The long-term outcome of angioplasty and anticoagulation alone&nbsp;is poor. The placement of a covered stent&nbsp;following thoracic&nbsp;outlet decompression&nbsp;is a&nbsp;reasonable option for patients with multiple comorbid conditions, but the&nbsp;optimal treatment&nbsp;option for a young patient with arterial thoracic outlet syndrome&nbsp;is cervical rib resection and standard surgical reconstruction. This option provides the most favorable and durable results.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2013%3B+27%3A1007-13" target="_blank">Marine L, Valdes F, Mertens R, Kramer A<span>,&nbsp;</span>Bergoeing M<span>,&nbsp;</span>Urbina J. Arterial thoracic outlet syndrome: a 32-year experience. &nbsp;Ann Vasc Surg 2013; 27:1007-13</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Card+Surg+2011+%3B26%3A309-12" target="_blank">Ikeda N, Nakamura M, Hara H, Takagi T<span>,&nbsp;</span>Sugi K<span>.</span>&nbsp; Combined endovascular and open surgical approach for the management of subclavian artery occlusion due to thoracic outlet syndrome. &nbsp;J Card Surg 2011 ;26:309-12.</a></p>
<p>QID: 30215</p></div><div class="rightanswer">The correct answer is: cervical rib resection, arterial reconstruction, and distal thromboembolectomy</div></div></div></div></div><div id="q350" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">89</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_965"><input type="hidden" name="q20803:350_:flagged" value="0"><input type="hidden" value="qaid=911234&amp;qubaid=20803&amp;qid=5143&amp;slot=350&amp;checksum=2a46f686053c71b76d397cb4be00193f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:350_:flaggedcheckbox" name="q20803:350_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q350&id=5143"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:350_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old female with post-prandial abdominal pain is referred to you after undergoing an exhaustive gastrointestinal work-up. The work-up included a right upper quadrant ultrasound, upper and lower endoscopy, and a small bowel enteroclysis study, all of which were negative. An arteriogram is obtained and shown below. Which of the following statements most accurately describes surgery for this condition?<br><br><a href="./VESAP3_files/AssetProxy_132.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_132.jpg" alt="img" width="100" height="129" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:350_answer" disabled="disabled" value="0" id="q20803:350_answer0"><label for="q20803:350_answer0">a. surgical intervention should be reserved for those patients with celiac compression during maximal expiration, which is absent in normal individuals</label> </div>
<div class="r1"><input type="radio" name="q20803:350_answer" disabled="disabled" value="1" id="q20803:350_answer1"><label for="q20803:350_answer1">b. surgical intervention produces pain relief through lysis of the splanchnic nerves during the surgical exposure of the celiac artery</label> </div>
<div class="r0"><input type="radio" name="q20803:350_answer" disabled="disabled" value="2" id="q20803:350_answer2"><label for="q20803:350_answer2">c. surgical intervention produces inferior results for patients with post-prandial abdominal pain</label> </div>
<div class="r1"><input type="radio" name="q20803:350_answer" disabled="disabled" value="3" id="q20803:350_answer3"><label for="q20803:350_answer3">d. surgical intervention is primarily aimed at reconstruction of the celiac artery, rather than lysis of the ganglionic tissue around the celiac axis</label> </div>
<div class="r0"><input type="radio" name="q20803:350_answer" disabled="disabled" value="4" id="q20803:350_answer4"><label for="q20803:350_answer4">e. surgical intervention produces the best results among patients with who have experienced no weight loss preoperatively</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:350_-submit" name="q20803:350_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>External compression of the celiac artery by the median arcuate ligament of the diaphragm has been reported to result in a variant of chronic intestinal ischemia. While some authors dispute the existence of this disease entity, an etiological mechanism has been proposed. During inspiration, the aorta and the celiac axis move downward with the abdominal viscera. Whereas, in expiration, the vessels move upward and result in maximal external compression. Reversible celiac axis compression can be demonstrated with both angiography and duplex scanning in many asymptomatic individuals. Thus, the mere presence of this compression is not sufficient for the diagnosis. Duplex studies of the celiac artery in normal subjects show little or no increase in celiac artery blood flow following a test meal. This finding is inconsistent with the concept of isolated celiac artery occlusive disease or external compression of the celiac artery producing postprandial abdominal pain solely on the basis of impaired celiac artery blood flow. Thus, some investigators have suggested alternative theories. Angiographically demonstrated celiac artery compression may be a marker of excessive celiac ganglion splanchnic nerve fiber entrapment. Under this theory, pain relief with decompression of the celiac artery results not from improvement in postprandial flow, but from destruction of the splanchnic nerves during the surgical exposure of the artery. The forces of the median arcuate ligament not only cause functional compression on the celiac artery but also frequently result in structural damage to the artery itself. This often necessitates bypass or angioplasty of the celiac artery, in addition to release of the ligamentous structures. Recent reports have described laparoscopic ganglionectomy with results that rival open repair, although there is a significant risk of open conversion of the laparoscopic approach. Symptomatic improvement following open surgical decompression have been observed among patients with a post-prandial pain pattern, rather than constant pain, and for those patients with weight loss.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=K.%20Delis,%20P.%20Gloviczki,%20M.%20Altuwaijri,%20M.%20McKusick.%20Median%20arcuate%20ligament%20syndrome:%20Open%20celiac%20artery%20reconstruction%20and%20ligament%20division%20after%20endovascular%20failure.%20J%20Vasc%20Surg;%202007;%2046%20(4):799-802" target="_blank">K. Delis, P. Gloviczki, M. Altuwaijri, M. McKusick. Median arcuate ligament syndrome: Open celiac artery reconstruction and ligament division after endovascular failure. J Vasc Surg 2007; 46(4):799-802.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Reilly%20LM,%20Ammar%20AD,%20Stoney%20RJ,%20et%20al.%20Late%20results%20following%20operative%20repair%20for%20celiac%20artery%20compression%20syndrome.%20J%20Vasc%20Surg;%201985;%202%20(1):79" target="_blank">Reilly LM, Ammar AD, Stoney RJ, Ehrenfeld WK. Late results following operative repair for celiac artery compression syndrome. J Vasc Surg 1985; 2(1):79-91.</a><br><br>Moneta GL. Diagnosis of intestinal ischemia. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1507-8.</p>
<p>QID: 30617</p></div><div class="rightanswer">The correct answer is: surgical intervention produces pain relief through lysis of the splanchnic nerves during the surgical exposure of the celiac artery</div></div></div></div></div><div id="q403" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">90</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_974"><input type="hidden" name="q20803:403_:flagged" value="0"><input type="hidden" value="qaid=911287&amp;qubaid=20803&amp;qid=4783&amp;slot=403&amp;checksum=d6d2f7b753500fdca1f42350691e3323&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:403_:flaggedcheckbox" name="q20803:403_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q403&id=4783"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:403_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old woman presents with chronic left leg edema and says that her leg becomes tight and painful when she walks. Duplex ultrasound exam of the limb is normal, other than asymmetrical phasicity in the common femoral vein suggesting proximal obstruction. The patient underwent ascending venography; the image obtained is shown below. Which of the following is the most appropriate treatment option for this patient?<br><br><a href="./VESAP3_files/AssetProxy_011.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_011.jpg" alt="img" width="100" height="63" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:403_answer" disabled="disabled" value="0" id="q20803:403_answer0"><label for="q20803:403_answer0">a. surgical transpostion of the left common iliac artery</label> </div>
<div class="r1"><input type="radio" name="q20803:403_answer" disabled="disabled" value="1" id="q20803:403_answer1"><label for="q20803:403_answer1">b. placement of an inferior vena cava filter</label> </div>
<div class="r0"><input type="radio" name="q20803:403_answer" disabled="disabled" value="2" id="q20803:403_answer2"><label for="q20803:403_answer2">c. left to right femoral to femoral vein bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:403_answer" disabled="disabled" value="3" id="q20803:403_answer3"><label for="q20803:403_answer3">d. anticoagulation alone</label> </div>
<div class="r0"><input type="radio" name="q20803:403_answer" disabled="disabled" value="4" id="q20803:403_answer4"><label for="q20803:403_answer4">e. stenting of common iliac vein stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:403_-submit" name="q20803:403_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The patient's symptoms are typical of iliac vein obstruction resulting in so-called venous claudication. The multiplanar venogram demonstrates compression of the left common iliac vein at the point that it is crossed by the right common iliac artery (May-Thurner Syndrome). Cross-pelvic collaterals indicate that the venous stenosis is hemodynamically significant. Intravascular ultrasound (IVUS) is recommended by some experts to further delineate the severity of venous stenosis and define the presence of intraluminal fibrous bands, which may be underestimated by AP venography. IVUS can demonstrate important anatomic features, such as a normal vena cava, compressed iliac vein, occluded iliac vein with increased echogenicity, and a partially recanalized iliac vein. Severely symptomatic iliac vein compression should be treated with venoplasty and stenting. Anticoagulation may reduce the risk of future DVT but will not improve her symptoms. An inferior vena cava filter is not necessary in this patient. While there have been anecdotal reports of successful treatment of May-Thurner Syndrome with a variety of surgical procedures, currently most experts favor endovascular treatment because of the favorable risk-benefit profile and reported long-term durability.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Neglen%20P,%20Raju%20S.%20Intravascular%20ultrasound%20scan%20evaluation%20of%20the%20obstructed%20vein.%20J%20Vasc%20Surg;%202002;%2035%20(4):694-700" target="_blank">Neglen P, Raju S. Intravascular ultrasound scan evaluation of the obstructed vein. J Vasc Surg; 2002; 35 (4):694-700.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Raju%20S,%20Neglen%20P.%20High%20prevalence%20of%20nonthrombotic%20iliac%20vein%20lesions%20in%20chronic%20venous%20disease:%20A%20permissive%20role%20in%20pathogenicity.%20J%20Vasc%20Surg;%202006;%2044%20(1):136-144" target="_blank">Raju S, Neglen P. High prevalence of nonthrombotic iliac vein lesions in chronic venous disease: A permissive role in pathogenicity. J Vasc Surg; 2006; 44 (1):136-44.</a></p>
<p>QID: 30721</p></div><div class="rightanswer">The correct answer is: stenting of common iliac vein stenosis</div></div></div></div></div><div id="q315" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">91</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_983"><input type="hidden" name="q20803:315_:flagged" value="0"><input type="hidden" value="qaid=911199&amp;qubaid=20803&amp;qid=5080&amp;slot=315&amp;checksum=a62f76300d6b7244a734f146a2e26db7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:315_:flaggedcheckbox" name="q20803:315_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q315&id=5080"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:315_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements&nbsp;regarding the performance of segmental Doppler pressures of the lower extremity is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:315_answer" disabled="disabled" value="0" id="q20803:315_answer0"><label for="q20803:315_answer0">a. stenosis of the superficial femoral artery is better evaluated with the three-cuff rather than the four- cuff technique</label> </div>
<div class="r1"><input type="radio" name="q20803:315_answer" disabled="disabled" value="1" id="q20803:315_answer1"><label for="q20803:315_answer1">b. pressures should be measured first with the most proximal cuff on the extremity</label> </div>
<div class="r0"><input type="radio" name="q20803:315_answer" disabled="disabled" value="2" id="q20803:315_answer2"><label for="q20803:315_answer2">c. the cuff width at each location on the extremity should be at least 20% more than the diameter of the limb at the site of application of the cuff</label> </div>
<div class="r1"><input type="radio" name="q20803:315_answer" disabled="disabled" value="3" id="q20803:315_answer3"><label for="q20803:315_answer3">d. a normal high thigh index with the four-cuff technique for performing segmental pressures is 1.0</label> </div>
<div class="r0"><input type="radio" name="q20803:315_answer" disabled="disabled" value="4" id="q20803:315_answer4"><label for="q20803:315_answer4">e. the ankle/brachial index normally is higher when measured with the four-cuff technique than when measured with the three cuff technique</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:315_-submit" name="q20803:315_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Segmental Doppler pressures of the lower extremities may be performed with the application of three or four cuffs to the lower extremity being examined.&nbsp; With the four-cuff technique, cuffs are placed on the high thigh, just above the knee, just below the knee, and at the ankle.&nbsp; With the three-cuff technique, the above the knee cuff is not used. The pressures are obtained by inflating the cuffs serially and individually from the ankle proximally and listening to the return of the Doppler signal at the ankle with slow deflation of each cuff.&nbsp; Cuffs are inflated from distal to proximal to avoid underestimating the systolic pressure. The width of each cuff should be at least 20% greater than the diameter of the limb at the site of application of the cuff.&nbsp; A cuff that is too narrow, with respect to the diameter of the leg, results in artificially elevated pressures. In many patients with large diameter thighs, the high-thigh cuff is often too narrow with respect to the diameter of the thigh and therefore, high- thigh pressures with the four-cuff technique are often artificially elevated. The result is that a normal high-thigh pressure will be considerably higher than the brachial pressure with the four-cuff technique and the normal high-thigh index (comparison of the high-thigh pressure with the highest brachial pressure) with four cuffs will be about 1.4, not 1.0.&nbsp; With three cuffs, the proximal thigh cuff can be of greater diameter, the pressure measurements are not artificially elevated, and the normal high-thigh index with the three-cuff technique is 1.0. The ankle pressure is the same with either technique. A potential advantage of the four-cuff technique is evaluation of superficial femoral artery stenosis by comparing the pressures between the high-thigh cuff and the above-knee cuff.<sup><br></sup></p>
<p>&nbsp;</p>
<h2>Reference:&nbsp;</h2>
<p>Rumwell C and McPharlin M.&nbsp; Vascular Technology: an Illustrated Review (4<sup>th</sup> edition). Davis Publishing, Pasadena, CA 2009, pp: 63-74.</p>
<p>QID: 30542</p></div><div class="rightanswer">The correct answer is: the cuff width at each location on the extremity should be at least 20% more than the diameter of the limb at the site of application of the cuff</div></div></div></div></div><div id="q462" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">92</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_992"><input type="hidden" name="q20803:462_:flagged" value="0"><input type="hidden" value="qaid=911346&amp;qubaid=20803&amp;qid=5182&amp;slot=462&amp;checksum=d823feeabf1a20ed15a60f19a38a24e1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:462_:flaggedcheckbox" name="q20803:462_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q462&id=5182"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:462_:sequencecheck" value="2"><div class="qtext"><p>A 59-year-old man with no history of coronary disease undergoes elective carotid endarterectomy. Post-operatively, he develops chest pain in the intensive care unit. Cardiac biomarkers and electrocardiogram (ECG) indicate non-ST elevation myocardial infarction (MI).&nbsp;Which of the following is <strong>not</strong>&nbsp;an appropriate therapy for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:462_answer" disabled="disabled" value="0" id="q20803:462_answer0"><label for="q20803:462_answer0">a. supplemental oxygen</label> </div>
<div class="r1"><input type="radio" name="q20803:462_answer" disabled="disabled" value="1" id="q20803:462_answer1"><label for="q20803:462_answer1">b. heparin</label> </div>
<div class="r0"><input type="radio" name="q20803:462_answer" disabled="disabled" value="2" id="q20803:462_answer2"><label for="q20803:462_answer2">c. intraarterial thrombolysis</label> </div>
<div class="r1"><input type="radio" name="q20803:462_answer" disabled="disabled" value="3" id="q20803:462_answer3"><label for="q20803:462_answer3">d. glycoprotein IIb/IIIa inhibitor</label> </div>
<div class="r0"><input type="radio" name="q20803:462_answer" disabled="disabled" value="4" id="q20803:462_answer4"><label for="q20803:462_answer4">e. aspirin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:462_-submit" name="q20803:462_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Concomitant carotid and coronary disease is a common clinical problem. Prospective studies have shown that 8-14% of patients undergoing coronary artery bypass have significant carotid stenosis, and up to 28% of patients undergoing carotid endarterectomy (CEA) have significant coronary disease. Furthermore, coronary artery disease is the leading cause of both early and late mortality after CEA.</p>
<p>In patients with post-operative MI, the diagnosis is based on the clinical symptoms, serum biomarkers (CPK and troponin) and electrocardiogram.</p>
<p>Cardiac catheterization, with thrombolysis (or other intervention), is typically reserved for MI patients with ST elevation. Additionally, the recent surgery is a relative contraindication to use of thrombolytic therapy.&nbsp;<span style="line-height: 1.5;">In patients with non-ST elevation MI, therapy usually consists of aspirin, clopidogrel, IIb/IIIa inhibitor, and heparin.&nbsp;</span></p>
<p>&nbsp;</p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=nteract+Cardiovasc+Thorac+Surg%3B+2009%3B+9+(2)%3A278-81." target="_blank">Guerra M, Mota JC, Veloso M, Gama V<span>,&nbsp;</span>Vouga L. Combined carotid stenting and urgent coronary artery surgery in unstable angina patients with severe carotid stenosis. Interact Cardiovasc Thorac Surg 2009; 9 (2):278-81.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+2000%3B+356+(9223)%3A9-16." target="_blank">Wallentin L, Lagerqvist B, Husted S, Kontny F<span>,&nbsp;</span>Ståhle E<span>,&nbsp;</span>Swahn E. Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: The FRISC II invasive randomized. Lancet 2000; 356 (9223):9-16.</a></p>
<p>QID: 30822</p></div><div class="rightanswer">The correct answer is: intraarterial thrombolysis</div></div></div></div></div><div id="q19" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">93</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1001"><input type="hidden" name="q20803:19_:flagged" value="0"><input type="hidden" value="qaid=910903&amp;qubaid=20803&amp;qid=4628&amp;slot=19&amp;checksum=1d0ad3a2edcdfa389c8cb3474c617a86&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:19_:flaggedcheckbox" name="q20803:19_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q19&id=4628"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:19_:sequencecheck" value="2"><div class="qtext"><p>A 58-year-old woman is referred for treatment of new onset, right lower extremity deep vein thrombosis (DVT)&nbsp;2 months after an initial episode of DVT in&nbsp;her left leg. She has been maintained on warfarin since the initial episode. She has a remote of history of oral ulcerations. By duplex ultrasound, she has acute right iliofemoral DVT and chronic left femoral DVT. An abdominal aortic aneurysm is incidentially identified. Which of the following is the most probable diagnosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:19_answer" disabled="disabled" value="0" id="q20803:19_answer0"><label for="q20803:19_answer0">a. multiple mycotic aneurysms of the aorta and internal iliac artery</label> </div>
<div class="r1"><input type="radio" name="q20803:19_answer" disabled="disabled" value="1" id="q20803:19_answer1"><label for="q20803:19_answer1">b. athersclerotic aneurysms of the aorta and internal iliac artery</label> </div>
<div class="r0"><input type="radio" name="q20803:19_answer" disabled="disabled" value="2" id="q20803:19_answer2"><label for="q20803:19_answer2">c. Bechet's disease</label> </div>
<div class="r1"><input type="radio" name="q20803:19_answer" disabled="disabled" value="3" id="q20803:19_answer3"><label for="q20803:19_answer3">d. antiphopholipid antibody syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:19_answer" disabled="disabled" value="4" id="q20803:19_answer4"><label for="q20803:19_answer4">e. Marfan's syndrome</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:19_-submit" name="q20803:19_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Behcet's disease was first defined by Hulusi Behcet in 1937 as a multisytem disorder with characteristic pathologic findings including recurrent orogenital ulcers, ocular (especially uveitis) and cutaneous lesions, and vascular abnormalities. In patients with so-called "vasculo-Bechet's", venous disorders outnumber arterial by about 4:1. The most common venous problem is DVT. The most common arterial problem is the development of multiple aneurysms. The histologic findings consist of a panvasculitis with a prominent round cell infiltrate, thickening of the media, and fractures of the elastic fibers. Aneurysms are more common than occlusive lesions, though both may be identified in the same patient, as in the case presented. Minor vascular trauma may lead to pseudoaneurysm formation;&nbsp;this&nbsp;has prompted some authors to recommend endovascular treatment if feasible. Vascular infection can lead to multiple aneurysms that develop over a short time frame. In this patient, the internal iliac aneurysm may have contributed to the left leg DVT by external compression of the iliac vein. The absence of systemic signs of infection or leukocytosis suggests a non-infectious etiology. Furthermore, mycotic aneurysms would not be directly associated with the risk of DVT. Antiphospholipid antibody (APLA) syndrome is an acquired prothrombotic state that can lead to both arterial and venous thrombosis. This&nbsp;could explain the recurrent DVT in this case, but there is no asssociation of APLA and aneurysms. The saccular shape, location in the aorta and internal iliac artery, and rapid progression argue against an atherosclerotic etiology. Marfan's syndrome is a systemic disorder of connective tissue caused by mutations in the extracellular matric protein fibrillin 1. Clinical manifestations include aortic aneurysm, dislocation of the ocular lens, and long-bone overgrowth. This patient was treated by coil embolization of the left internal iliac artery and endograft repair of the abdominal aorta. There is no evidence of recurrence at late follow-up.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Judge%20DP,%20Dietz%20HC.%20Marfan%27s%20Syndrome.%20The%20Lancet;%202005;%20366%20(9501):1965-76" target="_blank">Judge DP, Dietz HC. Marfan's Syndrome. The Lancet 2005; 366 (9501):1965-76.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Alpagut%20U,%20Ugurlucan%20M,%20Dayioglu%20E.%20Major%20arterial%20involvement%20and%20review%20of%20Behcet%27s%20disease.%20Annals%20of%20Vascular%20Surgery;%202007;%2021%20(2):" target="_blank">Alpagut U, Ugurlucan M, Dayioglu E. Major arterial involvement and review of Behcet's disease. Ann Vas Surg 2007; 21 (2)</a>.</p>
<p>QID: 30020</p></div><div class="rightanswer">The correct answer is: Bechet's disease</div></div></div></div></div><div id="q423" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">94</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1010"><input type="hidden" name="q20803:423_:flagged" value="0"><input type="hidden" value="qaid=911307&amp;qubaid=20803&amp;qid=4867&amp;slot=423&amp;checksum=51ed9cc8537f3bc6fc874b89d0022365&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:423_:flaggedcheckbox" name="q20803:423_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q423&id=4867"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:423_:sequencecheck" value="2"><div class="qtext"><p>A woman presents with a 10-year history of unilateral right lower extremity limb edema and obesity. Her BMI is 37 and she has areas of weeping on the leg, but no full, thickness ulceration (see image below). Prior physicians have attempted to treat her leg with compression hosiery (up to 50 mm Hg) and bandaging without success. The patient has difficulty applying the stockings, and the bandages consistently fall down her leg after application. What is the next best management option?</p>
<p>&nbsp;</p>
<p><img src="./VESAP3_files/leg edema.jpg" alt="right leg edema" width="245" height="376"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:423_answer" disabled="disabled" value="0" id="q20803:423_answer0"><label for="q20803:423_answer0">a. diuretic therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:423_answer" disabled="disabled" value="1" id="q20803:423_answer1"><label for="q20803:423_answer1">b. inelastic compression therapy</label> </div>
<div class="r0"><input type="radio" name="q20803:423_answer" disabled="disabled" value="2" id="q20803:423_answer2"><label for="q20803:423_answer2">c. Charles procedure</label> </div>
<div class="r1"><input type="radio" name="q20803:423_answer" disabled="disabled" value="3" id="q20803:423_answer3"><label for="q20803:423_answer3">d. lympho-venous bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:423_answer" disabled="disabled" value="4" id="q20803:423_answer4"><label for="q20803:423_answer4">e. intermittent pneumatic compression therapy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:423_-submit" name="q20803:423_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Patients with lymphedema or combined lymphedema and venous insufficiency may be resistant to standard methods of compression therapy. This may occur due to difficulty applying and maintaining compression hosiery or bandages in place because of irregularity in the size or shape of the calf and ankle. Some patients are unable to tolerate the 50 to 60 mm of compression that is required to control edema in these severe cases.&nbsp; In these situations, intermittent pneumatic compression devices have been found to be useful, applying active intermittent compression to the limb to reduce edema. In the current literature, multi-chamber pumps have been found to be more beneficial than single-chamber pumps, providing a sequential mobilization of fluid from the distal to more proximal limb. Therapists trained in manual lymphatic decongestive therapy may also be useful in this situation to assist with long-term edema control, if available in the patient’s community.</p>
<p>&nbsp;</p>
<h2><strong>Reference:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cochrane+Database+Syst+Rev+2011+Feb+16%3B(2)+Intermitent" target="_blank">Nelson EA, Mani R, Thomas K, Vowden K. Intermittent pneumatic compression for treating venous leg ulcers. Cochrane Database Syst Rev 2011;16;(2).</a></p>
<p>QID: 30748</p></div><div class="rightanswer">The correct answer is: intermittent pneumatic compression therapy</div></div></div></div></div><div id="q524" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">95</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1019"><input type="hidden" name="q20803:524_:flagged" value="0"><input type="hidden" value="qaid=911408&amp;qubaid=20803&amp;qid=5260&amp;slot=524&amp;checksum=c46235587bf1713a7470e201726ee397&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:524_:flaggedcheckbox" name="q20803:524_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q524&id=5260"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:524_:sequencecheck" value="2"><div class="qtext"><p>Radiation exposure affects different aspects of fetal development at varying time periods. Fetal survival is most affected by radiation during which of the following time periods?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:524_answer" disabled="disabled" value="0" id="q20803:524_answer0"><label for="q20803:524_answer0">a. 14-28 days post conception</label> </div>
<div class="r1"><input type="radio" name="q20803:524_answer" disabled="disabled" value="1" id="q20803:524_answer1"><label for="q20803:524_answer1">b. 0-8 days post conception</label> </div>
<div class="r0"><input type="radio" name="q20803:524_answer" disabled="disabled" value="2" id="q20803:524_answer2"><label for="q20803:524_answer2">c. 110-150 days post conception</label> </div>
<div class="r1"><input type="radio" name="q20803:524_answer" disabled="disabled" value="3" id="q20803:524_answer3"><label for="q20803:524_answer3">d. 160-200 days post conception</label> </div>
<div class="r0"><input type="radio" name="q20803:524_answer" disabled="disabled" value="4" id="q20803:524_answer4"><label for="q20803:524_answer4">e. 250-325 days post conception</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:524_-submit" name="q20803:524_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><div class="column">
<p style="text-align: left;" dir="ltr">The embryo is considered most sensitive to radiation at 0-8 days post conception/before implantation. This corresponds to the time period of 50-75% of all human spontaneous abortions; therefore, the role of radiation in these events is unclear. Animal studies suggest that radiation-induced prenatal death may occur at doses of 50-100 mGy (5 to 10 rad). &nbsp;At higher levels (&gt;250 mGy or 25 rad), other effects can occur. Vulnerable time periods post conception include growth retardation (8-56 days), small head size (14-105 days), mental retardation and/or intellectual deficit (56-105 days), and seizures (56 -105 days).</p>
<p style="text-align: left;" dir="ltr">&nbsp;</p>
<h2 style="text-align: left;" dir="ltr">References:&nbsp;</h2>
<p><span>Brent RL, Gorson RO. Radiation exposure in pregnancy. Curr Probl Radiol 1972; 2:1.&nbsp;</span></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Stewart+AM%2C+Webb+J%2C+Giles+D%2C+Hewitt+D.+Malignant+disease+in+child-+hood+and+diagnostic+irradiation+in+utero." target="_blank"><span>Stewart AM, Webb J, Giles D, Hewitt D. Malignant disease in child- hood and diagnostic irradiation in utero. Lancet 1956; 2:447. </span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Stewart+AM%2C+Kneale+GW.+Radiation+dose+effects+in+relation+to+obstetric+x-rays+and+childhood+cancers." target="_blank"><span>Stewart AM, Kneale GW. Radiation dose effects in relation to obstetric x-rays and childhood cancers. Lancet 1970; 1:1185-8. </span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kneale+GW%2C+Stewart+AM.+Mantel-Haenszel+analysis+of+Oxford+data.+I.+Independent+effects+of+several+birth+factors+including+fetal+irradiation" target="_blank"><span>Kneale GW, Stewart AM. Mantel-Haenszel analysis of Oxford data. I. Independent effects of several birth factors including fetal irradiation. J Natl Cancer Inst 1976; 56:879. </span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kneale+GW%2C+Stewart+AM.+Mantel-Haenszel+analysis+of+Oxford+data.+II.+Independent+effects+of+fetal+irradiation+subfactors." target="_blank">Kneale GW, Stewart AM. Mantel-Haenszel analysis of Oxford data. II. Independent effects of fetal irradiation subfactors. J Natl Cancer Inst 1976;57:1009.</a>&nbsp;</p>
<p>QID: 30928</p>
</div></div><div class="rightanswer">The correct answer is: 0-8 days post conception</div></div></div></div></div><div id="q88" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">96</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1028"><input type="hidden" name="q20803:88_:flagged" value="0"><input type="hidden" value="qaid=910972&amp;qubaid=20803&amp;qid=4904&amp;slot=88&amp;checksum=89b6f675195b6a8eca74f757a44ec610&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:88_:flaggedcheckbox" name="q20803:88_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q88&id=4904"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:88_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old man undergoes successful revascularization of his right lower extremity after nearly 6 hours of acute ischemic symptoms following a motor vehicle accident in vascular trauma. He also sustained concomitant orthopedic injuries and will require continued operative repair for an additional 4 hours. His calf feels soft.&nbsp; Which of the following would be most appropriate management option in this setting?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:88_answer" disabled="disabled" value="0" id="q20803:88_answer0"><label for="q20803:88_answer0">a. mannitol and bicarbonate administration</label> </div>
<div class="r1"><input type="radio" name="q20803:88_answer" disabled="disabled" value="1" id="q20803:88_answer1"><label for="q20803:88_answer1">b. four-compartment fasciotomy</label> </div>
<div class="r0"><input type="radio" name="q20803:88_answer" disabled="disabled" value="2" id="q20803:88_answer2"><label for="q20803:88_answer2">c. serial intraoperative CPK levels</label> </div>
<div class="r1"><input type="radio" name="q20803:88_answer" disabled="disabled" value="3" id="q20803:88_answer3"><label for="q20803:88_answer3">d. measure compartment pressures</label> </div>
<div class="r0"><input type="radio" name="q20803:88_answer" disabled="disabled" value="4" id="q20803:88_answer4"><label for="q20803:88_answer4">e. lactated ringers infusion</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:88_-submit" name="q20803:88_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Given the acute ischemic time associated with the patient’s injuries, he is at risk for ischemia reperfusion injury and possible compartment syndrome.&nbsp; Given the patient’s ongoing orthopedic repair, a reliable extremity exam is not possible, making prophylactic 4 compartment fasciotomy the safest option in this setting.&nbsp; Serial CPK would not be reliable intraoperatively.&nbsp; While mannitol, bicarbonate, and crystalloid infusion are useful adjuncts to diminish the sequelae of ischemia-reperfusion injury and subsequent myoglobinuria, they do not provide initial&nbsp;benefit in actually treating an acute compartment syndrome. Though compartment pressures could be measured intraoperatively, it is possible they could change during the remainder of the patient’s surgery and thus would not serve as a durable index.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>Modrall, JG.&nbsp; Compartment Syndrome. Rutherford’s Vascular Surgery; 7<sup>th</sup> edition. 2010. Vol 2:2412-2421.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Bone+Joint+Surg+Am+1976%3B+58%3A112-5." target="_blank">Sheridan GW, Matsen FA III. Fasciotomy in the Treatment of the Acute Compartment Syndrome. J Bone Joint Surg Am 1976; 58:112-5.</a></p>
<p>QID: 30134</p></div><div class="rightanswer">The correct answer is: four-compartment fasciotomy</div></div></div></div></div><div id="q326" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">97</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1037"><input type="hidden" name="q20803:326_:flagged" value="0"><input type="hidden" value="qaid=911210&amp;qubaid=20803&amp;qid=5090&amp;slot=326&amp;checksum=1941370c337fa38b40d2f9f84926bac1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:326_:flaggedcheckbox" name="q20803:326_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q326&id=5090"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:326_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old man underwent a left common iliac artery (CIA) stent for left lower extremity claudication.&nbsp;Surveillance study&nbsp;at his 6-month follow reveals the duplex examination shown below.&nbsp; Which of the following finding is compatible with restenosis?</p>
<p><a href="./VESAP3_files/iliacstentstenosis.jpg" target="images"><img src="./VESAP3_files/iliacstentstenosis.jpg" alt="" width="100"></a></p>
<p>&nbsp;CIA = common iliac artery, EIA = external iliac artery, PS = peak systolic velocity, ED = end diastolic velocity</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:326_answer" disabled="disabled" value="0" id="q20803:326_answer0"><label for="q20803:326_answer0">a. localized end diastolic velocity &lt; 50cm/sec</label> </div>
<div class="r1"><input type="radio" name="q20803:326_answer" disabled="disabled" value="1" id="q20803:326_answer1"><label for="q20803:326_answer1">b. decrease in ABI by &gt;0.15</label> </div>
<div class="r0"><input type="radio" name="q20803:326_answer" disabled="disabled" value="2" id="q20803:326_answer2"><label for="q20803:326_answer2">c. diminished femoral pulse</label> </div>
<div class="r1"><input type="radio" name="q20803:326_answer" disabled="disabled" value="3" id="q20803:326_answer3"><label for="q20803:326_answer3">d. localized elevated velocities &gt;200cm/sec with turbulent flow</label> </div>
<div class="r0"><input type="radio" name="q20803:326_answer" disabled="disabled" value="4" id="q20803:326_answer4"><label for="q20803:326_answer4">e. peak systolic velocity (PSV)/end diastolic velocity (EDV) &gt; 3</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:326_-submit" name="q20803:326_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Iliac stenting has become the accepted treatment option for localized aortoilaic disease.&nbsp; Patency rates have been shown to be increased with regular surveillance.&nbsp; As there can be elevated velocities throughout a stented artery, certain criteria should be found in order to recommend arteriography to further define and treat restenosis in a stented iliac artery.&nbsp; Criteria for restenosis have been extrapolated from the management of failing infrainguinal bypass grafts. Localized elevated velocities &gt;200cm/sec with turbulent flow, peak velocity ratios greater than 2.0, and monophasic common femoral waveforms are all indications for a hemodynamically significant restenosis of an iliac stent. Further physiological data should include decrease in ABIs &gt; 0.15 and recurrence of claudication symptoms.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Endovascular+Therapy+2001%3B+8%3A629-37" target="_blank">Back MR, Novotney M, Roth SM, Elkins D, Farber S, Cuthbertson D, et al. Utility of Duplex Surveillance Following Iliac Artery Angioplasty and Primary Stenting. J Endovasc Ther 2001; 8:629-37.&nbsp;</a></p>
<p>QID: 30560</p></div><div class="rightanswer">The correct answer is: localized elevated velocities &gt;200cm/sec with turbulent flow</div></div></div></div></div><div id="q333" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">98</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1046"><input type="hidden" name="q20803:333_:flagged" value="0"><input type="hidden" value="qaid=911217&amp;qubaid=20803&amp;qid=5098&amp;slot=333&amp;checksum=90c307db47641655c158c268cac69bb5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:333_:flaggedcheckbox" name="q20803:333_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q333&id=5098"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:333_:sequencecheck" value="2"><div class="qtext"><p>In this color-flow image of a tortuous right internal carotid artery, what is the cause for the narrow black area in the vessel lumen (indicated by the white arrow) separating the orange and blue segments of the artery?</p>
<p><a href="./VESAP3_files/Zierler Image 5.jpg" target="images"><img src="./VESAP3_files/Zierler Image 5.jpg" alt="Zierler Image 5" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:333_answer" disabled="disabled" value="0" id="q20803:333_answer0"><label for="q20803:333_answer0">a. a zero degree Doppler angle</label> </div>
<div class="r1"><input type="radio" name="q20803:333_answer" disabled="disabled" value="1" id="q20803:333_answer1"><label for="q20803:333_answer1">b. acoustic shadowing</label> </div>
<div class="r0"><input type="radio" name="q20803:333_answer" disabled="disabled" value="2" id="q20803:333_answer2"><label for="q20803:333_answer2">c. refraction artifact</label> </div>
<div class="r1"><input type="radio" name="q20803:333_answer" disabled="disabled" value="3" id="q20803:333_answer3"><label for="q20803:333_answer3">d. speed error</label> </div>
<div class="r0"><input type="radio" name="q20803:333_answer" disabled="disabled" value="4" id="q20803:333_answer4"><label for="q20803:333_answer4">e. flow separation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:333_-submit" name="q20803:333_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The “color box” used in this image is rectangular, indicating that the Doppler ultrasound beams are “vertical” or perpendicular to the transducer and skin surface. At the site indicated by the white arrow, the artery becomes parallel to the skin surface, resulting in a Doppler angle of 90 degrees and a Doppler frequency shift of 0 (cosine of 90 degrees = 0). Since the color assignments in a color-flow image depend on Doppler frequency shifts, no colors are assigned at this site and the color “drops out” until the angle changes and a Doppler frequency shift occurs. The color change from orange to blue is due to the change in flow direction with respect to the Doppler ultrasound beams. Acoustic shadowing refers to a reduction in the strength of the ultrasound echoes beyond a strongly attenuating or reflecting structure. A refraction artifact is the result ultrasound passing through tissues with different propagation speeds and causes a structure to be improperly positioned laterally in an ultrasound image. Speed error occurs when the assumed value for the speed of sound in soft tissues (typically 1.54 mm/µs) is incorrect and a structure is displayed at an incorrect distance from the transducer. Flow separation occurs when blood near the arterial wall slows down and creates a localized, low velocity flow pattern that is different from the forward flow pattern in the center of the vessel; this typically occurs in the normal carotid bulb.</p>
<p>QID: 30568</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>Kremkau FW. Chapter 5 Doppler Principles. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:125-75.</p>
<p>Kremkau FW. Chapter 6 Artifacts. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:176-210.</p></div><div class="rightanswer">The correct answer is: a zero degree Doppler angle</div></div></div></div></div><div id="q167" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">99</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1055"><input type="hidden" name="q20803:167_:flagged" value="0"><input type="hidden" value="qaid=911051&amp;qubaid=20803&amp;qid=4668&amp;slot=167&amp;checksum=419feea100c6d424556b867d199a8263&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:167_:flaggedcheckbox" name="q20803:167_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q167&id=4668"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:167_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old man with a history of bilateral internal carotid artery disease for many years presents following routine annual duplex surveillance. The patient is asymptomatic from his carotid artery disease. Duplex examination reveals:</p>
<table border="0" cellpadding="10">
<tbody>
<tr>
<td>&nbsp;</td>
<td>Right</td>
<td>Left</td>
</tr>
<tr>
<td>CCA PSV</td>
<td>100 cm/s</td>
<td>79 cm/s</td>
</tr>
<tr>
<td>ICA PSV</td>
<td>240 cm/s</td>
<td>0 cm/s</td>
</tr>
<tr>
<td>CCA EDV</td>
<td>30 cm/s</td>
<td>41 cm/s</td>
</tr>
<tr>
<td>ICA EDV</td>
<td>110 cm/s</td>
<td>0 cm/s</td>
</tr>
</tbody>
</table>
<p><br>Using evidence-based medicine, which of the following is the recommended therapy for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:167_answer" disabled="disabled" value="0" id="q20803:167_answer0"><label for="q20803:167_answer0">a. carotid angioplasty and stenting without embolic protection</label> </div>
<div class="r1"><input type="radio" name="q20803:167_answer" disabled="disabled" value="1" id="q20803:167_answer1"><label for="q20803:167_answer1">b. best medical therapy</label> </div>
<div class="r0"><input type="radio" name="q20803:167_answer" disabled="disabled" value="2" id="q20803:167_answer2"><label for="q20803:167_answer2">c. carotid endarterectomy with patch</label> </div>
<div class="r1"><input type="radio" name="q20803:167_answer" disabled="disabled" value="3" id="q20803:167_answer3"><label for="q20803:167_answer3">d. carotid angioplasty and stenting with embolic protection</label> </div>
<div class="r0"><input type="radio" name="q20803:167_answer" disabled="disabled" value="4" id="q20803:167_answer4"><label for="q20803:167_answer4">e. carotid endarterectomy without patch</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:167_-submit" name="q20803:167_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The best therapy option to reduce this patient's risk of stroke is medical therapy. Because the left internal carotid artery is occluded, the velocities on the right internal carotid artery are elevated. In this situation, the peak systolic velocity (PSV) and end diastolic velocity (EDV) are not reliable to determine the degree of stenosis. The ratio of the ICA/CCA PSV is valuable in situations of either low flow or high flow. In this example, the ratio on the right is 2.4, well below the 4.0 ratio threshold for a 70% stenosis. Thus, the stenosis on the right is consistent with &lt; 70% stenosis. According to the Asymptomatic Carotid Surgery Trial (ACST),&nbsp;this patient, who is asymptomatic,&nbsp;would not benefit from surgical intervention of the right carotid artery disease.<br><br></p>
<h3>References:</h3>
<p>Zweibel WJ, Pellerito JS. Carotid occlusion, unusual carotid pathology and tricky carotid cases. In: Zwiebel WJ, Pellerito JS, eds. Introduction to Vascular Ultrasonography. 5th ed. Philadelphia, PA: Elsevier Saunders 2005:191-210.<br><br>Armstrong PA, Bandyk DF. Arterial duplex scanning. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery, 7th ed. Philadelphia, PA: Elsevier Saunders; 2010:235-56.</p>
<p>QID: 30305</p></div><div class="rightanswer">The correct answer is: best medical therapy</div></div></div></div></div><div id="q528" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">100</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1064"><input type="hidden" name="q20803:528_:flagged" value="0"><input type="hidden" value="qaid=911412&amp;qubaid=20803&amp;qid=5264&amp;slot=528&amp;checksum=d0fb1b4ff1302d456600496d14b8a2ad&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:528_:flaggedcheckbox" name="q20803:528_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q528&id=5264"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:528_:sequencecheck" value="2"><div class="qtext"><p>A vascular surgery fellow is planning a pregnancy. Which of the following is the most important factor in protecting the fetus during interventional procedures?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:528_answer" disabled="disabled" value="0" id="q20803:528_answer0"><label for="q20803:528_answer0">a. immediate disclosure of plans to division chief</label> </div>
<div class="r1"><input type="radio" name="q20803:528_answer" disabled="disabled" value="1" id="q20803:528_answer1"><label for="q20803:528_answer1">b. use of 0.25 mm lead apron</label> </div>
<div class="r0"><input type="radio" name="q20803:528_answer" disabled="disabled" value="2" id="q20803:528_answer2"><label for="q20803:528_answer2">c. reporting of fetal radiation each trimester</label> </div>
<div class="r1"><input type="radio" name="q20803:528_answer" disabled="disabled" value="3" id="q20803:528_answer3"><label for="q20803:528_answer3">d. standing &gt;6 feet from the fluoroscopy unit during imaging runs</label> </div>
<div class="r0"><input type="radio" name="q20803:528_answer" disabled="disabled" value="4" id="q20803:528_answer4"><label for="q20803:528_answer4">e. recording of fetal radiation&nbsp;badge worn over the abdominal lead</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:528_-submit" name="q20803:528_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>If a pregnancy is planned, the operator has a choice of requesting an abdominal (fetal) badge to wear under the abdominal lead to monitor radiation. This can be done confidentially at most institutions before disclosure to the other members of the division. Rules may vary state to state, but all radiation levels should be reported monthly. The use of lead aprons, ideally wrap around skirts with 0.5-1.0mm lead is preferred. Some operators may use 'pregnancy' lead with additional thickness, or two skirts. &nbsp;As always, the ALARA principles should be employed. It is best practice to step away from the radiation unit or use a lead shield during imaging runs.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<div class="column">
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ned+Tijdschr+Geneeskd+2002%3B+146%3A299-+303." target="_blank">Kal HB, Struikmans H. Pregnancy and medical irradiation; summary and conclusions from the International Commission on Radiological Protection, Publication 84. Ned Tijdschr Geneeskd 2002; 146:299- 303. </a></p>
<p>National Council on Radiation Protection and Measurement. NCRP Scientific Committee 46-12. Rosenstein M, Chairman. NCRP Report No. 122. Use of personal monitors to estimate effective dose equivalent and effective dose to workers for external exposure to low-LET Radia- tion. Bethesda, MD: NCRP.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br+J+Radiol+2001%3B+74%3A629-37." target="_blank">Osei EK, Kotre CJ. Equivalent dose to the fetus from occupational exposure of pregnant staff in diagnostic radiology. Br J Radiol 2001; 74:629-37.&nbsp;</a></p>
<p>QID: 30932</p>
</div></div><div class="rightanswer">The correct answer is: standing &gt;6 feet from the fluoroscopy unit during imaging runs</div></div></div></div></div><div id="q515" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">101</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1073"><input type="hidden" name="q20803:515_:flagged" value="0"><input type="hidden" value="qaid=911399&amp;qubaid=20803&amp;qid=5250&amp;slot=515&amp;checksum=324da77a95e987880321ffe59d760a87&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:515_:flaggedcheckbox" name="q20803:515_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q515&id=5250"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:515_:sequencecheck" value="2"><div class="qtext"><p>With regard to decreasing frame rate during fluoroscopy, which of the following statements is most <strong>CORRECT</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:515_answer" disabled="disabled" value="0" id="q20803:515_answer0"><label for="q20803:515_answer0">a. increases image quality</label> </div>
<div class="r1"><input type="radio" name="q20803:515_answer" disabled="disabled" value="1" id="q20803:515_answer1"><label for="q20803:515_answer1">b. increases radiation exposure</label> </div>
<div class="r0"><input type="radio" name="q20803:515_answer" disabled="disabled" value="2" id="q20803:515_answer2"><label for="q20803:515_answer2">c. decreases radiation exposure</label> </div>
<div class="r1"><input type="radio" name="q20803:515_answer" disabled="disabled" value="3" id="q20803:515_answer3"><label for="q20803:515_answer3">d. magnifies the image</label> </div>
<div class="r0"><input type="radio" name="q20803:515_answer" disabled="disabled" value="4" id="q20803:515_answer4"><label for="q20803:515_answer4">e. does not change image quality</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:515_-submit" name="q20803:515_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Angiographic equipment operates in two basic modalities, flouroscopy and acquisition.&nbsp; During flouroscopy, images are produced by pulsing X-ray energy at a prespecified rate. The standard in the United States is 30 frames per second. The number of images generated per second of exposure has a direct correlation with the X-ray exposure of both the patient and the staff.&nbsp; While imaging quality does decrease with decreasing frame rates, this effect may be negligible during the flouroscopic portions of cases.&nbsp; Use of pulsed flouroscopy may decrease radiation exposures by up to 50%.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JACC+1998%3B31%3A892-913." target="_blank">Limacher MC, Douglas PS<span>,&nbsp;</span>Germano G<span>,&nbsp;</span>Laskey WK<span>,&nbsp;</span>Lindsay BD<span>,&nbsp;</span>McKetty MH<span>,&nbsp;</span>et al. ACC Expert Consensus Document. Radiation Sefety in the Practice of Cardiology. JACC 1998;31:892-913.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=.+J+Vasc+Interv+Radiol+2010%3B+21%3A607-615." target="_blank">Miller DL, Vañó E,&nbsp;Bartal G,&nbsp;Balter S,&nbsp;Dixon R,&nbsp;Padovani R,&nbsp;Schueler B,&nbsp;et al. Occupational Radiation Protection in Interventional Radiology: A Joint Guideline of the Cardiovascular and Interventional Radiology Society of Europe and the Society of Interventional Radiology. J Vasc Interv Radiol 2010; 21:607-15.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2005%3B+111(4)%3A511-32." target="_blank">Hirshfeld JW, Balter S<span>,&nbsp;</span>Brinker JA<span>,&nbsp;</span>Kern MJ<span>,&nbsp;</span>Klein LW<span>,&nbsp;</span>Lindsay BD<span>,&nbsp;</span>et al. ACCF/AHA/HRS/SCAI Fluoroscopy Clinical Competence Statement on Physician Knowledge to Optimize Patient Safety and Image Quaility in Fluoroscopically Guided Invasive Cardiovascular Procedures. Circulation 2005;111(4):511-32.</a></p>
<p>&nbsp;QID: 30918</p></div><div class="rightanswer">The correct answer is: decreases radiation exposure</div></div></div></div></div><div id="q416" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">102</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1082"><input type="hidden" name="q20803:416_:flagged" value="0"><input type="hidden" value="qaid=911300&amp;qubaid=20803&amp;qid=4790&amp;slot=416&amp;checksum=504d3e6783dfaddb24d75e85225a2502&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:416_:flaggedcheckbox" name="q20803:416_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q416&id=4790"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:416_:sequencecheck" value="2"><div class="qtext"><p>In use as a surveillance imaging modality to detect endoleaks after endovascular repair of abdominal aortic aneurysms, which of the following statements regarding duplex ultrasound (DUS) is <strong>true</strong>?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/Endoleak still.png" target="images"><img src="./VESAP3_files/Endoleak still.png" alt="Endoleak on duplex" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:416_answer" disabled="disabled" value="0" id="q20803:416_answer0"><label for="q20803:416_answer0">a. DUS has a decreased ability to distinguish the type of endoleak compared to CTA</label> </div>
<div class="r1"><input type="radio" name="q20803:416_answer" disabled="disabled" value="1" id="q20803:416_answer1"><label for="q20803:416_answer1">b. DUS results in a higher numbers of secondary interventions for treatment of endoleaks</label> </div>
<div class="r0"><input type="radio" name="q20803:416_answer" disabled="disabled" value="2" id="q20803:416_answer2"><label for="q20803:416_answer2">c. DUS has a superior specificity and sensitivity compared to computed tomography angiography (CTA)</label> </div>
<div class="r1"><input type="radio" name="q20803:416_answer" disabled="disabled" value="3" id="q20803:416_answer3"><label for="q20803:416_answer3">d. DUS is not cost effective when compared to CTA because of the high rate of false positive studies prompting further imaging</label> </div>
<div class="r0"><input type="radio" name="q20803:416_answer" disabled="disabled" value="4" id="q20803:416_answer4"><label for="q20803:416_answer4">e. accuracy is enhanced with the use of a contrast agent</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:416_-submit" name="q20803:416_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Some type of aortic aneurysm surveillance after endovascular repair is mandatory to detect early or late endoleaks, aneurysm growth, and other problems. Traditionally, surveillance was preformed with CTA. Due to the high cost of CTA as a surveillance tool, as well as risk of renal injury from repetitive contrast administration and the risks from cumulative radiation exposure, there has been increased interest in the use of duplex scanning for surveillance following aortic endografting. While sensitivity and specificity of duplex ultrasound detection of endoleaks varies depending on the study, it has not been shown to be superior to CTA. Because it is a dynamic study, duplex studies can often demonstrate the type of endoleak, and in this regard it is not inferior to CTA. In fact, a study by Schmieder et al showed that color duplex ultrasound imaging at the investigator’s institution has a high sensitivity in detecting endoleaks requiring intervention, and is better at identifying the type of endoleak compared to CTA. There are no studies that have shown that duplex surveillance is not cost effective compared to CTA, or that it results in a higher number of interventions for endoleak. Ultrasound contrast agents are gas-filled microbubbles that are injected into the bloodstream and enhance imaging as intravascular reflectors of ultrasound waves. The use of contrast enhanced ultrasonography (CEUS) has been shown to increase the accuracy of endoleak detection. A study by Cantisani et al demonstrated CEUS had a sensitivity of 93% and a specificity of 100% compared to CTA in the detection of endoleak. This is in contrast to a sensitivity of 58% and specificity of 83% for conventional duplex ultrasound.</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Vasc+Endovasc+Surg.+2011%3B+41(2)%3A186-92." target="_blank">Cantisani V, Ricci P, Grazhdani H, Napoli A<span>,&nbsp;</span>Fanelli F<span>,&nbsp;</span>Catalano C,&nbsp;et al. Prospective comparative analysis of colour-Doppler ultrasound, contrast-enhanced ultrasound, computed tomography and magnetic resonance in detecting endoleak after endovascular abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg. 2011; 41(2):186-92.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2009%3B+49(3)%3A552-60." target="_blank">Iezzi R, Basilico R, Giancristofaro D, Pascali D<span>,&nbsp;</span>Cotroneo AR<span>,&nbsp;</span>Storto ML. Contrast-enhance ultrasound versus color duplex ultrasound imaging in the follow-up of patients after endovascular abdominal aneurysm repair. J Vasc Surg 2009; 49(3):552-60.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2009%3B+50(5)%3A+1012-7." target="_blank">Schmieder GC, Stout CL, Stokes GK, Parent FN<span>,&nbsp;</span>Panneton JM. Endoleak after endovascular aneurysm repair: duplex ultrasound imaging is better than computed tomography at determining the need for intervention. J Vasc Surg 2009; 50(5): 1012-7.&nbsp;</a></p>
<p>QID: 30737</p></div><div class="rightanswer">The correct answer is: accuracy is enhanced with the use of a contrast agent</div></div></div></div></div><div id="q67" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">103</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1091"><input type="hidden" name="q20803:67_:flagged" value="0"><input type="hidden" value="qaid=910951&amp;qubaid=20803&amp;qid=4893&amp;slot=67&amp;checksum=19feb8c09975f3d4cbd863cf7c62b759&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:67_:flaggedcheckbox" name="q20803:67_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q67&id=4893"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:67_:sequencecheck" value="2"><div class="qtext"><p>A 67-year-old diabetic man has a nonhealing ulcer of his left fourth toe with radiographic evidence of osteomyelitis. Monophasic Doppler signals are audible at the dorsalis pedis (DP) and posterior tibial (PT) locations of the ankle; the ankle-brachial index (ABI) is 1.4. Arteriography shows patent common, superficial, and profunda femoris arteries. The superficial femoral artery (SFA) has a 6 cm occlusion in the region of the adductor canal with reconstitution of the popliteal artery beyond. All three tibial vessels occlude in the proximal calf but the DP artery reconstitutes in the proximal foot. Duplex vein mapping shows a 4 mm great saphenous vein (GSV) from the groin to the ankle. Which of the following management options represents the most durable intervention for revascularization?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:67_answer" disabled="disabled" value="0" id="q20803:67_answer0"><label for="q20803:67_answer0">a. femoral popliteal artery bypass with PTFE and popliteal-pedal bypass with GSV</label> </div>
<div class="r1"><input type="radio" name="q20803:67_answer" disabled="disabled" value="1" id="q20803:67_answer1"><label for="q20803:67_answer1">b. percutaneous transluminal angioplasty of the SFA and popliteal pedal bypass using GSV</label> </div>
<div class="r0"><input type="radio" name="q20803:67_answer" disabled="disabled" value="2" id="q20803:67_answer2"><label for="q20803:67_answer2">c. common femoral to dorsalis pedis bypass using GSV</label> </div>
<div class="r1"><input type="radio" name="q20803:67_answer" disabled="disabled" value="3" id="q20803:67_answer3"><label for="q20803:67_answer3">d. revascularization is not necessary; proceed with toe amputation</label> </div>
<div class="r0"><input type="radio" name="q20803:67_answer" disabled="disabled" value="4" id="q20803:67_answer4"><label for="q20803:67_answer4">e. percutaneous transluminal angioplasty of the SFA and anterior tibial arteries</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:67_-submit" name="q20803:67_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has critical ischemia with tissue loss and infection secondary to diffuse tibial occlusive disease. His ABI is inconsistent with his clinical and angiographic picture and likely represents a degree of incompressibility of his tibial vessels. Toe pressures, while not performed in this case, would likely yield a more sobering value. According to TASC criteria, long segment, diffuse tibial occlusion is best treated with surgical revascularization. Pedal bypass is an effective mode of revascularization for a select population of patients with limb-threatening ischemia. Infrapopliteal angioplasty may be considered for focal tibial vessel lesions in the setting of critical limb ischemia. However, in the patient described, the only patent and suitable distal target vessel is the dorsalis pedis artery, and an adequate length of good-caliber greater saphenous vein is available. If an adequate length of good quality GSV was not available to span the distance from the preferred common femoral artery graft origin to the DP artery, consideration could be given to using the contralateral GSV, if it were of acceptable caliber and length. However, given the likelihood that he has similar arterial insufficiency brewing on the opposite side and may need that GSV there in the near future, combined with the likelihood of harvest site wound healing problems, most would opt in this situation for a composite graft using ipsilateral lesser saphenous, or arm vein, to supplement whatever ipsilateral GSV was present. Despite these measures, only if an inadequate length of autologous conduit could be constructed would consideration be given to angioplasty of the SFA lesion to allow a more distal bypass graft origin, or to sequential bypass grafting with PTFE above the knee and an autologous bypass below. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+2005%3B+366+(9501)%3A1925-34." target="_blank">Adam DJ, Beard JD, Cleveland T,<span>&nbsp;</span>Bell J<span>,&nbsp;</span>Bradbury AW<span>,&nbsp;</span>Forbes JF,&nbsp;et al. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): Multicentre, randomized controlled trial. Lancet 2005; 366 (9501):1925-34.</a><br><br>TransAtlantic Inter-Society Consensus Working Group. Endovascular procedures for intermittent claudication. J Vasc Surg 2000; 31 (suppl):S97-S113.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Aulivola%20B,%20Pomposelli%20FB.%20Dorsalis%20pedis,%20tarsal%20and%20plantar%20artery%20bypass.%20J%20Cardiovasc%20Surg;%202004;%2045%20(3):203-212" target="_blank">Aulivola B, Pomposelli FB. Dorsalis pedis, tarsal and plantar artery bypass. J Cardiovasc Surg 2004; 45 (3):203-12.</a></p>
<p>QID: 30105</p></div><div class="rightanswer">The correct answer is: common femoral to dorsalis pedis bypass using GSV</div></div></div></div></div><div id="q544" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">104</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1100"><input type="hidden" name="q20803:544_:flagged" value="0"><input type="hidden" value="qaid=911428&amp;qubaid=20803&amp;qid=5278&amp;slot=544&amp;checksum=feced17fb763c6ac11d4959c8dbf57ef&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:544_:flaggedcheckbox" name="q20803:544_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q544&id=5278"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:544_:sequencecheck" value="2"><div class="qtext"><p>Which of the following terms best describes <b>skin erythema</b> detected after a lengthy fluoroscopic procedure?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:544_answer" disabled="disabled" value="0" id="q20803:544_answer0"><label for="q20803:544_answer0">a. non-threshold effect</label> </div>
<div class="r1"><input type="radio" name="q20803:544_answer" disabled="disabled" value="1" id="q20803:544_answer1"><label for="q20803:544_answer1">b. stochastic effect</label> </div>
<div class="r0"><input type="radio" name="q20803:544_answer" disabled="disabled" value="2" id="q20803:544_answer2"><label for="q20803:544_answer2">c. non-linear effect</label> </div>
<div class="r1"><input type="radio" name="q20803:544_answer" disabled="disabled" value="3" id="q20803:544_answer3"><label for="q20803:544_answer3">d. temporary effect</label> </div>
<div class="r0"><input type="radio" name="q20803:544_answer" disabled="disabled" value="4" id="q20803:544_answer4"><label for="q20803:544_answer4">e. deterministic effect</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:544_-submit" name="q20803:544_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>A deterministic effect, or non stochastic effect,&nbsp;describes a health effect where the severity varies with the dose for which a threshold is believed to exist. Radiation-induced cataract formation, skin damage, and adverse birth outcomes are examples of this.&nbsp;Stochastic effects describe health effects that occur randomly and for which the probability of the effect occurring, rather than its severity, is assumed to be a linear function of dose without threshold (non-threshold). &nbsp;These lead to hereditary effects such as genetic mutation and genomic instability, as well as radiogenic cancer.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.nrc.gov/reading-rm/doc-collections/cfr/part020/part020-1003.html" target="_blank">The Nuclear Regulatory Commission's (NRC) Standards for Protection Against Radiation (10 CFR Part 20 § 20.1003 Definitions.</a></p>
<p>QID: 30950</p></div><div class="rightanswer">The correct answer is: deterministic effect</div></div></div></div></div><div id="q341" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">105</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1109"><input type="hidden" name="q20803:341_:flagged" value="0"><input type="hidden" value="qaid=911225&amp;qubaid=20803&amp;qid=5133&amp;slot=341&amp;checksum=3a42944596222f2258002e4c1160e947&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:341_:flaggedcheckbox" name="q20803:341_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q341&id=5133"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:341_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old woman with post-prandial epigastric abdominal pain undergoes a mesenteric duplex ultrasonound evaluation. The duplex waveform displayed below from the proximal superior mesenteric artery is most consistent with which of the following patients?<br><br><a href="./VESAP3_files/AssetProxy_050.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_050.jpg" alt="img" width="100" height="68" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:341_answer" disabled="disabled" value="0" id="q20803:341_answer0"><label for="q20803:341_answer0">a. a postprandial patient, no spectral broadening, normal peak systolic velocity, no SMA stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:341_answer" disabled="disabled" value="1" id="q20803:341_answer1"><label for="q20803:341_answer1">b. a postprandial patient, spectral broadening, elevated peak systolic velocity, no SMA stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:341_answer" disabled="disabled" value="2" id="q20803:341_answer2"><label for="q20803:341_answer2">c. a fasting patient, no spectral broadening, elevated peak systolic velocity, SMA stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:341_answer" disabled="disabled" value="3" id="q20803:341_answer3"><label for="q20803:341_answer3">d. a fasting patient, spectral broadening, elevated peak systolic velocity, SMA stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:341_answer" disabled="disabled" value="4" id="q20803:341_answer4"><label for="q20803:341_answer4">e. a fasting patient, spectral broadening, normal peak systolic velocity (PSV), no superior mesenteric artery (SMA) stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:341_-submit" name="q20803:341_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Normal superior mesenteric artery (SMA) Doppler waveforms in the fasting patient show high resistance, with a peak systolic velocity (PSV) &lt; 275 cm/sec and without spectral broadening. Following a meal, the waveform becomes low resistance, with a slightly increased PSV and little to no spectral broadening. In the presence of a significant SMA stenosis (&gt; 70% diameter narrowing) in a fasting patient, there is a delay in the systolic upstroke, a markedly elevated PSV as shown in the image, and significant spectral broadening. Due to the stenosis, there is diastolic flow throughout diastole. End diastolic velocity &gt; 55 cm/sec is also consistent with a SMA stenosis &gt; 70%.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Moneta%20GL,%20Lee%20RW,%20Yeager%20RA,%20et%20al.%20Mesenteric%20duplex%20scanning:%20A%20blinded%20prospective%20study.%20J%20Vasc%20Surg;%201999;%2017%20(1):79" target="_blank">Moneta GL, Lee RW, Yeager RA, Taylor LM Jr<span>,&nbsp;</span>Porter JM. Mesenteric duplex scanning: A blinded prospective study. J Vasc Surg 1999; 17 (1):79-84.</a><br><br>Wyers MC, Zwolak RM. Physiology and diagnosis of splanchnic arterial occlusion. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1707-17.</p>
<p>QID: 30607</p></div><div class="rightanswer">The correct answer is: a fasting patient, spectral broadening, elevated peak systolic velocity, SMA stenosis</div></div></div></div></div><div id="q1" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">106</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1118"><input type="hidden" name="q20803:1_:flagged" value="0"><input type="hidden" value="qaid=910885&amp;qubaid=20803&amp;qid=4610&amp;slot=1&amp;checksum=ee21d286e898329ffd20dc15268c45a4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:1_:flaggedcheckbox" name="q20803:1_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q1&id=4610"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:1_:sequencecheck" value="2"><div class="qtext"><p>A 74-year-old otherwise healthy man presents with a 4.5 cm infrarenal abdominal aortic aneurysm (AAA). Based on recent published data, which of the following is true ?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:1_answer" disabled="disabled" value="0" id="q20803:1_answer0"><label for="q20803:1_answer0">a. rupture risk is 3-4% per year</label> </div>
<div class="r1"><input type="radio" name="q20803:1_answer" disabled="disabled" value="1" id="q20803:1_answer1"><label for="q20803:1_answer1">b. it will reach 5.5 cm in an average of 3 years</label> </div>
<div class="r0"><input type="radio" name="q20803:1_answer" disabled="disabled" value="2" id="q20803:1_answer2"><label for="q20803:1_answer2">c. the rupture risk of a saccular aneurysm is 3-4 times greater than a similar sized fusiform aneurysm</label> </div>
<div class="r1"><input type="radio" name="q20803:1_answer" disabled="disabled" value="3" id="q20803:1_answer3"><label for="q20803:1_answer3">d. prospective, randomized trials support early elective endovascular, but not open AAA repair for 4.5 cm AAA</label> </div>
<div class="r0"><input type="radio" name="q20803:1_answer" disabled="disabled" value="4" id="q20803:1_answer4"><label for="q20803:1_answer4">e. prospective, randomized trials support elective repair at this size in women, but not in men</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:1_-submit" name="q20803:1_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The Aneurysm Detection and Management (ADAM) trial was almost exclusively comprised of men, and the UK Small Aneurysm trial only enrolled 17% women. Because of these small sample sizes the results cannot be generalized to women.&nbsp;There are no data to support an increased rupture risk for saccular aneurysms. The annual rupture risk in the ADAM trial was .6% per year. In the UK Small Aneurysm trial it was 1% per year.&nbsp;However, the&nbsp;average expansion rate in both trials&nbsp;was approximately .33 cm per year.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Lederle%2C%20Wilson%20SE%2C%20Johnson%20GR%2C%20et%20al.%20Immediate%20repair%20compared%20with%20surveillance%20of%20small%20abdominal%20aortic%20aneurysms.%20N%20Engl%20J%20Med%3B%202002%3B%20346%20%2819%29%3A1437-1444" target="_blank">Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346 (19):1437-44.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/9853436" target="_blank">U.K. Small Aneurysm Trial Participants. Mortality results for randomized controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet 1998; 352 (9141):1649-55.</a></p>
<p>&nbsp;</p>
<p><span style="color: #808080;"><strong>QID</strong>: 30001</span></p></div><div class="rightanswer">The correct answer is: it will reach 5.5 cm in an average of 3 years</div></div></div></div></div><div id="q374" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">107</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1127"><input type="hidden" name="q20803:374_:flagged" value="0"><input type="hidden" value="qaid=911258&amp;qubaid=20803&amp;qid=5110&amp;slot=374&amp;checksum=c97ca4a980e06578641a9a4383844328&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:374_:flaggedcheckbox" name="q20803:374_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q374&id=5110"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:374_:sequencecheck" value="2"><div class="qtext"><p>A 40-year-old multigravida woman presents with left flank pain and hematuria. Her blood pressure is noted to be 180/95. A computed tomographic scan confirms a large, 3.5 cm left renal artery aneurysm. At the time of laparotomy for repair of this symptomatic renal artery aneurysm, which of the following is the most probable location and morphology of the aneurysm?</p>
<p><img src="./VESAP3_files/Rectenwald-2.jpg" alt="" width="394" height="404"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:374_answer" disabled="disabled" value="0" id="q20803:374_answer0"><label for="q20803:374_answer0">a. at the bifurcation of the main renal artery and saccular</label> </div>
<div class="r1"><input type="radio" name="q20803:374_answer" disabled="disabled" value="1" id="q20803:374_answer1"><label for="q20803:374_answer1">b. at the bifurcation of the main renal artery and fusiform</label> </div>
<div class="r0"><input type="radio" name="q20803:374_answer" disabled="disabled" value="2" id="q20803:374_answer2"><label for="q20803:374_answer2">c. within the renal parenchyma and fusiform</label> </div>
<div class="r1"><input type="radio" name="q20803:374_answer" disabled="disabled" value="3" id="q20803:374_answer3"><label for="q20803:374_answer3">d. involving the main renal artery proximally and saccular</label> </div>
<div class="r0"><input type="radio" name="q20803:374_answer" disabled="disabled" value="4" id="q20803:374_answer4"><label for="q20803:374_answer4">e. within the renal parenchyma and saccular</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:374_-submit" name="q20803:374_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Renal artery aneurysms (RAA) represent a relatively uncommon problem with an estimated incidence of approximately 0.1% in the general population.&nbsp;RAA are usually asymptomatic and are noted as incidental findings on imaging studies performed for other indications. Treatment of RAA is generally reserved for symptomatic disease or RAA &gt; 2 cm in size.&nbsp;Symptoms can include flank pain, hematuria, or hypertension refractory to medications.&nbsp;Although RAA can occur anywhere along the renal artery from the origin to its intraparanchymal segments, the most common location of RAA is at the bifurcation of the main renal artery.&nbsp;RAA can be fusiform in shape, but more often RAA have a saccular morphology. Open repair may involve aneurysmorraphy, resection of the aneurysm and reimplantation of renal artery segmental branches, or bypass with harvested saphenous vein graft or internal iliac artery.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Surg+2001%3B+234(4)%3A454-62." target="_blank">Henke PK, Cardneau JD, Welling TH, Upchurch GR, Wakefield TW, Jacobs LA, et al. Renal Artery Aneurysm: A 35-Year Clinical Experience with 252 Aneurysms in 168 Patients. Ann Surg 2001; 234(4):454-62.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Surg+2013%3B+217%3A263-9." target="_blank">Tsilimparis N, Reeves JG, Dayama A, Perez SD, Debus ES, Ricotta JJ 2<sup>nd</sup>. &nbsp;Endovascular vs Open Repair of Renal Artery Aneurysms: Outcomes of repair and Lont-term Renal Function.&nbsp; J Am Coll Surg 2013; 217:263-9.</a></p>
<p>QID: 30659</p></div><div class="rightanswer">The correct answer is: at the bifurcation of the main renal artery and saccular</div></div></div></div></div><div id="q337" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">108</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1136"><input type="hidden" name="q20803:337_:flagged" value="0"><input type="hidden" value="qaid=911221&amp;qubaid=20803&amp;qid=5130&amp;slot=337&amp;checksum=ba4b0790278e81cade2772d127f9abac&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:337_:flaggedcheckbox" name="q20803:337_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q337&id=5130"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:337_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old woman presents with a 1-year history of weight loss and intermittent abdominal pain. She has a history of a laparoscopic cholecystectomy. She has undergone an extensive workup that revealed only the presence of a hiatal hernia. She has lost 15 lbs and continues to have intermittent abdominal pain. Her serum creatinine is 3.5 mg/dL, which precluded intravenous (IV) contrast administration. A non-contrast CT scan of her abdomen revealed calcification of the SMA and celiac axis. A fasting duplex ultrasound is ordered and shown below. What peak systolic velocity (PSV)&nbsp;is recommended to identify hemodynamically significant SMA disease on Duplex imaging?<br><br><a href="./VESAP3_files/AssetProxy_075.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_075.jpg" alt="img" width="100" height="72" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:337_answer" disabled="disabled" value="0" id="q20803:337_answer0"><label for="q20803:337_answer0">a. PSV &gt; 325 cm/s</label> </div>
<div class="r1"><input type="radio" name="q20803:337_answer" disabled="disabled" value="1" id="q20803:337_answer1"><label for="q20803:337_answer1">b. PSV &gt; 275 cm/s</label> </div>
<div class="r0"><input type="radio" name="q20803:337_answer" disabled="disabled" value="2" id="q20803:337_answer2"><label for="q20803:337_answer2">c. PSV &gt; 225 cm/s</label> </div>
<div class="r1"><input type="radio" name="q20803:337_answer" disabled="disabled" value="3" id="q20803:337_answer3"><label for="q20803:337_answer3">d. PSV &gt; 125 cm/s</label> </div>
<div class="r0"><input type="radio" name="q20803:337_answer" disabled="disabled" value="4" id="q20803:337_answer4"><label for="q20803:337_answer4">e. PSV &gt; 175 cm/s</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:337_-submit" name="q20803:337_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The results obtained by use of receiver operator curves of duplex scan-derived velocities indicate that peak systolic velocity alone is an accurate predictor of a splanchnic artery stenosis. Specifically, a peak systolic velocity greater than or equal to 275 cm/sec in the superior mesenteric artery, greater than or equal to 200 cm/sec in the celiac artery, or no flow signal (superior mesenteric artery and/or celiac artery) predicted a 70-100% stenosis with sensitivity, specificity, and positive predictive values of 89%, 92%, and 80%, respectively, for the superior mesenteric artery. Corresponding figures for the celiac artery were 75%, 89%, and 85%, respectively. Other groups have reported that the diagnosis of &gt;50% stenosis in the SMA can be made with an EDV â‰¥ 45 cm/sec (sensitivity 90%, specificity 91%, positive predictive value 90%, negative predictive value 91%, and overall accuracy 91%). <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/1920649" target="_blank">Moneta GL, Yeager RA, Dalman R, Antonovic R<span>,&nbsp;</span>Hall LD<span>,&nbsp;</span>Porter JM. Duplex ultrasound criteria for diagnosis of splanchnic artery stenosis or occlusion. J Vasc Surg 1991;14 (4):511-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1998%3B+27+(6)%3A1078-87." target="_blank">Zwolak RM, Fillinger MF, Walsh DB, LaBombard FE<span>,&nbsp;</span>Musson A<span>,&nbsp;</span>Darling CE<span>,&nbsp;</span>et al. Mesenteric and celiac duplex scanning: A validation study. J Vasc Surg 1998; 27 (6):1078-87.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1991%3B+14+(6)%3A780-6." target="_blank">Bowersox JC, Zwolak RM, Walsh DB, Schneider JR,&nbsp;Musson A,&nbsp;LaBombard FE,&nbsp;et al. Duplex ultrasonography in the diagnosis of celiac and mesenteric artery occlusive disease. J Vasc Surg; 1991; 14 (6):780-6.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1993%3B+17+(1)%3A79-84." target="_blank">Moneta GL, Lee RW, Yeager RA, Taylor LM Jr, Porter JM. Mesenteric duplex scanning: A blinded prospective study. J Vasc Surg 1993; 17(1):79-84</a>.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Surg%3B+1995%3B+169+(5)%3A476-9." target="_blank">Gentile AT, Moneta GL, Lee RW, Masser PA<span>,&nbsp;</span>Taylor LM Jr<span>,&nbsp;</span>Porter JM. Usefulness of fasting and postprandial duplex ultrasound examinations for predicting high-grade superior mesenteric artery stenosis. Am J Surg; 1995; 169 (5):476-9.</a></p>
<p>QID: 30603</p></div><div class="rightanswer">The correct answer is: PSV &gt; 275 cm/s</div></div></div></div></div><div id="q201" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">109</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1145"><input type="hidden" name="q20803:201_:flagged" value="0"><input type="hidden" value="qaid=911085&amp;qubaid=20803&amp;qid=4692&amp;slot=201&amp;checksum=e3bad5da299600ded6fa826cb289a246&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:201_:flaggedcheckbox" name="q20803:201_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q201&id=4692"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:201_:sequencecheck" value="2"><div class="qtext"><p>During surgical exposure of the carotid artery for an asymptomatic high-grade stenosis, a 55-year-old man becomes severely bradycardic. Only occasional beats with long pauses are visible on the cardiac monitor. Which of the following is the most appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:201_answer" disabled="disabled" value="0" id="q20803:201_answer0"><label for="q20803:201_answer0">a. administer intravenous atropine</label> </div>
<div class="r1"><input type="radio" name="q20803:201_answer" disabled="disabled" value="1" id="q20803:201_answer1"><label for="q20803:201_answer1">b. administer norepinephrine</label> </div>
<div class="r0"><input type="radio" name="q20803:201_answer" disabled="disabled" value="2" id="q20803:201_answer2"><label for="q20803:201_answer2">c. electrical cardioversion</label> </div>
<div class="r1"><input type="radio" name="q20803:201_answer" disabled="disabled" value="3" id="q20803:201_answer3"><label for="q20803:201_answer3">d. abort procedure</label> </div>
<div class="r0"><input type="radio" name="q20803:201_answer" disabled="disabled" value="4" id="q20803:201_answer4"><label for="q20803:201_answer4">e. transect the vagus nerve</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:201_-submit" name="q20803:201_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The carotid sinus, located at the carotid bifurcation, is a collection of baroreceptor tissues that when stimulated by increased pressure (or surgical manipulation) produces bradycardia and hypotension. The carotid sinus is innervated by the carotid sinus nerve (nerve of Hering), which arises from the glossopharyngeal nerve. During a carotid endarterectomy, particularly during dissection near the bulb or with manipulation of the plaque, the carotid sinus may be stimulated, leading to bradycardia and even asystole. Some surgeons routinely inject the tissue near the sinus with 1-2 cc of lidocaine to prevent or treat bradycardia. In the setting of significant intraoperative bradycardia, atropine, or another anticholinergic drug, is the initial treatment of choice. Vasopressors may be required for persistent hypotension.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/16950419" target="_blank">Yakhou L, Constant I, Merle JC, Laude D<span>,&nbsp;</span>Becquemin JP<span>,&nbsp;</span>Duvaldestin P. Noninvasive investigation of autonomic activity after carotid stenting or carotid endarterectomy. J Vasc Surg 2006; 44 (3):472-9. </a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/9218293" target="_blank">Wong JH, Findlay JM, Suarez-Almazor ME. Hemodynamic instability after carotid endarterectomy: Risk factors and associations with operative complications. J Neurosurg 1997; 41(1):35-43. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/9218293"><br></a></p>
<p>QID: 30350</p></div><div class="rightanswer">The correct answer is: administer intravenous atropine</div></div></div></div></div><div id="q260" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">110</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1154"><input type="hidden" name="q20803:260_:flagged" value="0"><input type="hidden" value="qaid=911144&amp;qubaid=20803&amp;qid=4997&amp;slot=260&amp;checksum=e6bc79b5c04aa9433733bd2fde7161a7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:260_:flaggedcheckbox" name="q20803:260_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q260&id=4997"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:260_:sequencecheck" value="2"><div class="qtext"><p><span>A 46-year-old man with end-stage renal disease presents to the office from dialysis for evaluation of a right prosthetic radial antecubital forearm straight arteriovenous access. The dialysis unit reports difficulty achieving hemostasis after dialysis. Physical examination of the arm reveals a thrill and bruit with pulsatile masses and erosions overlying the masses. There is no erythema and there are palpable radial and brachial artery pulses. A Duplex ultrasound is obtained with a representative image shown below. Which of the following offers the safest treatment plan with the best long-term results?</span></p>
<p><span><img src="./VESAP3_files/2. US.png" alt="" width="278" height="278"></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:260_answer" disabled="disabled" value="0" id="q20803:260_answer0"><label for="q20803:260_answer0">a. <span>endograft deployment in the graft across the enlarged areas</span></label> </div>
<div class="r1"><input type="radio" name="q20803:260_answer" disabled="disabled" value="1" id="q20803:260_answer1"><label for="q20803:260_answer1">b. <span>ligation of the access with temporary catheter placement</span></label> </div>
<div class="r0"><input type="radio" name="q20803:260_answer" disabled="disabled" value="2" id="q20803:260_answer2"><label for="q20803:260_answer2">c. <span>percutaneous needle aspiration</span></label> </div>
<div class="r1"><input type="radio" name="q20803:260_answer" disabled="disabled" value="3" id="q20803:260_answer3"><label for="q20803:260_answer3">d. <span>incision and drainage with intraoperative cultures</span></label> </div>
<div class="r0"><input type="radio" name="q20803:260_answer" disabled="disabled" value="4" id="q20803:260_answer4"><label for="q20803:260_answer4">e. <span>prosthetic graft bypass around the mass with exclusion of the enlarged areas</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:260_-submit" name="q20803:260_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Possible complications of prosthetic arteriovenous grafts include pseudoaneurysms (PSA), infection, thrombosis, bleeding, and, more rarely, embolization. The diagnosis is made by clinical examination, but can be confirmed with duplex imaging. Small puncture site PSAs may be monitored without intervention, but dialysis personnel should be instructed to use alternative sections of the access for cannulation. Intervention is indicated if a PSA appears to be expanding or becomes ulcerated. Traditional open surgical treatment is to bypass around the involved portion of the AV access and replace it with either transposed vein or prosthetic graft. Excision of the aneurysmal areas is rarely required. In most cases, accessing the uninvolved portion of the access continues dialysis. An alternative approach is endovascular treatment with covered stent grafts. However, endograft deployment may lead to a higher incidence of future access site complications, especially in the presence of skin erosion.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank">Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg 2008; 48 (S):55S-80S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B57%3A144-8." target="_blank">Zink JN, Netzley R, Erzurum V, Wright D. Complications of endovascular grafts in the treatment of pseudoaneurysms and stenoses in arteriovenous access . J Vasc Surg 2013;57:144-8.</a></p>
<p>QID: 30444</p></div><div class="rightanswer">The correct answer is: <span>prosthetic graft bypass around the mass with exclusion of the enlarged areas</span></div></div></div></div></div><div id="q181" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">111</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1163"><input type="hidden" name="q20803:181_:flagged" value="0"><input type="hidden" value="qaid=911065&amp;qubaid=20803&amp;qid=4547&amp;slot=181&amp;checksum=99fca51f2a5ced48fdc5af8370f8914e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:181_:flaggedcheckbox" name="q20803:181_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q181&id=4547"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:181_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is a <strong>true</strong> statement regarding the long-term results of carotid endarterctomy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:181_answer" disabled="disabled" value="0" id="q20803:181_answer0"><label for="q20803:181_answer0">a. Restenosis following CEA is associated with a higher risk of stroke than de novo carotid stenosis.</label> </div>
<div class="r1"><input type="radio" name="q20803:181_answer" disabled="disabled" value="1" id="q20803:181_answer1"><label for="q20803:181_answer1">b. Restenosis rate is 5-15%.</label> </div>
<div class="r0"><input type="radio" name="q20803:181_answer" disabled="disabled" value="2" id="q20803:181_answer2"><label for="q20803:181_answer2">c. The annual incidence of restenosis increases after the first year</label> </div>
<div class="r1"><input type="radio" name="q20803:181_answer" disabled="disabled" value="3" id="q20803:181_answer3"><label for="q20803:181_answer3">d. Early restenosis (&lt;12 months post op) is typically due to atherosclerotic disease.</label> </div>
<div class="r0"><input type="radio" name="q20803:181_answer" disabled="disabled" value="4" id="q20803:181_answer4"><label for="q20803:181_answer4">e. Restenosis is higher when CEA is performed for symptomatic rather than asymptomatic lesions.</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:181_-submit" name="q20803:181_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Restenosis &nbsp;is an infrequent complication of carotid endarterectomy (CEA).&nbsp; In a meta-analysis of 55 studies, the overall incidence of restenosis was between&nbsp;5-14%.&nbsp; Most patients with restenosis remain asymptomatic. Preoperative symptom status has not been shown to be associated with restenosis risk. &nbsp;The rate of restenosis is not a linear process and it occurs with a greater incidence during the first year following CEA at a rate&nbsp;as high as&nbsp;10%. This&nbsp;decreases to 3% in the second year, and even less within the 3<sup>rd</sup> year. &nbsp;Early restenosis is typically secondary to the development of&nbsp;intimal hyperplasia and is associated with low embolic risk due to the nature of the fibrointimal process. Recurrent atherosclerotic disease usually takes several years to develop following initially successful carotid endarterectomy and is related to persistent smoking and elevated blood lipids. &nbsp; The role of duplex surveillance following carotid endarterectomy is controversial. Given the very low rate of symptoms in patients with restenosis, and the increased risk of cranial nerve injury with reoperation, some surgeons do not routinely perform post-operative ultrasound in the absence of symptoms.&nbsp;</p>
<p>&nbsp;</p>
<p>References:</p>
<p>1. Zierler RE, Bandyk DF, Thiele BL, Strandness Jr DE. Carotid artery stenosis following endarterectomy. Arch Surg1982; 117:1408-1415. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7138302">http://www.ncbi.nlm.nih.gov/pubmed/7138302</a></p>
<p>2. Lattimer CR, Burnand KG: Recurrent carotid stenosis after carotid endarterectomy. Br J Surg 1997; 84:1206-1219. <a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=lattimer+cr%2C+1997">http://www.ncbi.nlm.nih.gov/pubmed/?term=lattimer+cr%2C+1997</a></p>
<p>3. Frericks H, Kievit J, van Baalen JM, van Bockel JH. Carotid recurrent stenosis and risk of ipsilateral stroke: a systematic review of the literature. Stroke 1998; 29: 244-250. <a href="http://www.ncbi.nlm.nih.gov/pubmed/9445358">http://www.ncbi.nlm.nih.gov/pubmed/9445358</a></p>
<p>4. Bonati LH, Ederle J, McCabe DJ, et al. &nbsp;Long-term risk of carotid restenosis in patients randomly assigned to endovascular treatment or endarterectomy in the Carotid and Vertebral Artery Transluminal Angioplasty Study (CAVATAS): long-term follow-up of a randomised trial. Lancet Neurol 2009; 8(10):908-17. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19717347">http://www.ncbi.nlm.nih.gov/pubmed/19717347</a></p>
<p>QID: 30324</p></div><div class="rightanswer">The correct answer is: Restenosis rate is 5-15%.</div></div></div></div></div><div id="q399" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">112</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1172"><input type="hidden" name="q20803:399_:flagged" value="0"><input type="hidden" value="qaid=911283&amp;qubaid=20803&amp;qid=5050&amp;slot=399&amp;checksum=ea03a59bdf90f148326312c9f9185e11&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:399_:flaggedcheckbox" name="q20803:399_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q399&id=5050"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:399_:sequencecheck" value="2"><div class="qtext"><p>An 84-year-old woman presented with chest pain and shortness of breath 3 weeks after being diagnosed with deep vein thrombosis (DVT). She had been treated with oral anticoagulants and her INR has been 2.5 for the past week. A representative image from her chest CT scan is shown below. Which of the following is the most appropriate management option for this patient?<br><br><a href="./VESAP3_files/AssetProxy_014.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_014.jpg" alt="img" width="100" height="100" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:399_answer" disabled="disabled" value="0" id="q20803:399_answer0"><label for="q20803:399_answer0">a. initiate catheter-directed thrombolysis</label> </div>
<div class="r1"><input type="radio" name="q20803:399_answer" disabled="disabled" value="1" id="q20803:399_answer1"><label for="q20803:399_answer1">b. insert an inferior vena caval (IVC) filter and discontinue anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:399_answer" disabled="disabled" value="2" id="q20803:399_answer2"><label for="q20803:399_answer2">c. increase the dose of warfarin</label> </div>
<div class="r1"><input type="radio" name="q20803:399_answer" disabled="disabled" value="3" id="q20803:399_answer3"><label for="q20803:399_answer3">d. insert an inferior vena cava (IVC) filter and continue anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:399_answer" disabled="disabled" value="4" id="q20803:399_answer4"><label for="q20803:399_answer4">e. initiate systemic thrombolysis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:399_-submit" name="q20803:399_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Despite therapeutic anticoagulation, the patient had acute bilateral pulmonary emboli, as shown on the CT scan. This is considered a failure of anticoagulation and warrants placement of an IVC filter to provide prophylaxis against subsequent pulmonary emboli. However, this does not preempt the need for continued anticoagulation to treat the lower extremity DVT, as long as she does not develop any contraindications to anticoagulation. Systemic thrombolysis should be promptly initiated in patients with evidence of hemodynamic compromise such as hypotension, evidence of right heart strain on ECG or echocardiography, or an elevated troponin, provided that they have no contraindications owing to an increased risk of bleeding. While cases of catheter-directed thrombolysis and mechanical thrombectomy have both been described, current recommendations are against their use because of inconclusive evidence of a favorable risk:benefit ratio.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/15784297" target="_blank">Hann CL, Streiff MB. The role of vena caval filters in the management of venous thromboembolism. Blood 2005; 19 (4):179-202.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Curr+Opin+Hematol%3B+2009%3B+16+(5)%3A402-406" target="_blank">Ingber S, Geerts WH. Vena caval filters: Current knowledge, uncertainties and practical approaches. Curr Opin Hematol 2009; 16 (5):402-6.</a></p>
<p>QID: 30716</p></div><div class="rightanswer">The correct answer is: insert an inferior vena cava (IVC) filter and continue anticoagulation</div></div></div></div></div><div id="q547" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">113</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1181"><input type="hidden" name="q20803:547_:flagged" value="0"><input type="hidden" value="qaid=911431&amp;qubaid=20803&amp;qid=5282&amp;slot=547&amp;checksum=5fc7671865f2096805452f01a0d656b3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:547_:flaggedcheckbox" name="q20803:547_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q547&id=5282"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:547_:sequencecheck" value="2"><div class="qtext"><p>Lead is widely used to reduce radiation exposure of healthcare workers. In an apron, what thickness of lead&nbsp;is recommended to provide adequate shielding from radiation?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:547_answer" disabled="disabled" value="0" id="q20803:547_answer0"><label for="q20803:547_answer0">a. 2.0 mm</label> </div>
<div class="r1"><input type="radio" name="q20803:547_answer" disabled="disabled" value="1" id="q20803:547_answer1"><label for="q20803:547_answer1">b. 1.0 mm</label> </div>
<div class="r0"><input type="radio" name="q20803:547_answer" disabled="disabled" value="2" id="q20803:547_answer2"><label for="q20803:547_answer2">c. 0.25 mm</label> </div>
<div class="r1"><input type="radio" name="q20803:547_answer" disabled="disabled" value="3" id="q20803:547_answer3"><label for="q20803:547_answer3">d. 0.5 mm</label> </div>
<div class="r0"><input type="radio" name="q20803:547_answer" disabled="disabled" value="4" id="q20803:547_answer4"><label for="q20803:547_answer4">e. 5 mm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:547_-submit" name="q20803:547_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Regulations mandate that all individuals other than the patient must be protected using a 0.5mm lead equivalent to protect parts of the body struck by the useful beam. Additionally, they state that the x-ray operator and other staff should be protected from the direct scatter radiation by protective aprons or whole body barriers of no less than 0.25 mm lead equivalent. From a practical standpoint, 0.5 mm lead equivalent on the front and 0.25 mm lead equivalent on the back and sides provides acceptable protection from radiation exposure during medical procedures.</p>
<p>&nbsp;</p>
<p>References:</p>
<p><a href="http://www.mass.gov/eohhs/docs/dph/regs/105cmr120-400.pdf" target="_blank">Fluoroscopy dose reporting 105 CMR 120.403 Summary of changes, as of March 2012.</a></p>
<p><span style="line-height: 1.5;">Wagner LK, Archer BR. Minimizing Risk from Fluoroscopic X Rays, Bioeffects, Instrumentation and Examination. &nbsp;Third Edition, 2</span><sup style="line-height: 1.5;">nd</sup><span style="line-height: 1.5;"> printing; 2000.</span>&nbsp;</p>
<p>QID: 30953</p></div><div class="rightanswer">The correct answer is: 0.5 mm</div></div></div></div></div><div id="q436" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">114</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1190"><input type="hidden" name="q20803:436_:flagged" value="0"><input type="hidden" value="qaid=911320&amp;qubaid=20803&amp;qid=4881&amp;slot=436&amp;checksum=56112038bfecb86acbbade8dcfbecf9f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:436_:flaggedcheckbox" name="q20803:436_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q436&id=4881"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:436_:sequencecheck" value="2"><div class="qtext"><p>A 36-year-old woman underwent CT scanning because of intermittent abdominal pain. The study revealed the anatomic finding shown in the image below.</p>
<p><img src="./VESAP3_files/ROOKE-4.jpg" alt="" width="546" height="342"></p>
<p>In addition to abdominal pain, what other abnormality is frequently seen with this condition?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:436_answer" disabled="disabled" value="0" id="q20803:436_answer0"><label for="q20803:436_answer0">a. high-output congestive heart failure</label> </div>
<div class="r1"><input type="radio" name="q20803:436_answer" disabled="disabled" value="1" id="q20803:436_answer1"><label for="q20803:436_answer1">b. intestinal angina</label> </div>
<div class="r0"><input type="radio" name="q20803:436_answer" disabled="disabled" value="2" id="q20803:436_answer2"><label for="q20803:436_answer2">c. vena cava compression</label> </div>
<div class="r1"><input type="radio" name="q20803:436_answer" disabled="disabled" value="3" id="q20803:436_answer3"><label for="q20803:436_answer3">d. microhematuria</label> </div>
<div class="r0"><input type="radio" name="q20803:436_answer" disabled="disabled" value="4" id="q20803:436_answer4"><label for="q20803:436_answer4">e. mild jaundice</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:436_-submit" name="q20803:436_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The abnormality shown here is compression of the left renal vein as it passes between the superior mesenteric artery and the aorta.&nbsp; This is known as the “Nutcracker Syndrome” (NCS).&nbsp;&nbsp; Clinical features of this syndrome include abdominal pain, pelvic congestion, gross or microscopic hematuria, proteinuria, orthostatic intolerance, and others.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mayo+Clin+Proc.+2010%3B+85%3A552%E2%80%939." target="_blank">Kurklinsky AK, Rooke TW. Nutcracker phenomenon and nutcracker syndrome. Mayo Clin Proc. 2010; 85:552–9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=S+D+J+Med+1997%3B+50(12)%3A429-36." target="_blank">Hanna HE, Santella RN, Zawada ET Jr, Masterson TE. Nutcracker syndrome: an underdiagnosed cause for hematuria?&nbsp; S D J Med 1997; 50(12):429-36.</a></p>
<p>QID: 30762</p></div><div class="rightanswer">The correct answer is: microhematuria</div></div></div></div></div><div id="q15" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">115</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1199"><input type="hidden" name="q20803:15_:flagged" value="0"><input type="hidden" value="qaid=910899&amp;qubaid=20803&amp;qid=4624&amp;slot=15&amp;checksum=03b72f8170a34cdbb19928a504806546&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:15_:flaggedcheckbox" name="q20803:15_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q15&id=4624"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:15_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is the&nbsp;most common complication during endovascular repair of aortic aneurysms?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:15_answer" disabled="disabled" value="0" id="q20803:15_answer0"><label for="q20803:15_answer0">a. renal failure</label> </div>
<div class="r1"><input type="radio" name="q20803:15_answer" disabled="disabled" value="1" id="q20803:15_answer1"><label for="q20803:15_answer1">b. stroke</label> </div>
<div class="r0"><input type="radio" name="q20803:15_answer" disabled="disabled" value="2" id="q20803:15_answer2"><label for="q20803:15_answer2">c. paraplegia</label> </div>
<div class="r1"><input type="radio" name="q20803:15_answer" disabled="disabled" value="3" id="q20803:15_answer3"><label for="q20803:15_answer3">d. atheroemboli</label> </div>
<div class="r0"><input type="radio" name="q20803:15_answer" disabled="disabled" value="4" id="q20803:15_answer4"><label for="q20803:15_answer4">e. access artery injury</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:15_-submit" name="q20803:15_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>While all of the above complications can occur during any endovascular aneurysm repair, the most common complication is related to access and safe passage of the endograft delivery system. In the pivotal US clinical trials of aortic endografts, vascular access complications dominated the list of major adverse events. Nearly all of these complications could have been prevented by proper preoperative assessment and planning. A variety of techniques have been described to manage compromised access due to either small size and/or occlusive disease; the list of&nbsp;techniques includes&nbsp;direct common iliac access, iliac conduit, and "crack-and-pave" (iliac endografting with intentional rupture).<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Moore%20WS,%20Matsumura%20JS,%20Makaroun%20MS,%20et%20al.%20EVT/Guidant%20Investigators.%20Five-year%20interim%20comparison%20of%20the%20Guidant%20bifurcated%20endograft%20with%20open%20repair%20of%20abdominal%20aortic%20aneurysm.%20J%20Vasc%20Surg;%202003;%2038%20(1):46-55" target="_blank">Moore WS, Matsumura JS, Makaroun MS, Katzen BT, Deaton DH, Decker M, et al. EVT/Guidant Investigators. Five-year interim comparison of the Guidant bifurcated endograft with open repair of abdominal aortic aneurysm. J Vasc Surg 2003; 38 (1):46-55</a>.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Vallabhaneni%20SR,%20Harris%20PL.%20Lessons%20learnt%20from%20the%20EUROSTAR%20registry%20on%20endovascular%20repair%20of%20abdominal%20aortic%20aneurysm%20repair.%20Eur%20J%20Radiol;%202001;%2039%20(1):34-41" target="_blank">Vallabhaneni SR, Harris PL. Lessons learnt from the EUROSTAR registry on endovascular repair of abdominal aortic aneurysm repair. Eur J Radiol 2001; 39 (1):34-41</a>.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Zarins%20CK,%20White%20RA,%20Schwarten%20D,%20et%20al.%20AneuRx%20stent%20graft%20versus%20open%20surgical%20repair%20of%20abdominal%20aortic%20aneurysms:%20Multicenter%20prospective%20clinical%20trial.%20J%20Vasc%20Surg;%201999;%2029%20(2):292-305" target="_blank">Zarins CK, White RA, Schwarten D, Kinney E, Diethrich EB, Hodgson KJ, et al. AneuRx stent graft versus open surgical repair of abdominal aortic aneurysms: Multicenter prospective clinical trial. J Vasc Surg 1999; 29 (2):292-305</a>.</p>
<p>QID: 30016</p></div><div class="rightanswer">The correct answer is: access artery injury</div></div></div></div></div><div id="q33" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">116</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1208"><input type="hidden" name="q20803:33_:flagged" value="0"><input type="hidden" value="qaid=910917&amp;qubaid=20803&amp;qid=4642&amp;slot=33&amp;checksum=d67519599941401b3ff7a6c3624d0c77&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:33_:flaggedcheckbox" name="q20803:33_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q33&id=4642"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:33_:sequencecheck" value="2"><div class="qtext"><p>Which of the following anatomic configurations of a bypass graft&nbsp;has the highest flow rate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:33_answer" disabled="disabled" value="0" id="q20803:33_answer0"><label for="q20803:33_answer0">a. axillo-bifemoral bypass graft</label> </div>
<div class="r1"><input type="radio" name="q20803:33_answer" disabled="disabled" value="1" id="q20803:33_answer1"><label for="q20803:33_answer1">b. femoropoliteal bypass graft</label> </div>
<div class="r0"><input type="radio" name="q20803:33_answer" disabled="disabled" value="2" id="q20803:33_answer2"><label for="q20803:33_answer2">c. femorofemoral bypass graft</label> </div>
<div class="r1"><input type="radio" name="q20803:33_answer" disabled="disabled" value="3" id="q20803:33_answer3"><label for="q20803:33_answer3">d. axillo-unifemoral bypass graft</label> </div>
<div class="r0"><input type="radio" name="q20803:33_answer" disabled="disabled" value="4" id="q20803:33_answer4"><label for="q20803:33_answer4">e. axillo-popliteal bypass graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:33_-submit" name="q20803:33_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>For the past 20 years there has been extensive debate on the optimal configuration of axillofemoral bypass grafts.&nbsp; Axillo-bifemoral configurations have flow rates that are 600-900mL/min (which is comparable to arteriovenous grafts), while Axillo-unifemoral grafts have flow rates that are 250-400mL/min. Therefore, most surgeons attempt to perform bifemoral configurations when able. Patency reports for bifemoral grafts versus unifemoral grafts have varied widely (35% at 3 years to 75% at 5 years).&nbsp; The variances in patency reports can be explained by configuration differences, caliber of conduits utilized, clinical presentation (claudication versus critical limb ischemia), and runoff scores.&nbsp; Axillo-popliteal, femoropopliteal, and femorofemoral bypass grafts have flow rates of 200-350cc/sec.</p>
<h2><span style="color: #000000;"><span style="color: #000000;"><span style="color: #000000;">References:</span></span></span></h2>
<p><span style="color: #000000;"><span style="color: #000000;"><span style="color: #000000;"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Massry+S%2C+Saad+E%2C+Sauvage+LR%2C+Zammit+M%2C+Davis+CC%2C+Smith+JC%2C+Rittenhouse+EA%2C+Fisher+LD.+Axillofemoral+bypass+with+externally+supported%2C+knitted+Dacron+grafts%3A+a+follow-up+through+twelve+years.+J+Vasc+Surg.+1993+Jan%3B17(1)%3A107-14%3B+discussion+114-5." target="_blank">El-Massry S, Saad E, Sauvage LR, Zammit M, Davis CC, Smith JC, Rittenhouse EA, Fisher LD. Axillofemoral bypass with externally supported, knitted Dacron grafts: a follow-up through twelve years. J Vasc Surg 1993; 17(1):107-14; discussion 114-5</a>.</span></span></span></p>
<p><span style="color: #000000;"><span style="color: #000000;"><span style="color: #000000;"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Donaldson+MC%2C+Louras+JC%2C+Bucknam+CA.+Axillofemoral+bypass%3A+a+tool+with+a+limited+role.+J+Vasc+Surg.+1986+May%3B3(5)%3A757-63." target="_blank">Donaldson MC, Louras JC, Bucknam CA. Axillofemoral bypass: a tool with a limited role. J Vasc Surge 1986; 3(5):757-63</a>.</span></span></span></p>
<p><span style="color: #000000;"><span style="color: #000000;"><span style="color: #000000;">QID: 30036</span></span></span></p></div><div class="rightanswer">The correct answer is: axillo-bifemoral bypass graft</div></div></div></div></div><div id="q11" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">117</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1217"><input type="hidden" name="q20803:11_:flagged" value="0"><input type="hidden" value="qaid=910895&amp;qubaid=20803&amp;qid=4621&amp;slot=11&amp;checksum=e0eeea9bac5b61f618019c423103ea57&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:11_:flaggedcheckbox" name="q20803:11_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q11&id=4621"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:11_:sequencecheck" value="2"><div class="qtext"><p>A 50-year-old man presents with swallowing difficulty. Esophagogastroduodenoscopy (EGD) reveals a pulsatile mass impinging on the posterior wall of&nbsp;his upper esophagus. The CT scan of&nbsp;his chest reveals an arterial variant&nbsp;that is most likely to be:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:11_answer" disabled="disabled" value="0" id="q20803:11_answer0"><label for="q20803:11_answer0">a. an aberrant innominate artery</label> </div>
<div class="r1"><input type="radio" name="q20803:11_answer" disabled="disabled" value="1" id="q20803:11_answer1"><label for="q20803:11_answer1">b. the left vertebral artery arising directly from the aortic arch</label> </div>
<div class="r0"><input type="radio" name="q20803:11_answer" disabled="disabled" value="2" id="q20803:11_answer2"><label for="q20803:11_answer2">c. bovine anatomy of the left common carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:11_answer" disabled="disabled" value="3" id="q20803:11_answer3"><label for="q20803:11_answer3">d. an aberrant right subclavian artery</label> </div>
<div class="r0"><input type="radio" name="q20803:11_answer" disabled="disabled" value="4" id="q20803:11_answer4"><label for="q20803:11_answer4">e. a right-sided aortic arch</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:11_-submit" name="q20803:11_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Dysphagia lusoria is caused by an aberrant right subclavian artery which arises from the aortic arch as the last of the great vessels, lateral to the left subclavian artery, and courses posterior to the esophagus to reach the right upper extremity. The artery causes dysphagia by pressing on the esophagus, which is sandwiched between the aberrant right subclavian artery and the trachea. It is associated with aneurysmal degeneration; this&nbsp;compounds the esophageal compression. Its origin from the distal transverse arch may be from a diverticular outpouching known as a Kommerel's diverticulum, as shown in the image below. None of the other arterial anomalies&nbsp;included here would lead to dysphagia symptoms.<br><br><a href="./VESAP3_files/AssetProxy_122.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_122.jpg" alt="img" width="100" height="100" border="0" hspace="10" vspace="10"></a><br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Abraham%20V%2C%20Mathew%20A%2C%20Cherian%20V%2C%20et%20al.%20Aberrant%20subclavian%20artery%3A%20anatomical%20curiosity%20or%20clinical%20entity.%20Int%20J%20Surg%3B%202009%3B%207%20%282%29%3A106-109" target="_blank">Abraham V, Mathew A, Cherian V, Chandran S, Mathew G. Aberrant subclavian artery: anatomical curiosity or clinical entity. Int J Surg 2009; 7 (2):106-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Kelly%20MD.%20Endoscopy%20and%20the%20aberrant%20right%20subclavian%20artery.%20Am%20Surg%3B%202007%3B%2073%20%2812%29%3A1259-1261" target="_blank">Kelly MD. Endoscopy and the aberrant right subclavian artery. Am Surg 2007; 73 (12):1259-61.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Shennib%20H%2C%20Diethrich%20EB.%20Novel%20approaches%20for%20the%20treatment%20of%20the%20aberrant%20right%20subclavian%20artery%20and%20its%20aneurysms.%20J%20Vasc%20Surg%3B%202008%3B%2047%20%285%29%3A1066-1070" target="_blank">Shennib H, Diethrich EB. Novel approaches for the treatment of the aberrant right subclavian artery and its aneurysms. J Vasc Surg 2008; 47 (5):1066-70.</a></p>
<p>QID: 30012</p></div><div class="rightanswer">The correct answer is: an aberrant right subclavian artery</div></div></div></div></div><div id="q317" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">118</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1226"><input type="hidden" name="q20803:317_:flagged" value="0"><input type="hidden" value="qaid=911201&amp;qubaid=20803&amp;qid=4848&amp;slot=317&amp;checksum=3423151f7704d3e8195e0924f4b59b82&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:317_:flaggedcheckbox" name="q20803:317_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q317&id=4848"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:317_:sequencecheck" value="2"><div class="qtext"><p>Risk factors associated with development of an arterial access-site pseudoaneurysm include all of the following except</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:317_answer" disabled="disabled" value="0" id="q20803:317_answer0"><label for="q20803:317_answer0">a. Calcified vessel</label> </div>
<div class="r1"><input type="radio" name="q20803:317_answer" disabled="disabled" value="1" id="q20803:317_answer1"><label for="q20803:317_answer1">b. Large sheath size</label> </div>
<div class="r0"><input type="radio" name="q20803:317_answer" disabled="disabled" value="2" id="q20803:317_answer2"><label for="q20803:317_answer2">c. Interventional rather than diagnostic procedure</label> </div>
<div class="r1"><input type="radio" name="q20803:317_answer" disabled="disabled" value="3" id="q20803:317_answer3"><label for="q20803:317_answer3">d. Obesity</label> </div>
<div class="r0"><input type="radio" name="q20803:317_answer" disabled="disabled" value="4" id="q20803:317_answer4"><label for="q20803:317_answer4">e. Use of ultrasound to aid in access of the vessel</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:317_-submit" name="q20803:317_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Development of a pseudoaneurysm after arterial puncture can occur for various reasons. Risk factors associated with this complication occurring include obesity, female gender, calcified vessel, interventional rather than a diagnostic procedure, anticoagulation use, larger sheath size. Recent data supports the role of ultrasound guidance for vessel access versus manual palpation and anatomic landmarks in reducing access-site complications.</p>
<p><span style="text-decoration: underline;"><strong>References</strong></span></p>
<p>Seto AH, Abu-Fadel MS, Sparling JM, Real-time ultrasound guidance facilitates femoral arterial access and reduces vascular complications: FAUST (Femoral Arterial Access With Ultrasound Trial). JACC Cardiovasc Interv. 2010 Jul;3(7):751-8</p>
<p>Mansour MA, Gorsuch JM. Diagnosis and Management of Pseudoaneurysms. Perspect Vasc Surg Endovasc Therapy; 2007; 19 (1):58-64</p>
<p>Ahmad F, Turner SA, Torrie P, Gibson M. Iatrogenic femoral artery pseudoaneurysm- A review of current methods of diagnosis and treatment. Clinical Radiology; 2008; 63, 1310-1316</p>
<p>QID: 30551</p></div><div class="rightanswer">The correct answer is: Use of ultrasound to aid in access of the vessel</div></div></div></div></div><div id="q434" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">119</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1235"><input type="hidden" name="q20803:434_:flagged" value="0"><input type="hidden" value="qaid=911318&amp;qubaid=20803&amp;qid=4879&amp;slot=434&amp;checksum=9631b9464660255432024236091ebc91&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:434_:flaggedcheckbox" name="q20803:434_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q434&id=4879"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:434_:sequencecheck" value="2"><div class="qtext"><p>A 57-year-old man had ligation and stripping of his left great saphenous vein at the age of 42. Upon examination, there are extensive varicose veins in the thigh and leg (image shown below), as well as clusters of varices in the groin area under a well-healed oblique scar. He has leg heaviness and pain in the thigh and leg. What does the color flow duplex ultrasound exam (image 2) of the femoral region &nbsp;demonstrate?</p>
<p>1.</p>
<p><img src="./VESAP3_files/Figure 5a.jpg" alt="Figure 5a" width="386" height="507"></p>
<p>2.</p>
<p><img src="./VESAP3_files/Figure 5b.jpg" alt="Figure 2" width="510" height="334"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:434_answer" disabled="disabled" value="0" id="q20803:434_answer0"><label for="q20803:434_answer0">a. absence of the saphenofemoral junction</label> </div>
<div class="r1"><input type="radio" name="q20803:434_answer" disabled="disabled" value="1" id="q20803:434_answer1"><label for="q20803:434_answer1">b. minimal reflux in the anterior thigh accessory saphenous vein on ultrasound</label> </div>
<div class="r0"><input type="radio" name="q20803:434_answer" disabled="disabled" value="2" id="q20803:434_answer2"><label for="q20803:434_answer2">c. neovascularization at the saphenofemoral junction</label> </div>
<div class="r1"><input type="radio" name="q20803:434_answer" disabled="disabled" value="3" id="q20803:434_answer3"><label for="q20803:434_answer3">d. normal venous anatomy in the groin region</label> </div>
<div class="r0"><input type="radio" name="q20803:434_answer" disabled="disabled" value="4" id="q20803:434_answer4"><label for="q20803:434_answer4">e. duplicate femoral vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:434_-submit" name="q20803:434_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has recurrent symptomatic varicose veins. There are extensive varicose veins in the thigh and leg, and, given the location of the thigh varices, the anterior thigh accessory saphenous vein is in direct communication, likely with significant reflux. The description of clusters of varices in the groin area under the healed scar is suggestive of neovascularization at the previously ligated saphenofemoral stump; hence, it is extremely unlikely that there will be normal venous anatomy. The neovascular channels can render the anterior thigh accessory saphenous vein incompetent, with resultant varicosities seen along the thigh and continuing to the leg. Neovascularization is known to occur at the saphenofemoral junction after open surgical crossectomy with great saphenous vein stripping. The classic ultrasound finding is that of tortuous veins (small or large) with a mosaic pattern on color flow duplex ultrasound, and in communication with the femoral vein in the groin (Image 2). van Rij reported the incidence of neovascularization at the saphenofemoral junction in patients previously undergoing ligation and stripping to be 23% at 3 years. The neovascular channels forming at the stump of the saphenofemoral junctions can be a single, large (38%) channel or multiple, small (62%) channels. At the time of surgery, placement of non-biologic barriers has reduced the risk of neovascular channels at the saphenofemoral junction, following ligation and stripping in a randomized controlled trial. Re-operation usually requires redo surgery, foam sclerotherapy, endovenous ablation, or a combination of these techniques. Although duplicate femoral veins do occur, this is not the cause of the patient’s large recurrent varicose vein extending in the thigh and leg. Although the saphenofemoral junction was removed 15 years prior, neovascularization has led to the development of primitive neovascular channels connecting to the femoral vein. These channels have endothelium, but are primitive channels with incomplete layers of the venous wall, lacking both clearly defined intimal and adventitial layers and medial and adventitial elastic tissue.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B38%3A935-43" target="_blank">van Rij AM, Jiang P, Solomon C, Christie R, Hill GB. Recurrence after varicose vein surgery: A prospective long-term clinical study with duplex ultrasound scanning and air plethysmography. J Vasc Surg 2003;38:935-43.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2004%3B40%3A296-302" target="_blank">van Rij AM, Jones GT, Hill GB, Jiang P. Neovascularization and recurrent varicose veins: more histologic and ultrasound evidence. J Vasc Surg 2004;40:296-302.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2008%3B+118%3A66-74." target="_blank">van Rij AM, Jones GT, Hill BG, Amer M, Thomson IA, Pettigrew RA, et al. Mechanical inhibition of angiogenesis at the saphenofemoral junction in the surgical treatment of varicose veins: early results of a blinded randomized controlled trial. Circulation 2008; 118:66-74.</a></p>
<p>QID: 30760</p></div><div class="rightanswer">The correct answer is: neovascularization at the saphenofemoral junction</div></div></div></div></div><div id="q59" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">120</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1244"><input type="hidden" name="q20803:59_:flagged" value="0"><input type="hidden" value="qaid=910943&amp;qubaid=20803&amp;qid=4317&amp;slot=59&amp;checksum=fe2af0f98aa85a46df5c4c93c55e36aa&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:59_:flaggedcheckbox" name="q20803:59_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q59&id=4317"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:59_:sequencecheck" value="2"><div class="qtext"><p>On postoperative day one after EVAR, a patient complains of new onset right foot rest pain.&nbsp; On physical exam, the right femoral pulse is absent.&nbsp; An angiogram is performed.&nbsp; Which of the following statements regarding management of this complication is NOT correct?</p>
<p><a href="./VESAP3_files/EVAR limb occlusion.jpg" target="images"><img src="./VESAP3_files/EVAR limb occlusion.jpg" alt="EVAR limb occlusion" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:59_answer" disabled="disabled" value="0" id="q20803:59_answer0"><label for="q20803:59_answer0">a. This complication is more common when the endograft is extended into the external iliac arteries, the aortic bifurcation is narrow, or if the iliacs are tortuous.</label> </div>
<div class="r1"><input type="radio" name="q20803:59_answer" disabled="disabled" value="1" id="q20803:59_answer1"><label for="q20803:59_answer1">b. Limb occlusion is the most common ischemic complication following EVAR.</label> </div>
<div class="r0"><input type="radio" name="q20803:59_answer" disabled="disabled" value="2" id="q20803:59_answer2"><label for="q20803:59_answer2">c. Thrombolysis may be successful in spite of the large clot burden, but any underlying mechanical issues should be corrected with additional stents as necessary.</label> </div>
<div class="r1"><input type="radio" name="q20803:59_answer" disabled="disabled" value="3" id="q20803:59_answer3"><label for="q20803:59_answer3">d. Open thrombectomy is contraindicated because of the possibility of dislodging the endograft.</label> </div>
<div class="r0"><input type="radio" name="q20803:59_answer" disabled="disabled" value="4" id="q20803:59_answer4"><label for="q20803:59_answer4">e. The patient is at higher risk for recurrence of this problem in long-term follow-up.</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:59_-submit" name="q20803:59_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span style="font-family: Times New Roman;"><span style="font-size: medium;">Acute limb ischemia is the most common ischemic complication following EVAR.</span><sup><span style="font-size: small;">1</span></sup><span style="font-size: medium;">&nbsp; Endograft limb occlusion is the most common cause of acute limb ischemia acutely, although dissection and access site thrombosis also occur.&nbsp; Endograft migration and displacement may lead to limb occlusion in long term follow-up.&nbsp; Factors contributing to limb occlusion include type of endograft implanted, extension into the external iliac arteries, narrow aortic bifurcation, and tortuous iliacs arteries.</span><sup><span style="font-size: small;">2,3</span></sup><span style="font-size: medium;">&nbsp; Removal of the stiff wires during completion angiography may identify a limb at risk because of a kink or poor distal landing within a curve of the vessel.&nbsp; Limb occlusions may be treated with either endovascular approaches including thrombolysis, mechanical thrombectomy, large sheath aspiration followed by treatment of the underlying cause, generally limb extension or stenting, hybrid approaches through a femoral cutdown, or with extra-anatomic bypass.&nbsp; Open thrombectomy can be successful, although fluoroscopic guidance should be used to prevent endograft displacement during balloon passage.&nbsp; Disadvantages to extra-anatomic bypass include poorer patency rate and the risk of bilateral limb ischemia if the donor limb should occlude.</span><span style="font-size: small;"><sup>4</sup></span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Maldonado, T.S.<em>, et al.</em> Ischemic complications after endovascular abdominal aortic aneurysm repair. <em>J Vasc Surg</em> <strong>40</strong>, 703-709; discussion 709-710 (2004).</span></span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Carroccio, A.<em>, et al.</em> Predicting iliac limb occlusions after bifurcated aortic stent grafting: anatomic and device-related causes. <em>J Vasc Surg</em> <strong>36</strong>, 679-684 (2002).</span></span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Conway, A.M.<em>, et al.</em> Stent-graft limb deployment in the external iliac artery increases the risk of limb occlusion following endovascular AAA repair. <em>J Endovasc Ther</em> <strong>19</strong>, 79-85 (2012).</span></span></span></p>
<p><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Calibri;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Erzurum, V.Z.<em>, et al.</em> Initial management and outcome of aortic endograft limb occlusion. <em>J Vasc Surg</em> <strong>40</strong>, 419-423 (2004).</span></span></span></p>
<p><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Calibri;">QID: 30066</span></span></span></p></div><div class="rightanswer">The correct answer is: Open thrombectomy is contraindicated because of the possibility of dislodging the endograft.</div></div></div></div></div><div id="q265" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">121</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1253"><input type="hidden" name="q20803:265_:flagged" value="0"><input type="hidden" value="qaid=911149&amp;qubaid=20803&amp;qid=5002&amp;slot=265&amp;checksum=8e5fbac2a2d3956ccebe490b8b5de49c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:265_:flaggedcheckbox" name="q20803:265_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q265&id=5002"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:265_:sequencecheck" value="2"><div class="qtext"><p>&nbsp;A call is received from a dialysis center regarding a 56-year-old woman with an autogenous brachial-basilic upper arm transposed AV access in the right arm. The access was constructed 2 years ago and was working well at her last dialysis earlier in the week. However, there is no longer a thrill or pulse in the graft. By report, the patient has no edema, no erythema, no masses, and palpable radial, ulnar, and brachial arteries. Regarding this condition, which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:265_answer" disabled="disabled" value="0" id="q20803:265_answer0"><label for="q20803:265_answer0">a. tobacco use is a predictor of late fistula failure</label> </div>
<div class="r1"><input type="radio" name="q20803:265_answer" disabled="disabled" value="1" id="q20803:265_answer1"><label for="q20803:265_answer1">b. a high mean diastolic BP correlates with late fistula failure</label> </div>
<div class="r0"><input type="radio" name="q20803:265_answer" disabled="disabled" value="2" id="q20803:265_answer2"><label for="q20803:265_answer2">c. arterial inflow disease is a rare cause of AV access failure</label> </div>
<div class="r1"><input type="radio" name="q20803:265_answer" disabled="disabled" value="3" id="q20803:265_answer3"><label for="q20803:265_answer3">d. diabetics have a higher incidence of fistula failure due to intimal hyperplasia</label> </div>
<div class="r0"><input type="radio" name="q20803:265_answer" disabled="disabled" value="4" id="q20803:265_answer4"><label for="q20803:265_answer4">e. fistula failure is not associated with pseudoaneurysm formation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:265_-submit" name="q20803:265_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Late thrombosis and failure of arteriovenous fistulas for dialysis access is often associated with intimal hyperplasia in the fistula at the site of cannulation. However, it can also be associated with pseudoaneurysm formation and recent renal transplant. Many studies have reported a higher incidence of early and late fistula failure in smokers. Chronic hypotension, a low mean diastolic pressure, has been correlated with poor AV fistula survival in prospective series. Fistula thrombosis has also been associated with arterial inflow disease in 40% of cases. All other factors being equal, diabetes has not been shown to effect long-term performance of AV fistulas.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2012%3B55%3A849-55." target="_blank">Smith GE, Gohil R, Chetter IC. Factors affecting the patency of arteriovenous fistulas for dialysis access. J Vasc Surg 2012;55:849-55.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/15840048" target="_blank">Asif A, Gadalean FN, Merrill D, Cherla G, Cipleu CD, Epstein DL, et al. Inflow stenosis in arteriovenous fistulas and grafts; a multicenter, prospective study. Kidney Int 2005;67:1986-92.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11532689" target="_blank">Sedlacek M, Teodorescu V, Falk A, Vassalotti JA, Uribarri J. Hemodialysis access placement with preoperative noninvasive vascular mapping: comparison between patients with and without diabetes. Am J Kidney Dis 2001;38:560-4.</a></p>
<p>QID: 30449</p></div><div class="rightanswer">The correct answer is: tobacco use is a predictor of late fistula failure</div></div></div></div></div><div id="q84" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">122</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1262"><input type="hidden" name="q20803:84_:flagged" value="0"><input type="hidden" value="qaid=910968&amp;qubaid=20803&amp;qid=4898&amp;slot=84&amp;checksum=2f1b18c0bc6bb821bbc7ad0ba4d68caa&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:84_:flaggedcheckbox" name="q20803:84_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q84&id=4898"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:84_:sequencecheck" value="2"><div class="qtext"><p>Atherosclerotic plaque morphology may be characterized by all of the following <strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:84_answer" disabled="disabled" value="0" id="q20803:84_answer0"><label for="q20803:84_answer0">a. a necrotic core consisting of lipids and cholesterol crystals and macrophage accumulation</label> </div>
<div class="r1"><input type="radio" name="q20803:84_answer" disabled="disabled" value="1" id="q20803:84_answer1"><label for="q20803:84_answer1">b. intraluminal thrombus</label> </div>
<div class="r0"><input type="radio" name="q20803:84_answer" disabled="disabled" value="2" id="q20803:84_answer2"><label for="q20803:84_answer2">c. a thinned media deep to the necrotic core</label> </div>
<div class="r1"><input type="radio" name="q20803:84_answer" disabled="disabled" value="3" id="q20803:84_answer3"><label for="q20803:84_answer3">d. a fibrous cap of subendothelial stratified smooth muscle cells and fibrous tissue</label> </div>
<div class="r0"><input type="radio" name="q20803:84_answer" disabled="disabled" value="4" id="q20803:84_answer4"><label for="q20803:84_answer4">e. calcifications in advanced lesions</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:84_-submit" name="q20803:84_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The option that does not relate to plaque morphology is intraluminal thrombus.&nbsp; Atherosclerotic plaques consist of fibrous caps, necrotic cores, thin medial layers deep to the necrotic core, and, in advanced lesions, plaque calcification.&nbsp; While intraluminal thrombus may eventually be seen, it is usually only present after rupture of the fibrous cap and extrusion of thrombogenic contents into the lumen of the affected vessel.&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Heart+Lung+Circ+2013%3B+22%3A399-411." target="_blank">Sakakura K, Nakano M, Otsuka F, Ladich E, Kolodgre FD, Virmani R. Pathophysiology of&nbsp; atherosclerosis plaque progression. Heart Lung Circ 2013; 22:399-411.</a></p>
<p>QID: 30128</p></div><div class="rightanswer">The correct answer is: intraluminal thrombus</div></div></div></div></div><div id="q171" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">123</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1271"><input type="hidden" name="q20803:171_:flagged" value="0"><input type="hidden" value="qaid=911055&amp;qubaid=20803&amp;qid=4673&amp;slot=171&amp;checksum=1ecfae785bbd44f1e5066477ba79d40a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:171_:flaggedcheckbox" name="q20803:171_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q171&id=4673"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:171_:sequencecheck" value="2"><div class="qtext"><p>A 77-year-old woman is referred to your office with complaints of fever, malaise, and left arm claudication in the setting of a diminished left brachial pulse. The CT angiogram is shown below. The lab results show an elevated Erythrocyte Sedimentation Rate. Which of the following is the probable diagnosis <strong>and</strong>&nbsp;the optimal initial therapy for this patient?&nbsp;</p>
<p>&nbsp;</p>
<p><img alt="" src="./VESAP3_files/GCA.jpg" width="452" height="331"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:171_answer" disabled="disabled" value="0" id="q20803:171_answer0"><label for="q20803:171_answer0">a. Takayasu’s arteritis; PTA alone</label> </div>
<div class="r1"><input type="radio" name="q20803:171_answer" disabled="disabled" value="1" id="q20803:171_answer1"><label for="q20803:171_answer1">b. Giant cell arteritis; steroid therapy</label> </div>
<div class="r0"><input type="radio" name="q20803:171_answer" disabled="disabled" value="2" id="q20803:171_answer2"><label for="q20803:171_answer2">c. Giant cell arteritis; reconstruction with vein interposition graft</label> </div>
<div class="r1"><input type="radio" name="q20803:171_answer" disabled="disabled" value="3" id="q20803:171_answer3"><label for="q20803:171_answer3">d. Atherosclerosis; reconstruction with vein interposition graft</label> </div>
<div class="r0"><input type="radio" name="q20803:171_answer" disabled="disabled" value="4" id="q20803:171_answer4"><label for="q20803:171_answer4">e. Takayasu’s arteritis; steroid therapy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:171_-submit" name="q20803:171_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Takayasu's (TA) and Giant Cell Arteritis (GCA) both involve large vessels, however, they differ in respect to both patient population and anatomic distribution. TA occurs in younger patients with a female predominance. In contrast, GCA patients tend to be older, with an equal distribution between males and females. In respect to anatomic distribution, TA generally affects the aorta and primary branches, whereas GCA can affect more distal arterial segments; the axillary artery is a common location. Intervention (surgical or endovascular) is not recommended during the active, inflammatory phase of the disease, which is marked by systemic inflammatory symptoms of fever, myalgias, skin rash, and malaise, with laboratory findings of elevation in the ESR. Primary treatment with immunosuppression (traditionally with corticosteroids) will limit or prevent subsequent occlusive disease. During the quiescent or occlusive phase of the disease, symptomatic arterial occlusions are traditionally treated with open surgical reconstruction.</p>
<p>Currently, nearly half of all patients with TA or GCA are responsive to immunosuppressive therapy with glucocorticoids. However, the remaining patients are often resistant and require alternative immunosuppression. In those cases, azathioprine, methotrexate, mycophenolate mofetil, or cyclophosphamide have shown efficacy in controlling relapses of the inflammatory phase. In rare cases, anti-TNF alpha compounds such as infliximab have shown promise in cases refractory to all of the above.</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Hoffman+GS.+Treatment+of+resistant+Takayasu%27s+arteritis.+Rheum+Dis+Clin+North+Am+1995%3B21%3A73-80." target="_blank">Hoffman GS. Treatment of resistant Takayasu's arteritis. Rheum Dis Clin North Am&nbsp;1995;21:73-80.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mevorach+D%2C+Leibowitz+G%2C+Brezis+M%2C+Raz+E.+Induction+of+remission+in+a+patient+with+Takayasu%27s+arteritis+by+low+dose+pulses+of+methotrexate.+Ann+Rheum+Dis+1992%3B51%3A904-5." target="_blank">Mevorach D, Leibowitz G, Brezis M, Raz E. Induction of remission in a patient with&nbsp;Takayasu's arteritis by low dose pulses of methotrexate. Ann Rheum Dis 1992;51:904-5.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Valsakumar+AK%2C+Valappil+UC%2C+Jorapur+V%2C+Garg+N%2C+Nityanand+S%2C+Sinha+N.+Role+of+immunosuppressive+therapy+on+clinical%2C+immunological%2C+and+angiographic+outcome+in+active+Takayasu%27s+arteritis.+J+Rheumatol+2003%3B30%3A1793-8." target="_blank">Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N. Role of immunosuppressive&nbsp;therapy on clinical, immunological, and angiographic outcome in active&nbsp;Takayasu's arteritis. J Rheumatol 2003;30:1793-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Shelhamer+JH%2C+Volkman+DJ%2C+Parrillo+JE%2C+Lawley+TJ%2C+Johnston+MR%2C+Fauci+AS.+Takayasu%27s+arteritis+and+its+therapy.+Ann+Intern+Med+1985%3B103%3A121-6." target="_blank">Shelhamer JH, Volkman DJ, Parrillo JE, Lawley TJ, Johnston MR, Fauci AS. Takayasu's&nbsp;arteritis and its therapy. Ann Intern Med 1985;103:121-6.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Molloy+ES%2C+Langford+CA%2C+Clark+TM%2C+Gota+CE%2C+Hoffman+GS.+Anti-tumour+necrosis+factor+therapy+in+patients+with+refractory+Takayasu+arteritis%3A+long-term+follow-up.+Ann+Rheum+Dis+2008%3B67%3A1567-9." target="_blank">Molloy ES, Langford CA, Clark TM, Gota CE, Hoffman GS. Anti-tumour necrosis factor&nbsp;therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann&nbsp;Rheum Dis 2008;67:1567-9.</a></p>
<p>QID: 30311</p></div><div class="rightanswer">The correct answer is: Giant cell arteritis; steroid therapy</div></div></div></div></div><div id="q329" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">124</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1280"><input type="hidden" name="q20803:329_:flagged" value="0"><input type="hidden" value="qaid=911213&amp;qubaid=20803&amp;qid=5093&amp;slot=329&amp;checksum=9d8475900400c4915eddfa56db00cf6e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:329_:flaggedcheckbox" name="q20803:329_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q329&id=5093"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:329_:sequencecheck" value="2"><div class="qtext"><p>A Doppler angle of 60 degrees or less is recommended for measuring blood flow velocities in arterial duplex scanning. Why should Doppler angles greater than 60 degrees be avoided?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:329_answer" disabled="disabled" value="0" id="q20803:329_answer0"><label for="q20803:329_answer0">a. larger angles increase reflection of ultrasound at the vessel wall-blood boundary</label> </div>
<div class="r1"><input type="radio" name="q20803:329_answer" disabled="disabled" value="1" id="q20803:329_answer1"><label for="q20803:329_answer1">b. the Doppler shift frequency increases at larger angles</label> </div>
<div class="r0"><input type="radio" name="q20803:329_answer" disabled="disabled" value="2" id="q20803:329_answer2"><label for="q20803:329_answer2">c. the cosine function changes more rapidly at larger angles</label> </div>
<div class="r1"><input type="radio" name="q20803:329_answer" disabled="disabled" value="3" id="q20803:329_answer3"><label for="q20803:329_answer3">d. the aperture effect is more significant at larger angles</label> </div>
<div class="r0"><input type="radio" name="q20803:329_answer" disabled="disabled" value="4" id="q20803:329_answer4"><label for="q20803:329_answer4">e. larger angles result in lower calculated flow velocities</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:329_-submit" name="q20803:329_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>When Doppler ultrasound is used to measure blood flow velocity, the instrument actually measures the Doppler frequency shift and uses the Doppler equation to calculate a velocity.</p>
<p align="center">V = (Δf C) / (2 f cosθ)</p>
<p>In this version of the Doppler equation, V&nbsp;is the calculated blood flow velocity parallel to the vessel wall, Δf&nbsp;is the Doppler frequency shift, C&nbsp;is the propagation speed of ultrasound, f&nbsp;is the frequency of the transmitted ultrasound, and θ&nbsp;is the angle between the ultrasound beam and the vessel wall. Since the cosine function changes more rapidly at larger angles and approaches zero at 90 degrees, the Doppler frequency shift becomes very small. Thus, the system sensitivity is reduced and errors in the calculated flow velocity increase with Doppler angle. This effect is less significant for angles of 60 degrees or less. Using the Doppler equation, larger angles actually result in higher calculated flow velocities. The “aperture effect” results in decreasing calculated velocities as the angle decreases. This effect is produced because the focused ultrasound beam encounters the flow stream at a range of angles, not just the single set angle. Since these other angles tend to be smaller than the set Doppler angle, they result in lower calculated velocity values. The reflection of ultrasound at the vessel wall-blood boundary tends to increase at smaller Doppler angles.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Kremkau FW. Chapter 5 Doppler Principles. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:125-75.</p>
<p>QID: 30563</p></div><div class="rightanswer">The correct answer is: the cosine function changes more rapidly at larger angles</div></div></div></div></div><div id="q535" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">125</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1289"><input type="hidden" name="q20803:535_:flagged" value="0"><input type="hidden" value="qaid=911419&amp;qubaid=20803&amp;qid=5271&amp;slot=535&amp;checksum=31664f0b07719a35e03bb2f7ef355bf0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:535_:flaggedcheckbox" name="q20803:535_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q535&id=5271"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:535_:sequencecheck" value="2"><div class="qtext"><p>To quantify radiation exposure of patients and operators during endovascular procedures, which of the following measurements combines the best accuracy and ease of attainment?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:535_answer" disabled="disabled" value="0" id="q20803:535_answer0"><label for="q20803:535_answer0">a. absorbed dose</label> </div>
<div class="r1"><input type="radio" name="q20803:535_answer" disabled="disabled" value="1" id="q20803:535_answer1"><label for="q20803:535_answer1">b. peak skin dose</label> </div>
<div class="r0"><input type="radio" name="q20803:535_answer" disabled="disabled" value="2" id="q20803:535_answer2"><label for="q20803:535_answer2">c. fluoroscopy time</label> </div>
<div class="r1"><input type="radio" name="q20803:535_answer" disabled="disabled" value="3" id="q20803:535_answer3"><label for="q20803:535_answer3">d. kerma air product</label> </div>
<div class="r0"><input type="radio" name="q20803:535_answer" disabled="disabled" value="4" id="q20803:535_answer4"><label for="q20803:535_answer4">e. effective dose</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:535_-submit" name="q20803:535_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Using fluoroscopy time alone as a measure of radiation exposure is inaccurate. Methods such as effective dose, peak skin dose, and absorbed dose are very difficult to obtain, but more accurate. Kerma air product (KAP) is easier to determine and utilizes the area exposed to radiation and the air kerma. Dose area product is related to KAP and assess radiation risk in the hospital setting. It is defined as the "absorbed dose&nbsp;multiplied by the area irradiated, expressed in&nbsp;gray&nbsp;square centimetres&nbsp;(Gy*cm²)"&nbsp;(sometimes&nbsp;mGy*cm² or&nbsp;cGy*cm²). DAP may be a better indicator of the overall risk of inducing cancer than the dose within the field. It also has the advantages of being easily measured, with the permanent installation of a DAP meter on the x-ray set. From a practical standpoint KAP=DAP.</p>
<p>&nbsp;</p>
<p><a href="http://en.wikipedia.org/wiki/Dose_area_product" target="_blank">Dose area product (DAP). Wikipedia, the free encyclopedia.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+58%3A702-9." target="_blank">Mohapatra A, Greenberg RK, Mastracci TM, Eagleton MJ, Thornsberry B. Radiation exposure to operating room personnel and patients during endovascular procedures. J Vasc Surg 2013; 58:702-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53%3A22S-7S." target="_blank">Mitchell El, Furey P. Prevention of radiation injury from medical imaging. J Vasc Surg 2011; 53:22S-7S.</a></p>
<p>QID: 30939</p></div><div class="rightanswer">The correct answer is: kerma air product</div></div></div></div></div><div id="q538" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">126</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1298"><input type="hidden" name="q20803:538_:flagged" value="0"><input type="hidden" value="qaid=911422&amp;qubaid=20803&amp;qid=5276&amp;slot=538&amp;checksum=53809958dbc9efaa653b88b597937400&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:538_:flaggedcheckbox" name="q20803:538_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q538&id=5276"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:538_:sequencecheck" value="2"><div class="qtext"><p>An obese man with a thoracoabdominal aortic aneurysm has a fenestrated aortic endograft repair in which the patient radiation dose is 8 Gy reference air kerma (RAK).&nbsp; The patient suffers an &nbsp;acute myocardial infarction and is rushed to the cardiac cath lab after his aortic endograft placement. The patient receives 6 Gy RAK during the placement of 3 drug eluting coronary stents. Three days post operatively, the patient’s urine output drops and his creatinine doubles. He is taken back to the operating room for balloon angioplasty of the occluded renal artery stents; the patient radiation dose was 3 Gy RAK.</p>
<p>Finish this sentence: This patient's radiation exposure is...</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:538_answer" disabled="disabled" value="0" id="q20803:538_answer0"><label for="q20803:538_answer0">a. not a sentinel event because the Joint Commission does not regulate fluoroscopy procedures</label> </div>
<div class="r1"><input type="radio" name="q20803:538_answer" disabled="disabled" value="1" id="q20803:538_answer1"><label for="q20803:538_answer1">b. not a sentinel event by the Joint Commission because no one procedure reached a RAK of 15 Gy</label> </div>
<div class="r0"><input type="radio" name="q20803:538_answer" disabled="disabled" value="2" id="q20803:538_answer2"><label for="q20803:538_answer2">c. a sentinel event by the Joint Commission because the sum of the RAKs for all the cases is &gt;15 Gy</label> </div>
<div class="r1"><input type="radio" name="q20803:538_answer" disabled="disabled" value="3" id="q20803:538_answer3"><label for="q20803:538_answer3">d. a sentinel event by the Joint Commission if the patient’s cumulative skin dose is &gt; 15 Gy &nbsp;to a single skin field over a period of 6 months to 1 year</label> </div>
<div class="r0"><input type="radio" name="q20803:538_answer" disabled="disabled" value="4" id="q20803:538_answer4"><label for="q20803:538_answer4">e. not able to be assessed because RAK cannot be used to approximate skin dose</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:538_-submit" name="q20803:538_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The Joint Commission recommends that doses from previous procedures to the same body area be summed over a 6 to 12 month period. Interventional procedures&nbsp; with a cumulative skin dose &gt;15 Gy to a single skin field over a period of 6 months to 1 year is considered a sentinel event. This definition of sentinel event refers to patient skin dose. However, skin dose cannot be measured &nbsp;in real time during clinical procedures. A sentinel event does not always occur if the RAK for a patient exceeds 15 Gy during the time period because RAK is only an approximation of skin dose and does not account for gantry angulation or table position.&nbsp; Evaluation is made by reconstructing the skin dose from the procedure using the indirect dose measurements and the best available information on fluoroscopic technical factors used during the procedure.&nbsp; Mathematical&nbsp; models have been described to estimate D <sub>skin max</sub> &nbsp;based on this information.&nbsp; Gafchromic film placed under the patient’s back on the fluoroscopy&nbsp; table can also be analyzed further to approximate peak skin dose.&nbsp; Nonetheless, RAK is the best approximation of D <sub>skin max . </sub>Radiation doses of 15 Gy RAK over a 6 to 12 month period need to be further investigated to determine D <sub>skin max</sub>.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vasc+Interv+Radiol+2002%3B+13+(4)%3A+391-7." target="_blank">Fletcher DW, Miller DL, Balter S, Taylor MA. Comparison of four techniques to estimate radiation dose to skin during angiographic and interventional radiology procedures.&nbsp;J Vasc Interv Radiol&nbsp;2002; 13 (4): 391-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Med+Phys+2011%3B+38+(7)%3A+4196-204." target="_blank">Kwon D, Little MP, Miller DL. Reference air kerma and kerma-area product as estimators of peak skin dose for fluoroscopically guided interventions.&nbsp;Med Phys&nbsp;2011; 38 (7):196-204.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Appl+Clin+Med+Phys+2011%3B+12+(4)%3A3670." target="_blank">Jones AK, Pasciak AS. Calculating the peak skin dose resulting from fluoroscopically guided interventions. Part I: Methods.&nbsp;J Appl Clin Med Phys&nbsp;2011; 12 (4):3670.</a></p>
<p>NCRP. Radiation Dose Management for Fluoroscopically Guided Interventional Medical Procedures, Report No. 168 (National Council on Radiation Protection and Measurements, Bethesda, Md, 2010). Report No. 168.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Real-time+quantification+and+display+of+skin+radiation+during+coronary+angiography+and+intervention." target="_blank">den Boer A, de Feijter PJ, Serruys PW, Roelandt JR. Real-time quantification and display of skin radiation during coronary angiography and intervention.&nbsp;Circulation, 2001;104 (15) 1779-84.</a></p>
<p>QID: 30944</p></div><div class="rightanswer">The correct answer is: a sentinel event by the Joint Commission if the patient’s cumulative skin dose is &gt; 15 Gy &nbsp;to a single skin field over a period of 6 months to 1 year</div></div></div></div></div><div id="q262" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">127</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1307"><input type="hidden" name="q20803:262_:flagged" value="0"><input type="hidden" value="qaid=911146&amp;qubaid=20803&amp;qid=4999&amp;slot=262&amp;checksum=7b2e33012d7f9c8226fdc79da9f17f77&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:262_:flaggedcheckbox" name="q20803:262_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q262&id=4999"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:262_:sequencecheck" value="2"><div class="qtext"><p>A 72-year-old man has a functioning right autogenous brachial cephalic upper arm direct arteriovenous access&nbsp;develops.&nbsp;Over the course of several months, he develops progressive&nbsp;pain, coolness, and paresthesias in the right hand while on dialysis. On physical examination of the right upper extremity, he has a thrill and bruit overlying his arteriovenous (AV) access, no edema, a palpable brachial artery pulse, nonpalpable radial and ulnar artery pulses, a slightly cool hand with no wounds, and no sensory or motor deficits. Which of the following statements is <strong>not </strong>true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:262_answer" disabled="disabled" value="0" id="q20803:262_answer0"><label for="q20803:262_answer0">a. Volkmann’s ischemic contracture is possible if left untreated</label> </div>
<div class="r1"><input type="radio" name="q20803:262_answer" disabled="disabled" value="1" id="q20803:262_answer1"><label for="q20803:262_answer1">b. this condition occurs more commonly with upper arm grafts</label> </div>
<div class="r0"><input type="radio" name="q20803:262_answer" disabled="disabled" value="2" id="q20803:262_answer2"><label for="q20803:262_answer2">c. the next diagnostic test should be upper extremity arteriography</label> </div>
<div class="r1"><input type="radio" name="q20803:262_answer" disabled="disabled" value="3" id="q20803:262_answer3"><label for="q20803:262_answer3">d. diabetes is a significant predisposing factor to this condition</label> </div>
<div class="r0"><input type="radio" name="q20803:262_answer" disabled="disabled" value="4" id="q20803:262_answer4"><label for="q20803:262_answer4">e. immediate ligation of the fistula is indicated</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:262_-submit" name="q20803:262_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Arterial steal occurs secondary to low access tract resistance, creating a reversal of blood flow in the arterial outflow tract towards the access and away from the hand. This may be demonstrated in up to 90% of all AV accesses; however, it is clinically symptomatic in less than 10%. Clinical symptoms vary and range from mild ischemia, presenting as coolness and paresthesias which only occur on dialysis, to severe ischemia, presenting as constant rest pain, numbness, paralysis, finger contractures, and gangrene. Patients with clinically symptomatic arterial steal should be evaluated with an arteriogram to identify any proximal arterial stenosis. Treatment of the proximal artery alone with either endovascular or open surgical techniques may resolve symptoms without need for ligation or revision of the AV access.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Knox+RC%2C+Berman+SS%2C+Hughes+JK%2C+et+al.+Distal+revascularization-interval+ligation%3A" target="_blank">Knox RC, Berman SS, Hughes JK, Gentile AT<span>,&nbsp;</span>Mills JL<span>.</span>&nbsp;Distal revascularization-interval ligation: A durable and effective treatment for ischemic steal syndrome after hemodialysis access. J Vasc Surg; 2003; 36 (2):250-6.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B57%3A1073-8." target="_blank">Aimaq R, Katz SG. Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation. J Vasc Surg 2013;57:1073-8.</a></p>
<p>QID: 30446</p></div><div class="rightanswer">The correct answer is: immediate ligation of the fistula is indicated</div></div></div></div></div><div id="q264" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">128</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1316"><input type="hidden" name="q20803:264_:flagged" value="0"><input type="hidden" value="qaid=911148&amp;qubaid=20803&amp;qid=5001&amp;slot=264&amp;checksum=cc1cf9d46906e56978b6e3c735a23fb8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:264_:flaggedcheckbox" name="q20803:264_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q264&id=5001"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:264_:sequencecheck" value="2"><div class="qtext"><p>A call is received from a dialysis center regarding a 56-year-old woman with a left prosthetic brachial-axillary upper arm arteriovenous access placed 18 months ago. The access was working well at her last dialysis earlier in the week, but now there is no longer a thrill or pulse in the graft. By report, the patient has no edema, no erythema, no masses, and palpable radial, ulnar, and brachial pulses. Which of the following is the most probable cause for the change in this patient's AV access status?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:264_answer" disabled="disabled" value="0" id="q20803:264_answer0"><label for="q20803:264_answer0">a. intra-graft stenosis of the prosthetic material</label> </div>
<div class="r1"><input type="radio" name="q20803:264_answer" disabled="disabled" value="1" id="q20803:264_answer1"><label for="q20803:264_answer1">b. graft occlusion due to hyperplasia of the graft-venous anastomosis</label> </div>
<div class="r0"><input type="radio" name="q20803:264_answer" disabled="disabled" value="2" id="q20803:264_answer2"><label for="q20803:264_answer2">c. stenosis of the graft-arterial anastomosis</label> </div>
<div class="r1"><input type="radio" name="q20803:264_answer" disabled="disabled" value="3" id="q20803:264_answer3"><label for="q20803:264_answer3">d. central venous stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:264_answer" disabled="disabled" value="4" id="q20803:264_answer4"><label for="q20803:264_answer4">e. poor arterial inflow due to acceleration of atherosclerosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:264_-submit" name="q20803:264_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Access graft thrombosis is the most common complication of hemodialysis access surgery. Thrombosis 6-24 months after access placement is most commonly due to anastomotic intimal hyperplasia, with 80% being located at the graft-vein interface in prosthetic grafts. Prophylactic angioplasty of stenosing anastomotic lesions has not been shown to prevent graft thrombosis. Central venous stenosis, often related to previous dialysis catheters, can result in late AV access failure. However, this patient, who has no arm edema, an access that functioned well recently, no central lines for over a year, and a normal pulse examination, the most likely cause is intimal hyperplasia at the graft-venous anastomosis.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%20Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank">Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg; 2008; 48 (S):55S-80S.<br><br></a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2008%3B+48+(5S)%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarb A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vas Surg 2008; 48 (5S):2S-25S.</a></p>
<p>QID: 30448</p></div><div class="rightanswer">The correct answer is: graft occlusion due to hyperplasia of the graft-venous anastomosis</div></div></div></div></div><div id="q130" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">129</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1325"><input type="hidden" name="q20803:130_:flagged" value="0"><input type="hidden" value="qaid=911014&amp;qubaid=20803&amp;qid=4747&amp;slot=130&amp;checksum=11571b6ebc43328b49263fd7d75bf587&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:130_:flaggedcheckbox" name="q20803:130_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q130&id=4747"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:130_:sequencecheck" value="2"><div class="qtext"><p>A 22-year-old woman presents with 8 hours of forearm pain and paralysis. She undergoes urgent brachial thrombectomy. An intraoperative arteriogram is obtained and shown below.&nbsp;</p>
<p><img style="width: 368px; height: 202px;" src="./VESAP3_files/Arm ateriogram.jpeg" alt="Arm Arteriogram" width="290" height="147"></p>
<p>The patient requires a forearm fasciotomy due to severe ischemia and swelling after revascularization.&nbsp; With regard to her forearm fasciotomy, which of the following statements is most&nbsp;<strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:130_answer" disabled="disabled" value="0" id="q20803:130_answer0"><label for="q20803:130_answer0">a. the forearm can be divided anatomically into 2 compartments</label> </div>
<div class="r1"><input type="radio" name="q20803:130_answer" disabled="disabled" value="1" id="q20803:130_answer1"><label for="q20803:130_answer1">b. the volar compartment can be completely released with a “lazy S” incision through the superficial fascia overlying the flexor digitorum superficialis</label> </div>
<div class="r0"><input type="radio" name="q20803:130_answer" disabled="disabled" value="2" id="q20803:130_answer2"><label for="q20803:130_answer2">c. the most appropriate first incision is a longitudinal incision over the dorsal compartment</label> </div>
<div class="r1"><input type="radio" name="q20803:130_answer" disabled="disabled" value="3" id="q20803:130_answer3"><label for="q20803:130_answer3">d. full decompression can be obtained without release of the carpal tunnel</label> </div>
<div class="r0"><input type="radio" name="q20803:130_answer" disabled="disabled" value="4" id="q20803:130_answer4"><label for="q20803:130_answer4">e. the “mobile wad” is innervated by the radial nerve</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:130_-submit" name="q20803:130_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Anatomically, the forearm can be divided into 3 compartments, including the dorsal, volar, and the “mobile wad.”&nbsp; The mobile wad is innervated by the radial nerve, and the dorsal and volar compartments each contain superficial and deep muscles.&nbsp;</p>
<p>A “lazy S” incision should be performed first and will often adequately release the pressure in both the volar and dorsal compartments. However, <strong>full</strong> decompression requires release of the individual fascial compartments of each of the superficial and deep muscles in both the volar and dorsal compartments, as well as the mobile wad with concomitant carpal tunnel release.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/10795056" target="_blank">Whitesides TE, Heckman MM. Acute Compartment Syndrome: Update on Diagnosis and Treatment. J Am Acad Orthop Surg 1996; 4:209-18.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Forearm+compartment+syndrome%3A+Anatomical+analysis+of+surgical+approaches+to+the+deep+space." target="_blank">Ronel DN, Mtui E, Nolan WB III. Forearm compartment syndrome: Anatomical analysis of surgical approaches to the deep space. Plast &amp; Reconstr Surg 2004; 114: 697-705.</a></p>
<p>QID: 30223</p></div><div class="rightanswer">The correct answer is: the “mobile wad” is innervated by the radial nerve</div></div></div></div></div><div id="q529" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">130</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1334"><input type="hidden" name="q20803:529_:flagged" value="0"><input type="hidden" value="qaid=911413&amp;qubaid=20803&amp;qid=5265&amp;slot=529&amp;checksum=93e8c219d15eea9d20300c7e80d1a3d8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:529_:flaggedcheckbox" name="q20803:529_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q529&id=5265"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:529_:sequencecheck" value="2"><div class="qtext"><p>Obese patients may be susceptible to radiation skin injury during complex fenestrated endovascular aneurysm repair cases. &nbsp;However, skin injury may be reduced by which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:529_answer" disabled="disabled" value="0" id="q20803:529_answer0"><label for="q20803:529_answer0">a. using percutaneous access rather than surgical cutdown</label> </div>
<div class="r1"><input type="radio" name="q20803:529_answer" disabled="disabled" value="1" id="q20803:529_answer1"><label for="q20803:529_answer1">b. limiting gantry position</label> </div>
<div class="r0"><input type="radio" name="q20803:529_answer" disabled="disabled" value="2" id="q20803:529_answer2"><label for="q20803:529_answer2">c. utilizing magnification as much as possible</label> </div>
<div class="r1"><input type="radio" name="q20803:529_answer" disabled="disabled" value="3" id="q20803:529_answer3"><label for="q20803:529_answer3">d. limiting total fluoroscopy time</label> </div>
<div class="r0"><input type="radio" name="q20803:529_answer" disabled="disabled" value="4" id="q20803:529_answer4"><label for="q20803:529_answer4">e. completing the procedure in a single stage</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:529_-submit" name="q20803:529_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><div class="column">
<p><span>Skin entrance dose can be increased in obese patients due the increased radiation required to penetrate the body tissues. Similarly, if the patient is incorrectly positioned (ie, with an arm obscuring the field of view), more radiation is required to obtain the same view. Long exposure time is the major contributor to skin injuries, although varying the position of the beam is helpful to avoid prolonged exposure to one small area of skin. &nbsp;In addition, if the dose is starting to reach critical skin injury levels,&nbsp;</span>aborting the procedure and continuing another day may be the best choice. &nbsp;Other factors that increase skin entrance dose are: image magnification, use of a high-intensity mode, no dose monitoring, and steep xray beam angulation. There is no relationship between access technique (percutaneous vs open) and skin radiation exposure.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11418388" target="_blank"><span>Koenig TR, Wolff D, Mettler FA, Wagner LK. Skin injuries from&nbsp;</span><span>fluoroscopically guided procedures: part 1, characteristics of radiation </span>injury. AJR Am J Roentgenol 2001; 177:3-11.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11418390" target="_blank"><span>Koenig TR, Mettler FA, Wagner LK. Skin injuries from fluoroscopically&nbsp;</span>guided procedures: Part 2, review of 73 cases and recommendations for minimizing dose delivered to patient. AJR Am J Roentgenol 2001;177: 13-20.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Boyle+JR.+Ionizing+radiation+in+endovascular+interventions" target="_blank"><span>Walsh SR, Cousins C, Tang TY, Gaunt MD, Boyle JR. Ionizing radiation in endovascular interventions. J Endovasc Ther 2008; 15:680-7.&nbsp;</span></a></p>
<p><span>QID: 30933</span></p>
</div></div><div class="rightanswer">The correct answer is: limiting total fluoroscopy time</div></div></div></div></div><div id="q510" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">131</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1343"><input type="hidden" name="q20803:510_:flagged" value="0"><input type="hidden" value="qaid=911394&amp;qubaid=20803&amp;qid=5242&amp;slot=510&amp;checksum=698aea4e2a25657e2d5d1bf5c6280b68&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:510_:flaggedcheckbox" name="q20803:510_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q510&id=5242"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:510_:sequencecheck" value="2"><div class="qtext"><p>Multi-row detector CT scanners, as compared to single-row detectors, are associated with which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:510_answer" disabled="disabled" value="0" id="q20803:510_answer0"><label for="q20803:510_answer0">a. narrower sections</label> </div>
<div class="r1"><input type="radio" name="q20803:510_answer" disabled="disabled" value="1" id="q20803:510_answer1"><label for="q20803:510_answer1">b. higher radiation dose</label> </div>
<div class="r0"><input type="radio" name="q20803:510_answer" disabled="disabled" value="2" id="q20803:510_answer2"><label for="q20803:510_answer2">c. higher dose of contrast</label> </div>
<div class="r1"><input type="radio" name="q20803:510_answer" disabled="disabled" value="3" id="q20803:510_answer3"><label for="q20803:510_answer3">d. increased motion artifact</label> </div>
<div class="r0"><input type="radio" name="q20803:510_answer" disabled="disabled" value="4" id="q20803:510_answer4"><label for="q20803:510_answer4">e. increased acquisition time</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:510_-submit" name="q20803:510_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Multi-detector CT scanning (MDCT) is associated with lower doses of radiation, decreased motion artifact (particularly with cardiac cycle gating), lower contrast doses, shorter acquisition time, narrower sections, and decreased artifacts. Higher radiation doses can occur with MDCT if the collimation is decreased dramatically, or if the technique is adjusted in some other way relative to the comparable single row scan (eg, scanning a larger volume due to the more rapid acquisition time or using a "˜dynamic' CT). In general however, with large multi-row detectors, the collimation or slice thickness can be decreased by half or more, increasing the quality of the image without increasing radiation dose. MDCT has allowed more complex imaging of the aorta and also small branch vessels, obviating the need for diagnostic arteriography in many cases. Thus, attention must be paid to protocols at your own institution, the goals of the scan, and the overall radiation dose delivered for the entire evaluation sequence, not just the CT itself. Discussion with your radiologist may reduce the radiation dose significantly. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Radiol%3B+2003%3B+45+(1+Suppl)%3AS42-S49" target="_blank">Roubin GD. MDCT imaging of the aorta and peripheral vessels. Eur J Radiol 2003; 45 (1 Suppl):S42-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2006%3B+17+(1)%3A3-26." target="_blank">Fleischmann D, Hallett RL. Rubin GD. CT angiography of peripheral arterial disease. J Vasc Interv Radiol 2006; 17 (1):3-26.</a></p>
<p>QID: 30910</p></div><div class="rightanswer">The correct answer is: narrower sections</div></div></div></div></div><div id="q229" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">132</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1352"><input type="hidden" name="q20803:229_:flagged" value="0"><input type="hidden" value="qaid=911113&amp;qubaid=20803&amp;qid=4960&amp;slot=229&amp;checksum=7189bb04df41ff5f45795964e3a2c3f5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:229_:flaggedcheckbox" name="q20803:229_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q229&id=4960"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:229_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old, right arm dominant man with end-stage renal disease (ESRD) presents to the office in need of first time dialysis access. On physical examination of his left arm, he has visible cephalic and basilic veins measuring 3.5 mm, no edema, and nonpalpable radial, ulnar, and brachial artery pulses. <span>Which of the following represents the best pre-operative test to optimize the placement of an arteriovenous (AV) access in this patient?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:229_answer" disabled="disabled" value="0" id="q20803:229_answer0"><label for="q20803:229_answer0">a. upper extremity venography</label> </div>
<div class="r1"><input type="radio" name="q20803:229_answer" disabled="disabled" value="1" id="q20803:229_answer1"><label for="q20803:229_answer1">b. upper extremity deep venous duplex imaging</label> </div>
<div class="r0"><input type="radio" name="q20803:229_answer" disabled="disabled" value="2" id="q20803:229_answer2"><label for="q20803:229_answer2">c. upper extremity segmental pressures and pulse volume recordings</label> </div>
<div class="r1"><input type="radio" name="q20803:229_answer" disabled="disabled" value="3" id="q20803:229_answer3"><label for="q20803:229_answer3">d. No further testing is needed prior to placement of left arm AV access</label> </div>
<div class="r0"><input type="radio" name="q20803:229_answer" disabled="disabled" value="4" id="q20803:229_answer4"><label for="q20803:229_answer4">e. upper extremity superficial venous duplex imaging</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:229_-submit" name="q20803:229_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>If any abnormality is noted on pulse examination, the patient should be further evaluated with either upper extremity segmental pressures and pulse volume recordings (PVRs) or arteriography. If upper extremity segmental pressures and PVRs are chosen, any abnormality should prompt alternative site selection or be followed by arteriography. Upper extremity arteriography allows the surgeon to identify and possibly treat an arterial inflow stenosis. However, in pre-dialysis patients, the risk of iodinated contrast may be prohibitive. Given that this patient has adequate superficial veins and no edema or other signs of central venous stenosis, further venous evaluation is unnecessary. In this patient, upper extremity non-invasive arterial testing should be performed. <br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1998%3B+27+(2)%3A302-8." target="_blank">Silva MB, Hobson RW, Pappas PJ, Jamil Z<span>,&nbsp;</span>Araki CT<span>,&nbsp;</span>Goldberg MC<span>,&nbsp;</span>et al. A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27 (2):302-8.</a></p>
<p>QID: 30406</p></div><div class="rightanswer">The correct answer is: upper extremity segmental pressures and pulse volume recordings</div></div></div></div></div><div id="q22" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">133</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1361"><input type="hidden" name="q20803:22_:flagged" value="0"><input type="hidden" value="qaid=910906&amp;qubaid=20803&amp;qid=4632&amp;slot=22&amp;checksum=1327e31548c3741e13c3260f0d5a8223&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:22_:flaggedcheckbox" name="q20803:22_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q22&id=4632"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:22_:sequencecheck" value="2"><div class="qtext"><p>During an elective EVAR with a bifurcated device, the left hypogastric artery is inadvertently covered by the endograft limb in the setting of a chronically occluded right hypogastric artery. All of the following&nbsp;are clinical consequences of acute hypogastric artery occlusion EXCEPT:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:22_answer" disabled="disabled" value="0" id="q20803:22_answer0"><label for="q20803:22_answer0">a. cutaneous perineal necrosis</label> </div>
<div class="r1"><input type="radio" name="q20803:22_answer" disabled="disabled" value="1" id="q20803:22_answer1"><label for="q20803:22_answer1">b. colonic ischemia</label> </div>
<div class="r0"><input type="radio" name="q20803:22_answer" disabled="disabled" value="2" id="q20803:22_answer2"><label for="q20803:22_answer2">c. buttock claudication</label> </div>
<div class="r1"><input type="radio" name="q20803:22_answer" disabled="disabled" value="3" id="q20803:22_answer3"><label for="q20803:22_answer3">d. paraplegia</label> </div>
<div class="r0"><input type="radio" name="q20803:22_answer" disabled="disabled" value="4" id="q20803:22_answer4"><label for="q20803:22_answer4">e. small bowel ischemia</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:22_-submit" name="q20803:22_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Acute unilateral hypogastric artery occlusion either through intentional coil embolization or inadvertent coverage by an endograft limb results in a 30-40% risk of ipsilateral hip and buttock claudication. Symptoms typically improve over a 6-12 month period, but few patients ever become completely symptom-free. The accepted technical approach to planned coverage is placement of embolization coils proximal to the anterior and posterior hypogastric divisions. Acute bilateral occlusion is less predictable in terms of clinical outcome, and colon ischemia, paraplegia, and cutaneous perineal necrosis are all reported complications of the resultant pelvic ischemia. In the interest of erring on the safe side, most experts favor staged hypogastric artery occlusion in elective cases, potentially allowing time for collateralization, but there are numerous reports of uncomplicated simultaneous hypogastric artery occlusion. Small bowel ischemia would be an extremely unlikely complication of hypogastric artery occlusion, more often due to exclusion of the inferior mesenteric artery in a patient with severe celiac and superior mesenteric artery disease and unrecognized collateralization via the inferior mesenteric to meandering mesenteric artery pathway. <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Geraghty%20PJ,%20Sanchez%20LA,%20Rubin%20BG,%20et%20al.%20Overt%20ischemic%20colitis%20after%20endovascular%20repair%20of%20aortoiliac%20aneurysms.%20J%20Vasc%20Surg;%202004;%2040%20(3):413-418" target="_blank">Geraghty PJ, Sanchez LA, Rubin BG, Choi ET, Flye MW, Curci JA, et al. Overt ischemic colitis after endovascular repair of aortoiliac aneurysms. J Vasc Surg 2004; 40 (3):413-18.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Lee%20WA,%20Nelson%20PR,%20Berceli%20SA,%20et%20al.%20Outcome%20after%20hypogastric%20artery%20bypass%20and%20embolization%20during%20endovascular%20aneurysm%20repair.%20J%20Vasc%20Surg;%202006;%2044%20(6):1162-1168" target="_blank">Lee WA, Nelson PR, Berceli SA, Seeger JM, Huber TS. Outcome after hypogastric artery bypass and embolization during endovascular aneurysm repair. J Vasc Surg 2006; 44 (6):1162-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Criado%20FJ,%20Wilson%20EP,%20Velazquez%20OC,%20et%20al.%20Safety%20of%20coil%20embolization%20of%20the%20internal%20iliac%20artery%20in%20endovascular%20grafting%20of%20abdominal%20aortic%20aneurysms.%20J%20Vasc%20Surg;%202000;%2032%20(4):684-688" target="_blank">Criado FJ, Wilson EP, Velazquez OC, Carpenter JP, Barker C, Wellons E, et al. Safety of coil embolization of the internal iliac artery in endovascular grafting of abdominal aortic aneurysms. J Vasc Surg 2000; 32 (4):684-8</a>.</p>
<p>QID: 30024</p></div><div class="rightanswer">The correct answer is: small bowel ischemia</div></div></div></div></div><div id="q137" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">134</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1370"><input type="hidden" name="q20803:137_:flagged" value="0"><input type="hidden" value="qaid=911021&amp;qubaid=20803&amp;qid=4754&amp;slot=137&amp;checksum=285454f0a515aecc2bb3a30cc0dcce9a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:137_:flaggedcheckbox" name="q20803:137_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q137&id=4754"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:137_:sequencecheck" value="2"><div class="qtext"><p>A 51-year-old man presents with a 3-week history of increasing pain and discoloration of the little (5<sup>th</sup>) finger of his left hand. Physical examination reveals superficial finger ulcerations and palpable radial and ulnar pulses. Angiography before and after 24 hours of intra-arterial tPA is shown. &nbsp;Which of the following most accurately describes the pathophysiology leading to this clinical scenario?</p>
<p><br></p>
<p>Figure. Pre-tPA</p>
<p><img alt="" src="./VESAP3_files/Initial angiogram.jpg" width="406" height="406"></p>
<p><br></p>
<p>Figure. Post-tPA.</p>
<p><img alt="" src="./VESAP3_files/Post- Thrombolysis.jpg" width="432" height="432"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:137_answer" disabled="disabled" value="0" id="q20803:137_answer0"><label for="q20803:137_answer0">a. soft tissue calcification and necrosis</label> </div>
<div class="r1"><input type="radio" name="q20803:137_answer" disabled="disabled" value="1" id="q20803:137_answer1"><label for="q20803:137_answer1">b. vasospasm</label> </div>
<div class="r0"><input type="radio" name="q20803:137_answer" disabled="disabled" value="2" id="q20803:137_answer2"><label for="q20803:137_answer2">c. critical stenosis resulting in decreased flow</label> </div>
<div class="r1"><input type="radio" name="q20803:137_answer" disabled="disabled" value="3" id="q20803:137_answer3"><label for="q20803:137_answer3">d. thrombosis and/or embolization</label> </div>
<div class="r0"><input type="radio" name="q20803:137_answer" disabled="disabled" value="4" id="q20803:137_answer4"><label for="q20803:137_answer4">e. inflammation and edema</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:137_-submit" name="q20803:137_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The initial arteriogram demonstrates thrombosis of the&nbsp;ulnar artery. Following thrombolysis, there is restoration of flow through&nbsp;the abnormal segment of&nbsp;&nbsp;the ulnar artery. Ulnar artery aneurysms are typically fusiform and may have a "corkscrew" appearance due to tortuosity and/or irregular intraluminal thrombus. Ulnar artery aneurysms may present as part of the hypothenar hammer syndrome, characterized by focal aneurysmal degeneration due to repetitive blunt trauma to the hypothenar eminence. Symptoms are usually related to digital ischemia secondary to embolization. Less commonly,&nbsp;ulnar artery&nbsp;aneurysms may present as a pulsatile hypothenar mass. The definitive treatment is surgical. Bypass&nbsp;with an&nbsp;appropriately-sized vein graft is recommended. In the setting of recent thrombosis, thrombolysis may be effective in restoring patency and distal perfusion.&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Plast+Surg+2011%3B67(4)%3A429-38" target="_blank">Yuen JC, Wright E, Johnson LA, Culp WC. Hypothenar Hammer Syndrome An Update With Algorithms for Diagnosis and Treatment. Ann Plast Surg 2011;67(4):429-38.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Med+1985%3B79(5)%3A561-70" target="_blank">Pineda CJ, Weisman MH, Bookstein JJ, Saltzstein SL. Hypothenar hammer syndrome - form of reversible Raynauds-Phenomenon. Am J Med 1985;79(5):561-70.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1998%3B+28(4)%3A606-10." target="_blank">Gray RJ, Stone WM, Fowl RJ, Cherry RJ, Bower TC. Management of true aneurysms distal to the axillary artery. J Vasc Surg 1998; 28(4):606-10.</a></p>
<p>QID: 30230</p></div><div class="rightanswer">The correct answer is: thrombosis and/or embolization</div></div></div></div></div><div id="q6" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">135</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1379"><input type="hidden" name="q20803:6_:flagged" value="0"><input type="hidden" value="qaid=910890&amp;qubaid=20803&amp;qid=4615&amp;slot=6&amp;checksum=78c22cbd9b8499c3e296d7f580fa0ab5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:6_:flaggedcheckbox" name="q20803:6_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q6&id=4615"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:6_:sequencecheck" value="2"><div class="qtext"><p>A 72-year-old man has an asymptomatic, fusiform, infrarenal aortic aneurysm. In order to optimize his long-term survival the best available trial data recommends he undergo aortic aneurysm repair&nbsp;when his aneurysm reaches:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:6_answer" disabled="disabled" value="0" id="q20803:6_answer0"><label for="q20803:6_answer0">a. 4.5 cm</label> </div>
<div class="r1"><input type="radio" name="q20803:6_answer" disabled="disabled" value="1" id="q20803:6_answer1"><label for="q20803:6_answer1">b. 6 cm</label> </div>
<div class="r0"><input type="radio" name="q20803:6_answer" disabled="disabled" value="2" id="q20803:6_answer2"><label for="q20803:6_answer2">c. 5.5 cm</label> </div>
<div class="r1"><input type="radio" name="q20803:6_answer" disabled="disabled" value="3" id="q20803:6_answer3"><label for="q20803:6_answer3">d. 5 cm</label> </div>
<div class="r0"><input type="radio" name="q20803:6_answer" disabled="disabled" value="4" id="q20803:6_answer4"><label for="q20803:6_answer4">e. 4 cm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:6_-submit" name="q20803:6_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Balancing the risk of AAA rupture and&nbsp;AAA repair, the economics of healthcare, and the fear of rupture instilled in patients can be a challenging task. The data supporting 5.5 cm as the threshold size for AAA repair are derived from two randomized trials, the United States ADAM trial and the United Kingdom Small Aneurysm trial. Both of these trials&nbsp;followed patients with AAAs between 4.0 and 5.5 cm with serial CT or ultrasound scanning. Often times patients with AAAs in this range die of associated conditions before they ever experience rupture. As a result they incur unnecessary surgical risks and&nbsp;healthcare expenses, and they derive&nbsp;no benefit from the repair. Nonetheless, the likelihood of enlarging to the threshold size of 5.5 cm, and ultimately requiring repair, is about 65% at 5 years and 75% at 8 years. Consequently, there is a role for individualization in determining exactly when to repair an asymptomatic AAA that takes into account the patient's age, comorbidities, and informed preference-since the annual risk of rupture for small AAAs is low.</p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=United%20Kingdom%20Small%20Aneurysm%20Trial%20Participants.%20Long%20term%20outcomes%20of%20immediate%20repair%20compared%20with%20surveillance%20of%20small%20abdominal%20aortic%20aneurysms.%20N%20Engl%20J%20Med%3B%202002%3B%20346%20%2819%29%3A1445-1452" target="_blank">United Kingdom Small Aneurysm Trial Participants. Long term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346 (19):1445-52.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Lederle%20FA%2C%20Wilson%20SE%2C%20Johnson%20GR%2C%20et%20al.%20Immediate%20repair%20compared%20with%20surveillance%20of%20small%20abdominal%20aortic%20aneurysms.%20N%20Engl%20J%20Med%3B%202002%3B%20346%20%2819%29%3A1437-1444" target="_blank">Lederle FA, Wilson SE, Johnson GR, Reinke DB, Littooy FN, Acher CW, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346 (19):1437-44.</a></p>
<p>QID: 30006</p></div><div class="rightanswer">The correct answer is: 5.5 cm</div></div></div></div></div><div id="q79" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">136</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1388"><input type="hidden" name="q20803:79_:flagged" value="0"><input type="hidden" value="qaid=910963&amp;qubaid=20803&amp;qid=4991&amp;slot=79&amp;checksum=1517aa3eecc9f69f245a083a441542fd&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:79_:flaggedcheckbox" name="q20803:79_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q79&id=4991"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:79_:sequencecheck" value="2"><div class="qtext"><p>A 58-year-old woman with diabetes mellitus presents with gangrene of the fourth toe. Contrast arteriography demonstrates occlusion of the superficial femoral and popliteal arteries with reconstitution of the posterior tibial artery in the mid calf with continued patency to the foot. Her ipsilateral saphenous vein is intact. Which of the following represents the configuration of the saphenous vein graft most likely to give her the best, long-term results in terms of graft patency and limb salvage?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:79_answer" disabled="disabled" value="0" id="q20803:79_answer0"><label for="q20803:79_answer0">a. a non-reversed translocated saphenous vein bypass if the caliber of the proximal vein is larger than the distal vein</label> </div>
<div class="r1"><input type="radio" name="q20803:79_answer" disabled="disabled" value="1" id="q20803:79_answer1"><label for="q20803:79_answer1">b. an in-situ saphenous vein bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:79_answer" disabled="disabled" value="2" id="q20803:79_answer2"><label for="q20803:79_answer2">c. a reversed saphenous vein bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:79_answer" disabled="disabled" value="3" id="q20803:79_answer3"><label for="q20803:79_answer3">d. a non-reversed translocated saphenous vein bypass regardless of the presence of any tapering</label> </div>
<div class="r0"><input type="radio" name="q20803:79_answer" disabled="disabled" value="4" id="q20803:79_answer4"><label for="q20803:79_answer4">e. the configuration of the saphenous vein bypass does not affect graft patency or limb salvage</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:79_-submit" name="q20803:79_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Numerous studies have compared the various configurations of ipsilateral greater saphenous vein bypass grafts, especially reversed vein grafts and in-situ vein grafts. Results of several prospective trials and one large meta analysis comparing the two have shown no significant differences in graft patency or limb salvage in early or long-term follow up. The care with which vein grafts are harvested and prepared, having a diameter greater than 3 mm and the absence of intrinsic vein graft pathology, are far more important than the configuration of the vein graft chosen, which remains primarily a decision based on individual surgeon preference.<br><br></p>
<h3>References:</h3>
<p>Mamode N, Scott RN. Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev; 2000; (2):CD001487.<br><br>Mills J. Infrainguinal Bypass. In: Rutherford RB, ed. Vascular Surgery. 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1154-73.</p>
<p>QID: 30123</p></div><div class="rightanswer">The correct answer is: the configuration of the saphenous vein bypass does not affect graft patency or limb salvage</div></div></div></div></div><div id="q272" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">137</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1397"><input type="hidden" name="q20803:272_:flagged" value="0"><input type="hidden" value="qaid=911156&amp;qubaid=20803&amp;qid=5009&amp;slot=272&amp;checksum=353c21760eec105b3c4ea67130b534c2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:272_:flaggedcheckbox" name="q20803:272_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q272&id=5009"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:272_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old, right-handed diabetic man with stage 4 chronic kidney disease is referred for hemodialysis access. He has a patent left forearm and upper arm cephalic vein confirmed on duplex imaging to measure 3.5 mm in diameter. The forearm basilic vein is 2 mm in diameter. He has a palpable left brachial pulse and a diminished radial pulse with calcification. Duplex imaging confirms extensive circumferential calcification in the radial and ulnar arteries in the distal forearm. Proximal radial and ulnar arteries are normal. Initial hemodialysis access in this patient should be which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:272_answer" disabled="disabled" value="0" id="q20803:272_answer0"><label for="q20803:272_answer0">a. placement of forearm prosthetic arteriovenous access based on the radial artery at the wrist</label> </div>
<div class="r1"><input type="radio" name="q20803:272_answer" disabled="disabled" value="1" id="q20803:272_answer1"><label for="q20803:272_answer1">b. transposition of forearm basilic vein to radial artery</label> </div>
<div class="r0"><input type="radio" name="q20803:272_answer" disabled="disabled" value="2" id="q20803:272_answer2"><label for="q20803:272_answer2">c. ulnar artery to cephalic vein autogenous access at the wrist</label> </div>
<div class="r1"><input type="radio" name="q20803:272_answer" disabled="disabled" value="3" id="q20803:272_answer3"><label for="q20803:272_answer3">d. radial artery to cephalic vein autogenous access at the wrist</label> </div>
<div class="r0"><input type="radio" name="q20803:272_answer" disabled="disabled" value="4" id="q20803:272_answer4"><label for="q20803:272_answer4">e. brachial artery to forearm cephalic vein forearm loop transposition</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:272_-submit" name="q20803:272_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Principles of hemodialysis access surgery stress the need to start as far distally in the extremity as possible. Distal forearm access is usually limited by unsuitable veins but may also be limited by circumferential arterial calcification, which can preclude successful fistula maturation. Alternative access will require more proximal arterial inflow, such as from the brachial or proximal radial arteries. To accomplish this, a&nbsp;patent forearm cephalic vein can be transposed to the brachial or proximal radial artery in a loop configuration in the forearm. Alternatively, a direct fistula from the proximal radial artery to the cephalic or median antebrachial vein can be performed with destruction of valves in the forearm cephalic vein to provide bidirectional flow.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B48%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr,&nbsp;et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008; 48:2S-25S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2009%3B49%3A1325-36." target="_blank">Voormolen EH, Jahrome AK, Bartels LW, Moll FL<span>,&nbsp;</span>Mali WP<span>,&nbsp;</span>Blankestijn PJ. Nonmaturation of arm arteriovenous fistulas for hemodialysis access: A systematic review of risk factors and results of early treatment.&nbsp;J Vasc Surg 2009;49:1325-36.</a></p>
<p>QID: 30457</p></div><div class="rightanswer">The correct answer is: brachial artery to forearm cephalic vein forearm loop transposition</div></div></div></div></div><div id="q254" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">138</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1406"><input type="hidden" name="q20803:254_:flagged" value="0"><input type="hidden" value="qaid=911138&amp;qubaid=20803&amp;qid=4981&amp;slot=254&amp;checksum=53ce9bd10e9ebe3292b598fdb3dbb31e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:254_:flaggedcheckbox" name="q20803:254_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q254&id=4981"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:254_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old, right handed man with a history of automatic implantable cardioverter defibrillator (AICD) placement in the left chest area 10 years previously presents for progressive chronic kidney disease (CKD). He is expected to need hemodialysis within the next 3 months. On exam in the office, he has normal brachial, radial, and ulnar pulses, with a normal Allens test bilaterally. He has visible cephalic veins bilaterally, which appear to be about 3.5 mm at the wrist and 5 mm in the upper arm. They are clearly seen in continuity throughout the entire arm. The veins in the shoulder region are clearly visible in the left upper extremity only. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:254_answer" disabled="disabled" value="0" id="q20803:254_answer0"><label for="q20803:254_answer0">a. perform vein mapping of both upper extremities to assess the cephalic and basilic veins</label> </div>
<div class="r1"><input type="radio" name="q20803:254_answer" disabled="disabled" value="1" id="q20803:254_answer1"><label for="q20803:254_answer1">b. perform a radiocephalic autogenous AV access at the wrist on the left</label> </div>
<div class="r0"><input type="radio" name="q20803:254_answer" disabled="disabled" value="2" id="q20803:254_answer2"><label for="q20803:254_answer2">c. perform venogram to assess for central vein stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:254_answer" disabled="disabled" value="3" id="q20803:254_answer3"><label for="q20803:254_answer3">d. place a brachiocephalic autogenous AV access on the left</label> </div>
<div class="r0"><input type="radio" name="q20803:254_answer" disabled="disabled" value="4" id="q20803:254_answer4"><label for="q20803:254_answer4">e. perform upper extremity arterial duplex to assess arterial supply</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:254_-submit" name="q20803:254_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has an AICD in the left subclavian vein, placing him at risk for central venous lesions. As he is right handed, a left access would be preferred if the anatomy is suitable. A retrospective study assessed AVF and AVG success as compared to preoperative method of assessment. Group 1 had a higher rate of elderly patients, a higher mean number of prior central catheters, and underwent preoperative imaging and intervention for underlying central venous stenosis prior to access construction. Group 1 had a 90% success rate in access placement and a longer mean patency rate for the access. The other group had a 69% success rate without preoperative assessment. The study identified 66 central venous stenosis in 260 patients studied.&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2007%2C+21%3B+481-9." target="_blank">Karakayali, F, Ekici, Y, Gorur, SK, Arat Z<span>,&nbsp;</span>Boyvat F<span>,&nbsp;</span>Karakayali H,&nbsp;et al. The value of preoperative vascular imaging in the selection and success of hemodialysis access. Ann Vasc Surg 2007, 21; 481-9.</a></p>
<p><span>QID: 30438</span></p></div><div class="rightanswer">The correct answer is: perform venogram to assess for central vein stenosis</div></div></div></div></div><div id="q371" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">139</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1415"><input type="hidden" name="q20803:371_:flagged" value="0"><input type="hidden" value="qaid=911255&amp;qubaid=20803&amp;qid=5114&amp;slot=371&amp;checksum=afdb466c0ace557dfd772ad8edf36d86&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:371_:flaggedcheckbox" name="q20803:371_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q371&id=5114"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:371_:sequencecheck" value="2"><div class="qtext"><p>Which of the following combinations of symptoms, signs, and laboratory findings are most consistent with the diagnosis of acute mesenteric ischemia?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:371_answer" disabled="disabled" value="0" id="q20803:371_answer0"><label for="q20803:371_answer0">a. crampy abdominal pain,&nbsp;high-pitched bowel sounds, and&nbsp;metabolic acidosis</label> </div>
<div class="r1"><input type="radio" name="q20803:371_answer" disabled="disabled" value="1" id="q20803:371_answer1"><label for="q20803:371_answer1">b. mid-epigastric abdominal pain, soft abdomen, and&nbsp;elevated creatine kinase</label> </div>
<div class="r0"><input type="radio" name="q20803:371_answer" disabled="disabled" value="2" id="q20803:371_answer2"><label for="q20803:371_answer2">c. postprandial abdominal pain, soft abdomen, and normal pH</label> </div>
<div class="r1"><input type="radio" name="q20803:371_answer" disabled="disabled" value="3" id="q20803:371_answer3"><label for="q20803:371_answer3">d. severe abdominal pain, mild abdominal tenderness, and metabolic acidosis</label> </div>
<div class="r0"><input type="radio" name="q20803:371_answer" disabled="disabled" value="4" id="q20803:371_answer4"><label for="q20803:371_answer4">e. migratory abdominal pain, focal right lower quadrant rebound, and leukocytosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:371_-submit" name="q20803:371_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Acute onset of abdominal pain out of proportion to the physical findings remains the hallmark of clinical diagnosis of acute mesenteric ischemia. Eventually, acute mesenteric ischemia will lead to full thickness intestinal necrosis and signs of acute abdomen. A number of laboratory abnormalities have been reported in association with acute mesenteric ischemia but these abnormalities are mostly nonspecific and include leukocytosis,&nbsp;elevated creatine kinase and amylase, and lactic acidosis. Lactic acidosis may be present with acute mesenteric ischemia, but it is often a late finding after bowel necrosis has occurred. Postprandial abdominal pain is present in a spectrum of disease entities of the gastrointestinal tract, including&nbsp;chronic mesenteric ischemia and other non-vascular conditions. Crampy abdominal pain and high-pitched bowel sounds suggest an obstructive etiology. Focal RLQ tenderness and migratory pain is typical of acute appendicitis. Midepigastric pain and a benign abdominal exam can be present in a wide variety of conditions. Myocardial ischemia should certainly be considered in any patient with abdominal or chest pain.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Intern+Med.+2004%3B164%3A1054-62." target="_blank">Oldenburg WA, Lau LL, Rodenberg TJ, Edmonds HJ, Burger CD. Acute mesenteric ischemia: A clinical review. Arch Intern Med 2004;164:1054-62.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B46%3A467-74." target="_blank">Kougias P, Lau D, El Sayed HF, Zhou W, Huynh TT, Lin PH. Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia. J Vasc Surg&nbsp;2007;46:467-74.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Gastrointest+Endosc+Clin+N+Am+2011%3B21%3A721-30." target="_blank">Bingener J, Gostout CJ. Management of nonvariceal upper gastrointestinal bleeding. Gastrointest Endosc Clin N Am 2011;21:721-30.</a></p>
<p>QID: 30653</p></div><div class="rightanswer">The correct answer is: severe abdominal pain, mild abdominal tenderness, and metabolic acidosis</div></div></div></div></div><div id="q263" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">140</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1424"><input type="hidden" name="q20803:263_:flagged" value="0"><input type="hidden" value="qaid=911147&amp;qubaid=20803&amp;qid=5000&amp;slot=263&amp;checksum=c02ddabd1c00d4cd804736d8f390cf4f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:263_:flaggedcheckbox" name="q20803:263_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q263&id=5000"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:263_:sequencecheck" value="2"><div class="qtext"><p><span>A 78-year-old man with end-stage renal disease presents with complaints of increasing edema of the right upper extremity 2 years after placement of a right autogenous brachial basilic upper arm direct arteriovenous access. On physical examination of his right arm, he has a prominent pulse overlying his access, moderate edema, and palpable radial, ulnar, and brachial artery pulses (see image below). Venography of the right upper extremity shows a significant subclavian vein stenosis, a patent internal jugular vein with no stenosis, and a patent innominate vein with no stenosis. Which of the following statements is <span><strong>not&nbsp;</strong>true</span>?</span></p>
<p><span><img src="./VESAP3_files/5. Venous HTN.png" alt="" width="265" height="359"></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:263_answer" disabled="disabled" value="0" id="q20803:263_answer0"><label for="q20803:263_answer0">a. <span>possible intervention includes right subclavian vein angioplasty without stenting</span></label> </div>
<div class="r1"><input type="radio" name="q20803:263_answer" disabled="disabled" value="1" id="q20803:263_answer1"><label for="q20803:263_answer1">b. <span>possible intervention includes right subclavian to internal jugular venous bypass</span></label> </div>
<div class="r0"><input type="radio" name="q20803:263_answer" disabled="disabled" value="2" id="q20803:263_answer2"><label for="q20803:263_answer2">c. <span>the arteriovenous hemodialysis access should be ligated and access placed in the contralateral extremity</span></label> </div>
<div class="r1"><input type="radio" name="q20803:263_answer" disabled="disabled" value="3" id="q20803:263_answer3"><label for="q20803:263_answer3">d. <span>venography is indicated</span></label> </div>
<div class="r0"><input type="radio" name="q20803:263_answer" disabled="disabled" value="4" id="q20803:263_answer4"><label for="q20803:263_answer4">e. <span>the underlying pathology is commonly associated with dialysis catheters in the subclavian vein</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:263_-submit" name="q20803:263_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p id="yui_3_13_0_2_1388277018339_90">Venous hypertension occurs secondary to venous outflow stenosis. The outflow obstruction is commonly located in the subclavian vein due to intimal hyperplasia, but it may be located anywhere along the venous outflow tract. In dialysis patients, venous stenosis is often associated with central venous catheters, especially those placed in the subclavian vein. Clinical presentation ranges from asymptomatic, with only increased dialysis venous pressures, to symptomatic, including prolonged puncture site bleeding, extremity edema, varicosities, pigmentation, and venous ulceration. Patients with clinically symptomatic venous hypertension should be evaluated further with venography. Subclavian vein stenosis may be treated by endovascular or open surgical methods, but due to their minimally invasive nature, endovascular techniques should be attempted first. Successful central venous angioplasty with high pressure balloons can be successful, but with limited durability. Bare metal or covered stents post-angioplasty would seem to increase durability, but this remains to be proven, with current application reserved for suboptimal angioplasty results or recurrent stenosis. If endovascular methods are not possible or are unsuccessful, open surgical methods include subclavian to internal jugular bypass and jugular turndown. Ligation of the AV access should only be used as a last resort, such as instances when the subclavian stenosis is not amenable to treatment options described above or with total occlusion of the innominate vein.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank">Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg 2008; 48 (S):55S-80S.</a></p>
<p><a href="http://svsvesap.com/question/question.php?returnurl=%2Fquestion%2Fedit.php%3Fcourseid%3D2%26cat%3D62%252C15%26qpage%3D4&courseid=2&id=3149" target="_blank">Kundu S. Review of central venous disease in hemodialysis patients. J Vasc Inter Radiol 2010; 21:963-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17398386" target="_blank">Bakken AM, Protack CD, Saad WE, Lee DE, Waldman DL, Davies MG. Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg 2007;45:776-83.</a></p>
<p>QID: 30447</p></div><div class="rightanswer">The correct answer is: <span>the arteriovenous hemodialysis access should be ligated and access placed in the contralateral extremity</span></div></div></div></div></div><div id="q103" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">141</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1433"><input type="hidden" name="q20803:103_:flagged" value="0"><input type="hidden" value="qaid=910987&amp;qubaid=20803&amp;qid=4925&amp;slot=103&amp;checksum=7b6ab430876f987eabe9b25dbab95c9b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:103_:flaggedcheckbox" name="q20803:103_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q103&id=4925"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:103_:sequencecheck" value="2"><div class="qtext"><p>The use of drug-eluting stents may result in improved primary patency when compared to bare metal stents in patients requiring treatment of the superficial femoral artery.&nbsp; Which of the following is the mechanism of action of paclitaxel?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:103_answer" disabled="disabled" value="0" id="q20803:103_answer0"><label for="q20803:103_answer0">a. mTOR activator</label> </div>
<div class="r1"><input type="radio" name="q20803:103_answer" disabled="disabled" value="1" id="q20803:103_answer1"><label for="q20803:103_answer1">b. beta-lactamase inhibitor</label> </div>
<div class="r0"><input type="radio" name="q20803:103_answer" disabled="disabled" value="2" id="q20803:103_answer2"><label for="q20803:103_answer2">c. microtubule inhibitor/stabilizer</label> </div>
<div class="r1"><input type="radio" name="q20803:103_answer" disabled="disabled" value="3" id="q20803:103_answer3"><label for="q20803:103_answer3">d. mTOR inhibitor</label> </div>
<div class="r0"><input type="radio" name="q20803:103_answer" disabled="disabled" value="4" id="q20803:103_answer4"><label for="q20803:103_answer4">e. ADP competitive inhibitor</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:103_-submit" name="q20803:103_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Two year follow-up from the Zilver PTX randomized control trial (which evaluated patients with superficial femoral artery lesions) demonstrated both improved event-free survival (87% vs 79%, <em>P</em> = .02) and improved primary patency (75% vs 27%, <em>P</em> &lt; .01) in the drug-eluting stent cohort, when compared to the bare-metal stent cohort.&nbsp;</p>
<p>Paclitaxel is a chemotherapeutic in the category of taxanes; it functions as a microtubule inhibitor/stabilizer and thereby interferes with the process of mitosis, which translates into diminished neointimal hyperplasia.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+2013%3B+61(24)%3A2417-27." target="_blank">Dake MD, Ansel GM, Jaff MR, Ohki T, Saxon RR, Smouse HB; Zilver PTX Investigators.&nbsp; Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies.&nbsp; J Am Coll Cardiol 2013; 61(24):2417-27.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol.+2011%3B+22(5)%3A603-10." target="_blank">Dake MD, Van Alstine WG, Zhou Q, Ragheb AO. Polymer-free paclitaxel-coated Zilver PTX Stents--evaluation of pharmacokinetics and comparative safety in porcine arteries. J Vasc Interv Radiol. 2011; 22(5):603-10.&nbsp;</a></p>
<p>QID: 30155</p></div><div class="rightanswer">The correct answer is: microtubule inhibitor/stabilizer</div></div></div></div></div><div id="q276" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">142</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1442"><input type="hidden" name="q20803:276_:flagged" value="0"><input type="hidden" value="qaid=911160&amp;qubaid=20803&amp;qid=5013&amp;slot=276&amp;checksum=50d7a08e0fdab30b427a397185cf78ed&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:276_:flaggedcheckbox" name="q20803:276_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q276&id=5013"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:276_:sequencecheck" value="2"><div class="qtext"><p>Ten weeks ago, a 65-year-old man with end stage renal disease underwent a left brachiocephalic arteriovenous autogenous access for hemodialysis. On duplex ultrasonography, the vein is 4 mm in diameter and the average blood flow in the access is 300 ml/min. Which of the following is the most probable explanation for the failure of the graft to mature?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:276_answer" disabled="disabled" value="0" id="q20803:276_answer0"><label for="q20803:276_answer0">a. technical error</label> </div>
<div class="r1"><input type="radio" name="q20803:276_answer" disabled="disabled" value="1" id="q20803:276_answer1"><label for="q20803:276_answer1">b. large accessory vein</label> </div>
<div class="r0"><input type="radio" name="q20803:276_answer" disabled="disabled" value="2" id="q20803:276_answer2"><label for="q20803:276_answer2">c. arterial stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:276_answer" disabled="disabled" value="3" id="q20803:276_answer3"><label for="q20803:276_answer3">d. anastomotic stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:276_answer" disabled="disabled" value="4" id="q20803:276_answer4"><label for="q20803:276_answer4">e. venous stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:276_-submit" name="q20803:276_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Due to superior long-term patency rates and resistance to infection, arteriovenous fistulas (AVFs) are recommended by the National Kidney Foundation Kidney Disease Outcomes Quality Initiative as the best available access for hemodialysis. However, between 28 - 53% of AVFs fail to mature within 6 weeks of creation. The two most common causes of early failure are stenosis within the access circuit and the presence of accessory veins. In a prospective observational study of 100 consecutive patients with early AVF failure, Beathard et al reported the cause as a venous stenosis in 78% of cases, while accessory veins were present in 43% of cases, and arterial stenosis was present in 38%.&nbsp; Angioplasty of the arterial or venous stenosis can result in long-term graft salvage in the vast majority of cases.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kidney+Int+2003%3B+64%3A+1487-94." target="_blank">Beathard GA, Arnold P, Jackson, J, Litchfield T<span>;&nbsp;</span>Physician Operators Forum of RMS Lifeline<span>.&nbsp;</span>Aggressive treatment of early fistula failure. Kidney Int 2003; 64: 1487-94.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2006%3B+17%3A+807-13." target="_blank">Falk A. Maintenance and salvage of arteriovenous fistulas. J Vasc Interv Radiol 2006; 17: 807-13.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+J+Am+Soc+Nephrol+2006%3B+1%3A+332-9." target="_blank">Asif A, Roy-Chaudhury P, Beathard GA. Early arteriovenous fistula failure: a logical proposal for when and how to intervene. Clin J Am Soc Nephrol 2006; 1: 332-9.</a></p>
<p>QID: 30461</p></div><div class="rightanswer">The correct answer is: venous stenosis</div></div></div></div></div><div id="q389" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">143</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1451"><input type="hidden" name="q20803:389_:flagged" value="0"><input type="hidden" value="qaid=911273&amp;qubaid=20803&amp;qid=5039&amp;slot=389&amp;checksum=aef52d7f860c244dd34e2d9cc6b2e932&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:389_:flaggedcheckbox" name="q20803:389_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q389&id=5039"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:389_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old man with a heterozygous factor V Leiden deficiency, obesity (BMI of 29), and a history of deep vein thrombosis (DVT) x2 in his right leg presents with severe post-thrombotic syndrome (C5). In regards to this patient, which of the following is the clinical factor most strongly correlated with post-thrombotic syndrome (PTS)?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:389_answer" disabled="disabled" value="0" id="q20803:389_answer0"><label for="q20803:389_answer0">a. age</label> </div>
<div class="r1"><input type="radio" name="q20803:389_answer" disabled="disabled" value="1" id="q20803:389_answer1"><label for="q20803:389_answer1">b. recurrent ipsilateral DVT</label> </div>
<div class="r0"><input type="radio" name="q20803:389_answer" disabled="disabled" value="2" id="q20803:389_answer2"><label for="q20803:389_answer2">c. documented hypercoagulable state</label> </div>
<div class="r1"><input type="radio" name="q20803:389_answer" disabled="disabled" value="3" id="q20803:389_answer3"><label for="q20803:389_answer3">d. obesity</label> </div>
<div class="r0"><input type="radio" name="q20803:389_answer" disabled="disabled" value="4" id="q20803:389_answer4"><label for="q20803:389_answer4">e. ongoing smoking</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:389_-submit" name="q20803:389_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Multiple high-quality studies have confirmed that recurrent ipsilateral DVT is highly correlated with PTS. Recurrent ipsilateral DVT increases the risk of PTS by at least 1.8-fold. Other independently associated factors include proximal iliofemoral DVT (OR ~ 2.3), obesity, older age, and female gender. While obesity and age correlate with PTS, these factors are not as strongly correlated as recurrent ipsilateral DVT. Thus, proper intensity and duration of anticoagulation are essential. Importantly, the severity of PTS symptoms and signs at 1 month after DVT is predictive of long-term PTS development. Ongoing tobacco use does not correlate with PTS.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Intern+Med+2008%3B+149+(10)%3A698-707." target="_blank">Kahn SR, Shrier I, Julian JA, Ducruet T<span>,&nbsp;</span>Arsenault L<span>,&nbsp;</span>Miron MJ<span>,&nbsp;</span>et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149 (10):698-707.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Intern+Med+1996%3B+125+(1)%3A1-7." target="_blank">Prandoni P, Lensing AW, Cogo A, Cuppini S<span>,&nbsp;</span>Villalta S<span>,&nbsp;</span>Carta M<span>,&nbsp;</span>et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125 (1):1-7.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Janssen+MC%2C+van+Rossum+J%2C+et+al.+Inflammation+in+deep-vein+thrombosis+and+the+development" target="_blank">Roumen-Klappe EM, Janssen MC, van Rossum J, Holewijn S<span>,&nbsp;</span>Van Bokhoven MM<span>,&nbsp;</span>Kaasjager K<span>,&nbsp;</span>et al. Inflammation in deep-vein thrombosis and the development of the post-thrombotic syndrome: A prospective study. J Thromb Haemost 2009; 7 (4):582-7.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Blood+2009%3B+114+(21)%3A4624-31." target="_blank">Kahn SR. How I manage the postthrombotic syndrome. Blood 2009; 114 (21):4624-31.</a></p>
<p>QID: 30706</p></div><div class="rightanswer">The correct answer is: recurrent ipsilateral DVT</div></div></div></div></div><div id="q460" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">144</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1460"><input type="hidden" name="q20803:460_:flagged" value="0"><input type="hidden" value="qaid=911344&amp;qubaid=20803&amp;qid=5180&amp;slot=460&amp;checksum=2ef563168c467131c5367f78c2f9b3f0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:460_:flaggedcheckbox" name="q20803:460_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q460&id=5180"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:460_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man (100kg) develops heparin induced thrombocytopenia (HIT) following total hip replacement surgery. On postoperative day 8, he developed thrombocytopenia (pre-operative platelets=265,000/uL) and a calf deep venous thrombosis. Argatroban therapy was initiated. He was positive for PF4 antibodies. His platelet count reached a nadir at 42,000/uL on postoperative day 10. On postoperative day 12, his platelet count is 85,000/uL.&nbsp;The medical management of HIT in this patient includes which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:460_answer" disabled="disabled" value="0" id="q20803:460_answer0"><label for="q20803:460_answer0">a. waiting until platelets &gt;150,000/uL, then starting low dose warfarin(2mg), and discontinuing argatroban after INR &gt; 2.0</label> </div>
<div class="r1"><input type="radio" name="q20803:460_answer" disabled="disabled" value="1" id="q20803:460_answer1"><label for="q20803:460_answer1">b. waiting until platelets &gt;150,000/uL, then starting a loading dose of warfarin(10mg), and discontinuing argatroban after INR &gt; 2.0.</label> </div>
<div class="r0"><input type="radio" name="q20803:460_answer" disabled="disabled" value="2" id="q20803:460_answer2"><label for="q20803:460_answer2">c. waiting until platelets &gt;150,000/uL, discontinuing argatroban, and discharge on dual antiplatelet therapy (aspirin and clopidogrel)</label> </div>
<div class="r1"><input type="radio" name="q20803:460_answer" disabled="disabled" value="3" id="q20803:460_answer3"><label for="q20803:460_answer3">d. waiting until platelets &gt;150,000/uL, starting warfarin(5mg), discontinue argatroban and discharge with low-molecular weight heparin bridge until INR &gt; 2.0</label> </div>
<div class="r0"><input type="radio" name="q20803:460_answer" disabled="disabled" value="4" id="q20803:460_answer4"><label for="q20803:460_answer4">e. starting warfarin (5mg) and discontinuing argatroban when INR &gt; 2.0</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:460_-submit" name="q20803:460_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Heparin induced thrombocytopenia (HIT) is an acquired hypercoagulable condition secondary to the formation of PF4-IgG heparin complexes. The treatment of HIT is based on avoiding further heparin or low molecular weight heparin exposure. In addition, if not identified as part of the presentation, the upper and lower extremities should be screened for deep venous thrombosis. The primary pharmacologic regimen is based on direct thrombin inhibitors (argatroban, lepirudin, and bivalirudin) during the time period that the patient is susceptible to thromboembolic complications. This period is highest when the patient is thrombocytopenic and PF4-IgG titers are elevated; therefore, direct thrombin inhibitors are continued until the patient's platelet count recovers. The absolute safe cut-off is controversial. At a minimum, it should be &gt;100,000/uL, and most recommendations suggest &gt;150,000/uL before oral vitamin-k antagonists are initiated. The treatment of HIT associated deep venous thrombosis with warfarin alone, in the absence of simultaneous direct thrombin inhibition, is associated with a 5-20% risk of venous limb gangrene. Whereas warfarin skin necrosis typically affects skin over fatty areas of the body (breast, buttocks, and torso), venous gangrene related to HIT typically involves the entire arm or leg and can lead to amputation. The condition is associated with supratherapeutic INR levels (&gt; 3.5) after initiation of warfarin; therefore, patients should be started on low doses (2-5 mg). The primary serologic abnormality is rapid reduction of Protein C and Factor VII leading to microvascular thrombosis secondary to overriding thrombin activation by HIT complexes. Direct thrombin inhibitors should be continued until platelet count recovery (&gt;150,000/uL) INR has reached target &gt; 2.0 on warfarin, and after a minimum overlap of at least 5 days with initiation of warfarin therapy. Low-molecular weight heparin cannot be used as an anti-coagulation bridge in HIT deep venous thrombosis, and dual anti-platelet therapy is inadequate treatment for HIT associated venous thrombosis.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/18574270" target="_blank">Warkentin TE, Greinacher A, Koster A,&nbsp;Lincoff AM;&nbsp;American&nbsp;College&nbsp;of&nbsp;Chest&nbsp;Physicians.&nbsp;Treatment and Prevention of Heparin-induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 2008; (133):340S-380S.&nbsp;Erratum in:&nbsp;Chest&nbsp;2011 May;139(5):1261. Dosage error in article text.</a></p>
<p>QID: 30820</p></div><div class="rightanswer">The correct answer is: waiting until platelets &gt;150,000/uL, then starting low dose warfarin(2mg), and discontinuing argatroban after INR &gt; 2.0</div></div></div></div></div><div id="q214" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">145</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1469"><input type="hidden" name="q20803:214_:flagged" value="0"><input type="hidden" value="qaid=911098&amp;qubaid=20803&amp;qid=4706&amp;slot=214&amp;checksum=ecfe27651a12b9757eca4f52da8b5f8e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:214_:flaggedcheckbox" name="q20803:214_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q214&id=4706"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:214_:sequencecheck" value="2"><div class="qtext"><p>A 72-year-old right handed man complains of dizziness when lifting and using his right arm. &nbsp;In regards to this patient, which of the following statements is <strong>not</strong> true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:214_answer" disabled="disabled" value="0" id="q20803:214_answer0"><label for="q20803:214_answer0">a. his duplex scan may demonstrate "to and fro" vertebral flow</label> </div>
<div class="r1"><input type="radio" name="q20803:214_answer" disabled="disabled" value="1" id="q20803:214_answer1"><label for="q20803:214_answer1">b. proximal subclavian stenosis may result in these symptoms</label> </div>
<div class="r0"><input type="radio" name="q20803:214_answer" disabled="disabled" value="2" id="q20803:214_answer2"><label for="q20803:214_answer2">c. his duplex scan would show high grade right carotid stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:214_answer" disabled="disabled" value="3" id="q20803:214_answer3"><label for="q20803:214_answer3">d. ipsilateral retrograde vertebral flow would be diagnostic of subclavian steal syndrome</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:214_-submit" name="q20803:214_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The term subclavian steal syndrome refers to a clinical scenario of reduced, upper extremity, or cerebral, blood flow. The vertebral artery demonstrates reversal of blood flow or alternates antegrade and retrograde flow (known as the "to and fro" pattern) on duplex imaging. The cause of the reversal of flow is the stenosis or occlusion of the vessel proximal to the vertebral artery&nbsp;and can be either the inominate or subclavian arteries. Upon demand for more blood flow in the upper extremity during use or exercise, the vertebral artery becomes an important collateral supplying the arm. The resulting lower antegrade flow in the basilar artery can lead to posterior circulation ischemia and symptoms. While these flow changes may be seen on routine duplex, they may not be accompanied by corresponding symptoms.&nbsp; Reversal of blood flow in the vertebral artery is often a benign finding and findings on duplex alone do not warrant surgical or interventional therapy. During conventional angiography of the vertebral artery, reversal of flow can be seen with forceful injections and without a proximal subclavian stenosis. Hennerci et al reported a series of 324 patients with reversal of vertebral flow and noted that only 31% of patients had hemispheric events. They concluded that reversal of blood flow was a stronger indicator of the atherosclerotic disease in the patient rather than a predictor of neurologic events.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/1878290" target="_blank">Nicholls SC, Koutlas TC, Strandness DE. Clinical significance of retrograde flow in the vertebral artery.&nbsp; Ann Vasc&nbsp;Surg&nbsp;1991; 5:331-6. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/1878290"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/3965748" target="_blank">Walker PM, Paley D, Harris KA, Thompson A<span>,&nbsp;</span>Johnston KW. What determines the symptoms associated with subclavian occlusive disease?&nbsp;J Vasc Surg 1985; 2:154-7. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/3965748"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/3362359" target="_blank">Hennerici M, Klemm C, Rautenberg W. The subclavian steal phenomena: A common vascular disorder with rare neurological deficits. Neurology 1988; 38:669-73. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/3362359"><br></a></p>
<p>QID: 30364</p></div><div class="rightanswer">The correct answer is: his duplex scan would show high grade right carotid stenosis</div></div></div></div></div><div id="q102" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">146</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1478"><input type="hidden" name="q20803:102_:flagged" value="0"><input type="hidden" value="qaid=910986&amp;qubaid=20803&amp;qid=4924&amp;slot=102&amp;checksum=e051cad5bda5166bf555e6c4cb42d7d1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:102_:flaggedcheckbox" name="q20803:102_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q102&id=4924"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:102_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old woman with a 40-pack-year smoking history presents to you 10 years status post aorto-bifemoral bypass grafting with a Dacron conduit. She draws your attention to a lump in her right groin. Duplex scanning confirms an anastomotic aneurysm measuring 2.3 x 1.8 cm. She denies fevers or any additional local or systemic signs of infection. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:102_answer" disabled="disabled" value="0" id="q20803:102_answer0"><label for="q20803:102_answer0">a. operative repair with interposition graft</label> </div>
<div class="r1"><input type="radio" name="q20803:102_answer" disabled="disabled" value="1" id="q20803:102_answer1"><label for="q20803:102_answer1">b. ultrasound-guided thrombin injection</label> </div>
<div class="r0"><input type="radio" name="q20803:102_answer" disabled="disabled" value="2" id="q20803:102_answer2"><label for="q20803:102_answer2">c. graft limb excision with extra-anatomic revascularization</label> </div>
<div class="r1"><input type="radio" name="q20803:102_answer" disabled="disabled" value="3" id="q20803:102_answer3"><label for="q20803:102_answer3">d. surveillance Duplex scanning in 3 months</label> </div>
<div class="r0"><input type="radio" name="q20803:102_answer" disabled="disabled" value="4" id="q20803:102_answer4"><label for="q20803:102_answer4">e. CTA abdomen/pelvis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:102_-submit" name="q20803:102_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In patients presenting with a groin pseudoaneurysm following an aortobifemoral repair, up to 20% will have a concomitant pseudoaneurysm at the proximal anastomosis. A CTA abdomen/pelvis allows for an accurate delineation of the anatomy from the aorta to the femoral arteries. This information is required to help assess for the nature of the pseudoaneurysm(s), indications for treatment, and possible treatment approaches. Most delayed anastomotic pseusoandeurysms are attributable to degeneration of the graft, suture line, or artery. Early onset pseudoaneurysms are more likely to have an infectious etiology, particularly coagulase negative staph. The patient warrants a more immediate evaluation than surveillance duplex, which will also not provide information regarding the remainder of the conduit or paraanastomotic vasculature. &nbsp;Lastly, treatment with ultrasound-guided thrombin injection is appropriate for groin pseudoaneurysms related to percutaneous access but not for anastomotic pseudoaneurysms, especially when the anatomy has not been delineated more clearly. Therefore, the correct answer is CTA of the abdomen and pelvis.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2001%3B14(4)%3A282-91" target="_blank">Abou-Zamzam AM Jr, Ballard JL. Management of sterile para-anastomotic aneurysms of the aorta. Semin Vasc Surg 2001;14(4):282-91.</a></p>
<p>Tedesco MM, Dalman RL. Chapter 8 - Arterial Aneurysms. In: Rutherford's Vascular Surgery, 7th Edition. Philadelphia, PA: Elsevier Saunders; 2010:117-130.</p>
<p>QID: 30154</p></div><div class="rightanswer">The correct answer is: CTA abdomen/pelvis</div></div></div></div></div><div id="q144" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">147</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1487"><input type="hidden" name="q20803:144_:flagged" value="0"><input type="hidden" value="qaid=911028&amp;qubaid=20803&amp;qid=4762&amp;slot=144&amp;checksum=062302d9eac16c338fcc467835603c37&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:144_:flaggedcheckbox" name="q20803:144_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q144&id=4762"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:144_:sequencecheck" value="2"><div class="qtext"><p>A&nbsp;56-year-old man who is right-handed presents with pallor and pain of his right third finger that developed spontaneously about 3 weeks ago. He has no pertinent co-morbidities. His occupation requires frequent use of both hands to strike objects. On examination, he had normal bilateral arm pulses and equal blood pressures. An image from the arteriography is shown below. &nbsp;Which of the following is the most appropriate management option for this patient?</p>
<p>&nbsp;</p>
<p><img src="./VESAP3_files/2(2).jpg" alt="" width="468" height="268"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:144_answer" disabled="disabled" value="0" id="q20803:144_answer0"><label for="q20803:144_answer0">a. oral corticosteroids</label> </div>
<div class="r1"><input type="radio" name="q20803:144_answer" disabled="disabled" value="1" id="q20803:144_answer1"><label for="q20803:144_answer1">b. calcium channel blockers</label> </div>
<div class="r0"><input type="radio" name="q20803:144_answer" disabled="disabled" value="2" id="q20803:144_answer2"><label for="q20803:144_answer2">c. anticoagulation with heparin, followed by vitamin k antagonist</label> </div>
<div class="r1"><input type="radio" name="q20803:144_answer" disabled="disabled" value="3" id="q20803:144_answer3"><label for="q20803:144_answer3">d. avoidance of cold environments or emotional stress</label> </div>
<div class="r0"><input type="radio" name="q20803:144_answer" disabled="disabled" value="4" id="q20803:144_answer4"><label for="q20803:144_answer4">e. interposition vein graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:144_-submit" name="q20803:144_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has hypothenar hammer syndrome, or digital ischemia, caused by an embolus from his palmar ulnar artery associated with repetitive trauma. The superficial path of the ulnar artery as it passes adjacent to the hamate is believed to make this vessel particularly vulnerable to injury. Aneurysmal degeneration, intraluminal thrombus formation, and digital artery embolization may subsequently occur. The most appropriate therapy consists of excision of the affected patent ulnar artery segment with vein graft interposition.</p>
<p>Operation through a longitudinal palmar incision (Fig 1) confirmed localized aneurysm formation in the ulnar artery (Fig 2), with intraluminal thrombus (Fig 3). Ligation of the palmar ulnar artery is also an acceptable treatment, assuming an intact radial artery/palmar arch. Asymptomatic palmar ulnar artery occlusions do not require treatment. Elective replacement of diseased but asymptomatic patent palmar ulnar artery segments discovered during bilateral arteriography performed for investigation of contralateral symptoms seems reasonable. This patient’s symptoms resolved and he gradually returned to all normal activities.</p>
<p><em><img src="./VESAP3_files/3.jpg" alt="" width="407" height="305"></em></p>
<p><img src="./VESAP3_files/4.jpg" alt="" width="392" height="294"></p>
<p><img src="./VESAP3_files/5.jpg" alt="" width="336" height="252"></p>
<p><em>&nbsp;</em></p>
<p>&nbsp;</p>
<h2>References</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B+37(3)%3A697." target="_blank">Taylor LM Jr. Hypothenar hammer syndrome. J Vasc Surg&nbsp;2003; 37(3):697.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2000%3B+31%3A104-13." target="_blank">Ferris BL, Taylor LM Jr, Oyama K, McLafferty RB<span>,&nbsp;</span>Edwards JM<span>,&nbsp;</span>Moneta GL,&nbsp;et al. Hypothenar hammer syndrome: proposed etiology. J Vasc Surg<em>&nbsp;</em>2000; 31:104-13.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Surg+206%3A188-9." target="_blank">Marques E. Ulnar artery thrombosis: hypothenar hammer syndrome. J Am Coll Surg 2008; 206:188-9.</a></p>
<p>QID: 30238</p></div><div class="rightanswer">The correct answer is: interposition vein graft</div></div></div></div></div><div id="q151" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">148</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1496"><input type="hidden" name="q20803:151_:flagged" value="0"><input type="hidden" value="qaid=911035&amp;qubaid=20803&amp;qid=4769&amp;slot=151&amp;checksum=596f97fda9cbf569565dc8e64c33da6d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:151_:flaggedcheckbox" name="q20803:151_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q151&id=4769"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:151_:sequencecheck" value="2"><div class="qtext"><p>A 34-year-old man presents with pain in his right second and third fingers. He reports significant cold intolerance in these fingers. Radial and ulnar pulses are palpable. The first and second fingers are cool and cyanotic. A computed tomographic (CT) angiogram is performed and is shown below. In addition to reconstruction of the subclavian artery, which of the following therapeutic options is the most appropriate?<br></p><p><img src="./VESAP3_files/Cull - 6 image.jpg" alt="Cull - 6 image" width="359" height="238"></p>
<p><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:151_answer" disabled="disabled" value="0" id="q20803:151_answer0"><label for="q20803:151_answer0">a. cervical rib resection</label> </div>
<div class="r1"><input type="radio" name="q20803:151_answer" disabled="disabled" value="1" id="q20803:151_answer1"><label for="q20803:151_answer1">b. lifelong anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:151_answer" disabled="disabled" value="2" id="q20803:151_answer2"><label for="q20803:151_answer2">c. anterior and middle scalenectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:151_answer" disabled="disabled" value="3" id="q20803:151_answer3"><label for="q20803:151_answer3">d. cervical sympathectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:151_answer" disabled="disabled" value="4" id="q20803:151_answer4"><label for="q20803:151_answer4">e. excision of subclavius muscle</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:151_-submit" name="q20803:151_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has developed chronic, degenerative changes in the subclavian artery as a result of arterial thoracic outlet syndrome. Intermittent compression of his subclavian artery aneurysm has resulted in distal embolization. This pathology is most often seen in patients with a cervical rib. Cervical rib resection can be safely performed through a cervical approach. If a first rib resection is required, it may be performed through a supraclavicular, infraclavicular, or transaxillary approach. Cervical sympathectomy may be of value as an adjunct procedure, especially if there was digital tissue loss or severe occlusive disease in the hand, but this would not address the underlying pathology and would not be required in the clinical situation described above. Lifelong anticoagulation is not indicated and does not treat the underlying osseous compression. The subclavius muscle plays a significant role in venous thoracic outlet syndrome by compressing the anterior/cranial surface of the subclavian vein. The subclavius muscle does not play a significant role in compression of the subclavian artery. The subclavian artery and vein are separated at the level of the first rib by the insertion of the anterior scalene muscle on the scalene tubercle. Scalene muscle hypertrophy plays an etiologic role in neurogenic thoracic outlet, but is less important in contributing to arterial compression.</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1995%3B+21%3A57-69." target="_blank">Durham JR, Yao JS, Pearce WH, Nuber GM<span>,&nbsp;</span>McCarthy WJ 3rd<span>.</span>&nbsp;Arterial injuries in the thoracic outlet syndrome. J Vasc Surg 1995; 21:57-69.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2010%3B+52%3A406-11." target="_blank">Criado E, Berguer R, Greenfield L. The spectrum of arterial compression at the thoracic outlet. J Vasc Surg 2010; 52:406-11.</a></p>
<p>QID: 30245</p></div><div class="rightanswer">The correct answer is: cervical rib resection</div></div></div></div></div><div id="q431" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">149</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1505"><input type="hidden" name="q20803:431_:flagged" value="0"><input type="hidden" value="qaid=911315&amp;qubaid=20803&amp;qid=4875&amp;slot=431&amp;checksum=f8f1ae5b77a58100e931bb0a0d531aaf&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:431_:flaggedcheckbox" name="q20803:431_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q431&id=4875"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:431_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old man has a left leg recurring venous ulcer over the medial malleolus. The extremity is moderately swollen up to mid calf. Ten years earlier, he had ligation and stripping of the entire great saphenous vein. He has no history of deep venous thrombosis. Venous duplex ultrasound demonstrates a patent deep system in the popliteal and femoral veins with valve closure times between 1.25 and 1.67 seconds. The tibial veins are patent and normal. In the thigh, there is an accessory saphenous vein with reflux of 0.87 seconds. The reflux time of the small saphenous vein&nbsp;is 0.67 seconds; a calf perforator&nbsp;has a reflux time of&nbsp;0.74 seconds and is 2 mm in diameter and 15 cm above the ulcer margin. The common femoral vein is patent with the Doppler flow pattern shown in the image below. Which of the following is the most likely diagnosis for the recurrent venous ulcer?</p>
<p><a href="./VESAP3_files/Raffetto Fig 1.jpg" target="images"><img src="./VESAP3_files/Raffetto Fig 1.jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:431_answer" disabled="disabled" value="0" id="q20803:431_answer0"><label for="q20803:431_answer0">a. perforator vein incompetence</label> </div>
<div class="r1"><input type="radio" name="q20803:431_answer" disabled="disabled" value="1" id="q20803:431_answer1"><label for="q20803:431_answer1">b. remnant or duplicate great saphenous vein incompetence missed on ultrasonography</label> </div>
<div class="r0"><input type="radio" name="q20803:431_answer" disabled="disabled" value="2" id="q20803:431_answer2"><label for="q20803:431_answer2">c. proximal iliac vein obstruction</label> </div>
<div class="r1"><input type="radio" name="q20803:431_answer" disabled="disabled" value="3" id="q20803:431_answer3"><label for="q20803:431_answer3">d. incompetent anterior thigh accessory saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:431_answer" disabled="disabled" value="4" id="q20803:431_answer4"><label for="q20803:431_answer4">e. small saphenous vein incompetence</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:431_-submit" name="q20803:431_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The patient has a recurrent venous ulcer with calf swelling in the setting of a previous great saphenous vein ligation and stripping. The abnormal spectral pattern with continuous flow on Doppler ultrasound (absence of respiratory variation) is highly suggestive of proximal venous obstruction. Approximately 37% of patients presenting with venous ulcers, or a healed venous ulcer, have iliocaval vein obstruction. In fact, in a study evaluating iliocaval obstruction by CT or MR venography, 23% of patients with an active or healed venous ulcer had evidence of at least 80% iliocaval obstruction. No ulcer or healed ulcer patient with isolated superficial reflux had iliocaval obstruction. This patient's deep system reflux is most likely a result of increased venous pressure from iliocaval obstruction. Although perforator insufficiency can lead to recurrent ulcers, the perforator in this patient is of a small diameter and at a significant distance from the ulcer margin, making it unlikely to be the source of recurrence. Most perforators that are pathologic are at least 3.5 mm in diameter and in the immediate vicinity of or under the ulcer. Isolated small saphenous vein incompetence can cause venous ulcers, but this is usually on the lateral malleolus and associated with great saphenous vein incompetence. Duplicate or remnant great saphenous veins that are incompetent can lead to skin changes, but this is rare. Moreover, the patient had stripping of his great saphenous vein, so it is unlikely that this vein was missed on the ultrasound exam. An incompetent anterior thigh accessory saphenous vein can cause pain and varicose veins, but is not a source of venous ulcer or significant skin changes.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53%3A1303-8." target="_blank">Marston W, Fish D, Unger J, Keagy B. Incidence of and risk factors for iliocaval venous obstruction in patients with active or healed venous leg ulcers. J Vasc Surg 2011; 53:1303-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53%3A2S-48S." target="_blank">Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.&nbsp;J Vasc Surg 2011;53:2S-48S.</a></p>
<p>QID: 30756</p></div><div class="rightanswer">The correct answer is: proximal iliac vein obstruction</div></div></div></div></div><div id="q323" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">150</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1514"><input type="hidden" name="q20803:323_:flagged" value="0"><input type="hidden" value="qaid=911207&amp;qubaid=20803&amp;qid=5088&amp;slot=323&amp;checksum=635f7878624a28dc9d8525be03f46f2f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:323_:flaggedcheckbox" name="q20803:323_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q323&id=5088"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:323_:sequencecheck" value="2"><div class="qtext"><p>Which of the following patients would be expected to have the best outcome (improved blood pressure control, renal function, and kidney survival) after percutaneous renal intervention?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:323_answer" disabled="disabled" value="0" id="q20803:323_answer0"><label for="q20803:323_answer0">a. peak systolic velocity 250 cm/sec, renal aortic ratio 3.9, renal resistive index = 0.88</label> </div>
<div class="r1"><input type="radio" name="q20803:323_answer" disabled="disabled" value="1" id="q20803:323_answer1"><label for="q20803:323_answer1">b. peak systolic velocity 250 cm/sec, renal aortic ratio 3.8, renal resistive index&nbsp;= 0.60</label> </div>
<div class="r0"><input type="radio" name="q20803:323_answer" disabled="disabled" value="2" id="q20803:323_answer2"><label for="q20803:323_answer2">c. peak systolic velocity 350cm/sec, renal aortic ratio 4.0, renal resistive index = 0.90</label> </div>
<div class="r1"><input type="radio" name="q20803:323_answer" disabled="disabled" value="3" id="q20803:323_answer3"><label for="q20803:323_answer3">d. peak systolic velocity 100 cm/sec, renal aortic ratio 1.0, renal resistive index = 0.70</label> </div>
<div class="r0"><input type="radio" name="q20803:323_answer" disabled="disabled" value="4" id="q20803:323_answer4"><label for="q20803:323_answer4">e. peak systolic velocity 250 cm/sec, renal aortic ratio 2.0, renal resistive index = 0.70</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:323_-submit" name="q20803:323_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Renal resistive index (RRI) is a simple parameter that can be derived from a renal ultrasound Doppler spectrum. The index describes the percentage reduction of end-diastolic blood flow (Vmin) in the investigated vessel (interlobar artery in that particular study) in relation to maximal systolic blood flow (Vmax): resistive index = (Vmax – Vmin)/Vmax. It is considered as a marker of downstream vascular impedance. The index can be correlated with glomerular sclerosis, tubulo-interstitial changes, and arteriolosclerosis in renal parenchymal disease.</p>
<p>Radermacher et al tested Renal Resistive Index (RRI) as a predictor of outcomes in a study with 131 patients with renal vascular disease who underwent corrective surgery or angioplasty. The authors found that a RRI value less than 0.8 to be a reliable marker in identifying patients in whom angioplasty or surgery is likely to improve renal function, blood pressure, or kidney survival. In a recently published retrospective analysis of 592 renal interventions, parenchymal volume preservation after the renal interventions was assessed as an outcome measure after renal interventions. In this series, parenchymal volume loss occurred in one-third of patients, and higher RRI values (0.75 ± 0.9 vs 0.73 ± 0.10; <em>P&nbsp;</em>= .0001) were found to be correlated with renal parenchymal loss even after a successful procedure.&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11172177" target="_blank">Radermacher J, Chavan A, Bleck J, Vitzthum A,&nbsp;Stoess B,&nbsp;Gebel MJ,&nbsp;et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med. 2001;344(6):410-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Davies+MG%2C+Saad+WE%2C+Bismuth+J%2C+Naoum+JJ%2C+Peden+EK%2C+Lumsden+AB.+Renal+parenchymal+preservation+after+percutaneous+renal+angioplasty+and+stenting." target="_blank">Davies MG, Saad WE, Bismuth J, Naoum JJ, Peden EK, Lumsden AB. Renal parenchymal preservation after percutaneous renal angioplasty and stenting. J Vasc Surg 2010; 51(5):1222-9.</a></p>
<p>QID: 30557</p></div><div class="rightanswer">The correct answer is: peak systolic velocity 250 cm/sec, renal aortic ratio 3.8, renal resistive index&nbsp;= 0.60</div></div></div></div></div><div id="q481" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">151</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1523"><input type="hidden" name="q20803:481_:flagged" value="0"><input type="hidden" value="qaid=911365&amp;qubaid=20803&amp;qid=5207&amp;slot=481&amp;checksum=72607c554c6b23bdc89e005728864cdb&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:481_:flaggedcheckbox" name="q20803:481_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q481&id=5207"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:481_:sequencecheck" value="2"><div class="qtext"><p>With use of lovastatin, a HMG CoA reductase (hydroxymethylglutaryl CoA reductase) inhibitor, which of the following increases the risk of serious myopathy the most?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:481_answer" disabled="disabled" value="0" id="q20803:481_answer0"><label for="q20803:481_answer0">a. chronic hepatitis C infection</label> </div>
<div class="r1"><input type="radio" name="q20803:481_answer" disabled="disabled" value="1" id="q20803:481_answer1"><label for="q20803:481_answer1">b. hypothyroidism</label> </div>
<div class="r0"><input type="radio" name="q20803:481_answer" disabled="disabled" value="2" id="q20803:481_answer2"><label for="q20803:481_answer2">c. southwestern USA Native American ethnicity</label> </div>
<div class="r1"><input type="radio" name="q20803:481_answer" disabled="disabled" value="3" id="q20803:481_answer3"><label for="q20803:481_answer3">d. daily consumption of 6oz of grapefruit juice</label> </div>
<div class="r0"><input type="radio" name="q20803:481_answer" disabled="disabled" value="4" id="q20803:481_answer4"><label for="q20803:481_answer4">e. combination therapy with gemfibrozil</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:481_-submit" name="q20803:481_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Of lipid lowering drugs, statins have the greatest LDL-cholesterol lowering effect and are best at improving cardiovascular disease outcomes. Currently available statins include lovastatin, pravastatin, simvastatin, fluvastatin, atorvastatin, and rosuvastatin.</p>
<p>While discontinuation of statin therapy for side effects is relatively common, adverse reactions occur less frequently with statins than with other classes of lipid lowering agents. Many patients will tolerate the same statin or another statin when therapy is restarted.</p>
<p>Myopathy is the most common statin side effect. Myalgia can occur in 2-11% of those treated with statin. Muscle symptoms usually begin within weeks to months after initiation of therapy and resolve over days to weeks after drug discontinuation. Statin-induced myalgias may occur without an elevation in serum creatine kinase (CK) concentration. Serious muscle complications are uncommon (myositis 0.5%; rhabdomyolysis &lt;1%).</p>
<p>The combination of any statin with vibrates (gemfibrozil in particular) increases the risk of muscle toxicity.</p>
<p>Co-administration of a statin and a fibrate may be effective for mixed dyslipidemia, for patients with hypertriglyceridemia (with or without diabetes mellitus), or for patients with high triglyceride levels who have achieved their targeted LDL-cholesterol goal with statin monotherapy. Pravastatin is preferred for combination therapy with fibric acid derivatives, but only if the benefit is likely to outweigh the low risk of myopathy.</p>
<p>Risks of adverse reactions are increased when statins that have significant metabolism by cytochrome P 450 3A4 (including lovastatin, simvastatin, and atorvastatin) are used concurrently with drugs that interfere with CYP3A4. Grapefruit juice also inhibits CYP3A4; however, less than 8oz of grapefruit juice daily (the equivalent of half of a grapefruit) is not a risk factor for myopathy or other statin-related complications.</p>
<p>Hepatic dysfunction may incur a modest increased risk for statin-related liver injury, but the risk appears to be very small. FDA-required labeling information for statins recommends liver function testing prior to initiation of therapy, but to repeat testing&nbsp;<span style="line-height: 1.5;">only&nbsp;</span><span style="line-height: 1.5;">for clinical indications. Hepatitis C infection is not a specific risk.</span></p>
<p>Genetic differences in the rate of statin metabolism contribute to variability in effectiveness and risk side effects associated with statins. However, Native Americans have not been specifically identified as having increased risk.</p>
<p>Hypothyroidism is a potential cause of dyslipidemia and there are reports of hypothyroidism contributing to statin-induced myopathy. Though this occurrence is rare, it may be appropriate to check TSH level prior to starting therapy with a statin.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Int+J+Cardiol+2012%3B+159(3)%3A169-76." target="_blank">Rallidis LS, Fountoulaki K, Anastasiou-Nana M. Managing the underestimated risk of statin-associated myopathy. Int J Cardiol 2012; 159(3):169-76.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Endocrinol+Metab+Clin+North+Am+2009%3B+38(1)%3A121-36." target="_blank">Venero CV, Thompson PD. Managing statin myopathy. Endocrinol Metab Clin North Am 2009; 38(1):121-36.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Cardiol.+2007+Mar+19%3B99(6A)%3A3C-18C." target="_blank">Davidson MH, Armani A, McKenney JM, Jacobson TA. Safety considerations with fibrate therapy. Am J Cardiol 2007; 99(6A):3C-18C.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2003%3B+289(13)%3A1681-90." target="_blank">Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA 2003; 289(13):1681-90.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Pharmacother.+2001+Sep%3B35(9)%3A1096-107." target="_blank">Omar MA, Wilson JP, Cox TS. Rhabdomyolysis and HMG-CoA reductase inhibitors. Ann Pharmacother 2001; 35(9):1096-107. Erratum in: Ann Pharmacother 2001; 35(10):1296.</a></p>
<p>QID: 30846</p></div><div class="rightanswer">The correct answer is: combination therapy with gemfibrozil</div></div></div></div></div><div id="q133" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">152</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1532"><input type="hidden" name="q20803:133_:flagged" value="0"><input type="hidden" value="qaid=911017&amp;qubaid=20803&amp;qid=4750&amp;slot=133&amp;checksum=ce4d508fcd382cfdc21368c9dbdbb086&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:133_:flaggedcheckbox" name="q20803:133_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q133&id=4750"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:133_:sequencecheck" value="2"><div class="qtext"><p>A 44-year-old woman presents with right 4<sup>th</sup> and 5<sup>th</sup> finger pain and discoloration. Her arm blood pressures are equal, with normal bilateral upper extremity pulses. There is a mild pulsation palpable below the clavicle which is not present on the left. A peri-clavicular right bruit is present. The distal right 4<sup>th</sup> and 5<sup>th</sup> digits are dusky and painful to touch. The imaging obtained is shown below. Which of the following statements regarding this patient's condition is <strong>true</strong>?</p>
<p><a href="./VESAP3_files/CervRib .jpg" target="images"><img src="./VESAP3_files/CervRib .jpg" alt="Cervical rib on CTA scout radiography" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:133_answer" disabled="disabled" value="0" id="q20803:133_answer0"><label for="q20803:133_answer0">a. X-ray shows the most common etiology of arterial thoracic outlet syndrome (TOS)</label> </div>
<div class="r1"><input type="radio" name="q20803:133_answer" disabled="disabled" value="1" id="q20803:133_answer1"><label for="q20803:133_answer1">b. symptoms caused by arterial compression&nbsp;is the most common presentation of thoracic outlet syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:133_answer" disabled="disabled" value="2" id="q20803:133_answer2"><label for="q20803:133_answer2">c. the patient's symptoms are most likely caused by brachial plexus compression</label> </div>
<div class="r1"><input type="radio" name="q20803:133_answer" disabled="disabled" value="3" id="q20803:133_answer3"><label for="q20803:133_answer3">d. the patient's symptoms are most likely caused by subclavian vein compression</label> </div>
<div class="r0"><input type="radio" name="q20803:133_answer" disabled="disabled" value="4" id="q20803:133_answer4"><label for="q20803:133_answer4">e. the patient's symptoms are most likely due to a vasospastic disorder</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:133_-submit" name="q20803:133_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This radiograph shows bilateral cervical ribs. Cervical ribs occur in less than 1% of the population, and most are asymptomatic. There is an anatomic spectrum from prominent C7 transverse process to full C7 rib with fusion to the 1<sup>st</sup> thoracic rib. Repetitive trauma to the subclavian artery with arm use appears to be the causative factor leading to dilation, aneurysmal degeneration, and subsequent laminar thrombus formation. Speaking to the repetitive use theory, it has been suggested that symptomatic arterial TOS occurs more frequently on the hand-dominant side, even in the face of bilateral osseus abnormalities. It is not infrequent for these patients to develop secondary Raynaud’s phenomenon, or to be misdiagnosed with primary vasospastic disorder.</p>
<p>Arterial TOS is due to a narrowed costoclavicular space and the noted repetitive arterial trauma. Cervical ribs are the causative anatomic anomaly in nearly two-thirds&nbsp;of arterial TOS cases. First rib abnormalities occur in 20%, fibrocartilagnious bands in 10%, and both prior clavicular fractures and enlarged C7 transverse processes in less than 5% each. Arterial TOS is the least frequent form of TOS occurring in some 3-6% of cases, with neurogenic accounting for 80-85% and venous 12-16%. Although subclavian artery thrombosis and retrograde vertebral stroke may rarely occur, the most common symptomatic development in arterial TOS is thromboembolism, as represented in this described case. Brachial plexus compression, like neurogenic TOS, leads to pain more proximal in the arm. Venous TOS with thrombosis presents with acute edema and cyanosis.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+57%3A771-5." target="_blank">Chang KZ, Likes K, Davis K, Demos J, Freischlag JA. The significance of cervical ribs in thoracic outlet syndrome. J Vasc Surg 2013; 57:771-5.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2010%3B+52%3A406-11." target="_blank">Criado E, Berguer R, Greenfield L. The spectrum of arterial compression of the thoracic outlet. J Vasc Surg 2010; 52:406-11.</a></p>
<p>QID: 30226</p></div><div class="rightanswer">The correct answer is: X-ray shows the most common etiology of arterial thoracic outlet syndrome (TOS)</div></div></div></div></div><div id="q176" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">153</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1541"><input type="hidden" name="q20803:176_:flagged" value="0"><input type="hidden" value="qaid=911060&amp;qubaid=20803&amp;qid=4679&amp;slot=176&amp;checksum=03920596674477015f8435b3ee28fa46&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:176_:flaggedcheckbox" name="q20803:176_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q176&id=4679"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:176_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old man presents with a 50-69% right internal carotid stenosis. Each of the following imaging&nbsp;findings is characteristic of a vulnerable plaque <strong>except</strong><em>:</em></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:176_answer" disabled="disabled" value="0" id="q20803:176_answer0"><label for="q20803:176_answer0">a. thin or ruptured fibrous cap</label> </div>
<div class="r1"><input type="radio" name="q20803:176_answer" disabled="disabled" value="1" id="q20803:176_answer1"><label for="q20803:176_answer1">b. lipid-rich necrotic core</label> </div>
<div class="r0"><input type="radio" name="q20803:176_answer" disabled="disabled" value="2" id="q20803:176_answer2"><label for="q20803:176_answer2">c. intraplaque hemorrhage</label> </div>
<div class="r1"><input type="radio" name="q20803:176_answer" disabled="disabled" value="3" id="q20803:176_answer3"><label for="q20803:176_answer3">d. plaque ulceration</label> </div>
<div class="r0"><input type="radio" name="q20803:176_answer" disabled="disabled" value="4" id="q20803:176_answer4"><label for="q20803:176_answer4">e. <p>absence&nbsp;of gadolinium enhancement on contrast MRI</p></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:176_-submit" name="q20803:176_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>During the last decade, investigators have pursued efforts to identify imaging characteristics of carotid plaques beyond degree of stenosis that identify those more likely to result in stroke. Such plaques are referred to as being unstable or vulnerable, based on the notion that they are more likely to undergo rupture with subsequent stroke due to athero-embolization. It is the desire that by identifying such imaging characteristics of vulnerable plaques, vascular specialists may be able to optimize treatment of the asymptomatic patient by identifying those who are most likely to benefit from carotid intervention. Specific plaque characteristics on MRI, CT, or duplex US imaging that have been associated with increased event rates include&nbsp;the presence of a lipid rich necrotic core,&nbsp;intra-plaque hemorrhage,&nbsp;plaque ulceration, and&nbsp;a thin or ruptured plaque.</p>
<p>Other factors, including gadolinium enhancement on contrast MRI and high FDG uptake on PET imaging, have also been associated with higher event rates.&nbsp; In addition to the degree of stenosis, the presence of plaque ulceration is considered by some surgeons to be a relative indication for CEA in asymptomatic patients. Efforts to promote the use of these newer imaging characteristics are underway. Whether these factors will add specificity to our current stenosis-based risk stratification remains to be determined.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21640306" target="_blank">Young VE, Sadat U, Gillard JH. Noninvasive carotid artery imaging with a focus on the vulnerable plaque. Neuroimaging Clinics of North America 2011; 21(2): 391-405. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/21640306"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23375613" target="_blank">Millon A, Mathevet JL<span>,&nbsp;</span>Boussel L<span>,&nbsp;</span>Faries PL<span>,&nbsp;</span>Fayad ZA<span>,&nbsp;</span>Douek PC,&nbsp;et al. High-resolution magnetic resonance imaging of carotid atherosclerosis identifies vulnerable carotid plaques. J Vasc Surg 2013; 57(4): 1046-51</a><a href="http://www.ncbi.nlm.nih.gov/pubmed/23375613"><br></a></p>
<p>QID: 30317</p></div><div class="rightanswer">The correct answer is: <p>absence&nbsp;of gadolinium enhancement on contrast MRI</p></div></div></div></div></div><div id="q197" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">154</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1550"><input type="hidden" name="q20803:197_:flagged" value="0"><input type="hidden" value="qaid=911081&amp;qubaid=20803&amp;qid=4688&amp;slot=197&amp;checksum=f78be5a5dd298913dfa65a47b1d47e97&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:197_:flaggedcheckbox" name="q20803:197_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q197&id=4688"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:197_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old man with a symptomatic 80% right internal carotid artery stenosis (TIA) presents for evaluation for carotid revascularization. His co-morbidities include CAD, HTN, DM, and COPD. He has had a previous CABG and several coronary stents but still occasionally gets angina. He is on home oxygen for his COPD. You recommend carotid stenting and he asks about potential complications from the procedure. With regards to complications of CAS, which of the following statements is true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:197_answer" disabled="disabled" value="0" id="q20803:197_answer0"><label for="q20803:197_answer0">a. oral antiplatelet agents should not be administered until after the sheath is removed to minimize the risk of hematoma</label> </div>
<div class="r1"><input type="radio" name="q20803:197_answer" disabled="disabled" value="1" id="q20803:197_answer1"><label for="q20803:197_answer1">b. hyperperfusion is not a risk after carotid stenting in comparison to carotid endarterectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:197_answer" disabled="disabled" value="2" id="q20803:197_answer2"><label for="q20803:197_answer2">c. tachycardia after stent deployment is common</label> </div>
<div class="r1"><input type="radio" name="q20803:197_answer" disabled="disabled" value="3" id="q20803:197_answer3"><label for="q20803:197_answer3">d. major access site complications occur less than 5% of the time</label> </div>
<div class="r0"><input type="radio" name="q20803:197_answer" disabled="disabled" value="4" id="q20803:197_answer4"><label for="q20803:197_answer4">e. hypotension during post-dilation of the stent should be treated with epinephrine infusion</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:197_-submit" name="q20803:197_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Complications of CAS include: systemic, access-related, technical, and neurologic. Systemic complications consist of arrhythmias, hemodynamic instability, cardiac complications, and renal dysfunction. Bradycardia, hypertension or hypotension, and even asystole can occur with angioplasty or stenting from stimulation of the carotid sinus; it is usually transient but can persist for several days after the procedure. Access-related complications include hemorrhage, hematoma, pseudoaneurysm, AV fistula, and infection. They occur less than 5% of the time and should not be significantly different from other invasive arterial procedures.&nbsp; Technical complications can be stent or filter thrombosis, vasospasm, arterial kinking, or arterial injury. Careful patient selection, device selection, and technique should limit these types of complications. Neurologic complications can be TIA, stroke, seizure, cerebral hemorrhage, or hyperperfusion.&nbsp; If a neurologic complication arises, it should be managed&nbsp;with supportive care. Neurologic complications from embolization during the procedure may benefit from attempted neurorescue.</p>
<p><span style="font-size: medium;">&nbsp;</span></p>
<h2><span style="font-size: medium;">References:</span></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/10512911" target="_blank">Qureshi AI, Luft AR, Sharma M, Janardhan V, Lopes DK, Khan J, et al. Frequency and determinants of postprocedural hemodynamic instability after carotid angioplasty and stenting. Stroke 1999; 30(10):2086-93. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/10512911"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/12891103" target="_blank">Tan KT, Cleveland TJ, Berczi V, McKevitt FM, Venables GS, Gaines PA. Timing and frequency of complications after carotid artery stenting: what is the optimal period of observation? J Vasc Surg 2003; 38(2):236-43. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/12891103"><br></a></p>
<p>QID: 30346</p></div><div class="rightanswer">The correct answer is: major access site complications occur less than 5% of the time</div></div></div></div></div><div id="q106" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">155</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1559"><input type="hidden" name="q20803:106_:flagged" value="0"><input type="hidden" value="qaid=910990&amp;qubaid=20803&amp;qid=4936&amp;slot=106&amp;checksum=09716608d723652a3303e36edba9ddc9&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:106_:flaggedcheckbox" name="q20803:106_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q106&id=4936"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:106_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man sees you in the office for his routine 6-month follow-up following a femoral-below-knee popliteal artery bypass grafting with a reversed saphenous vein graft. He denies any claudication symptoms out to 3 blocks, which is the farthest he usually ambulates. An ipsilateral femoral pulse is palpable, but distal pulses are not palpable. Office duplex ultrasound scanning demonstrates that the graft is patent with velocities at the proximal anastomosis of 390 cm/s and velocities throughout the remainder of the graft ranging from 25-35 cm/s. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:106_answer" disabled="disabled" value="0" id="q20803:106_answer0"><label for="q20803:106_answer0">a. perform exercise treadmill testing</label> </div>
<div class="r1"><input type="radio" name="q20803:106_answer" disabled="disabled" value="1" id="q20803:106_answer1"><label for="q20803:106_answer1">b. repeat surveillance duplex scanning and ABIs in 6 months</label> </div>
<div class="r0"><input type="radio" name="q20803:106_answer" disabled="disabled" value="2" id="q20803:106_answer2"><label for="q20803:106_answer2">c. initiate dual antiplatelet treatment</label> </div>
<div class="r1"><input type="radio" name="q20803:106_answer" disabled="disabled" value="3" id="q20803:106_answer3"><label for="q20803:106_answer3">d. initiate cilostazol therapy</label> </div>
<div class="r0"><input type="radio" name="q20803:106_answer" disabled="disabled" value="4" id="q20803:106_answer4"><label for="q20803:106_answer4">e. diagnostic angiogram with possible intervention</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:106_-submit" name="q20803:106_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The patient demonstrates duplex ultrasound findings that are suggestive of imminent graft occlusion. Specifically, a severe stenosis is signified by a peak systolic velocity (PSV) of greater than 300 cm/s or a ratio to adjacent arterial segments of greater than 3.5. Moreover, a low graft velocity distal to the area of stenosis with PSVs less than 45cm/s is suggestive of imminent graft failure. Given these findings, the patient requires further imaging in preparation for possible intervention. Surveillance is not appropriate given the concerning duplex ultrasound findings. Initiating alternative treatment with antiplatelets or cilostazol is not appropriate in the setting of a possibly failing graft, as it has not been shown to contribute to improved graft patency.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2009%3B+22(4)%3A252-60." target="_blank">Tinder CN, Bandyk DF. Detection of imminent vein graft occlusion: what is the optimal surveillance program? Semin Vasc Surg 2009; 22(4):252-60.</a>&nbsp;</p>
<p>QID: 30159</p></div><div class="rightanswer">The correct answer is: diagnostic angiogram with possible intervention</div></div></div></div></div><div id="q237" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">156</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1568"><input type="hidden" name="q20803:237_:flagged" value="0"><input type="hidden" value="qaid=911121&amp;qubaid=20803&amp;qid=1288&amp;slot=237&amp;checksum=825aadaf98f8903c4862bab34f258043&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:237_:flaggedcheckbox" name="q20803:237_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q237&id=1288"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:237_:sequencecheck" value="2"><div class="qtext"><p>An 84 year old man presents to the office for follow-up 2 weeks after placement of a left autogenous radial-cephalic wrist direct access. On physical examination of his left arm, he has no thrill or bruit in the arteriovenous (AV) access outflow, no edema, and nonpalpable radial, ulnar, and brachial artery pulses. What is the most appropriate next step in management?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:237_answer" disabled="disabled" value="0" id="q20803:237_answer0"><label for="q20803:237_answer0">a. superficial venous duplex scanning</label> </div>
<div class="r1"><input type="radio" name="q20803:237_answer" disabled="disabled" value="1" id="q20803:237_answer1"><label for="q20803:237_answer1">b. venography</label> </div>
<div class="r0"><input type="radio" name="q20803:237_answer" disabled="disabled" value="2" id="q20803:237_answer2"><label for="q20803:237_answer2">c. a hypercoagulable work-up</label> </div>
<div class="r1"><input type="radio" name="q20803:237_answer" disabled="disabled" value="3" id="q20803:237_answer3"><label for="q20803:237_answer3">d. arteriography</label> </div>
<div class="r0"><input type="radio" name="q20803:237_answer" disabled="disabled" value="4" id="q20803:237_answer4"><label for="q20803:237_answer4">e. segmental pressures and pulse volume recordings</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:237_-submit" name="q20803:237_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Access failure that occurs within 30 days of surgery is defined as early access failure. In the absence of a technical failure, such as a twisted or stenotic anastomosis, it is most commonly due to inadequate venous outflow which may be secondary to inadequate caliber of the outflow vein or central venous stenosis. Other less common causes include poor arterial inflow and anastomotic stenosis. In this patient with nonpalpable pulses, the most likely cause is inadequate arterial inflow. Upper extremity arterial inflow may be further evaluated with either segmental pressures and pulse volume recordings (PVRs) or arteriography. If upper extremity segmental pressures and PVRs are chosen, the left and right upper extremities are compared to each other; any abnormality on the left compared to the right should prompt either alternative site selection or arteriography. However, if the right upper extremity is chosen as an alternative site, this may also have an underlying arterial inflow abnormality, just not as significant as the left, which may lead to another early access thrombosis. Therefore, arteriography remains the gold standard, allowing the surgeon to both identify and possibly treat an arterial inflow stenosis, followed by performing a new AV access in the ipsilateral arm, leaving the contralateral arm for future access procedures. However, in pre-dialysis patients, the risk of iodinated contrast administration may be prohibitive.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Silva%20MB,%20Hobson%20RW,%20Pappas%20PJ,%20et%20al.%20A%20strategy%20for%20increasing%20use%20of%20autogenous%20hemodialysis%20access%20procedures:%20Impact%20of%20preoperative%20noninvasive%20evaluation.%20J%20Vasc%20Surg;%201998;%2027%20(2):302-308" target="_blank">Silva MB, Hobson RW, Pappas PJ, et al. A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation. J Vasc Surg; 1998; 27 (2):302-308</a>.</p>
<p>QID: 30415</p></div><div class="rightanswer">The correct answer is: arteriography</div></div></div></div></div><div id="q342" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">157</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1577"><input type="hidden" name="q20803:342_:flagged" value="0"><input type="hidden" value="qaid=911226&amp;qubaid=20803&amp;qid=5134&amp;slot=342&amp;checksum=67673fbd1fad26d843a1de857d8d160c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:342_:flaggedcheckbox" name="q20803:342_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q342&id=5134"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:342_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old woman with end stage renal disease, coronary artery disease, and a myocardial infarction from 6 months ago presents with progressive weight loss and postprandial abdominal pain. Mesenteric angiography is performed and an image shown below. Which of the following is the best treatment option for this patient?<br><br><a href="./VESAP3_files/AssetProxy_131.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_131.jpg" alt="img" width="100" height="131" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:342_answer" disabled="disabled" value="0" id="q20803:342_answer0"><label for="q20803:342_answer0">a. percutaneous transluminal angioplasty (PTA) and stenting of the celiac artery</label> </div>
<div class="r1"><input type="radio" name="q20803:342_answer" disabled="disabled" value="1" id="q20803:342_answer1"><label for="q20803:342_answer1">b. PTA and stenting of the superior mesenteric artery (SMA)</label> </div>
<div class="r0"><input type="radio" name="q20803:342_answer" disabled="disabled" value="2" id="q20803:342_answer2"><label for="q20803:342_answer2">c. retrograde aorta-SMA bypass with an 8 mm PTFE graft</label> </div>
<div class="r1"><input type="radio" name="q20803:342_answer" disabled="disabled" value="3" id="q20803:342_answer3"><label for="q20803:342_answer3">d. antegrade aorta to SMA and celiac artery bypass with a 12 x 6 mm bifurcated Dacron graft</label> </div>
<div class="r0"><input type="radio" name="q20803:342_answer" disabled="disabled" value="4" id="q20803:342_answer4"><label for="q20803:342_answer4">e. PTA and stenting of the SMA and celiac artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:342_-submit" name="q20803:342_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Endovascular management of visceral occlusive disease has been shown to be effective in the short- and mid-term. It is particularly helpful in high risk patients with significant co-morbidities in whom open revascularization would be hazardous, such as the patient presented. The number of vessels to be revascularized in patients with visceral disease has been debated, but it appears that for open revascularization addressing both significant celiac and SMA disease provides for improved late outcomes. Recent data also suggests that this may also be true for endovascular management. Consequently, an endovascular approach in which both the celiac and SMA disease are treated is the best option.<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2010%3B+51+(1)%3A140-7." target="_blank">Peck MA, Conrad MF<span>,&nbsp;</span>Kwolek CJ<span>,&nbsp;</span>LaMuraglia GM<span>,&nbsp;</span>Paruchuri V<span>,&nbsp;</span>Cambria RP. Intermediate-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia. J Vasc Surg 2010; 51 (1):140-7.</a></p>
<p>QID: 30608</p></div><div class="rightanswer">The correct answer is: PTA and stenting of the SMA and celiac artery</div></div></div></div></div><div id="q439" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">158</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1586"><input type="hidden" name="q20803:439_:flagged" value="0"><input type="hidden" value="qaid=911323&amp;qubaid=20803&amp;qid=4886&amp;slot=439&amp;checksum=ce9a9ff43741398bb6bdd0636790dd7c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:439_:flaggedcheckbox" name="q20803:439_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q439&id=4886"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:439_:sequencecheck" value="2"><div class="qtext"><p>Traditional therapy for DVT has been heparin/low-molecular-weight heparin (LMWH) overlapped for approximately 5 days with an oral vitamin K antagonist, which is continued for a minimum of 3 months. There is now accumulating evidence that LMWH for a prolonged period may have advantages over oral vitamin K antagonists in some clinical situations. In which of the following clinical situations would this <strong>not</strong> be the case?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:439_answer" disabled="disabled" value="0" id="q20803:439_answer0"><label for="q20803:439_answer0">a. patients aged 80 years or older</label> </div>
<div class="r1"><input type="radio" name="q20803:439_answer" disabled="disabled" value="1" id="q20803:439_answer1"><label for="q20803:439_answer1">b. cancer of solid organs which remains active</label> </div>
<div class="r0"><input type="radio" name="q20803:439_answer" disabled="disabled" value="2" id="q20803:439_answer2"><label for="q20803:439_answer2">c. patients who cannot obtain INR measurements for various logistic reasons</label> </div>
<div class="r1"><input type="radio" name="q20803:439_answer" disabled="disabled" value="3" id="q20803:439_answer3"><label for="q20803:439_answer3">d. patients in whom INRs cannot be regulated despite intense monitoring</label> </div>
<div class="r0"><input type="radio" name="q20803:439_answer" disabled="disabled" value="4" id="q20803:439_answer4"><label for="q20803:439_answer4">e. patients with idiopathic femoropopliteal level DVT</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:439_-submit" name="q20803:439_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In certain situations, the continuation of LMWH is preferred over bridging to oral anticoagulant therapy. In cancer patients, both Fragmin and Enoxaparin have been shown to be superior to standard oral anticoagulation in preventing recurrent VTE and mortality, with either no change or a decrease in major bleeding. If the INRs cannot be regulated, if INRs cannot be obtained, and in elderly patients :&gt;80 years of age, LMWH is preferred. However, there is no evidence for this policy in standard idiopathic femoropopliteal DVT.</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Intern+Med+2002%3B+162(15)%3A1729-35." target="_blank">Meyer G, Marjanovic Z, Valcke J, Lorcerie B<span>,&nbsp;</span>Gruel Y<span>,&nbsp;</span>Solal-Celigny P,&nbsp;et al.&nbsp; Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study.&nbsp; Arch Intern Med 2002; 162(15):1729-35.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+2003%3B+349%3A146-53." target="_blank">Lee AY, Levine MN, Baker RI, Bowden C<span>,&nbsp;</span>Kakkar AK<span>,&nbsp;</span>Prins M,&nbsp;et al. Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer. N Engl J Med 2003; 349:146-53.</a></p>
<p>QID: 30766</p></div><div class="rightanswer">The correct answer is: patients with idiopathic femoropopliteal level DVT</div></div></div></div></div><div id="q47" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">159</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1595"><input type="hidden" name="q20803:47_:flagged" value="0"><input type="hidden" value="qaid=910931&amp;qubaid=20803&amp;qid=4655&amp;slot=47&amp;checksum=da5693d768759eed712c7314b40dbf04&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:47_:flaggedcheckbox" name="q20803:47_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q47&id=4655"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:47_:sequencecheck" value="2"><div class="qtext"><p>A 56-year-old man underwent an open repair for a 6.5 cm abdominal aortic aneurysm (AAA). The patient had an extended hospital stay due to difficulty to wean from the ventilator, prolonged ileus, and the development of a urinary tract infection with septicemia. The patient was subsequently discharged and did well overall. The patient presented to&nbsp;your hospital 1 year later with lethargy, fevers, and fatigue and was diagnosed with an aortic graft infection. Which of the following periprocedural factors is most likely associated with the onset of aortic graft infection in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:47_answer" disabled="disabled" value="0" id="q20803:47_answer0"><label for="q20803:47_answer0">a. the development of the urinary tract infection</label> </div>
<div class="r1"><input type="radio" name="q20803:47_answer" disabled="disabled" value="1" id="q20803:47_answer1"><label for="q20803:47_answer1">b. the use of prolonged mechanical ventilation</label> </div>
<div class="r0"><input type="radio" name="q20803:47_answer" disabled="disabled" value="2" id="q20803:47_answer2"><label for="q20803:47_answer2">c. anuerysm size</label> </div>
<div class="r1"><input type="radio" name="q20803:47_answer" disabled="disabled" value="3" id="q20803:47_answer3"><label for="q20803:47_answer3">d. the type of repair performed, open compared to endovascular (EVAR)</label> </div>
<div class="r0"><input type="radio" name="q20803:47_answer" disabled="disabled" value="4" id="q20803:47_answer4"><label for="q20803:47_answer4">e. prolonged ileus</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:47_-submit" name="q20803:47_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The incidence of aortic graft infection is relatively low (1-2%). While it may become clinically evident at any time after the procedure, it most commonly occurs in the first postoperative year. The risk of aortic graft infection is similar among patients undergoing open AAA repair and EVAR. Nosocomial infections during the initial hospitalization are associated with an earlier presentation of aortic graft infection. Aortic graft infections occur more frequently in patients with septicemia and surgical site infections during the periprocedural hospitalization. Other sources of graft infection include direct perioperative contamination, mechanical erosion of the graft into the GI tract, the presence of contaminated aortic thrombus in the aneurysm sac, or bacteremia related to other interventional procedures and catheterizations. Mechanical ventilation and prolonged ileus have not been shown to predict subsequent graft infection. Graft infection is not associated with aortic diameter.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Laser+A%2C+Baker+N%2C+Rectenwald+J%2C+Eliason+JL%2C+Criado-Pallares+E%2C+Upchurch+GR%2C+Jr.+Graft+infection+after+endovascular+abdominal+aortic+aneurysm+repair.+J+Vasc+Surg+2011%3B54(1)%3A58-63." target="_blank">Laser A, Baker N, Rectenwald J, Eliason JL, Criado-Pallares E, Upchurch GR, Jr. Graft infection after endovascular abdominal aortic aneurysm repair. J Vasc Surg&nbsp;2011; 54(1):58-63.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vogel+TR%2C+Symons+R%2C+Flum+DR.+The+incidence+and+factors+associated+with+graft+infection+after+aortic+aneurysm+repair.+J+Vasc+Surg+2008%3B47(2)%3A264-269." target="_blank">Vogel TR, Symons R, Flum DR. The incidence and factors associated with graft infection after aortic aneurysm repair. J Vasc Surg 2008;47(2):264-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Bandyk+DF.+Vascular+surgical+site+infection%3A+risk+factors+and+preventive+measures.+Seminars+in+Vasc+Surg+2008%3B21(3)%3A119-123." target="_blank">Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Seminars in Vasc Surg&nbsp;2008; 21(3):119-23.</a></p>
<p>QID: 30051</p></div><div class="rightanswer">The correct answer is: the development of the urinary tract infection</div></div></div></div></div><div id="q87" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">160</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1604"><input type="hidden" name="q20803:87_:flagged" value="0"><input type="hidden" value="qaid=910971&amp;qubaid=20803&amp;qid=4902&amp;slot=87&amp;checksum=705cfb4490392b02de1abbcfc38f235a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:87_:flaggedcheckbox" name="q20803:87_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q87&id=4902"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:87_:sequencecheck" value="2"><div class="qtext"><p>A 71-year-old diabetic man presents with a history of progressively worsening claudication. He smokes 2 packs of cigarettes per day and experiences right calf pain after walking only one block. He has a 2 mm ulceration on the dorsal aspect of his right second toe. &nbsp;Which of the following represents both the appropriate Rutherford&nbsp;Classification category and the appropriate initial treatment?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:87_answer" disabled="disabled" value="0" id="q20803:87_answer0"><label for="q20803:87_answer0">a. Category 4; conservative management to include smoking cessation and a supervised exercise program</label> </div>
<div class="r1"><input type="radio" name="q20803:87_answer" disabled="disabled" value="1" id="q20803:87_answer1"><label for="q20803:87_answer1">b. Category 6; conservative management or open surgical intervention</label> </div>
<div class="r0"><input type="radio" name="q20803:87_answer" disabled="disabled" value="2" id="q20803:87_answer2"><label for="q20803:87_answer2">c. Category 3; conservative measures including smoking cessation and a supervised excercise program</label> </div>
<div class="r1"><input type="radio" name="q20803:87_answer" disabled="disabled" value="3" id="q20803:87_answer3"><label for="q20803:87_answer3">d. Category 5; endovascular or open surgical intervention</label> </div>
<div class="r0"><input type="radio" name="q20803:87_answer" disabled="disabled" value="4" id="q20803:87_answer4"><label for="q20803:87_answer4">e. Category 4; endovascular or open surgical intervention</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:87_-submit" name="q20803:87_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The Rutherford Classification for lower extremity ischemia was established for analyzing and reporting on lower extremity ischemia. The standards&nbsp;were first established in 1986 and then revised in 1997.&nbsp;&nbsp;Categories &nbsp;4-6 are those of critical limb ischemia (ischemia rest pain or tissue loss). Intervention is definitely indicated for categories 4-6. Typically, Categories 0-3 are treated with non-interventional therapies, at least initially for Categories 2 and 3.</p>
<p>The 6 categories are:</p>
<p>0- asymptomatic</p>
<p>1- mild claudication</p>
<p>2 - moderate claudication</p>
<p>3- severe claudication</p>
<p>4 - ischemia rest pain without tissue loss</p>
<p>5- minor tissue loss; ischemic ulceration not esceeding ulcer of the digits of the foot</p>
<p>6 - major tissue loss; severe ischemic ulcers or frank gangrene</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1997+%3B26%3A517-38." target="_blank">Rutherford RB, Baker JD, Ernst C, Johnston KW, Porter JP, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: Revised version.&nbsp; J Vasc Surg 1997 ;26:517-38.</a></p>
<p>QID: 30132</p></div><div class="rightanswer">The correct answer is: Category 5; endovascular or open surgical intervention</div></div></div></div></div><div id="q183" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">161</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1613"><input type="hidden" name="q20803:183_:flagged" value="0"><input type="hidden" value="qaid=911067&amp;qubaid=20803&amp;qid=4550&amp;slot=183&amp;checksum=b3dffd6239d3250db181457deda07491&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:183_:flaggedcheckbox" name="q20803:183_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q183&id=4550"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:183_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is an indication for emergency carotid endarterectomy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:183_answer" disabled="disabled" value="0" id="q20803:183_answer0"><label for="q20803:183_answer0">a. Severe stroke with an 80 - 99% stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:183_answer" disabled="disabled" value="1" id="q20803:183_answer1"><label for="q20803:183_answer1">b. Retinal infarction with an 80 - 99% stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:183_answer" disabled="disabled" value="2" id="q20803:183_answer2"><label for="q20803:183_answer2">c. Asymptomatic with an 80 - 99% internal carotid artery stenosis.</label> </div>
<div class="r1"><input type="radio" name="q20803:183_answer" disabled="disabled" value="3" id="q20803:183_answer3"><label for="q20803:183_answer3">d. Transient ischemic attacks in the distribution of tandem lesions at the carotid bifurcation and intracranial carotid siphon</label> </div>
<div class="r0"><input type="radio" name="q20803:183_answer" disabled="disabled" value="4" id="q20803:183_answer4"><label for="q20803:183_answer4">e. Crescendo transient ischemic attacks with a 50 - 99% stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:183_-submit" name="q20803:183_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Crescendo transient ischemic attacks (TIAs) represents an unstable plaque and calls for an emergent carotid endarterectomy. The retinal infarction from carotid stenosis is certainly an indication for carotid endarterectomy but not necessarily on an emergent basis. Asymptomatic high grade carotid artery stenosis does not require emergent surgery. After a severe stroke, there is usually an interval of recovery before endarterectomy should be considered, the exact length of which remains debated. Most now believe that waiting longer than 2-4 weeks places the patient at an unnecessary risk of recurrent stroke. Transient ischemic attacks (TIAs) with a carotid stenosis should be treated aggressively whether it is associated with an intracranial stenosis or not, but this is not considered an indication for emergent surgery.</p>
<p>References:</p>
<p>1. Johnston SC, Nguyen-Huynh MN, Schwarz ME, et al. National Stroke Association guidelines for the management of transient ischemic attacks. Ann Neurol 2006, 60: 301-13. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16912978">http://www.ncbi.nlm.nih.gov/pubmed/16912978</a></p>
<p>2. Chaturvedi S, Bruno A, Feasby T, et al. Carotid endarterectomy—an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005; 65:794-801. <a href="http://www.ncbi.nlm.nih.gov/pubmed/16186516">http://www.ncbi.nlm.nih.gov/pubmed/16186516</a></p>
<p>3. Rothwell PM, Giles MF, Chandratheva A, et al. Effect of urgent treatment of transient ischaemic attack and minor stroke on early recurrent stroke (EXPRESS study): a prospective population-based sequential comparison. Lancet 2007; 370:1432-42. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19200786">http://www.ncbi.nlm.nih.gov/pubmed/19200786</a></p>
<p>4. Rothwell PM, Eliasziw M, Gutnikov SA, et al. Carotid Endarterectomy Trialists Collaboration. Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363:915-24. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15043958">http://www.ncbi.nlm.nih.gov/pubmed/15043958</a></p>
<p>5. Falkensammer J, Duschek N, Skrinjar E, et al. &nbsp;Indications and techniques for emergency carotid interventions. J Cardiovasc Surg 2013; 54(1 Suppl 1):9-14. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23443584">http://www.ncbi.nlm.nih.gov/pubmed/23443584</a></p>
<p>QID: 30327</p></div><div class="rightanswer">The correct answer is: Crescendo transient ischemic attacks with a 50 - 99% stenosis</div></div></div></div></div><div id="q66" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">162</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1622"><input type="hidden" name="q20803:66_:flagged" value="0"><input type="hidden" value="qaid=910950&amp;qubaid=20803&amp;qid=4892&amp;slot=66&amp;checksum=5ce6698a20c3eeb8b6ebc9fce28cba8c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:66_:flaggedcheckbox" name="q20803:66_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q66&id=4892"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:66_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old diabetic man is referred to you for the treatment of his foot ulcer (shown in image below). His blood pressure is 120/80 mmHg, ankle:brachial index 0.9, and his toe:brachial index is 0.8. Which of the following statements is <strong>true</strong>?</p>
<p><a href="./VESAP3_files/20722.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/20722.jpg" alt="Img" width="67" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:66_answer" disabled="disabled" value="0" id="q20803:66_answer0"><label for="q20803:66_answer0">a. the patient has peripheral neuropathy</label> </div>
<div class="r1"><input type="radio" name="q20803:66_answer" disabled="disabled" value="1" id="q20803:66_answer1"><label for="q20803:66_answer1">b. the ulcer is unlikely to heal without revascularization</label> </div>
<div class="r0"><input type="radio" name="q20803:66_answer" disabled="disabled" value="2" id="q20803:66_answer2"><label for="q20803:66_answer2">c. there is significant occlusive disease in the digital arteries</label> </div>
<div class="r1"><input type="radio" name="q20803:66_answer" disabled="disabled" value="3" id="q20803:66_answer3"><label for="q20803:66_answer3">d. the ABI is falsely elevated due to tibial calcification</label> </div>
<div class="r0"><input type="radio" name="q20803:66_answer" disabled="disabled" value="4" id="q20803:66_answer4"><label for="q20803:66_answer4">e. transmetatarsal  amputation is the preferred surgical option</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:66_-submit" name="q20803:66_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a classic neuropathic ulcer under the metatarsal head. It is also referred to as a "mal perforans" ulcer (literally "bad penetration"). It may develop in the absence of significant arterial disease. The most obvious finding is the accumulation of a large amount of fibrotic callus over the metatarsal head. The callus acts like a foreign body under the weight-bearing surface and contributes to the development of a pressure sore. Sensory neuropathy leads to a loss of protective functions of the foot so that the development of the callus goes unnoticed. In addition, it is believed that dysfunction of the intrinsic motor nerves of the foot results in changes in the shape of the foot that favors ulcer formation. In particular, motor denervation contributes to the elevated arch and flexed position of the toes ("clawed toes") that results in excess pressure on the metatarsal heads. The callus should be debrided to the level of viable tissue. Repeated debridement is the rule, rather than the exception, because of the tendency of the callus to recur. The formation of callus requires adequate blood supply and is a subtle reminder that revascularization is unnecessary in most patients. In addition, the pressure over the metatarsal head must be reduced in order to achieve healing. This can be accomplished with a variety of techniques including orthotics, total contact casting, and making the patient non-weight-bearing.</p>
<p>In this patient, both the ankle:brachial index and the toe:brachial indices are normal. There is no evidence of tibial calcification and there is no need for revascularization to achieve healing. With appropriate care, most neuropathic diabetic foot ulcers can be healed and amputation avoided.<br><br></p>
<h2>Reference:</h2>
<p>Andros G, Lavery LA. Diabetic foot ulcers. In: Rutherford RB, ed. Vascular Surgery 7th Edition. Saunders Elsevier; 2010:1735-46.</p>
<p>QID: 30104</p></div><div class="rightanswer">The correct answer is: the patient has peripheral neuropathy</div></div></div></div></div><div id="q207" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">163</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1631"><input type="hidden" name="q20803:207_:flagged" value="0"><input type="hidden" value="qaid=911091&amp;qubaid=20803&amp;qid=4699&amp;slot=207&amp;checksum=ee61d88a12e27ccf7ecacc933748f4e8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:207_:flaggedcheckbox" name="q20803:207_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q207&id=4699"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:207_:sequencecheck" value="2"><div class="qtext"><p>A 63-year-old woman presents with positional vertigo. When she rotates her head to look upwards she has transient dizziness; this limits her ability to drive. She has undergone a CT scan which showed a large patent left vertebral artery and diminutive right vertebral artery. Her subclavian arteries are patent. She undergoes dynamic vertebral angiography. The findings obtained are shown below. Which of the following is the best treatment option for this patient?<br></p><p>&nbsp;<img style="width: 100px; height: 300px;" src="./VESAP3_files/vertebral dynamic.jpg" alt="vertebral dynamic" width="399" height="474"></p>
<p>With neck extension.&nbsp;</p>
<p><img style="width: 101px; height: 142px;" src="./VESAP3_files/vertebral 1.jpg" alt="dynamic vertebral angiogram 2" width="378" height="471"></p><p>Neutral neck position.</p>
<p><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:207_answer" disabled="disabled" value="0" id="q20803:207_answer0"><label for="q20803:207_answer0">1. extracranial to intracranial (EC-IC) bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:207_answer" disabled="disabled" value="1" id="q20803:207_answer1"><label for="q20803:207_answer1">2. right vertebral artery bypass with autologous conduit</label> </div>
<div class="r0"><input type="radio" name="q20803:207_answer" disabled="disabled" value="2" id="q20803:207_answer2"><label for="q20803:207_answer2">3. distal vertebral bypass with venous conduit</label> </div>
<div class="r1"><input type="radio" name="q20803:207_answer" disabled="disabled" value="3" id="q20803:207_answer3"><label for="q20803:207_answer3">4. management with anti platelet therapy and a neck immobilizer</label> </div>
<div class="r0"><input type="radio" name="q20803:207_answer" disabled="disabled" value="4" id="q20803:207_answer4"><label for="q20803:207_answer4">5. left vertebral transposition to the common carotid artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:207_-submit" name="q20803:207_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has classic symptoms of positional posterior insufficiency caused by dynamic compromise of the dominant vertebral artery. It is also known as Bowhunter's Syndrome and is typically caused by the compression of the vessel by a hypertrophic osteophyte, cervical spondylosis, fibrous band, or thickened atlantoaxial membrane. Digital subtraction angiography is the preferred diagnostic tool as it identifies the precise location of the lesion and confirms rotational compression. The use of rotational computed tomography and duplex imaging have also been reported. Treatment options include cervical fixation, osseous decompression with removal of the bone, or fibrous tissue for extrinsic compression. Distal vertebral bypass in the setting of atherosclerotic disease is curative.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9257311" target="_blank">Keuther TA, Nesbit GM, Clark W, Barnwell S. Rotational vertebral artery occlusion: a mechanism of vertebrobasilar insufficiency.&nbsp; Neurosurgery 1997; 41(2):427-32. <br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Taylor+WB%2C+Vandergriff+CL%2C+Opatowsky+MJ%2C+Layton+KF.++Bowhunter%27s+syndrome+diagnosed+with+provocative+digital+subtraction+cerebral+angiography.+Proc(Bayl+Univ+Med+Cent)++2012%3B+25(1)%3A26-27." target="_blank">Taylor WB, Vandergriff CL, Opatowsky MJ,&nbsp;Layton KF. &nbsp;Bowhunter's&nbsp;syndrome diagnosed with provocative digital subtraction cerebral angiography.&nbsp;Proc(Bayl Univ Med Cent) &nbsp;2012; 25(1):26-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21216557" target="_blank">Lee V, Riles TS, Stableford J, Berguer RA. Two case presentations and surgical management of Bow Hunter's syndrome associated with bony abnormalities of the C7 vertebra.&nbsp; J Vasc Surg 2011; 53(5):1381-5.&nbsp;</a></p>
<p>QID: 30357</p></div><div class="rightanswer">The correct answer is: distal vertebral bypass with venous conduit</div></div></div></div></div><div id="q417" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">164</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1640"><input type="hidden" name="q20803:417_:flagged" value="0"><input type="hidden" value="qaid=911301&amp;qubaid=20803&amp;qid=4791&amp;slot=417&amp;checksum=aabab8de90112a507b11925275d263f9&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:417_:flaggedcheckbox" name="q20803:417_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q417&id=4791"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:417_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old smoker with severe hypertension is referred for a renal artery duplex evaluation. Images and waveforms of the right renal artery were obtained and are shown below. Which of the following statements regarding this patient's condition is <strong>true</strong>?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/FMD renal jpg.jpg" target="images"><img src="./VESAP3_files/FMD renal jpg.jpg" alt="renal FMD" width="100"></a></p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:417_answer" disabled="disabled" value="0" id="q20803:417_answer0"><label for="q20803:417_answer0">a. long-term vessel patency and blood pressure control is improved with the use of percutaneous stents</label> </div>
<div class="r1"><input type="radio" name="q20803:417_answer" disabled="disabled" value="1" id="q20803:417_answer1"><label for="q20803:417_answer1">b. associated renal artery aneurysm is rare</label> </div>
<div class="r0"><input type="radio" name="q20803:417_answer" disabled="disabled" value="2" id="q20803:417_answer2"><label for="q20803:417_answer2">c. it most commonly affects the orifice of the renal artery</label> </div>
<div class="r1"><input type="radio" name="q20803:417_answer" disabled="disabled" value="3" id="q20803:417_answer3"><label for="q20803:417_answer3">d. percutaneous renal angioplasty is the treatment of choice when intervention is indicated</label> </div>
<div class="r0"><input type="radio" name="q20803:417_answer" disabled="disabled" value="4" id="q20803:417_answer4"><label for="q20803:417_answer4">e. it is more commonly seen in men</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:417_-submit" name="q20803:417_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Percutaneous renal angioplasty is the treatment of choice when intervention is indicated. The duplex images show alternating dilated and stenotic areas in the mid to distal renal artery, sparing the renal artery orifice. These findings are consistent with a diagnosis of fibromuscular dysplasia (FMD). On angiography, the vessel often appears as a “string of pearls”. FMD is non-atherosclerotic noninflammatory angiopathy involving medium sized arteries<em>. </em>Unlike atherosclerotic renal artery stenosis, the origin of the renal artery is often spared. It is more commonly seen in women than in men. Associated renal artery aneurysms are found in as many as 17% of renal FMD patients. Unlike treatment of atherosclerotic renal artery stenosis, the use of stents does not improve long-term patency when treating renal artery stenosis from FMD. The treatment of choice for the renal artery FMD when intervention is indicated is percutaneous renal artery angioplasty.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cleve+Clin+J+Med%3A+2007%3B+74(4)+Olin" target="_blank">Olin JW. Recognizing and managing fibromuscular dysplasia. Cleve Clin J Med: 2007; 74(4):273-4.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2012%3B+125(25)%3A3182-90." target="_blank">Olin JW, Froehlich J, Bacharach JM, Eagle K<span>,&nbsp;</span>Gray BH<span>,&nbsp;</span>Jaff MR<span>,&nbsp;</span>et al. The United States Registry for Fibromuscular Dysplasia: Results in the first 447 patients. Circulation 2012; 125(25):3182-90.</a></p>
<p>QID: 30738</p></div><div class="rightanswer">The correct answer is: percutaneous renal angioplasty is the treatment of choice when intervention is indicated</div></div></div></div></div><div id="q384" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">165</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1649"><input type="hidden" name="q20803:384_:flagged" value="0"><input type="hidden" value="qaid=911268&amp;qubaid=20803&amp;qid=5101&amp;slot=384&amp;checksum=2599deea17c3dbd5b952164d3132ef6c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:384_:flaggedcheckbox" name="q20803:384_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q384&id=5101"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:384_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old male smoker, with a history of an aorto-bifemoral bypass graft &nbsp;and a left colon resection for diverticulitis, presents with a 5-month history of post-prandial abdominal pain.&nbsp;A duplex scan reveals a&nbsp;&gt;70% stenosis of the celiac artery orifice and occlusion of the superior mesenteric artery and&nbsp;inferior mesenteric artery origins. Which of the following is the most important visceral collateral network for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:384_answer" disabled="disabled" value="0" id="q20803:384_answer0"><label for="q20803:384_answer0">a. left gastric artery</label> </div>
<div class="r1"><input type="radio" name="q20803:384_answer" disabled="disabled" value="1" id="q20803:384_answer1"><label for="q20803:384_answer1">b. superior and inferior pancreaticoduodenal arteries</label> </div>
<div class="r0"><input type="radio" name="q20803:384_answer" disabled="disabled" value="2" id="q20803:384_answer2"><label for="q20803:384_answer2">c. meandering artery and marginal artery of Drummond</label> </div>
<div class="r1"><input type="radio" name="q20803:384_answer" disabled="disabled" value="3" id="q20803:384_answer3"><label for="q20803:384_answer3">d. inferior phrenic artery and right colic artery</label> </div>
<div class="r0"><input type="radio" name="q20803:384_answer" disabled="disabled" value="4" id="q20803:384_answer4"><label for="q20803:384_answer4">e. inferior mesenteric artery and hypogastric arteries</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:384_-submit" name="q20803:384_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Chronic mesenteric ischemia secondary to atherosclerosis is often times a slowly progressive, &nbsp;insidious disease of the mesenteric vessels.&nbsp;Given the extensive collateral network that develops, patients usually complain of symptoms when at least two of the three visceral arteries have hemodynamically significant stenoses or occlusions. Predominant collateral networks involve a connection between the major axial visceral vessels (celiac axis, superior mesenteric, inferior mesenteric) and not the tertiary branches, such as the inferior phrenic and right colic branches.&nbsp;Since the inferior mesenteric artery network was disrupted by the left colon resection 2 years ago, the main collateral network is from the celiac artery branches, including the gastroduodenal artery and the&nbsp;superior and inferior pancreaticoduodenal arteries. The SMA can be reconstituted from these collaterals via the middle colic artery.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1998%3B27%3A840-4." target="_blank">Thomas JH, Blake K, Pierce GE, Hermreck AS<span>,&nbsp;</span>Seigel E<span>.</span>&nbsp;The clinical course of asymptomatic mesenteric arterial stenosis. J Vasc Surg&nbsp;1998;27:840-4.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vasc+Med+2010%3B15(4)%3A333-8." target="_blank">Zeller T, Rastan A, Sixt S. Chronic atherosclerotic mesenteric ischemia (CMI). Vasc Med 2010;15(4):333-8.</a></p>
<p>QID: 30671</p></div><div class="rightanswer">The correct answer is: superior and inferior pancreaticoduodenal arteries</div></div></div></div></div><div id="q480" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">166</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1658"><input type="hidden" name="q20803:480_:flagged" value="0"><input type="hidden" value="qaid=911364&amp;qubaid=20803&amp;qid=5206&amp;slot=480&amp;checksum=c31715b998519a3927b4ff968ab24dff&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:480_:flaggedcheckbox" name="q20803:480_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q480&id=5206"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:480_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old man with a history of hepatitis B presents to the emergency department for evaluation of nausea and abdominal pain. A CT scan demonstrates multiple small aneurysms (&lt;1 cm) of the superior mesenteric artery and vascular surgery consultation is requested.</p>
<p>The patient reports headache, malaise, and shoulder pain. Temperature is 38.0 Celcius. There is only mild tenderness on abdominal examination. Pulses are normal. A test for fecal occult blood is positive.&nbsp;Which of the following treatments should be provided?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:480_answer" disabled="disabled" value="0" id="q20803:480_answer0"><label for="q20803:480_answer0">a. glucocorticoids and cyclophosphamide</label> </div>
<div class="r1"><input type="radio" name="q20803:480_answer" disabled="disabled" value="1" id="q20803:480_answer1"><label for="q20803:480_answer1">b. coil embolization of the aneurysms</label> </div>
<div class="r0"><input type="radio" name="q20803:480_answer" disabled="disabled" value="2" id="q20803:480_answer2"><label for="q20803:480_answer2">c. interferon alfa</label> </div>
<div class="r1"><input type="radio" name="q20803:480_answer" disabled="disabled" value="3" id="q20803:480_answer3"><label for="q20803:480_answer3">d. sulfasalazine</label> </div>
<div class="r0"><input type="radio" name="q20803:480_answer" disabled="disabled" value="4" id="q20803:480_answer4"><label for="q20803:480_answer4">e. surgical resection of the abnormal sections of small intestine and mesentery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:480_-submit" name="q20803:480_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has polyarteritis nodosa (PAN), a systemic necrotizing vasculitis that affects medium- and small-sized muscular arteries. PAN is most common in middle-aged or older adults, the incidence rises with age and there is a moderate male predominance. Presentation with systemic symptoms is common and many organ systems can be involved, including the kidneys, skin, joints, muscles, nerves, and gastrointestinal tract, often in some combination. The disease is usually idiopathic, but it may be associated with hepatitis B or C infection and hairy cell leukemia.</p>
<p>Multiple aneurysm formation in renal, celiac, or mesenteric arteries is a characteristic finding in polyarteritis nodosa.</p>
<p>Neither coil embolization of the small visceral artery aneurysms of PAD nor surgical resection is warranted in a stable patient.</p>
<p>Treatment of moderate and severe disease (PAN with renal insufficiency, mesenteric artery ischemia, mononeuropathy multiplex) is medical, with a combination of oral cyclophosphamide (1.5 to 2 mg/kg per day) and prednisone (1 mg/kg per day; up to maximum of 60 to 80 mg per day). The initial high prednisone dose is continued until significant improvement is observed (up to 4 weeks) and is then tapered gradually. Treatment continues for months. Treatment improves 5-year survival of PAN from less than 20% to approximately 80%.</p>
<p>Interferon alfa is not used for polyarteritis nodosa. It may worsen the vasculitis and new cases of PAN have occurred during interferon alfa therapy for hepatitis C.</p>
<p>Sulfasalazine may be used for treatment of rheumatoid arthritis, ulcerative colitis, or Crohn's disease, but it has no role for PAN treatment.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+Rheumatol+2005%3B+24(5)%3A507-15." target="_blank">Beuthien W, Mellinghoff HU, Kempis Jv. Vasculitic complications of interferon-alpha treatment for chronic hepatitis C virus infection: case report and review of the literature. Clin Rheumatol 2005; 24(5):507-15.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+Rheumatol+2005%3B+24(6)%3A628-31." target="_blank">Kato T, Fujii K, Ishii E, Wada R, Hidaka Y. A case of polyarteritis nodosa with lesions of the superior mesenteric artery illustrating the diagnostic usefulness of three-dimensional computed tomographic angiography. Clin Rheumatol 2005; 24(6):628-31.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arthritis+Rheum+1990%3B33(8)%3A1065-7." target="_blank">Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990;33(8):1065-7.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics.+2000%3B+20(3)%3A779-94." target="_blank">Ha HK, Lee SH, Rha SE, Kim JH, Byun JY, Lim HK. Radiologic features of vasculitis involving the gastrointestinal tract. Radiographics. 2000; 20(3):779-94.</a></p>
<p>QID: 30845</p></div><div class="rightanswer">The correct answer is: glucocorticoids and cyclophosphamide</div></div></div></div></div><div id="q540" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">167</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1667"><input type="hidden" name="q20803:540_:flagged" value="0"><input type="hidden" value="qaid=911424&amp;qubaid=20803&amp;qid=5281&amp;slot=540&amp;checksum=647773951508d83edcb4ac32491277f6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:540_:flaggedcheckbox" name="q20803:540_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q540&id=5281"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:540_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is <strong>not </strong>considered to be a&nbsp;risk factor for radiation induced skin injury?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:540_answer" disabled="disabled" value="0" id="q20803:540_answer0"><label for="q20803:540_answer0">a. renal failure</label> </div>
<div class="r1"><input type="radio" name="q20803:540_answer" disabled="disabled" value="1" id="q20803:540_answer1"><label for="q20803:540_answer1">b. collagen vascular disorders</label> </div>
<div class="r0"><input type="radio" name="q20803:540_answer" disabled="disabled" value="2" id="q20803:540_answer2"><label for="q20803:540_answer2">c. ataxia telangiectasia</label> </div>
<div class="r1"><input type="radio" name="q20803:540_answer" disabled="disabled" value="3" id="q20803:540_answer3"><label for="q20803:540_answer3">d. complex procedure</label> </div>
<div class="r0"><input type="radio" name="q20803:540_answer" disabled="disabled" value="4" id="q20803:540_answer4"><label for="q20803:540_answer4">e. obesity</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:540_-submit" name="q20803:540_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Radiation induced skin injury is rare, with the majority of reports documented during cardiac catheterization and neuroembolization procedures.&nbsp; A few patient risk factors have been suggested based on scattered case reports. Patient obesity is a risk factor because more radiation is necessary to penetrate the body in larger patients, therefore a higher dose accrues.&nbsp; In one study evaluating the radiation dose in endovascular aneurysm repair, obese patients had up to three times higher peak skin doses then patients with a normal BMI. Case complexity is also a risk factor in that more complex cases require more fluoroscopy time and higher doses of radiation. Atherectomy, embolization procedures, and EVAR have all been associated with high radation doses. Fenestrated abdominal aortic aneurysm repair has emerged as one of the highest dose fluoroscopically guided interventions. In one report, fenestrated stent grafts had a median radiation dose of 6.3 Gy with three patients exceeding 15 Gy.&nbsp; Interestingly, connective tissue disorders, particularly Lupus, scleroderma, and mixed connective tissue disease have been associated with radiation-induced skin injury.&nbsp; Ataxia telangiectasia, a rare autosomal recessive disorder resulting from a mutation in both copies of the DNA repair gene (ATM gene), as well as diabetes and hyperthyroidism, have also been associated with radiation hypersensitivity; however, only scattered case reports of radiation injury exist in the literature. Therefore, the causative assocation of these conditions with skin injury is only assumed and has not been proven. Renal failure has not been associated with radiation induced skin injury.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53+(1)%3A15S-21S." target="_blank">Brown KR, Rzucidlo E. Acute and Chronic Radiation Injury.&nbsp;J Vasc Surg&nbsp;2011; 53 (1):15S-21S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2008%3B22%3A723-9." target="_blank">Weiss DJ, Pipinos II, Longo GM, Lynch TG, Rutar FJ, Johanning JM. Direct and indirect measurement of patient radiation exposure during endovascular aortic aneurysm repair. Ann Vasc Surg 2008;22:723-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Comparison+of+indirect+radiation+dose+estimates+with+directly+measured+radation+dose+for+patients+and+operators+during+complex+endovascular+procedures." target="_blank">Panuccio G, Greenberg R, Wunderle K, Mastracci T, Eagleton M, Davros W. Comparison of indirect radiation dose estimates with directly measured radation dose for patients and operators during complex endovascular procedures. J Vasc Surg 2011;53(4):885-94.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+58+(3)%3A715-21." target="_blank">Kirkwood ML, Arbique GM, Guild JB, Timaran C, Chung J, Anderson JA, et al. "Surgeon Education Decreases Radiation Dose in Complex Endovascular Procedures and Improves Patient Safety.&nbsp;J Vasc Surg&nbsp;2013; 58 (3):715-21.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=luoroscopically+Guided+Interventional+procedures%3A+A+review+of+radiation+effects+on+patients%E2%80%99+skin+and+hair." target="_blank">Balter S, Hopewell J, Miller D, Wagner L, Zelefsky M. Fluoroscopically guided interventional procedures: A review of radiation effects on patients’ skin and hair. &nbsp;Radiology, 2010; 254(2) 326-41.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=AJR+Am+J+Roentgenol+2001+177+(1)%3A+13-20.">Koenig TR, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures: part 2, review of 73 cases and recommendations for minimizing dose delivered to patient.&nbsp;AJR Am J Roentgenol&nbsp;2001 177 (1): 13-20.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Fife+C.+Radiation+dermatitis%3A+clinical+presentation%2C" target="_blank">Hymes SR, Strom EA, Fife C. Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006; 54(1):28-46.</a></p>
<p>QID: 30946</p></div><div class="rightanswer">The correct answer is: renal failure</div></div></div></div></div><div id="q525" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">168</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1676"><input type="hidden" name="q20803:525_:flagged" value="0"><input type="hidden" value="qaid=911409&amp;qubaid=20803&amp;qid=5261&amp;slot=525&amp;checksum=9eaddc4fb3433a8d9d0a0c793f77201e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:525_:flaggedcheckbox" name="q20803:525_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q525&id=5261"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:525_:sequencecheck" value="2"><div class="qtext"><p>A 32-year-old woman in her second trimester is evaluated in the emergency department for injuries sustained in a motor vehicle collision. A renal artery injury is suspected on screening ultrasound. Which of the following imaging modalities has the highest fetal/uterine radiation exposure?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:525_answer" disabled="disabled" value="0" id="q20803:525_answer0"><label for="q20803:525_answer0">a. chest xray (AP and lateral)</label> </div>
<div class="r1"><input type="radio" name="q20803:525_answer" disabled="disabled" value="1" id="q20803:525_answer1"><label for="q20803:525_answer1">b. lumbar spine xray</label> </div>
<div class="r0"><input type="radio" name="q20803:525_answer" disabled="disabled" value="2" id="q20803:525_answer2"><label for="q20803:525_answer2">c. cervical spine trauma series</label> </div>
<div class="r1"><input type="radio" name="q20803:525_answer" disabled="disabled" value="3" id="q20803:525_answer3"><label for="q20803:525_answer3">d. CTA of the abdomen and pelvis</label> </div>
<div class="r0"><input type="radio" name="q20803:525_answer" disabled="disabled" value="4" id="q20803:525_answer4"><label for="q20803:525_answer4">e. renal arteriogram</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:525_-submit" name="q20803:525_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The health care team should be well-versed in the relative exposure of the conceptus to radiation in pregnant patients. The Health Physics Society suggests that if the amount of radiation exposure is not known, the radiation safety officer and the institution's physicist should be contacted to calculate the dosage to the fetus. In general, conceptus dose in mGy for the following exams are C-spine trauma series (&lt;0.001), CXR (AP and lateral) (0.0025), thoracic spine&nbsp;(AP and lateral) (0.0026), lumbar spine series (2.0), excretory KUB (3.4), barium enema (7), renal angiogram (8), pelvic arterial embolization (20), CT abdomen/pelvis routine (29), and CT angiogram aorta (34). &nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://hps.org/hpspublications/articles/pregnancyandradiationexposureinfosheet.html" target="_blank">Health Physics Society. Pregnancy and radiation exposure.</a></p>
<p>Wagner LK, Lester RG, Saldana LR. Prenatal risks from ionizing&nbsp;radiations, ultrasound, magnetic fields and radiofrequency waves. In: Exposure of the Patient to Diagnostic Radiations: A Guide to Medical Management. 2nd ed. Madison, WI: Medical Physics Publishing; 1997. p. 77-105</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B53%3A28S-34S." target="_blank">Shaw P, Duncan A, Vouyouka A, Ozsvath K. &nbsp;Radiation exposure and pregnancy. &nbsp;J Vasc Surg 2011;53:28S-34S.&nbsp;</a></p>
<p>QID: 30929</p></div><div class="rightanswer">The correct answer is: CTA of the abdomen and pelvis</div></div></div></div></div><div id="q516" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">169</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1685"><input type="hidden" name="q20803:516_:flagged" value="0"><input type="hidden" value="qaid=911400&amp;qubaid=20803&amp;qid=5251&amp;slot=516&amp;checksum=5d7efd8c7e45f28308fac63d4d03f54b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:516_:flaggedcheckbox" name="q20803:516_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q516&id=5251"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:516_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding X-ray beam collimation is most <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:516_answer" disabled="disabled" value="0" id="q20803:516_answer0"><label for="q20803:516_answer0">a. decreases scatter radiation and degrades image contrast</label> </div>
<div class="r1"><input type="radio" name="q20803:516_answer" disabled="disabled" value="1" id="q20803:516_answer1"><label for="q20803:516_answer1">b. decreases scatter radiation and improves image contrast</label> </div>
<div class="r0"><input type="radio" name="q20803:516_answer" disabled="disabled" value="2" id="q20803:516_answer2"><label for="q20803:516_answer2">c. increases scatter radiation and degrades image contrast</label> </div>
<div class="r1"><input type="radio" name="q20803:516_answer" disabled="disabled" value="3" id="q20803:516_answer3"><label for="q20803:516_answer3">d. does not affect radiation scatter</label> </div>
<div class="r0"><input type="radio" name="q20803:516_answer" disabled="disabled" value="4" id="q20803:516_answer4"><label for="q20803:516_answer4">e. increases scatter radiation and improves image contrast</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:516_-submit" name="q20803:516_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>When X-rays are directed toward a patient, some of these change direction and are "scattered". These altered beams may go through a patient, exit at angles, exit the sides, or even be reflected back toward the X-ray source.&nbsp; This scatter&nbsp;can be&nbsp;a significant source of radiation exposure to interventionalists and staff. The larger the size of the X-ray beam entering the patient, the greater the amount of scatter radiation produced.&nbsp; Scatter radiation contributes to loss of contrast in image production.&nbsp; By using collimation, X-ray beam size is reduced, thus scatter radiation is reduced, producing sharper, higher quality images.&nbsp; Collimation also reduces patient radiation exposure by decreasing exposure to&nbsp;parts of the body&nbsp;outside the area of interest.&nbsp;Use of collimation during radiology procedures is considered a "best practice" modality.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p dir="ltr" align="left"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics.+1999%3B+19(5)%3A1289-302." target="_blank">Parry RA,&nbsp;Glaze SA,&nbsp;Archer BR.&nbsp;The AAPM/RSNA physics tutorial for residents. Typical patient radiation doses in diagnostic radiology.&nbsp;Radiographics. 1999; 19(5):1289-302.</a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Parry%20RA%5BAuthor%5D&cauthor=true&cauthor_uid=10489180"><br></a></p>
<p dir="ltr" align="left"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+1998%3B+31(4)%3A892-913." target="_blank">Limacher MC,&nbsp;Douglas PS,&nbsp;Germano G,&nbsp;Laskey WK,&nbsp;Lindsay BD,&nbsp;McKetty MH, et al.&nbsp;ACC expert consensus document. Radiation safety in the practice of cardiology. American College of Cardiology.&nbsp;J Am Coll Cardiol 1998; 31(4):892-913.</a></p>
<p dir="ltr" align="left">QID: 30919</p></div><div class="rightanswer">The correct answer is: decreases scatter radiation and improves image contrast</div></div></div></div></div><div id="q162" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">170</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1694"><input type="hidden" name="q20803:162_:flagged" value="0"><input type="hidden" value="qaid=911046&amp;qubaid=20803&amp;qid=4392&amp;slot=162&amp;checksum=c16be77cd635e0a0d33ce3b248c2b589&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:162_:flaggedcheckbox" name="q20803:162_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q162&id=4392"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:162_:sequencecheck" value="2"><div class="qtext"><p>A 72 year-old woman with ovarian cancer presents with right arm swelling. She has a&nbsp;functioning right subclavian portacath.&nbsp;By duplex, &nbsp;she has right axillo-subclavian deep venous thrombosis. She is scheduled to receive chemotherapy for the next six months. &nbsp;How best should this patient be treated?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:162_answer" disabled="disabled" value="0" id="q20803:162_answer0"><label for="q20803:162_answer0">a. Therapeutic anticoagulation for three months without port removal</label> </div>
<div class="r1"><input type="radio" name="q20803:162_answer" disabled="disabled" value="1" id="q20803:162_answer1"><label for="q20803:162_answer1">b. Therapeutic anticoagulation until the port is removed</label> </div>
<div class="r0"><input type="radio" name="q20803:162_answer" disabled="disabled" value="2" id="q20803:162_answer2"><label for="q20803:162_answer2">c. Immediate port removal and therapeutic anticoagulation for three months</label> </div>
<div class="r1"><input type="radio" name="q20803:162_answer" disabled="disabled" value="3" id="q20803:162_answer3"><label for="q20803:162_answer3">d. Immediate port removal without anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:162_answer" disabled="disabled" value="4" id="q20803:162_answer4"><label for="q20803:162_answer4">e. Port removal one week after therapeutic anticoagulation is initiated and continuation of anticoagulation for three months</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:162_-submit" name="q20803:162_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The 9th edition of therapeutic guidelines for the treatment of DVT from Chest recommend treating thrombosis of the axillary vein or more proximal veins with at least three months of anticoagulation when feasible and if a central venous catheter is in place on that side until the catheter is removed. Anticoagulation for thrombus isolated to the brachial vein is only recommended for symptomatic patients, patients with an ipsilateral central catheter, or patients with cancer. The removal of a central venous catheter is only recommended for non-functioning catheters or catheters which are no longer needed. Three months of anticoagulation is still recommended for these patients after the catheter is removed. There is no evidence available suggesting the optimal timing of catheter removal in relation to the timing of anticoagulation.</p>
<p><br>Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson <br>ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR; American College of Chest<br>Physicians. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and<br>Prevention of Thrombosis, 9th ed: American College of Chest Physicians<br>Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2<br>Suppl):e419S-94S. doi: 10.1378/chest.11-2301. Erratum in: Chest. 2012<br>Dec;142(6):1698-1704. PubMed PMID: 22315268; PubMed Central PMCID: PMC3278049.</p>
<p>QID: 30256</p></div><div class="rightanswer">The correct answer is: Therapeutic anticoagulation until the port is removed</div></div></div></div></div><div id="q505" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">171</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1703"><input type="hidden" name="q20803:505_:flagged" value="0"><input type="hidden" value="qaid=911389&amp;qubaid=20803&amp;qid=5236&amp;slot=505&amp;checksum=2fca774fd5ecbc868229a4f043bad922&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:505_:flaggedcheckbox" name="q20803:505_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q505&id=5236"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:505_:sequencecheck" value="2"><div class="qtext"><p>Finish this sentence: The risk of radiation injury to a patient undergoing arteriography is highest when...</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:505_answer" disabled="disabled" value="0" id="q20803:505_answer0"><label for="q20803:505_answer0">a. using digital subtraction compared to digital cine angiography</label> </div>
<div class="r1"><input type="radio" name="q20803:505_answer" disabled="disabled" value="1" id="q20803:505_answer1"><label for="q20803:505_answer1">b. positioning the patient as close to the image intensifier</label> </div>
<div class="r0"><input type="radio" name="q20803:505_answer" disabled="disabled" value="2" id="q20803:505_answer2"><label for="q20803:505_answer2">c. using multiple different gantry angles</label> </div>
<div class="r1"><input type="radio" name="q20803:505_answer" disabled="disabled" value="3" id="q20803:505_answer3"><label for="q20803:505_answer3">d. using pulsed rather than constant fluoroscopy</label> </div>
<div class="r0"><input type="radio" name="q20803:505_answer" disabled="disabled" value="4" id="q20803:505_answer4"><label for="q20803:505_answer4">e. positioning the patient as far as possible from the emitter</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:505_-submit" name="q20803:505_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The highest dose of radiation during arteriography is incurred with digital subtraction imaging. Therefore, if the increase in clarity is not needed, fluoroscopic images alone may be used. Patient dose may be reduced by decreasing the air gap (distance between the patient and the detector), increasing distance between the patient and the source (emitter), decreasing tube voltage (kVp), lowering the frame rate, using pulsed fluoroscopy, using collimation, and avoidance of magnification. Differing the skin entry portal (altering gantry rotation or angle) when feasible will decrease the dose of radiation to any one skin site, thereby minimizing the risk of burn at an individual site. Radiation induced skin burns may take weeks or even months to develop, necessitating careful followup after procedures with prolonged fluoroscopy times.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/14514852" target="_blank">Cardella JF, Miller DL, Cole PE, Lewis CA. Society for Interventional Radiology position statement on radiation safety. J Vasc Interv Radiol; 2003; 14 (9;Pt 2):S387.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology%3B+2010%3B+254+(2)%3A326-341." target="_blank">Balter S, Hopewell JW, Miller DL, Wagner LK<span>,&nbsp;</span>Zelefsky MJ. Fluoroscopically guided interventional procedures: A review of radiation effects on patients' skin and hair. Radiology 2010; 254(2):326-41.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol%3B+2009%3B+20+(7+Suppl)%3AS263-273" target="_blank">Stecker MS, Balter S, Towgin RB, Miller DL<span>,&nbsp;</span>Vañó E<span>,&nbsp;</span>Bartal G<span>,&nbsp;</span>et al. Guidelines for patient radiation dose management. J Vasc Interv Radiol 2009; 20(7 Suppl):S263-73.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2005%3B+111(4)%3A511-32." target="_blank">Hirshfeld JW Jr., Balter S, Brinker JA, Kern MJ,&nbsp;Klein LW,&nbsp;Lindsay BD,&nbsp;et al. ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures: A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Circulation 2005; 111(4):511-32.</a></p>
<p>QID: 30904</p></div><div class="rightanswer">The correct answer is: using digital subtraction compared to digital cine angiography</div></div></div></div></div><div id="q381" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">172</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1712"><input type="hidden" name="q20803:381_:flagged" value="0"><input type="hidden" value="qaid=911265&amp;qubaid=20803&amp;qid=5104&amp;slot=381&amp;checksum=d99299905f042e82731ebb2eb7e014bf&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:381_:flaggedcheckbox" name="q20803:381_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q381&id=5104"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:381_:sequencecheck" value="2"><div class="qtext"><p>A 54-year-old man presents with a 2-day history of severe abdominal and flank pain.&nbsp;His CT scan with contrast confirms a renal stone; however, an incidental finding of an isolated superior mesenteric artery (SMA) dissection is noted (image shown below). The dissection is 3 cm in length, beginning at the SMA origin, and&nbsp;compromises the lumen of the SMA by &lt;50%.&nbsp;No aortic dissection is present. Which of the following is the most appropriate management of the SMA dissection?</p>
<p><img src="./VESAP3_files/Rowe-5.jpg" alt="" width="664" height="775"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:381_answer" disabled="disabled" value="0" id="q20803:381_answer0"><label for="q20803:381_answer0">a. antiplatelet therapy and a follow-up CT scan in 6 months</label> </div>
<div class="r1"><input type="radio" name="q20803:381_answer" disabled="disabled" value="1" id="q20803:381_answer1"><label for="q20803:381_answer1">b. superior mesenteric artery stent placement</label> </div>
<div class="r0"><input type="radio" name="q20803:381_answer" disabled="disabled" value="2" id="q20803:381_answer2"><label for="q20803:381_answer2">c. superior mesenteric artery bypass with vein</label> </div>
<div class="r1"><input type="radio" name="q20803:381_answer" disabled="disabled" value="3" id="q20803:381_answer3"><label for="q20803:381_answer3">d. superior mesenteric artery bypass with prosthetic graft</label> </div>
<div class="r0"><input type="radio" name="q20803:381_answer" disabled="disabled" value="4" id="q20803:381_answer4"><label for="q20803:381_answer4">e. resection of the involved arterial segment and interposition prosthetic graft reconstruction</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:381_-submit" name="q20803:381_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Isolated spontaneous dissection can occur in any visceral artery, although the SMA seems to be the most common site. Although atherosclerosis, medial degeneration, trauma, fibromuscular disease, pregnancy, and a host of arteriopathies have been implicated, the underlying cause remains unknown. Consensus treatment guidelines&nbsp;for isolated dissections do not exist. Conservative treatment with or without antiplatelet agents or anticoagulation is sufficient for asymptomatic patients.&nbsp;Symptomatic patients, including patients with rupture,&nbsp;acute mesenteric ischemia, or persistent pain, merit&nbsp;repair with either endovascular stenting or open surgical repair.&nbsp;Aneurysmal degeneration (&gt;2.0 cm in diameter) is also an indication for repair. The presence of compression of the true lumen of the SMA, creating a hemodynamically significant stenosis, is considered an indication for repair by some authors, but the largest series found that observation with anti-platelet therapy or anticoagulation was adequate if there were not associated symptoms.&nbsp;Serial CT arteriograms to monitor for aneurysmal degeneration of the affected vessel is recommended.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg++2008%3B+48%3A329-33." target="_blank">Takayama T, Miyata T, Shirakawa M, Nagawa H. Isolated spontaneous dissection of the splanchnic arteries. J Vasc Surg&nbsp; 2008; 48:329-33.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23992995" target="_blank">Li DL, He YY, Alkalei AM, Chen XD, Jin W, Li M, et al. Management strategy for spontaneous isolated dissection of the superior mesenteric artery based on morphologic classification. &nbsp;&nbsp;J Vasc Surg 2014; 59:165-72.</a></p>
<p>QID: 30667</p></div><div class="rightanswer">The correct answer is: antiplatelet therapy and a follow-up CT scan in 6 months</div></div></div></div></div><div id="q411" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">173</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1721"><input type="hidden" name="q20803:411_:flagged" value="0"><input type="hidden" value="qaid=911295&amp;qubaid=20803&amp;qid=4784&amp;slot=411&amp;checksum=4c215fa8487f32890bfa5e873d1e3cfc&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:411_:flaggedcheckbox" name="q20803:411_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q411&id=4784"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:411_:sequencecheck" value="2"><div class="qtext"><p>A 57-year-old woman presents with several years of lower extremity pain and fatigue that worsens at the end of the day, as well as after prolonged periods of standing. She complains of new skin ulceration with associated pruritus and symptom progression. Venous duplex scanning reveals no evidence of thrombus, normal augmentation patterns, a 5 mm perforator located beneath the ulcer bed with outward flow of ≥ 500 ms, and the following vein valve closure times:&nbsp; CFV = 2.5 sec and GSV = 3.6 sec. &nbsp;Which of the following represents the most appropriate therapy to promote healing of her venous ulcer?<a href="./VESAP3_files/Venous Ulcer.jpg" target="images"><img src="./VESAP3_files/Venous Ulcer.jpg" alt="Venous Ulcer" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:411_answer" disabled="disabled" value="0" id="q20803:411_answer0"><label for="q20803:411_answer0">a. compression therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:411_answer" disabled="disabled" value="1" id="q20803:411_answer1"><label for="q20803:411_answer1">b. percutaneous ablation of the calf perforator</label> </div>
<div class="r0"><input type="radio" name="q20803:411_answer" disabled="disabled" value="2" id="q20803:411_answer2"><label for="q20803:411_answer2">c. endovenous thermal ablation of the great saphenous vein</label> </div>
<div class="r1"><input type="radio" name="q20803:411_answer" disabled="disabled" value="3" id="q20803:411_answer3"><label for="q20803:411_answer3">d. high ligation, division and stripping of the great saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:411_answer" disabled="disabled" value="4" id="q20803:411_answer4"><label for="q20803:411_answer4">e. pentoxifylline</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:411_-submit" name="q20803:411_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Compression therapy is the primary modality to aid ulcer healing in patients with advanced chronic venous disease and venous ulceration.&nbsp;A large randomized trial concluded that compression therapy alone is as effective as compression with surgery to heal venous ulcers.&nbsp;Ulcer healing with local wound care and compression approximates 97% in compliant patients over an average of 5.3 months. Additionally, the recurrence rate is decreased from 100% to 16% with compliance.&nbsp;Strong-compression hosiery (30-40 mmHg) may be more effective than medium- or low-compression stockings, but they are less well-tolerated by patients.&nbsp;However, getting the ulcer healed and keeping it healed are two different matters. Compression therapy is considered an adjuvant therapy to superficial vein ablation to prevent ulcer recurrence; this is based on data that suggests a reduced 12-month rate of recurrence (12% vs 28%) that persists out to 4 years in patients managed with compression and ablation, compared to compression alone.&nbsp;</p>
<p>Pentoxifylline, a competitive nonselective phosphodiesterase inhibitor, (400 mg oral dose TID) may accelerate healing of venous ulceration and may be suggested as an adjunct to local wound care and compression. There is grade 2B evidence to support the treatment of ‘pathologic perforators’ in patients with advanced chronic venous insufficiency (class C5-6) in the absence of deep venous obstruction, defined as large (≥ 3.5 mm), high-volume, incompetent (reflux ≥ 500ms) perforator veins located in the affected area of the limb with outward flow on duplex scanning in patients with class C5 or C6 disease.<a title="Gloviczki, 2011 #561" href="http://svsvesap.com/beta#_ENREF_1"><sup><br></sup></a></p>
<p><strong>References:</strong></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53%3A2S-48S." target="_blank">Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG<span>,&nbsp;</span>Gillespie DL<span>,&nbsp;</span>Gloviczki ML,&nbsp;et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53:2S-48S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+2004%3B363%3A1854-9." target="_blank">Barwell JR, Davies CE, Deacon J,<span class="nolink"> Harvey K<span>,&nbsp;</span>Minor J<span>,&nbsp;</span>Sassano A</span>,&nbsp;et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomised controlled trial. Lancet 2004;363:1854-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Long+term+results+of+compression+therapy+alone+versus+compression+plus+surgery+in+chronic+venous+ulceration+(ESCHAR)%3A" target="_blank">Gohel MS, Barwell JR, Taylor M, Chant T<span>,&nbsp;</span>Foy C<span>,&nbsp;</span>Earnshaw JJ<span>,&nbsp;</span>et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial. Bmj 2007; 335:83.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surg+1991%3B+109%3A575-81." target="_blank">Mayberry JC, Moneta GL, Taylor LM, Jr., Porter JM. Fifteen-year results of ambulatory compression therapy for chronic venous ulcers. Surg 1991;109:575-81.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Union+of+Angiology+2008%3B27%3A193-219." target="_blank">Partsch H, Flour M, Smith PC, International Compression C. Indications for compression therapy in venous and lymphatic disease consensus based on experimental data and scientific evidence. Int Angiol 2008;27:193-219.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22895929" target="_blank">Nelson EA, Bell-Syer SE. Compression for preventing recurrence of venous ulcers. Cochrane Database Syst Rev 2012;8.</a></p>
<p>QID: 30731</p></div><div class="rightanswer">The correct answer is: compression therapy</div></div></div></div></div><div id="q20" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">174</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1730"><input type="hidden" name="q20803:20_:flagged" value="0"><input type="hidden" value="qaid=910904&amp;qubaid=20803&amp;qid=4629&amp;slot=20&amp;checksum=ad40da6acb177c73c8de6da81bd30e4c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:20_:flaggedcheckbox" name="q20803:20_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q20&id=4629"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:20_:sequencecheck" value="2"><div class="qtext"><p>A patient is emergently explored through a midline laparotomy incision for a ruptured abdominal aortic aneurysm and is found to have a ruptured Type IV thoraco-abdominal aortic aneurysm (TAAA). Which of the following is the most efficient way to obtain proximal control and exposure?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:20_answer" disabled="disabled" value="0" id="q20803:20_answer0"><label for="q20803:20_answer0">a. perform right-sided visceral rotation with placement of a supraceliac clamp</label> </div>
<div class="r1"><input type="radio" name="q20803:20_answer" disabled="disabled" value="1" id="q20803:20_answer1"><label for="q20803:20_answer1">b. close the incision and perform a retroperitoneal incision using a left flank approach</label> </div>
<div class="r0"><input type="radio" name="q20803:20_answer" disabled="disabled" value="2" id="q20803:20_answer2"><label for="q20803:20_answer2">c. use digital control of the infrarenal aorta and place a clamp in the suprarenal region</label> </div>
<div class="r1"><input type="radio" name="q20803:20_answer" disabled="disabled" value="3" id="q20803:20_answer3"><label for="q20803:20_answer3">d. place an aortic cross-clamp clamp at or above the diaphragmatic hiatus and perform a medial visceral rotation</label> </div>
<div class="r0"><input type="radio" name="q20803:20_answer" disabled="disabled" value="4" id="q20803:20_answer4"><label for="q20803:20_answer4">e. extend the incision cephalad and place a clamp on the distal descending thoracic aorta</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:20_-submit" name="q20803:20_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Placing a clamp at the diaphragmatic hiatus will allow for proximal control in the situation described. This is performed by opening the lesser sac and mobilizing the left lobe of the liver to the patient's right and the esophagus to the left. The retroperitoneum is incised on each side of the aorta and a clamp placed. To visualize the proximal aorta in this situation, a medial visceral rotation is used to mobilize the spleen and pancreas to the right.&nbsp;This is associated with injury to the spleen in up to 15% of procedures. Once mobilized, the proximal vessels and entire aorta can be exposed. Placing a clamp in the suprarenal aorta would be too low to repair a Type IV TAAA-which extends up to the base of the celiac and superior mesenteric vessels.&nbsp;Whereas&nbsp;extending the incision cephalad&nbsp;may allow for placing a clamp for proximal control of the aorta. The aneurysm cannot be repaired unless a medial visceral rotation is performed. If a right-sided rotation is used the vena cava hinders complete visualization.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%20Stoney%20RJ,%20Wylie%20EJ.%20Surgical%20management%20of%20arterial%20lesions%20of%20the%20thoracoabdominal%20aorta.%20Am%20J%20Surg;%201973;%20126%20(2):157-164" target="_blank">Stoney RJ, Wylie EJ. Surgical management of arterial lesions of the thoracoabdominal aorta. Am J Surg 1973; 126 (2):157-64.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Reilly%20LM,%20Ramos%20TK,%20Marray%20SP,%20et%20al.%20Optimal%20exposure%20of%20the%20proximal%20abdominal%20aorta:%20a%20critical%20appraisal%20of%20transabdominal%20medial%20visceral%20rotation.%20J%20Vasc%20Surg;%201994;%2019%20(3):89-90" target="_blank">Reilly LM, Ramos TK, Marray SP, Cheng SW, Stoney RJ. Optimal exposure of the proximal abdominal aorta: a critical appraisal of transabdominal medial visceral rotation. J Vasc Surg 1994; 19 (3):89-90</a>.</p>
<p>QID: 30021</p></div><div class="rightanswer">The correct answer is: place an aortic cross-clamp clamp at or above the diaphragmatic hiatus and perform a medial visceral rotation</div></div></div></div></div><div id="q441" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">175</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1739"><input type="hidden" name="q20803:441_:flagged" value="0"><input type="hidden" value="qaid=911325&amp;qubaid=20803&amp;qid=4888&amp;slot=441&amp;checksum=aad61ed197886d6caa04f8d57c5d1aa5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:441_:flaggedcheckbox" name="q20803:441_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q441&id=4888"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:441_:sequencecheck" value="2"><div class="qtext"><p>In addition to low-molecular-weight heparin, alternative anticoagulants are being evaluated for the treatment of venous thromboembolism and atrial fibrillation. Which of the following statements regarding agents and their targets is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:441_answer" disabled="disabled" value="0" id="q20803:441_answer0"><label for="q20803:441_answer0">a. apixaban inhibits factor IIa</label> </div>
<div class="r1"><input type="radio" name="q20803:441_answer" disabled="disabled" value="1" id="q20803:441_answer1"><label for="q20803:441_answer1">b. rivaroxaban inhibits factor Xa</label> </div>
<div class="r0"><input type="radio" name="q20803:441_answer" disabled="disabled" value="2" id="q20803:441_answer2"><label for="q20803:441_answer2">c. fondaparinux inhibits factor IIa</label> </div>
<div class="r1"><input type="radio" name="q20803:441_answer" disabled="disabled" value="3" id="q20803:441_answer3"><label for="q20803:441_answer3">d. low-molecular-weight heparin only inhibits factor IIa</label> </div>
<div class="r0"><input type="radio" name="q20803:441_answer" disabled="disabled" value="4" id="q20803:441_answer4"><label for="q20803:441_answer4">e. dabigatran inhibits factor Xa</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:441_-submit" name="q20803:441_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Fondaparinux is a parenteral pentasaccharide that inhibits activated factor Xa. Low-molecular-weight heparins have both anti-Xa and anti-IIa activity. Dabigatran, rivaroxaban, and apixaban are among the family of new oral anticoagulants. Dabigatran is a direct thrombin inhibitor (IIa), whereas rivaroxaban and apixaban are direct Xa inhibitors.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.sciencedirect.com/science/article/pii/S2213333X13000528" target="_blank">Knepper J, Horne D, Obi A, Wakefield TW.&nbsp; A systematic update on the state of novel anticoagulants and a primer on reversal and bridging.&nbsp; J Vasc Surg Venous and Lymphatic 2013; 1:418-26.</a></p>
<p>QID: 30768</p></div><div class="rightanswer">The correct answer is: rivaroxaban inhibits factor Xa</div></div></div></div></div><div id="q113" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">176</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1748"><input type="hidden" name="q20803:113_:flagged" value="0"><input type="hidden" value="qaid=910997&amp;qubaid=20803&amp;qid=4725&amp;slot=113&amp;checksum=04b101686395be9d674cbdd289f7d267&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:113_:flaggedcheckbox" name="q20803:113_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q113&id=4725"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:113_:sequencecheck" value="2"><div class="qtext"><p>A "bovine" arch refers to:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:113_answer" disabled="disabled" value="0" id="q20803:113_answer0"><label for="q20803:113_answer0">a. an accurate reflection of a cow's arch anatomy</label> </div>
<div class="r1"><input type="radio" name="q20803:113_answer" disabled="disabled" value="1" id="q20803:113_answer1"><label for="q20803:113_answer1">b. the left common carotid arising from the innominate artery</label> </div>
<div class="r0"><input type="radio" name="q20803:113_answer" disabled="disabled" value="2" id="q20803:113_answer2"><label for="q20803:113_answer2">c. a common origin of the left common carotid and subclavian arteries</label> </div>
<div class="r1"><input type="radio" name="q20803:113_answer" disabled="disabled" value="3" id="q20803:113_answer3"><label for="q20803:113_answer3">d. a common origin of the left and right common carotid arteries</label> </div>
<div class="r0"><input type="radio" name="q20803:113_answer" disabled="disabled" value="4" id="q20803:113_answer4"><label for="q20803:113_answer4">e. a common origin of the left and right subclavian arteries</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:113_-submit" name="q20803:113_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The term "bovine" arch is a misnomer as it does not describe the arch anatomy of cows. Instead, it is a clinical term typically used to describe the origin of the left common carotid artery arising from the innominate (brachiocephalic) artery, as shown in the image below, rather than its more usual origin directly from the aortic arch. The geometry of this innominate "trifurcation" is highly variable with the greatest variability being in the distance between the arch and the left common carotid artery origin. This anatomy has implications for selective catheterization of the left common carotid artery during carotid interventions. Furthermore, since the origin of the innominate artery tends to be quite large, it is often possible to partially over-stent the origin of the innominate artery during TEVAR without compromising carotid perfusion, effectively extending the proximal seal zone. Single origin of the left and right subclavian arteries and single origin of the left common carotid and subclavian arteries are extremely rare aortic arch variants, while the so-called "bi-carotid" trunk has been associated with aberrant right subclavian artery.<br><br><a href="./VESAP3_files/AssetProxy_044.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_044.jpg" alt="img" width="100" height="100" border="0" hspace="10" vspace="10"></a><br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg%3B+2006%3B+20+(6)%3A809-12" target="_blank">Chahwan S, Miller MT, Kim KA, Mantell M<span>,&nbsp;</span>Kirksey L. Aberrant right subclavian artery associated with a common origin of carotid arteries. Ann Vasc Surg 2006; 20:809-12.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Neuroradiol+2006%3B+27%3A1541-2." target="_blank">Layton KF, Kallmes DF, Cloft HJ, Lindell EP<span>,&nbsp;</span>Cox VS. Bovine aortic arch variant in humans: Clarification of a common misnomer. Am J Neuroradiol 2006; 27:1541-2.</a></p>
<p>QID: 30200</p></div><div class="rightanswer">The correct answer is: the left common carotid arising from the innominate artery</div></div></div></div></div><div id="q284" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">177</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1757"><input type="hidden" name="q20803:284_:flagged" value="0"><input type="hidden" value="qaid=911168&amp;qubaid=20803&amp;qid=5021&amp;slot=284&amp;checksum=ca3bbeac5699ee75a02c915bb5ca469c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:284_:flaggedcheckbox" name="q20803:284_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q284&id=5021"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:284_:sequencecheck" value="2"><div class="qtext"><p>A 76-year-old woman is discovered to have a bruit in the right side of her neck. The internal carotid artery (ICA) waveform (image shown below)&nbsp;is obtained from the proximal right internal carotid artery and is consistent with which of the following?<br><br><a href="./VESAP3_files/AssetProxy_052.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_052.jpg" alt="img" width="100" height="42" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:284_answer" disabled="disabled" value="0" id="q20803:284_answer0"><label for="q20803:284_answer0">a. internal carotid artery fibromuscular disease</label> </div>
<div class="r1"><input type="radio" name="q20803:284_answer" disabled="disabled" value="1" id="q20803:284_answer1"><label for="q20803:284_answer1">b. compensatory flow secondary to high-grade left internal carotid artery stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:284_answer" disabled="disabled" value="2" id="q20803:284_answer2"><label for="q20803:284_answer2">c. internal carotid artery dissection</label> </div>
<div class="r1"><input type="radio" name="q20803:284_answer" disabled="disabled" value="3" id="q20803:284_answer3"><label for="q20803:284_answer3">d. high-grade stenosis of the proximal internal carotid artery</label> </div>
<div class="r0"><input type="radio" name="q20803:284_answer" disabled="disabled" value="4" id="q20803:284_answer4"><label for="q20803:284_answer4">e. proximal common carotid artery stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:284_-submit" name="q20803:284_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The normal internal carotid artery waveform has a rapid upstroke and continuous flow at the end of diastole. A rapid upstroke of the ICA waveform indicates lack of stenosis proximal to the site from which the waveform was obtained. Continuous flow at the end of the diastole indicates the internal carotid artery is feeding a relatively low resistance circulation with high metabolic needs. In contrast, a high-grade stenosis of the internal carotid artery at the site where the waveform is obtained would be characterized by an increase in peak systolic velocity, turbulent flow (as indicated by filling in the systolic window of the waveform), and, when the stenosis is severe, elevation of end-diastolic velocity. When diastolic flow is diminished in the internal carotid artery (characteristic of higher resistance to flow), distal obstruction of the internal carotid artery should be suspected. When the upstroke of the systolic portion of the waveform is delayed and overall amplitude decreased, as in this case, stenosis or obstruction of the carotid artery proximal to where the waveform was obtained should be suspected.<br><br></p>
<h2>Reference:</h2>
<p>Moneta GL, Mitchell EL, Esmonde N, et al. Extracranial carotid and vertebral arteries. In: Strandness's Duplex Scanning in Vascular Disorders, 4th ed. Zierler RE, ed. Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2010:87-100.</p>
<p>QID: 30501</p></div><div class="rightanswer">The correct answer is: proximal common carotid artery stenosis</div></div></div></div></div><div id="q255" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">178</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1766"><input type="hidden" name="q20803:255_:flagged" value="0"><input type="hidden" value="qaid=911139&amp;qubaid=20803&amp;qid=4992&amp;slot=255&amp;checksum=4acada8ec546205bdf026d981713be50&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:255_:flaggedcheckbox" name="q20803:255_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q255&id=4992"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:255_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man is postoperative day 20 from an open repair of a ruptured abdominal aortic aneurysm. On post-op day 3 he required dialysis, and a short-term dialysis catheter was placed urgently at bedside in his right femoral vein. He has stabilized but will require long-term dialysis. &nbsp;While waiting for a long-term arteriovenous hemodialysis access to mature, which of the following is the best strategy for dialysis in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:255_answer" disabled="disabled" value="0" id="q20803:255_answer0"><label for="q20803:255_answer0">a. place a new long-term dialysis catheter in his right internal jugular vein</label> </div>
<div class="r1"><input type="radio" name="q20803:255_answer" disabled="disabled" value="1" id="q20803:255_answer1"><label for="q20803:255_answer1">b. place a new short-term dialysis catheter in his right internal jugular vein</label> </div>
<div class="r0"><input type="radio" name="q20803:255_answer" disabled="disabled" value="2" id="q20803:255_answer2"><label for="q20803:255_answer2">c. continue dialysis through his short-term dialysis catheter in his right femoral vein</label> </div>
<div class="r1"><input type="radio" name="q20803:255_answer" disabled="disabled" value="3" id="q20803:255_answer3"><label for="q20803:255_answer3">d. place a new long term dialysis catheter through the right subclavian vein</label> </div>
<div class="r0"><input type="radio" name="q20803:255_answer" disabled="disabled" value="4" id="q20803:255_answer4"><label for="q20803:255_answer4">e. convert his short-term dialysis catheter in his right femoral vein to a long-term dialysis catheter in his right femoral vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:255_-submit" name="q20803:255_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Short-term dialysis catheters are double lumen non-cuffed catheters that may be placed at bedside without fluoroscopic guidance. They are ideal for an unstable patient in need of acute dialysis, as this patient likely was on post-op day 3. However, due to the high risk of complications associated with short-term dialysis catheters, particularly infection, they should be removed or converted to long-term dialysis catheters that are placed with fluoroscopic guidance and intended to be used over weeks to months duration. They are ideal for placement in a stable patient while waiting for permanent AV access to be placed and fully mature. Due to higher blood flow rates and lower complication rates, access through the right internal jugular vein with the catheter tip in the right atrium is ideal.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephrology+2003%3B+8(1)%3A16-20." target="_blank">Jefferys A, Chow J, Suranyi MG. Acute vascular access catheters for haemodialysis: complications limiting technique survival. Nephrology 2003; 8(1):16-20.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephron+1990%3B+54(2)%3A154-61." target="_blank">Cimochoswki GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990; 54(2):154-61.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Infection+Control+and+Hospital+Epidemiology+2003%3B+21(3)%3A200-203." target="_blank">Stevenson KB, Adcox MJ, Mallea MC, Narasimhan N, Wagnild J. Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatien, multifacility hemodialysis center. Infect Control Hosp Epidemiol 2003; 21(3):200-3.</a></p>
<p><span>QID: 30439</span></p></div><div class="rightanswer">The correct answer is: place a new long-term dialysis catheter in his right internal jugular vein</div></div></div></div></div><div id="q253" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">179</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1775"><input type="hidden" name="q20803:253_:flagged" value="0"><input type="hidden" value="qaid=911137&amp;qubaid=20803&amp;qid=1934&amp;slot=253&amp;checksum=6631b382d4b637fed015e1cd60cd1625&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:253_:flaggedcheckbox" name="q20803:253_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q253&id=1934"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:253_:sequencecheck" value="2"><div class="qtext"><p>A 16 year old African American boy, with CKD V presents for creation of a new access.&nbsp; Workup is still being conducted as to the etiology of his renal failure.&nbsp; He is right handed.&nbsp; On physical exam, the cephalic veins in both arms&nbsp;are 3.5 mm to the level of the wrist.&nbsp; The basilic veins are not visible on physical exam.&nbsp; He does not have an easily palpable ulnar pulse on the left side. What should be the next step in management?&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:253_answer" disabled="disabled" value="0" id="q20803:253_answer0"><label for="q20803:253_answer0">a. proceed with upper extremity arterial testing with assessment of palmar arch patency, with or without vein mapping.</label> </div>
<div class="r1"><input type="radio" name="q20803:253_answer" disabled="disabled" value="1" id="q20803:253_answer1"><label for="q20803:253_answer1">b. Proceed with placement of a right autogenous radiocephalic access</label> </div>
<div class="r0"><input type="radio" name="q20803:253_answer" disabled="disabled" value="2" id="q20803:253_answer2"><label for="q20803:253_answer2">c. proceed with placement of a proximal autogenous radiocephalic access on the left</label> </div>
<div class="r1"><input type="radio" name="q20803:253_answer" disabled="disabled" value="3" id="q20803:253_answer3"><label for="q20803:253_answer3">d. Proceed with vein mapping of both upper extremities to determine the most suitable vein prior to autogenous AV access placement</label> </div>
<div class="r0"><input type="radio" name="q20803:253_answer" disabled="disabled" value="4" id="q20803:253_answer4"><label for="q20803:253_answer4">e. Proceed with placement of a radiocephalic autogenous arteriovenous access on the left</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:253_-submit" name="q20803:253_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>While a young patient is unlikely to have PAD compromising circulation, multiple variations exist in anatomy of the palmar arch.&nbsp; It is necessary to ensure digital flow adequacy from the ulnar artery prior to utilizing the radial artery for inflow.</p>
<p><span>QID: 30437</span></p></div><div class="rightanswer">The correct answer is: proceed with upper extremity arterial testing with assessment of palmar arch patency, with or without vein mapping.</div></div></div></div></div><div id="q258" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">180</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1784"><input type="hidden" name="q20803:258_:flagged" value="0"><input type="hidden" value="qaid=911142&amp;qubaid=20803&amp;qid=4995&amp;slot=258&amp;checksum=cacc2a4165215b86ca368b3e3dc0e893&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:258_:flaggedcheckbox" name="q20803:258_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q258&id=4995"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:258_:sequencecheck" value="2"><div class="qtext"><p>Which dialysis catheter has the highest risk of infection?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:258_answer" disabled="disabled" value="0" id="q20803:258_answer0"><label for="q20803:258_answer0">a. short-term dialysis cathter placed in the right subclavian vein</label> </div>
<div class="r1"><input type="radio" name="q20803:258_answer" disabled="disabled" value="1" id="q20803:258_answer1"><label for="q20803:258_answer1">b. long-term dialysis catheter placed in the right internal jugular vein</label> </div>
<div class="r0"><input type="radio" name="q20803:258_answer" disabled="disabled" value="2" id="q20803:258_answer2"><label for="q20803:258_answer2">c. long-term dialysis catheter placed in the right femoral vein</label> </div>
<div class="r1"><input type="radio" name="q20803:258_answer" disabled="disabled" value="3" id="q20803:258_answer3"><label for="q20803:258_answer3">d. short-term dialysis catheter placed in the right internal jugular vein</label> </div>
<div class="r0"><input type="radio" name="q20803:258_answer" disabled="disabled" value="4" id="q20803:258_answer4"><label for="q20803:258_answer4">e. short-term dialysis catheter placed in the right femoral vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:258_-submit" name="q20803:258_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Infection rates are higher with short-term dialysis catheters (15.6 to 18.9 per 1000 catheters) than long-term dialysis catheters (2.9 to 13.6 per 1000 catheters). Infection rates as high as 20 per 1000 catheters are seen with short-term dialysis catheters placed in the femoral vein. Sepsis is associated with catheter infection in 0.3 to 1.3 per 1000 catheters. Organisms most commonly associated with catheter infections are Staphylococcus, Enterococcus, and Pseudomonas; often these infections are polymicrobial.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Stevenson+KB%2C+Adcox+MJ%2C+Mallea+MC%2C+narasimhan+N%2C+Wagnild+J.+Standardized+surveillance+of+hemodialysis+vacular+access+infections%3A+18-month+experience" target="_blank">Stevenson KB, Adcox MJ, Mallea MC, narasimhan N, Wagnild J. Standardized surveillance of hemodialysis vacular access infections: 18-month experience at an outpatient, multifacility hemodialysis center.&nbsp; Infect Control Hosp Epidemiol 2003; 21(3):200-3, 2003.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephrology+Dialysis+Transplantation+2004%3B+19(3)%3A670-7." target="_blank">Weijmer MC, Vervloet MG, ter Wee PM. &nbsp;Compared to tunneled cuffed haemodialysis cathters, temporary untunneled catheters are associated with more complications already within 2 weeks of use.&nbsp; Nehprol Dial Transpl 2004; 19(3):670-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=American+Journal+of+Kidney+Disease+1999%3B+34%3A1114-24." target="_blank">Saad, TF. Bacteremia associcated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34:1114-24.</a></p>
<p>QID: 30442</p></div><div class="rightanswer">The correct answer is: short-term dialysis catheter placed in the right femoral vein</div></div></div></div></div><div id="q478" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">181</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1793"><input type="hidden" name="q20803:478_:flagged" value="0"><input type="hidden" value="qaid=911362&amp;qubaid=20803&amp;qid=5203&amp;slot=478&amp;checksum=bea5f45b7652a04a1bd53597128e385f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:478_:flaggedcheckbox" name="q20803:478_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q478&id=5203"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:478_:sequencecheck" value="2"><div class="qtext"><p>A 48-year man who had prior hospitalizations for complications of alcoholism and methamphetamine abuse, presents with back and abdominal pain. His systolic blood pressure is 230 mmHg and aortic dissection is suspected.&nbsp;Initial laboratory values include hemoglobin 9.8 gm/dl, total bilirubin 4.3 mg/dl, and creatinine 3.5 mg/dl. His electrocardiogram demonstrates a heart rate of 46 bpm, Mobitz II heart block, and left ventricular hypertrophy.&nbsp;Which of the following medications should be used to treat his uncontrolled hypertension?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:478_answer" disabled="disabled" value="0" id="q20803:478_answer0"><label for="q20803:478_answer0">a. hydralazine</label> </div>
<div class="r1"><input type="radio" name="q20803:478_answer" disabled="disabled" value="1" id="q20803:478_answer1"><label for="q20803:478_answer1">b. fenoldopam</label> </div>
<div class="r0"><input type="radio" name="q20803:478_answer" disabled="disabled" value="2" id="q20803:478_answer2"><label for="q20803:478_answer2">c. esmolol</label> </div>
<div class="r1"><input type="radio" name="q20803:478_answer" disabled="disabled" value="3" id="q20803:478_answer3"><label for="q20803:478_answer3">d. nitroprusside</label> </div>
<div class="r0"><input type="radio" name="q20803:478_answer" disabled="disabled" value="4" id="q20803:478_answer4"><label for="q20803:478_answer4">e. nitroglycerine</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:478_-submit" name="q20803:478_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The immediate medical management of a patient with aortic dissection is focused on pain management, decreasing blood pressure, and decreasing the velocity of left ventricular contraction (dv/dt).</p>
<p>Systolic blood pressure should be reduced to 100-120 mmHg, or the lowest tolerated level. Treatment often includes a vasodilator in combination with a beta-blocker, targeting a heart rate of 55-65 beat per minute.</p>
<p>Esmolol can be an excellent beta-blocker for treatment of aortic dissection, but&nbsp; contraindications to its use include certain rhythm and conduction disturbances, including severe sinus bradycardia, heart block greater than first degree, and sick sinus syndrome. Thus, esmolol would not be appropriate for this patient.</p>
<p>Nitroprusside is a vasodilator that produces both arterial and venous dilation, has a rapid onset of action, and has a short half-life (3-4 minutes). It is appropriate for control of severe hypertension, but its use is contraindicated in patients with hepatic and renal impairment.</p>
<p>Hydralazine is a direct vasodilator. Its use for aortic dissection should be avoided since it increases aortic wall shear stress and has prolonged and relatively unpredictable antihypertensive effects.&nbsp;Nitroglycerin has relatively weak effect as an arterial vasodilator and it is not a good choice for hypertensive emergencies.&nbsp;</p>
<p>Fenoldopam is an arteriolar vasodilator acting via a dopamine-1 agonist effect. It has a rapid onset of action and a short half-life (5 minutes). Fenoldopam may be the drug of choice for treatment of patients with renal impairment as its dopaminergic effect increases renal blood flow. Thus, fenoldapam is the most appropriate choice for the patient in this scenario.</p>
<p>Other treatment options might include a calcium channel blocker (eg, nicardipine) or an angiotensin converting enzyme (ACE) inhibitor.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Card+Surg+2006%3B+21+Suppl+1%3AS3-7." target="_blank">Khoynezhad A, Plestis KA. Managing emergency hypertension in aortic dissection and aortic aneurysm surgery. J Card Surg 2006; 21 Suppl 1:S3-7.&nbsp;</a></p>
<p>QID: 30842</p></div><div class="rightanswer">The correct answer is: fenoldopam</div></div></div></div></div><div id="q390" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">182</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1802"><input type="hidden" name="q20803:390_:flagged" value="0"><input type="hidden" value="qaid=911274&amp;qubaid=20803&amp;qid=5041&amp;slot=390&amp;checksum=2d2d273c5469094f7774d4235c8eade9&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:390_:flaggedcheckbox" name="q20803:390_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q390&id=5041"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:390_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old man is admitted with acute shortness of breath and hypoxemia 10 days after surgery for small bowel obstruction. An echocardiogram shows right heart strain. CT angiography shows a right main pulmonary artery embolus. Which of the following findings most strongly supports the use of intra-arterial thrombolysis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:390_answer" disabled="disabled" value="0" id="q20803:390_answer0"><label for="q20803:390_answer0">a. elevated troponin T and brain naturetic peptide</label> </div>
<div class="r1"><input type="radio" name="q20803:390_answer" disabled="disabled" value="1" id="q20803:390_answer1"><label for="q20803:390_answer1">b. elevated interleukin-6</label> </div>
<div class="r0"><input type="radio" name="q20803:390_answer" disabled="disabled" value="2" id="q20803:390_answer2"><label for="q20803:390_answer2">c. elevated hsCRP and serum lactate</label> </div>
<div class="r1"><input type="radio" name="q20803:390_answer" disabled="disabled" value="3" id="q20803:390_answer3"><label for="q20803:390_answer3">d. right bundle branch block</label> </div>
<div class="r0"><input type="radio" name="q20803:390_answer" disabled="disabled" value="4" id="q20803:390_answer4"><label for="q20803:390_answer4">e. AA gradient &gt; 400 mm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:390_-submit" name="q20803:390_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Current 2008 Chest guidelines recommend thrombolytic therapy in all patients with hemodynamic compromise and objectively diagnosed pulmonary embolus (PE) who do not have contraindications owing to elevated risk of bleeding. Selected PE patients without hypotension and with a low risk for bleeding should also be considered for thrombolytic therapy based on the clinician's assessment of PE severity, prognosis, and risk of bleeding. Based on recent data, significant right heart strain with markers of cardiac injury (troponin T) and myocyote strain (BNP) indicate significant outflow obstruction that should be eliminated to decrease the risk of death and chronic thromboembolic pulmonary hypertension. In the majority of patients, the thrombolytic agents should be administered systemically, but in selected highly compromised patients who are unable to receive systemic thrombolytics due to bleeding risk or who are felt to be too hemodynamically compromised to allow sufficient time for systemic thrombolytics to be effective, intra-arterial thrombolysis via selective catheterization should be considered, given the availability of appropriate clinical expertise with the techniques required. Endoluminal techniques such as pharmacomechanical thrombolysis are used for rapid clearance of acute pulmonary artery embolic obstruction, recognizing that clot fragmentation plays as much of a role as clot dissolution or extraction.</p>
<p>The patient presented has contraindications to systemic thrombolysis due to his recent surgery. Contemporary surgical pulmonary embolectomy has reasonable morbidity and mortality but is generally considered a second line therapy to endovascular methods. Post procedure anticoagulation is no different than those not treated by aggressive means.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Piazza%20G,%20Goldhaber%20SZ.%20Acute%20pulmonary%20embolism:%20Part%20II:%20Treatment%20and%20prophylaxis.%20Circulation;%202006;%20114%20(3):e42-47" target="_blank">Piazza G, Goldhaber SZ. Acute pulmonary embolism: Part II: Treatment and prophylaxis. Circulation 2006; 114 (3):e42-7.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Tapson%20VF.%20Acute%20pulmonary%20embolism.%20N%20Engl%20J%20Med;%202008;%20358%20(10):1037-1052" target="_blank">Tapson VF. Acute pulmonary embolism. N Engl J Med 2008; 358 (10):1037-52.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Geerts%20W.%20Antithrombotic%20and%20thrombolytic%20therapy.%20Chest;%202008;%20133%20(8th%20Ed:%20ACCP%20Guidelines):381s-451s" target="_blank">Geerts W, Bergqvist D,&nbsp;Pineo GF,&nbsp;Heit JA,&nbsp;Samama CM,&nbsp;Lassen MR, et al.&nbsp;Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).&nbsp;Chest 2008; 133:381S-451S.</a></p>
<p>QID: 30707</p></div><div class="rightanswer">The correct answer is: elevated troponin T and brain naturetic peptide</div></div></div></div></div><div id="q35" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">183</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1811"><input type="hidden" name="q20803:35_:flagged" value="0"><input type="hidden" value="qaid=910919&amp;qubaid=20803&amp;qid=4662&amp;slot=35&amp;checksum=7f9d25536f2eabec0d24a11e812933ce&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:35_:flaggedcheckbox" name="q20803:35_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q35&id=4662"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:35_:sequencecheck" value="2"><div class="qtext"><p><span>A healthy 75-year-old man presents for routine follow-up 18 months following endovascular aneurysm repair.&nbsp;At the time of treatment, the maximum&nbsp;aortic diameter was 5.7 cm.&nbsp;On surveillance duplex ultrasound, the sac size has increased to 8 cm.&nbsp;CTA reveals a type IA endoleak with an 8.5 cm aneurysm sac. The imaging obtained is shown below.&nbsp;The renal arteries and superior mesenteric artery are marked. The aorta at the level of the superior mesenteric artery measures 18 mm.&nbsp;</span>Which&nbsp;of the following is the best&nbsp;management option&nbsp;for this patient?</p>
<p><a href="./VESAP3_files/Type I Endoleak.jpg" target="images"><img src="./VESAP3_files/Type I Endoleak.jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:35_answer" disabled="disabled" value="0" id="q20803:35_answer0"><label for="q20803:35_answer0">a. <span style="color: #000000;">aortic endograft explant and in situ aortic graft</span></label> </div>
<div class="r1"><input type="radio" name="q20803:35_answer" disabled="disabled" value="1" id="q20803:35_answer1"><label for="q20803:35_answer1">b. <span style="color: #000000;">physician-modified fenestrated endograft to include both renal arteries, the superior mesenteric artery, and a scallop for the celiac artery</span></label> </div>
<div class="r0"><input type="radio" name="q20803:35_answer" disabled="disabled" value="2" id="q20803:35_answer2"><label for="q20803:35_answer2">c. <span style="color: #000000;">placement of a Palmaz stent in order to achieve seal in the proximal neck</span></label> </div>
<div class="r1"><input type="radio" name="q20803:35_answer" disabled="disabled" value="3" id="q20803:35_answer3"><label for="q20803:35_answer3">d. <span style="color: #000000;">selective mesenteric angiography and hypogastric artery angiography with sac embolization</span></label> </div>
<div class="r0"><input type="radio" name="q20803:35_answer" disabled="disabled" value="4" id="q20803:35_answer4"><label for="q20803:35_answer4">e. <span style="color: #000000;">placement of an additional aortic cuff to increase the seal zone</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:35_-submit" name="q20803:35_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span>Infrarenal graft explant occurs in .05-1% of patients and is directly related to whether the device is implanted within the instructions for use guidelines.&nbsp;In this patient, there is a new type Ia endoleak with rapid expansion of the aneurysm sac.&nbsp;Sac embolization is typically reserved for sac expansion secondary to type II endoleaks.&nbsp; Aortic cuff extensions are useful when there is adequate length of infrarenal neck. In this case, the endograft fabric is directly below the left renal artery on the coronal view.&nbsp;Palmaz stents have also been utilized when there is adequate seal length, but in this case the graft fabric appears to be adjacent to the aortic wall and additional outward compression is unlikely to eliminate the proximal endoleak. &nbsp;</span></p>
<p><span>There are several anatomic aspects that make this case unfavorable for a fenestrated endograft.&nbsp; The suprarenal struts are partially collapsed toward the aortic centerline, which will make rotation of any device extremely challenging.&nbsp;In addition, the aortic lumen is only 18 mm, which will complicate the catheterization of the visceral arteries.&nbsp;In the absence of contraindications to open surgical repair, aortic explant is the best choice in this patient.&nbsp; In an elective setting, endograft explant can be performed with a perioperative mortality of 5-8%.&nbsp;Endoleaks with sac expansion account for 70% of endograft explants, followed by graft migration, infection, and aorto-enteric fistulas.</span></p>
<h2><span>References:</span></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arthurs+ZM%2C+Lyden+SP%2C+Rajani+RR%2C+Eagleton+MJ%2C+Clair+DG.+Long-term+outcomes+of+Palmaz+stent+placement+for+intraoperative+type+Ia+endoleak+during+endovascular+aneurysm+repair.+Ann+Vasc+Surg.+2011+Jan%3B25(1)%3A120-6." target="_blank"><span>Arthurs ZM, Lyden SP, Rajani RR, Eagleton MJ, Clair DG. Long-term outcomes of Palmaz stent placement for intraoperative type Ia endoleak during endovascular aneurysm repair. Ann Vasc Surg 2011; 25(1):120-6.</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kelso+RL%2C+Lyden+SP%2C+Butler+B%2C+Greenberg+RK%2C+Eagleton+MJ%2C+Clair+DG.+Late+conversion+of+aortic+stent+grafts.+J+Vasc+Surg.+2009%3B+49(3)%3A589-95." target="_blank"><span>Kelso RL, Lyden SP, Butler B, Greenberg RK, Eagleton MJ, Clair DG. Late conversion of aortic stent grafts. J Vasc Surg 2009; 49(3):589-95.&nbsp;</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kelso+RL%2C+Lyden+SP%2C+Butler+B%2C+Greenberg+RK%2C+Eagleton+MJ%2C+Clair+DG.+Late+conversion+of+aortic+stent+grafts.+J+Vasc+Surg.+2009%3B+49(3)%3A589-95." target="_blank"><span>Brinster CJ, Fairman RM, Woo EY, Wang GJ, Carpenter JP, Jackson BM. Late open conversion and explantation of abdominal aortic stent grafts. J Vasc Surg 2011; 54(1):42-6.</span></a></p>
<p><span>QID: 30038</span></p></div><div class="rightanswer">The correct answer is: <span style="color: #000000;">aortic endograft explant and in situ aortic graft</span></div></div></div></div></div><div id="q362" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">184</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1820"><input type="hidden" name="q20803:362_:flagged" value="0"><input type="hidden" value="qaid=911246&amp;qubaid=20803&amp;qid=5297&amp;slot=362&amp;checksum=eb117d3fc917c8b36d9e13f6558374be&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:362_:flaggedcheckbox" name="q20803:362_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q362&id=5297"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:362_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is the best initial treatment of superior mesenteric artery (SMA) syndrome?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:362_answer" disabled="disabled" value="0" id="q20803:362_answer0"><label for="q20803:362_answer0">a. percutaneous endoscopic&nbsp;gastrostomy tube placement</label> </div>
<div class="r1"><input type="radio" name="q20803:362_answer" disabled="disabled" value="1" id="q20803:362_answer1"><label for="q20803:362_answer1">b. superior mesenteric artery stenting</label> </div>
<div class="r0"><input type="radio" name="q20803:362_answer" disabled="disabled" value="2" id="q20803:362_answer2"><label for="q20803:362_answer2">c. gastric decompression and post obstructive enteral feeding&nbsp;or TPN</label> </div>
<div class="r1"><input type="radio" name="q20803:362_answer" disabled="disabled" value="3" id="q20803:362_answer3"><label for="q20803:362_answer3">d. intestinal bypass via gastrojejunostomy</label> </div>
<div class="r0"><input type="radio" name="q20803:362_answer" disabled="disabled" value="4" id="q20803:362_answer4"><label for="q20803:362_answer4">e. autologous bypass of the superior mesenteric artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:362_-submit" name="q20803:362_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Superior mesenteric artery (SMA) syndrome, a.k.a. Cast syndrome&nbsp;or&nbsp;Wilkie syndrome, is a rare condition of proximal intestinal obstruction.&nbsp;It is characterized by a reduction in the angle between the superior mesenteric artery and the aorta, which is normally 35-60 degrees and maintained by a mesenteric fat pad.&nbsp;In&nbsp;SMA syndrome, the angle can&nbsp;narrow to as little 6 degrees,&nbsp;compressing the third portion of the duodenum&nbsp;as it passes&nbsp;between&nbsp;the SMA and the aorta.&nbsp;The diagnosis of this&nbsp;sydrome is often controversial.&nbsp;Patient symptoms and radiological findings&nbsp;do not always correlate. &nbsp;Symptoms are typical of proximal intestinal obstruction and are&nbsp;highly variable, ranging from post-prandial&nbsp;epigastric pain and early&nbsp;satiety to severe nausea,&nbsp;bilious emesis, and severe weight loss.&nbsp;Diagnosis usually requires an imaging test, such as a CTA, to&nbsp;assess the&nbsp;relationship between the SMA, the aorta, and the duodenum. An aorto-SMA artery angle of less than 25 degrees is the most sensitive&nbsp;radiologic finding for&nbsp;the diagnosis.&nbsp;Additional information&nbsp;to support the diagnosis is evidence of&nbsp;duodenal obstruction with active peristalsis.&nbsp;Treatment&nbsp;may be conservative, including gastric decompression, weight gain (post&nbsp;obstructive&nbsp;enteral feedings), and correction of fluid and electrolytes. Surgical&nbsp;options include dividing of the ligament of&nbsp;Treitz and repositioning of the fully mobilized duodenum to the right of the&nbsp;SMA (Strong's procedure) or intestinal bypass operations, such&nbsp;as&nbsp;&nbsp;gastrojejunostomy or duodenojejunostomy.&nbsp;</p>
<p>&nbsp;</p>
<div class="abstractRow">
<h2 class="value"><strong>References:</strong></h2>
<div class="value"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Clin+Gastroenterol+1985%3B7(2)%3A113." target="_blank">Cohen LB, Field SP, Sachar DB. The superior mesenteric artery syndrome. The disease that isn't, or is it? &nbsp;J Clin Gastroenterol 1985;7(2):113.</a></div>
<div class="value">&nbsp;</div>
<div class="value"><a href="http://www.ncbi.nlm.nih.gov/pubmed/15788004" target="_blank">Neri S, Signorelli SS, Mondati E, Pulvirenti D, Campanile E, Di Pino L, et al. Ultrasound imaging in diagnosis of superior mesenteric artery syndrome. &nbsp;J Intern Med 2005;257(4):346-51.</a></div>
<div class="value">QID: 30634</div>
</div></div><div class="rightanswer">The correct answer is: gastric decompression and post obstructive enteral feeding&nbsp;or TPN</div></div></div></div></div><div id="q188" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">185</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1829"><input type="hidden" name="q20803:188_:flagged" value="0"><input type="hidden" value="qaid=911072&amp;qubaid=20803&amp;qid=4556&amp;slot=188&amp;checksum=4392d94027b51b0cf064d02fc9f8128f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:188_:flaggedcheckbox" name="q20803:188_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q188&id=4556"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:188_:sequencecheck" value="2"><div class="qtext"><p>A 70 year old man with a history of COPD, previous EVAR for AAA underwent TEVAR with concomitant left carotid subclavian bypass for a thoracic aneurysm. Postoperatively, the patient had prolonged ventilator dependence. CXR demonstrated an elevated left hemidiaphragm. The most likely cause of this finding is</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:188_answer" disabled="disabled" value="0" id="q20803:188_answer0"><label for="q20803:188_answer0">a. Injury to the left phrenic nerve during exposure of the left subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:188_answer" disabled="disabled" value="1" id="q20803:188_answer1"><label for="q20803:188_answer1">b. Injury to the left phrenic nerve during exposure of the left common carotid artery</label> </div>
<div class="r0"><input type="radio" name="q20803:188_answer" disabled="disabled" value="2" id="q20803:188_answer2"><label for="q20803:188_answer2">c. Injury to the left vagus nerve during exposure of the proximal subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:188_answer" disabled="disabled" value="3" id="q20803:188_answer3"><label for="q20803:188_answer3">d. Chylothorax from injury to the thoracic duct</label> </div>
<div class="r0"><input type="radio" name="q20803:188_answer" disabled="disabled" value="4" id="q20803:188_answer4"><label for="q20803:188_answer4">e. Compression of the left phrenic nerve by the thoracic aneurysm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:188_-submit" name="q20803:188_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In a meta-analysis from 2009 evaluating the effect of coverage of the left subclavian artery with and without revascularization during TEVAR, the combined rate of phrenic nerve injury was 4.4%. <sup>1</sup> The left phrenic nerve courses over the anterior scalene muscle which lies between the left subclavian vein (anterior) and artery (posterior). An injured left phrenic nerve and resulting elevated left hemidiaphragm can result in respiratory distress particularly in those with already compromised lung function. <sup>2</sup></p>
<p>1. Rizvi AZ, Murad MH, Fairman RM, et al. The effect of left subclavian artery coverage on morbidity and mortality in patients undergoing endovascular thoracic aortic interventions: A systemic review and meta-analysis.&nbsp; J Vasc Surg 2009; 50: 1159-69. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19878792">http://www.ncbi.nlm.nih.gov/pubmed/19878792</a></p>
<p>2. Aguirre VJ, Sinha P, Zimmet A, et al. Phrenic nerve injury during cardiac surgery: mechanisms, management and prevention. Heart Lung Circ 2013; 22(11): 895-902. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23948287">http://www.ncbi.nlm.nih.gov/pubmed/23948287</a></p>
<p>QID: 30333</p></div><div class="rightanswer">The correct answer is: Injury to the left phrenic nerve during exposure of the left subclavian artery</div></div></div></div></div><div id="q470" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">186</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1838"><input type="hidden" name="q20803:470_:flagged" value="0"><input type="hidden" value="qaid=911354&amp;qubaid=20803&amp;qid=5194&amp;slot=470&amp;checksum=51c89832510471ba5f11ed08b0ee1c2c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:470_:flaggedcheckbox" name="q20803:470_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q470&id=5194"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:470_:sequencecheck" value="2"><div class="qtext"><p>A 79-year-old man who is anticoagulated with warfarin for chronic atrial fibrillation presents to the emergency department with a symptomatic 6.5 cm abdominal aortic aneurysm. His CT scan shows a small retroperitoneal hematoma. Anatomic criteria mandate open surgical repair. He is awake, alert, and hemodynamically stable. His INR is 2.9.&nbsp;Which of the following is preferred for warfarin reversal prior to operation?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:470_answer" disabled="disabled" value="0" id="q20803:470_answer0"><label for="q20803:470_answer0">a. fresh frozen plasma (FFP), 10 mL/kg, intravenous (IV) infusion</label> </div>
<div class="r1"><input type="radio" name="q20803:470_answer" disabled="disabled" value="1" id="q20803:470_answer1"><label for="q20803:470_answer1">b. prothrombin complex concentrate, 25 IU/kg, intravenous (IV) infusion</label> </div>
<div class="r0"><input type="radio" name="q20803:470_answer" disabled="disabled" value="2" id="q20803:470_answer2"><label for="q20803:470_answer2">c. vitamin K, 10 mg IV and intravenous prothrombin complex concentrate, 25 IU/kg IV</label> </div>
<div class="r1"><input type="radio" name="q20803:470_answer" disabled="disabled" value="3" id="q20803:470_answer3"><label for="q20803:470_answer3">d. <span style="color: #000000;">vitamin K, 10 mg subcutaneous injection (SQ)</span></label> </div>
<div class="r0"><input type="radio" name="q20803:470_answer" disabled="disabled" value="4" id="q20803:470_answer4"><label for="q20803:470_answer4">e. vitamin K, 10 mg intravenously (IV)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:470_-submit" name="q20803:470_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>There are 3 treatment options for reversal of warfarin anticoagulation: vitamin K, fresh frozen plasma (FFP), and prothrombin complex concentrate (PCC).</p>
<p>PCC has been used in Europe for more than 20 years. Data from several cohort studies and one randomized clinical trial demonstrated advantages of PCC over FFP, including significantly reduced time to administration, reduced time to reversal once administered, substantially lower administration volumes (reduced risk of heart failure), and virtually no risk of allergic reaction or disease transmission. Risk of venous thromboembolism and other thrombotic complications with FFP and PCC appear equivalent.</p>
<p>In the United States, FFP is still the most frequently used therapy for urgent warfarin reversal. However, potential disadvantages of its use include delays in thawing, delays in warfarin reversal once administered, volume overload and congestive heart failure, allergic reactions, and a small potential for infectious disease transmission.</p>
<p>Intravenous vitamin K is expected to result in more rapid and effective warfarin reversal than subcutaneous administration, but vitamin K is not sufficient for anticoagulation reversal in this setting because the effect of vitamin K takes several hours to days.</p>
<p>The proper dose of FFP and PCC both depend on patient weight and INR. Current ACCP guidelines suggest PCC rather than FFP for urgent warfarin reversal, in combination with 5-10 mg intravenous vitamin K.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest+2012%3B+141(2+Suppl)%3Ae152S-84S." target="_blank">Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl):e152S-84S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation.+2013%3B+128(4)%3A360-4." target="_blank">Hickey M, Gatien M, Taljaard M, Aujnarain A, Giulivi A, Perry JJ. Outcomes of urgent warfarin reversal with frozen plasma versus prothrombin complex concentrate in the emergency department. Circulation 2013; 128(4):360-4.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation.+2013%3B128%3A1234-43." target="_blank">Sarode R, Milling TJ, Jr, Refaai MA, Mangione A<span>,&nbsp;</span>Schneider A<span>,&nbsp;</span>Durn BL<span>,&nbsp;</span>Goldstein JN.&nbsp;Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation 2013;128:1234-43.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Crit+Care+2009%3B13(6)%3AR191." target="_blank">Schick KS, Fertmann JM, Jauch KW, Hoffmann JN. Prothrombin complex concentrate in surgical patients: retrospective evaluation of vitamin K antagonist reversal and treatment of severe bleeding. Crit Care 2009;13(6):R191.&nbsp;</a></p>
<p>QID: 30833</p></div><div class="rightanswer">The correct answer is: vitamin K, 10 mg IV and intravenous prothrombin complex concentrate, 25 IU/kg IV</div></div></div></div></div><div id="q61" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">187</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1847"><input type="hidden" name="q20803:61_:flagged" value="0"><input type="hidden" value="qaid=910945&amp;qubaid=20803&amp;qid=4658&amp;slot=61&amp;checksum=ca19b0371824fee84e0582a41624bdd8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:61_:flaggedcheckbox" name="q20803:61_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q61&id=4658"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:61_:sequencecheck" value="2"><div class="qtext"><p>With regard to the incidence of erectile dysfunction following abdominal aortic aneurysm (AAA) repair, which of the following statements is true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:61_answer" disabled="disabled" value="0" id="q20803:61_answer0"><label for="q20803:61_answer0">a. erectile function worsens immediately postoperatively following either open repair or EVAR, but then returns to baseline by 6 months after repair</label> </div>
<div class="r1"><input type="radio" name="q20803:61_answer" disabled="disabled" value="1" id="q20803:61_answer1"><label for="q20803:61_answer1">b. retrograde ejaculation may occur after open or endovascular repair</label> </div>
<div class="r0"><input type="radio" name="q20803:61_answer" disabled="disabled" value="2" id="q20803:61_answer2"><label for="q20803:61_answer2">c. unilateral hypogastric artery embolization rarely leads to erectile dysfunction</label> </div>
<div class="r1"><input type="radio" name="q20803:61_answer" disabled="disabled" value="3" id="q20803:61_answer3"><label for="q20803:61_answer3">d. baseline erectile dysfunction is high among patients with AAA and should be assessed prior to repair</label> </div>
<div class="r0"><input type="radio" name="q20803:61_answer" disabled="disabled" value="4" id="q20803:61_answer4"><label for="q20803:61_answer4">e. EVAR results in better preservation of erectile function than open repair</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:61_-submit" name="q20803:61_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The DREAM and OVER trials specifically assessed erectile function in patients after either open or endovascular repair. The DREAM trial assessed erectile function using 5 questions modified from the Medical Outcomes Study. Both groups had a significant decline in sexual function immediately postoperatively but returned to baseline by 3 months, despite a higher number of occluded hypogastric arteries in the EVAR group.&nbsp;The OVER trial used the validated 5-item International Index of Erectile Function and showed no differences at either 1 or 2 years after repair. Both groups had relatively poor baseline scores (11.4 for the EVAR group and 10.3 for the open group on a scale from 5-25, with 25 representing better function).&nbsp;There was approximately 35-40% baseline erectile dysfunction in the ADAM trial, with gradual worsening of erectile function over time-rather than a significant increase immediately after repair.&nbsp;Unilateral hypogastric artery embolization is associated with an approximately 17% risk of new erectile dysfunction, while bilateral hypogastric artery embolization was associated with a 24% risk.&nbsp;These numbers may be overestimated since they were derived when embolization of both the anterior and posterior division was more common than hypogastric trunk embolization with preservation of the bifurcation. With increased emphasis on hypogastric preservation with branched endografts or more proximal embolization with nitinol plug occluders rather than distal branch embolization, it is possible that the incidence of erectile dysfunction after EVAR may improve over that seen in the OVER trial. Retrograde ejaculation has only been reported after open repair and is presumed to be secondary to disruption of the autonomic nerve plexus around the aortic bifurcation and left iliac artery.</p>
<p>&nbsp;</p>
<h2><span style="font-family: Times New Roman;"><span style="font-family: Times New Roman;">References:</span></span></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Prinssen%2C+M.%2C+et+al.+Sexual+dysfunction+after+conventional+and+endovascular+AAA+repair%3A+results+of+the+DREAM+trial.+J+Endovasc+Ther+11%2C+613-620+(2004)." target="_blank">Prinssen M,&nbsp;Buskens E,&nbsp;Nolthenius RP,&nbsp;van Sterkenburg SM,&nbsp;Teijink JA,&nbsp;Blankensteijn JD.&nbsp;Sexual dysfunction after conventional and endovascular AAA repair: results of the DREAM trial. J Endovasc There&nbsp;2004; 11, 613-20.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lederle+FA%2C+Freischlag+JA%2C+Kyriakides+TC%2C+Padberg+FT+Jr%2C+Matsumura+JS%2C+Kohler+TR%2C+et+al.+Outcomes+following+endovascular+vs+open+repair+of+abdominal+aortic+aneurysm%3A+a+randomized+trial.+JAMA+302%2C+1535-1542+2009." target="_blank">Lederle FA, Freischlag JA,&nbsp;Kyriakides TC,&nbsp;Padberg FT Jr,&nbsp;Matsumura JS,&nbsp;Kohler TR,&nbsp;et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA 2009; 302, 1535-42.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lederle+FA%2C+Johnson+GR%2C+Wilson+SE%2C+Acher+CW%2C+Ballard+DJ%2C+Littooy+FN%2C+et+al.+Quality+of+life%2C+impotence%2C+and+activity+level+in+a+randomized+trial+of+immediate+repair+versus+surveillance+of+small+abdominal+aortic+aneurysm.+J+Vasc+Surg+38%2C+745-752+(2003)." target="_blank">Lederle FA,&nbsp;Johnson GR,&nbsp;Wilson SE,&nbsp;Acher CW,&nbsp;Ballard DJ,&nbsp;Littooy FN,&nbsp;et al. Quality of life, impotence, and activity level in a randomized trial of immediate repair versus surveillance of small abdominal aortic aneurysm. J Vasc Surg&nbsp;2003; 38, 745-52.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lin%2C+P.H.%2C+Chen%2C+A.Y.+%26+Vij%2C+A.+Hypogastric+artery+preservation+during+endovascular+aortic+aneurysm+repair%3A+is+it+important%3F+Semin+Vasc+Surg+22%2C+193-200+(2009)." target="_blank">Lin, P.H., Chen, A.Y. &amp; Vij, A. Hypogastric artery preservation during endovascular aortic aneurysm repair: is it important? Semin Vasc Surg 2009; 22, 193-200.</a></p>
<p>QID: 30070</p></div><div class="rightanswer">The correct answer is: baseline erectile dysfunction is high among patients with AAA and should be assessed prior to repair</div></div></div></div></div><div id="q414" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">188</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1856"><input type="hidden" name="q20803:414_:flagged" value="0"><input type="hidden" value="qaid=911298&amp;qubaid=20803&amp;qid=4787&amp;slot=414&amp;checksum=b7be95811a694e7559c6e8c1dafb1931&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:414_:flaggedcheckbox" name="q20803:414_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q414&id=4787"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:414_:sequencecheck" value="2"><div class="qtext"><p>A 28-year-old man presents in clinic with swelling and pain in his calf. One year ago he was treated with 3 months of anticoagulation for a calf vein deep venous thrombosis (DVT) that occurred after a sports injury. &nbsp;On duplex ultrasound, which of the following features would favor a diagnosis of post-thrombotic syndrome over a new acute DVT?</p>
<p>&nbsp;</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:414_answer" disabled="disabled" value="0" id="q20803:414_answer0"><label for="q20803:414_answer0">a. dilatation of the calf veins</label> </div>
<div class="r1"><input type="radio" name="q20803:414_answer" disabled="disabled" value="1" id="q20803:414_answer1"><label for="q20803:414_answer1">b. presence of reflux in the calf veins</label> </div>
<div class="r0"><input type="radio" name="q20803:414_answer" disabled="disabled" value="2" id="q20803:414_answer2"><label for="q20803:414_answer2">c. absence of collateral vessels</label> </div>
<div class="r1"><input type="radio" name="q20803:414_answer" disabled="disabled" value="3" id="q20803:414_answer3"><label for="q20803:414_answer3">d. lack of spontaneous and phasic flow in the calf veins</label> </div>
<div class="r0"><input type="radio" name="q20803:414_answer" disabled="disabled" value="4" id="q20803:414_answer4"><label for="q20803:414_answer4">e. increased echogenicity of the calf veins</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:414_-submit" name="q20803:414_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Patients with previous DVT are at risk for both a second DVT and post-thrombotic syndrome (PTS). Each can cause leg pain and swelling, although clinically, a second acute DVT is more likely to present with an acute exacerbation of symptoms when compared to PTS. In general, duplex ultrasound can differentiate between acute DVT and chronic venous changes associated with PTS. Reflux in calf veins is common with PTS, but can also be seen in patients with acute DVT, either existing as simple reflux before the first episode of thrombosis, or as a result of valvular damage from the first DVT.&nbsp; Dilatation of the calf veins is a duplex finding associated with acute DVT. With chronic venous changes, the veins are usually contracted/smaller than normal. Lack of spontaneous and phasic flow in the calf veins can be seen with either acute or chronic venous obstruction. The development of collateral vessels is seen with chronic obstruction, and would be expected with PTS but not with acute DVT. A finding associated with PTS is increased echogenicity of the calf veins. Vessels with acute DVT tend to be echolucent.&nbsp;</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Phlebology.+2103%3B+28(Suppl1)%3A158-61." target="_blank">Malgor RD, Labropoulos N. Diagnosis of venous disease with duplex ultrasound. Phlebology. 2103; 28:158-61.</a></p>
<p>Dawson DL, Beals H. Acute Lower Extremity Deep Vein Thrombosis, Standness’s Duplex Scanning in Vascular Disorders, 4<sup>th</sup> Edition, p179-198, Lippincott Williams and Wilkins, Philadelphia, PA 2010.</p>
<p>QID: 30734</p></div><div class="rightanswer">The correct answer is: increased echogenicity of the calf veins</div></div></div></div></div><div id="q388" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">189</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1865"><input type="hidden" name="q20803:388_:flagged" value="0"><input type="hidden" value="qaid=911272&amp;qubaid=20803&amp;qid=5037&amp;slot=388&amp;checksum=8872c107cecf0c5f67775eea3eda9a42&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:388_:flaggedcheckbox" name="q20803:388_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q388&id=5037"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:388_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old, obese man with advanced colorectal cancer and liver mets is scheduled to have an abdominal perineal resection. Which of the following is the recommended DVT prophylaxis for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:388_answer" disabled="disabled" value="0" id="q20803:388_answer0"><label for="q20803:388_answer0">a. sequential compression device only</label> </div>
<div class="r1"><input type="radio" name="q20803:388_answer" disabled="disabled" value="1" id="q20803:388_answer1"><label for="q20803:388_answer1">b. unfractionated heparin 5000 units subcutaneous BID while in the hospital, then low dose warfarin for life</label> </div>
<div class="r0"><input type="radio" name="q20803:388_answer" disabled="disabled" value="2" id="q20803:388_answer2"><label for="q20803:388_answer2">c. low-molecular-weight-heparin while in the hospital</label> </div>
<div class="r1"><input type="radio" name="q20803:388_answer" disabled="disabled" value="3" id="q20803:388_answer3"><label for="q20803:388_answer3">d. unfractionated heparin 5000 units subcutaneous BID while in the hospital, then aspirin after discharge</label> </div>
<div class="r0"><input type="radio" name="q20803:388_answer" disabled="disabled" value="4" id="q20803:388_answer4"><label for="q20803:388_answer4">e. sequential compression device and low molecular weight heparin while in the hospital and 4 weeks postoperatively</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:388_-submit" name="q20803:388_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient is at the highest risk for perioperative DVT with advanced age, obesity, abdominal surgery, and active cancer. Combination prophylaxis with mechanical and pharmacological methods is recommended. Randomized trial data and current consensus recommends that patients with malignancy undergoing major surgery, or those undergoing major orthopedic surgery, should receive pharmacological prophylaxis both in hospital and for a month after discharge. Subcutaneous unfractionated heparin (UFH) for prophylaxis should be administered TID, not BID.</p>
<p>Sequential compression devices (SCDs) alone would not be adequate in this high-risk patient and the presence of liver metastasis is not a high risk factor for hemorrhage.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Osborne%20NH,%20Wakefield%20TW,%20Henke%20PK.%20Venous%20thromboembolism%20in%20cancer%20patients%20undergoing%20major%20surgery.%20Ann%20Surg%20Oncol;%202008;%2015%20(12):3567-3578" target="_blank">Osborne NH, Wakefield TW, Henke PK. Venous thromboembolism in cancer patients undergoing major surgery. Ann Surg Oncol 2008; 15 (12):3567-78.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+2002%3B+346+(13)%3A975-80." target="_blank">Bergqvist D, Agnelli G, Cohen AT, Eldor A<span>,&nbsp;</span>Nilsson PE<span>,&nbsp;</span>Le Moigne-Amrani A,&nbsp;et al. ENOXACAN II Investigators. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002; 346 (13):975-80.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/18574271" target="_blank">Geerts WH, Bergqvist D, Pineo GF, Heit JA,&nbsp;Samama CM,&nbsp;Lassen MR,&nbsp;et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest; 2008; 133 (6 Suppl):381S-453S.</a></p>
<p>QID: 30704</p></div><div class="rightanswer">The correct answer is: sequential compression device and low molecular weight heparin while in the hospital and 4 weeks postoperatively</div></div></div></div></div><div id="q345" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">190</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1874"><input type="hidden" name="q20803:345_:flagged" value="0"><input type="hidden" value="qaid=911229&amp;qubaid=20803&amp;qid=5137&amp;slot=345&amp;checksum=8e7601ee53982a841d9b8c5234c05707&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:345_:flaggedcheckbox" name="q20803:345_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q345&id=5137"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:345_:sequencecheck" value="2"><div class="qtext"><p>A 67-year-old woman has a history of severe hypertension requiring 4 antihypertensive medications and chronic renal insufficiency in the setting of bilateral renal artery stenosis. She undergoes renal revascularization with transaortic endarterectomy. Which of the following is the strongest predictor of dialysis free and overall survival for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:345_answer" disabled="disabled" value="0" id="q20803:345_answer0"><label for="q20803:345_answer0">a. blood pressure improvement postoperatively</label> </div>
<div class="r1"><input type="radio" name="q20803:345_answer" disabled="disabled" value="1" id="q20803:345_answer1"><label for="q20803:345_answer1">b. renal function improvement postoperatively</label> </div>
<div class="r0"><input type="radio" name="q20803:345_answer" disabled="disabled" value="2" id="q20803:345_answer2"><label for="q20803:345_answer2">c. degree of preoperative renal insufficiency</label> </div>
<div class="r1"><input type="radio" name="q20803:345_answer" disabled="disabled" value="3" id="q20803:345_answer3"><label for="q20803:345_answer3">d. degree of preoperative hypertension</label> </div>
<div class="r0"><input type="radio" name="q20803:345_answer" disabled="disabled" value="4" id="q20803:345_answer4"><label for="q20803:345_answer4">e. presence of bilateral stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:345_-submit" name="q20803:345_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The selection of patients for open renal revascularization for atherosclerotic renovascular disease remains controversial. Generally, revascularization is considered in patients with severe hypertension, with or without renal insufficiency. Among the choices listed, the postoperative improvement in renal function is the strongest predictor favoring overall survival and dialysis-free survival. Cure, but not improvement in blood pressure postoperatively, also favorably affects overall and dialysis-free survival. Although 85% of patients will experience an improvement in blood pressure and renal function improves in 60% of patients with ischemic nephropathy, predictors of blood pressure cure and improved renal function are lacking. Treatment of bilateral versus unilateral stenosis does not confer increased survival benefit.<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2002%3B+35+(2)%3A236-45." target="_blank">Cherr GS, Hansen KJ, Craven TE, Edwards MS<span>,&nbsp;</span>Ligush J Jr<span>,&nbsp;</span>Levy PJ<span>,&nbsp;</span>et al. Surgical management of atherosclerotic renovascular disease. J Vasc Surg 2002; 35(2):236-45.</a></p>
<p>QID: 30611</p></div><div class="rightanswer">The correct answer is: renal function improvement postoperatively</div></div></div></div></div><div id="q355" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">191</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1883"><input type="hidden" name="q20803:355_:flagged" value="0"><input type="hidden" value="qaid=911239&amp;qubaid=20803&amp;qid=5148&amp;slot=355&amp;checksum=8e04c1f6c8bc7342ffd6c4e67b0f5908&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:355_:flaggedcheckbox" name="q20803:355_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q355&id=5148"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:355_:sequencecheck" value="2"><div class="qtext"><p>A 26-year-old man was the restrained driver of a high-speed motor vehicle collision. The patient was unconscious at the scene and intubated; he had a blood pressure of 90/60 mm Hg and a heart rate of&nbsp;120 bpm.&nbsp;On physical exam, the abdomen is distended with a "seatbelt sign" (ecchymosis) across the abdomen. The femoral and pedal pulses are nonpalpable. Which of the following is the best diagnostic test to assess the arterial injury in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:355_answer" disabled="disabled" value="0" id="q20803:355_answer0"><label for="q20803:355_answer0">a. digital subtraction angiography (DSA)</label> </div>
<div class="r1"><input type="radio" name="q20803:355_answer" disabled="disabled" value="1" id="q20803:355_answer1"><label for="q20803:355_answer1">b. diagnostic peritoneal lavage (DPL)</label> </div>
<div class="r0"><input type="radio" name="q20803:355_answer" disabled="disabled" value="2" id="q20803:355_answer2"><label for="q20803:355_answer2">c. abdominal duplex ultrasound</label> </div>
<div class="r1"><input type="radio" name="q20803:355_answer" disabled="disabled" value="3" id="q20803:355_answer3"><label for="q20803:355_answer3">d. magnetic resonance angiogram (MRA)</label> </div>
<div class="r0"><input type="radio" name="q20803:355_answer" disabled="disabled" value="4" id="q20803:355_answer4"><label for="q20803:355_answer4">e. computed tomographic angiogram (CTA)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:355_-submit" name="q20803:355_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Blunt aortic injury of the infrarenal abdominal aorta is uncommon; however, it has been&nbsp;associated &nbsp;with&nbsp;“seatbelt” injuries. It is hypothesized that the abdominal aorta is compressed against the lumbar vertebral bodies by the seatbelt during violent deceleration. While Duplex ultrasound (FAST) of the abdomen is a valuable component of the initial evaluation of the patient,&nbsp;the&nbsp;sensitivity and specificity for detecting this type of injury is not established.&nbsp;Similarly, DPL will fail to identify infrarenal aortic injuries in the absence of hemorrhage.&nbsp;MRA would be able to identify the injury, but typically takes too long to perform relative to CTA; it also lacks sufficient detail in evaluation of the bowel and other intra-abdominal organs.&nbsp;DSA would be indicated if endovascular therapies were to be entertained. CTA offers the best combination of sensitivity, specificity, and availability in the emergency setting in most hospitals.&nbsp;</p>
<p>Blunt infrarenal aortic injuries can range from subtle, asymptomatic CTA findings to frank rupture. A grading system for grading blunt aortic injuries was proposed by Starnes and colleagues. Although their intent was to categorize the more common blunt aortic injury of the thoracic aorta, their grading system can also be applied to infrarenal aortic injuries.</p>
<ul>
<li>Grade 1:&nbsp;&nbsp;Intimal tear—absence of aortic external contour abnormality and intimal defect and/or thrombus of &lt;10 mm length or width.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>Grade 2:&nbsp; Large intimal flap—absence of aortic external contour abnormality and intimal defect and/or thrombus of &gt;10 mm length or width.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>Grade 3:&nbsp; Pseudoaneurysm—presence of aortic external contour abnormality and contained rupture.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>Grade 4:&nbsp; Rupture—presence of aortic external contour abnormality and free contrast extravasation or hemothorax at thoracotomy.</li>
</ul>
<p>In the figure below, there is a subtle finding on CTA of intramural&nbsp;hematoma within the infrarenal aorta of&nbsp;a 20-year-old man after a motor vehicle injury. This injury would be classified as a&nbsp;Grade 1 injury.</p>
<p><img src="./VESAP3_files/Chung-6 (for Discussion).jpg" alt="" width="506" height="306"></p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2013%3B+27%3A1074-80." target="_blank">Harris DG, Drucker CB, Brenner ML, Sarkar R, Narayan M, Crawford RS. Patterns and management of blunt abdominal aortic injury.&nbsp;Ann&nbsp;Vasc Surg 2013; 27:1074-80.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2012%3B+55%3A47-54." target="_blank">Starnes BW. Lundgren RS. Gunn M. Quade S. Hatsukami TS, Tran NT, et al. A new classification scheme for treating blunt aortic injury. J Vasc Surg 2012; 55:47-54.</a></p>
<p>QID: 30624</p></div><div class="rightanswer">The correct answer is: computed tomographic angiogram (CTA)</div></div></div></div></div><div id="q409" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">192</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1892"><input type="hidden" name="q20803:409_:flagged" value="0"><input type="hidden" value="qaid=911293&amp;qubaid=20803&amp;qid=4952&amp;slot=409&amp;checksum=c7d1ee95bc656b8da51d6b46cbbbc966&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:409_:flaggedcheckbox" name="q20803:409_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q409&id=4952"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:409_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old woman presents with recurrent varicose veins. Her only complaint is aching, along the varicosities. Which of the following options would be <strong>least</strong>&nbsp;valuable in developing a treatment strategy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:409_answer" disabled="disabled" value="0" id="q20803:409_answer0"><label for="q20803:409_answer0">a. ejection fraction</label> </div>
<div class="r1"><input type="radio" name="q20803:409_answer" disabled="disabled" value="1" id="q20803:409_answer1"><label for="q20803:409_answer1">b. history of contributing factors</label> </div>
<div class="r0"><input type="radio" name="q20803:409_answer" disabled="disabled" value="2" id="q20803:409_answer2"><label for="q20803:409_answer2">c. venous filling index</label> </div>
<div class="r1"><input type="radio" name="q20803:409_answer" disabled="disabled" value="3" id="q20803:409_answer3"><label for="q20803:409_answer3">d. reflux on venous duplex ultrasound</label> </div>
<div class="r0"><input type="radio" name="q20803:409_answer" disabled="disabled" value="4" id="q20803:409_answer4"><label for="q20803:409_answer4">e. venography</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:409_-submit" name="q20803:409_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Patients with recurrent varicose veins should be evaluated in a standardized fashion. Air plethysmography values are valuable in patients with recurrent varicose veins, since progression of disease will result in deterioration of the venous filling index (valve incompetence). When recurrence is defined as a venous filling index &gt; 2 ml/sec, 66% of limbs will have deterioration at 5 years. A history of previous surgery is essential. A classification known as REVAS (recurrent varices after surgery) evaluates 8 parameters, including a history of contributing factors such as family history, obesity, pregnancy (since initial surgery), oral contraceptive, and lifestyle factors (standing, sedentary). Venous duplex ultrasound is essential to define the region of the limb involved, the venous segments involved, and if the source of reflux is from the same site or from new sites.</p>
<p>Venography provides anatomical information, but it does not provide physiologic information on venous hemodynamics. Venography has largely been replaced by duplex ultrasound.</p>
<p>&nbsp;</p>
<h3>References</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B+38+(5)%3A935-43." target="_blank">van Rij AM, Jiang P, Solomon C, <span>&nbsp;</span>Christie RA<span>,&nbsp;</span>Hill GB<span>.</span>&nbsp;Recurrence after varicose vein surgery: A prospective long-term clinical study with duplex ultrasound scanning and air plethysmography. J Vasc Surg 2003; 38 (5):935-43.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2006%3B+43+(2)%3A327-34." target="_blank">Perrin MR, Labropoulos N, Leon LR Jr. Presentation of the patient with recurrent varices after surgery (REVAS). J Vasc Surg 2006; 43 (2):327-34.</a></p>
<p>QID: 30729</p></div><div class="rightanswer">The correct answer is: venography</div></div></div></div></div><div id="q75" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">193</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1901"><input type="hidden" name="q20803:75_:flagged" value="0"><input type="hidden" value="qaid=910959&amp;qubaid=20803&amp;qid=5158&amp;slot=75&amp;checksum=6625ce1691824cc4bc96fa98eaece41f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:75_:flaggedcheckbox" name="q20803:75_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q75&id=5158"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:75_:sequencecheck" value="2"><div class="qtext"><p>The lesion shown below is in a 6 month old child. Regarding this disease, which of the following is most <strong>true</strong>?<br><br><a href="./VESAP3_files/AssetProxy_049.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_049.jpg" alt="img" width="100" height="157" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:75_answer" disabled="disabled" value="0" id="q20803:75_answer0"><label for="q20803:75_answer0">a. if left untreated, this will grow significantly within 3-7 years</label> </div>
<div class="r1"><input type="radio" name="q20803:75_answer" disabled="disabled" value="1" id="q20803:75_answer1"><label for="q20803:75_answer1">b. it is a tumor arising from the mesothelium</label> </div>
<div class="r0"><input type="radio" name="q20803:75_answer" disabled="disabled" value="2" id="q20803:75_answer2"><label for="q20803:75_answer2">c. the risk of such a lesion increases with preeclampsia</label> </div>
<div class="r1"><input type="radio" name="q20803:75_answer" disabled="disabled" value="3" id="q20803:75_answer3"><label for="q20803:75_answer3">d. laser therapy is the treatment of choice</label> </div>
<div class="r0"><input type="radio" name="q20803:75_answer" disabled="disabled" value="4" id="q20803:75_answer4"><label for="q20803:75_answer4">e. the lesion is linked to the sex chromosome</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:75_-submit" name="q20803:75_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This image shows an infantile hemangioma. Mendelian inheritance does not play a role in the formation of these tumors, which arise from the endothelium. These typically increase in size during the first 6-10 months of life, and then go through an involution phase over the next 5-7 years. There is an increased incidence in children of mothers who have had preeclampsia or placentia previa, conditions that compromise the maternal-fetal barrier. Corticosteriods have been used to treat hemangiomas that are in problematic areas, such as the eye lid, but are generally not advised for those on the extremities. Laser therapy is generally ineffective and may result in hyperpigmentation.<br><br></p>
<h3>Reference:</h3>
<p>Greene AK, Fishman SJ. Vascular tumors in childhood. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:1077-85.</p>
<p>QID: 30116</p></div><div class="rightanswer">The correct answer is: the risk of such a lesion increases with preeclampsia</div></div></div></div></div><div id="q534" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">194</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1910"><input type="hidden" name="q20803:534_:flagged" value="0"><input type="hidden" value="qaid=911418&amp;qubaid=20803&amp;qid=5270&amp;slot=534&amp;checksum=00d83bb7daede0b10329eafc1669b853&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:534_:flaggedcheckbox" name="q20803:534_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q534&id=5270"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:534_:sequencecheck" value="2"><div class="qtext"><p>During an endovascular procedure, and using standard shielding, which body part of the operator experiences the greatest radiation exposure?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:534_answer" disabled="disabled" value="0" id="q20803:534_answer0"><label for="q20803:534_answer0">a. eyes</label> </div>
<div class="r1"><input type="radio" name="q20803:534_answer" disabled="disabled" value="1" id="q20803:534_answer1"><label for="q20803:534_answer1">b. calf of the leg</label> </div>
<div class="r0"><input type="radio" name="q20803:534_answer" disabled="disabled" value="2" id="q20803:534_answer2"><label for="q20803:534_answer2">c. pelvis</label> </div>
<div class="r1"><input type="radio" name="q20803:534_answer" disabled="disabled" value="3" id="q20803:534_answer3"><label for="q20803:534_answer3">d. back</label> </div>
<div class="r0"><input type="radio" name="q20803:534_answer" disabled="disabled" value="4" id="q20803:534_answer4"><label for="q20803:534_answer4">e. neck</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:534_-submit" name="q20803:534_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Using standard shielding, including a lead apron, thyroid shield, and protective eyewear, the area of the body which receives the greatest radiation dose is the calves of the legs. This is because they are closest to the x-ray tube.&nbsp; Very little radiation leaks through the tube housing; most radiation received by the operator is from scatter.&nbsp; When 2 dosimeters are worn, the "collar” badge is worn outside any shielding, but the "torso” badge should be worn inside the lead apron, at the level of the waist.&nbsp; In a recent study, Haskal et al demonstrated that 8% of 59 interventional radiologists screened during the 2004 Radiological Society of North America Annual meeting had &nbsp;cataracts.&nbsp; Another study showed that radiologic technologists in the United States have an excess relative risk of cataract formation with an odds ratio of 1.98. The human fetus is most susceptible to radiation effects between 8 and 15 weeks of pregnancy.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>Wagner&nbsp; LK, Archer BR. Minimizing Risks from Fluoroscopic X-rays. Houston: University of Houston, 2004, pp 30-66.</p>
<p>Haskal ZJ. Interventional radiology carries occupational risk for cataracts. RSNA News 2004;14:5-6.</p>
<p style="text-align: left;"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Epidemiol+2008%3B+168%3A620-31." target="_blank">ChodickG, Bekiroglu N, Hauptmann M, Alexander BH, Freedman DM, Doody MM, et al. Risk of cataract after exposure to low doses of ionizing radiation: a 20-year prospective cohort study among US radiologic technologists. Am J Epidemiol 2008; 168:620-31.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53%3A28S-34S." target="_blank">Shaw P, Duncan A, Vouyouka A, Ozsvath K. Radiation exposure and pregnancy. J Vasc Surg 2011; 53:28S-34S.</a></p>
<p>QID: 30938</p></div><div class="rightanswer">The correct answer is: calf of the leg</div></div></div></div></div><div id="q81" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">195</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1919"><input type="hidden" name="q20803:81_:flagged" value="0"><input type="hidden" value="qaid=910965&amp;qubaid=20803&amp;qid=4895&amp;slot=81&amp;checksum=c3dbed855f88e154a71cf804e9ddffda&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:81_:flaggedcheckbox" name="q20803:81_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q81&id=4895"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:81_:sequencecheck" value="2"><div class="qtext"><p>Lower extremity amputation presents a significant challenge to patients in terms of rehabilitation and achieving an independent ambulatory status. Which of the below patients with peripheral arterial disease is most likely to achieve ambulation and live independently after a lower extremity amputation?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:81_answer" disabled="disabled" value="0" id="q20803:81_answer0"><label for="q20803:81_answer0">a. A 55-year-old ambulatory man with CAD living at home. He's on statin medication and is undergoing a below knee amputation.</label> </div>
<div class="r1"><input type="radio" name="q20803:81_answer" disabled="disabled" value="1" id="q20803:81_answer1"><label for="q20803:81_answer1">b. A 75-year-old non-ambulatory man with end stage renal disease (ESRD) residing in skilled nursing facility and undergoing an above knee amputation.</label> </div>
<div class="r0"><input type="radio" name="q20803:81_answer" disabled="disabled" value="2" id="q20803:81_answer2"><label for="q20803:81_answer2">c. A 65-year-old ambulatory woman with coronary artery disease (CAD) living at home. She's not on statin medication and is undergoing a below knee amputation.</label> </div>
<div class="r1"><input type="radio" name="q20803:81_answer" disabled="disabled" value="3" id="q20803:81_answer3"><label for="q20803:81_answer3">d. A 60-year-old non-ambulatory man with ESRD and CAD (on statin medication) who lives at home and is undergoing an above knee amputation.</label> </div>
<div class="r0"><input type="radio" name="q20803:81_answer" disabled="disabled" value="4" id="q20803:81_answer4"><label for="q20803:81_answer4">e. A 55-year-old ambulatory woman with CAD (no statin medication) and congestive heart failure. &nbsp;She lives at home, has a previous contralateral below knee amputation, and is undergoing below knee amputation.</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:81_-submit" name="q20803:81_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Taylor et al studied functional outcomes after amputation and identified several preoperative factors that were statistically significantly independently associated with failure of ambulation after lower extremity amputation.&nbsp; In decreasing order of magnitude they included: age &gt;70 years (HR, 2.3), bilateral amputation (HR, 1.8), age 60 to 69 (HR, 1.6),&nbsp; and end-stage renal disease (HR, 1.4). Statistically significant preoperative factors independently associated with failure to maintain independent living status in decreasing order of influence included: age &gt;70 years (HR, 4.0), age 60 to 69 (HR, 2.7), level of amputation (HR, 1.8), homebound ambulatory status (HR, 1.6), and the presence of dementia (HR, 1.6).</p>
<p>Suckow et al demonstrated that patients most likely to remain ambulatory and live independently despite undergoing a lower extremity amputation were those living at home preoperatively (HR 6.8) and those with preoperative statin use (HR: 1.6).&nbsp; Similarly, the presence of several comorbidities identified patients less likely to achieve a functional outcome, including coronary artery disease (HR: 0.6), dialysis dependency (HR: 0.5), and congestive heart failure (HR: 0.5).</p>
<p>Among patients undergoing major amputations, 65% of patients who underwent BKA were ambulatory, whereas only 41% of patients who underwent AKA were ambulatory ( <em>P&nbsp;</em>= .003). Above-knee amputees were therefore more likely to require a wheelchair compared with below-knee amputees (56 vs. 35%, <em>P</em>&nbsp;= .008). Patients who underwent minor amputations had equivalent rates of ambulation compared to patients who underwent lower extremity bypass without amputation (95.8% and 96.2%, respectively, <em>P</em>&nbsp;= .9).</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2005%3B42%3A227-35." target="_blank">Taylor SM, Kalbaugh CA, Blackhurst DW, Hamontree SE, Cull DL, Messich HS, et al. Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: An analysis of 553 consecutive patients. J Vasc Surg 2005;42:227-35.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2012%3B+26%3A+67-78." target="_blank">Suckow BD, Goodney PP, Cambria RA, Bertges DJ, Eldrup-Jorgensen J, Indes JE, et al. Predicting Functional Status Following Amputation After Lower Extremity Bypass. Ann Vasc Surg 2012; 26: 67-78.</a></p>
<p>QID: 30125</p></div><div class="rightanswer">The correct answer is: A 55-year-old ambulatory man with CAD living at home. He's on statin medication and is undergoing a below knee amputation.</div></div></div></div></div><div id="q165" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">196</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1928"><input type="hidden" name="q20803:165_:flagged" value="0"><input type="hidden" value="qaid=911049&amp;qubaid=20803&amp;qid=4666&amp;slot=165&amp;checksum=af507406e42d0347d4ef03f6d2c13b78&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:165_:flaggedcheckbox" name="q20803:165_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q165&id=4666"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:165_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old man is involved in a motor vehicle accident and sustains whiplash. Which of the following is not associated with carotid dissection?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:165_answer" disabled="disabled" value="0" id="q20803:165_answer0"><label for="q20803:165_answer0">a. Horner's syndrome</label> </div>
<div class="r1"><input type="radio" name="q20803:165_answer" disabled="disabled" value="1" id="q20803:165_answer1"><label for="q20803:165_answer1">b. asymptomatic</label> </div>
<div class="r0"><input type="radio" name="q20803:165_answer" disabled="disabled" value="2" id="q20803:165_answer2"><label for="q20803:165_answer2">c. stroke</label> </div>
<div class="r1"><input type="radio" name="q20803:165_answer" disabled="disabled" value="3" id="q20803:165_answer3"><label for="q20803:165_answer3">d. hoarseness</label> </div>
<div class="r0"><input type="radio" name="q20803:165_answer" disabled="disabled" value="4" id="q20803:165_answer4"><label for="q20803:165_answer4">e. headache</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:165_-submit" name="q20803:165_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Carotid dissections are generally classified as either spontaneous or traumatic. Traumatic injuries typically occur with hyperextension and rotation of the neck that results in a stretch injury to the distal internal carotid artery at the C2-C3 level. While most dissections are associated with unilateral headaches, stroke, and/or a Horner's syndrome, absence of symptoms may also be present. Most dissections are managed with anticoagulation or antiplatelet agents unless contraindicated; surgery or endoluminal interventions are reserved for patients that fail medical therapy. A long-term risk of pseudoaneurysm formation at the injury site is known to occur in an indeterminate number of cases.<br><br></p>
<h3>Reference:</h3>
<p>Krupski WC. Uncommon disorders affecting the carotid arteries. In: Rutherford RB, ed. Vascular Surgery. 6th ed. Philadelphia, Pa: Elsevier Saunders; 2005:2064-92.</p>
<p>QID: 30303</p></div><div class="rightanswer">The correct answer is: hoarseness</div></div></div></div></div><div id="q128" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">197</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1937"><input type="hidden" name="q20803:128_:flagged" value="0"><input type="hidden" value="qaid=911012&amp;qubaid=20803&amp;qid=4745&amp;slot=128&amp;checksum=194b6b8d54c1588cd4235feb1ebe2c7b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:128_:flaggedcheckbox" name="q20803:128_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q128&id=4745"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:128_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding aberrant human aortic arch anatomy is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:128_answer" disabled="disabled" value="0" id="q20803:128_answer0"><label for="q20803:128_answer0">a. an aberrant subclavian artery most commonly passes anterior to the esophagus and posterior to the trachea</label> </div>
<div class="r1"><input type="radio" name="q20803:128_answer" disabled="disabled" value="1" id="q20803:128_answer1"><label for="q20803:128_answer1">b. an aberrant subclavian artery is typically asymptomatic and discovered incidentally</label> </div>
<div class="r0"><input type="radio" name="q20803:128_answer" disabled="disabled" value="2" id="q20803:128_answer2"><label for="q20803:128_answer2">c. the most common aberrant arch anatomy is an independent L vertebral artery origin</label> </div>
<div class="r1"><input type="radio" name="q20803:128_answer" disabled="disabled" value="3" id="q20803:128_answer3"><label for="q20803:128_answer3">d. patients with an aberrant right subclavian artery typically present with dysphagia to solids and liquids</label> </div>
<div class="r0"><input type="radio" name="q20803:128_answer" disabled="disabled" value="4" id="q20803:128_answer4"><label for="q20803:128_answer4">e. a “normal” arch anatomy consisting of a left-sided 3-vessel arch (innominate, L carotid, L subclavian) occurs in approximately 50% of individuals</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:128_-submit" name="q20803:128_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><img src="./VESAP3_files/Question 2 Graphic.jpg" alt="Arch anatomy variants" width="659" height="617"></p>
<p>&nbsp;</p>
<p>A “normal” aortic arch occurs in approximately 75% of the population, with the most common aberrant anatomy being the “bovine arch” with the L carotid artery arising as a common trunk from the innominate artery. A bovine arch occurs in approximately 21% of patients; an independent L vertebral artery origin occurs in about 3% of patients. Aberrant subclavian arteries are typically asymptomatic, discovered incidentally, and only occasionally present with the classic dysphagia leading to the term dysphagia lusoria<em>.</em>&nbsp;</p>
<p>Aberrant subclavian arteries typically pass posterior to the esophagus (~80%), but can also pass between the esophagus and trachea (~15%) or anterior to the trachea (5%).</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>Image from: Celikyay ZRY, Koner AE, Celikyay F, Deniz C, Acu B, Firat MM. Frequency and imaging findings of variations in human aortic arch anatomy based on multidetector computed tomography data. Clinical Imaging, 2013.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Int+J+Surg.+2009+Apr%3B+7(2)%3A106-9." target="_blank">Abraham V, Mathew A, Cherian V, Chandran S, Mathew G. Aberrant subclavian artery: anatomical curiosity or clinical entity. Int J Surg 2009; 7(2):106-9.</a></p>
<p>QID: 30221</p></div><div class="rightanswer">The correct answer is: an aberrant subclavian artery is typically asymptomatic and discovered incidentally</div></div></div></div></div><div id="q294" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">198</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1946"><input type="hidden" name="q20803:294_:flagged" value="0"><input type="hidden" value="qaid=911178&amp;qubaid=20803&amp;qid=5052&amp;slot=294&amp;checksum=153f184a7b5e272c02aed74b2444530a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:294_:flaggedcheckbox" name="q20803:294_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q294&id=5052"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:294_:sequencecheck" value="2"><div class="qtext"><p>In the intravascular ultrasound image of the abdominal aorta (image shown below), the white arrow indicates which of the following?</p>
<p><a href="./VESAP3_files/11680.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/11680.jpg" alt="Img" width="92" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:294_answer" disabled="disabled" value="0" id="q20803:294_answer0"><label for="q20803:294_answer0">a. an artifact</label> </div>
<div class="r1"><input type="radio" name="q20803:294_answer" disabled="disabled" value="1" id="q20803:294_answer1"><label for="q20803:294_answer1">b. the inferior vena cava</label> </div>
<div class="r0"><input type="radio" name="q20803:294_answer" disabled="disabled" value="2" id="q20803:294_answer2"><label for="q20803:294_answer2">c. the left renal vein</label> </div>
<div class="r1"><input type="radio" name="q20803:294_answer" disabled="disabled" value="3" id="q20803:294_answer3"><label for="q20803:294_answer3">d. the duodenum</label> </div>
<div class="r0"><input type="radio" name="q20803:294_answer" disabled="disabled" value="4" id="q20803:294_answer4"><label for="q20803:294_answer4">e. the pancreas</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:294_-submit" name="q20803:294_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The location where the left renal vein crosses the abdominal aorta is a key anatomic landmark when performing intravascular ultrasound of the aorta and its branches. The left renal vein is usually near the renal arteries. In this illustration, the right renal artery (black arrow) can be differentiated from the left renal artery because the left renal vein provides orientation as to which part of the aorta is anterior.<br><br></p>
<h2>Reference:</h2>
<p>Vogt KC, Schroeder TV. Intravascular ultrasound. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:371-81.</p>
<p>QID: 30514</p></div><div class="rightanswer">The correct answer is: the left renal vein</div></div></div></div></div><div id="q483" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">199</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1955"><input type="hidden" name="q20803:483_:flagged" value="0"><input type="hidden" value="qaid=911367&amp;qubaid=20803&amp;qid=5209&amp;slot=483&amp;checksum=5f27dc262633b52ee0fcba211aed8cc2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:483_:flaggedcheckbox" name="q20803:483_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q483&id=5209"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:483_:sequencecheck" value="2"><div class="qtext"><p>A 56-year-old woman presented with hypertensive urgency, with systolic blood pressure of 200 mmHg requiring 3 medications for control. She regularly experiences abdominal pain after meals, or when her blood pressure was lowered. She has bilateral calf claudication. Her symptoms have been present for 20 years, but have been progressively worsening. She denies recent symptoms of fever, malaise, weight loss, or myalgias. Her erythrocyte sedimentation rate was 30 mm/h.</p>
<p>A 3-dimensional reconstruction and sagittal maximum intensity projection (MIP) view of a CT angiogram are shown.&nbsp;Which of the following is the most probable diagnosis?</p>
<p><a href="./VESAP3_files/Slide1(1).JPG" target="images"><img src="./VESAP3_files/Slide1(1).JPG" alt="Aortic CTA" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:483_answer" disabled="disabled" value="0" id="q20803:483_answer0"><label for="q20803:483_answer0">a. giant cell arteritis</label> </div>
<div class="r1"><input type="radio" name="q20803:483_answer" disabled="disabled" value="1" id="q20803:483_answer1"><label for="q20803:483_answer1">b. congential middle aortic coarctation</label> </div>
<div class="r0"><input type="radio" name="q20803:483_answer" disabled="disabled" value="2" id="q20803:483_answer2"><label for="q20803:483_answer2">c. atherosclerosis</label> </div>
<div class="r1"><input type="radio" name="q20803:483_answer" disabled="disabled" value="3" id="q20803:483_answer3"><label for="q20803:483_answer3">d. Takayasu arteritis</label> </div>
<div class="r0"><input type="radio" name="q20803:483_answer" disabled="disabled" value="4" id="q20803:483_answer4"><label for="q20803:483_answer4">e. chronic type B aortic dissection</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:483_-submit" name="q20803:483_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This is an example of Takayasu arteritis, a chronic large vessel&nbsp;vasculitis of unknown etiology. Takayasu arteritis affects the aorta and primary branches. Inflammation may be localized to a portion of the thoracic or abdominal aorta and branches, or may involve the entire vessel. It affects women in 80-90% of cases, with&nbsp;the age of onset typically between 10 and 40 years.</p>
<p>American College of Rheumatology diagnostic criteria for Takayasu arteritis distinguish this disorder from other vasculitides. The diagnosis can be made if at least 3 of the 6 criteria are present:</p>
<ul>
<li>Age of disease onset ≤40 years</li>
<li>Extremity claudication</li>
<li>Decreased brachial artery pulses (one or both sides)</li>
<li>≥10 mmHg in systolic blood pressure difference between the arms</li>
<li>Bruit over one or both subclavian arteries or the abdominal aorta</li>
<li>Arteriographic narrowing or occlusion of the aorta, its primary branches, or large arteries in the proximal upper or lower extremities, not due to arteriosclerosis, fibromuscular dysplasia, or other causes</li>
</ul>
<p>Early Takayasu arteritis is associated with non-specific symptoms of systemic inflammation: fatigue, malaise, myalgia, arthralgia, and low-grade fever. Acute phase reactants, including elevated erythrocyte sedimentation rate (ESR), increased serum C-reactive protein (CRP) and α-2 globulin concentrations, and hypoalbuminemia, reflect the inflammatory process characteristic of the early, active phase of the disease. Inflammatory symptoms and biomarkers are often absent in the later stages of the disease.</p>
<p>Diagnosis is usually based upon clinical features and arterial imaging with MRI, CT, or angiography, which&nbsp;can demonstrate smoothly tapered luminal narrowings or occlusion, which may be accompanied by thickening of the vessel wall.</p>
<p>The most difficult distinction is between Takayasu arteritis and giant cell (temporal) arteritis. Both involve large arteries&nbsp;and have a&nbsp;granulomatous vasculitis on histologic examination. Both respond to corticosteroids. The two conditions can be distinguished by the age of the patient and the distribution of lesions.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arthritis+Rheum+1990%3B33(8)%3A1065-7." target="_blank">Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum 1990;33(8):1065-7.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surg+Clin+North+Am.+2013%3B+93(4)%3A833-75%2C+viii." target="_blank">Wu W, Chaer RA. Nonarteriosclerotic vascular disease. Surg Clin North Am 2013; 93(4):833-75, viii.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nat+Rev+Rheumatol.+2010%3B+6(7)%3A406-15." target="_blank">Mason JC. Takayasu arteritis--advances in diagnosis and management. Nat Rev Rheumatol 2010; 6(7):406-15.&nbsp;</a></p>
<p>QID: 30848</p></div><div class="rightanswer">The correct answer is: Takayasu arteritis</div></div></div></div></div><div id="q70" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">200</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1964"><input type="hidden" name="q20803:70_:flagged" value="0"><input type="hidden" value="qaid=910954&amp;qubaid=20803&amp;qid=4943&amp;slot=70&amp;checksum=5518b0a3a26b513ca584698950b04149&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:70_:flaggedcheckbox" name="q20803:70_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q70&id=4943"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:70_:sequencecheck" value="2"><div class="qtext"><p>The criteria necessary for the diagnosis of Buerger's disease include all of the following <strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:70_answer" disabled="disabled" value="0" id="q20803:70_answer0"><label for="q20803:70_answer0">a. "cork-screw" appearance of collaterals of distal vessels that are thought to be secondary to enlarged vasa vasorum</label> </div>
<div class="r1"><input type="radio" name="q20803:70_answer" disabled="disabled" value="1" id="q20803:70_answer1"><label for="q20803:70_answer1">b. arterial pathology arising distal to the knees and elbows</label> </div>
<div class="r0"><input type="radio" name="q20803:70_answer" disabled="disabled" value="2" id="q20803:70_answer2"><label for="q20803:70_answer2">c. a history of tobacco use</label> </div>
<div class="r1"><input type="radio" name="q20803:70_answer" disabled="disabled" value="3" id="q20803:70_answer3"><label for="q20803:70_answer3">d. male gender</label> </div>
<div class="r0"><input type="radio" name="q20803:70_answer" disabled="disabled" value="4" id="q20803:70_answer4"><label for="q20803:70_answer4">e. onset of symptoms before the age 45</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:70_-submit" name="q20803:70_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Buerger's disease, also known as thromboangiitis obliterans, is a syndrome distinct from other conditions associated with small- and medium-sized arterial occlusions. Central to the diagnosis is the involvement of small- and medium-sized arteries of the distal upper and lower extremities with segmental thrombotic occlusions associated with chronic inflammation of the arterial wall. The classic history includes an extremely strong addiction to tobacco. Many patients are unwilling or unable to quit, even after multiple amputations. The onset is generally in the third and fourth decades of life and occurs typically, but not exclusively, in males. The reported incidence of Buerger's disease in females ranges from 11 to 23%. A diagnostic feature by arteriography is occlusion of the distal small- and medium-sized arteries with corkscrew appearance of collaterals that are thought to be secondary to enlarged and hypertrophied vasa vasorum. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg%3B+1993%3B+6+(1)%3A14-23." target="_blank">Mills JL, Porter JM. Buerger's disease: a review and update. Semin Vasc Surg; 1993; 6 (1):14-23.</a><br><br>Olin JW. 25: Thromboangiitis Obliterans. In: Rutherford Vascular Surgery, 6th ed. Elsevier Saunders, Philadelphia, PA; 2005:404-19.</p>
<p>QID: 30110</p></div><div class="rightanswer">The correct answer is: male gender</div></div></div></div></div><div id="q241" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">201</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1973"><input type="hidden" name="q20803:241_:flagged" value="0"><input type="hidden" value="qaid=911125&amp;qubaid=20803&amp;qid=4970&amp;slot=241&amp;checksum=abdb30265d8a0d43e996fb54205dff3e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:241_:flaggedcheckbox" name="q20803:241_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q241&id=4970"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:241_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old man presents to the office 1 year after placement of a left autogenous brachial-cephalic upper arm direct access with complaints of coolness, numbness, and pain in the left hand while on dialysis. On physical examination of the left arm, he has a thrill and bruit overlying his arteriovenous (AV) access, no edema, a palpable brachial artery pulse, nonpalpable radial and ulnar artery pulses, a cool hand with gangrenous ulcers of the tips of his second and third digits, generalized decreased sensation, and normal motor function. Arteriogram of the left upper extremity shows no arterial stenosis. Which of the following is the best treatment plan for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:241_answer" disabled="disabled" value="0" id="q20803:241_answer0"><label for="q20803:241_answer0">a. banding of the AV access outflow</label> </div>
<div class="r1"><input type="radio" name="q20803:241_answer" disabled="disabled" value="1" id="q20803:241_answer1"><label for="q20803:241_answer1">b. distal revascularization with interval ligation procedure</label> </div>
<div class="r0"><input type="radio" name="q20803:241_answer" disabled="disabled" value="2" id="q20803:241_answer2"><label for="q20803:241_answer2">c. ligation of the brachial artery</label> </div>
<div class="r1"><input type="radio" name="q20803:241_answer" disabled="disabled" value="3" id="q20803:241_answer3"><label for="q20803:241_answer3">d. ligation of the AV access</label> </div>
<div class="r0"><input type="radio" name="q20803:241_answer" disabled="disabled" value="4" id="q20803:241_answer4"><label for="q20803:241_answer4">e. observation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:241_-submit" name="q20803:241_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Arterial steal occurs secondary to low access tract resistance, creating a reversal of blood flow in the arterial outflow tract towards the access and away from the hand. This may be demonstrated in up to 90% of all AV accesses, but it is clinically symptomatic in less than 10%. Clinical symptoms vary and range from mild ischemia presenting as coolness and paresthesias, which only occur on dialysis, to severe ischemia presenting as constant rest pain, numbness, paralysis, finger contractures, and gangrene. Patients with clinically symptomatic arterial steal should be evaluated with an arteriogram to identify any proximal arterial stenosis. Treatment of the proximal artery alone with either endovascular or open surgical techniques may resolve symptoms without need for ligation or revision of the AV access. In patients without proximal arterial stenosis or who do not resolve their symptoms with treatment of the inflow stenosis, further treatment options exist. Ligation of the access will instantly resolve the symptoms, but it leaves the patient without a dialysis access. Banding of the access tract creates a stenosis that increases the resistance to the blood flow in the access and reverses arterial flow in the distal artery. However, it is difficult to judge the degree of stenosis required to alleviate the steal without causing thrombosis of the access. In patients with a forearm access and a patent palmer arch, the distal outflow artery may be ligated, but this approach does not restore possible required inflow to the hand. Distal revascularization with interval ligation entails ligation of the arterial outflow tract just distal to the takeoff of the access, followed by placement of a bypass from the artery proximal to the takeoff of the access to the artery distal to the area of ligation. This procedure eliminates reversal of flow in the distal outflow artery while keeping the access patent and perfusion pressures to the hand constant, making this an ideal procedure for this patient.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Distal+revascularization-interval+ligation%3A+A+durable+and+effective+treatment+for+ischemic+steal+syndrome+after+hemodialysis+access.+J+Vasc+Surg+2003" target="_blank">Knox RC, Berman SS, Hughes JD, Gentile AT<span>,&nbsp;</span>Mills JL. Distal revascularization-interval ligation: A durable and effective treatment for ischemic steal syndrome after hemodialysis access. J Vasc Surg 2003; 36 (2):250-6.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephrol+Dial+Transplant+2003%3B+18+(11)%3A2387-90." target="_blank">Lazrides MK, Staramos DN, Kopadis G, Maltezos C<span>,&nbsp;</span>Tzilalis VD<span>,&nbsp;</span>Georgiadis GS. Onset of arterial "steal" following proximal angioaccess: Immediate and delayed types. Nephrol Dial Transplant 2003; 18 (11):2387-90.</a></p>
<p>QID: 30421</p></div><div class="rightanswer">The correct answer is: distal revascularization with interval ligation procedure</div></div></div></div></div><div id="q107" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">202</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1982"><input type="hidden" name="q20803:107_:flagged" value="0"><input type="hidden" value="qaid=910991&amp;qubaid=20803&amp;qid=4935&amp;slot=107&amp;checksum=52fa4278316d8cd6a0aece1a66a6e2e1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:107_:flaggedcheckbox" name="q20803:107_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q107&id=4935"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:107_:sequencecheck" value="2"><div class="qtext"><p>&nbsp;All of the following statements regarding nephrogenic systemic fibrosis following exposure to gadolinium&nbsp;are true&nbsp;<strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:107_answer" disabled="disabled" value="0" id="q20803:107_answer0"><label for="q20803:107_answer0">a. glomerular filtration rate of &lt;15 ml/min at the time of gadolinium administration is a known risk factor for its development</label> </div>
<div class="r1"><input type="radio" name="q20803:107_answer" disabled="disabled" value="1" id="q20803:107_answer1"><label for="q20803:107_answer1">b. gadolinium can be detected in skin biopsies</label> </div>
<div class="r0"><input type="radio" name="q20803:107_answer" disabled="disabled" value="2" id="q20803:107_answer2"><label for="q20803:107_answer2">c. it can be treated by dialysis</label> </div>
<div class="r1"><input type="radio" name="q20803:107_answer" disabled="disabled" value="3" id="q20803:107_answer3"><label for="q20803:107_answer3">d. its incidence can be reduced significantly by screening, and not administering gadolinium to patients with a GFR &lt;30 ml/min</label> </div>
<div class="r0"><input type="radio" name="q20803:107_answer" disabled="disabled" value="4" id="q20803:107_answer4"><label for="q20803:107_answer4">e. it may manifest clinically up to 18 months after exposure to gadolinium</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:107_-submit" name="q20803:107_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><div class="cit">Nephrogenic Systemic Fibrosis (NSF) cannot be treated with dialysis. It may occur up to 18 months after gadolinium exposure. Gadolinium can be detected in skin biopsies. GFR of &lt;15 ml/min has been identified as a risk factor and, after screening for patients with GFR&lt;30 ml/min, the incidence of NSF has been reported to be as low as 0-.004%. Without screening, its reported incidence is as high as .036%.</div>
<div class="cit">&nbsp;</div>
<div class="cit">&nbsp;</div>
<h2 class="cit">References:</h2>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology+2009%3B+250(2)%3A371-7." target="_blank">Perez-Rodriguez J,&nbsp;Lai S,&nbsp;Ehst BD,&nbsp;Fine DM,&nbsp;Bluemke DA.&nbsp;Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases.&nbsp;Radiology&nbsp;2009; 250(2):371-7.</a></div>
<div>&nbsp;</div>
<div>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology+2011%3B+260(1)%3A105-11" target="_blank">Wang Y,&nbsp;Alkasab TK,&nbsp;Narin O,&nbsp;Nazarian RM,&nbsp;Kaewlai R,&nbsp;Kay J, et al.&nbsp;Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.&nbsp;Radiology&nbsp;2011; 260(1):105-11.</a></p>
<div>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=AJR+Am+J+Roentgenol+2008%3B+190(4)%3A1060-8" target="_blank">Wiginton CD,&nbsp;Kelly B,&nbsp;Oto A,&nbsp;Jesse M,&nbsp;Aristimuno P,&nbsp;Ernst R, et al.&nbsp;Gadolinium-based contrast exposure,&nbsp;nephrogenic systemic fibrosis, and gadolinium detection in tissue.&nbsp;AJR Am J Roentgenol 2008; 190(4):1060-8.</a>&nbsp;</div>
<div>&nbsp;</div>
<div>QID: 30160&nbsp;</div>
</div>
</div></div><div class="rightanswer">The correct answer is: it can be treated by dialysis</div></div></div></div></div><div id="q296" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">203</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_1991"><input type="hidden" name="q20803:296_:flagged" value="0"><input type="hidden" value="qaid=911180&amp;qubaid=20803&amp;qid=5054&amp;slot=296&amp;checksum=8844bc2398fef825b5737c5f4e66979b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:296_:flaggedcheckbox" name="q20803:296_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q296&id=5054"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:296_:sequencecheck" value="2"><div class="qtext"><p>The intravascular ultrasound (IVUS) image of a common iliac artery shown below demonstrates which of the following?</p>
<p><a href="./VESAP3_files/11683.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/11683.jpg" alt="Img" width="104" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:296_answer" disabled="disabled" value="0" id="q20803:296_answer0"><label for="q20803:296_answer0">a. guidewire artifact</label> </div>
<div class="r1"><input type="radio" name="q20803:296_answer" disabled="disabled" value="1" id="q20803:296_answer1"><label for="q20803:296_answer1">b. a stent with good wall apposition</label> </div>
<div class="r0"><input type="radio" name="q20803:296_answer" disabled="disabled" value="2" id="q20803:296_answer2"><label for="q20803:296_answer2">c. thrombus in the arterial wall</label> </div>
<div class="r1"><input type="radio" name="q20803:296_answer" disabled="disabled" value="3" id="q20803:296_answer3"><label for="q20803:296_answer3">d. an intramural hematoma</label> </div>
<div class="r0"><input type="radio" name="q20803:296_answer" disabled="disabled" value="4" id="q20803:296_answer4"><label for="q20803:296_answer4">e. attenuation of the ultrasound signal by calcified plaque</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:296_-submit" name="q20803:296_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>IVUS can be a useful adjunct for the evaluation of stents for occlusive disease and for demonstrating good versus poor stent apposition to the vessel wall, residual stenosis, and thrombus. Some studies suggest it can predict and even improve the outcome of stenting for occlusive disease. The image shown demonstrates complete stent expansion with good wall apposition. There is no infolding or area of poor apposition, ulceration, thrombus, or hematoma. Calcified plaque signal attenuation or guidewire artifacts would produce signal drop-out analogous to the acoustic shadowing seen with duplex ultrasonography, which is not apparent here. <br><br></p>
<h2>References:</h2>
<p style="text-align: left;"><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Vogt%20KC,%20Just%20S,%20Rasmussen%20JG,%20Schroeder%20TV.%20Prediction%20of%20outcome%20after%20femoropopliteal%20balloon%20angioplasty%20by%20intravascular%20ultrasound.%20Eur%20J%20Vasc%20Endovasc%20Surg.%20J;%201997;%2013%20(6):563-568" target="_blank">Vogt KC, Just S, Rasmussen JG, Schroeder TV. Prediction of outcome after femoropopliteal balloon angioplasty by intravascular ultrasound. Eur J Vasc Endovasc Surg J 1997; 13 (6):563-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Vogt%20KJ,%20Rasmussen%20JG,%20Just%20S,%20Schroeder%20TV.%20Effect%20and%20outcome%20of%20balloon%20angioplasty%20and%20stenting%20of%20the%20iliac%20arteries%20evaluated%20by%20intravascular%20ultrasound.%20Eur%20J%20Vasc%20Endovasc%20Surg;%201999;%2017%20(1):47-55" target="_blank">Vogt KJ, Rasmussen JG, Just S, Schroeder TV. Effect and outcome of balloon angioplasty and stenting of the iliac arteries evaluated by intravascular ultrasound. Eur J Vasc Endovasc Surg; 1999; 17 (1):47-55.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2002%3B+35+(2)%3A316-23." target="_blank">Buckley CJ, Arko FR, Lee S, Mettauer M<span>,&nbsp;</span>Little D<span>,&nbsp;</span>Atkins M<span>,&nbsp;</span>et al. Intravascular ultrasound scanning improves long-term patency of iliac lesions treated with balloon angioplasty and primary stenting. J Vasc Surg 2002; 35 (2):316-23.</a></p>
<p style="text-align: left;">QID: 30516</p></div><div class="rightanswer">The correct answer is: a stent with good wall apposition</div></div></div></div></div><div id="q116" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">204</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2000"><input type="hidden" name="q20803:116_:flagged" value="0"><input type="hidden" value="qaid=911000&amp;qubaid=20803&amp;qid=4732&amp;slot=116&amp;checksum=c399a35d3817e3fa0ff7e214742eb8be&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:116_:flaggedcheckbox" name="q20803:116_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q116&id=4732"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:116_:sequencecheck" value="2"><div class="qtext"><p>A 36-year-old woman presents with acute onset of left arm weakness. The angiogram obtained is shown below. Which of the following is a true statement regarding this diagnosis?<br><br><a href="./VESAP3_files/AssetProxy_042.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_042.jpg" alt="img" width="100" height="82" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:116_answer" disabled="disabled" value="0" id="q20803:116_answer0"><label for="q20803:116_answer0">a. optimal operative exposure should be obtained through a median sternotomy</label> </div>
<div class="r1"><input type="radio" name="q20803:116_answer" disabled="disabled" value="1" id="q20803:116_answer1"><label for="q20803:116_answer1">b. it is frequently caused by radiation injury</label> </div>
<div class="r0"><input type="radio" name="q20803:116_answer" disabled="disabled" value="2" id="q20803:116_answer2"><label for="q20803:116_answer2">c. it is effectively treated with catheter directed thrombolysis</label> </div>
<div class="r1"><input type="radio" name="q20803:116_answer" disabled="disabled" value="3" id="q20803:116_answer3"><label for="q20803:116_answer3">d. it may be associated with arrhythmia and dizziness</label> </div>
<div class="r0"><input type="radio" name="q20803:116_answer" disabled="disabled" value="4" id="q20803:116_answer4"><label for="q20803:116_answer4">e. corticosteroids are the preferred treatment of the underlying disease</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:116_-submit" name="q20803:116_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>A subclavian artery embolus straddling the origin of the vertebral artery is likely of cardiac origin, which is often associated with arrhythmia. While unilateral arm symptoms are frequent, patients can also present with vertebrobasilar symptoms such as dizziness and ataxia. Catheter directed thrombolysis is contraindicated due to the probability of vertebral artery embolization. Surgical thrombectomy is the procedure of choice, preferably through a supraclavicular incision with control of the vertebral artery or through brachial artery access. A median sternotomy is not necessary and is suboptimal for left subclavian artery exposure. Radiation injury to the mediastinum can cause stenotic lesions in the proximal brachiocephalic vessels, typically several years after exposure. Takayasu's arteritis also can cause proximal brachiocephalic arterial stenosis and is treated with corticosteroids.<br><br></p>
<h3>Reference:</h3>
<p>Morasch MD. Vertebral artery disease. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier 2010:1557-74.</p>
<p>QID: 30207</p></div><div class="rightanswer">The correct answer is: it may be associated with arrhythmia and dizziness</div></div></div></div></div><div id="q466" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">205</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2009"><input type="hidden" name="q20803:466_:flagged" value="0"><input type="hidden" value="qaid=911350&amp;qubaid=20803&amp;qid=5189&amp;slot=466&amp;checksum=e609f9f41343afab8a52513613a706a2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:466_:flaggedcheckbox" name="q20803:466_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q466&id=5189"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:466_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old man presents with an asymptomatic, severe left internal carotid artery stenosis and is scheduled for a carotid endarterectomy. He has chronic atrial fibrillation, for which he takes oral rivaroxaban.&nbsp; What instructions should be given regarding anticoagulation in the peri-operative period?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:466_answer" disabled="disabled" value="0" id="q20803:466_answer0"><label for="q20803:466_answer0">a. stop rivaroxaban 3 days prior to surgery; resume on postoperative day 2</label> </div>
<div class="r1"><input type="radio" name="q20803:466_answer" disabled="disabled" value="1" id="q20803:466_answer1"><label for="q20803:466_answer1">b. stop taking rivaroxaban 1 week prior to surgery, bridge with low molecular weight heparin, then resume rivaroxaban on postoperative day 1</label> </div>
<div class="r0"><input type="radio" name="q20803:466_answer" disabled="disabled" value="2" id="q20803:466_answer2"><label for="q20803:466_answer2">c. continue rivaroxaban&nbsp;up to the day prior surgery, with resumption 1 day after the operation</label> </div>
<div class="r1"><input type="radio" name="q20803:466_answer" disabled="disabled" value="3" id="q20803:466_answer3"><label for="q20803:466_answer3">d. stop rivaroxaban&nbsp;on the day of surgery, with resumption on postoperative day 2</label> </div>
<div class="r0"><input type="radio" name="q20803:466_answer" disabled="disabled" value="4" id="q20803:466_answer4"><label for="q20803:466_answer4">e. continue rivaroxaban throughout the perioperative period with no change in dosing.</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:466_-submit" name="q20803:466_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Rivaroxaban (Xarelto®) is an oral factor Xa inhibitor approved for nonvalvular atrial fibrillation. The medication works as a selective direct inhibitor of factor Xa. Rivaroxaban has high oral bioavailability. About one-third is excreted by the kidney, while two-thirds are metabolized by the liver. The half-life of elimination is 5-9 hours, but may be more prolonged (11-13) hours in the elderly.&nbsp;There is no specific antidote.</p>
<p>American College of Chest Physicians guidelines for patients with atrial fibrillation advise against “bridging” therapy when invasive procedures are performed on patients at low risk for stroke and at high risk for bleeding.</p>
<p>In a patient undergoing a carotid endarterectomy, elimination of the anticoagulant effect by the time of the surgery is important. Cessation of rivaroxaban 3 days prior to surgery will cover more than 4 half-lives and lead to undetectable drug levels. Due to the rapid time to action with rivaroxaban and lack of reversal agents, resumption of anticoagulation should not begin immediately following surgery.</p>
<p>The best answer&nbsp;allows for safe surgery and early resumption of anticoagulation.</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Douketis+JD%2C+Spyropoulos+AC%2C+Spencer+FA%2C+Mayr+M%2C+Jaffer+AK%2C+Eckman+MH%2C+Dunn+AS%2C+Kunz+R%3B+American+College+of+Chest+Physicians." target="_blank">Douketis JD, Spyropoulos AC, Spencer FA, Mayr M, Jaffer AK, Eckman MH, et al. Perioperative management of&nbsp;antithrombotic therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice&nbsp;Guidelines. Chest 2012 Feb;141(2 Suppl):e326S-50S. Erratum in: Chest 2012 Apr;141(4):1129.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Phlebology+2011+Feb%3B26(1)%3A3-7." target="_blank">Knepper J, Ramacciotti E, Wakefield TW. Novel anticoagulants: a discussion of clinical use in the treatment and prevention of venous thromboembolism.&nbsp;Phlebology 2011; 26(1):3-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=BMJ+2012%3B13%3A345%3Ae7498." target="_blank">Fox BD, Kahn SR, Langleben D, Eisenberg MJ, Shimony A. Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct&nbsp;and adjusted indirect meta-analysis of randomised controlled trials. BMJ 2012;13:345:e7498.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+2010%3B+363(26)%3A2499-510." target="_blank">EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Buller HR,&nbsp;Decousus H, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J&nbsp;Med 2010; 363(26):2499-510.</a></p>
<p>QID: 30828</p></div><div class="rightanswer">The correct answer is: stop rivaroxaban 3 days prior to surgery; resume on postoperative day 2</div></div></div></div></div><div id="q295" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">206</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2018"><input type="hidden" name="q20803:295_:flagged" value="0"><input type="hidden" value="qaid=911179&amp;qubaid=20803&amp;qid=5053&amp;slot=295&amp;checksum=ec2e9593fdc7bf47117f34b5a860de64&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:295_:flaggedcheckbox" name="q20803:295_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q295&id=5053"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:295_:sequencecheck" value="2"><div class="qtext"><p>The intravascular ultrasound (IVUS) image shown below demonstrates an aortic dissection. The probe is in the true lumen and demonstrates which of the following?</p>
<p><a href="./VESAP3_files/11681.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/11681.jpg" alt="Img" width="101" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:295_answer" disabled="disabled" value="0" id="q20803:295_answer0"><label for="q20803:295_answer0">a. perforation of the aortic wall with ulceration</label> </div>
<div class="r1"><input type="radio" name="q20803:295_answer" disabled="disabled" value="1" id="q20803:295_answer1"><label for="q20803:295_answer1">b. perfusion of the branch artery from both the true and false lumen</label> </div>
<div class="r0"><input type="radio" name="q20803:295_answer" disabled="disabled" value="2" id="q20803:295_answer2"><label for="q20803:295_answer2">c. complete occlusion of a visceral vessel by a dissection flap</label> </div>
<div class="r1"><input type="radio" name="q20803:295_answer" disabled="disabled" value="3" id="q20803:295_answer3"><label for="q20803:295_answer3">d. stagnant flow in the true lumen</label> </div>
<div class="r0"><input type="radio" name="q20803:295_answer" disabled="disabled" value="4" id="q20803:295_answer4"><label for="q20803:295_answer4">e. thrombus within the false lumen</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:295_-submit" name="q20803:295_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>In this IVUS image shown, one can see the aortic dissection with the probe in the true lumen. An artifact from the guidewire adjacent to the IVUS probe is seen in the 7 o'clock position, not thrombus or stagnant flow. The branch vessel (seen at roughly the 11 o'clock position) appears to be fed by both the true and false lumen and does not appear to be occluded. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2005%3B+112+(9+Suppl)%3AI260-4." target="_blank">Koschyk DH, Nienaber CA, Knap M, Hofmann T<span>,&nbsp;</span>Kodolitsch YV<span>,&nbsp;</span>Skriabina V<span>,&nbsp;</span>et al. How to guide stent-graft implantation in type B aortic dissection? Comparison of angiography, transesophageal echocardiography, and intravascular ultrasound. Circulation 2005; 112 (9 Suppl):I260-4.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Song%20TK,%20Donayre%20CE,%20Kopchok%20GE,%20White%20RA.%20Intravascular%20ultrasound%20use%20in%20the%20treatment%20of%20thoracoabdominal%20dissections,%20aneurysms,%20and%20transections.%20Semin%20Vasc%20Surg;%202006;%2019%20(3):145-149" target="_blank">Song TK, Donayre CE, Kopchok GE, White RA. Intravascular ultrasound use in the treatment of thoracoabdominal dissections, aneurysms, and transections. Semin Vasc Surg 2006; 19 (3):145-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2006%3B+43+(Suppl+A)%3A53A-61A." target="_blank">White RA, Donayre CE, Walot I, Kopchok GE. Intraprocedural imaging: Thoracic aortography techniques, intravascular ultrasound, and special equipment. J Vasc Surg 2006; 43 (Suppl A):53A-61A.</a></p>
<p>QID: 30515</p></div><div class="rightanswer">The correct answer is: perfusion of the branch artery from both the true and false lumen</div></div></div></div></div><div id="q551" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">207</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2027"><input type="hidden" name="q20803:551_:flagged" value="0"><input type="hidden" value="qaid=911435&amp;qubaid=20803&amp;qid=5289&amp;slot=551&amp;checksum=ec9b99c4fb0fe455a149936575eee950&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:551_:flaggedcheckbox" name="q20803:551_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q551&id=5289"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:551_:sequencecheck" value="2"><div class="qtext"><p>Radiation injury can cause biological damage by which of the following mechanisms?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:551_answer" disabled="disabled" value="0" id="q20803:551_answer0"><label for="q20803:551_answer0">A. destroying free radicals</label> </div>
<div class="r1"><input type="radio" name="q20803:551_answer" disabled="disabled" value="1" id="q20803:551_answer1"><label for="q20803:551_answer1">B. damaging DNA and RNA</label> </div>
<div class="r0"><input type="radio" name="q20803:551_answer" disabled="disabled" value="2" id="q20803:551_answer2"><label for="q20803:551_answer2">C. repairing chromosomal aberrations</label> </div>
<div class="r1"><input type="radio" name="q20803:551_answer" disabled="disabled" value="3" id="q20803:551_answer3"><label for="q20803:551_answer3">D. forming chemical bonds</label> </div>
<div class="r0"><input type="radio" name="q20803:551_answer" disabled="disabled" value="4" id="q20803:551_answer4"><label for="q20803:551_answer4">E. forming new protein structures</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:551_-submit" name="q20803:551_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Radiation injury is the result of the ionization of atoms within the biological tissue.&nbsp; When ionizing radiation is absorbed, energy is transferred to the atoms within the tissue causing them to be more reactive. In particular, ionizing radiation breaks apart the molecular bonds that hold a molecule together.&nbsp; Within the DNA, radiation injury can occur due to direct ionization of a portion of the DNA molecule or to indirect injury by free radicals in the DNA environment.&nbsp; DNA radiation injuries can manifest as base pair deletion, cross-linking injuries, single-strand break, double-strand break, or multi/complex lesions.&nbsp; Similar mechanisms occur in radiation damage of RNA and protein molecules.</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+ICRP+2012+Feb%3B41(1-2)%3A1-322." target="_blank">Stewart FA, Akleyev AV<span>,&nbsp;</span>Hauer-Jensen M<span>,&nbsp;</span>Hendry JH<span>,&nbsp;</span>Kleiman NJ<span>,&nbsp;</span>Macvittie TJ<span>,</span>&nbsp;et al. ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context. Ann ICRP 2012; 41(1-2):1-322.</a></p>
<p>QID: 30960</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=The+radiation+issue+in+cardiology%3A+the+time+for+action+is+now" target="_blank">Picano E, Vano E<span>.</span>&nbsp;The radiation issue in cardiology: the time for action is now. Cardiovasc Ultrasound 2011; 21;9:35.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=CMAJ+2011+Mar8%3B+183(4)%3A430." target="_blank">Eisenberg MJ, Afilalo J<span>,&nbsp;</span>Lawler PR<span>,&nbsp;</span>Abrahamowicz M<span>,&nbsp;</span>Richard H<span>,&nbsp;</span>Pilote L. Cancer risk related to low-dose ionizing radiation from cardiac imaging in patients after acute myocardial infarction. CMAJ 2011; 183(4):430.</a></p></div><div class="rightanswer">The correct answer is: damaging DNA and RNA</div></div></div></div></div><div id="q297" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">208</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2036"><input type="hidden" name="q20803:297_:flagged" value="0"><input type="hidden" value="qaid=911181&amp;qubaid=20803&amp;qid=5055&amp;slot=297&amp;checksum=b42aaa0d7c699e1744f1d290f4e2e753&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:297_:flaggedcheckbox" name="q20803:297_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q297&id=5055"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:297_:sequencecheck" value="2"><div class="qtext"><p>The intravascular ultrasound (IVUS) image shown below demonstrates which of the following?</p>
<p><a href="./VESAP3_files/11684.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/11684.jpg" alt="Img" width="97" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:297_answer" disabled="disabled" value="0" id="q20803:297_answer0"><label for="q20803:297_answer0">a. imaging artifact from the guidewire</label> </div>
<div class="r1"><input type="radio" name="q20803:297_answer" disabled="disabled" value="1" id="q20803:297_answer1"><label for="q20803:297_answer1">b. normal artery anatomy</label> </div>
<div class="r0"><input type="radio" name="q20803:297_answer" disabled="disabled" value="2" id="q20803:297_answer2"><label for="q20803:297_answer2">c. "soft plaque" or thrombus in the artery</label> </div>
<div class="r1"><input type="radio" name="q20803:297_answer" disabled="disabled" value="3" id="q20803:297_answer3"><label for="q20803:297_answer3">d. a partially-deployed, compressed stent</label> </div>
<div class="r0"><input type="radio" name="q20803:297_answer" disabled="disabled" value="4" id="q20803:297_answer4"><label for="q20803:297_answer4">e. a dissection with patent true and false lumens</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:297_-submit" name="q20803:297_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The image demonstrates an arterial lumen that is narrowed by either thrombus or "soft" non-calcified plaque spanning the 11 to 5 o'clock position. While this could potentially be the result of a dissection, this interpretation would require that either the true or false lumen was thrombosed, not patent. There is no guidewire or stent apparent in this image, only the IVUS probe itself.<br><br></p>
<h2>References:</h2>
<p>Vogt KC, Schroeder TV. Intravascular ultrasound. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:371-81.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2006%3B+19+(3)%3A139-44." target="_blank">Lee JT, Fang TD, White RA. Applications of intravascular ultrasound in the treatment of peripheral occlusive disease. Semin Vasc Surg 2006; 19 (3):139-44.</a></p>
<p>QID: 30517</p></div><div class="rightanswer">The correct answer is: "soft plaque" or thrombus in the artery</div></div></div></div></div><div id="q101" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">209</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2045"><input type="hidden" name="q20803:101_:flagged" value="0"><input type="hidden" value="qaid=910985&amp;qubaid=20803&amp;qid=4923&amp;slot=101&amp;checksum=3549308344c556e7faeedfac77e54e9d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:101_:flaggedcheckbox" name="q20803:101_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q101&id=4923"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:101_:sequencecheck" value="2"><div class="qtext"><p>A 58-year-old male postal worker who is a former smoker presents with disabling (1/2 block) claudication in the left lower extremity. ABI’s are 0.7 on the right and 0.4 on the left. Preoperative CTA demonstrates normal aortoiliac anatomy, a 2 cm long&nbsp;high-grade stenosis in the left common femoral artery, and multifocal tibial disease bilaterally. The patient is already on ASA and atorvastatin and has attempted a trial of formal exercise therapy and cilostazol. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:101_answer" disabled="disabled" value="0" id="q20803:101_answer0"><label for="q20803:101_answer0">a. percutaneous atherectomy of left common femoral artery and left anterior tibial artery</label> </div>
<div class="r1"><input type="radio" name="q20803:101_answer" disabled="disabled" value="1" id="q20803:101_answer1"><label for="q20803:101_answer1">b. left common femoral endarterectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:101_answer" disabled="disabled" value="2" id="q20803:101_answer2"><label for="q20803:101_answer2">c. add pentoxifylline to the patient’s regimen</label> </div>
<div class="r1"><input type="radio" name="q20803:101_answer" disabled="disabled" value="3" id="q20803:101_answer3"><label for="q20803:101_answer3">d. continued conservative management</label> </div>
<div class="r0"><input type="radio" name="q20803:101_answer" disabled="disabled" value="4" id="q20803:101_answer4"><label for="q20803:101_answer4">e. obtain an MRA to better visualize the tibial vasculature</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:101_-submit" name="q20803:101_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In this scenario, the patient exhibits lifestyle-limiting claudication that may influence his employment. He has already exhausted maximum medical therapy, including risk factor modification, the use of an antiplatelet and statin agents, cilostazol, and a formal exercise regimen. Common femoral artery endarterectomy is still the preferred treatment for atherosclerotic lesions involving the common femoral artery. Treatment of the tibial vasculature is not the initial preferred approach in the setting of claudication and MR angiography is typically less diagnostic than CT angiography in the infrapopliteal region.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Siracuse+JJ%2C+Gill+HL%2C+Schneider+DB%2C+Graham+AR%2C+Connolly+PH%2C+Jones+DW%2C+et+al.+Assessing+the+Perioperative+Safety+of+Common" target="_blank">Siracuse JJ, Gill HL, Schneider DB, Graham AR, Connolly PH, Jones DW, et al. Assessing the Perioperative Safety of Common Femoral Endarterectomy in the Endovascular Era. Vasc Endovascular Surg 2014; 48:27-33.</a></p>
<p>QID: 30153</p></div><div class="rightanswer">The correct answer is: left common femoral endarterectomy</div></div></div></div></div><div id="q51" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">210</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2054"><input type="hidden" name="q20803:51_:flagged" value="0"><input type="hidden" value="qaid=910935&amp;qubaid=20803&amp;qid=4306&amp;slot=51&amp;checksum=bbb7fb9d8165d1acf445ccd719a32e5a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:51_:flaggedcheckbox" name="q20803:51_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q51&id=4306"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:51_:sequencecheck" value="2"><div class="qtext"><p>A 73 year old male underwent endovascular repair of a 5.8 cm infrarenal abdominal aortic aneurysm 2 years ago.&nbsp; He was subsequently lost to follow-up.&nbsp; He now presents with a CT scan demonstrating a 7 cm infrarenal AAA with contrast enhancement in the aneurysm sac (See figure).&nbsp; Transarterial angiography demonstrates no type I or III endoleak, but there is late filling of the aneurysm sac through an apparent lumbar branch.&nbsp; SMA and iliac selective arteriography fail to demonstrate the source of endoleak.&nbsp; What is the next best step in management?</p>
<p><a href="./VESAP3_files/endoleak.jpg" target="images"><img style="vertical-align: middle;" src="./VESAP3_files/endoleak.jpg" alt="Figure" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:51_answer" disabled="disabled" value="0" id="q20803:51_answer0"><label for="q20803:51_answer0">a. Open graft explantation</label> </div>
<div class="r1"><input type="radio" name="q20803:51_answer" disabled="disabled" value="1" id="q20803:51_answer1"><label for="q20803:51_answer1">b. Translumbar angiography with embolization</label> </div>
<div class="r0"><input type="radio" name="q20803:51_answer" disabled="disabled" value="2" id="q20803:51_answer2"><label for="q20803:51_answer2">c. Placement of proximal and distal extension cuffs</label> </div>
<div class="r1"><input type="radio" name="q20803:51_answer" disabled="disabled" value="3" id="q20803:51_answer3"><label for="q20803:51_answer3">d. Repeat imaging in 6 months</label> </div>
<div class="r0"><input type="radio" name="q20803:51_answer" disabled="disabled" value="4" id="q20803:51_answer4"><label for="q20803:51_answer4">e. Empiric embolization of bilateral internal iliac arteries</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:51_-submit" name="q20803:51_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Endoleak with subsequent aortic sac enlargement should always prompt an investigation into identification of the source and obliteration of the underlying cause.&nbsp; The initial step in management is to definitively rule out a type I or type III endoleak, which is usually able to be accomplished by a combination of CT scanning and transarterial arteriography.&nbsp; The scenario described is consistent with a type II endoleak from a persistent feeding lumbar branch.&nbsp; Most surgeons would next elect to proceed with translumbar embolization of the offending vessel.&nbsp; While short-term success has been demonstrated, there is increasing literature that a type II endoleak is not a 'benign' condition, and that a significant portion of these patients will ultimately require graft explantation.</p>
<p>&nbsp;</p>
<p>Treatment of type 2 endoleaks after endovascular repair of abdominal aortic aneurysms:&nbsp;comparison of transarterial and translumbar techniques.&nbsp; Baum RA, Carpenter JP, Golden MA, et al.&nbsp; J Vasc Surg.&nbsp; 2002 Jan; 35 (1):23-9.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/11802129">http://www.ncbi.nlm.nih.gov/pubmed/11802129</a></p>
<p>Long-term follow-up of type II endoleak embolization reveals the need for close surveillance.&nbsp; Sarac TP, Gibbons C, Vargas L, et al.&nbsp; J Vasc Surg.&nbsp; 2012 Jan; 55(1):33-40.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/22056249">http://www.ncbi.nlm.nih.gov/pubmed/22056249</a></p>
<p>Midterm outcomes after treatment of type II endoleaks associated with aneurysm sac expansion.&nbsp; Gallagher KA, Ravin RA, Meltzer AJ, et al.&nbsp; J Endovasc Ther. 2012 Apr;19(2): 182-92.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/22545883">http://www.ncbi.nlm.nih.gov/pubmed/22545883</a></p>
<p>QID: 30055</p></div><div class="rightanswer">The correct answer is: Translumbar angiography with embolization</div></div></div></div></div><div id="q261" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">211</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2063"><input type="hidden" name="q20803:261_:flagged" value="0"><input type="hidden" value="qaid=911145&amp;qubaid=20803&amp;qid=4998&amp;slot=261&amp;checksum=a06e61c8a214901a7868ad3542368cec&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:261_:flaggedcheckbox" name="q20803:261_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q261&id=4998"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:261_:sequencecheck" value="2"><div class="qtext"><p><span>A 68-year-old man develops pain in the left hand 6 weeks after creation of a left autogenous brachial-basilic upper arm transposed arteriovenous access for dialysis access. The patient presents with a cool hand; he has numbness while on dialysis. On physical examination of the left arm, the fistula has a palpable thrill with no edema, a palpable brachial artery pulse, non-palpable radial and ulnar artery pulses, and a cool hand with gangrenous ulcers at the tips of his second and third digits. He has decreased sensation, but normal motor function. An arteriogram is obtained (image is show below). Which of the&nbsp;following is the best treatment plan for this patient?</span></p>
<p><span><img src="./VESAP3_files/3. AVF steal.png" alt="" width="494" height="240"></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:261_answer" disabled="disabled" value="0" id="q20803:261_answer0"><label for="q20803:261_answer0">a. <span>a distal revascularization with interval ligation procedure</span></label> </div>
<div class="r1"><input type="radio" name="q20803:261_answer" disabled="disabled" value="1" id="q20803:261_answer1"><label for="q20803:261_answer1">b. <span>banding of the AV access outflow</span></label> </div>
<div class="r0"><input type="radio" name="q20803:261_answer" disabled="disabled" value="2" id="q20803:261_answer2"><label for="q20803:261_answer2">c. <span>emergent ligation of the brachial artery</span></label> </div>
<div class="r1"><input type="radio" name="q20803:261_answer" disabled="disabled" value="3" id="q20803:261_answer3"><label for="q20803:261_answer3">d. <span>observation with a nitropaste patch to the hand</span></label> </div>
<div class="r0"><input type="radio" name="q20803:261_answer" disabled="disabled" value="4" id="q20803:261_answer4"><label for="q20803:261_answer4">e. <span>emergent ligation of the AV access</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:261_-submit" name="q20803:261_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Arterial steal can lead to ischemia in the distal extremity after placement of a dialysis graft or fistula. Decreased resistance in the access outflow tract creates a reversal of blood flow towards the access and away from the hand. Physiologic steal occurs in up to 90% of all AV accesses, but it is clinically symptomatic in less than 10%. Steal is more common in upper arm grafts and less in distal autogenous fistulas. Clinical symptoms range from mild ischemia, presenting as coolness and paresthesias on dialysis, to severe ischemia, presenting as rest pain, numbness, paralysis, finger contractures, and gangrene. Patients with clinically symptomatic arterial steal should be evaluated with an arteriogram to identify any proximal arterial stenosis. Treatment of the proximal artery alone with either endovascular or open surgical techniques may resolve symptoms.</p>
<p>In patients without proximal arterial stenosis or who do not resolve their symptoms with treatment of the inflow stenosis, further treatment options exist.&nbsp;Ligation of the access will resolve the symptoms, but it leaves the patient without an access for dialysis. Banding of the access outflow tract increases the resistance in the fistula. However, it may be difficult to judge the degree of stenosis required to alleviate the steal without causing thrombosis of the access. Distal revascularization with interval ligation (DRIL) involves ligation of the arterial outflow tract just distal to the arterial anastomosis, followed by a bypass from the artery proximal to the anastomosis to the artery distal to the area of ligation. The DRIL procedure is effective in treating ischemic pain and tissue loss, but may be less effective for neurologic deficits that have already occurred.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Knox+RC%2C+Berman+SS%2C+Hughes+JK%2C+et+al.+Distal+revascularization-interval+ligation%3A" target="_blank">Knox RC, Berman SS, Hughes JD, Gentile AT<span>,&nbsp;</span>Mills JL. Distal revascularization-interval ligation: A durable and effective treatment for ischemic steal syndrome after hemodialysis access. J Vasc Surg 2003; 36 (2):250-6.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B57%3A1073-8." target="_blank">Aimaq R, Katz SG. Using distal revascularization with interval ligation as the primary treatment of hand ischemia after dialysis access creation. J Vasc Surg 2013;57:1073-8.</a></p>
<p>QID: 30445</p></div><div class="rightanswer">The correct answer is: <span>a distal revascularization with interval ligation procedure</span></div></div></div></div></div><div id="q267" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">212</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2072"><input type="hidden" name="q20803:267_:flagged" value="0"><input type="hidden" value="qaid=911151&amp;qubaid=20803&amp;qid=5004&amp;slot=267&amp;checksum=10285fd494aab90858b465bede485a82&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:267_:flaggedcheckbox" name="q20803:267_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q267&id=5004"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:267_:sequencecheck" value="2"><div class="qtext"><p>A patient presents to the emergency department after percutaneous embolectomy of an AV access with intense forearm pain, hand pain, and motor dysfunction. He has palpable radial and ulnar pulses at the wrist. Angiography at a free standing access center suggested “possible minor extravasation in the forearm that seemed to stop”.&nbsp; Regarding the management of this patient, which of the following is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:267_answer" disabled="disabled" value="0" id="q20803:267_answer0"><label for="q20803:267_answer0">a. patient has developed Ischemic Monomelic Neuropathy and immediate access ligation is indicated</label> </div>
<div class="r1"><input type="radio" name="q20803:267_answer" disabled="disabled" value="1" id="q20803:267_answer1"><label for="q20803:267_answer1">b. treatment must include exploration of the forearm compartments with fascial release</label> </div>
<div class="r0"><input type="radio" name="q20803:267_answer" disabled="disabled" value="2" id="q20803:267_answer2"><label for="q20803:267_answer2">c. symptoms are most likely to resolve with elevation and time</label> </div>
<div class="r1"><input type="radio" name="q20803:267_answer" disabled="disabled" value="3" id="q20803:267_answer3"><label for="q20803:267_answer3">d. repeat angiography and embolization will be the most effective treatment</label> </div>
<div class="r0"><input type="radio" name="q20803:267_answer" disabled="disabled" value="4" id="q20803:267_answer4"><label for="q20803:267_answer4">e. if swelling is not impressive, significant bleeding is unlikely</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:267_-submit" name="q20803:267_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Upper extremity compartment syndrome can be clinically elusive because the swelling is not proportionate to the pain; this is a result of the relatively small and tightly restrictive fascial compartments. Careful observation is warranted in any patient with extravasation, and bleeding can often be arrested with endovascular techniques such as endografting or embolization. If a patient has already developed compartment syndrome, as in this question, exploration is necessary because without release of the pressurized deep compartments, the patient is likely to have long-term sequelae of compartment syndrome, most notably, disabling neurologic deficits, with or without neuropathic pain.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23538359" target="_blank">Al-Benna S,&nbsp;Elenin H.&nbsp;Delayed compartment syndrome following brachiocephalic arteriovenous fistula formation in a hemodialysis patient.&nbsp;Saudi J Kidney Dis Transpl&nbsp;2013; 24(2):326-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22924805" target="_blank">Lee WY,&nbsp;Yen TH,&nbsp;Lee SY.&nbsp;Acute forearm compartment syndrome associated with dialysis access bleeding.&nbsp;Nephrology (Carlton)&nbsp;2012; 17(7):665-6.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17162155" target="_blank">Wang KL,&nbsp;Li SY,&nbsp;Chuang CL,&nbsp;Chen TW,&nbsp;Chen JY.&nbsp;Subfascial hematoma progressed to arm compartment syndrome due to a nontransposed brachiobasilic fistula.&nbsp;<span>Am J Kidney Dis</span><span>&nbsp;2006; 48(6):990-2.</span></a></p>
<p><span>QID: 30451</span></p></div><div class="rightanswer">The correct answer is: treatment must include exploration of the forearm compartments with fascial release</div></div></div></div></div><div id="q308" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">213</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2081"><input type="hidden" name="q20803:308_:flagged" value="0"><input type="hidden" value="qaid=911192&amp;qubaid=20803&amp;qid=5068&amp;slot=308&amp;checksum=8ef343cf7cb83ac0ddcabaf325cad321&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:308_:flaggedcheckbox" name="q20803:308_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q308&id=5068"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:308_:sequencecheck" value="2"><div class="qtext"><p>A 48-year-old woman with painful varicose veins on her left lower extremity undergoes venous duplex ultrasonography. The findings are shown below. Which of the following signs on the ultrasound identify this vessel as a perforating vein?</p>
<p><a href="./VESAP3_files/4(1).jpg" target="images"><img src="./VESAP3_files/4(1).jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:308_answer" disabled="disabled" value="0" id="q20803:308_answer0"><label for="q20803:308_answer0">a. superficial location compared to artery</label> </div>
<div class="r1"><input type="radio" name="q20803:308_answer" disabled="disabled" value="1" id="q20803:308_answer1"><label for="q20803:308_answer1">b. extent of tortuousity</label> </div>
<div class="r0"><input type="radio" name="q20803:308_answer" disabled="disabled" value="2" id="q20803:308_answer2"><label for="q20803:308_answer2">c. spectral broadening</label> </div>
<div class="r1"><input type="radio" name="q20803:308_answer" disabled="disabled" value="3" id="q20803:308_answer3"><label for="q20803:308_answer3">d. peaked waves reaching 20 cm/s</label> </div>
<div class="r0"><input type="radio" name="q20803:308_answer" disabled="disabled" value="4" id="q20803:308_answer4"><label for="q20803:308_answer4">e. to and fro flow</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:308_-submit" name="q20803:308_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p class="BasicParagraph">"To and fro" flow is used to initially identify perforating veins, which are distinguished by a very stereotypical signal seen from perforating arteries (see figure below). When cannulating the perforating vein for ablation, care should be taken to avoid the perforating artery. The initial localization and marking of the perforator vein is achieved with a linear pulsed wave transducer 4-12 MHz. For injection in the office setting or operating room, using the “hockey-stick” probe (10-12 MHz) is technically easier, but the same can be achieved with the standard diagnostic transducer.</p>
<p>&nbsp;<img src="./VESAP3_files/4B.jpg" alt="" width="633" height="427"></p>
<p>Content adapted from the Clinical Review of Phlebology and Venous Ultrasound, Eds Eric Mowatt-Larssen, MD, Sapan S. Desai, MD, PhD, MBA, and Cynthia Shortell, MD. “Perforator Veins” by Elna Masuda, MD and Darcy Kessler, RVT. Copyright 2013 Surgisphere Corporation. Content and figure used with permission.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p class="References"><a href="http://www.ncbi.nlm.nih.gov/pubmed/11296331" target="_blank">Delis KT, Husmann M, Kalodiki E, Wolfe JH, Nicolaides AN. In situ hemodynamics of perforating veins in chronic venous insufficiency. J Vasc Surg 2001;33:773-82.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Vasc+endoVasc+Surg+2006%3B31%3A535-41." target="_blank">Ibegbuna V, Delis KT, Nicolaides AN. Haemodynamic and clinical impact of superficial, deep and perforator vein incompetence. Eur J Vasc endoVasc Surg 2006;31:535-41.</a></p>
<p>QID: 30530</p></div><div class="rightanswer">The correct answer is: to and fro flow</div></div></div></div></div><div id="q158" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">214</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2090"><input type="hidden" name="q20803:158_:flagged" value="0"><input type="hidden" value="qaid=911042&amp;qubaid=20803&amp;qid=4778&amp;slot=158&amp;checksum=86c08829a7a7d937f4306dc362c41391&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:158_:flaggedcheckbox" name="q20803:158_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q158&id=4778"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:158_:sequencecheck" value="2"><div class="qtext"><p>Follow up venography during thrombolysis for a symptomatic unprovoked DVT in an otherwise healthy 32-year-old man reveals significant stenosis of the proximal subclavian vein.&nbsp; Which of the following statements regarding the management of this stenosis is&nbsp;<strong>true</strong><strong>?</strong></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:158_answer" disabled="disabled" value="0" id="q20803:158_answer0"><label for="q20803:158_answer0">a. balloon angioplasty alone is usually sufficient</label> </div>
<div class="r1"><input type="radio" name="q20803:158_answer" disabled="disabled" value="1" id="q20803:158_answer1"><label for="q20803:158_answer1">b. due to the elastic&nbsp;nature of stenoses at this site,&nbsp;a self expanding stent should be used</label> </div>
<div class="r0"><input type="radio" name="q20803:158_answer" disabled="disabled" value="2" id="q20803:158_answer2"><label for="q20803:158_answer2">c. a balloon expandable stent&nbsp;provides&nbsp;the&nbsp;radial force needed to expand the inelastic&nbsp;venous stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:158_answer" disabled="disabled" value="3" id="q20803:158_answer3"><label for="q20803:158_answer3">d. jugular-subclavian venous bypass is the best option</label> </div>
<div class="r0"><input type="radio" name="q20803:158_answer" disabled="disabled" value="4" id="q20803:158_answer4"><label for="q20803:158_answer4">e. none of the above are true</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:158_-submit" name="q20803:158_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>An unprovoked, upper extremity&nbsp;deep venous thrombosis that occurs&nbsp;in a young, active patient is usually caused by venous compression at the thoracic outlet (venous thoracic outlet syndrome). The preferred treatment for patients with symptomatic upper extremity venous thrombosis (Paget Schroetter Syndrome) remains uncertain. Most surgeons agree that first rib resection is appropriate. The role of catheter-directed thrombolysis is somewhat controversial. Some surgeons have suggested that thrombolysis is unnecessary prior to first rib resection, whereas others recommend thrombolysis followed by first rib resection and venolysis. The optimal surgical treatment of the subclavian vein itself is also a subject of considerable debate. Some surgeons recommend open endovenectomy and patch venoplasty at the time of first rib resection. Interposition grafting with saphenous vein, femoral deep vein, or PTFE has also been advocated. Stent placement without resection of the bony compression can result in stent deformity and fracture and therefore is not recommended.&nbsp;</p>
<p><img src="./VESAP3_files/Figure.png" alt="" width="148" height="116">&nbsp;</p>
<p>After thrombolysis, if venography fails to identify a stenosis, functional testing with hyperabduction of the arm should be performed. &nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Skalicka+L%2C+Lubanda+JC%2C+Jirat+S%2C+et+al.+Endovascular+treatment+combined+with+stratified+surgery+is+effective+in+the+management+of+venous+thoracic+outlet+syndrome+complications%3A" target="_blank">Skalicka L, Lubanda JC, Jirat S, Varejka P,&nbsp;Beran S,&nbsp;Dostal O,&nbsp;et al. Endovascular treatment combined with stratified surgery is effective in the management of venous thoracic outlet syndrome complications: a long term ultrasound follow-up study in patients with thrombotic events due to venous thoracic outlet syndrome. Heart Vessels 2011; 26:612-21.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2007%3B+21%3A723-9." target="_blank">Doyle A, Wolford HY, Davies MG, Adams JT,&nbsp;Singh MJ,&nbsp;Saad WE,&nbsp;et al. Management of effort thrombosis of the subclavian vein: today's treatment. Ann Vasc Surg 2007; 21:723-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Intervent+Radiol+2012%3B+29%3A44-51." target="_blank">Thompson RW. Comprehensive management of subclavian vein effort thrombosis. Semin Intervent Radiol 2012; 29:44-51.</a></p>
<p>QID: 30252</p></div><div class="rightanswer">The correct answer is: none of the above are true</div></div></div></div></div><div id="q173" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">215</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2099"><input type="hidden" name="q20803:173_:flagged" value="0"><input type="hidden" value="qaid=911057&amp;qubaid=20803&amp;qid=4675&amp;slot=173&amp;checksum=d81340a17e4e4e69ac6af313f7637fb6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:173_:flaggedcheckbox" name="q20803:173_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q173&id=4675"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:173_:sequencecheck" value="2"><div class="qtext"><p>A 66-year-old man underwent external beam radiation for treatment of a cervical head and neck malignancy 10 years ago. Which of the following is the incidence of &gt;70% internal carotid stenosis compared to his age and comorbidity-matched controls with no prior cervical radiation?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:173_answer" disabled="disabled" value="0" id="q20803:173_answer0"><label for="q20803:173_answer0">a. 5% with radiation, 5% control</label> </div>
<div class="r1"><input type="radio" name="q20803:173_answer" disabled="disabled" value="1" id="q20803:173_answer1"><label for="q20803:173_answer1">b. 5% with radiation, 40% control</label> </div>
<div class="r0"><input type="radio" name="q20803:173_answer" disabled="disabled" value="2" id="q20803:173_answer2"><label for="q20803:173_answer2">c. 22% with radiation, 4% control</label> </div>
<div class="r1"><input type="radio" name="q20803:173_answer" disabled="disabled" value="3" id="q20803:173_answer3"><label for="q20803:173_answer3">d. 50% with radiation, 50% control</label> </div>
<div class="r0"><input type="radio" name="q20803:173_answer" disabled="disabled" value="4" id="q20803:173_answer4"><label for="q20803:173_answer4">e. 70% with radiation, 5% control</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:173_-submit" name="q20803:173_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>A history of cervical radiation, most commonly for head and neck malignancies, is associated with a higher incidence of carotid stenosis from atherosclerosis than age and comorbidity-matched controls without radiation. The rates have been reported as high as a 40% incidence of carotid stenosis (&gt;50%) with prior radiation.&nbsp; A case-control study showed that patients with prior radiation had a 21.7% incidence of &gt;70% carotid stenosis versus 4% in the control group.&nbsp; The pathogenesis of radiation-induced stenosis is thought to result from intimal and medial damage with resulting atheroma formation. These lesions are also known to occur in more proximal locations in the common carotid arteries in addition to the carotid bulb.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/10772307" target="_blank">Cheng&nbsp;SW,&nbsp;Ting&nbsp;AC,&nbsp;Lam&nbsp;LK, Wei, WI. Carotid stenosis after&nbsp;radiotherapy for nasopharyngeal carcinoma.&nbsp;Arch Otolaryngol Head Neck Surg 2000;&nbsp;126:517-21. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/10772307"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/10587388" target="_blank">Carmody&nbsp;BJ,&nbsp;Arora&nbsp;S,&nbsp;Avena&nbsp;R,&nbsp;Curry KM<span>,&nbsp;</span>Simpkins J<span>,&nbsp;</span>Cosby K,&nbsp;et al. Accelerated carotid artery disease after high-dose head and&nbsp;neck radiotherapy: is thera role for routine carotid duplex surveillance?&nbsp;&nbsp;J Vasc Surg 1999;&nbsp;30:1045-51. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/10587388"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/15135672" target="_blank">Steele&nbsp;SR,&nbsp;Martin&nbsp;MJ,&nbsp;Mullenix&nbsp;PS,Crawford JV<span>,&nbsp;</span>Cuadrado DS<span>,&nbsp;</span>Andersen CA. Focused high-risk population screening for carotid arterial stenosis after radiation therapy for head and neck cancer. Am J Surg 2004;&nbsp;187:594-8.</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/15135672"><br></a></p>
<p>QID: 30313</p></div><div class="rightanswer">The correct answer is: 22% with radiation, 4% control</div></div></div></div></div><div id="q216" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">216</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2108"><input type="hidden" name="q20803:216_:flagged" value="0"><input type="hidden" value="qaid=911100&amp;qubaid=20803&amp;qid=4711&amp;slot=216&amp;checksum=da8365495cd36cc69e4144306062b4db&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:216_:flaggedcheckbox" name="q20803:216_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q216&id=4711"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:216_:sequencecheck" value="2"><div class="qtext"><p>An 80-year-old woman becomes hypotensive from presumed urosepsis in the MICU. During her resuscitation a large central venous catheter (7.5 Fr) was attempted in the right neck. A pulsatile waveform is noticed when it is connected to a transducer. The imaging performed is shown below. Which of the following options is associated with the highest risk of complications?</p>
<p><img src="./VESAP3_files/Vallabhaneni Question 1 Fig 1.jpg" alt="" width="441" height="296"></p><p><img src="./VESAP3_files/Vallabhaneni Question 1 Figure 2.jpg" alt="" width="380" height="314"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:216_answer" disabled="disabled" value="0" id="q20803:216_answer0"><label for="q20803:216_answer0">a. removing the central line and then balloon tamponade the insertion site until hemostasis is verified</label> </div>
<div class="r1"><input type="radio" name="q20803:216_answer" disabled="disabled" value="1" id="q20803:216_answer1"><label for="q20803:216_answer1">b. pulling the central line and holding external compression until hemostasis is achieved</label> </div>
<div class="r0"><input type="radio" name="q20803:216_answer" disabled="disabled" value="2" id="q20803:216_answer2"><label for="q20803:216_answer2">c. exposing and directly repairing the arterial injury through a supraclavicular incision</label> </div>
<div class="r1"><input type="radio" name="q20803:216_answer" disabled="disabled" value="3" id="q20803:216_answer3"><label for="q20803:216_answer3">d. placing a percutaneous vascular closure device through the neck</label> </div>
<div class="r0"><input type="radio" name="q20803:216_answer" disabled="disabled" value="4" id="q20803:216_answer4"><label for="q20803:216_answer4">e. placing a stent graft at the site of injury</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:216_-submit" name="q20803:216_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Inadvertent arterial catheterization of the supraaortic branches during attempted central venous catheterization is a relatively rare occurrence. That being said, this is a complication that vascular surgeons will be asked to treat several times in their career. The gold standard therapy for arterial injury from a 7 Fr (or greater) catheter on the right side of the neck is open repair by either a cervical approach or a combination of supraclavicular approach with partial median sternotomy if there is an injury to the innominate artery or aorta. If there is involvement of the aorta, the left side of the neck may require a posterolateral thoractomy or even possibly a trapdoor procedure, depending on the location of the catheterization. The pull and hold pressure approach has been associated with a complication rate of up to 47%, with a 13% death rate in some reports from a combination of airway compromise, hemorrhage, or stroke.&nbsp;Endovascular techniques have been described with good success rates, including use of vascular closure devices, balloon tamponade, and placement of endovascular stent grafts. Knowledge of the position of the vertebral artery in relation to catheter insertion is important for inadvertent subclavian artery catheterizations, as in the figures above. Prevention with good technique, use of an ultrasound, and knowledge of anatomic landmarks are the keys to avoiding these injuries.</p>
<p>As with all complex surgical problems, the surgeon must weigh the risk of various treatment options in the context of the clinical scenario. There is no one size fits all.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+48%3A918-25" target="_blank">Guilbert M, Elkouri S, Bracco D, Corriveau MM,&nbsp;Beaudoin N,&nbsp;Dubois MJ,&nbsp;et al. Arterial trauma during central venous catheter insertion: Case series, review and proposed algorithm. J Vasc Surg 2008; 48:918-25.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Euro+J+Vasc+Endovasc+Surg+2009%3B+38%3A707-14" target="_blank">Pikwer A, Acosta S, Kolbel T, Malina M,&nbsp;Sonesson B,&nbsp;Akeson J. Management of arterial catheterisation associated with central venous access procedures. Euro J Vasc Endovasc Surg 2009; 38:707-14.&nbsp;</a><a style="line-height: 1.5;" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Euro+J+Vasc+Endovasc+Surg+2009%3B+38%3A707-14.">&nbsp;</a></p>
<p>QID: 30367</p></div><div class="rightanswer">The correct answer is: pulling the central line and holding external compression until hemostasis is achieved</div></div></div></div></div><div id="q306" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">217</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2117"><input type="hidden" name="q20803:306_:flagged" value="0"><input type="hidden" value="qaid=911190&amp;qubaid=20803&amp;qid=5064&amp;slot=306&amp;checksum=cb917f31c26dddeeb0b5b1def130342c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:306_:flaggedcheckbox" name="q20803:306_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q306&id=5064"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:306_:sequencecheck" value="2"><div class="qtext"><p>A 33-year-old woman has an abdominal bruit and undergoes duplex scanning of the renal and visceral vessels. The Doppler waveform image shown below was obtained from the left renal artery.&nbsp;These findings indicate which of the following?</p>
<p><a href="./VESAP3_files/12244.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/12244.jpg" alt="Img" width="146" height="100"></a></p>
<p>Abbreviations in this image are: RA = renal artery, PS = peak systolic velocity, ED = end diastolic velocity, RI = resistive index.&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:306_answer" disabled="disabled" value="0" id="q20803:306_answer0"><label for="q20803:306_answer0">a. normal hemodynamics</label> </div>
<div class="r1"><input type="radio" name="q20803:306_answer" disabled="disabled" value="1" id="q20803:306_answer1"><label for="q20803:306_answer1">b. a moderate renal artery stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:306_answer" disabled="disabled" value="2" id="q20803:306_answer2"><label for="q20803:306_answer2">c. a high-grade renal artery stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:306_answer" disabled="disabled" value="3" id="q20803:306_answer3"><label for="q20803:306_answer3">d. fibromuscular disease</label> </div>
<div class="r0"><input type="radio" name="q20803:306_answer" disabled="disabled" value="4" id="q20803:306_answer4"><label for="q20803:306_answer4">e. diseased renal parenchyma</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:306_-submit" name="q20803:306_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This is a normal renal artery (RA) waveform and normal velocities. Normal RA waveforms are characterized by rapid systolic rise and low resistance, manifested by high-end diastolic flow. The RA waveform exhibited here shows these characteristics. A high-grade RA stenosis is generally diagnosed by a&nbsp;RA peak systolic velocity (PSV) &gt; 180-200 cm/sec and/or renal-aortic ratio (RAR) greater than 3.5 (RAR= maximum RA PSV/maximum&nbsp;PSV in the aorta at the level of the renal arteries).&nbsp;The waveform seen in the image would not be indicative of a high-grade renal artery stenosis. It is also not indicative of a waveform obtained distal to a renal artery stenosis, as the waveform exhibits only moderate spectral broadening and is not a blunted waveform, which would be expected distal to high-grade stenosis. Thresholds defining parenchymal resistance are generally obtained from intra-renal arteries and not the main renal artery. In addition, there is a large component of diastolic flow in this renal artery waveform, with end-diastolic ratio (EDV/PSV of &gt; 30%, with &gt; 20% in the normal range). Parenchymal disease produces increased resistance to flow within the kidney and decreased diastolic flow. Fibromuscular disease is certainly possible at this location, but would not be diagnosed by a single normal renal artery waveform.<br><br></p>
<h2>Reference:</h2>
<p>Pellerito JS, Zwiebel WJ. Ultrasound assessment of native renal vessels and renal allografts. In: Introduction to Vascular Ultrasonography. Zwiebel WJ, Pellerito JS. eds. Philadelphia, PA: Elsevier Saunders; 2005:611-36.</p>
<p>QID: 30526</p></div><div class="rightanswer">The correct answer is: normal hemodynamics</div></div></div></div></div><div id="q96" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">218</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2126"><input type="hidden" name="q20803:96_:flagged" value="0"><input type="hidden" value="qaid=910980&amp;qubaid=20803&amp;qid=4917&amp;slot=96&amp;checksum=969346f8b304b064f01426b0af2e1d78&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:96_:flaggedcheckbox" name="q20803:96_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q96&id=4917"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:96_:sequencecheck" value="2"><div class="qtext"><p>A 45-year-old man complains of disabling claudication of the left lower extremity. An MRA performed at rest and during forced plantar-flexion against resistance was obtained and is shown below. Which of the following is the most probable diagnosis?</p>
<p><img src="./VESAP3_files/Q1 Neutral.jpg" alt="" width="402" height="994"></p>
<p><img src="./VESAP3_files/Q1 Plantar flexion.jpg" alt="" width="380" height="956"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:96_answer" disabled="disabled" value="0" id="q20803:96_answer0"><label for="q20803:96_answer0">a. <span>adventitial cystic disease</span></label> </div>
<div class="r1"><input type="radio" name="q20803:96_answer" disabled="disabled" value="1" id="q20803:96_answer1"><label for="q20803:96_answer1">b. normal positional arterial compression</label> </div>
<div class="r0"><input type="radio" name="q20803:96_answer" disabled="disabled" value="2" id="q20803:96_answer2"><label for="q20803:96_answer2">c. <span>popliteal artery entrapment syndrome</span></label> </div>
<div class="r1"><input type="radio" name="q20803:96_answer" disabled="disabled" value="3" id="q20803:96_answer3"><label for="q20803:96_answer3">d. <span>Buerger disease or thromboangiitis obliterans</span></label> </div>
<div class="r0"><input type="radio" name="q20803:96_answer" disabled="disabled" value="4" id="q20803:96_answer4"><label for="q20803:96_answer4">e. <span>persistent sciatic artery</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:96_-submit" name="q20803:96_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The anatomic basis of popliteal artery entrapment syndrome lies in the anaomalous embryonic development of 2 independent structures, the popliteal artery and the gastrocnemius muscle. The classification system of popliteal entrapment is based on 4 main variants of the popliteal artery and surrounding musculature. In type 1 (50% of cases), the popliteal artery deviates medial to the normally placed medial head of the gastrocnemius muscle. In type 2 (25% of cases), the medial head of the gastrocnemius attaches abnormally, with the popliteal artery passing medially but with less deviation than in type 1. In type 3 (6% of cases and in the example shown), the normally situated popliteal artery is compressed by muscle slips of the medial head of the gastrocnemius. In type 4, associated fibrous bands of the popliteus or plantar muscles compress the popliteal artery. In type 5, the popliteal vein accompanies the artery in its abnormal course.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Surg+1979%3B+114%3A1377%E2%80%931384." target="_blank">Rich NM, Collins G Jr, McDonald PT, Kozloff L<span>,&nbsp;</span>Clagett GP<span>,&nbsp;</span>Collins JT. Popliteal vascular entrapment: its increasing interest.&nbsp;Arch Surg&nbsp;1979; 114:1377–1384.</a></p>
<p>Landry GJ, Edwards JM. Nonatherosclerotic Vascular Disease.&nbsp;In: Moore WS, ed. Vascular and Endovascular Surgery: A Comprehensive Review. 8th ed. Elsevier Saunders: Philadelphia; 2013. p. 123-124.</p>
<p>QID: 30147</p></div><div class="rightanswer">The correct answer is: <span>popliteal artery entrapment syndrome</span></div></div></div></div></div><div id="q89" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">219</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2135"><input type="hidden" name="q20803:89_:flagged" value="0"><input type="hidden" value="qaid=910973&amp;qubaid=20803&amp;qid=4905&amp;slot=89&amp;checksum=9db0beda6fa2a8fd0cd3d574c5d005aa&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:89_:flaggedcheckbox" name="q20803:89_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q89&id=4905"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:89_:sequencecheck" value="2"><div class="qtext"><p>For patients with pre-existing renal insufficiency (serum creatinine &gt; 1.4 mg/dl or glomerular filtration rate &lt; 60 ml/min), contrast induced acute kidney injury can best be prevented by which of the following management options?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:89_answer" disabled="disabled" value="0" id="q20803:89_answer0"><label for="q20803:89_answer0">a. administration of fenoldopam</label> </div>
<div class="r1"><input type="radio" name="q20803:89_answer" disabled="disabled" value="1" id="q20803:89_answer1"><label for="q20803:89_answer1">b. administration of acetylcysteine</label> </div>
<div class="r0"><input type="radio" name="q20803:89_answer" disabled="disabled" value="2" id="q20803:89_answer2"><label for="q20803:89_answer2">c. hydration with normal saline and sodium bicarbonate</label> </div>
<div class="r1"><input type="radio" name="q20803:89_answer" disabled="disabled" value="3" id="q20803:89_answer3"><label for="q20803:89_answer3">d. remote ischemic preconditioning</label> </div>
<div class="r0"><input type="radio" name="q20803:89_answer" disabled="disabled" value="4" id="q20803:89_answer4"><label for="q20803:89_answer4">e. use of iodinated contrast</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:89_-submit" name="q20803:89_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The answer is remote ischemic preconditioning. Recent publications have shown that in patients with underlying renal insufficiency, contrast induced acute kidney injury can be prevented by ischemic preconditioning, consisting of 4 cycles of 5 minutes of upper extremity ischemia induced with a blood pressure cuff prior to contrast administration.</p>
<p>Although the exact mechanism is unclear, the remote ischemic preconditioning stimulus induces biochemical markers such as NO, free radicals, kinases, and others to decrease oxidative stress and protect mitochondrial function. While often employed, the other methods listed have not been definitively shown to be effective in reducing contrast induced acute kidney injury in patients with pre-existing renal insufficiency.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Surg+Res+2008+%3B150(2)%3A304-30." target="_blank">Tapuria N,&nbsp;Kumar Y,&nbsp;Habib MM,&nbsp;Abu Amara M,&nbsp;Seifalian AM,&nbsp;Davidson BR.&nbsp;Remote ischemic preconditioning: a novel protective method from ischemia reperfusion injury--a review.&nbsp;J Surg Res&nbsp;2008 ;150(2):304-30.</a></p>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2012%3B+126(3)%3A296-303." target="_blank">Er F, Nia AM, Dopp H, Hellmich M, Dahlem KM, Caglayan E, et al.&nbsp;Ischemic preconditioning for prevention of contrast medium-induced nephropathy: randomized pilot RenPro Trial (Renal Protection Trial).&nbsp;Circulation 2012; 126(3):296-303.</a></div>
<div>QID: 30135</div></div><div class="rightanswer">The correct answer is: remote ischemic preconditioning</div></div></div></div></div><div id="q546" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">220</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2144"><input type="hidden" name="q20803:546_:flagged" value="0"><input type="hidden" value="qaid=911430&amp;qubaid=20803&amp;qid=5280&amp;slot=546&amp;checksum=44bb9bec5fb86b8deb48dd463d5a081f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:546_:flaggedcheckbox" name="q20803:546_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q546&id=5280"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:546_:sequencecheck" value="2"><div class="qtext"><p>Maneuvers to <b>decrease</b> radiation exposure during procedures include which of the following?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:546_answer" disabled="disabled" value="0" id="q20803:546_answer0"><label for="q20803:546_answer0">a. increased beam-time on</label> </div>
<div class="r1"><input type="radio" name="q20803:546_answer" disabled="disabled" value="1" id="q20803:546_answer1"><label for="q20803:546_answer1">b. decreased x-ray source to skin distance</label> </div>
<div class="r0"><input type="radio" name="q20803:546_answer" disabled="disabled" value="2" id="q20803:546_answer2"><label for="q20803:546_answer2">c. increased patient to Image Intensifier distance</label> </div>
<div class="r1"><input type="radio" name="q20803:546_answer" disabled="disabled" value="3" id="q20803:546_answer3"><label for="q20803:546_answer3">d. collimation of the beam</label> </div>
<div class="r0"><input type="radio" name="q20803:546_answer" disabled="disabled" value="4" id="q20803:546_answer4"><label for="q20803:546_answer4">e. increased magnification</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:546_-submit" name="q20803:546_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Safety recommendations to decrease radiation exposure to patients and staff include the following:</p>
<p>1.) Maintain adequate x-ray source-skin distance</p>
<p>2.) Keep image intensifier as close as possible to patient</p>
<p>3.) Apply positive beam limitation (collimators)</p>
<p>4.) Limit magnification and beam-time</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.mass.gov/eohhs/docs/dph/regs/105cmr120-400.pdf" target="_blank">Fluoroscopy dose reporting 105 CMR 120.405 Summary of changes, as of March 2012</a></p>
<p>QID: 30952</p></div><div class="rightanswer">The correct answer is: collimation of the beam</div></div></div></div></div><div id="q498" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">221</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2153"><input type="hidden" name="q20803:498_:flagged" value="0"><input type="hidden" value="qaid=911382&amp;qubaid=20803&amp;qid=5217&amp;slot=498&amp;checksum=53d2dfb0f6eb16c490e807b0681f7429&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:498_:flaggedcheckbox" name="q20803:498_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q498&id=5217"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:498_:sequencecheck" value="2"><div class="qtext"><p>Which of the following medications has been shown to have the greatest increase in walking time and quality of life in patients with intermittent claudication?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:498_answer" disabled="disabled" value="0" id="q20803:498_answer0"><label for="q20803:498_answer0">a. metoprolol</label> </div>
<div class="r1"><input type="radio" name="q20803:498_answer" disabled="disabled" value="1" id="q20803:498_answer1"><label for="q20803:498_answer1">b. ramipril</label> </div>
<div class="r0"><input type="radio" name="q20803:498_answer" disabled="disabled" value="2" id="q20803:498_answer2"><label for="q20803:498_answer2">c. clopidogrel</label> </div>
<div class="r1"><input type="radio" name="q20803:498_answer" disabled="disabled" value="3" id="q20803:498_answer3"><label for="q20803:498_answer3">d. aspirin</label> </div>
<div class="r0"><input type="radio" name="q20803:498_answer" disabled="disabled" value="4" id="q20803:498_answer4"><label for="q20803:498_answer4">e. simvastatin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:498_-submit" name="q20803:498_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The correct choice is ramipril (Altace®), an angiotensin-onverting enzyme (ACE) inhibitor that is FDA-approved for use as an antihypertensive. It is also used for heart failure management and to reduce risk of myocardial infarction, stroke, and death from cardiovascular causes. The initial adult dose in patients not receiving a diuretic is 2.5 mg once daily; titrate to effect, up to 20 mg daily in one or two divided doses.</p>
<p>ACE-inhibitors have been investigated as a therapy for intermittent claudication.&nbsp;In a randomized, double-blind, placebo-controlled trial of 212 patients with intermittent claudication, ramipril increased treadmill-assessed pain-free walking time by 77% and maximum walking time by 123%.&nbsp; These increases are greater than those reported for other medical therapies for intermittent claudication, including pentoxifilline and cilostazol, though cilostazol's benefit was reproducibly demonstrated in multiple placebo-controlled trials and meta-analyses.</p>
<p>Ramipril's hypothesized mechanism of action is through increased peripheral blood flow and adaptations in the skeletal muscle structure. Studies found ramipril to be associated with an increase in biomarkers of&nbsp;angiogenesis and arteriogenesis, and reduction in markers of thrombosis, inflammation,&nbsp;and leukocyte adhesion.</p>
<p>Meta-analysis of angiotensin converting enzyme inhibitors' effect on walking&nbsp;ability have also suggested benefit for treatment of intermittent&nbsp;claudication.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=vid+Based+Med+2014%3B19(1)%3A16." target="_blank">Brittenden J. Ramipril improves walking times and quality of life in patients&nbsp;with stable intermittent claudication. Evid Based Med 2014;19(1):16.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ahimastos+A%2C+Latouche+C%2C+Natoli+AK%2C+Reddy-Luthmoodoo+M%2C+Golledge+J%2C+Kingwell+BA." target="_blank">Ahimastos A, Latouche C, Natoli AK, Reddy-Luthmoodoo M, Golledge J, Kingwell&nbsp;BA. Potential Vascular Mechanisms of Ramipril Induced Increases in Walking&nbsp;Ability in Patients with Intermittent Claudication. Circ Res 2014;114(7):1144-55.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=2013+Dec%3B231(2)%3A283-90." target="_blank">Shahin Y, Barnes R, Barakat H, Chetter IC. Meta-analysis of angiotensin&nbsp;converting enzyme inhibitors effect on walking ability and ankle brachial&nbsp;pressure index in patients with intermittent claudication. Atherosclerosis. 2013; 231(2):283-90.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br+J+Surg.+2013+Aug%3B100(9)%3A1154-63." target="_blank">Shahin Y, Cockcroft JR, Chetter IC. Randomized clinical trial of&nbsp;angiotensin-converting enzyme inhibitor, ramipril, in patients with intermittent claudication. Br J Surg. 2013; 100(9):1154-63.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2013%3B+309(5)%3A453-60." target="_blank">Ahimastos AA, Walker PJ, Askew C, Leicht A, Pappas E, Blombery P, et al. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a&nbsp;randomized controlled trial. JAMA 2013; 309(5):453-60.</a></p>
<p>QID: 30865</p></div><div class="rightanswer">The correct answer is: ramipril</div></div></div></div></div><div id="q204" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">222</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2162"><input type="hidden" name="q20803:204_:flagged" value="0"><input type="hidden" value="qaid=911088&amp;qubaid=20803&amp;qid=4696&amp;slot=204&amp;checksum=a0d311323b4e50b73dfc099b517bfa21&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:204_:flaggedcheckbox" name="q20803:204_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q204&id=4696"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:204_:sequencecheck" value="2"><div class="qtext"><p>You are called by the recovery room nurse to evaluate a possible wound hematoma in a 70-year-old man 1 hour after a challenging carotid endarterectomy. You had to repair the posterior wall of the carotid bulb due to perforation that happened while removing the plaque. He is hemodynamically stable, arousable, and not complaining of pain or shortness of breath. The neck is distinctly assymetrical and you think there is a substantial hematoma. What is of the following is the best next step of care in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:204_answer" disabled="disabled" value="0" id="q20803:204_answer0"><label for="q20803:204_answer0">a. exploration in the operating room</label> </div>
<div class="r1"><input type="radio" name="q20803:204_answer" disabled="disabled" value="1" id="q20803:204_answer1"><label for="q20803:204_answer1">b. immediate exploration in the recovery room</label> </div>
<div class="r0"><input type="radio" name="q20803:204_answer" disabled="disabled" value="2" id="q20803:204_answer2"><label for="q20803:204_answer2">c. needle aspiration</label> </div>
<div class="r1"><input type="radio" name="q20803:204_answer" disabled="disabled" value="3" id="q20803:204_answer3"><label for="q20803:204_answer3">d. CT angiography</label> </div>
<div class="r0"><input type="radio" name="q20803:204_answer" disabled="disabled" value="4" id="q20803:204_answer4"><label for="q20803:204_answer4">e. emergency cricothyroidotomy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:204_-submit" name="q20803:204_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Unfortunately, this is a common scenario following a carotid endarterectomy. Failure to manage this situation effectively can lead to devastating consequences. Physical examination is the best technique to evaluate a postoperative neck hematoma. In most cases, it is best to err on the side of safety and perform a controlled exploration in the operating room. Neck hematomas can progress rapidly to airway compromise, especially in the sedated post operative patient. Immediate exploration in the recovery room is not necessary in this patient without symptoms or airway obstruction, but may be appropriate in occasional emergencies. Likewise, emergency cricothyroidotomy would be excessively aggressive and potentially harmful. Needle aspiration is unlikely to be effective or diagnostic and runs the risk of inducing hemorrhage. The logistics of arranging a CTA and the risks associated with transport make this option less appealing. Ultrasound is usually difficult to interpret in the immediate post op patient and does not replace the physical exam.<br><br></p>
<h3>References:</h3>
<p style="text-align: left;"><a href="http://www.ncbi.nlm.nih.gov/pubmed/2775637" target="_blank">Welling RS, Ramadas HS, Gansmuller KJ. Cervical wound hematoma after carotid endarterectomy. Ann Vasc Surg 1989; 3:229-31. </a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/10733850" target="_blank">Gunel M, Awad IA. Carotid endarterectomy prevention strategies and complications management. Neurosurg Clin N Am 2000; 11 (2):351-64.</a></p>
<p style="text-align: left;">QID: 30354</p></div><div class="rightanswer">The correct answer is: exploration in the operating room</div></div></div></div></div><div id="q501" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">223</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2171"><input type="hidden" name="q20803:501_:flagged" value="0"><input type="hidden" value="qaid=911385&amp;qubaid=20803&amp;qid=5213&amp;slot=501&amp;checksum=3e29c77e1a768e2cde153443a1db9af3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:501_:flaggedcheckbox" name="q20803:501_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q501&id=5213"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:501_:sequencecheck" value="2"><div class="qtext"><p>To further evaluate a carotid stenosis prior to possible endarterectomy, a 58-year-old diabetic with serum creatinine of 3.4 mg/dl is evaluated with contrast-enhanced MR angiogram. Medical, rather than surgical management, is elected and the patient is treated with antiplatelet therapy and a statin. When he is seen 4 weeks later, he complains of new, painful, itchy rashes, joint stiffness, and muscle weakness. Examination demonstrates erythematous, symmetrical, bilateral fibrotic indurated papules and subcutaneous nodules on the legs and forearms.&nbsp;Which of the following tests is most likely to confirm the suspected diagnosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:501_answer" disabled="disabled" value="0" id="q20803:501_answer0"><label for="q20803:501_answer0">a. serum C-reactive protein level</label> </div>
<div class="r1"><input type="radio" name="q20803:501_answer" disabled="disabled" value="1" id="q20803:501_answer1"><label for="q20803:501_answer1">b. deep incisional or punch biopsy of skin</label> </div>
<div class="r0"><input type="radio" name="q20803:501_answer" disabled="disabled" value="2" id="q20803:501_answer2"><label for="q20803:501_answer2">c. serum ionized calcium level</label> </div>
<div class="r1"><input type="radio" name="q20803:501_answer" disabled="disabled" value="3" id="q20803:501_answer3"><label for="q20803:501_answer3">d. radiographs to evaluate for vascular calcification</label> </div>
<div class="r0"><input type="radio" name="q20803:501_answer" disabled="disabled" value="4" id="q20803:501_answer4"><label for="q20803:501_answer4">e. parathyroid hormone level</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:501_-submit" name="q20803:501_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The diagnosis of nephrogenic systemic fibrosis (NSF) should be suspected in a patient with renal disease who has had gadolinium administration.</p>
<p>Nephrogenic systemic fibrosis is seen only in patients with severe kidney disease, most frequently in patients with dialysis-dependent renal failure, but also in patients with renal insufficiency or functioning kidney transplants. It is characterized by thickening and hardening of the skin with dermal fibrosis. The disorder was initially called nephrogenic fibrosing dermopathy (NFD) because of these characteristic skin findings, but the term nephrogenic systemic fibrosis is preferred because the fibrosis often affects muscle, fascia, the lungs, and heart. NSF has a chronic and unremitting course and it can be fatal.</p>
<p>NSF usually manifests between 2 to 4 weeks of exposure to gadolium containing contrast agents that are used in MR angiopgraphy. The agents that are most likely to release free gadolinium ions Gd(III) are thought to be those with the highest risk for causing NSF; these are the non-ionic agents with linear structure: gadodiamide (Omniscan®) and gadoversetamide (OptiMARK®).</p>
<p>A deep skin biopsy is most likely to be diagnostic. Dermal fibrotic lesions may extend into the subcutaneous tissue. The dermis may be thickened with a proliferation of fibrocytes with long dendritic processes. Thick collagen bundles with surrounding clefts may be prominent and there can be a variable increase in dermal mucin and elastic fibers evident with special stains. Immunohistochemical staining typically shows CD34+ dermal dendritic cells.</p>
<p>There may be subcutaneous calcification, especially later in the course of the disease, but this is not a sensitive or specific finding. Inflammatory markers may be elevated, but again, this is not a specific finding.</p>
<p>NSF is not a disorder of calcium metabolism.&nbsp;The major preventive measure to avoid nephrogenic systemic fibrosis is to avoid use of gadolinium in patients on dialysis or with a creatinine clearance (GFR) less than &lt;30 mL/min per 1.73m.<sup><br></sup></p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=AJR+Am+J+Roentgenol.+2012%3B+199(1)%3AW17-23." target="_blank">Kaewlai R, Abujudeh H. Nephrogenic systemic fibrosis. AJR Am J Roentgenol 2012; 199(1):W17-23.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JACC+Cardiovasc+Imaging+2011%3B+4(11)%3A1206-16." target="_blank">Zou Z, Zhang HL, Roditi GH, Leiner T, Kucharczyk W, Prince MR. Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging 2011; 4(11):1206-16.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Nephrol.+2011+May%3B31(3)%3A310-6." target="_blank">Hellman RN. Gadolinium-induced nephrogenic systemic fibrosis. Semin Nephrol 2011; 31(3):310-6.</a></p>
<p>QID: 30869</p></div><div class="rightanswer">The correct answer is: deep incisional or punch biopsy of skin</div></div></div></div></div><div id="q124" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">224</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2180"><input type="hidden" name="q20803:124_:flagged" value="0"><input type="hidden" value="qaid=911008&amp;qubaid=20803&amp;qid=4741&amp;slot=124&amp;checksum=06c4d1fb8a6b115e645ada2ee43c3635&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:124_:flaggedcheckbox" name="q20803:124_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q124&id=4741"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:124_:sequencecheck" value="2"><div class="qtext"><p>Following cardiac catheterization via the radial artery a&nbsp;patient develops paresthesia and coolness of the hand.&nbsp;&nbsp;Vascular&nbsp;studies&nbsp;show that the distal radial artery is occluded. The ulnar artery is patent and finger pressures are normal. Which of the following statements regarding access via the radial artery&nbsp;is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:124_answer" disabled="disabled" value="0" id="q20803:124_answer0"><label for="q20803:124_answer0">a. short-term anticoagulation may increase the likelihood of arterial recanalization following radial artery thrombosis</label> </div>
<div class="r1"><input type="radio" name="q20803:124_answer" disabled="disabled" value="1" id="q20803:124_answer1"><label for="q20803:124_answer1">b. radial artery thrombosis resulting from catheterization often requires treatment using an open revascularization procedure</label> </div>
<div class="r0"><input type="radio" name="q20803:124_answer" disabled="disabled" value="2" id="q20803:124_answer2"><label for="q20803:124_answer2">c. arterial occlusion occurs in 75% of patients who undergo cardiac catheterization via the radial artery</label> </div>
<div class="r1"><input type="radio" name="q20803:124_answer" disabled="disabled" value="3" id="q20803:124_answer3"><label for="q20803:124_answer3">d. the risk of arterial thrombosis following radial artery catheterization is not related to sheath size</label> </div>
<div class="r0"><input type="radio" name="q20803:124_answer" disabled="disabled" value="4" id="q20803:124_answer4"><label for="q20803:124_answer4">e. it is not necessary to perform an Allen's test prior to attempting radial artery access</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:124_-submit" name="q20803:124_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The radial artery is increasingly&nbsp;being used as a vascular access for coronary intervention. Radial artery thrombosis occurs in 5-10% of cases and radial artery stenosis occurs in 25% of cases. The risk of arterial thrombosis is&nbsp;increased with larger&nbsp;sheath size. An Allen's test is recommended prior to transradial access to determine the risk of digital ischemia if occlusion occurs. Most radial artery stenoses related to catheterization resolve with time. Patients with radial artery thrombosis who are treated with 4 weeks of anticoagulation are more likely to have arterial recanalization, compared to those patients treated expectantly. Open surgical revascularization of a thrombosed radial artery is rarely necessary.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circ+Cardiovasc+Interv+2012%3B+5%3A127-133." target="_blank">Kotowycz MA, Dzavik V. Radial artery patency after transradial catheterization. Circ Cardiovasc Interv 2012; 5:127-33.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+Res+Cardiol+2010%3B+99%3A841-7." target="_blank">Zankl AR, Andrassy M, Volz C, Ivandic B<span>,&nbsp;</span>Krumsdorf U<span>,&nbsp;</span>Katus HA,&nbsp;et al. Radial artery thrombosis following transradial coronary angiography: incidence and rationale for treatment of symptomatic patients with low-molecular-weight heparins. Clin Res Cardiol 2010; 99:841-7.</a></p>
<p>QID: 30217</p></div><div class="rightanswer">The correct answer is: short-term anticoagulation may increase the likelihood of arterial recanalization following radial artery thrombosis</div></div></div></div></div><div id="q301" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">225</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2189"><input type="hidden" name="q20803:301_:flagged" value="0"><input type="hidden" value="qaid=911185&amp;qubaid=20803&amp;qid=5059&amp;slot=301&amp;checksum=b91363e0b0bbae1c759af4e57a8149d5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:301_:flaggedcheckbox" name="q20803:301_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q301&id=5059"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:301_:sequencecheck" value="2"><div class="qtext"><p>Complete this sentence: The depth of view (penetration) using intravascular ultrasound (IVUS) is...</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:301_answer" disabled="disabled" value="0" id="q20803:301_answer0"><label for="q20803:301_answer0">a. best using 30 MHz catheters</label> </div>
<div class="r1"><input type="radio" name="q20803:301_answer" disabled="disabled" value="1" id="q20803:301_answer1"><label for="q20803:301_answer1">b. dependent on the gain settings of the machine</label> </div>
<div class="r0"><input type="radio" name="q20803:301_answer" disabled="disabled" value="2" id="q20803:301_answer2"><label for="q20803:301_answer2">c. lower with a larger French size catheter</label> </div>
<div class="r1"><input type="radio" name="q20803:301_answer" disabled="disabled" value="3" id="q20803:301_answer3"><label for="q20803:301_answer3">d. enhanced by injecting saline into the vessel</label> </div>
<div class="r0"><input type="radio" name="q20803:301_answer" disabled="disabled" value="4" id="q20803:301_answer4"><label for="q20803:301_answer4">e. inversely proportional to the ultrasound frequency</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:301_-submit" name="q20803:301_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The depth of view (or size of the field of view) using intravascular ultrasound is inversely proportional to the ultrasound frequency. The higher the frequency, the smaller the depth of view or depth of penetration. Thus, a high-frequency 30 MHz IVUS probe is typical for small vessel (eg, coronary) use. To get adequate depth of penetration to see the periphery of an aortic aneurysm, a low frequency probe (eg, 8 MHz) would be used. In general, larger French size catheters have a lower frequency and therefore greater depth of field, but there is not a one-to-one correlation. Injection of contrast-enhancing agents may improve the image, but will not alter depth of view. Gain settings have nothing to do with depth of ultrasound penetration. <br><br></p>
<h2>References:</h2>
<p>Vogt KC, Schroeder TV. Intravascular ultrasound. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:371-81.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Lee%20JT,%20White%20RA.%20Basics%20of%20intravascular%20ultrasound:%20An%20essential%20tool%20for%20the%20endovascular%20surgeon.%20Semin%20Vasc%20Surg;%202004;%2017%20(2):110-118" target="_blank">Lee JT, White RA. Basics of intravascular ultrasound: An essential tool for the endovascular surgeon. Semin Vasc Surg 2004; 17 (2):110-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Murphy%20EH,%20Broker%20HS,%20Johnson%20EJ,%20et%20al.%20Device%20and%20imaging-specific%20volumetric%20analysis%20of%20clot%20lysis%20after%20percutaneous%20mechanical%20thrombectomy%20for%20iliofemoral%20DVT.%20J%20Endovasc%20Ther;%202010;%2017%20(3):423-433" target="_blank">Murphy EH, Broker HS, Johnson EJ, Modrall JG<span>,&nbsp;</span>Valentine RJ<span>,&nbsp;</span>Arko FR 3rd. Device and imaging-specific volumetric analysis of clot lysis after percutaneous mechanical thrombectomy for iliofemoral DVT. J Endovasc There 2010; 17 (3):423-3.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Ultrasound+1998%3B+7+(3)%3A159-65.">Vogt KC, Jensen F, Schroeder TV. Does Doppler signal enhancement with Levovist improve the diagnostic confidence of duplex scanning of the iliac arteries? A pilot study with correlation to intravascular ultrasound. Eur J Ultrasound 1998; 7 (3):159-65.</a></p>
<p>QID: 30521</p></div><div class="rightanswer">The correct answer is: inversely proportional to the ultrasound frequency</div></div></div></div></div><div id="q537" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">226</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2198"><input type="hidden" name="q20803:537_:flagged" value="0"><input type="hidden" value="qaid=911421&amp;qubaid=20803&amp;qid=5274&amp;slot=537&amp;checksum=55e050898ad6bc63b498fb63dc9c1e5a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:537_:flaggedcheckbox" name="q20803:537_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q537&id=5274"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:537_:sequencecheck" value="2"><div class="qtext"><p>The dose of radiation delivered to the operator consists primarily of leakage radiation and radiation scatter. This radiation exposure level changes as a function of distance away from the x-ray source (r). The relationship between radiation dose to the operator and r is which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:537_answer" disabled="disabled" value="0" id="q20803:537_answer0"><label for="q20803:537_answer0">a. &nbsp;1/r<sup>2</sup></label> </div>
<div class="r1"><input type="radio" name="q20803:537_answer" disabled="disabled" value="1" id="q20803:537_answer1"><label for="q20803:537_answer1">b. r<sup>4</sup></label> </div>
<div class="r0"><input type="radio" name="q20803:537_answer" disabled="disabled" value="2" id="q20803:537_answer2"><label for="q20803:537_answer2">c. r<sup>2</sup></label> </div>
<div class="r1"><input type="radio" name="q20803:537_answer" disabled="disabled" value="3" id="q20803:537_answer3"><label for="q20803:537_answer3">d. 1/r</label> </div>
<div class="r0"><input type="radio" name="q20803:537_answer" disabled="disabled" value="4" id="q20803:537_answer4"><label for="q20803:537_answer4">e. r<sup>2</sup></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:537_-submit" name="q20803:537_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The operator is exposed to secondary radiation in fluoroscopy which consists primarily of leakage radiation from the x-ray tube and scattered radiation emitted from the patient in the primary beam. The leakage radiation is usually low, in the range of 0.001 to 0.01 mGy/hour at 1 meter from the x-ray tube source. Scattered radiation levels during fluoroscopic imaging are higher, with air kerma rates adjacent to the patient in the range of 1 to 10 mGy/hour.</p>
<p>The combination of leakage and scatter radiation delivered to the operator is considered secondary radiation, which exponentially decreases with increasing distance from the radiation source &nbsp;following the inverse square law.&nbsp; The air kerma rate (kinetic energy released in the medium) decreases in proportion to the inverse of the distance from the x-ray source squared. &nbsp;For example, when the operator doubles the distance away from the x-ray source, the air kerma rate is decreased by a factor of four. &nbsp;Fluoroscopic operators can significantly reduce their exposure by moving away from the source.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>NCRP. "Radiation Dose Management for Fluoroscopically Guided Interventional Medical Procedures," Report No. 168 (National Council on Radiation Protection and Measurements, Bethesda, Md, 2010). Report No. 168.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiat+Prot+Dosimetry+2001%3B+94(1-2)%3A183-8." target="_blank">Balter, S. Stray Radiation in the Cardiac Catheterisation Laboratory.&nbsp;Radiat Prot Dosimetry&nbsp;2001; 94(1-2):183-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+1998%3B+4%3A+892-913." target="_blank">Limacher MC, Douglas PS, Germano G, Laskey WK, Lindsay BD, McKetty MH, et al. Acc Expert Consensus Document. Radiation Safety in the Practice of Cardiology. American College of Cardiology." J Am Coll Cardiol&nbsp;1998; 4: 892-913.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics+2006%3B+26(5)%3A1533-41." target="_blank">Schueler BA, Vrieze TJ, Bjarnason H, Stanson AW. An Investigation of Operator Exposure in Interventional Radiology.&nbsp;Radiographics&nbsp;2006; 26(5):1533-41.</a></p>
<p>QID: 30942</p></div><div class="rightanswer">The correct answer is: &nbsp;1/r<sup>2</sup></div></div></div></div></div><div id="q375" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">227</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2207"><input type="hidden" name="q20803:375_:flagged" value="0"><input type="hidden" value="qaid=911259&amp;qubaid=20803&amp;qid=5109&amp;slot=375&amp;checksum=d4ab5617e4e316fcf566bd408bde6043&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:375_:flaggedcheckbox" name="q20803:375_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q375&id=5109"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:375_:sequencecheck" value="2"><div class="qtext"><p>A&nbsp;38-year-old man with a history of a renal transplant several years ago is referred with worsening hypertension and hematuria 2 days after a percutaneous renal transplant biopsy performed with a 14 gauge needle. An arteriogram&nbsp;shows a renal arteriovenous fistula within the transplanted kidney (image shown below). Which of the following represents the most appropriate management of this problem?</p>
<p><img src="./VESAP3_files/Rectenwald-3.jpg" alt="" width="473" height="420"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:375_answer" disabled="disabled" value="0" id="q20803:375_answer0"><label for="q20803:375_answer0">a. transplant nephrectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:375_answer" disabled="disabled" value="1" id="q20803:375_answer1"><label for="q20803:375_answer1">b. coil embolization of the involved segmental renal artery</label> </div>
<div class="r0"><input type="radio" name="q20803:375_answer" disabled="disabled" value="2" id="q20803:375_answer2"><label for="q20803:375_answer2">c. close observation with repeat duplex in 3 months</label> </div>
<div class="r1"><input type="radio" name="q20803:375_answer" disabled="disabled" value="3" id="q20803:375_answer3"><label for="q20803:375_answer3">d. embolization of the involved segmental outflow vein with N-butyle-2-cyanoacrylate</label> </div>
<div class="r0"><input type="radio" name="q20803:375_answer" disabled="disabled" value="4" id="q20803:375_answer4"><label for="q20803:375_answer4">e. ultrasound-guided percutaneous thrombin injection</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:375_-submit" name="q20803:375_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Renal arteriovenous fistulae (AVF) are classified as congenital and acquired. Congenital AVF are rare with an incidence of 0.04% and represent only 20-25% of all renal AVFs. Acquired renal AVFs may occur spontaneously and may be associated with fibromuscular dysplasia, renal artery aneurysms, renal malignancies (such as renal cell carcinoma), or secondary to trauma, such as a percutaneous kidney biopsy.&nbsp;With the routine use of needle biopsy for the diagnosis of rejection in transplanted kidneys, the incidence of acquired AVF has increased.&nbsp;Approximately 1-2% of patients who have renal biopsies develop symptomatic AVFs.&nbsp;The majority of both congenital and acquired AVFs do not cause symptoms and do not require treatment.&nbsp;This is particularly the case with AVFs discovered early&nbsp;after renal artery biopsy.&nbsp;If a post-biopsy AVF persists after 1 year, it is not likely to close spontaneously.&nbsp;Treatment, however, should be delayed until the development of symptoms. Treatment of renal AVMs is generally endovascular.&nbsp;Injection of absolute alcohol&nbsp;is the most accepted endovascular treatment for small AVFs, while large AVFs can be managed with coil embolization. Partial or complete nephrectomy may be required for large, symptomatic AVFs not responsive to endovascular treatment.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>Calligaro KD, Dougherty MJ.&nbsp; Renovascular Disease: Aneurysms and Arteriovenous Fistulae.&nbsp; Chapter 145 in Rutherford’s Vascular Surgery. 7<sup>th</sup> Edition.&nbsp; Eds: Cronenwett and Johnston.&nbsp; Saunder Elsevier, Philadelphia, PA. 2010.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sem+Intervent+Radiol+2009%3B+26(3)%3A253-61." target="_blank">Chimpiri AR, Natarajan B. Renal Vascular Lesions: Diagnosis and Endovascular Management.&nbsp; Sem Intervent Radiol 2009; 26(3):253-61.</a></p>
<p>QID: 30660</p></div><div class="rightanswer">The correct answer is: close observation with repeat duplex in 3 months</div></div></div></div></div><div id="q482" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">228</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2216"><input type="hidden" name="q20803:482_:flagged" value="0"><input type="hidden" value="qaid=911366&amp;qubaid=20803&amp;qid=5208&amp;slot=482&amp;checksum=9c40a37479d30caad712ab5fa37bc93f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:482_:flaggedcheckbox" name="q20803:482_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q482&id=5208"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:482_:sequencecheck" value="2"><div class="qtext"><p>Monotherapy with with which of the following agents would be expected to have the greatest effect lowering elevated serum triglyceride levels?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:482_answer" disabled="disabled" value="0" id="q20803:482_answer0"><label for="q20803:482_answer0">a. bile acid resins</label> </div>
<div class="r1"><input type="radio" name="q20803:482_answer" disabled="disabled" value="1" id="q20803:482_answer1"><label for="q20803:482_answer1">b. ezetimibe</label> </div>
<div class="r0"><input type="radio" name="q20803:482_answer" disabled="disabled" value="2" id="q20803:482_answer2"><label for="q20803:482_answer2">c. extended-release niacin</label> </div>
<div class="r1"><input type="radio" name="q20803:482_answer" disabled="disabled" value="3" id="q20803:482_answer3"><label for="q20803:482_answer3">d. statins</label> </div>
<div class="r0"><input type="radio" name="q20803:482_answer" disabled="disabled" value="4" id="q20803:482_answer4"><label for="q20803:482_answer4">e. fibrates</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:482_-submit" name="q20803:482_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Fibrates are associated with the greatest reduction in triglycerides. This is followed by niacin, omega 3 fatty acids, statins, and ezetimibe. Triglyceride levels are increased by bile acid resins. The Helsinki heart study, Bezafibrate Infarction Prevention study, and the Fenofibrate Intervention and Event Lowering in Diabetes study demonstrated particularly benefit of fibrates in high cardiovascular risk subgroups that had increased triglyceride levels, especially at levels over 240 mg/dL.&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2011%3B+123(20)%3A2292-333." target="_blank">Miller M, Stone NJ, Ballantyne C, Bittner V, Criqui MH, Ginsberg HN, et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 2011; 123(20):2292-333.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/10880410" target="_blank">The BIP Study Group. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: the Bezafibrate Infarction Prevention (BIP) study. Circulation 2000; 102: 21-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Intern+Med+2005%3B+165%3A1154-60." target="_blank">Tenenbaum A, Motro M, Fisman EZ, Tanne D, Boyko V, Behar S. Bezafibrate for the secondary prevention of myocardial infarction in patients with metabolic syndrome. Arch Intern Med 2005; 165:1154-60.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet.+2005%3B+366%3A+1849-61." target="_blank">Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet. 2005; 366: 1849-61.&nbsp;Erratum in&nbsp;<span class="highlight" style="line-height: 1.5;">Lancet</span><span class="highlight" style="line-height: 1.5;">. 2006 Oct 21;368(9545):1415.&nbsp;</span><span class="highlight" style="line-height: 1.5;">Lancet</span><span class="highlight" style="line-height: 1.5;">. 2006 Oct 21;368(9545):1420.</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+1999%3B+341%3A410-8." target="_blank">Rubins HB, Robins SJ, Collins D, Fye CL, Anderson JW, Elam MB, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group.&nbsp;N Engl J Med 1999; 341:410-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2001%3B+285%3A+1585-91." target="_blank">Robins SJ, Collins D, Wittes JT, Papademetriou V, Deedwania PC, Schaefer EJ, et al. Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial. JAMA 2001; 285: 1585-91.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+2010%3B+362%3A+1563-1574." target="_blank">Ginsberg HN, Elam MB, Lovato LC, Crouse JR 3rd., Leiter LA, Linz P, et al. Effects of combination lipid therapy in type 2 diabetes mellitus [published correction appears in N Engl J Med. 2010;362:1748.</a>&nbsp;</p>
<p>QID: 30847</p></div><div class="rightanswer">The correct answer is: fibrates</div></div></div></div></div><div id="q309" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">229</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2225"><input type="hidden" name="q20803:309_:flagged" value="0"><input type="hidden" value="qaid=911193&amp;qubaid=20803&amp;qid=5070&amp;slot=309&amp;checksum=34a517c9cea59ea57ad095980a84c37c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:309_:flaggedcheckbox" name="q20803:309_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q309&id=5070"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:309_:sequencecheck" value="2"><div class="qtext"><p>A 51-year-old man with longstanding claudication presents with an open ulcer on his heel and dry gangrene of his great toe. Ankle-brachial indices reveal a ratio of 0.6 in his affected extremity, ankle pressure of 40 mmHg, a toe pressure of 25 mmHg, a transcutaneous oxygen pressure measurement of 25 mmHg, and a monophasic Doppler waveform. Which of these measurements is the strongest predictor of failure to heal this patient’s wounds?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:309_answer" disabled="disabled" value="0" id="q20803:309_answer0"><label for="q20803:309_answer0">a. ankle pressure</label> </div>
<div class="r1"><input type="radio" name="q20803:309_answer" disabled="disabled" value="1" id="q20803:309_answer1"><label for="q20803:309_answer1">b. TcPO2</label> </div>
<div class="r0"><input type="radio" name="q20803:309_answer" disabled="disabled" value="2" id="q20803:309_answer2"><label for="q20803:309_answer2">c. toe pressure</label> </div>
<div class="r1"><input type="radio" name="q20803:309_answer" disabled="disabled" value="3" id="q20803:309_answer3"><label for="q20803:309_answer3">d. doppler waveform</label> </div>
<div class="r0"><input type="radio" name="q20803:309_answer" disabled="disabled" value="4" id="q20803:309_answer4"><label for="q20803:309_answer4">e. ABI</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:309_-submit" name="q20803:309_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p class="BasicParagraph">Non-invasive vascular testing remains one of the most important parts of assessing patients with a chronic ulcer of the lower extremities. These tests can identify which components of the vascular tree are involved, what the pathologic process may be, and what level is involved. Different aspects of venous disease are primarily diagnosed by duplex ultrasound imaging. Acute and chronic deep venous thrombosis or abnormal venous wall pathology is diagnosed by the use of duplex ultrasound. Additionally, venous valve reflux can be performed by using duplex ultrasound and measuring venous valve closure times. All patients should undergo ankle and toe blood pressures to assess for arterial insufficiency as the primary cause or a contributing factor to a non-healing leg ulcer. Further adjunctive testing for arterial insufficiency may include trancutaneous oxygen measurement, pulse volume recordings, and Doppler waveform studies. These tests may be helpful if patients have heavily calcified tibial arteries or those with toe amputations.</p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left"><span style="text-decoration: underline;">Ankle Brachial Index</span></p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">≥ 0.9 to 1.3</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">normal range</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">≥ 0.6 to 0.8</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">borderline perfusion</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">≤ 0.5</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">severe ischemia</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">Ankle pressure ≤ 40 mmHg</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">critical limb ischemia</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">Toe pressure ≤ 30 mmHg</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">critical limb ischemia</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left"><span style="text-decoration: underline;">Trancutaneous Oxygen Pressure Measurement TcPO<sub>2</sub></span></p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">&gt; 40 mmHg</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">sufficient to support ulcer healing</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">20 – 40 mmHg</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">equivocal wound ulcer healing</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">&lt; 20 mmHg</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">inability to support ulcer healing</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left"><span style="text-decoration: underline;">Pulse Volume Recordings or Doppler Waveforms</span></p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">Triphasic</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">normal</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">Biphasic</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">mild to moderate arterial obstruction</p>
</td>
</tr>
<tr>
<td valign="top">
<p class="BasicParagraph" align="left">Monophasic</p>
</td>
<td valign="top">
<p class="BasicParagraph" align="left">severe arterial obstruction</p>
</td>
</tr>
</tbody>
</table>
<p>Content adapted from the Clinical Review of Phlebology and Venous Ultrasound, Eds Eric Mowatt-Larssen, MD, Sapan S. Desai, MD, PhD, MBA, and Cynthia Shortell, MD. “Venous Leg Ulcers” by Robert McLafferty, MD. Copyright 2013 Surgisphere Corporation. Content and table used with permission.</p>
<h2>References:</h2>
<p class="References"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1989%3B10%3A425-31." target="_blank">Van Bemmelen PS, Bedford G, Beach K, Strandness DE. Qualitative segmental evaluation of venous valvular reflux with duplex ultrasound scanning. J Vasc Surg 1989;10:425-31.</a></p>
<p class="BasicParagraph"><a href="http://www.ncbi.nlm.nih.gov/pubmed/12585831" target="_blank">de Araujo T, Valencia I, Federman DG, Kirsner RS. Managing the patient with venous ulcers. Ann Intern Med 2003;138:326-34.</a></p>
<p class="BasicParagraph">QID: 30532</p></div><div class="rightanswer">The correct answer is: TcPO2</div></div></div></div></div><div id="q3" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">230</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2234"><input type="hidden" name="q20803:3_:flagged" value="0"><input type="hidden" value="qaid=910887&amp;qubaid=20803&amp;qid=4612&amp;slot=3&amp;checksum=cdd0e35048323e85984ce8880cd45670&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:3_:flaggedcheckbox" name="q20803:3_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q3&id=4612"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:3_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old otherwise healthy man has a 5.5 cm abdominal aortic aneurysm (AAA). &nbsp;Which of the following anatomical factors would lead one to recommend open repair&nbsp;in place&nbsp;of&nbsp;endovascular repair?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:3_answer" disabled="disabled" value="0" id="q20803:3_answer0"><label for="q20803:3_answer0">a. an aortic bifurcation diameter of 25 mm</label> </div>
<div class="r1"><input type="radio" name="q20803:3_answer" disabled="disabled" value="1" id="q20803:3_answer1"><label for="q20803:3_answer1">b. unilateral internal iliac artery occlusion</label> </div>
<div class="r0"><input type="radio" name="q20803:3_answer" disabled="disabled" value="2" id="q20803:3_answer2"><label for="q20803:3_answer2">c. a length of 60 mm between the lowest renal artery and aortic bifurcation</label> </div>
<div class="r1"><input type="radio" name="q20803:3_answer" disabled="disabled" value="3" id="q20803:3_answer3"><label for="q20803:3_answer3">d. a 15 mm long proximal aortic neck</label> </div>
<div class="r0"><input type="radio" name="q20803:3_answer" disabled="disabled" value="4" id="q20803:3_answer4"><label for="q20803:3_answer4">e. bilateral ectatic common iliac arteries 17 mm in diameter</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:3_-submit" name="q20803:3_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Developing a&nbsp;treatment plan for a patient with an abdominal aneurysm is a complex process that must include the consideration of a number of factors. These factors include anatomical (eg aortic diameter, suitability of access vessels, neck angulation, calcification, and thrombus), physiological (eg age and&nbsp;cardiopulmonary risk), technical (eg surgeon training, skill, and experience), and emotional issues (patient preferences). The long-term performance of endovascular aneurysm repair is&nbsp;clearly related to the anatomic suitability of the native aorta and iliac arteries.&nbsp;When EVAR is limited to the anatomic constraints of the Instructions For Use (IFU) the performance appears to be superior&nbsp;to the&nbsp;situations where we "push the limits" of the devices.&nbsp;</p>
<p>This&nbsp;patient is a healthy, relatively young&nbsp;man who can likely tolerate open repair of his aneurysm. With all presently available&nbsp;bifurcated aortic endografts, a short distance between the renal arteries and the aortic bifurcation will either result in limb jailing (deployment of the contralateral gate in the ipsilateral common iliac artery) or renal artery coverage. The typical minimum distance between the top of the main body and bottom of the contralateral gate is 70 mm; at least 10 mm of additional distance should be available to allow for measurement errors, inadvertent low deployment, and guidewire manipulation to access the gate junction. Although an aorto-uni-iliac endovascular repair is possible, this is not ideal in a young, healthy patient. It is particularly not ideal in runners, as femoro-femoral bypass grafting would be required. A patient's age, in of itself, may be an indication for open repair, but&nbsp;it is certainly so in this situation where the patient's anatomy would compromise the endovascular aneurysm repair. None of the other choices contraindicate endovascular repair.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Yilmaz%20LP%2C%20Abraham%20CZ%2C%20Reilly%20LM%2C%20et%20al.%20Is%20cross-femoral%20bypass%20grafting%20a%20disadvantage%20of%20aortomonoiliac%20endovascular%20aortic%20aneurysm%20repair%3F.%20J%20Vasc%20Surg%3B%202003%3B%2038%20%284%29%3A753-757" target="_blank">Yilmaz LP, Abraham CZ, Reilly LM, Gordon RL, Schneider DB, Messina LM, et al. Is cross-femoral bypass grafting a disadvantage of aortomonoiliac endovascular aortic aneurysm repair? J Vasc Surg 2003; 38 (4):753-7.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Sheehan%20MK%2C%20Marone%20L%2C%20Makaroun%20MS.%20Use%20of%20endoluminal%20aortic%20stent-grafts%20for%20the%20repair%20of%20abdominal%20aortic%20aneurysms.%20Perspect%20Vasc%20Surg%20Endovasc%20Ther%3B%202005%3B%2017%20%284%29%3A289-296" target="_blank">Sheehan MK, Marone L, Makaroun MS. Use of endoluminal aortic stent-grafts for the repair of abdominal aortic aneurysms. Perspect Vasc Surg Endovasc Ther 2005; 17 (4):289-96.</a></p>
<p>&nbsp;</p>
<p>QID: 30003</p></div><div class="rightanswer">The correct answer is: a length of 60 mm between the lowest renal artery and aortic bifurcation</div></div></div></div></div><div id="q368" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">231</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2243"><input type="hidden" name="q20803:368_:flagged" value="0"><input type="hidden" value="qaid=911252&amp;qubaid=20803&amp;qid=5118&amp;slot=368&amp;checksum=0f00ba91b3ec6604fdbc7d68a6bdada3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:368_:flaggedcheckbox" name="q20803:368_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q368&id=5118"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:368_:sequencecheck" value="2"><div class="qtext"><p><span>A 43-year-old mildly obese woman has chronic abdominal pain.&nbsp;She has undergone appendectomy and cholecystectomy without relief. She has been evaluated by multiple gastroenterologists. She is referred for evaluation of median arcuate ligament compression of the celiac artery. A duplex ultrasound is ordered. During inspiration, what changes are expected in the celiac artery in a patient with celiac compression?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:368_answer" disabled="disabled" value="0" id="q20803:368_answer0"><label for="q20803:368_answer0">a. <span>decrease in the severity of the SMA stenosis</span></label> </div>
<div class="r1"><input type="radio" name="q20803:368_answer" disabled="disabled" value="1" id="q20803:368_answer1"><label for="q20803:368_answer1">b. <span>increase in the severity of the SMA stenosis</span></label> </div>
<div class="r0"><input type="radio" name="q20803:368_answer" disabled="disabled" value="2" id="q20803:368_answer2"><label for="q20803:368_answer2">c. <span>no change in severity of the celiac artery stenosis</span></label> </div>
<div class="r1"><input type="radio" name="q20803:368_answer" disabled="disabled" value="3" id="q20803:368_answer3"><label for="q20803:368_answer3">d. <span>decrease in severity of the celiac artery stenosis</span></label> </div>
<div class="r0"><input type="radio" name="q20803:368_answer" disabled="disabled" value="4" id="q20803:368_answer4"><label for="q20803:368_answer4">e. <span>increase in severity of the celiac artery stenosis</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:368_-submit" name="q20803:368_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Median arcuate ligament syndrome&nbsp;(MALS) is caused by extrinsic compression of the celiac axis that is worse with expiration. The syndrome is controversial because many asymptomatic patients demonstrate anatomic compression of the celiac trunk with respiration. On duplex ultrasound, the peak systolic velocity is usually normal on inspiration (Fig. 1) and elevated abnormally on expiration in MALS (Fig. 2). When other causes of abdominal pain and mesenteric ischemia are excluded, angiographic and/or CTA confirmation is obtained by showing stenosis of the celiac&nbsp;origin and post-stenotic dilatation. The pain is thought to be secondary to compression of the artery and celiac ganglia. There also appears to be a significant supratentorial component in some patients. Treatment consists of decompression by dividing the median arcuate ligament, performed either with an open or laparoscopic technique. Complete and durable relief of symptoms is elusive.</p>
<p>Figure 1.</p>
<p><img src="./VESAP3_files/Kashyap-5 (Figure 1 for Discussion).jpg" alt="" width="679" height="509"></p>
<p>Figure 2.&nbsp;</p>
<p><img src="./VESAP3_files/Kashyap-5 (Figure 2 for Discussion).jpg" alt="" width="682" height="511"></p>
<p>&nbsp;</p>
<h2><span class="reference-text" data-mce-mark="1">References:</span></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Curr+Treat+Options+Cardiovasc+Med++2008%3B+10(2)%3A112%E2%80%936." target="_blank">Duncan AA.&nbsp;Median arcuate ligament syndrome.&nbsp;Curr Treat Options Cardiovasc Med 2008; 10(2):112–6.</a></p>
<p>QID: 30650</p></div><div class="rightanswer">The correct answer is: <span>decrease in severity of the celiac artery stenosis</span></div></div></div></div></div><div id="q41" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">232</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2252"><input type="hidden" name="q20803:41_:flagged" value="0"><input type="hidden" value="qaid=910925&amp;qubaid=20803&amp;qid=4652&amp;slot=41&amp;checksum=3723c600dde91513eb49161b61a7c185&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:41_:flaggedcheckbox" name="q20803:41_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q41&id=4652"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:41_:sequencecheck" value="2"><div class="qtext"><p>An 82-year-old man is admitted to the emergency center with chest pain. On exam, the patient is in mild distress. His blood pressure is 156/92, heart rate 84, respiratory rate 18, and temperature 98.6. On exam, his heart has a regular rhythm, lungs have bibasilar rales, and the abdomen is soft and non-tender. Bilateral upper and lower extremity pulses are palpable. An EKG shows right bundle branch block. Cardiac enzymes are negative. A CXR shows an enlarged aortic shadow with bilateral pleural effusions. The CTA obtained is show below. Which of the following is the best treatment option for this patient?</p>
<p><a href="./VESAP3_files/4(2).jpg" target="images"><img src="./VESAP3_files/4(2).jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:41_answer" disabled="disabled" value="0" id="q20803:41_answer0"><label for="q20803:41_answer0">a. open repair of the descending thoracic aorta</label> </div>
<div class="r1"><input type="radio" name="q20803:41_answer" disabled="disabled" value="1" id="q20803:41_answer1"><label for="q20803:41_answer1">b. bilateral tube thoracostomy</label> </div>
<div class="r0"><input type="radio" name="q20803:41_answer" disabled="disabled" value="2" id="q20803:41_answer2"><label for="q20803:41_answer2">c. thoracic endovascular aortic repair (TEVAR)</label> </div>
<div class="r1"><input type="radio" name="q20803:41_answer" disabled="disabled" value="3" id="q20803:41_answer3"><label for="q20803:41_answer3">d. open repair of the ascending aorta</label> </div>
<div class="r0"><input type="radio" name="q20803:41_answer" disabled="disabled" value="4" id="q20803:41_answer4"><label for="q20803:41_answer4">e. anti-impulse therapy with esmolol</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:41_-submit" name="q20803:41_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This man presented with a ruptured penetrating aortic ulcer. The best course of treatment for this patient is thoracic endovascular aortic repair (TEVAR). The halo visualized around the ascending aortic aorta is a motion artifact. Endovascular treatment is preferred to open repair in this setting and is associated with reduced perioperative morbidity and mortality. Anti-impulse therapy and bilateral tube thoracostomy are unlikely to alter the clinical course of this presentation.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Xenos+ES%2C+Minion+DJ%2C+Davenport+DL%2C+Hamdallah+O%2C+Abedi+NN%2C+Sorial+EE%2C+et+al.+Endovascular+versus+open+repair+for+descending+thoracic+aortic+rupture%3A+institutional+experience+and+meta-analysis.++Eur+J+Cardiothorac+Surg.+2009+Feb%3B35(2)%3A282-6." target="_blank">Xenos ES, Minion DJ, Davenport DL, Hamdallah O, Abedi NN, Sorial EE, et al.&nbsp;Endovascular versus open repair for descending thoracic aortic rupture: institutional experience and meta-analysis.&nbsp; Eur J Cardiothorac Surge 2009; 35(2):282-6.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Akin+I%2C+Kische+S%2C+Ince+H%2C+Nienaber+C.++Penetrating+aortic+ulcer%2C+intramural+hematoma%2C+acute+aortic+syndrome%3A+when+to+do+what.++J+Cardiovasc+Surg+(Torino).+2012+Feb%3B53(1+Suppl+1)%3A83-90." target="_blank">Akin I, Kische S, Ince H, Nienaber C.&nbsp; Penetrating aortic ulcer, intramural hematoma, acute aortic syndrome: when to do what.&nbsp; J Cardiovasc Surg (Torino) 2012; 53(1 Suppl 1):83-90.</a></p>
<p>QID: 30045</p></div><div class="rightanswer">The correct answer is: thoracic endovascular aortic repair (TEVAR)</div></div></div></div></div><div id="q492" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">233</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2261"><input type="hidden" name="q20803:492_:flagged" value="0"><input type="hidden" value="qaid=911376&amp;qubaid=20803&amp;qid=5223&amp;slot=492&amp;checksum=4b5e0499961eab9de725c66c7add9c71&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:492_:flaggedcheckbox" name="q20803:492_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q492&id=5223"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:492_:sequencecheck" value="2"><div class="qtext"><p>A 59-year-old man is referred for evaluation of focal&nbsp;dry gangrene of the distal right great toe, which has been present for 3 weeks.&nbsp;He has&nbsp;type II diabetes, hypertension, and hyperlipidemia. He is a current smoker, with a 100 pack-year smoking history. He denies rest pain. His ankle/brachial index (ABI) is 0.2 in the affected extremity, with no measurable toe pressures.&nbsp;He has not had prior vascular interventions. Regarding this patient’s situation, which of the following is&nbsp;<strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:492_answer" disabled="disabled" value="0" id="q20803:492_answer0"><label for="q20803:492_answer0">a. 1-year predicted mortality is approximately 20%</label> </div>
<div class="r1"><input type="radio" name="q20803:492_answer" disabled="disabled" value="1" id="q20803:492_answer1"><label for="q20803:492_answer1">b. prompt intervention is essential, with either revascularization or major amputation</label> </div>
<div class="r0"><input type="radio" name="q20803:492_answer" disabled="disabled" value="2" id="q20803:492_answer2"><label for="q20803:492_answer2">c. surgical bypass to a popliteal or tibial artery is effective for limb preservation, with less than a 5% risk of amputation at 12 months</label> </div>
<div class="r1"><input type="radio" name="q20803:492_answer" disabled="disabled" value="3" id="q20803:492_answer3"><label for="q20803:492_answer3">d. the presence of diabetes is not an independent risk factor for major amputation or postoperative complications</label> </div>
<div class="r0"><input type="radio" name="q20803:492_answer" disabled="disabled" value="4" id="q20803:492_answer4"><label for="q20803:492_answer4">e. hypertension is his most significant risk factor</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:492_-submit" name="q20803:492_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has critical limb ischemia (CLI), the most severe clinical manifestation of peripheral arterial disease. This patient, who presents with tissue loss, is at increased risk for MI, stroke, and death over the general population. The ankle-brachial index, which is an objective method to define PAD, has been conclusively demonstrated to be inversely proportional to this risk.</p>
<p>For patients with CLI, there is roughly a 20%, one-year mortality rate. His medical comorbidities are each independent risk factors for PAD, but also work in an additive fashion to accelerate the disease process, with diabetes and smoking being the strongest risk factors.&nbsp; Despite a seemingly logical progression from claudication to rest pain then tissue loss, it is known that fewer than half of patients presenting with CLI have exhibited symptoms of PAD for longer than 6 months. It is also known that these patients with CLI have worse surgical outcomes following revascularization procedures as compared to claudicants, with greater than 10% of patients with CLI requiring major amputation following attempts at revascularization. It has also been shown that outcomes are worse in diabetic patients following revascularization procedures, with increased rates of perioperative complications, mortality, and limb loss, compared to non-diabetics.</p>
<p>While tissue loss in patients with CLI is a recognized indication for surgical or endovascular intervention, the overall comorbid state of the patient must be taken into consideration.&nbsp; In a select group of patients with minor tissue loss and a prohibitive cardiovascular risk profile, local wound care and medical management alone may be reasonable.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B45+Suppl+S%3AS5-67." target="_blank">Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II&nbsp;Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007;45 Suppl S:S5-67.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation.+2011+Nov+1%3B124(18)%3A2020-45." target="_blank">2011 WRITING GROUP MEMBERS; 2005 WRITING COMMITTEE MEMBERS; ACCF/AHA TASK&nbsp;FORCE MEMBERS. 2011 ACCF/AHA Focused Update of the Guideline for the Management&nbsp;of patients with peripheral artery disease (Updating the 2005 Guideline): a&nbsp;report of the American College of Cardiology Foundation/American Heart&nbsp;Association Task Force on practice guidelines. Circulation 2011; 124(18):2020-45.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation.+2006+Mar+21%3B113(11)%3Ae463-654." target="_blank">Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American&nbsp;Association for Vascular Surgery/Society for Vascular Surgery, Society for&nbsp;Cardiovascular Angiography and Interventions, Society for Vascular Medicine and&nbsp;Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on&nbsp;Practice Guidelines (Writing Committee to Develop Guidelines for the Management&nbsp;of Patients With Peripheral Arterial Disease): endorsed by the American&nbsp;Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung,&nbsp;and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society&nbsp;Consensus; and Vascular Disease Foundation. Circulation 2006 Mar&nbsp;21;113(11):e463-654</a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation.+2006+Mar+21%3B113(11)%3Ae463-654." target="_blank">.&nbsp;</a></p>
<p>QID: 30859</p></div><div class="rightanswer">The correct answer is: 1-year predicted mortality is approximately 20%</div></div></div></div></div><div id="q193" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">234</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2270"><input type="hidden" name="q20803:193_:flagged" value="0"><input type="hidden" value="qaid=911077&amp;qubaid=20803&amp;qid=4563&amp;slot=193&amp;checksum=e1119ffad28da9b09bce39c4e6c4b8b3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:193_:flaggedcheckbox" name="q20803:193_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q193&id=4563"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:193_:sequencecheck" value="2"><div class="qtext"><p>An 87 year old woman was brought to the ER by her family because she lost consciousness and fell while brushing her hair with her dominant, left hand.&nbsp; She reported episodes of left arm fatigue recently. &nbsp;Her SP was 40 points lower on the left than on the right. Her PMH was significant for an MI two months ago and heart failure.&nbsp; An angiogram was performed. The next best step in her management is:</p>
<p><img src="./VESAP3_files/Picture3.jpg" alt="" width="381" height="344"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:193_answer" disabled="disabled" value="0" id="q20803:193_answer0"><label for="q20803:193_answer0">a. Angioplasty and stenting of the left subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:193_answer" disabled="disabled" value="1" id="q20803:193_answer1"><label for="q20803:193_answer1">b. Interrogation of the pacemaker</label> </div>
<div class="r0"><input type="radio" name="q20803:193_answer" disabled="disabled" value="2" id="q20803:193_answer2"><label for="q20803:193_answer2">c. Angioplasty without stenting of the left subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:193_answer" disabled="disabled" value="3" id="q20803:193_answer3"><label for="q20803:193_answer3">d. Left carotid-subclavian transposition</label> </div>
<div class="r0"><input type="radio" name="q20803:193_answer" disabled="disabled" value="4" id="q20803:193_answer4"><label for="q20803:193_answer4">e. Angioplasty and stenting of the left vertebral artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:193_-submit" name="q20803:193_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The image demonstrates a focal occlusion of the proximal subclavian artery at it’s origin. An attempt to recanalize the subclavian artery with angioplasty and stenting is less morbid in this elderly patient with a significant cardiac risk factor for surgery, namely her recent MI.&nbsp; While carotid-subclavian transposition is a good surgical procedure that avoids the use of prosthetic, avoiding surgery in this patient would be optimal. &nbsp;Angioplasty without stenting in this location has been reported, although primary as well as compiled data from a recent meta-analysis support stenting over PTA alone to maintain patency at one year. <sup>1,2</sup>&nbsp; While there is mild stenosis of the vertebral artery, angioplasty and stenting is unlikely to help her symptoms without re-establishing flow to the subclavian artery.</p>
<p>References:</p>
<p>1. Sixt S, Rastan A, Schwarzwälder U, et al.&nbsp;Results after balloon angioplasty or stenting of atherosclerotic subclavian artery obstruction.&nbsp; Catheter Cardiovasc Interv 2009;&nbsp;73: 395-403. <a href="http://www.ncbi.nlm.nih.gov/pubmed/19214979">http://www.ncbi.nlm.nih.gov/pubmed/19214979</a></p>
<p>2. Chatterjee S, Nerella N, Chakravarty S, Shani J.&nbsp; Angioplasty alone versus angioplasty and stenting for subclavian artery stenosis – A systematic review and meta-analysis. Am J Ther, 2013 [Jan; Epub ahead of print]. <a href="http://www.ncbi.nlm.nih.gov/pubmed/23344091">http://www.ncbi.nlm.nih.gov/pubmed/23344091</a></p>
<p>QID: 30340</p>
<p>&nbsp;</p></div><div class="rightanswer">The correct answer is: Angioplasty and stenting of the left subclavian artery</div></div></div></div></div><div id="q221" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">235</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2279"><input type="hidden" name="q20803:221_:flagged" value="0"><input type="hidden" value="qaid=911105&amp;qubaid=20803&amp;qid=4716&amp;slot=221&amp;checksum=4b1639f7761d172f5fdd86e4cd9562dc&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:221_:flaggedcheckbox" name="q20803:221_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q221&id=4716"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:221_:sequencecheck" value="2"><div class="qtext"><p>A 30-year-old woman has dizziness, headaches, and effort ischemia of both arms. A CT scan shows stenosis of the proximal left subclavian artery and severe stenosis of the left common carotid artery. Her erythrocyte sedimentation rate (ESR) is 85 mm/hr. Which of the following is the most appropriate treatment for this patient's condition?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:221_answer" disabled="disabled" value="0" id="q20803:221_answer0"><label for="q20803:221_answer0">a. percutaneous transluminal angioplasty and stenting of the left carotid and left subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:221_answer" disabled="disabled" value="1" id="q20803:221_answer1"><label for="q20803:221_answer1">b. right to left carotid-carotid bypass and left carotid to left subclavian bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:221_answer" disabled="disabled" value="2" id="q20803:221_answer2"><label for="q20803:221_answer2">c. corticosteroid therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:221_answer" disabled="disabled" value="3" id="q20803:221_answer3"><label for="q20803:221_answer3">d. anticoagulation with warfarin</label> </div>
<div class="r0"><input type="radio" name="q20803:221_answer" disabled="disabled" value="4" id="q20803:221_answer4"><label for="q20803:221_answer4">e. ascending aorta to left carotid and left subclavian artery bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:221_-submit" name="q20803:221_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>A 30-year-old woman with stenosis of the proximal parts of the supra-aortic trunks most likely has arteritis, probably Takayasu's arteritis. This is an inflammatory vasculitis that needs anti-inflammatory therapy as initial treatment. This is typically done with prednisone initially and other anti-inflammatory agents such as combination azathioprine and methotrexate for refractory disease.</p>
<p>This patient has high-grade stenoses and is symptomatic; her erythrocyte sedimentation rate (ESR) suggests that the disease is not quiescent. She would therefore benefit from corticosteroid therapy initially.</p>
<p>The most durable and appropriate revascularization in young patients with medically quiescent disease are bypass grafts from the ascending aorta, which is uninvolved with Takayasu's arteritis. Endovascular management with angioplasty has become an increasingly performed alternative to open surgery. However, endovascular management with angioplasty of these lesions has recurrence of stenosis in over 50% of patients at mid-term follow-up. There have been suggestions that stenting with stent grafts may prove to be superior to stents or angioplasty, but the literature is too sparse to make any firm conclusions in this patient population.</p>
<h2><br>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/10742426" target="_blank">Sparks SR, Chock A, Seslar S, Bergan JJ,&nbsp;Owens EL. Surgical treatment of Takayasu’s arteritis: case report and literature review. Ann Vasc Surg 2000; 14:125-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/2901440" target="_blank">Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasu’s arteriopathy. J Am Coll Cardiol 1988; 12:964-72.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22119246" target="_blank">Kim YW, Kim DI, Park YJ, Yang SS,&nbsp;Lee GY,&nbsp;Kim DK, et al. Surgical Bypass vs endovascular treatment for patients with supra-aortic arterial occlusive disease due to Takayasu Arteritis. J Vasc Surg. 2012;3:693-700.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22230484" target="_blank">Saadoun D,&nbsp;Lambert M,&nbsp;Mirault T, Resche-Rigon M,&nbsp;Koskas F,&nbsp;Cluzel P,&nbsp;et.al. Retrospective analysis of surgery versus&nbsp;endovascular&nbsp;intervention in&nbsp;Takayasu&nbsp;arteritis: a multicenter experience. Circulation 2012; 125:813-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21718932" target="_blank">Qureshi MA,&nbsp;Martin Z,&nbsp;Greenberg RK.&nbsp;Endovascular management of patients with Takayasu arteritis: stents versus stent grafts. Semin Vasc Surg&nbsp;2011; 24(1):44-52.</a></p>
<p>QID: 30372</p></div><div class="rightanswer">The correct answer is: corticosteroid therapy</div></div></div></div></div><div id="q438" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">236</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2288"><input type="hidden" name="q20803:438_:flagged" value="0"><input type="hidden" value="qaid=911322&amp;qubaid=20803&amp;qid=4885&amp;slot=438&amp;checksum=00b838263029660065be18bbc4f638dc&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:438_:flaggedcheckbox" name="q20803:438_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q438&id=4885"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:438_:sequencecheck" value="2"><div class="qtext"><p>The most accurate test for the diagnosis of pulmonary embolism (PE) today is spiral CT imaging.&nbsp; Which of the following statements best describes the appropriate use of this test in the diagnosis of PE?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:438_answer" disabled="disabled" value="0" id="q20803:438_answer0"><label for="q20803:438_answer0">1. spiral CT imaging alone, without any other clinical input, may be used to make treatment recommendations</label> </div>
<div class="r1"><input type="radio" name="q20803:438_answer" disabled="disabled" value="1" id="q20803:438_answer1"><label for="q20803:438_answer1">2. spiral CT imaging results should always supersede clinical probability</label> </div>
<div class="r0"><input type="radio" name="q20803:438_answer" disabled="disabled" value="2" id="q20803:438_answer2"><label for="q20803:438_answer2">3. spiral CT and clinical probability are best evaluated together, and if they are concordant definitive treatment recommendations may be made</label> </div>
<div class="r1"><input type="radio" name="q20803:438_answer" disabled="disabled" value="3" id="q20803:438_answer3"><label for="q20803:438_answer3">4. spiral CT imaging should not include the legs and should be limited to the chest only</label> </div>
<div class="r0"><input type="radio" name="q20803:438_answer" disabled="disabled" value="4" id="q20803:438_answer4"><label for="q20803:438_answer4">5. none of the above are true</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:438_-submit" name="q20803:438_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The NIH Prospective Investigation of Pulmonary Embolus Diagnosis (PIOPED II) study showed that the positive predictive value of a high probability spiral CT scan with a high clinical suspicion of PE was &gt;95%, but was only 58% in a patient with low clinical suspicion of PE.&nbsp; Likewise, the negative predictive value of a low probability spiral CT scan with a low clinical suspicion of PE was &gt;95%, but was only 60% in a patient with high clinical suspicion of PE. Accordingly, both clinical parameters and CT findings should be considered in arriving at a definitive plan of treatment.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=AJR+Am+J+Roentgenol+2007%3B+189%3A1071-6." target="_blank">Goodman LR, Stein PD, Matta F, Sostman HD<span>,&nbsp;</span>Wakefield TW<span>,&nbsp;</span>Woodard PK,&nbsp;et al. CT venography and compression sonography are diagnostically equivalent: data from PIOPED II. AJR Am J Roentgenol 2007; 189:1071-6.</a></p>
<p>QID: 30765</p></div><div class="rightanswer">The correct answer is: spiral CT and clinical probability are best evaluated together, and if they are concordant definitive treatment recommendations may be made</div></div></div></div></div><div id="q474" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">237</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2297"><input type="hidden" name="q20803:474_:flagged" value="0"><input type="hidden" value="qaid=911358&amp;qubaid=20803&amp;qid=5199&amp;slot=474&amp;checksum=2dd9c2a97756eb1530bb4c9e2c9032d9&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:474_:flaggedcheckbox" name="q20803:474_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q474&id=5199"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:474_:sequencecheck" value="2"><div class="qtext"><p>What response to angiographic contrast agent is associated with the most severe adverse reaction?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:474_answer" disabled="disabled" value="0" id="q20803:474_answer0"><label for="q20803:474_answer0">a. non-idiosyncratic non-anaphylactoid reactions</label> </div>
<div class="r1"><input type="radio" name="q20803:474_answer" disabled="disabled" value="1" id="q20803:474_answer1"><label for="q20803:474_answer1">b. Ig-E mediated anaphylaxis</label> </div>
<div class="r0"><input type="radio" name="q20803:474_answer" disabled="disabled" value="2" id="q20803:474_answer2"><label for="q20803:474_answer2">c. iodine toxicity</label> </div>
<div class="r1"><input type="radio" name="q20803:474_answer" disabled="disabled" value="3" id="q20803:474_answer3"><label for="q20803:474_answer3">d. anaphlyactoid reaction</label> </div>
<div class="r0"><input type="radio" name="q20803:474_answer" disabled="disabled" value="4" id="q20803:474_answer4"><label for="q20803:474_answer4">e. type-4 hypersensitivity response</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:474_-submit" name="q20803:474_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span style="line-height: 1.5;">Acute reactions to iodinated contrast are not due to an antibody-mediated immunologic reaction (ie, an anaphylactic (allergic) reaction). However, the response may be similar and is termed "anaphylactoid.” These reactions are attributed to enzyme induction, release of vasoactive substances, including histamine and serotonin, and complement activation. These non-allergic drug hypersensitivities do not involve either IgE-mediated (type 1) or delayed (type 4) hypersensitivity.&nbsp;</span><span style="line-height: 1.5;">Anaphylactoid reactions may have serious, occasionally fatal, complications.</span></p>
<p>Risk factors for acute anaphylactoid constrast reactions include asthma, previous reactions, cardiovascular and renal disease. These reactions usually begin within 20 min of exposure and are dose-independent. Symptoms may be mild (rash, pruritis, nasal congestion, nausea, and vomiting), moderate (laryngeal edema, bronchospasm, dyspnea, tachycardia, or bradycardia), or severe (arrhythmias, hypotension, pulmonary edema, seizure, syncope, and death).</p>
<p>The best strategy for reducing risk of non-allergic drug hypersensitivity is avoidance. Alternatively, patients can be premedicated with steroids and histamine blockers, although the success of premedication varies.</p>
<p>Nonanaphylactoid reactions (physiochemotoxic or nonidiosyncratic) are related to the physical properties of the contrast medium (ionicity and osmolality) and increased concentration of iodine, which also increases the risk of these reactions. High rate, high volume, and intraarterial route of administration of contrast increase the likelihood of nonanaphylactoid reactions (larger volumes are more likely to produce a reaction). Symptoms of nonanaphylactoid reactions include warmth, metallic taste, nausea, vomiting, bradycardia, hypotension, vasovagal reactions, neuropathy, and delayed reactions.</p>
<p>Excess iodine is generally well tolerated, but some patients with thyroid disease or other risk factors may be susceptible to iodine-induced thyroid dysfunction following acute or chronic exposures.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20Manual/2013_Contrast_Media.pdf" target="_blank">American College of Radiology, Committee on Drugs and Contrast Media. ACR Manual on Contrast Media, version 9. 2013.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Obes.+2012%3B+19(5)%3A414-9." target="_blank">Leung AM, Braverman LE. Iodine-induced thyroid dysfunction. Curr Opin Endocrinol Diabetes Obes. 2012; 19(5):414-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Int+Arch+Allergy+Immunol.+2012%3B159(4)%3A327-45." target="_blank">Farnam K, Chang C, Teuber S, Gershwin ME. Nonallergic drug hypersensitivity reactions. Int Arch Allergy Immunol 2012;159(4):327-45.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J++Nucl+Med+Technol.+2008+Jun%3B36(2)%3A69-74" target="_blank">Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol. 2008; 36(2):69-77.</a></p>
<p>QID: 30838</p></div><div class="rightanswer">The correct answer is: anaphlyactoid reaction</div></div></div></div></div><div id="q93" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">238</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2306"><input type="hidden" name="q20803:93_:flagged" value="0"><input type="hidden" value="qaid=910977&amp;qubaid=20803&amp;qid=4911&amp;slot=93&amp;checksum=77b7af619968b772512e254f5bdc92c7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:93_:flaggedcheckbox" name="q20803:93_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q93&id=4911"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:93_:sequencecheck" value="2"><div class="qtext"><p>A 74-year-old otherwise healthy woman underwent repair of a right acetabular fracture. In the recovery room she is noted to have a cool right foot, but motor and sensation are intact. The right femoral pulse is weakly palpable, but difficult to evaluate because of postoperative pain. Pedal pulses are not palpable, but they are audible by Doppler. The contralateral foot has palpable pulses. Which of the following is the appropriate first step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:93_answer" disabled="disabled" value="0" id="q20803:93_answer0"><label for="q20803:93_answer0">a. immediate return to operating room for right femoral artery exploration</label> </div>
<div class="r1"><input type="radio" name="q20803:93_answer" disabled="disabled" value="1" id="q20803:93_answer1"><label for="q20803:93_answer1">b. administer IV heparin and perform immediate angiography with consideration for open or endovascular repair of possible injury</label> </div>
<div class="r0"><input type="radio" name="q20803:93_answer" disabled="disabled" value="2" id="q20803:93_answer2"><label for="q20803:93_answer2">c. administer IV heparin and perform immediate Duplex scan of the right external iliac, common, deep, and superficial femoral arteries</label> </div>
<div class="r1"><input type="radio" name="q20803:93_answer" disabled="disabled" value="3" id="q20803:93_answer3"><label for="q20803:93_answer3">d. administration of vasodilators to release arterial spasm</label> </div>
<div class="r0"><input type="radio" name="q20803:93_answer" disabled="disabled" value="4" id="q20803:93_answer4"><label for="q20803:93_answer4">e. IV heparinization and close observation with serial hourly bedside exams for the next 8 hours</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:93_-submit" name="q20803:93_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>There have been increasingly common reports of injury to the external iliac, common femoral, superficial femoral, and deep femoral arteries (and their branches) with orthopedic procedures. Acetabular fracture repairs may result in both external iliac artery and common femoral artery injuries. Femoral neck fracture repairs may result in superficial femoral or deep femoral artery injuries. These injuries may result from application of hardware or from external torque on the vessels resulting in localized dissection. Clinical findings may be subtle in the early postoperative period. Initial imaging should be by Duplex scan, but, if this is inadequate or unavailable, angiography should be performed. Injuries may be repaired with endovascular angioplasty, covered stents, embolization, or open surgery.&nbsp; Observation is incorrect because missed injuries can result in propagated thrombus and permanent vascular compromise. Anticoagulation with heparin is indicated to prevent thrombus formation.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vasc+Surg+2011%3B+54(1)%3A219-21." target="_blank"><span style="line-height: 1.5;">Koelling E</span>, <span style="line-height: 1.5;">Mukherjee D</span>.&nbsp;Extrinsic compression of the external iliac artery following internal fixation of an acetabular fracture. Vasc Surg 2011; 54(1):219-21.&nbsp;</a></div>
<div>QID: 30141</div>
<div>&nbsp;</div></div><div class="rightanswer">The correct answer is: administer IV heparin and perform immediate Duplex scan of the right external iliac, common, deep, and superficial femoral arteries</div></div></div></div></div><div id="q400" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">239</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2315"><input type="hidden" name="q20803:400_:flagged" value="0"><input type="hidden" value="qaid=911284&amp;qubaid=20803&amp;qid=5051&amp;slot=400&amp;checksum=1725796b6434f9adb54cfd1f5acc6b6f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:400_:flaggedcheckbox" name="q20803:400_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q400&id=5051"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:400_:sequencecheck" value="2"><div class="qtext"><p>The procedure for placement of a venous stent for distal inferior vena cava obstruction utilizes intravascular ultrasound (IVUS). The structure shown in the image below (arrows) represents which of the following?<br><br><a href="./VESAP3_files/AssetProxy_017.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_017.jpg" alt="img" width="100" height="97" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:400_answer" disabled="disabled" value="0" id="q20803:400_answer0"><label for="q20803:400_answer0">a. right renal artery</label> </div>
<div class="r1"><input type="radio" name="q20803:400_answer" disabled="disabled" value="1" id="q20803:400_answer1"><label for="q20803:400_answer1">b. superior mesenteric artery</label> </div>
<div class="r0"><input type="radio" name="q20803:400_answer" disabled="disabled" value="2" id="q20803:400_answer2"><label for="q20803:400_answer2">c. duodenum</label> </div>
<div class="r1"><input type="radio" name="q20803:400_answer" disabled="disabled" value="3" id="q20803:400_answer3"><label for="q20803:400_answer3">d. inferior mesenteric vein</label> </div>
<div class="r0"><input type="radio" name="q20803:400_answer" disabled="disabled" value="4" id="q20803:400_answer4"><label for="q20803:400_answer4">e. left renal artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:400_-submit" name="q20803:400_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Venous stenting procedures are becoming more common due to a heightened awareness of chronic venous obstruction and the pathologic role it plays in causing post-thrombotic syndrome. In addition to traditional venography, computed tomography and magnetic resonance imaging can produce reconstructed venograms to assist in the diagnosis and to help guide the treatment approach. Intravascular ultrasound imaging ( IVUS) plays a critical role in complimenting venography for precise placement of stents in relation to diameter measurements, accurate visualization of residual obstruction, and identifying important venous tributaries. The right renal artery can be easily observed traversing posterior to the inferior vena cava in a perpendicular manner. This artery remains a key anatomic landmark to obtain location bearing and to identify the iliac vein bifurcation and the right and left renal veins.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Hollis+KC%2C+Olivier+J%2C+Raju+S.+Stenting+of+the+venous" target="_blank">Neglen P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: Long-term stent-related outcome, clinical and hemodynamic result. J Vasc Surg 2007; 46 (5):979-90.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Raju+S.+Endovenous+treatment+of+patients+with+iliac-caval+venous+obstruction.+J+Cardiovasc+Surg%3B+2008%3B+49+(1)%3A27-33." target="_blank">Raju S. Endovenous treatment of patients with iliac-caval venous obstruction. J Cardiovasc Surg; 2008; 49 (1):27-33.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Neglen+P.+Chronic+deep+venous+obstruction%3A+Definition%2C+prevalence%2C+diagnosis%2C+management.+Phlebology%3B+2008%3B+23+(4)%3A149-57." target="_blank">Neglen P. Chronic deep venous obstruction: Definition, prevalence, diagnosis, management. Phlebology; 2008; 23 (4):149-57.</a></p>
<p>QID: 30717</p></div><div class="rightanswer">The correct answer is: right renal artery</div></div></div></div></div><div id="q397" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">240</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2324"><input type="hidden" name="q20803:397_:flagged" value="0"><input type="hidden" value="qaid=911281&amp;qubaid=20803&amp;qid=5048&amp;slot=397&amp;checksum=aa96b75d064dc6a0202c3bc9a6a043ac&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:397_:flaggedcheckbox" name="q20803:397_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q397&id=5048"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:397_:sequencecheck" value="2"><div class="qtext"><p>A 74-year-old woman presents with swelling and pain in the right lower extremity. She has a palpable cord in the right great saphenous vein in the medial thigh. She had a total hip replacement 7 years ago and she has no history of venous thrombosis. The views from her venous ultrasound exam are shown below. They demonstrate which of the following?<br><br><a href="./VESAP3_files/AssetProxy_013.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_013.jpg" alt="img" width="100" height="35" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:397_answer" disabled="disabled" value="0" id="q20803:397_answer0"><label for="q20803:397_answer0">a. atherosclerotic plaque in the femoral artery and acute thrombosis in the femoral vein</label> </div>
<div class="r1"><input type="radio" name="q20803:397_answer" disabled="disabled" value="1" id="q20803:397_answer1"><label for="q20803:397_answer1">b. acute thrombosis in the femoral vein and chronic thrombosis in the great saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:397_answer" disabled="disabled" value="2" id="q20803:397_answer2"><label for="q20803:397_answer2">c. acute thrombosis in both the great saphenous and femoral veins</label> </div>
<div class="r1"><input type="radio" name="q20803:397_answer" disabled="disabled" value="3" id="q20803:397_answer3"><label for="q20803:397_answer3">d. acute thrombosis in the great saphenous vein and chronic thrombotic disease of the femoral vein</label> </div>
<div class="r0"><input type="radio" name="q20803:397_answer" disabled="disabled" value="4" id="q20803:397_answer4"><label for="q20803:397_answer4">e. normal great saphenous and femoral veins</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:397_-submit" name="q20803:397_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The ultrasound images show acute thrombosis in the great saphenous vein, which is in accordance with the palpable cord in the medial thigh. The vein is dilated and noncompressible with echolucent material in the lumen. These are ultrasound signs of acute venous thrombosis. The femoral vein has echogenic material similar to the surrounding tissues and the adventitia of the vein, which is typical of the chronic thrombus. Asymptomatic thrombi in the deep veins may occur in patients who undergo major surgery, particularly when they are older-as in this case.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+48+(2)%3A407-12." target="_blank">Labropoulos N, Waggoner T, Sammis W, Samali S<span>,&nbsp;</span>Pappas PJ. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg 2008; 48 (2):407-12.</a><br><br>Abai B, Labropoulos N. Duplex ultrasound scanning for chronic venous obstruction and valvular incompetence. In: Gloviczki P, ed. Handbook of venous disorders. 3rd ed. London, UK: Hodder Arnold; 2009:142-55.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Vasc+Endovasc+Surg+2005%3B+29+(1)%3A10-7." target="_blank">Leon L, Giannoukas AD, Dodd D, Chan P<span>,&nbsp;</span>Labropoulos N<span>.</span>&nbsp;Clinical significance of superficial vein thrombosis. Eur J Vasc Endovasc Surg 2005; 29 (1):10-7.</a></p>
<p>QID: 30714</p></div><div class="rightanswer">The correct answer is: acute thrombosis in the great saphenous vein and chronic thrombotic disease of the femoral vein</div></div></div></div></div><div id="q149" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">241</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2333"><input type="hidden" name="q20803:149_:flagged" value="0"><input type="hidden" value="qaid=911033&amp;qubaid=20803&amp;qid=4767&amp;slot=149&amp;checksum=bf770a67b6b8ed05dd708e8a2fb2f118&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:149_:flaggedcheckbox" name="q20803:149_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q149&id=4767"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:149_:sequencecheck" value="2"><div class="qtext"><p>A 58-year-old flute player complains of short episodes of dizziness, slurred speech, and left arm fatigue while he is playing his flute. On physical examination, there is a difference of 40 mm Hg in brachial pressure between his arms. The Duplex ultrasound shows reversed flow in the left vertebral artery. An arch aortogram and selective angiography of the left subclavian artery is performed, an image from which is shown below. No significant occlusive disease is present in the carotid arteries. All of the following treatment options are acceptable&nbsp;<strong>except:</strong><br></p><p><img src="./VESAP3_files/Cull - 3 image.jpg" alt="Cull - 3 image" width="355" height="326"></p>
<p><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:149_answer" disabled="disabled" value="0" id="q20803:149_answer0"><label for="q20803:149_answer0">a. subclavian artery transposition</label> </div>
<div class="r1"><input type="radio" name="q20803:149_answer" disabled="disabled" value="1" id="q20803:149_answer1"><label for="q20803:149_answer1">b. subclavian artery primary stenting</label> </div>
<div class="r0"><input type="radio" name="q20803:149_answer" disabled="disabled" value="2" id="q20803:149_answer2"><label for="q20803:149_answer2">c. exercise therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:149_answer" disabled="disabled" value="3" id="q20803:149_answer3"><label for="q20803:149_answer3">d. subclavian artery balloon angioplasty</label> </div>
<div class="r0"><input type="radio" name="q20803:149_answer" disabled="disabled" value="4" id="q20803:149_answer4"><label for="q20803:149_answer4">e. carotid to subclavian bypass with polytetrafluoroethylene (PTFE) graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:149_-submit" name="q20803:149_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has subclavian steal syndrome, a term used to describe the symptoms associated with proximal subclavian artery stenosis or occlusion resulting in&nbsp;retrograde blood flow in the ipsilateral vertebral artery. Many patients with subclavian occlusive disease remain asymptomatic due to the efficiency of retrograde vertebral flow in supplying the upper extremity. In most patients with subclavian steal, blood flow in the basilar artery remains antegrade due to the adequacy of contralateral vertebral supply.</p>
<p>Subclavian occlusive disease may present in one or both of the two primary vascular beds supplied by the subclavian artery: the upper extremity and the cerebellum. Upper extremity symptoms are more common than vertebrobasilar symptoms. In fact, the onset of neurological symptoms with upper extremity exertion is actually quite uncommon. Less commonly, subclavian occlusive disease may present with thromboembolism to either the posterior cerebral/cerebellar distribution or to the hand and fingers. While percutaneous treatment of subclavian disease is usually both safe and effective, the presence of embolic symptoms should raise a caution flag. Some surgeons recommend the use of embolic protection in the vertebral artery at the time of subclavian angioplasty and stenting in patients with preoperative embolic symptoms.</p>
<p>Exercise therapy has not been evaluated for treatment of subclavian steal syndrome. Antiplatelet therapy is appropriate to decrease the risk of cardiovascular and cerebrovascular events. Endovascular treatment (catheter-based procedures) of the proximal subclavian artery is the most common intervention for the proximal subclavian and should be considered the initial procedure of choice for stenotic lesions. The technical success rate is high (86-100%) and the complication rate is low. Total occlusions may have a somewhat lower success rate.&nbsp; Although balloon angioplasty has been used with acceptable results, primary stenting of the subclavian artery is presently the recommended procedure to treat such lesions. Stenting is associated with both improved immediate technical success as well as durability, with a reported long-term primary patency rate as high as 90%. Open revascularization procedures include carotid-subclavian bypass using a prosthetic conduit or subclavian artery transposition with end-to-side anastomosis to the common carotid artery. Surgical exposure is easily obtained through a transverse incision at the base of the neck extending 5-7 cm laterally from the sternal notch and 1-2 cm above and parallel to the clavicle. Transposition requires more extensive dissection, but does not use prosthetic graft material. The long-term results of subclavian transposition procedures are similar to those of carotid-subclavian bypass, with reported 3- and 5- year patency rates up to 98%. These procedures are usually well tolerated; however, they expose the patient to an approximately 1% risk for stroke due to common carotid manipulation and a 5-21% risk for cranial nerve injury during the dissection. In addition, surgery may result in injury to the thoracic duct. Open revascularization procedures should be considered when primary or recurrent lesion cannot be crossed with a guidewire.</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+58%3A901-9." target="_blank">Scali ST, Chang CK, Pape SG, Feezor RJ<span>,&nbsp;</span>Berceli SA<span>,&nbsp;</span>Huber TS<span>,&nbsp;</span>et al. Subclavian revascularization in the age of thoracic endovascular aortic repair and comparison of outcomes in patients with occlusive disease. J Vasc Surg 2013; 58:901-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1994%3B+20(3)%3A411-7." target="_blank">Vitti MJ, Thompson BW, Read RC, Gagne PJ<span>,&nbsp;</span>Barone GW<span>,&nbsp;</span>Barnes RW,&nbsp;et al. Carotid-subclavian bypass: a twenty-two-year experience. J Vasc Surg&nbsp;1994; 20(3):411-7.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2000%3B+32(3)%3A411-8." target="_blank">AbuRahma AF, Robinson PA, Jennings TG. Carotid-subclavian bypass grafting with polytetrafluoroethylene grafts for symptomatic subclavian artery stenosis or occlusion: a 20-year experience. J Vasc Surg&nbsp;2000; 32(3):411-8.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2005%3B+41(1)%3A19-23." target="_blank">De Vries JP, Jager LC, Van den Berg JC, Overtoom TT<span>,&nbsp;</span>Ackerstaff RG<span>,&nbsp;</span>Van de Pavoordt ED,&nbsp;et al. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results. J Vasc Surg<em>&nbsp;</em>2005; 41(1):19-23.</a></p>
<p>QID: 30243</p></div><div class="rightanswer">The correct answer is: exercise therapy</div></div></div></div></div><div id="q117" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">242</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2342"><input type="hidden" name="q20803:117_:flagged" value="0"><input type="hidden" value="qaid=911001&amp;qubaid=20803&amp;qid=4733&amp;slot=117&amp;checksum=87f2e06b1eb3392b2acf75c18c79047b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:117_:flaggedcheckbox" name="q20803:117_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q117&id=4733"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:117_:sequencecheck" value="2"><div class="qtext"><p>A common anomaly of the aortic arch is shown in this MRA. All of the following anatomical findings would be expected in a patient with this anomaly <strong>except</strong>:<br><br><a href="./VESAP3_files/AssetProxy_110.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_110.jpg" alt="img" width="100" height="99" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:117_answer" disabled="disabled" value="0" id="q20803:117_answer0"><label for="q20803:117_answer0">a. normal origin of the vertebral arteries</label> </div>
<div class="r1"><input type="radio" name="q20803:117_answer" disabled="disabled" value="1" id="q20803:117_answer1"><label for="q20803:117_answer1">b. bicuspid aortic valve</label> </div>
<div class="r0"><input type="radio" name="q20803:117_answer" disabled="disabled" value="2" id="q20803:117_answer2"><label for="q20803:117_answer2">c. esophageal compression</label> </div>
<div class="r1"><input type="radio" name="q20803:117_answer" disabled="disabled" value="3" id="q20803:117_answer3"><label for="q20803:117_answer3">d. non-recurrent laryngeal nerve</label> </div>
<div class="r0"><input type="radio" name="q20803:117_answer" disabled="disabled" value="4" id="q20803:117_answer4"><label for="q20803:117_answer4">e. dysphagia</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:117_-submit" name="q20803:117_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The image shows an aberrant right subclavian artery arising as the fourth trunk (last vessel) off the aortic arch. The aberrant vessel typically courses behind the esophagus, but it occasionally passes between the trachea and esophagus. As such, local compression can result in symptoms of tracheal compression and/or dysphagia (dysphagia lusoria). Adjacent to the origin of the aberrant vessel, a congenital dilatation of the wall of the aorta (diverticulum of Kommerell) can develop into a degenerative aneurysm. Additionally, the recurrent laryngeal nerve on the right side is not "recurrent" since it exits the vagus higher in the neck when an aberrant right subclavian artery is present. There is no association between an aberrant right subclavian artery and a bicuspid aortic valve.<br><br></p>
<h3>References:</h3>
<p>Morasch MD, Berguer R. Brachiocephalic vessel reconstruction. In: Rutherford RB, ed. Vascular Surgery. 6th ed. Philadelphia, Pa: Elsevier Saunders; 2005:1294-1313.</p>
<p>QID: 30208</p></div><div class="rightanswer">The correct answer is: bicuspid aortic valve</div></div></div></div></div><div id="q232" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">243</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2351"><input type="hidden" name="q20803:232_:flagged" value="0"><input type="hidden" value="qaid=911116&amp;qubaid=20803&amp;qid=4964&amp;slot=232&amp;checksum=d2c36c6de28ff206b37bda893fdf0bcc&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:232_:flaggedcheckbox" name="q20803:232_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q232&id=4964"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:232_:sequencecheck" value="2"><div class="qtext"><p>A 58-year-old man with end-stage renal disease (ESRD) presents to the office for follow-up 2 weeks after placement of a left autogenous radial-cephalic wrist direct access. On physical examination of his left arm, he has no thrill or bruit in the arteriovenous (AV) access outflow, no edema, and palpable radial, ulnar, and brachial artery pulses. Which of the following is the most probable cause of AV access thrombosis in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:232_answer" disabled="disabled" value="0" id="q20803:232_answer0"><label for="q20803:232_answer0">a. anastomotic stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:232_answer" disabled="disabled" value="1" id="q20803:232_answer1"><label for="q20803:232_answer1">b. poor arterial inflow</label> </div>
<div class="r0"><input type="radio" name="q20803:232_answer" disabled="disabled" value="2" id="q20803:232_answer2"><label for="q20803:232_answer2">c. central venous stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:232_answer" disabled="disabled" value="3" id="q20803:232_answer3"><label for="q20803:232_answer3">d. hypercoagulability</label> </div>
<div class="r0"><input type="radio" name="q20803:232_answer" disabled="disabled" value="4" id="q20803:232_answer4"><label for="q20803:232_answer4">e. inadequate caliber of venous outflow</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:232_-submit" name="q20803:232_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Access failure that occurs within 30 days of surgery is defined as early access failure. In the absence of a technical failure, such as a twisted or stenotic anastomosis, it is most commonly due to inadequate venous outflow, which may be secondary to inadequate caliber of the outflow vein or central venous stenosis. Since this patient has no arm edema or other signs of central venous stenosis, the most likely cause of access thrombosis is inadequate caliber of the venous outflow. Reported minimal diameter for use ranges from 2-3 mm; however, as vein diameters decrease, primary failure rates increase. Other less common causes include poor arterial inflow, anastomotic stenosis, or a hypercoagulable state.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+48+(5S)%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008; 48 (5S):2S-25S.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vas+Surg+2003+38+(3)%3A439-45." target="_blank">Patel ST, Hughes J, Mills JL. Failure of arteriovenous fistula maturation: An unintended consequence of exceeding Dialysis Outcome Quality Initiative guidelines for hemodialysis access. J Vas Surg 2003 38 (3):439-45.</a></p>
<p>QID: 30410</p></div><div class="rightanswer">The correct answer is: inadequate caliber of venous outflow</div></div></div></div></div><div id="q396" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">244</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2360"><input type="hidden" name="q20803:396_:flagged" value="0"><input type="hidden" value="qaid=911280&amp;qubaid=20803&amp;qid=5047&amp;slot=396&amp;checksum=ab27b7805c19fcb98148145b6359d688&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:396_:flaggedcheckbox" name="q20803:396_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q396&id=5047"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:396_:sequencecheck" value="2"><div class="qtext"><p>A 59-year-old man developed acute calf pain during a game of tennis. The pain was sharp and localized in the posteromedial calf. An ultrasound exam was performed and the image is shown below. Which of the following is the most probable diagnosis?<br><br><a href="./VESAP3_files/AssetProxy_003.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_003.jpg" alt="img" width="100" height="71" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:396_answer" disabled="disabled" value="0" id="q20803:396_answer0"><label for="q20803:396_answer0">a. soleal vein thrombosis</label> </div>
<div class="r1"><input type="radio" name="q20803:396_answer" disabled="disabled" value="1" id="q20803:396_answer1"><label for="q20803:396_answer1">b. dilation of the gastrocnemial veins</label> </div>
<div class="r0"><input type="radio" name="q20803:396_answer" disabled="disabled" value="2" id="q20803:396_answer2"><label for="q20803:396_answer2">c. rupture of the gastrocnemius muscle</label> </div>
<div class="r1"><input type="radio" name="q20803:396_answer" disabled="disabled" value="3" id="q20803:396_answer3"><label for="q20803:396_answer3">d. gastrocnemius vein thrombosis</label> </div>
<div class="r0"><input type="radio" name="q20803:396_answer" disabled="disabled" value="4" id="q20803:396_answer4"><label for="q20803:396_answer4">e. soft tissue tumor</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:396_-submit" name="q20803:396_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Rupture of the calf muscles is a known sports injury mimicking the signs and symptoms of venous thrombosis. The ultrasound image presented shows the deeper part of the gastrocnemius muscle (first muscle under the skin in the posteromedial calf) with disruption of the normal architecture of the muscle fibers and fresh hemorrhage from the middle of the muscle to the Achilles' tendon. The soleus muscle just below the gastrocnemius is normal.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology%3B+2002%3B+224+(1)%3A112-119." target="_blank">Delgado GJ, Chung CB, Lektrakul N, Azocar P<span>,&nbsp;</span>Botte MJ<span>,&nbsp;</span>Coria D<span>,&nbsp;</span>et al. Tennis leg: Clinical US study of 141 patients and anatomic investigation of four cadavers with MR imaging and US. Radiology 2002; 224 (1):112-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics+2008%3B+28+(6)%3A1785-97." target="_blank">Useche JN, de Castro AM, Galvis GE, Mantilla RA<span>,&nbsp;</span>Ariza A. Use of US in the evaluation of patients with symptoms of deep venous thrombosis of the lower extremities. Radiographics 2008; 28 (6):1785-97.</a></p>
<p>QID: 30713</p></div><div class="rightanswer">The correct answer is: rupture of the gastrocnemius muscle</div></div></div></div></div><div id="q72" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">245</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2369"><input type="hidden" name="q20803:72_:flagged" value="0"><input type="hidden" value="qaid=910956&amp;qubaid=20803&amp;qid=4982&amp;slot=72&amp;checksum=465538e309e31fe2bf35bfd1110a675f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:72_:flaggedcheckbox" name="q20803:72_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q72&id=4982"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:72_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old avid golfer presents with an infected left femoral pseudoaneurysm 6 years after an aortobifemoral bypass for aneurysmal disease. He has a low grade fever and leukocytosis. He had a coronary bypass using left internal mammary artery graft and is completely asymptomatic from the cardiac standpoint. CTA shows the infection is confined to the groin and there is normal runoff. Blood cultures grow Pseudomonas. His deep femoral veins are not suitable as donor vessels due to prior deep vein thrombosis. In addition to resection of the infected graft in the groin, which of the following is the best management option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:72_answer" disabled="disabled" value="0" id="q20803:72_answer0"><label for="q20803:72_answer0">a. ligation of the common femoral, superficial femoral, and profunda femurs arteries, and primary amputation</label> </div>
<div class="r1"><input type="radio" name="q20803:72_answer" disabled="disabled" value="1" id="q20803:72_answer1"><label for="q20803:72_answer1">b. in-line synthetic graft and muscle flap coverage</label> </div>
<div class="r0"><input type="radio" name="q20803:72_answer" disabled="disabled" value="2" id="q20803:72_answer2"><label for="q20803:72_answer2">c. extraanatomic bypass through the obturator foramen</label> </div>
<div class="r1"><input type="radio" name="q20803:72_answer" disabled="disabled" value="3" id="q20803:72_answer3"><label for="q20803:72_answer3">d. ligation of the common femoral, superficial femoral, and profunda femurs arteries, and observation</label> </div>
<div class="r0"><input type="radio" name="q20803:72_answer" disabled="disabled" value="4" id="q20803:72_answer4"><label for="q20803:72_answer4">e. right femoral to left popliteal bypass with PTFE</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:72_-submit" name="q20803:72_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a severe gram negative graft infection with signs of systemic sepsis. The most conservative treatment involves complete excision of the infected graft material, followed by bypass through uninfected tissue. Ligation of the groin vessels will almost certainly result in limb threatening ischemia, supporting a plan to revascularize the limb at the initial operation. A bypass through the obturator foramen is ideal in this setting, as it achieves revascularization through uninvolved tissue planes, avoids potential contamination of the contralateral graft limb, and does not interfere with future groin wound management options such as debridements or muscle flaps. The left axillary artery is not an ideal inflow source in a patient with a LIMA graft and is associated with a significant rate of late graft failure due to thrombosis or reinfection. In situ synthetic bypass in the setting of gram negative infection has a significant risk of suture line failure and exsanguination. Because of the other viable surgical options, there is no need for primary amputation.<br><br></p>
<h3>Reference:</h3>
<p>Ouriel K, Rutherford RB. Obturator bypass. In: Atlas of Vascular Surgery: Operative Procedures. Philadelphia, PA: WB Saunders; 1998:79-82.</p>
<p>QID: 30112</p></div><div class="rightanswer">The correct answer is: extraanatomic bypass through the obturator foramen</div></div></div></div></div><div id="q91" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">246</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2378"><input type="hidden" name="q20803:91_:flagged" value="0"><input type="hidden" value="qaid=910975&amp;qubaid=20803&amp;qid=4909&amp;slot=91&amp;checksum=4f63dc688dbc0114f7bf19d28b010df7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:91_:flaggedcheckbox" name="q20803:91_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q91&id=4909"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:91_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old man undergoes a percutaneous coronary intervention via right femoral access for an ST elevation myocardial infarction. Three days later the patient develops severe right groin pain and swelling. Noninvasive duplex imaging is completed. Which of the following is the strongest indication for open surgical intervention in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:91_answer" disabled="disabled" value="0" id="q20803:91_answer0"><label for="q20803:91_answer0">a. transient hypotension corrected with a fluid bolus</label> </div>
<div class="r1"><input type="radio" name="q20803:91_answer" disabled="disabled" value="1" id="q20803:91_answer1"><label for="q20803:91_answer1">b. a 3 point drop in the hematocrit</label> </div>
<div class="r0"><input type="radio" name="q20803:91_answer" disabled="disabled" value="2" id="q20803:91_answer2"><label for="q20803:91_answer2">c. a 4 cm pseudoaneurysm with a narrow neck</label> </div>
<div class="r1"><input type="radio" name="q20803:91_answer" disabled="disabled" value="3" id="q20803:91_answer3"><label for="q20803:91_answer3">d. recent myocardial infarction</label> </div>
<div class="r0"><input type="radio" name="q20803:91_answer" disabled="disabled" value="4" id="q20803:91_answer4"><label for="q20803:91_answer4">e. cellulitis of the skin overlying the affected region</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:91_-submit" name="q20803:91_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Absolute indications for open surgical repair for patients with a femoral artery pseudoaneurysm include an infected hematoma, hemodynamic instability, an expanding pulsatile mass or ongoing bleeding, skin necrosis or overlying cellulitis, limb ischemia or loss of pulses, neurologic deficit, pseudoaneurysms over 5 cm in size with a wide neck, and failure of conservative therapies such as ultrasound-guided thrombin injection and compression. The findings in the case described suggest an infected hematoma which needs to be drained. While his recent MI certainly elevates his risks, the need for surgery remains and consideration could be given to hematoma evacuation, with or without arterial repair, as indicated under local anesthesia. A 4 cm false aneurysm with a narrow neck would be ideal for percutaneous thrombin injection. Neither easily corrected hypotension nor a minimal drop in hematocrit would justify surgery at that time.</p>
<p>Surgical management involves achieving proximal and distal control, primary repair of the arteriotomy, and in most cases, delayed primary closure due to the extensive cavity created by a large hematoma. If the hematoma is sufficiently small, primary closure can be attempted, but postoperative infection rates can be high. Other postoperative complications include bleeding and neuralgia.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2006%3B+43(3)%3A520-4." target="_blank">Ates M, Sahin S, Konuralp C, Gullu U, Cimen S, Kizilay M, et al. Evaluation of risk factors associated with femoral pseudoaneurysms after cardiac catheterization. J Vasc Surg 2006; 43(3):520-4.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Int+Angiol+2001%3B+20%3A66-73." target="_blank">Canova CR, Schneider E, Fischer L, Leu AJ<span>,&nbsp;</span>Hoffmann U<span>.</span>&nbsp;Long-term results of percutaneous thrombo-embolectomy in patients with infrainguinal embolic occlusions. Int Angiol 2001; 20:66-73.</a></p>
<p>QID: 30139</p></div><div class="rightanswer">The correct answer is: cellulitis of the skin overlying the affected region</div></div></div></div></div><div id="q147" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">247</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2387"><input type="hidden" name="q20803:147_:flagged" value="0"><input type="hidden" value="qaid=911031&amp;qubaid=20803&amp;qid=4765&amp;slot=147&amp;checksum=c1d2e9fda78933fdbefeb22ed17c2a51&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:147_:flaggedcheckbox" name="q20803:147_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q147&id=4765"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:147_:sequencecheck" value="2"><div class="qtext"><p>A 32-year-old woman presents with progressive dysphagia. The CT scan obtained is shown below. Regarding this patient's diagnosis, which of the following statements is the most accurate?<br></p><p><img src="./VESAP3_files/Cull - 14 image.jpg" alt="Cull - 14 image" width="373" height="224"></p>
<p><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:147_answer" disabled="disabled" value="0" id="q20803:147_answer0"><label for="q20803:147_answer0">a. this abnormality is more common in males</label> </div>
<div class="r1"><input type="radio" name="q20803:147_answer" disabled="disabled" value="1" id="q20803:147_answer1"><label for="q20803:147_answer1">b. presence of a diverticulum of Kommeral is an indication for intervention</label> </div>
<div class="r0"><input type="radio" name="q20803:147_answer" disabled="disabled" value="2" id="q20803:147_answer2"><label for="q20803:147_answer2">c. limb ischemia is the most common indication for treatment</label> </div>
<div class="r1"><input type="radio" name="q20803:147_answer" disabled="disabled" value="3" id="q20803:147_answer3"><label for="q20803:147_answer3">d. 70% of patients develop aneurysmal dilation of the abnormal artery</label> </div>
<div class="r0"><input type="radio" name="q20803:147_answer" disabled="disabled" value="4" id="q20803:147_answer4"><label for="q20803:147_answer4">e. most patients with this abnormality are asymptomatic</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:147_-submit" name="q20803:147_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Aberrant right subclavian artery is a common aortic arch anomaly, second only to "bovine" arch. This condition is usually identified as an incidental finding on imaging obtained for unrelated reasons. Symptoms are often related to compression of the esophagus or, less commonly, the trachea. Aneurysmal degeneration of the aberrant subclavian artery occurs in approximately 5% of patients.&nbsp;Kommerell's diverticulum is present in approximately 20% of patients, and appears as a&nbsp;wide-mouthed origin of the&nbsp;aberrant subclavian artery.&nbsp;The presence of a diverticulum of Kommerell is not an indication for intervention. There is no recurrent laryngeal nerve on the side of the aberrant artery. In symptomatic patients, or patients with large or expanding aneurysms involving the aberrant artery, intervention is warranted. One treatment option consists of ligation of the origin of the aberrant right subclavian artery combined with carotid subclavian bypass. Alternative endovascular options that have been reported may not result in sufficient decompression of the aneurysmal segment to reliably relieve symptoms of dysphagia. The term "dysphagia lusoria" can be loosely translated to mean "freak" or "accident of nature" (lusus naturae).</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p class="desc"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2011%3B+25(4)%3A508-14." target="_blank">Stone WM, Ricotta JJ 2nd, Fowl RJ, Garg N, Bower TC, Money SR.&nbsp;Contemporary management of aberrant right subclavian arteries.&nbsp;Ann Vasc Surg 2011; 25(4):508-14.</a></p>
<p class="desc"><a href="http://www.sciencedirect.com/science/article/pii/S074152141102129X" target="_blank">Farhang B, Garg N,Stone WM, Ricotta JJ, Bower TC.&nbsp; Aberrant subclavian artery: presentation and outcomes.&nbsp; J Vasc Surg 2011; 54(5):1542.</a></p>
<p class="desc"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+57(4)%3A1123-5" target="_blank">Silveira PG, Franklin RN, Cunha JR, Neves TT, Nascimento GG, Bortoluzzi CT. J Vasc Surg 2013; 57(4):1123-5.</a></p>
<p class="desc">QID: 30241</p></div><div class="rightanswer">The correct answer is: most patients with this abnormality are asymptomatic</div></div></div></div></div><div id="q16" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">248</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2396"><input type="hidden" name="q20803:16_:flagged" value="0"><input type="hidden" value="qaid=910900&amp;qubaid=20803&amp;qid=4625&amp;slot=16&amp;checksum=d8f7ec4c38bd97a63eb2db8990632f40&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:16_:flaggedcheckbox" name="q20803:16_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q16&id=4625"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:16_:sequencecheck" value="2"><div class="qtext"><p>Accessory renal arteries are frequently present in the setting of abdominal aortic aneurysms. In most patients, endograft coverage of an accessory renal artery will result in:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:16_answer" disabled="disabled" value="0" id="q20803:16_answer0"><label for="q20803:16_answer0">a. transient decline in renal function</label> </div>
<div class="r1"><input type="radio" name="q20803:16_answer" disabled="disabled" value="1" id="q20803:16_answer1"><label for="q20803:16_answer1">b. segmental renal infarct on postoperative CT scan</label> </div>
<div class="r0"><input type="radio" name="q20803:16_answer" disabled="disabled" value="2" id="q20803:16_answer2"><label for="q20803:16_answer2">c. persistent hypertension</label> </div>
<div class="r1"><input type="radio" name="q20803:16_answer" disabled="disabled" value="3" id="q20803:16_answer3"><label for="q20803:16_answer3">d. no clinical sequelae</label> </div>
<div class="r0"><input type="radio" name="q20803:16_answer" disabled="disabled" value="4" id="q20803:16_answer4"><label for="q20803:16_answer4">e. transient hematuria</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:16_-submit" name="q20803:16_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Elective coverage of accessory renal arteries has been a topic of debate since the inception of endovascular aneurysm repair (EVAR). Nearly 60% of the human population has some variant of renal arterial anatomy other than&nbsp;the "classic" single main renal trunk. However, no more than 15% are anatomically relevant from an endovascular standpoint-those being&nbsp;the ones that arise below the main renal artery and exceed 2 mm in diameter. The fractional, segmental perfusion of an accessory renal artery can be roughly estimated using selective angiography, which may be indicated in patients with mild chronic renal insufficiency or solitary kidneys. Despite some anatomic basis that the renal arterioles essentially are "end-arteries" without collateral perfusion, this may not be entirely correct in the context of segmental perfusion. Candidate collateral sources include both&nbsp;intracortical and transcortical pathways. Studies examining evidence of renal infarction in post-EVAR CT angiograms showed that only a minor subset of patients had any radiographic evidence of ischemia. In addition,&nbsp;the incidence of physiologic effects, such as new-onset renovascular hypertension or decrement in the estimated glomerular filtration rate, has been even rarer. Thus, when deciding between "to cover or not to cover" in order to gain (or lose) additional proximal neck length, evidence would support routine coverage.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Aquino%20RV,%20Rhee%20RY,%20Muluk%20SC,%20et%20al.%20Exclusion%20of%20accessory%20renal%20arteries%20during%20endovascular%20repair%20of%20abdominal%20aortic%20aneurysms.%20J%20Vasc%20Surg;%202001;%2034%20(5):878-884" target="_blank">Aquino RV, Rhee RY, Muluk SC, Tzeng EY, Carrol NM, Makaroun MS. Exclusion of accessory renal arteries during endovascular repair of abdominal aortic aneurysms. J Vasc Surg 2001; 34 (5):878-84</a>.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Karmacharya%20J,%20Parmer%20SS,%20Antezana%20JN,%20et%20al.%20Outcomes%20of%20accessory%20renal%20artery%20occlusion%20during%20endovascular%20aneurysm%20repair.%20J%20Vasc%20Surg;%202006;%2043%20(1):8-13" target="_blank">Karmacharya J, Parmer SS, Antezana JN, Fairman RM, Woo EY, Velazquez OC, et al. Outcomes of accessory renal artery occlusion during endovascular aneurysm repair. J Vasc Surg 2006; 43 (1):8-13</a>.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Kim%20B,%20Donayre%20CE,%20Hansen%20CJ,%20et%20al.%20Endovascular%20abdominal%20aortic%20aneurysm%20repair%20using%20the%20AneuRx%20stent%20graft:%20Impact%20of%20excluding%20accessory%20renal%20arteries.%20Ann%20Vasc%20Surg;%202004;%2018%20(1):32-37" target="_blank">Kim B, Donayre CE, Hansen CJ, Aziz I, Walot I, Lippmann M, et al. Endovascular abdominal aortic aneurysm repair using the AneuRx stent graft: Impact of excluding accessory renal arteries. Ann Vasc Surg 2004; 18 (1):32-7</a>.</p>
<p>QID: 30017</p></div><div class="rightanswer">The correct answer is: no clinical sequelae</div></div></div></div></div><div id="q343" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">249</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2405"><input type="hidden" name="q20803:343_:flagged" value="0"><input type="hidden" value="qaid=911227&amp;qubaid=20803&amp;qid=5135&amp;slot=343&amp;checksum=0ef9823967f7405ea32c6b3b570e52aa&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:343_:flaggedcheckbox" name="q20803:343_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q343&id=5135"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:343_:sequencecheck" value="2"><div class="qtext"><p>A 35-year-old woman presents with severe, 3-drug hypertension. She has a history of extended febrile illness 7 years ago. She has no neurological symptoms, chest or back pain, and no left arm symptoms, but does admit to bilateral lower extremity claudication at 3 blocks of ambulation. Her right brachial blood pressure is 170/110 mmHg, her left is 90/60 mmHg, and she has a midabdominal bruit. Her serum creatinine is 1.7 mg/dL. Erythrocyte sedimentation rate (ESR) and C reactive protein (CRP) levels are normal. An arch aortogram shows stenoses at the origins of the left common carotid artery and left subclavian artery. An image of the abdominal arteriogram is shown below. Which of the following is the most appropriate management option for this patient?</p>
<p><br><a href="./VESAP3_files/AssetProxy_154.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_154.jpg" alt="img" width="100" height="86" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:343_answer" disabled="disabled" value="0" id="q20803:343_answer0"><label for="q20803:343_answer0">a. angioplasty and stenting of the left carotid and subclavian arteries</label> </div>
<div class="r1"><input type="radio" name="q20803:343_answer" disabled="disabled" value="1" id="q20803:343_answer1"><label for="q20803:343_answer1">b. hepatorenal bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:343_answer" disabled="disabled" value="2" id="q20803:343_answer2"><label for="q20803:343_answer2">c. renal artery angioplasty with selective stenting</label> </div>
<div class="r1"><input type="radio" name="q20803:343_answer" disabled="disabled" value="3" id="q20803:343_answer3"><label for="q20803:343_answer3">d. infrarenal aortic interposition grafting with aortorenal bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:343_answer" disabled="disabled" value="4" id="q20803:343_answer4"><label for="q20803:343_answer4">e. medical therapy with corticosteroids</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:343_-submit" name="q20803:343_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Takayasu's arteritis is a recognized etiology for renal artery stenosis and other stenotic or occlusive lesions of major aortic branches. Asymptomatic lesions related to Takayasu's arteritis should not be surgically treated, except in rare circumstances. In this scenario, the patient is clearly symptomatic with renovascular hypertension and ischemic nephropathy due to bilateral renal artery stenoses, as well as lower extremity claudication. There is a role for steroids in the treatment of patients in the active phase of their disease with constitutional symptoms or with significantly elevated ESR or CRP levels. In the absence of these markers for active disease, treatment of the aortic and renal artery stenoses should be the focus of this patient's management. Although renal artery angioplasty with or without stenting has been employed with success for lesions related to Takayasu's arteritis, there is a 14-21% incidence of restenosis and this would leave the aortic stenosis untreated. Open bypass for Takayasu's arteritis offers a low incidence of mortality (&lt; 2%), particularly in this young and otherwise healthy patient, and excellent long-term outcomes. Performing interposition aortic grafting with concomitant aortorenal bypass grafting addresses all of her presently symptomatic vascular territories.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arthritis+Rheum+1990%3B+33+(8)%3A1129-34." target="_blank">Arend WP, Michel BA, Bloch DA, Hunder GG<span>,&nbsp;</span>Calabrese LH<span>,&nbsp;</span>Edworthy SM,&nbsp;et al. The American College of Rheumatology criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33 (8):1129-34.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol%3B+1998%3B+9+(3)%3A429-35." target="_blank">Sharma S, Gupta H, Saxena A,&nbsp;Kothari SS<span>,&nbsp;</span>Taneja K<span>,&nbsp;</span>Guleria S<span>,</span> et al. Results of renal angioplasty in nonspecific aortoarteritis (Takayasu disease). J Vasc Interv Radiol 1998; 9 (3):429-35.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2004%3B+39+(4)%3A749-57." target="_blank">Weaver FA, Kumar SR, Yellin AE, Anderson S,&nbsp;Hood DB,&nbsp;Rowe VL,&nbsp;et al. Renal revascularization in Takayasu arteritis induced renal artery stenosis. J Vasc Surg 2004; 39 (4):749-57.</a></p>
<p>QID: 30609</p></div><div class="rightanswer">The correct answer is: infrarenal aortic interposition grafting with aortorenal bypass</div></div></div></div></div><div id="q123" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">250</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2414"><input type="hidden" name="q20803:123_:flagged" value="0"><input type="hidden" value="qaid=911007&amp;qubaid=20803&amp;qid=4740&amp;slot=123&amp;checksum=373bb6ad76a619bf0b2d6a12f59c3fb3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:123_:flaggedcheckbox" name="q20803:123_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q123&id=4740"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:123_:sequencecheck" value="2"><div class="qtext"><p>Thoracoscopic sympathectomy is a highly effective treatment for which of the following conditions:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:123_answer" disabled="disabled" value="0" id="q20803:123_answer0"><label for="q20803:123_answer0">a. palmar hyperhidrosis</label> </div>
<div class="r1"><input type="radio" name="q20803:123_answer" disabled="disabled" value="1" id="q20803:123_answer1"><label for="q20803:123_answer1">b. complex regional pain syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:123_answer" disabled="disabled" value="2" id="q20803:123_answer2"><label for="q20803:123_answer2">c. horner's syndrome</label> </div>
<div class="r1"><input type="radio" name="q20803:123_answer" disabled="disabled" value="3" id="q20803:123_answer3"><label for="q20803:123_answer3">d. truncal hyperhidrosis</label> </div>
<div class="r0"><input type="radio" name="q20803:123_answer" disabled="disabled" value="4" id="q20803:123_answer4"><label for="q20803:123_answer4">e. digital vasoocclusive disease&nbsp;with ulceration</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:123_-submit" name="q20803:123_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Thorascopic sympathectomy has been used to treat a number of upper extremity&nbsp;conditions and is&nbsp;an effective treatment for&nbsp;palmar hyperhidrosis. It&nbsp;is&nbsp;a less effective treatment for complex&nbsp;regional pain syndrome of the upper extremity or for Raynaud's-related ulceration. Local (digital) sympathectomy may assist healing of an ulceration&nbsp;caused by&nbsp;digital vasoocclusive disease. The most common complication of thoracoscopic sympathectomy for palmar hyperhidrosis is axillary and truncal sweating. Injury to the stellate ganglion during sympathectomy results in Horner's syndrome.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11854724" target="_blank">Bandyk DF, Johnson BL, Kirkpatrick AF, Novotney ML<span>,&nbsp;</span>Back MR<span>,&nbsp;</span>Schmacht DC. Surgical sympathectomy for&nbsp;reflex sympathetic dystrophy&nbsp;syndromes. J Vasc Surg&nbsp;2002;35:269-77.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2009%3B23%3A1-7." target="_blank">Baumgartner FJ, Bertin S, Konecny J.&nbsp; Superiority of thoracoscopic sympathectomy over medical management for the palmoplantar subset of severe hyperhidrosis. Ann Vasc Surg 2009;23:1-7.</a></p>
<p>QID: 30216</p></div><div class="rightanswer">The correct answer is: palmar hyperhidrosis</div></div></div></div></div><div id="q42" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">251</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2423"><input type="hidden" name="q20803:42_:flagged" value="0"><input type="hidden" value="qaid=910926&amp;qubaid=20803&amp;qid=4653&amp;slot=42&amp;checksum=93c7b26b634c309efcab13a4e2ab3bb2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:42_:flaggedcheckbox" name="q20803:42_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q42&id=4653"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:42_:sequencecheck" value="2"><div class="qtext"><p>A 32-year-old woman presents to the emergency center after a lateral impact motor vehicle collision. Work-up includes a CTA, intravascular ultrasound, and angiogram. The images obtained are shown below. &nbsp;She is started on anti-impulse therapy with Esmolol and maintained on Metoprolol as an outpatient. A follow-up CTA at 3 months is most likely to reveal which of the following?</p><p><img src="./VESAP3_files/5(1).jpg" alt="" width="512" height="512" role="presentation" style="vertical-align:text-bottom; margin: 0 .5em;" class="img-responsive"><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:42_answer" disabled="disabled" value="0" id="q20803:42_answer0"><label for="q20803:42_answer0">a. progression of this lesion to a saccular aneurysm</label> </div>
<div class="r1"><input type="radio" name="q20803:42_answer" disabled="disabled" value="1" id="q20803:42_answer1"><label for="q20803:42_answer1">b. complete healing of this lesion</label> </div>
<div class="r0"><input type="radio" name="q20803:42_answer" disabled="disabled" value="2" id="q20803:42_answer2"><label for="q20803:42_answer2">c. progression of this lesion to a pseudoaneurysm</label> </div>
<div class="r1"><input type="radio" name="q20803:42_answer" disabled="disabled" value="3" id="q20803:42_answer3"><label for="q20803:42_answer3">d. progression of this lesion to an intramural hematoma</label> </div>
<div class="r0"><input type="radio" name="q20803:42_answer" disabled="disabled" value="4" id="q20803:42_answer4"><label for="q20803:42_answer4">e. no change in this lesion</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:42_-submit" name="q20803:42_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has an intimal tear consistent with a grade 1 traumatic aortic injury. Traumatic aortic injuries (TAI) represent a spectrum of lesions ranging from intimal tear to free rupture.&nbsp; Classification is based on the extent of injury to the anatomical layers of the aortic wall. Based on imaging, TAI is classified into IV grades: intimal tears (grade I), intramural hematoma (grade II), pseudoaneurysm (grade III), and rupture (grade IV). Grade I injuries are limited to the intima, do not cause an external aortic contour abnormality, and usually heal with medical therapy. Injuries involving the media, such as intramural hematomas or dissections, are considered grade II. Grade II injuries often cause an abnormality in the aortic contour. The diagnosis of pseudoaneurysms and ruptures (grade III and IV) is relatively straight forward. &nbsp;Based on the current Society for Vascular Surgery Practice Guidelines, medical therapy is suggested for grade 1 injuries, while endovascular repair is suggested for anatomically suitable candidates with grade II-IV injuries. This patient has an injury that is limited to the intima. A follow up CTA at 3 months shows complete healing of the lesion with medical therapy (see figure below).</p>
<p><img src="./VESAP3_files/5(2).jpg" alt="" width="512" height="512"></p>
<p><img src="./VESAP3_files/6.jpg" alt="" width="515" height="666"></p>
<p><img src="./VESAP3_files/7.jpg" alt="" width="514" height="454"></p>
<p><img src="./VESAP3_files/8.jpg" alt="" width="512" height="512"></p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Azizzadeh+A%2C+Keyhani+K%2C+Miller+CC%2C+Coogan+SM%2C+Safi+HJ%2C+Estrera+AL.+Blunt+Traumatic+Aortic+Injury%3A+Initial+Experience+with+endovascular+repair.+J+Vasc+Surg+2009%3B49%3A1403-8." target="_blank">Azizzadeh A, Keyhani K, Miller CC, Coogan SM, Safi HJ, Estrera AL. Blunt Traumatic Aortic Injury: Initial Experience with endovascular repair. J Vasc Surg 2009; 49:1403-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lee+WA%2C+Matsumura+JS%2C+Mitchell+RS%2C+Farber+MA%2C+Greenberg+RK%2C+Azizzadeh+A%2C+et+al.+Endovascular+repair+of+traumatic+thoracic+aortic+injury%3A+clinical+practice+guidelines+of+the+Society+for+Vascular+Surgery.+J+Vasc+Surg+2011+Jan%3B53(1)%3A187-92." target="_blank">Lee WA, Matsumura JS, Mitchell RS, Farber MA, Greenberg RK, Azizzadeh A, et al. Endovascular repair of traumatic thoracic aortic injury: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg 2011; 53(1):187-92.&nbsp;</a></p>
<p>QID: 30046</p></div><div class="rightanswer">The correct answer is: complete healing of this lesion</div></div></div></div></div><div id="q239" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">252</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2432"><input type="hidden" name="q20803:239_:flagged" value="0"><input type="hidden" value="qaid=911123&amp;qubaid=20803&amp;qid=4968&amp;slot=239&amp;checksum=49f6ce4660ba21d7ddc98d93faa78a4e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:239_:flaggedcheckbox" name="q20803:239_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q239&id=4968"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:239_:sequencecheck" value="2"><div class="qtext"><p>A 72-year-old, right arm dominant man presents to the emergency department from dialysis with a thrombosed left autogenous radial-cephalic wrist direct access. The arteriovenous (AV) access was placed 2 years ago; it was working well until 2 weeks ago. On physical examination of his left arm, he has no thrill or bruit in his AV access outflow, no edema, and palpable radial, ulnar, and brachial artery pulses. Superficial vein mapping of the patient showed patent left upper arm cephalic and basilic veins and patent right lower and upper arm cephalic and basilic veins, all greater than 3 mm in diameter. Which of the following is the least preferred strategy to restore permanent AV access in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:239_answer" disabled="disabled" value="0" id="q20803:239_answer0"><label for="q20803:239_answer0">a. right forearm synthetic AV graft</label> </div>
<div class="r1"><input type="radio" name="q20803:239_answer" disabled="disabled" value="1" id="q20803:239_answer1"><label for="q20803:239_answer1">b. left autogenous brachial-cephalic upper arm direct access</label> </div>
<div class="r0"><input type="radio" name="q20803:239_answer" disabled="disabled" value="2" id="q20803:239_answer2"><label for="q20803:239_answer2">c. percutaneous pharmaco-mechanical thrombolysis and angioplasty</label> </div>
<div class="r1"><input type="radio" name="q20803:239_answer" disabled="disabled" value="3" id="q20803:239_answer3"><label for="q20803:239_answer3">d. open surgical thrombectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:239_answer" disabled="disabled" value="4" id="q20803:239_answer4"><label for="q20803:239_answer4">e. left braciocephalic forearm synthetic loop graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:239_-submit" name="q20803:239_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The management of autogenous AV fistula thrombosis is in evolution. At one time, it was felt that thrombectomy was&nbsp;inappropriate&nbsp;due to an excessive risk&nbsp;for rethrombosis. Recent data suggest that an attempt at thrombectomy is justified based on satisfactory patency rates and the&nbsp;minimal morbidity related to the procedure.&nbsp;An alternative approach involves creation of a new upper arm autogneous fistula. In general, autogenous access in the non-dominant arm is preferable, thus a new radiocephalic fistula in the&nbsp;right arm is not recommended. Some surgeons might opt for a forearm AV graft&nbsp; to preserve an upper arm autogenous access in the future.&nbsp; Percutaneous treatment of&nbsp;autogenous access thrombosis may be appropriate depending on resources and skills.&nbsp;</p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank">Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg; 2008; 48 (S):55S-80S.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Sidawy%20AN,%20Spergel%20LM,%20Besarb%20A,%20et%20al.%20The%20Society%20for%20Vascular%20Surgery:%20Clinical%20practice%20guidelines%20for%20the%20surgical%20placement%20and%20maintenance%20of%20arteriovenous%20hemodialysis%20access.[all]&cmd=correctspelling" target="_blank">Sidawy AN, Spergel LM, Besarb A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vas Surg 2008; 48 (5S):2S-25S.</a></p>
<p>QID: 30417</p></div><div class="rightanswer">The correct answer is: right forearm synthetic AV graft</div></div></div></div></div><div id="q189" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">253</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2441"><input type="hidden" name="q20803:189_:flagged" value="0"><input type="hidden" value="qaid=911073&amp;qubaid=20803&amp;qid=4557&amp;slot=189&amp;checksum=3c56c2d708b511da67bc0f7f0995de98&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:189_:flaggedcheckbox" name="q20803:189_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q189&id=4557"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:189_:sequencecheck" value="2"><div class="qtext"><p>A 65 year old, left-handed man underwent right subclavian artery angioplasty and stenting for steal and evidence of cerebral hypoperfusion.&nbsp; Two hours after the procedure, the patient developed left sided hemiparesis and aphasia. The most likely cause of these findings are</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:189_answer" disabled="disabled" value="0" id="q20803:189_answer0"><label for="q20803:189_answer0">a. Embolization to the right vertebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:189_answer" disabled="disabled" value="1" id="q20803:189_answer1"><label for="q20803:189_answer1">b. Hypoperfusion secondary to procedural hypotension</label> </div>
<div class="r0"><input type="radio" name="q20803:189_answer" disabled="disabled" value="2" id="q20803:189_answer2"><label for="q20803:189_answer2">c. Embolization to the right common carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:189_answer" disabled="disabled" value="3" id="q20803:189_answer3"><label for="q20803:189_answer3">d. Embolization to the left common carotid artery</label> </div>
<div class="r0"><input type="radio" name="q20803:189_answer" disabled="disabled" value="4" id="q20803:189_answer4"><label for="q20803:189_answer4">e. Cardiac arrhythmia from wire manipulation in the aortic arch</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:189_-submit" name="q20803:189_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Cerebrovascular ischemia complicates subclavian artery angioplasty and stenting in 3-9% of cases. <sup>1-2</sup>&nbsp;The risk of procedure-related cerebrovascular events is higher on the right side than the left presumably due to the proximity of the common carotid artery to the subclavian lesion.The most likely cause of this is embolization secondary to wire manipulation in the arch and across the origins of the common carotid arteries. Interestingly, embolization to the vertebral artery is relatively uncommon during percutaneous treatment of subclavian occlusive disease. However, in patients who present with peripheral embolism as the initial sign of subclavian disease, the risk of procedure-related vertebral embolism is higher than in patients who present with symptoms of subclavian steal (i.e. hemodynamic symptoms in the upper extremity or posterior cerebral symptoms).&nbsp;</p>
<p>1. De Vries JP, Jager LC, Van den Berg JC, et al. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results. J Vasc Surg 2005;&nbsp;41(1): 19-23. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15696038">http://www.ncbi.nlm.nih.gov/pubmed/15696038</a></p>
<p>2. Higashimori A, Morioka N, Shiotani S, et al.&nbsp; Long-term results of primary stenting for subclavian artery disease. Catheter Cardiovasc Interv 2013, 82: 696-700.&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/23475737">http://www.ncbi.nlm.nih.gov/pubmed/23475737</a></p>
<p>QID: 30334</p></div><div class="rightanswer">The correct answer is: Embolization to the right common carotid artery</div></div></div></div></div><div id="q334" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">254</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2450"><input type="hidden" name="q20803:334_:flagged" value="0"><input type="hidden" value="qaid=911218&amp;qubaid=20803&amp;qid=5099&amp;slot=334&amp;checksum=ef2ac7d987c36b496909fc8a2218b8e2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:334_:flaggedcheckbox" name="q20803:334_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q334&id=5099"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:334_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old man underwent emergency repair of a strangulated sliding left inguinal hernia that required a small bowel resection. His recovery was initially uneventful, resuming a normal diet and entering a rehabilitation facility. After 3 weeks, he was transferred back to the acute care hospital for the onset of fever, chills, and mid-abdominal pain. He had mild abdominal tenderness but active bowel sounds. His white count was 17 x 10<sup>3</sup>. Echocardiography showed vegetations on the aortic valve, and a CTA was performed and is shown below. Which of the following is the most appropriate management option for this patient?</p>
<p><a href="./VESAP3_files/20763.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/20763.jpg" alt="Img" width="98" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:334_answer" disabled="disabled" value="0" id="q20803:334_answer0"><label for="q20803:334_answer0">a. interposition vein grafting</label> </div>
<div class="r1"><input type="radio" name="q20803:334_answer" disabled="disabled" value="1" id="q20803:334_answer1"><label for="q20803:334_answer1">b. coil embolization of aneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:334_answer" disabled="disabled" value="2" id="q20803:334_answer2"><label for="q20803:334_answer2">c. aneurysmorrhaphy</label> </div>
<div class="r1"><input type="radio" name="q20803:334_answer" disabled="disabled" value="3" id="q20803:334_answer3"><label for="q20803:334_answer3">d. ligation of the aneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:334_answer" disabled="disabled" value="4" id="q20803:334_answer4"><label for="q20803:334_answer4">e. placement of a covered stent</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:334_-submit" name="q20803:334_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a mycotic superior mesenteric artery aneurysm. In the past, it has been reported that more than 60% of SMA aneurysms have an infectious etiology. A history of antecedent bacteremia such as with bacterial endocarditis is frequently reported. However, a recent report from the Mayo Clinic indicated that only 5% of the SMA aneurysms they treated were mycotic, and the majority were attributed the degenerative atherosclerosis. Clearly referral patterns may influence the relative proportion of mycotic and other aneurysms in a single institution. Due to their rarity, treatment must be individualized and based on the etiology, size, anatomic location, patient co-morbidities, and surgeon capability. In the present case, aneurysmorrhaphy is not a good option because the infected remnant vessel is at risk for catastrophic deterioration. A covered stent might be considered, but there is a risk of contamination/infection of the stent graft. In addition, a stent graft would necessitate coverage of multiple jejunal branches of the SMA. Because the aneurysm involves the mid portion of the main trunk of the SMA, ligation would likely require additional small bowel resection. If test clamping of the SMA proximal and distal to the aneurysm at the time of laparotomy confirmed that only a small segment of bowel was in jeopardy, this might represent a reasonable choice. The aneurysm is probably too large to preserve flow in the main trunk of the SMA, even using detachable coils or a stent/coils technique. Complete coil occlusion of the SMA would run the risk of inducing bowel infarction and is absent the benefit of direct observation of the bowel afforded at laparotomy.</p>
<p>Of these choices, an autogenous in-situ reconstruction is most appealing. It reduces the risk of persistence or recurrence of infection and allows the surgeon to examine the bowel immediately at the time of vascular reconstruction. Long-term antibiotics are appropriate regardless of the treatment selected.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%3Fterm%3DShiraishi+M%2C+Ohki+S%2C+Misawa+Y.+Mycotic+superior+mesenteric+pseudoaneurysm+draining+into+a+vein.+Interactive+Cardiovascular+and+Thoracic+Surgery%3B+2011%3B+12%3A+91-93" target="_blank">Shiraishi M, Ohki S, Misawa Y. Mycotic superior mesenteric pseudoaneurysm draining into a vein. Interact Cardiovasc Thorac Surg 2011; 12:91-3.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2002%3B+36+(2)%3A234-7." target="_blank">Stone WM, Abbas M, Cherry K, Fowl RJ<span>,&nbsp;</span>Gloviczki P<span>.</span>&nbsp;Superior mesenteric artery aneurysms: Is presence an indication for treatment? J Vasc Surg 2002; 36(2):234-7.</a><br><br>Rockman C, Maldonado TS. Splanchnic artery aneurysms. In: Rutherford RB, ed. Vascular Surgery 7th Edition: Philadelphia: PA. Elsevier Saunders; 2010:online.</p>
<p>QID: 30600</p></div><div class="rightanswer">The correct answer is: interposition vein grafting</div></div></div></div></div><div id="q65" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">255</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2459"><input type="hidden" name="q20803:65_:flagged" value="0"><input type="hidden" value="qaid=910949&amp;qubaid=20803&amp;qid=4891&amp;slot=65&amp;checksum=4cd8640cf9f1e968493f8ae4b74f4eca&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:65_:flaggedcheckbox" name="q20803:65_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q65&id=4891"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:65_:sequencecheck" value="2"><div class="qtext"><p>Regarding complications of groin puncture for common femoral access, which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:65_answer" disabled="disabled" value="0" id="q20803:65_answer0"><label for="q20803:65_answer0">a. the location of the inguinal ligament is typically at, or 1-2 cm above, the line connecting the anatomic landmarks of the anterior superior iliac spine and the pubic tubercle</label> </div>
<div class="r1"><input type="radio" name="q20803:65_answer" disabled="disabled" value="1" id="q20803:65_answer1"><label for="q20803:65_answer1">b. high puncture is associated with increased risk of pseudoaneurysm and arteriovenous fistula</label> </div>
<div class="r0"><input type="radio" name="q20803:65_answer" disabled="disabled" value="2" id="q20803:65_answer2"><label for="q20803:65_answer2">c. low puncture is associated with retroperitoneal hematoma</label> </div>
<div class="r1"><input type="radio" name="q20803:65_answer" disabled="disabled" value="3" id="q20803:65_answer3"><label for="q20803:65_answer3">d. the risk of puncture above or below the common femoral artery may be reduced with fluoroscopic identification of the femoral head</label> </div>
<div class="r0"><input type="radio" name="q20803:65_answer" disabled="disabled" value="4" id="q20803:65_answer4"><label for="q20803:65_answer4">e. the common femoral artery is typically located over the lateral third of the femoral head on fluoroscopy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:65_-submit" name="q20803:65_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The goal of femoral access is to puncture the common femoral artery, preferably in an area of minimal plaque and over the femoral head where manual compression can be employed to compress the artery to obtain hemostasis after sheath removal. A high puncture of the external iliac artery (EIA) may lead to retroperitoneal hematoma that may not be recognized until there has been substantial blood loss. Low puncture (below the femoral bifurcation) has a higher incidence of pseudoaneurysm and arteriovenous fistula. The common femoral artery typically lies over the medial third of the femoral head in AP radiologic imaging. Fluoroscopic guidance with puncture over the femoral head has been shown to decrease the incidence of low puncture (superficial femoral or profunda femoris arteries) or high puncture (above the inguinal ligament). Ultrasound guidance allows visualization of the femoral bifurcation, detection of plaque within the common femoral artery, and visualization of the needle entering the correct location. Ultrasound may be most beneficial in obese patients, or those without an easily palpable femoral pulse. The inguinal ligament is often 1-2 cm lower than expected, based solely on bony landmarks, particularly in obese patients. Utilization of a micropuncture needle for access reduces the consequences of unrecognized puncture or inability to advance the entry guidewire once puncture has been achieved. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Fitts%20J,%20Ver%20Lee%20P,%20Hofmaster%20P,%20Malenka%20D.%20Fluoroscopy-guided%20femoral%20artery%20puncture%20reduces%20the%20risk%20of%20PCI-related%20vascular%20complications.%20J%20Interv%20Cardiol;%202008;%2021%20(3):273-278" target="_blank">Fitts J, Ver Lee P, Hofmaster P, Malenka D. Fluoroscopy-guided femoral artery puncture reduces the risk of PCI-related vascular complications. J Interv Cardiol 2008; 21 (3):273-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Pirotte%20T.%20Ultrasound-guided%20vascular%20access%20in%20adults%20and%20children:%20Beyond%20the%20internal%20jugular%20vein%20puncture.%20Acta%20Anaesthesiol%20Belg;%202008;%2059%20(3):157-166" target="_blank">Pirotte T. Ultrasound-guided vascular access in adults and children: Beyond the internal jugular vein puncture. Acta Anaesthesiol Belg 2008; 59 (3):157-66.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Altin%20RS,%20Flicker%20S,%20Naidech%20HJ.%20Pseudoaneurysm%20and%20arteriovenous%20fistula%20after%20femoral%20artery%20catheterization:%20Association%20with%20low%20femoral%20punctures.%20AJR%20Am%20J%20Roentgenol;%201989;%2052%20(3):629-631" target="_blank">Altin RS, Flicker S, Naidech HJ. Pseudoaneurysm and arteriovenous fistula after femoral artery catheterization: Association with low femoral punctures. AJR Am J Roentgenol; 1989; 52 (3):629-31.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Rupp%20SB,%20Vogelzang%20RL,%20Nemcek%20AA,%20Jr,%20Yungbluth%20MM.%20Relationship%20of%20the%20inguinal%20ligament%20to%20pelvic%20radiographic%20landmarks:%20Anatomic%20correlation%20and%20its%20role%20in%20femoral%20arteriography.%20J%20Vasc%20Interv%20Radiol;%201993;%204%20(3):409-413" target="_blank">Rupp SB, Vogelzang RL, Nemcek AA, Jr, Yungbluth MM. Relationship of the inguinal ligament to pelvic radiographic landmarks: Anatomic correlation and its role in femoral arteriography. J Vasc Interv Radiol 1993; 4 (3):409-13</a>.</p>
<p>QID: 30103</p></div><div class="rightanswer">The correct answer is: the risk of puncture above or below the common femoral artery may be reduced with fluoroscopic identification of the femoral head</div></div></div></div></div><div id="q223" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">256</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2468"><input type="hidden" name="q20803:223_:flagged" value="0"><input type="hidden" value="qaid=911107&amp;qubaid=20803&amp;qid=4718&amp;slot=223&amp;checksum=4f017dbbba5fa75d7fd2938f814343b0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:223_:flaggedcheckbox" name="q20803:223_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q223&id=4718"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:223_:sequencecheck" value="2"><div class="qtext"><p>A 69-year-old man with a left carotid bruit has a CT angiogram performed. All of the following are&nbsp;associated with the anatomic anomaly shown on the CT scan below&nbsp;<strong>except</strong>:</p>
<p>&nbsp;</p>
<p><img src="./VESAP3_files/hedgepeth_1.jpg" alt="" width="225" height="374"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:223_answer" disabled="disabled" value="0" id="q20803:223_answer0"><label for="q20803:223_answer0">a. aberrant right vertebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:223_answer" disabled="disabled" value="1" id="q20803:223_answer1"><label for="q20803:223_answer1">b. nonrecurrent laryngeal nerve</label> </div>
<div class="r0"><input type="radio" name="q20803:223_answer" disabled="disabled" value="2" id="q20803:223_answer2"><label for="q20803:223_answer2">c. aneurysmal degeneration of the left subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:223_answer" disabled="disabled" value="3" id="q20803:223_answer3"><label for="q20803:223_answer3">d. difficulty swallowing</label> </div>
<div class="r0"><input type="radio" name="q20803:223_answer" disabled="disabled" value="4" id="q20803:223_answer4"><label for="q20803:223_answer4">e. aneurysmal dilatation of the right subclavian artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:223_-submit" name="q20803:223_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Aberrant right subclavian arteries occur in approximately 1% of patients and are secondary to involution of the fourth vascular arch during ontogeny. Subsequently, a persistent intersegmental artery attaches to the aberrant vessel in a retroesophageal position, a disorder that can compress the esophagus and cause dysphagia. Also known as dysphagia lusoria, aneurysmal degeneration of the proximal portion of this vessel can occur in over half of all patients. This disorder is also associated with an aberrant right vertebral artery origin from the aortic arch or the right common carotid artery. Due to the malposition of the right subclavian artery, a nonrecurrent laryngeal nerve can also occur in these patients.&nbsp;</p>
<h2 class="cit">Reference:</h2>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed/22788890" target="_blank">Yang C,&nbsp;Shu C,&nbsp;Li M,&nbsp;Li Q,&nbsp;Kopp R.&nbsp;Aberrant subclavian artery&nbsp;pathologies and Kommerell's diverticulum: a&nbsp;review&nbsp;and analysis of published endovascular/hybrid treatment options.&nbsp;J Endovasc Ther&nbsp;2012; 19:373-82.&nbsp;</a></div>
<div>QID: 30374</div></div><div class="rightanswer">The correct answer is: aneurysmal degeneration of the left subclavian artery</div></div></div></div></div><div id="q406" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">257</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2477"><input type="hidden" name="q20803:406_:flagged" value="0"><input type="hidden" value="qaid=911290&amp;qubaid=20803&amp;qid=4947&amp;slot=406&amp;checksum=2d2a55ea24988d6a722c3651208ca6df&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:406_:flaggedcheckbox" name="q20803:406_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q406&id=4947"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:406_:sequencecheck" value="2"><div class="qtext"><p>A 56-year-old man with primary chronic venous disease has a recurrent venous ulcer in his right lower extremity. He underwent great saphenous vein ligation and stripping 8 years ago. On duplex ultrasound, there is absence of the great saphenous vein, deep vein reflux in the popliteal and tibial veins, and perforator veins proximal to the ankle ulcer. There is no evidence of deep venous thrombosis. Along with compression, which of the following is the most appropriate next step in the treatment of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:406_answer" disabled="disabled" value="0" id="q20803:406_answer0"><label for="q20803:406_answer0">a. axillary vein-valve transplant to the popliteal vein</label> </div>
<div class="r1"><input type="radio" name="q20803:406_answer" disabled="disabled" value="1" id="q20803:406_answer1"><label for="q20803:406_answer1">b. venography</label> </div>
<div class="r0"><input type="radio" name="q20803:406_answer" disabled="disabled" value="2" id="q20803:406_answer2"><label for="q20803:406_answer2">c. ablation of the incompetent perforator veins</label> </div>
<div class="r1"><input type="radio" name="q20803:406_answer" disabled="disabled" value="3" id="q20803:406_answer3"><label for="q20803:406_answer3">d. ligation of the saphenofemoral junction</label> </div>
<div class="r0"><input type="radio" name="q20803:406_answer" disabled="disabled" value="4" id="q20803:406_answer4"><label for="q20803:406_answer4">e. repeat ultrasound in 3 months</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:406_-submit" name="q20803:406_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The patient has a recurrent venous ulcer. The ultrasound demonstrates the absence of his great saphenous vein and reflux in the popliteal and tibial veins. In addition, the perforator veins are incompetent. The next best treatment for this recurrent venous ulcer would be to ablate the perforator veins. Studies have demonstrated increased ulcer healing and decreased recurrence with subfascial endoscopic perforator surgery, especially for primary disease and in patients with recurrent ulcers. In most studies, the ulcer recurrence rate is between 20-25%. Compression along with surgical ablation is imperative for controlling symptoms. Recently endovenous ablation has also been applied to treat perforator vein insufficiency, although large trials are necessary to define its long term effectiveness. Venography for refluxing perforator and deep veins has been replaced by duplex ultrasound. Axillary vein-valve transplant can be helpful in selected patients; however, it is a much larger and potentially morbid procedure compared to perforator ablation for this patient. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1999%3B+29+(3)%3A489-502." target="_blank">Gloviczki P, Bergan JJ, Rhodes JM, Canton LG<span>,&nbsp;</span>Harmsen S<span>,&nbsp;</span>Ilstrup DM<span>.</span>&nbsp;Mid-term results of endoscopic perforator vein interruption for chronic venous insufficiency: Lessons learned from the North American subfascial endoscopic perforator surgery registry. J Vasc Surg 1999; 29 (3):489-502.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2001%3B+33+(5)%3A1028-32." target="_blank">Sybrandy JE, van Gent WB, Pierik EG, Wittens CH. Endoscopic versus open subfascial division of incompetent perforating veins in the treatment of venous leg ulceration: Long-term follow-up. J Vasc Surg; 2001; 33 (5):1028-32.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2006%3B+44+(3)%3A563-71." target="_blank">Van Gent WB, Hop WC, Van Praag MC, Mackaay AJ<span>,&nbsp;</span>de Boer EM<span>,&nbsp;</span>Wittens CH<span>.</span>&nbsp;Conservative versus surgical treatment of venous leg ulcers: A prospective, randomized, multicenter trial. J Vasc Surg; 2006; 44 (3):563-71.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Proebstle+TM%2C+Herdemann+S.+Early+results+and+feasibility+of+incompetent+perforator+vein+ablation+by+endovenous+laser+treatment." target="_blank">Proebstle TM, Herdemann S. Early results and feasibility of incompetent perforator vein ablation by endovenous laser treatment. Dermatol Surg 2007; 33 (2):162-68.</a></p>
<p>QID: 30724</p></div><div class="rightanswer">The correct answer is: ablation of the incompetent perforator veins</div></div></div></div></div><div id="q467" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">258</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2486"><input type="hidden" name="q20803:467_:flagged" value="0"><input type="hidden" value="qaid=911351&amp;qubaid=20803&amp;qid=5191&amp;slot=467&amp;checksum=634ac663fa537f6dc9b9357bf4a486d3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:467_:flaggedcheckbox" name="q20803:467_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q467&id=5191"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:467_:sequencecheck" value="2"><div class="qtext"><p>All of the following anticoagulants have significant anti-factor Xa activity except __________.</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:467_answer" disabled="disabled" value="0" id="q20803:467_answer0"><label for="q20803:467_answer0">a. rivaroxaban (Xarelto)</label> </div>
<div class="r1"><input type="radio" name="q20803:467_answer" disabled="disabled" value="1" id="q20803:467_answer1"><label for="q20803:467_answer1">b. danaparoid (Orgaran)</label> </div>
<div class="r0"><input type="radio" name="q20803:467_answer" disabled="disabled" value="2" id="q20803:467_answer2"><label for="q20803:467_answer2">c. dabigatran (Pradaxa)</label> </div>
<div class="r1"><input type="radio" name="q20803:467_answer" disabled="disabled" value="3" id="q20803:467_answer3"><label for="q20803:467_answer3">d. apixaban (Eliquis)</label> </div>
<div class="r0"><input type="radio" name="q20803:467_answer" disabled="disabled" value="4" id="q20803:467_answer4"><label for="q20803:467_answer4">e. fondaparinux (Arixta)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:467_-submit" name="q20803:467_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The oral and parenteral classes of drugs with anti-factor Xa activity have been expanding.&nbsp; These agents have indications ranging from the treatment of atrial fibrillation to deep venous thrombosis and heparin-induced thrombocytopenia (HIT). Recently, rivaroxaban and apixaban, two new oral anti-factor Xa agents, have been approved for the treatment of atrial fibrillation. Parenteral agents with anti-factor Xa activity have been used for several years.&nbsp; Danaparoid is a heparinoid with predominately anti-factor Xa activity and may be used in the setting of HIT. Fondaparinux is a synthetic pentasaccharide with indirect anti-Xa activity.&nbsp; Dabigatran (Pradaxa) is an oral agent used for the treatment of atrial fibrillation. Dabigatran acts as an oral direct thrombin inhibitor and does not possess significant anti-Xa activity.&nbsp; There is no specific reversal agent for these medications. Therefore, the answer is dabigatran.</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a href="http://www.sciencedirect.com/science/article/pii/S2213333X13000528" target="_blank">Knepper, Horne D, Obi A, Wakefield TW.</a><span style="line-height: 1.5; color: #333333;"><a href="http://www.sciencedirect.com/science/article/pii/S2213333X13000528" target="_blank">&nbsp;A systematic update on the state of novel anticoagulants and a primer on reversal and bridging.&nbsp; J Vasc Surg: Venous and Lym Dis 2013;1:418-26.</a><a id="authname_N8a7a74a0N9b9078f0" class="authorName" href="http://www.sciencedirect.com/science/article/pii/S2213333X13000528" data-t="a" data-fn="Danielle" data-ln="Horne" data-pos="2" data-tb=""></a></span></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23606934" target="_blank">Bakchoul T, Greinacher A. Recent advances in the diagnosis and treatment of heparin-induced thrombocytopenia. Ther Adv Hematol 2012;3(4):237-51.</a> <strong><br></strong></p>
<p>QID: 30830</p></div><div class="rightanswer">The correct answer is: dabigatran (Pradaxa)</div></div></div></div></div><div id="q456" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">259</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2495"><input type="hidden" name="q20803:456_:flagged" value="0"><input type="hidden" value="qaid=911340&amp;qubaid=20803&amp;qid=5174&amp;slot=456&amp;checksum=2deea80e91828083bc6e65f91f530904&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:456_:flaggedcheckbox" name="q20803:456_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q456&id=5174"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:456_:sequencecheck" value="2"><div class="qtext"><p>Heparin Induced Thrombocytopenia (HIT) syndrome is an immunologically based event where antibodies generated during exposure to heparin affect platelet activation and endothelial dysfunction resulting in thrombocytopenia and thrombosis. Which of the following macromolecules, when bound to heparin, forms the antigenic target for antibodies responsible for HIT?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:456_answer" disabled="disabled" value="0" id="q20803:456_answer0"><label for="q20803:456_answer0">a. antithrombin III</label> </div>
<div class="r1"><input type="radio" name="q20803:456_answer" disabled="disabled" value="1" id="q20803:456_answer1"><label for="q20803:456_answer1">b. factor Xa</label> </div>
<div class="r0"><input type="radio" name="q20803:456_answer" disabled="disabled" value="2" id="q20803:456_answer2"><label for="q20803:456_answer2">c. platelet glycoprotein IIB/IIIA receptor</label> </div>
<div class="r1"><input type="radio" name="q20803:456_answer" disabled="disabled" value="3" id="q20803:456_answer3"><label for="q20803:456_answer3">d. platelet factor-4</label> </div>
<div class="r0"><input type="radio" name="q20803:456_answer" disabled="disabled" value="4" id="q20803:456_answer4"><label for="q20803:456_answer4">e. cell surface glycosoaminoglycans</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:456_-submit" name="q20803:456_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The antigenic target for the antibodies responsible for heparin induced thrombocytopenia is heparin bound platelet factor 4. Platelet factor 4 is a cytokine produced by megakaryocytes and stored within platelet alpha granules. With platelet activation and degranulation, platelet factor 4 is released and available to bind to cell surface glycosoaminoglycans and heparin. Heparin is a mixture of glycosoaminoglycans that bind to antithrombin III and factor Xa, resulting in increased activity of antithrombin III 1000 fold. Approximately 17% of patients treated with heparin and 8% of patients treated with low molecular weight heparin will form antibodies against heparin and platelet factor 4. Most of these patients suffer no clinical consequences, although as many as 20% will develop functionally active antibody complexes which trigger platelet activation, additional platelet factor 4 release, and destabilization of the endothelium. These patients are at significant risk of developing thrombocytopenia, thrombosis, bleeding, and occasionally death with administration of heparin.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest+2001%3B+119+(1+Suppl)%3A64S-94S." target="_blank">Hirsh J, Warkentin TE, Shaughnessy SG, Anand SS<span>,&nbsp;</span>Halperin JL<span>,&nbsp;</span>Raschke R<span>,&nbsp;</span>et al. Heparin and low-molecular-weight heparin: Mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy, and safety. Chest 2001; 119 (1 Suppl):64S-94S.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surgery%3B+2008%3B+143+(3)%3A305-12." target="_blank">Baldwin ZK, Spitzer AL, Ng VL, Harken AH. Contemporary standards for the diagnosis and treatment of heparin induced thrombocytopenia. Surgery 2008; 143 (3):305-12.</a></p>
<p>QID: 30814</p></div><div class="rightanswer">The correct answer is: platelet factor-4</div></div></div></div></div><div id="q82" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">260</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2504"><input type="hidden" name="q20803:82_:flagged" value="0"><input type="hidden" value="qaid=910966&amp;qubaid=20803&amp;qid=4896&amp;slot=82&amp;checksum=c6ea2095b898735c02e23461aeb4ab2d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:82_:flaggedcheckbox" name="q20803:82_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q82&id=4896"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:82_:sequencecheck" value="2"><div class="qtext"><p>The deep femoral artery courses medial to the medial aspect of the femur and typically gives rise to a&nbsp;<strong>branch</strong> that provides collateral circulation to the genicular branches&nbsp;around the knee in the setting of superficial femoral artery occlusion. Which of the following represents the branch described above?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:82_answer" disabled="disabled" value="0" id="q20803:82_answer0"><label for="q20803:82_answer0">a. medial femoral circumflex artery</label> </div>
<div class="r1"><input type="radio" name="q20803:82_answer" disabled="disabled" value="1" id="q20803:82_answer1"><label for="q20803:82_answer1">b. deep circumflex iliac artery</label> </div>
<div class="r0"><input type="radio" name="q20803:82_answer" disabled="disabled" value="2" id="q20803:82_answer2"><label for="q20803:82_answer2">c. lateral circumflex femoral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:82_answer" disabled="disabled" value="3" id="q20803:82_answer3"><label for="q20803:82_answer3">d. perforating branches</label> </div>
<div class="r0"><input type="radio" name="q20803:82_answer" disabled="disabled" value="4" id="q20803:82_answer4"><label for="q20803:82_answer4">e. superficial epigastric artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:82_-submit" name="q20803:82_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The correct answer is lateral femoral circumflex artery. The three branches of the lateral femoral circumflex artery including the ascending, descending, and transverse branches. The descending branch provides collateral circulation to the knee by way of the geniculate branches and becomes particularly important when the superficial femoral artery is occluded.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>&nbsp;Wind GG, Valentine RJ. Anatomic Exposures in Vascular Surgery. Baltimore, Williams &amp; Wilkins, 1990, p 349.</p>
<p>QID: 30126</p></div><div class="rightanswer">The correct answer is: lateral circumflex femoral artery</div></div></div></div></div><div id="q46" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">261</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2513"><input type="hidden" name="q20803:46_:flagged" value="0"><input type="hidden" value="qaid=910930&amp;qubaid=20803&amp;qid=4722&amp;slot=46&amp;checksum=8a505fa25168eb5c06882e3f95fae30e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:46_:flaggedcheckbox" name="q20803:46_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q46&id=4722"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:46_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old woman presents to the ER with an acutely ischemic left leg. She has no palpable dorsalis pedis or posterior tibial pulses, but femoral pulses are present. Clinical findings are consistent with a Rutherford 2B threatened limb. Her labs include Hgb 10.2, WBC 12,000, and platelet count 1.2 million. The aPTT and INR are normal. She undergoes successful emergent open thrombectomy with re-establishment of blood flow to the leg.&nbsp; Post-op CT reveals a residual aortic thrombus as shown below. Appropriate management of this patient's condition includes which of the following?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/aortic thrombus ES.jpg" target="images"><img src="./VESAP3_files/aortic thrombus ES.jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:46_answer" disabled="disabled" value="0" id="q20803:46_answer0"><label for="q20803:46_answer0">a. open aortic thrombectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:46_answer" disabled="disabled" value="1" id="q20803:46_answer1"><label for="q20803:46_answer1">b. therapeutic low molecular weight heparin, followed by oral vitamin K antagonist for 6 months with repeat CT</label> </div>
<div class="r0"><input type="radio" name="q20803:46_answer" disabled="disabled" value="2" id="q20803:46_answer2"><label for="q20803:46_answer2">c. exclusion of the thrombus with endograft placement</label> </div>
<div class="r1"><input type="radio" name="q20803:46_answer" disabled="disabled" value="3" id="q20803:46_answer3"><label for="q20803:46_answer3">d. initiation of antiplatelet therapy with aspirin and hydroxyurea</label> </div>
<div class="r0"><input type="radio" name="q20803:46_answer" disabled="disabled" value="4" id="q20803:46_answer4"><label for="q20803:46_answer4">e. intraarterial thrombolysis, followed by systemic anticoagulation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:46_-submit" name="q20803:46_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Essential thrombocytosis is a relatively rare myeloproliferative disorder with multiple clinical manifestations. Thrombocytosis can present with either hemorrhagic complications or thromboembolic complications. In this case, it presented as an embolic event with limb-threatening consequences. Clinically, this patient required surgery to regain blood flow to the threatened limb. Following resolution of the emergent issues, a dilemma arises with regard to appropriate management of the aortic thrombus found on CT scan. Data are available suggesting that an acceptable management option exists with antiplatelet therapy and hydroxyurea. Hydroxyurea is effective not only in reducing the platelet count in patients with essential thrombocytosis, but it also reduces the frequency of further thrombotic events.</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=New+England+Journal+of+Medicine+332.17+(1995)%3A+1132-7." target="_blank">Cortelazzo S, Finazzi G<span>,&nbsp;</span>Ruggeri M<span>,&nbsp;</span>Vestri O<span>,&nbsp;</span>Galli M<span>,&nbsp;</span>Rodeghiero F,&nbsp;et al. Hydroxyurea for patients with essential thrombocythemia and a high risk of thrombosis.&nbsp;N Eng J Med&nbsp;1995; 332:1132-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2013%3B+27%3A282-90." target="_blank">Fayad ZY, Semaan E, Fahoum B, Briggs M, Tortolani A, D’Ayala M. Aortic Mural Thrombus in the Normal or&nbsp;Minimally Atherosclerotic Aorta. Ann Vasc Surg 2013; 27:282-90.</a></p>
<p>QID: 30050</p></div><div class="rightanswer">The correct answer is: initiation of antiplatelet therapy with aspirin and hydroxyurea</div></div></div></div></div><div id="q392" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">262</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2522"><input type="hidden" name="q20803:392_:flagged" value="0"><input type="hidden" value="qaid=911276&amp;qubaid=20803&amp;qid=5043&amp;slot=392&amp;checksum=4df1793d17baec9f42cfe63003f6ad85&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:392_:flaggedcheckbox" name="q20803:392_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q392&id=5043"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:392_:sequencecheck" value="2"><div class="qtext"><p>In patients with deep vein thrombosis, both the extent of vein wall damage and the severity of clinical symptoms are related to which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:392_answer" disabled="disabled" value="0" id="q20803:392_answer0"><label for="q20803:392_answer0">a. the presence of an inherited hypercoagulable state</label> </div>
<div class="r1"><input type="radio" name="q20803:392_answer" disabled="disabled" value="1" id="q20803:392_answer1"><label for="q20803:392_answer1">b. the size of thrombus</label> </div>
<div class="r0"><input type="radio" name="q20803:392_answer" disabled="disabled" value="2" id="q20803:392_answer2"><label for="q20803:392_answer2">c. the use of low molecular weight heparin rather than unfractionated heparin</label> </div>
<div class="r1"><input type="radio" name="q20803:392_answer" disabled="disabled" value="3" id="q20803:392_answer3"><label for="q20803:392_answer3">d. the duration of thrombus-vein wall contact</label> </div>
<div class="r0"><input type="radio" name="q20803:392_answer" disabled="disabled" value="4" id="q20803:392_answer4"><label for="q20803:392_answer4">e. the magnitude of vein wall leukocyte influx</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:392_-submit" name="q20803:392_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Both in humans (as extrapolated from duplex ultrasound natural history studies) and in experimental models, the rate of thrombus resolution correlates with later symptoms and vein wall damage, respectively. Genetic factors of inflammation, clot formation and consistency, and lysability likely also play a role; however, these are not yet well defined. It is likely that the prolonged thrombus-vein wall contact causes permanent changes due to growth factor and leukocyte mediated events. Hypercoagulable states are not independently associated with greater vein wall damage, and thrombus size itself is not correlated experimentally with vein wall injury. However, thrombus location is, at least in humans.</p>
<p>Low molecular weight heparin may confer an anti-inflammatory effect in addition to the anticoagulant effect, but no consistent data have come from human studies.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1993%3B+18+(4)%3A596-605%2C+discussion+606-598." target="_blank">Meissner MH, Manzo RA, Bergelin RO, Markel A<span>,&nbsp;</span>Strandness DE Jr. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993; 18 (4):596-605, discussion 606-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Thromb+Haemost%3B+2007%3B+98+(5)%3A1045-55." target="_blank">Henke PK, Varma MR, Moaveni DK, Dewyer NA<span>,&nbsp;</span>Moore AJ<span>,&nbsp;</span>Lynch EM<span>,&nbsp;</span>et al. Fibrotic injury after experimental deep vein thrombosis is determined by the mechanism of thrombogenesis. Thromb Haemost; 2007; 98 (5):1045-55.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1998%3B+28+(5)%3A826-33." target="_blank">Meissner MH, Caps MT, Zierler BK, Polissar N,&nbsp;Bergelin RO,&nbsp;Manzo RA,&nbsp;et al. Determinants of chronic venous disease after acute deep venous thrombosis. J Vasc Surg 1998; 28 (5):826-33.</a></p>
<p>QID: 30709</p></div><div class="rightanswer">The correct answer is: the duration of thrombus-vein wall contact</div></div></div></div></div><div id="q63" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">263</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2531"><input type="hidden" name="q20803:63_:flagged" value="0"><input type="hidden" value="qaid=910947&amp;qubaid=20803&amp;qid=4926&amp;slot=63&amp;checksum=e4083a6f2cb2e43e7c4ccc0f14dd5543&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:63_:flaggedcheckbox" name="q20803:63_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q63&id=4926"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:63_:sequencecheck" value="2"><div class="qtext"><p>A 24-year-old man is brought to the emergency department (ED) with gunshot wounds to the abdomen and the right popliteal fossa. At the scene, he was found down with a blood pressure of 50/0. At the ED his pH is 7.15, temperature 34<sup>o </sup>C, and his INR is 1.3. He is resuscitated and taken directly to the operating room to control the hemorrhage in his abdomen. A Sundt<sup>© </sup>looped&nbsp;vascular shunt is placed to temporarily restore perfusion to his right lower extremity. He is taken to the ICU with the shunt in place.&nbsp; Which of the following is the most common complication of a vascular shunt?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:63_answer" disabled="disabled" value="0" id="q20803:63_answer0"><label for="q20803:63_answer0">a. infection</label> </div>
<div class="r1"><input type="radio" name="q20803:63_answer" disabled="disabled" value="1" id="q20803:63_answer1"><label for="q20803:63_answer1">b. thrombosis</label> </div>
<div class="r0"><input type="radio" name="q20803:63_answer" disabled="disabled" value="2" id="q20803:63_answer2"><label for="q20803:63_answer2">c. dislodgement</label> </div>
<div class="r1"><input type="radio" name="q20803:63_answer" disabled="disabled" value="3" id="q20803:63_answer3"><label for="q20803:63_answer3">d. fistula</label> </div>
<div class="r0"><input type="radio" name="q20803:63_answer" disabled="disabled" value="4" id="q20803:63_answer4"><label for="q20803:63_answer4">e. misplacement</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:63_-submit" name="q20803:63_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Recent clinical studies based in war data have demonstrated that temporary vascular shunts are most effective in proximal extremity vascular injuries, such as those of the femoral and popliteal vessels of the lower extremity. The most common complications of shunting are thrombosis and distal embolization. Smaller vessels (such as tibials) are at highest risk for occlusion. Inadequate clearance of preexisting clot from the inflow and outflow vessels and/or aggressive manipulation of the shunt itself renders the risk of thrombosis high. Risk of thrombosis also increases significantly with shunt dwell time of greater than 8–12 h. &nbsp;Shunt occlusion is typically not accompanied by distal embolization. Dislodgement is a rare but a severe complication of shunting; this has particularly been reported when the shunt becomes tangled in the wound closure material.</p>
<p><img src="./VESAP3_files/1(1).jpg" alt="" width="482" height="445"></p>
<p>Operative exposure of the right popliteal artery shunted with a long external (or looped) Sundt<sup>©</sup>&nbsp;vascular shunt in the presence of concomitant orthopedic injury (not visualized).</p>
<p><strong>&nbsp;</strong></p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Trauma+2006%3B+61(1)%3A8%E2%80%9312." target="_blank">Rasmussen TE, Clouse WD, Jenkins DH, Peck MA, Eliason JL, Smith DL. The use of temporary vascular shunts as a damage control adjunct in the management of wartime vascular injury. J Trauma 2006; 61(1):8–12.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2009%3B+50(3)%3A549%E2%80%9355." target="_blank">Gifford SM, Aidinian G, Clouse WD, Fox CJ, Porras CA, Jones WT, et al. Effect of temporary shunting on extremity vascular injury: an outcome analysis from the Global War on Terror vascular injury initiative. J Vasc Surg 2009; 50(3):549–55.</a></p>
<p>QID: 30100</p></div><div class="rightanswer">The correct answer is: thrombosis</div></div></div></div></div><div id="q43" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">264</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2540"><input type="hidden" name="q20803:43_:flagged" value="0"><input type="hidden" value="qaid=910927&amp;qubaid=20803&amp;qid=4720&amp;slot=43&amp;checksum=8ce5d5d1901c5f4511de1e68b3996164&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:43_:flaggedcheckbox" name="q20803:43_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q43&id=4720"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:43_:sequencecheck" value="2"><div class="qtext"><p>The following image shows coronal and sagittal reconstructed images of a patient with an aortic aneurysm. Which of the following is the accurate modified Crawford classification?</p>
<p><span style="font-family: &#39;Tahoma&#39;,&#39;sans-serif&#39;; color: black; font-size: 10pt;"><img src="./VESAP3_files/TAAA question.jpg" alt="" width="462" height="346"></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:43_answer" disabled="disabled" value="0" id="q20803:43_answer0"><label for="q20803:43_answer0">1</label> </div>
<div class="r1"><input type="radio" name="q20803:43_answer" disabled="disabled" value="1" id="q20803:43_answer1"><label for="q20803:43_answer1">2</label> </div>
<div class="r0"><input type="radio" name="q20803:43_answer" disabled="disabled" value="2" id="q20803:43_answer2"><label for="q20803:43_answer2">3</label> </div>
<div class="r1"><input type="radio" name="q20803:43_answer" disabled="disabled" value="3" id="q20803:43_answer3"><label for="q20803:43_answer3">4</label> </div>
<div class="r0"><input type="radio" name="q20803:43_answer" disabled="disabled" value="4" id="q20803:43_answer4"><label for="q20803:43_answer4">5</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:43_-submit" name="q20803:43_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The original Crawford classification system included TAAA extent 1-4. Safi modified this to add extent 5. The classification scheme is important because it indicates the extent of exposure required and correlates with the outcomes after surgical repair. Extent 1 and 2 aneurysms require more complex operative planning, typically with cardio-pulmonary bypass. Conversely, extent 4 TAAA are often repaired in a “clamp and sew” method and have only slightly increased morbidity compared to open AAA or juxta-renal AAA repair. Extent 3 and 5 TAAA are treated with various methods for distal perfusion, but as the proximal clamp is distal to the aortic arch, cardiopulmonary bypass is not always required.</p>
<p>In this case, the aorta at the T6 level is normal in diameter at 3.1 cm. Although there is some mild mural atheroma, the aorta at the level would be suitable for clamping and sewing or for proximal fixation of an endovascular stent graft. This excludes an extent 1 or 2 TAAA. The aorta is ectatic at the distal descending thoracic aorta at 4.2 cm. This precludes clamping and sewing at this level, and therefore excludes the extent 4 classification. The infra-renal aorta is ectatic at 3.3 cm and there is a clear bulge at the L4 level. This excludes the extent 5 classification. Therefore, this aneuryms is an extent 3 thoraco-abdominal aortic aneurysm, as there is no normal segment of aorta between the T6 level and the aortic bifurcation.</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cardiovasc+Surg+1999%3B7%3A607-13." target="_blank">Safi HJ. How I do it: thoracoabdominal aortic aneurysm graft replacement. Cardiovasc Surg 1999; 7:607-13.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Surg+2011%3B212%3A569-581." target="_blank">Wong DR, Parenti JL<span>,&nbsp;</span>Green SY<span>,&nbsp;</span>Chowdhary V<span>,&nbsp;</span>Liao JM<span>,&nbsp;</span>Zarda S,&nbsp;et al. Open Repair of Thoracoabdominal Aortic Aneurysm in the Modern Surgical Era: Contemporary Outcomes in 509 Patients. J Am Coll Surg 2011; 212:569-81.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B53%3A1492-8." target="_blank">Patel VI, Ergul E<span>,&nbsp;</span>Conrad MF<span>,&nbsp;</span>Cambria M<span>,&nbsp;</span>LaMuraglia GM<span>,&nbsp;</span>Kwolek CJ,&nbsp;et al. Continued favorable results with open surgical repair of type IV thoracoabdominal aortic aneurysms. J Vasc Surg 2011;53:1492-8.</a></p>
<p>QID: 30047</p></div><div class="rightanswer">The correct answer is: 3</div></div></div></div></div><div id="q240" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">265</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2549"><input type="hidden" name="q20803:240_:flagged" value="0"><input type="hidden" value="qaid=911124&amp;qubaid=20803&amp;qid=1294&amp;slot=240&amp;checksum=9499a4d4143ee34362de8787f99c6f7d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:240_:flaggedcheckbox" name="q20803:240_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q240&id=1294"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:240_:sequencecheck" value="2"><div class="qtext"><p>A 78 year old male presents to the office one year after placement of a left autogenous brachial-cephalic upper arm direct access with complaints of coolness, numbness, and pain in the left hand while on dialysis. On physical examination of the left arm, he has a thrill and bruit overlying his arteriovenous (AV) access, no edema, a palpable brachial artery pulse, non-palpable radial and ulnar artery pulses, a slightly cool hand with no wounds and no sensory or motor deficits. What is the best initial treatment plan for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:240_answer" disabled="disabled" value="0" id="q20803:240_answer0"><label for="q20803:240_answer0">a. arteriography of the upper extremity</label> </div>
<div class="r1"><input type="radio" name="q20803:240_answer" disabled="disabled" value="1" id="q20803:240_answer1"><label for="q20803:240_answer1">b. banding of the AV access outflow</label> </div>
<div class="r0"><input type="radio" name="q20803:240_answer" disabled="disabled" value="2" id="q20803:240_answer2"><label for="q20803:240_answer2">c. ligation of the brachial artery</label> </div>
<div class="r1"><input type="radio" name="q20803:240_answer" disabled="disabled" value="3" id="q20803:240_answer3"><label for="q20803:240_answer3">d. ligation of the AV access</label> </div>
<div class="r0"><input type="radio" name="q20803:240_answer" disabled="disabled" value="4" id="q20803:240_answer4"><label for="q20803:240_answer4">e. distal revascularization with interval ligation procedure</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:240_-submit" name="q20803:240_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Arterial steal occurs secondary to low access tract resistance, creating a reversal of blood flow in the arterial outflow tract towards the access and away from the hand. This may be demonstrated in up to 90% of all AV accesses, however, it is clinically symptomatic in less than 10%. Clinical symptoms vary and range from mild ischemia presenting as coolness and paresthesias which only occur on dialysis to severe ischemia presenting as constant rest pain, numbness, paralysis, finger contractures, and gangrene. Patients with clinically symptomatic arterial steal should be evaluated with an arteriogram to identify any proximal arterial stenosis, treatment of the proximal artery alone with either endovascular or open surgical techniques may resolve symptoms without need for ligation or revision of the AV access.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Knox%20RC,%20Berman%20SS,%20Hughes%20JK,%20et%20al.%20Distal%20revascularization-interval%20ligation:%20A%20durable%20and%20effective%20treatment%20for%20ischemic%20steal%20syndrome%20after%20hemodialysis%20access.%20J%20Vasc%20Surg;%202003;%2036%20(2):250-256" target="_blank">Knox RC, Berman SS, Hughes JK, et al. Distal revascularization-interval ligation: A durable and effective treatment for ischemic steal syndrome after hemodialysis access. J Vasc Surg; 2003; 36 (2):250-256.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Lazrides%20MK,%20Staramos%20DN,%20Kopadis%20G,%20et%20al.%20Onset%20of%20arterial" target="_blank">Lazrides MK, Staramos DN, Kopadis G, et al. Onset of arterial "steal" following proximal angioaccess: Immediate and delayed types. Nephrol Dial Transplant; 2003; 18 (11):2387-2390</a>.</p>
<p>QID: 30420</p></div><div class="rightanswer">The correct answer is: arteriography of the upper extremity</div></div></div></div></div><div id="q146" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">266</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2558"><input type="hidden" name="q20803:146_:flagged" value="0"><input type="hidden" value="qaid=911030&amp;qubaid=20803&amp;qid=4764&amp;slot=146&amp;checksum=652a9da515f3375321a79aae1a780044&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:146_:flaggedcheckbox" name="q20803:146_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q146&id=4764"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:146_:sequencecheck" value="2"><div class="qtext"><p>A 25-year-old man is brought to the emergency department after a high-speed, single-vehicle motor crash. He was wearing a seat belt, but the air bags did not deploy. The paramedics report loss of consciousness at the scene and that he was not moving his left upper extremity. On arrival, he is hemodynamically normal. Computed tomographic (CT) scan shows an intracranial bleed, a widened mediastinum, and no significant blood in the abdomen. An emergency arch aortogram was performed and the image is shown below. Which of the following is the appropriate next step in the management of this patient?&nbsp;<br></p><p><img src="./VESAP3_files/Cull - 13 image.jpg" alt="Cull - 13 image" width="395" height="493"></p>
<p><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:146_answer" disabled="disabled" value="0" id="q20803:146_answer0"><label for="q20803:146_answer0">a. observation</label> </div>
<div class="r1"><input type="radio" name="q20803:146_answer" disabled="disabled" value="1" id="q20803:146_answer1"><label for="q20803:146_answer1">b. urgent sternotomy and aorto-innominate bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:146_answer" disabled="disabled" value="2" id="q20803:146_answer2"><label for="q20803:146_answer2">c. placement of an endovascular graft in the interventional suite</label> </div>
<div class="r1"><input type="radio" name="q20803:146_answer" disabled="disabled" value="3" id="q20803:146_answer3"><label for="q20803:146_answer3">d. emergency arch reconstruction using total circulatory arrest</label> </div>
<div class="r0"><input type="radio" name="q20803:146_answer" disabled="disabled" value="4" id="q20803:146_answer4"><label for="q20803:146_answer4">e. systemic anticoagulation for dissection and stroke</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:146_-submit" name="q20803:146_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient’s angiogram demonstrates partial transection of the innominate artery, which requires urgent repair. An aorto-innominate bypass could be performed safely (without the use of cardiopulmonary bypass) with a side-biting clamp on the ascending aorta with no or minimal heparin. The proximal innominate would need to be ligated, but the procedure could be completed without clamping the diseased segment of the patient’s vasculature. The intracranial bleed is a contraindication to the anticoagulation required for circulatory arrest, and circulatory arrest is not indicated since the innominate artery (as opposed to the entire arch) is in need of repair. The options of observation or anticoagulation would not be appropriate in this patient. An endovascular stent-graft would be possible, but it is unclear whether this approach would adequately treat the lesion or whether an endovascular repair could be performed safely in the arch and arch branches without the use of systemic anticoagulation.</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1998%3B+27(1)%3A34-42" target="_blank">Berguer R, Morasch MD, Kline RA. Transthoracic repair of innominate and common carotid artery disease: immediate and long-term outcome for 100 consecutive surgical reconstructions. J Vasc Surg&nbsp;1998; 27(1):34-42.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Trauma+1982%3B+22%3A647-55." target="_blank">Graham JM, Feliciano DV, Mattox KL, Beall AC Jr.&nbsp;Innominate vascular injury. J Trauma 1982; 22:647-55.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Injury+2008%3B+39%3A1257-74" target="_blank">Hoffer EK. Endovascular intervention in thoracic arterial trauma. Injury 2008; 39:1257-74.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Perspect+Vasc+Surg+Endovasc+Ther+2006%3B18%3A102-12" target="_blank">Goaley TJ, Dente CJ, Feliciano DV. Torso vascular trauma as an urban level I trauma center. Perspect Vasc Surg Endovasc Ther 2006;18:102-12.</a></p>
<p>QID: 30240</p></div><div class="rightanswer">The correct answer is: urgent sternotomy and aorto-innominate bypass</div></div></div></div></div><div id="q300" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">267</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2567"><input type="hidden" name="q20803:300_:flagged" value="0"><input type="hidden" value="qaid=911184&amp;qubaid=20803&amp;qid=5058&amp;slot=300&amp;checksum=79b69995d3cb922c00a886330f21848c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:300_:flaggedcheckbox" name="q20803:300_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q300&id=5058"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:300_:sequencecheck" value="2"><div class="qtext"><p>The intravascular ultrasound (IVUS) image of an iliac artery shown below demonstrates what finding in the 10 o'clock position?</p>
<p><a href="./VESAP3_files/11688.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/11688.jpg" alt="Img" width="98" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:300_answer" disabled="disabled" value="0" id="q20803:300_answer0"><label for="q20803:300_answer0">a. normal vessel wall with 3 layers</label> </div>
<div class="r1"><input type="radio" name="q20803:300_answer" disabled="disabled" value="1" id="q20803:300_answer1"><label for="q20803:300_answer1">b. guidewire artifact and gain level that makes the lumen appear dense</label> </div>
<div class="r0"><input type="radio" name="q20803:300_answer" disabled="disabled" value="2" id="q20803:300_answer2"><label for="q20803:300_answer2">c. thrombosis of a stent due to poor apposition</label> </div>
<div class="r1"><input type="radio" name="q20803:300_answer" disabled="disabled" value="3" id="q20803:300_answer3"><label for="q20803:300_answer3">d. vessel occlusion by heavily calcified plaque</label> </div>
<div class="r0"><input type="radio" name="q20803:300_answer" disabled="disabled" value="4" id="q20803:300_answer4"><label for="q20803:300_answer4">e. a subintimal dissection containing the probe or guidewire</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:300_-submit" name="q20803:300_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The image demonstrates guidewire artifact (in the 10 o'clock position) and a gain level that makes the lumen appear overly dense. The wall does not appear normal. The gain is set in a manner that the lumen does not appear as dark black as would be more typical with a patent artery and flowing blood; thus pointing out the importance of visualizing the lumen in the context of the surrounding echo-dense structures and adjusting the gain settings to optimize the interpretation of the images. Upon close inspection (or withdrawing to see the 'big picture' in context), one can see a non-calcific plaque or partial thrombus in the vessel causing a stenosis, but there is no calcific plaque. There could be thrombosis given the absence of context for the image, but there is no stent visible, only the probe itself. The wire and probe are clearly not within a subintimal dissection plane. The vessel is not normal, but there is an artifact caused by the guide wire - going away from the probe in a sunburst or ray-type pattern.<br><br></p>
<h2>References:</h2>
<p>Vogt KC, Schroeder TV. Intravascular ultrasound. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:371-81.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2006%3B+19+(3)%3A139-44." target="_blank">Lee JT, Fang TD, White RA. Applications of intravascular ultrasound in the treatment of peripheral occlusive disease. Semin Vasc Surg 2006; 19 (3):139-44.</a></p>
<p>QID: 30520</p></div><div class="rightanswer">The correct answer is: guidewire artifact and gain level that makes the lumen appear dense</div></div></div></div></div><div id="q427" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">268</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2576"><input type="hidden" name="q20803:427_:flagged" value="0"><input type="hidden" value="qaid=911311&amp;qubaid=20803&amp;qid=4871&amp;slot=427&amp;checksum=452c9a6a15e101c3ead582eb3238e526&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:427_:flaggedcheckbox" name="q20803:427_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q427&id=4871"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:427_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old man presents with progressive diffuse abdominal pain that has been occurring for over 3 days. His pain is moderate to severe and examination shows only mild tenderness with no guarding. Computed tomography of the abdomen demonstrates acute venous thrombosis of the superior mesenteric vein. After aggressive full anticoagulation with heparin, surgical treatment would be indicated for:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:427_answer" disabled="disabled" value="0" id="q20803:427_answer0"><label for="q20803:427_answer0">a. peritonitis&nbsp;</label> </div>
<div class="r1"><input type="radio" name="q20803:427_answer" disabled="disabled" value="1" id="q20803:427_answer1"><label for="q20803:427_answer1">b. peritonitis if accompanied by evidence of small bowel perforation</label> </div>
<div class="r0"><input type="radio" name="q20803:427_answer" disabled="disabled" value="2" id="q20803:427_answer2"><label for="q20803:427_answer2">c. evidence of small bowel wall thickening</label> </div>
<div class="r1"><input type="radio" name="q20803:427_answer" disabled="disabled" value="3" id="q20803:427_answer3"><label for="q20803:427_answer3">d. a rising D-dimer and evidence of thrombus propagation into the portal vein</label> </div>
<div class="r0"><input type="radio" name="q20803:427_answer" disabled="disabled" value="4" id="q20803:427_answer4"><label for="q20803:427_answer4">e. surgery is not indicated for this condition</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:427_-submit" name="q20803:427_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Heparin and subsequent long-term anticoagulation with warfarin will adequately treat the majority of patients with mesenteric venous thrombosis. The decision to operate can be complex and is dependent upon a high suspicion of evidence of bowel infarction. Serial examinations, computed tomography scans, and laboratory tests, such as a complete blood count, arterial blood gas, and serum lactate, can assist in making a decision to operate. Both peritonitis and evidence of small bowel perforation are clear indications for surgical exploration, with resection of any encountered dead bowel. A “second-look” operation 24 hours later is often indicated to assure that bowel viability is good and anastomoses can be more safely performed. In selected patients, venous thrombectomy remains a possible option depending on the thrombus burden and extent of small bowel that is dangerously affected. Additionally, rising liver transaminases with accompanied portal vein thrombosis may justify performance of thrombectomy when resecting gangrenous small bowel. &nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=World+J+Gastroenterol+2013%3B19%3A5025-8." target="_blank">Kim HK, Chun JM, Huh S. Anticoagulation and delayed bowel resection in the management of mesenteric venous thrombosis. World J Gastroenterol 2013;19:5025-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1994%3B20%3A688-97." target="_blank">Rhee RY, Gloviczki P, Mendonca CT, Petterson TM<span>,&nbsp;</span>Serry RD<span>,&nbsp;</span>Sarr MG,&nbsp;et al. Mesenteric venous thrombosis: still a lethal disease in the 1990s. J Vasc Surg 1994;20:688-97.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mayo+Clin+Proc+2013%3B88%3A285-94." target="_blank">Singal AK, Kamath PS, Terreri A. Mesenteric venous thrombosis. Mayo Clin Proc 2013;88:285-94.</a></p>
<p>QID: 30752</p></div><div class="rightanswer">The correct answer is: peritonitis&nbsp;</div></div></div></div></div><div id="q281" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">269</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2585"><input type="hidden" name="q20803:281_:flagged" value="0"><input type="hidden" value="qaid=911165&amp;qubaid=20803&amp;qid=5018&amp;slot=281&amp;checksum=e75d09c9c5918b14fddf8f01635fa053&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:281_:flaggedcheckbox" name="q20803:281_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q281&id=5018"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:281_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man underwent placement of a 6 mm PTFE brachiocephalic loop access graft in the left forearm 12 weeks ago. He now presents with a 7 cm perigraft seroma near the arterial anastomosis. There is a strong thrill in the graft. The seroma recurs after two aspirations. This patient's treatment should consist of which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:281_answer" disabled="disabled" value="0" id="q20803:281_answer0"><label for="q20803:281_answer0">a. observation</label> </div>
<div class="r1"><input type="radio" name="q20803:281_answer" disabled="disabled" value="1" id="q20803:281_answer1"><label for="q20803:281_answer1">b. continued serial aspirations</label> </div>
<div class="r0"><input type="radio" name="q20803:281_answer" disabled="disabled" value="2" id="q20803:281_answer2"><label for="q20803:281_answer2">c. closed suction drainage</label> </div>
<div class="r1"><input type="radio" name="q20803:281_answer" disabled="disabled" value="3" id="q20803:281_answer3"><label for="q20803:281_answer3">d. replacement of the involved graft segment</label> </div>
<div class="r0"><input type="radio" name="q20803:281_answer" disabled="disabled" value="4" id="q20803:281_answer4"><label for="q20803:281_answer4">e. replacement of the entire graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:281_-submit" name="q20803:281_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Perigraft seromas consist of sterile, clear, ultrafiltered serum surrounded by a fibrous tissue pseudocapsule and may affect as many as 2-4% of patients undergoing upper extremity arteriovenous graft placement. The underlying cause is failure of the synthetic graft to become encapsulated. Various theories include fibroblast inhibition, allergic reaction to the graft, and graft “wetting”. Perigraft seromas may lead to graft infection, skin necrosis, graft thrombosis, or loss of graft puncture area. Some perigraft seromas resolve spontaneously but most require intervention. A number of treatments have been proposed, but removal of the seroma and replacement of the involved portion of graft have the highest cure rate. Continued serial aspiration and closed suction drainage are associated with a higher rate of infection.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Surg+2006%3B+203%3A+506-11." target="_blank">Dauria DM, Dyk P, Garvin P. Incidence and management of seroma after arteriovenous graft placement. J Am Coll Surg 2006; 203: 506-11.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Surg+1985%3B+149%3A+587-90." target="_blank">Sladen JG, Mandl MAJ, Grossman L, Denegri JF. Fibroblast inhibition: a new and treatable cause of prosthetic graft failure. Am J Surg 1985; 149: 587-90.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Access+2001%3B+1%3A+28-31." target="_blank">Allaria PM, Lucatello A, Gardini E, Giangrande A. Relapsing seroma in a uremic patient bearing a PTFE graft as vascular access. J Vasc Access 2001; 1: 28-31.</a></p>
<p>QID: 30466</p></div><div class="rightanswer">The correct answer is: replacement of the involved graft segment</div></div></div></div></div><div id="q86" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">270</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2594"><input type="hidden" name="q20803:86_:flagged" value="0"><input type="hidden" value="qaid=910970&amp;qubaid=20803&amp;qid=4901&amp;slot=86&amp;checksum=fbb361f099d8657f50fc2d43f010f78d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:86_:flaggedcheckbox" name="q20803:86_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q86&id=4901"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:86_:sequencecheck" value="2"><div class="qtext"><p>A 26-year-old man is seen in consultation for symptoms of lower extremity pain on ambulation. He has palpable pedal pulses at rest and normal resting ABIs. CT angiography did not reveal any anatomic abnormalities or anomalies.&nbsp; Following the onset of symptoms with exercise, compartment pressures are measured revealing lateral compartment pressures of 65mm Hg bilaterally. &nbsp;Which of the following is the best treatment option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:86_answer" disabled="disabled" value="0" id="q20803:86_answer0"><label for="q20803:86_answer0">a. catheter angiography and possible percutaneous intervention</label> </div>
<div class="r1"><input type="radio" name="q20803:86_answer" disabled="disabled" value="1" id="q20803:86_answer1"><label for="q20803:86_answer1">b. fasciotomy and fasciectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:86_answer" disabled="disabled" value="2" id="q20803:86_answer2"><label for="q20803:86_answer2">c. physical therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:86_answer" disabled="disabled" value="3" id="q20803:86_answer3"><label for="q20803:86_answer3">d. cilostazol</label> </div>
<div class="r0"><input type="radio" name="q20803:86_answer" disabled="disabled" value="4" id="q20803:86_answer4"><label for="q20803:86_answer4">e. fasciotomy alone</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:86_-submit" name="q20803:86_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Young patients with claudication must be considered for atypical etiologies for their underlying symptoms. These can include popliteal entrapment syndrome, adventitial cystic disease, medial tibial syndrome, and chronic exertional compartment syndrome. In this instance, workup was unremarkable for anatomic anomalies, which would likely detect popliteal entrapment or adventitial cystic disease. The elevation of compartment pressures is consistent with chronic exertional compartment syndrome which can present in young patients. Optimal treatment for this condition should include fasciotomy and resection of the fascia enveloping the muscles of the leg, in order to assure adequate decompression and durable results.</p>
<p>&nbsp;</p>
<h2>Reference:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2004%3B+40(1)%3A79-85" target="_blank">Turnipseed WD. Clinical review of patients treated for atypical claudication: a 28-year experience. J Vasc Surg 2004; 40(1):79-85.</a></p>
<p>QID: 30131</p></div><div class="rightanswer">The correct answer is: fasciotomy and fasciectomy</div></div></div></div></div><div id="q548" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">271</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2603"><input type="hidden" name="q20803:548_:flagged" value="0"><input type="hidden" value="qaid=911432&amp;qubaid=20803&amp;qid=5283&amp;slot=548&amp;checksum=0b480a9785dc7e992b5ae8b8016e4b3e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:548_:flaggedcheckbox" name="q20803:548_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q548&id=5283"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:548_:sequencecheck" value="2"><div class="qtext"><p>Intensity of the radiation dramatically drops off with distance due to the inverse square law:&nbsp;Exposure rate at 0.5 m = 100 mR/hr.&nbsp;What is the radiation exposure rate at 2 m ?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:548_answer" disabled="disabled" value="0" id="q20803:548_answer0"><label for="q20803:548_answer0">a. 4.50 mR/hr</label> </div>
<div class="r1"><input type="radio" name="q20803:548_answer" disabled="disabled" value="1" id="q20803:548_answer1"><label for="q20803:548_answer1">b. 11.1 mR/hr</label> </div>
<div class="r0"><input type="radio" name="q20803:548_answer" disabled="disabled" value="2" id="q20803:548_answer2"><label for="q20803:548_answer2">c. 6.25 mR/hr</label> </div>
<div class="r1"><input type="radio" name="q20803:548_answer" disabled="disabled" value="3" id="q20803:548_answer3"><label for="q20803:548_answer3">d. 4.5 R/hr</label> </div>
<div class="r0"><input type="radio" name="q20803:548_answer" disabled="disabled" value="4" id="q20803:548_answer4"><label for="q20803:548_answer4">e. 2.25 mR/hr</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:548_-submit" name="q20803:548_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Distance is used as a shield. The dose rate drops significantly as the distance from the source increases. Even one step back from the irradiated area will significantly decrease the operator’s exposure. The inverse square law applies here. In this example, the distance increased by a factor of 4, so the effective radiation exposure decreases by a factor of 16.</p>
<p>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; Original intensity&nbsp;&nbsp;&nbsp; =&nbsp; (New distance)<sup>2</sup></p>
<p>&nbsp;&nbsp;&nbsp; &nbsp;&nbsp; New intensity&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (Old distance)<sup>2</sup></p>
<p><strong><sup>&nbsp;</sup></strong>(100 mR/hr)/( ? mR/hr) = (2.0 m)<sup>2</sup> /(0.5 m)<sup>2</sup>&nbsp;</p>
<p>100/x =&nbsp;&nbsp; 4.0/0.25</p>
<p>4.0 x = (0.25 x 100)</p>
<p>4.0 x = 25</p>
<p>&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;x =&nbsp;&nbsp; 25/4.0</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.25 mR/hr at 2.0 m</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Wagner LK, Archer BR. Minimizing Risk from Fluoroscopic X Rays, Bioeffects, Instrumentation and Examination. Third Edition, 2<sup>nd</sup> printing. 2000, pg. 41.</p>
<p>QID: 30954</p></div><div class="rightanswer">The correct answer is: 6.25 mR/hr</div></div></div></div></div><div id="q517" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">272</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2612"><input type="hidden" name="q20803:517_:flagged" value="0"><input type="hidden" value="qaid=911401&amp;qubaid=20803&amp;qid=5252&amp;slot=517&amp;checksum=c18c15048dd38c9984b33af8f3fbc457&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:517_:flaggedcheckbox" name="q20803:517_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q517&id=5252"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:517_:sequencecheck" value="2"><div class="qtext"><p>Finish this sentence: Keeping the image intensifier close to the patient&nbsp;exposes the patient to a lower dose of radiation due to use of...</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:517_answer" disabled="disabled" value="0" id="q20803:517_answer0"><label for="q20803:517_answer0">a. lower frame rate</label> </div>
<div class="r1"><input type="radio" name="q20803:517_answer" disabled="disabled" value="1" id="q20803:517_answer1"><label for="q20803:517_answer1">b. increased table height</label> </div>
<div class="r0"><input type="radio" name="q20803:517_answer" disabled="disabled" value="2" id="q20803:517_answer2"><label for="q20803:517_answer2">c. increased collimation</label> </div>
<div class="r1"><input type="radio" name="q20803:517_answer" disabled="disabled" value="3" id="q20803:517_answer3"><label for="q20803:517_answer3">d. less magnification</label> </div>
<div class="r0"><input type="radio" name="q20803:517_answer" disabled="disabled" value="4" id="q20803:517_answer4"><label for="q20803:517_answer4">e. lower energy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:517_-submit" name="q20803:517_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Optimal imaging technique contributes to lowering radiation doses for both patients and operators. By increasing the distance of the patient from the X-ray source, the radiation dose that the patient recieves is significantly decreased. By decreasing the distance of the image intensifier from the patient, the energy needed to penetrate the patient and reach the image intensifier to generate an image is also decreased. By decreasing the energy requirement, less radiation is generated and&nbsp;less scatter is created. Likewise, image quality improves. However, the geometric magnification is decreased, thus the image appears smaller. This principal is illustrated by creating shadows with a light source. The closer you hold your hand to the light, the hotter your hand gets and the larger the shadow image appears on the projection surface. The further the hand is from the source, the cooler&nbsp;your hand feels and the closer to normal size the shadow appears relative to your hand. &nbsp;The use of optimal imaging geometry is an important component in radiation safety.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol.+1998+Mar+15%3B31(4)%3A892-913." target="_blank">Limacher MC,&nbsp;Douglas PS,&nbsp;Germano G,&nbsp;Laskey WK,&nbsp;Lindsay BD,&nbsp;McKetty MH, et al.&nbsp;ACC expert consensus document. Radiation safety in the practice of cardiology. American College of Cardiology.&nbsp;J Am Coll Cardiol 1998; 31(4):892-913.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/15687141" target="_blank">Hirshfeld JW, Balter S,&nbsp;Brinker JA,&nbsp;Kern MJ,&nbsp;Klein LW,&nbsp;Lindsay BD,&nbsp;Tommaso CL,&nbsp;et al. ACCF/AHA/HRS/SCAI Fluoroscopy Clinical Competence Statement on Physician Knowledge to Optimize Patient Safety and Image Quaility in Fluoroscopically Guided Invasive Cardiovascular Procedures. Circulation 2005;111(4):511-32.</a></p>
<p>QID: 30920</p></div><div class="rightanswer">The correct answer is: lower energy</div></div></div></div></div><div id="q52" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">273</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2621"><input type="hidden" name="q20803:52_:flagged" value="0"><input type="hidden" value="qaid=910936&amp;qubaid=20803&amp;qid=4307&amp;slot=52&amp;checksum=b7fef90bf517aade2e79f162d89d4663&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:52_:flaggedcheckbox" name="q20803:52_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q52&id=4307"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:52_:sequencecheck" value="2"><div class="qtext"><p>A 55 year old male is undergoing open repair of an infrarenal abdominal aortic aneurysm.&nbsp; Which of the following is the best indication for reimplantation of the inferior mesenteric artery?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:52_answer" disabled="disabled" value="0" id="q20803:52_answer0"><label for="q20803:52_answer0">a. Occluded superior mesenteric artery</label> </div>
<div class="r1"><input type="radio" name="q20803:52_answer" disabled="disabled" value="1" id="q20803:52_answer1"><label for="q20803:52_answer1">b. Brisk back bleeding from transected IMA</label> </div>
<div class="r0"><input type="radio" name="q20803:52_answer" disabled="disabled" value="2" id="q20803:52_answer2"><label for="q20803:52_answer2">c. Occluded right internal iliac artery</label> </div>
<div class="r1"><input type="radio" name="q20803:52_answer" disabled="disabled" value="3" id="q20803:52_answer3"><label for="q20803:52_answer3">d. Occluded IMA on preoperative CT scan</label> </div>
<div class="r0"><input type="radio" name="q20803:52_answer" disabled="disabled" value="4" id="q20803:52_answer4"><label for="q20803:52_answer4">e. Aneurysm measuring greater than 7 cm in maximal diameter</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:52_-submit" name="q20803:52_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The inferior mesenteric artery is usually ligated during open abdominal aortic aneurysm repair.&nbsp; Unfortunately, this can place the patient at risk for postoperative colonic ischemia under certain conditions.&nbsp; If the IMA is occluded on preoperative imaging or is found to be occluded intraoperatively, ligation is unlikely to cause colonic hypoperfusion.&nbsp; Conversely, an open IMA that vigorously back-bleeds implies a large amount of intact collateralization from the SMA and iliac vessels.&nbsp; Aneurysm size is not correlate with risk for colonic ischemia.&nbsp; An occluded SMA, however, places the patient at serious risk for visceral hypoperfusion if the IMA is ligated.</p>
<p><span class="sb-contribution"><span class="sb-authors">1.&nbsp; Brewster&nbsp;DC, Franklin&nbsp;DP, Cambria&nbsp;RP, Darling&nbsp;RC, Moncure&nbsp;AC, Tamuraglia&nbsp;GM, et&nbsp;al.</span>&nbsp;Intestinal ischemia complicating abdominal aortic surgery. </span><span class="sb-issue"><em>Surgery</em>. <span class="sb-date">1991;</span><span class="sb-volume-nr">109</span>:</span><span class="sb-pages">447–454.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/1844392">http://www.ncbi.nlm.nih.gov/pubmed/1844392</a></span></p>
<p><span class="sb-pages"><span class="sb-contribution"><span class="sb-authors">2.&nbsp; Senekowitsch&nbsp;C, Assadian&nbsp;A, Assadian&nbsp;O, Hartleb&nbsp;H, Ptakovsky&nbsp;H, Hagmuller&nbsp;GW</span>. Replanting the inferior mesentery artery during infrarenal aortic aneurysm repair: influence on postoperative colon ischemia. </span><span class="sb-issue"><em>J Vasc Surg</em>. <span class="sb-date">2006;</span><span class="sb-volume-nr">43</span>:</span><span class="sb-pages">689–694.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/16616221">http://www.ncbi.nlm.nih.gov/pubmed/16616221</a></span></span></p>
<p><span class="sb-pages"><span class="sb-pages">3.&nbsp; Levison&nbsp;JA , Halpern&nbsp;VJ , Kline&nbsp;RG , Faust&nbsp;GR , Cohen&nbsp;JR .&nbsp; Perioperative predictors of colonic ischemia after ruptured abdominal aortic aneurysm<strong> . </strong>&nbsp; <span class="sb-issue"><em>J Vasc Surg </em>. <span class="sb-date">1999;</span><span class="sb-volume-nr">29</span>:</span><span class="sb-pages">40–45.&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/9882788">http://www.ncbi.nlm.nih.gov/pubmed/9882788</a></span></span></span></p>
<p><span class="sb-pages"><span class="sb-pages"><span class="sb-pages">QID: 30056</span></span></span></p></div><div class="rightanswer">The correct answer is: Occluded superior mesenteric artery</div></div></div></div></div><div id="q476" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">274</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2630"><input type="hidden" name="q20803:476_:flagged" value="0"><input type="hidden" value="qaid=911360&amp;qubaid=20803&amp;qid=5201&amp;slot=476&amp;checksum=6fb58a59ac9b32cc6dee738ed22c3024&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:476_:flaggedcheckbox" name="q20803:476_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q476&id=5201"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:476_:sequencecheck" value="2"><div class="qtext"><p>Vascular surgery consultation is requested for evaluation of a 31-year-old woman who is recovering from complications related to uterine rupture in early labor. There is a family history of aortic aneurysm rupture; her mother died from aortic rupture at age 40. The patient was noted to have thin skin and she reports that she bruises easily. Joint hypermobility is noted on examination.&nbsp;What testing is appropriate to confirm the diagnosis suggested by this clinical presentation.?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:476_answer" disabled="disabled" value="0" id="q20803:476_answer0"><label for="q20803:476_answer0">a. serum matrix metalloproteinase-9 (MMP-9) assay</label> </div>
<div class="r1"><input type="radio" name="q20803:476_answer" disabled="disabled" value="1" id="q20803:476_answer1"><label for="q20803:476_answer1">b. testing for COL1A2 gene mutation</label> </div>
<div class="r0"><input type="radio" name="q20803:476_answer" disabled="disabled" value="2" id="q20803:476_answer2"><label for="q20803:476_answer2">c. slit lamp microscopy of the eye</label> </div>
<div class="r1"><input type="radio" name="q20803:476_answer" disabled="disabled" value="3" id="q20803:476_answer3"><label for="q20803:476_answer3">d. histochemical staining for elastin on skin biopsy</label> </div>
<div class="r0"><input type="radio" name="q20803:476_answer" disabled="disabled" value="4" id="q20803:476_answer4"><label for="q20803:476_answer4">e. ultrasound of the abdominal aorta</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:476_-submit" name="q20803:476_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The diagnosis of Ehlers-Danlos syndrome (EDS) is suggested. EDS is a group of genetic connective tissue disorders characterized by skin hyperextensibility, joint hypermobility, and/or tissue fragility.</p>
<p>Ehler-Danlos syndrome (EDS) classification uses clinical diagnostic criteria and laboratory findings to define 6 main descriptive types of EDS: classic type (EDS I and II), hypermobility type (EDS III), vascular type (EDS IV), kyphoscoliosis type (EDS VI), arthrochalasia type (EDS VIIA and VIIB), and dermatosparaxis type (EDS VIIC).</p>
<p>EDS IV is particularly malignant due to the occurrence of spontaneous rupture of bowel or large arteries. Complications of EDS IV tend to occur in young adulthood. One large review found that &gt;80% of patients had at least 1 complication by the age of 40 and that median survival was 48 years. Most deaths resulted from arterial rupture. Bowel rupture was a common non-fatal complication. Complications of pregnancy (including uterine rupture) led to death in 15% of women who became pregnant. The diagnosis of EDS IV should be considered in young people who come to medical attention because of uterine rupture during pregnancy or arterial or visceral rupture.&nbsp;This patient, in addition to a suggestive family history, also has two major diagnostic features of EDS IV (the vascular type), and hence the diagnosis can be made.</p>
<p>Vascular EDS is an autosomal dominant condition that results from mutations in the gene for type III procollagen. Laboratory and genetic testing may help confirm the diagnosis. Analysis of type III procollagen from fibroblasts may also be performed, but testing for mutation of the COL3A1 gene offers high diagnostic sensitivity.</p>
<p>Ultrasound of the aorta is not a sensitive test for EDS IV. Aneurysms, when they develop, may be saccular and may not be limited to the infrarenal aorta.&nbsp;Matrix metalloproteinase 9 (MMP-9) has a role in the development of degenerative aneurysms, but it is not part of the pathophysiology of EDS IV.&nbsp;Ehlers-Danlos results from collagen abnormalities and histologic evaluation of elastin or elastase activity are not diagnostic.</p>
<p>Ocular involvement is atypical of most forms of EDS, but scleral fragility, risk of rupture of globe, keratoconus, retinal detachment, and glaucoma are features of kyphoscoliosis EDS (EDS VI), which typically presents in newborns. A slit lamp examination is not helpful in the diagnosis of vascular EDS.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+2000+Mar+9%3B342(10)%3A673-80." target="_blank">Pepin M, Schwarze U, Superti-Furga A, Byers PH. Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. N Engl J Med 2000; 342(10):673-80. Erratum in: N Engl J Med 2001 Feb 1;344(5):392.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2005%3B+42(1)%3A98-106." target="_blank">Oderich GS, Panneton JM, Bower TC, Lindor NM, Cherry KJ, Noel AA, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg 2005; 42(1):98-106.&nbsp;</a></p>
<p>QID: 30840</p></div><div class="rightanswer">The correct answer is: testing for COL1A2 gene mutation</div></div></div></div></div><div id="q442" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">275</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2639"><input type="hidden" name="q20803:442_:flagged" value="0"><input type="hidden" value="qaid=911326&amp;qubaid=20803&amp;qid=5040&amp;slot=442&amp;checksum=7466fb74f8224abd22bf80c6b667f718&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:442_:flaggedcheckbox" name="q20803:442_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q442&id=5040"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:442_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old woman presents with painless left foot edema, nonpitting edema of the leg, and no antecedent trauma or surgery. A D-dimer test is negative and her calf is non-tender. Which of the following represents the most likely diagnosis and the most appropriate workup for this patient?<br><br><a href="./VESAP3_files/AssetProxy_023.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_023.jpg" alt="img" width="100" height="167" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:442_answer" disabled="disabled" value="0" id="q20803:442_answer0"><label for="q20803:442_answer0">a. lymphedema praecox; lymphangiogram</label> </div>
<div class="r1"><input type="radio" name="q20803:442_answer" disabled="disabled" value="1" id="q20803:442_answer1"><label for="q20803:442_answer1">b. arterial occlusion with dependent edema; ankle-brachial index (ABI)</label> </div>
<div class="r0"><input type="radio" name="q20803:442_answer" disabled="disabled" value="2" id="q20803:442_answer2"><label for="q20803:442_answer2">c. acute deep vein thrombosis (DVT); duplex exam</label> </div>
<div class="r1"><input type="radio" name="q20803:442_answer" disabled="disabled" value="3" id="q20803:442_answer3"><label for="q20803:442_answer3">d. chronic DVT: duplex exam and venogram</label> </div>
<div class="r0"><input type="radio" name="q20803:442_answer" disabled="disabled" value="4" id="q20803:442_answer4"><label for="q20803:442_answer4">e. secondary lymphedema; CT abdomen and pelvis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:442_-submit" name="q20803:442_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This clinical scenario, with foot edema on physical exam, is most consistent with secondary lymphedema. It is imperative to evaluate the patient for a retroperitoneal process that may be causing the unilateral lymphedema due to lymphatic obstruction; this includes malignancy. Acute deep vein thrombosis is unlikely in the setting of a negative D-dimer (negative predictive value &gt; 95%). A chronic post thrombotic syndrome (PTS) is possible, but foot edema is not typically observed with PTS. Lymphedema praecox is primary idiopathic lymphedema that occurs sporadically and presents between the ages of 2 and 25. An acute arterial occlusion does not present with painless swelling. In general, evaluating for treatable causes of limb swelling is first and foremost. The therapy for lymphedema is manual lymphatic massage and compression. Surgical therapy is rare. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Warren%20AG,%20Brorson%20H,%20Borud%20LJ,%20Slavin%20SA.%20Lymphedema:%20A%20comprehensive%20review.%20Ann%20Plast%20Surg;%202007;%2059%20(4):464-472" target="_blank">Warren AG, Brorson H, Borud LJ, Slavin SA. Lymphedema: A comprehensive review. Ann Plast Surg 2007; 59 (4):464-72.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Rockson%20SG.%20Diagnosis%20and%20management%20of%20lymphatic%20vascular%20disease.%20J%20Am%20Coll%20Cardiol;%202008;%2052%20(10):799-806" target="_blank">Rockson SG. Diagnosis and management of lymphatic vascular disease. J Am Coll Cardiol; 2008; 52 (10):799-806.</a><br><br>Rooke T, Felty C. Lymphedema: Pathophysiology, classification, and clinical evaluation. In: Gloviczki P, ed. Handbook on Venous Disorders. London, UK: Hodder Arnold; 2009:629 - 634.</p>
<p>QID: 30769</p></div><div class="rightanswer">The correct answer is: secondary lymphedema; CT abdomen and pelvis</div></div></div></div></div><div id="q479" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">276</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2648"><input type="hidden" name="q20803:479_:flagged" value="0"><input type="hidden" value="qaid=911363&amp;qubaid=20803&amp;qid=5204&amp;slot=479&amp;checksum=52810da914132970cf756bcbda5de390&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:479_:flaggedcheckbox" name="q20803:479_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q479&id=5204"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:479_:sequencecheck" value="2"><div class="qtext"><p>A previously healthy 5-year-old girl was admitted to the hospital with conjunctivitis, erythema of the lips and oral mucosa, rash, and cervical lymphadenopathy. The mother reports the illness started with “the flu” (fever, malaise, cough, and diarrhea). Vascular surgery consultation is requested after bilateral signs of hand ischemia were noted.&nbsp;Which of the following diagnoses is suspected?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:479_answer" disabled="disabled" value="0" id="q20803:479_answer0"><label for="q20803:479_answer0">a. Ehlers-Danlos syndrome</label> </div>
<div class="r1"><input type="radio" name="q20803:479_answer" disabled="disabled" value="1" id="q20803:479_answer1"><label for="q20803:479_answer1">b. <span style="color: #000000;">infectious arteritis</span></label> </div>
<div class="r0"><input type="radio" name="q20803:479_answer" disabled="disabled" value="2" id="q20803:479_answer2"><label for="q20803:479_answer2">c. Kawasaki disease</label> </div>
<div class="r1"><input type="radio" name="q20803:479_answer" disabled="disabled" value="3" id="q20803:479_answer3"><label for="q20803:479_answer3">d. moyamoya syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:479_answer" disabled="disabled" value="4" id="q20803:479_answer4"><label for="q20803:479_answer4">e. fibromuscular dysplasia</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:479_-submit" name="q20803:479_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Kawasaki disease is the best choice. Kawasaki disease is a medium-vessel vasculitis that usually occurs in children and is often associated with a mucocutaneous lymph node syndrome following an acute febrile illness. Kawasaki disease is classically associated with coronary arteritis that leads to formation of aneurysms and their complications (ischemic heart disease, sudden death, and congestive heart failure). Peripheral vasculitis manifestations can occur, including acute ischemia from the vasculitis or delayed complications due to progressive arterial occlusive disease.</p>
<p>Moyamoya syndrome is characterized by progressive stenosis of the internal carotid arteries and formation of collateral vessels.</p>
<p>Arterial dissection can occur in children and young adults. Connective tissue disorders, including vascular Ehlers-Danlos syndrome and Marfan syndrome, can predispose to dissection that can result is ischemic complications, including stroke. Spontaneous dissection would not be characteristic of this patient’s systemic illness.</p>
<p>Infectious arteritis is a potential complication of bacteremia, but the constellation of symptoms with this presentation is not suggestive of this diagnosis.&nbsp;While fibromuscular dysplasia (most frequenty the intimal fibroplasia type) may rarely occur in children, it is not associated with the hand.&nbsp;Intimal fibroplasia has&nbsp;no inflammatory component.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Pediatr+Cardiol.+1999%3B+20(2)%3A139-42." target="_blank">Chang JS, Lin JS, Peng CT, Tsai CH. Kawasaki disease complicated by peripheral gangrene. Pediatr Cardiol 1999; 20(2):139-42.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arthritis+Rheum.+2013%3B+65(1)%3A1-11." target="_blank">Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65(1):1-11.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arthritis+Rheum+Aug%3B33(8)%3A1065-7." target="_blank">Hunder GG, Arend WP, Bloch DA, Calabrese LH, Fauci AS, Fries JF, et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis. Introduction. Arthritis Rheum1990; 33(8):1065-7.&nbsp;</a></p>
<p>QID: 30843</p></div><div class="rightanswer">The correct answer is: Kawasaki disease</div></div></div></div></div><div id="q119" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">277</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2657"><input type="hidden" name="q20803:119_:flagged" value="0"><input type="hidden" value="qaid=911003&amp;qubaid=20803&amp;qid=4735&amp;slot=119&amp;checksum=e6a75765587bdff02561d6e6b15a9416&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:119_:flaggedcheckbox" name="q20803:119_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q119&id=4735"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:119_:sequencecheck" value="2"><div class="qtext"><p>A 52-year-old diabetic man was hospitalized for a small subdural hematoma after falling. His history was notable for a coronary bypass with a left internal mammary artery (LIMA) graft. He described episodes of lightheadedness associated with loss of balance. The patient underwent a series of diagnostic tests. Which of the following is the most appropriate treatment option for this patient?<br><a href="./VESAP3_files/AssetProxy_150.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_150.jpg" alt="img" width="100" height="92" border="0" hspace="10" vspace="10"></a><br><a href="./VESAP3_files/AssetProxy_059.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_059.jpg" alt="img" width="100" height="103" border="0" hspace="10" vspace="10"></a><br><a href="./VESAP3_files/AssetProxy_125.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_125.jpg" alt="img" width="100" height="103" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:119_answer" disabled="disabled" value="0" id="q20803:119_answer0"><label for="q20803:119_answer0">a. left carotid endarterectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:119_answer" disabled="disabled" value="1" id="q20803:119_answer1"><label for="q20803:119_answer1">b. resection of left carotid body tumor</label> </div>
<div class="r0"><input type="radio" name="q20803:119_answer" disabled="disabled" value="2" id="q20803:119_answer2"><label for="q20803:119_answer2">c. carotid to carotid bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:119_answer" disabled="disabled" value="3" id="q20803:119_answer3"><label for="q20803:119_answer3">d. left carotid subclavian bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:119_answer" disabled="disabled" value="4" id="q20803:119_answer4"><label for="q20803:119_answer4">e. left subclavian carotid transposition</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:119_-submit" name="q20803:119_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>A diagnosis of vertebrobasilar insufficiency is supported by the patient's history of dizziness and falling, as well as the ultrasound showing reversed flow in the left vertebral artery.&nbsp;The aortogram is noteworthy for 4 findings:&nbsp;1) occlusion of the left subclavian artery at the origin, 2) "bovine" origin of the left common carotid from the innominate artery, 3) an aberrant origin of the right subclavian artery, and 4) splaying of the left carotid bifurcation ("goblet sign") suggestive of carotid body tumor.</p>
<p>The absence of left carotid stenosis eliminates carotid endarterectomy as a viable therapeutic option. Subclavian to carotid transposition is contraindicated in the setting of an internal mammary graft. Carotid to carotid bypass would not address the subclavian steal physiology. Carotid body tumors do not cause vertebrobasilar symptoms. Carotid to subclavian bypass is the preferred treatment option in this case.</p>
<p>&nbsp;</p>
<h3>Reference:</h3>
<p>Morasch M, Berguer R. Brachiocephalic vessel reconstruction. In: Rutherford RB, ed. Vascular Surgery. 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1294-1313.</p>
<p>QID: 30211</p></div><div class="rightanswer">The correct answer is: left carotid subclavian bypass</div></div></div></div></div><div id="q30" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">278</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2666"><input type="hidden" name="q20803:30_:flagged" value="0"><input type="hidden" value="qaid=910914&amp;qubaid=20803&amp;qid=4639&amp;slot=30&amp;checksum=e5b640049e64a7d7ec93332e707f4b9f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:30_:flaggedcheckbox" name="q20803:30_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q30&id=4639"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:30_:sequencecheck" value="2"><div class="qtext"><p><span style="color: #000000;">An 82-year-old man presents with a ruptured abdominal aortic aneurysm and undergoes emergent endovascular repair.&nbsp;He was hypotensive on arrival&nbsp;(SBP&lt;70 mmHg) with mental status changes.&nbsp;An aortic occlusion balloon was utilized to augment systolic blood pressure during the case.&nbsp;He received 10 units of blood, 8 units of plasma, and 2 packs of platelets.&nbsp; His temperature&nbsp;was 35.5 Celsius.&nbsp;He made no urine during the case. Completion angiogram showed both renal arteries and confirmed exclusion of the aneurysm. </span></p>
<p><span style="color: #000000;">At the end of the case, Anesthesia is experiencing difficulty with&nbsp;oxygenation secondary to peak airway pressures of 50mmHg.&nbsp;His mean arterial pressure is 45-50 mmHg.&nbsp;His abdomen is distended and tight, and he has pulses in both femoral arteries.&nbsp;</span>Which of the following is the appropriate next step in the&nbsp;management&nbsp;of this patient?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:30_answer" disabled="disabled" value="0" id="q20803:30_answer0"><label for="q20803:30_answer0">a. <span style="color: #000000;">laparotomy and decompression of the peritoneal space</span></label> </div>
<div class="r1"><input type="radio" name="q20803:30_answer" disabled="disabled" value="1" id="q20803:30_answer1"><label for="q20803:30_answer1">b. <span style="color: #000000;">bladder pressure measurement</span></label> </div>
<div class="r0"><input type="radio" name="q20803:30_answer" disabled="disabled" value="2" id="q20803:30_answer2"><label for="q20803:30_answer2">c. <span style="color: #000000;">urgent laparotomy and graft explant for ongoing hemorrhage</span></label> </div>
<div class="r1"><input type="radio" name="q20803:30_answer" disabled="disabled" value="3" id="q20803:30_answer3"><label for="q20803:30_answer3">d. <span style="color: #000000;">transfer to the intensive care unit for goal-directed resuscitation</span></label> </div>
<div class="r0"><input type="radio" name="q20803:30_answer" disabled="disabled" value="4" id="q20803:30_answer4"><label for="q20803:30_answer4">e. <span style="color: #000000;">initiation of inverse-ratio ventilation to improve oxygenation</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:30_-submit" name="q20803:30_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span style="color: #000000;">Due to hypotension, hypoxia, renal impairment, and a distended abdomen, urgent surgical intervention is required. Transfer to the SICU without resolution of current clincal picture would be unwise. Adjustment of the ventilator (reverse I:E ratio) is unlikely to have a sustained impact on hypoxia due to the mechanical effect of the elevated diaphragm. This patient has several risk factors for the development of abdominal compartment syndrome (ACS).&nbsp; Mehta et al highlighted&nbsp;4 factors for the development of ACS following EVAR for ruptured abdominal aortic aneurysms: use of an aortic occlusion balloon, massive transfusion, coagulopathy, and need to convert to an aorto-uniiliac device. In addition, shock, cardiac arrest, and initial hemoglobin &lt;10 mg/dl have been associated with ACS. The current patient is demonstrating signs of ACS with impending renal and pulmonary failure.&nbsp;At this time, the next step in management should include laparotomy, temporary abdominal closure, and then transfer to the ICU for ongoing resuscitation.&nbsp;Measuring the bladder pressure will only delay the abdominal decompression. In the absence of ongoing hemorrhage, explant of the endograft is not indicated. The abdomen should always be included in the surgical field to prevent the need for a second prep.</span></p>
<p>&nbsp;</p>
<h2><span style="color: #000000;">References:</span></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/16376190" target="_blank"><span style="color: #000000;">Mehta M, Darling RC 3rd, Roddy SP, Fecteau S, Ozsvath KJ, Kreienberg PB, et al. Factors associated with abdominal compartment syndrome complicating endovascular repair of ruptured abdominal aortic aneurysms. J Vasc Surg 2005; 42(6):1047-51.</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mayer+D%2C+Rancic+Z%2C+Meier+C%2C+Pfammatter+T%2C+Veith+FJ%2C+Lachat+M.+Open+abdomen+treatment+following+endovascular+repair+of+ruptured+abdominal+aortic+aneurysms.+J+Vasc+Surg.+2009+Jul%3B50(1)%3A1-7.+doi%3A+10.1016%2Fj.jvs.2008.12.030." target="_blank"><span style="color: #000000;">Mayer D, Rancic Z, Meier C, Pfammatter T, Veith FJ, Lachat M. Open abdomen treatment following endovascular repair of ruptured abdominal aortic aneurysms. J Vasc Surg 2009; 50(1):1-7.</span></a></p>
<p><span style="color: #000000;">QID: 30033</span></p></div><div class="rightanswer">The correct answer is: <span style="color: #000000;">laparotomy and decompression of the peritoneal space</span></div></div></div></div></div><div id="q499" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">279</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2675"><input type="hidden" name="q20803:499_:flagged" value="0"><input type="hidden" value="qaid=911383&amp;qubaid=20803&amp;qid=5215&amp;slot=499&amp;checksum=4eadb4143a04cba84d9fd512c8701e12&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:499_:flaggedcheckbox" name="q20803:499_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q499&id=5215"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:499_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old diabetic man undergoes percutaneous stenting of the superficial femoral artery for claudication. Which of the following medical therapies administered pre-intervention will result in the greatest decrease in the patient’s 6-month, post-procedure risk of a repeat peripheral intervention or conversion to bypass surgery?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:499_answer" disabled="disabled" value="0" id="q20803:499_answer0"><label for="q20803:499_answer0">a. statin only</label> </div>
<div class="r1"><input type="radio" name="q20803:499_answer" disabled="disabled" value="1" id="q20803:499_answer1"><label for="q20803:499_answer1">b. aspirin and statin</label> </div>
<div class="r0"><input type="radio" name="q20803:499_answer" disabled="disabled" value="2" id="q20803:499_answer2"><label for="q20803:499_answer2">c. ACE-inhibitor only</label> </div>
<div class="r1"><input type="radio" name="q20803:499_answer" disabled="disabled" value="3" id="q20803:499_answer3"><label for="q20803:499_answer3">d. aspirin only</label> </div>
<div class="r0"><input type="radio" name="q20803:499_answer" disabled="disabled" value="4" id="q20803:499_answer4"><label for="q20803:499_answer4">e. aspirin and ACE-inhibitor</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:499_-submit" name="q20803:499_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Aspirin and a statin is the correct choice.&nbsp;In a study of 1357 peripheral vascular interventions, the use of either aspirin or statin prior to the intervention decreased the risk for repeat vascular intervention at 6 months with an odds ratio of 0.67.&nbsp; The combination of aspirin and a statin prior to the intervention was associated with an even greater risk reduction with an odds ratio of 0.45.&nbsp;&nbsp;</p>
<p>Dual antiplatelet therapy with aspirin and clopidogrel is commonly used after peripheral arterial interventions, such as femoropopliteal stenting, but compelling evidence that this better than aspirin monotherapy is lacking.</p>
<p>The combination of an oral anticoagulant (warfarin) and antiplatelet therapy is not more effective than antiplatelet therapy alone in preventing major cardiovascular complications after&nbsp;peripheral arterial interventions, and is associated with increased bleeding risk.</p>
<p>Cilostazol, which is FDA approved for treating claudication symptoms, has been found in some studies to reduce restenosis after coronary and peripheral interventions, but a clear benefit with respect to clinical outcome improvement has not been established.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circ+Cardiovasc+Interv+2012%3B+5(6)%3A850-5." target="_blank">Ardati AK, Kaufman SR, Aronow HD, Nypaver TJ, Bove PG, Gurm HS, et al.&nbsp;The quality and impact of risk factor control in patients with stable&nbsp;claudication presenting for peripheral vascular interventions. Circ Cardiovasc&nbsp;Interv 2012; 5(6):850-5.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2013%3B+128(7)%3A749-57" target="_blank">Sobieszczyk P, Eisenhauer A. Management of patients after endovascular&nbsp;interventions for peripheral artery disease. Circulation 2013; 128(7):749-57.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17634457" target="_blank">Warfarin Antiplatelet Vascular Evaluation Trial Investigators, Anand S, Yusuf S, Xie C, Pogue J, Eikelboom J, Budaj A, et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med. 2007;357(3):217-27.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation.+2013+Jun+11%3B127(23)%3A2307-15." target="_blank">Iida O, Yokoi H, Soga Y, Inoue N, Suzuki K, Yokoi Y, et al. Cilostazol reduces angiographic restenosis after endovascular therapy for femoropopliteal&nbsp;lesions in the Sufficient Treatment of Peripheral Intervention by Cilostazol&nbsp;study. Circulation 2013; 127(23):2307-15.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Blood+Rev+2011%3B25(3)%3A123-9." target="_blank">Paikin JS, Wright DS, Eikelboom JW. Effectiveness and safety of combined&nbsp;antiplatelet and anticoagulant therapy: a critical review of the evidence from&nbsp;randomized controlled trials. Blood Rev 2011;25(3):123-9.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Perspect+Vasc+Surg+Endovasc+Ther+2008%3B20(1)%3A28-35." target="_blank">Comerota AJ, Thakur S. Antiplatelet therapy for vascular interventions.&nbsp;Perspect Vasc Surg Endovasc Ther 2008;20(1):28-35.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Cardiovasc+Drugs+2007%3B7(1)%3A59-66." target="_blank">Mannava K, Money SR. Current management of peripheral arterial occlusive&nbsp;disease: a review of pharmacologic agents and other interventions. Am J&nbsp;Cardiovasc Drugs 2007;7(1):59-66.</a></p>
<p>QID: 30867</p></div><div class="rightanswer">The correct answer is: aspirin and statin</div></div></div></div></div><div id="q279" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">280</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2684"><input type="hidden" name="q20803:279_:flagged" value="0"><input type="hidden" value="qaid=911163&amp;qubaid=20803&amp;qid=5016&amp;slot=279&amp;checksum=2aed3b7954a3557f0a49a267fd493b74&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:279_:flaggedcheckbox" name="q20803:279_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q279&id=5016"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:279_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old man with a history of coronary artery disease and chronic renal insufficiency underwent placement of a left brachiocephalic arteriovenous autogenous access 4 months ago. He has since developed orthopnea and been admitted to the hospital on three separate occasions for congestive heart failure. The access is patent and has an average blood flow of 1600 ml/min. The patient has a resting heart rate of 120 beats/min that decreases to 90 beats/min when the access is compressed. Which of the following is the best treatment option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:279_answer" disabled="disabled" value="0" id="q20803:279_answer0"><label for="q20803:279_answer0">a. ligation of the fistula</label> </div>
<div class="r1"><input type="radio" name="q20803:279_answer" disabled="disabled" value="1" id="q20803:279_answer1"><label for="q20803:279_answer1">b. re-siting the anastomosis to the radial artery</label> </div>
<div class="r0"><input type="radio" name="q20803:279_answer" disabled="disabled" value="2" id="q20803:279_answer2"><label for="q20803:279_answer2">c. administration of digoxin</label> </div>
<div class="r1"><input type="radio" name="q20803:279_answer" disabled="disabled" value="3" id="q20803:279_answer3"><label for="q20803:279_answer3">d. distal revascularization and interval ligation (DRIL)</label> </div>
<div class="r0"><input type="radio" name="q20803:279_answer" disabled="disabled" value="4" id="q20803:279_answer4"><label for="q20803:279_answer4">e. banding the brachial artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:279_-submit" name="q20803:279_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>High-output cardiac failure is a rare complication of high-flow arteriovenous fistulas (AVFs).&nbsp; Cardiac effects seen in all renal patients with AVFs include increased left ventricular end-diastolic dimensions and left ventricular hypertrophy, which are usually reversed with fistula closure. These effects are due to decreased peripheral resistance and increased cardiac output, but they rarely progress to cardiac failure. However, in a small percentage of patients, an increase in blood volume leads to increases in right atrial pressure, pulmonary artery pressure, and left ventricular end-diastolic pressure until the myocardium decompensates. That then leads to LV dilation with decreased systolic ejection fraction, leading to symptoms of congestive heart failure. Risk factors for high-output CHF in patients with AVF include underlying cardiac disease, anemia, upper arm AVF (vs. forearm), male sex, and an upper arm fistula in the same arm as a previously functioning forearm fistula.</p>
<p>Treatment of high-output CHF in patients with high-flow AVF should be directed at reducing peripheral resistance; inotropic agents are not effective. Ligation of the fistula has been used to manage this condition, but results in loss of access. Banding of the fistula has been recommended, using intraoperative measures of fistula flow to assess efficacy. Banding of the inflow artery is not recommended. Re-siting the AV anastomosis to a smaller, distal artery has been used successfully to reduce fistula flow and correct CHF while maintaining fistula patency. The DRIL procedure is effective to treat steal syndrome, but should not be used to treat high-output CHF because it will not reduce the flow rate through the fistula.</p>
<p>&nbsp;</p>
<h2>References</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Kidney+Dis+2004%3B+43%3A+e17-e22" target="_blank">MacRae JM, Pandeya S, Humen DP, Krivitski N<span>,&nbsp;</span>Lindsay RM<span>.</span>&nbsp;Arteriovenous fistula-associated high-output cardiac failure: a review of mechanisms. Am J Kidney Dis 2004; 43: e17-e22.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sem+Dialysis+2007%3B+20%3A+68-72." target="_blank">Chemia ES, Morsey M, Anderson L, Whitemore A. Inflow reduction by distalization of anastomosis treats efficiently high-inflow high-cardiac output vascular access for hemodialysis. Sem Dialysis 2007; 20: 68-72.</a></p>
<p>QID: 30464</p></div><div class="rightanswer">The correct answer is: re-siting the anastomosis to the radial artery</div></div></div></div></div><div id="q401" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">281</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2693"><input type="hidden" name="q20803:401_:flagged" value="0"><input type="hidden" value="qaid=911285&amp;qubaid=20803&amp;qid=4780&amp;slot=401&amp;checksum=2a161410ab86a7c6ec52d34f372d6331&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:401_:flaggedcheckbox" name="q20803:401_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q401&id=4780"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:401_:sequencecheck" value="2"><div class="qtext"><p>A 32-year-old woman presents with acute massive left lower extremity swelling. Duplex ultrasound confirms acute deep venous thrombosis of the ipsilateral common and external iliac veins. The patient is fully anticoagulated with heparin. A venogram (via the popliteal vein) is obtained and shown below. Which of the following is the most appropriate next step in the management of this patient?<br><br><a href="./VESAP3_files/AssetProxy_018.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_018.jpg" alt="img" width="100" height="131" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:401_answer" disabled="disabled" value="0" id="q20803:401_answer0"><label for="q20803:401_answer0">a. venous thrombectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:401_answer" disabled="disabled" value="1" id="q20803:401_answer1"><label for="q20803:401_answer1">b. pharmacomechanical thrombolysis</label> </div>
<div class="r0"><input type="radio" name="q20803:401_answer" disabled="disabled" value="2" id="q20803:401_answer2"><label for="q20803:401_answer2">c. catheter-directed thrombolysis with tPA infusion</label> </div>
<div class="r1"><input type="radio" name="q20803:401_answer" disabled="disabled" value="3" id="q20803:401_answer3"><label for="q20803:401_answer3">d. continue heparin with transition to warfarin sodium</label> </div>
<div class="r0"><input type="radio" name="q20803:401_answer" disabled="disabled" value="4" id="q20803:401_answer4"><label for="q20803:401_answer4">e. manual pulse-spray thrombolysis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:401_-submit" name="q20803:401_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Iliofemoral deep venous thrombosis (DVT) represents a more virulent form of lower extremity venous thrombosis compared to femoropopliteal DVT, particularly with regard to the development of the post-thrombotic syndrome. For this reason, recent recommendations as to the optimal treatment have changed considerably. Guidelines from the American College of Chest Physicians now state that catheter-directed thrombolysis can be used to reduce acute symptoms and post-thrombotic morbidity in&nbsp;patients with "extensive acute proximal DVT (eg, iliofemoral DVT, symptoms for &lt; 14 days, good functional status, life-expectancy 1 year) who have a low risk of bleeding". Power-pulse thrombolysis, using a rheolytic mechanical catheter, represents one type of pharmacomechanical catheter commercially available. Pharmacomechanical catheters combine the ability to deliver thrombolytic drug in combination with direct, high-powered mechanical dissolution of venous thrombus. This combination leads to a decrease in thrombolytic drug dosing and overall treatment times. This option contrasts significantly to standard pulse spray by hand-powered injection alone or in combination with catheters designed to simply drip thrombolytic drug into the thrombus. Historically, these treatments had longer treatment times, higher doses of thrombolytic drug used, and greater hemorrhagic complications. Although standard pulse-spray followed by catheter-drip of thrombolytic drug is an acceptable method of treatment, newer treatments with pharmacomechanical catheters remain the preferred method.<br><br></p>
<h3>References:</h3>
<p>American College of Chest Physicians. Antithrombotic and Thrombolytic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest; 2008; 133 Suppl (6 Suppl):465S-7S.<br><br>Comerota AJ, Assi ZI. Catheter-Based interventions for acute deep venous thrombosis. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier; 2005:2179-87.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2008%3B+48+(6)%3A1532-7" target="_blank">Martinez Trabal JL, Comerota AJ, Laporte FB, Kazanjian S<span>,&nbsp;</span>DiSalle R<span>,&nbsp;</span>Sepanski DM. The quantitative benefit of isolated, segmental, pharmacomechanical thrombolysis (ISPMT) for iliofemoral venous thrombosis. J Vasc Surg; 2008; 48 (6):1532-7.</a></p>
<p>QID: 30718</p></div><div class="rightanswer">The correct answer is: pharmacomechanical thrombolysis</div></div></div></div></div><div id="q38" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">282</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2702"><input type="hidden" name="q20803:38_:flagged" value="0"><input type="hidden" value="qaid=910922&amp;qubaid=20803&amp;qid=4649&amp;slot=38&amp;checksum=cba8b4a0a23f500154fb7030b21ad50c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:38_:flaggedcheckbox" name="q20803:38_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q38&id=4649"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:38_:sequencecheck" value="2"><div class="qtext"><p>You are called emergently to the operating room where a trauma surgeon has performed an emergent exploratory laparotomy on a 24-year-old man after multiple gunshot wounds to the flank and abdomen. Upon exploration, the surgeon has identified and controlled an infrarenal abdominal aortic injury. The aortic defect involves greater than 50% of the anterior and lateral walls for a segment of 3 cm. The injury is located below the renal arteries and the inferior mesenteric artery is intact distally. Associated injuries identified at the time of exploration include a splenic injury, necessitating splenectomy, and a right colon injury resulting in heavy fecal contamination of the abdomen. The patient remains hypotensive with significant ongoing resuscitative needs. &nbsp;Which of the following is the most appropriate management option for this aortic injury?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:38_answer" disabled="disabled" value="0" id="q20803:38_answer0"><label for="q20803:38_answer0">a. creation of a neoaorta using femoral vein</label> </div>
<div class="r1"><input type="radio" name="q20803:38_answer" disabled="disabled" value="1" id="q20803:38_answer1"><label for="q20803:38_answer1">b. ligation of the aorta above and below the level of injury with delayed extra-anatomic axillobifemoral artery bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:38_answer" disabled="disabled" value="2" id="q20803:38_answer2"><label for="q20803:38_answer2">c. primary repair of the aortic injury after mobilization</label> </div>
<div class="r1"><input type="radio" name="q20803:38_answer" disabled="disabled" value="3" id="q20803:38_answer3"><label for="q20803:38_answer3">d. synthetic graft repair with omental coverage of graft and fecal diversion</label> </div>
<div class="r0"><input type="radio" name="q20803:38_answer" disabled="disabled" value="4" id="q20803:38_answer4"><label for="q20803:38_answer4">e. saphenous vein patch repair of the injury</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:38_-submit" name="q20803:38_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Abdominal aortic injuries are associated with significant mortality. In one of the largest series of abdominal vascular injuries published to date, Tyburski et al found mortality correlated with location of the injury (92% mortality among those with injuries of the pararenal or suprarenal segments, compared to 66% in the infrarenal segment). Patients surviving to operation are most commonly in profound hypovolemic shock with associated hypothermia, acidosis, and coagulopathy. Among patients surviving initial operation, primary suturing is the most common repair technique utilized (69-86%), followed by prosthetic graft in 14-23%.</p>
<p>In this scenario, optimal management is dictated by consideration of both patient condition and the associated injuries. Ligation, while the most expedient of options presented, will result in significant additional hypoperfusion of the lower extremities. Delayed, or even expedient, extra-anatomic bypass after ligation will contribute to an ischemia-reperfusion insult that would not be well tolerated. Saphenous vein patch repair is an option but requires the time needed to harvest and prepare the vein. The natural history of saphenous vein patch at this location is not well known and there is a concern that the saphenous vein repair may be more prone to disruption than more robust venous or prosthetic conduits. The creation of a neoaorta using femoral vein utilizes a more robust venous conduit, but this procedure demands considerable time and expertise to complete and is not appropriate in this acute setting for a patient being actively resuscitated in hypovolemic shock. Primary repair is not likely an option when considering the degree of missing aortic wall that is described in this scenario.</p>
<p>Among the options offered, and based upon the current published experience, synthetic &nbsp;graft repair with omental or muscle flap coverage and fecal diversion is the most appropriate option. The choice of graft material is largely a matter of surgeon preference, but there is some experimental evidence that PTFE is more resistant to infection than polyester fabric.&nbsp;This option is expedient and rapidly restores the perfusion to the lower extremities to limit ischemic insult. Infection of synthetic graft in the setting of fecal contamination remains a significant concern, necessitating omental or muscle flap coverage to exclude the graft from the peritoneal field. Although primary repair of colon injuries in this setting is well described in the modern trauma literature, the sequela of intra-abdominal sepsis in the setting of synthetic aortic graft warrant strong consideration of fecal diversion to mitigate this risk.</p>
<p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Tyburski+JG%2C++Wilson+RF%2C+Dente+C%2C+et+al.+Factors+affecting+mortality+rates+in+patients+with+abdominal+vascular+injuries.+J+Trauma%2C+2001%3B+50%3A1020-1026." target="_blank">Tyburski JG,&nbsp; Wilson RF, Dente C, Steffes C,&nbsp;Carlin AM. Factors affecting mortality rates in patients with abdominal vascular injuries. J Trauma 2001; 50:1020-26.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Asensio+JA%2C+Chawan+S%2C+Hanpeter+D%2C+et+al.+Operative+management+and+outcome+of+302+abdominal+vascular+injuries.+Am+J+Surg+2000%3B180%3A528-33." target="_blank">Asensio JA, Chawan S, Hanpeter D, Demetriades D,&nbsp;Forno W,&nbsp;Gambaro E. Operative management and outcome of 302 abdominal vascular injuries. Am J Surg 2000;180:528-33.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Asensio+JA%2C+Chawan+S%2C+Hanpeter+D%2C+et+al.+Operative+management+and+outcome+of+302+abdominal+vascular+injuries.+Am+J+Surg+2000%3B180%3A528-33." target="_blank">Davis TP, Feliciano DV, Rozycki GS, Demetriades D<span>,&nbsp;</span>Forno W<span>,&nbsp;</span>Gambaro E,&nbsp;et al. Results with abdominal vascular trauma in the modern era. Am Surg 2001; 67:565-70.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=tarnes+BW%2C+Arthurs+ZM.+Endovascular+management+of+vascular+trauma.+Perspect+Vasc+Surg+Endovasc+Ther+2006%3B18%3A114-129." target="_blank">Starnes BW, Arthurs ZM. Endovascular management of vascular trauma. Perspect Vasc Surg Endovasc Ther 2006;18:114-29.</a></p>
<p>QID: 30042</p></div><div class="rightanswer">The correct answer is: synthetic graft repair with omental coverage of graft and fecal diversion</div></div></div></div></div><div id="q196" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">283</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2711"><input type="hidden" name="q20803:196_:flagged" value="0"><input type="hidden" value="qaid=911080&amp;qubaid=20803&amp;qid=4687&amp;slot=196&amp;checksum=7477a53fab7bfbcc34a0ab271a05aef7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:196_:flaggedcheckbox" name="q20803:196_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q196&id=4687"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:196_:sequencecheck" value="2"><div class="qtext"><p><span style="font-size: 10pt;">A 70-year-old woman is 1 year post-op from staged bilateral carotid endarterectomies when she suffers a left hemispheric stroke. Her symptoms consist of expressive aphasia and right hemiparesis. Carotid duplex and CT angiogram show 70% recurrent stenosis of the right ICA and 95% stenosis of the left ICA. You recommend stenting of the left ICA. After stent deployment, she develops recurrent aphasia and is unable to move her right arm. Which of the following statements is <span style="font-size: 10pt;"><strong>not</strong></span> true?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:196_answer" disabled="disabled" value="0" id="q20803:196_answer0"><label for="q20803:196_answer0">a. <span style="font-size: 10pt;">vasospasm of the distal internal carotid artery can be treated with intra-arterial nitroglycerin administration</span></label> </div>
<div class="r1"><input type="radio" name="q20803:196_answer" disabled="disabled" value="1" id="q20803:196_answer1"><label for="q20803:196_answer1">b. <span style="font-size: 10pt;">obstruction of the filter should be treated with aspiration, expeditious completion of the procedure, and adequate anticoagulation</span></label> </div>
<div class="r0"><input type="radio" name="q20803:196_answer" disabled="disabled" value="2" id="q20803:196_answer2"><label for="q20803:196_answer2">c. <span style="font-size: 10pt;">embolization to the proximal anterior cerebral artery should be treated with neurorescue</span></label> </div>
<div class="r1"><input type="radio" name="q20803:196_answer" disabled="disabled" value="3" id="q20803:196_answer3"><label for="q20803:196_answer3">d. <span style="font-size: 10pt;">symptomatic intracranial emboli can be treated intra-arterial tPA, angioplasty, or mechanical embolectomy</span></label> </div>
<div class="r0"><input type="radio" name="q20803:196_answer" disabled="disabled" value="4" id="q20803:196_answer4"><label for="q20803:196_answer4">e. <span style="font-size: 10pt;">embolization to the M1or M2 segments of the middle cerebral artery will improve spontaneously</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:196_-submit" name="q20803:196_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The incidence of neurologic complications from CAS has varied with different studies. In CREST, the periprocedural stroke rate was 4.1%. Neurologic complications during CAS can be due to embolization, hemodynamic instability, flow obstruction from filter thrombosis, vasospasm, and/or arterial injury. Patients&nbsp;should be continuously&nbsp;assessed neurologically throughout the procedure. If a neurologic deficit develops, biplanar cerebral angiography should be performed and compared to baseline images. If there are no major branch emboli, the&nbsp;deficit usually improves spontaneously.&nbsp;&nbsp;Embolization involving the M1, M2, A1, A2 segments, or other&nbsp;major branch&nbsp;are unlikely to&nbsp;resolve.&nbsp; Neurorescue&nbsp;with intra-cranial&nbsp;catheter directed thrombolysis, angioplasty, and/or&nbsp;mechanical thrombectomy should be attempted.&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21326801" target="_blank">Fanelli F, Bezzi M, Boatta E, Passariello R. Carotid intervention 3: the evidence for cerebral protection. Semin Intervent Radiol 2007; 24(2): 234-43.&nbsp; </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/15986328" target="_blank">Cunningham EJ, Fiorella D, Masaryk TJ. Neurovascular rescue. Semin Vasc Surg 2005; 18(2): 101-9.</a>&nbsp;</p>
<p>QID: 30345</p></div><div class="rightanswer">The correct answer is: <span style="font-size: 10pt;">embolization to the M1or M2 segments of the middle cerebral artery will improve spontaneously</span></div></div></div></div></div><div id="q313" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">284</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2720"><input type="hidden" name="q20803:313_:flagged" value="0"><input type="hidden" value="qaid=911197&amp;qubaid=20803&amp;qid=5078&amp;slot=313&amp;checksum=e07baa204f725df8fbeccbf8e5800ac1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:313_:flaggedcheckbox" name="q20803:313_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q313&id=5078"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:313_:sequencecheck" value="2"><div class="qtext"><p>The ultrasound images below were obtained from&nbsp;a patient with acute left hemiparesis.&nbsp; This patient's images are most consistent with which of the following?</p>
<p><img style="line-height: 1.5;" src="./VESAP3_files/1(2).jpg" alt="" width="346" height="233"></p>
<p>Image 1, left common carotid artery (CCA), green arrow&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;&nbsp;</p>
<p><img style="line-height: 1.5;" src="./VESAP3_files/2(3).jpg" alt="" width="345" height="232"></p>
<p>Image 2, left internal carotid artery (ICA)&nbsp;</p>
<p><img src="./VESAP3_files/3(1).jpg" alt="" width="346" height="232"></p>
<p>Image 3, left external carotid artery (ECA)</p>
<p><img src="./VESAP3_files/4(3).jpg" alt="" width="344" height="231"></p>
<p>Image 4, right internal carotid artery (ICA)</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:313_answer" disabled="disabled" value="0" id="q20803:313_answer0"><label for="q20803:313_answer0">a. occlusion of the left common carotid artery and high-grade stenosis of the right internal carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:313_answer" disabled="disabled" value="1" id="q20803:313_answer1"><label for="q20803:313_answer1">b. antegrade flow in the left external carotid artery (ECA) and high-grade stenosis of the left CCA and right ICA</label> </div>
<div class="r0"><input type="radio" name="q20803:313_answer" disabled="disabled" value="2" id="q20803:313_answer2"><label for="q20803:313_answer2">c. occlusion of the left common artery (CCA) and the right internal carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:313_answer" disabled="disabled" value="3" id="q20803:313_answer3"><label for="q20803:313_answer3">d. high-grade stenosis of the left and right internal carotid arteries (ICAs)</label> </div>
<div class="r0"><input type="radio" name="q20803:313_answer" disabled="disabled" value="4" id="q20803:313_answer4"><label for="q20803:313_answer4">e. occlusion of the left and right internal carotid arteries</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:313_-submit" name="q20803:313_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In image 1, there is no color filling of the left common carotid artery (CCA), green arrow.&nbsp; In image 2, the left internal carotid artery (ICA) waveform is normal, as evidenced by low resistant antegrade flow in the left ICA, flow above the baseline, and end-diastolic flow, also considerably above the baseline. In Image 3, however, there is retrograde flow (below the baseline) in the external carotid artery (ECA) with a low resistance pattern (high end-diastolic flow), rather than the normal high resistance pattern of the ECA (low end-diastolic flow).&nbsp; This indicates reversed flow in the normally high resistance left external carotid artery feeding the normally low resistance ICA circulation. &nbsp;The left side of the image therefore indicates occlusion of the left CCA, with the left CCA bifurcation remaining patent via retrograde flow in the ECA into the ICA. On the right, the ICA waveform is spiked with low velocity (18cm/sec) and no diastolic flow.&nbsp; This indicates occlusion of the right ICA just above the site where the waveform was taken.</p>
<p>The correct answer is therefore occlusion of the left common and right internal carotid arteries. The patient’s acute left hemiparesis suggests the left CCA occlusion was chronic and the right ICA occlusion acute.</p>
<p>QID: 30540</p></div><div class="rightanswer">The correct answer is: occlusion of the left common artery (CCA) and the right internal carotid artery</div></div></div></div></div><div id="q508" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">285</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2729"><input type="hidden" name="q20803:508_:flagged" value="0"><input type="hidden" value="qaid=911392&amp;qubaid=20803&amp;qid=5239&amp;slot=508&amp;checksum=f76f02f9f0ef8fb286734e80508d3928&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:508_:flaggedcheckbox" name="q20803:508_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q508&id=5239"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:508_:sequencecheck" value="2"><div class="qtext"><p>Increasing the distance from the C-arm tube to the surgeon from 1 to 2 feet will reduce the radiation exposure to the surgeon by what factor?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:508_answer" disabled="disabled" value="0" id="q20803:508_answer0"><label for="q20803:508_answer0">a. 8</label> </div>
<div class="r1"><input type="radio" name="q20803:508_answer" disabled="disabled" value="1" id="q20803:508_answer1"><label for="q20803:508_answer1">b. 1</label> </div>
<div class="r0"><input type="radio" name="q20803:508_answer" disabled="disabled" value="2" id="q20803:508_answer2"><label for="q20803:508_answer2">c. 2</label> </div>
<div class="r1"><input type="radio" name="q20803:508_answer" disabled="disabled" value="3" id="q20803:508_answer3"><label for="q20803:508_answer3">d. 3</label> </div>
<div class="r0"><input type="radio" name="q20803:508_answer" disabled="disabled" value="4" id="q20803:508_answer4"><label for="q20803:508_answer4">e. 4</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:508_-submit" name="q20803:508_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>As Low As Reasonably Achievable (ALARA) guidelines suggest 3 factors for lowering radiation exposure to the health care professional. These include&nbsp;time (decreased time of direct exposure), distance (doubling the distance from the radiation source will reduce the radiation exposure by a factor of 4, as dose drops with the square of the distance), and&nbsp;shielding (using materials such as Plexiglass for beta particles and lead for X-rays/gamma rays will absorb radiation and lower the exposure). Monitoring of radiation exposure is an important measure to assure safety of the healthcare professional who frequently interacts with radiation. This requires compliance with wearing the appropriate dosimetry monitor and replacing the monitor at the appropriate intervals.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Cardella%20JF,%20Miller%20DL,%20Cole%20PE,%20Lewis%20CA.%20Society%20of%20Interventional%20Radiology%20position%20statement%20on%20radiation%20safety.%20J%20Vasc%20Interv%20Radiol;%202003;%2014%20(9%20Pt%202):S387" target="_blank">Cardella JF, Miller DL, Cole PE, Lewis CA. Society of Interventional Radiology position statement on radiation safety. J Vasc Interv Radiol; 2003; 14 (9 Pt 2):S387.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B+46+(3)%3A455-9." target="_blank">Ho P, Cheng SW, Wu PM, Ting AC<span>,&nbsp;</span>Poon JT<span>,&nbsp;</span>Cheng CK,&nbsp;et al. Ionizing radiation absorption of vascular surgeons during endovascular procedures. J Vasc Surg 2007; 46 (3):455-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol%3B+2009%3B+20+(7+Suppl)%3AS263-73." target="_blank">Stecker MS, Balter S, Towbin RB, Miller DL,&nbsp;Vañó E,&nbsp;Bartal G,&nbsp;et al. Guidelines for patient radiation dose management. J Vasc Interv Radiol 2009; 20 (7 Suppl):S263-73.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation%3B+2005%3B+111+(4)%3A511-32." target="_blank">Hirshfeld JW, Jr., Balter S, Brinker JA, Kern MJ<span>,&nbsp;</span>Klein LW<span>,&nbsp;</span>Lindsay BD,&nbsp;et al. ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures: A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Circulation 2005; 111 (4):511-32.</a></p>
<p>QID: 30907</p></div><div class="rightanswer">The correct answer is: 4</div></div></div></div></div><div id="q514" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">286</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2738"><input type="hidden" name="q20803:514_:flagged" value="0"><input type="hidden" value="qaid=911398&amp;qubaid=20803&amp;qid=5246&amp;slot=514&amp;checksum=255719f7c19325c1f538c0bf41e8fdb6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:514_:flaggedcheckbox" name="q20803:514_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q514&id=5246"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:514_:sequencecheck" value="2"><div class="qtext"><p>You are referred a 63-year-old diabetic woman with gangrene of her left great toe extending to the first metatarsal head. Her creatinine is 5mg/dl, but she has not started dialysis, with a stable creatinine at this level for the past several months. You decide to perform CO2 angiography. These two images (A and B) are at the level of the proximal thigh; these images demonstrate&nbsp;which of the following?</p>
<p><a href="./VESAP3_files/12250.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/12250.jpg" alt="Img" width="157" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:514_answer" disabled="disabled" value="0" id="q20803:514_answer0"><label for="q20803:514_answer0">a. SFA occlusive disease before and after stenting</label> </div>
<div class="r1"><input type="radio" name="q20803:514_answer" disabled="disabled" value="1" id="q20803:514_answer1"><label for="q20803:514_answer1">b. severe vasospasm relieved with nitroglycerin</label> </div>
<div class="r0"><input type="radio" name="q20803:514_answer" disabled="disabled" value="2" id="q20803:514_answer2"><label for="q20803:514_answer2">c. acute embolus and subsequent lysis</label> </div>
<div class="r1"><input type="radio" name="q20803:514_answer" disabled="disabled" value="3" id="q20803:514_answer3"><label for="q20803:514_answer3">d. chronic profunda occlusive disease before and after percutaneous transluminal angioplasty</label> </div>
<div class="r0"><input type="radio" name="q20803:514_answer" disabled="disabled" value="4" id="q20803:514_answer4"><label for="q20803:514_answer4">e. typical CO2 gas bubbles and subsequent filling</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:514_-submit" name="q20803:514_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Injection of CO2 with its decreased radiodensity creates radiographic contrast by transiently displacing blood from the artery being imaged. In the early portion of a subtraction run with CO2, the bubbles will appear similar to obstructions from emboli, with sharp cutoffs, but these pass quite quickly, and the vessel fills as long as the injection is adequate and the vessel to be imaged is at a similar level or higher than the injection point (as the gas is less dense than blood and rises anteriorly). Historically, CO2 arteriography has had limited use because of poor imaging quality in comparison to conventional contrast agents. However, with improved equipment, technology, and image-processing software, CO2 arteriography can be used in a wide variety of cases, and with much less reservation than in the past. Digital subtraction technology has greatly enhanced anatomic definition and visualization with this contrast agent, but imaging quality still remains inferior to that of conventional contrast agents. Overestimation of the degree of stenosis can occur when one is unable to completely fill the diameter of the artery with CO2. Many techniques can be used to enhance the quality of CO2 arteriography, including rapid frame rates (4 to 8 frames per second), selective catheterization, and magnified views. For lower extremity arteriography, Trendelenburg positioning or elevation of the extremity to about 20 to 30 degrees will slow distal blood flow and promote concentration of the CO2 as it rises, thus slowing the dispersion rate as CO2 travels distally. The CO2 delivery system must include purging of the tubing to prevent the possibility of accidental injection of air. Nitrogen gas in ambient air is not soluble and can lead to gas embolization, "air lock", and thrombosis. With the proper precautions, complications related to CO2 arteriography are very uncommon.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Surg+1993%3B+217+()%3A688-97." target="_blank">Seeger JM, Self S, Harward TR, Flynn TC<span>,&nbsp;</span>Hawkins IF Jr. Carbon dioxide gas as an arterial contrast agent. Ann Surg 1993; 217 ():688-97.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Carbon+dioxide+angiography+for+endovascular+grafting+in+high-risk+patients+with+infrarenal+abdominal+aortic+aneurysms.+J+Vasc+Surg%3B+2001%3B+33+()%3A646-649" target="_blank">Gahlen J, Hansmann J, Schumacher H, Seelos R<span>,&nbsp;</span>Richter GM<span>,&nbsp;</span>Allenberg JR. Carbon dioxide angiography for endovascular grafting in high-risk patients with infrarenal abdominal aortic aneurysms. J Vasc Surg 2001; 33 ():646-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Carbon+dioxide+angiography%3A+Effect+of+injection+parameters+on+bolus+configurations.+J+Vasc+Interv+Radiol%3B+1999%3B+10+()%3A41-49" target="_blank">Lang EV, Gossler AA, Fick LJ, Barnhart W<span>,&nbsp;</span>Lacey DL.&nbsp;Carbon dioxide angiography: Effect of injection parameters on bolus configurations. J Vasc Interv Radiol 1999; 10 (1):41-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Carbon+dioxide+digital+subtraction+angiography%3A+The+practical+approach.+Tech+Vasc+Interv+Radiol%3B+2001%3B+4+(1)%3A57-65" target="_blank">Caridi JG, Hawkins Jr IF, Klioze SD, Leveen RF. Carbon dioxide digital subtraction angiography: The practical approach. Tech Vasc Interv Radiol 2001; 4 (1):57-65.</a><br><br>Rana NR, McLafferty RB. Arteriography. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. Philadelphia, PA: Saunders Elsevier; 2010:285-304.</p>
<p>QID: 30914</p></div><div class="rightanswer">The correct answer is: typical CO2 gas bubbles and subsequent filling</div></div></div></div></div><div id="q394" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">287</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2747"><input type="hidden" name="q20803:394_:flagged" value="0"><input type="hidden" value="qaid=911278&amp;qubaid=20803&amp;qid=5045&amp;slot=394&amp;checksum=fb88a7bb35100835f5d0ecadc656bd96&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:394_:flaggedcheckbox" name="q20803:394_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q394&id=5045"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:394_:sequencecheck" value="2"><div class="qtext"><p>A 63-year-old man presents with swelling, pain, and skin discoloration in the left lower extremity. He was treated for acute deep vein thrombosis (DVT) in the left femoral, popliteal, peroneal, and posterior tibial veins 5 years ago. A duplex ultrasound image of his left popliteal vein is shown below. The image demonstrates which of the following?<br><br><a href="./VESAP3_files/AssetProxy_010.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_010.jpg" alt="img" width="100" height="63" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:394_answer" disabled="disabled" value="0" id="q20803:394_answer0"><label for="q20803:394_answer0">a. partial recanalization with of the popliteal vein with valvular reflux</label> </div>
<div class="r1"><input type="radio" name="q20803:394_answer" disabled="disabled" value="1" id="q20803:394_answer1"><label for="q20803:394_answer1">b. a popliteal venous aneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:394_answer" disabled="disabled" value="2" id="q20803:394_answer2"><label for="q20803:394_answer2">c. partial recanalization of the popliteal vein with normal valve function</label> </div>
<div class="r1"><input type="radio" name="q20803:394_answer" disabled="disabled" value="3" id="q20803:394_answer3"><label for="q20803:394_answer3">d. complete recanalization of the popliteal vein with valvular reflux</label> </div>
<div class="r0"><input type="radio" name="q20803:394_answer" disabled="disabled" value="4" id="q20803:394_answer4"><label for="q20803:394_answer4">e. complete recanalization of the popliteal vein with normal valve function</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:394_-submit" name="q20803:394_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Recanalization of the deep veins is often observed after an episode of acute DVT. Duplex ultrasound in this case shows thrombus, collagen, and prolonged valve reflux. The intraluminal material is more echogenic in the chronic phase, as the thrombus becomes organized. The diameter of the vein may be normal or reduced as the vein wall becomes more sclerotic. Recanalized veins often develop reflux. In this case, the popliteal vein was partially recanalized with reflux. Echogenic material is present in the lumen and channels of refluxing blood are seen in red color. The Doppler tracing demonstrate cephalad flow during calf compression and prolonged reflux during release of the compression.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2009%3B+49+(3)%3A704-10." target="_blank">Labropoulos N, Gasparis A, Pefanis D, Leon LR Jr<span>,&nbsp;</span>Tassiopoulos AK. Secondary chronic venous disease progresses faster than primary. J Vasc Surg 2009; 49 (3):704-10.</a><br><br>Abai B, Labropoulos N. Duplex ultrasound scanning for chronic venous obstruction and valvular incompetence. In: Gloviczki P, ed. Handbook of venous disorders. 3rd ed. London, UK: Hodder Arnold; 2009:142-55.</p>
<p>QID: 30711</p></div><div class="rightanswer">The correct answer is: partial recanalization with of the popliteal vein with valvular reflux</div></div></div></div></div><div id="q110" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">288</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2756"><input type="hidden" name="q20803:110_:flagged" value="0"><input type="hidden" value="qaid=910994&amp;qubaid=20803&amp;qid=4930&amp;slot=110&amp;checksum=6fb923a9ee83820cbc9eb53590c1ac72&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:110_:flaggedcheckbox" name="q20803:110_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q110&id=4930"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:110_:sequencecheck" value="2"><div class="qtext"><p>A 72-year-old diabetic woman presents with severe ischemic rest pain of her left foot and a severely diminished ankle brachial index (0.4). A CT angiogram demonstrates isolated bulky near-occlusive plaque in the common femoral artery with patent vasculature beyond. For this patient, which of the following revascularization options&nbsp;offers the best long-term patency?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:110_answer" disabled="disabled" value="0" id="q20803:110_answer0"><label for="q20803:110_answer0">a. endarterectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:110_answer" disabled="disabled" value="1" id="q20803:110_answer1"><label for="q20803:110_answer1">b. balloon angioplasty</label> </div>
<div class="r0"><input type="radio" name="q20803:110_answer" disabled="disabled" value="2" id="q20803:110_answer2"><label for="q20803:110_answer2">c. angioplasty with conformable stent</label> </div>
<div class="r1"><input type="radio" name="q20803:110_answer" disabled="disabled" value="3" id="q20803:110_answer3"><label for="q20803:110_answer3">d. cyroplasty</label> </div>
<div class="r0"><input type="radio" name="q20803:110_answer" disabled="disabled" value="4" id="q20803:110_answer4"><label for="q20803:110_answer4">e. percutaneous atherectomy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:110_-submit" name="q20803:110_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Common femoral artery plaque treated with endovascular techniques&nbsp;is generally associated with increased technical failure and poor long-term patency when compared with surgical repair. Furthermore, since common femoral plaque typically extends into the profunda femorus and superficial femoral arteries, successful treatment may put either or both of these critical vessels at risk. If an endovascular approach is attempted, stenting is not recommended, as the incidence of stent fracture in this region of high mobility is increased. Additionally, stenting of the CFA prohibits percutaneous access through the treated site and reduces future open surgical options. The best choice is surgical endarterectomy.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><span>Cronenwett JL, Johnston W.&nbsp;</span>Rutherford’s Vascular Surgery 7<sup>th</sup> Edition, Vol 2. Page 1716.&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+1997%3B+11%3A574-80." target="_blank">Schneider&nbsp;PA,&nbsp;Abcarian&nbsp;PW,&nbsp;Ogawa&nbsp;DY, Leduc JR<span>,&nbsp;</span>Wright PW<span>.</span>&nbsp;Should balloon angioplasty and stents have any role in operative intervention for lower extremity ischemia?&nbsp;Ann Vasc Surg&nbsp;1997;&nbsp;11:574-80.</a></p>
<p>QID: 30165</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg++2002%3B+35%3A1107-13." target="_blank">Nelson&nbsp;PR,&nbsp;Powell&nbsp;RJ,&nbsp;Schermerhorn&nbsp;ML,&nbsp;Fillinger MF<span>,&nbsp;</span>Zwolak RM<span>,&nbsp;</span>Walsh DB,&nbsp;et al.&nbsp;<span style="line-height: 1.5;">Early results of external iliac artery stenting combined with common femoral artery endarterectomy.</span>&nbsp;J Vasc Surg&nbsp;2002;&nbsp;35:1107-13.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Dosluoglu+HH%2C+Harris+LM%2C+Cherr+GS.+Recanalization+of+concomitant" target="_blank">Dosluoglu&nbsp;HH,&nbsp;Harris&nbsp;LM,&nbsp;Cherr&nbsp;GS.&nbsp;<span style="line-height: 1.5;">Recanalization of concomitant iliac artery and common femoral artery occlusions using an antegrade hybrid (open/endovascular) approach.</span>&nbsp;Vasc Endovasc Surg&nbsp;2007;&nbsp;41:130-4.</a></p></div><div class="rightanswer">The correct answer is: endarterectomy</div></div></div></div></div><div id="q32" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">289</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2765"><input type="hidden" name="q20803:32_:flagged" value="0"><input type="hidden" value="qaid=910916&amp;qubaid=20803&amp;qid=4641&amp;slot=32&amp;checksum=b80adbf52ffff3a2a8f7a0714f1c8987&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:32_:flaggedcheckbox" name="q20803:32_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q32&id=4641"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:32_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old man presents to the emergency department with hematemesis and syncope. On arrival, he is confused and pale.&nbsp;His heart rate is 119 bpm and his blood pressure is 80/50 mmHg. His past surgical history is significant for aortobifemoral bypass 3 years prior.&nbsp;Gastric lavage produces bright red blood.&nbsp;His white blood cell count is 16,000 and his hemoglobin is 6.7mg/dl.&nbsp;The CTA obtained is shown below.&nbsp;Which&nbsp;of the following&nbsp;is the appropriate&nbsp;management&nbsp;for this patient?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/248070384.jpg" target="images"><img src="./VESAP3_files/248070384.jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt"><a href="./VESAP3_files/248070384.jpg" target="images">Select one:</a></div><div class="answer"><div class="r0"><a href="./VESAP3_files/248070384.jpg" target="images"><input type="radio" name="q20803:32_answer" disabled="disabled" value="0" id="q20803:32_answer0"><label for="q20803:32_answer0">a. admission to the ICU, proton pump inhibitor drip, and upper GI endoscopy</label> </a></div><a href="./VESAP3_files/248070384.jpg" target="images">
<div class="r1"><input type="radio" name="q20803:32_answer" disabled="disabled" value="1" id="q20803:32_answer1"><label for="q20803:32_answer1">b. emergent laparotomy, repair of the enteral defect, and primary repair of the aortic graft</label> </div>
<div class="r0"><input type="radio" name="q20803:32_answer" disabled="disabled" value="2" id="q20803:32_answer2"><label for="q20803:32_answer2">c. emergent laparotomy, repair of the enteral defect, complete prosthetic explant, neo-aortic reconstruction with femoral vein</label> </div>
<div class="r1"><input type="radio" name="q20803:32_answer" disabled="disabled" value="3" id="q20803:32_answer3"><label for="q20803:32_answer3">d. emergent laparotomy, repair of the enteral defect, complete prosthetic explant, and extra-anatomic revascularization</label> </div>
<div class="r0"><input type="radio" name="q20803:32_answer" disabled="disabled" value="4" id="q20803:32_answer4"><label for="q20803:32_answer4">e. emergent aortography and selective embolization of the bleeding source</label> </div>
</a></div></div><div class="im-controls"><a href="./VESAP3_files/248070384.jpg" target="images"><input type="submit" id="q20803:32_-submit" name="q20803:32_-submit" value="Check" class="submit btn" disabled="disabled"></a></div></div><div class="outcome"><h4 class="accesshide"><a href="./VESAP3_files/248070384.jpg" target="images">Feedback</a></h4><div class="feedback"><div class="specificfeedback"><p><a href="./VESAP3_files/248070384.jpg" target="images">Your answer is incorrect.</a></p></div><div class="generalfeedback"><p><a href="./VESAP3_files/248070384.jpg" target="images">Secondary aorto-enteric fistulas occur infrequently after aortic reconstructions, .2-.4%.&nbsp;The median time to presentation is 2 years; however, this entity can occur at any interval after prosthetic implant.&nbsp;Most patients present with an indolent anemia followed by a herald bleed. This patient presented with vascular collapse followed by shock.&nbsp; Positive gastric lavage combined with the CT scan confirmed the diagnosis.&nbsp;On the CT scan there is a large cavity of air and fluid around the proximal end-to-end aortic anastomosis.&nbsp;Presentation with aorto-enteric fistula carries the highest mortality when compared to primary graft infections and mycotic aneurysms. The goals of therapy in this patient are to arrest ongoing blood loss, replace intravascular blood volume, explant all prosthetic material, cover the aortic stump with vascularized tissue, and then revascularize the extremities via extra-anatomic methods.&nbsp;&nbsp;In situ&nbsp;reconstruction with femoral vein is inappropriate in the setting of hemorrhagic shock due to the time required to harvest the deep veins and construct the graft segments. In situ reconstruction with rifampin bonded polyester graft might be appropriate if there is inadequate infrarenal neck to allow secure ligation of the aorta but was not an option in this question. Cryopreserved aortic allograft must usually be ordered in advance of elective reconstructions and is not available for emergency aortic procedures in most hospitals.</a></p><a href="./VESAP3_files/248070384.jpg" target="images">
<p>&nbsp;</p>
<h2><span style="color: #333300;">References:</span></h2>
</a><p><a href="./VESAP3_files/248070384.jpg" target="images"></a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=O%E2%80%99Hara+PJ%2C+Hertzer+NR%2C+Beven+EG%2C+et+al%3A+Surgical+management+of+infected+abdominal+aortic+grafts%3A+review+of+25-year+experience.+J+Vasc+Surg++1986%3B+3%3A725." target="_blank"><span style="color: #333300;">O’Hara&nbsp;PJ,&nbsp;Hertzer&nbsp;NR,&nbsp;Beven&nbsp;EG,&nbsp;Krajewski LP.&nbsp;<span style="color: #333300;">Surgical management of infected abdominal aortic grafts: review of 25-year experience.</span>&nbsp;J Vasc Surg 1986;&nbsp;3:725.</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kuestner+LM%2C+Reilly+LM%2C+Jicha+DL%2C+et+al%3A+Secondary+aortoenteric+fistula%3A+contemporary+outcome+with+use+of+extraanatomic+bypass+and+infected+graft+excision.+J+Vasc+Surg++1995%3B+21%3A184." target="_blank"><span style="color: #000000;">Kuestner&nbsp;LM,&nbsp;Reilly&nbsp;LM,&nbsp;Jicha&nbsp;DL,&nbsp;Ehrenfeld WK, Goldstone J, Stoney RJ.&nbsp;<span style="color: #000000;">Secondary aortoenteric fistula: contemporary outcome with use of extraanatomic bypass and infected graft excision.</span>&nbsp;J Vasc Surg 1995;&nbsp;21:184.</span></a></p>
<p><span style="color: #000000;">QID: 30035</span></p></div><div class="rightanswer">The correct answer is: emergent laparotomy, repair of the enteral defect, complete prosthetic explant, and extra-anatomic revascularization</div></div></div></div></div><div id="q257" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">290</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2774"><input type="hidden" name="q20803:257_:flagged" value="0"><input type="hidden" value="qaid=911141&amp;qubaid=20803&amp;qid=4994&amp;slot=257&amp;checksum=bcd73e57dc6f8d295dc66b785fc6ac3b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:257_:flaggedcheckbox" name="q20803:257_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q257&id=4994"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:257_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man is post-operative day 10 from an open repair of a ruptured abdominal aortic aneurysm. On post-op day 3 he required dialysis, and a short-term dialysis catheter was placed urgently at bedside in his right femoral vein. He is now febrile, with a white blood cell count of 23,000. The short-term dialysis catheter has erythema and exudate at the insertion site, cultures of which grow Staphylococcus Aureus. &nbsp;Which of the following is the best strategy to treat the short-term dialysis catheter infection?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:257_answer" disabled="disabled" value="0" id="q20803:257_answer0"><label for="q20803:257_answer0">a. start the patient on vancomycin and continue dialysis through current short-term dialysis catheter</label> </div>
<div class="r1"><input type="radio" name="q20803:257_answer" disabled="disabled" value="1" id="q20803:257_answer1"><label for="q20803:257_answer1">b. start the patient on vancomycin and replace short-term dialysis catheter over a guide wire with a new short-term dialysis catheter</label> </div>
<div class="r0"><input type="radio" name="q20803:257_answer" disabled="disabled" value="2" id="q20803:257_answer2"><label for="q20803:257_answer2">c. start the patient on vancomycin, remove short-term dialysis catheter, and place a new long-term dialysis catheter in the right internal jugular vein</label> </div>
<div class="r1"><input type="radio" name="q20803:257_answer" disabled="disabled" value="3" id="q20803:257_answer3"><label for="q20803:257_answer3">d. <p>start the patient on vancomycin and remove short-term dialysis catheter ("catheter holiday")</p></label> </div>
<div class="r0"><input type="radio" name="q20803:257_answer" disabled="disabled" value="4" id="q20803:257_answer4"><label for="q20803:257_answer4">e. start the patient on vancomycin, remove short-term dialysis catheter, and place a new short-term dialysis catheter in the right internal jugular vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:257_-submit" name="q20803:257_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Infection rates are higher with short-term dialysis catheters than long-term dialysis catheters; they are the highest in short-term catheters placed in the femoral vein. Sepsis is often associated with these catheter infections. Treatment options may include broad spectrum antibiotics converted to bacteria specific antibiotics with catheter salvage or guide wire exchange of the catheter. However, definitive treatment requires removal of the infected catheter. A catheter holiday with antibiotics should be given until another session of dialysis is required to minimize the risk of a second catheter infection.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=andardized+surveilance+of+hemodialysis+vascular+access+infections%3A+18-month+experience+at+an+outpatient%2C+multifacility+hemodialysis+center.+Infect+Control+Hosp+Epidemiol+2003%3B+21(3)%3A200-3." target="_blank">Stevenson KB, Adcox MJ, Mallea MC, narasimhan N, Wagnild J. Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol 2003; 21(3):200-3.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephrology+Dialysis+Transplantation+2004%3B+19(3)%3A670-7." target="_blank">Weijmer MC, Vervloet MG, ter Wee PM. Compared to tunneled cuffed haemodialysis catheters, temporary untunneled catheters are associated with more complications already within two weeks of use. Nephrology Dialysis Transplantation 2004; 19(3):670-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=American+Journal+of+Kidney+Disease+1999%3B+34%3A1114-24." target="_blank">Saad, TF. Bacteremia assoicated with tunneled, cuffed hemodialysis catheters.&nbsp; Am J Kidney Dis 1999; 34:1114-24.</a></p>
<p>QID: 30441</p></div><div class="rightanswer">The correct answer is: <p>start the patient on vancomycin and remove short-term dialysis catheter ("catheter holiday")</p></div></div></div></div></div><div id="q513" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">291</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2783"><input type="hidden" name="q20803:513_:flagged" value="0"><input type="hidden" value="qaid=911397&amp;qubaid=20803&amp;qid=5245&amp;slot=513&amp;checksum=46e43b7c8153e3103f3592fdb05b3797&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:513_:flaggedcheckbox" name="q20803:513_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q513&id=5245"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:513_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old man has a 6 cm abdominal aortic aneurysm by ultrasound. His medical history includes chronic pulmonary obstructive disease, hypertension, hyperlipidemia, and sick sinus syndrome status post pacemaker implantation. He is referred to you for evaluation regarding endovascular aortic aneurysm repair (EVAR). He is concerned when you recommend CT evaluation due to recent press reports of excessive radiation risk. Which of the following is true regarding his radiation risk from a CT scan of the abdomen and pelvis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:513_answer" disabled="disabled" value="0" id="q20803:513_answer0"><label for="q20803:513_answer0">a. higher than the risk of aneurysm repair</label> </div>
<div class="r1"><input type="radio" name="q20803:513_answer" disabled="disabled" value="1" id="q20803:513_answer1"><label for="q20803:513_answer1">b. about the same as 40 chest x-rays</label> </div>
<div class="r0"><input type="radio" name="q20803:513_answer" disabled="disabled" value="2" id="q20803:513_answer2"><label for="q20803:513_answer2">c. of greatest concern over the next 10 years</label> </div>
<div class="r1"><input type="radio" name="q20803:513_answer" disabled="disabled" value="3" id="q20803:513_answer3"><label for="q20803:513_answer3">d. higher than the risk of aneurysm rupture</label> </div>
<div class="r0"><input type="radio" name="q20803:513_answer" disabled="disabled" value="4" id="q20803:513_answer4"><label for="q20803:513_answer4">e. on the order of 1 in 1000 for cancer</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:513_-submit" name="q20803:513_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The risk of malignancy from ionizing radiation has received more attention of late due to the rapid increase in the amount of ionizing radiation patients are being subjected to in the course of medical imaging. CT scans account for a large percentage of the total radiation dose from medical imaging. Radiation dose is cumulative over the patient's lifetime, so the risk must be taken seriously. In a recent study, the overall median effective doses ranged from 2 millisieverts (mSv) for a routine head CT scan to 31 mSv for a multiphase abdomen and pelvis CT scan. The dose for a CT scan of the abdomen and pelvis, with and without contrast, for aneurysm evaluation is 12-40 mSv, which is over 200 chest x-rays. Typical background radiation doses (from cosmic rays, radon, etc.) are about 3 mSv/year.&nbsp;</p><p>The estimated number of CT scans that will lead to the development of a cancer varied widely depending on the specific type of CT examination and the patient's age and gender. Malignancy secondary to ionizing radiation occurs a number of years after the exposure, with solid tumor incidence in the time frame of 15-20 years after exposure. Even if the patient in this scenario were 60 years old, the estimated lifetime risk of cancer from the proposed CT would be less than 1 in 1200. This risk is far less than the risk of aneurysm rupture, open repair, or even a typical endovascular repair, so the risk of the scan is far outweighed by the benefit. Estimated lifetime cancer incidence without radiation exposure is 28%. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiation+dose+associated+with+common+computed+tomography+examinations+and+the+associated+lifetime+attributable+risk+of+cancer.+Arch+Intern+Med%3B+2009%3B+169+(22)%3A2078-2086" target="_blank">Smith-Bindman R, Lipson J, Marcus R, Kim KP<span>,&nbsp;</span>Mahesh M<span>,&nbsp;</span>Gould R,&nbsp;et al. Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009; 169 (22):2078-86.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+2009%3B+361+(9)%3A849-57." target="_blank">Fazel R, Krumholz HM, Wang Y, Ross JS,&nbsp;Chen J,&nbsp;Ting HH,&nbsp;et al. Exposure to low-dose ionizing radiation from medical imaging procedures. N Engl J Med 2009; 361 (9):849-57.</a></p>
<p>QID: 30913</p></div><div class="rightanswer">The correct answer is: on the order of 1 in 1000 for cancer</div></div></div></div></div><div id="q5" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">292</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2792"><input type="hidden" name="q20803:5_:flagged" value="0"><input type="hidden" value="qaid=910889&amp;qubaid=20803&amp;qid=4614&amp;slot=5&amp;checksum=6626134430ed31053826111f744c5ee0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:5_:flaggedcheckbox" name="q20803:5_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q5&id=4614"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:5_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old man with severe back pain and a blood pressure of 200/115 mmHg presents to the emergency department; a CT angiogram demonstrates a Type B aortic dissection. He responds to medical management with resolution of the back pain, but develops ischemia of the right lower extremity 36 hours later.&nbsp;There are currently no&nbsp;intravascular ultrasound or thoracic endograft devices available for&nbsp;your&nbsp;use.&nbsp;Which&nbsp;of the following is the&nbsp;most appropriate&nbsp;management option&nbsp;for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:5_answer" disabled="disabled" value="0" id="q20803:5_answer0"><label for="q20803:5_answer0">a. open surgical fenestration</label> </div>
<div class="r1"><input type="radio" name="q20803:5_answer" disabled="disabled" value="1" id="q20803:5_answer1"><label for="q20803:5_answer1">b. open surgical repair of the thoracoabdominal aorta</label> </div>
<div class="r0"><input type="radio" name="q20803:5_answer" disabled="disabled" value="2" id="q20803:5_answer2"><label for="q20803:5_answer2">c. catheter-based fenestration</label> </div>
<div class="r1"><input type="radio" name="q20803:5_answer" disabled="disabled" value="3" id="q20803:5_answer3"><label for="q20803:5_answer3">d. crossover femoral-femoral bypass grafting</label> </div>
<div class="r0"><input type="radio" name="q20803:5_answer" disabled="disabled" value="4" id="q20803:5_answer4"><label for="q20803:5_answer4">e. continued medical management</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:5_-submit" name="q20803:5_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a "complicated" Type B aortic dissection with acute lower extremity malperfusion. He needs expeditious restoration of blood flow to the ischemic leg.&nbsp;The&nbsp;current management of ischemic complications related to aortic dissection remain in flux. However, many&nbsp;surgeons recommend an "endovascular first" approach. The endovascular approach&nbsp;typically involves&nbsp;placement of&nbsp;a&nbsp;thoracic endograft to cover the proximal tear. The hope is that this will result in improved flow to the true lumen. Due to distal re-entry tears in the dissection membrane, persistent filling of the false lumen is common. This strategy may be complicated by spinal cord ischemia, catheter-related stroke, and&nbsp;contrast-induced nephropathy and may not always restore visceral or extremity perfusion. On the other hand, direct open surgical repair of acute aortic Type B dissection is associated with significant risks and most experienced surgeons prefer to avoid this option if possible. &nbsp;</p>
<p>Endovascular options for safe treatment involve the use of intravascular ultrasound (IVUS) to adequately assess the anatomy to allow for either percutaneous fenestration or for thoracic stent graft coverage of the tear and possible added coverage to reestablish adequate flow into the true aortic lumen. Crossover femoral-femoral bypass grafting accomplishes this in the absence of the necessary endovascular resources and avoids the pitfalls associated with direct repair. At the present time, there are insufficient data to identify the "standard of care". Each case&nbsp;must be approached based on factors unique to the patient, surgeon, and facility.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Wong%20DR%2C%20Lemaire%20SA%2C%20Coselli%20JS.%20Managing%20dissections%20of%20the%20thoracic%20aorta.%20Am%20Surg%3B%202008%3B%2074%20%285%29%3A364-380" target="_blank">Wong DR, Lemaire SA, Coselli JS. Managing dissections of the thoracic aorta. Am Surg 2008; 74 (5):364-80.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Estrera%20AL%2C%20Miller%20CC%2C%20Goodrick%20J%2C%20et%20al.%20Update%20on%20outcomes%20of%20acute%20type%20B%20aortic%20dissection.%20Ann%20Thor%20Surg%3B%202007%3B%2083%20%282%29%3AS842-845" target="_blank">Estrera AL, Miller CC, Goodrick J, Porat EE, Achouh PE, Dhareshwar J, et al. Update on outcomes of acute type B aortic dissection. Ann Thor Surg 2007; 83 (2):S842-5.</a></p>
<p>&nbsp;</p>
<p>QID: 30005</p></div><div class="rightanswer">The correct answer is: crossover femoral-femoral bypass grafting</div></div></div></div></div><div id="q115" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">293</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2801"><input type="hidden" name="q20803:115_:flagged" value="0"><input type="hidden" value="qaid=910999&amp;qubaid=20803&amp;qid=4728&amp;slot=115&amp;checksum=46e6a0339ee45977f002ad06ae9269af&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:115_:flaggedcheckbox" name="q20803:115_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q115&id=4728"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:115_:sequencecheck" value="2"><div class="qtext"><p>A 66-year-old woman presents with lower extremity claudication. On exam, she has a 40 mmHg blood pressure differential between her upper extremities (left lower than right). A duplex scan is performed demonstrating significantly elevated velocities at the origin of the left subclavian artery. She has no symptoms of upper extremity effort fatigue or posterior circulation ischemic symptoms. Which of the following is the best treatment option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:115_answer" disabled="disabled" value="0" id="q20803:115_answer0"><label for="q20803:115_answer0">a. carotid-subclavian transposition</label> </div>
<div class="r1"><input type="radio" name="q20803:115_answer" disabled="disabled" value="1" id="q20803:115_answer1"><label for="q20803:115_answer1">b. left subclavian angioplasty</label> </div>
<div class="r0"><input type="radio" name="q20803:115_answer" disabled="disabled" value="2" id="q20803:115_answer2"><label for="q20803:115_answer2">c. left carotid-subclavian bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:115_answer" disabled="disabled" value="3" id="q20803:115_answer3"><label for="q20803:115_answer3">d. left subclavian stent</label> </div>
<div class="r0"><input type="radio" name="q20803:115_answer" disabled="disabled" value="4" id="q20803:115_answer4"><label for="q20803:115_answer4">e. observation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:115_-submit" name="q20803:115_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Asymptomatic subclavian artery stenosis occurs in up to 17% of large angiographic series. In this group of patients, proximal stenosis or occlusion is often well tolerated as collateral circulation can maintain adequate flow to the arm. If reversal of flow from the vertebral artery causes subclavian steal symptoms, intervention is warranted by open surgical or endovascular means. Asymptomatic patients do not require treatment, but they should be counseled to use the unaffected extremity for blood pressure monitoring as hypertension may otherwise not be detected and therefore be left untreated.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Berguer%20R,%20Higgins%20R,%20Nelson%20R.%20Noninvasive%20diagnosis%20of%20reversal%20of%20vertebral-artery%20blood%20flow.%20N%20Engl%20J%20Med;%201980;%20302%20(24):1349-1351" target="_blank">Berguer R, Higgins R, Nelson R. Noninvasive diagnosis of reversal of vertebral-artery blood flow. N Engl J Med 1980; 302:1349-51.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cathet+Cardiovasc+Intervent+2001%3B+54+(1)%3A8-11." target="_blank">English JA, Carell ES, Guidera SA, Tripp HF. Angiographic prevalence and clinical predictors of left subclavian stenosis in patients undergoing diagnostic cardiac catheterization. Cathet Cardiovasc Intervent 2001; 54 (1):8-11<span style="line-height: 1.5;">.</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Anesthesiology+1991%3B+75+(3)%3A457-63." target="_blank">Frank SM, Norris EJ, Christopherson R, Beattie C. Right- and left-arm blood pressure discrepancies in vascular surgery patients. Anesthesiology 1991; 75 (3):457-63.</a></p>
<p>&nbsp;QID: 30204</p></div><div class="rightanswer">The correct answer is: observation</div></div></div></div></div><div id="q203" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">294</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2810"><input type="hidden" name="q20803:203_:flagged" value="0"><input type="hidden" value="qaid=911087&amp;qubaid=20803&amp;qid=4694&amp;slot=203&amp;checksum=cd0ba6b5df73a282ec731552fe09773b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:203_:flaggedcheckbox" name="q20803:203_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q203&id=4694"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:203_:sequencecheck" value="2"><div class="qtext"><p>Three days post op, a 65-year-old man develops a severe headache ipsilateral to the side of a carotid endarterectomy. &nbsp;Regarding this condition, which of the following statements is most likely to be true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:203_answer" disabled="disabled" value="0" id="q20803:203_answer0"><label for="q20803:203_answer0">a. it is related to postoperative hypovolemia</label> </div>
<div class="r1"><input type="radio" name="q20803:203_answer" disabled="disabled" value="1" id="q20803:203_answer1"><label for="q20803:203_answer1">b. it is associated with elevated, middle cerebral artery flow velocities on transcranial Doppler</label> </div>
<div class="r0"><input type="radio" name="q20803:203_answer" disabled="disabled" value="2" id="q20803:203_answer2"><label for="q20803:203_answer2">c. it is related to intraoperative denervation of the carotid body</label> </div>
<div class="r1"><input type="radio" name="q20803:203_answer" disabled="disabled" value="3" id="q20803:203_answer3"><label for="q20803:203_answer3">d. it involves abnormalities in vascular autoregulation at the capillary level</label> </div>
<div class="r0"><input type="radio" name="q20803:203_answer" disabled="disabled" value="4" id="q20803:203_answer4"><label for="q20803:203_answer4">e. it is associated with microembolization from the operative site</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:203_-submit" name="q20803:203_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The onset of severe, unilateral headache following carotid endarterectomy should raise a strong suspicion for cerebral hyperperfusion syndrome. This syndrome is believed to be due to loss of vascular autoregulation at the arteriolar level, resulting in cerebral edema and potentially progressing to intracranial hemorrhage. Cerebral hyperperfusion has been observed after both carotid endarterectomy and carotid stenting. The condition is not believed to be related to ongoing microembolization or postoperative hypovolemia. Elevated mean velocities in the middle cerebral artery may be observed with transcranial Doppler. Patients presenting with severe headache following carotid endarterectomy should have aggressive blood pressure management to prevent potential life threatening complications.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Moulakakis+KG%2C+Mylonas+SN%2C+Sfyroeras+GS%2C+et+al.+Hyperperfusion+syndrome+after+carotid+revascularization.+J+Vasc+Surg%3B+2009%3B+49+(4)%3A1060-8." target="_blank">Moulakakis KG, Mylonas SN, Sfyroeras GS, Andrikopoulos V. Hyperperfusion syndrome after carotid revascularization. J Vasc Surg 2009; 49 (4):1060-8.</a><br><br>Roseborough GS, Perler BA. Carotid artery disease: Endarterectomy. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:1487-96.</p>
<p>QID: 30352</p></div><div class="rightanswer">The correct answer is: it is associated with elevated, middle cerebral artery flow velocities on transcranial Doppler</div></div></div></div></div><div id="q83" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">295</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2819"><input type="hidden" name="q20803:83_:flagged" value="0"><input type="hidden" value="qaid=910967&amp;qubaid=20803&amp;qid=4897&amp;slot=83&amp;checksum=65b68bc9dee76862df67cf4d45786054&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:83_:flaggedcheckbox" name="q20803:83_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q83&id=4897"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:83_:sequencecheck" value="2"><div class="qtext"><p><span>A 68-year-old male smoker presents to the emergency department with a 2-month history of left great toe ulceration.&nbsp; He undergoes arteriography demonstrating multiple bypass targets in the foot (shown in the image below). &nbsp;Based on the angiosome model, targeting reperfusion to which vessel would best increase odds of wound healing?</span></p>
<p><span><img src="./VESAP3_files/Schanzer Angiosome pic.jpg" alt="Picture of foot" width="433" height="578"></span></p>
<p><span>&nbsp;<img src="./VESAP3_files/AS Angiosome arteriogram.jpg" alt="Angiosome arteriogram" width="431" height="310"></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:83_answer" disabled="disabled" value="0" id="q20803:83_answer0"><label for="q20803:83_answer0">a. <span>lateral plantar artery</span></label> </div>
<div class="r1"><input type="radio" name="q20803:83_answer" disabled="disabled" value="1" id="q20803:83_answer1"><label for="q20803:83_answer1">b. <span>medial plantar artery</span></label> </div>
<div class="r0"><input type="radio" name="q20803:83_answer" disabled="disabled" value="2" id="q20803:83_answer2"><label for="q20803:83_answer2">c. <span>peroneal artery</span></label> </div>
<div class="r1"><input type="radio" name="q20803:83_answer" disabled="disabled" value="3" id="q20803:83_answer3"><label for="q20803:83_answer3">d. <span>posterior tibial artery</span></label> </div>
<div class="r0"><input type="radio" name="q20803:83_answer" disabled="disabled" value="4" id="q20803:83_answer4"><label for="q20803:83_answer4">e. <span>anterior tibial artery</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:83_-submit" name="q20803:83_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has an ischemic ulceration of his great toe, located within the angiosome of the dorsalis pedis artery.&nbsp; Most commonly, the anterior tibial artery supplies the anterior ankle, the dorsalis pedis supplies the dorsum of the foot, the posterior tibial artery supplies the plantar foot, and the peroneal artery supplies anterolateral ankle and rear foot.&nbsp; Therefore, targeted reperfusion of the dorsalis pedis artery would increase the likelihood of wound healing, as well as shorten the time required.&nbsp; Given the arteriogram findings, no hemodynamically significant stenoses are identified along the course of the anterior tibial artery. Therefore, reperfusion of that vessel will provide the best option for pulsatile in-line flow to the great toe.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2009%3B23%3A+367-73." target="_blank">Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN. Revascularization of a specific angiosome for limb salvage: does the target artery matter?&nbsp; Ann Vasc Surg 2009;23: 367-73.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B57%3A+427-35" target="_blank">Soderstrom M, Alback A, Biancari F, Lappalainen K, Lepantalo M, Venermo M. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers.&nbsp; J Vasc Surg 2013;57: 427-35.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Plast+Reconstr+Surg.+2006%3B117%3A261S-293S." target="_blank">Attinger CE, Evans KK, Bulan E, Blume P, Cooper P.&nbsp; Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization.&nbsp; Plast Reconstr Surg 2006;117:261S-293S.</a></p>
<p>QID: 30127</p></div><div class="rightanswer">The correct answer is: <span>anterior tibial artery</span></div></div></div></div></div><div id="q211" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">296</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2828"><input type="hidden" name="q20803:211_:flagged" value="0"><input type="hidden" value="qaid=911095&amp;qubaid=20803&amp;qid=4703&amp;slot=211&amp;checksum=bd5075f15292138f823add65db394742&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:211_:flaggedcheckbox" name="q20803:211_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q211&id=4703"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:211_:sequencecheck" value="2"><div class="qtext"><p>A 64-year-old man underwent left brachial access for cardiac catheterization of a LIMA graft. He now complains of bilateral ocular blindness. All of the following statements are true <strong>except</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:211_answer" disabled="disabled" value="0" id="q20803:211_answer0"><label for="q20803:211_answer0">a. placement of a wire and sheath will prevent vessel trauma</label> </div>
<div class="r1"><input type="radio" name="q20803:211_answer" disabled="disabled" value="1" id="q20803:211_answer1"><label for="q20803:211_answer1">b. vertebral artery catheterization can result in arterial spasm</label> </div>
<div class="r0"><input type="radio" name="q20803:211_answer" disabled="disabled" value="2" id="q20803:211_answer2"><label for="q20803:211_answer2">c. minimal volume of contrast injection may prevent vertebral vessel trauma</label> </div>
<div class="r1"><input type="radio" name="q20803:211_answer" disabled="disabled" value="3" id="q20803:211_answer3"><label for="q20803:211_answer3">d. occlusion of the vertebral artery from catheter placement can cause ischemic symptoms</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:211_-submit" name="q20803:211_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Vertebral angiography can be complicated by technical errors with the potential&nbsp;for tia, stroke, and death. Alterations in mental status, visual disturbance, blindness, and stroke have all been reported. Due to diminutive caliber, tendency to spasm, and ease of inadvertent cannulation, vertebral injury can occur during routine cerebral angiography. The most common mechanism is obstruction of vertebral artery flow by the catheter.&nbsp;This can be avoided by flouroscopic confirmation of antegrade flow around the catheter by&nbsp;injecting a small amount of contrast to ensure that the vessel is not blocked; stagnant flow should be avoided. Rapid sweep of the contrast agent assures luminal flow and safe positioning of the catheter.&nbsp;Inattentive wire placement may result in&nbsp;spasm, emboli, and dissection of the vessel. In addition, the contrast agents may produce side effects due to tonicity and pH. The Brown Sequard syndrome following vertebral angiography has been reported. While&nbsp;symptoms may be apparent during&nbsp;or immediately after imaging, delays in the presentation of neurologic changes are not uncommon.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/5699611" target="_blank">Howieson J, Megison LC Jr. Complications vertebral artery catheterization. Radiology 1968; 91:1109-11.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ederli+a%2C+1962" target="_blank"><span style="line-height: 1.5;">Ederli A, Sassaroli S, Spaccarelli G. Vertebral angiography as a cause of necrosis of the cervical spinal&nbsp;cord. Br J Radiol 1962; 35:261-4.&nbsp;</span></a></p>
<p><span style="line-height: 1.5;">QID: 30361</span></p></div><div class="rightanswer">The correct answer is: placement of a wire and sheath will prevent vessel trauma</div></div></div></div></div><div id="q230" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">297</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2837"><input type="hidden" name="q20803:230_:flagged" value="0"><input type="hidden" value="qaid=911114&amp;qubaid=20803&amp;qid=4962&amp;slot=230&amp;checksum=7162d886fefcdd1e2b400790bc07e6a5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:230_:flaggedcheckbox" name="q20803:230_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q230&id=4962"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:230_:sequencecheck" value="2"><div class="qtext"><p>What is the preferred method for monitoring arteriovenous (AV) access after initial maturation is confirmed?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:230_answer" disabled="disabled" value="0" id="q20803:230_answer0"><label for="q20803:230_answer0">a. biannual duplex surveillance</label> </div>
<div class="r1"><input type="radio" name="q20803:230_answer" disabled="disabled" value="1" id="q20803:230_answer1"><label for="q20803:230_answer1">b. monthly measurement of access recirculation using dilution technique</label> </div>
<div class="r0"><input type="radio" name="q20803:230_answer" disabled="disabled" value="2" id="q20803:230_answer2"><label for="q20803:230_answer2">c. monthly measurement of static venous pressures</label> </div>
<div class="r1"><input type="radio" name="q20803:230_answer" disabled="disabled" value="3" id="q20803:230_answer3"><label for="q20803:230_answer3">d. monthly physical examination evaluating physical findings such as arm edema, altered characteristics of access thrill, or notation of prolonged puncture site bleeding</label> </div>
<div class="r0"><input type="radio" name="q20803:230_answer" disabled="disabled" value="4" id="q20803:230_answer4"><label for="q20803:230_answer4">e. monthly determination of access flow by ultrasound dilution</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:230_-submit" name="q20803:230_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>After initial maturation, AV access should be monitored routinely&nbsp;for signs of impending failure.&nbsp;The preferred method of<strong> monitoring </strong>is monthly <strong>physical examination </strong>evaluating physical findings such as arm edema, altered characteristics of access thrill, or notation of prolonged puncture site bleeding. A variety of surveillance techniques have been described but has none have been shown to be superior to routine monitoring with physical examination. These surveillance techniques include monthly determinations of access flow by ultrasound dilution, conductance dilution, thermal dilution, or Doppler technique. Access flow less than 600 mL/min, or access flow less than 1000 mL/min which has decreased by 25% over 4 months, should generally be further evaluated with duplex&nbsp;imaging followed by fistulography if further information is needed. Routine duplex surveillance may identify hemodynamically significant stenosis of an AV access. However, without any flow limitations noted on dialysis there is no long term benefit to prophylactic repair.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.kidney.org/professionals/KDOQI/guidelines.cfm">http://www.kidney.org/professionals/KDOQI/guidelines.cfm</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=McLafferty+RB%2C+Pryor+RW%2C+Johnson+CM%2C+et+al.+Outcome+of+a+comprehensive+follow-up+program+to+enhance+maturation+of+autogenous+arteriovenous+hemodialysis+access." target="_blank">McLafferty RB, Pryor RW, Johnson CM, Ramsey DE<span>,&nbsp;</span>Hodgson KJ<span>.</span>&nbsp;Outcome of a comprehensive follow-up program to enhance maturation of autogenous arteriovenous hemodialysis access. J Vas Surg 2007; 45 (5):981-5.</a></p>
<p>QID: 30408</p></div><div class="rightanswer">The correct answer is: monthly physical examination evaluating physical findings such as arm edema, altered characteristics of access thrill, or notation of prolonged puncture site bleeding</div></div></div></div></div><div id="q169" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">298</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2846"><input type="hidden" name="q20803:169_:flagged" value="0"><input type="hidden" value="qaid=911053&amp;qubaid=20803&amp;qid=4670&amp;slot=169&amp;checksum=72ae90cf3551c48d599044f8f171b757&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:169_:flaggedcheckbox" name="q20803:169_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q169&id=4670"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:169_:sequencecheck" value="2"><div class="qtext"><p>A 36-year-old woman presents to the emergency room with R hemispheric TIA symptoms and a CTA showing a “string of beads” appearance in the R internal carotid artery.&nbsp; This location is most commonly associated with which type of fibromuscular dysplasia:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:169_answer" disabled="disabled" value="0" id="q20803:169_answer0"><label for="q20803:169_answer0">a. adventitial hyperplasia</label> </div>
<div class="r1"><input type="radio" name="q20803:169_answer" disabled="disabled" value="1" id="q20803:169_answer1"><label for="q20803:169_answer1">b. perimedial dysplasia</label> </div>
<div class="r0"><input type="radio" name="q20803:169_answer" disabled="disabled" value="2" id="q20803:169_answer2"><label for="q20803:169_answer2">c. medial fibroplasia</label> </div>
<div class="r1"><input type="radio" name="q20803:169_answer" disabled="disabled" value="3" id="q20803:169_answer3"><label for="q20803:169_answer3">d. medial hyperplasia</label> </div>
<div class="r0"><input type="radio" name="q20803:169_answer" disabled="disabled" value="4" id="q20803:169_answer4"><label for="q20803:169_answer4">e. intimal fibroplasia</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:169_-submit" name="q20803:169_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Fibromuscular dysplasia (FMD) is an arteriopathy which most commonly affects the renal and internal carotid arteries; however, it can involve any artery. The extracranial cerebrovascular circulation is involved in 25-30% of patients with FMD in another arterial bed. Carotid FMD can present with symptomatic cerebral ischemia. This is not associated with atherosclerosis or an arteritis, but is classified based on the layer of the vessel wall involved in the resulting lesion. Medial fibroplasia is associated with the “string of beads” appearance and is the most frequent type overall. In contrast, intimal fibroplasia and medial hyperplasia commonly appear as a single, concentric stenosis or long tapering stenosis of the renal and internal carotid arteries.&nbsp;Adventitial hyperplasia is very rare and is usually seen in localized stenoses. Perimedial dysplasia commonly affects renal arteries and is associated with macroaneurysms.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ehrenfeld+WK%2C+Stoney+RJ%2C+Wylie+EJ.++Fibromuscular+hyperplasia+of+the+internal+carotid+artery.++Arch+Surg+1967%3B+95(2)%3A+284-7." target="_blank">Ehrenfeld WK, Stoney RJ, Wylie EJ.&nbsp; Fibromuscular hyperplasia of the internal carotid artery.&nbsp; Arch Surg 1967; 95(2): 284-7. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Slovut+DP%2C+Olin+JW.+Fibromuscular+dysplasia.+N+Engl+J+Med+2004%3B+350(18)%3A+1862-71." target="_blank">Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350(18): 1862-71. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ehrenfeld+WK%2C+Stoney+RJ%2C+Wylie+EJ.++Fibromuscular+hyperplasia+of+the+internal+carotid+artery.++Arch+Surg+1967%3B+95(2)%3A+284-7." target="_blank"><br></a></p>
<p>QID: 30308</p></div><div class="rightanswer">The correct answer is: medial fibroplasia</div></div></div></div></div><div id="q491" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">299</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2855"><input type="hidden" name="q20803:491_:flagged" value="0"><input type="hidden" value="qaid=911375&amp;qubaid=20803&amp;qid=5226&amp;slot=491&amp;checksum=6bbc356fca44cda978aca2ed7ff347c5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:491_:flaggedcheckbox" name="q20803:491_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q491&id=5226"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:491_:sequencecheck" value="2"><div class="qtext"><p>Which of the following increases a patient's risk for hemorrhagic complications during thrombolytic therapy for treatment of an occluded prosthetic femoropopliteal bypass graft?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:491_answer" disabled="disabled" value="0" id="q20803:491_answer0"><label for="q20803:491_answer0">a. serum fibrinogen level of 170 mg/dL</label> </div>
<div class="r1"><input type="radio" name="q20803:491_answer" disabled="disabled" value="1" id="q20803:491_answer1"><label for="q20803:491_answer1">b. stroke of indeterminate cause 8 months prior</label> </div>
<div class="r0"><input type="radio" name="q20803:491_answer" disabled="disabled" value="2" id="q20803:491_answer2"><label for="q20803:491_answer2">c. total infusion time &gt;72 hours</label> </div>
<div class="r1"><input type="radio" name="q20803:491_answer" disabled="disabled" value="3" id="q20803:491_answer3"><label for="q20803:491_answer3">d. blood pressure 162/89</label> </div>
<div class="r0"><input type="radio" name="q20803:491_answer" disabled="disabled" value="4" id="q20803:491_answer4"><label for="q20803:491_answer4">e. activated partial thromboplastin time (aPTT) of 55 seconds</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:491_-submit" name="q20803:491_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Bleeding is the most common and potentially dangerous risk of thrombolytic therapy. Intracranial hemorrhage is the most feared of the bleeding complications, but clinically significant bleeding can also occur at vascular access sites, the gastrointestinal tract, and into the retroperitoneum.</p>
<p>Patient factors associated with an increased risk of bleeding that are considered absolute contraindications to thrombolysis include active internal bleeding, recent (within 3 months) stroke/significant trauma/intracranial or spinal operation, severe uncontrolled hypertension, intracranial neoplasm, and a history of an uncontrolled bleeding diathesis.&nbsp;A remote history of stroke is not significant contraindication to thrombolysis.</p>
<p>Longer duration of therapy and higher aggregate dose of thrombolytic agents are associated with increased risk of bleeding complications.</p>
<p>A serum fibrinogen level less than 100 mg/dL and an activated partial thromboplastin time (aPTT) greater than 100 seconds are both associated with an increased rate of hemorrhagic complications.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest.+1990%3B97(4+Suppl)%3A124S-31S." target="_blank">Hirsch DR, Goldhaber SZ. Bleeding time and other laboratory tests to monitor&nbsp;the safety and efficacy of thrombolytic therapy. Chest 1990;97(4&nbsp;Suppl):124S-31S.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9545358" target="_blank">Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with&nbsp;vascular surgery as initial treatment for acute arterial occlusion of the legs.&nbsp;Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators. N Engl J Med 1998;338(16):1105-11.&nbsp;</a></p>
<p><a href="http://www.gene.com/download/pdf/activase_prescribing.pdf" target="_blank"><span style="line-height: 1.5;">Genentech Inc. Package Insert for Activase (Alteplase) 2012.</span></a></p>
<p><span style="line-height: 1.5;">QID: 30857</span></p></div><div class="rightanswer">The correct answer is: total infusion time &gt;72 hours</div></div></div></div></div><div id="q310" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">300</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2864"><input type="hidden" name="q20803:310_:flagged" value="0"><input type="hidden" value="qaid=911194&amp;qubaid=20803&amp;qid=5075&amp;slot=310&amp;checksum=ccd83f1c98c70108b154fe58ee3726d6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:310_:flaggedcheckbox" name="q20803:310_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q310&id=5075"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:310_:sequencecheck" value="2"><div class="qtext"><p>A 54-year-old woman presents with a discrete pulsatile vertically fixed right 2 cm neck mass. Based on the carotid duplex below, which of the following statements is most <strong>true</strong>?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/Mquest5.jpg" target="images"><img src="./VESAP3_files/Mquest5.jpg" alt="Carotid body tumor" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:310_answer" disabled="disabled" value="0" id="q20803:310_answer0"><label for="q20803:310_answer0">a. the incidence of malignancy is over 30%</label> </div>
<div class="r1"><input type="radio" name="q20803:310_answer" disabled="disabled" value="1" id="q20803:310_answer1"><label for="q20803:310_answer1">b. carotid angiography is required before attempting resection</label> </div>
<div class="r0"><input type="radio" name="q20803:310_answer" disabled="disabled" value="2" id="q20803:310_answer2"><label for="q20803:310_answer2">c. bilateral disease is present in half the patients</label> </div>
<div class="r1"><input type="radio" name="q20803:310_answer" disabled="disabled" value="3" id="q20803:310_answer3"><label for="q20803:310_answer3">d. cranial nerve injury is the most frequent complication</label> </div>
<div class="r0"><input type="radio" name="q20803:310_answer" disabled="disabled" value="4" id="q20803:310_answer4"><label for="q20803:310_answer4">e. the stroke rate with resection is 3%</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:310_-submit" name="q20803:310_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Carotid body tumors (CBTs) are rare neoplasms that develop within the adventitia of the medial aspect of the carotid bifurcation. The carotid body originates in the neural crest and is responsible for acute adaptation to fluctuating concentrations of oxygen, carbon dioxide, and pH. Most are sporadic (85%) in etiology but familial type (10-50%) is more common in younger patients. The rare hyperplastic form is seen primarily in patients who have chronic obstructive pulmonary disease (COPD) or cyanotic heart disease. Carotid body tumors are slow growing and present most commonly as an asymptomatic palpable neck mass in the anterior triangle of the neck. The tumors may present with a nerve palsy (pain, hoarseness, dysphagia, Horner syndrome, or shoulder drop) if they involve (10%) the hypoglossal, glossopharyngeal, recurrent laryngeal, or spinal accessory nerve, or the sympathetic chain.</p>
<p>The carotid body is highly vascularized by branches of the ascending pharyngeal artery, itself a branch of the external carotid artery. The Shamblin classification is used to stage carotid body tumors. Type I lesions are small and can be dissected in the periadventitial plane. Type II partially surround the carotid artery. Type III tumors encircle the carotid bifurcation. Most type II and III lesions require carotid resection and interposition graft placement.</p>
<p>Carotid body tumors are treated with either surgery or radiotherapy depending on the presence or absence of other paragangliomas and the patient's age and health status. Preoperative imaging is necessary to evaluate the extent of the disease and its multiplicity. If catacholamine levels are elevated, an evaluation for adrenal pheochromocytomas should also be performed. If detected these tumors should be removed prior to the carotid surgery.<br></p>
<p>Surgical treatment is the mainstay for most tumors and can be associated with significant morbidities, especially with large Shamblin III tumors (greater than 5 cm). Radiation is usually reserved for patients who have poor medical conditions, elderly patients, or patients with recurrent tumors. Pre-operative embolization of carotid body tumor can reduce operative blood loss and is usually reserved for large tumors exceeding 4 cm in size. Bilateral arteriography may be required pre-operatively to delineate the vascularity of the tumor and to detect any tumors on the contralateral side.</p>
<p>QID: 30537<br></p></div><div class="rightanswer">The correct answer is: cranial nerve injury is the most frequent complication</div></div></div></div></div><div id="q39" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">301</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2873"><input type="hidden" name="q20803:39_:flagged" value="0"><input type="hidden" value="qaid=910923&amp;qubaid=20803&amp;qid=4650&amp;slot=39&amp;checksum=93c900b1891f6e7c1b7a50ac8b282a3f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:39_:flaggedcheckbox" name="q20803:39_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q39&id=4650"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:39_:sequencecheck" value="2"><div class="qtext"><p>A previously healthy 23-year-old man was recently involved in a motor vehicle accident. He underwent an uneventful thoracic endovascular aortic repair (TEVAR) for blunt traumatic aortic injury. At 1 month, he reports chest pain and bilateral calf pain with walking. His blood pressure is 180/90, heart rate 60, respiratory rate 16, temperature 98.4. Radial and femoral pulses are present but foot pulses are absent. Both feet are warm and well-perfused and&nbsp;Doppler signals are present.&nbsp;Physical exam is otherwise unremarkable. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:39_answer" disabled="disabled" value="0" id="q20803:39_answer0"><label for="q20803:39_answer0">a. obtain bilateral lower extremity segmental pressures and ankle brachial indices</label> </div>
<div class="r1"><input type="radio" name="q20803:39_answer" disabled="disabled" value="1" id="q20803:39_answer1"><label for="q20803:39_answer1">b. obtain a bilateral lower extremity venous ultrasound</label> </div>
<div class="r0"><input type="radio" name="q20803:39_answer" disabled="disabled" value="2" id="q20803:39_answer2"><label for="q20803:39_answer2">c. obtain an EKG</label> </div>
<div class="r1"><input type="radio" name="q20803:39_answer" disabled="disabled" value="3" id="q20803:39_answer3"><label for="q20803:39_answer3">d. start oral beta-blockers</label> </div>
<div class="r0"><input type="radio" name="q20803:39_answer" disabled="disabled" value="4" id="q20803:39_answer4"><label for="q20803:39_answer4">e. obtain a CTA chest, abdomen and pelvis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:39_-submit" name="q20803:39_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient presented with graft collapse, which is shown in the figure below. The appropriate next step in the management of this patient is to obtain a CTA to evaluate the device. Device infolding is a rare complication after TEVAR and primarily occurs in young trauma patients secondary to excessive oversizing and severe proximal aortic angulation. In a study of 139 patients with graft compression, the overall reported incidence was .4%, with 60% of the events occurring in trauma patients. The average oversizing in the graft compression cohort was 33%. Most patients (51%) were asymptomatic with the diagnosis made on routine follow-up imaging. The median time to diagnosis was 9.5 days (range, 0-2190 days; average, 76 <span style="text-decoration: underline;">+</span> 222 days). Approximately 75% of all compressions were diagnosed within 1 month of initial treatment. Overall, 30% of the patients had symptoms related to the event. The most common presenting symptoms were hypertension, back or chest pain, oliguria, claudication, and paraplegia. Device infolding was treated with open surgical conversion (24%), placement of large balloon-expandable stent(s) (40%), relining with additional endograft(s) (31%), or repeat angioplasty (5%).</p>
<p>&nbsp;</p>
<p>&nbsp;<img src="./VESAP3_files/3(2).jpg" alt="" width="350" height="313"></p>
<p>&nbsp;</p>
<h2>&nbsp;Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kasirajan+K%2C+Dake+MD%2C+Lumsden+A%2C+Bavaria+J%2C+Makaroun+MS.++Incidence+and+outcomes+after+infolding+or+collapse+of+thoracic+stent+grafts.++J+Vasc+Surg.+2012+Mar%3B55(3)%3A652-8%3B+discussion+658.+doi%3A+10.1016%2Fj.jvs.2011.09.079.+Epub+2011+Dec+9." target="_blank">Kasirajan K, Dake MD, Lumsden A, Bavaria J, Makaroun MS.&nbsp; Incidence and outcomes after infolding or collapse of thoracic stent grafts.&nbsp; J Vasc Surg 2012; 55(3):652-8</a>.</p>
<p>QID: 30043</p></div><div class="rightanswer">The correct answer is: obtain a CTA chest, abdomen and pelvis</div></div></div></div></div><div id="q56" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">302</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2882"><input type="hidden" name="q20803:56_:flagged" value="0"><input type="hidden" value="qaid=910940&amp;qubaid=20803&amp;qid=4656&amp;slot=56&amp;checksum=6f38d93e11796425d66c88650f41467c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:56_:flaggedcheckbox" name="q20803:56_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q56&id=4656"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:56_:sequencecheck" value="2"><div class="qtext"><p>Which of the following risk factors most strongly predicts adverse outcome after elective abdominal aortic aneurysm (AAA) repair?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:56_answer" disabled="disabled" value="0" id="q20803:56_answer0"><label for="q20803:56_answer0">a. coronary artery disease with a history of MI 3 years ago, EF 45%, asymptomatic</label> </div>
<div class="r1"><input type="radio" name="q20803:56_answer" disabled="disabled" value="1" id="q20803:56_answer1"><label for="q20803:56_answer1">b. Diabetes Mellitus with HgA1c 8.4</label> </div>
<div class="r0"><input type="radio" name="q20803:56_answer" disabled="disabled" value="2" id="q20803:56_answer2"><label for="q20803:56_answer2">c. current tobacco abuse of 1 pack per day</label> </div>
<div class="r1"><input type="radio" name="q20803:56_answer" disabled="disabled" value="3" id="q20803:56_answer3"><label for="q20803:56_answer3">d. FEV1/FVC ratio of .58 on inhaled steroids but not on home oxygen</label> </div>
<div class="r0"><input type="radio" name="q20803:56_answer" disabled="disabled" value="4" id="q20803:56_answer4"><label for="q20803:56_answer4">e. eGFR 25 mL/min not yet on dialysis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:56_-submit" name="q20803:56_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In a large review of the over 2300 elective AAA repairs from the Vascular Quality Initiative, De Martino and colleagues demonstrated that age over 80, unstable angina, oxygen dependent COPD, and end-stage renal failure with eGFR &lt;30 mL/min were significantly associated with decreased long-term survival. Coronary artery disease and COPD are common among patients with AAA. When stable (i.e. prior revascularization for CAD, compensated mild CHF, and COPD controlled on inhaled medications without need for home oxygen), they are not highly predictive of adverse outcomes after elective AAA repair. Post-operative troponin elevation does appear to predict decreased long-term survival, but this information is not known prior to the operation and is not helpful in pre-operative risk stratification. Diabetes does not, in of itself, seem to confer significant increased peri-operative risk other than wound complications. The impact of DM is likely related to its adverse effect on renal function and CAD. Current tobacco use is a risk factor for respiratory and wound complications after surgery, but this effect is less significant than the above mentioned risk factors. Renal failure, particularly when stage 4 or 5 (eg eGFR &lt; 30 mL/min) has consistently been shown to be a strong predictor of adverse outcome after aneurysm repair in multiple studies.</p>
<p>Although none of these clinical criteria are an absolute contra-indication to aneurysm repair, they inform the decision process about which patients with AAA are most likely to benefit from elective operative repair. In the cited reference below, the authors propose a risk stratification tool to assist in pre-operative patient selection. They propose that their risk tool can discriminate between high, moderate, and low risk patient groups with 5-year survival rates of 43%, 69%, and 85%, respectively.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=De+Martino+R+et+al.+Optimal+selection+of+patients+for+elective+abdominal+aortic+aneurysm+repair+based+on+life+expectancy.+J+Vasc+Surg+2013%3B58%3A589-95." target="_blank">De Martino R,&nbsp;Goodney PP,&nbsp;Nolan BW,&nbsp;Robinson WP,&nbsp;Farber A,&nbsp;Patel VI,&nbsp;et al. Optimal selection of patients for elective abdominal aortic aneurysm repair based on life expectancy. J Vasc Surg 2013; 58:589-95.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23721931" target="_blank">Hughes K,&nbsp;Jackson JD,&nbsp;Prendergast TI,&nbsp;Rose DA,&nbsp;Bolorunduro O,&nbsp;Obirieze A,&nbsp;et al. Diabetes mellitus is not associated with major morbidity following open abdominal aortic aneurysm repair. J Surg Res 2013; 184:751-4.</a></p>
<p>QID: 30061</p></div><div class="rightanswer">The correct answer is: eGFR 25 mL/min not yet on dialysis</div></div></div></div></div><div id="q290" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">303</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2891"><input type="hidden" name="q20803:290_:flagged" value="0"><input type="hidden" value="qaid=911174&amp;qubaid=20803&amp;qid=5029&amp;slot=290&amp;checksum=6c8a675dce044bc613b2dc08e6533e55&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:290_:flaggedcheckbox" name="q20803:290_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q290&id=5029"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:290_:sequencecheck" value="2"><div class="qtext"><p>A 46-year-old woman undergoes radiofrequency endovenous ablation of the greater saphenous vein. Routine follow-up duplex scanning of the common femoral vein is shown below. This image demonstrates which of the following?</p>
<p><a href="./VESAP3_files/10991.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/10991.jpg" alt="Img" width="118" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:290_answer" disabled="disabled" value="0" id="q20803:290_answer0"><label for="q20803:290_answer0">a. a recanalized greater saphenous vein</label> </div>
<div class="r1"><input type="radio" name="q20803:290_answer" disabled="disabled" value="1" id="q20803:290_answer1"><label for="q20803:290_answer1">b. a peri-venous hematoma</label> </div>
<div class="r0"><input type="radio" name="q20803:290_answer" disabled="disabled" value="2" id="q20803:290_answer2"><label for="q20803:290_answer2">c. thrombus extending into the common femoral vein</label> </div>
<div class="r1"><input type="radio" name="q20803:290_answer" disabled="disabled" value="3" id="q20803:290_answer3"><label for="q20803:290_answer3">d. a normal common femoral vein</label> </div>
<div class="r0"><input type="radio" name="q20803:290_answer" disabled="disabled" value="4" id="q20803:290_answer4"><label for="q20803:290_answer4">e. occlusive thrombus in the common femoral vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:290_-submit" name="q20803:290_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Endovenous ablation of the greater saphenous vein infrequently results in thrombus extending from the greater saphenous vein into the common femoral vein as depicted in the image. This entity has been termed "endovenous heat induced thrombosis" (EHIT). The lesion appears to have benign natural history and the progression to complete thrombosis of the common femoral vein is very unusual. Short-term anti-coagulation with low molecular weight heparin is recommended by some, but, without documented progression of the thrombotic process, long-term anti-coagulation does not seem to be required.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+2005%3B+41+(1)%3A130-5." target="_blank">Mozes G, Kalra M, Carmo M, Swenson L<span>,&nbsp;</span>Gloviczki P. Extension of saphenous thrombus into the femoral vein: A potential complication of new endovenous ablation techniques. J Vasc Surg; 2005; 41 (1):130-5.</a><br><br>Morrison N. Laser treatment of the incompetent saphenous vein. In: Handbook of Venous Disorders, 3rd ed. Gloviczki P (ed). London, UK: Hodder Arnold; 2010:418-28.</p>
<p>QID: 30510</p></div><div class="rightanswer">The correct answer is: thrombus extending into the common femoral vein</div></div></div></div></div><div id="q292" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">304</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2900"><input type="hidden" name="q20803:292_:flagged" value="0"><input type="hidden" value="qaid=911176&amp;qubaid=20803&amp;qid=5031&amp;slot=292&amp;checksum=1445460fd73f4891f39003e7cd4c627e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:292_:flaggedcheckbox" name="q20803:292_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q292&id=5031"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:292_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old man is referred to you for painful swelling in his right groin 1 week after undergoing&nbsp;coronary catheterization and stenting. He is&nbsp;being&nbsp;treated with aspirin and Plavix.&nbsp;Right groin duplex ultrasonography reveals a 3 cm diameter pseudoaneurysm (PSA) arising off of the right common femoral artery. The PSA&nbsp;neck measures&nbsp;1 cm in length and&nbsp;2 mm in diameter. Which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:292_answer" disabled="disabled" value="0" id="q20803:292_answer0"><label for="q20803:292_answer0">a. ultrasound-guided  compression is effective for more than 75% of patients who are anticoagulated with heparin or warfarin</label> </div>
<div class="r1"><input type="radio" name="q20803:292_answer" disabled="disabled" value="1" id="q20803:292_answer1"><label for="q20803:292_answer1">b. thrombin injection is preferred if there is a concomitant arteriovenous fistula</label> </div>
<div class="r0"><input type="radio" name="q20803:292_answer" disabled="disabled" value="2" id="q20803:292_answer2"><label for="q20803:292_answer2">c. infection is the most common cause of pseudoaneurysm following cardiac catheterization</label> </div>
<div class="r1"><input type="radio" name="q20803:292_answer" disabled="disabled" value="3" id="q20803:292_answer3"><label for="q20803:292_answer3">d. urgent surgical repair is indicated for this pseudoaneurysm due to its size</label> </div>
<div class="r0"><input type="radio" name="q20803:292_answer" disabled="disabled" value="4" id="q20803:292_answer4"><label for="q20803:292_answer4">e. thrombin should be injected into the pseudoaneurysm using ultrasound guidance</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:292_-submit" name="q20803:292_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>PSAs most commonly result from complications related to arterial access. The common femoral artery (CFA) is the most common access site for catheter-based interventions. There is an increased incidence of femoral artery PSAs when the puncture site is in the external iliac artery (EIA) or superficial (SFA) and profunda femoral arteries (PFA) rather than the&nbsp;CFA. Complexity of intra-arterial interventions has been shown to increase the risk of vascular complications. Therapeutic interventions, such as arterial angioplasty and stenting, atherectomy, and intraprocedural thrombolytic therapy, have a higher rate of PSA formation (2-8%) than diagnostic procedures (0.05-2%).&nbsp;Infection is a very rare complication of cardiac catheterization, though the incidence has increased with the use of closure devices.</p>
<p>A number of treatment options for iatrogenic femoral PSAs exist depending on the PSA size, neck characteristics, and the patient’s symptoms. Treatment options include observation, US-guided compression, percutaneous US-guided thrombin injection, and open surgical repair.&nbsp;</p>
<p>Studies have shown that the majority of small PSAs (&lt; 2-3 cm) thrombose spontaneously within 4 weeks. Conservative management, or a watch-and-wait policy, has been advocated for small asymptomatic PSAs in patients who are not anticoagulated. However, spontaneous resolution can be unpredictable. Therefore, patients with small PSAs require surveillance with DUS. The disadvantage of this wait-and-watch policy is that patients undergoing surveillance may have activity restrictions, discomfort with serial DUS, and prolonged hospital stays.</p>
<p>Ultrasound-guided compression (USGC) therapy has been shown to be a safe and noninvasive method for treatment of PSAs, with success rates ranging between 30-60% in patients on anticoagulation and 75-95% without anticoagulation.&nbsp;Successful USGC can be limited by patient and operator&nbsp;factors. The procedure is generally restricted to lower extremity peripheral&nbsp;arterial PSAs. Supra-inguinal PSA compression is generally not recommended, as&nbsp;it may result in PSA rupture and inability to quickly control bleeding. Brachial&nbsp;artery PSA’s usually require operative decompression because of concomitant nerve compression symptoms. Unfortunately, PSA neck compression can&nbsp;be time consuming and is often not tolerated by patients, despite conscious sedation.&nbsp; Compression can also be technically challenging and tiring in the morbidly obese patient. Predictors of poor outcome include concomitant anticoagulation, large PSA size (&gt;4 cm), and patient obesity. Patients with these negative predictors generally have lower technical success rates (25-35%), higher recurrence rates (20%), and greater complication rates (3.6%) than patients without these factors.</p>
<p>Ultrasound-guided thrombin injection (UGTI) has become the treatment of choice for post-catheterization PSAs. Thrombin is injected into the PSA sac for immediate thrombosis of the PSA. It should be noted that this is off-label use of thrombin; thrombin is FDA approved “for topical use only”. UGTI is contraindicated in the setting of lower extremity ischemia, infection, arteriovenous fistula, and pregnancy. UGTI has many advantages over USGC therapy for the treatment of PSAs. Procedural times are shorter and the procedure is better tolerated by patients. It achieves greater technical success (&gt;96%) and can be used effectively in the setting of concomitant anticoagulation or for supra-inguinal PSAs. The ability to perform this&nbsp;procedure in the outpatient setting or at the bedside also reduces the relative&nbsp;cost. Complications for UGTI include intra-arterial thrombosis (&lt;2%), PSA&nbsp;rupture, or allergic response to bovine thrombin. Arterial thrombosis has been associated with the treatment of small PSAs (&lt;2.5 cm) but appears not to be related to short neck length (&lt;5 mm).</p>
<p>Open surgical repair is indicated for patients with contraindications to non-operative management (ie, peripheral or cutaneous ischemia, infection, surgical graft, large supra-inguinal PSA) or those who present with complications (ie, rapid enlargement, skin necrosis, distal embolization, rupture).</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br+J+Radiol.+2008+Feb%3B81(962)%3A154-63.+doi%3A+10.1259%2Fbjr%2F52029321." target="_blank">Hanson JM, Atri M, Power N. Ultrasound-guided thrombin injection of iatrogenic groin pseudoaneurysm: Doppler features and technical tips. Br J Radiol 2008; 81 (962):154-63.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Amer+Jour+Surg%3B+2001%3B+182+(6)%3A658-62." target="_blank">Smith T, Cruz C, Moursi M, Eidt J. Infectious complications resulting from use of hemostatic puncture devices. Amer Jour Surg 2001; 182 (6):658-62.</a></p>
<p>Dargon PT, Mitchell EL. Psuedoaneurysms and arteriovenous fistulas. Current Surgical Therapy, Eleventh edition. Cameron &amp; Cameron, 2013.&nbsp;</p>
<p>QID: 30512</p></div><div class="rightanswer">The correct answer is: thrombin should be injected into the pseudoaneurysm using ultrasound guidance</div></div></div></div></div><div id="q485" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">305</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2909"><input type="hidden" name="q20803:485_:flagged" value="0"><input type="hidden" value="qaid=911369&amp;qubaid=20803&amp;qid=5211&amp;slot=485&amp;checksum=00a200c0aa8c4456b5d0e51d29d04e41&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:485_:flaggedcheckbox" name="q20803:485_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q485&id=5211"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:485_:sequencecheck" value="2"><div class="qtext"><p>A patient presented with severe shock due to a ruptured aortic aneurysm. After open surgical placement of an infrarenal aortic graft there is concern for coagulopathic bleeding. His core temperature is 34 Celcius. His arterial pH is 7.19. Which test is able to distinguish between coagulopathy from hypothermia and consumptive coagulopathy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:485_answer" disabled="disabled" value="0" id="q20803:485_answer0"><label for="q20803:485_answer0">a. cold reactivity platelet testing</label> </div>
<div class="r1"><input type="radio" name="q20803:485_answer" disabled="disabled" value="1" id="q20803:485_answer1"><label for="q20803:485_answer1">b. thromboelastography</label> </div>
<div class="r0"><input type="radio" name="q20803:485_answer" disabled="disabled" value="2" id="q20803:485_answer2"><label for="q20803:485_answer2">c. reptilase time (RT)</label> </div>
<div class="r1"><input type="radio" name="q20803:485_answer" disabled="disabled" value="3" id="q20803:485_answer3"><label for="q20803:485_answer3">d. activated partial thromboplastin time</label> </div>
<div class="r0"><input type="radio" name="q20803:485_answer" disabled="disabled" value="4" id="q20803:485_answer4"><label for="q20803:485_answer4">e. prothrombin time (international normalized ratio)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:485_-submit" name="q20803:485_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Thromboelastography (TEG) is a point-of-care test of coagulation function, used most commonly in operating room, emergency room, and critical care settings to guide transfusion therapy. Routine coagulation tests, including prothrombin time (PT,INR) and partial thromboplastin time (aPTT) measure coagulation factor function, but TEG is a viscoelastic measure of clot formation and clot dissolution that can assess platelet function, clot strength, and fibrinolysis.</p>
<p>Results from TEG testing are often displayed in a graph, including (1) reaction time (R value), (2) K value, (3) alpha (a) angle, and (4) maximum amplitude (MA). The reaction time (R value) is the duration of the latent period before the first evidence of a clot is detected. The K value is the time from onset of clot formation until the clot formation has reached a specific mark (20mm on the graph); this reflects the speed of clot formation. The angle is the tangent of the curve made as the K is reached and offers similar information to K. The R value and K value are increased by anticoagulation, factor depletion, thrombocytopenia, and hypofibrinogenemia (conditions that interfere with clot formation). These values are decreased with fibrinolysis. Maximum amplitude (MA) is a reflection of early clot strength, which reflects platelet number and function.</p>
<p>The standard temperature for testing is 37°C, but different temperatures can be used. This adjustment allows the test to reflect in vivo coagulation function for a hypothermic patient. TEG values may be abnormal when standard PT and aPTT tests are normal.</p>
<p>Early identification of abnormal TEG patterns may guide administration of plasma, platelets, and cryoprecipate in patients requiring large volume transfusions. A large Danish retrospective study (Johansson PI et al, 2009) of patients who experienced massive bleeding (842 patients) found resuscitation strategies guided by thrombelastography to be associated with improved survival.</p>
<p>Reptilase is an enzyme from the venom of Bothrops snakes. It acts similar to thrombin but differs by generating fibrinopeptide A (not fibrinopeptide B) from fibrinogen.</p>
<p>RT measures conversion of fibrinogen to fibrin. It resists inhibition by antithrombin (AT) and heparin, and thus differs from the thrombin time (TT). (Heparin prolongs the TT, but not the RT.) Thus, RT can be used to detect heparin effects, as well as detecting abnormalities in fibrinogen.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20374650" target="_blank">Schöchl H, Nienaber U, Hofer G, Voelckel W, Jambor C, Scharbert G, et al. Goal-directed coagulation management of major trauma patients using thromboelastometry (ROTEM)-guided administration of fibrinogen concentrate and prothrombin complex concentrate. Crit Care 2010;14(2):R55.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Surg+2010%3B+251(4)%3A604-14." target="_blank">Kashuk JL, Moore EE, Sawyer M, Le T, Johnson J, Biffl WL, et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg 2010; 251(4):604-14.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Trauma+2011%3B+71(2)%3A407-14" target="_blank">Cotton BA, Faz G, Hatch QM, Radwan ZA, Podbielski J, Wade C, et al. Rapid thrombelastography delivers real-time results that predict transfusion within 1 hour of admission. J Trauma 2011; 71(2):407-14; discussion 414-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vox+Sang+2009%3B+96(2)%3A111-8." target="_blank">Johansson PI, Stensballe J. Effect of Haemostatic Control Resuscitation on&nbsp;mortality in massively bleeding patients: a before and after study. Vox Sang 2009; 96(2):111-8.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Transfus+Med+Rev+2013%3B+27(4)%3A213-20." target="_blank">Bolliger D, Tanaka KA. Roles of thrombelastography and thromboelastometry for patient blood management in cardiac surgery. Transfus Med Rev 2013; 27(4):213-20.&nbsp;</a></p>
<p>QID: 30850</p></div><div class="rightanswer">The correct answer is: thromboelastography</div></div></div></div></div><div id="q285" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">306</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2918"><input type="hidden" name="q20803:285_:flagged" value="0"><input type="hidden" value="qaid=911169&amp;qubaid=20803&amp;qid=5023&amp;slot=285&amp;checksum=e7b85ef524ee380cf81d262cbc8f59ff&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:285_:flaggedcheckbox" name="q20803:285_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q285&id=5023"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:285_:sequencecheck" value="2"><div class="qtext"><p>The Doppler waveform shown below was most likely obtained from which of the following arteries?<br><br><a href="./VESAP3_files/AssetProxy_062.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_062.jpg" alt="img" width="100" height="42" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:285_answer" disabled="disabled" value="0" id="q20803:285_answer0"><label for="q20803:285_answer0">a. superficial femoral artery at rest</label> </div>
<div class="r1"><input type="radio" name="q20803:285_answer" disabled="disabled" value="1" id="q20803:285_answer1"><label for="q20803:285_answer1">b. renal transplant with acute rejection</label> </div>
<div class="r0"><input type="radio" name="q20803:285_answer" disabled="disabled" value="2" id="q20803:285_answer2"><label for="q20803:285_answer2">c. superior mesenteric artery while fasting</label> </div>
<div class="r1"><input type="radio" name="q20803:285_answer" disabled="disabled" value="3" id="q20803:285_answer3"><label for="q20803:285_answer3">d. external carotid artery</label> </div>
<div class="r0"><input type="radio" name="q20803:285_answer" disabled="disabled" value="4" id="q20803:285_answer4"><label for="q20803:285_answer4">e. superior mesenteric artery after meal</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:285_-submit" name="q20803:285_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The depicted waveform shows rapid systolic upstroke and persistence of flow throughout diastole. This indicates the waveform was obtained from an artery supplying a low-resistance circulation. Low-resistance circulations tend to be those of organs requiring high metabolic needs. The brain, kidneys, spleen, and liver all have low-resistance arterial waveforms with persistence of diastolic flow at the end of diastole. More highly resistant circulations, such as the superficial femoral artery, external carotid artery, and fasting superior mesenteric artery exhibit minimal flow at the end of diastole. An internal carotid artery dissection waveform would be characterized by to-and-fro flow: flow above and below the baseline. <br><br></p>
<h2>Reference:</h2>
<p>Zwolak RM, Musson A. Mesenteric arteries. In: Strandness's Duplex Scanning in Vascular Disorders, 4th ed. Zierler RE, ed. Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2010:275-81.</p>
<p>QID: 30503</p></div><div class="rightanswer">The correct answer is: superior mesenteric artery after meal</div></div></div></div></div><div id="q104" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">307</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2927"><input type="hidden" name="q20803:104_:flagged" value="0"><input type="hidden" value="qaid=910988&amp;qubaid=20803&amp;qid=4939&amp;slot=104&amp;checksum=c062e93b9f55faa0f2fdc47041e4dd0b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:104_:flaggedcheckbox" name="q20803:104_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q104&id=4939"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:104_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old man undergoes a right to left crossover&nbsp;femoro-femoral artery bypass with an&nbsp;8 mm ringed-PTFE graft to treat disabling claudication due to a TASC C lesion affecting the left iliac system. Upon completion of the bypass and restoration of blood flow, the patient has a patent bypass but suddenly loses his right femoral pulse distal to the graft.&nbsp; Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:104_answer" disabled="disabled" value="0" id="q20803:104_answer0"><label for="q20803:104_answer0">a. revise the proximal anastomosis</label> </div>
<div class="r1"><input type="radio" name="q20803:104_answer" disabled="disabled" value="1" id="q20803:104_answer1"><label for="q20803:104_answer1">b. revise the distal anastomosis</label> </div>
<div class="r0"><input type="radio" name="q20803:104_answer" disabled="disabled" value="2" id="q20803:104_answer2"><label for="q20803:104_answer2">c. complete the procedure since this is a normal phenomenon following fem-fem bypass grafting</label> </div>
<div class="r1"><input type="radio" name="q20803:104_answer" disabled="disabled" value="3" id="q20803:104_answer3"><label for="q20803:104_answer3">d. perform a banding procedure around the proximal anastomosis</label> </div>
<div class="r0"><input type="radio" name="q20803:104_answer" disabled="disabled" value="4" id="q20803:104_answer4"><label for="q20803:104_answer4">e. perform a right iliac artery angiogram</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:104_-submit" name="q20803:104_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Vascular steal may develop following femorofemoral bypass grafting secondary to a previously undetected inflow lesion in the donor iliac artery. In the setting of a fixed resistance secondary to an inflow lesion, the increased flow resulting from the extraantomic bypass may result in a pressure drop causing a loss in pulse in the donor femoral artery. If this occurs, the evaluation should start with an ipsilateral iliac artery angiogram with pressure measurements and intravascular ultrasound, or some other diagnostic modality to search for a hemodynamically significant inflow lesion in the donor iliac system that may require treatment.</p>
<p>The correct answer is perform a right iliac artery angiogram.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Vasc+Endovasc+Surg+2000%3B19(2)%3A178-83." target="_blank">Vogt KC, Rasmussen JG, Schroeder TV. The clinical importance and prediction of steal following femoro-femoral cross-over bypass: study of the donor iliac artery by intravascular ultrasound, arteriography, duplex scanning and pressure measurements. Eur J Vasc Endovasc Surg 2000;19(2):178-83.</a></p>
<p>QID: 30156</p></div><div class="rightanswer">The correct answer is: perform a right iliac artery angiogram</div></div></div></div></div><div id="q346" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">308</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2936"><input type="hidden" name="q20803:346_:flagged" value="0"><input type="hidden" value="qaid=911230&amp;qubaid=20803&amp;qid=5139&amp;slot=346&amp;checksum=8df2c5175f2b25f6e40beb71a6c85d28&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:346_:flaggedcheckbox" name="q20803:346_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q346&id=5139"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:346_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old woman presents to the emergency department complaining of severe abdominal pain. Your working diagnosis is acute mesenteric ischemia. A CT scan of the abdomen is obtained (image shown below). Which of the following demonstrates the most specific finding for bowel infarction in the setting of acute arterial mesenteric ischemia?<br><br><a href="./VESAP3_files/AssetProxy_086.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_086.jpg" alt="img" width="100" height="65" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:346_answer" disabled="disabled" value="0" id="q20803:346_answer0"><label for="q20803:346_answer0">a. pneumatosis intestinalis</label> </div>
<div class="r1"><input type="radio" name="q20803:346_answer" disabled="disabled" value="1" id="q20803:346_answer1"><label for="q20803:346_answer1">b. the target sign</label> </div>
<div class="r0"><input type="radio" name="q20803:346_answer" disabled="disabled" value="2" id="q20803:346_answer2"><label for="q20803:346_answer2">c. dilatation of the bowel lumen</label> </div>
<div class="r1"><input type="radio" name="q20803:346_answer" disabled="disabled" value="3" id="q20803:346_answer3"><label for="q20803:346_answer3">d. mesenteric stranding</label> </div>
<div class="r0"><input type="radio" name="q20803:346_answer" disabled="disabled" value="4" id="q20803:346_answer4"><label for="q20803:346_answer4">e. bowel wall thickening</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:346_-submit" name="q20803:346_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Pneumatosis intestinalis (gas in the bowel wall) is the most specific CT finding for bowel infarction in a patient presenting with acute arterial mesenteric ischemia. Acute arterial mesenteric ischemia may cause dilatation of the bowel lumen due to reduced peristalsis, although this is neither a sensitive nor specific predictor of ischemia or infarction. Mesenteric stranding is associated with a host of inflammatory bowel pathologies. Bowel wall thickening may be commonly demonstrated after arterial revascularization but is less common at initial presentation. The typical CT findings in a patient with acute arterial mesenteric occlusion include defects or occlusion of the mesenteric arteries, normal or decreased bowel wall thickness, pneumatosis intestinalis, and decreased bowel wall contrast enhancement.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Roentgenol%3B+2009%3B+192+(2)%3A408-16." target="_blank">Furukawa A, Kanasaki S, Kono N, Wakamiya M<span>,&nbsp;</span>Tanaka T<span>,&nbsp;</span>Takahashi M,&nbsp;et al. CT diagnosis of acute mesenteric ischemia from various causes. Am J Roentgenol 2009; 192(2):408-16.</a></p>
<p>QID: 30613</p></div><div class="rightanswer">The correct answer is: pneumatosis intestinalis</div></div></div></div></div><div id="q112" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">309</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2945"><input type="hidden" name="q20803:112_:flagged" value="0"><input type="hidden" value="qaid=910996&amp;qubaid=20803&amp;qid=4927&amp;slot=112&amp;checksum=37100e2b92f0cfcf58313069c9fdece4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:112_:flaggedcheckbox" name="q20803:112_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q112&id=4927"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:112_:sequencecheck" value="2"><div class="qtext"><p>A 67-year-old man is 2 years s/p a right femoral to below knee popliteal bypass with reversed saphenous vein conduit for rest pain. On routine follow-up he is ambulating without pain, however, he typically walks only 5-6 blocks at a time because he is limited by shortness of breath from COPD. On exam there is a weakly palpable posterior tibial pulse and a warm foot. His ankle brachial index is 0.8; 6 months ago it was 0.9.&nbsp; A duplex scan of the bypass graft shows a peak systolic velocity of 200 cm/sec at the proximal anastomosis, which declines to 80 cm/sec just distal to that location. Which of the following is the most appropriate management option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:112_answer" disabled="disabled" value="0" id="q20803:112_answer0"><label for="q20803:112_answer0">a. continued surveillance with repeat duplex scan in 3-6&nbsp;months</label> </div>
<div class="r1"><input type="radio" name="q20803:112_answer" disabled="disabled" value="1" id="q20803:112_answer1"><label for="q20803:112_answer1">b. angiogram with plan for open surgical revision of bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:112_answer" disabled="disabled" value="2" id="q20803:112_answer2"><label for="q20803:112_answer2">c. continued surveillance with duplex scan in 1 year</label> </div>
<div class="r1"><input type="radio" name="q20803:112_answer" disabled="disabled" value="3" id="q20803:112_answer3"><label for="q20803:112_answer3">d. angiogram with plan for endovascular revision of bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:112_answer" disabled="disabled" value="4" id="q20803:112_answer4"><label for="q20803:112_answer4">e. duplex guided balloon angioplasty of stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:112_-submit" name="q20803:112_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Bypass graft surveillance should include a clinical exam, ankle and brachial pressure determinations, and duplex scanning of the bypass graft and immediate inflow and outflow vessels. The frequency of post-operative evaluation is somewhat physician specific but generally consists of reevaluation every 3-6 months in the first 2 years. After this, if there is no evidence of stenosis, yearly follow up is usually adequate. However,&nbsp;surveillance should be more frequent if claudication worsens, the&nbsp;ABI drops by more than 0.1, and/or velocities on duplex scanning suggest a developing stenosis. Current criteria for intervention for severe (&gt;70%) stenoses are peak systolic velocity of &gt;300 cm/sec or peak systolic velocity ration&nbsp; of &gt;3.5. The most commons areas of stenosis&nbsp;are the proximal anastomosis of reversed saphenous vein grafts, followed by mid graft or distal anastomotic stenoses. Symptoms of claudication can be difficult to evaluate if ambulation is limited by other factors, such as COPD.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sem+Vasc+Surg+2009+22%3A252-60." target="_blank">Tinder CN, Bandyk DF. Detection of imminent vein graft occlusion: what is the optimal surveillance program? Sem Vasc Surg 2009 22:252-60.</a></p>
<p>QID: 30168</p></div><div class="rightanswer">The correct answer is: continued surveillance with repeat duplex scan in 3-6&nbsp;months</div></div></div></div></div><div id="q236" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">310</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2954"><input type="hidden" name="q20803:236_:flagged" value="0"><input type="hidden" value="qaid=911120&amp;qubaid=20803&amp;qid=4966&amp;slot=236&amp;checksum=28d80dddd7845c48b991f489bd4034b5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:236_:flaggedcheckbox" name="q20803:236_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q236&id=4966"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:236_:sequencecheck" value="2"><div class="qtext"><p>An 84-year-old previously healthy man presents to the office for follow-up 2 weeks after placement of a left autogenous radial-cephalic wrist direct access, which was placed in anticipation of the need for dialysis within the next 6 months. His pre-operative superficial venous duplex evaluation had indicated that the cephalic vein was 3.5 - 4 mm in diameter throughout its length. On physical examination of his left arm, he has no thrill or bruit in the arteriovenous (AV) access outflow, no edema, and nonpalpable radial, ulnar, and brachial artery pulses. Which of the following is the most probable cause of AV access thrombosis in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:236_answer" disabled="disabled" value="0" id="q20803:236_answer0"><label for="q20803:236_answer0">a. poor arterial inflow</label> </div>
<div class="r1"><input type="radio" name="q20803:236_answer" disabled="disabled" value="1" id="q20803:236_answer1"><label for="q20803:236_answer1">b. inadequate caliber of the outflow vein</label> </div>
<div class="r0"><input type="radio" name="q20803:236_answer" disabled="disabled" value="2" id="q20803:236_answer2"><label for="q20803:236_answer2">c. anastomotic stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:236_answer" disabled="disabled" value="3" id="q20803:236_answer3"><label for="q20803:236_answer3">d. hypercoagulability</label> </div>
<div class="r0"><input type="radio" name="q20803:236_answer" disabled="disabled" value="4" id="q20803:236_answer4"><label for="q20803:236_answer4">e. central venous stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:236_-submit" name="q20803:236_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Access failure that occurs within 30 days of surgery is defined as early access failure. In the absence of a technical failure, such as a twisted or stenotic anastomosis, it is most commonly due to inadequate venous outflow, which may be secondary to inadequate caliber of the outflow vein in the arm&nbsp;or central venous stenosis. Other less common causes early access failure&nbsp;include poor arterial inflow and anastomotic stenosis. In this patient, however, there are no signs of a central venous stenosis, no history of previous central venous catheterizations, his pre-operative upper extremity superficial venous duplex scan indicated an adequate quality vein, and he has nonpalpable pulses. The most probable cause of his early access failure is inadequate arterial inflow.<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1998%3B+27+(2)%3A302-8." target="_blank">Silva MB, Hobson RW, Pappas PJ, Jamil Z<span>,&nbsp;</span>Araki CT<span>,&nbsp;</span>Goldberg MC<span>,&nbsp;</span>et al. A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27 (2):302-8.</a></p>
<p>QID: 30414</p></div><div class="rightanswer">The correct answer is: poor arterial inflow</div></div></div></div></div><div id="q327" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">311</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2963"><input type="hidden" name="q20803:327_:flagged" value="0"><input type="hidden" value="qaid=911211&amp;qubaid=20803&amp;qid=5091&amp;slot=327&amp;checksum=9e76c4b4c05fa48fec3e07be0ffdc521&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:327_:flaggedcheckbox" name="q20803:327_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q327&id=5091"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:327_:sequencecheck" value="2"><div class="qtext"><p>A vascular technologist is evaluating the flow pattern in a superficial femoral artery with duplex ultrasound. The technologist switches from a 2.5 MHz transducer to a 5 MHz transducer with no change in the imaging location. Which of the following parameters will increase?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:327_answer" disabled="disabled" value="0" id="q20803:327_answer0"><label for="q20803:327_answer0">a. doppler frequency shift of the reflected ultrasound</label> </div>
<div class="r1"><input type="radio" name="q20803:327_answer" disabled="disabled" value="1" id="q20803:327_answer1"><label for="q20803:327_answer1">b. pulse repetition frequency of the transmitted ultrasound</label> </div>
<div class="r0"><input type="radio" name="q20803:327_answer" disabled="disabled" value="2" id="q20803:327_answer2"><label for="q20803:327_answer2">c. wavelength of the transmitted ultrasound</label> </div>
<div class="r1"><input type="radio" name="q20803:327_answer" disabled="disabled" value="3" id="q20803:327_answer3"><label for="q20803:327_answer3">d. amplitude of the transmitted ultrasound</label> </div>
<div class="r0"><input type="radio" name="q20803:327_answer" disabled="disabled" value="4" id="q20803:327_answer4"><label for="q20803:327_answer4">e. propagation speed of the reflected ultrasound</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:327_-submit" name="q20803:327_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Parameters describing sound waves include frequency, period, wavelength, amplitude, and propagation speed. The transmitted frequency is determined by the sound source, which in this case is the transducer. Higher MHz transducers produce higher frequency ultrasound; therefore, switching from a 2.5 MHz transducer to a 5 MHz transducer will increase the transmitted frequency. According to the Doppler equation, the Doppler frequency shift of the reflected ultrasound increases as the transmitted ultrasound frequency increases. The period is the time required for one cycle of ultrasound to occur, and the wavelength is the distance in space that one cycle takes up. Both period and wavelength decrease as the transmitted frequency increases. Amplitude represents the strength of the sound waves and is independent of transmitted frequency. The propagation speed of ultrasound is determined by the medium or tissue through which it travels. All ultrasound travels at the same speed through a particular tissue, regardless of frequency. In diagnostic ultrasound, short bursts or pulses of acoustic energy are used to produce anatomic images and Doppler waveforms. The number of pulses that occur in 1 second is referred to as the "pulse repetition frequency" or PRF. The PRF is not related to the transmitted ultrasound frequency; it will not change with the transducer frequency.</p>
<p>&nbsp;</p>
<h2>References<strong>:</strong></h2>
<p>Kremkau FW. Chapter 5 Doppler Principles. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:125-75.</p>
<p>Kremkau FW. Chapter 2 Ultrasound. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:13-39.</p>
<p>QID: 30561</p></div><div class="rightanswer">The correct answer is: doppler frequency shift of the reflected ultrasound</div></div></div></div></div><div id="q271" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">312</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2972"><input type="hidden" name="q20803:271_:flagged" value="0"><input type="hidden" value="qaid=911155&amp;qubaid=20803&amp;qid=5008&amp;slot=271&amp;checksum=0c348060571ab757368c914752ff7fbd&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:271_:flaggedcheckbox" name="q20803:271_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q271&id=5008"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:271_:sequencecheck" value="2"><div class="qtext"><p>When compared with autogenous radiocephalic arteriovenous accesses, autogenous brachiocephalic arteriovenous accesses have which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:271_answer" disabled="disabled" value="0" id="q20803:271_answer0"><label for="q20803:271_answer0">a. lower blood flow volumes</label> </div>
<div class="r1"><input type="radio" name="q20803:271_answer" disabled="disabled" value="1" id="q20803:271_answer1"><label for="q20803:271_answer1">b. reduced incidence of cephalic arch stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:271_answer" disabled="disabled" value="2" id="q20803:271_answer2"><label for="q20803:271_answer2">c. higher incidence of ischemic monomelic neuropathy</label> </div>
<div class="r1"><input type="radio" name="q20803:271_answer" disabled="disabled" value="3" id="q20803:271_answer3"><label for="q20803:271_answer3">d. lower incidence of steal syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:271_answer" disabled="disabled" value="4" id="q20803:271_answer4"><label for="q20803:271_answer4">e. higher risk of infection</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:271_-submit" name="q20803:271_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Brachiocephalic arteriovenous autogenous accesses are appropriate options for hemodialysis access when the forearm veins are unavailable. Brachial artery based access procedures have the potential advantage of higher blood flow volumes and improved autogenous access maturation rates. Because of the higher flow volumes, they have the potential disadvantages of higher risk of steal syndrome and higher incidence of cephalic arch stenosis. Ischemic monomelic neuropathy is an uncommon but potentially devastating condition affecting all three forearm nerves; this occurs uniquely after brachial artery based autogenous and prosthetic accesses. There is no difference in the infection rate between radiocephalic and brachiocephalic autogenous accesses.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>National Kidney Foundation KDOQI 2006 Vascular Access Guidelines.&nbsp; Am J Kidney DIsease 2006;48(suppl 1):S177-322.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B48%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M,&nbsp;Jennings WC,&nbsp;Padberg FT Jr,&nbsp;et al.&nbsp; The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.&nbsp; J Vasc Surg;2008:2S-25S.</a></p>
<p>QID: 30456</p></div><div class="rightanswer">The correct answer is: higher incidence of ischemic monomelic neuropathy</div></div></div></div></div><div id="q249" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">313</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2981"><input type="hidden" name="q20803:249_:flagged" value="0"><input type="hidden" value="qaid=911133&amp;qubaid=20803&amp;qid=1918&amp;slot=249&amp;checksum=5ed31bf97eed331155a40c06bd71b23c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:249_:flaggedcheckbox" name="q20803:249_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q249&id=1918"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:249_:sequencecheck" value="2"><div class="qtext"><p>A 46 year old Caucasian male with CAD, hypertension and dyslipidemia is referred for access creation. He is new to dialysis.&nbsp; He is left handed.&nbsp; He has a normal Allens test bilaterally.&nbsp; Duplex vein mapping demonstrates:</p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top" width="123">
<p>&nbsp;</p>
</td>
<td valign="top" width="119">
<p>right</p>
</td>
<td valign="top" width="118">
<p>left</p>
</td>
</tr>
<tr>
<td valign="top" width="123">
<p><strong>Cephalic</strong>- wrist</p>
</td>
<td valign="top" width="119">
<p>3.5</p>
</td>
<td valign="top" width="118">
<p>4</p>
</td>
</tr>
<tr>
<td valign="top" width="123">
<p>Forearm</p>
</td>
<td valign="top" width="119">
<p>3.5</p>
</td>
<td valign="top" width="118">
<p>4.5</p>
</td>
</tr>
<tr>
<td valign="top" width="123">
<p>Antecubital</p>
</td>
<td valign="top" width="119">
<p>3.5</p>
</td>
<td valign="top" width="118">
<p>4.5</p>
</td>
</tr>
<tr>
<td valign="top" width="123">
<p>Proximal</p>
</td>
<td valign="top" width="119">
<p>4.5</p>
</td>
<td valign="top" width="118">
<p>5</p>
</td>
</tr>
<tr>
<td valign="top" width="123">
<p><strong>Basilic</strong>- forearm</p>
</td>
<td valign="top" width="119">
<p>3.5</p>
</td>
<td valign="top" width="118">
<p>3.5</p>
</td>
</tr>
<tr>
<td valign="top" width="123">
<p>Antecubital</p>
</td>
<td valign="top" width="119">
<p>4.5</p>
</td>
<td valign="top" width="118">
<p>5</p>
</td>
</tr>
<tr>
<td valign="top" width="123">
<p>proximal</p>
</td>
<td valign="top" width="119">
<p>5</p>
</td>
<td valign="top" width="118">
<p>5.5</p>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<p>What procedure should be performed?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:249_answer" disabled="disabled" value="0" id="q20803:249_answer0"><label for="q20803:249_answer0">a. right brachiocephalic fistula</label> </div>
<div class="r1"><input type="radio" name="q20803:249_answer" disabled="disabled" value="1" id="q20803:249_answer1"><label for="q20803:249_answer1">b. left brescia-cimino fistula</label> </div>
<div class="r0"><input type="radio" name="q20803:249_answer" disabled="disabled" value="2" id="q20803:249_answer2"><label for="q20803:249_answer2">c. right brescia-cimino fistula</label> </div>
<div class="r1"><input type="radio" name="q20803:249_answer" disabled="disabled" value="3" id="q20803:249_answer3"><label for="q20803:249_answer3">d. left basilic vein transposition fistula</label> </div>
<div class="r0"><input type="radio" name="q20803:249_answer" disabled="disabled" value="4" id="q20803:249_answer4"><label for="q20803:249_answer4">e. left brachiocephalic fistula</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:249_-submit" name="q20803:249_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>As the patient is left hand dominant, the right arm is preferred.&nbsp; The cephalic vein appears suitable on both sides by any criteria used (3.5mm).&nbsp; The patient has no reason to proceed to an upper arm fistula based upon comorbidities, gender, or physical exam findings.</p>
<p>KDOQI guidelines</p>
<p>Silva MB Jr, Hobson RW II, Pappas PJ, et al: A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=9510284&query_hl=1075&itool=pubmed_docsum">J Vasc Surg 27:302-307; discussion 307-308, 1998<br></a></p>
<p>Malovrh M: Approach to patients with end-stage renal disease who need an arteriovenous fistula. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=12817071&query_hl=1083&itool=pubmed_docsum">Nephrol Dial Transplant 18:Sv50-Sv52, 2003 (suppl 5)</a><br><br>Wong V, Ward R, Taylor J, Selvakumar S, How TV, Bakran A: Factors associated with early failure of arteriovenous fistulae for haemodialysis access. <a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=8760984&query_hl=1085&itool=pubmed_docsum">Eur J Vasc Endovasc Surg 12:207-213, 1996</a></p>
<p><span>QID: 30433</span></p></div><div class="rightanswer">The correct answer is: right brescia-cimino fistula</div></div></div></div></div><div id="q473" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">314</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2990"><input type="hidden" name="q20803:473_:flagged" value="0"><input type="hidden" value="qaid=911357&amp;qubaid=20803&amp;qid=5198&amp;slot=473&amp;checksum=04128b89be6623ad0f1e0eebe165aa0e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:473_:flaggedcheckbox" name="q20803:473_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q473&id=5198"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:473_:sequencecheck" value="2"><div class="qtext"><p>Which contrast agent delivers the most iodine with the least effect on osmolality?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:473_answer" disabled="disabled" value="0" id="q20803:473_answer0"><label for="q20803:473_answer0">a. Iohexol</label> </div>
<div class="r1"><input type="radio" name="q20803:473_answer" disabled="disabled" value="1" id="q20803:473_answer1"><label for="q20803:473_answer1">b. Iodixanol</label> </div>
<div class="r0"><input type="radio" name="q20803:473_answer" disabled="disabled" value="2" id="q20803:473_answer2"><label for="q20803:473_answer2">c. Ioxaglate</label> </div>
<div class="r1"><input type="radio" name="q20803:473_answer" disabled="disabled" value="3" id="q20803:473_answer3"><label for="q20803:473_answer3">d. Iopamidol</label> </div>
<div class="r0"><input type="radio" name="q20803:473_answer" disabled="disabled" value="4" id="q20803:473_answer4"><label for="q20803:473_answer4">e. metrizoate</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:473_-submit" name="q20803:473_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span style="line-height: 1.5;">All contrast media currently used for arteriography are based on molecules with modifications of a 2, 4, 6-triiodinated benzene ring. Classification is based on physical and chemical characteristics, including chemical structure, osmolality, iodine content, and ionization in solution. Contrast media are more viscous and have greater osmolality than blood. Viscosity and osmolality contribute to contrast reactions.</span></p>
<p><span style="line-height: 1.5;">Ionic contrast media generally have higher osmolality and more side-effects. Ionic contrast agents include:</span></p>
<ul>
<li><span style="line-height: 1.5;">Diatrizoate (Hypaque 50)</span></li>
<li><span style="line-height: 1.5;">Metrizoate (Isopaque 370)</span></li>
<li><span style="line-height: 1.5;">Ioxaglate (Hexabrix)</span></li>
</ul>
<p><span style="line-height: 1.5;">Non-ionic contrast media have the iodine bound to an organic molecule. They are less osmolar and tend to have fewer side-effects. Commonly used monomeric non-ionic contrast agents include:</span></p>
<ul>
<li><span style="line-height: 1.5;">Iopamidol (Isovue 370)</span></li>
<li><span style="line-height: 1.5;">Iohexol (Omnipaque 350)</span></li>
<li><span style="line-height: 1.5;">Ioxilan (Oxilan 350)</span></li>
<li><span style="line-height: 1.5;">Iopromide (Ultravist 370)</span></li>
</ul>
<p><span style="line-height: 1.5;">One dimeric non-ionic agent is available:</span></p>
<ul>
<li><span style="line-height: 1.5;">Iodixanol (Visipaque 320)</span></li>
</ul>
<p><span style="line-height: 1.5;">This has the lowest osmolality (290 mosm/L) of available agents. It is iso-osmolar with blood. Nonionic dimers deliver the most iodine with the least effect on osmolality. Iodixanol (Visipaque 320) is the correct answer.</span></p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.acr.org/~/media/ACR/Documents/PDF/QualitySafety/Resources/Contrast%20Manual/2013_Contrast_Media.pdf" target="_blank">American College of Radiology, Committee on Drugs and Contrast Media. ACR Manual on Contrast Media, version 9. 2013&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Nucl+Med+Technol.+2008%3B+36(2)%3A69-74." target="_blank">Singh J, Daftary A. Iodinated contrast media and their adverse reactions. J Nucl Med Technol. 2008; 36(2):69-77.</a></p>
<p>QID: 30837</p></div><div class="rightanswer">The correct answer is: Iodixanol</div></div></div></div></div><div id="q443" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">315</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_2999"><input type="hidden" name="q20803:443_:flagged" value="0"><input type="hidden" value="qaid=911327&amp;qubaid=20803&amp;qid=5160&amp;slot=443&amp;checksum=3d30c7396bf1fa85f698f9b5c830bdf1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:443_:flaggedcheckbox" name="q20803:443_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q443&id=5160"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:443_:sequencecheck" value="2"><div class="qtext"><p>A 71-year-old woman is scheduled for elective thoracoabdominal aneurysm repair. She has heart disease and was treated with a coronary stent, for which she takes dual antiplatelet therapy with aspirin and clopidogrel. With respect to her coronary stent and medications, which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:443_answer" disabled="disabled" value="0" id="q20803:443_answer0"><label for="q20803:443_answer0">a. clopidogrel may be stopped after 6 months following drug eluting stent placement</label> </div>
<div class="r1"><input type="radio" name="q20803:443_answer" disabled="disabled" value="1" id="q20803:443_answer1"><label for="q20803:443_answer1">b. aspirin and clopidogrel should be continued indefinitely following any coronary stent placement.</label> </div>
<div class="r0"><input type="radio" name="q20803:443_answer" disabled="disabled" value="2" id="q20803:443_answer2"><label for="q20803:443_answer2">c. clopidogrel may be stopped after 1 month following placement of a bare metal stent</label> </div>
<div class="r1"><input type="radio" name="q20803:443_answer" disabled="disabled" value="3" id="q20803:443_answer3"><label for="q20803:443_answer3">d. aspirin alone may be stopped after 1 month following bare metal stent placement</label> </div>
<div class="r0"><input type="radio" name="q20803:443_answer" disabled="disabled" value="4" id="q20803:443_answer4"><label for="q20803:443_answer4">e. aspirin alone may be stopped after 6 months following drug eluting stent placement</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:443_-submit" name="q20803:443_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>With increasing use of percutaneous coronary stenting procedures, including drug eluting stents, more patients are presenting on potent antiplatelet agents. Stopping these agents may risk stent thrombosis (with associated risk of myocardial infarction or death); this risk needs to be measured against the risk of bleeding and the magnitude of the proposed vascular operation. Current Class I recommendations support the use of aspirin indefinitely after percutaneous coronary interventions, the use of clopidogrel for at least 12 months after drug eluting stent placement, and the use of clopidogrel for at least 1 month (and ideally up to 12 months) after bare metal stent placement.<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=a+report+of+the+American+College+of+Cardiology+Foundation%2FAmerican+Heart+Association+Task+Force+on+Practice+Guidelines.+J+Am+Coll+Cardiol+2009+Dec+1%3B54(23)%3A2205-41." target="_blank">Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, et al. 2009 focused updates: ACC/AHA guidelines for the management of&nbsp;patients with ST-elevation myocardial infarction (updating the 2004 guideline and&nbsp;2007 focused update) and ACC/AHA/SCAI guidelines on percutaneous coronary&nbsp;intervention (updating the 2005 guideline and 2007 focused update) a report of&nbsp;the American College of Cardiology Foundation/American Heart Association Task&nbsp;Force on Practice Guidelines. J Am Coll Cardiol 2009 Dec 1;54(23):2205-41.&nbsp;</a></p>
<p>QID: 30800</p></div><div class="rightanswer">The correct answer is: clopidogrel may be stopped after 1 month following placement of a bare metal stent</div></div></div></div></div><div id="q464" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">316</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3008"><input type="hidden" name="q20803:464_:flagged" value="0"><input type="hidden" value="qaid=911348&amp;qubaid=20803&amp;qid=5186&amp;slot=464&amp;checksum=76bb8f2ca8fc134d0e982a895211aed3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:464_:flaggedcheckbox" name="q20803:464_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q464&id=5186"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:464_:sequencecheck" value="2"><div class="qtext"><p>After undergoing a femoropopliteal bypass for limb ischemia, a patient with known heparin-induced thrombocytopenia (HIT) and a replaced mitral valve is transitioned from argatroban to warfarin. His INR 3 days after the initiation of oral anticoagulation is 3.6.&nbsp;Which of the following therapeutic decisions is most appropriate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:464_answer" disabled="disabled" value="0" id="q20803:464_answer0"><label for="q20803:464_answer0">a. discharge the patient home on current dose of warfarin</label> </div>
<div class="r1"><input type="radio" name="q20803:464_answer" disabled="disabled" value="1" id="q20803:464_answer1"><label for="q20803:464_answer1">b. check liver function tests (including albumin) to evaluate for hepatic dysfunction</label> </div>
<div class="r0"><input type="radio" name="q20803:464_answer" disabled="disabled" value="2" id="q20803:464_answer2"><label for="q20803:464_answer2">c. hold warfarin dosing for 1 day</label> </div>
<div class="r1"><input type="radio" name="q20803:464_answer" disabled="disabled" value="3" id="q20803:464_answer3"><label for="q20803:464_answer3">d. continue both argatroban and warfarin</label> </div>
<div class="r0"><input type="radio" name="q20803:464_answer" disabled="disabled" value="4" id="q20803:464_answer4"><label for="q20803:464_answer4">e. transition from argatroban to lepirudin due to elevated INR</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:464_-submit" name="q20803:464_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Argatroban, a FDA approved agent for anticoagulation in patients with heparin-induced thrombocytopenia, is a direct thrombin inhibitor that irreversibly binds to the active thrombin site resulting in inhibition of fibrin formation, activation of clotting factors V, VIII, XII, activated protein C, and platelet aggregation. Its action is independent of antithrombin III. The drug is metabolized by the liver and no dose adjustments are needed for renal impairment.</p>
<p>Because argatroban is a direct thrombin inhibitor, coadministration with warfarin produces a combined effect on the laboratory measurement of the INR. Since both warfarin and argatroban elevate the PT/INR, institutional guidelines should be reviewed to determine the appropriate INR target when both agents are used in order to achieve an INR in the range of 2.0-3.0 when argatroban is discontinued.</p>
<p>This target will differ according to the reagents used to determine the PT/INR in each particular institution. The relationship between the INR on co-therapy is somewhat complex, but, in general, an INR of 4-5 while on argatroban and warfarin correlates to an approximate INR of 2 on warfarin alone. Therefore, in this scenario, the patient would most correctly be continued on both argatroban and warfarin until he reaches an INR of greater than 4-5 before cessation of argatroban and discharge home.</p>
<p>It is safe to initiate warfarin in patients who have been effectively anticoagulated once their platelet count recovers to at least 150,000 cells per microliter. The thrombin inhibitor can then be discontinued approximately 5 days after initiating warfarin. Due to the short half-life of protein C and the risk of thrombosis, warfarin should not be initiated without the patient being therapeutically anticoagulated with another agent (ie, fondaparinux).</p>
<p>The target INR is 2-3, and treatment should continue for about 3 months. Six months of therapy is indicated in patients with prior DVT.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>Argatroban. GlaxoSmithKline package insert. Research Triangle Park, NC; 2005.</p>
<p>UpToDate. Heparin Induced Thrombocytopenia. 2012 Stephen Coutre.</p>
<p>QID: 30825</p></div><div class="rightanswer">The correct answer is: continue both argatroban and warfarin</div></div></div></div></div><div id="q448" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">317</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3017"><input type="hidden" name="q20803:448_:flagged" value="0"><input type="hidden" value="qaid=911332&amp;qubaid=20803&amp;qid=5165&amp;slot=448&amp;checksum=871497b7074a398233620de1ca6db3d4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:448_:flaggedcheckbox" name="q20803:448_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q448&id=5165"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:448_:sequencecheck" value="2"><div class="qtext"><p>A 58-year-old male smoker presents with bilateral calf claudication. Duplex scanning demonstrates bilateral superficial femoral artery stenoses. Which pharmaceutical agents is most likely to improve pain free walking distance?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:448_answer" disabled="disabled" value="0" id="q20803:448_answer0"><label for="q20803:448_answer0">a. pentoxyphylline</label> </div>
<div class="r1"><input type="radio" name="q20803:448_answer" disabled="disabled" value="1" id="q20803:448_answer1"><label for="q20803:448_answer1">b. aspirin</label> </div>
<div class="r0"><input type="radio" name="q20803:448_answer" disabled="disabled" value="2" id="q20803:448_answer2"><label for="q20803:448_answer2">c. persantine</label> </div>
<div class="r1"><input type="radio" name="q20803:448_answer" disabled="disabled" value="3" id="q20803:448_answer3"><label for="q20803:448_answer3">d. cilostazol</label> </div>
<div class="r0"><input type="radio" name="q20803:448_answer" disabled="disabled" value="4" id="q20803:448_answer4"><label for="q20803:448_answer4">e. clopidogrel</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:448_-submit" name="q20803:448_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Pharmacotherapy assumes an important role in the non-interventional management of claudication. Treatment should be directed toward risk factor modification, cardiovascular event reduction, and relief of symptoms. Of the agents listed, only cilostazol has demonstrated clinical efficacy in the amelioration of claudication symptoms. Cilostazol is a phosphodiesterase III inhibitor with vasodilator, metabolic, and antiplatelet activity. At least 7 randomized, placebo-controlled, double blind studies have demonstrated improvements in pain-free walking distance with cilostazol. This benefit is seen at both the standard 100 mg twice daily dose and, to a lesser degree but still significant, at the 50 mg twice daily dose, as compared to placebo.</p>
<p>While early trials of pentoxyphylline were positive on the endpoint of improvement in treadmill exercise performance, later studies demonstrated that it was no more effective than placebo on improving treadmill walking distance or functional status assessed by questionnaires.</p>
<p>Aspirin and lipid-lowering agents should be used to reduce the cardiovascular event rate. Current data do not show an advantage of dual antiplatelet therapy (ie, aspirin and clopidogrel) over single agent therapy in patients with peripheral arterial disease.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17223489" target="_blank">Norgren L, Hiatt WR. Dormandy JA, Nehler MR<span>,&nbsp;</span>Harris KA<span>,&nbsp;</span>Fowkes FG,<span>&nbsp;</span>et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(1):S5-S67.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/18254032" target="_blank">Robless P, Mikhailidis DP, Stansby GP. Cilostazol for peripheral arterial disease. Cochrane Database of Systematic Reviews; 2008; Jan23(1):CD003748.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+2007%3B+356+(12)%3A1241-50." target="_blank">White C. Intermittent claudication. N Engl J Med 2007; 356 (12):1241-50.</a></p>
<p>QID: 30805</p></div><div class="rightanswer">The correct answer is: cilostazol</div></div></div></div></div><div id="q553" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">318</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3026"><input type="hidden" name="q20803:553_:flagged" value="0"><input type="hidden" value="qaid=911437&amp;qubaid=20803&amp;qid=5149&amp;slot=553&amp;checksum=1383adb454dc7ce4106246a0fb57bead&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:553_:flaggedcheckbox" name="q20803:553_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q553&id=5149"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:553_:sequencecheck" value="2"><div class="qtext"><p>An 18-year-old man was the restrained driver of a motor-vehicle collision. His vital signs&nbsp;include a blood pressure of 90/60 mm Hg and a heart rate of 120 bpm. The patient had a grade IV splenic injury on computed tomographic (CTA) imaging, with moderate hemoperitoneum. No other significant injuries were discovered. The patient’s initial hematocrit was 22.1. &nbsp;Which of the following is the next step in the management of the patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:553_answer" disabled="disabled" value="0" id="q20803:553_answer0"><label for="q20803:553_answer0">a. transfusion with serial examination</label> </div>
<div class="r1"><input type="radio" name="q20803:553_answer" disabled="disabled" value="1" id="q20803:553_answer1"><label for="q20803:553_answer1">b. splenic artery embolization</label> </div>
<div class="r0"><input type="radio" name="q20803:553_answer" disabled="disabled" value="2" id="q20803:553_answer2"><label for="q20803:553_answer2">c. beta blockade, vasopressor support, and observation</label> </div>
<div class="r1"><input type="radio" name="q20803:553_answer" disabled="disabled" value="3" id="q20803:553_answer3"><label for="q20803:553_answer3">d. exploratory laparotomy and splenectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:553_answer" disabled="disabled" value="4" id="q20803:553_answer4"><label for="q20803:553_answer4">e. crystalloid resuscitation and observation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:553_-submit" name="q20803:553_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The utility of splenic artery embolization in trauma is an area of continuing controversy.&nbsp; However, the largest series of splenic artery embolization for blunt splenic injury would suggest that hemodynamically stable patients with AAST Grade 3-5 injuries, or those with evidence of extravasation, pseudoaneurysm, or arteriovenous fistula on CTA, would benefit from arteriography and possible embolization.&nbsp;When following this protocol, Haan et al were able to achieve successful non-operative management of splenic artery injuries in over 80% of patients.&nbsp;However, patients that are hemodynamically unstable with high-grade splenic artery injuries require operative exploration.&nbsp;In Haan's study, the specific technique of splenic embolization (proximal, distal, both) or choice of embolic agent (coils, plugs, embolic spheres, absorbable thrombin soaked gel-foam) did not alter the outcomes.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Trauma+2005%3B58%3A492-8." target="_blank">Haan JM, Bochicchio GV, Kramer N, Scalea T. Nonoperative management of blunt splenic injury: A 5-year experience. J Trauma&nbsp;2005; 58:492-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Trauma+Acute+Care+Surg+2013%3B74%3A1567-74." target="_blank">Olthof DC, van der Vlies CH, Joosse P, van Delden OM, Jurkovich GJ, Goslings JC, et al.&nbsp;Consensus strategies for the nonoperative management of patients with blunt splenic injury: a Delphi study.&nbsp;J Trauma Acute Care Surg 2013;74:1567-74.</a></p>
<p>QID: 30625</p></div><div class="rightanswer">The correct answer is: exploratory laparotomy and splenectomy</div></div></div></div></div><div id="q97" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">319</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3035"><input type="hidden" name="q20803:97_:flagged" value="0"><input type="hidden" value="qaid=910981&amp;qubaid=20803&amp;qid=4918&amp;slot=97&amp;checksum=63b5d833e47b7a365f206edb3d3bb263&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:97_:flaggedcheckbox" name="q20803:97_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q97&id=4918"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:97_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old man presents to the trauma bay with a gunshot wound to the right lower extremity. He is hemodynamically stable. He has a right tibial-fibular fracture, no distal pulses, and some soft tissue damage.&nbsp; Which of the following factors is most significantly associated with limb loss?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:97_answer" disabled="disabled" value="0" id="q20803:97_answer0"><label for="q20803:97_answer0">a. compound fracture</label> </div>
<div class="r1"><input type="radio" name="q20803:97_answer" disabled="disabled" value="1" id="q20803:97_answer1"><label for="q20803:97_answer1">b. <span>combined above- and below-knee injury</span></label> </div>
<div class="r0"><input type="radio" name="q20803:97_answer" disabled="disabled" value="2" id="q20803:97_answer2"><label for="q20803:97_answer2">c. <span>tense compartments on presentation</span></label> </div>
<div class="r1"><input type="radio" name="q20803:97_answer" disabled="disabled" value="3" id="q20803:97_answer3"><label for="q20803:97_answer3">d. penetrating injury mechanism</label> </div>
<div class="r0"><input type="radio" name="q20803:97_answer" disabled="disabled" value="4" id="q20803:97_answer4"><label for="q20803:97_answer4">e. failed revascularization</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:97_-submit" name="q20803:97_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Multiple factors influence limb salvage outcomes following trauma. Independent risk factors for amputation include occluded graft (odds ratio [OR] 16.7), combined above- and below-knee injury (OR 4.4), tense compartment (OR 4.2), arterial transection (OR 2.8), and&nbsp;associated&nbsp;compound fracture (OR 2.7). High-velocity firearm injuries are likely to lead to amputation, but the most significant independent risk&nbsp;factor&nbsp;for&nbsp;limb loss&nbsp;is failed revascularization. Early (≤ 30 days) graft thrombosis remains the most common complication of vascular injury repair, with a incidence rate of 5-17%. Thrombosis and subsequent early graft failure is the most common cause of amputation. Amputation rates from this complication range from 13-30%.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vasc+2005%3B+13(3)%3A141-7." target="_blank">Davidovic LB,&nbsp;Cinara IS,&nbsp;Ille T,&nbsp;Kostic DM,&nbsp;Dragas MV,&nbsp;Markovic DM. Civil and war peripheral arterial trauma: review of risk factors&nbsp;associated&nbsp;with&nbsp;limb loss. Vascular 2005; 13(3):141-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg.+2001%3B+33(6)%3A1212-9." target="_blank">Hafez HM,&nbsp;Woolgar J,&nbsp;Robbs JV. Lower&nbsp;extremity&nbsp;arterial injury: results of 550 cases and review of risk factors&nbsp;associated&nbsp;with&nbsp;limb loss. J Vasc Surg 2001; 33(6):1212-9.</a></p>
<p>QID: 30148</p></div><div class="rightanswer">The correct answer is: failed revascularization</div></div></div></div></div><div id="q31" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">320</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3044"><input type="hidden" name="q20803:31_:flagged" value="0"><input type="hidden" value="qaid=910915&amp;qubaid=20803&amp;qid=4640&amp;slot=31&amp;checksum=e36a0e21562b9ef77854e6f348c5203b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:31_:flaggedcheckbox" name="q20803:31_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q31&id=4640"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:31_:sequencecheck" value="2"><div class="qtext"><p>&nbsp;A 72-year-old man with a history of aorto-bi-iliac bypass with&nbsp;a prosthetic graft&nbsp;presents with 1 week of fevers, chills, and back pain.&nbsp;Six weeks prior to his bypass surgery, he had an episode of diverticulitis and was&nbsp;treated with colon resection, descending colostomy, and drainage of a large retroperitoneal abscess.&nbsp;His past medical history is significant for coronary artery disease, peripheral arterial disease, and multiple lower extremity deep venous thromboses.&nbsp;His WBC is 14,000, and his CTA demonstrates a 4 cm focal fluid collection adjacent to his aortic graft with fat stranding around the body of the graft. He is taken to the OR for aortic graft excision and in situ reconstruction with rifampin-soaked dacron graft. Upon exploring the retroperitoneum, there is inflammation in the retroperitoneum and extensive tissue destruction.&nbsp;The fluid cavity is filled with&nbsp;purulence that is encompassing the graft and there is necrosis of the retroperitoneal fat and psoas muscle.&nbsp;Gram stain yields multiple WBC’s and gram-negative rods.&nbsp; Which of the following is the appropriate&nbsp;next step&nbsp;in&nbsp;management after debridement of the retroperitoneum?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:31_answer" disabled="disabled" value="0" id="q20803:31_answer0"><label for="q20803:31_answer0">a. place Daptomycin and Tobramycin beads with planned re-operation in 72 hours for primary graft salvage</label> </div>
<div class="r1"><input type="radio" name="q20803:31_answer" disabled="disabled" value="1" id="q20803:31_answer1"><label for="q20803:31_answer1">b. use&nbsp;cryopreserved allograft for in situ aortic graft replacement</label> </div>
<div class="r0"><input type="radio" name="q20803:31_answer" disabled="disabled" value="2" id="q20803:31_answer2"><label for="q20803:31_answer2">c. continue with in situ rifampin-soaked dacron reconstruction</label> </div>
<div class="r1"><input type="radio" name="q20803:31_answer" disabled="disabled" value="3" id="q20803:31_answer3"><label for="q20803:31_answer3">d. use femoral veins in situ&nbsp;for neoaortoiliac (NAIS) reconstruction</label> </div>
<div class="r0"><input type="radio" name="q20803:31_answer" disabled="disabled" value="4" id="q20803:31_answer4"><label for="q20803:31_answer4">e. complete graft explant, wide debridement, aortic ligation, and extra-anatomic bypass graft placement</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:31_-submit" name="q20803:31_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Intracavitary graft infections can be extremely challenging to manage; they carry a high rate of mortality, limb loss, and re-infection.&nbsp; The "gold standard" for the treatment of graft infections is 1) complete graft explant, 2) arterial ligation, and 3) extra-anatomic bypass if needed, although there are situations when in situ replacement may be favorable.&nbsp;Increasingly, in situ rifampin-soaked dacron grafts, allografts, or neoartoiliac reconstructions using deep vein&nbsp;have been utilized to avoid some of the limitations of aortic ligation and extra-anatomic bypass.&nbsp;In situ reconstructions are expedient, avoid an aortic stump, and may be associated with lower amputation rates.&nbsp; In addition, and depending on the length of the aortic neck between the renal arteries and proximal graft, they avoid renal artery reconstructions to achieve aortic closure. However, in situ reconstructions are associated with high mortality and re-infection rates when there is gross purulence in the wound bed.&nbsp; In addition, low-virulence infections (e.g. Staphylococcus aureus or Staphylococcus epidermis) have favorable outcomes with in situ reconstructions, whereas polymicrobial infections (gram-negative rods, anaerobes, and fungi) are associated with higher mortality and re-infection rates.&nbsp; The gross infection, purulence, and tissue necrosis identified in the operative theater is indicative of the autolytic enzymes produced by polymicrobial infections.&nbsp; Graft preservation with antibiotic beads has not had widespread use for aggressive cavity infections. Cryoperserved allograft is&nbsp;rarely immediately availble, unless it has been ordered from the supplier in advance.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Long-term+results+of+the+treatment+of+aortic+graft+infection+by+in+situ+replacement+with+femoral+popliteal+vein+grafts." target="_blank">Ali AT, Modrall JG, Hocking J, Valentine RJ, Spencer H, Eidt JF, et al. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts.&nbsp; J Vasc Surg 2009; 50(1):30-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JM%2C+Sullivan+TM%2C+Noel+AA%2C+et+al.++Evolution+from+axillofemoral+to+in+situ+prosthetic+reconstruction+for+the+treatment+of+aortic+graft+infections+at+a+single+center." target="_blank">Oderich GS, Bower TC, Cherry KJ Jr, Panneton JM, Sullivan TM, Noel AA, et al.&nbsp; Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center.&nbsp;J Vasc Surg 2006; 43(6):1166-74.</a></p>
<p>QID: 30034</p></div><div class="rightanswer">The correct answer is: complete graft explant, wide debridement, aortic ligation, and extra-anatomic bypass graft placement</div></div></div></div></div><div id="q420" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">321</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3053"><input type="hidden" name="q20803:420_:flagged" value="0"><input type="hidden" value="qaid=911304&amp;qubaid=20803&amp;qid=4794&amp;slot=420&amp;checksum=7171e8a7c2f49d9e963e639171ae0365&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:420_:flaggedcheckbox" name="q20803:420_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q420&id=4794"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:420_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old man presented with a chronic ulcer in his left leg (see image below). This is his second recurrence of an ulcer in the same area. Previous ulcerations were treated successfully with compression bandages. He has varicose veins in his left posterior calf. A duplex ultrasound scan showed a patent deep venous system and a competent great saphenous vein (GSV) in this leg. Spectral Doppler waveforms from his left small saphenous vein (SSV) are depicted in the bottom figure. To prevent future recurrences this patient should be managed with which of the following treatments?</p>
<p>&nbsp;<img src="./VESAP3_files/LURIE-3new.jpg" alt="" width="398" height="404"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:420_answer" disabled="disabled" value="0" id="q20803:420_answer0"><label for="q20803:420_answer0">1. thermal ablation of his left SSV</label> </div>
<div class="r1"><input type="radio" name="q20803:420_answer" disabled="disabled" value="1" id="q20803:420_answer1"><label for="q20803:420_answer1">2. a 2-month course of venotonic drugs</label> </div>
<div class="r0"><input type="radio" name="q20803:420_answer" disabled="disabled" value="2" id="q20803:420_answer2"><label for="q20803:420_answer2">3. high ligation and stripping of his left GSV</label> </div>
<div class="r1"><input type="radio" name="q20803:420_answer" disabled="disabled" value="3" id="q20803:420_answer3"><label for="q20803:420_answer3">4. laser ablation of the great saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:420_answer" disabled="disabled" value="4" id="q20803:420_answer4"><label for="q20803:420_answer4">5. class 1 compression stockings</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:420_-submit" name="q20803:420_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Venous ulcers in the lateral ankle area are less frequent than in the medial leg and are most likely associated with an incompetent SSV. Small series have reported improved healing rates of lateral ulcers after surgical treatment of reflux in the SSV. Although no randomized trials are currently available for SSV incompetence, it has been shown that elimination of the reflux in the GSV reduces recurrent leg ulcerations.&nbsp; Ablation of the great saphenous vein is not indicated in the absence of varicosities or reflux.&nbsp; While compression therapy will be integral to his long term healing, recurrent ulceration with SSV incompetence argue for a more aggressive approach.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lateral+venous+ulcer+and+short+saphenous+vein+insufficiencym.+J+Vasc+Surg+1997%3B" target="_blank">Bass A, Chayen D, Weinmann E, Ziss M. Lateral venous ulcer and short saphenous vein insufficiencym. J Vasc Surg 1997; 25(5):654-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Long+term+results+of+compression+therapy+alone+versus+compression+plus+surgery+in+chronic+venous+ulceration+(ESCHAR)%3A" target="_blank">Gohel MS, Barwell JR, Taylor M, Chant T,&nbsp;Foy C,&nbsp;Earnshaw JJ,&nbsp;et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial. BMJ 2007; 355:83-9.</a></p>
<p>QID: 30741</p></div><div class="rightanswer">The correct answer is: thermal ablation of his left SSV</div></div></div></div></div><div id="q125" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">322</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3062"><input type="hidden" name="q20803:125_:flagged" value="0"><input type="hidden" value="qaid=911009&amp;qubaid=20803&amp;qid=4742&amp;slot=125&amp;checksum=a325c1fb9c5aa84392afa4d7c9eadccb&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:125_:flaggedcheckbox" name="q20803:125_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q125&id=4742"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:125_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding catheter-associated upper extremity deep venous thrombosis (DVT)&nbsp;is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:125_answer" disabled="disabled" value="0" id="q20803:125_answer0"><label for="q20803:125_answer0">a. placement of a superior vena caval filter should be considered for patients who have catheter-related DVT if the catheter cannot be removed</label> </div>
<div class="r1"><input type="radio" name="q20803:125_answer" disabled="disabled" value="1" id="q20803:125_answer1"><label for="q20803:125_answer1">b. patients with catheter-related upper extremity DVT are best treated by removing the catheter and 3 months of anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:125_answer" disabled="disabled" value="2" id="q20803:125_answer2"><label for="q20803:125_answer2">c. pulmonary embolism rarely occurs with catheter-related upper extremity DVT</label> </div>
<div class="r1"><input type="radio" name="q20803:125_answer" disabled="disabled" value="3" id="q20803:125_answer3"><label for="q20803:125_answer3">d. patients with catheter-related upper extremity DVT are best treated with catheter-preservation and 6 months of anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:125_answer" disabled="disabled" value="4" id="q20803:125_answer4"><label for="q20803:125_answer4">e. the risk of catheter-related upper extremity DVT is reduced with the prophylactic administration of&nbsp;low dose vit K antagonists</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:125_-submit" name="q20803:125_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Although a study published several years ago suggested&nbsp;that the risk of catheter-associated upper extremity DVT&nbsp;could be reduced with low dose coumadin, multiple subsequent studies since have failed to corroborate those findings. Upper extremity DVT, regardless of etiology, probably carries similar risk of pulmonary embolus as lower extremity DVT, if left untreated. Current evidence suggests catheter removal and anticoagulation for 3 months is the best treatment alternative. If the catheter is functional and cannot be removed because it is clinically necessary, it is recommended that anticoagulation be continued as long as the catheter remains in place. SVC filters are not typically recommended under these circumstances.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Antithrombotic therapy and prevention of thrombosis. 9th Edition ACCPE (Chest consensus). 2012;141(2)(suppl):41.</p>
<p>QID: 30218</p></div><div class="rightanswer">The correct answer is: patients with catheter-related upper extremity DVT are best treated by removing the catheter and 3 months of anticoagulation</div></div></div></div></div><div id="q532" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">323</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3071"><input type="hidden" name="q20803:532_:flagged" value="0"><input type="hidden" value="qaid=911416&amp;qubaid=20803&amp;qid=5268&amp;slot=532&amp;checksum=de19a01096a62ab7b2c44375ea9bd7e7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:532_:flaggedcheckbox" name="q20803:532_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q532&id=5268"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:532_:sequencecheck" value="2"><div class="qtext"><p>Which of the following techniques will most effectively reduce the radiation dose to the patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:532_answer" disabled="disabled" value="0" id="q20803:532_answer0"><label for="q20803:532_answer0">a. placing the emitter closer to the patient</label> </div>
<div class="r1"><input type="radio" name="q20803:532_answer" disabled="disabled" value="1" id="q20803:532_answer1"><label for="q20803:532_answer1">b. geometric magnification</label> </div>
<div class="r0"><input type="radio" name="q20803:532_answer" disabled="disabled" value="2" id="q20803:532_answer2"><label for="q20803:532_answer2">c. a higher kVp</label> </div>
<div class="r1"><input type="radio" name="q20803:532_answer" disabled="disabled" value="3" id="q20803:532_answer3"><label for="q20803:532_answer3">d. Digital (electronic) magnification</label> </div>
<div class="r0"><input type="radio" name="q20803:532_answer" disabled="disabled" value="4" id="q20803:532_answer4"><label for="q20803:532_answer4">e. a lower frame rate</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:532_-submit" name="q20803:532_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Decreasing the pulse (frame) rate decreases the radiation dose. &nbsp; When electronic (digital) magnification is used, the image intensifier produces a magnified image and the radiation dose is increased to sharpen and brighten the image.&nbsp; Geometric magnification, obtained by moving the image intensifier away from the patient, produces a magnified, but not sharper, image and increases the amount of radiation scatter. &nbsp;A higher kVp results in a higher radiation dose. Placing the x-ray tube closer to the patient does not reduce the dose and results in a greater amount of scatter since the image intensifier is farther away. &nbsp;</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B53%3A+22S-7S." target="_blank">Mitchell EL, Furey P. Prevention of radiation injury from medical imaging. J Vasc Surg 2011;53: 22S-7S.</a></p>
<p>Wagner&nbsp; LK, Archer BR. Minimizing Risks from Fluoroscopic X-rays. Houston: University of Houston, 2004, pg 30-66.</p>
<p>QID: 30936</p></div><div class="rightanswer">The correct answer is: a lower frame rate</div></div></div></div></div><div id="q486" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">324</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3080"><input type="hidden" name="q20803:486_:flagged" value="0"><input type="hidden" value="qaid=911370&amp;qubaid=20803&amp;qid=5224&amp;slot=486&amp;checksum=acb5811a7e66fa2fac7c0aa90b888eff&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:486_:flaggedcheckbox" name="q20803:486_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q486&id=5224"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:486_:sequencecheck" value="2"><div class="qtext"><p>Which statement about varenicline is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:486_answer" disabled="disabled" value="0" id="q20803:486_answer0"><label for="q20803:486_answer0">a. the absence of cardiovascular side effects make it ideal for smokers with peripheral artery disease</label> </div>
<div class="r1"><input type="radio" name="q20803:486_answer" disabled="disabled" value="1" id="q20803:486_answer1"><label for="q20803:486_answer1">b. patients treated with varenicline should be monitored for neuropyschiatric side effects</label> </div>
<div class="r0"><input type="radio" name="q20803:486_answer" disabled="disabled" value="2" id="q20803:486_answer2"><label for="q20803:486_answer2">c. monotherapy is preferred when varenicline is used</label> </div>
<div class="r1"><input type="radio" name="q20803:486_answer" disabled="disabled" value="3" id="q20803:486_answer3"><label for="q20803:486_answer3">d. it is a second-line drug therapy for smoking cessation</label> </div>
<div class="r0"><input type="radio" name="q20803:486_answer" disabled="disabled" value="4" id="q20803:486_answer4"><label for="q20803:486_answer4">e. varenicline is indicated for smoking cessation after failure of behavioral interventions</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:486_-submit" name="q20803:486_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Varenicline is a partial nAChR agonist and works to decrease nicotine withdrawal symptoms while reducing the addicting effects of nicotine. As a result, it is an effective intervention for smoking cessation. Either buproprion or varenicline can be effectively used in combination with nicotine replacement therapy (NRT). Second-line agents for smoking cessation include nortriptyline, a tricyclic antidepressant, and clonidine. These agents have less demonstrated efficacy and side effects are more frequently reported.</p>
<p>The FDA reviewed a randomized clinical trial of 700 smokers with cardiovascular disease and found that varenicline appeared to be associated with a slight increased risk of certain cardiovascular adverse events in these patients. Because smoking is an independent and major risk factor for cardiovascular disease, smoking cessation is of particular importance in this patient population. Subjects received either varenicline 1 mg twice daily or placebo for 12 weeks and were followed for an additional 40 weeks. The clinical trial showed that varenicline was effective in helping patients with cardiovascular disease quit smoking, and more than doubled the chance that patients remain abstinent from smoking for as long as 1 year, compared to patients treated with placebo. Side effects include angina, MI, and need for CABG, but these were not statistically significant.</p>
<p>Based on post-marketing safety report data, the FDA has warned of risks of neuropsychiatric symptoms with both varenicline and bupropion. Patients treated with these agents should be monitored for rare but potentially serious symptoms of behavior change, hostility, agitation, depressed mood, suicidal ideation, suicidal behavior, and attempted suicide. Patients with serious psychiatric illnesses such as schizophrenia, bipolar disorder, and major depressive disorder, may have worsening of their pre-existing psychiatric illness while taking varenicline or bupropion. &nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/books/NBK63952/" target="_blank">Tobacco Use and Dependence Guideline Panel. Treating Tobacco Use and Dependence: 2008 Update. Rockville (MD): US Department of Health and Human Services; 2008 May.&nbsp;</a><a href="http://www.ncbi.nlm.nih.gov/books/NBK63952/"><br></a></p>
<p><a href="http://www.fda.gov/Drugs/DrugSafety/ucm264436.htm" target="_blank">FDA Drug Safety Communication: Chantix (varenicline) drug label now contains updated efficacy and safety information. US Food and Drug Administration. June 22, 2011.</a>&nbsp;<a href="http://www.fda.gov/Drugs/DrugSafety/ucm264436.htm"><br></a></p>
<p><a href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm169986.htm" target="_blank">Information for Healthcare Professionals: Varenicline (marketed as Chantix) and Bupropion (marketed as Zyban, Wellbutrin, and generics).&nbsp;US Food and Drug Administration. July 1, 2009.</a>&nbsp;<a href="http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm169986.htm"><br></a></p>
<p>QID: 30851</p></div><div class="rightanswer">The correct answer is: patients treated with varenicline should be monitored for neuropyschiatric side effects</div></div></div></div></div><div id="q299" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">325</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3089"><input type="hidden" name="q20803:299_:flagged" value="0"><input type="hidden" value="qaid=911183&amp;qubaid=20803&amp;qid=5057&amp;slot=299&amp;checksum=5fb121510944b33b85972412ffa88086&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:299_:flaggedcheckbox" name="q20803:299_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q299&id=5057"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:299_:sequencecheck" value="2"><div class="qtext"><p>In the intravascular ultrasound (IVUS) image of a common iliac artery shown below, the white arrows&nbsp;demonstrate which of the following?</p>
<p><a href="./VESAP3_files/11686.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/11686.jpg" alt="Img" width="144" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:299_answer" disabled="disabled" value="0" id="q20803:299_answer0"><label for="q20803:299_answer0">a. veins immediately adjacent to the arterial lumen</label> </div>
<div class="r1"><input type="radio" name="q20803:299_answer" disabled="disabled" value="1" id="q20803:299_answer1"><label for="q20803:299_answer1">b. calcified plaques causing farfield attenuation</label> </div>
<div class="r0"><input type="radio" name="q20803:299_answer" disabled="disabled" value="2" id="q20803:299_answer2"><label for="q20803:299_answer2">c. a stenosis due to thrombus at the site of a vascular anastomosis</label> </div>
<div class="r1"><input type="radio" name="q20803:299_answer" disabled="disabled" value="3" id="q20803:299_answer3"><label for="q20803:299_answer3">d. soft thrombus in the arterial lumen causing partial obstruction</label> </div>
<div class="r0"><input type="radio" name="q20803:299_answer" disabled="disabled" value="4" id="q20803:299_answer4"><label for="q20803:299_answer4">e. intraluminal guidewires creating artifacts</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:299_-submit" name="q20803:299_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The image demonstrates 2 calcific plaques at the white arrows. Calcific plaques are characterized by two key features: 1) a high density (appearing more white or grey than the surrounding tissue), and 2) attenuation of the ultrasound signal, with the signal "drop-out" causing an acoustic "shadow" on the far side of the plaque. Note that the ultrasound goes out directly from the probe in a radial fashion toward the plaque, and if a straight line is drawn from the probe to each of these plaques, there is a black acoustic shadow on the opposite side of the plaque away from the probe (no tissue density material at all).<br><br></p>
<h2>References:</h2>
<p>Vogt KC, Schroeder TV. Intravascular ultrasound. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:371-81.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2006%3B+19+(3)%3A139-44." target="_blank">Lee JT, Fang TD, White RA. Applications of intravascular ultrasound in the treatment of peripheral occlusive disease. Semin Vasc Surg 2006; 19 (3):139-44.</a></p>
<p>QID: 30519</p></div><div class="rightanswer">The correct answer is: calcified plaques causing farfield attenuation</div></div></div></div></div><div id="q233" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">326</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3098"><input type="hidden" name="q20803:233_:flagged" value="0"><input type="hidden" value="qaid=911117&amp;qubaid=20803&amp;qid=1284&amp;slot=233&amp;checksum=c11014c67e62efcc5309ea6e1d4c96be&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:233_:flaggedcheckbox" name="q20803:233_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q233&id=1284"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:233_:sequencecheck" value="2"><div class="qtext"><p>A 58 year old male with end-stage renal disease (ESRD) presents to the office for follow-up 2 weeks after placement of a left autogenous radial-cephalic wrist direct access. On physical examination of his left arm, he has no thrill or bruit in the arteriovenous (AV) access outflow, no edema, and palpable radial, ulnar, and brachial artery pulses. Upon review of the pre-operative duplex scan, the patient was noted to have a patent left cephalic vein measuring 2.2 mm in the lower arm and 2.8 mm in the upper arm and a patent left basilic vein measuring 3.0 mm in the lower arm and 4.2 mm in the upper arm. What is the best strategy to restore permanent AV access in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:233_answer" disabled="disabled" value="0" id="q20803:233_answer0"><label for="q20803:233_answer0">a. left autogenous brachial-cephalic upper arm direct access</label> </div>
<div class="r1"><input type="radio" name="q20803:233_answer" disabled="disabled" value="1" id="q20803:233_answer1"><label for="q20803:233_answer1">b. left autogenous radial-basilic forearm transposition</label> </div>
<div class="r0"><input type="radio" name="q20803:233_answer" disabled="disabled" value="2" id="q20803:233_answer2"><label for="q20803:233_answer2">c. left prosthetic radial-antecubital forearm straight access</label> </div>
<div class="r1"><input type="radio" name="q20803:233_answer" disabled="disabled" value="3" id="q20803:233_answer3"><label for="q20803:233_answer3">d. thrombectomy and open surgical revision of the left autogenous radial-cephalic wrist direct access</label> </div>
<div class="r0"><input type="radio" name="q20803:233_answer" disabled="disabled" value="4" id="q20803:233_answer4"><label for="q20803:233_answer4">e. thrombolysis and endovascular revision of the left autogenous radial-cephalic wrist direct access</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:233_-submit" name="q20803:233_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Access failure that occurs within 30 days of surgery is defined as early access failure. In the absence of a technical failure, such as a twisted or stenotic anastomosis, it is most commonly associated with inadequate venous outflow which may be secondary to inadequate caliber of the outflow vein or central venous stenosis. In this patient, with no arm edema or other signs of central venous stenosis, the most likely cause of access thrombosis is inadequate caliber of the venous outflow. Reported minimal diameter for use ranges from 2.0-3.0 mm; however, as vein diameters decrease, primary failure rates increase. Other less common causes include poor arterial inflow, anastomotic stenosis, or a hypercoagulable state. The upper arm cephalic or lower arm basilic veins are both of adequate calibers for use; however, by using the lower arm basilic vein, the upper arm is left available for future AV access placements. Therefore, a new autogenous radial-basilic forearm transposition should be placed. Thrombolysis and thrombectomies are rarely successful with autogenous access and neither option would treat the underlying problem of small caliber forearm cephalic vein. Prosthetic AV access should only be performed if no options for autogenous AV access are available.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Sidawy%20AN,%20Spergel%20LM,%20Besarab%20A,%20et%20al.%20The%20Society%20for%20Vascular%20Surgery:%20Clinical%20practice%20guidelines%20for%20the%20surgical%20placement%20and%20maintenance%20of%20arteriovenous%20hemodialysis%20access.%20J%20Vasc%20Surg;%202008;%2048%20(5S):2S-25S" target="_blank">Sidawy AN, Spergel LM, Besarab A, et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg; 2008; 48 (5S):2S-25S.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Patel%20ST,%20Hughes%20J,%20Mills%20JL.%20Failure%20of%20arteriovenous%20fistula%20maturation:%20An%20unintended%20consequence%20of%20exceeding%20Dialysis%20Outcome%20Quality%20Initiative%20guidelines%20for%20hemodialysis%20access.%20J%20Vas%20Surg;%202003;%2038%20(3):439-445" target="_blank">Patel ST, Hughes J, Mills JL. Failure of arteriovenous fistula maturation: An unintended consequence of exceeding Dialysis Outcome Quality Initiative guidelines for hemodialysis access. J Vas Surg; 2003; 38 (3):439-445</a>.</p>
<p>QID: 30411</p></div><div class="rightanswer">The correct answer is: left autogenous radial-basilic forearm transposition</div></div></div></div></div><div id="q422" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">327</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3107"><input type="hidden" name="q20803:422_:flagged" value="0"><input type="hidden" value="qaid=911306&amp;qubaid=20803&amp;qid=4798&amp;slot=422&amp;checksum=b48688bde54d092483b7a322e49a9200&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:422_:flaggedcheckbox" name="q20803:422_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q422&id=4798"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:422_:sequencecheck" value="2"><div class="qtext"><p>A 44-year-old woman is undergoing treatment for a chronic leg ulcer near the medial malleolus (see image below). The patient has been receiving topical alginate and a multilayered, high-strength compression bandage for 6 weeks. During this time frame, the ulcer size decreased by 18%. On duplex evaluation, the patient has evidence of reflux in the great saphenous vein throughout its length and no reflux in the deep venous system. Which of the following treatments, in addition to continued high-strength compression, has been shown in prospective studies to significantly improve the chances of wound healing, compared to compression alone?</p>
<p style="margin-left: 30px;">&nbsp;</p>
<p style="margin-left: 30px;"><img src="./VESAP3_files/medial calf ulceration.jpg" alt="medial calf ulcer" width="311" height="312"></p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:422_answer" disabled="disabled" value="0" id="q20803:422_answer0"><label for="q20803:422_answer0">a. application of topical antibiotics to the wound based on culture results and bacteria-specific antibiotics</label> </div>
<div class="r1"><input type="radio" name="q20803:422_answer" disabled="disabled" value="1" id="q20803:422_answer1"><label for="q20803:422_answer1">b. endovenous ablation of the great saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:422_answer" disabled="disabled" value="2" id="q20803:422_answer2"><label for="q20803:422_answer2">c. injection of bone marrow derived mononuclear cells into the wound bed</label> </div>
<div class="r1"><input type="radio" name="q20803:422_answer" disabled="disabled" value="3" id="q20803:422_answer3"><label for="q20803:422_answer3">d. application of platelet-derived growth factor</label> </div>
<div class="r0"><input type="radio" name="q20803:422_answer" disabled="disabled" value="4" id="q20803:422_answer4"><label for="q20803:422_answer4">e. application of bilayered living skin equivalent (Apligraf)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:422_-submit" name="q20803:422_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Application of a bilayered living skin equivalent (Apligraf), in addition to compression therapy, was found to significantly increase the incidence of wound closure in comparison to compression alone. This modality must be used in combination with other standards of wound healing, including bacterial control, debridement, and elimination of edema. Platelet derived growth factor has been found to accelerate healing of diabetic foot ulcers but has not been found beneficial in healing venous ulers.&nbsp; In the Eschar study, patients treated with surgical stripping plus compression did not achieve a better rate of healing than those treated with compression alone. However, the rate of recurrent ulceration after healing was significantly lower after stripping. Saphenous elimination in the situation of abnormal reflux can be recommended for patients with venous ulceration to prevent recurrence, but not to heal the ulcer.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Wound+Repair+Regen+1999.+7(4)%3A+p.+201-7." target="_blank">Falanga, V. and M. Sabolinski, A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers. Wound Repair Regen 1999;&nbsp;<strong>7</strong>:201-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+2004%3B+363%3A1854-9." target="_blank">Barwell JR, Davies CE, Deacon J, Harvey D, Minor J, Sassano A, et al. Comparison of surgery and compression with compression alone in chronic venous ulceration (ESCHAR study): randomized controlled trial. Lancet 2004; 363:1854-9.</a></p>
<p>QID: 30745</p></div><div class="rightanswer">The correct answer is: application of bilayered living skin equivalent (Apligraf)</div></div></div></div></div><div id="q325" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">328</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3116"><input type="hidden" name="q20803:325_:flagged" value="0"><input type="hidden" value="qaid=911209&amp;qubaid=20803&amp;qid=5089&amp;slot=325&amp;checksum=dcc2887e3a94c731894ba9c6da1f018f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:325_:flaggedcheckbox" name="q20803:325_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q325&id=5089"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:325_:sequencecheck" value="2"><div class="qtext"><p>The results below were obtained for preoperative evaluation of a patient requiring dialysis access. &nbsp;The patient is right handed and all left arm veins are compressible on duplex ultrasound. &nbsp;Which of the following is the best access option for this patient?</p>
<p><a href="./VESAP3_files/dialysispreopevaluation.jpg" target="images"><img src="./VESAP3_files/dialysispreopevaluation.jpg" alt="dialysis preop evaluation" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:325_answer" disabled="disabled" value="0" id="q20803:325_answer0"><label for="q20803:325_answer0">a. brachial cephalic fistula</label> </div>
<div class="r1"><input type="radio" name="q20803:325_answer" disabled="disabled" value="1" id="q20803:325_answer1"><label for="q20803:325_answer1">b. brachial cephalic AV graft</label> </div>
<div class="r0"><input type="radio" name="q20803:325_answer" disabled="disabled" value="2" id="q20803:325_answer2"><label for="q20803:325_answer2">c. temporary&nbsp;internal jugular&nbsp;catheter</label> </div>
<div class="r1"><input type="radio" name="q20803:325_answer" disabled="disabled" value="3" id="q20803:325_answer3"><label for="q20803:325_answer3">d. basilic radial AV fistula</label> </div>
<div class="r0"><input type="radio" name="q20803:325_answer" disabled="disabled" value="4" id="q20803:325_answer4"><label for="q20803:325_answer4">e. radial cephalic fistula</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:325_-submit" name="q20803:325_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The preferred sites for AV fistulas include (in order of preference) the wrist (radiocephalic) and the elbow (brachiocephalic). If it is not possible to establish either of these types of fistula, access may be established using either a transposed brachial-basilic vein fistula or an AV graft of synthetic material (eg, polytetrafluoroethylene [PTFE]). Preoperative evaluation should include history and physical exam, specifically focusing on the examination of brachial, radial, and ulnar pulses, as well as visualization of superficial arm veins.&nbsp; Arterial and venous anatomy should be assessed for compressibility and equality bilaterally. An Allen's test should be performed to evaluate palmar arch patency. The superficial venous system should be evaluated with and without a venous pressure tourniquet in place, examining for distensibility and interruptions.&nbsp; Given the positive Allen’s test, small caliber cephalic vein at the wrist, adequate sized upper arm cephalic vein, and normal central venous waveform and response to respiration, left brachial cephalic fistula is recommended.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.kidney.org/professionals/kdoqi/guideline_uphd_pd_va/index.htm" target="_blank">National Kidney Foundation. NKF - K/DOQI Clinical Practice Guidelines and Clinical Practice Recommendations. Update 2006. </a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+Surg+1981%3B+47%3A145-51." target="_blank">Humphries AL Jr, Nesbit RR Jr, Caruna RJ, Hutchins RS, Heimburger RA, Wray CH. Thirty-six recommendations for vascular access operations: Lessons learned from our first thousand operations. Am Surg 1981; 47:145-51.</a></p>
<p>QID: 30559</p></div><div class="rightanswer">The correct answer is: brachial cephalic fistula</div></div></div></div></div><div id="q145" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">329</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3125"><input type="hidden" name="q20803:145_:flagged" value="0"><input type="hidden" value="qaid=911029&amp;qubaid=20803&amp;qid=4763&amp;slot=145&amp;checksum=3c7893252e2afca22658ecc396ee6145&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:145_:flaggedcheckbox" name="q20803:145_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q145&id=4763"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:145_:sequencecheck" value="2"><div class="qtext"><p>All of the following criteria are necessary for the diagnosis of Buerger’s disease&nbsp;<strong>except</strong>:<strong><br></strong></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:145_answer" disabled="disabled" value="0" id="q20803:145_answer0"><label for="q20803:145_answer0">a. "cork-screw" appearance of distal collateral vessels</label> </div>
<div class="r1"><input type="radio" name="q20803:145_answer" disabled="disabled" value="1" id="q20803:145_answer1"><label for="q20803:145_answer1">b. arterial pathology arising distal to the knees and elbows</label> </div>
<div class="r0"><input type="radio" name="q20803:145_answer" disabled="disabled" value="2" id="q20803:145_answer2"><label for="q20803:145_answer2">c. a history of tobacco use</label> </div>
<div class="r1"><input type="radio" name="q20803:145_answer" disabled="disabled" value="3" id="q20803:145_answer3"><label for="q20803:145_answer3">d. male gender</label> </div>
<div class="r0"><input type="radio" name="q20803:145_answer" disabled="disabled" value="4" id="q20803:145_answer4"><label for="q20803:145_answer4">e. onset of symptoms earlier than age 45</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:145_-submit" name="q20803:145_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Buerger’s disease, also known as thromboangiitis obliterans, is a syndrome distinct from other conditions associated with small- and medium-sized arterial occlusions. Central to the diagnosis is involvement of small- and medium-sized arteries of the distal upper and lower extremities with segmental thrombotic occlusions associated with chronic inflammation of the arterial wall. Inflammation in superficial veins may lead to thrombophlebitis. The classic history includes an extremely strong addiction to tobacco. Many patients are unwilling or unable to quit, even after multiple amputations. The onset is generally in the third and fourth decades and occurs typically, but not exclusively, in males. A diagnostic feature by arteriography is occlusion of the distal small- and medium-sized arteries with corkscrew appearance of collaterals that are thought to be secondary to enlarged and hypertrophied vasa vasorum. Buerger's almost invariably affects more than one extremity and the presence of findings in only one limb should prompt a search for an alternative diagnosis.&nbsp;</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+1993%3B+6(1)%3A14-23." target="_blank">Mills JL, Porter JM. Buerger's disease: a review and update. Semin Vasc Surg<em>&nbsp;</em>1993; 6(1):14-23.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+2000%3B+343%3A864-9." target="_blank">Olin JW. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med 2000; 343:864-9.</a></p>
<p>QID: 30239</p></div><div class="rightanswer">The correct answer is: male gender</div></div></div></div></div><div id="q497" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">330</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3134"><input type="hidden" name="q20803:497_:flagged" value="0"><input type="hidden" value="qaid=911381&amp;qubaid=20803&amp;qid=5218&amp;slot=497&amp;checksum=c4243dc6ed652db59536bfb7c9f8ffd4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:497_:flaggedcheckbox" name="q20803:497_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q497&id=5218"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:497_:sequencecheck" value="2"><div class="qtext"><p dir="ltr" align="left">A 52-year-old man with type 2 diabetes is referred for evaluation of severe burning foot pain, not associated with exertion. Ankle blood&nbsp;pressures could not be measured due to vessel incompressibility. Posterior tibial and dorsalis pedis pulses were normal. Examination with a Semmes-Weinstein 5.07 (10-g) monofilament showed loss of sensation. Hemoglobin A1c was 11.2%. &nbsp;Which therapy option should be provided for symptom relief?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:497_answer" disabled="disabled" value="0" id="q20803:497_answer0"><label for="q20803:497_answer0">a. oral duloxetine</label> </div>
<div class="r1"><input type="radio" name="q20803:497_answer" disabled="disabled" value="1" id="q20803:497_answer1"><label for="q20803:497_answer1">b. improved glycemic control with insulin therapy</label> </div>
<div class="r0"><input type="radio" name="q20803:497_answer" disabled="disabled" value="2" id="q20803:497_answer2"><label for="q20803:497_answer2">c. lumbar sympathectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:497_answer" disabled="disabled" value="3" id="q20803:497_answer3"><label for="q20803:497_answer3">d. topical capsasin</label> </div>
<div class="r0"><input type="radio" name="q20803:497_answer" disabled="disabled" value="4" id="q20803:497_answer4"><label for="q20803:497_answer4">e. angiography and tibial artery angioplasty</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:497_-submit" name="q20803:497_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p dir="ltr" align="left">Duloxetine (Cymbalta®) is&nbsp;an appropriate&nbsp;choice for treatment of pain from diabetic peripheral neuropathy.</p>
<p dir="ltr" align="left">Diabetic peripheral neuropathy is a common complication of diabetes. Symptoms include neuropathic pain, burning, tingling, decreased sensation, and loss of temperature perception. Neuropathic pain can reduce the quality of life and independence of up to 30-50% of patients with diabetes.</p>
<p dir="ltr" align="left">In patients with significant peripheral arterial disease, neuropathy can overlap with claudication symptoms and ischemic rest pain, confounding the clinical picture. Neuropathic pain will not improve with revascularization.</p>
<p dir="ltr" align="left">Medications recommended as first-line treatments for neuropathic pain include certain antidepressants, such as the dual reuptake inhibitors of both serotonin and norepinephrine, duloxetine (Cymbalta®) and venlafaxine (Effexor XR®); calcium channel alpha-2-delta-1 ligands, such as gabapentin (Neurontin®) and pregabalin(Lyrica®); and topical lidocaine.</p>
<p dir="ltr" align="left">Opioid analgesics and tramadol are second-line treatments that may be considered for first-line use in select clinical circumstances, but not as monotherapy.</p>
<p dir="ltr" align="left">Third-line treatments include certain other antidepressant and antiepileptic medications, topical capsaicin, mexiletine, and N-methyl-d-aspartate receptor antagonists.</p>
<p dir="ltr" align="left">Lumbar sympathectomy has shown benefit for patients with complex regional pain syndrome and critical limb ischemia without revascularization options, but has not been shown to be effective in treating the pain of diabetic peripheral neuropathy.</p>
<p dir="ltr" align="left">Better glyemic control is indicated, but it would not be expected to improve neuropathic pain.</p>
<p dir="ltr" align="left">&nbsp;</p>
<h2 dir="ltr" align="left">References:</h2>
<p dir="ltr" align="left"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Syst+Rev+2012%3B+1%3A61." target="_blank">Griebeler ML, Tsapas A, Brito JP, Wang Z, Phung OJ, Montori VM, et al. Pharmacologic interventions for painful diabetic neuropathy: an umbrella systematic review and comparative effectiveness network meta-analysis (Protocol). Syst Rev 2012; 1:61.&nbsp;</a></p>
<p dir="ltr" align="left"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Med+2009%3B122(10+Suppl)%3AS22-32." target="_blank">O'Connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009;122(10 Suppl):S22-32.</a></p>
<p dir="ltr" align="left"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=BMC+Neurol+2008%3B+8%3A29." target="_blank">Sultan A, Gaskell H, Derry S, Moore RA. Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trials. BMC Neurol 2008; 8:29.&nbsp;</a></p>
<p dir="ltr" align="left"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Clin+Neuromuscul+Dis+2001%3B+3(2)%3A53-62." target="_blank">Simpson DA. Gabapentin and venlafaxine for the treatment of painful diabetic neuropathy. J Clin Neuromuscul Dis 2001; 3(2):53-62.</a></p>
<p dir="ltr" align="left">QID: 30864</p></div><div class="rightanswer">The correct answer is: oral duloxetine</div></div></div></div></div><div id="q539" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">331</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3143"><input type="hidden" name="q20803:539_:flagged" value="0"><input type="hidden" value="qaid=911423&amp;qubaid=20803&amp;qid=5277&amp;slot=539&amp;checksum=121a22498a69262d7d3c52fedd801fee&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:539_:flaggedcheckbox" name="q20803:539_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q539&id=5277"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:539_:sequencecheck" value="2"><div class="qtext"><p>Which of the following patients is likely to have the highest radiation dose after the same complex endovascular procedure?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:539_answer" disabled="disabled" value="0" id="q20803:539_answer0"><label for="q20803:539_answer0">a. a thin, 35-year-old woman where 20% of the angiographic runs utilized 45 degree left anterior oblique projection</label> </div>
<div class="r1"><input type="radio" name="q20803:539_answer" disabled="disabled" value="1" id="q20803:539_answer1"><label for="q20803:539_answer1">b. an obese, 60-year-old man with a BMI of 50, where the entire case was spent in the AP projection</label> </div>
<div class="r0"><input type="radio" name="q20803:539_answer" disabled="disabled" value="2" id="q20803:539_answer2"><label for="q20803:539_answer2">c. a cachectic, elderly woman whose procedure utilized collimation and limited magnification views</label> </div>
<div class="r1"><input type="radio" name="q20803:539_answer" disabled="disabled" value="3" id="q20803:539_answer3"><label for="q20803:539_answer3">d. a small child where 20% of the angiographic runs were performed in the 45 degree right anterior &nbsp;oblique projection</label> </div>
<div class="r0"><input type="radio" name="q20803:539_answer" disabled="disabled" value="4" id="q20803:539_answer4"><label for="q20803:539_answer4">e. a 45-year-old, obese patient with a BMI of 50 who required multiple angiographic runs in cranial and caudal oblique orientation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:539_-submit" name="q20803:539_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Modern fluoroscopy equipment operates in the automatic brightness control mode (ABC), whereby the peak kilovolts (kVp) and the miliamperes (mA) are adjusted by the machine to maintain a constant image brightness at the detector.&nbsp; When brightness is inadequate, the ABC automatically increases the mA or kVP, or both, to increase the x-ray penetration through the patient to provide appropriate image brightness. &nbsp;Penetration by x-rays of thicker, more obese patients requires higher radiation doses to maintain a constant image brightness at the detector. Therefore, dose rates in obese patients can be 4 - 10 times higher than in thin patients. The use of steeply angled projections has the same effect as obesity.&nbsp; The machine detects a much thicker tissue path and increases the dose to maintain penetration and an appropriately bright image. &nbsp;Cranio-caudal angulation causes the highest increase in dose of any angulation because as the c-arm is rotated along the cranio-caudal axis the source to skin distance is decreased and the patient’s thickness along the central ray is increased, which leads to a higher patient skin dose. Magnification should be used sparingly because it increases image sharpness at the expense of increased radiation dose. Magnification uses the image intensifier to enlarge the field of view; therefore, the ABC mode uses more radiation to brighten and sharpen the image. Magnification views should always be coupled with collimation to limit overlapping fields of view.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53+(1)%3A+9S-14S." target="_blank">Killewich LA, Falls G, Mastracci TM, Brown KR. Factors affecting radiation injury.&nbsp;J Vasc Surg&nbsp;2011; 53 (1): 9S-14S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53+(1)%3A+22S-27S." target="_blank">Mitchell EL, Furey P. Prevention of radiation injury from medical maging.&nbsp;J Vasc Surg&nbsp;2011; 53 (1): 22S-27S.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2011%3B+22(4)%3A+443-52." target="_blank">Pasciak AS, Jones AK. Does "spreading" skin dose by rotating the C-arm during an intervention work?&nbsp;J Vasc Interv Radiol&nbsp;2011; 22(4): 443-52.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology+2010%3B+257(2)%3A321-32." target="_blank">Miller DL, Balter S, Schueler BA, Wagner LK, Strauss KJ, Vano E. Clinical Radiation Management for Fluoroscopically Guided Interventional Procedures.&nbsp;Radiology&nbsp;2010; 257(2):321-32.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=AJR+Am+J+Roentgenol+2001+177+(1)%3A+13-20.">Koenig TR, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures: part 2, review of 73 cases and recommendations for minimizing dose delivered to patient.&nbsp;AJR Am J Roentgenol&nbsp;2001 177 (1): 13-20.</a></p>
<p>QID: 30945</p></div><div class="rightanswer">The correct answer is: a 45-year-old, obese patient with a BMI of 50 who required multiple angiographic runs in cranial and caudal oblique orientation</div></div></div></div></div><div id="q57" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">332</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3152"><input type="hidden" name="q20803:57_:flagged" value="0"><input type="hidden" value="qaid=910941&amp;qubaid=20803&amp;qid=4723&amp;slot=57&amp;checksum=e5047a08c7348a88d783c427d74b1bf7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:57_:flaggedcheckbox" name="q20803:57_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q57&id=4723"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:57_:sequencecheck" value="2"><div class="qtext"><p>All of the following statements regarding the current role of intra-vascular ultrasound during TEVAR in patients with aortic dissection are true <strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:57_answer" disabled="disabled" value="0" id="q20803:57_answer0"><label for="q20803:57_answer0">a. marks the position of left subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:57_answer" disabled="disabled" value="1" id="q20803:57_answer1"><label for="q20803:57_answer1">b. identifies retrograde Type A dissection after TEVAR</label> </div>
<div class="r0"><input type="radio" name="q20803:57_answer" disabled="disabled" value="2" id="q20803:57_answer2"><label for="q20803:57_answer2">c. quantifies flow in the true lumen before and after TEVAR</label> </div>
<div class="r1"><input type="radio" name="q20803:57_answer" disabled="disabled" value="3" id="q20803:57_answer3"><label for="q20803:57_answer3">d. accurately measures aortic diameter</label> </div>
<div class="r0"><input type="radio" name="q20803:57_answer" disabled="disabled" value="4" id="q20803:57_answer4"><label for="q20803:57_answer4">e. ensures true lumen access</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:57_-submit" name="q20803:57_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Many surgeons consider intra-vascular ultrasound (IVUS) to be an essential tool when performing endovascular treatment of aortic dissection. IVUS provides exceptional imaging of the aorta, particularly in the setting of dissection where angiography may not adequately differentiate the true and false lumens. IVUS can ensure that the wire is in the true rather than the false lumen. This is essential as deployment of a stent graft from the true into the false lumen could result in immediate and catastrophic malperfusion. IVUS can also be used to measure the aorta and mark the position of the arch vessels to aid in accurate deployment, confirm vessel patency, and reduce the amount of IV contrast administration. IVUS can be used before stent graft deployment to ensure the diagnosis of Type B dissection and after deployment to ensure that the wires/devices instrumenting the aortic arch have not caused a retrograde Type A dissection. IVUS also allows the surgeon to examine the relative true/false lumen sizes before and after stent graft deployment, thereby demonstrating preferential true lumen flow. In common clinical practice, IVUS is used as an imaging tool and does not provide physiological measurements such as blood velocity or flow.&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2008%3B22%3A742-9." target="_blank">Pearce BJ, Passman MA<span>,&nbsp;</span>Patterson MA<span>,&nbsp;</span>Taylor SM<span>,&nbsp;</span>Lecroy CJ<span>,&nbsp;</span>Combs BR<span>,&nbsp;</span>et al. Early Outcomes of Thoracic Endovascular Stent-Graft Repair for Acute Complicated Type B Dissection Using the Gore TAG Endoprosthesis. Ann Vasc Surg 2008; 22:742-9.</a></p>
<p>QID: 30062</p></div><div class="rightanswer">The correct answer is: quantifies flow in the true lumen before and after TEVAR</div></div></div></div></div><div id="q8" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">333</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3161"><input type="hidden" name="q20803:8_:flagged" value="0"><input type="hidden" value="qaid=910892&amp;qubaid=20803&amp;qid=4617&amp;slot=8&amp;checksum=0bad59baf6e5cdcc3df4adbcaef477cd&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:8_:flaggedcheckbox" name="q20803:8_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q8&id=4617"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:8_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements&nbsp;regarding&nbsp;ultrasound screening (US) for abdominal aortic aneurysms (AAA) is true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:8_answer" disabled="disabled" value="0" id="q20803:8_answer0"><label for="q20803:8_answer0">a. US in women results in an overall reduction in AAA related mortality</label> </div>
<div class="r1"><input type="radio" name="q20803:8_answer" disabled="disabled" value="1" id="q20803:8_answer1"><label for="q20803:8_answer1">b. US for non-ruptured AAA results in an overall sensitivity and specificity that approaches 100%</label> </div>
<div class="r0"><input type="radio" name="q20803:8_answer" disabled="disabled" value="2" id="q20803:8_answer2"><label for="q20803:8_answer2">c. US should not be performed on patients with less than 5 years of life expectancy</label> </div>
<div class="r1"><input type="radio" name="q20803:8_answer" disabled="disabled" value="3" id="q20803:8_answer3"><label for="q20803:8_answer3">d. US should be offered to everyone as part of their "Welcome to Medicare physical exam" in accordance to the Screening Abdominal Aortic Aneurysms Very Efficiently (SAAAVE) Act</label> </div>
<div class="r0"><input type="radio" name="q20803:8_answer" disabled="disabled" value="4" id="q20803:8_answer4"><label for="q20803:8_answer4">e. US results in an overall reduction in AAA related mortality that is not sustained beyond 5 years</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:8_-submit" name="q20803:8_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The sensitivity of ultrasound ranges from 94 to 100%, and specificity from 98 to 100% for the detection of non-ruptured abdominal aortic aneurysms. The study may be technically limited secondary to obesity or non-fasting state, and rupture may be missed in up to 50% of patients. No significant decrease in mortality from AAA or identification of rupture has been found in women, due to their relatively lower incidence; as a result, ultrasound screening criteria for women is controversial. The MASS study demonstrates the efficacy of ultrasound as far out as seven years. Ultrasound is indicated as a screening test for men who have smoked more than 100 cigarettes in their lifetime, or anyone with a family history of AAA.</p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19786250" target="_blank">Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sicard GA, et al. Society for Vascular Surgery. The care of patients with an abdominal aortic aneurysm: The Society for Vascular Surgery Practice Guidelines. J Vasc Surg 2009; 50 (4 Suppl):S2-49.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/17502630" target="_blank">Kim LG, Scott AP, Ashton HA, Thompson SG. A sustained mortality benefit from screening for abdominal aortic aneurysm. Ann Intern Med 2007; 146 (10):699-706.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Costantino%20TG%2C%20Bruno%20EC%2C%20Handly%20N%2C%20Dean%20AJ.%20Accuracy%20of%20emergency%20medicine%20ultrasound.%20J%20Emerg%20Med%3B%202005%3B%2029%20%284%29%3A455-460" target="_blank">Costantino TG, Bruno EC, Handly N, Dean AJ. Accuracy of emergency medicine ultrasound. J Emerg Med 2005; 29 (4):455-60.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Tayal%20VS%2C%20Graf%20CD%2C%20Gibbs%20MA.%20Prospective%20study%20of%20accuracy%20and%20outcome%20of%20emergency%20ultrasound%20for%20abdominal%20aortic%20aneurysm%20over%20two%20years.%20Acad%20Emerg%20Med%3B%202003%3B%2010%20%288%29%3A867-871" target="_blank">Tayal VS, Graf CD, Gibbs MA. Prospective study of accuracy and outcome of emergency ultrasound for abdominal aortic aneurysm over two years. Acad Emerg Med; 2003; 10 (8):867-871.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Cosford%20PA%2C%20Leng%20GC%2C%20Thomas%20J.%20Screening%20for%20abdominal%20aortic%20aneurysm.%20Cochrane%20Database%20Syst%20Rev%3B%202007%3B%20%282%29%3AD002945" target="_blank">Cosford PA, Leng GC, Thomas J. Screening for abdominal aortic aneurysm. Cochrane Database Syst Rev 2007; (2):D002945.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Lindholt%20JS%2C%20Vammen%20S%2C%20Juul%20S%2C%20et%20al.%20The%20validity%20of%20ultrasonographic%20scanning%20as%20screening%20for%20abdominal%20aortic%20aneurysm.%20Eur%20J%20Vasc%20Endovasc%20Surg%3B%201999%3B%2017%20%286%29%3A472-475" target="_blank">Lindholt JS, Vammen S, Juul S, Henneberg EW, Fasting H. The validity of ultrasonographic scanning as screening for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg; 1999; 17 (6):472-475.</a></p>
<p>&nbsp;</p>
<p>QID: 30008</p></div><div class="rightanswer">The correct answer is: US for non-ruptured AAA results in an overall sensitivity and specificity that approaches 100%</div></div></div></div></div><div id="q468" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">334</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3170"><input type="hidden" name="q20803:468_:flagged" value="0"><input type="hidden" value="qaid=911352&amp;qubaid=20803&amp;qid=5192&amp;slot=468&amp;checksum=405c77c30f5890bb5cdbb322e52e51be&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:468_:flaggedcheckbox" name="q20803:468_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q468&id=5192"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:468_:sequencecheck" value="2"><div class="qtext"><p>A 25-year-old patient presented with chest pain. Imaging determined the presence of a mildly dilated aortic root (3.5 cm) without evidence of a dissection. The patient is noted to have a slight build, widely spaced eyes, and a bifid uvula. A diagnosis of Loeys-Dietz syndrome is confirmed thorough genetic testing. The patient is taking a beta-blocker. In this patient, similar to patients with Marfan’s syndrome, long-term additional treatment with which class of medications may delay dilatation of the aortic root?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:468_answer" disabled="disabled" value="0" id="q20803:468_answer0"><label for="q20803:468_answer0">a. angiotensin receptor blockers</label> </div>
<div class="r1"><input type="radio" name="q20803:468_answer" disabled="disabled" value="1" id="q20803:468_answer1"><label for="q20803:468_answer1">b. antiplatelet agents</label> </div>
<div class="r0"><input type="radio" name="q20803:468_answer" disabled="disabled" value="2" id="q20803:468_answer2"><label for="q20803:468_answer2">c. angiotensin-converting enzyme inhibitors</label> </div>
<div class="r1"><input type="radio" name="q20803:468_answer" disabled="disabled" value="3" id="q20803:468_answer3"><label for="q20803:468_answer3">d. statins</label> </div>
<div class="r0"><input type="radio" name="q20803:468_answer" disabled="disabled" value="4" id="q20803:468_answer4"><label for="q20803:468_answer4">e. diuretics</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:468_-submit" name="q20803:468_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Loeys-Dietz is a disorder similar to, but distinct from, Marfan’s syndrome. The pathogenesis stems from disorganized collagen deposition in the aortic wall. Arterial involvement typically includes the ascending aorta.</p>
<p>The genetic disorder appears to affect the gene encoding the transforming growth factor-beta (TGF-β) receptor. The resulting increase in TGF-β signaling is felt central to the disease.&nbsp; Marfan’s syndrome results from genetic mutations in the fibrillin gene yet also results in increased TGF-β&nbsp;signaling. Losartan, an angiotensin II receptor (type-AT<sub>1</sub>) antagonist, also antagonizes the TGF-β receptor.</p>
<p>The mechanism is thought to provide a new treatment model for patients with Loeys-Dietz and Marfan’s syndrome.&nbsp; Initial animal studies in mice models of Marfan’s have been positive.&nbsp; Ongoing clinical trials are underway.&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>Black, JH III. Chapter 140: Aneurysms caused by connective tissue abnormalities. In Rutherford’s Vascular Surgery, 7th edition. Saunders, Philadelphia, 2010, pages 2168-84.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/18579813" target="_blank">Brooke BS, Habashi JP<span>,&nbsp;</span>Judge DP<span>,&nbsp;</span>Patel N<span>,&nbsp;</span>Loeys B<span>,&nbsp;</span>Dietz HC 3rd. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 2008; 358(26):2787-95.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19635970" target="_blank">Matt P, Schoenhoff F<span>,&nbsp;</span>Habashi J<span>,&nbsp;</span>Holm T<span>,&nbsp;</span>Van Erp C<span>,&nbsp;</span>Loch D,&nbsp;et al. Circulating transforming growth factor-beta in Marfan syndrome. Circulation 2009; 120(6):526-32.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23622922" target="_blank">Lacro RV, Guey LT<span>,&nbsp;</span>Dietz HC<span>,&nbsp;</span>Pearson GD<span>,&nbsp;</span>Yetman AT<span>,&nbsp;</span>Gelb BD,&nbsp;et al. Characteristics of children and young adults with Marfan syndrome and aortic root dilation in a randomized trial comparing atenolol and losartan therapy. Am Heart J 2013; 165(5):828-35.e3.&nbsp;</a></p>
<p>QID: 30831</p></div><div class="rightanswer">The correct answer is: angiotensin receptor blockers</div></div></div></div></div><div id="q402" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">335</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3179"><input type="hidden" name="q20803:402_:flagged" value="0"><input type="hidden" value="qaid=911286&amp;qubaid=20803&amp;qid=4781&amp;slot=402&amp;checksum=bc274d68abbfa7366666eb521b34f4ca&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:402_:flaggedcheckbox" name="q20803:402_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q402&id=4781"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:402_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old man presents with a 10-hour history of left shoulder aching and acute swelling of his left arm and hand. Duplex examination reveals acute thrombosis of the subclavian, axillary, and proximal brachial veins. The patient undergoes catheter-directed thrombolysis for 12 hours, followed by repeat venography. The venography obtained is shown below. Which of the following is the best, next treatment option for this patient?<br><br><a href="./VESAP3_files/AssetProxy_004.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_004.jpg" alt="img" width="100" height="91" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:402_answer" disabled="disabled" value="0" id="q20803:402_answer0"><label for="q20803:402_answer0">a. warfarin sodium and repeat venography in 6-8 weeks</label> </div>
<div class="r1"><input type="radio" name="q20803:402_answer" disabled="disabled" value="1" id="q20803:402_answer1"><label for="q20803:402_answer1">b. heparin with venography of contralateral upper extremity</label> </div>
<div class="r0"><input type="radio" name="q20803:402_answer" disabled="disabled" value="2" id="q20803:402_answer2"><label for="q20803:402_answer2">c. angioplasty, placement of self-expanding stent, and warfarin sodium</label> </div>
<div class="r1"><input type="radio" name="q20803:402_answer" disabled="disabled" value="3" id="q20803:402_answer3"><label for="q20803:402_answer3">d. first-rib resection</label> </div>
<div class="r0"><input type="radio" name="q20803:402_answer" disabled="disabled" value="4" id="q20803:402_answer4"><label for="q20803:402_answer4">e. angioplasty, warfarin sodium, and repeat venography in 6-8 weeks</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:402_-submit" name="q20803:402_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>While many patients with acute thrombosis of the axillary and subclavian veins (also known as effort thrombosis or Paget-Schroetter Syndrome) have a history of recent repetitive motion of the upper extremity, upwards of 50% have no recollection of recent strenuous activity or overuse of the arm. Additionally, acute thrombosis of these veins typically affects younger individuals with healthy lifestyles, making treatment with catheter-directed thrombolysis all the more important in relieving morbid arm edema. Unlike deep venous thrombosis of the lower extremity, spontaneous recanalization of the axillary and subclavian veins following thrombosis is rare. First rib removal with subsequent angioplasty of the vein that has suffered repetitive trauma from compression represents the best and most widely accepted option. Angioplasty as an initial step after thrombolysis may be temporizing but not corrective. Stenting a lesion between the first rib and clavicle is contraindicated, as the stent will be crushed. In some patients with no residual abnormality after thrombolysis, continued anticoagulation with a complete hypercoagulable evaluation is a reasonable course of action. Venography upon completion of thrombolysis must be performed in the neutral and hyperextended position to fully evaluate the underlying etiology. <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1998%3B+27+(6)%3A1101-7" target="_blank">Lee MC, Grassi CJ, Belkin M, Mannick JA<span>,&nbsp;</span>Whittemore AD<span>,&nbsp;</span>Donaldson MC<span>.</span>&nbsp;Early operative intervention after thrombolytic therapy for primary subclavian vein thrombosis: An effective treatment approach. J Vasc Surg; 1998; 27 (6):1101-7.</a><br><br>Taylor LM Jr, Moneta GL, Porter JM. Surgical treatment of upper extremity venous occlusion. In: Ernst CB, Stanley JC, eds. Current Therapy in Vascular Surgery 4th ed. St. Louis, MO: Mosby; 2001:693-697.</p>
<p>QID: 30719</p></div><div class="rightanswer">The correct answer is: first-rib resection</div></div></div></div></div><div id="q495" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">336</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3188"><input type="hidden" name="q20803:495_:flagged" value="0"><input type="hidden" value="qaid=911379&amp;qubaid=20803&amp;qid=5220&amp;slot=495&amp;checksum=0f0982467ef3800f492c58f7ea15d5d1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:495_:flaggedcheckbox" name="q20803:495_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q495&id=5220"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:495_:sequencecheck" value="2"><div class="qtext"><p>Which statement regarding ultrasound screening for carotid artery stenosis in asymptomatic patients is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:495_answer" disabled="disabled" value="0" id="q20803:495_answer0"><label for="q20803:495_answer0">a. a &gt;60% carotid stenosis is found in less than 5% of patients with peripheral artery disease</label> </div>
<div class="r1"><input type="radio" name="q20803:495_answer" disabled="disabled" value="1" id="q20803:495_answer1"><label for="q20803:495_answer1">b. a &gt;60% carotid stenosis is found in more than 20% of patients with abdominal aortic aneurysms greater than 5 cm</label> </div>
<div class="r0"><input type="radio" name="q20803:495_answer" disabled="disabled" value="2" id="q20803:495_answer2"><label for="q20803:495_answer2">c. a &gt;75% carotid stenosis is found in only 1-2% of asymptomatic patients with a carotid bruit</label> </div>
<div class="r1"><input type="radio" name="q20803:495_answer" disabled="disabled" value="3" id="q20803:495_answer3"><label for="q20803:495_answer3">d. patients undergoing coronary artery revascularization should be routinely screened</label> </div>
<div class="r0"><input type="radio" name="q20803:495_answer" disabled="disabled" value="4" id="q20803:495_answer4"><label for="q20803:495_answer4">e. carotid screening is recommended for patients with a prior history of&nbsp;neck irradiation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:495_-submit" name="q20803:495_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Carotid bifurcation disease is responsible for a significant proportion of ischemic strokes. However, in the absence of symptoms, identifying those at risk remains a challenge. Physical exam findings are notoriously unreliable, as only 1-2% of patients found to have a bruit will have greater than 75% stenosis when screened for this indication alone. Therefore, ultrasound evaluation for the sole indication of a bruit is not recommended as cost-effective and may potentially result in harm from increased interventions on low-risk populations.</p>
<p>Several factors increase the risk for carotid bifurcation disease, such as age &gt;65 years, hypercholesterolemia, diabetes, ischemic stroke in a first-degree relative, active smoking, and coronary artery disease, among others. It has also been shown that the prevalence of &gt;60% carotid stenosis in peripheral artery disease patient cohorts may be 20% or higher.&nbsp; Conversely, the prevalence of &gt;60% carotid stenosis in patients with abdominal aortic aneurysms is low. While a history neck irradiation does increase the risk for carotid stenosis significantly, screening is not recommended in asymptomatic patients, as interventions in this patient population have not been widely investigated.</p>
<p>Screening patients with symptomatic coronary artery disease (CAD) is reasonable in certain patient populations, but is not universally accepted as mandatory for all patients undergoing coronary artery bypass operations.&nbsp; While CAD patients do have increased incidence of carotid stenosis compared to the general population, certain high-risk factors (such as left main disease and others) may justify carotid screening.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg.+2011+Sep%3B54(3)%3Ae1-31." target="_blank">Ricotta JJ, Aburahma A, Ascher E, Eskandari M, Faries P, Lal BK; Society for Vascular Surgery. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg 2011; 54(3):e1-31.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mayo+Clin+Proc+2007%3B82(7)%3A851-8." target="_blank">Meschia JF, Brott TG, Hobson RW 2nd. Diagnosis and invasive management of&nbsp;carotid atherosclerotic stenosis. Mayo Clin Proc 2007;82(7):851-8.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2004%3B39(1)%3A44-51" target="_blank">Rockman CB, Jacobowitz GR, Gagne PJ, Adelman MA, Lamparello PJ, Landis R, et al. Focused screening for occult carotid artery disease: patients with&nbsp;known heart disease are at high risk. J Vasc Surg 2004;39(1):44-51.&nbsp;</a></p>
<p>QID: 30862</p></div><div class="rightanswer">The correct answer is: a &gt;75% carotid stenosis is found in only 1-2% of asymptomatic patients with a carotid bruit</div></div></div></div></div><div id="q192" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">337</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3197"><input type="hidden" name="q20803:192_:flagged" value="0"><input type="hidden" value="qaid=911076&amp;qubaid=20803&amp;qid=4562&amp;slot=192&amp;checksum=3f233338dd29469a3f3528cd717322ab&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:192_:flaggedcheckbox" name="q20803:192_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q192&id=4562"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:192_:sequencecheck" value="2"><div class="qtext"><p>The image shown below demonstrates a:</p>
<p><img src="./VESAP3_files/Picture2.jpg" alt="" width="401" height="401"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:192_answer" disabled="disabled" value="0" id="q20803:192_answer0"><label for="q20803:192_answer0">a. Bovine arch</label> </div>
<div class="r1"><input type="radio" name="q20803:192_answer" disabled="disabled" value="1" id="q20803:192_answer1"><label for="q20803:192_answer1">b. Retroesophageal carotid-carotid bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:192_answer" disabled="disabled" value="2" id="q20803:192_answer2"><label for="q20803:192_answer2">c. Kommerell’s diverticulum</label> </div>
<div class="r1"><input type="radio" name="q20803:192_answer" disabled="disabled" value="3" id="q20803:192_answer3"><label for="q20803:192_answer3">d. Aberrant right subclavian artery</label> </div>
<div class="r0"><input type="radio" name="q20803:192_answer" disabled="disabled" value="4" id="q20803:192_answer4"><label for="q20803:192_answer4">e. Saccular aneurysm of the descending thoracic aorta</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:192_-submit" name="q20803:192_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The image demonstrates an aberrant right subclavian artery which originates from the descending thoracic aorta. Over time, the origin of these arteries can become aneurismal which is termed Kommerell’s diverticulum. &nbsp;In up to 60% of patients, the origin of the aberrant right subclavian artery is larger than the rest of the artery. <sup>1</sup> Rarely, the anatomic location of this aberrant artery can result in difficulty swallowing, resulting in dysphagia lusoria.<sup>2</sup></p>
<p>&nbsp;</p>
<p>References:</p>
<p>1. Stone WM, Ricotta JJ II, Fowl RJ, et al. Contemporary management of aberrant right subclavian arteries. Ann Vasc Surg 2011; 25: 545-551. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21549920">http://www.ncbi.nlm.nih.gov/pubmed/21549920</a></p>
<p>2. Miller JM, Miller KS.&nbsp;&nbsp; A note on the historical aspects of dysphagia lusoria.&nbsp; Am Surg 1992;&nbsp;&nbsp;58(8): 502-503. <a href="http://www.ncbi.nlm.nih.gov/pubmed/1642389">http://www.ncbi.nlm.nih.gov/pubmed/1642389</a></p>
<p>3. Knepper J, Criado E. Surgical treatment of Kommerell's diverticulum and other saccular arch aneurysms. J Vasc Surg 2013; 57(4): 951-4.&nbsp;&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/23332243">http://www.ncbi.nlm.nih.gov/pubmed/23332243</a></p>
<p>QID: 30339</p></div><div class="rightanswer">The correct answer is: Aberrant right subclavian artery</div></div></div></div></div><div id="q195" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">338</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3206"><input type="hidden" name="q20803:195_:flagged" value="0"><input type="hidden" value="qaid=911079&amp;qubaid=20803&amp;qid=4565&amp;slot=195&amp;checksum=bc914742db73290c88ca540780a10849&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:195_:flaggedcheckbox" name="q20803:195_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q195&id=4565"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:195_:sequencecheck" value="2"><div class="qtext"><p>The following image demonstrates:</p>
<p><img src="./VESAP3_files/Picture4.jpg" alt="" width="355" height="266"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:195_answer" disabled="disabled" value="0" id="q20803:195_answer0"><label for="q20803:195_answer0">a. Moderate stenosis of the left vertebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:195_answer" disabled="disabled" value="1" id="q20803:195_answer1"><label for="q20803:195_answer1">b. Flow reversal in the left vertebral artery</label> </div>
<div class="r0"><input type="radio" name="q20803:195_answer" disabled="disabled" value="2" id="q20803:195_answer2"><label for="q20803:195_answer2">c. Critically elevated end-diastolic velocity in the left vertebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:195_answer" disabled="disabled" value="3" id="q20803:195_answer3"><label for="q20803:195_answer3">d. Normal flow in the left vertebral artery</label> </div>
<div class="r0"><input type="radio" name="q20803:195_answer" disabled="disabled" value="4" id="q20803:195_answer4"><label for="q20803:195_answer4">e. High grade stenosis of the left vertebral artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:195_-submit" name="q20803:195_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The image demonstrates reversal of flow in the vertebral artery. In the setting of subclavian artery stenosis or occlusion, the blood flow to the arm is maintained by collateral flow to the V4 segment of the vertebral artery through the basilar artery, provided the ipsilateral vertebral artery is a normal size. In early stenosis of the subclavian artery, antegrade flow to the vertebral artery may be maintained. Compression of an arm cuff can result in hyperemia upon release, and may elucidate inverted vertebral flow.&nbsp; In severe cases of stenosis or occlusion, inverted vertebral flow to the arm is sustained.<sup>1</sup></p>
<p>&nbsp;</p>
<p>References: &nbsp;</p>
<p>1. Vicenzini E, Ricciardi MC, Sirimarco G, et al. Extracranial and intracranial sonographic findings in vertebral artery diseases.&nbsp; J Ultrasound Med 2010;&nbsp;29: 1811-1824. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21098853">http://www.ncbi.nlm.nih.gov/pubmed/21098853</a></p>
<p>QID: 30342</p></div><div class="rightanswer">The correct answer is: Flow reversal in the left vertebral artery</div></div></div></div></div><div id="q45" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">339</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3215"><input type="hidden" name="q20803:45_:flagged" value="0"><input type="hidden" value="qaid=910929&amp;qubaid=20803&amp;qid=4654&amp;slot=45&amp;checksum=79ece68b25e04158c6203641b99b9d99&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:45_:flaggedcheckbox" name="q20803:45_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q45&id=4654"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:45_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old man presents with an asymptomatic 7 cm aneurysm of the descending thoracic aorta. Which of the following is a contraindication to thoracic endovascular repair (TEVAR)?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:45_answer" disabled="disabled" value="0" id="q20803:45_answer0"><label for="q20803:45_answer0">a. with coverage of the left subclavian artery, the proximal seal zone is 31 mm long and 38 mm in diameter</label> </div>
<div class="r1"><input type="radio" name="q20803:45_answer" disabled="disabled" value="1" id="q20803:45_answer1"><label for="q20803:45_answer1">b. the patient has Marfan syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:45_answer" disabled="disabled" value="2" id="q20803:45_answer2"><label for="q20803:45_answer2">c. without coverage of the left subclavian artery,&nbsp;the proximal seal zone is 25 mm long and 22 mm in diameter</label> </div>
<div class="r1"><input type="radio" name="q20803:45_answer" disabled="disabled" value="3" id="q20803:45_answer3"><label for="q20803:45_answer3">d. the patient has chronic renal insufficiency with eGFR of 40 mL/min</label> </div>
<div class="r0"><input type="radio" name="q20803:45_answer" disabled="disabled" value="4" id="q20803:45_answer4"><label for="q20803:45_answer4">e. the patient is asymptomatic</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:45_-submit" name="q20803:45_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Endovascular stent grafts have not been rigorously tested in a large population of patients with connective tissue disease (CTD). As such, endovascular aneurysm repair is considered “off-label” in patients with CTD. As summarized in a recent multi-disciplinary consensus statement from Europe, “TEVAR is not recommended in patients with connective tissue disease except as a bail-out procedure or bridge to definitive open surgical therapy, or as a procedure following prior aortic repair when both landing zones lie within previously sited prosthetic grafts.” Although some surgeons have had clinical success using TEVAR in patients with CTD, most of those patients have undergone prior open surgical repair of the ascending aorta and/or arch, creating a sound proximal landing zone for the stent graft to fixate and preventing creation of a new retrograde Type A dissection flap. One series by a group at UF Gainesville showed satisfactory medium term outcomes, however, there was a high incidence of complications, as is to be expected in such complex patients.</p>
<p>The other options are not contra-indications for TEVAR. At 7 cm, the risk of aneurysm rupture exceeds 10-20% annually and, as such, symptoms are not required to recommend treatment in an otherwise reasonable risk patient. Renal insufficiency, although an important predictor of adverse long-term outcome, is not in of itself a contra-indication to treatment. The seal zones described are both within FDA approved instructions for use criteria of more than&nbsp;one commercial thoracic stent graft.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=he+treatment+of+aortic+disease%3A+a+position+statement+from+the+European+Association+for++Cardio-Thoracic+Surgery+and+the+European+Society+of+Cardiology.+Eur+J+Cardio-Thoracic+Surgery+2012%3B42%3A17-24" target="_blank">Grabenwoger M, Alfonso F<span>,&nbsp;</span>Bachet J<span>,&nbsp;</span>Bonser R<span>,&nbsp;</span>Czerny M<span>,&nbsp;</span>Eggebrecht H,&nbsp;et al. TEVAR for the treatment of aortic disease: a position statement from the European Association for&nbsp; Cardio-Thoracic Surgery and the European Society of Cardiology. Eur J Cardio-Thoracic Surgery 2012; 42:17-24.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Waterman+AL%2C+et+al.+Endovascular+treatment+of+acute+and+chronic+aortic+pathology+in+patients+with+Marfan+syndrome.+J+Vasc+Surg+2012%3B55%3A1254" target="_blank">Waterman AL, Feezor RJ,&nbsp;Lee WA,&nbsp;Hess PJ,&nbsp;Beaver TM,&nbsp;Martin TD,&nbsp;et al. Endovascular treatment of acute and chronic aortic pathology in patients with Marfan syndrome. J Vasc Surg 2012; 55:1254</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Matsumura+JS%2C+et+al.+International+controlled+clinical+trial+of+thoracic+endovascular+aneurysm+repair+with+the+Zenith+TX2+endovascular+graft%3A+1-year+results.+J+Vasc+Surg+2008%3B47%3A247-57." target="_blank">Matsumura JS, Cambria RP<span>,&nbsp;</span>Dake MD<span>,&nbsp;</span>Moore RD<span>,&nbsp;</span>Svensson LG<span>,&nbsp;</span>Snyder S,&nbsp;et al. International controlled clinical trial of thoracic endovascular aneurysm repair with the Zenith TX2 endovascular graft: 1-year results. J Vasc Surg 2008; 47:247-57.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Fairman+RM%2C+Tuchek+JM%2C+Lee+WA%2C+Kasirajan+K%2C+White+R%2C+Mehta+M%2C+et+al.+Pivotal+results+for+the+Medtronic+Valiant+Thoracic+Stent+Graft+System+in+the+VALOR+II+trial.+J+Vasc+Surg+2012%3B+56%3A1222-31." target="_blank">Fairman RM,&nbsp;Tuchek JM,&nbsp;Lee WA,&nbsp;Kasirajan K,&nbsp;White R,&nbsp;Mehta M,&nbsp;et al. Pivotal results for the Medtronic Valiant Thoracic Stent Graft System in the VALOR II trial. J Vasc Surg 2012; 56:1222-31.</a></p>
<p>QID: 30049</p></div><div class="rightanswer">The correct answer is: the patient has Marfan syndrome</div></div></div></div></div><div id="q365" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">340</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3224"><input type="hidden" name="q20803:365_:flagged" value="0"><input type="hidden" value="qaid=911249&amp;qubaid=20803&amp;qid=5121&amp;slot=365&amp;checksum=408fd584a451f58f622233116e3c8dd8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:365_:flaggedcheckbox" name="q20803:365_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q365&id=5121"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:365_:sequencecheck" value="2"><div class="qtext"><p>Which of the following vessels is <strong>least</strong> likely to provide collateral circulation to the left colon in the setting of IMA (inferior mesenteric artery) occlusion?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:365_answer" disabled="disabled" value="0" id="q20803:365_answer0"><label for="q20803:365_answer0">a. meandering mesenteric artery</label> </div>
<div class="r1"><input type="radio" name="q20803:365_answer" disabled="disabled" value="1" id="q20803:365_answer1"><label for="q20803:365_answer1">b. external iliac artery</label> </div>
<div class="r0"><input type="radio" name="q20803:365_answer" disabled="disabled" value="2" id="q20803:365_answer2"><label for="q20803:365_answer2">c. left colic artery</label> </div>
<div class="r1"><input type="radio" name="q20803:365_answer" disabled="disabled" value="3" id="q20803:365_answer3"><label for="q20803:365_answer3">d. internal iliac artery</label> </div>
<div class="r0"><input type="radio" name="q20803:365_answer" disabled="disabled" value="4" id="q20803:365_answer4"><label for="q20803:365_answer4">e. middle colic artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:365_-submit" name="q20803:365_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Occlusion of the inferior mesenteric artery (IMA) is a common finding in patients with aortic aneurysms and/or occlusive disease. Multiple arterial collateral pathways can supply the usual distribution of the IMA. There is considerable variation in the arterial blood supply of the colon and this has led to a lack of clarity in the nomenclature applied to these vascular structures. The Arc of Riolan is variously described as either a normal communication between the SMA and IMA (that is referred to as the meandering mesenteric artery when hypertrophied) or a collateral pathway that includes the so-called marginal artery of Drummond and the ascending branch of he left colic artery. The critical point is that there are significant collaterals between the SMA and IMA that compensate for disease in either vessel. The external iliac artery usually does not have branches, nor does it typically contribute to these collateral pathways. As noted by Lange et al in an illuminating discussion of left colon blood supply, there is no mention of the left colon circulation in the original writings of Riolan.</p>
<p><img src="./VESAP3_files/1-s2.0-S0002961007001869-gr1.jpg" alt="mesenteric diagram" width="344" height="922"></p>
<p><strong><img src="./VESAP3_files/1-s2.0-S0002961007001869-gr3.jpg" alt="riolan" width="357" height="259"></strong></p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Intervent+Radiol+2009%3B+26(3)%3A167%E2%80%9374." target="_blank">Walker TG. Mesenteric vasculature and collateral pathways. <span class="citation-abbreviation">Semin Intervent Radiol&nbsp;</span><span class="citation-publication-date">2009; </span><span class="citation-volume">26</span><span class="citation-issue">(3)</span><span class="citation-flpages">:167–74.</span></a></p>
<p><span class="citation-flpages"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lange+JF%2C+Komen+N%2C+Akkerman+G%2C+Nout+E%2C+Horstmanshoff+H%2C+Schlesinger+F%2C+et+al.+Riolan%E2%80%99s+arch%3A+confusing%2C+misnomer%2C+and+obsolete.+A+literature+survey+of+the+connection(s)" target="_blank">Lange JF, Komen N, Akkerman G, Nout E, Horstmanshoff H, Schlesinger F, et al.&nbsp;Riolan’s arch: confusing, misnomer, and obsolete. A literature survey of the connection(s) between the superior and inferior mesenteric arteries.&nbsp;Am J Surg 2007;&nbsp;193(6):742-8.</a><br></span></p>
<p><span class="citation-flpages">QID: 30645</span></p></div><div class="rightanswer">The correct answer is: external iliac artery</div></div></div></div></div><div id="q330" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">341</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3233"><input type="hidden" name="q20803:330_:flagged" value="0"><input type="hidden" value="qaid=911214&amp;qubaid=20803&amp;qid=5094&amp;slot=330&amp;checksum=e85d86b24bb782d1f7d74a53c9435bc3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:330_:flaggedcheckbox" name="q20803:330_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q330&id=5094"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:330_:sequencecheck" value="2"><div class="qtext"><p>In this color-flow image of a left subclavian artery (SCA), what is the structure indicated by the two white arrows?</p>
<p><a href="./VESAP3_files/Zierler Image 6.jpg" target="images"><img src="./VESAP3_files/Zierler Image 6.jpg" alt="Zierler Image 6" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:330_answer" disabled="disabled" value="0" id="q20803:330_answer0"><label for="q20803:330_answer0">a. the first rib</label> </div>
<div class="r1"><input type="radio" name="q20803:330_answer" disabled="disabled" value="1" id="q20803:330_answer1"><label for="q20803:330_answer1">b. a mirror-image artifact</label> </div>
<div class="r0"><input type="radio" name="q20803:330_answer" disabled="disabled" value="2" id="q20803:330_answer2"><label for="q20803:330_answer2">c. the subclavian vein</label> </div>
<div class="r1"><input type="radio" name="q20803:330_answer" disabled="disabled" value="3" id="q20803:330_answer3"><label for="q20803:330_answer3">d. a pleural effusion</label> </div>
<div class="r0"><input type="radio" name="q20803:330_answer" disabled="disabled" value="4" id="q20803:330_answer4"><label for="q20803:330_answer4">e. a refraction artifact</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:330_-submit" name="q20803:330_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>A mirror-image artifact is caused by reverberation of ultrasound and shows structures that exist on one side of a strong reflector as also being present on the other side of the reflector. Mirror-image artifacts are particularly common around the pleura (as in this case) and the diaphragm, due to the strong reflection of ultrasound from the air-filled lung. These artifacts can occur in both B-mode imaging and Doppler flow detection, including color-flow images. The indicated structure is not the subclavian vein because it is located deep to the pleura and the color-flow image shows flow in the same direction as the artery. It is not the first rib based on anatomic location and the presence of flow, also a pleural effusion would not show this degree of flow. A refraction artifact is the result ultrasound passing through tissues with different propagation speeds and causes a structure to be improperly positioned laterally in an ultrasound image.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Kremkau FW. Chapter 6 Artifacts. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:176-210.</p>
<p>QID: 30564</p></div><div class="rightanswer">The correct answer is: a mirror-image artifact</div></div></div></div></div><div id="q363" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">342</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3242"><input type="hidden" name="q20803:363_:flagged" value="0"><input type="hidden" value="qaid=911247&amp;qubaid=20803&amp;qid=5298&amp;slot=363&amp;checksum=8fc7b7ddb34e136bcb93ded0810bec57&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:363_:flaggedcheckbox" name="q20803:363_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q363&id=5298"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:363_:sequencecheck" value="2"><div class="qtext"><p>The use of an ACE inhibitor&nbsp;is contraindicated in patients with severe bilateral renal artery stenosis because of disruption of which of the following mechanisms? &nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:363_answer" disabled="disabled" value="0" id="q20803:363_answer0"><label for="q20803:363_answer0">a. angiotensin II production, which reduces glomerular filtration rate (GFR)</label> </div>
<div class="r1"><input type="radio" name="q20803:363_answer" disabled="disabled" value="1" id="q20803:363_answer1"><label for="q20803:363_answer1">b. renal glomerular fibrosis, which affects renal function<br>the renal cortex causing glomerular cell death</label> </div>
<div class="r0"><input type="radio" name="q20803:363_answer" disabled="disabled" value="2" id="q20803:363_answer2"><label for="q20803:363_answer2">c. endothelin production, which decreases systemic blood pressure</label> </div>
<div class="r1"><input type="radio" name="q20803:363_answer" disabled="disabled" value="3" id="q20803:363_answer3"><label for="q20803:363_answer3">d. proximal tubular sodium retention, which decreases&nbsp;systemic blood pressure</label> </div>
<div class="r0"><input type="radio" name="q20803:363_answer" disabled="disabled" value="4" id="q20803:363_answer4"><label for="q20803:363_answer4">e. aldosterone production, which decreases systemic blood pressure</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:363_-submit" name="q20803:363_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>With stenosis of the renal artery, renin is released by the juxta-glomerular apparatus in response to decreased renal perfusion pressure.&nbsp;Renin is an enzyme that converts angiotensinogen to angiotensin I. Angiotensin converting enzyme (ACE) converts angiotensin I to angiotensin II.&nbsp;Angiotensin II has several intra- and extrarenal effects that impact blood pressure. Within the kidney, an important function of angiotensin II is to induce&nbsp;vasoconstriction of the efferent arterioles in the glomerulus, which increases glomerular filtration rate (GFR).&nbsp;Other key effects include sodium retention at the proximal and&nbsp;distal tubules and&nbsp;increased production of aldosterone by the adrenal gland, which result in&nbsp;sodium retention and volume expansion.</p>
<p>ACE inhibitors are used to treat hypertension and congestive heart failure. ACE inhibitors prevent the conversion of angiotensin I to angiotensin II. Blocking angiotensin II production in the kidney&nbsp;blunts the kidneys' ability to increase GFR in response to decreased&nbsp;perfusion pressure.&nbsp;This response is usually tolerated but can become severe and&nbsp;may lead to acute renal failure, especially in patients with either a solitary kidney with renal artery stenosis or a patient with bilateral renal artery stenosis.&nbsp;Decreased angiotensin II production may also&nbsp;decrease systemic pressure, which can reduce&nbsp;GFR in patients with&nbsp;bilateral renal artery stenosis, but that&nbsp;is the not the primary effect of angiotensin II on GFR in patients with bilateral renal artery stenosis.&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Soc+Nephrol+1990%3B1%3A845-58." target="_blank">Hricik DE, Dunn MJ. Angiotensin-converting enzyme inhibitor-induced renal failiure: causes, consequences, and diagnostic uses. J Am Soc Nephrol 1990;1:845-58.</a></p>
<div id="cit-104.16.1985.31" class="cit ref-cit ref-other">
<div class="cit-metadata"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Nephrol+1997%3B17%3A67-76." target="_blank">Textor SC. Renal failure related to angiotensin-converting enzyme inhibitors. Semin Nephrol 1997;17:67-76.</a></div>
<div class="cit-metadata">QID: 30635</div>
</div></div><div class="rightanswer">The correct answer is: angiotensin II production, which reduces glomerular filtration rate (GFR)</div></div></div></div></div><div id="q234" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">343</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3251"><input type="hidden" name="q20803:234_:flagged" value="0"><input type="hidden" value="qaid=911118&amp;qubaid=20803&amp;qid=4965&amp;slot=234&amp;checksum=0142b54d5f8997f34ccacbd67056b23e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:234_:flaggedcheckbox" name="q20803:234_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q234&id=4965"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:234_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old woman with end-stage renal disease (ESRD) presents to the office for follow-up 2 weeks after placement of a left prosthetic brachial-axillary upper arm straight access. Her history is significant for multiple previous failed attempts at left upper extremity arteriovenous (AV) access; she is currently being dialyzed via a left internal jugular long-term dialysis catheter. On physical examination of her left arm, she has no thrill or bruit in her graft or AV access outflow, moderate edema, and palpable radial, ulnar, and brachial artery pulses. Which of the following is the most probable cause of AV access thrombosis in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:234_answer" disabled="disabled" value="0" id="q20803:234_answer0"><label for="q20803:234_answer0">a. poor arterial inflow</label> </div>
<div class="r1"><input type="radio" name="q20803:234_answer" disabled="disabled" value="1" id="q20803:234_answer1"><label for="q20803:234_answer1">b. inadequate caliber of outflow vein</label> </div>
<div class="r0"><input type="radio" name="q20803:234_answer" disabled="disabled" value="2" id="q20803:234_answer2"><label for="q20803:234_answer2">c. anastomotic stenosis</label> </div>
<div class="r1"><input type="radio" name="q20803:234_answer" disabled="disabled" value="3" id="q20803:234_answer3"><label for="q20803:234_answer3">d. hypercoagulability</label> </div>
<div class="r0"><input type="radio" name="q20803:234_answer" disabled="disabled" value="4" id="q20803:234_answer4"><label for="q20803:234_answer4">e. central venous stenosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:234_-submit" name="q20803:234_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Access failure that occurs within 30 days of surgery is defined as early access failure. In the absence of a technical failure, such as a twisted or stenotic anastomosis, it is most commonly associated with inadequate venous outflow, which may be secondary to inadequate caliber of the outflow vein or central venous stenosis. Since this patient has a history of multiple previous access attempts, a central line in place, and arm edema, the most likely cause is central venous stenosis. Other less common causes include poor arterial inflow, anastomotic stenosis, or a hypercoagulable state.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank">Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg 2008; 48 (S):55S-80S.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+48+(5S)%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008; 48 (5S):2S-25S.</a></p>
<p>QID: 30412</p></div><div class="rightanswer">The correct answer is: central venous stenosis</div></div></div></div></div><div id="q288" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">344</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3260"><input type="hidden" name="q20803:288_:flagged" value="0"><input type="hidden" value="qaid=911172&amp;qubaid=20803&amp;qid=5027&amp;slot=288&amp;checksum=b63684639dd022ed94d1b40a26cf467b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:288_:flaggedcheckbox" name="q20803:288_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q288&id=5027"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:288_:sequencecheck" value="2"><div class="qtext"><p>This waveform was obtained from the mid-portion of the cervical internal carotid artery on the left. Which of the following is the most probable diagnosis?</p>
<p><a href="./VESAP3_files/10988.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/10988.jpg" alt="Img" width="200" height="77"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:288_answer" disabled="disabled" value="0" id="q20803:288_answer0"><label for="q20803:288_answer0">a. occlusion of the left common carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:288_answer" disabled="disabled" value="1" id="q20803:288_answer1"><label for="q20803:288_answer1">b. dissection of the left common carotid artery</label> </div>
<div class="r0"><input type="radio" name="q20803:288_answer" disabled="disabled" value="2" id="q20803:288_answer2"><label for="q20803:288_answer2">c. high-grade stenosis of the proximal cervical internal carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:288_answer" disabled="disabled" value="3" id="q20803:288_answer3"><label for="q20803:288_answer3">d. occlusion and reconstitution of the left internal carotid artery</label> </div>
<div class="r0"><input type="radio" name="q20803:288_answer" disabled="disabled" value="4" id="q20803:288_answer4"><label for="q20803:288_answer4">e. severe left internal carotid artery intracranial occlusive disease</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:288_-submit" name="q20803:288_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The internal carotid artery normally has a peak systolic velocity less than 125 cm/second, a rapid upstroke in systole, and preservation of diastolic flow. An internal carotid artery waveform obtained distal to a high-grade stenosis or occlusion will show a slowing of the upstroke in systole, but preservation of diastolic flow. A high-grade stenosis of the internal carotid artery is marked by peak systolic velocities greater than 125 cm/second, as well as elevation of end diastolic velocity. If there is severe intracranial internal carotid occlusive disease, peak systolic velocities in the internal carotid artery are decreased while the rapidity of systolic upstroke is maintained. There is increased resistance to flow, and therefore, diastolic flow is reduced.<br><br></p>
<h2>Reference:</h2>
<p>Moneta GL, Mitchell EL, Esmonde N, et al. Extracranial carotid and vertebral arteries. In: Strandness's Duplex Scanning in Vascular Disorders, 4th ed. Zierler RE, ed. Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2010:87-100.</p>
<p>QID: 30508</p></div><div class="rightanswer">The correct answer is: severe left internal carotid artery intracranial occlusive disease</div></div></div></div></div><div id="q387" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">345</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3269"><input type="hidden" name="q20803:387_:flagged" value="0"><input type="hidden" value="qaid=911271&amp;qubaid=20803&amp;qid=5035&amp;slot=387&amp;checksum=c35496dcdbc657ca522e1bfcb76b9598&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:387_:flaggedcheckbox" name="q20803:387_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q387&id=5035"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:387_:sequencecheck" value="2"><div class="qtext"><p>Which of the following factors has been shown to have a strong association with deep vein thrombosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:387_answer" disabled="disabled" value="0" id="q20803:387_answer0"><label for="q20803:387_answer0">a. peripheral monocytosis</label> </div>
<div class="r1"><input type="radio" name="q20803:387_answer" disabled="disabled" value="1" id="q20803:387_answer1"><label for="q20803:387_answer1">b. elevated hsCRP</label> </div>
<div class="r0"><input type="radio" name="q20803:387_answer" disabled="disabled" value="2" id="q20803:387_answer2"><label for="q20803:387_answer2">c. interleukin-8</label> </div>
<div class="r1"><input type="radio" name="q20803:387_answer" disabled="disabled" value="3" id="q20803:387_answer3"><label for="q20803:387_answer3">d. rheumatoid arthritis</label> </div>
<div class="r0"><input type="radio" name="q20803:387_answer" disabled="disabled" value="4" id="q20803:387_answer4"><label for="q20803:387_answer4">e. postoperative infection (pneumonia or UTI)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:387_-submit" name="q20803:387_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Recent data from both surgical and medical service patients suggest a strong association of infection with VTE (venous thromboembolism); this may be related to the systemic inflammatory response. In a large database with validated VTE diagnosis, postoperative urinary tract infection or pneumonia were associated with an approximately 2-fold increase in VTE; the specific mechanisms are unknown. While there is strong evidence of the association of hsCRP with atherosclerotic clinical events, and common inflammatory pathways exist between atherosclerosis and venous disease, this serum factor has neither been correlated with VTE occurrence nor linked as a predictive risk marker. Leukocytosis, whether a monocytosis or neutrophilia, is neither directly associated with DVT nor a specific marker for risk. While rheumatologic diseases may accompany DVT in those with anticardiolipin or antiphospholipid antibodies, arthritis itself is not associated. Lastly, no specific biomarkers outside of D-dimer, P-selectin, or TAT have been used for DVT prediction. However, work is ongoing in this regard.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+2006%3B+367+(9516)%3A1075-79." target="_blank">Smeeth L, Cook C, Thomas S, Hall AJ<span>,&nbsp;</span>Hubbard R<span>,&nbsp;</span>Vallance P<span>.</span>&nbsp;Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting. Lancet 2006; 367 (9516):1075-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Upchurch+GR%2C+et+al.+Risk+factors+and+clinical+impact+of+postoperative+symptomatic+venous+thromboembolism." target="_blank">Gangireddy C, Rectenwald JR, Upchurch GR, Wakefield TW<span>,&nbsp;</span>Khuri S<span>,&nbsp;</span>Henderson WG<span>,&nbsp;</span>et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 2007; 45 (2):335-42.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Thromb+Haemost%3B+2005%3B+94+(6)%3A1312-17." target="_blank">Rectenwald JE, Myers DD, Jr., Hawley AE, Longo C<span>,&nbsp;</span>Henke PK<span>,&nbsp;</span>Guire KE<span>,&nbsp;</span>et al. D-dimer, P-selectin, and microparticles: Novel markers to predict deep venous thrombosis. A pilot study. Thromb Haemost 2005; 94 (6):1312-17.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arterioscler+Thromb+Vasc+Biol+2008%3B+28+(3)%3A387-91." target="_blank">Wakefield TW, Myers DD, Henke PK. Mechanisms of venous thrombosis and resolution. Arterioscler Thromb Vasc Biol 2008; 28 (3):387-91.</a></p>
<p>QID: 30702</p></div><div class="rightanswer">The correct answer is: postoperative infection (pneumonia or UTI)</div></div></div></div></div><div id="q545" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">346</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3278"><input type="hidden" name="q20803:545_:flagged" value="0"><input type="hidden" value="qaid=911429&amp;qubaid=20803&amp;qid=5279&amp;slot=545&amp;checksum=773e283c2d1f6fcd40aff0e61923baf1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:545_:flaggedcheckbox" name="q20803:545_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q545&id=5279"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:545_:sequencecheck" value="2"><div class="qtext"><p>If the life-time cumulative radiation dose exceeds _____, &nbsp;the Nuclear Regulatory Commission mandates follow-up evaluation of the patient to identify radiation-induced injury.</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:545_answer" disabled="disabled" value="0" id="q20803:545_answer0"><label for="q20803:545_answer0">a. 2000 &nbsp;mGy</label> </div>
<div class="r1"><input type="radio" name="q20803:545_answer" disabled="disabled" value="1" id="q20803:545_answer1"><label for="q20803:545_answer1">b. 1000 mGy</label> </div>
<div class="r0"><input type="radio" name="q20803:545_answer" disabled="disabled" value="2" id="q20803:545_answer2"><label for="q20803:545_answer2">c. 500 mGy</label> </div>
<div class="r1"><input type="radio" name="q20803:545_answer" disabled="disabled" value="3" id="q20803:545_answer3"><label for="q20803:545_answer3">d. 10 Gy</label> </div>
<div class="r0"><input type="radio" name="q20803:545_answer" disabled="disabled" value="4" id="q20803:545_answer4"><label for="q20803:545_answer4">e. 5000 mGy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:545_-submit" name="q20803:545_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Absorbed dose represents the energy imparted by ionizing radiation per unit mass of irradiated material. Units of absorbed dose are the rad and the gray (Gy)<sup> 1</sup>.</p>
<p>Recommendations regarding proper protocol for radiation exposure include the following:</p>
<p>Any cumulative absorbed dose to the skin equal to or greater than 2.0 Gy (200 rads) shall be noted in the patient’s medical record and reviewed by the Radiation Safety Committee. The facility shall maintain records for 5 years of the cumulative fluoroscopic exposure time used and the number of spot films for each examination. The record shall reflect the patient identification, type of examination, date of examination, and operator’s name. &nbsp;If cumulative doses &gt; 5 Gy are recorded, fluoroscopist follow-up is requested by the Radiation Safety Committee.<sup><br></sup></p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.nrc.gov/reading-rm/doc-collections/cfr/part020/part020-1003.html%20%20" target="_blank">The Nuclear Regulatory Commission's (NRC) Standards for Protection Against Radiation (10 CFR Part 20 § 20.1003 Definitions.</a></p>
<p><a href="http://www.mass.gov/eohhs/docs/dph/regs/105cmr120-400.pdf" target="_blank">105 CMR 120.405 Summary of changes, as of March 2012, pg. 42.</a></p>
<p>QID: 30951</p></div><div class="rightanswer">The correct answer is: 5000 mGy</div></div></div></div></div><div id="q228" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">347</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3287"><input type="hidden" name="q20803:228_:flagged" value="0"><input type="hidden" value="qaid=911112&amp;qubaid=20803&amp;qid=4959&amp;slot=228&amp;checksum=fe8b0dd8352bdaf652ad1fc280fce9b1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:228_:flaggedcheckbox" name="q20803:228_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q228&id=4959"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:228_:sequencecheck" value="2"><div class="qtext"><p>A 74-year-old, obese woman with end-stage renal disease (ESRD) presents to the office in need of first time dialysis access. She is left arm dominant. On physical examination of her right arm, she has no visible superficial veins with a venous tourniquet in place, no edema, and palpable radial, ulnar, and brachial artery pulses. Which of the following represents the best pre-operative test to optimize the placement of an arteriovenous (AV) access in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:228_answer" disabled="disabled" value="0" id="q20803:228_answer0"><label for="q20803:228_answer0">a. upper extremity segmental pressures and pulse volume recordings</label> </div>
<div class="r1"><input type="radio" name="q20803:228_answer" disabled="disabled" value="1" id="q20803:228_answer1"><label for="q20803:228_answer1">b. upper extremity arteriography</label> </div>
<div class="r0"><input type="radio" name="q20803:228_answer" disabled="disabled" value="2" id="q20803:228_answer2"><label for="q20803:228_answer2">c. upper extremity superficial venous duplex imaging</label> </div>
<div class="r1"><input type="radio" name="q20803:228_answer" disabled="disabled" value="3" id="q20803:228_answer3"><label for="q20803:228_answer3">d. upper extremity venography</label> </div>
<div class="r0"><input type="radio" name="q20803:228_answer" disabled="disabled" value="4" id="q20803:228_answer4"><label for="q20803:228_answer4">e. upper extremity deep venous duplex imaging</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:228_-submit" name="q20803:228_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>If superficial veins cannot be visualized with a venous pressure tourniquet in place or any other abnormality is noted on the superficial venous exam, the patient should be further evaluated with superficial venous duplex imaging. Superficial veins should be examined for diameter, distensability, and continuity. Minimal diameter for vein use has been reported as small as 2 mm by Mendes et al, with a 76% primary maturation rate. Given that this patient has no edema or any other sign of central venous stenosis, deep venous evaluation is unnecessary. With a normal pulse exam, further arterial evaluation is unnecessary.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1998%3B+27+(2)%3A302-8." target="_blank">Silva MB, Hobson RW, Pappas PJ, Jamil Z<span>,&nbsp;</span>Araki CT<span>,&nbsp;</span>Goldberg MC<span>,&nbsp;</span>et al. A strategy for increasing use of autogenous hemodialysis access procedures: Impact of preoperative noninvasive evaluation. J Vasc Surg 1998; 27 (2):302-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Mendes+RR%2C+Farber+MA%2C+Marston+WA%2C+et+al.+Prediction+of+wrist+arteriovenous+fistula+maturation+with+preoperative+vein+mapping+with+ultrasonography." target="_blank">Mendes RR, Farber MA, Marston WA, Dinwiddie LC<span>,&nbsp;</span>Keagy BA<span>,&nbsp;</span>Burnham SJ. Prediction of wrist arteriovenous fistula maturation with preoperative vein mapping with ultrasonography. J Vas Surg 2002; 36 (3):460-3.</a></p>
<p>QID: 30405</p></div><div class="rightanswer">The correct answer is: upper extremity superficial venous duplex imaging</div></div></div></div></div><div id="q266" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">348</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3296"><input type="hidden" name="q20803:266_:flagged" value="0"><input type="hidden" value="qaid=911150&amp;qubaid=20803&amp;qid=5003&amp;slot=266&amp;checksum=f07ff290989ab0a6df4bc3f754b0e0aa&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:266_:flaggedcheckbox" name="q20803:266_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q266&id=5003"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:266_:sequencecheck" value="2"><div class="qtext"><p>&nbsp;A 56-year-old patient presents to the emergency department with erythema over a dialysis access placed 1 year ago. The access appears to be a straight AV graft located in the forearm from the wrist to the antecubital fossa. The graft has a palpable thrill and audible bruit with no masses or edema. There is moderate drainage and purulence arising from one of the needle puncture sites, with surrounding erythema along the entire length of&nbsp; the graft. The patient is febrile and has a systolic blood pressure of 80 mmHg. After inital hydration and antibiotic therapy, which of the following is the the most appropriate course of therapy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:266_answer" disabled="disabled" value="0" id="q20803:266_answer0"><label for="q20803:266_answer0">a. excision of the involved portion of the AV graft</label> </div>
<div class="r1"><input type="radio" name="q20803:266_answer" disabled="disabled" value="1" id="q20803:266_answer1"><label for="q20803:266_answer1">b. excision of the entire graft with vein patch angioplasty of the arterial anastomosis</label> </div>
<div class="r0"><input type="radio" name="q20803:266_answer" disabled="disabled" value="2" id="q20803:266_answer2"><label for="q20803:266_answer2">c. warm compresses and local wound care</label> </div>
<div class="r1"><input type="radio" name="q20803:266_answer" disabled="disabled" value="3" id="q20803:266_answer3"><label for="q20803:266_answer3">d. excise only the arterial end of the graft to prevent anastomotic rupture and exanguination</label> </div>
<div class="r0"><input type="radio" name="q20803:266_answer" disabled="disabled" value="4" id="q20803:266_answer4"><label for="q20803:266_answer4">e. incision and drainage of the draining site</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:266_-submit" name="q20803:266_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Infection of prosthetic arteriovenous access can be a significant problem, especially when AV prosthetic grafts are involved. Approximately 10% of access grafts become infected within 1 year of implantation due to frequent cannulation and the effect of renal failure on the immune system. Staphylococcus aureus is the most common organism. Although most episodes of erythema and cellulitis can be treated with antibiotics, graft excision is required for sepsis. If the graft needs to be excised, then complete excision is recommended to avoid leaving residual, infected graft material. To effect complete excision, the arterial anastomosis may need to be repaired with an autogenous patch to avoid stenosis and distal arm and hand ischemia.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Inf+Dis+Clin+NA+2012%3B26(1)%3A127-41." target="_blank">Bagdasarian N, Heung M, Malani P. Infectious complications of dialysis access devices. Inf Dis Clin NA 2012;26(1):127-41.</a></p>
<p>QID: 30450</p></div><div class="rightanswer">The correct answer is: excision of the entire graft with vein patch angioplasty of the arterial anastomosis</div></div></div></div></div><div id="q364" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">349</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3305"><input type="hidden" name="q20803:364_:flagged" value="0"><input type="hidden" value="qaid=911248&amp;qubaid=20803&amp;qid=5122&amp;slot=364&amp;checksum=74189494e07442d74751e6c380fa7eda&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:364_:flaggedcheckbox" name="q20803:364_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q364&id=5122"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:364_:sequencecheck" value="2"><div class="qtext"><p>A 64-year-old woman presents with post-prandial abdominal pain over the past 2 years that is associated with a&nbsp;15 lb weight loss.&nbsp;She has a history of hypertension, hyperlipidemia, and is a 40-pack a year smoker.&nbsp;Which of the following is the appropriate next diagnostic test for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:364_answer" disabled="disabled" value="0" id="q20803:364_answer0"><label for="q20803:364_answer0">a. computed tomographic angiography</label> </div>
<div class="r1"><input type="radio" name="q20803:364_answer" disabled="disabled" value="1" id="q20803:364_answer1"><label for="q20803:364_answer1">b. gallbladder ultrasound</label> </div>
<div class="r0"><input type="radio" name="q20803:364_answer" disabled="disabled" value="2" id="q20803:364_answer2"><label for="q20803:364_answer2">c. mesenteric duplex ultrasound</label> </div>
<div class="r1"><input type="radio" name="q20803:364_answer" disabled="disabled" value="3" id="q20803:364_answer3"><label for="q20803:364_answer3">d. magnetic resonance angiography</label> </div>
<div class="r0"><input type="radio" name="q20803:364_answer" disabled="disabled" value="4" id="q20803:364_answer4"><label for="q20803:364_answer4">e. catheter angiography</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:364_-submit" name="q20803:364_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This clinical scenario presents a typical case of a patient with chronic mesenteric ischemia (CMI). These patients are often symptomatic for a long period of time, are misdiagnosed as having one of the more common abdominal conditions, and undergo a multitude of tests before arriving at the correct diagnosis.</p>
<p>Duplex ultrasonography is often the first test used in making the diagnosis of CMI. Real-time images and flow characteristics of both the celiac trunk and the superior mesenteric artery are obtained. This is relatively inexpensive, non-invasive, and associated with sensitivity, specificity, and accuracy in excess of 90% in the evaluation of patients with suspected CMI. Normal celiac and superior mesenteric artery (SMA) velocities in an adequately performed study essentially exclude the presence of mesenteric ischemia.&nbsp;The most commonly used criterion for a hemodynamically significant (&gt;70%) celiac artery stenosis is a peak systolic velocity over&nbsp;250 cm/sec. The most commonly used criterion for a hemodynamically significant SMA stenosis is a peak systolic velocity over 275 cm/sec. An example of a duplex with an SMA stenosis is provided (image shown below). The main limitation of&nbsp;mesenteric&nbsp;ultrasonography for mesenteric disease is&nbsp;that it is highly operator-dependent.</p>
<p>MR angiography is less commonly used in the diagnostic algorithm of patients with CMI than computed tomographic (CT) angiography (CTA). It is of particular value when CT is contraindicated. MRA and CTA&nbsp;can both help confirm or exclude the diagnosis of CMI; they can also determine whether an alternative or associated abdominal pathology are present. An MRA is associated with claustrophobia, takes longer to perform than CT, may overestimate the degree of stenosis, and causes signal dropout in patients with prior stent placement.&nbsp; Both should be reserved as confirmatory tests after Duplex ultrasound, given the cost and radiation/contrast exposure for CT.</p>
<p>Conventional angiography is of value in both diagnosis and treatment of CMI.&nbsp; Anteroposterior and lateral views, as well as pressure transductions with or without administration of vasodilators, are utilized in making the diagnosis. When amenable to angiographic intervention, angioplasty and stenting have emerged as the first-line therapy in patients with CMI in many institutions across the country. However, prior to&nbsp;proceeding to an&nbsp;invasive study with its associated complications, diagnostic testing with duplex is indicated.</p>
<p><img src="./VESAP3_files/Kashyap-1 (for Discussion).jpg" alt="" width="737" height="491"></p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1993%3B17(1)%3A79-84." target="_blank">Moneta GL, Lee RW, Yeager RA, Taylor LM,Jr, Porter JM. Mesenteric duplex scanning: A blinded prospective study. J Vasc Surg 1993;17(1):79-84.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1998%3B27(6)%3A1078-87." target="_blank">Zwolak RM, Fillinger MF, Walsh DB, LaBombard FE, Musson A, Darling CE, et al. Mesenteric and celiac duplex scanning: A validation study. J Vasc Surg 1998;27(6):1078-87.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Sarac+TP%2C+Altinel+O%2C+Kashyap+V%2C+Bena+J%2C+Lyden+S%2C+Sruvastava+S%2C+et+al.+Endovascular+treatment" target="_blank">Sarac TP, Altinel O, Kashyap V, Bena J, Lyden S, Sruvastava S, et al. Endovascular treatment of stenotic and occluded visceral arteries for chronic mesenteric ischemia. J Vasc Surg 2008; 47(3):485-91.</a></p>
<p>QID: 30644</p></div><div class="rightanswer">The correct answer is: mesenteric duplex ultrasound</div></div></div></div></div><div id="q415" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">350</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3314"><input type="hidden" name="q20803:415_:flagged" value="0"><input type="hidden" value="qaid=911299&amp;qubaid=20803&amp;qid=4789&amp;slot=415&amp;checksum=e4ebd55aaa81f766e7cc9ac2b431fe2f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:415_:flaggedcheckbox" name="q20803:415_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q415&id=4789"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:415_:sequencecheck" value="2"><div class="qtext"><p>A 63-year-old diabetic man has an occluded superficial femoral and above knee popliteal artery with reconstitution of a below knee popliteal artery. In preparation for an autologous bypass, he has a preoperative vein mapping. Which of the following findings would be most predictive of future vein graft failure?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:415_answer" disabled="disabled" value="0" id="q20803:415_answer0"><label for="q20803:415_answer0">a. calcification (phlebosclerosis) within the vein</label> </div>
<div class="r1"><input type="radio" name="q20803:415_answer" disabled="disabled" value="1" id="q20803:415_answer1"><label for="q20803:415_answer1">b. valvular insufficiency of the vein</label> </div>
<div class="r0"><input type="radio" name="q20803:415_answer" disabled="disabled" value="2" id="q20803:415_answer2"><label for="q20803:415_answer2">c. vein diameter of &lt; 3.0 mm</label> </div>
<div class="r1"><input type="radio" name="q20803:415_answer" disabled="disabled" value="3" id="q20803:415_answer3"><label for="q20803:415_answer3">d. position of the vein above the saphenous fascia</label> </div>
<div class="r0"><input type="radio" name="q20803:415_answer" disabled="disabled" value="4" id="q20803:415_answer4"><label for="q20803:415_answer4">e. dilated segments (varicosities) of the vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:415_-submit" name="q20803:415_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Multiple studies have shown the most durable conduit for lower extremity bypass to be the autogenous saphenous vein. Both short-and long-term patency of autogenous vein grafts are dependent on the quality of the vein itself. Preoperative vein mapping with duplex scanning allows identification of defects within the vein that may make it a poor choice for conduit. Valvular insufficiency and dilated segments within the GSV are not uncommon and do not predict graft failure, although such veins may be thin walled and require careful dissection and handling. Calcium may be seen in some veins on duplex scanning, but, as long as the vein is not stenotic in these areas, it does not eliminate the vein as a potential conduit. Position of a vein above the saphenous fascia is not a contraindication for use, although such veins often have more branches than veins beneath the saphenous fascia. Vein graft diameter influences graft patency. Observations from a large multicenter trial were reported by Schanzer and colleagues. It was found that in univariate analysis, vein graft diameter &lt; 3.5 mm was associated with both early (30-day) and late (1-year) graft failure. Conduits less than 3.0 mm in diameter were associated with a 2.1 fold risk of early graft failure, as well as decreased patency at 1 year, increased length of initial hospital stay, and increased need for reinterventions compared to conduits &gt; 3.0 mm in diameter.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B+46%3A+1180-90." target="_blank">Schanzer A, Hevelone N, Owens, CD, Belkin M,&nbsp;Bandyk DF,&nbsp;Clowes AW,&nbsp;et al. Technical factors affecting autogenous vein graft failure: Observations from a large multicenter trial. J Vasc Surg 2007; 46: 1180-90.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Int+Angiol.+2008+Aug%3B+27(4)%3A329-32." target="_blank">Matsushita M, Ikezawa T, Banno H, Relationship between the diameter of the vein graft and postoperative ankle brachial pressure index following femoro-popliteal bypass. Int Angiol. 2008; 27(4):329-32.</a></p>
<p>QID: 30736</p></div><div class="rightanswer">The correct answer is: vein diameter of &lt; 3.0 mm</div></div></div></div></div><div id="q127" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">351</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3323"><input type="hidden" name="q20803:127_:flagged" value="0"><input type="hidden" value="qaid=911011&amp;qubaid=20803&amp;qid=4744&amp;slot=127&amp;checksum=9681c98f1b49caa16812dadaf7379d6a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:127_:flaggedcheckbox" name="q20803:127_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q127&id=4744"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:127_:sequencecheck" value="2"><div class="qtext"><p dir="ltr">A 72-year-old man with postprandial abdominal pain, weight loss, and frequent diarrhea undergoes a successful trans-brachial superior mesenteric artery stent placement. He complains of hand pain 6 hours after the procedure. Non-invasive studies demonstrate the following findings:</p>
<p dir="ltr"><a href="./VESAP3_files/Question 1 Graphic.jpeg" target="images"><img src="./VESAP3_files/Question 1 Graphic.jpeg" alt="Noninvasive upper extremity study. " width="100"></a></p>
<p>Regarding this patient and study, which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:127_answer" disabled="disabled" value="0" id="q20803:127_answer0"><label for="q20803:127_answer0">a. this complication occurs in approximately 10% of patients undergoing trans-brachial access</label> </div>
<div class="r1"><input type="radio" name="q20803:127_answer" disabled="disabled" value="1" id="q20803:127_answer1"><label for="q20803:127_answer1">b. this presentation likely represents a axillo-subclavian dissection or thrombosis</label> </div>
<div class="r0"><input type="radio" name="q20803:127_answer" disabled="disabled" value="2" id="q20803:127_answer2"><label for="q20803:127_answer2">c. brachial access site complications are more common in women</label> </div>
<div class="r1"><input type="radio" name="q20803:127_answer" disabled="disabled" value="3" id="q20803:127_answer3"><label for="q20803:127_answer3">d. brachial access is typically less successful than trans-femoral access for mesenteric intervention</label> </div>
<div class="r0"><input type="radio" name="q20803:127_answer" disabled="disabled" value="4" id="q20803:127_answer4"><label for="q20803:127_answer4">e. no difference in complication rates occurs with increasing sheath size</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:127_-submit" name="q20803:127_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This non-invasive study and patient presentation&nbsp;are consistent with a brachial artery occlusion at the access site.&nbsp; Note that the brachial pressure above the occlusion is the same as the contralateral side, excluding the likelihood of an axillo-subclavian issue.&nbsp;</p>
<p>Brachial access site complications occur in 2-6% of patients and are more common in women; this is likely related to their smaller vessel size. Increasing sheath size does increase the likelihood of access site complications. Trans-brachial access is an acceptable method of access for a number of vascular beds and carries a success rate similar to trans-femoral access with similar complication rates.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+of+Vasc+Surg+2003%3B+17%2C+107-10" target="_blank">Armstrong PJ, Han DC, Baxter JA, Elmore JR, Franklin DP. Complication rates of percutaneous brachial artery access in peripheral vascular angiography. Ann of Vasc Surg&nbsp;2003; 17, 107-10.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+1997%3B29%3A1269-75." target="_blank">Kiemeneij F, Laarman GJ, Odekerken D, Slagboom T, van der Wieken R. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The Access study FREE. J Am Coll Cardiol&nbsp;1997;29:1269-75.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19028057" target="_blank">Alvarez-Tostado JA, Moise MA, Bena JF, Pavkov ML, Greenberg RK, Clair DG, et al. The brachial artery: A critical access for endovascular procedures. J Vasc Surg 2009; 49:378-85.</a></p>
<p>QID: 30220</p></div><div class="rightanswer">The correct answer is: brachial access site complications are more common in women</div></div></div></div></div><div id="q286" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">352</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3332"><input type="hidden" name="q20803:286_:flagged" value="0"><input type="hidden" value="qaid=911170&amp;qubaid=20803&amp;qid=4805&amp;slot=286&amp;checksum=98a404ab95fcd6222bfb734cf4d07834&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:286_:flaggedcheckbox" name="q20803:286_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q286&id=4805"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:286_:sequencecheck" value="2"><div class="qtext"><p>A 64 year old woman has remote history of right hemispheric transient ischemic attacks and undergoes a carotid duplex scan, a representative image from which is shown below. Which of the following is depicted in this image?</p>
<p><a href="./VESAP3_files/10986.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/10986.jpg" alt="Img" width="145" height="118"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:286_answer" disabled="disabled" value="0" id="q20803:286_answer0"><label for="q20803:286_answer0">a. carotid artery dissection</label> </div>
<div class="r1"><input type="radio" name="q20803:286_answer" disabled="disabled" value="1" id="q20803:286_answer1"><label for="q20803:286_answer1">b. fibromuscular disease of the internal carotid artery</label> </div>
<div class="r0"><input type="radio" name="q20803:286_answer" disabled="disabled" value="2" id="q20803:286_answer2"><label for="q20803:286_answer2">c. stenosis of the external carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:286_answer" disabled="disabled" value="3" id="q20803:286_answer3"><label for="q20803:286_answer3">d. a carotid body tumor</label> </div>
<div class="r0"><input type="radio" name="q20803:286_answer" disabled="disabled" value="4" id="q20803:286_answer4"><label for="q20803:286_answer4">e. occlusion of the common carotid artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:286_-submit" name="q20803:286_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The color bar to the right of the image indicates that flow towards the probe is depicted in blue, and flow away from the probe is depicted in red. Both the jugular and external carotid arteries have flows in a similar direction indicating reverse flow in the external carotid artery. Flow in the internal carotid artery is away from the probe in the opposite direction of the jugular vein and is therefore antegrade. There is no color depicted in the common carotid artery indicating no Doppler shift within the common carotid artery and therefore occlusion of the common carotid artery. Fibromuscular disease of the internal carotid artery is best seen with power Doppler and is depicted as a classic string of beads. An internal carotid artery dissection would have a flap within the lumen of the internal carotid artery and to-and-fro flow within the internal carotid artery, neither of which is seen in the image. Therefore, the correct answer is occlusion of the common carotid artery.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Edelman%20SK.%20Doppler.%20In:%20Edelman%20SK,%20Understanding%20Ultrasound%20Physics,%203rd%20ed.%20Canada:%20ESP,%20Inc;%202004:293-328" target="_blank">Edelman SK. Doppler. In: Edelman SK, Understanding Ultrasound Physics, 3rd ed. Canada: ESP, Inc; 2004:293-328.</a></p>
<p>QID: 30506</p></div><div class="rightanswer">The correct answer is: occlusion of the common carotid artery</div></div></div></div></div><div id="q166" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">353</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3341"><input type="hidden" name="q20803:166_:flagged" value="0"><input type="hidden" value="qaid=911050&amp;qubaid=20803&amp;qid=4667&amp;slot=166&amp;checksum=a808b6cda18931a200870363bad3b8d8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:166_:flaggedcheckbox" name="q20803:166_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q166&id=4667"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:166_:sequencecheck" value="2"><div class="qtext"><p>The end diastolic velocity of a Doppler signal obtained from the external carotid artery reflects a:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:166_answer" disabled="disabled" value="0" id="q20803:166_answer0"><label for="q20803:166_answer0">a. similarity to the renal artery</label> </div>
<div class="r1"><input type="radio" name="q20803:166_answer" disabled="disabled" value="1" id="q20803:166_answer1"><label for="q20803:166_answer1">b. low resistance outflow bed</label> </div>
<div class="r0"><input type="radio" name="q20803:166_answer" disabled="disabled" value="2" id="q20803:166_answer2"><label for="q20803:166_answer2">c. similarity to the internal carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:166_answer" disabled="disabled" value="3" id="q20803:166_answer3"><label for="q20803:166_answer3">d. high resistance outflow bed</label> </div>
<div class="r0"><input type="radio" name="q20803:166_answer" disabled="disabled" value="4" id="q20803:166_answer4"><label for="q20803:166_answer4">e. similarity to the celiac artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:166_-submit" name="q20803:166_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The brain is a low resistance organ that demands a high volume of blood. As a result, the internal carotid artery normally exhibits a velocity waveform consistent with a low resistance outflow bed (ie with an end diastolic velocity above zero). The face represents a variable resistance bed and shares characteristic velocity patterns with the upper and lower extremities. Thus, the external carotid artery normally exhibits a velocity waveform consistent with a high resistance outflow bed. The common carotid artery supplies both the internal carotid artery and external carotid artery, and the velocity pattern seen in the common carotid artery represents both outflow beds. This pattern is referred to as "quasi-steady", which means that the flow in the pulse cycle is above&nbsp;zero at all times.<br><br></p>
<h3>References:</h3>
<p>Strandness DE. Hemodynamics of the normal arterial and venous system. In: Strandness DE, ed. Duplex Scanning in Vascular Disorders. 3rd ed. Philadelphia, PA: Lippincott, Williams &amp; Wilkins; 2002:32-60.<br><br>Rzucidlo EM, Zwolak RM. Arterial duplex scanning. In: Rutherford RB, ed. Vascular Surgery.6th ed. Philadelphia, PA: Elsevier Saunders 2005:233-53.</p>
<p>QID: 30304</p></div><div class="rightanswer">The correct answer is: high resistance outflow bed</div></div></div></div></div><div id="q530" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">354</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3350"><input type="hidden" name="q20803:530_:flagged" value="0"><input type="hidden" value="qaid=911414&amp;qubaid=20803&amp;qid=5266&amp;slot=530&amp;checksum=54bdbc3b1a3a45dcb5507160d23f6553&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:530_:flaggedcheckbox" name="q20803:530_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q530&id=5266"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:530_:sequencecheck" value="2"><div class="qtext"><p>A 52-year-old morbidly obese woman undergoes a complex endograft repair of aortoiliac aneurysm requiring hypogastric artery embolization. A total of 6000 mGy is used. For this patient and scenario, which of the following is the most common symptom of radiation skin injury?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:530_answer" disabled="disabled" value="0" id="q20803:530_answer0"><label for="q20803:530_answer0">a. sacral ulceration with blisters within 3 days of operation</label> </div>
<div class="r1"><input type="radio" name="q20803:530_answer" disabled="disabled" value="1" id="q20803:530_answer1"><label for="q20803:530_answer1">b. erythema over the lower back within 48 hours of operation</label> </div>
<div class="r0"><input type="radio" name="q20803:530_answer" disabled="disabled" value="2" id="q20803:530_answer2"><label for="q20803:530_answer2">c. hair loss within 1 week of operation</label> </div>
<div class="r1"><input type="radio" name="q20803:530_answer" disabled="disabled" value="3" id="q20803:530_answer3"><label for="q20803:530_answer3">d. hyperpigmentation within 1 week of operation</label> </div>
<div class="r0"><input type="radio" name="q20803:530_answer" disabled="disabled" value="4" id="q20803:530_answer4"><label for="q20803:530_answer4">e. redness, burning, itching within 12 hours of operation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:530_-submit" name="q20803:530_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span>Deterministic effects of ionizing radiation occur with varying threshold doses and manifest at varying times after exposure. At a threshold of 2Gy, transient skin irritation can occur at 24-48 hours ("early phase") and typically resembles a sunburn. &nbsp;With higher dose exposure (10Gy), changes in the skin (so-called "main erythematous phase") may become apparent at 10-28 days as burning, itching, and tenderness. Temporary epilation (3Gy) or permanent epilation (7Gy) usually occurs after 3 weeks. &nbsp;If the hair grows back, it is often thinner. &nbsp;A third phase of erythema can be observed later, between 8-20 weeks after irradiation. This phase is associated with dermal ischemia and may also evolve towards necrosis.&nbsp;In the evolution of the fourth phase, skin reactions can be responsible for late radiodermatitis. Increased pigmentation is usual, but depigmentation can also be observed (usually at higher doses), with a combination of both being observed in some cases. The skin may also become hyperkeratotic. &nbsp;<br></span></p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Endovasc+Ther+2008%3B+15%3A680-7." target="_blank"><span>Walsh SR, Cousins C, Tang TY, Gaunt ME, Boyle JR. Ionizing radiation in endovascular interventions. J Endovasc Ther 2008; 15:680-7.</span><span>&nbsp;</span></a></p>
<div class="column">
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br.J+Radiol+2005%3B+78%3A+906-12." target="_blank"><span>Geijer H, Larzon T, Popek R, Beckman KW. Radiation exposure in stent-grafting of abdominal aortic aneurysms. Br J Radiol 2005; 78: 906-12. </span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br+J+Surg+2008%3B95%3A699-702." target="_blank"><span>Weerakkody RA, Walsh SR, Cousins C, Goldstone KE, Tang TY,Gaunt ME. Radiation exposure during endovascular aneurysm repair. Br J Surg 2008;95:699-702.&nbsp;</span></a></p>
<p><span>QID: 30934</span></p>
</div></div><div class="rightanswer">The correct answer is: erythema over the lower back within 48 hours of operation</div></div></div></div></div><div id="q141" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">355</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3359"><input type="hidden" name="q20803:141_:flagged" value="0"><input type="hidden" value="qaid=911025&amp;qubaid=20803&amp;qid=4759&amp;slot=141&amp;checksum=f293ee187340e66fde09f565a55fad22&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:141_:flaggedcheckbox" name="q20803:141_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q141&id=4759"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:141_:sequencecheck" value="2"><div class="qtext"><p>A 25-year-old man presents after a self-inflicted gunshot wound to the right upper extremity (Fig 1). He is hemodynamically stable. The physical exam reveals absent right brachial, radial, and ulnar pulses and a sensory and motor deficit. The CT arteriogram is shown below (Fig 2). Which of the following is the most appropriate management option for this patient?</p>
<p>&nbsp;</p>
<p>Fig 1.</p>
<p><img src="./VESAP3_files/GSW axilla.jpg" alt="GSW axilla" width="315" height="291"></p>
<p>Figure 2.</p>
<p><img src="./VESAP3_files/GSW axilla CTA.jpg" alt="GSW axilla CTA" width="368" height="380"></p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:141_answer" disabled="disabled" value="0" id="q20803:141_answer0"><label for="q20803:141_answer0">a. local wound exploration with proximal control using balloon occlusion, debridement, and primary repair</label> </div>
<div class="r1"><input type="radio" name="q20803:141_answer" disabled="disabled" value="1" id="q20803:141_answer1"><label for="q20803:141_answer1">b. interposition vein bypass with proximal control through an infra-clavicular incision</label> </div>
<div class="r0"><input type="radio" name="q20803:141_answer" disabled="disabled" value="2" id="q20803:141_answer2"><label for="q20803:141_answer2">c. transfemoral arteriography, catheter thrombectomy, and covered stent insertion</label> </div>
<div class="r1"><input type="radio" name="q20803:141_answer" disabled="disabled" value="3" id="q20803:141_answer3"><label for="q20803:141_answer3">d. trans-brachial thrombectomy, arteriogram, and covered stent insertion</label> </div>
<div class="r0"><input type="radio" name="q20803:141_answer" disabled="disabled" value="4" id="q20803:141_answer4"><label for="q20803:141_answer4">e. interposition vein bypass with proximal control through a supra-clavicular incision</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:141_-submit" name="q20803:141_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>These images are consistent with a distal axillary artery injury. Proximal axillary control for repair of this injury is possible through an infra-clavicular incision, without the need for a more time consuming exposure of the subclavian artery through a supra-clavicular approach. Local exploration may be possible but would likely still require an infra-clavicular incision to achieve proximal control. Balloon occlusion would be an alternative means of proximal control, but is likely not required given the accessible nature of the proximal axillary artery. Reversed saphenous vein is the conduit of choice for interposition bypass reconstruction, particularly in a potentially infected field. Covered stent insertion would be less ideal due to the degree of mobility of the axillary artery at this location (and associated adverse effects on patency), regardless of the approach.</p>
<p>&nbsp;</p>
<p>&nbsp;</p>
<h2 style="text-align: left;" align="center">References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Curr+Opin+Crit+Care+2010%3B16(6)%3A602-8." target="_blank">Feliciano DV. Management of peripheral arterial injury. Curr Opin Crit Care 2010;16(6):602-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surg+Clin+North+Am+2001%3B81(6)%3A1357-73%2C" target="_blank">Demetriades D, Asensio JA. Subclavian and axillary vascular injuries. Surg Clin North Am 2001;81(6):1357-73, xiii.</a></p>
<p>QID: 30235</p></div><div class="rightanswer">The correct answer is: interposition vein bypass with proximal control through an infra-clavicular incision</div></div></div></div></div><div id="q331" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">356</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3368"><input type="hidden" name="q20803:331_:flagged" value="0"><input type="hidden" value="qaid=911215&amp;qubaid=20803&amp;qid=5095&amp;slot=331&amp;checksum=083ac392c291f7492cae56ac8c85072e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:331_:flaggedcheckbox" name="q20803:331_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q331&id=5095"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:331_:sequencecheck" value="2"><div class="qtext"><p>In this duplex ultrasound image of a right brachial artery, what feature is present in the color-flow display?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/Zierler Image 2.jpg" target="images"><img src="./VESAP3_files/Zierler Image 2.jpg" alt="Zierler Image 2" width="100"></a></p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:331_answer" disabled="disabled" value="0" id="q20803:331_answer0"><label for="q20803:331_answer0">a. shadowing</label> </div>
<div class="r1"><input type="radio" name="q20803:331_answer" disabled="disabled" value="1" id="q20803:331_answer1"><label for="q20803:331_answer1">b. speed error</label> </div>
<div class="r0"><input type="radio" name="q20803:331_answer" disabled="disabled" value="2" id="q20803:331_answer2"><label for="q20803:331_answer2">c. aliasing</label> </div>
<div class="r1"><input type="radio" name="q20803:331_answer" disabled="disabled" value="3" id="q20803:331_answer3"><label for="q20803:331_answer3">d. reverberation</label> </div>
<div class="r0"><input type="radio" name="q20803:331_answer" disabled="disabled" value="4" id="q20803:331_answer4"><label for="q20803:331_answer4">e. enhancement</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:331_-submit" name="q20803:331_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Pulsed wave Doppler instruments determine blood flow velocity by taking intermittent “samples” of the flow; the rate of this sampling is the pulse repetition frequency or PRF. The upper limit of the Doppler shift frequency that can be detected accurately by this process is called the Nyquist limit, which is commonly defined as PRF/2 or one-half of the PRF. Aliasing is an artifact of Doppler flow detection that occurs when the Doppler frequency shift exceeds the Nyquist limit. When aliasing occurs, the velocity information is displayed improperly. This tends to occur more often in color-flow imaging than in Doppler spectral waveforms because color-flow images are acquired at lower PRF rates. In this aliased color-flow image, the colors displayed in the center of the brachial artery depict flow in the wrong direction (the color scale has “wrapped around” with bright yellow occurring next to bright blue). Shadowing refers to a reduction in the strength of the ultrasound echoes beyond a strongly attenuating or reflecting structure. Enhancement is the strengthening of echoes from reflectors that lie beyond a weakly attenuating structure. Reverberation occurs between two strongly reflecting structures (or between the transducer surface and a single strong reflector) and results in multiple recurring images of the same structure. Speed error occurs when the assumed value for the speed of sound in soft tissues (typically 1.54 mm/µs) is incorrect and a structure is displayed at an incorrect distance from the transducer.&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Kremkau FW. Chapter 6 Artifacts. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:176-210</p>
<p>QID: 30565</p></div><div class="rightanswer">The correct answer is: aliasing</div></div></div></div></div><div id="q360" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">357</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3377"><input type="hidden" name="q20803:360_:flagged" value="0"><input type="hidden" value="qaid=911244&amp;qubaid=20803&amp;qid=5156&amp;slot=360&amp;checksum=32798f5f9f04109feba08d4c23806ae6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:360_:flaggedcheckbox" name="q20803:360_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q360&id=5156"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:360_:sequencecheck" value="2"><div class="qtext"><p>Which of the following outcomes is associated with open renal artery revascularization for the treatment of renovascular hypertension?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:360_answer" disabled="disabled" value="0" id="q20803:360_answer0"><label for="q20803:360_answer0">a. morbidity rates of less than 7 %</label> </div>
<div class="r1"><input type="radio" name="q20803:360_answer" disabled="disabled" value="1" id="q20803:360_answer1"><label for="q20803:360_answer1">b. improved patency compared to percutaneous renal artery revascularization</label> </div>
<div class="r0"><input type="radio" name="q20803:360_answer" disabled="disabled" value="2" id="q20803:360_answer2"><label for="q20803:360_answer2">c. decreased incidence of acute coronary syndromes</label> </div>
<div class="r1"><input type="radio" name="q20803:360_answer" disabled="disabled" value="3" id="q20803:360_answer3"><label for="q20803:360_answer3">d. mortality rates of less than 1%</label> </div>
<div class="r0"><input type="radio" name="q20803:360_answer" disabled="disabled" value="4" id="q20803:360_answer4"><label for="q20803:360_answer4">e. improved survival for patients with improved hypertension</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:360_-submit" name="q20803:360_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The pattern of treatment for&nbsp;renovascular hypertension has changed dramatically over the past 15 years. Between 2000 and 2004, the U.S. experienced a 30% reduction in the number of open revasularization cases, and that trend continues today. Nationwide statistics suggest that operative mortality&nbsp;for open reconstructions for&nbsp;renovascular disease&nbsp;may be as high as 10%, with morbidity rates as high as 24% in these patients.&nbsp;The primary&nbsp;advantage of open&nbsp;renal artery&nbsp;revascularization&nbsp;over renal artery stenting is the durability of open reconstruction (patency rates of 95% at 3 years, compared to 70% in&nbsp;angioplasty/stenting group). Hypertension cure rates or improvement are similar between the groups (90% PTA and 86% surgery).&nbsp;Hansen et al showed that improved renal function after&nbsp;open renal artery&nbsp;revascularization is associated with improved survival compared to those without improved renal function. A similar&nbsp;impact on survival was not evident&nbsp;in patients with improved blood pressure after open renal artery reconstruction. Although renal artery reconstruction may decrease episodes of recurrent pulmonary edema associated with renal artery occlusive disease, there has been&nbsp;no&nbsp;clear impact on&nbsp;the incidence of acute coronary syndromes.&nbsp;&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19907044" target="_blank">Dworkin LD, Cooper CJ. Clinical practice. Renal artery stenosis. N Engl J Med&nbsp; 2009;361(20):1972-8.&nbsp;</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+48(2)%3A317" target="_blank">Modrall JG, Rosero EB, Smith ST, Arko FR, Valentine RJ, Clagett GP, et al. Operative mortality for renal artery bypass in the US: Results from the Nastional Inpatient Sample. J Vasc Surg 2008; 48(2):317-22.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/8230572" target="_blank">Weibull H, Bergqvist D. Bergentz SE, Jonsson K, Hulthen L, Manhem P.&nbsp;Percutaneous tranluminal renal angioplasty versus surgical reconstruction of atherosclerotic renal artery stenosis: a prospective randomized study. J Vasc Surg 1993;18(5):841-50.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/10957653" target="_blank">Hansen KJ, Cherr GS, Craven TE, Motew SJ, Travis JA, Wong JM, et al. Management of&nbsp;ischemic nephropathy: dialysis-free survival after surgical repair. J Vasc Surg 2000; 32:472-81.</a></p>
<p>QID: 30632</p></div><div class="rightanswer">The correct answer is: improved patency compared to percutaneous renal artery revascularization</div></div></div></div></div><div id="q366" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">358</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3386"><input type="hidden" name="q20803:366_:flagged" value="0"><input type="hidden" value="qaid=911250&amp;qubaid=20803&amp;qid=5120&amp;slot=366&amp;checksum=a7a0fd0963a2b1181ea6c820c567e9f3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:366_:flaggedcheckbox" name="q20803:366_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q366&id=5120"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:366_:sequencecheck" value="2"><div class="qtext"><p>A 33-year-old man has chronic abdominal pain. After eating, he feels bloated and, eventually, nauseated.&nbsp;This pattern has resulted in a&nbsp;20 lb weight loss over 4 months. He is becoming&nbsp;increasingly debilitated: to the point of losing his job.&nbsp;Extensive gastrointestinal workup is unremarkable, except CT imaging showing a downsloping superior mesenteric artery compressing the duodenum (image shone below). Which of the following is the appropriate next step in the treatment of this patient?</p>
<p><img src="./VESAP3_files/SMA syndrome.jpeg" alt="" width="396" height="456"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:366_answer" disabled="disabled" value="0" id="q20803:366_answer0"><label for="q20803:366_answer0">a. gastro-jejunostomy</label> </div>
<div class="r1"><input type="radio" name="q20803:366_answer" disabled="disabled" value="1" id="q20803:366_answer1"><label for="q20803:366_answer1">b. SMA reimplantation on the infrarenal aorta</label> </div>
<div class="r0"><input type="radio" name="q20803:366_answer" disabled="disabled" value="2" id="q20803:366_answer2"><label for="q20803:366_answer2">c. naso-jejunal tube feeds</label> </div>
<div class="r1"><input type="radio" name="q20803:366_answer" disabled="disabled" value="3" id="q20803:366_answer3"><label for="q20803:366_answer3">d. SMA bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:366_answer" disabled="disabled" value="4" id="q20803:366_answer4"><label for="q20803:366_answer4">e. duodenal stenting</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:366_-submit" name="q20803:366_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Superior mesenteric artery (SMA) syndrome is a rare condition causing chronic abdominal pain, food fear, and weight loss secondary to compression of the duodenum by the SMA.&nbsp; Controversy exists as to whether this is a primary condition or related secondarily to extensive loss of mesenteric fat during a catabolic state. Given its rarity, patients often undergo extensive evaluation by multiple practitioners.&nbsp;The&nbsp;diagnosis requires an aorto-SMA angle of less than 25 degrees.&nbsp;Implicit in the diagnosis is a lack of significant mesenteric arterial occlusive disease.&nbsp;Most reports advocate a conservative management of SMA syndrome with jejunal feedings via either a naso-jejunal tube or surgically implanted jejunal tube. With an anabolic state and increasing weight, the SMA to aorta angle should increase and thus decrease duodenal pressure. In intractable cases, rerouting the bowel appears to be safer than rerouting the SMA and arterial compression.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Gastroenterol+2002%3B+37%3A640%E2%80%933." target="_blank"><span data-mce-mark="1">Lippl F, Hannig C, Weiss W, Allescher HD,Classen M, Kurjak M. Superior mesenteric artery syndrome: diagnosis and treatment from the gastroenterologist’s view.</span>J Gastroenterol<span data-mce-mark="1"> 2002; 37:640–3.</span></a></p>
<p><span data-mce-mark="1">QID: 30647</span></p></div><div class="rightanswer">The correct answer is: naso-jejunal tube feeds</div></div></div></div></div><div id="q58" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">359</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3395"><input type="hidden" name="q20803:58_:flagged" value="0"><input type="hidden" value="qaid=910942&amp;qubaid=20803&amp;qid=4315&amp;slot=58&amp;checksum=b4922ae2128d7b1f3e6f1251510f5464&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:58_:flaggedcheckbox" name="q20803:58_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q58&id=4315"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:58_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding the role of matrix metalloproteinases (MMPs) in aneurysm formation is correct?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:58_answer" disabled="disabled" value="0" id="q20803:58_answer0"><label for="q20803:58_answer0">a. The normal aortic wall expresses high levels of MMPs.</label> </div>
<div class="r1"><input type="radio" name="q20803:58_answer" disabled="disabled" value="1" id="q20803:58_answer1"><label for="q20803:58_answer1">b. Development of small molecule inhibitors of MMPs is critical for medical management of aneurysms because the MMPs are the only proteases that are overexpressed in aneurysms.</label> </div>
<div class="r0"><input type="radio" name="q20803:58_answer" disabled="disabled" value="2" id="q20803:58_answer2"><label for="q20803:58_answer2">c. MMP-9 is elevated in small aneurysms, and MMP-2 is elevated in larger aneurysms and ruptured aneurysms.</label> </div>
<div class="r1"><input type="radio" name="q20803:58_answer" disabled="disabled" value="3" id="q20803:58_answer3"><label for="q20803:58_answer3">d. MMPs are predominantly expressed by adventitial fibroblasts in aneurysms.</label> </div>
<div class="r0"><input type="radio" name="q20803:58_answer" disabled="disabled" value="4" id="q20803:58_answer4"><label for="q20803:58_answer4">e. <span style="font-size: medium;"><span style="font-family: Times New Roman;"> Doxycycline is thought to decrease aneurysm rate of growth because it is a non-specific matrix metalloproteinase inhibitor.</span></span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:58_-submit" name="q20803:58_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span style="font-family: Times New Roman;"><span style="font-size: medium;">Multiple lines of evidence suggest a critical role for matrix metalloproteinases in aneurysm formation.&nbsp; Expression of MMPs is elevated within tissue macrophages (especially MMP9) and aortic smooth muscle cells (especially MMP2) in aneurysms but not within the normal aorta.&nbsp; MMP9 levels are elevated in larger and ruptured aneurysms, while MMP2 levels are elevated in small aneurysms.&nbsp; Mice genetically knocked out for MMP9 are resistant to aneurysm formation by the elastase perfusion model.&nbsp; The balance between tissue inhibitors of metalloproteinases and MMPs is disrupted favoring matrix degradation within aneurysms.</span><sup><span style="font-size: small;">1</span></sup><span style="font-size: medium;">&nbsp; In addition to MMPs, cathepsins ,lysosomal cysteine proteases, which have also been found to be upregulated in human aneurismal tissue</span><sup><span style="font-size: small;">2</span></sup><span style="font-size: medium;"> and in the plasma of patients with AAA</span><sup><span style="font-size: small;">3</span></sup><span style="font-size: medium;"> and serine proteases are likely to play a part in aneurysm formation.&nbsp; </span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Aziz, F. &amp; Kuivaniemi, H. Role of matrix metalloproteinase inhibitors in preventing abdominal aortic aneurysm. <em>Ann Vasc Surg</em> <strong>21</strong>, 392-401 (2007).</span></span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Sukhova, G.K. &amp; Shi, G.P. Do cathepsins play a role in abdominal aortic aneurysm pathogenesis? <em>Ann N Y Acad Sci</em> <strong>1085</strong>, 161-169 (2006).</span></span></span></p>
<p><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Calibri;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lv, B.J., Lindholt, J.S., Cheng, X., Wang, J. &amp; Shi, G.P. Plasma cathepsin S and cystatin C levels and risk of abdominal aortic aneurysm: a randomized population-based study. <em>PLoS One</em> <strong>7</strong>, e41813 (2012).</span></span></span></p>
<p><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Calibri;">QID: 30064</span></span></span></p></div><div class="rightanswer">The correct answer is: <span style="font-size: medium;"><span style="font-family: Times New Roman;"> Doxycycline is thought to decrease aneurysm rate of growth because it is a non-specific matrix metalloproteinase inhibitor.</span></span></div></div></div></div></div><div id="q536" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">360</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3404"><input type="hidden" name="q20803:536_:flagged" value="0"><input type="hidden" value="qaid=911420&amp;qubaid=20803&amp;qid=5272&amp;slot=536&amp;checksum=3699705502ebb9fdc3a85d8d7676da72&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:536_:flaggedcheckbox" name="q20803:536_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q536&id=5272"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:536_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old man underwent a diagnostic aortogram and bilateral lower extremity angiogram, which was followed 1 week later by placement of a stent in the common iliac artery. Three months later he developed an area of ulceration on the lower back. The most probable diagnosis is a radiation injury resulting from which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:536_answer" disabled="disabled" value="0" id="q20803:536_answer0"><label for="q20803:536_answer0">a. the deterministic effect of the x-rays on multiple skin cells</label> </div>
<div class="r1"><input type="radio" name="q20803:536_answer" disabled="disabled" value="1" id="q20803:536_answer1"><label for="q20803:536_answer1">b. the deterministic effect of the x-rays associated with an absorbed dose of 6Gy</label> </div>
<div class="r0"><input type="radio" name="q20803:536_answer" disabled="disabled" value="2" id="q20803:536_answer2"><label for="q20803:536_answer2">c. the stochastic effect associated with an absorbed dose of 6Gy</label> </div>
<div class="r1"><input type="radio" name="q20803:536_answer" disabled="disabled" value="3" id="q20803:536_answer3"><label for="q20803:536_answer3">d. the deterministic effect of the x-rays on a single cell</label> </div>
<div class="r0"><input type="radio" name="q20803:536_answer" disabled="disabled" value="4" id="q20803:536_answer4"><label for="q20803:536_answer4">e. the stochastic effect of the x-rays on multiple skin cells</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:536_-submit" name="q20803:536_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>A stochastic effect is defined as one which effects only a single cell. There is no threshold below which it cannot occur; it results in DNA injury and cancer. A deterministic effect is one which effects many cells and does have a threshold below which no adverse effect occurs. &nbsp;A skin ulceration is an example of a deterministic effect that does not usually occur unless the skin entrance dose is &gt;18Gy.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11418388" target="_blank">Koenig TR, Wolff D, Mettler FA, Wagner LK. Skin injuries from fluoroscopically guided procedures: part 1, characteristics of radiation injury. AJR Am J Roentgenol 2001;177:3-11. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/16384753" target="_blank">Hymes SR, Strom EA, Fife C. Radiation dermatitis: Clinical presentation, pathophysiology, and treatment 2006. J Am Acad Dermatol 2006; 54:23-46.</a></p>
<p>QID: 30940</p></div><div class="rightanswer">The correct answer is: the deterministic effect of the x-rays on multiple skin cells</div></div></div></div></div><div id="q78" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">361</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3413"><input type="hidden" name="q20803:78_:flagged" value="0"><input type="hidden" value="qaid=910962&amp;qubaid=20803&amp;qid=4985&amp;slot=78&amp;checksum=65464fd64cb30c79f7650fb542dca6a2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:78_:flaggedcheckbox" name="q20803:78_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q78&id=4985"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:78_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man with hypertension and hypercholesterolemia who quit smoking 3 years ago is referred for pain in the buttocks, thighs, and calves. The pain occurs after approximately 100 yards of walking and is relieved by rest. He works as a construction site supervisor and is having severe difficulty with his job responsibilities due to his inability to walk. On physical examination, he has palpable femoral, popliteal, and posterior tibial pulses and normal ankle-brachial indices. At this point in his evaluation, which of the following is the most appropriate diagnostic study?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:78_answer" disabled="disabled" value="0" id="q20803:78_answer0"><label for="q20803:78_answer0">a. digital subtraction angiography of the aorta and iliac arteries</label> </div>
<div class="r1"><input type="radio" name="q20803:78_answer" disabled="disabled" value="1" id="q20803:78_answer1"><label for="q20803:78_answer1">b. non-invasive arterial studies, including ankle brachial indices at rest and after exercise</label> </div>
<div class="r0"><input type="radio" name="q20803:78_answer" disabled="disabled" value="2" id="q20803:78_answer2"><label for="q20803:78_answer2">c. magnetic resonance angiography without gadolinium</label> </div>
<div class="r1"><input type="radio" name="q20803:78_answer" disabled="disabled" value="3" id="q20803:78_answer3"><label for="q20803:78_answer3">d. CT angiography with three dimensional reconstruction</label> </div>
<div class="r0"><input type="radio" name="q20803:78_answer" disabled="disabled" value="4" id="q20803:78_answer4"><label for="q20803:78_answer4">e. magnetic resonance arteriography of the aorta and iliac arteries using gadolinium</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:78_-submit" name="q20803:78_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Although the patient has a normal pulse exam and ankle-brachial indices (ABIs) at rest, his age, risk factors, and history all suggest that he has intermittent claudication due to atherosclerosis. In patients with stenosis of the infrarenal aorta or iliac arteries, leg pulses may still be present at rest and the resting ankle brachial index (ABI) may be normal. Exercise decreases peripheral vascular resistance, resulting in an increased pressure gradient across the area of stenosis and causing a reduction in pressure distal to the stenosis and a reduction in the ABI. The usual protocol is walking on a treadmill at a fixed speed of 2 mph with a slight elevation in grade (4-10%) for 5 minutes, after which the ABIs are immediately repeated and compared to the pre-exercise ABIs. If there is no reduction in the ABI after exercise, some other cause for the symptoms should be sought, such as spinal stenosis. If the ABIs do decline, the amount of time at rest prior to their return to baseline is generally indicative of the severity of the occlusive disease.</p>
<p>Not only are CT or MR angiography overly invasive and needlessly expensive, but neither demonstrate the hemodynamic significance of any occlusive disease that they might demonstrate. It must be recognized that the mere presence of atherosclerotic occlusive disease, even with suggestive symptoms, does not establish a causal relationship without a correspondingly diminished resting or exercise ABI. Digital subtraction angiography would be even more inappropriate as the next test because of the invasiveness and expense of the procedure.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Carter%20SA.%20Response%20of%20ankle%20systolic%20pressure%20to%20leg%20exercise%20in%20mild%20or%20questionable%20arterial%20disease.%20N%20Engl%20J%20Med;%201972;%20287%20(12):578-582" target="_blank">Carter SA. Response of ankle systolic pressure to leg exercise in mild or questionable arterial disease. N Engl J Med 1972; 287 (12):578-82.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Sumner%20DS,%20Strandness%20DE,%20Jr.%20The%20relationship%20between%20calf%20blood%20flow%20and%20ankle%20blood%20pressure%20in%20patients%20with%20intermittent%20claudication.%20Surgery;%201969;%2065%20(5):763-771" target="_blank">Sumner DS, Strandness DE, Jr. The relationship between calf blood flow and ankle blood pressure in patients with intermittent claudication. Surgery 1969; 65 (5):763-71</a>.</p>
<p>QID: 30122</p></div><div class="rightanswer">The correct answer is: non-invasive arterial studies, including ankle brachial indices at rest and after exercise</div></div></div></div></div><div id="q291" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">362</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3422"><input type="hidden" name="q20803:291_:flagged" value="0"><input type="hidden" value="qaid=911175&amp;qubaid=20803&amp;qid=5030&amp;slot=291&amp;checksum=425ede2ad48a33c820485bca82e6367c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:291_:flaggedcheckbox" name="q20803:291_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q291&id=5030"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:291_:sequencecheck" value="2"><div class="qtext"><p>A 74-year-old woman presents with an acutely swollen&nbsp;left lower extremity. A venous duplex examination reveals no evidence of venous thrombus in the common femoral, femoral,&nbsp;popliteal, and tibial veins bilaterally. Waveforms from the right (Image A) and left (Image B) common femoral veins are shown below. Which of the following is the most probable diagnosis for this patient?</p>
<p><a href="./VESAP3_files/10992.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/10992.jpg" alt="Img" width="83" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:291_answer" disabled="disabled" value="0" id="q20803:291_answer0"><label for="q20803:291_answer0">a. occlusion of the inferior vena cava</label> </div>
<div class="r1"><input type="radio" name="q20803:291_answer" disabled="disabled" value="1" id="q20803:291_answer1"><label for="q20803:291_answer1">b. occlusion of the left common or external iliac veins</label> </div>
<div class="r0"><input type="radio" name="q20803:291_answer" disabled="disabled" value="2" id="q20803:291_answer2"><label for="q20803:291_answer2">c. tricuspid regurgitation</label> </div>
<div class="r1"><input type="radio" name="q20803:291_answer" disabled="disabled" value="3" id="q20803:291_answer3"><label for="q20803:291_answer3">d. congestive heart failure</label> </div>
<div class="r0"><input type="radio" name="q20803:291_answer" disabled="disabled" value="4" id="q20803:291_answer4"><label for="q20803:291_answer4">e. occlusion of the right common or external iliac vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:291_-submit" name="q20803:291_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Bilateral common femoral vein venous waveforms should be obtained in all cases of venous duplex scanning. Comparison of the common femoral vein waveforms is quite useful in eliciting pathology proximal to the inguinal ligament. Patients presenting with tricuspid regurgitation or congestive heart failure have bilateral pulsatile femoral venous waveforms with minimal variation with respirations. Loss of respiratory variation and continuous flow in&nbsp;the&nbsp;common femoral veins bilaterally would be indicative of high grade inferior vena cava stenosis or caval occlusion. The image depicts normal respiratory variation&nbsp;in the right common femoral vein and minimal respiratory variation&nbsp;in the left common femoral vein; which is suggestive of high grade stenosis or occlusion of the left common iliac or external iliac vein.<br><br></p>
<h2>Reference:</h2>
<p>Dawson DL, Beals H. Acute lower extremity deep vein thrombosis. In: Strandness's Duplex Scanning in Vascular Disorders, 4th ed. Zierler RE,ed. Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2010:179-98.</p>
<p>QID: 30511</p></div><div class="rightanswer">The correct answer is: occlusion of the left common or external iliac veins</div></div></div></div></div><div id="q199" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">363</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3431"><input type="hidden" name="q20803:199_:flagged" value="0"><input type="hidden" value="qaid=911083&amp;qubaid=20803&amp;qid=4690&amp;slot=199&amp;checksum=4fbf8289f6f4fc63d08e0619af4e8e53&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:199_:flaggedcheckbox" name="q20803:199_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q199&id=4690"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:199_:sequencecheck" value="2"><div class="qtext"><p>You perform a left CEA on a 62-year-old woman for an asymptomatic 80% stenosis. She has no intra-operative complications and is discharged home on the first post-operative day.&nbsp; When she returns to the office for follow-up 2 weeks later, she is neurologically intact but complains of voice fatigue.&nbsp; Her voice is initially normal but quickly fades after 1 or 2 sentences. This result is likely due to an injury to which of the following cranial nerves?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:199_answer" disabled="disabled" value="0" id="q20803:199_answer0"><label for="q20803:199_answer0">a. spinal accessory nerve</label> </div>
<div class="r1"><input type="radio" name="q20803:199_answer" disabled="disabled" value="1" id="q20803:199_answer1"><label for="q20803:199_answer1">b. hypoglossal nerve</label> </div>
<div class="r0"><input type="radio" name="q20803:199_answer" disabled="disabled" value="2" id="q20803:199_answer2"><label for="q20803:199_answer2">c. recurrent laryngeal nerve</label> </div>
<div class="r1"><input type="radio" name="q20803:199_answer" disabled="disabled" value="3" id="q20803:199_answer3"><label for="q20803:199_answer3">d. glossopharyngeal nerve</label> </div>
<div class="r0"><input type="radio" name="q20803:199_answer" disabled="disabled" value="4" id="q20803:199_answer4"><label for="q20803:199_answer4">e. superior laryngeal nerve</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:199_-submit" name="q20803:199_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The incidence of cranial nerve injury varies from 2-15%. Unless the nerve is transected, most deficits resolve within 6 months of surgery. Depending on the reference, the most commonly injured cranial nerve is either the hypoglossal or the vagus nerve. Voice fatigue is typically a symptom related to an injury to the superior laryngeal nerve. It may be asymptomatic or disabling, especially in people who used their voice frequently. Injury to the recurrent laryngeal nerve results in hoarseness, impaired phonation, and an ineffective cough. Injury to the hypoglossal nerve results in hemiparesis of the tongue. Injury to the spinal accessory nerve results in weakness of the trapezius. Injury to the glossopharyngeal nerve is rare and results in impaired swallowing and recurrent aspiration due to inability to elevate the larynx and pharynx.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/7444729" target="_blank">Hertzer NR, Fledman BJ, Beven EG, Tucker HM.&nbsp;A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg Gynecol Obstet 1980; 151:781-4.</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/7444729"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Evans+WE%2C+Medelowitz+DS%2C+Liapis+C%2C+et+al.+Motor+speech+deficit+following+carotid+endarterectomy.+Ann+Surg+1982%3B+196%3A461-4." target="_blank">Evans WE, Medelowitz DS, Liapis C, Wolfe V<span>,&nbsp;</span>Florence CL. Motor speech deficit following carotid endarterectomy.&nbsp;Ann Surg&nbsp;1982; 196:461-4. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/7125731"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/3509598" target="_blank">Tucker JA, Gee W, Nicholas GG, McDonald KM<span>,&nbsp;</span>Goodreau JJ.&nbsp;Accessory nerve injury during carotid endarterectomy. J Vasc Surg 1987; &nbsp;5:440-4. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/3509598"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/3509601" target="_blank">Rosenbloom M, Friedman SG, Lamparello PJ, Riles TS<span>,&nbsp;</span>Imparato AM.&nbsp;Glossopharyngeal nerve injury following carotid endarterectomy. J Vasc Surg 1987; 5:469-471. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/3509601"><br></a></p>
<p>QID: 30348</p></div><div class="rightanswer">The correct answer is: superior laryngeal nerve</div></div></div></div></div><div id="q109" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">364</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3440"><input type="hidden" name="q20803:109_:flagged" value="0"><input type="hidden" value="qaid=910993&amp;qubaid=20803&amp;qid=4932&amp;slot=109&amp;checksum=076509b29e3cddbee47f96a1feeed44e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:109_:flaggedcheckbox" name="q20803:109_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q109&id=4932"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:109_:sequencecheck" value="2"><div class="qtext"><p>What is the most specific, non-invasive vascular laboratory method of predicting wound healing when determining the appropriate level of lower extremity amputation?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:109_answer" disabled="disabled" value="0" id="q20803:109_answer0"><label for="q20803:109_answer0">a. tcPO<sup>2</sup></label> </div>
<div class="r1"><input type="radio" name="q20803:109_answer" disabled="disabled" value="1" id="q20803:109_answer1"><label for="q20803:109_answer1">b. skin perfusion pressure</label> </div>
<div class="r0"><input type="radio" name="q20803:109_answer" disabled="disabled" value="2" id="q20803:109_answer2"><label for="q20803:109_answer2">c. ambulatory venous pressure</label> </div>
<div class="r1"><input type="radio" name="q20803:109_answer" disabled="disabled" value="3" id="q20803:109_answer3"><label for="q20803:109_answer3">d. toe blood pressure</label> </div>
<div class="r0"><input type="radio" name="q20803:109_answer" disabled="disabled" value="4" id="q20803:109_answer4"><label for="q20803:109_answer4">e. ankle blood pressure</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:109_-submit" name="q20803:109_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Physical examination is the essential first step in determining the level of amputation. The extent of gangrene and infection dictates the maximal length attainable. In this evaluation, the presence of dependent rubor should be considered analogous to gangrene because this tissue is ischemic. The presence of pulses should be accurately assessed. The presence of a palpable pulse immediately proximal to a proposed amputation level predicts successful healing in nearly 100% of patients undergoing either major or minor amputation.&nbsp;However, the absence of a pulse does not necessarily lead to failure of wound healing; therefore, sole reliance on the presence of a pulse leads to unnecessarily proximal amputations.</p>
<p>Using “clinical judgment,” which incorporates physical findings and consideration of the patient's overall status, yields wound healing rates of 80% in BKAs and 90% in AKAs. Wagner et al found that objective data may supplement clinical judgment but not replace it; more distal amputations were achieved with clinical judgment than with sole reliance on objective examinations.</p>
<p>Yamada et al studied various non-invasive parameters and found that toe blood pressure was the most specific parameter (see table below).&nbsp; Therefore, although toe blood pressure is the correct answer to this question, the non-invasive values should be used to supplement clinical judgment in each individual patient situation.</p>
<p>Prediction of Wound Healing by Noninvasive Vascular Studies:</p>
<table border="0" cellspacing="3" cellpadding="0">
<thead>
<tr>
<td rowspan="2">
<p align="center"><strong>Study</strong></p>
</td>
<td rowspan="2">
<p align="center"><strong>Threshold (mm Hg)</strong></p>
</td>
<td colspan="2">
<p align="center"><strong>Wound Healing (%)</strong></p>
</td>
<td rowspan="2">
<p align="center"><strong>Sensitivity (%)</strong></p>
</td>
<td rowspan="2">
<p align="center"><strong>Specificity (%)</strong></p>
</td>
</tr>
<tr>
<td>
<p align="center"><strong>Below Threshold</strong></p>
</td>
<td>
<p align="center"><strong>Above Threshold</strong></p>
</td>
</tr>
</thead>
<tbody>
<tr>
<td>
<p>SPP</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;40</p>
</td>
<td>
<p>&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;10</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 69</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 72</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 88</p>
</td>
</tr>
<tr>
<td>
<p>tcPO<sup>2</sup> &nbsp;</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;30</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 14</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 63</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 87</p>
</td>
</tr>
<tr>
<td>
<p>TBP</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;30</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 67</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 63</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 90</p>
</td>
</tr>
<tr>
<td>
<p>ABP</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;80</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 11</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 74</p>
</td>
<td>
<p>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 70</p>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+47(2)%3A318-23" target="_blank">Yamada T, Ohta T, Ishibashi H, Sugimoto I,&nbsp;Iwata H,&nbsp;Takahashi M,&nbsp;et al. &nbsp;Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs—comparison with other noninvasive diagnostic methods. J Vasc Surg 2008; 47(2):318-23.</a>&nbsp;</p>
<p>Cronenwett JL, Johnston W.&nbsp;Rutherford's Vascular Surgery, 7<sup>th</sup> Edition.&nbsp; Chapter 114, Lower Extremity Amputation:p. 1761-71.</p>
<p>QID: 30163</p></div><div class="rightanswer">The correct answer is: toe blood pressure</div></div></div></div></div><div id="q168" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">365</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3449"><input type="hidden" name="q20803:168_:flagged" value="0"><input type="hidden" value="qaid=911052&amp;qubaid=20803&amp;qid=4669&amp;slot=168&amp;checksum=b82de297b0fae60d27efdc007bb8de10&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:168_:flaggedcheckbox" name="q20803:168_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q168&id=4669"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:168_:sequencecheck" value="2"><div class="qtext"><p>A 48-year-old woman presents to the emergency room with a 1 day history of a right-sided headache, facial pain, and nausea. A CT scan is obtained which shows a small, right temporo-parietal infarction. On presentation, her blood pressure is 160/100 mmHg and she has a partial Horner's syndrome on the right side. She smokes 1 pack of cigarettes a day and has for 30 plus years. Which of the following is the most probable diagnosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:168_answer" disabled="disabled" value="0" id="q20803:168_answer0"><label for="q20803:168_answer0">a. right carotid bifurcation atherosclerosis with stroke</label> </div>
<div class="r1"><input type="radio" name="q20803:168_answer" disabled="disabled" value="1" id="q20803:168_answer1"><label for="q20803:168_answer1">b. right carotid artery dissection with stroke</label> </div>
<div class="r0"><input type="radio" name="q20803:168_answer" disabled="disabled" value="2" id="q20803:168_answer2"><label for="q20803:168_answer2">c. malignant hypertension induced stroke</label> </div>
<div class="r1"><input type="radio" name="q20803:168_answer" disabled="disabled" value="3" id="q20803:168_answer3"><label for="q20803:168_answer3">d. rupture of a right carotid artery aneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:168_answer" disabled="disabled" value="4" id="q20803:168_answer4"><label for="q20803:168_answer4">e. symptomatic carotid FMD with renal artery involvement</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:168_-submit" name="q20803:168_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The patient profile of facial pain, headache, and a partial Horner's syndrome is a classic presentation of carotid artery dissection. The stroke can be a result of the acute dissection with extension into the intracranial carotid artery or, more commonly, acute dissection with thrombus formation and concomitant embolization. The partial Horner's syndrome occurs ipsilateral to the carotid artery dissection.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.nejm.org/doi/full/10.1056/NEJM199609193351220" target="_blank">Callow A. Carotid disease. In: Callow AD, ed. Surgery of the Carotid and Vertebral Arteries for the Prevention of Stroke. Baltimore, Md: Williams &amp; Wilkins 1996:119-68.</a></p>
<p>QID: 30306</p></div><div class="rightanswer">The correct answer is: right carotid artery dissection with stroke</div></div></div></div></div><div id="q398" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">366</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3458"><input type="hidden" name="q20803:398_:flagged" value="0"><input type="hidden" value="qaid=911282&amp;qubaid=20803&amp;qid=5049&amp;slot=398&amp;checksum=5ecf4873d2412eab071d251f716b3266&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:398_:flaggedcheckbox" name="q20803:398_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q398&id=5049"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:398_:sequencecheck" value="2"><div class="qtext"><p>A 59-year-old man presents with calf pain that started within the last 48 hours. His ultrasound showed acute peroneal vein thrombosis. He was treated with aspirin and elastic compression stockings. He had a follow-up ultrasound 5 days later. Which of the following most accurately describes the ultrasound findings shown below?<br><br><a href="./VESAP3_files/AssetProxy_024.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_024.jpg" alt="img" width="100" height="37" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:398_answer" disabled="disabled" value="0" id="q20803:398_answer0"><label for="q20803:398_answer0">a. recanalization of the peroneal vein thrombus</label> </div>
<div class="r1"><input type="radio" name="q20803:398_answer" disabled="disabled" value="1" id="q20803:398_answer1"><label for="q20803:398_answer1">b. thrombus in the peroneal and posterior tibial vein</label> </div>
<div class="r0"><input type="radio" name="q20803:398_answer" disabled="disabled" value="2" id="q20803:398_answer2"><label for="q20803:398_answer2">c. thrombus propagation into the popliteal vein</label> </div>
<div class="r1"><input type="radio" name="q20803:398_answer" disabled="disabled" value="3" id="q20803:398_answer3"><label for="q20803:398_answer3">d. thrombus in the peroneal vein only</label> </div>
<div class="r0"><input type="radio" name="q20803:398_answer" disabled="disabled" value="4" id="q20803:398_answer4"><label for="q20803:398_answer4">e. thrombus propagation into the femoral vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:398_-submit" name="q20803:398_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>In the left panel, the ultrasound image shows both peroneal veins with acute thrombosis. The peroneal artery in red has flow, whereas both peroneal veins are dilated and have no color flow. In the follow-up exam, the popliteal vein is thrombosed, as evidenced by echogenic material within its lumen and lack of collapse with compression. Current guidelines recommend anticoagulation therapy for symptomatic calf thromboses (not performed in this case) because of their propensity to propagate into the popliteal vein as happened in this case. In the absence of anticoagulation, propagation of calf vein thrombosis to the popliteal vein or higher is observed in 10-20% of patients with initially isolated calf deep vein thrombosis.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1997%3B+26+(5)%3A749-56." target="_blank">Meissner MH, Caps MT, Bergelin RO, Manzo RA<span>,&nbsp;</span>Strandness DE Jr<span>.</span>&nbsp;Early outcome after isolated calf vein thrombosis. J Vasc Surg 1997; 26 (5):749-56.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Vasc+Endovasc+Surg+2002%3B+23+(4)%3A344-48." target="_blank">Labropoulos N, Kang SS, Mansour MA, Giannoukas AD<span>,&nbsp;</span>Moutzouros V<span>,&nbsp;</span>Baker WH<span>.</span>&nbsp;Early thrombus remodeling of isolated calf deep vein thrombosis. Eur J Vasc Endovasc Surg 2002; 23 (4):344-48.</a></p>
<p>QID: 30715</p></div><div class="rightanswer">The correct answer is: thrombus propagation into the popliteal vein</div></div></div></div></div><div id="q218" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">367</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3467"><input type="hidden" name="q20803:218_:flagged" value="0"><input type="hidden" value="qaid=911102&amp;qubaid=20803&amp;qid=4713&amp;slot=218&amp;checksum=6a8f85df6c54771a959a7fd27883e9f3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:218_:flaggedcheckbox" name="q20803:218_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q218&id=4713"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:218_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old man who works as a painter complains of dizziness, chest pain, and increased fatigue in in his left arm when he uses it to paint. He had a 4-vessel CABG with LIMA graft 3 years ago. The carotid duplex demonstrates the waveforms shown below. The BP measurement of his right arm is 40 mmHG greater than his left arm. Which of the following is the most appropriate <strong>open surgical</strong>&nbsp;treatment for this patient?&nbsp;</p>
<p>&nbsp;</p>
<p><img src="./VESAP3_files/Vallabhaneni 3-Right vert.jpg" alt="" width="391" height="291"></p><p><img src="./VESAP3_files/Vallabhaneni-3 left vert.jpg" alt="" width="451" height="321"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:218_answer" disabled="disabled" value="0" id="q20803:218_answer0"><label for="q20803:218_answer0">a. left carotid-subclavian bypass with saphenous vein</label> </div>
<div class="r1"><input type="radio" name="q20803:218_answer" disabled="disabled" value="1" id="q20803:218_answer1"><label for="q20803:218_answer1">b. left carotid-vertebral bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:218_answer" disabled="disabled" value="2" id="q20803:218_answer2"><label for="q20803:218_answer2">c. left carotid-subclavian bypass with prosthetic graft</label> </div>
<div class="r1"><input type="radio" name="q20803:218_answer" disabled="disabled" value="3" id="q20803:218_answer3"><label for="q20803:218_answer3">d. left subclavian to carotid artery transposition</label> </div>
<div class="r0"><input type="radio" name="q20803:218_answer" disabled="disabled" value="4" id="q20803:218_answer4"><label for="q20803:218_answer4">e. redo CABG</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:218_-submit" name="q20803:218_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has coronary-subclavian steal syndrome secondary to proximal left subclavian artery occlusion. The duplex ultrasound of the left vertebral artery demonstrates retrograde flow consistent with a steal phenomenon. The most appropriate open surgical option would be carotid-subclavian bypass with prosthetic graft. Short prosthetic grafts have superior patency over vein grafts in the supraclavicular region. Subclavian to carotid transposition would not be indicated in a patient with a LIMA coronary graft because of the ischemic time during the anastomosis. A carotid-subclavian artery bypass may be performed distal to the take-off of the LIMA without disturbing flow to the heart. A carotid-vertebral bypass is not indicated in this patient.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1986%3B+3%3A1(140-45)" target="_blank">Ziomek S, Quinones-Baldrich WJ, Busuttil RW, Baker JD<span>,&nbsp;</span>Machleder HI<span>,&nbsp;</span>Moore WS. The superiority of synthetic arterial grafts over autologous vein in carotid-subclavian bypass. J Vasc Surg 1986; 3:140-5.</a></p>
<p>QID: 30369</p></div><div class="rightanswer">The correct answer is: left carotid-subclavian bypass with prosthetic graft</div></div></div></div></div><div id="q410" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">368</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3476"><input type="hidden" name="q20803:410_:flagged" value="0"><input type="hidden" value="qaid=911294&amp;qubaid=20803&amp;qid=4953&amp;slot=410&amp;checksum=d85bd80ea0a4c7bf31ee456685d660db&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:410_:flaggedcheckbox" name="q20803:410_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q410&id=4953"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:410_:sequencecheck" value="2"><div class="qtext"><p>A 24-year-old woman develops deep venous thrombosis 2 days postpartum. Which of the following is a risk factor for peripartum venous thromboembolism?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:410_answer" disabled="disabled" value="0" id="q20803:410_answer0"><label for="q20803:410_answer0">a. blood group A</label> </div>
<div class="r1"><input type="radio" name="q20803:410_answer" disabled="disabled" value="1" id="q20803:410_answer1"><label for="q20803:410_answer1">b. African-American race</label> </div>
<div class="r0"><input type="radio" name="q20803:410_answer" disabled="disabled" value="2" id="q20803:410_answer2"><label for="q20803:410_answer2">c. puerperal infection</label> </div>
<div class="r1"><input type="radio" name="q20803:410_answer" disabled="disabled" value="3" id="q20803:410_answer3"><label for="q20803:410_answer3">d. first pregnancy</label> </div>
<div class="r0"><input type="radio" name="q20803:410_answer" disabled="disabled" value="4" id="q20803:410_answer4"><label for="q20803:410_answer4">e. history of collagen vascular disease</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:410_-submit" name="q20803:410_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The number of venous thromboembolism (VTE) cases occurring in the peripartum and postpartum periods is 7.2 and 4.3 per 10,000 pregnancies, respectively. Another way to evaluate the risk is the incidence of VTE estimated at 0.76 to 1.72 per 1,000 pregnancies, which is four times as great as the non-pregnant population. Aside from having a hypercoagulable disorder (factor V Leiden, prothrombin 20210 mutation, antithrombin deficiency, proteins C and S deficiencies), the highest risk for VTE during the postpartum period is Cesarean section, especially if emergent. Other risk factors for VTE are previous deep vein thrombosis, obesity, heart disease, antiphospholipid syndrome, history of circulatory disease, transfusion, major puerperal infection, immobilization, placental abruption, and preeclampsia. Multiparous women, (not first child) especially if &gt; 3, have an increased risk of VTE, as do women over the age of 35. Race and collagen vascular disorders have not been associated with an increased risk of VTE.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Thromb+Haemost+2003%3B+1+(7)%3A1435-42." target="_blank">Ginsberg JS, Bates SM. Management of venous thromboembolism during pregnancy. J Thromb Haemost 2003; 1 (7):1435-42.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B+37+(3)%3A528-32." target="_blank">Pillny M, Sandmann W, Luther B, Müller BT<span>,&nbsp;</span>Tutschek B<span>,&nbsp;</span>Gerhardt A<span>,&nbsp;</span>et al. Deep venous thrombosis during pregnancy and after delivery: Indications for and results of thrombectomy. J Vasc Surg 2003; 37 (3):528-32.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+2008%3B+359+(19)%3A2025-33." target="_blank">Marik PE, Plante LA. Venous thromboembolic disease and pregnancy. N Engl J Med 2008; 359 (19):2025-33.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Obstet+Gynaecol+Can%3B+2009%3B+31+(7)%3A611-20." target="_blank">Liu S, Rouleau J, Joseph KS, Sauve R<span>,&nbsp;</span>Liston RM<span>,&nbsp;</span>Young D<span>,&nbsp;</span>et al. Maternal Health Study Group of the Canadian Perinatal Surveillance System. Epidemiology of pregnancy-associated venous thromboembolism: A population-based study in Canada. J Obstet Gynaecol Can; 2009; 31 (7):611-20.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Angiology%3B+2002%3B+53+(4)%3A429-34." target="_blank">Soomro RM, Bucur IJ, Noorani S. Cumulative incidence of venous thromboembolism during pregnancy and puerperium: A hospital-based study. Angiology 2002; 53 (4):429-34.</a></p>
<p>QID: 30730</p></div><div class="rightanswer">The correct answer is: puerperal infection</div></div></div></div></div><div id="q225" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">369</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3485"><input type="hidden" name="q20803:225_:flagged" value="0"><input type="hidden" value="qaid=911109&amp;qubaid=20803&amp;qid=4956&amp;slot=225&amp;checksum=ade1d33f1b6ce8836cdd1ee4d879018b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:225_:flaggedcheckbox" name="q20803:225_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q225&id=4956"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:225_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man is in the surgical intensive care unit (SICU) post-operative day 1 from an open abdominal aortic aneurysm repair for a ruptured aneurysm. He is hemodynamically unstable, requiring ongoing fluid resuscitation and pressor support; he is acidotic, hyperkalemic, and anuric. Which of the following represents the best strategy for dialysis access in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:225_answer" disabled="disabled" value="0" id="q20803:225_answer0"><label for="q20803:225_answer0">a. short-term dialysis catheter placed via the right internal jugular vein in the SICU</label> </div>
<div class="r1"><input type="radio" name="q20803:225_answer" disabled="disabled" value="1" id="q20803:225_answer1"><label for="q20803:225_answer1">b. short-term dialysis catheter placed via the left subclavian vein in the SICU</label> </div>
<div class="r0"><input type="radio" name="q20803:225_answer" disabled="disabled" value="2" id="q20803:225_answer2"><label for="q20803:225_answer2">c. short-term dialysis catheter placed via the right femoral vein in the SICU</label> </div>
<div class="r1"><input type="radio" name="q20803:225_answer" disabled="disabled" value="3" id="q20803:225_answer3"><label for="q20803:225_answer3">d. long-term dialysis catheter placed via the left subclavian vein in the fluoroscopy suite</label> </div>
<div class="r0"><input type="radio" name="q20803:225_answer" disabled="disabled" value="4" id="q20803:225_answer4"><label for="q20803:225_answer4">e. long-term dialysis catheter placed via the right internal jugular vein in the fluoroscopy suite</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:225_-submit" name="q20803:225_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Short-term dialysis catheters are double lumen non-cuffed catheters that can be placed at the bedside without fluoroscopic guidance. These catheters are ideal for patients who are in need of acute dialysis access but are too unstable to transfer to a fluoroscopic suite (such as the patient described here). Due to the higher risk of complications associated with short-term catheters, in particular infection, they should be removed or converted to a long-term catheter after 3 weeks of use. Short-term dialysis catheters may be placed in the internal jugular, subclavian, or femoral veins. To achieve best flow rates, the catheter should be placed in the right internal jugular vein with the distal tip in the superior vena cava just above the atrium. To avoid central venous stenosis, the subclavian vein approach should be avoided if at all possible. Due to its higher incidence of infection, the femoral vein is a second choice approach. <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Salgado%20OJ,%20Urdaneta%20B,%20Colmenares%20B,%20et%20al.%20Right%20versus%20left%20internal%20jugular%20vein%20catheterization%20for%20hemodialysis:%20Complications%20and%20impact%20on%20ipsilateral%20access%20creation.%20Artificial%20Organs;%202004;%2028%20(8):728-733" target="_blank">Salgado OJ, Urdaneta B, Colmenares B, </a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Garc%C3%ADa%20R%5BAuthor%5D&cauthor=true&cauthor_uid=15270954">García R</a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Salgado%20OJ,%20Urdaneta%20B,%20Colmenares%20B,%20et%20al.%20Right%20versus%20left%20internal%20jugular%20vein%20catheterization%20for%20hemodialysis:%20Complications%20and%20impact%20on%20ipsilateral%20access%20creation.%20Artificial%20Organs;%202004;%2028%20(8):728-733" target="_blank"><span>,&nbsp;</span></a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Flores%20C%5BAuthor%5D&cauthor=true&cauthor_uid=15270954">Flores C</a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Salgado%20OJ,%20Urdaneta%20B,%20Colmenares%20B,%20et%20al.%20Right%20versus%20left%20internal%20jugular%20vein%20catheterization%20for%20hemodialysis:%20Complications%20and%20impact%20on%20ipsilateral%20access%20creation.%20Artificial%20Organs;%202004;%2028%20(8):728-733" target="_blank"><span>.</span>&nbsp;Right versus left internal jugular vein catheterization for hemodialysis: Complications and impact on ipsilateral access creation. Artificial Organs 2004; 28 (8):728-33</a>.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Spinowitz%20BS,%20Galler%20M,%20Golden%20RA,%20et%20al.%20Subclavian%20vein%20stenosis%20as%20a%20complication%20of%20subclavian%20catheterization%20for%20hemodialysis.%20Arch%20Intern%20Med;%201987;%20147%20(2):305-307" target="_blank">Spinowitz BS, Galler M, Golden RA, </a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Rascoff%20JH%5BAuthor%5D&cauthor=true&cauthor_uid=3813748">Rascoff JH</a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Spinowitz%20BS,%20Galler%20M,%20Golden%20RA,%20et%20al.%20Subclavian%20vein%20stenosis%20as%20a%20complication%20of%20subclavian%20catheterization%20for%20hemodialysis.%20Arch%20Intern%20Med;%201987;%20147%20(2):305-307" target="_blank"><span>,&nbsp;</span></a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Schechter%20L%5BAuthor%5D&cauthor=true&cauthor_uid=3813748">Schechter L</a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Spinowitz%20BS,%20Galler%20M,%20Golden%20RA,%20et%20al.%20Subclavian%20vein%20stenosis%20as%20a%20complication%20of%20subclavian%20catheterization%20for%20hemodialysis.%20Arch%20Intern%20Med;%201987;%20147%20(2):305-307" target="_blank"><span>,&nbsp;</span></a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Held%20B%5BAuthor%5D&cauthor=true&cauthor_uid=3813748">Held B</a><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Spinowitz%20BS,%20Galler%20M,%20Golden%20RA,%20et%20al.%20Subclavian%20vein%20stenosis%20as%20a%20complication%20of%20subclavian%20catheterization%20for%20hemodialysis.%20Arch%20Intern%20Med;%201987;%20147%20(2):305-307" target="_blank"><span>,&nbsp;</span>et al. Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis. Arch Intern Med 1987; 147 (2):305-7</a>.</p>
<p>QID: 30402</p></div><div class="rightanswer">The correct answer is: short-term dialysis catheter placed via the right internal jugular vein in the SICU</div></div></div></div></div><div id="q205" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">370</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3494"><input type="hidden" name="q20803:205_:flagged" value="0"><input type="hidden" value="qaid=911089&amp;qubaid=20803&amp;qid=4697&amp;slot=205&amp;checksum=7c56dadd5a2cb043e62adca39eb9b82c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:205_:flaggedcheckbox" name="q20803:205_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q205&id=4697"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:205_:sequencecheck" value="2"><div class="qtext"><p>Asymmetry and variation of the paired vertebral arteries is frequent. All of the following statements regarding vertebral artery anatomy are&nbsp;true&nbsp;<strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:205_answer" disabled="disabled" value="0" id="q20803:205_answer0"><label for="q20803:205_answer0">a. bifid vertebral arteries are more common on the right side and occur in association with a retroesophageal subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:205_answer" disabled="disabled" value="1" id="q20803:205_answer1"><label for="q20803:205_answer1">b. the left vertebral artery is dominant in 50% of individuals</label> </div>
<div class="r0"><input type="radio" name="q20803:205_answer" disabled="disabled" value="2" id="q20803:205_answer2"><label for="q20803:205_answer2">c. origination of the left vertebral artery directly from the aorta occurs in approximately 5-7% of individuals</label> </div>
<div class="r1"><input type="radio" name="q20803:205_answer" disabled="disabled" value="3" id="q20803:205_answer3"><label for="q20803:205_answer3">d. the vertebral artery may terminate in the posterior inferior cerebellar artery (PICA)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:205_-submit" name="q20803:205_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The vertebrobasilar system is formed from the fusion of 2 sets of vascular plexuses. Thus, there is considerable asymmetry of the vertebral arteries. The left vertebral artery is frequently larger and dominant. The most common&nbsp;origin aberrancy of the vertebral artery is the separate aortic origin of the left vertebral artery. Hypoplasia of the vertebral artery, which occurs in 7-12% of individuals, results in termination of the vessel in the posterior inferior cerebellar artery or occipital artery. Bifid vertebral arteries are associated with aneurysmal formation and dissection. The most common right vertebral anomaly is the origin from the aortic arch. It can arise from the right common carotid less commonly and is usually accompanied by the right subclavian artery retroesphageal aberrancy.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/16778246" target="_blank">Layton KF, Miller GM<span>,&nbsp;</span>Kalina P<span>.</span>&nbsp;Aberrant origin of the right vertebral artery from the right common carotid artery. Journal of Vascular and Interventional Radiology 2006; 17:1065-7. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23721141" target="_blank">Saade C, Bourne R, Wilkinson M, Brennan PC. MDCT angiography of the major congenital anomalies of the extracranial arteries: pictoral review. J Med Imaging Radiat Oncol 2013; 57:321-8. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/12772251" target="_blank">Koenigsberg RA, Pereira L, Nair B<span>,&nbsp;</span>McCormick D<span>,&nbsp;</span>Schwartzman R. Unusual vertebral artery origins:Examples and related pathology.&nbsp;Catheter Cardiovasc Interv 2003;59:244-50. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/12016382" target="_blank">Sanelli PC, Tong S, Gonzalez RG, Eskey CJ.&nbsp; Normal variation of vertebral artery on CT angiograph and its implications for diagnosis of acquired pathology.&nbsp; J Comput Assist Tomogr&nbsp; 2002; 26:462-70. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/12772251" target="_blank"><br></a></p>
<p>QID: 30355</p></div><div class="rightanswer">The correct answer is: bifid vertebral arteries are more common on the right side and occur in association with a retroesophageal subclavian artery</div></div></div></div></div><div id="q302" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">371</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3503"><input type="hidden" name="q20803:302_:flagged" value="0"><input type="hidden" value="qaid=911186&amp;qubaid=20803&amp;qid=5060&amp;slot=302&amp;checksum=ccd6cb2cfc35ee869cc9f6eab11160f6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:302_:flaggedcheckbox" name="q20803:302_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q302&id=5060"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:302_:sequencecheck" value="2"><div class="qtext"><p>A 72-year-old postoperative man develops swelling of both of his lower extremities. The Doppler tracing shown in the image below was obtained from the right common femoral vein with the patient supine. The tracing suggests which of the following?</p>
<p><a href="./VESAP3_files/12234.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/12234.jpg" alt="Img" width="272" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:302_answer" disabled="disabled" value="0" id="q20803:302_answer0"><label for="q20803:302_answer0">a. occlusion of the iliac venous system</label> </div>
<div class="r1"><input type="radio" name="q20803:302_answer" disabled="disabled" value="1" id="q20803:302_answer1"><label for="q20803:302_answer1">b. severe arterial inflow restriction</label> </div>
<div class="r0"><input type="radio" name="q20803:302_answer" disabled="disabled" value="2" id="q20803:302_answer2"><label for="q20803:302_answer2">c. a normal waveform for this location</label> </div>
<div class="r1"><input type="radio" name="q20803:302_answer" disabled="disabled" value="3" id="q20803:302_answer3"><label for="q20803:302_answer3">d. congestive heart failure</label> </div>
<div class="r0"><input type="radio" name="q20803:302_answer" disabled="disabled" value="4" id="q20803:302_answer4"><label for="q20803:302_answer4">e. an arteriovenous fistula distal to this location</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:302_-submit" name="q20803:302_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Knowledge of venous flow patterns is important in interpretation of venous ultrasound studies. Patients with severe volume overload or congestive heart failure have&nbsp;marked pulsatility of the&nbsp;common femoral venous waveforms with the cardiac cycle. Normal venous flow in the common femoral vein in a supine patient varies with respiration and has little variation with the cardiac cycle. The common femoral vein waveform is likely to be normal or near normal in a patient with venous thrombosis distally in the ipsilateral lower extremity. Conversely, flow will be continuous (no respiratory variation) at the level of the common femoral vein in a patient with venous obstruction more central to the common femoral vein. An arterial venous fistula below the level of the common femoral vein would present with very high peak systolic velocities and high levels of diastolic flow. A more centrally located arterial venous fistula would likely not affect common femoral vein flow dramatically. <br><br></p>
<h2>Reference:</h2>
<p>Zwiebel WJ. Non-vascular pathology encountered during venous sonography. In: Introduction to Vascular Ultrasonography, 5th ed. Zwiebel WJ and Pellerito, JS, eds. Philadelphia, PA: Elsevier Saunders; 2005:501-10.</p>
<p>QID: 30522</p></div><div class="rightanswer">The correct answer is: congestive heart failure</div></div></div></div></div><div id="q50" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">372</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3512"><input type="hidden" name="q20803:50_:flagged" value="0"><input type="hidden" value="qaid=910934&amp;qubaid=20803&amp;qid=4304&amp;slot=50&amp;checksum=88c2de3c7d6acd301f5caa21c801a78e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:50_:flaggedcheckbox" name="q20803:50_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q50&id=4304"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:50_:sequencecheck" value="2"><div class="qtext"><p>A 66 year old male smoker with a 100 pack year history undergoes an ultrasound screening for an abdominal aortic aneurysm. He is asymptomatic but the maximum transverse measurement of the abdominal aorta is 2.8 cm. Which of the following should be performed?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:50_answer" disabled="disabled" value="0" id="q20803:50_answer0"><label for="q20803:50_answer0">a. Annual follow up ultrasound of the abdominal aorta.</label> </div>
<div class="r1"><input type="radio" name="q20803:50_answer" disabled="disabled" value="1" id="q20803:50_answer1"><label for="q20803:50_answer1">b. No follow up ultrasound of the abdominal aorta.</label> </div>
<div class="r0"><input type="radio" name="q20803:50_answer" disabled="disabled" value="2" id="q20803:50_answer2"><label for="q20803:50_answer2">c. CT scan of the abdomen and pelvis.</label> </div>
<div class="r1"><input type="radio" name="q20803:50_answer" disabled="disabled" value="3" id="q20803:50_answer3"><label for="q20803:50_answer3">d. Follow up ultrasound in 5 years</label> </div>
<div class="r0"><input type="radio" name="q20803:50_answer" disabled="disabled" value="4" id="q20803:50_answer4"><label for="q20803:50_answer4">e. Endovascular repair.</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:50_-submit" name="q20803:50_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>A repeat measurement of the aorta with ultrasound imaging should be planned for in five years.</p>
<p>No additional imaging information is needed for immediate management. Repeat imaging in the short term is not likely to change management.</p>
<p>The 13-year results of the Multicentre Aneurysm Screening Study (MASS) demonstrated that screening for abdominal aortic aneurysms (AAA) resulted in the reduction in all-cause mortality and a benefit in AAA-related mortality throughout follow up. However, the mortality benefit 10-13 years after initial screening was less than the benefit seen within the first 10 years of the screening program. The decreased screening benefit was found mainly due to late ruptures of abdominal aortas that initially screened 2.5-3.0 cm in diameter. The MASS investigators have suggested a follow up study 5 years after the initial screen to reduce risk of late rupture in patients who are initially identified to have an abdominal aorta 2.5 cm – 3.0 cm in diameter.</p>
<p><strong>Reference:</strong></p>
<p>Thompson SG, Ashton HA, Gao L, Buxton MJ, Scott RA; Multicentre Aneurysm&nbsp;Screening Study (MASS) Group. Final follow-up of the Multicentre Aneurysm&nbsp;Screening Study (MASS) randomized trial of abdominal aortic aneurysm screening.&nbsp;Br J Surg. 2012 Dec;99(12):1649-56. doi: 10.1002/bjs.8897. Epub 2012 Oct 3.&nbsp;PubMed PMID: 23034729; PubMed Central PMCID: PMC3569614.&nbsp;</p>
<p>&nbsp;QID: 30054</p></div><div class="rightanswer">The correct answer is: Follow up ultrasound in 5 years</div></div></div></div></div><div id="q269" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">373</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3521"><input type="hidden" name="q20803:269_:flagged" value="0"><input type="hidden" value="qaid=911153&amp;qubaid=20803&amp;qid=5006&amp;slot=269&amp;checksum=783ce5c70c4ee824b8d5947c80a50c47&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:269_:flaggedcheckbox" name="q20803:269_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q269&id=5006"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:269_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding patency rates of arteriovenous accesses is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:269_answer" disabled="disabled" value="0" id="q20803:269_answer0"><label for="q20803:269_answer0">a. primary patency rates are better for direct AV fistulas than transposed arteriovenous fistulas</label> </div>
<div class="r1"><input type="radio" name="q20803:269_answer" disabled="disabled" value="1" id="q20803:269_answer1"><label for="q20803:269_answer1">b. primary patency rates of autogenous arteriovenous fistulas and prosthetic arteriovenous grafts are equivalent</label> </div>
<div class="r0"><input type="radio" name="q20803:269_answer" disabled="disabled" value="2" id="q20803:269_answer2"><label for="q20803:269_answer2">c. balloon angioplasty has had no effect on improving patency and maturation rates for autogenous arteriovenous accesses using small veins</label> </div>
<div class="r1"><input type="radio" name="q20803:269_answer" disabled="disabled" value="3" id="q20803:269_answer3"><label for="q20803:269_answer3">d. more interventions are required to maintain secondary patency for prosthetic arteriovenous grafts than are required to maintain secondary patency for autogenous arteriovenous accesses</label> </div>
<div class="r0"><input type="radio" name="q20803:269_answer" disabled="disabled" value="4" id="q20803:269_answer4"><label for="q20803:269_answer4">e. smoking has no impact on patency rates arteriovenous accesses</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:269_-submit" name="q20803:269_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Primary and secondary patency rates for autogenous arteriovenous accesses are higher than those for prosthetic arteriovenous grafts.&nbsp; In addition, prosthetic arteriovenous grafts require more interventions than autogenous fistulas to maintain secondary patency. Transposed basilic vein accesses demonstrate improved patency rates when compared with prosthetic grafts and similar patency rates to those for direct autogenous accesses. Diabetes mellitus has a negative impact on primary patency rates and maturation rates for autogenous hemodialysis accesses. Recent data suggests that balloon angioplasty has had a significant impact on patency and maturation rates for autogenous accesses done with small (&lt;2 mm) cephalic veins.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2007%3B20%3A148-157." target="_blank">Farber A, Woo K.&nbsp; Transposed arteriovenous fistulae: do the results justify the effort?&nbsp; Semin Vasc Surg 2007;20:148-57.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B38%3A1005-11." target="_blank">Huber TS, Carter JW, Carter RL, Seeger JM. Patency of autogenous and polytetraflouroethylene upper extremity arteriovenous hemodialysis access.&nbsp; J Vasc Surg 2003;38:1005-11.</a></p>
<div class="supp">
<p class="desc"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg.+2013%3B57%3A131-6." target="_blank">Veroux P, Giaquinta A, Tallarita T, Sinagra N,&nbsp;Virgilio C,&nbsp;Zerbo D,&nbsp;et al.&nbsp; Primary balloon angioplasty of small (&lt;2 mm) cephalic veins improves patency of arteriovenous fistulae and decreases reintervention rates. <span class="jrnl" title="Journal of vascular surgery">J Vasc Surg</span>. 2013;57:131-6.</a></p>
<p class="desc">QID: 30453</p>
</div></div><div class="rightanswer">The correct answer is: more interventions are required to maintain secondary patency for prosthetic arteriovenous grafts than are required to maintain secondary patency for autogenous arteriovenous accesses</div></div></div></div></div><div id="q111" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">374</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3530"><input type="hidden" name="q20803:111_:flagged" value="0"><input type="hidden" value="qaid=910995&amp;qubaid=20803&amp;qid=4929&amp;slot=111&amp;checksum=a98bc58bcad9c7a690ca2456597f180e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:111_:flaggedcheckbox" name="q20803:111_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q111&id=4929"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:111_:sequencecheck" value="2"><div class="qtext"><p>All of the following statements regarding Cilostazol for the&nbsp;treatment of intermittent claudication are true <strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:111_answer" disabled="disabled" value="0" id="q20803:111_answer0"><label for="q20803:111_answer0">a. cilostazol reduces blood viscosity via its rheolytic effect on red blood cells</label> </div>
<div class="r1"><input type="radio" name="q20803:111_answer" disabled="disabled" value="1" id="q20803:111_answer1"><label for="q20803:111_answer1">b. cilostazol decreases smooth muscle cell proliferation</label> </div>
<div class="r0"><input type="radio" name="q20803:111_answer" disabled="disabled" value="2" id="q20803:111_answer2"><label for="q20803:111_answer2">c. cilostazol increases cyclic adenosine monophosphate</label> </div>
<div class="r1"><input type="radio" name="q20803:111_answer" disabled="disabled" value="3" id="q20803:111_answer3"><label for="q20803:111_answer3">d. cilostazol decreases serum triglycerides</label> </div>
<div class="r0"><input type="radio" name="q20803:111_answer" disabled="disabled" value="4" id="q20803:111_answer4"><label for="q20803:111_answer4">e. cilostazol is a phosphodiesterase III inhibitor</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:111_-submit" name="q20803:111_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Cilostazol (Pletal) is a phophodiesterase III inhibitor which increases cyclic adenosine monophosphate (cAMP) and results in a series of physiologic effects, including inhibition of smooth muscle cell proliferation, decrease in serum triglycerides, and increased HDL. Pentoxifylline (Trental), an alternative agent to treat claudication, is a methylxanthine derivative that is thought to improve oxygen delivery (as a result of its rheolytic effect on&nbsp;red blood cells) and ultimate reduction in blood viscocity.</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><span>Cronenwett JL, Johnston W.&nbsp;</span>Rutherford’s Vascular Surgery 7<sup>th</sup> Edition, Vol 2. Pages 1597-8.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Med+2000%3B+109%3A523-30." target="_blank">Dawson&nbsp;DL,&nbsp;Cutler&nbsp;BS,&nbsp;Hiatt&nbsp;WR,&nbsp;Hobson RW 2nd<span>,&nbsp;</span>Martin JD<span>,&nbsp;</span>Bortey EB<span>,&nbsp;</span>et al.&nbsp;A comparison of cilostazol and pentoxifylline for treating intermittent claudication.&nbsp;Am J Med&nbsp;2000;&nbsp;109:523-30.</a></p>
<p>QID: 30166</p></div><div class="rightanswer">The correct answer is: cilostazol reduces blood viscosity via its rheolytic effect on red blood cells</div></div></div></div></div><div id="q469" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">375</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3539"><input type="hidden" name="q20803:469_:flagged" value="0"><input type="hidden" value="qaid=911353&amp;qubaid=20803&amp;qid=5193&amp;slot=469&amp;checksum=303833f9933fc358606633edfa582408&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:469_:flaggedcheckbox" name="q20803:469_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q469&id=5193"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:469_:sequencecheck" value="2"><div class="qtext"><p>Which statement regarding the ADP receptor P2Y12 inhibitors, prasugrel (Effient®) and ticagrelor (Brilinta®), is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:469_answer" disabled="disabled" value="0" id="q20803:469_answer0"><label for="q20803:469_answer0">a. both prasugrel and ticagrelor irreversibly inhibit platelet function; discontinuation for at least 7 days prior to surgery is needed to assure normal perioperative platelet function</label> </div>
<div class="r1"><input type="radio" name="q20803:469_answer" disabled="disabled" value="1" id="q20803:469_answer1"><label for="q20803:469_answer1">b. prasugrel and ticagrelor demonstrate the same genetic variability in activity that clopidogrel has</label> </div>
<div class="r0"><input type="radio" name="q20803:469_answer" disabled="disabled" value="2" id="q20803:469_answer2"><label for="q20803:469_answer2">c. both prasugrel and ticagrelor have greater cardiovascular risk reduction effects than clopidogrel (Plavix®), but with an increased risk of major bleeding complications</label> </div>
<div class="r1"><input type="radio" name="q20803:469_answer" disabled="disabled" value="3" id="q20803:469_answer3"><label for="q20803:469_answer3">d. both prasugrel and ticagrelor are indicated for the treatment of patients with carotid artery stenosis with a recent history of stroke or transient ischemic attack</label> </div>
<div class="r0"><input type="radio" name="q20803:469_answer" disabled="disabled" value="4" id="q20803:469_answer4"><label for="q20803:469_answer4">e. both prasugrel and ticagrelor are administered once daily</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:469_-submit" name="q20803:469_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Both prasugrel and ticagrelor have greater cardiovascular risk reduction effects than clopidogrel (Plavix®), but with an increase in major bleeding complications.</p>
<p>Prasugrel and ticagrelor are promising new antiplatelet drugs. Both have been demonstrated in large randomized clinical trials of patients with acute coronary syndromes to be superior to clopidogrel for reducing the risk of myocardial infarction, cardiac death, and coronary stent thrombosis, albeit at the expense of increased bleeding complications.</p>
<p>Like clopidogrel, both are inhibitors of the platelet ADP receptor P2Y12. Prasugrel (Effient®) is a thienopyridine in the same pharmacologic class as ticlopidine and clopidogrel. It is an irreversible inhibitor with a 7-day wash-out period, similar to clopidogrel. Ticagrelor (Brilinta®) is in a separate drug class (nucleoside analog) and is a reversible inhibitor of the P2Y12 receptor and therefore has a much shorter (1-2 days) washout period, allowing it to be stopped much closer to planned procedures.</p>
<p>Both agents are converted to active metabolites, but the conversion process is much simpler and more reliable than for clopidogrel; thus, the clinical activity of these drugs is not subject to the genetic variability in drug activity and efficacy that are observed with clopidogrel.</p>
<p>Neither drug has been shown to reduce the risk of stroke. On the contrary, both agents are associated with a small increase in the risk of intracranial bleeding. Prasugrel is contraindicated in patients with a history of stroke or TIA and ticagrelor should be used with caution in these patients.&nbsp;Prasugrel has a once daily maintenance dose while ticagrelor has twice daily maintenance dosing.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Thromb+Haemost+2013%3B11+Suppl+1%3A316-29." target="_blank">Capodanno D, Ferreiro JL, Angiolillo DJ. Antiplatelet therapy: new pharmacological agents and changing paradigms. J Thromb Haemost 2013;11 Suppl 1:316-29.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+2009%3B+361(11)%3A1045-57." target="_blank">Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009; 361(11):1045-57.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+2010%3B+375(9711)%3A283-93." target="_blank">Cannon CP, Harrington RA, James S, Ardissino D, Becker RC, Emanuelsson H, et al. Comparison of ticagrelor with clopidogrel in patients with a planned invasive strategy for acute coronary syndromes (PLATO): a randomised double-blind study. Lancet 2010; 375(9711):283-93.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+2007%3B+357(20)%3A2001-15." target="_blank">Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007; 357(20):2001-15.&nbsp;</a></p>
<p>QID: 30832</p></div><div class="rightanswer">The correct answer is: both prasugrel and ticagrelor have greater cardiovascular risk reduction effects than clopidogrel (Plavix®), but with an increased risk of major bleeding complications</div></div></div></div></div><div id="q37" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">376</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3548"><input type="hidden" name="q20803:37_:flagged" value="0"><input type="hidden" value="qaid=910921&amp;qubaid=20803&amp;qid=4648&amp;slot=37&amp;checksum=fc3688d2b12c40dc402e39bc69bf25ae&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:37_:flaggedcheckbox" name="q20803:37_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q37&id=4648"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:37_:sequencecheck" value="2"><div class="qtext"><p>A 14-year-old&nbsp;boy was admitted to the ER after a side-impact, motor vehicle accident. On arrival, his vital signs are stable. On physical examination there is evidence of blunt trauma to the chest. The CTA of his chest is shown in the 2 Figures below. The aortic diameter at the level of the left subclavian artery is 12 mm. Which of the following is best treatment option for this patient?</p>
<p><a href="./VESAP3_files/1(3).jpg" target="images"><img src="./VESAP3_files/1(3).jpg" alt="" width="100"></a></p>
<p><a href="./VESAP3_files/2(4).jpg" target="images"><img src="./VESAP3_files/2(4).jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:37_answer" disabled="disabled" value="0" id="q20803:37_answer0"><label for="q20803:37_answer0">a. TEVAR with left common carotid to left subclavian artery bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:37_answer" disabled="disabled" value="1" id="q20803:37_answer1"><label for="q20803:37_answer1">b. TEVAR with left common carotid to left subclavian artery bypass and cerebrospinal fluid drainage</label> </div>
<div class="r0"><input type="radio" name="q20803:37_answer" disabled="disabled" value="2" id="q20803:37_answer2"><label for="q20803:37_answer2">c. open repair using left heart bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:37_answer" disabled="disabled" value="3" id="q20803:37_answer3"><label for="q20803:37_answer3">d. medical management with anti-impulse therapy</label> </div>
<div class="r0"><input type="radio" name="q20803:37_answer" disabled="disabled" value="4" id="q20803:37_answer4"><label for="q20803:37_answer4">e. thoracic endovascular aortic repair (TEVAR)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:37_-submit" name="q20803:37_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Open repair using left heart bypass is the best treatment option for this patient. The current Society for Vascular Surgery Clinical Practice Guidelines suggest that endovascular repair be performed preferentially over open repair or medical therapy for all anatomically suitable candidates regardless of age. The smallest diameter aorta that would qualify for endovascular repair, using one of the current US FDA approved devices, is 16 mm. This patient has an aortic diameter of 12 mm, and therefore, does not meet anatomical sizing criteria for endovascular repair.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lee+WA%2C+Matsumura+JS%2C+Mitchell+RS%2C+Farber+MA%2C+Greenberg+RK%2C+Azizzadeh+A%2C+et+al.+Endovascular+repair+of+traumatic+thoracic+aortic+injury%3A+clinical+practice+guidelines+of+the+Society+for+Vascular+Surgery.+J+Vasc+Surg.+2011+Jan%3B53(1)%3A187-92.+Epub+2010+Oct+25." target="_blank">Lee WA, Matsumura JS, Mitchell RS, Farber MA, Greenberg RK, Azizzadeh A, et al. Endovascular repair of traumatic thoracic aortic injury: clinical practice guidelines of the Society for Vascular Surgery. J Vasc Surg 2011; 53(1):187-92.</a>&nbsp;</p>
<p>QID: 30041</p></div><div class="rightanswer">The correct answer is: open repair using left heart bypass</div></div></div></div></div><div id="q29" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">377</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3557"><input type="hidden" name="q20803:29_:flagged" value="0"><input type="hidden" value="qaid=910913&amp;qubaid=20803&amp;qid=4282&amp;slot=29&amp;checksum=8aaa79f6d8a9e711020734b6454c4bb5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:29_:flaggedcheckbox" name="q20803:29_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q29&id=4282"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:29_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old man presents to the ER with acute onset of severe pain in&nbsp;his bilateral lower extremities. He has a history of intermittent claudication, which was&nbsp;treated with iliac angioplasty in the past. He has had prior percutaneous coronary intervention for an MI and has an ejection fraction of 25%.&nbsp; He has decreased sensation and decreased motor function in&nbsp;both lower extremities. He has no arterial or venous doppler signals below the groins.&nbsp;The CTA obtained is shown below.&nbsp;Which of the following is the most appropriate treatment option for this patient?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/Aortic occlusion and options for reconstruction .jpg" target="images"><img src="./VESAP3_files/Aortic occlusion and options for reconstruction .jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:29_answer" disabled="disabled" value="0" id="q20803:29_answer0"><label for="q20803:29_answer0">a. bilateral embolectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:29_answer" disabled="disabled" value="1" id="q20803:29_answer1"><label for="q20803:29_answer1">b. axillo-bi-femoral bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:29_answer" disabled="disabled" value="2" id="q20803:29_answer2"><label for="q20803:29_answer2">c. endovascular stent graft placement</label> </div>
<div class="r1"><input type="radio" name="q20803:29_answer" disabled="disabled" value="3" id="q20803:29_answer3"><label for="q20803:29_answer3">d. thrombolysis</label> </div>
<div class="r0"><input type="radio" name="q20803:29_answer" disabled="disabled" value="4" id="q20803:29_answer4"><label for="q20803:29_answer4">e. aortobifemoral bypass graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:29_-submit" name="q20803:29_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Patients who present with lower limb ischemia can have a range of symptoms, from cool extremities to frank mottling with myonecrosis and compartment syndrome. Sudden aortic occlusion and its subsequent effects vary by patient and the extent of their collateral blood supply. Acutely, rapid development of compartment syndrome with subsequent myoglobinuria and renal failure can occur. Those with a pre-existing hypercoagulable condition are at particular risk. Anticoagulation, hydration, and improving cardiac function are the cornerstones of preoperative management.</p><p>This man presented with Rutherford 2B acute limb ischemia and clinical findings of aortic occlusion. His history of claudication and presence of aortoiliac calcification on CTA suggests acute thrombosis of a chronically diseased aortoiliac segment. The severity of the clinical findings argues against cathter-based intervention. Embolectomy is unlikely to succeed based on the degree of calcification, distribution of the clot, and extent of the occlusion.&nbsp;Direct aortic reconstruction may be preferable in patients whose left ventricular function is adequate, but&nbsp;this patient's&nbsp;cardiac history supports an extra-anatomic approach.<br></p>
<p>&nbsp;</p>
<h2><strong>Reference:</strong>&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=babu+sc+acute+aortic+occlusion" target="_blank">Babu SC, Shah PM, Nitahara J. Acute aortic occlusion--factors that influence outcome. J Vasc Surg 1995; 21(4):567-72.&nbsp;</a></p>
<p>QID: 30032</p></div><div class="rightanswer">The correct answer is: axillo-bi-femoral bypass</div></div></div></div></div><div id="q280" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">378</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3566"><input type="hidden" name="q20803:280_:flagged" value="0"><input type="hidden" value="qaid=911164&amp;qubaid=20803&amp;qid=5017&amp;slot=280&amp;checksum=3626cebe5f07845c1bc954ce40577af2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:280_:flaggedcheckbox" name="q20803:280_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q280&id=5017"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:280_:sequencecheck" value="2"><div class="qtext"><p>A 25-year-old woman with end stage renal disease (ESRD) requires permanent hemodialysis access. Preoperative vein mapping shows that both forearm cephalic veins are patent but small (diameters of 2 mm). The radial arteries are normal. The referring nephrologist is urging consideration of a radiocephalic autogenous access. Which of the following technical details has been shown to increase the chance of a functional radiocephalic fistula?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:280_answer" disabled="disabled" value="0" id="q20803:280_answer0"><label for="q20803:280_answer0">a. end-to-end anastomosis&nbsp; with minimal vein manipulation</label> </div>
<div class="r1"><input type="radio" name="q20803:280_answer" disabled="disabled" value="1" id="q20803:280_answer1"><label for="q20803:280_answer1">b. ligation of all venous side branches in the forearm</label> </div>
<div class="r0"><input type="radio" name="q20803:280_answer" disabled="disabled" value="2" id="q20803:280_answer2"><label for="q20803:280_answer2">c. long (5 mm) end-to-side anastomosis</label> </div>
<div class="r1"><input type="radio" name="q20803:280_answer" disabled="disabled" value="3" id="q20803:280_answer3"><label for="q20803:280_answer3">d. primary balloon angioplasty of the entire forearm cephalic vein</label> </div>
<div class="r0"><input type="radio" name="q20803:280_answer" disabled="disabled" value="4" id="q20803:280_answer4"><label for="q20803:280_answer4">e. hydrostatic dilatation of the vein at the level of the anastomosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:280_-submit" name="q20803:280_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Arteriovenous fistulas (AVFs) are favored over grafts for hemodialysis access. The Kidney Disease Outcomes Quality Initiative (NK-DOQI 2001) established a “fistula first” policy in 2001, with the goal of having 66% of all dialysis patients undergo AVF by 2009. However, the proportion of patients with AVF in 2009 fell far short of this goal. One important factor limiting more widespread AVF use is the availability of adequately sized veins. In particular, cephalic veins &lt; 2.5 mm have been associated with early failure and decreased primary patency rates. To increase the primary patency rates of small veins, several groups have advocated primary balloon angioplasty (PBA) at the time of radiocephalic AVF creation. The technique involves dilatation of the entire cephalic vein to the level of the elbow using a 3-4 mm X 150 mm non-compliant balloon before the anastomosis is created. Additional balloon dilatations may be required in the early postoperative period to improve maturation rates (balloon angioplasty maturation, BAM). In a series of 40 patients randomized to PBA or hydrostatic dilatation, Veroux and associates reported that 100% of AVF treated with PBA were being used for hemodialysis, compared to 57% of AVF treated only with hydrostatic dilatation. Other reports indicate that the majority of patients require BAM to treat residual stenosis and aid in maturation. Further experience suggests that 75-90% of patients with small veins can achieve a functional AVF with PBA and BAM, including patients with totally occluded vein segments.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B+57%3A+131-6." target="_blank">Veroux P, Giaquinta A, Tallarita T, Sinagra N<span>,&nbsp;</span>Virgilio C<span>,&nbsp;</span>Zerbo D<span>,&nbsp;</span>et al. Primary balloon angioplasty of small (<span style="text-decoration: underline;">&lt;</span> 2 mm) cephalic vein improves primary patency of arteriovenous fistulae and decreases reintervention rates. J Vasc Surg 2013; 57: 131-6.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2010%3B+52%3A+139-44." target="_blank">De Marco Garcia LP, Davila-Santini LR, Feng Q, Calderin J<span>,&nbsp;</span>Krishnasastry KV<span>,&nbsp;</span>Panetta TF. Primary balloon angioplasty plus balloon angioplasty maturation to upgrade small-caliber veins (&lt; 3 mm) for arteriovenous fistulas. J Vasc Surg 2010; 52: 139-44.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2011%3B+24%3A+82-88." target="_blank">Chawla A, DiRaimo R, Panetta TF. Balloon angioplasty to facilitate autogenous arteriovenous access maturation: a new paradigm for upgrading small-caliber veins, improved function, and surveillance. Semin Vasc Surg 2011; 24: 82-88.</a></p>
<p>QID: 30465</p></div><div class="rightanswer">The correct answer is: primary balloon angioplasty of the entire forearm cephalic vein</div></div></div></div></div><div id="q154" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">379</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3575"><input type="hidden" name="q20803:154_:flagged" value="0"><input type="hidden" value="qaid=911038&amp;qubaid=20803&amp;qid=4772&amp;slot=154&amp;checksum=1e0f9304170a958b6eadd9c643b2b702&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:154_:flaggedcheckbox" name="q20803:154_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q154&id=4772"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:154_:sequencecheck" value="2"><div class="qtext"><p>A 20-year-old man is brought to the emergency department with a gunshot wound to the sternal notch. He is hemodynamically stable. An arteriogram shows two major vascular injuries: a false aneurysm of the proximal left common carotid artery 3 cm from its origin and contained extravasation of contrast from the proximal left subclavian artery 4 cm from its origin. Which of the following is the ideal operative exposure for open repair of both injured arteries?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:154_answer" disabled="disabled" value="0" id="q20803:154_answer0"><label for="q20803:154_answer0">a. median sternotomy</label> </div>
<div class="r1"><input type="radio" name="q20803:154_answer" disabled="disabled" value="1" id="q20803:154_answer1"><label for="q20803:154_answer1">b. left anterior thoracotomy</label> </div>
<div class="r0"><input type="radio" name="q20803:154_answer" disabled="disabled" value="2" id="q20803:154_answer2"><label for="q20803:154_answer2">c. left posterior thoracotomy</label> </div>
<div class="r1"><input type="radio" name="q20803:154_answer" disabled="disabled" value="3" id="q20803:154_answer3"><label for="q20803:154_answer3">d. left anterior trapdoor incision (left anterior thoracotomy, partial superior median sternotomy, left supraclavicular incision)</label> </div>
<div class="r0"><input type="radio" name="q20803:154_answer" disabled="disabled" value="4" id="q20803:154_answer4"><label for="q20803:154_answer4">e. left supraclavicular incision</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:154_-submit" name="q20803:154_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Although rarely used due to morbidity, the best exposure to repair both of these injuries is an anterior thoracotomy with partial superior median sternotomy and left supraclavicular incision (so-called trapdoor incision). A left supraclavicular incision alone would not allow proper exposure for obtaining proximal control of either injured artery. A median sternotomy alone would provide excellent exposure of the left common carotid artery, but it would be difficult to gain proximal control and repair the left subclavian artery. A left anterior thoracotomy would allow for proximal control of the left subclavian artery and possibly the left common carotid artery, but repair of either artery would be extremely difficult through this incision alone.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Thorac+Surg+Clin+2007%3B+17%3A95-108." target="_blank">Brinkman WT, Szeto WY, Bavaria JE. Overview of great vessel trauma. Thorac Surg Clin 2007; 17:95-108.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21810804" target="_blank">Dente CJ, Feliciano DV. Torso vascular trauma at an urban level I trauma center. <span>Perspect Vasc Surg Endovasc Ther</span>&nbsp;2006; 18:102-12.</a></p>
<p>QID: 30248</p></div><div class="rightanswer">The correct answer is: left anterior trapdoor incision (left anterior thoracotomy, partial superior median sternotomy, left supraclavicular incision)</div></div></div></div></div><div id="q542" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">380</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3584"><input type="hidden" name="q20803:542_:flagged" value="0"><input type="hidden" value="qaid=911426&amp;qubaid=20803&amp;qid=5299&amp;slot=542&amp;checksum=7e81f92aa174f630f0df8d711fe79201&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:542_:flaggedcheckbox" name="q20803:542_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q542&id=5299"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:542_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old, obese patient status post EVAR for AAA, undergos a complex arterial embolization of a type II endoleak. The radiation dose delivered is 9 Gy RAK.&nbsp; Reconstructed skin dose maps estimate the central portion of the patients back to have been exposed to a peak skin dose of 6 Gy. If the patient sustains a skin injury, what is the time course and expected spectrum of injury?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:542_answer" disabled="disabled" value="0" id="q20803:542_answer0"><label for="q20803:542_answer0">a. 0-2 days:&nbsp;erythema;&nbsp;2- 6 days: epilation and desquamation;&nbsp;2 weeks: recovery</label> </div>
<div class="r1"><input type="radio" name="q20803:542_answer" disabled="disabled" value="1" id="q20803:542_answer1"><label for="q20803:542_answer1">b. 0-2 weeks:&nbsp;dermal atrophy;&nbsp;4-8 weeks: erythema;&nbsp;12 weeks: induration and ulceration</label> </div>
<div class="r0"><input type="radio" name="q20803:542_answer" disabled="disabled" value="2" id="q20803:542_answer2"><label for="q20803:542_answer2">c. no skin findings because the peak skin dose did not reach 15 Gy, which Is the JCHO threshold for a sentinel event</label> </div>
<div class="r1"><input type="radio" name="q20803:542_answer" disabled="disabled" value="3" id="q20803:542_answer3"><label for="q20803:542_answer3">d. 0-2&nbsp; weeks: telangiectasia;&nbsp;4-8 weeks: dermal necrosis;&nbsp;12 weeks: bullae</label> </div>
<div class="r0"><input type="radio" name="q20803:542_answer" disabled="disabled" value="4" id="q20803:542_answer4"><label for="q20803:542_answer4">e. 0-2 weeks: erythema;&nbsp;2 -6 weeks: epilation, desquamation;&nbsp;6 -12 weeks: recovery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:542_-submit" name="q20803:542_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The minimum radiation dose causing skin injury, as well as the times of onset and resolution of specific radiation injuries, are best expressed as ranges.&nbsp; For most patients, clinically relevant skin and hair reactions can occur when the skin dose is higher than 5 Gy.&nbsp; Prompt reactions occur less than 2 weeks from the exposure, with the most common being transient erythema. This reaction is thought to represent an acute inflammatory reaction with an associated increase in vascular permeability. Early reactions occur after 2-8 weeks and affect the basal cells of the epidermis and the germinal region of the hair follicles. These are the most rapidly proliferating cells of the skin. Cell proliferation is inhibited by the radiation damage, yet cell loss continues at the normal rate. Therefore, the onset of the response depends on the epidermal turnover time.&nbsp; A steady decline occurs in both the density of cells and in the number of viable cell layers in the epidermis. This is usually seen between &nbsp;4-6 weeks following the exposure and can manifest as desquamation and epilation. The severity of the response, however, is dose dependent. Midterm reactions occur 6-52 weeks after exposure. At doses between 2- 10 Gy there is usually complete recovery from the radiation damage. At higher doses, permanent epilation, prolonged erythema and dermal atrophy with secondary ulceration can develop. &nbsp;Long-term reactions occur more than 40 weeks after irradiation and include further dermal thinning, telangiectasia, petechial hemorrhages, and focal dermal necrosis.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Fluoroscopically+Guided+Interventional+procedures%3A+A+review+of+radiation+effects+on+patients%E2%80%99+skin+and+hair." target="_blank">Balter S, Hopewell J, Miller D, Wagner L, Zelefsky M. Fluoroscopically guided interventional&nbsp;procedures: A review of radiation effects on patients’ skin and hair. &nbsp;Radiology 2010; 254 (2):326-41.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3A+53(1)%3A9S-14S." target="_blank">Killewich LA, Falls G, Mastracci TM, Brown KR. Factors Affecting Radiation Injury.&nbsp;J Vasc Surg&nbsp;2011: 53(1):9S-14S.</a></p>
<p>QID: 30948</p></div><div class="rightanswer">The correct answer is: 0-2 weeks: erythema;&nbsp;2 -6 weeks: epilation, desquamation;&nbsp;6 -12 weeks: recovery</div></div></div></div></div><div id="q170" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">381</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3593"><input type="hidden" name="q20803:170_:flagged" value="0"><input type="hidden" value="qaid=911054&amp;qubaid=20803&amp;qid=4671&amp;slot=170&amp;checksum=b39237e902b697c8efae01de4e1c2e03&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:170_:flaggedcheckbox" name="q20803:170_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q170&id=4671"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:170_:sequencecheck" value="2"><div class="qtext"><p>The external carotid artery (ECA) can be differentiated from the internal carotid artery (ICA) by all of the following except:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:170_answer" disabled="disabled" value="0" id="q20803:170_answer0"><label for="q20803:170_answer0">a. <p>a position posterolateral to the&nbsp;internal carotid artery</p></label> </div>
<div class="r1"><input type="radio" name="q20803:170_answer" disabled="disabled" value="1" id="q20803:170_answer1"><label for="q20803:170_answer1">b. the presence of cervical arterial branches</label> </div>
<div class="r0"><input type="radio" name="q20803:170_answer" disabled="disabled" value="2" id="q20803:170_answer2"><label for="q20803:170_answer2">c. the presence of reflected pulse wave from “temporal tap” during duplex examination</label> </div>
<div class="r1"><input type="radio" name="q20803:170_answer" disabled="disabled" value="3" id="q20803:170_answer3"><label for="q20803:170_answer3">d. <p>embryologic origin</p></label> </div>
<div class="r0"><input type="radio" name="q20803:170_answer" disabled="disabled" value="4" id="q20803:170_answer4"><label for="q20803:170_answer4">e. high resistance Doppler waveform</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:170_-submit" name="q20803:170_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The external and internal carotid arteries differ&nbsp;in both anatomy and physiology, related to their downstream vascular beds. The external carotid artery has a high resistance triphasic Doppler waveform, due to the high resistance of the facial vascular bed, whereas the ICA feeds the low resistance cerebral circulation.&nbsp; Anatomically the ECA has cervical branches to supply segmental perfusion of the face, while the normal&nbsp;ICA has no cervical, extracranial branches. Often on carotid duplex examination, the use of a gentle tap over the temporal artery will assist in the identification of the ECA from the ICA due to the reflected wave from the temporal artery. The usual anatomic position of the ECA is&nbsp;antero-medial to the ICA but the relationship between can vary. The internal carotid artery orginates from the dorsal aorta; the external carotid artery originates from the third aortic arch.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/7355433" target="_blank">Blackshear&nbsp;WM,&nbsp;Phillips&nbsp;DJ,&nbsp;Chikos&nbsp;PM, Harley JD<span>,&nbsp;</span>Thiele BL<span>,&nbsp;</span>Strandness DE Jr. Carotid artery velocity patterns in normal and stenotic vessels. Stroke&nbsp;1980;&nbsp;11:67-71. </a></p>
<p>Carlson&nbsp;BM:&nbsp;Human Embryology and Developmental Biology. &nbsp;4th ed.&nbsp;Philadelphia,&nbsp;Elsevier,&nbsp;2009.</p>
<p>QID: 30309</p></div><div class="rightanswer">The correct answer is: <p>a position posterolateral to the&nbsp;internal carotid artery</p></div></div></div></div></div><div id="q433" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">382</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3602"><input type="hidden" name="q20803:433_:flagged" value="0"><input type="hidden" value="qaid=911317&amp;qubaid=20803&amp;qid=4878&amp;slot=433&amp;checksum=4e0965bf3e666d77fe4ccfd543a31f93&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:433_:flaggedcheckbox" name="q20803:433_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q433&id=4878"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:433_:sequencecheck" value="2"><div class="qtext"><p>A 45-year-old patient presents with 2 days of pain in the medial thigh in an area of venous varicosities. The patient has had asymptomatic varicose veins for the past 5 years and has occasionally worn compression stockings. Venous ultrasound demonstrated a varicosity with thrombus in continuation with a 10 cm segment of mid thigh great saphenous vein thrombosis that was 10 cm distant to the saphenofemoral junction. Practicing the best evidence-based medicine, which of the following is the next management step for the prevention of venous thromboembolism?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:433_answer" disabled="disabled" value="0" id="q20803:433_answer0"><label for="q20803:433_answer0">a. repeat ultrasound in 6 weeks</label> </div>
<div class="r1"><input type="radio" name="q20803:433_answer" disabled="disabled" value="1" id="q20803:433_answer1"><label for="q20803:433_answer1">b. non-steroidal anti-inflammatory medication</label> </div>
<div class="r0"><input type="radio" name="q20803:433_answer" disabled="disabled" value="2" id="q20803:433_answer2"><label for="q20803:433_answer2">c. immediate removal of the affected vein</label> </div>
<div class="r1"><input type="radio" name="q20803:433_answer" disabled="disabled" value="3" id="q20803:433_answer3"><label for="q20803:433_answer3">d. prophylactic anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:433_answer" disabled="disabled" value="4" id="q20803:433_answer4"><label for="q20803:433_answer4">e. compression</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:433_-submit" name="q20803:433_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has acute superficial venous thrombophlebitis (SVT). To determine the efficacy and safety of treatment in patients with acute symptomatic SVT in the lower extremities but no venous thromboembolism (VTE, DVT and/or PE) at initial presentation, a large randomized controlled trial called CALISTO (<strong>C</strong>omparison of <strong>A</strong>rixtra in Lower <strong>Li</strong>mb <strong>S</strong>uperficial Vein <strong>T</strong>hrombosis with Placeb<strong>O</strong>) was performed. The trial was a double-blind study, enrolling 3002 patients randomized to fondaparinux (2.5 mg daily) vs. placebo for 45 days. The primary endpoint was the composite of death from any cause, symptomatic pulmonary embolus (PE), symptomatic deep venous thrombosis (DVT), symptomatic extension to saphenofemoral junction, and symptomatic SVT recurrence at 47 days, with follow-up to 77 days. At both 47 and 77 days, the primary endpoint favored the treated group with a 0.9% event rate versus 5.9% with placebo. Except for death, all other individual endpoints were also significantly reduced in the fondaparinux group at both 47 and 77 days. Importantly, the rate of symptomatic VTE in untreated patients at follow-up was only 1.3%. In addition, the rate of serious bleeding occurred in only one patient in each group, and serious adverse events were 0.7% in the treated and 1.1% in the placebo groups. Based on this large trial, the 2012 Chest Guidelines of the American College of Chest Physicians have stated, “In patients with SVT of the lower limb of at least 5 cm in length, we suggest the use of a prophylactic dose of fondaparinux or LMWH for 45 days over no anticoagulation (Grade 2B).” Therefore, based on the current best evidence, the patient should receive fondaparinux for 45 days for the prevention of VTE.</p>
<p>Compression stockings are widely used for patients with varicose veins, edema, skin changes, and active venous ulcers; however, there is little evidence available on their use for the treatment of SVT. Repeat ultrasound can be performed in 6 weeks to assess for progression, but this would not be the next best medical treatment. Non-steroidal anti-inflammatory agents can be used along with warm compresses, but, as with compression, there are no evidence-based guidelines. Scattered reports of removal of the affected thrombosed veins and/or ligation of the junctions (femoral and popliteal) are described; however, these are based on theoretical perspectives as opposed to randomized trials and hence would not be the best evidenced based practices.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20860504" target="_blank">Decousus H, Prandoni P, Mismetti P, Bauersachs RM, Boda Z, Brenner B. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Engl J Med 2010;363:1222-32.</a></p>
<p>Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, Nelson ME, Wells PS, Gould MK, Dentali F, Crowther M, Kahn SR. Antithrombotic Therapy for VTE Disease Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest Journal 2012 9th ed. Chest;141:e425s.</p>
<p>QID: 30759</p></div><div class="rightanswer">The correct answer is: prophylactic anticoagulation</div></div></div></div></div><div id="q159" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">383</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3611"><input type="hidden" name="q20803:159_:flagged" value="0"><input type="hidden" value="qaid=911043&amp;qubaid=20803&amp;qid=4776&amp;slot=159&amp;checksum=9eb1a1487524665f3f674be6320095b7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:159_:flaggedcheckbox" name="q20803:159_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q159&id=4776"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:159_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding arterial access for endovascular procedures is&nbsp;<strong>true?</strong></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:159_answer" disabled="disabled" value="0" id="q20803:159_answer0"><label for="q20803:159_answer0">a. numbness in the hand following a brachial puncture is common and not concerning as long as a good pulse is present distally and there is no hematoma</label> </div>
<div class="r1"><input type="radio" name="q20803:159_answer" disabled="disabled" value="1" id="q20803:159_answer1"><label for="q20803:159_answer1">b. spasm with the loss of a distal pulse commonly occurs following brachial artery puncture</label> </div>
<div class="r0"><input type="radio" name="q20803:159_answer" disabled="disabled" value="2" id="q20803:159_answer2"><label for="q20803:159_answer2">c. the brachial artery can be safely punctured anywhere the median nerve does not directly overlie the artery</label> </div>
<div class="r1"><input type="radio" name="q20803:159_answer" disabled="disabled" value="3" id="q20803:159_answer3"><label for="q20803:159_answer3">d. the proximity of the cerebral vessels to the brachial artery results in an increased risk of stroke compared to femoral artery access</label> </div>
<div class="r0"><input type="radio" name="q20803:159_answer" disabled="disabled" value="4" id="q20803:159_answer4"><label for="q20803:159_answer4">e. both saline flush and heparin flush are equally effective&nbsp;at preventing thromboembolic complications associated with upper extremity arterial access</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:159_-submit" name="q20803:159_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Access from radial or brachial sites is more commonly used&nbsp;for coronary imaging and interventions than for imaging and intervention for peripheral artery disease. A large body of evidence has been accumulated documenting it’s safety and efficacy. In women, the complication rate for radial access is greater than femoral access. The incidence of stroke is the same at .4% in a large trial. Of particular concern in brachial artery access is the relatively tight brachial sheath. The presence of any neurological symptom in the hand following brachial puncture should raise concern for brachial sheath hematoma.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2011%3B+25%3A697.e5-8." target="_blank">Tran DD, Andersen CA. Axillary sheath hematomas causing neurologic complications following arterial access. Ann Vasc Surg 2011; 25:697.e5-8.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology+1989%3B+173%3A149-54" target="_blank">Smith DC, Mitchell DA, Peterson GW, Will AD<span>,&nbsp;</span>Mera SS<span>,&nbsp;</span>Smith LL. Medial brachial fascial compartment syndrome: anatomic basis of neuropathy after transaxillary arteriography. Radiology 1989; 173:149-54.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Roentgenol+2012%3B+199%3A683-90." target="_blank">Yan Y, Soulen MC, Shlansky-Goldberg RD, Stavropoulos SW<span>,&nbsp;</span>Dagli M<span>,&nbsp;</span>Itkin M,&nbsp;et al.&nbsp;Evaluation of immature hemodialysis arteriovenous fistulas based on 3-French retrograde micropuncture of brachial artery. Am J Roentgenol 2012; 199:683-90.</a></p>
<p>QID: 30253</p></div><div class="rightanswer">The correct answer is: spasm with the loss of a distal pulse commonly occurs following brachial artery puncture</div></div></div></div></div><div id="q489" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">384</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3620"><input type="hidden" name="q20803:489_:flagged" value="0"><input type="hidden" value="qaid=911373&amp;qubaid=20803&amp;qid=5231&amp;slot=489&amp;checksum=d1035392869d9688b2d6b920d450a4b2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:489_:flaggedcheckbox" name="q20803:489_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q489&id=5231"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:489_:sequencecheck" value="2"><div class="qtext"><p><span style="color: #000000;">What is the most effective <span style="color: #000000;">pharmacotherapy for&nbsp;</span>smoking cessation?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:489_answer" disabled="disabled" value="0" id="q20803:489_answer0"><label for="q20803:489_answer0">A. nortriptyline</label> </div>
<div class="r1"><input type="radio" name="q20803:489_answer" disabled="disabled" value="1" id="q20803:489_answer1"><label for="q20803:489_answer1">B. varenicline</label> </div>
<div class="r0"><input type="radio" name="q20803:489_answer" disabled="disabled" value="2" id="q20803:489_answer2"><label for="q20803:489_answer2">C. clonidine</label> </div>
<div class="r1"><input type="radio" name="q20803:489_answer" disabled="disabled" value="3" id="q20803:489_answer3"><label for="q20803:489_answer3">D. buproprion</label> </div>
<div class="r0"><input type="radio" name="q20803:489_answer" disabled="disabled" value="4" id="q20803:489_answer4"><label for="q20803:489_answer4">E. nicotine patch</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:489_-submit" name="q20803:489_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Cigarette smoking continues to be a major modifiable risk factor for vascular disease and smoking cessation should continue to be a key ingredient in improving overall vascular health.</p>
<p>First-line medications are nicotine replacement therapies (nicotine patch, lozenge, gum, or spray), bupropion, and varenicline. Nortriptyline, an antidepressant and clonidine, an antihypertensive have been effective in smoking cessation, but the evidence is small and generally considered second-line treatment.</p>
<p>Randomized controlled trials have shown Varenicline to be superior to buproprion and placebo for smoking cessation. For weeks 9-12, the continuous abstinence rates were 44% for varenicline, 17.7% for placebo, and 29.5% for buproprion.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Respir+Care+2008%3B+53(9)%3A1217-22." target="_blank">2008 PHS Guideline Update Panel, Liaisons, and Staff. Treating tobacco use and&nbsp;dependence: 2008 update U.S. Public Health Service Clinical Practice Guideline&nbsp;executive summary. Respir Care 2008; 53(9):1217-22.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2006%3B+296(1)%3A47-55." target="_blank">Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an&nbsp;alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs&nbsp;sustained-release bupropion and placebo for smoking cessation: a randomized&nbsp;controlled trial. JAMA 2006; 296(1):47-55.&nbsp;</a></p>
<p>QID: 30854</p></div><div class="rightanswer">The correct answer is: varenicline</div></div></div></div></div><div id="q289" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">385</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3629"><input type="hidden" name="q20803:289_:flagged" value="0"><input type="hidden" value="qaid=911173&amp;qubaid=20803&amp;qid=5028&amp;slot=289&amp;checksum=aeb78964f98456e3dea661c847d81cae&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:289_:flaggedcheckbox" name="q20803:289_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q289&id=5028"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:289_:sequencecheck" value="2"><div class="qtext"><p>A 26-year-old woman is referred for chronic abdominal pain after extensive negative work-up including right upper quadrant ultrasound, abdominal CT, and upper and lower endoscopy. A visceral arterial duplex scan was obtained and is shown below. Which of the following statements regarding images A and B is most probable?</p>
<p><a href="./VESAP3_files/10990.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/10990.jpg" alt="Img" width="100" height="113"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:289_answer" disabled="disabled" value="0" id="q20803:289_answer0"><label for="q20803:289_answer0">a. image A is of the celiac artery in expiration; image B is of the celiac artery in inspiration</label> </div>
<div class="r1"><input type="radio" name="q20803:289_answer" disabled="disabled" value="1" id="q20803:289_answer1"><label for="q20803:289_answer1">b. image A is of the superior mesenteric artery in inspiration; image B is of the superior mesenteric artery in expiration</label> </div>
<div class="r0"><input type="radio" name="q20803:289_answer" disabled="disabled" value="2" id="q20803:289_answer2"><label for="q20803:289_answer2">c. image A is of the inferior mesenteric artery in expiration; image B is of the inferior mesenteric artery in inspiration</label> </div>
<div class="r1"><input type="radio" name="q20803:289_answer" disabled="disabled" value="3" id="q20803:289_answer3"><label for="q20803:289_answer3">d. image A is of the celiac artery in inspiration; image B is of the celiac artery in expiration</label> </div>
<div class="r0"><input type="radio" name="q20803:289_answer" disabled="disabled" value="4" id="q20803:289_answer4"><label for="q20803:289_answer4">e. Image A is of the superior mesenteric artery in expiration; image B is of the superior mesenteric artery in inspiration</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:289_-submit" name="q20803:289_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Median arcuate ligament syndrome of the celiac artery is characterized by an increase in celiac artery flow velocities with expiration and a decrease in flow velocities with inspiration. The postulated etiology of this condition is compression of the celiac axis by the median arcuate ligament. With inspiration, the diaphragm descends, pushing the abdominal organs down and straightening the celiac axis to decrease peak systolic velocity. With expiration, the diaphragm rises, the abdominal organs rise, and the celiac axis may become kinked at the level of the median arcuate ligament, which increases peak systolic velocity. A similar pattern of respiratory variation of superior mesenteric artery flow can also be seen, but it is very rare. Flow velocities in the inferior mesenteric artery do not vary with respiration.<br><br></p>
<h2>Reference:</h2>
<p>Zwolak RM, Musson A. Mesenteric arteries. In: Strandness's Duplex Scanning in Vascular Disorders, 4th ed. Zierler RE, ed. Philadelphia, PA: Lippincott Williams &amp; Wilkins; 2010:275-81.</p>
<p>QID: 30509</p></div><div class="rightanswer">The correct answer is: image A is of the celiac artery in inspiration; image B is of the celiac artery in expiration</div></div></div></div></div><div id="q136" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">386</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3638"><input type="hidden" name="q20803:136_:flagged" value="0"><input type="hidden" value="qaid=911020&amp;qubaid=20803&amp;qid=4753&amp;slot=136&amp;checksum=3cbd12d2a768361dc9708bfa8e7e22af&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:136_:flaggedcheckbox" name="q20803:136_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q136&id=4753"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:136_:sequencecheck" value="2"><div class="qtext"><p>A 76-year-old man who had a drug-eluting coronary stent placed 2 months previously undergoes fenestrated endovascular aneurysm repair (FEVAR) for treatment of a 7.2 cm symptomatic juxtarenal aortic aneurysm. That procedure required bilateral common femoral and left brachial access. He returns 1 week later with left arm bruising, swelling, and progressive hand weakness. Duplex study of the left brachial access site is obtained and shown below. Which of the following is the appropriate treatment option for this patient?</p>
<p><a href="./VESAP3_files/brach psa.JPG" target="images"><img src="./VESAP3_files/brach psa.JPG" alt="brachial pseudoaneurysm-partially thrombosed" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:136_answer" disabled="disabled" value="0" id="q20803:136_answer0"><label for="q20803:136_answer0">a. elevation and compression of the left arm will suffice</label> </div>
<div class="r1"><input type="radio" name="q20803:136_answer" disabled="disabled" value="1" id="q20803:136_answer1"><label for="q20803:136_answer1">b. since the neck of the pseudoaneurysm is long and narrow, thrombin injection is the best treatment option</label> </div>
<div class="r0"><input type="radio" name="q20803:136_answer" disabled="disabled" value="2" id="q20803:136_answer2"><label for="q20803:136_answer2">c. the Duplex shows that the brachial artery pseudoaneurysm has thrombosed; thus, no treatment is necessary</label> </div>
<div class="r1"><input type="radio" name="q20803:136_answer" disabled="disabled" value="3" id="q20803:136_answer3"><label for="q20803:136_answer3">d. the neurologic symptoms in his hand are concerning and open operative decompression with brachial artery repair or patch is the best treatment option</label> </div>
<div class="r0"><input type="radio" name="q20803:136_answer" disabled="disabled" value="4" id="q20803:136_answer4"><label for="q20803:136_answer4">e. the Duplex shows a pseudoaneurysm with intraluminal thrombus and a narrow neck. discontinuation of clopidogrel and aspirin will provide the best possibility of complete thrombosis and non-operative management</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:136_-submit" name="q20803:136_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The Duplex scan demonstrates a pseudoaneurysm&nbsp;after left brachial artery access. Although it is partially thrombosed, the key component here is that motor neurologic symptoms are present, suggesting median nerve compression. Thus, observation is not a reasonable option.&nbsp;Although it might be possible to obliterate residual flow within the pseudoaneurysm with Duplex-guided thrombin injection, such treatment will&nbsp;not decompress the pressure on the nerve. Further nerve ischemia, necrosis, and disability may occur. The patient recently had a drug-eluting stent placed in the coronary arteries and removal of antiplatelet therapy is contraindicated. Non-operative management with arm elevation is not sufficient.&nbsp; Decompression with brachial artery repair is the correct management strategy for this patient. Complications of brachial access include brachial artery thrombosis, distal embolization, hematoma, or, as in this case, pseudoaneurysm. Median nerve compression and neurologic symptoms indicate urgent need for open decompression. Pseudoaneurysm after brachial access for endovascular intervention is not uncommon, occurring in 1- 3% of brachial access. The occurrence of access complications is more common with larger&nbsp;sheath sizes and in women. Complications requiring operative intervention occur in up to 4% of patients who undergo access via a brachial artery approach. &nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2009%3B49%3A378-85" target="_blank">Alvarez-Tostado JA, Moise MA, Bena JF, Pavkov ML,&nbsp;Greenberg RK,&nbsp;Clair DG,&nbsp;et al. The brachial artery: A critical access for endovascular procedures. J Vasc Surg 2009;49:378-85.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2003%3B17%3A107-10" target="_blank">Armstrong PJ, Han DC, Baxter JA, Elmore JR,&nbsp;Franklin DP. Complication rates of percutaneous brachial artery access in peripheral vascular angiography. Ann Vasc Surg 2003;17:107-10.</a></p>
<p>QID: 30229</p></div><div class="rightanswer">The correct answer is: the neurologic symptoms in his hand are concerning and open operative decompression with brachial artery repair or patch is the best treatment option</div></div></div></div></div><div id="q298" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">387</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3647"><input type="hidden" name="q20803:298_:flagged" value="0"><input type="hidden" value="qaid=911182&amp;qubaid=20803&amp;qid=5056&amp;slot=298&amp;checksum=4cecc64d7e1555f738ca6caab56f019d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:298_:flaggedcheckbox" name="q20803:298_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q298&id=5056"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:298_:sequencecheck" value="2"><div class="qtext"><p>The intravascular ultrasound (IVUS) image shown below demonstrates which of the following?</p>
<p><a href="./VESAP3_files/11685.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/11685.jpg" alt="Img" width="95" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:298_answer" disabled="disabled" value="0" id="q20803:298_answer0"><label for="q20803:298_answer0">a. an IVUS probe within a subintimal dissection</label> </div>
<div class="r1"><input type="radio" name="q20803:298_answer" disabled="disabled" value="1" id="q20803:298_answer1"><label for="q20803:298_answer1">b. arterial wall perforation with extravasating blood</label> </div>
<div class="r0"><input type="radio" name="q20803:298_answer" disabled="disabled" value="2" id="q20803:298_answer2"><label for="q20803:298_answer2">c. bowel adjacent to the aortic lumen</label> </div>
<div class="r1"><input type="radio" name="q20803:298_answer" disabled="disabled" value="3" id="q20803:298_answer3"><label for="q20803:298_answer3">d. contrast enhancement of a collateral artery</label> </div>
<div class="r0"><input type="radio" name="q20803:298_answer" disabled="disabled" value="4" id="q20803:298_answer4"><label for="q20803:298_answer4">e. aortic dissection with stagnant flow in the false lumen</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:298_-submit" name="q20803:298_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Intravascular ultrasound (IVUS) typically demonstrates dramatic changes after successful repair of an aortic dissection with an endograft. This image demonstrates an aortic dissection with stagnant flow in the false lumen following coverage of the primary entry tear by an endograft. The image demonstrates the typical relatively circular aortic wall outline, containing two ovoid cross-sections. One of these cross-sections is dark black (the patent true lumen in this case), while the other cross-section has a more dense gray/white appearance, typical of stagnant blood or early thrombus formation.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation%3B+2005%3B+112+(9+Suppl)%3AI260-1264." target="_blank">Koschyk DH, Nienaber CA, Knap M, Hofmann T<span>,&nbsp;</span>Kodolitsch YV<span>,&nbsp;</span>Skriabina V,&nbsp;et al. How to guide stent-graft implantation in Type B aortic dissection? Comparison of angiography, transesophageal echocardiography, and intravascular ultrasound. Circulation; 2005; 112 (9 Suppl):I260-4.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=White%20RA,%20Donayre%20CE,%20Walot%20I,%20Kopchok%20GE.%20Intraprocedural%20imaging:%20Thoracic%20aortography%20techniques,%20intravascular%20ultrasound,%20and%20special%20equipment.%20J%20Vasc%20Surg;%202006;%2043%20(Suppl%20A):53A-61A" target="_blank">White RA, Donayre CE, Walot I, Kopchok GE. Intraprocedural imaging: Thoracic aortography techniques, intravascular ultrasound, and special equipment. J Vasc Surg; 2006; 43 (Suppl A):53A-61A.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2006%3B+19+(3)%3A145-9." target="_blank">Song TK, Donayre CE, Kopchok GE, White RA. Intravascular ultrasound use in the treatment of thoracoabdominal dissections, aneurysms, and transections. Semin Vasc Surg 2006; 19 (3):145-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Bartel+T%2C+Eggebrecht+H%2C+Muller+S%2C+et+al.+Comparison+of+diagnostic" target="_blank">Bartel T, Eggebrecht H, Muller S, Gutersohn A<span>,&nbsp;</span>Bonatti J<span>,&nbsp;</span>Pachinger O<span>,&nbsp;</span>et al. Comparison of diagnostic and therapeutic value of transesophageal echocardiography, intravascular ultrasonic imaging, and intraluminal phased-array imaging in aortic dissection with tear in the descending thoracic aorta (type B). Am J of Cardio 2007; 99 (2):270-4.</a></p>
<p>QID: 30518</p></div><div class="rightanswer">The correct answer is: aortic dissection with stagnant flow in the false lumen</div></div></div></div></div><div id="q2" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">388</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3656"><input type="hidden" name="q20803:2_:flagged" value="0"><input type="hidden" value="qaid=910886&amp;qubaid=20803&amp;qid=4611&amp;slot=2&amp;checksum=613944d1ff9ef3b119f5cefca54258f8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:2_:flaggedcheckbox" name="q20803:2_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q2&id=4611"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:2_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old man with significant chronic pulmonary artery disease (COPD) is 10 years status post endovascular aneurysm repair (EVAR) and has enlargement of the aneurysm sac on a follow-up non-contrast CT scan. He's had&nbsp;short-distance right lower extremity claudication for the past 6 months. Two arteriogram images are shown below. Which of the following is the most appropriate management option?&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p>&nbsp;&nbsp;&nbsp;&nbsp;</p>
<p><a href="./VESAP3_files/AssetProxy_029.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_029.jpg" alt="img" width="100" height="133" border="0" hspace="10" vspace="10"></a><a href="./VESAP3_files/AssetProxy_085.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_085.jpg" alt="img" width="100" height="133" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:2_answer" disabled="disabled" value="0" id="q20803:2_answer0"><label for="q20803:2_answer0">a. Fogarty catheter thrombectomy of the right limb of the endograft</label> </div>
<div class="r1"><input type="radio" name="q20803:2_answer" disabled="disabled" value="1" id="q20803:2_answer1"><label for="q20803:2_answer1">b. thrombolysis and placement of a covered stent within the right limb of the endograft</label> </div>
<div class="r0"><input type="radio" name="q20803:2_answer" disabled="disabled" value="2" id="q20803:2_answer2"><label for="q20803:2_answer2">c. placement of an aorto-uni-iliac device and femorofemoral bypass grafting</label> </div>
<div class="r1"><input type="radio" name="q20803:2_answer" disabled="disabled" value="3" id="q20803:2_answer3"><label for="q20803:2_answer3">d. performance of a left to right femorofemoral bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:2_answer" disabled="disabled" value="4" id="q20803:2_answer4"><label for="q20803:2_answer4">e. explant of the endograft and aorto-bi-femoral bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:2_-submit" name="q20803:2_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has disruption of the endograft at the junction of the distal main body and origin of the right iliac limb with a large Type III endoleak and right iliac limb occlusion. Any chosen therapy must address both issues. Thrombolysis is unlikely to be successful after 6 months of occlusion and could require technically challenging guidewire navigation through the aneurysm sac to span the endograft gap. Given the apparent severity of the endograft disruption (which is more than just a simple component separation), bridging the gap with either a covered stent or an endograft limb cannot be relied upon to address the endoleak. Fogarty catheter thrombectomy of the graft limb is&nbsp;also unlikely to be successful as it risks further graft disruption and does not address the endoleak. A femorofemoral bypass graft will address the patient's claudication but&nbsp;it fails to address the&nbsp;endoleak. Explant of the endograft can be performed, but this may be of prohibitive risk in a patient with a longstanding endograft. If, however, the explantation&nbsp;is to be undertaken, the dissection should be limited as there is no need to explant the entire endograft or perform an aorto-bi-femoral bypass. Since there is no Type I endoleak, the best option in this case is to reline the graft with an aorto-uni-iliac device so as&nbsp;to address the Type III leak and a femorofemoral bypass to address the claudication. This approach is the least invasive, the least technically challenging, and offers a high probability of success. <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Lipsitz%2C%20EC%2C%20Ohki%20T%2C%20Veith%20FJ%2C%20et%20al.%20Delayed%20open%20conversion%20following%20endovascular%20aortoiliac%20aneurysm%20repair%3A%20Partial%20%28or%20Complete%29%20endograft%20preservation%20as%20a%20useful%20adjunct.%20J%20Vasc%20Surg%3B%202003%3B%2038%20%286%29%3A1191-1198" target="_blank">Lipsitz EC, Ohki T, Veith FJ, Suggs WD, Wain RA, Rhee SJ, et al. Delayed open conversion following endovascular aortoiliac aneurysm repair: Partial (or Complete) endograft preservation as a useful adjunct. J Vasc Surg 2003; 38 (6):1191-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Conrad%20MF%2C%20Adams%20AB%2C%20Guest%20JM%2C%20et%20al.%20Secondary%20intervention%20after%20endovascular%20abdominal%20aortic%20aneurysm%20repair.%20Ann%20Surg%3B%202009%3B%20250%20%283%29%3A383-389" target="_blank">Conrad MF, Adams AB, Guest JM, Paruchuri V, Brewster DC, LaMuraglia GM, et al. Secondary intervention after endovascular abdominal aortic aneurysm repair. Ann Surg 2009; 250 (3):383-9.</a><br><br><a href="http://www.expertconsultbook.com/" target="_blank">Buth J, Harris P. Endovascular treatment of aortic aneurysms. In: Rutherford RB, ed. Vascular Surgery. 6th ed. Philadelphia, PA: Elsevier Saunders 2005:1452-75.</a></p>
<p><strong>QID</strong><span>: 30002</span></p></div><div class="rightanswer">The correct answer is: placement of an aorto-uni-iliac device and femorofemoral bypass grafting</div></div></div></div></div><div id="q487" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">389</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3665"><input type="hidden" name="q20803:487_:flagged" value="0"><input type="hidden" value="qaid=911371&amp;qubaid=20803&amp;qid=5229&amp;slot=487&amp;checksum=b857aa588a2d633b741959df57eba31d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:487_:flaggedcheckbox" name="q20803:487_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q487&id=5229"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:487_:sequencecheck" value="2"><div class="qtext"><p>An 82-year-old woman with a history of chronic deep venous thrombosis stopped long-term warfarin use due to an elevated international normalized ratio (INR) of 6.2. Upon resumption of warfarin, the following lesions developed. Regarding this condition, which of the following is <strong>true</strong>?</p>
<p><a href="./VESAP3_files/Warfarin skin necrosis.jpg" target="images"><img src="./VESAP3_files/Warfarin skin necrosis.jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:487_answer" disabled="disabled" value="0" id="q20803:487_answer0"><label for="q20803:487_answer0">a. the risk of developing this condition is increased in thin patients</label> </div>
<div class="r1"><input type="radio" name="q20803:487_answer" disabled="disabled" value="1" id="q20803:487_answer1"><label for="q20803:487_answer1">b. patients with hereditary protein C or S deficiency are immune from this complication</label> </div>
<div class="r0"><input type="radio" name="q20803:487_answer" disabled="disabled" value="2" id="q20803:487_answer2"><label for="q20803:487_answer2">c. the pathophysiology involves diffuse microthrombi occurring within subcutaneous capillaries and venules</label> </div>
<div class="r1"><input type="radio" name="q20803:487_answer" disabled="disabled" value="3" id="q20803:487_answer3"><label for="q20803:487_answer3">d. the condition is less likely if a sufficiently high loading dose of warfarin is used</label> </div>
<div class="r0"><input type="radio" name="q20803:487_answer" disabled="disabled" value="4" id="q20803:487_answer4"><label for="q20803:487_answer4">e. treatment includes decreasing warfarin and monitoring the effect low molecular weight heparin therapy with&nbsp;<span>anti-activated factor X (anti-Xa) assays</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:487_-submit" name="q20803:487_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Warfarin-induced skin necrosis is a rare but serious complication (&lt; 0.1% of treated patients) associated with this medication. The mechanism involves diffuse microthrombi occurring within subcutaneous capillaries and venules which damage endothelial cells leading to necrotic skin lesions. Treatment involves cessation of warfarin and immediate initiation of an alternative anticoagulant. Patients with protein C or S deficiency and high "loading" doses of warfarin are particularly at risk. This condition occurs most commonly in obese females.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Gen+Intern+Med+2014%3B+29(1)%3A248-9." target="_blank">Kozac N, Schattner A. Warfarin-induced skin necrosis. J Gen Intern Med 2014; 29(1):248-9.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br+J+Surg+2000%3B+87(3)%3A266-72." target="_blank">Chan YC, Valenti D, Mansfield AO, Stansby G. Warfarin induced skin necrosis.&nbsp;Br J Surg 2000; 87(3):266-72.&nbsp;</a></p>
<p>QID: 30852</p></div><div class="rightanswer">The correct answer is: the pathophysiology involves diffuse microthrombi occurring within subcutaneous capillaries and venules</div></div></div></div></div><div id="q140" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">390</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3674"><input type="hidden" name="q20803:140_:flagged" value="0"><input type="hidden" value="qaid=911024&amp;qubaid=20803&amp;qid=4758&amp;slot=140&amp;checksum=5a8b515e1c72f8d7d87172d03996a30c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:140_:flaggedcheckbox" name="q20803:140_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q140&id=4758"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:140_:sequencecheck" value="2"><div class="qtext"><p>A 64-year-old woman presents with acute onset of left upper-extremity pain and swelling. She is being treated for colon cancer and has a left subclavian central venous port. She will complete her planned course of chemotherapy in 1 month. Physical examination reveals mild edema of the hand and forearm with normal pulses and a normal neurological examination. &nbsp;Which of the following represents the most appropriate management option for this patient?</p>
<p>&nbsp;</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:140_answer" disabled="disabled" value="0" id="q20803:140_answer0"><label for="q20803:140_answer0">a. immediate removal of the catheter; avoid anticoagulation due to risk of bleeding</label> </div>
<div class="r1"><input type="radio" name="q20803:140_answer" disabled="disabled" value="1" id="q20803:140_answer1"><label for="q20803:140_answer1">b. anticoagulation with unfractionated heparin and transition to vitamin K antagonist; immediate removal of the central venous catheter</label> </div>
<div class="r0"><input type="radio" name="q20803:140_answer" disabled="disabled" value="2" id="q20803:140_answer2"><label for="q20803:140_answer2">c. anticoagulation with low molecular weight heparin; immediate removal of the central venous catheter</label> </div>
<div class="r1"><input type="radio" name="q20803:140_answer" disabled="disabled" value="3" id="q20803:140_answer3"><label for="q20803:140_answer3">d. injection of 1 mg of alteplase (t-PA) into the port; retain catheter</label> </div>
<div class="r0"><input type="radio" name="q20803:140_answer" disabled="disabled" value="4" id="q20803:140_answer4"><label for="q20803:140_answer4">e. anticoagulation with low molecular weight heparin; retain catheter</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:140_-submit" name="q20803:140_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The management of catheter-associated upper extremity DVT is poorly standardized due to the absence of high-quality data. The treatment is largely extrapolated from data derived from lower-extremity clinical trials. Both pulmonary embolism and post-thrombotic syndrome appear to occur less frequently and with less severity following upper-extremity DVT in comparison to the lower extremity.</p>
<p>In the absence of contraindication, anticoagulation &nbsp;is recommended for catheter-associated upper-extremity DVT. The choice of anticoagulant and the duration of anticoagulation is uncertain. There are no large, randomized trials comparing treatment strategies in upper-extremity DVT. In general, the catheter should not be removed if it is functional and there is an ongoing need. The CHEST Guidelines suggest anticoagulation with either vitamin K antagonists (VKA), unfractionated heparin, or low molecular weight heparin for a period of at least 3 months. Some prefer to maintain anticoagulation as long as the catheter remains in place. Low molecular weight heparin may be preferable to VKA &nbsp;for patients with cancer. &nbsp;Although trans-catheter injection of thrombolytic agents may be useful for dealing with catheter occlusion, thrombolysis is not recommended as first line therapy for upper-extremity DVT.</p>
<p>&nbsp;</p>
<h2 style="text-align: left;" align="center">References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest.+2012%3B141(2+Suppl)%3Ae419S-94S." target="_blank">Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl):e419S-94S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20824828" target="_blank">Erkens PM, Prins MH. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism. Cochrane Database Syst Rev 2010(9) :CD001100.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=official+journal+of+the+International+Academy+of+Clinical+and+Applied+Thrombosis%2FHemostasis.+2006%3B12(4)%3A389-96" target="_blank">Deitcher SR, Kessler CM, Merli G, Rigas JR, Lyons RM, Fareed J, et al. Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period. Clin Appl Thromb Hemost 2006;12(4):389-96.</a></p>
<p id="patTopicTitle"><a href="http://www.uptodate.com/contents/catheter-related-upper-extremity-venous-thrombosis" target="_blank">Berube C, Zehnder JL, Eidt JF, Mills JL, Collins KA. Catheter-related upper extremity venous thrombosis. Up to Date. 2013.&nbsp;</a></p>
<p>QID: 30234</p></div><div class="rightanswer">The correct answer is: anticoagulation with low molecular weight heparin; retain catheter</div></div></div></div></div><div id="q526" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">391</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3683"><input type="hidden" name="q20803:526_:flagged" value="0"><input type="hidden" value="qaid=911410&amp;qubaid=20803&amp;qid=5262&amp;slot=526&amp;checksum=e33873cf31fcec5c53e78bc04ba326b6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:526_:flaggedcheckbox" name="q20803:526_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q526&id=5262"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:526_:sequencecheck" value="2"><div class="qtext"><p>If a pregnant operator is exposed to 100 mGy during the first trimester, what is the risk of radiation-induced childhood cancer?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:526_answer" disabled="disabled" value="0" id="q20803:526_answer0"><label for="q20803:526_answer0">a. No increased risk</label> </div>
<div class="r1"><input type="radio" name="q20803:526_answer" disabled="disabled" value="1" id="q20803:526_answer1"><label for="q20803:526_answer1">b. &lt;0.01%</label> </div>
<div class="r0"><input type="radio" name="q20803:526_answer" disabled="disabled" value="2" id="q20803:526_answer2"><label for="q20803:526_answer2">c. &lt;0.1%</label> </div>
<div class="r1"><input type="radio" name="q20803:526_answer" disabled="disabled" value="3" id="q20803:526_answer3"><label for="q20803:526_answer3">d. 1-2%</label> </div>
<div class="r0"><input type="radio" name="q20803:526_answer" disabled="disabled" value="4" id="q20803:526_answer4"><label for="q20803:526_answer4">e. 5-10%</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:526_-submit" name="q20803:526_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><div class="column">
<div>Based on multiple studies, the likelihood of not developing cancer with no radiation exposure is 99.93%, whereas the likelihood of not developing cancer with a 50 mSv (5 rem) dose is 99.12%. &nbsp;Therefore, the&nbsp;chance of developing childhood cancer due to in utero radiation exposure from most medical exams is likely theoretical. &nbsp;If there are cases with excessive exposure (ie, 100mGy as in this question), the likelihood of NOT developing childhood cancer is 98.25% if the exposure is in the 1st trimester, and 99.48% if the exposure is in the 2nd or 3rd trimester. Therefore, the best estimate of the risk of radiation-induced childhood cancer is 1.5-2.0%.&nbsp;</div>
<div>&nbsp;</div>
<div>&nbsp;</div>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Otake+M%2C+Schull+WJ%2C+Fujikoshi+Y%2C+Yoshimaru+H.+Effect+on+school+performance+of+prenatal+exposure+to+ionizing+radiation+in+Hiroshima%2C" target="_blank">Otake M, Schull WJ, Fujikoshi Y, Yoshimaru H. Effect on school performance of prenatal exposure to ionizing radiation in Hiroshima, RERF TR2-88. Japan: Radiation Effects Research Foundation.&nbsp;Nihon Eiseigaku Zasshi&nbsp;1991; 46(3):747-54.</a></p>
<p>National Radiological Protection Board. Diagnostic medical exposures: exposure to ionizing radiation of pregnant women-biological basis of the board’s statement. Doc NRPB 1993; 4:7-14.&nbsp;</p>
<p>QID: 30930</p>
</div></div><div class="rightanswer">The correct answer is: 1-2%</div></div></div></div></div><div id="q533" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">392</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3692"><input type="hidden" name="q20803:533_:flagged" value="0"><input type="hidden" value="qaid=911417&amp;qubaid=20803&amp;qid=5269&amp;slot=533&amp;checksum=082b4ad610b53f4191ac0794e85c36ad&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:533_:flaggedcheckbox" name="q20803:533_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q533&id=5269"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:533_:sequencecheck" value="2"><div class="qtext"><p>Finish this sentence: The endovascular procedures with the highest levels of radiation exposure are...</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:533_answer" disabled="disabled" value="0" id="q20803:533_answer0"><label for="q20803:533_answer0">a. lower extremity angioplasty and stenting</label> </div>
<div class="r1"><input type="radio" name="q20803:533_answer" disabled="disabled" value="1" id="q20803:533_answer1"><label for="q20803:533_answer1">b. endovascular abdominal aortic aneurysm repair (EVAR)</label> </div>
<div class="r0"><input type="radio" name="q20803:533_answer" disabled="disabled" value="2" id="q20803:533_answer2"><label for="q20803:533_answer2">c. thoracic endovascular aneurysm repair (TEVAR)</label> </div>
<div class="r1"><input type="radio" name="q20803:533_answer" disabled="disabled" value="3" id="q20803:533_answer3"><label for="q20803:533_answer3">d. fenestrated endovascular aneurysm repair (FEVAR)</label> </div>
<div class="r0"><input type="radio" name="q20803:533_answer" disabled="disabled" value="4" id="q20803:533_answer4"><label for="q20803:533_answer4">e. cerebrovascular interventions</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:533_-submit" name="q20803:533_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In general, longer, more complex endovascular procedures result in the highest levels of radiation exposure. A recent study demonstrated that FEVAR was associated with the highest levels, followed by the other types of endovascular aneurysm repair (EVAR, TEVAR—Kirkwood et al.).&nbsp; An older study showed that EVAR and atherectomy were associated with the elevated radiation exposures, but atherectomy is not an answer choice in this question.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surgeon+education+decreases+radiation+dose+in+complex+endovascular+procedures+and+improves+patient+safety." target="_blank">Kirkwood ML, Arbique GM, Guild JB, Timaran C, Chung J, Anderson JA, et al. Surgeon education decreases radiation dose in complex endovascular procedures and improves patient safety. J Vasc Surg 2013; 8:715-21.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2009%3B+49%3A1520-4." target="_blank">Bannazadeh M, Altinel O, Kashyap VS, Sun Z, Clair D, Sarac TP. Patterns of procedure-specific radiation exposure in the endovascular era: impetus for further innovation. J Vasc Surg 2009; 49:1520-4.</a></p>
<p>QID: 30937</p></div><div class="rightanswer">The correct answer is: fenestrated endovascular aneurysm repair (FEVAR)</div></div></div></div></div><div id="q503" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">393</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3701"><input type="hidden" name="q20803:503_:flagged" value="0"><input type="hidden" value="qaid=911387&amp;qubaid=20803&amp;qid=5234&amp;slot=503&amp;checksum=d79b63af45a3c3fcd274adb94a642681&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:503_:flaggedcheckbox" name="q20803:503_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q503&id=5234"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:503_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old man experienced flushing and urticaria 1 hour after a CT angiogram a month ago. He is scheduled for a lower extremity arteriogram. In regards to this patient, which of the following is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:503_answer" disabled="disabled" value="0" id="q20803:503_answer0"><label for="q20803:503_answer0">a. he should receive intramuscular epinephrine prior to angiography</label> </div>
<div class="r1"><input type="radio" name="q20803:503_answer" disabled="disabled" value="1" id="q20803:503_answer1"><label for="q20803:503_answer1">b. the risk of a reaction with the next contrast exposure is more than 60%</label> </div>
<div class="r0"><input type="radio" name="q20803:503_answer" disabled="disabled" value="2" id="q20803:503_answer2"><label for="q20803:503_answer2">c. lower contrast dose will decrease the risk of a recurrent contrast reaction</label> </div>
<div class="r1"><input type="radio" name="q20803:503_answer" disabled="disabled" value="3" id="q20803:503_answer3"><label for="q20803:503_answer3">d. he should be pretreated with corticosteroids prior to angiography</label> </div>
<div class="r0"><input type="radio" name="q20803:503_answer" disabled="disabled" value="4" id="q20803:503_answer4"><label for="q20803:503_answer4">e. the use of contrast is contraindicated</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:503_-submit" name="q20803:503_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The strongest risk factors for contrast reactions include prior contrast reaction (17-35% of those with a prior reaction will react again upon re-exposure) and asthma (which increases the risk of contrast reaction several-fold). Other risk factors include: female gender, older age, heart disease, renal disease, hematologic disease, and diabetes. Contrast reactions may range from mild (nausea, vomiting, flushing, urticaria, pruritis) to moderate (laryngeal or facial edema or mild bronchospasm) to severe (respiratory or cardiac arrest and anaphylactic shock). The more severe reactions are less common and are unlikely to occur, even in patients with a prior mild contrast reaction. Pre-treatment with corticosteroids, with or without antihistamines, can reduce, but not completely eliminate, the risk of contrast reactions; pretreatment is indicated in those with prior contrast reactions and advisable in those patients with asthma. Low osmolality contrast agents have a lower rate of contrast reactions. Unlike contrast induced nephropathy, allergic contrast reaction is NOT dose dependent, and lowering the dose of contrast does not reduce the risk of reaction. Treatment of established contrast reactions depends on the severity as noted above: mild - observation, moderate - intramuscular or intravenous epinephrine and intravenous diphenhydramine, severe - ACLS protocol with an intravenous epinephrine drip and intravenous hydration.<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Invasive+Cardiol+2009%3B+21+(10)%3A548-51." target="_blank">Nayak KR, White AA, Cavendish JJ, Barker CM<span>,&nbsp;</span>Kandzari DE. Anaphylactoid reactions to radiocontrast agents: Prevention and treatment in the cardiac catheterization laboratory. J Invasive Cardiol 2009; 21 (10):548-51.</a></p>
<p>QID: 30902</p></div><div class="rightanswer">The correct answer is: he should be pretreated with corticosteroids prior to angiography</div></div></div></div></div><div id="q198" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">394</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3710"><input type="hidden" name="q20803:198_:flagged" value="0"><input type="hidden" value="qaid=911082&amp;qubaid=20803&amp;qid=4689&amp;slot=198&amp;checksum=c61fbe2084655deacbdf932bbf7a7434&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:198_:flaggedcheckbox" name="q20803:198_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q198&id=4689"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:198_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old, right-handed man with CAD, HTN, COPD, and DM presents with an episode of expressive aphasia and right arm weakness that lasted for 3 hours and then resovled. Carotid duplex exam shows &gt; 70% stenosis of the left internal carotid artery and &lt; 50% stenosis of the right internal carotid artery. He had coronary stents placed 4 months ago for an NSTEMI and is on 2L NC oxygen intermittently. You recommend left carotid artery stenting. With regards to cerebral embolic protection, which of the following is <strong>not</strong> true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:198_answer" disabled="disabled" value="0" id="q20803:198_answer0"><label for="q20803:198_answer0">a. flow reversal devices do not cross the carotid lesion</label> </div>
<div class="r1"><input type="radio" name="q20803:198_answer" disabled="disabled" value="1" id="q20803:198_answer1"><label for="q20803:198_answer1">b. embolic protection filters must cross the carotid lesion and be deployed distally</label> </div>
<div class="r0"><input type="radio" name="q20803:198_answer" disabled="disabled" value="2" id="q20803:198_answer2"><label for="q20803:198_answer2">c. sluggish flow in the distal carotid artery may be due to vasospasm from the filter</label> </div>
<div class="r1"><input type="radio" name="q20803:198_answer" disabled="disabled" value="3" id="q20803:198_answer3"><label for="q20803:198_answer3">d. filters should be aspirated before recapture and removal</label> </div>
<div class="r0"><input type="radio" name="q20803:198_answer" disabled="disabled" value="4" id="q20803:198_answer4"><label for="q20803:198_answer4">e. absence of flow distal to the filter may be from filter thombosis or occlusion from emboli</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:198_-submit" name="q20803:198_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Distal embolization is common during carotid stenting procedures; most are small emboli that are clinically insignificant, but macroemboli with neurologic deficits do occur. Distal embolic protection devices are believed to make performance of CAS safer. The 2 main types of embolic protection devices used today are distal filters and flow reversal devices. Each device has its own advantages and disadvantages. Distal filters must be advanced through the lesion and deployed in the normal distal internal carotid artery to be effective. They can thrombose, become occluded with embolic debris, and/or cause distal vasospasm. Flow reversal catheters do not have to cross the lesion, but depending on their collateral circulation are not tolerated by some patients.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/14691774" target="_blank">Ohki T, Veith FJ. <span class="highlight">Critical</span> <span class="highlight">analysis</span> of <span class="highlight">distal</span> <span class="highlight">protection</span> <span class="highlight">devices</span>. <span>Semin Vasc Surg</span>&nbsp;2003; 16(4):317-25. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/14691774"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22322116" target="_blank">Alvarez B, Matas M, Ribo M, Maeso J, Yugueros X, Alvarez-Sabin J. Transcervical <span class="highlight">carotid</span> <span class="highlight">stenting</span> with <span class="highlight">flow</span> <span class="highlight">reversal</span> is a safe technique for high-risk patients older than 70 years. <span>J Vasc Surg</span> 2012; 55(4):978-84. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/22322116"><br></a></p>
<p>QID: 30347</p></div><div class="rightanswer">The correct answer is: filters should be aspirated before recapture and removal</div></div></div></div></div><div id="q278" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">395</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3719"><input type="hidden" name="q20803:278_:flagged" value="0"><input type="hidden" value="qaid=911162&amp;qubaid=20803&amp;qid=5014&amp;slot=278&amp;checksum=4d724268a999900ae41e6e87a306c685&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:278_:flaggedcheckbox" name="q20803:278_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q278&id=5014"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:278_:sequencecheck" value="2"><div class="qtext"><p>A 63-year-old diabetic man undergoes a left brachiocephalic arteriovenous autogenous access for hemodialysis. In the recovery room he is found to have severe pain and weakness of the muscles of the left forearm and hand. There is a strong thrill in the fistula and palpable radial pulse. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:278_answer" disabled="disabled" value="0" id="q20803:278_answer0"><label for="q20803:278_answer0">a. perform forearm fasciotomy</label> </div>
<div class="r1"><input type="radio" name="q20803:278_answer" disabled="disabled" value="1" id="q20803:278_answer1"><label for="q20803:278_answer1">b. obtain finger pressures</label> </div>
<div class="r0"><input type="radio" name="q20803:278_answer" disabled="disabled" value="2" id="q20803:278_answer2"><label for="q20803:278_answer2">c. thoracoscopic sympathectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:278_answer" disabled="disabled" value="3" id="q20803:278_answer3"><label for="q20803:278_answer3">d. immediate ligation of the fistula</label> </div>
<div class="r0"><input type="radio" name="q20803:278_answer" disabled="disabled" value="4" id="q20803:278_answer4"><label for="q20803:278_answer4">e. obtain nerve conduction studies</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:278_-submit" name="q20803:278_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Ischemic monomelic neuropathy (IMN) is a rare complication of vascular access that requires prompt recognition and treatment to avoid permanent neurologic injury. The complication is seen almost exclusively in diabetic patients and presents immediately after creation of an arteriovenous access in the brachiocephalic or antecubital position. IMN is characterized by acute pain and weakness or paralysis of the forearm and hand muscles; it is often accompanied by sensory loss. Affected patients frequently have wrist drop. In contrast to vascular steal syndrome, the hand is often warm and the radial pulse may be palpable. The underlying cause is sudden diversion of the blood supply to the nerves of the forearm and hand with resulting injury to nerve fibers. Untreated patients develop a claw-hand deformity with loss of function and severe neuropathic pain. Immediate ligation of the access is required to reduce the risk of irreversible neurologic injury. Although nerve conduction studies may help to diagnose IMN, the test will result in unnecessary delay and lead to a higher risk of permanent neurologic injury. Neither fasciotomy nor sympathectomy treats the underlying cause of this condition.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Hand+Surg+Am+2010%3B+35%3A+842-3." target="_blank">Wodicka R, Isaacs J. Ischemic monomelic neuropathy. J Hand Surg Am 2010; 35: 842-3.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Access+2011%3B+12%3A+113-9." target="_blank">Thermann F, Kornhuber M. Ischemic monomelic neuropathy: a rare but important complication of hemodialysis access placement – a review. J Vasc Access 2011; 12: 113-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Redfern+AB%2C+Zimmerman+NB.+Neurologic+and+ischemic+complications+of+upper+extremity+vascular+access+for+dialysis." target="_blank">Redfern AB, Zimmerman NB. Neurologic and ischemic complications of upper extremity vascular access for dialysis. J Hand Surg Am 1995; 20: 199-204.</a></p>
<p>QID: 30463</p></div><div class="rightanswer">The correct answer is: immediate ligation of the fistula</div></div></div></div></div><div id="q153" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">396</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3728"><input type="hidden" name="q20803:153_:flagged" value="0"><input type="hidden" value="qaid=911037&amp;qubaid=20803&amp;qid=4771&amp;slot=153&amp;checksum=2c4393ca149908d4dc0bf21df86edba2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:153_:flaggedcheckbox" name="q20803:153_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q153&id=4771"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:153_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old woman underwent left mastectomy for breast cancer 8 years ago and subsequently developed lymphedema in her arm. Five months ago a raised, pigmented, and slightly tender lesion appeared on her forearm, which is shown below.&nbsp;With regards to this patient, which of the following statements is the most accurate?<br></p><p><img src="./VESAP3_files/Cull - 8 image.jpg" alt="Cull - 8 image" width="462" height="347"></p>
<p><br></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:153_answer" disabled="disabled" value="0" id="q20803:153_answer0"><label for="q20803:153_answer0">a. this lesion is most likely a metastatic recurrence of breast cancer</label> </div>
<div class="r1"><input type="radio" name="q20803:153_answer" disabled="disabled" value="1" id="q20803:153_answer1"><label for="q20803:153_answer1">b. this lesion will progress to elephantiasis if the lymphedema is not managed more aggressively</label> </div>
<div class="r0"><input type="radio" name="q20803:153_answer" disabled="disabled" value="2" id="q20803:153_answer2"><label for="q20803:153_answer2">c. this lesion requires a course of parenteral corticosteroids</label> </div>
<div class="r1"><input type="radio" name="q20803:153_answer" disabled="disabled" value="3" id="q20803:153_answer3"><label for="q20803:153_answer3">d. biopsy is likely to show angiosarcoma</label> </div>
<div class="r0"><input type="radio" name="q20803:153_answer" disabled="disabled" value="4" id="q20803:153_answer4"><label for="q20803:153_answer4">e. this lesion will respond to appropriate antibiotics</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:153_-submit" name="q20803:153_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This is an angiosarcoma, which is sometimes called Stewart-Treves syndrome, in the setting of lymphedema. Lymphangiosarcomas often develop as multicentric lesions that are likely to metastasize. Most of these lesions have been described in breast cancer survivors who have chronic, significant arm lymphedema. They are rarely seen in other forms of lymphedema. The prognosis for survival is poor. This lesion is unlikely to be a recurrence of the patient’s breast cancer because it does not have the typical appearance and it is in the wrong location. Limbs with lymphedema certainly are at risk for cellulitis and additional episodes of lymphangitis; however, this does not appear to be an infection and certainly will not respond to antibiotics. A steroid-responsive lesion such as pyoderma gangrenosum has an entirely different appearance, and corticosteroids would not help this patient. This is not the typical verrucous lesion of lymphedema and does not suggest that this patient is progressing toward elephantiasis.</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Surg+2007%3B+204%3A328." target="_blank">Schiffman S, Berger A. Stewart-Treves syndrome. J Am Coll Surg 2007; 204:328.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20087653" target="_blank">Styring E, Fernebro J, Jonsson PE, Ehinger A,&nbsp;Engellau J,&nbsp;Rissler P,&nbsp;et al. Changing clinical presentation of angiosarcomas after breast cancer: from late tumors in edematous arms to earlier tumors on the thoracic wall. Breast Cancer Res Treat 2010;122:883-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Acad+Dermatol2012%3B+67%3A1342-8." target="_blank">Sharma A, Schwartz RA. Stewart-Treves syndrome: pathogenesis and management. J Am Acad Dermatol2012; 67:1342-8.</a></p>
<p>QID: 30247</p></div><div class="rightanswer">The correct answer is: biopsy is likely to show angiosarcoma</div></div></div></div></div><div id="q458" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">397</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3737"><input type="hidden" name="q20803:458_:flagged" value="0"><input type="hidden" value="qaid=911342&amp;qubaid=20803&amp;qid=5176&amp;slot=458&amp;checksum=00bd484eb402d1544dbb0351f505d4cb&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:458_:flaggedcheckbox" name="q20803:458_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q458&id=5176"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:458_:sequencecheck" value="2"><div class="qtext"><p>Smoking cessation therapy includes pharmacotherapy, individual or group counseling, and self-help support. Which of the following medications, in addition to nicotine replacement therapy and varenicline, is considered a first-line therapy for smoking cessation?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:458_answer" disabled="disabled" value="0" id="q20803:458_answer0"><label for="q20803:458_answer0">a. bupropion</label> </div>
<div class="r1"><input type="radio" name="q20803:458_answer" disabled="disabled" value="1" id="q20803:458_answer1"><label for="q20803:458_answer1">b. nortriptyline</label> </div>
<div class="r0"><input type="radio" name="q20803:458_answer" disabled="disabled" value="2" id="q20803:458_answer2"><label for="q20803:458_answer2">c. amitriptyline</label> </div>
<div class="r1"><input type="radio" name="q20803:458_answer" disabled="disabled" value="3" id="q20803:458_answer3"><label for="q20803:458_answer3">d. clonidine</label> </div>
<div class="r0"><input type="radio" name="q20803:458_answer" disabled="disabled" value="4" id="q20803:458_answer4"><label for="q20803:458_answer4">e. diazepam</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:458_-submit" name="q20803:458_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Nicotine replacement therapy, varenicline (Chantix), and bupropion (Wellbutrin, Zyban) are considered first-line pharmacotherapy for smoking cessation. These medications have been shown to reliably increase long-term smoking abstinence rates. Clonidine and nortriptyline are considered second-line pharmacotherapy agents. While some studies have demonstrated their efficacy, results have been less compelling and side-effects greater than for the first-line agents. These medications are recommended treatment when first-line therapy is not effective. Amitriptyline is a tricyclic antidepressant and diazepam is a benzodiazepam anxiolytic. These medications are not recommended pharmacotherapy for smoking cessation.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Erhardt%20L.%20Cigarette%20smoking:%20An%20undertreated%20risk%20factor%20for%20cardiovascular%20disease.%20Atherosclerosis;%202009;%20205%20():23-32" target="_blank">Erhardt L. Cigarette smoking: An undertreated risk factor for cardiovascular disease. Atherosclerosis; 2009; 205 (1):23-32.</a><br><br>Fiore MC, Bailey WC, Cohen SJ, et al. Treating Tobacco Use and Dependence. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services. Public Health Service; 6/1/2000.</p>
<p>QID: 30816</p></div><div class="rightanswer">The correct answer is: bupropion</div></div></div></div></div><div id="q17" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">398</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3746"><input type="hidden" name="q20803:17_:flagged" value="0"><input type="hidden" value="qaid=910901&amp;qubaid=20803&amp;qid=4626&amp;slot=17&amp;checksum=ccbc9019a6cfb30adcc9d08ef7991b9e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:17_:flaggedcheckbox" name="q20803:17_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q17&id=4626"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:17_:sequencecheck" value="2"><div class="qtext"><p>An otherwise healthy 50-year-old man presents with a&nbsp;3-week history of progressive lower back pain. His past history is notable for an infected sebaceous cyst on his neck&nbsp;4 weeks prior to admission. He is afebrile and his vital signs are stable. He has palpable radial and pedal pulses. A CT is completed&nbsp;and demonstrates obliteration of the plane between the aorta and the left psoas muscle;&nbsp;this is worrisome for early leak. You elect to perform an aortoiliac bypass with deep vein. Regarding this procedure, which of the following statements is most accurate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:17_answer" disabled="disabled" value="0" id="q20803:17_answer0"><label for="q20803:17_answer0">a. limb occlusion is the most frequent complication</label> </div>
<div class="r1"><input type="radio" name="q20803:17_answer" disabled="disabled" value="1" id="q20803:17_answer1"><label for="q20803:17_answer1">b. amputation is reported in more than 25% of patients</label> </div>
<div class="r0"><input type="radio" name="q20803:17_answer" disabled="disabled" value="2" id="q20803:17_answer2"><label for="q20803:17_answer2">c. prior deep vein thrombosis is a relative contraindication</label> </div>
<div class="r1"><input type="radio" name="q20803:17_answer" disabled="disabled" value="3" id="q20803:17_answer3"><label for="q20803:17_answer3">d. graft disruption due to reinfection occurs in more than 25% of patients</label> </div>
<div class="r0"><input type="radio" name="q20803:17_answer" disabled="disabled" value="4" id="q20803:17_answer4"><label for="q20803:17_answer4">e. most patients have severe leg swelling</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:17_-submit" name="q20803:17_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a primary aortic infection with evidence of impending rupture; he needs definitive surgical treatment. There is lack of consensus regarding the optimal treatment strategy. The gold-standard against which other options are compared is ligation of the aorta and extraanatomic bypass. In situ reconstruction with deep veins has been reported to be successful in the treatment of a variety of both native arterial and graft infections. Autogenous deep vein reconstructions are relatively resistant to reinfection but are reportedly vulnerable to graft rupture in the setting of enteric erosion. Surprisingly, most patients do not experience significant venous morbidity. In the largest series in the literature, amputation was reported in only 7.4% of patients. Prior deep vein thrombosis is a relative contraindication. All patients should undergo duplex ultrasound evaluation of the deep veins prior to surgery to evaluate their size and quality. Limb occlusion has been reported infrequently and the long-term patency is greater than 80%. Rifampin-bonded grafts have been reported to perform well in selected patients-such as infections with low virulence organisms (e.g. Staph epidermidis).<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Modrall%20G,%20Hocking%20J,%20Timaran%20C,%20et%20al.%20ate%20incidence%20of%20chronic%20venous%20insufficiency%20after%20deep%20vein%20harvest.%20J%20Vasc%20Surg;%202007;%2046%20(3):520-5" target="_blank">Modrall G, Hocking J, Timaran C, Rosero E, Arko F, Valentine R, et al. Late incidence of chronic venous insufficiency after deep vein harvest. J Vasc Surg 2007; 46 (3):520-5.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Ali%20A,%20Modrall%20G,%20Hocking%20J,%20et%20al.%20Long-term%20results%20of%20the%20treatment%20of%20aortic%20graft%20infection%20by%20in%20situ%20replacement%20with%20femoral%20popliteal%20vein%20grafts.%20J%20Vasc%20Surg;%202009;%2050%20(1):30" target="_blank">Ali A, Modrall G, Hocking J, Valentine R, Spencer H, Eidt J, et al. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts. J Vasc Surg 2009; 50 (1):30</a>.</p>
<p>QID: 30018</p></div><div class="rightanswer">The correct answer is: prior deep vein thrombosis is a relative contraindication</div></div></div></div></div><div id="q105" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">399</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3755"><input type="hidden" name="q20803:105_:flagged" value="0"><input type="hidden" value="qaid=910989&amp;qubaid=20803&amp;qid=4938&amp;slot=105&amp;checksum=8f23aa94527c89d1caf05632322af215&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:105_:flaggedcheckbox" name="q20803:105_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q105&id=4938"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:105_:sequencecheck" value="2"><div class="qtext"><p>An 80-year-old woman presents with bilateral cyanotic toes and evidence of livedo reticularis in both of her lower extremities following cardiac catheterization. Her renal function has deteriorated to the extent that she is not a candidate for contrast-based imaging at this time. She has palpable pulses bilaterally and no evidence of deep venous thrombosis bilaterally by non-invasive imaging. Which of the following is the most appropriate treatment for this patient at this time?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:105_answer" disabled="disabled" value="0" id="q20803:105_answer0"><label for="q20803:105_answer0">a. administer urokinase systemically</label> </div>
<div class="r1"><input type="radio" name="q20803:105_answer" disabled="disabled" value="1" id="q20803:105_answer1"><label for="q20803:105_answer1">b. administer tPA systemically</label> </div>
<div class="r0"><input type="radio" name="q20803:105_answer" disabled="disabled" value="2" id="q20803:105_answer2"><label for="q20803:105_answer2">c. add an antiplatelet agent to her medication regimen</label> </div>
<div class="r1"><input type="radio" name="q20803:105_answer" disabled="disabled" value="3" id="q20803:105_answer3"><label for="q20803:105_answer3">d. initiate a 3-month course of low molecular weight heparin</label> </div>
<div class="r0"><input type="radio" name="q20803:105_answer" disabled="disabled" value="4" id="q20803:105_answer4"><label for="q20803:105_answer4">e. initiate treatment with a direct thrombin inhibitor and transition to warfarin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:105_-submit" name="q20803:105_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Cholesterol embolism syndrome is associated with catheter/guidewire manipulation and may present with end-organ ischemia secondary to arteriolar occlusion by cholesterol emboli.&nbsp; Patients may present with a constellation of symptoms, including renal failure, peripheral cyanosis, and livedo reticularis. Accepted treatment consists of supportive care and adding an antiplatelet agent. Interventional treatments (eg, angioplasty and stenting) may be required to stabilize any identifiable inciting lesion to prevent future embolization, but will not alter the course of the current event. Anticoagulation and thrombolytics are not indicated, given that they do not treat the inciting pathology and may prevent laminated thrombus from forming over the inciting lesion, resulting in the potential for continued embolization.&nbsp; Anticoagulation with a direct thrombin inhibitor followed by warfarin would be the appropriate treatment for heparin-induced thrombocytopenia.&nbsp; While not listed as an option, maintenance of hydration and diuresis may help mitigate the severity of renal dysfunction.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Curr+Atheroscler+Rep+2013%3B+15(4)%3A315." target="_blank">Quinones A, Saric M. The cholesterol emboli syndrome in atherosclerosis. Curr Atheroscler Rep 2013; 15(4):315.</a></p>
<p>QID: 30157</p></div><div class="rightanswer">The correct answer is: add an antiplatelet agent to her medication regimen</div></div></div></div></div><div id="q191" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">400</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3764"><input type="hidden" name="q20803:191_:flagged" value="0"><input type="hidden" value="qaid=911075&amp;qubaid=20803&amp;qid=4559&amp;slot=191&amp;checksum=13227df489249b9fdf681ecc2f0022f8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:191_:flaggedcheckbox" name="q20803:191_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q191&id=4559"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:191_:sequencecheck" value="2"><div class="qtext"><p>A 70 year old man presents with a two year history of worsening dizziness when using his left arm.&nbsp; On PE, his SBP on the right arm is 138/84 and on the left is 95/47.&nbsp; He has Doppler signals only at the left brachial, radial and ulnar arteries. Duplex demonstrates retrograde flow in the vertebral artery on the left.&nbsp; CT angiogram of the chest demonstrates a long segment occlusion of the left subclavian artery extending from the aortic arch to the origin of the left vertebral artery which is patent and dominant. The most appropriate management for this patient is:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:191_answer" disabled="disabled" value="0" id="q20803:191_answer0"><label for="q20803:191_answer0">a. Antegrade stenting of the proximal left subclavian artery through a femoral approach</label> </div>
<div class="r1"><input type="radio" name="q20803:191_answer" disabled="disabled" value="1" id="q20803:191_answer1"><label for="q20803:191_answer1">b. Retrograde stenting of the proximal left subclavian artery through a brachial approach</label> </div>
<div class="r0"><input type="radio" name="q20803:191_answer" disabled="disabled" value="2" id="q20803:191_answer2"><label for="q20803:191_answer2">c. Retrograde thrombectomy of the subclavian artery through a brachial cutdown</label> </div>
<div class="r1"><input type="radio" name="q20803:191_answer" disabled="disabled" value="3" id="q20803:191_answer3"><label for="q20803:191_answer3">d. Left carotid-subclavain bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:191_answer" disabled="disabled" value="4" id="q20803:191_answer4"><label for="q20803:191_answer4">e. Left carotid-subclavian transposition</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:191_-submit" name="q20803:191_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The long segment occlusion of the proximal subclavian artery in this case makes both endovascular management as well as carotid – subclavian transposition less optimal. Carotid-subclavian bypass in this instance is appropriate. In a recent analysis of extra-anatomic arch vessel reconstruction, 5 year patency of these grafts is &gt; 90% and is well tolerated in patients 70 years and older. <sup>1</sup>&nbsp; In another study evaluating surgery versus stenting, primary patency rates at 1, 3, and 5 years were 100%, 98%, and 96% for bypass and 93%, 78%, and 70% for the stent group, respectively (p&lt;0.0001). <sup>2</sup> In another study evaluating the outcomes of endovascular management of subclavian artery occlusive disease, technical success for stenosis was much greater than for occlusion (100 vs. 65%, respectively). Prosthetic bypass using PTFE appear to have longer patency than vein (95 vs. 64%).<sup> 3-4</sup></p>
<p>1.&nbsp;Byrne J, Darling RC III, Roddy SP, et al.&nbsp; Long-term outcome for extra-anatomic arch reconstruction. An analysis of 143 procedures.Eur J Vasc Endovasc Surg 2007; 35: 444-450. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17689113">http://www.ncbi.nlm.nih.gov/pubmed/17689113</a></p>
<p>2. AbuRahma AF, Bates MC, Stone PA, et al.&nbsp;Angioplasty and stenting versus carotid-subclavian bypass for the treatment of isolated subclavian artery disease. J Endovasc Ther 2007; 14(5): 698-704. <a href="http://www.ncbi.nlm.nih.gov/pubmed/17924737">http://www.ncbi.nlm.nih.gov/pubmed/17924737</a></p>
<p>3. de Vries JP, Jager LC, van den Berg JC, et al. Durability of percutaneous transluminal angioplasty for obstructive lesions of proximal subclavian artery: long-term results. J Vasc Surg 2005; 41:19–23. <a href="http://www.ncbi.nlm.nih.gov/pubmed/15696038">http://www.ncbi.nlm.nih.gov/pubmed/15696038</a></p>
<p>4. Law M, Colburn M, Moore W, et al.&nbsp; Carotid-subclavian bypass for brachiocephalic occlusive disease. Choice of conduit and long-term follow-up.&nbsp;Stroke 1995, 26; 1565-7. <a href="http://www.ncbi.nlm.nih.gov/pubmed/7660399">http://www.ncbi.nlm.nih.gov/pubmed/7660399</a></p>
<p>QID: 30336</p></div><div class="rightanswer">The correct answer is: Left carotid-subclavain bypass</div></div></div></div></div><div id="q335" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">401</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3773"><input type="hidden" name="q20803:335_:flagged" value="0"><input type="hidden" value="qaid=911219&amp;qubaid=20803&amp;qid=5128&amp;slot=335&amp;checksum=560c9ba9abf94d74ee43ea23d6e82b7d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:335_:flaggedcheckbox" name="q20803:335_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q335&id=5128"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:335_:sequencecheck" value="2"><div class="qtext"><p>A 25-year-old Hispanic woman presents with left flank pain, hematuria, proteinuria, and an abrupt elevation in her creatinine from 0.7 to 2.2 mg/dL. Abdominal ultrasonography showed an 11 cm long left kidney with no evidence of hydronephrosis. Duplex ultrasonography showed pulsatile flow in the renal artery with a "water-hammer" type of waveform. A CT angiogram was performed and is shown below. Fluid resuscitation and correction of electrolyte disorders are underway. Which of the following is the most appropriate treatment in the management of this patient?<br><br><a href="./VESAP3_files/AssetProxy_103.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_103.jpg" alt="img" width="100" height="76" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:335_answer" disabled="disabled" value="0" id="q20803:335_answer0"><label for="q20803:335_answer0">a. surgical thrombectomy with intra-arterial infusion of thrombolytic agents</label> </div>
<div class="r1"><input type="radio" name="q20803:335_answer" disabled="disabled" value="1" id="q20803:335_answer1"><label for="q20803:335_answer1">b. surgical thrombectomy of the renal vein</label> </div>
<div class="r0"><input type="radio" name="q20803:335_answer" disabled="disabled" value="2" id="q20803:335_answer2"><label for="q20803:335_answer2">c. percutaneous catheter-directed thrombectomy with thrombolysis</label> </div>
<div class="r1"><input type="radio" name="q20803:335_answer" disabled="disabled" value="3" id="q20803:335_answer3"><label for="q20803:335_answer3">d. systemic anticoagulation with unfractionated heparin</label> </div>
<div class="r0"><input type="radio" name="q20803:335_answer" disabled="disabled" value="4" id="q20803:335_answer4"><label for="q20803:335_answer4">e. systemic anticoagulation with a direct thrombin inhibitor</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:335_-submit" name="q20803:335_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Acute renal vein thrombosis (RVT), a rare form of venous thromboembolism, is frequently associated with the nephrotic syndrome and is the most common etiology for renal vein occlusion in adults. The anatomy of the renal vein is of primary importance in understanding the pathophysiological responses to renal vein thrombosis and the clinical and diagnostic presentation of patients with this condition. The reaction of the kidney to occlusion of its primary outflow vein is determined by the balance between the acuteness of the disease, the extent of the development of collateral outflow veins, involvement of one or both kidneys, and the etiology of the underlying disease. CT angiography is considered the investigation of choice; alternatives include MR angiography or catheter venography in highly selected patients, an example of which is shown below.<br><br><a href="./VESAP3_files/AssetProxy_039.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_039.jpg" alt="img" width="100" height="118" border="0" hspace="10" vspace="10"></a><br><br>As the condition is relatively uncommon, consensus on the best form of therapy for this condition has been slow to evolve. Initial therapy should include correction of any fluid and electrolyte imbalances, dialysis if indicated, antihypertensive medication, and systemic anti-coagulation. Systemic anticoagulation is achieved with intravenous unfractionated heparin unless there is evidence of heparin-induced thrombocytopenia, in which case a direct thrombin inhibitor, such as one of the hirudin derivatives or argatroban, should be substituted for heparin. In patients without contraindications, percutaneous catheter-directed thrombectomy (with or without thrombolysis) for acute RVT is associated with a rapid improvement in renal function and a low incidence of morbidity. Deteriorating renal function is a compelling indication for this approach. Surgical thrombectomy is rarely used since renal parenchymal thrombus is not cleared with surgical thrombectomy and commonly leads to failure of this approach. Regardless of the initial approach, all patients should undergo a workup for hypercoagulable states and receive warfarin therapy for an undetermined period of time (at least 3 months, and longer if a hypercoaguable state or underlying cancer is diagnosed). <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Eur+J+Vasc+Endovasc+Surg%3B+2007%3B+34+(2)%3A217-23" target="_blank">Asghar M, Ahmed K, Shah SS, Siddique MK<span>,&nbsp;</span>Dasgupta P<span>,&nbsp;</span>Khan MS. Renal vein thrombosis. Eur J Vasc Endovasc Surg 2007; 34 (2):217-23.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2006%3B+17+(5)%3A815-22." target="_blank">Kim HS, Fine DM, Atta MG. Catheter-directed thrombectomy and thrombolysis for acute renal vein thrombosis. J Vasc Interv Radiol 2006; 17 (5):815-22.</a></p>
<p>QID: 30601</p></div><div class="rightanswer">The correct answer is: percutaneous catheter-directed thrombectomy with thrombolysis</div></div></div></div></div><div id="q447" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">402</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3782"><input type="hidden" name="q20803:447_:flagged" value="0"><input type="hidden" value="qaid=911331&amp;qubaid=20803&amp;qid=5164&amp;slot=447&amp;checksum=6ecb60e8e7c53114a2f45be37bfb69c2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:447_:flaggedcheckbox" name="q20803:447_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q447&id=5164"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:447_:sequencecheck" value="2"><div class="qtext"><p>A 57-year-old car salesman presents with left thigh and buttock pain with ambulation that limit him at work. His pain free walking distance is 150 feet with an absolute claudication distance of 300 feet. He quit smoking 1 year ago. Femoral pulses are not palpable.&nbsp;Which of the following alternatives is <strong>least</strong>&nbsp;likely to provide symptomatic improvement?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:447_answer" disabled="disabled" value="0" id="q20803:447_answer0"><label for="q20803:447_answer0">a. arteriography and percutaneous intervention if symptoms worsen after a 3 month trial of supervised exercise</label> </div>
<div class="r1"><input type="radio" name="q20803:447_answer" disabled="disabled" value="1" id="q20803:447_answer1"><label for="q20803:447_answer1">b. stenting occluded external iliac arteries</label> </div>
<div class="r0"><input type="radio" name="q20803:447_answer" disabled="disabled" value="2" id="q20803:447_answer2"><label for="q20803:447_answer2">c. a 4-day per week supervised treadmill exercise program without cilostazol</label> </div>
<div class="r1"><input type="radio" name="q20803:447_answer" disabled="disabled" value="3" id="q20803:447_answer3"><label for="q20803:447_answer3">d. a supervised treadmill exercise program in conjunction with resistance training</label> </div>
<div class="r0"><input type="radio" name="q20803:447_answer" disabled="disabled" value="4" id="q20803:447_answer4"><label for="q20803:447_answer4">e. cilostazol 50 mg daily in conjunction with a twice weekly supervised treadmill exercise program with 20 minutes of treadmill walking</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:447_-submit" name="q20803:447_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The initial approach to the treatment of claudication focuses on structured exercise and, in selected patients, pharmacotherapy to treat the exercise limitations. Failure to respond to exercise and/or drug therapy would prompt consideration for limb revascularization.</p>
<p>However, in patients in whom a proximal (iliac artery) lesion is suspected (findings of buttocks claudication, reduced or absent femoral pulse), the patient could be considered for revascularization without initially undergoing extensive medical therapy. Considerable evidence supports the clinical benefits of a supervised exercise program in improving exercise performance and community-based walking ability. Although selected pharmacotherapy (such as cilostazol) has shown efficacy in the treatment of claudication, exercise therapy remains the cornerstone of therapy; many patients can continue to derive the benefit of an exercise program if they are intolerant of pharmacotherapy.</p>
<p>Several studies have suggested that some level of supervision is necessary to achieve optimal results (general, unstructured recommendations to exercise by the physician do not result in any clinical benefit). In prospective studies of supervised exercise conducted for 3 months or longer, there are clear increases in treadmill exercise performance and a lessening of claudication pain severity during exercise. Training on a treadmill has been shown to be more effective than strength training. However, the addition of lower extremity resistance training in one study improved functional performance, measured by treadmill walking, quality of life, and stair climbing ability.</p>
<p>The exercise prescription should be based on exercise sessions that are held at least 3 times a week, beginning with 30 minutes of training and then increasing to approximately 1 hour per session. During the exercise session, treadmill exercise is performed at a speed and grade that will induce claudication within 3-5 minutes. The patient should stop walking when claudication pain is considered moderate (a less optimal training response will occur when the patient stops at the onset of claudication). The patient will then rest until claudication has abated, after which the patient should resume walking until moderate claudication discomfort recurs.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17223489" target="_blank">Norgren L, Hiatt WR. Dormandy JA, Nehler MR<span>,&nbsp;</span>Harris KA<span>,&nbsp;</span>Fowkes FG,<span>&nbsp;</span>et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(1):S5-S67.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2009%3B+301+(2)%3A165-74." target="_blank">McDermott MM, Ades P<span>,&nbsp;</span>Guralnik JM<span>,&nbsp;</span>Dyer A<span>,&nbsp;</span>Ferrucci L<span>,&nbsp;</span>Liu K, et al&nbsp;Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: A randomized controlled trial. JAMA 2009; 301 (2):165-74.</a></p>
<p>QID: 30804</p></div><div class="rightanswer">The correct answer is: cilostazol 50 mg daily in conjunction with a twice weekly supervised treadmill exercise program with 20 minutes of treadmill walking</div></div></div></div></div><div id="q522" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">403</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3791"><input type="hidden" name="q20803:522_:flagged" value="0"><input type="hidden" value="qaid=911406&amp;qubaid=20803&amp;qid=5258&amp;slot=522&amp;checksum=7625d4da0fd0936d9160220c524dfcd3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:522_:flaggedcheckbox" name="q20803:522_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q522&id=5258"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:522_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is consistent with the ALARA principles?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:522_answer" disabled="disabled" value="0" id="q20803:522_answer0"><label for="q20803:522_answer0">a. utilize pulse rate fluoroscopy at a rate of 30 pulse/s rather than continuous fluoroscopy</label> </div>
<div class="r1"><input type="radio" name="q20803:522_answer" disabled="disabled" value="1" id="q20803:522_answer1"><label for="q20803:522_answer1">b. reduce the field of view by closing collimators</label> </div>
<div class="r0"><input type="radio" name="q20803:522_answer" disabled="disabled" value="2" id="q20803:522_answer2"><label for="q20803:522_answer2">c. use geometric magnification whenever possible</label> </div>
<div class="r1"><input type="radio" name="q20803:522_answer" disabled="disabled" value="3" id="q20803:522_answer3"><label for="q20803:522_answer3">d. use high dose fluoroscopy at a rate of 20 R/min</label> </div>
<div class="r0"><input type="radio" name="q20803:522_answer" disabled="disabled" value="4" id="q20803:522_answer4"><label for="q20803:522_answer4">e. use steep angle projections</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:522_-submit" name="q20803:522_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In general, pulse rate fluoroscopy decreases radiation exposure by decreasing exposure time and decreasing blurriness of the image by giving short bursts of xray.&nbsp; However, if the pulse rate is increased to 30 pulse/s then the radiation dose is roughly equivalent to continuous fluoroscopy. &nbsp;Normal dose fluoroscopy uses rates of &lt;10 R/min and should be used preferentially over high dose fluoroscopy for all procedures, unless very high detail is needed. &nbsp;Geometric magnification moves the image intensifier away from the patient to give a magnified image. This maneuver increases the radiation dose to the patient, increases xray scatter, reduces image quality, and should not be used if possible. &nbsp;A steep angle projection requires higher radiation to get adequate penetration &nbsp;through a thicker tissue path.&nbsp; These projections require a higher dose and should only be used when absolutely necessary.</p>
<p>The larger the field of view, the more radiation the patient and operator receive. Closing the collimators reduces exposure for all and results in a sharper image.</p>
<p>&nbsp;</p>
<p>References:</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Ultrasound+CT+MR+2002%3B+23%3A428-42." target="_blank">MettlerFA, KoenigTR, WagnerLK, KelseyCA. Radiation injuries after fluoroscopic procedures. Semin Ultrasound CT MR 2002; 23:428-42.</a></p>
<p>Bushberg J, Seibert A, Leidholdt E, Boone J. The essential physics of medical imaging. 2nd ed. Philadelphia: Lippincott, Williams &amp; Wilkins; 2002.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Brit+J+Radiol+1992%3B+65%3A44-9." target="_blank">Marshall NW, Faulkner K. The dependence of the scattered radiation dose to personnel on technique factors in diagnostic radiology. Brit J Radiol 1992; 65:44-9.</a></p>
<p>QID: 30926</p></div><div class="rightanswer">The correct answer is: reduce the field of view by closing collimators</div></div></div></div></div><div id="q454" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">404</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3800"><input type="hidden" name="q20803:454_:flagged" value="0"><input type="hidden" value="qaid=911338&amp;qubaid=20803&amp;qid=5172&amp;slot=454&amp;checksum=25e9986b020759f8ea201bd6a5aa81c1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:454_:flaggedcheckbox" name="q20803:454_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q454&id=5172"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:454_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is <strong>not</strong>&nbsp;a pleotropic effect associated with statins?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:454_answer" disabled="disabled" value="0" id="q20803:454_answer0"><label for="q20803:454_answer0">a. down regulation of angiotensinogen production</label> </div>
<div class="r1"><input type="radio" name="q20803:454_answer" disabled="disabled" value="1" id="q20803:454_answer1"><label for="q20803:454_answer1">b. improved endothelial function</label> </div>
<div class="r0"><input type="radio" name="q20803:454_answer" disabled="disabled" value="2" id="q20803:454_answer2"><label for="q20803:454_answer2">c. modulation of inflammatory responses</label> </div>
<div class="r1"><input type="radio" name="q20803:454_answer" disabled="disabled" value="3" id="q20803:454_answer3"><label for="q20803:454_answer3">d. prevention of thrombus formation</label> </div>
<div class="r0"><input type="radio" name="q20803:454_answer" disabled="disabled" value="4" id="q20803:454_answer4"><label for="q20803:454_answer4">e. maintenance of plaque stability</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:454_-submit" name="q20803:454_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>In addition to the cholesterol lowering properties of statins, these medications have also been shown to improve endothelial function, modulate inflammatory responses, maintain plaque stability, and prevent thrombus formation in experimental models. These non-cholesterol lowering effects (known as pleotropic effects) are believed to be responsible for some of the cardiovascular benefits observed with statin medications.</p>
<p>The ability to down regulate the formation of angiotensinogen has not been shown to be a property of statin medications.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Furberg%20CD.%20Natural%20statins%20and%20stroke%20risk.%20Circulation;%201999;%2099%20(2):185-188" target="_blank">Furberg CD. Natural statins and stroke risk. Circulation 1999; 99 (2):185-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2006%3B+295+(5)%3A547-53." target="_blank">Hankey GJ, Norman PE, Eikelboon JW. Medical treatment of peripheral arterial disease. JAMA 2006; 295 (5):547-53.</a></p>
<p>QID: 30812</p></div><div class="rightanswer">The correct answer is: down regulation of angiotensinogen production</div></div></div></div></div><div id="q429" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">405</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3809"><input type="hidden" name="q20803:429_:flagged" value="0"><input type="hidden" value="qaid=911313&amp;qubaid=20803&amp;qid=4873&amp;slot=429&amp;checksum=c9c4942ab19c0d2bc7524eb0ef4cfd5c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:429_:flaggedcheckbox" name="q20803:429_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q429&id=4873"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:429_:sequencecheck" value="2"><div class="qtext"><p>When performing thrombolysis for acute iliofemoral deep venous thrombosis, the use of pharmacomechanical ("combination") thrombectomy devices, instead of a simple infusion catheter, results in which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:429_answer" disabled="disabled" value="0" id="q20803:429_answer0"><label for="q20803:429_answer0">a. greater preservation of valve function</label> </div>
<div class="r1"><input type="radio" name="q20803:429_answer" disabled="disabled" value="1" id="q20803:429_answer1"><label for="q20803:429_answer1">b. avoidance of the need for peri-procedural heparin</label> </div>
<div class="r0"><input type="radio" name="q20803:429_answer" disabled="disabled" value="2" id="q20803:429_answer2"><label for="q20803:429_answer2">c. shorter duration of treatment</label> </div>
<div class="r1"><input type="radio" name="q20803:429_answer" disabled="disabled" value="3" id="q20803:429_answer3"><label for="q20803:429_answer3">d. increased doses of thrombolytic drug</label> </div>
<div class="r0"><input type="radio" name="q20803:429_answer" disabled="disabled" value="4" id="q20803:429_answer4"><label for="q20803:429_answer4">e. more complete thrombolysis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:429_-submit" name="q20803:429_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>A host of endovascular thrombolytic devices that combine pharmacologic and mechanical mechanisms of action, termed "combination thrombectomy" devices, are now available.&nbsp; Through a variety of methods, they actively mix the lytic drug into the clot. After waiting 10-20 minutes to allow the lytic agent to work, the mechanical action can once again be used to further churn the liquefied clot and, ultimately, extract it. The primary advantage of these "combination" thrombectomy devices is shorter treatment times, which results in a reduction in the amount of thrombolytic drug infused. Often, these devices can be used to remove acute deep venous thrombosis in a single setting, though perhaps not as completely as after a more prolonged infusion of lytic agent. Nonetheless, in the venous circulation this is usually sufficient. While thrombolytic therapy by any means is believed to preserve valve function better than simple anticoagulation, no difference has been noted between the various methods of thrombolysis.</p>
<p>Standard multi-hole catheters infusing the lytic drug into the thrombus required longer infusion times (sometimes 2-3 days) and overall much higher doses of lytic drug. This can increase the risk of both access site and systemic bleeding complications. With either method, low dose heparin infusion is given, followed by full anticoagulation once lysis is finished.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Phlebology+2012%3B27+Suppl+2%3A61-72." target="_blank">Nyamekye I, Merker L. Management of proximal deep venous thrombosis. Phlebology 2012;27 Suppl 2:61-72.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Hematol+2012%3B87+Suppl+1%3AS113-8." target="_blank">Vedantham S. Interventional approaches to deep vein thrombosis. Am J Hematol 2012;87 Suppl 1:S113-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2004%3B15%3A565-74." target="_blank">Vedantham S, Veseley TM, Sicard GA, Brown D<span>,&nbsp;</span>Rubin B<span>,&nbsp;</span>Sanchez LA,&nbsp;et al. Pharmacomechanical thrombolysis and early stent placement for iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2004;15:565-74.</a></p>
<p>QID: 30754</p></div><div class="rightanswer">The correct answer is: shorter duration of treatment</div></div></div></div></div><div id="q179" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">406</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3818"><input type="hidden" name="q20803:179_:flagged" value="0"><input type="hidden" value="qaid=911063&amp;qubaid=20803&amp;qid=4684&amp;slot=179&amp;checksum=78072ec19af43655d4edafb23a6155ef&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:179_:flaggedcheckbox" name="q20803:179_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q179&id=4684"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:179_:sequencecheck" value="2"><div class="qtext"><p>Eversion endarterectomy is used as an alternative to conventional endarterectomy. Which of the following statements regarding eversion endarterectomy is true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:179_answer" disabled="disabled" value="0" id="q20803:179_answer0"><label for="q20803:179_answer0">a. <p>it results in&nbsp;worsening of&nbsp;tortuosity within&nbsp;the ICA</p></label> </div>
<div class="r1"><input type="radio" name="q20803:179_answer" disabled="disabled" value="1" id="q20803:179_answer1"><label for="q20803:179_answer1">b. <p>It precludes the use of a shunt</p></label> </div>
<div class="r0"><input type="radio" name="q20803:179_answer" disabled="disabled" value="2" id="q20803:179_answer2"><label for="q20803:179_answer2">c. <p>it is preferred&nbsp;for plaques that extend into the distal ICA</p></label> </div>
<div class="r1"><input type="radio" name="q20803:179_answer" disabled="disabled" value="3" id="q20803:179_answer3"><label for="q20803:179_answer3">d. it has similar long-term results to conventional endarterectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:179_answer" disabled="disabled" value="4" id="q20803:179_answer4"><label for="q20803:179_answer4">e. patch reconstruction decreases restenosis rates</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:179_-submit" name="q20803:179_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The initial description of eversion endarterectomy&nbsp;involved transection of the CCA, however, due to difficulties in managing the bifurcation it was modified to transecting the ICA at the bifurcation. A shunt can be used but care must be taken to avoid an&nbsp;intimal flap at the distal&nbsp;point of&nbsp;endarterectomy.&nbsp;&nbsp;In comparison to conventional endarterectomy,&nbsp;eversion endarterectomy in the EVEREST (EVERsion carotid Endarterectomy versus Standard Trial) trial showed similar rates&nbsp;of perioperative major stroke and death, neck hematoma, and early carotid occlusion. The restenosis rate was 2.4% in the eversion group and 4.1% in the endarterectomy group. One of the advantages of the eversion technique&nbsp;is that it does not require a patch. In addition, it particularly appropriate in patients with excessive tortuosity&nbsp;or kinks since the excessive length&nbsp;can be excised prior to reimplantation of the ICA.&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cao+P%2C+Giordano+G%2C+De+Rango+P%2C+et+al.+Eversion+versus+conventional+carotid+endarterectomy%3A+late+results+of+a+prospective+multicenter+randomized+trial.+J+Vasc+Surg+2000%3B+31(1+pt+1)%3A19-30." target="_blank">Cao P, Giordano G, De Rango P,&nbsp;Zannetti S,&nbsp;Chiesa R,&nbsp;Coppi G,&nbsp;et al. Eversion versus conventional carotid endarterectomy: late results of a prospective multicenter randomized trial. J Vasc Surg 2000; 31(1):19-30.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Koskas+F%2C+Kieffer+E%2C+Bahnini+A%2C+et+al.+Carotid+eversion+endarterectomy%3A+short-+and+long-term+results.+Ann+Vasc+Surg+1995%3B+9(1)%3A+9-15." target="_blank">Koskas F, Kieffer E, Bahnini A, Ruotolo C,&nbsp;Rancurel G. Carotid eversion endarterectomy: short- and long-term results. Ann Vasc Surg 1995; 9(1): 9-15.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Shah+DM%2C+Darling+RC+3rd%2C+Chang+BB%2C+et+al.+Carotid+endarterectomy+by+eversion+technique%3A+its+safety+and+durability.+Ann+Surg+1998%3B+228(4)%3A471-8." target="_blank">Shah DM, Darling RC 3rd, Chang BB, Paty PS,&nbsp;Kreienberg PB,&nbsp;Lloyd WE,&nbsp;et al. Carotid endarterectomy by eversion technique: its safety and durability. Ann Surg 1998; 228(4):471-8.</a><a style="LINE-HEIGHT: 1.5" href="http://www.ncbi.nlm.nih.gov/pubmed/9790337">&nbsp;</a>&nbsp;</p>
<p>The correct answer is: it has similar rates of restenosis compared to conventional endarterectomy.</p>
<p>QID: 30322</p></div><div class="rightanswer">The correct answer is: it has similar long-term results to conventional endarterectomy</div></div></div></div></div><div id="q426" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">407</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3827"><input type="hidden" name="q20803:426_:flagged" value="0"><input type="hidden" value="qaid=911310&amp;qubaid=20803&amp;qid=4870&amp;slot=426&amp;checksum=28ffd1f2b57be7f156d5934cf0e6d058&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:426_:flaggedcheckbox" name="q20803:426_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q426&id=4870"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:426_:sequencecheck" value="2"><div class="qtext"><p>A 17-year-old volleyball player presents with acute edema and pain in her right upper extremity. Examination reveals a markedly swollen arm with dilated peripheral veins and mild bluish mottling. Pulse examination and motor function are normal. Duplex ultrasound demonstrates acute deep venous thrombosis involving the brachial, axillary, and subclavian veins. After successful selective catheter thrombolysis her symptoms completely resolve and venography shows normal flow through the vein with some moderate subclavian vein obstruction when the arm is abducted. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:426_answer" disabled="disabled" value="0" id="q20803:426_answer0"><label for="q20803:426_answer0">a. self-expanding stenting of the subclavian vein across the thoracic outlet, followed by full warfarin anticoagulation for 6 months</label> </div>
<div class="r1"><input type="radio" name="q20803:426_answer" disabled="disabled" value="1" id="q20803:426_answer1"><label for="q20803:426_answer1">b. anterior approach to first rib removal with external venolysis and possible patch venoplasty after 6 weeks of full anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:426_answer" disabled="disabled" value="2" id="q20803:426_answer2"><label for="q20803:426_answer2">c. full anticoagulation with subcutaneous fractionated heparin for 6 weeks with return to endovascular suite for repeat venography</label> </div>
<div class="r1"><input type="radio" name="q20803:426_answer" disabled="disabled" value="3" id="q20803:426_answer3"><label for="q20803:426_answer3">d. transaxillary first rib removal with external venolysis during the same hospitalization</label> </div>
<div class="r0"><input type="radio" name="q20803:426_answer" disabled="disabled" value="4" id="q20803:426_answer4"><label for="q20803:426_answer4">e. balloon angioplasty of the subclavian vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:426_-submit" name="q20803:426_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>While some of the listed options have been recommended for the treatment of Paget-Schroetter Syndrome in the past, evidence is mounting that early rib removal is the best treatment due to recurrent deep venous thrombosis in 30–89% of patients over a 6-week period of time. The optimal approach to first rib removal with external venolysis depends on several factors. These include surgeon skill and comfort, and the degree of residual stenosis and chronic changes in the subclavian vein across the thoracic outlet. In this patient there are minimal changes observed on the venogram, and transaxillary first rib removal should negate any further compression risk in the abducted position. A minimum of 6 weeks of anticoagulation should still be given, as well as repeat venogram to assure no residual stenosis.</p>
<p>For those patients who have significant residual stenosis after thrombolysis, typically resulting from long-term chronic compression of the subclavian vein, other approaches may be more optimal. These include the anterior approach to first rib removal with external venolysis and possible patch venoplasty or venous interposition grafting. Alternatively, some may perform angioplasty of the subclavian vein, with or without stenting, followed by either transaxillary or anterior approach first rib removal. Given the patient’s age, stenting would not be a first choice if surgical decompression of the thoracic outlet could be safely performed. Lastly, all aspects being equal, the transaxillary approach does afford a better cosmetic result.</p>
<p>&nbsp;</p>
<h2><strong>References</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Thoracic+outlet+syndrome%3A+a+50-year+experience+at+Baylor+University+Medical+Center" target="_blank">Urschel HC, Kourlis H. Thoracic outlet syndrome: a 50-year experience at Baylor University Medical Center. Proc (Bayl Univ Med Cent) 2007;20:125-35.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br+J+Surg+2013%3B100%3A1459-64." target="_blank">Taylor JM, Telford RJ, Kinsella DC, Watkinson AF, Thompson JF. Long-term clinical and functional outcome following treatment for Paget-Schroetter Syndrome. Br J Surg 2013;100:1459-64.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Comprehensive+surgical+management+of+the+competitive+athlete+with+effort+thrombosis+of+the+subclavian+vein+(Paget-Schroetter+Syndrome)." target="_blank">Melby SJ, Vedantham S, Narra VR, Paletta GA Jr, Khoo-Summers L, Driskill M, et al. Comprehensive surgical management of the competitive athlete with effort thrombosis of the subclavian vein (Paget-Schroetter Syndrome). J Vasc Surg 2008;47:809-20.</a></p>
<p>QID: 30751</p></div><div class="rightanswer">The correct answer is: transaxillary first rib removal with external venolysis during the same hospitalization</div></div></div></div></div><div id="q235" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">408</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3836"><input type="hidden" name="q20803:235_:flagged" value="0"><input type="hidden" value="qaid=911119&amp;qubaid=20803&amp;qid=1286&amp;slot=235&amp;checksum=918744420dd2a7ea1feae62048378466&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:235_:flaggedcheckbox" name="q20803:235_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q235&id=1286"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:235_:sequencecheck" value="2"><div class="qtext"><p>A 70 year old woman with end-stage renal disease (ESRD) presents to the office for follow-up 2 weeks after placement of a left prosthetic brachial artery-axillary vein&nbsp;upper arm straight access. Her history is significant for multiple previous failed attempts at left upper extremity arteriovenous (AV) access; she is currently being dialyzed via a left internal jugular long-term dialysis catheter. On physical examination of her left arm, she has no thrill or bruit in her graft or AV access outflow, moderate edema, and palpable radial, ulnar, and brachial artery pulses. What is the best strategy to restore permanent AV access in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:235_answer" disabled="disabled" value="0" id="q20803:235_answer0"><label for="q20803:235_answer0">a. percutaneous thrombolysis using lyse-and-wait technique and angioplasty of the graft-axillary vein anastomosis</label> </div>
<div class="r1"><input type="radio" name="q20803:235_answer" disabled="disabled" value="1" id="q20803:235_answer1"><label for="q20803:235_answer1">b. open surgical thrombectomy with patch angioplasty of the graft-axillary vein anastomosis</label> </div>
<div class="r0"><input type="radio" name="q20803:235_answer" disabled="disabled" value="2" id="q20803:235_answer2"><label for="q20803:235_answer2">c. percutaneous thrombolysis using cross catheter technique and post-operative anticoagulation</label> </div>
<div class="r1"><input type="radio" name="q20803:235_answer" disabled="disabled" value="3" id="q20803:235_answer3"><label for="q20803:235_answer3">d. percutaneous mechanical thrombectomy and post-operative anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:235_answer" disabled="disabled" value="4" id="q20803:235_answer4"><label for="q20803:235_answer4">e. open surgical thrombectomy with venogram and subclavian vein angioplasty</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:235_-submit" name="q20803:235_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Access failure that occurs within 30 days of surgery is defined as early access failure. In the absence of a technical failure, such as a twisted or stenotic anastomosis, it is most commonly associated with inadequate venous outflow which may be secondary to inadequate caliber of the outflow vein or central venous stenosis. In this patient, with a history of multiple previous access attempts, a central line in place, and arm edema, the most likely cause is central venous stenosis. Other less common causes include poor arterial inflow, anastomotic stenosis, or a hypercoagulable state. Unlike autogenous access, thrombectomies and thrombolysis may be successful to restore patency of a prosthetic AV access; however, the underlying problem must also be treated. Simple anticoagulation will not solve the technical problem of a central venous stenosis. Open surgical thrombectomy with venogram and subclavian vein angioplasty will reopen the prosthetic AV access and treat the underlying technical problem. Stenosis of the graft-axillary vein anastomosis is seen with late access thrombosis, usually 1 to 2 years after access placement and is due to intimal hyperplasia.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank">Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg; 2008; 48 (S):55S-80S.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Sidawy%20AN,%20Spergel%20LM,%20Besarab%20A,%20et%20al.%20The%20Society%20for%20Vascular%20Surgery:%20Clinical%20practice%20guidelines%20for%20the%20surgical%20placement%20and%20maintenance%20of%20arteriovenous%20hemodialysis%20access.%20J%20Vasc%20Surg;%202008;%2048%20(5S):2S-25S" target="_blank">Sidawy AN, Spergel LM, Besarab A, et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg; 2008; 48 (5S):2S-25S</a>.</p>
<p>QID: 30413</p></div><div class="rightanswer">The correct answer is: open surgical thrombectomy with venogram and subclavian vein angioplasty</div></div></div></div></div><div id="q471" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">409</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3845"><input type="hidden" name="q20803:471_:flagged" value="0"><input type="hidden" value="qaid=911355&amp;qubaid=20803&amp;qid=5195&amp;slot=471&amp;checksum=7b74d5c72d967e639e8e8b525355aa5a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:471_:flaggedcheckbox" name="q20803:471_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q471&id=5195"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:471_:sequencecheck" value="2"><div class="qtext"><p>Which herbal supplement is <strong>least</strong>&nbsp;likely to increase the risk of peri-operative bleeding?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:471_answer" disabled="disabled" value="0" id="q20803:471_answer0"><label for="q20803:471_answer0">a. ginseng</label> </div>
<div class="r1"><input type="radio" name="q20803:471_answer" disabled="disabled" value="1" id="q20803:471_answer1"><label for="q20803:471_answer1">b. St John's wort</label> </div>
<div class="r0"><input type="radio" name="q20803:471_answer" disabled="disabled" value="2" id="q20803:471_answer2"><label for="q20803:471_answer2">c. ephedra</label> </div>
<div class="r1"><input type="radio" name="q20803:471_answer" disabled="disabled" value="3" id="q20803:471_answer3"><label for="q20803:471_answer3">d. garlic</label> </div>
<div class="r0"><input type="radio" name="q20803:471_answer" disabled="disabled" value="4" id="q20803:471_answer4"><label for="q20803:471_answer4">e. ginkgo</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:471_-submit" name="q20803:471_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Vascular surgeons should understand which herbal supplements are being used by their patients, as several supplements are known to have potentially harmful effects in the peri-operative period. Bleeding risks are of particular concern.</p>
<p>Approximately 12% of the US population uses supplements, but use may be higher among patients undergoing surgery. Furthermore, because patients may not report herbal supplement use, it is important for healthcare providers to specifically ask preoperative patients about their use. It is also important to recognize that herbal supplements are not subject to the same FDA scrutiny regarding safety and efficacy as over-the-counter and prescription drugs, and that different preparations of the same supplement can have variable effects.</p>
<p>Garlic, ginkgo, and ginseng can all effect platelet function. For garlic and ginseng, the effects can be irreversible, whereas for ginkgo, the effects are reversible. Therefore, for major surgical procedures with a significant bleeding risk, ginkgo should be held for at least 2 days, and garlic and ginseng should be held for at least a week.</p>
<p>Ephedra, known as ma huang in Chinese medicine, contains alkaloids such as ephedrine, pseudoephedrine, and norephedrine. Ephedra causes an increase in blood pressure and heart rate and can therefore cause increased bleeding via its sympathomimetic effects.</p>
<p>St John's wort is an herb that is used for the treatment of depression. St John’s wort does not have anticoagulant effects.&nbsp;It induces the cytochrome P450 system, which may increase metabolism of many prescription drugs, including warfarin. Thus, it may decrease the anticoagulant effectiveness of warfarin.&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA.+2001%3B+286(2)%3A208-16." target="_blank">Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA. 2001; 286(2):208-16.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Drugs.+2005%3B65(9)%3A1239-82." target="_blank">Hu Z, Yang X, Ho PC, Chan SY, Heng PW, Chan E, et al. Herb-drug interactions: a literature review. Drugs 2005;65(9):1239-82.</a>&nbsp;</p>
<p>QID: 30834</p></div><div class="rightanswer">The correct answer is: St John's wort</div></div></div></div></div><div id="q425" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">410</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3854"><input type="hidden" name="q20803:425_:flagged" value="0"><input type="hidden" value="qaid=911309&amp;qubaid=20803&amp;qid=4869&amp;slot=425&amp;checksum=0fdbae66f4abab88835f857ce647273a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:425_:flaggedcheckbox" name="q20803:425_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q425&id=4869"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:425_:sequencecheck" value="2"><div class="qtext"><p>A 46-year-old woman, G3P2, presents with an approximate 10-year history of worsening left leg pain and moderate edema. Symptoms began after her last pregnancy and have increasingly progressed over the past 12 months. There is no known history of deep venous thrombosis. Symptoms include heaviness and diffuse aching that increases throughout the day and does not seem to be exacerbated with activity. Exam shows the left leg with diffuse non-pitting edema, with the calf measuring 1.5 cm larger in circumference than the right. The foot is spared of edema and there is no evidence of varicose veins. Which of the following is the most probably diagnosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:425_answer" disabled="disabled" value="0" id="q20803:425_answer0"><label for="q20803:425_answer0">a. chronic left common and external iliac vein obstruction from occult deep venous thrombosis during pregnancy</label> </div>
<div class="r1"><input type="radio" name="q20803:425_answer" disabled="disabled" value="1" id="q20803:425_answer1"><label for="q20803:425_answer1">b. lipoedema</label> </div>
<div class="r0"><input type="radio" name="q20803:425_answer" disabled="disabled" value="2" id="q20803:425_answer2"><label for="q20803:425_answer2">c. iliac vein compression syndrome (May-Thurner syndrome)</label> </div>
<div class="r1"><input type="radio" name="q20803:425_answer" disabled="disabled" value="3" id="q20803:425_answer3"><label for="q20803:425_answer3">d. Klippel-Trenaunay syndrome</label> </div>
<div class="r0"><input type="radio" name="q20803:425_answer" disabled="disabled" value="4" id="q20803:425_answer4"><label for="q20803:425_answer4">e. lymphedema</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:425_-submit" name="q20803:425_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>All of the clinical entities can cause unilateral edema of the lower extremity. Iliac vein compression syndrome, or May-Thurner Syndrome, is the most likely diagnosis given the constellation of symptoms and examination findings. The most common place for compression of venous outflow is where the right common iliac artery crosses the left common iliac vein anteriorly; it pinches it against the sacral promontory. There are other areas where iliac vein compression can occur. It's less frequent, but another area includes where the left internal iliac artery crosses over the border of the left common and external iliac veins. The right external iliac vein can become compressed as it crosses posteriorly and medially to the right external iliac artery, which traverses medially to laterally.</p>
<p>The criterion standard for diagnosis of iliac vein compression syndrome is intravascular ultrasound. While no strict criteria exist as to what constitutes a significant stenosis, greater than 50% stenosis from compression is thought to be significant. Treatment consists of stenting followed by angioplasty of the stenotic area. Venography can be suggestive of a venous stenosis due to visualization of collaterals and a splaying out of the vessel, but in the absence of these findings, intravascular ultrasound is still necessary to make the diagnosis.</p>
<p>&nbsp;</p>
<h2><span style="text-decoration: underline;">References</span></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2010%3B51%3A401-8." target="_blank">Raju S, Darcey R, Neglén P. Unexpected major role for venous stenting in deep venous reflux. J Vasc Surg 2010;51:401-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Stenting+of+the+venous+outflow+in+chronic+venous+disease%3A+long-term+stent-related+outcome%2C+clinical%2C+and+hemodynamic+result." target="_blank">Neglén P, Hollis KC, Olivier J, Raju S. Stenting of the venous outflow in chronic venous disease: long-term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg 2007;46:979-90.</a></p>
<p>QID: 30750</p></div><div class="rightanswer">The correct answer is: iliac vein compression syndrome (May-Thurner syndrome)</div></div></div></div></div><div id="q36" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">411</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3863"><input type="hidden" name="q20803:36_:flagged" value="0"><input type="hidden" value="qaid=910920&amp;qubaid=20803&amp;qid=4646&amp;slot=36&amp;checksum=641df3cd36aa3a1df89626698acf4caf&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:36_:flaggedcheckbox" name="q20803:36_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q36&id=4646"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:36_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old man presents 6 years after aortobifemoral bypass graft with fevers, malaise, and physical decline. His WBC, inflammatory markers, and axial imaging are all consistent with late graft infection. There is no evidence of aortoduodenal fistula. Which of the following is the most common pathogen for late graft infection?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:36_answer" disabled="disabled" value="0" id="q20803:36_answer0"><label for="q20803:36_answer0">a. anaerobic infection</label> </div>
<div class="r1"><input type="radio" name="q20803:36_answer" disabled="disabled" value="1" id="q20803:36_answer1"><label for="q20803:36_answer1">b. staphylococcus infection</label> </div>
<div class="r0"><input type="radio" name="q20803:36_answer" disabled="disabled" value="2" id="q20803:36_answer2"><label for="q20803:36_answer2">c. candida infection</label> </div>
<div class="r1"><input type="radio" name="q20803:36_answer" disabled="disabled" value="3" id="q20803:36_answer3"><label for="q20803:36_answer3">d. pseudomonas infection</label> </div>
<div class="r0"><input type="radio" name="q20803:36_answer" disabled="disabled" value="4" id="q20803:36_answer4"><label for="q20803:36_answer4">e. streptococcus infection</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:36_-submit" name="q20803:36_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Late aortic graft infection is most likely secondary to Staphylococcal infections.&nbsp;Staph. epidermis and Staph. aureus occur in equal frequency, accounting for 50% of all late graft infections.&nbsp;Staph. epidermis has the ability to adhere to biomaterials and create a biofilm on the surface of prostheses that evades the immune system.&nbsp;Due to the biofilm and slow growth rate, these patients typically do not present with sepsis; instead, they present with failure to thrive from the indolent infection. In addition, methicilin-resistant Staphylococcus infection has also increased dramatically, accounting for 50-70% of Staph. aureus infections. This has led several centers to adjust their prophylactic antibiotic regimen accordingly.&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ali+AT%2C+Modrall+JG%2C+Hocking+J%2C+Valentine+RJ%2C+Spencer+H%2C+Eidt+JF%2C+Clagett+GP.+Long-term+results+of+the+treatment+of+aortic+graft+infection+by+in+situ+replacement+with+femoral+popliteal+vein+grafts.+J+Vasc+Surg.+2009+Jul%3B50(1)%3A30-9." target="_blank">Ali AT, Modrall JG, Hocking J, Valentine RJ, Spencer H, Eidt JF, Clagett GP. Long-term results of the treatment of aortic graft infection by in situ replacement with femoral popliteal vein grafts.&nbsp;J Vasc Surg 2009; 50(1):30-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Oderich+GS%2C+Bower+TC%2C+Cherry+KJ+Jr%2C+Panneton+JM%2C+Sullivan+TM%2C+Noel+AA%2C+Carmo+M%2C+Cha+S%2C+Kalra+M%2C+Gloviczki+P.++Evolution+from+axillofemoral+to+in+situ+prosthetic+reconstruction+for+the+treatment+of+aortic+graft+infections+at+a+single+center.+J+Vasc+Surg.+2006+Jun%3B43(6)%3A1166-74." target="_blank">Oderich GS, Bower TC, Cherry KJ Jr, Panneton JM, Sullivan TM, Noel AA, et al.&nbsp; Evolution from axillofemoral to in situ prosthetic reconstruction for the treatment of aortic graft infections at a single center.&nbsp;J Vasc Surg 2006; 43(6):1166-74.</a></p>
<p>QID: 30039</p></div><div class="rightanswer">The correct answer is: staphylococcus infection</div></div></div></div></div><div id="q444" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">412</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3872"><input type="hidden" name="q20803:444_:flagged" value="0"><input type="hidden" value="qaid=911328&amp;qubaid=20803&amp;qid=5161&amp;slot=444&amp;checksum=6b9add8904417e6898ecf59e7441a0ab&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:444_:flaggedcheckbox" name="q20803:444_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q444&id=5161"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:444_:sequencecheck" value="2"><div class="qtext"><p>A 64-year-old female smoker with chronic obstructive pulmonary disease (COPD), for which she is on inhaled bronchodilators, is scheduled for elective surgical bypass for chronic mesenteric ischemia. Which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:444_answer" disabled="disabled" value="0" id="q20803:444_answer0"><label for="q20803:444_answer0">a. preoperative chest physiotherapy decreases the risk of postoperative pulmonary complications</label> </div>
<div class="r1"><input type="radio" name="q20803:444_answer" disabled="disabled" value="1" id="q20803:444_answer1"><label for="q20803:444_answer1">b. preoperative pulmonary function testing helps guide postoperative management and predict the risk of postoperative pulmonary complications</label> </div>
<div class="r0"><input type="radio" name="q20803:444_answer" disabled="disabled" value="2" id="q20803:444_answer2"><label for="q20803:444_answer2">c. a room air PO2 of less than 60 mmHg predicts a significantly increased risk of postoperative pulmonary complications</label> </div>
<div class="r1"><input type="radio" name="q20803:444_answer" disabled="disabled" value="3" id="q20803:444_answer3"><label for="q20803:444_answer3">d. the risk of postoperative pulmonary complications is reduced 2 weeks after quitting cigarette use</label> </div>
<div class="r0"><input type="radio" name="q20803:444_answer" disabled="disabled" value="4" id="q20803:444_answer4"><label for="q20803:444_answer4">e. reoperative systemic corticosteroids rarely benefit pulmonary function and they increase wound complication rates</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:444_-submit" name="q20803:444_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Increasing severity of chronic lung disease increases the risk of postoperative pulmonary complications, but there is no prohibitive degree of severity that precludes surgery. Abstinence from smoking before surgery reduces postoperative pulmonary complication rates but most of the evidence suggests a need for at least 2 months of preoperative cessation to maximally reduce risk. Sputum production increases in the first 1 to 2 months after quitting, which may account for the higher complication risks among recent quitters. Although spirometry diagnoses obstructive lung disease, it does not translate into effective risk prediction for individual patients. Furthermore, the few studies that have compared spirometric data with clinical data have not consistently shown spirometry to be superior to history and physical examination in predicting postoperative pulmonary complications. A short course (up to 1 week) of preoperative systemic steroids may shorten hospital and intensive care unit stays and does not increase postoperative wound infections or delay wound healing. Preoperative chest physiotherapy, including muscle training, decreases postoperative pulmonary complication rates. Multiple studies, including a recent VA NSQIP study of over 100,000 patients, have failed to find a correlation between room air preoperative PO<sub>2</sub> and postoperative pulmonary complication rates for nonthoracic surgery.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Johnson%20RG,%20Arozullah%20AM,%20Neumayer%20L,%20et%20al.%20Multivariable%20predictors%20of%20postoperative%20respiratory%20failure%20after%20general%20and%20vascular%20surgery:%20Results%20from%20the%20patient%20safety%20in%20surgery%20study.%20J%20Am%20Coll%20Surg;%202007;%20204%20(6):1188-1198" target="_blank">Johnson RG, Arozullah AM, Neumayer L, Henderson WG<span>,&nbsp;</span>Hosokawa P<span>,&nbsp;</span>Khuri SF. Multivariable predictors of postoperative respiratory failure after general and vascular surgery: Results from the patient safety in surgery study. J Am Coll Surg 2007; 204 (6):1188-98.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=http%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpubmed%3Fterm%3DSweitzer+BJ%2C+Smetana+GW.+Identification+and+evaluation+of+the+patient+with+lung+disease.+Med+Clin+N+Am%3B+2009%3B+93+(5)%3A1017-1030" target="_blank">Sweitzer BJ, Smetana GW. Identification and evaluation of the patient with lung disease. Med Clin N Am; 2009; 93 (5):1017-30.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Int+Med+2006%3B+144+(8)%3A575-80." target="_blank">Qaseem A, Snow V, Fitterman N<span>,&nbsp;</span>Hornbake ER<span>,&nbsp;</span>Lawrence VA<span>,&nbsp;</span>Smetana GW<span>,&nbsp;</span>et al. Risk assessment for and strategies to reduce perioperative pulmonary complications for patients undergoing noncardiothoracic surgery: A guideline from the American College of Physicians. Ann Int Med 2006; 144 (8):575-80.</a></p>
<p>QID: 30801</p></div><div class="rightanswer">The correct answer is: preoperative chest physiotherapy decreases the risk of postoperative pulmonary complications</div></div></div></div></div><div id="q445" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">413</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3881"><input type="hidden" name="q20803:445_:flagged" value="0"><input type="hidden" value="qaid=911329&amp;qubaid=20803&amp;qid=5162&amp;slot=445&amp;checksum=bd3294c161bbf94f969017683db832eb&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:445_:flaggedcheckbox" name="q20803:445_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q445&id=5162"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:445_:sequencecheck" value="2"><div class="qtext"><p>A 64-year-old female smoker presents with complaints of bilateral leg pain with walking. Which of the following is most helpful to confirm the presence of peripheral arterial disease?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:445_answer" disabled="disabled" value="0" id="q20803:445_answer0"><label for="q20803:445_answer0">a. symptoms are reproduced with exercise and relieved by rest within 10 minutes</label> </div>
<div class="r1"><input type="radio" name="q20803:445_answer" disabled="disabled" value="1" id="q20803:445_answer1"><label for="q20803:445_answer1">b. resting ankle brachial index of less than 0.90</label> </div>
<div class="r0"><input type="radio" name="q20803:445_answer" disabled="disabled" value="2" id="q20803:445_answer2"><label for="q20803:445_answer2">c. walking impairment questionnaire (WIQ)</label> </div>
<div class="r1"><input type="radio" name="q20803:445_answer" disabled="disabled" value="3" id="q20803:445_answer3"><label for="q20803:445_answer3">d. absent pedal pulses</label> </div>
<div class="r0"><input type="radio" name="q20803:445_answer" disabled="disabled" value="4" id="q20803:445_answer4"><label for="q20803:445_answer4">e. initial and absolute claudication distance on treadmill testing</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:445_-submit" name="q20803:445_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The classic claudication symptoms of leg pain that occurs during ambulation and resolves within 10 minutes of rest is found in only a minority of patients with peripheral arterial disease (PAD). Atypical claudication symptoms may include pain that begins at rest or pain that does not completely resolve within 10 minutes. Despite the utility of the pulse examination, the finding of absent pedal pulses tends to over-diagnose PAD, whereas if only classic claudication symptoms are used to identify PAD it will lead to a significant under-diagnosis of PAD. Thus, PAD must be confirmed in suspected patients with non-invasive testing using the ankle-brachial index, with 0.90 (at rest) commonly used as the threshold for the PAD diagnosis of PAD. Although treadmill testing correlates with daily walking ability, its ability to diagnose PAD may be limited by concomitant functional limitations or deconditioning. The Walking Impairment Questionnaire (WIQ) is the most specific questionnaire for evaluation of walking ability in patients with PAD; it can validly detect improvement or deterioration, and therefore, it is helpful in assessing the effectiveness of treatment.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Gardner%20AW,%20Montgomery%20PS,%20Afaq%20A.%20Exercise%20performance%20in%20patients%20with%20peripheral%20arterial%20disease%20who%20have%20different%20types%20of%20exertional%20leg%20pain.%20J%20Vasc%20Surg;%202007;%2046%20(1):79-86" target="_blank">Gardner AW, Montgomery PS, Afaq A. Exercise performance in patients with peripheral arterial disease who have different types of exertional leg pain. J Vasc Surg 2007; 46 (1):79-86.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Nicolai%20SPA,%20Kruidenier%20LM,%20Rouwet%20EV,%20et%20al.%20The%20Walking%20impairment%20questionnaire:%20An%20effective%20tool%20to%20assess%20the%20effect%20of%20treatment%20in%20patients%20with%20intermittent%20claudication.%20J%20Vasc%20Surg;%202009;%2050%20(1):89-94" target="_blank">Nicolai SPA, Kruidenier LM, Rouwet EV, Graffius K<span>,&nbsp;</span>Prins MH<span>,&nbsp;</span>Teijink JA. The Walking impairment questionnaire: An effective tool to assess the effect of treatment in patients with intermittent claudication. J Vasc Surg 2009; 50 (1):89-94.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/17223489" target="_blank">Norgren L, Hiatt WR. Dormandy JA, Nehler MR<span>,&nbsp;</span>Harris KA<span>,&nbsp;</span>Fowkes FG,&nbsp;et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(1):S5-S67.</a></p>
<p>QID: 30802</p></div><div class="rightanswer">The correct answer is: resting ankle brachial index of less than 0.90</div></div></div></div></div><div id="q450" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">414</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3890"><input type="hidden" name="q20803:450_:flagged" value="0"><input type="hidden" value="qaid=911334&amp;qubaid=20803&amp;qid=5167&amp;slot=450&amp;checksum=90613259b196af90226cb8548b131f84&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:450_:flaggedcheckbox" name="q20803:450_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q450&id=5167"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:450_:sequencecheck" value="2"><div class="qtext"><p>Elevated homocysteine levels are an independent risk factor for which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:450_answer" disabled="disabled" value="0" id="q20803:450_answer0"><label for="q20803:450_answer0">a. coronary heart disease</label> </div>
<div class="r1"><input type="radio" name="q20803:450_answer" disabled="disabled" value="1" id="q20803:450_answer1"><label for="q20803:450_answer1">b. stroke</label> </div>
<div class="r0"><input type="radio" name="q20803:450_answer" disabled="disabled" value="2" id="q20803:450_answer2"><label for="q20803:450_answer2">c. peripheral arterial disease</label> </div>
<div class="r1"><input type="radio" name="q20803:450_answer" disabled="disabled" value="3" id="q20803:450_answer3"><label for="q20803:450_answer3">d. venous thromboembolism</label> </div>
<div class="r0"><input type="radio" name="q20803:450_answer" disabled="disabled" value="4" id="q20803:450_answer4"><label for="q20803:450_answer4">e. all of the above</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:450_-submit" name="q20803:450_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Prospective and retrospective studies have suggested that elevated homocysteine levels are an independent risk factor for vascular disease, being associated with a mildly increased risk of coronary heart disease, stroke, peripheral arterial disease, and venous thromboembolism. Supplementation with B-vitamins or folate does not have a proven benefit in cardiovascular risk reduction, but it does help regulate homocysteine plasma levels.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=.+J+Vasc+Surg%3B+2009%3B+49+(5)%3A1348-54." target="_blank">Liapis CS, Avgerinos ED, Kadoglou NP, Kakisis JD. What a vascular surgeon should know and do about atherosclerotic risk factors. J Vasc Surg 2009; 49 (5):1348-54.</a></p>
<p>QID: 30807</p></div><div class="rightanswer">The correct answer is: all of the above</div></div></div></div></div><div id="q321" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">415</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3899"><input type="hidden" name="q20803:321_:flagged" value="0"><input type="hidden" value="qaid=911205&amp;qubaid=20803&amp;qid=5086&amp;slot=321&amp;checksum=4f6e56b2065e38c82259ae6a82927919&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:321_:flaggedcheckbox" name="q20803:321_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q321&id=5086"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:321_:sequencecheck" value="2"><div class="qtext"><p>A 28-year-old, right-handed woman presents with a 6-month history of pain in the right neck region and discomfort in the arm and hand. She has also developed radiating pain and intermittent parasthesia of the affected hand. Elevating her right arm above her head exacerbates these symptoms. On exam, the patient demonstrates a loss of her right radial pulse when she is in a seated position with her arms on her thigh and when she breaths in deep while her head is rotated to her right. She undergoes a non-invasive arterial study. What findings would be “positive” for thoracic outlet compression on non-invasive imaging?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:321_answer" disabled="disabled" value="0" id="q20803:321_answer0"><label for="q20803:321_answer0">a. on color Doppler, normal waveforms in the subclavian, axillary, and brachial artery with the affected arm abducted at 170 degrees</label> </div>
<div class="r1"><input type="radio" name="q20803:321_answer" disabled="disabled" value="1" id="q20803:321_answer1"><label for="q20803:321_answer1">b. normal waveforms in the subclavian, axillary, brachial, radial, and ulnar artery at a neutral position, with thoracic outlet maneuvers; flat digital waveforms at both a neutral position and with thoracic outlet maneuvers</label> </div>
<div class="r0"><input type="radio" name="q20803:321_answer" disabled="disabled" value="2" id="q20803:321_answer2"><label for="q20803:321_answer2">c. normal waveforms in the subclavian, axillary, brachial, radial, and ulnar artery at a neutral position; with the arm abducted at 170 degrees there is complete loss of flow in the subclavian and axillary artery</label> </div>
<div class="r1"><input type="radio" name="q20803:321_answer" disabled="disabled" value="3" id="q20803:321_answer3"><label for="q20803:321_answer3">d. monophasic waveforms in the subclavian and axillary artery, with the arm in neutral position</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:321_-submit" name="q20803:321_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This case study is an evaluation for&nbsp;neurogenic thoracic outlet syndrome (TOS). Diagnosis of this disease process can be challenging. Typical findings on physical exam include arm pain elicited&nbsp;by extreme ipsilateral arm abduction and rotation of the head to the affected side. The Adson test, as described in the question, is not pathognomonic of thoracic outlet syndrome. Loss of the radial pulse with the Adson test is observed in 11-49% of healthy individuals. Debate persists as to whether non-invasive arterial studies are indicated when evaluating patients suspected of having neurogenic TOS. Answer A is a normal study at rest and with provocative TOS maneuvers. Answer B suggests small vessel disease as the waveforms in the larger vessels are normal at a neutral position and with provocative TOS maneuvers. Answer D suggests a more proximal stenosis or occlusion at the ostium of the subclavian artery. Positive findings on non-invasive arterial studies for TOS are dampening or loss of pulse on waveform analysis with ultrasonography with provocative maneuvers for TOS compared to the affected limb in a neutral position.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg.+2007+Sep%3B46(3)%3A601-4." target="_blank">Sanders RJ, Hammond SL, Rao NM. Diagnosis of thoracic outlet syndrome. J Vasc Surg. 2007; 46(3):601-4.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20541346" target="_blank">Criado E, Berguer R, Greenfield L. The spectrum of arterial compression at the thoracic outlet. J Vasc Surg 2010;52(2):406-11.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Ultrasound+Med.+2006+Feb%3B25(2)%3A217-24." target="_blank">Demondion X, Vidal C, Herbinet P, Gautier C, Duquesnoy B, Cotten A. Ultrasonographic assessment of arterial cross-sectional area in the thoracic outlet on postural maneuvers measured with power Doppler ultrasonography in both asymptomatic and symptomatic populations. J Ultrasound Med. 2006 Feb;25(2):217-24.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics.+2006%3B+26(6)%3A1735-50." target="_blank">Demondion X, Herbinet P, Van Sint Jan S, Boutry N, Chantelot C, Cotten A. Imaging assessment of thoracic outlet syndrome. Radiographics 2006; 26(6):1735-50.</a></p>
<p>QID: 30555</p></div><div class="rightanswer">The correct answer is: normal waveforms in the subclavian, axillary, brachial, radial, and ulnar artery at a neutral position; with the arm abducted at 170 degrees there is complete loss of flow in the subclavian and axillary artery</div></div></div></div></div><div id="q311" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">416</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3908"><input type="hidden" name="q20803:311_:flagged" value="0"><input type="hidden" value="qaid=911195&amp;qubaid=20803&amp;qid=5076&amp;slot=311&amp;checksum=e684a00414f9eae179adc3f35bc542d4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:311_:flaggedcheckbox" name="q20803:311_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q311&id=5076"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:311_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding ultrasound measurement of the diameter of the abdominal aorta is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:311_answer" disabled="disabled" value="0" id="q20803:311_answer0"><label for="q20803:311_answer0">a. transverse measurement of the abdominal aorta are more repeatable than anterior posterior measurements</label> </div>
<div class="r1"><input type="radio" name="q20803:311_answer" disabled="disabled" value="1" id="q20803:311_answer1"><label for="q20803:311_answer1">b. the Society for Vascular Surgery recommends outer to outer wall measurements of the abdominal aorta</label> </div>
<div class="r0"><input type="radio" name="q20803:311_answer" disabled="disabled" value="2" id="q20803:311_answer2"><label for="q20803:311_answer2">c. the posterior outer wall of the aorta has the best resolution from surrounding structures</label> </div>
<div class="r1"><input type="radio" name="q20803:311_answer" disabled="disabled" value="3" id="q20803:311_answer3"><label for="q20803:311_answer3">d. reflective boundaries of the inner walls of the aorta are less than reflective boundaries of the outer walls of the aorta</label> </div>
<div class="r0"><input type="radio" name="q20803:311_answer" disabled="disabled" value="4" id="q20803:311_answer4"><label for="q20803:311_answer4">e. axial resolution of ultrasound at the depth of the aorta is 4 to 5mm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:311_-submit" name="q20803:311_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Resolution of an ultrasound image is best at the point where the near and far fields of the ultrasound beam begin to diverge. Axial resolution of ultrasound decreases with decreasing frequency of the ultrasound pulse and is therefore dependent on the frequency of the ultrasound transducer and the depth of the structure being examined. The level of the aorta ultrasound resolution is 1 to 2 mm.&nbsp; The ability to distinguish between adjacent structures is also dependent on acoustic impedance mismatch between the structures.&nbsp; Acoustic mismatch is greater between blood and tissue than between tissue and tissue. Therefore, the posterior wall of the aorta has the poorest resolution from surrounding structures.&nbsp; Aortas may be measured either in the anterior-posterior or transverse planes. Measurements in the antero-posterior measurements are more repeatable,&nbsp;and therefore recommended for serial ultrasound examinations of the abdominal aorta. The Society for Vascular Surgery recommends outer to outer wall measurement of the abdominal aorta.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Brit+J+Surg+1991%3B+78%3A+614-6." target="_blank">Ellis M, Powell JT, Greenhalgh RM.&nbsp; Limitations of ultrasonography in the surveillance of small abdominal aortic aneurysms. &nbsp;Brit J Surg 1991; 78: 614-6.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=The+care+of+patients+with+abdominal+aortic+aneurysm%3A++The+Society+for+Vascular+Surgery+practice+guidelines.+J+Vasc+Surg+2009%3B+50" target="_blank">Chaikof EL, Brewster DC, Dalman RL, Makaroun MS<span>,&nbsp;</span>Illig KA<span>,&nbsp;</span>Sicard GA,&nbsp;et al.&nbsp; The care of patients with abdominal aortic aneurysm:&nbsp; The Society for Vascular Surgery practice guidelines. J Vasc Surg 2009; 50: S2-49.</a>&nbsp;</p>
<p>QID: 30538</p></div><div class="rightanswer">The correct answer is: the Society for Vascular Surgery recommends outer to outer wall measurements of the abdominal aorta</div></div></div></div></div><div id="q217" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">417</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3917"><input type="hidden" name="q20803:217_:flagged" value="0"><input type="hidden" value="qaid=911101&amp;qubaid=20803&amp;qid=4712&amp;slot=217&amp;checksum=4e401ff1d79fd6ba2de6c0f26faf25ad&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:217_:flaggedcheckbox" name="q20803:217_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q217&id=4712"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:217_:sequencecheck" value="2"><div class="qtext"><p>A 38-year-old woman presents with low grade fevers, generalized fatigue, ataxia, and several presyncopal episodes. CT angiogram of her neck shows bilateral 90% common carotid artery stenoses, as well as 70% left subclavian artery stenosis. Her ESR is 75 mm/h. Based on published data, all of the following statements regarding Takayasu's arteritis are true <strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:217_answer" disabled="disabled" value="0" id="q20803:217_answer0"><label for="q20803:217_answer0">a. corticosteroid therapy should be first line therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:217_answer" disabled="disabled" value="1" id="q20803:217_answer1"><label for="q20803:217_answer1">b. less than 20% of patients with this disease will require an intervention</label> </div>
<div class="r0"><input type="radio" name="q20803:217_answer" disabled="disabled" value="2" id="q20803:217_answer2"><label for="q20803:217_answer2">c. open surgical bypass has superior patency to endovascular revascularizations</label> </div>
<div class="r1"><input type="radio" name="q20803:217_answer" disabled="disabled" value="3" id="q20803:217_answer3"><label for="q20803:217_answer3">d. the disease is more common in women by a 2:1 ratio</label> </div>
<div class="r0"><input type="radio" name="q20803:217_answer" disabled="disabled" value="4" id="q20803:217_answer4"><label for="q20803:217_answer4">e. FDG-PET CT scan may be useful in identifying location and activity of this disease</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:217_-submit" name="q20803:217_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Takayasu's arteritis is a disease that mostly affects young women. The female:male ratio is 8:1, not 2:1. There are several diagnostic criteria for active inflammatory disease. Serum markers, such as ESR and CRP, may be elevated. &nbsp;Recently FDG-PET CT scans have been evaluated to identify and localize signs of active inflammation. The first line of therapy in patients with Takayasu's arteritis should be corticosteroids. Several reports have stated the superiority in patency of open surgical bypass over endovascular techniques. Multiple registries of patients with Takayasu's arteritis have demonstrated that less than 20% of all patients will need either an open or endovascular intervention. &nbsp;Persistent arm claudication, transient ischemic attacks, or evidence of global cerebral ischemia are all indications for intervention.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<div class="auths"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23522715" target="_blank">Gallagher&nbsp;KA,&nbsp;Tracci MC,&nbsp;Scovell SD.Vascular&nbsp;arteritides&nbsp;in women.&nbsp;J Vasc Surg&nbsp;2013; 57:27S-36S.</a></div>
<div class="auths">&nbsp;</div>
<div class="auths"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23075530" target="_blank">Karapolat I,&nbsp;Kalfa M,&nbsp;Keser G, Yalçin M,&nbsp;Inal V,&nbsp;Kumanlioğlu K,&nbsp;et al.&nbsp;Comparison of F18-FDG PET/CT&nbsp;findings with current clinical disease status in patients with&nbsp;Takayasu's arteritis.Clin Exp Rheumatol&nbsp;2013 ;31(1 Suppl 75):S15-21.</a><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Yal%C3%A7in%20M%5BAuthor%5D&cauthor=true&cauthor_uid=23075530"><br></a></div>
<div class="auths">
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22119246" target="_blank">Kim YW, Kim DI, Park YJ, Yang SS,&nbsp;Lee GY,&nbsp;Kim DK,&nbsp;et al. Surgical Bypass vs endovascular treatment for patients with supra-aortic arterial occlusive disease due to Takayasu Arteritis. J Vasc Surg 2012; 3:693-700.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+22230484" target="_blank">Saadoun D,&nbsp;Lambert M,&nbsp;Mirault T, Resche-Rigon M,&nbsp;Koskas F,&nbsp;Cluzel P,&nbsp;et al.Retrospective analysis of surgery versus&nbsp;endovascular&nbsp;intervention in&nbsp;Takayasu&nbsp;arteritis: a multicenter experience.Circulation.&nbsp;2012 Feb 14;125(6):813-9.&nbsp;</a></p>
<p>QID: 30368</p>
</div></div><div class="rightanswer">The correct answer is: the disease is more common in women by a 2:1 ratio</div></div></div></div></div><div id="q440" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">418</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3926"><input type="hidden" name="q20803:440_:flagged" value="0"><input type="hidden" value="qaid=911324&amp;qubaid=20803&amp;qid=4887&amp;slot=440&amp;checksum=ac3798510fc5204dce68edde40956208&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:440_:flaggedcheckbox" name="q20803:440_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q440&id=4887"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:440_:sequencecheck" value="2"><div class="qtext"><p>After the diagnosis of DVT, anticoagulation with heparin or low-molecular-weight heparin is immediately begun.&nbsp; Which of the following is the appropriate next step in the management of DVT?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:440_answer" disabled="disabled" value="0" id="q20803:440_answer0"><label for="q20803:440_answer0">a. bed rest and leg elevation should be used for the first 5 days after the diagnosis</label> </div>
<div class="r1"><input type="radio" name="q20803:440_answer" disabled="disabled" value="1" id="q20803:440_answer1"><label for="q20803:440_answer1">b. ambulation is encouraged, and compression should be applied as soon as the patient is anticoagulated</label> </div>
<div class="r0"><input type="radio" name="q20803:440_answer" disabled="disabled" value="2" id="q20803:440_answer2"><label for="q20803:440_answer2">c. surgical compression is contraindicated in patients with DVT</label> </div>
<div class="r1"><input type="radio" name="q20803:440_answer" disabled="disabled" value="3" id="q20803:440_answer3"><label for="q20803:440_answer3">d. thrombolysis should only be used in the face of impending lower extremity gangrene</label> </div>
<div class="r0"><input type="radio" name="q20803:440_answer" disabled="disabled" value="4" id="q20803:440_answer4"><label for="q20803:440_answer4">e. bed rest and leg elevation should be used for at least 10 days after the diagnosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:440_-submit" name="q20803:440_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The use of strong compression and early ambulation after DVT treatment can significantly reduce the pain and swelling resulting from the DVT. The rate and severity of postthrombotic syndrome after proximal DVT can be decreased by approximately 50% by the use of compression stockings. Discussion with the patient about the importance of compression is critical to ensure good compliance. Additionally, walking with good compression does not increase the risk of PE, whereas it significantly decreases the incidence and severity of the postthrombotic syndrome.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+1997%3B+349%3A759-62." target="_blank">Brandjes DP, Büller HR, Heijboer H,<span>&nbsp;</span>Huisman MV<span>,&nbsp;</span>de Rijk M<span>,&nbsp;</span>Jagt H<span>,</span>&nbsp;et al.&nbsp;Randomised trial of effect of compression stockings in patients with symptomatic proximal-vein thrombosis.&nbsp; Lancet 1997; 349:759-62.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Thromb+Haemost+1999%3B+82%3A127-9." target="_blank">Schellong SM, Schwarz T, Kropp J, Prescher Y,&nbsp;Beuthien-Baumann B,&nbsp;Daniel WG.&nbsp;Bed rest in deep vein thrombosis and the incidence of scintigraphic pulmonary embolism.&nbsp; Thromb Haemost 1999; 82:127-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Thromb+Haemost+2001%3B+85%3A42-6." target="_blank">Aschwanden M, Labs KH, Engel H, Schwob A<span>,&nbsp;</span>Jeanneret C<span>,&nbsp;</span>Mueller-Brand J,&nbsp;et al.&nbsp;Acute deep vein thrombosis: early mobilization does not increase the frequency of pulmonary embolism.&nbsp;Thromb Haemost 2001; 85:42-6.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Int+Med+2004%3B+141%3A249-56." target="_blank">Prandoni P, Lensing AW, Prins MH, Frulla M<span>,&nbsp;</span>Marchiori A<span>,&nbsp;</span>Bernardi E<span>,&nbsp;</span>et al. Below-knee elastic compression stockings to prevent the post-thrombotic syndrome: a randomized, controlled trial.&nbsp; Ann Int Med 2004; 141:249-56.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Vasc+Surg+2005%3B+18%3A148-52." target="_blank">Partsch H.&nbsp; Ambulation and compression after deep vein thrombosis: dispelling myths.&nbsp; Semin Vasc Surg 2005; 18:148-52.</a></p>
<p>QID: 30767</p></div><div class="rightanswer">The correct answer is: ambulation is encouraged, and compression should be applied as soon as the patient is anticoagulated</div></div></div></div></div><div id="q118" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">419</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3935"><input type="hidden" name="q20803:118_:flagged" value="0"><input type="hidden" value="qaid=911002&amp;qubaid=20803&amp;qid=4734&amp;slot=118&amp;checksum=ade89b6fd5a1839d100d3694668985a3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:118_:flaggedcheckbox" name="q20803:118_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q118&id=4734"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:118_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old man with a thoracic aortic aneurysm undergoes a left subclavian-to-carotid transposition prior to his thoracic endograft placement. All of the following structures are commonly divided in the conduct of this operation <strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:118_answer" disabled="disabled" value="0" id="q20803:118_answer0"><label for="q20803:118_answer0">a. subclavian artery</label> </div>
<div class="r1"><input type="radio" name="q20803:118_answer" disabled="disabled" value="1" id="q20803:118_answer1"><label for="q20803:118_answer1">b. omohyoid muscle</label> </div>
<div class="r0"><input type="radio" name="q20803:118_answer" disabled="disabled" value="2" id="q20803:118_answer2"><label for="q20803:118_answer2">c. anterior scalene muscle</label> </div>
<div class="r1"><input type="radio" name="q20803:118_answer" disabled="disabled" value="3" id="q20803:118_answer3"><label for="q20803:118_answer3">d. thoracic duct</label> </div>
<div class="r0"><input type="radio" name="q20803:118_answer" disabled="disabled" value="4" id="q20803:118_answer4"><label for="q20803:118_answer4">e. vertebral vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:118_-submit" name="q20803:118_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Left subclavian transposition onto the left common carotid artery is performed through a transverse supraclavicular incision over the two heads of the sternocleidomastoid (SCM) muscle. After development of subplatysmal flaps, the dissection is carried down between the two heads of the SCM. The thoracic duct is ligated and divided as well as the left vertebral vein. The omohyoid muscle is divided to improve exposure of the proximal subclavian artery and origin of the vertebral artery. The anterior scalene muscle is not usually divided because the dissection involves the more proximal segment of the subclavian artery. After ligation and division of the left subclavian artery proximal to the left vertebral artery, the left subclavian artery is anastomosed to the side of the common carotid artery posterior to the jugular vein.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Morasch%20MD.%20Technique%20for%20subclavian%20to%20carotid%20transposition,%20tips,%20and%20tricks.%20J%20Vasc%20Surg;%202009;%2049%20(1):251-254" target="_blank">Morasch MD. Technique for subclavian to carotid transposition, tips, and tricks. J Vasc Surg 2009; 49 (1):251-4</a>.</p>
<p>QID: 30210</p></div><div class="rightanswer">The correct answer is: anterior scalene muscle</div></div></div></div></div><div id="q383" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">420</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3944"><input type="hidden" name="q20803:383_:flagged" value="0"><input type="hidden" value="qaid=911267&amp;qubaid=20803&amp;qid=5292&amp;slot=383&amp;checksum=9bc0992524181a3c7d20cd1dedec7e9e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:383_:flaggedcheckbox" name="q20803:383_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q383&id=5292"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:383_:sequencecheck" value="2"><div class="qtext"><p><span>The mechanism of action of&nbsp;renal artery radiofrequency ablation (RFA) for treatment&nbsp;of essential hypertension is which of the following?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:383_answer" disabled="disabled" value="0" id="q20803:383_answer0"><label for="q20803:383_answer0">a. <span>stimulation of afferent sympathetic fibers</span></label> </div>
<div class="r1"><input type="radio" name="q20803:383_answer" disabled="disabled" value="1" id="q20803:383_answer1"><label for="q20803:383_answer1">b. <span>ablation of nitric oxide-producing endothelial cells</span></label> </div>
<div class="r0"><input type="radio" name="q20803:383_answer" disabled="disabled" value="2" id="q20803:383_answer2"><label for="q20803:383_answer2">c. <span>transmural disruption of sympathetic fibers in the renal artery adventia</span></label> </div>
<div class="r1"><input type="radio" name="q20803:383_answer" disabled="disabled" value="3" id="q20803:383_answer3"><label for="q20803:383_answer3">d. <span>stimulation of glomerular parasympathetic signals</span></label> </div>
<div class="r0"><input type="radio" name="q20803:383_answer" disabled="disabled" value="4" id="q20803:383_answer4"><label for="q20803:383_answer4">e. <span>ablation of angiotensin II-producing cells</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:383_-submit" name="q20803:383_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The renal sympathetic nerves arise from the thoracic nerve roots and innervate the renal artery, the renal pelvis, and the renal parenchyma. Radiofrequency ablation (RFA) is thought to decrease both the afferent sympathetic signals from the kidney to the brain and the efferent signals from the brain to the kidney. This decreases sympathetic activation with a consequent of&nbsp;decrease in&nbsp;vasoconstriction and blunted&nbsp;activation of the renin-angiotensin system.</p>
<p>To perform the radiofrequency ablation, a specially designed catheter is advanced into&nbsp;the distal renal artery, and low-power radiofrequency energy is delivered to the endothelial layer. Delivering radiofrequency energy transmits transmurally and damages the sympathetic fibers traveling in the adventitia of the arterial wall. Overall, RFA therapy is directed at disrupting the sympathetic innervation to the kidneys.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+2012%3B60(14)%3A1271-1277." target="_blank">Geisler BP, Egan BM, Cohen JT, Garner AM,&nbsp;Akehurst RL,&nbsp;Esler MD,&nbsp;et al. Cost-effectiveness and clinical effectiveness of catheter-based renal denervation for resistant hypertension. J Am Coll Cardiol 2012; 60(14):1271-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2012%3B126(25)%3A2976-82." target="_blank">Esler MD, Krum H, Schlaich M, Schmieder RE, Böhm M, Sobotka PA. Renal sympathetic denervation for treatment of drug-resistant hypertension: One-year results from the symplicity HTN-2 randomized, controlled trial. Circulation 2012;126(25):2976-82.</a></p>
<p>QID: 30670</p></div><div class="rightanswer">The correct answer is: <span>transmural disruption of sympathetic fibers in the renal artery adventia</span></div></div></div></div></div><div id="q7" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">421</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3953"><input type="hidden" name="q20803:7_:flagged" value="0"><input type="hidden" value="qaid=910891&amp;qubaid=20803&amp;qid=4616&amp;slot=7&amp;checksum=506ae743e0373a6cc13e5e934925e4c0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:7_:flaggedcheckbox" name="q20803:7_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q7&id=4616"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:7_:sequencecheck" value="2"><div class="qtext"><p>A 27-year-old&nbsp;white man with a known history of ectopia lentis presents with excruciating chest pain radiating to his back. The physical exam reveals a&nbsp;tall, white man lying in bed in moderate distress. His vitals are: BP=90/50 mmHg, HR=20, RR=26, Ht=6'7", Wt=180 lbs (82 kgs), SaO2=95% on room air. Pertinent findings&nbsp;include an unrepaired pectus excavatum, muffled heart sounds, and fluctuating lower extremity pulses.&nbsp;For this patient, the&nbsp;most likely genetic mutation involves which protein?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:7_answer" disabled="disabled" value="0" id="q20803:7_answer0"><label for="q20803:7_answer0">a. Fibrillin 1</label> </div>
<div class="r1"><input type="radio" name="q20803:7_answer" disabled="disabled" value="1" id="q20803:7_answer1"><label for="q20803:7_answer1">b. Fibrillin 2</label> </div>
<div class="r0"><input type="radio" name="q20803:7_answer" disabled="disabled" value="2" id="q20803:7_answer2"><label for="q20803:7_answer2">c. Type III collagen</label> </div>
<div class="r1"><input type="radio" name="q20803:7_answer" disabled="disabled" value="3" id="q20803:7_answer3"><label for="q20803:7_answer3">d. Type I collagen</label> </div>
<div class="r0"><input type="radio" name="q20803:7_answer" disabled="disabled" value="4" id="q20803:7_answer4"><label for="q20803:7_answer4">e. none of the above</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:7_-submit" name="q20803:7_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The phenotype described is that of a patient with Marfan Syndrome. Included in the description are four diagnostic criteria: height, pectus excavatum, ectopia lentis, and evidence of a dissection. The etiology of Marfan Syndrome is a mutation of the Fibrillin 1 gene located on chromosome 15. The syndrome itself is an autosomal dominant gene with variable penetrance. Mutation of Fibrillin 2 results in Beals Syndrome. Patients with this syndrome tend to have a similar phenotype to those with Marfan Syndrome,&nbsp;however, they&nbsp;are unlikely to&nbsp;have the cardiovascular complications. Type III collagen is associated with Ehlers Danlos Syndrome and Type I collagen mutation is associated with Osteogenesis Imperfecta,&nbsp;neither of which present as the patient described.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/12389231" target="_blank">Van Vlijmen-van Keulen CJ, Pals G, Rauwerda JA. Familial abdominal aortic aneurysm: A systematic review of a genetic background. Eur J Vasc Endovasc Surg 2002; 24 (2):105-16.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Callewaert%20BL%2C%20Loeys%20BL%2C%20Ficcadenti%20A%2C%20et%20al.%20Comprehensive%20clinical%20and%20molecular%20assessment%20of%2032%20probands%20with%20congenital%20contractural%20arachnodactyly%3A%20Report%20of%2014%20novel%20mutations%20and%20review%20of%20the%20literature.%20Human%20mutation%3B%202009%3B%2030%20%283%29%3A334-341" target="_blank">Callewaert BL, Loeys BL, Ficcadenti A, Vdrmeer S, Landgren M. Kroes HY, et al. Comprehensive clinical and molecular assessment of 32 probands with congenital contractural arachnodactyly: Report of 14 novel mutations and review of the literature. Human mutation 2009; 30 (3):334-41.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Viljoen%20D.%20Congenital%20contractural%20arachnodactyly%20%28Beals%20syndrome%29.%20J%20Med%20Genet%3B%201994%3B%2031%20%288%29%3A640-643" target="_blank">Viljoen D. Congenital contractural arachnodactyly (Beals syndrome). J Med Genet 1994; 31 (8):640-3.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/19786250" target="_blank">Chaikof EL, Brewster DC, Dalman RL, Makaroun MS, Illig KA, Sincard GA, et al. The care of patients with an abdominal aortic aneurysm: The Society for Vascular Surgery Practice Guidelines. J Vasc Surg; 2009; 50 (Suppl 4):1S-49S.</a></p>
<p>QID: 30007</p></div><div class="rightanswer">The correct answer is: Fibrillin 1</div></div></div></div></div><div id="q94" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">422</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3962"><input type="hidden" name="q20803:94_:flagged" value="0"><input type="hidden" value="qaid=910978&amp;qubaid=20803&amp;qid=4912&amp;slot=94&amp;checksum=b4113608ea8b526a6f06c1bcfc955f28&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:94_:flaggedcheckbox" name="q20803:94_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q94&id=4912"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:94_:sequencecheck" value="2"><div class="qtext"><p><span>An 89-year-old man who underwent an aortobifemoral bypass for occlusive disease 25 years ago now presents with painless pulsatile masses in both groins. CT angiography shows large bilateral aneurysms at both femoral anastomoses but no proximal anastomotic aneurysms, peri-graft fluid, or inflammation. On the right, a large superior false aneurysm measures 11.7 x 7.3 x 8.8 cm and an additional inferior false aneurysm measures 9.0 x 7.2 x 8.1 cm. On the left, a false aneurysm measures 5.1 x 4.3 x 4.9 cm. There is a large degree of intramural thrombus and turbulent flow within the false aneurysms. &nbsp;What is the best treatment choice for this patient?</span></p>
<p>&nbsp;<br></p>
<p><img src="./VESAP3_files/Q4 Anastomotic pseudoaneurysm 1.jpg" alt="" width="236" height="512"></p>
<p><img src="./VESAP3_files/Q4 Anastomotic pseudoaneurysm 2.jpg" alt="" width="244" height="222"></p>
<p>&nbsp;</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:94_answer" disabled="disabled" value="0" id="q20803:94_answer0"><label for="q20803:94_answer0">a. <span>percutaneous drainage of the fluid collection</span></label> </div>
<div class="r1"><input type="radio" name="q20803:94_answer" disabled="disabled" value="1" id="q20803:94_answer1"><label for="q20803:94_answer1">b. <span>endovascular stent graft placement</span></label> </div>
<div class="r0"><input type="radio" name="q20803:94_answer" disabled="disabled" value="2" id="q20803:94_answer2"><label for="q20803:94_answer2">c. <span>ultrasound-guided thrombin injection</span></label> </div>
<div class="r1"><input type="radio" name="q20803:94_answer" disabled="disabled" value="3" id="q20803:94_answer3"><label for="q20803:94_answer3">d. <span>open repair of anastomotic aneurysms</span></label> </div>
<div class="r0"><input type="radio" name="q20803:94_answer" disabled="disabled" value="4" id="q20803:94_answer4"><label for="q20803:94_answer4">e. <span>conservative management</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:94_-submit" name="q20803:94_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Anastomotic false aneurysms after aortofemoral bypass grafting most commonly occur at the femoral anastomoses. Femoral anastomtoic aneurysms (FAAs) develop in about 3% of all femoral anastomoses and about 6-9% of patients undergoing aortofemoral bypass. FAAs may be bilateral or recurrent in 3% of patients. Pathologically, there is a partial separation of the graft from the arterial wall. Repair is indicated in good-risk patients with recurrent FAAs larger than 2 cm. While this is the best of the options listed, one should always harbor a degree of concern for any underlying infectious etiology.&nbsp; Given the age of this patient's aortobifemoral bypass and his lack of infectious indicators, it is unlikely in this case.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Hunter GC, Westerband A.&nbsp; Noninfectious Complicstions in Vascular Surgery.&nbsp;In: Moore WS, ed. Vascular and Endovascular Surgery: A Comprehensive Review. 8th ed.&nbsp; Elsevier Saunders: Philadelphia; 2013. p 944-45.</p>
<p>QID: 30142</p></div><div class="rightanswer">The correct answer is: <span>open repair of anastomotic aneurysms</span></div></div></div></div></div><div id="q432" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">423</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3971"><input type="hidden" name="q20803:432_:flagged" value="0"><input type="hidden" value="qaid=911316&amp;qubaid=20803&amp;qid=4876&amp;slot=432&amp;checksum=939b47585e53ad24e999eced6275f3fa&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:432_:flaggedcheckbox" name="q20803:432_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q432&id=4876"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:432_:sequencecheck" value="2"><div class="qtext"><p>Which statement regarding the 1-year outcomes comparing endovenous laser ablation (EVLT) and radiofrequency ablation (RFA) for patients with varicose veins is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:432_answer" disabled="disabled" value="0" id="q20803:432_answer0"><label for="q20803:432_answer0">a. both EVLT and RFA had an improvement in the venous clinical severity score (VCSS) but not in the overall quality of life (QoL)</label> </div>
<div class="r1"><input type="radio" name="q20803:432_answer" disabled="disabled" value="1" id="q20803:432_answer1"><label for="q20803:432_answer1">b. there was significantly more pain post-procedure in the RFA treated group than the EVLT treated group</label> </div>
<div class="r0"><input type="radio" name="q20803:432_answer" disabled="disabled" value="2" id="q20803:432_answer2"><label for="q20803:432_answer2">c. both EVLT and RFA had an improvement in the QoL but not in the VCSS</label> </div>
<div class="r1"><input type="radio" name="q20803:432_answer" disabled="disabled" value="3" id="q20803:432_answer3"><label for="q20803:432_answer3">d. at 1-year follow-up both EVLT and RFA were equally effective with reduction in VCSS scores and improvement in QoL</label> </div>
<div class="r0"><input type="radio" name="q20803:432_answer" disabled="disabled" value="4" id="q20803:432_answer4"><label for="q20803:432_answer4">e. there was an increased recanalization rate in the EVLT group compared to the RFA group</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:432_-submit" name="q20803:432_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>A recently reported randomized trial compared the effectiveness, venous outcomes, and QoL of 500 patients (580 limbs) with varicose veins and great saphenous vein insufficieny treated with either EVLT (1470 nm diode), RFA, foam sclerotherapy, or ligation and stripping. The groups were well matched for age, sex, previous venous surgery, CEAP clinical class, and phlebectomies performed. At 1-year follow-up, both EVLT and RFA significantly improved VCSS scores and QoL, as measured by the Aberdeen Varicose Vein Symptom Severity Score (this was also true for foam sclerotherapy and ligation and stripping). Pain scores were measured on a visual analogue scale as the mean (+/- sd) from 0 (no pain) to 10 (worst imaginable pain) for the first 10 days after treatment. EVLT patients had the highest pain score (2.58 [2.41]) and RFA patients had the lowest (1.21 [1.72]) scores of all treatment groups (foam sclerotherapy 1.60+/-2.04 and ligation and stripping 2.25+/-2.23). The primary outcome of the study was the failure rates, as measured by the presence of a patent refluxing great saphenous vein. There were no differences at 1 year between EVLT (5.8%) and RFA (4.8%). The highest failure rates were seen in the patients treated with foam sclerotherapy (16.3%).&nbsp; Ligation and stripping (4.8%) was similar to EVLT and RFA. The authors will be publishing their 3-year follow up results soon.</p>
<p>Other smaller studies comparing EVLT and RFA have found a similar benefit in VCSS and QoL, but have seen higher recanalization rates with RFA.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21725957" target="_blank">Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins Br J Surg 2011;98:1079-87.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20638231" target="_blank">Gale SS, Lee JN, Walsh ME, Wojnarowski DL, Comerota AJ. A randomized, controlled trial of endovenous thermal ablation using the 810-nm wavelength laser and the ClosurePLUS radiofrequency ablation methods for superficial venous insufficiency of the great saphenous vein. J Vasc Surg 2010;52:645-50.</a></p>
<p>QID: 30757</p></div><div class="rightanswer">The correct answer is: at 1-year follow-up both EVLT and RFA were equally effective with reduction in VCSS scores and improvement in QoL</div></div></div></div></div><div id="q407" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">424</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3980"><input type="hidden" name="q20803:407_:flagged" value="0"><input type="hidden" value="qaid=911291&amp;qubaid=20803&amp;qid=4949&amp;slot=407&amp;checksum=5b65a2b4d1a4b006532662f53beb3247&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:407_:flaggedcheckbox" name="q20803:407_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q407&id=4949"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:407_:sequencecheck" value="2"><div class="qtext"><p>A 33-year-old woman undergoes great saphenous vein ablation and returns for follow-up. Her only complaints are some mild bruising of the thigh and swelling. A repeat ultrasound reveals an ablated vein; the saphenofemoral junction is shown in the figure below. Which of the following is the most important next step in the management of this patient?<br><br><a href="./VESAP3_files/AssetProxy_021.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_021.jpg" alt="img" width="100" height="107" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:407_answer" disabled="disabled" value="0" id="q20803:407_answer0"><label for="q20803:407_answer0">a. repeat endovenous ablation</label> </div>
<div class="r1"><input type="radio" name="q20803:407_answer" disabled="disabled" value="1" id="q20803:407_answer1"><label for="q20803:407_answer1">b. anticoagulation</label> </div>
<div class="r0"><input type="radio" name="q20803:407_answer" disabled="disabled" value="2" id="q20803:407_answer2"><label for="q20803:407_answer2">c. analgesics for pain</label> </div>
<div class="r1"><input type="radio" name="q20803:407_answer" disabled="disabled" value="3" id="q20803:407_answer3"><label for="q20803:407_answer3">d. repeat ultrasound in 6 weeks</label> </div>
<div class="r0"><input type="radio" name="q20803:407_answer" disabled="disabled" value="4" id="q20803:407_answer4"><label for="q20803:407_answer4">e. compression</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:407_-submit" name="q20803:407_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The venous ultrasound demonstrates extension of venous thrombus into the common femoral vein. The incidence of thrombus extension into the common femoral vein or deep vein thrombosis in published clinical series is between 0.3% and 2.1%. Post-procedure surveillance is important to both identify this problem and institute proper treatment. The majority of the thrombus extension resolves with anticoagulation and should be initiated immediately. A repeat ultrasound at 6 weeks is appropriate, but it would not be the next step if the patient has a thrombus. There is no indication for repeat endovenous ablation. Although compression is part of the treatment of all patients with acute deep vein thrombosis (DVT), its benefit in patients with asymptomatic DVT has not been established. Analgesics can be used as indicated; however, they do not address the underlying thrombosis.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2005%3B+41+(1)%3A130-5." target="_blank">Mozes G, Kalra M, Carmo M, Swenson L<span>,&nbsp;</span>Gloviczki P<span>.</span>&nbsp;Extension of saphenous thrombus into the femoral vein: A potential complication of new endovenous ablation techniques. J Vasc Surg 2005; 41 (1):130-5.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2004%3B+40+(3)%3A500-4." target="_blank">Hingorani AP, Ascher E, Markevich N, Schutzer RW<span>,&nbsp;</span>Kallakuri S<span>,&nbsp;</span>Hou A<span>,&nbsp;</span>et al. Deep venous thrombosis after radiofrequency ablation of greater saphenous vein: A word of caution. J Vasc Surg 2004; 40 (3):500-4.</a></p>
<p>QID: 30726</p></div><div class="rightanswer">The correct answer is: anticoagulation</div></div></div></div></div><div id="q28" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">425</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3989"><input type="hidden" name="q20803:28_:flagged" value="0"><input type="hidden" value="qaid=910912&amp;qubaid=20803&amp;qid=4638&amp;slot=28&amp;checksum=fa9ab6e22d4d6ed6c9bc9442c5a053ec&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:28_:flaggedcheckbox" name="q20803:28_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q28&id=4638"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:28_:sequencecheck" value="2"><div class="qtext"><p>A 77-year-old man presents with left chest and back pain. His medical history includes chronic obstructive pulmonary disease (COPD) and coronary artery disease, for which he has undergone coronary artery bypass grafting with a left internal mammary artery (LIMA) to left anterior descending (LAD) artery bypass and 2 saphenous vein grafts.&nbsp;The CT scan obtained is shown below. Which of the following is the appropriate next step in the&nbsp;management&nbsp;of this patient?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/AssetProxy_090.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_090.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:28_answer" disabled="disabled" value="0" id="q20803:28_answer0"><label for="q20803:28_answer0">a. debranching of the arch vessels from the aortic arch and endovascular repair of the thoracic aorta</label> </div>
<div class="r1"><input type="radio" name="q20803:28_answer" disabled="disabled" value="1" id="q20803:28_answer1"><label for="q20803:28_answer1">b. repeat CT scan in 3-6 months</label> </div>
<div class="r0"><input type="radio" name="q20803:28_answer" disabled="disabled" value="2" id="q20803:28_answer2"><label for="q20803:28_answer2">c. endovascular repair of the thoracic aorta with subclavian revascularization if symptoms develop</label> </div>
<div class="r1"><input type="radio" name="q20803:28_answer" disabled="disabled" value="3" id="q20803:28_answer3"><label for="q20803:28_answer3">d. subclavian revascularization and endovascular repair of the thoracic aorta</label> </div>
<div class="r0"><input type="radio" name="q20803:28_answer" disabled="disabled" value="4" id="q20803:28_answer4"><label for="q20803:28_answer4">e. open repair of the thoracic aorta</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:28_-submit" name="q20803:28_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a pseudoaneurysm of the proximal descending thoracic aorta beginning approximately 5 mm distal to the left subclavian artery origin and an internal mammary graft to the LAD. Thoracic endovascular aortic repair (TEVAR) has demonstrated excellent results for treatment of such lesions in patients with suitable or modifiable anatomy. On the basis of a short proximal landing zone, if the subclavian artery is left in direct circulation, and likely coronary ischemia if the subclavian artery is covered by the endograft, this patient requires revascularization of the left subclavian artery prior to placement of an endograft. Given the need to maintain flow through the LIMA, a subclavian-carotid transposition is not the best option for revascularization. A carotid-subclavian bypass, with the subclavian anastomosis placed distal to the LIMA takeoff, is the preferred option, as shown in the pre-TEVAR arch aortogram below. <br><br><a href="./VESAP3_files/AssetProxy_034.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_034.jpg" alt="img" width="100" height="96" border="0" hspace="10" vspace="10"></a><br><br>In this case, coronary flow is preserved during construction of the bypass and the subclavian artery can then be ligated proximal to the LIMA takeoff when the revascularization is complete. Open repair and debranching can be undertaken but will result in a higher morbidity and mortality given the patient's pulmonary dysfunction and the need for a re-do sternotomy. The patient has new onset ipsilateral chest pain and observation is not a good option. Selective subclavian revascularization can be undertaken in circumstances when urgent repair necessitates coverage of the subclavian artery, but that would rarely be the preferred approach in a patient with a LIMA coronary revascularization.<br><br></p>
<h3>References:</h3>
<p>Buth J, Harris P. Endovascular treatment of aortic aneurysms. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1452-75.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Matsumura%20JS,%20Lee%20WA,%20Mitchell%20RS,%20et%20al.%20The%20Society%20for%20Vascular%20Surgery%20Practice%20Guidelines:%20Management%20of%20the%20left%20subclavian%20artery%20with%20thoracic%20endovascular%20aortic%20repair.%20J%20Vasc%20Surg;%202009;%2050%20(5):1155-1158" target="_blank">Matsumura JS, Lee WA, Mitchell RS, Farber MA, Murad MH, Lumsden AB, et al. The Society for Vascular Surgery Practice Guidelines: Management of the left subclavian artery with thoracic endovascular aortic repair. J Vasc Surg 2009; 50 (5):1155-8</a>.</p>
<p>QID: 30030</p></div><div class="rightanswer">The correct answer is: subclavian revascularization and endovascular repair of the thoracic aorta</div></div></div></div></div><div id="q283" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">426</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_3998"><input type="hidden" name="q20803:283_:flagged" value="0"><input type="hidden" value="qaid=911167&amp;qubaid=20803&amp;qid=5015&amp;slot=283&amp;checksum=ff1d3fd263c2eaadaaf94837ce43973b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:283_:flaggedcheckbox" name="q20803:283_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q283&id=5015"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:283_:sequencecheck" value="2"><div class="qtext"><p>A 47-year-old man receiving peritoneal dialysis has completed a 2-week course of intraperitoneal antibiotics to treat staphylococcal peritonitis. The effluent remains cloudy and cultures are now positive for Candida albicans. There is no evidence of catheter site infection. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:283_answer" disabled="disabled" value="0" id="q20803:283_answer0"><label for="q20803:283_answer0">a. immediate catheter removal</label> </div>
<div class="r1"><input type="radio" name="q20803:283_answer" disabled="disabled" value="1" id="q20803:283_answer1"><label for="q20803:283_answer1">b. change catheter over a guidewire</label> </div>
<div class="r0"><input type="radio" name="q20803:283_answer" disabled="disabled" value="2" id="q20803:283_answer2"><label for="q20803:283_answer2">c. intravenous vancomycin and amphotericin B</label> </div>
<div class="r1"><input type="radio" name="q20803:283_answer" disabled="disabled" value="3" id="q20803:283_answer3"><label for="q20803:283_answer3">d. intraperitoneal administration of amphotericin B</label> </div>
<div class="r0"><input type="radio" name="q20803:283_answer" disabled="disabled" value="4" id="q20803:283_answer4"><label for="q20803:283_answer4">e. exploratory laparotomy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:283_-submit" name="q20803:283_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>There are 3 types of peritoneal dialysis (PD)-related infection: exit-site or tunnel infections, and peritonitis. Exit site infections usually present with purulent drainage and erythema at the catheter-skin interface; more intensive exit-site cleaning is recommended in these cases. Tunnel infections present as erythema, edema, and tenderness over the subcutaneous portion of the catheter and are usually associated with exit site infections. Oral antibiotic therapy is recommended for treatment of tunnel infections. Primary peritonitis is a major complication of PD and is a contributing cause in 16% of deaths in patients on PD. Affected patients usually present with cloudy effluent and abdominal pain associated with rebound tenderness. Empiric treatment with intraperitoneal administration of antibiotics is indicated as this method is more efficacious than the intravenous route. Catheter removal is not necessary unless cultures or gram stain reveal fungal organisms. Fungal peritonitis is considered to be a serious complication that can lead to death in up to 25% of affected PD patients. It is most common after recent antibiotic treatment for bacterial peritonitis. Immediate catheter removal is indicated; catheter exchange is not recommended until the patient has completed treatment and organisms have been cleared. Intraperitoneal administration of amphotericin B causes chemical peritonitis and pain, while intravenous administration is associated with poor peritoneal availability. Other antifungal agents such as voriconazole and posaconazole have been effective in treating Candida peritonitis. In the absence of positive cultures for methicillin-resistant S. aureus, vancomycin is not necessary. Exploratory laparotomy is not necessary unless there is evidence of intra-abdominal pathology.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Perit+Dial+Int+2010%3B+30%3A+393-423." target="_blank">Li PK, Szeto CC, Piraino B, Bernardini J<span>,&nbsp;</span>Figueiredo AE<span>,&nbsp;</span>Gupta A<span>,&nbsp;</span>et al. Peritoneal dialysis-related infections. Recommendations: 2010 update. Perit Dial Int 2010; 30: 393-423.</a></p>
<p>Wiggins KJ, Craig JC, Johnson DW, Strippoli GF. Treatment for peritoneal dialysis-associated peritonitis. Cochrane Database of Systemic Review 2008; 4(7): 356-7.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kidney+Int+2009%3B+76%3A+622-8." target="_blank">Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB<span>,&nbsp;</span>Wiggins KJ,&nbsp;et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 2009; 76: 622-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Kidney+Dis+2000%3B+36%3A+1183-92." target="_blank">Wang AY, Yu AW, Li PK, Lam PK, Leung CB,&nbsp;Lai KN,&nbsp;et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis 2000; 36: 1183-92.</a></p>
<p>QID: 30468</p></div><div class="rightanswer">The correct answer is: immediate catheter removal</div></div></div></div></div><div id="q53" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">427</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4007"><input type="hidden" name="q20803:53_:flagged" value="0"><input type="hidden" value="qaid=910937&amp;qubaid=20803&amp;qid=4309&amp;slot=53&amp;checksum=904c59fbdbe60b6e54a619fefde315c3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:53_:flaggedcheckbox" name="q20803:53_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q53&id=4309"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:53_:sequencecheck" value="2"><div class="qtext"><p>Which of the following patients is covered under Medicare for a screening abdominal aortic duplex ultrasound to evaluate for aneurysm?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:53_answer" disabled="disabled" value="0" id="q20803:53_answer0"><label for="q20803:53_answer0">a. A 70 year old male with three first-degree relatives who have died from aneurysm disease</label> </div>
<div class="r1"><input type="radio" name="q20803:53_answer" disabled="disabled" value="1" id="q20803:53_answer1"><label for="q20803:53_answer1">b. An 80 year old male who has never smoked</label> </div>
<div class="r0"><input type="radio" name="q20803:53_answer" disabled="disabled" value="2" id="q20803:53_answer2"><label for="q20803:53_answer2">c. A 70 year old female who has smoked 100 cigarettes over his life</label> </div>
<div class="r1"><input type="radio" name="q20803:53_answer" disabled="disabled" value="3" id="q20803:53_answer3"><label for="q20803:53_answer3">d. A 60 year old male who has smoked 100 cigarettes over his life</label> </div>
<div class="r0"><input type="radio" name="q20803:53_answer" disabled="disabled" value="4" id="q20803:53_answer4"><label for="q20803:53_answer4">e. A 66 year old male who has smoked 50 cigarettes over his life</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:53_-submit" name="q20803:53_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p align="left">Medicare currently offers a screening ultrasound to males aged 65 to 75 who have smoked over 100 cigarettes in their life and men or women who have a strong family history of aneurysm disease.&nbsp; There is disagreement between this recommendation (US Preventative Services Task Force) and that of the Society for Vascular Surgery Practice Guidelines for Care of the Patient with an Abdominal Aortic Aneurysm.</p>
<p>Screening for Abdominal Aortic Aneurysm, Topic Page. February 2005. U.S. Preventive Services Task Force. http://www.uspreventiveservicestaskforce.org/uspstf/uspsaneu.htm</p>
<p>The care of patients with an abdominal aortic aneurysm:&nbsp;the Society for Vascular Surgery practice guidelines.&nbsp; Chaikof EL, Brewster DC, Dalman RL, et al.&nbsp; J Vasc Surg. 2009 Oct; 50(4&nbsp;Suppl): S2-49.&nbsp;&nbsp; <a href="http://www.ncbi.nlm.nih.gov/pubmed/19786241">http://www.ncbi.nlm.nih.gov/pubmed/19786241</a></p>
<p>QID: 30058</p>
<hr>
<p align="left">&nbsp;</p></div><div class="rightanswer">The correct answer is: A 70 year old male with three first-degree relatives who have died from aneurysm disease</div></div></div></div></div><div id="q412" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">428</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4016"><input type="hidden" name="q20803:412_:flagged" value="0"><input type="hidden" value="qaid=911296&amp;qubaid=20803&amp;qid=4785&amp;slot=412&amp;checksum=5de5bbed370d9962c71823c560f97a4f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:412_:flaggedcheckbox" name="q20803:412_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q412&id=4785"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:412_:sequencecheck" value="2"><div class="qtext"><p>A 57-year-old woman presents with several years of lower extremity pain and fatigue that worsens at the end of the day, as well as following prolonged periods of standing. She complains of new skin ulceration with associated pruritus and symptom progression.&nbsp; Venous duplex revealed no evidence of thrombus, normal augmentation patterns, a 5 mm perforator located beneath the ulcer bed with outward flow of ≥ 500 ms, and the following vein valve closure times: CFV = 2.5 sec and GSV = 3.6 sec.&nbsp; Which of the following represents this patient’s CEAP classification?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:412_answer" disabled="disabled" value="0" id="q20803:412_answer0"><label for="q20803:412_answer0">a. C<sub>4</sub> E<sub>p</sub> A<sub>dsp</sub> P<sub>r</sub></label> </div>
<div class="r1"><input type="radio" name="q20803:412_answer" disabled="disabled" value="1" id="q20803:412_answer1"><label for="q20803:412_answer1">b. C<sub>6</sub> E<sub>p </sub>A<sub>dsp</sub> P<sub>r</sub></label> </div>
<div class="r0"><input type="radio" name="q20803:412_answer" disabled="disabled" value="2" id="q20803:412_answer2"><label for="q20803:412_answer2">c. C<sub>6</sub> E<sub>s</sub> A<sub>s</sub> P<sub>o</sub></label> </div>
<div class="r1"><input type="radio" name="q20803:412_answer" disabled="disabled" value="3" id="q20803:412_answer3"><label for="q20803:412_answer3">d. C<sub>5</sub> E<sub>p</sub> A<sub>dsp</sub> P<sub>o</sub></label> </div>
<div class="r0"><input type="radio" name="q20803:412_answer" disabled="disabled" value="4" id="q20803:412_answer4"><label for="q20803:412_answer4">e. C<sub>5</sub> E<sub>s</sub> A<sub>s</sub> P<sub>r</sub></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:412_-submit" name="q20803:412_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The CEAP classification objectively documents the clinical class, etiology, anatomy and pathophysiology of chronic venous disease as follows:<a title="Gloviczki, 2011 #561" href="http://svsvesap.com/beta#_ENREF_1"><sup><br></sup></a></p>
<table border="1" cellspacing="0" cellpadding="0">
<tbody>
<tr>
<td valign="top" width="292">
<p>C (Clinical Classification)</p>
</td>
<td valign="top" width="299">
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td colspan="2" valign="top" width="590">
<p align="center">C0 - No visible or palpable signs of venous disease</p>
<p align="center">C1 - Telangiectases or reticular veins</p>
<p align="center">C2 - Varicose veins</p>
<p align="center">C3 - Edema</p>
<p align="center">C4a - Pigmentation/ecyzyma</p>
<p align="center">C4b - Lipodermatosclerosis and /or atrophie blanche</p>
<p align="center">C5 - Healed venous ulcer</p>
<p align="center">C6 - Active venous ulcer</p>
</td>
</tr>
<tr>
<td valign="top" width="292">
<p>E (Etiologic Classification)</p>
</td>
<td valign="top" width="299">
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td colspan="2" valign="top" width="590">
<p align="center">E<sub>c</sub> – Congenital</p>
<p align="center">E<sub>p</sub> – Primary</p>
<p align="center">E<sub>s</sub> - Secondary (post-thrombotic)</p>
</td>
</tr>
<tr>
<td valign="top" width="292">
<p>A (Anatomic Classification)</p>
</td>
<td valign="top" width="299">
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td colspan="2" valign="top" width="590">
<p align="center">A<sub>s</sub> – Superficial veins</p>
<p align="center">A<sub>p</sub> – Perforator veins</p>
<p align="center">A<sub>d</sub> – Deep veins</p>
</td>
</tr>
<tr>
<td valign="top" width="292">
<p>P (Pathophysiologic Classification)</p>
</td>
<td valign="top" width="299">
<p>&nbsp;</p>
</td>
</tr>
<tr>
<td colspan="2" valign="top" width="590">
<p align="center">P<sub>r</sub> – Reflux</p>
<p align="center">P<sub>o</sub> – Obstruction</p>
<p align="center">P<sub>r,o</sub> – Reflux and obstruction</p>
</td>
</tr>
</tbody>
</table>
<p>&nbsp;</p>
<p><strong>References:</strong>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53%3A2S-48S." target="_blank">Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG<span>,&nbsp;</span>Gillespie DL<span>,&nbsp;</span>Gloviczki ML<span>,&nbsp;</span>et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011;53:2S-48S.</a></p>
<p>QID: 30732</p></div><div class="rightanswer">The correct answer is: C<sub>6</sub> E<sub>p </sub>A<sub>dsp</sub> P<sub>r</sub></div></div></div></div></div><div id="q90" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">429</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4025"><input type="hidden" name="q20803:90_:flagged" value="0"><input type="hidden" value="qaid=910974&amp;qubaid=20803&amp;qid=4907&amp;slot=90&amp;checksum=30760f389ff5b4a71c47d807e7fe4eb6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:90_:flaggedcheckbox" name="q20803:90_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q90&id=4907"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:90_:sequencecheck" value="2"><div class="qtext"><p>A 37-year-old obese female smoker presents to the clinic complaining of 2 weeks of exquisite right third&nbsp;toe pain and duskiness. She denies any antecedent trauma to the foot and her medical history is otherwise unremarkable.&nbsp; She has palpable pedal pulses on physical exam and a CT scan of the abdomen/pelvis with bilateral runoff was obtained (image is shown below).</p>
<p><a href="./VESAP3_files/Blue Toe.JPG" target="images"><img src="./VESAP3_files/Blue Toe.JPG" alt="" width="100"></a></p>
<p>All of the following would be appropriate for the management of this condition <strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:90_answer" disabled="disabled" value="0" id="q20803:90_answer0"><label for="q20803:90_answer0">a. <span>dual antiplatelet therapy</span></label> </div>
<div class="r1"><input type="radio" name="q20803:90_answer" disabled="disabled" value="1" id="q20803:90_answer1"><label for="q20803:90_answer1">b. <span>pain control</span></label> </div>
<div class="r0"><input type="radio" name="q20803:90_answer" disabled="disabled" value="2" id="q20803:90_answer2"><label for="q20803:90_answer2">c. <span>stent graft placement across lesion</span></label> </div>
<div class="r1"><input type="radio" name="q20803:90_answer" disabled="disabled" value="3" id="q20803:90_answer3"><label for="q20803:90_answer3">d. <span>sympathectomy</span></label> </div>
<div class="r0"><input type="radio" name="q20803:90_answer" disabled="disabled" value="4" id="q20803:90_answer4"><label for="q20803:90_answer4">e. <span>smoking cessation</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:90_-submit" name="q20803:90_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has findings consistent with microemboli to the third digit of the foot, also known as Blue Toe Syndrome. Often times, this finding will present in the context of palpable pedal pulses in patients with significant smoking histories. Initial management will involve inspection and management of any localized tissue loss, pain control, and risk factor modification, including smoking cessation and optimal medical therapy (ie, antiplatelet and statin agents). Additional imaging is required to interrogate for a vascular lesion with embolic potential as demonstrated in the above CT scan. Duplex arterial imaging and echocardiography would also be appropriate as additional imaging modalities. &nbsp;Endovascular therapy or open surgical treatment are indicated in the setting of recurrent microembolization in patients who are medically optimally managed.&nbsp;</p>
<p>&nbsp;</p>
<h2 class="desc2">References:&nbsp;</h2>
<p class="desc2"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2000%3B+11(5)%3A585-92." target="_blank">Matchett WJ, McFarland DR, Eidt JF, Moursi MM. Blue toe syndrome: treatment with intra-arterial stents and review of therapies.&nbsp; J Vasc Interv Radiol 2000; 11(5):585-92.</a></p>
<div>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vasc+Endovascular+Surg+2002%3B+36(2)%3A155-9." target="_blank">Renshaw A, McCowen T, Waltke EA, Wattenhofer SP, Tahara RW, Baxter BT. Angioplasty with stenting is effective in treating blue toe syndrome. Vasc Endovascular Surg 2002; 36(2):155-9.</a></p>
<p>QID: 30137</p>
</div></div><div class="rightanswer">The correct answer is: <span>sympathectomy</span></div></div></div></div></div><div id="q320" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">430</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4034"><input type="hidden" name="q20803:320_:flagged" value="0"><input type="hidden" value="qaid=911204&amp;qubaid=20803&amp;qid=5085&amp;slot=320&amp;checksum=59030a4c433db31216d3e6b5c4911750&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:320_:flaggedcheckbox" name="q20803:320_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q320&id=5085"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:320_:sequencecheck" value="2"><div class="qtext"><p>A 48-year-old man complains of right calf discomfort after walking 1 block. The discomfort has progressively worsened over the past 3 months. He has no significant cardiovascular risk factors. He has a normal vascular exam on the left leg, and on the right leg he has absent pedal pulses. He undergoes a lower extremity arterial duplex study with ankle-brachial index measurements. The findings seen on the color duplex below are most consistent with which of the following diagnoses?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/Slide1(2).jpg" target="images"><img src="./VESAP3_files/Slide1(2).jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:320_answer" disabled="disabled" value="0" id="q20803:320_answer0"><label for="q20803:320_answer0">a. cystic adventitial disease of the popliteal artery</label> </div>
<div class="r1"><input type="radio" name="q20803:320_answer" disabled="disabled" value="1" id="q20803:320_answer1"><label for="q20803:320_answer1">b. atherosclerotic occlusive disease of the popliteal artery</label> </div>
<div class="r0"><input type="radio" name="q20803:320_answer" disabled="disabled" value="2" id="q20803:320_answer2"><label for="q20803:320_answer2">c. popliteal artery embolus</label> </div>
<div class="r1"><input type="radio" name="q20803:320_answer" disabled="disabled" value="3" id="q20803:320_answer3"><label for="q20803:320_answer3">d. popliteal artery dissection</label> </div>
<div class="r0"><input type="radio" name="q20803:320_answer" disabled="disabled" value="4" id="q20803:320_answer4"><label for="q20803:320_answer4">e. popliteal artery aneurysm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:320_-submit" name="q20803:320_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Cystic adventitial disease is a rare cause of arterial claudication. It typically presents in middle age (40-50 years) and is more common in men than women (5:1). Intermittent claudication involving the calf muscle is common. Typical findings on duplex ultrasound include extra-luminal compression of the popliteal artery by the adventitial cyst, which will appear anechoic or hypoechoic with no color flow. The ABI may be diminished compared to the uninvolved limb depending on the severity of the stenosis. The velocity may be elevated beyond the stenosis caused by the cyst resulting in monophasic waveforms on duplex imaging beyond the affected area. Further imaging is typically necessary to guide surgical intervention. Catheter-based angiography will show a “scimitar” –sign (Image A - shown below) if the cyst is eccentric or an “hourglass”-sign (Image B) if the cyst is concentric.</p>
<p><img src="./VESAP3_files/Slide1(3).jpg" alt="" width="519" height="389"></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B+45(6)%3A1249-52." target="_blank">Tsilimparis N, Hanack U, Yousefi S, Alevizakos P, Rückert RI. Cystic adventitial disease of the popliteal artery: an argument for the developmental theory. J Vasc Surg 2007; 45(6):1249-52.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vasc+Med.+2012+Aug%3B17(4)%3A283-4." target="_blank">Hai Z, Shao G. Images in vascular medicine. Cystic adventitial disease of the popliteal artery. Vasc Med 2012; 17(4):283-4.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vascular+2012%3B+20(6)%3A311-3." target="_blank">Bucci F, Plagnol P. Cystic adventitial disease of the popliteal artery. Vascular 2012; 20(6):311-3.</a></p>
<p>QID: 30554</p></div><div class="rightanswer">The correct answer is: cystic adventitial disease of the popliteal artery</div></div></div></div></div><div id="q226" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">431</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4043"><input type="hidden" name="q20803:226_:flagged" value="0"><input type="hidden" value="qaid=911110&amp;qubaid=20803&amp;qid=4957&amp;slot=226&amp;checksum=9fa8e461a115f8368bb8794e53aec539&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:226_:flaggedcheckbox" name="q20803:226_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q226&id=4957"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:226_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man with end-stage renal disease (ESRD) presents to the emergency department from the dialysis unit with a thrombosed autogenous radial-cephalic wrist access. It&nbsp;had been functional for 2 years.&nbsp;His expected survival is less than two years.&nbsp;He denies any shortness of breath, but on physical examination he has diffuse rales throughout his lung fields. His laboratory values are significant for a potassium of 5.8 and BUN of 82. Which of the following represents the&nbsp;least preferable option&nbsp;to restore dialysis access in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:226_answer" disabled="disabled" value="0" id="q20803:226_answer0"><label for="q20803:226_answer0">a. urgent thrombectomy and open surgical revision of his autogenous radial-cephalic wrist direct access</label> </div>
<div class="r1"><input type="radio" name="q20803:226_answer" disabled="disabled" value="1" id="q20803:226_answer1"><label for="q20803:226_answer1">b. placement of a long-term dialysis catheter via the right subclavian vein in the fluoroscopic suite</label> </div>
<div class="r0"><input type="radio" name="q20803:226_answer" disabled="disabled" value="2" id="q20803:226_answer2"><label for="q20803:226_answer2">c. urgent thrombolysis and endovascular revision of his autogenous radial-cephalic wrist direct access</label> </div>
<div class="r1"><input type="radio" name="q20803:226_answer" disabled="disabled" value="3" id="q20803:226_answer3"><label for="q20803:226_answer3">d. placement of a short-term dialysis catheter via the right internal jugular vein in the emergency department</label> </div>
<div class="r0"><input type="radio" name="q20803:226_answer" disabled="disabled" value="4" id="q20803:226_answer4"><label for="q20803:226_answer4">e. urgent placement of a prosthetic radial-antecubital forearm straight access</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:226_-submit" name="q20803:226_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Given the low morbidity associated with either surgical thrombectomy or percutaneous thrombolysis, most surgeons would probably attempt to restore patency of the of the autogenous fistula. If the fistula cannot be salvaged, an upper arm sistual or a forearm graft represent resonable alternatives in this patient with a relatively short life expectancy. Short-term dialysis via a temporary catheter may be required. Long-term catheterization is the least preferable option in this patient. Subclavian access is associated with higher rates of central vein stenosis than the IJ route.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Salgado%20OJ,%20Urdaneta%20B,%20Colmenares%20B,%20et%20al.%20Right%20versus%20left%20internal%20jugular%20vein%20catheterization%20for%20hemodialysis:%20Complications%20and%20impact%20on%20ipsilateral%20access%20creation.%20Artificial%20Organs;%202004;%2028%20(8):728-733" target="_blank">Salgado OJ, Urdaneta B, Colmenares B, García R<span>,&nbsp;</span>Flores C. Right versus left internal jugular vein catheterization for hemodialysis: Complications and impact on ipsilateral access creation. Artificial Organs 2004; 28 (8):728-33.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Spinowitz%20BS,%20Galler%20M,%20Golden%20RA,%20et%20al.%20Subclavian%20vein%20stenosis%20as%20a%20complication%20of%20subclavian%20catheterization%20for%20hemodialysis.%20Arch%20Intern%20Med;%201987;%20147%20(2):305-307" target="_blank">Spinowitz BS, Galler M, Golden RA, Rascoff JH<span>,&nbsp;</span>Schechter L<span>,&nbsp;</span>Held B,&nbsp;et al. Subclavian vein stenosis as a complication of subclavian catheterization for hemodialysis. Arch Intern Med 1987; 147 (2):305-7.</a></p>
<p>&nbsp;</p>
<p>QID: 30403</p></div><div class="rightanswer">The correct answer is: placement of a long-term dialysis catheter via the right subclavian vein in the fluoroscopic suite</div></div></div></div></div><div id="q92" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">432</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4052"><input type="hidden" name="q20803:92_:flagged" value="0"><input type="hidden" value="qaid=910976&amp;qubaid=20803&amp;qid=4910&amp;slot=92&amp;checksum=4c2f2fc1e4ce331251e745bf72ae5079&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:92_:flaggedcheckbox" name="q20803:92_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q92&id=4910"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:92_:sequencecheck" value="2"><div class="qtext"><p>A 64-year-old woman with a history of renal artery fibrodysplasia now presents with complaints of progressively worsening right thigh pain. The pain occurs after walking&nbsp;1 block and prevents her from performing her activities of daily living.&nbsp;She is a non-smoker and&nbsp;attempts to walk daily. She has a diminshed right femoral pulse and normal left leg pulses. CT angiography shows a series of stenoses with intervening mural aneurysms in the right external iliac artery consistent with fibrodysplasia. Which of the following is the preferred initial treatment option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:92_answer" disabled="disabled" value="0" id="q20803:92_answer0"><label for="q20803:92_answer0">a. crossover femoral femoral bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:92_answer" disabled="disabled" value="1" id="q20803:92_answer1"><label for="q20803:92_answer1">b. interposition bypass grafting of the external iliac artery</label> </div>
<div class="r0"><input type="radio" name="q20803:92_answer" disabled="disabled" value="2" id="q20803:92_answer2"><label for="q20803:92_answer2">c. percutaneous transluminal angioplasty with stent placement</label> </div>
<div class="r1"><input type="radio" name="q20803:92_answer" disabled="disabled" value="3" id="q20803:92_answer3"><label for="q20803:92_answer3">d. medical management with control of hypertension and an exercise program</label> </div>
<div class="r0"><input type="radio" name="q20803:92_answer" disabled="disabled" value="4" id="q20803:92_answer4"><label for="q20803:92_answer4">e. percutaneous transluminal angioplasty</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:92_-submit" name="q20803:92_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The answer is percutaneous transluminal angioplasty. Fibrodysplastic lesions typically respond well to angioplasty alone, and stenting is usually unnecessary unless there is&nbsp; a suboptimal result from angioplasty alone. This patient is already medically optimized, has been exercising regularly, and will likely not improve from additional medical management.&nbsp; Surgical bypass should be reserved&nbsp;for patients who do not respond to endovascular therapy.</p>
<p>Fibrodysplasia is rare in the lower extremities, is most commonly seen in the proximal one third of the external iliac artery, and is often associated with fibrodysplasia in other locations, such as the renal or extracranial carotid arteries.</p>
<p>QID: 30140</p></div><div class="rightanswer">The correct answer is: percutaneous transluminal angioplasty</div></div></div></div></div><div id="q129" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">433</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4061"><input type="hidden" name="q20803:129_:flagged" value="0"><input type="hidden" value="qaid=911013&amp;qubaid=20803&amp;qid=4746&amp;slot=129&amp;checksum=853ce672138c7b848e8a83ce5a47c5bd&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:129_:flaggedcheckbox" name="q20803:129_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q129&id=4746"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:129_:sequencecheck" value="2"><div class="qtext"><p>A 25-year-old man presents with a pulsatile tender mass in his left antecubital fossa and admits to chronic IV drug abuse with frequent injections into his antecubital space. Based on this patient, which of the following statements is the most accurate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:129_answer" disabled="disabled" value="0" id="q20803:129_answer0"><label for="q20803:129_answer0">a. most infected aneurysms in the upper extremity are related to cardiac emboli</label> </div>
<div class="r1"><input type="radio" name="q20803:129_answer" disabled="disabled" value="1" id="q20803:129_answer1"><label for="q20803:129_answer1">b. arm vein conduit is the most available and frequently used conduit in these patients</label> </div>
<div class="r0"><input type="radio" name="q20803:129_answer" disabled="disabled" value="2" id="q20803:129_answer2"><label for="q20803:129_answer2">c. distal emboli from upper extremity infected pseudoaneurysms are rare</label> </div>
<div class="r1"><input type="radio" name="q20803:129_answer" disabled="disabled" value="3" id="q20803:129_answer3"><label for="q20803:129_answer3">d. wide debridement is typically not necessary as these tend to be localized infections at the site of injection</label> </div>
<div class="r0"><input type="radio" name="q20803:129_answer" disabled="disabled" value="4" id="q20803:129_answer4"><label for="q20803:129_answer4">e. Gram-positive organisms are the most common etiology of the infection</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:129_-submit" name="q20803:129_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Brachial artery pseudoaneurysms are most commonly related to direct arterial trauma from brachial artery access for procedures, or from illicit drug use. Distal emboli with brachial and&nbsp;radial artery pseudoaneurysms are not uncommon.</p>
<p>As with most superficial infected arterial pseudoaneurysms, the most common organisms tend to be Gram-positive; Methicillin-resistant organisms are increasingly prevalent. These infections tend to be extensive and require wide debridement for control of the infection.&nbsp;</p>
<p>Arm vein conduit is frequently unavailable in these patients secondary to their long-term drug use; the leg vein may be unavailable due to the same reason. Autogenous conduit is preferred, but cryopreserved grafts can be used in the setting of a patient with no autogenous options.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Surg+2005%3B201(1)%3A18-22." target="_blank">Valentine RJ, Modrall JG, Clagett GP. Hand ischemia after radial artery cannulation. J Am Coll Surg&nbsp;2005; 201:18-22.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2005%3B+19%3A657-61." target="_blank">Siu WT, Yau KK, Cheung HYS, Law BK<span>,&nbsp;</span>Tang CN<span>,&nbsp;</span>Yang GP,&nbsp;et al. Management of brachial artery pseudoaneurysms secondary to drug abuse. Ann Vasc Surg&nbsp;2005; 19:657-61.</a></p>
<p>QID: 30222</p></div><div class="rightanswer">The correct answer is: Gram-positive organisms are the most common etiology of the infection</div></div></div></div></div><div id="q488" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">434</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4070"><input type="hidden" name="q20803:488_:flagged" value="0"><input type="hidden" value="qaid=911372&amp;qubaid=20803&amp;qid=5230&amp;slot=488&amp;checksum=3a47bd7b6952a85575cb48299c7ab43d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:488_:flaggedcheckbox" name="q20803:488_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q488&id=5230"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:488_:sequencecheck" value="2"><div class="qtext"><p>Regarding fondaparinux (Arixtra®), which of the following is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:488_answer" disabled="disabled" value="0" id="q20803:488_answer0"><label for="q20803:488_answer0">a. it activates antithrombin III, leading to inactivitation of Factor X</label> </div>
<div class="r1"><input type="radio" name="q20803:488_answer" disabled="disabled" value="1" id="q20803:488_answer1"><label for="q20803:488_answer1">b. effectiveness is monitored using aPTT or ACT</label> </div>
<div class="r0"><input type="radio" name="q20803:488_answer" disabled="disabled" value="2" id="q20803:488_answer2"><label for="q20803:488_answer2">c. it be used without risk of heparin induced thrombocytopenia</label> </div>
<div class="r1"><input type="radio" name="q20803:488_answer" disabled="disabled" value="3" id="q20803:488_answer3"><label for="q20803:488_answer3">d. it has equal bioavailabililty with oral and intravenous administration</label> </div>
<div class="r0"><input type="radio" name="q20803:488_answer" disabled="disabled" value="4" id="q20803:488_answer4"><label for="q20803:488_answer4">e. it is primarily metabolized by the liver</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:488_-submit" name="q20803:488_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Fondaparinux is a subcutaneously administered antithrombotic agent which acts as a selective inhibitor of activated factor X. This pentasaccharide selectively binds to antithrombin, rapidly inhibiting Factor Xa, a key enzyme in the anticoagulation pathway.</p>
<p>Fondaparinux is 100% bioavailable, with peak serum concentrations reached 1.7 hours following subcutaneous injection. The 15–17 hour half-life is much longer than that of heparin and low molecular weight heparins, allowing fondaparinux to be administered once daily.</p>
<p>This drug is renally excreted and contraindicated in patients with renal failure. There is a small risk of associated heparin-induced thrombocytopenia with its use. No serologic monitoring is generally required.</p>
<p>Fondaparinux is not inactivated by protamine. No antidote is known, although high doses of recombinant factor VIIa (90 mcg/kg) partially normalize the prolonged aPTT.</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+2001%3B+345(18)%3A1305-10." target="_blank">Bauer KA, Eriksson BI, Lassen MR, Turpie AG; Steering Committee of the&nbsp;Pentasaccharide in Major Knee Surgery Study. Fondaparinux compared with&nbsp;enoxaparin for the prevention of venous thromboembolism after elective major knee&nbsp;surgery. N Engl J Med 2001; 345(18):1305-10.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Thromb+Haemost+2013%3B+11(10)%3A1833-43." target="_blank">Samama CM, Lecoules N, Kierzek G, Claessens YE, Riou B, Rosencher N, et al. Comparison of fondaparinux with low molecular weight&nbsp;heparin for venous thromboembolism prevention in patients requiring rigid or&nbsp;semi-rigid immobilization for isolated non-surgical below-knee injury. J Thromb&nbsp;Haemost 2013; 11(10):1833-43.&nbsp;</a></p>
<p>QID: 30853</p></div><div class="rightanswer">The correct answer is: it activates antithrombin III, leading to inactivitation of Factor X</div></div></div></div></div><div id="q405" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">435</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4079"><input type="hidden" name="q20803:405_:flagged" value="0"><input type="hidden" value="qaid=911289&amp;qubaid=20803&amp;qid=4946&amp;slot=405&amp;checksum=5c7ada115a57077d9ef7c87a299d474d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:405_:flaggedcheckbox" name="q20803:405_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q405&id=4946"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:405_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old man presents with a cutaneous ulcer in the region of his right medial malleolus. The ulcer has been present for 6 months and is slowly healing with compression bandages. It is shallow and has surrounding hyperpigmentation. He has no other complaints. Which of the following is the appropriate next step in evaluating the underlying abnormality as a cause for a slow healing wound?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:405_answer" disabled="disabled" value="0" id="q20803:405_answer0"><label for="q20803:405_answer0">a. descending venography</label> </div>
<div class="r1"><input type="radio" name="q20803:405_answer" disabled="disabled" value="1" id="q20803:405_answer1"><label for="q20803:405_answer1">b. venous duplex ultrasound of the superficial and deep veins</label> </div>
<div class="r0"><input type="radio" name="q20803:405_answer" disabled="disabled" value="2" id="q20803:405_answer2"><label for="q20803:405_answer2">c. ankle-brachial index</label> </div>
<div class="r1"><input type="radio" name="q20803:405_answer" disabled="disabled" value="3" id="q20803:405_answer3"><label for="q20803:405_answer3">d. magnetic resonance venography of the pelvic veins</label> </div>
<div class="r0"><input type="radio" name="q20803:405_answer" disabled="disabled" value="4" id="q20803:405_answer4"><label for="q20803:405_answer4">e. biopsy of the ulcer</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:405_-submit" name="q20803:405_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The patient has a slow healing venous ulcer that has been&nbsp;minimally&nbsp;responsive&nbsp;to compression therapy. He has no other complaints to suggest other pathologies. The most appropriate test is to perform a venous duplex ultrasound to define reflux and/or obstruction of the superficial and deep veins. The figure below demonstrates a &gt; 4-second reflux (spectral waveform below the baseline). <br><br><a href="./VESAP3_files/AssetProxy_016.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_016.jpg" alt="img" width="100" height="97" border="0" hspace="10" vspace="10"></a><br>A biopsy may be helpful to quantify bacteria in infected ulcer beds. However, it will usually demonstrate inflammatory tissue; it will rarely denote a malignancy. Biopsy may demonstrate other rare pathology in &lt; 2% of patients. Magnetic resonance venography is used to evaluate outflow obstruction by external compression. Although this may be a possible reason for venous ulceration, it is less likely than venous insufficiency of the superficial and deep veins of the extremity. Descending venography would demonstrate different grades of reflux, but it is more invasive and has largely been replaced by Duplex ultrasound. Although venous ulcers can present with mixed venous and arterial etiology, the patient specifically had no other complaints related to arterial insufficiency.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Surg%3B+1995%3B+169+(6)%3A572-74." target="_blank">Labropoulos N, Leon M, Geroulakos G, Volteas N<span>,&nbsp;</span>Chan P<span>,&nbsp;</span>Nicolaides AN<span>.</span>&nbsp;Venous hemodynamic abnormalities in patients with leg ulceration. Am J Surg 1995; 169 (6):572-74.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1992%3B+16+(6)%3A913-20." target="_blank">Welch HJ, Faliakou EC, McLaughlin RL, Umphrey SE<span>,&nbsp;</span>Belkin M<span>,&nbsp;</span>O'Donnell TF Jr<span>.</span>&nbsp;Comparison of descending phlebography with quantitative photoplethysmography, air plethysmography, and duplex quantitative valve closure time in assessing deep venous reflux. J Vasc Surg 1992; 16 (6):913-20.</a></p>
<p>QID: 30723</p></div><div class="rightanswer">The correct answer is: venous duplex ultrasound of the superficial and deep veins</div></div></div></div></div><div id="q282" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">436</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4088"><input type="hidden" name="q20803:282_:flagged" value="0"><input type="hidden" value="qaid=911166&amp;qubaid=20803&amp;qid=5019&amp;slot=282&amp;checksum=acb1841be484407c74ade5ecf8c6a123&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:282_:flaggedcheckbox" name="q20803:282_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q282&id=5019"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:282_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old woman was initiated on hemodialysis using a left forearm loop graft 1 week ago. Following her second dialysis session, she has continued oozing at the puncture sites after 2 hours. The template bleeding time is prolonged. The next step in the treatment of this patient should include both continued digital pressure and administration of which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:282_answer" disabled="disabled" value="0" id="q20803:282_answer0"><label for="q20803:282_answer0">a. fresh frozen plasma</label> </div>
<div class="r1"><input type="radio" name="q20803:282_answer" disabled="disabled" value="1" id="q20803:282_answer1"><label for="q20803:282_answer1">b. factor VIII concentrate</label> </div>
<div class="r0"><input type="radio" name="q20803:282_answer" disabled="disabled" value="2" id="q20803:282_answer2"><label for="q20803:282_answer2">c. vitamin K</label> </div>
<div class="r1"><input type="radio" name="q20803:282_answer" disabled="disabled" value="3" id="q20803:282_answer3"><label for="q20803:282_answer3">d. platelets</label> </div>
<div class="r0"><input type="radio" name="q20803:282_answer" disabled="disabled" value="4" id="q20803:282_answer4"><label for="q20803:282_answer4">e. desmopressin (DDAVP)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:282_-submit" name="q20803:282_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Uremic patients have an increased bleeding tendency due to platelet dysfunction. A specific mechanism is not known, but a number of features have been elucidated that lead to abnormal platelet-platelet and platelet-vessel wall interactions. These include platelet defects (eg, decreased thromboxane A2 formation, low serotonin and ADP content, increased cyclic AMP, impaired granule release), as well as defects of platelet adhesion (eg, von Willebrand factor [vWF] dysfunction, enhanced nitric oxide production). The platelet count and most coagulation assays are normal. Bleeding may involve deep organs (eg, gastrointestinal hemorrhage, subdural hematomas) or may be superficial (eg, puncture sites, catheter entry sites); the template bleeding time is a reliable test to determine patients at risk for bleeding. Management of acute bleeding should include administration of 1-deamino-8-D-arginine vasopression (DDAVP) as a single dose (0.3 μg/kg IV added to 50 mL of saline over 30 minutes). DDAVP provides a hemostatic effect that is maximal at 1 hour and lasts 4-6 hours.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Hematology+Am+Soc+Hematol+Educ+Prog+2012%3B+2012%3A+168-73." target="_blank">Mannucci PM, Tripodi A. Hemostatic defects in liver and renal dysfunction. Hematology Am Soc Hematol Educ Prog 2012; 2012: 168-73.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B+48%3A+55S-80S." target="_blank">Padberg FT Jr, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: recognition and management. J Vasc Surg 2008; 48: 55S-80S.</a></p>
<p>QID: 30467</p></div><div class="rightanswer">The correct answer is: desmopressin (DDAVP)</div></div></div></div></div><div id="q64" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">437</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4097"><input type="hidden" name="q20803:64_:flagged" value="0"><input type="hidden" value="qaid=910948&amp;qubaid=20803&amp;qid=4889&amp;slot=64&amp;checksum=dfc342a6fa38ebb885bc0028a5e37cff&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:64_:flaggedcheckbox" name="q20803:64_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q64&id=4889"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:64_:sequencecheck" value="2"><div class="qtext"><p>A 39-year-old man presents with right calf claudication for the past 3 months. He has never smoked and has no other medical history. Which of the following is the most probable diagnosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:64_answer" disabled="disabled" value="0" id="q20803:64_answer0"><label for="q20803:64_answer0">a. ergotism</label> </div>
<div class="r1"><input type="radio" name="q20803:64_answer" disabled="disabled" value="1" id="q20803:64_answer1"><label for="q20803:64_answer1">b. Factor V Leiden positivity with primary thrombosis</label> </div>
<div class="r0"><input type="radio" name="q20803:64_answer" disabled="disabled" value="2" id="q20803:64_answer2"><label for="q20803:64_answer2">c. Buerger's disease</label> </div>
<div class="r1"><input type="radio" name="q20803:64_answer" disabled="disabled" value="3" id="q20803:64_answer3"><label for="q20803:64_answer3">d. atherosclerosis</label> </div>
<div class="r0"><input type="radio" name="q20803:64_answer" disabled="disabled" value="4" id="q20803:64_answer4"><label for="q20803:64_answer4">e. popliteal artery entrapment syndrome</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:64_-submit" name="q20803:64_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Claudication in a patient under the age of 40 is most commonly due to nonatherosclerotic causes. In addition, a non-atherosclerotic etiology for claudication should be strongly considered in a patient under 50 with no vascular risk factors. Although any of the above choices would be included in the differential diagnosis, popliteal artery entrapment and popliteal cystic adventitial disease are the most common causes of claudication among patients under 40. Typically, the symptoms are of sudden onset and usually precipitated by exercise. If occlusion has not occurred, resting ankle pulses and ankle-brachial indices may be normal and may remain normal after moderate exercise (eg, on a treadmill). The pathognomonic diagnostic sign is the presence of normal pulses at rest that diminish or disappear with forced active plantar flexion or passive dorsiflexion. The four described variants of popliteal entrapment are illustrated below (Fig 1).<br><br><a href="./VESAP3_files/AssetProxy_137.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_137.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a><br>Figure 1. Types of popliteal artery entrapment syndromes. Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery, 7th ed. Philadelphia, PA: Saunders Elsevier; 2010. Reproduced with permission.<br><br></p>
<h3>References:</h3>
<p>Levien LJ. Nonatheromatous causes of popliteal artery disease. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1236-1255.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Levien%20LJ.%20Popliteal%20artery%20entrapment%20syndrome.%20Sem%20Vasc%20Surgery;%202003;%2016%20(3):223-231" target="_blank">Levien LJ. Popliteal artery entrapment syndrome. Sem Vasc Surgery; 2003; 16 (3):223-31.</a></p>
<p>QID: 30101</p></div><div class="rightanswer">The correct answer is: popliteal artery entrapment syndrome</div></div></div></div></div><div id="q504" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">438</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4106"><input type="hidden" name="q20803:504_:flagged" value="0"><input type="hidden" value="qaid=911388&amp;qubaid=20803&amp;qid=5235&amp;slot=504&amp;checksum=7b9944218d625e9bbf560f6db1a8105a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:504_:flaggedcheckbox" name="q20803:504_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q504&id=5235"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:504_:sequencecheck" value="2"><div class="qtext"><p>Regarding nephrogenic systemic fibrosis (NSF) and gadolinium-enhanced MRI, which of the following is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:504_answer" disabled="disabled" value="0" id="q20803:504_answer0"><label for="q20803:504_answer0">a. pretreatment with corticosteroids and diphenhydramine reduces the risk of NSF</label> </div>
<div class="r1"><input type="radio" name="q20803:504_answer" disabled="disabled" value="1" id="q20803:504_answer1"><label for="q20803:504_answer1">b. the risk of NSF is increased with both chronic and acute renal insufficiency</label> </div>
<div class="r0"><input type="radio" name="q20803:504_answer" disabled="disabled" value="2" id="q20803:504_answer2"><label for="q20803:504_answer2">c. the risk of NSF is unrelated to the dose of gadolinium</label> </div>
<div class="r1"><input type="radio" name="q20803:504_answer" disabled="disabled" value="3" id="q20803:504_answer3"><label for="q20803:504_answer3">d. NSF is typically self limited</label> </div>
<div class="r0"><input type="radio" name="q20803:504_answer" disabled="disabled" value="4" id="q20803:504_answer4"><label for="q20803:504_answer4">e. the risk of NSF is decreased in patients already on dialysis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:504_-submit" name="q20803:504_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Nephrogenic systemic fibrosis (NSF) is a severe, debilitating condition that involves widespread tissue fibrosis due to deposition of fibroblasts and collagen, affecting primarily the skin. It is an uncommon complication of MRI with gadolinium-based contrast agents and has been reported only in patients with pre-existing renal disease. The likelihood of NSF after gadolinium appears to be dose dependent. Symptoms tend to occur 2-3 months after exposure to gadolinium. The risk is higher in patients on dialysis than those with only chronic renal insufficiency. Current recommendations call for avoidance of gadolinium in those patients with glomerular filtration rates &lt;30, if possible. Newer, more stable cyclic gadolinium-based contrast agents may have a lower incidence of NSF. Corticosteroids and antihistamines have not been beneficial in preventing NSF after gadolinium administration.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology%3B+2007%3B+243+(1)%3A148-157" target="_blank">Sadowski EA, Bennett LK, Chan MR, Wentland AL<span>,&nbsp;</span>Garrett AL<span>,&nbsp;</span>Garrett RW<span>,&nbsp;</span>et al. Nephrogenic systemic fibrosis: Risk factors and incidence estimation. Radiology 2007; 243(1):148-57.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=radiology%3B+2009%3B+253+(3)+689-696" target="_blank">Altun E, Martin DR, Wertman R, Lugo-Somolinos A<span>,&nbsp;</span>Fuller ER 3rd<span>,&nbsp;</span>Semelka RC. Nephrogenic systemic fibrosis: Change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities. Radiology; 2009; 253 (3):689-96.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Roentgenol+2007%3B+188(6)%3A1447-74." target="_blank">Kanal E, Barkovich AJ, Bell C, Borgstede JP,&nbsp;Bradley WG Jr,&nbsp;Froelich JW,&nbsp;et al. ACR guidance document for safe MR practices: 2007. Am J Roentgenol 2007; 188(6):1447-74.</a></p>
<p>QID: 30903</p></div><div class="rightanswer">The correct answer is: the risk of NSF is increased with both chronic and acute renal insufficiency</div></div></div></div></div><div id="q215" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">439</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4115"><input type="hidden" name="q20803:215_:flagged" value="0"><input type="hidden" value="qaid=911099&amp;qubaid=20803&amp;qid=4708&amp;slot=215&amp;checksum=72b78bc80dbdb80ffa9c427d15ad1294&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:215_:flaggedcheckbox" name="q20803:215_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q215&id=4708"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:215_:sequencecheck" value="2"><div class="qtext"><p>Which of the following represents the aortic arch variations in order from most to least common?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:215_answer" disabled="disabled" value="0" id="q20803:215_answer0"><label for="q20803:215_answer0">a. right-sided aortic arch &gt; aberrant right subclavian artery in left-sided aortic arch &gt; vertebral artery originating from aortic arch &gt; bovine arch</label> </div>
<div class="r1"><input type="radio" name="q20803:215_answer" disabled="disabled" value="1" id="q20803:215_answer1"><label for="q20803:215_answer1">b. aberrant right subclavian artery in left-sided aortic arch &gt; bovine arch &gt; vertebral artery originating from aortic arch &gt; right-sided aortic arch</label> </div>
<div class="r0"><input type="radio" name="q20803:215_answer" disabled="disabled" value="2" id="q20803:215_answer2"><label for="q20803:215_answer2">c. bovine arch &gt; vertebral artery originating from aortic arch &gt; aberrant right subclavian artery in left-sided aortic arch &gt; right-sided aortic arch</label> </div>
<div class="r1"><input type="radio" name="q20803:215_answer" disabled="disabled" value="3" id="q20803:215_answer3"><label for="q20803:215_answer3">d. bovine arch &gt; vertebral artery originating from aortic arch &gt; right-sided aortic arch &gt; aberrant right subclavian artery in left-sided aortic arch</label> </div>
<div class="r0"><input type="radio" name="q20803:215_answer" disabled="disabled" value="4" id="q20803:215_answer4"><label for="q20803:215_answer4">e. vertebral artery originating from aortic arch &gt; bovine arch &gt; right-sided aortic arch &gt; aberrant right subclavian artery in left-sided aortic arch</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:215_-submit" name="q20803:215_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>There are several variations in aortic arch anatomy that are clinically important. The most common variation is the "bovine arch" or the common trunk of the innominate artery and left common carotid artery, which occurs in 16-24% of people (see A and B). An origin of the vertebral artery from the aortic arch (7%) most commonly occurs between the left common carotid artery and the left subclavian artery (C). An aberrant right subclavian artery in a left-sided aortic arch occurs when the right subclavian artery originates distal to the left subclavian artery (.5-1%) (D). &nbsp;A right-sided aortic arch is extremely rare, occurring in only .1% of patients.</p>
<p><img src="./VESAP3_files/arch.png" alt="" width="478" height="668"></p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin.+Radiol.+2010+Jun%3B65(6)%3A481-7%20" target="_blank">Jakanani GC, Adair W. Frequency of variations in aortic arch anatomy depicted on multidetector CT. Clin Radiol 2010; 65(6):481-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2010%3B+52%3A71S-76S." target="_blank">Vallabhaneni R, Sanchez LA. Open techniques for arch vessel reconstruction during thoracic endovascular aneurysm repair. J Vasc Surg 2010; 52:71S-6S.&nbsp;</a></p>
<p>QID: 30366</p></div><div class="rightanswer">The correct answer is: bovine arch &gt; vertebral artery originating from aortic arch &gt; aberrant right subclavian artery in left-sided aortic arch &gt; right-sided aortic arch</div></div></div></div></div><div id="q465" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">440</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4124"><input type="hidden" name="q20803:465_:flagged" value="0"><input type="hidden" value="qaid=911349&amp;qubaid=20803&amp;qid=5188&amp;slot=465&amp;checksum=fd02c5aecddcffb30b84831b9f692d2e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:465_:flaggedcheckbox" name="q20803:465_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q465&id=5188"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:465_:sequencecheck" value="2"><div class="qtext"><p>A 25-year-old woman presents to the emergency department with a headache. A head CT scan reveals extensive cerebral vein thrombosis. She is started on therapeutic anticoagulation with unfractionated heparin (UFH). Subsequent history obtained from her mother indicates that both the mother and daughter have an antithrombin deficiency. Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:465_answer" disabled="disabled" value="0" id="q20803:465_answer0"><label for="q20803:465_answer0">a. increase the heparin dose to overcome the deficiency</label> </div>
<div class="r1"><input type="radio" name="q20803:465_answer" disabled="disabled" value="1" id="q20803:465_answer1"><label for="q20803:465_answer1">b. discontinue unfractionated heparin and start low molecular weight heparin</label> </div>
<div class="r0"><input type="radio" name="q20803:465_answer" disabled="disabled" value="2" id="q20803:465_answer2"><label for="q20803:465_answer2">c. administer fresh frozen plasma with weight-based UFH infusion</label> </div>
<div class="r1"><input type="radio" name="q20803:465_answer" disabled="disabled" value="3" id="q20803:465_answer3"><label for="q20803:465_answer3">d. discontinue unfractionated heparin after starting warfarin</label> </div>
<div class="r0"><input type="radio" name="q20803:465_answer" disabled="disabled" value="4" id="q20803:465_answer4"><label for="q20803:465_answer4">e. discontinue unfractionated heparin and start fondaparinux</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:465_-submit" name="q20803:465_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Antithrombin is a serine protease inhibitor of thrombin; kallikrein; factors Xa, IXa, VIIa, XIIa and Xia. Antithrombin is synthesized by the liver and has a half-life of 2.8 days. A congenital (autosomal dominant) or acquired deficiency account for 1-2% of venous thromboembolism and may occur in unusual sites, such as the cerebral or mesenteric venous circulation. Congenital homozygous individuals usually die in utero and heterozygous individuals have less than 70% of the circulating antithrombin activity.</p>
<p>Heparin, low molecular weight heparin (LMWH), and factor Xa inhibitors all bind to antithrombin, causing a conformational change in the tertiary structure allowing for an increased anti-factor Xa activity of 17,000 fold for heparin and LMWH and 270 fold for fondaparinux.</p>
<p>Warfarin should not be used initially as it may increase the risk of further thromboembolic events and thrombus propagation. Fresh frozen plasma should be administered; usually 2 units initially, followed by 1 unit every 8 hours. Fresh frozen plasma provides the needed amount of antithrombin to allow for proper binding of heparin and anticoagulation. Antithrombin concentrates, both recombinant and human pooled, are also available.</p>
<p>An alternative to using a medication requiring antithrombin as an intermediary is using a direct thrombin inhibitor as these do not require antithrombin for their activity.<br><br></p>
<h3>References:</h3>
<p>Meissner MH. Antithrombotic therapy. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:511-29.<br><br>Henke PK, Schmaier A, Wakefield TW. Vascular thrombosis due to hypercoagulable state. In: Rutherford RB, ed. Vascular Surgery. 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:568-78.<br><br>Seligsohn U, Griffin JH. Hereditary thrombophilia. In: Lichtman MA, Beutler E, Kipps TJ, et al, eds. Williams Hematology, 7th ed. NY, NY: McGraw Hill; 2001:1697-1714.</p>
<p>QID: 30827</p></div><div class="rightanswer">The correct answer is: administer fresh frozen plasma with weight-based UFH infusion</div></div></div></div></div><div id="q213" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">441</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4133"><input type="hidden" name="q20803:213_:flagged" value="0"><input type="hidden" value="qaid=911097&amp;qubaid=20803&amp;qid=4705&amp;slot=213&amp;checksum=a0e7f6d00d93f5a278b8d910bb9d8ed6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:213_:flaggedcheckbox" name="q20803:213_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q213&id=4705"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:213_:sequencecheck" value="2"><div class="qtext"><p>A 52-year-old woman is followed for hypertension and develops tinnitus. Carotid duplex imaging demonstrates elevated velocities in bilateral vertebral arteries. A CT scan of her aortic arch to Circle of Willis shows alternating stenoses and dilation in the bilateral vertebral arteries without aneurysmal dilation. Based on published data, which of the following statements is true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:213_answer" disabled="disabled" value="0" id="q20803:213_answer0"><label for="q20803:213_answer0">a. extracranial vertebral fibromuscular dysplasia is the most common site of fibromuscular dysplasia</label> </div>
<div class="r1"><input type="radio" name="q20803:213_answer" disabled="disabled" value="1" id="q20803:213_answer1"><label for="q20803:213_answer1">b. she would benefit from open transluminal gradual dilation</label> </div>
<div class="r0"><input type="radio" name="q20803:213_answer" disabled="disabled" value="2" id="q20803:213_answer2"><label for="q20803:213_answer2">c. aspirin therapy is the first line treatment for asymptomatic extracranial vertebral fibromuscular dysplasia</label> </div>
<div class="r1"><input type="radio" name="q20803:213_answer" disabled="disabled" value="3" id="q20803:213_answer3"><label for="q20803:213_answer3">d. percutaneous dilation and bare metal stenting are indicated to eliminate her tinnitus</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:213_-submit" name="q20803:213_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Fibromuscular dysplasia (FMD) most commonly affects women between the age of 2 and 60. Often underdiagnosed, FMD is a nonatherosclerotic process affecting nearly every medium sized vascular bed in the body, although it is more commonly seen in the renal and carotid circulation. Vertebral FMD has also been described.&nbsp;The presentation of FMD in the cerebrovascular circulation is varied. While both transient ischemic attacks and cerebrovascular accidents have been reported, more patients are asymptomatic and present with incidental findings of FMD. Other benign presentations include pulsatile tinnitus, a "whooshing" sound in the ear, and headaches.&nbsp;</p>
<p>The treatment for asymptomatic carotid or vertebral&nbsp;fibromuscular dysplasia is antiplatelet therapy with aspirin. In symptomatic patients, transluminal balloon angioplasty can be considered. Stents should be avoided in this condition and have not been shown to be superior to balloon angioplasty alone. The advantages of percutaneous angioplasty over open transluminal dilation include the accurate wire and balloon placement with flouroscopic guidance, precise dilation of the stenotic lesion, and the gradual dilation of the vessel wall as opposed to the longitudinal shear stress created&nbsp;with mechanical dilators. Patients who have FMD and present with a vertebral dissection acutely are started on&nbsp;anticoagulation therapy with heparin and transition to warfarin. This treatment is continued for 3-6 months to permit healing of the dissection and prevent propagation of potential thrombus.&nbsp; However, in patients who are refractory to anticoagulation and continue to have symptoms, percutaneous stent therapy may be of benefit. Percutaneous coil embolization and covered stent placement have been described to treat aneurysmal degeneration of the vertebral artery from dissection.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21236620" target="_blank">Olin J and Sealove BA.&nbsp;Diagnosis, management and future developments of fibromuscular dysplasia.&nbsp; J Vasc Surg 2011; 53:826-36. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11259724" target="_blank">Shievink WI. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med 2001; 344:898-906. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/3944934" target="_blank">Stewart M, Moritz MW, Smith RB 3rd, Fulenwider JT<span>,&nbsp;</span>Perdue GD. The natural history of carotid fibromuscular dysplasia.&nbsp; J Vasc Surg 1986; 3:305-10. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/11259724" target="_blank"><br></a></p>
<p>QID: 30363</p></div><div class="rightanswer">The correct answer is: aspirin therapy is the first line treatment for asymptomatic extracranial vertebral fibromuscular dysplasia</div></div></div></div></div><div id="q10" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">442</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4142"><input type="hidden" name="q20803:10_:flagged" value="0"><input type="hidden" value="qaid=910894&amp;qubaid=20803&amp;qid=4619&amp;slot=10&amp;checksum=aab4f40cd98952a57ffa6e61c0d93d6d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:10_:flaggedcheckbox" name="q20803:10_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q10&id=4619"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:10_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old man presents with an incidental discovery of a pulsatile mass behind his right knee. An ultrasound reveals the right popliteal artery to be 1.8 cm with minimal thrombus and the left popliteal artery to be normal in size.&nbsp;Which of the following is the appropriate next step in the&nbsp;management&nbsp;of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:10_answer" disabled="disabled" value="0" id="q20803:10_answer0"><label for="q20803:10_answer0">a. no further work-up</label> </div>
<div class="r1"><input type="radio" name="q20803:10_answer" disabled="disabled" value="1" id="q20803:10_answer1"><label for="q20803:10_answer1">b. repeat bilateral popliteal ultrasound in 6 months</label> </div>
<div class="r0"><input type="radio" name="q20803:10_answer" disabled="disabled" value="2" id="q20803:10_answer2"><label for="q20803:10_answer2">c. repair of the right popliteal artery aneurysm</label> </div>
<div class="r1"><input type="radio" name="q20803:10_answer" disabled="disabled" value="3" id="q20803:10_answer3"><label for="q20803:10_answer3">d. ultrasound of the abdominal aorta</label> </div>
<div class="r0"><input type="radio" name="q20803:10_answer" disabled="disabled" value="4" id="q20803:10_answer4"><label for="q20803:10_answer4">e. ultrasound of the carotid arteries</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:10_-submit" name="q20803:10_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The literature suggests that at least 25%, and as many as 62%, of people with popliteal artery aneurysms have abdominal aortic aneurysms. Conversely, only a small percentage of people with an abdominal aortic aneurysm have a popliteal artery aneurysm. Therefore, an ultrasound of the abdominal aorta is the appropriate next step in the management of this patient. At only 1.8 cm and asymptomatic, there is no present indication for repair of the right popliteal artery aneurysm. Most surgeons recommend repair of asymptomatic popliteal aneurysm at 2.0-2.5 cm if there are no significant contraindications to surgery. However, the patient should be followed with serial ultrasound examinations to monitor further enlargement, as well as&nbsp;clinical evaluations for evidence of thrombosis or embolization. There is no specific association of popliteal artery aneurysms with carotid artery disease. If&nbsp;the ultrasound reveals an abdominal aortic aneurysm (AAA) that is greater than 5 - 5.5 cm in size, then a CT angiogram should be performed to evaluate the repair options.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Claridge%20M%2C%20Hobbs%20S%2C%20Quick%20C%2C%20et%20al.%20Screening%20for%20popliteal%20aneurysms%20should%20not%20be%20a%20routine%20part%20of%20a%20community-based%20aneurysm%20screening%20program.%20Vasc%20Health%20Risk%20Manag%3B%202006%3B%202%20%282%29%3A189-191" target="_blank">Claridge M, Hobbs S, Quick C, Adam D, Bradbury A, Wilmink T. Screening for popliteal aneurysms should not be a routine part of a community-based aneurysm screening program. Vasc Health Risk Manag 2006; 2 (2):189-91.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Morris-Stiff%20G%2C%20Haynes%20M%2C%20Ogunbiyi%20S%2C%20et%20al.%20Is%20assessment%20of%20popliteal%20artery%20diameter%20in%20patients%20undergoing%20screening%20for%20abdominal%20aortic%20aneurysms%20a%20worthwhile%20procedure%3F%20Eur%20J%20Vasc%20Endovasc%20Surg%3B%202005%3B%2030%20%281%29%3A71-74" target="_blank">Morris-Stiff G, Haynes M, Ogunbiyi S, Townsend E, Shetty S, Winter RK, et al. Is assessment of popliteal artery diameter in patients undergoing screening for abdominal aortic aneurysms a worthwhile procedure? Eur J Vasc Endovasc Surg 2005; 30 (1):71-4.</a></p>
<p>QID: 30010</p></div><div class="rightanswer">The correct answer is: ultrasound of the abdominal aorta</div></div></div></div></div><div id="q511" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">443</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4151"><input type="hidden" name="q20803:511_:flagged" value="0"><input type="hidden" value="qaid=911395&amp;qubaid=20803&amp;qid=5243&amp;slot=511&amp;checksum=67f51fdeff58c776a981f06eb6aed75c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:511_:flaggedcheckbox" name="q20803:511_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q511&id=5243"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:511_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old man with lower extremity occlusive disease is scheduled for arteriography. One of his current medications is metformin (glucophage). Which of the following is the most prudent course of action during the periprocedural period?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:511_answer" disabled="disabled" value="0" id="q20803:511_answer0"><label for="q20803:511_answer0">a. discontinue metformin prior to the contrast study and 48 hours after the study</label> </div>
<div class="r1"><input type="radio" name="q20803:511_answer" disabled="disabled" value="1" id="q20803:511_answer1"><label for="q20803:511_answer1">b. discontinue metformin for 24 hours after the procedure only if estimated glomerular filtration rate is &lt;60 ml/min</label> </div>
<div class="r0"><input type="radio" name="q20803:511_answer" disabled="disabled" value="2" id="q20803:511_answer2"><label for="q20803:511_answer2">c. discontinue metformin permanently due to the risk of nephropathy in patients with lower extremity occlusive disease</label> </div>
<div class="r1"><input type="radio" name="q20803:511_answer" disabled="disabled" value="3" id="q20803:511_answer3"><label for="q20803:511_answer3">d. discontinue metformin for 1 week prior to the procedure, then restart more than 1 hour after the last contrast dose</label> </div>
<div class="r0"><input type="radio" name="q20803:511_answer" disabled="disabled" value="4" id="q20803:511_answer4"><label for="q20803:511_answer4">e. continue metformin without interruption</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:511_-submit" name="q20803:511_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Metformin, a biguanide drug, is widely used to control hyperglycemia in type 2 diabetes mellitus. The predecessor to this drug, phenformin, was withdrawn from the market by the U.S. Food and Drug Administration because of its association with lactic acidosis. Metformin acts as hypoglycemic agent by inhibiting the hepatic conversion of lactate to glucose, and by inhibiting intestinal absorption of glucose. Metformin itself is not directly nephrotoxic, but it can contribute to acute metabolic acidosis by inhibiting liver production of glucose from lactate, thus resulting in accumulation of lactate. Metformin is cleared by the kidney and accumulates in the setting of decreased renal function, thus exacerbating the accumulation of lactate. There is a current lack of consensus regarding the optimal management of metformin at the time of contrast radiologic procedures. Some have questioned the need to interrupt metformin dosing during contrast angiography in patients with normal renal function, but most recommendations suggest stopping metformin immediately before the contrast study and for 48 hours after the study. In patients with decreased renal function, or at increased risk for contrast nephropathy (eGFR &lt; 60 ml/min), cessation for 48 hours before and after the study is recommended. In both instances, metformin should only be resumed after any acute decline of renal function has been ruled out.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=CIN+Consensus+Working+Panel.+Strategies+to+reduce+the+risk+of+contrast-induced+nephropathy.+Am+J+Cardiology%3B+2006%3B+98+(Supp+1)%3A59-77" target="_blank">Fulvio S, Adam AMB, Becker CR, Davidson C<span>,&nbsp;</span>Lameire N<span>,&nbsp;</span>McCullough PA<span>, et al;</span>&nbsp;CIN Consensus Working Panel. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiology 2006; 98 (Supp 1):59-77.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Systematic+Review+of+Current+Guidelines%2C+and+Their+Evidence+Base%2C+on+Risk+of+Lactic+Acidosis+after+Administration" target="_blank">Goergen SK, Rumbold G, Compton G, Harris C. Systematic Review of Current Guidelines, and Their Evidence Base, on Risk of Lactic Acidosis after Administration of Contrast Medium for Patients Receiving Metformin. Radiology 2010; 254 ():261-9.</a></p>
<p>QID: 30911</p></div><div class="rightanswer">The correct answer is: discontinue metformin prior to the contrast study and 48 hours after the study</div></div></div></div></div><div id="q373" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">444</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4160"><input type="hidden" name="q20803:373_:flagged" value="0"><input type="hidden" value="qaid=911257&amp;qubaid=20803&amp;qid=5293&amp;slot=373&amp;checksum=442aea40fdb35bf36efb2d7a35cbdad3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:373_:flaggedcheckbox" name="q20803:373_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q373&id=5293"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:373_:sequencecheck" value="2"><div class="qtext"><p><span>A 68-year-old woman presents with a 36 hour history of acute, severe abdominal pain. For the past 6 months, she has experienced progressive post-prandial abdominal pain and a 25lb. weight loss. Physical exam shows an ill-appearing thin female with diffuse abdominal tenderness and guarding. A CT scan is obtained (image is shown below). In addition to laparotomy, the most appropriate management of this patient involves which of the following?</span></p>
<p>&nbsp;</p>
<p><span><img src="./VESAP3_files/Pneumatosis Q5a.jpg" alt="" width="418" height="418"></span></p>
<p>&nbsp;</p>
<p><img src="./VESAP3_files/Pneumatosis Q5b.jpg" alt="" width="523" height="523"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:373_answer" disabled="disabled" value="0" id="q20803:373_answer0"><label for="q20803:373_answer0">a. <span>systemic&nbsp;anticoagulation with heparin</span></label> </div>
<div class="r1"><input type="radio" name="q20803:373_answer" disabled="disabled" value="1" id="q20803:373_answer1"><label for="q20803:373_answer1">b. <span>catheter-directed thrombolysis</span></label> </div>
<div class="r0"><input type="radio" name="q20803:373_answer" disabled="disabled" value="2" id="q20803:373_answer2"><label for="q20803:373_answer2">c. <span>SMA bypass</span></label> </div>
<div class="r1"><input type="radio" name="q20803:373_answer" disabled="disabled" value="3" id="q20803:373_answer3"><label for="q20803:373_answer3">d. <span>pharmaco-mechanical thrombectomy of the superior mesenteric artery (SMA)</span></label> </div>
<div class="r0"><input type="radio" name="q20803:373_answer" disabled="disabled" value="4" id="q20803:373_answer4"><label for="q20803:373_answer4">e. <span>SMA embolectomy</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:373_-submit" name="q20803:373_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient presents with advanced acute mesenteric ischemia, which is supported by&nbsp;the clinical findings and confirmed by the presence of pneumatosis intestinalis (Fig. 1) and free air in the portal system (Fig. 2). Emergent operative treatment is indicated. Necrotic or perforated bowel should be resected. Ischemic bowel that is not yet frankly necrotic should not be resected, as it may improve with mesenteric revascularization. Given the antecedent history of postprandial pain and weight loss,&nbsp;the most likely etiology for the acute mesenteric ischemia&nbsp;is acute thrombosis with underlying atherosclerotic disease. In these cases, at least two (and commonly all three) of the mesenteric arteries are involved with atherosclerotic arterial occlusive disease. In such cases, anticoagulation alone is insufficient treatment. Pharmaco-mechanical thrombolysis and catheter-directed thrombolysis may be options if combined with stenting of the mesenteric arterial occlusive disease after clearing the thrombus, but that approach is usually reserved with patients without&nbsp;advanced clinical findings&nbsp;that require a aparotomy.&nbsp;Embolectomy would not be helpful in a patient with pre-existing mesenteric arterial occlusive disease. The only reasonable option is a mesenteric bypass. Both antegrade and retrograde approaches have been described;&nbsp;the approach should be tailored to the circumstances.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+Surg+2011%3B77%3A832-8." target="_blank">Newton WB, 3rd, Sagransky MJ, Andrews JS, Hansen KJ, Corriere MA, Goodney PP, et al. Outcomes of revascularized acute mesenteric ischemia in the American College of Surgeons National Surgical Quality Improvement Program database. Am Surg 2011;77:832-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22000191" target="_blank">Gupta PK, Natarajan B, Gupta H, Fang X, Fitzgibbons RJ, Jr. Morbidity and mortality after bowel resection for acute mesenteric ischemia.&nbsp;Surgery&nbsp;2011;150:779-87</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B46%3A467-74." target="_blank">Kougias P, Lau D, El Sayed HF, Zhou W, Huynh TT, Lin PH. Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia.&nbsp;J Vasc Surg&nbsp;2007;46:467-74.</a></p>
<p>QID: 30658</p></div><div class="rightanswer">The correct answer is: <span>SMA bypass</span></div></div></div></div></div><div id="q502" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">445</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4169"><input type="hidden" name="q20803:502_:flagged" value="0"><input type="hidden" value="qaid=911386&amp;qubaid=20803&amp;qid=5212&amp;slot=502&amp;checksum=8b9ce9ff039ca2509376fb16fc15713f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:502_:flaggedcheckbox" name="q20803:502_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q502&id=5212"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:502_:sequencecheck" value="2"><div class="qtext"><p>A 71-year-old man who has a serum creatinine of 1.7 mg/dl undergoes endovascular aortic aneurysm repair (EVAR) using iodinated contrast.&nbsp;Which statement about potential renal complications is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:502_answer" disabled="disabled" value="0" id="q20803:502_answer0"><label for="q20803:502_answer0">a. contast-induced nephropathy is rarely reversible in patients over the age of 70 without prompt therapy</label> </div>
<div class="r1"><input type="radio" name="q20803:502_answer" disabled="disabled" value="1" id="q20803:502_answer1"><label for="q20803:502_answer1">b. maintaining serum glucose &lt; 150 mg/dl using biguanide antihyperglycemic drugs reduces risk of contrast-induced nephropathy</label> </div>
<div class="r0"><input type="radio" name="q20803:502_answer" disabled="disabled" value="2" id="q20803:502_answer2"><label for="q20803:502_answer2">c. current therapy with a statin (HMG-CoA reductase inhibitor) increases risk of contrast-induced nephropathy</label> </div>
<div class="r1"><input type="radio" name="q20803:502_answer" disabled="disabled" value="3" id="q20803:502_answer3"><label for="q20803:502_answer3">d. transient eosinophilia and hypocomplementemia are markers for atheroembolic injury to the kidney</label> </div>
<div class="r0"><input type="radio" name="q20803:502_answer" disabled="disabled" value="4" id="q20803:502_answer4"><label for="q20803:502_answer4">e. oliguric acute renal failure within 24 hours of contrast administration is characteristic of anaphylactoid contrast reactions</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:502_-submit" name="q20803:502_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Atheroembolization (cholesterol embolization syndrome) may cause acute renal insufficiency after arterial catheterization. Transient eosinophilia, decreased serum complement levels, and the presence of eosinophils in the urine may be seen with renal atheroembolization. Renal failure from emboli may be early, severe, and irreversible.</p>
<p>In patients without risk factors, the incidence contrast-induced nephropathy (CIN) is low, approximately 1-2%. The risk increases with the presence of risk factors, especially diabetes and pre-existing renal disease. Other patient-related risk factors for contrast-induced nephropathy include heart failure, older age, anemia, and left ventricular systolic dysfunction. Procedure related risk factors include use of high-osmolar and ionic contrast agents and increased volume of contrast delivered. Periprocedueal hydration, bicarbonate, and low volumes of iso- or low-osmolar contrast are recommended for patients at elevated risk for CIN. N-acetylcysteine use remains controversial and the evidence conflicting, but it may be of value in very high-risk patients.</p>
<p>In most cases, including in patients over age 70, CIN is reverible with supportive measures. There is no specific treatment for CIN.</p>
<p>Renal insufficiency from CIN is often non-oliguric, with peak onset 2-3 days after contrast administration. Acute tubular injury leading to CIN is not a histamine mediated response, which is distinct from the acute anaphylaxis-like contrast reactions that can occur within minutes of contrast administration.</p>
<p>Statins do not increase risk of CIN. Rather, there may be some protective effect from use of statins.&nbsp;Biguanide antihyperglycemic drugs, such as metformin, do not reduce CIN risk. Lactic acidosis is a known complication of metformin use, especially in patients with renal insufficiency. CIN can increase the risk of metformin-associated metabolic acidosis. Because of this, use of metformin in the immediate perioperative procedure is not advised.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Minerva+Chir+2011%3B+66(6)%3A553-60." target="_blank">Zaraca F, Wiedermann CJ, Ebner H. Contrast media-induced nephropathy in patients undergoing angiography prior to or during vascular surgery: a systematic review. Minerva Chir 2011; 66(6):553-60.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephrol+Dial+Transplant+2006%3B+21(6)%3Ai2-10." target="_blank">Finn WF. The clinical and renal consequences of contrast-induced nephropathy. Nephrol Dial Transplant 2006; 21(6):i2-10.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2006+21%3B+295(23)%3A2765-79." target="_blank">Pannu N, Wiebe N, Tonelli M; Alberta Kidney Disease Network. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006 21; 295(23):2765-79.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+2003%3B+42(2)%3A211-6." target="_blank">Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A, Takeshita A; Cholesterol Embolism Study(CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol 2003; 42(2):211-6.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation+2012%3B+126(25)%3A3008-16." target="_blank">Quintavalle C, Fiore D, De Micco F, Visconti G, Focaccio A, Golia B. Impact of a high loading dose of atorvastatin on contrast-induced acute kidney injury. Circulation 2012; 126(25):3008-16.&nbsp;</a></p>
<p>QID: 30870</p></div><div class="rightanswer">The correct answer is: transient eosinophilia and hypocomplementemia are markers for atheroembolic injury to the kidney</div></div></div></div></div><div id="q161" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">446</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4178"><input type="hidden" name="q20803:161_:flagged" value="0"><input type="hidden" value="qaid=911045&amp;qubaid=20803&amp;qid=4774&amp;slot=161&amp;checksum=abfb30217ddf4f35d5d46035d7243f4e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:161_:flaggedcheckbox" name="q20803:161_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q161&id=4774"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:161_:sequencecheck" value="2"><div class="qtext"><p>A 42-year-old woman is diagnosed with spontaneous acute left axillary vein thrombosis. It has been determined that she is not a candidate for anticoagulation due to excessive bleeding risk.&nbsp;With regards to this patient, which of the following statements is most accurate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:161_answer" disabled="disabled" value="0" id="q20803:161_answer0"><label for="q20803:161_answer0">a. the high risk of pulmonary embolism warrants anticoagulation regardless of bleeding risk</label> </div>
<div class="r1"><input type="radio" name="q20803:161_answer" disabled="disabled" value="1" id="q20803:161_answer1"><label for="q20803:161_answer1">b. venography is necessary to determine the optimal treatment</label> </div>
<div class="r0"><input type="radio" name="q20803:161_answer" disabled="disabled" value="2" id="q20803:161_answer2"><label for="q20803:161_answer2">c. observation is the preferred treatment</label> </div>
<div class="r1"><input type="radio" name="q20803:161_answer" disabled="disabled" value="3" id="q20803:161_answer3"><label for="q20803:161_answer3">d. a superior vena cava filter should be placed</label> </div>
<div class="r0"><input type="radio" name="q20803:161_answer" disabled="disabled" value="4" id="q20803:161_answer4"><label for="q20803:161_answer4">e. anticoagulation is not indicated for axillary vein thrombosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:161_-submit" name="q20803:161_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The 9th edition of Therapeutic Guidelines for the Treatment of DVT from Chest recommends treating thrombosis of the axillary vein or more proximal veins with at least 3 months of anticoagulation when feasible. Anticoagulation for thrombus isolated to the brachial vein is only recommended for symptomatic patients, patients with an ipsilateral central catheter, or patients with cancer. In this patient, anticoagulation is contraindicated due to bleeding risk.&nbsp;While some authors have championed the use of superior vena cava filters when anticoagulation is not feasible, there is no level I evidence to support this off-label use. Venography is usually unnecessary for the diagnosis of upper extremity DVT and is reserved for patients likely to benefit from thrombolytic therapy and/or percutaneous thrombectomy. Thus, in this patient with a contraindication to anticoagulation, the best option is conservative management with elevation alone.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+11054219" target="_blank">Ascher E, Hingorani A, Tsemekhin B, Yorkovich W, Gunduz Y. Lessons learned</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+11054219" target="_blank">from a 6-year clinical experience with superior vena cava Greenfield filters. J</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+11054219" target="_blank">Vasc Surg 2000; 32(5):881-7.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+22315268" target="_blank">Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+22315268" target="_blank">Prevention of Thrombosis, 9th ed: American College of Chest Physicians</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+22315268" target="_blank">Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+22315268" target="_blank">Suppl):e419S-94S.</a></p>
<p>QID: 30255</p></div><div class="rightanswer">The correct answer is: observation is the preferred treatment</div></div></div></div></div><div id="q209" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">447</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4187"><input type="hidden" name="q20803:209_:flagged" value="0"><input type="hidden" value="qaid=911093&amp;qubaid=20803&amp;qid=4701&amp;slot=209&amp;checksum=653e772db5191b9f1406468e597c79a1&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:209_:flaggedcheckbox" name="q20803:209_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q209&id=4701"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:209_:sequencecheck" value="2"><div class="qtext"><p>Abundant collateral pathways exist between the vertebral and carotid systems. Examples of vessels connecting the anterior and posterior circulation include all of the following&nbsp;<strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:209_answer" disabled="disabled" value="0" id="q20803:209_answer0"><label for="q20803:209_answer0">a. the posterior communicating artery to posterior cerebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:209_answer" disabled="disabled" value="1" id="q20803:209_answer1"><label for="q20803:209_answer1">b. the vertebral artery to the occipital artery</label> </div>
<div class="r0"><input type="radio" name="q20803:209_answer" disabled="disabled" value="2" id="q20803:209_answer2"><label for="q20803:209_answer2">c. the anterior communicating artery to the middle cerebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:209_answer" disabled="disabled" value="3" id="q20803:209_answer3"><label for="q20803:209_answer3">d. the trigeminal artery to the basilar artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:209_-submit" name="q20803:209_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The anterior and posterior cerebral vascular beds are connected by numerous complex channels. The most well known is the circle of Willis, which is a vascular ring comprising inflow from both carotid and vertebral systems with outflow to the anterior, middle, and posterior cerebral vessels. The anterior communicating artery serves as an effective pathway between the internal carotid systems. The vertebrobasilar system is connected to the anterior circulation through the posterior communicating arteries. Branches of the external carotid artery also serve as important collateral pathways to the vertebral artery. The V3 segment of the vertebral artery receives anastomotic branches from the occipital artery (most commonly) and the cervical ascending artery.&nbsp; Persistent fetal communications may also serve as important anastomic bridges between the carotid and vertebral systems. These fetal connections include the trigeminal, hypoglossal, proatlantal, and otic arteries. When these bridges exist, the vertebral or basilar artery are usually hypoplastic or incomplete.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Guttenbert%2C+Roberto+Andres.++Fetal+carotid+vertebrobasilar+anasomoses%3Apersistent+hypoglossal+artery+associated+with+further+variations+of+the+circle+of+Willis.+Surgical+Radiologic+Anatomy+2009%3B31%3A311-5" target="_blank">Guttenbert RA.&nbsp; Fetal carotid vertebrobasilar anasomoses:persistent hypoglossal artery associated with further variations of the circle of Willis. Surg Radiol Anat 2009; 31:311-5.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ouriel%2C+Kenneth+et+al.+Anomalous+carotid-basilar+anastomoses+in+cerebrovascular+surgery.++J+Vasc+Surg+1988%3B+7%3A774-7." target="_blank">Ouriel K<span>,&nbsp;</span>Green RM<span>,&nbsp;</span>DeWeese JA. Anomalous carotid-basilar anastomoses in cerebrovascular surgery.&nbsp; J Vasc Surg 1988; 7:774-7.</a></p>
<p>QID: 30359</p></div><div class="rightanswer">The correct answer is: the anterior communicating artery to the middle cerebral artery</div></div></div></div></div><div id="q273" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">448</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4196"><input type="hidden" name="q20803:273_:flagged" value="0"><input type="hidden" value="qaid=911157&amp;qubaid=20803&amp;qid=5010&amp;slot=273&amp;checksum=926c5c9e6492388628eb6b97c9204706&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:273_:flaggedcheckbox" name="q20803:273_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q273&id=5010"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:273_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding arteriovenous grafts for hemodialysis access is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:273_answer" disabled="disabled" value="0" id="q20803:273_answer0"><label for="q20803:273_answer0">a. modifications in PTFE grafts, such as cuffs, hood, or rings, have not produced any significant improvements in their patency</label> </div>
<div class="r1"><input type="radio" name="q20803:273_answer" disabled="disabled" value="1" id="q20803:273_answer1"><label for="q20803:273_answer1">b. failure of prosthetic grafts is usually due to stenosis at the arterial anastomosis</label> </div>
<div class="r0"><input type="radio" name="q20803:273_answer" disabled="disabled" value="2" id="q20803:273_answer2"><label for="q20803:273_answer2">c. initial prosthetic access should be placed utilizing larger, more proximal vessels</label> </div>
<div class="r1"><input type="radio" name="q20803:273_answer" disabled="disabled" value="3" id="q20803:273_answer3"><label for="q20803:273_answer3">d. biologic grafts have shown clear advantages over PTFE grafts in reducing infection rates and improving patency rates</label> </div>
<div class="r0"><input type="radio" name="q20803:273_answer" disabled="disabled" value="4" id="q20803:273_answer4"><label for="q20803:273_answer4">e. <p>standard wall PTFE grafts can be cannulated immediately without a significant increase in complications rates</p></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:273_-submit" name="q20803:273_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>When autogenous access is not feasible, placement of an arteriovenous prosthetic graft should be considered for patients on dialysis or in patients in whom the need for hemodialysis is imminent. The use of larger, more proximal vessels for initial graft placement should be avoided in efforts to preserve more proximal sites for future access. For over three decades, PTFE has been the material of choice for arteriovenous grafts. Despite suboptimal primary patency, no alternative graft material to date has demonstrated better long-term outcomes. Modification of PTFE with anastomotic hoods or cuffs, support rings, or other design changes has failed to consistently improve outcomes. Likewise, newer biologic grafts constructed from bovine mesenteric vein, bovine carotid artery, and other materials have shown promise, but to date have failed to demonstrate unequivocal benefits over the use of PTFE. Tapered grafts are intended to reduce inflow and reduce the risk of steal syndrome, but their effectiveness is questionable. Newer graft materials such as polyurethane can be cannulated immediately without a significant increase in complication rates and may reduce dependence on tunneled catheters.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>National Kidney Foundation KDOQI 2006 Vascular Access Guidelines.&nbsp; Am J Kidney Disease 2006;48(suppl 1):S177-322.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B48%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al.&nbsp; The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.&nbsp; J Vasc Surg 2008; 48:2S-25S.</a></p>
<p>QID: 30458</p></div><div class="rightanswer">The correct answer is: modifications in PTFE grafts, such as cuffs, hood, or rings, have not produced any significant improvements in their patency</div></div></div></div></div><div id="q475" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">449</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4205"><input type="hidden" name="q20803:475_:flagged" value="0"><input type="hidden" value="qaid=911359&amp;qubaid=20803&amp;qid=5200&amp;slot=475&amp;checksum=803479befb6b373c4d4a9c00c163aea9&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:475_:flaggedcheckbox" name="q20803:475_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q475&id=5200"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:475_:sequencecheck" value="2"><div class="qtext"><p><span style="color: #000000;">A 40-year-old man with chronic hepatitis C is referred for new symptoms of Raynaud’s phenomenon following cold exposure. He reports fatigue, myalgies, and arthralgias. On examination, he is noted to have a prominent skin rash with patchy palpable purpura. The skin is not ulcerated.&nbsp;</span><span style="color: #000000;">A small-vessel vasculitis is suspected. Which of the following is most probable?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:475_answer" disabled="disabled" value="0" id="q20803:475_answer0"><label for="q20803:475_answer0">a. eosinophilic granulomatosis with polyangiitis (Churg-Strauss)</label> </div>
<div class="r1"><input type="radio" name="q20803:475_answer" disabled="disabled" value="1" id="q20803:475_answer1"><label for="q20803:475_answer1">b. microscopic polyangiitis or polyarteritis</label> </div>
<div class="r0"><input type="radio" name="q20803:475_answer" disabled="disabled" value="2" id="q20803:475_answer2"><label for="q20803:475_answer2">c. granulomatosis with polyangiitis (Wegener’s)</label> </div>
<div class="r1"><input type="radio" name="q20803:475_answer" disabled="disabled" value="3" id="q20803:475_answer3"><label for="q20803:475_answer3">d. cryoglobulinemic vasculitis</label> </div>
<div class="r0"><input type="radio" name="q20803:475_answer" disabled="disabled" value="4" id="q20803:475_answer4"><label for="q20803:475_answer4">e. Henoch-Schönlein purpura (IgA vasculitis)</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:475_-submit" name="q20803:475_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has cryoglobulinemic vasculitis, an immune-complex-mediated systemic vasculitis involving medium- and small-sized vessels. The relationship of cold exposure to symptom onset suggests this diagnosis.&nbsp;Infection with hepatitis C virus is causal in over 80%. Cryoglobulinemic vasculitis, previously known as “essential” cryoglobulinemic vasculitis, is characterized by the presence of serum proteins that precipitate in the cold and dissolve upon rewarming. Cryoglobulins are composed of immunoglobulins and complement components. Immune complexes are deposited in the walls of capillaries, venules, or arterioles, resulting in small vessel inflammation. This disorder is most often due to hepatitis C virus infection.</p>
<p>Skin manifestations are common. This vasculitis can cause Raynaud's phenomenon and, in some cases, skin necrosis or digit gangrene.</p>
<p>Survival is significantly lower compared with the general population. Therapies for cryoglobulinemic vasculitis may target the etiology (antiviral medication), pathogenesis (cyclophosfamide, rituximab), or symptoms (steroids, plasmapheresis).</p>
<p>Association with hepatitis C is not typical of other types of small vessel vasculitis &nbsp;[eosinophilic granulomatosis with polyangiitis (Churg-Strauss), granulomatosis with polyangiitis (Wegener’s), microscopic polyangiitis or polyarteritis, or Henoch-Schönlein purpura (IgA vasculitis)], though some skin manifestations may be similar.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Curr+Opin+Rheumatol+2006%3B+18(1)%3A54-63." target="_blank">Ferri C, Mascia MT. Cryoglobulinemic vasculitis. Curr Opin Rheumatol 2006; 18(1):54-63.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+Exp+Rheumatol.+2008+Sep-Oct%3B26(5+Suppl+51)%3AS94-104." target="_blank">Phillip R, Luqmani R. Mortality in systemic vasculitis: a systematic review. Clin Exp Rheumatol. 2008; 26(5 Suppl 51):S94-104.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+1997%3B+337(21)%3A1512-23." target="_blank">Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med. 1997; 337(21):1512-23.&nbsp;</a></p>
<p>QID: 30839</p></div><div class="rightanswer">The correct answer is: cryoglobulinemic vasculitis</div></div></div></div></div><div id="q27" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">450</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4214"><input type="hidden" name="q20803:27_:flagged" value="0"><input type="hidden" value="qaid=910911&amp;qubaid=20803&amp;qid=4637&amp;slot=27&amp;checksum=0f40ba5b6d3c0dac02f6be7c20679f81&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:27_:flaggedcheckbox" name="q20803:27_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q27&id=4637"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:27_:sequencecheck" value="2"><div class="qtext"><p>An otherwise healthy 74-year-old man presents to the emergency department&nbsp;18 months following endovascular abdominal aortic aneurysm repair of a 7 cm infrarenal abdominal aortic aneurysm (AAA) with a 7 mm in length and angulated aortic neck. A contrast CT scan performed&nbsp;1-year post-operatively had shown exclusion of the aneurysm and no endoleak. The patient now presents with several days of increasing left flank discomfort. The CT scan and aortogram obtained are shown below. Which of the following is the appropriate next step in the&nbsp;management&nbsp;of this patient?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/AssetProxy_145.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_145.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a><br><a href="./VESAP3_files/AssetProxy_079.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_079.jpg" alt="img" width="100" height="85" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:27_answer" disabled="disabled" value="0" id="q20803:27_answer0"><label for="q20803:27_answer0">a. immediate conversion to open repair</label> </div>
<div class="r1"><input type="radio" name="q20803:27_answer" disabled="disabled" value="1" id="q20803:27_answer1"><label for="q20803:27_answer1">b. placement of a proximal aortic cuff</label> </div>
<div class="r0"><input type="radio" name="q20803:27_answer" disabled="disabled" value="2" id="q20803:27_answer2"><label for="q20803:27_answer2">c. coil embolization of the endoleak</label> </div>
<div class="r1"><input type="radio" name="q20803:27_answer" disabled="disabled" value="3" id="q20803:27_answer3"><label for="q20803:27_answer3">d. conversion to an aorto-uni-iliac configuration EVAR with femorofemoral bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:27_answer" disabled="disabled" value="4" id="q20803:27_answer4"><label for="q20803:27_answer4">e. observation with a follow up non-contrast CT scan in 1 month to assess AAA size</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:27_-submit" name="q20803:27_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a proximal Type I endoleak with pressurization of the aneurysm sac and rupture seen at the left posterior aspect of the aneurysm. Immediate open repair is required with either complete or partial explant of the endograft. The proximal aspect of the endograft has slipped from the neck and should be easy to remove. The endograft's iliac limbs may be well incorporated and can be cut at the iliac orifices; the new graft can be secured by suturing through both the endograft and the native iliac arteries. Proximal control can be obtained either by a supraceliac clamp or endoluminally using an aortic occlusion balloon in the supraceliac position. There is no role for coil embolization of a large Type I endoleak with graft migration, nor should a cuff be placed in this patient with a compromised proximal neck anatomy. Even in the absence of rupture or AAA enlargement, a large proximal Type I endoleak is an indication for repair and observation is not indicated. Conversion to an aorto-uni-iliac configuration has no impact on the proximal endoleak. Physician modified fenestrated endografts or snorkel techniques to extend the proximal landing zone are experimental at this time and lack sufficient data to support widespread use except in exceptional cases. Commercially available fenestrated endografts are not available for off-the-shelf use at this time.</p>
<p>&nbsp;</p>
<h3>Reference:</h3>
<p>Buth J, Harris P. Endovascular treatment of aortic aneurysms. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:1452-75.</p>
<p>QID: 30029</p></div><div class="rightanswer">The correct answer is: immediate conversion to open repair</div></div></div></div></div><div id="q314" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">451</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4223"><input type="hidden" name="q20803:314_:flagged" value="0"><input type="hidden" value="qaid=911198&amp;qubaid=20803&amp;qid=5079&amp;slot=314&amp;checksum=50b3baf148ff75b8884235d24f8c88ed&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:314_:flaggedcheckbox" name="q20803:314_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q314&id=5079"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:314_:sequencecheck" value="2"><div class="qtext"><p>Rates of high-grade restenosis /occlusion following carotid endarterectomy (CEA) and carotid artery stenting (CAS) at 2 years are best characterized as which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:314_answer" disabled="disabled" value="0" id="q20803:314_answer0"><label for="q20803:314_answer0">a. &lt;3% for CAS and &gt;10% for CEA</label> </div>
<div class="r1"><input type="radio" name="q20803:314_answer" disabled="disabled" value="1" id="q20803:314_answer1"><label for="q20803:314_answer1">b. &gt;10% for CEA and &gt;10% for CAS</label> </div>
<div class="r0"><input type="radio" name="q20803:314_answer" disabled="disabled" value="2" id="q20803:314_answer2"><label for="q20803:314_answer2">c. 1% for CEA and 5% for CAS</label> </div>
<div class="r1"><input type="radio" name="q20803:314_answer" disabled="disabled" value="3" id="q20803:314_answer3"><label for="q20803:314_answer3">d. equal for CEA and CAS</label> </div>
<div class="r0"><input type="radio" name="q20803:314_answer" disabled="disabled" value="4" id="q20803:314_answer4"><label for="q20803:314_answer4">e. &lt;3% for CEA and &gt;10% for CAS</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:314_-submit" name="q20803:314_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>It has generally been assumed that restenosis following CAS would be higher than that following CEA, but no large multicenter comparison studies were previously available. However, the CREST investigators performed an analysis of restenosis/occlusion at 2 years following CAS and CEA. Follow-up was with duplex scanning with images interpreted in a core imaging center and restenosis rates determined by the proportion of patients with internal carotid artery peak systolic velocities &gt;300 cm/sec, indicating a &gt;70% Stenosis. At 2 years, 58 patients who underwent CAS (Kaplan-Meier rate 6.0%) and 62 patients who had undergone CEA (Kaplan-Meier rate 6.3%) had high-grade restenosis or occlusion of the ICA, hazard ratio 0.90, 95% CI 0.63-1.29, <em>P&nbsp;</em>= .58.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+Neurol+2012%3B+11%3A755-63." target="_blank">Lal, BK, Beach KW, Roubin GS, <span>&nbsp;</span>Lutsep HL<span>,&nbsp;</span>Moore WS<span>,&nbsp;</span>Malas MB,&nbsp;et al.&nbsp; Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomized, controlled trial.&nbsp; Lancet Neurol 2012; 11:755-63.</a></p>
<p>QID: 30541</p></div><div class="rightanswer">The correct answer is: equal for CEA and CAS</div></div></div></div></div><div id="q494" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">452</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4232"><input type="hidden" name="q20803:494_:flagged" value="0"><input type="hidden" value="qaid=911378&amp;qubaid=20803&amp;qid=5221&amp;slot=494&amp;checksum=d9b0cd8fb3eec99772d91b29e36f6e2d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:494_:flaggedcheckbox" name="q20803:494_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q494&id=5221"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:494_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements about unfractionated heparin (UFH) and low molecular weight heparins (LMWH)&nbsp;is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:494_answer" disabled="disabled" value="0" id="q20803:494_answer0"><label for="q20803:494_answer0">a. LMWH has a predictable anticoagulant response despite&nbsp;low bioavailability with subcutaneous injection</label> </div>
<div class="r1"><input type="radio" name="q20803:494_answer" disabled="disabled" value="1" id="q20803:494_answer1"><label for="q20803:494_answer1">b. the elimination half-life of UFH is dose-independent, allowing for a predictable duration of anticoagulant effect</label> </div>
<div class="r0"><input type="radio" name="q20803:494_answer" disabled="disabled" value="2" id="q20803:494_answer2"><label for="q20803:494_answer2">c. <span style="line-height: 1.5;">UFH dosing should be adjusted when estimated creatinine clearance is &lt; 40 ml/min</span></label> </div>
<div class="r1"><input type="radio" name="q20803:494_answer" disabled="disabled" value="3" id="q20803:494_answer3"><label for="q20803:494_answer3">d. UFH undergoes cellular metabolism throughout the body, by binding to endothelial cells and macrophages</label> </div>
<div class="r0"><input type="radio" name="q20803:494_answer" disabled="disabled" value="4" id="q20803:494_answer4"><label for="q20803:494_answer4">e. variability in LMWH metabolism by CYP3A4 (an enzyme induced or inhibited by several drugs and foods) can lead to risk of bleeding or thrombosis</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:494_-submit" name="q20803:494_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Unfractionated heparin is a heterogeneous mixture of variably sulfated disaccharide units of varying length, with a mean molecular weight of approximately 12,000-15,000 kDa. The average heparin molecule contains 45 saccharide units.&nbsp;Low molecular weight heparins have a mean molecular weight of approximately 4,000-5,000 kDa, corresponding to on average 15 saccharide units. Both UFH and LMWH catalyze the activity of antithrombin, resulting in inactivation of factor Xa and other coagulation factors, whereas UFH is also capable of significantly inactivating thrombin given its longer polysaccharide chain. This activity relies on a unique pentasaccharide sequence found on less than one third of both UFH and LMWH molecules.</p>
<p>The longer length molecules present in UFH as compared to LMWH largely account for most pharmacokinetic differences. The large UFH molecules readily bind to plasma proteins, as well as many cell types, including endothelial cells and macrophages. UFH is metabolized largely by uptake into these cells at therapeutic concentrations.&nbsp; At higher concentrations, UFH will saturate this clearance mechanism, thus leading to a prolonged half-life, meaning that the elimination half-life is dose-dependent.&nbsp; Although a minor fraction of UFH will undergo renal excretion, dose adjustments are not necessary for those with significant renal impairment.</p>
<p>UFH is not metabolized within the liver. Hepatic dysfunction does not preclude the use of heparin, nor is its metabolism affected by medications relying on the cytochrome p450 system.&nbsp;</p>
<p>Because elimination of low molecular weight heparins is primarily by renal excretion, they have a dose-independent&nbsp;elimination half-life and require dosing adjustments for renal insufficiency.</p>
<p>While LMWHs are approximately 90% bioavailable following subcutaneous injection, UFH is much less bioavailable.&nbsp;</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest.+2012+Feb%3B141(2+Suppl)%3Ae24S-43S." target="_blank">Garcia DA, Baglin TP, Weitz JI, Samama MM; American College of Chest&nbsp;Physicians. Parenteral anticoagulants: Antithrombotic Therapy and Prevention of&nbsp;Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e24S-43S. Erratum in: Chest. 2013 Aug;144(2):721. Dosage&nbsp;error in article text. Chest. 2012 May;141(5):1369. Dosage error in article text.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest+2012%3B+141(2+Suppl)%3Ae152S-84S." target="_blank">Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al.&nbsp;Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and&nbsp;Prevention of Thrombosis, 9th ed: American College of Chest Physicians&nbsp;Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2&nbsp;Suppl):e152S-84S.</a></p>
<p>QID: 30861</p></div><div class="rightanswer">The correct answer is: UFH undergoes cellular metabolism throughout the body, by binding to endothelial cells and macrophages</div></div></div></div></div><div id="q71" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">453</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4241"><input type="hidden" name="q20803:71_:flagged" value="0"><input type="hidden" value="qaid=910955&amp;qubaid=20803&amp;qid=4944&amp;slot=71&amp;checksum=4d0945e9c275b9776552c5dfc9ab7ff6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:71_:flaggedcheckbox" name="q20803:71_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q71&id=4944"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:71_:sequencecheck" value="2"><div class="qtext"><p>A patient complains of calf pain with ambulation. At rest he has palpable pedal pulses and normal ankle-brachial indices (ABIs). Immediately after exercise, the distal pulses are not palpable and the ABI is reduced. Which of the following statements is the best explanation for this phenomenon?&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:71_answer" disabled="disabled" value="0" id="q20803:71_answer0"><label for="q20803:71_answer0">a. as blood flow increases across a fixed lesion, energy is lost and pressure drops</label> </div>
<div class="r1"><input type="radio" name="q20803:71_answer" disabled="disabled" value="1" id="q20803:71_answer1"><label for="q20803:71_answer1">b. as the velocity of blood flow increases with exercise, energy is lost and oxygen extraction is increased</label> </div>
<div class="r0"><input type="radio" name="q20803:71_answer" disabled="disabled" value="2" id="q20803:71_answer2"><label for="q20803:71_answer2">c. as the vessels dilate with exercise, the effect of a proximal atherosclerotic lesion becomes less significant</label> </div>
<div class="r1"><input type="radio" name="q20803:71_answer" disabled="disabled" value="3" id="q20803:71_answer3"><label for="q20803:71_answer3">d. exercise stimulates collaterals, which siphon pressure and flow away from the distal circulation</label> </div>
<div class="r0"><input type="radio" name="q20803:71_answer" disabled="disabled" value="4" id="q20803:71_answer4"><label for="q20803:71_answer4">e. exercise increases the heart rate, which causes less time to be spent in systole</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:71_-submit" name="q20803:71_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This question addresses one of the fundamental phenomena in arterial hemodynamics: the relationship between pressure gradient, resistance, and flow. With the relationship as a whole given by the simplified formula Î”P = flow X resistance, it can be seen that an increase in flow across a fixed resistance will cause an increase in the pressure gradient across the lesion, resulting in a decreased pressure distal to it. This is the phenomenon explaining the decrease in ABIs following exercise, as well as the "disappearing pulse phenomenon" described before the era of widespread hemodynamic testing. While the pressure drop results from the stenosis, the claudication symptoms themselves result from a decrease in oxygen delivery due to an actual decrease in flow.<br><br></p>
<h2>References:</h2>
<p>Zierler RE, Sumner DS. Arterial physiology. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery.7th ed. Philadelphia, PA: Saunders Elsevier; 2010:131-49.<br><br>Kohler TR, Sumner, DS. Vascular laboratory: Arterial physiologic assessment. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery.7th ed. Philadelphia, PA: Saunders Elsevier; 2010:217-33.</p>
<p>QID: 30111</p></div><div class="rightanswer">The correct answer is: as blood flow increases across a fixed lesion, energy is lost and pressure drops</div></div></div></div></div><div id="q500" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">454</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4250"><input type="hidden" name="q20803:500_:flagged" value="0"><input type="hidden" value="qaid=911384&amp;qubaid=20803&amp;qid=5214&amp;slot=500&amp;checksum=74915fafad1641dcdbef8368905ea5fe&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:500_:flaggedcheckbox" name="q20803:500_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q500&id=5214"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:500_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old diabetic man is evaluated for right calf pain with walking after 2 blocks that resolves with rest. His daily medications include: glipizide 5 mg, lisinopril 10mg, aspirin 81 mg, and twice daily niacin 500 mg. His blood pressure is 126/78 mmHg, heart rate is 73/min and he has a palpable right femoral pulse, but no palpable popliteal or pedal pulses.&nbsp;</p>
<p>Laboratory studies:</p>
<p>Hemoglobin A<sup>1C</sup>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6.8%</p>
<p>Total cholesterol &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 175 mg/dL</p>
<p>LDL cholesterol &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 114 mg/dL</p>
<p>HDL cholesterol &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42 mg/dL</p>
<p>Triglycerides &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 94 mg/dL</p>
<p>Which of the following is the most appropriate medical management for this patient?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:500_answer" disabled="disabled" value="0" id="q20803:500_answer0"><label for="q20803:500_answer0">a. add clopidogrel to aspirin</label> </div>
<div class="r1"><input type="radio" name="q20803:500_answer" disabled="disabled" value="1" id="q20803:500_answer1"><label for="q20803:500_answer1">b. substitute pravastatin for niacin</label> </div>
<div class="r0"><input type="radio" name="q20803:500_answer" disabled="disabled" value="2" id="q20803:500_answer2"><label for="q20803:500_answer2">c. increase niacin dose, as tolerated by side effects</label> </div>
<div class="r1"><input type="radio" name="q20803:500_answer" disabled="disabled" value="3" id="q20803:500_answer3"><label for="q20803:500_answer3">d. increase glipizide dose</label> </div>
<div class="r0"><input type="radio" name="q20803:500_answer" disabled="disabled" value="4" id="q20803:500_answer4"><label for="q20803:500_answer4">e. add fibrate to niacin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:500_-submit" name="q20803:500_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The best choice is to substitute pravastatin for niacin.&nbsp;According to the National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) this patient is at high risk for cardiovascular events due to the presence of peripheral arterial disease and diabetes. The LDL goal for this patient is &lt;70 mg/dl.&nbsp; Statins remain the first line therapy to achieve this goal.&nbsp;</p>
<p>The American College of Cardiology and the American Heart Association (ACC/AHA) released an updated clinical practice guideline in 2013, with recommendations for the treatment of blood cholesterol levels to reduce atherosclerotic cardiovascular disease (ASCVD) risk in adults. The new guideline recommends moderate- or high-intensity statin therapy for these 4 groups: "1) Patients who have clinical ASCVD, 2) Patients with an LDL cholesterol level (LDL-C) of 190 mg/dL or higher; 3) Patients with type 1 or type 2 diabetes who are between 40 and 75 years of age and have an LDL-C 70-189 mg/dL without ASCVD; and 4) Patients with an estimated 10-year risk of ASCVD 7.5% or higher and an LDL-C 70-189 mg/dL who are between 40 and 75 years of age without clinical ASCVD or diabetes." The guideline also emphasizes the value of adopting a heart-healthy lifestyle (diet and exercise) (see reference).</p>
<p>Pravastatin is a HMG-CoA reductase inhibitor indicated for treatment of hyperlipidemias, primary prevention of coronary events and secondary prevention of cardiovascular events. The adult starting dose is typically 40 mg once daily; titrating dosage to response (usual range: 10-80 mg; maximum dose: 80 mg once daily). Doses should be individualized according to the baseline LDL-cholesterol levels; adjustments should be made at intervals of 4 weeks or more.</p>
<p>Of note, the relationship of the LDL-cholesterol response to therapy and the magnitude of ASCVD risk reduction is not clear. The patient's hemoglobin A<sub>1c</sub> suggests good glycemic control. Blood glucose management is not expected to affect claudication symptoms.&nbsp;Antiplatelet therapy with aspirin and clopidogrel does not improve claudication symptoms.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/24222018" target="_blank">Stone NJ, Robinson J, Lichtenstein AH, Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2013 Nov 12 [epub ahead of print].&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation.+2002+Dec+17%3B106(25)%3A3143-421." target="_blank">National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106(25):3143-421.&nbsp;</a></p>
<p>QID: 30868</p></div><div class="rightanswer">The correct answer is: substitute pravastatin for niacin</div></div></div></div></div><div id="q380" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">455</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4259"><input type="hidden" name="q20803:380_:flagged" value="0"><input type="hidden" value="qaid=911264&amp;qubaid=20803&amp;qid=5105&amp;slot=380&amp;checksum=6bc62bc3aa4e68e4415dbd2985b5bce7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:380_:flaggedcheckbox" name="q20803:380_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q380&id=5105"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:380_:sequencecheck" value="2"><div class="qtext"><p>An 84-year-old woman with a history of atrial fibrillation is brought into the emergency department with a 12-hour history of severe diffuse abdominal pain out of proportion to her abdominal examination. Which of the following is the most common&nbsp;laboratory abnormality in acute mesenteric ischemia? &nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:380_answer" disabled="disabled" value="0" id="q20803:380_answer0"><label for="q20803:380_answer0">a. leukocytosis</label> </div>
<div class="r1"><input type="radio" name="q20803:380_answer" disabled="disabled" value="1" id="q20803:380_answer1"><label for="q20803:380_answer1">b. elevated serum amylase</label> </div>
<div class="r0"><input type="radio" name="q20803:380_answer" disabled="disabled" value="2" id="q20803:380_answer2"><label for="q20803:380_answer2">c. elevated serum&nbsp;lactate</label> </div>
<div class="r1"><input type="radio" name="q20803:380_answer" disabled="disabled" value="3" id="q20803:380_answer3"><label for="q20803:380_answer3">d. elevated hematocrit</label> </div>
<div class="r0"><input type="radio" name="q20803:380_answer" disabled="disabled" value="4" id="q20803:380_answer4"><label for="q20803:380_answer4">e. decreased serum bicarbonate</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:380_-submit" name="q20803:380_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Patients presenting with acute mesenteric ischemia pose a significant challenge to accurately diagnose the problem in a timely fashion. The most common laboratory abnormalities include hemoconcentration, leukocytosis, a high anion gap, and possibly lactic acidosis with more advanced ischemia.&nbsp;High amylase, aspartate aminotransferase, and lactate dehydrogenase&nbsp;may also be present. Unfortunately, no specific abnormal laboratory result has been proven to provide a high sensitivity or specificity in the workup of this disorder.&nbsp;However, the most common laboratory abnormality is leukocytosis. Unfortunately, it&nbsp;is not specific for mesenteric ischemia.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/15922412" target="_blank">Altinyollar H, Boyabatli M, Berberoglu U. D-dimer as a marker for early diagnosis of acute mesenteric ischemia. Thromb Res 2006; 117(4):463-7.&nbsp;&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2003%3B17(3)%3A323-8." target="_blank">Chang JB, Stein TA. Mesenteric ischemia: acute and chronic. Ann Vasc Surg 2003;17(3):323-8.</a></p>
<p>QID: 30666</p></div><div class="rightanswer">The correct answer is: leukocytosis</div></div></div></div></div><div id="q48" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">456</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4268"><input type="hidden" name="q20803:48_:flagged" value="0"><input type="hidden" value="qaid=910932&amp;qubaid=20803&amp;qid=4302&amp;slot=48&amp;checksum=4f9e48c79379b97fd05eed5b397fc666&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:48_:flaggedcheckbox" name="q20803:48_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q48&id=4302"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:48_:sequencecheck" value="2"><div class="qtext"><p>&nbsp;<span style="font-family: &#39;Tahoma&#39;,&#39;sans-serif&#39;; color: black; font-size: 10pt;">A defect in which gene is associated with Marfan Syndrome?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:48_answer" disabled="disabled" value="0" id="q20803:48_answer0"><label for="q20803:48_answer0">a. Interleuken-2</label> </div>
<div class="r1"><input type="radio" name="q20803:48_answer" disabled="disabled" value="1" id="q20803:48_answer1"><label for="q20803:48_answer1">b. COL3A-1</label> </div>
<div class="r0"><input type="radio" name="q20803:48_answer" disabled="disabled" value="2" id="q20803:48_answer2"><label for="q20803:48_answer2">c. Matrix metalloproteinase-9</label> </div>
<div class="r1"><input type="radio" name="q20803:48_answer" disabled="disabled" value="3" id="q20803:48_answer3"><label for="q20803:48_answer3">d. Fibrillin-1</label> </div>
<div class="r0"><input type="radio" name="q20803:48_answer" disabled="disabled" value="4" id="q20803:48_answer4"><label for="q20803:48_answer4">e. Plasmin activator inhibitor-1</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:48_-submit" name="q20803:48_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Marfan syndrome&nbsp;is an autosomal dominant genetic connective tissue disorder that is the most common cause of connective tissue disease-related aortic dissection. It is caused by a loss-of-function mutation in Fibrillin-1. Fibrillin-1 binds to TGF-beta, regulating its effects on the aortic wall and heart valves. Therefore, defects in Fibrillin-1 result in dysregulation of TGF-beta with resulting tissue injury. Angiotensin receptor blockers inhibit TGF-beta and have been shown in preliminary studies to reduce the rate of aneurysmal degeneration of the aorta of patients with Marfan Syndrome. Loeys-Dietz Sydrome is due to mutations in the TGF-beta receptors 1 and 2. Ehlers-Danlos Type IV (vascular type) is due to a mutation in the COL3A1 gene which is involved in type 3 collagen assembly.</p>
<p>&nbsp;</p>
<p>Plasmin activator inhibitor-1 (PAI-1) is an inhibitor of tissue plasminogen activator (tPA) and urokinase produced by the vascular endothelium. Therefore, it blocks fibrinolysis. PAI-1 is thought to be increased in patients with metabolic syndrome and may play a role in increased thrombotic complications in such patients, such as acute MI due to plaque rupture. Activation of matrix metalloproteinases is thought to play a role in degeneration of the aortic wall in degenerative aneurysms. Doxycycline inhibits MMP activity and has been used to slow the growth of degenerative aneurysms. Sirolimus (rapamycin) and tacrolimus interfere with Interleuken-2 activation of T and B cells in order to prevent restenosis after angioplasty.</p>
<p>&nbsp;</p>
<p>References:</p>
<ol>
<li>Kaartinen V &amp; Warburton D. Fibrillin controls TGF-beta activation. Nature Genetics;2003:331-2.</li>
<li>Brooke BS et al. Angiotensin II blockade and aortic-root dilation in Marfans syndrome. N Engl J Med 2008;358:2787-95.</li>
</ol>
<p>QID: 30052</p></div><div class="rightanswer">The correct answer is: Fibrillin-1</div></div></div></div></div><div id="q208" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">457</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4277"><input type="hidden" name="q20803:208_:flagged" value="0"><input type="hidden" value="qaid=911092&amp;qubaid=20803&amp;qid=4700&amp;slot=208&amp;checksum=129b206ac817d87724f26aa96fcd9c43&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:208_:flaggedcheckbox" name="q20803:208_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q208&id=4700"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:208_:sequencecheck" value="2"><div class="qtext"><p>The anatomy of the vertebral artery has been divided into 4 segments, with implications for surgical access and pathology.&nbsp; Which of the following statements regarding the vertebral artery segments is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:208_answer" disabled="disabled" value="0" id="q20803:208_answer0"><label for="q20803:208_answer0">a. the most common site of atherosclerotic disease is the V1 segment of the vertebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:208_answer" disabled="disabled" value="1" id="q20803:208_answer1"><label for="q20803:208_answer1">b. the V2 segment of the vertebral artery travels through the transverse foramina rendering it surgically inaccessible</label> </div>
<div class="r0"><input type="radio" name="q20803:208_answer" disabled="disabled" value="2" id="q20803:208_answer2"><label for="q20803:208_answer2">c. the V3 segment is the continuation of the artery as it exits the foramina and can be&nbsp;surgically accessed for a distal&nbsp;target for vertebral bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:208_answer" disabled="disabled" value="3" id="q20803:208_answer3"><label for="q20803:208_answer3">d. the V4 segment is intracranial and is more vulnerable to trauma and stretch injuries than atherosclerosis</label> </div>
<div class="r0"><input type="radio" name="q20803:208_answer" disabled="disabled" value="4" id="q20803:208_answer4"><label for="q20803:208_answer4">e. all of the above</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:208_-submit" name="q20803:208_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The anatomy of the vertebral artery is divided into 4 segments (V1-V4). These segments are defined as follows:</p>
<p>The V1 segment originates at the subclavian artery and lies between the anterior scalene muscle and longus colli.&nbsp;It enters the transverse foramina at C5 or C6. It is the most common site of atherosclerotic disease of the vertebral artery.&nbsp;</p>
<p>The V2 segment extends from the C6 to the top of the C2 foramen. It travels in the bony tranvserse foramina and is surrounded by the anterior and posterior intertranversarium muscles.</p>
<p>The V3 segment begins at the exit of the transverse foramen of C2 and ends at the atlanto-occipital membrane, where it penetrates the dura mater and passes through the occiptal foramen.</p>
<p>The V4 segment of the vessel begins after it crosses the atlantoocciptal membrane and is intracranial. In this segment, the vertebral artery gives off the anterior and posterior spinal arteries, the medullary arteries, and the posteriorinferior cerebellar artery, which is it's largest branch. The vessel architecture in this segment is less robust with thinning of the media, absence of the advent, and external elastic membrane rendering more vulnerable to trauma from blunt injury and endovascular interventions.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p style="text-align: left;"><a href="http://www.ncbi.nlm.nih.gov/pubmed/5078895" target="_blank">Wilkinson IM. The vertebral artery: Extracranial and intracranial structure. Arch Neurol 1972; 27:392-6.</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/5078895"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21718929" target="_blank">Lee CJ, Morasch MD.&nbsp;Treatment of vertebral disease: Appropriate use of open and endovascular techniques. Semin in Vasc Surg 2011; 24:24-30. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/21718929"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9620137" target="_blank">Berguer R, Morasch MD, Kline RA. A review of 100 consecutive reconstructions of the distal vertebral artery for embolic and hemodynamic disease.&nbsp; J Vasc Surg 1998; 27:852-9. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/9620137"><br></a></p>
<p>QID: 30358</p></div><div class="rightanswer">The correct answer is: all of the above</div></div></div></div></div><div id="q174" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">458</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4286"><input type="hidden" name="q20803:174_:flagged" value="0"><input type="hidden" value="qaid=911058&amp;qubaid=20803&amp;qid=4677&amp;slot=174&amp;checksum=0c393ea7b33f9e73327e7ea5de3edbaf&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:174_:flaggedcheckbox" name="q20803:174_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q174&id=4677"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:174_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old man is undergoing carotid endarterectomy for a symptomatic 70-79% stenosis.&nbsp;For this patient, perioperative statin use is associated with:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:174_answer" disabled="disabled" value="0" id="q20803:174_answer0"><label for="q20803:174_answer0">a. a reduced risk of MI but no effect on perioperative stroke risk</label> </div>
<div class="r1"><input type="radio" name="q20803:174_answer" disabled="disabled" value="1" id="q20803:174_answer1"><label for="q20803:174_answer1">b. a significant reduction in perioperative stroke risk</label> </div>
<div class="r0"><input type="radio" name="q20803:174_answer" disabled="disabled" value="2" id="q20803:174_answer2"><label for="q20803:174_answer2">c. a reduction in stroke risk but an increase in mortality</label> </div>
<div class="r1"><input type="radio" name="q20803:174_answer" disabled="disabled" value="3" id="q20803:174_answer3"><label for="q20803:174_answer3">d. an increased risk of perioperative bleeding</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:174_-submit" name="q20803:174_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In a retrospective study involving 1566 patients undergoing carotid endarterectomy, the risk of perioperative stroke in those taking&nbsp;versus not taking statins&nbsp;was 1.2% compared with 4.5% &nbsp;(<em>P</em>&nbsp;&lt; .01), respectively. All-cause mortality was also lower (.3% vs 2.1%; <em>P</em> &lt; .01).&nbsp; Multivariable logistic regression analysis yielded a decreased odds ratio for perioperative stroke (.35 [CI .15-.85]; <em>P</em> &lt; .05) for those patients receiving versus not receiving statins.&nbsp;Similar reductions in stroke and death rates were identified in a study using an administrative database from Western Canada involving 3360 patients undergoing CEA.&nbsp;Ischemic stroke or death in symptomatic CEA patients was lower for those on versus not on statins (2.5% v 4.1%; <em>P</em> = .045). Neither study demonstrated a change in perioperative rates of MI or bleeding.</p>
<p>&nbsp;</p>
<h2>References:&nbsp;</h2>
<p><a style="line-height: 1.5;" href="http://www.ncbi.nlm.nih.gov/pubmed/?term=McGirt+MJ%2C+Perler+BA%2C+Brooke+BS%2C+Woodworth+GF%2C+Coon+A%2C+Jain+S%2C+et+al.+3-Hydroxy-3-methylglutaryl+coenzyme+A+reductase+inhibitors+reduce+the+risk+of+perioperative+stroke+and+mortality+after+carotid+endarterectomy.+J+Vasc+Surg+2005%3B+42(5)%3A+829-36." target="_blank">McGirt MJ, Perler BA<span>,&nbsp;</span>Brooke BS<span>,&nbsp;</span>Woodworth GF<span>,&nbsp;</span>Coon A<span>,&nbsp;</span>Jain S,&nbsp;et al. 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors reduce the risk of perioperative stroke and mortality after carotid endarterectomy. J Vasc Surg 2005;&nbsp;42(5): 829-36.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Kennedy%2C+Stroke%2C+Statins%2C++2005" target="_blank">Kennedy J, Quan H,&nbsp;Buchan AM,&nbsp;Ghali WA,&nbsp;Feasby TE. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 2005;&nbsp;36(10): 2072-6. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=McGirt+MJ%2C+Perler+BA%2C+Brooke+BS%2C+Woodworth+GF%2C+Coon+A%2C+Jain+S%2C+et+al.+3-Hydroxy-3-methylglutaryl+coenzyme+A+reductase+inhibitors+reduce+the+risk+of+perioperative+stroke+and+mortality+after+carotid+endarterectomy.+J+Vasc+Surg+2005%3B+42(5)%3A+829-36." target="_blank"><br></a></p>
<p>QID: 30315</p></div><div class="rightanswer">The correct answer is: a significant reduction in perioperative stroke risk</div></div></div></div></div><div id="q202" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">459</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4295"><input type="hidden" name="q20803:202_:flagged" value="0"><input type="hidden" value="qaid=911086&amp;qubaid=20803&amp;qid=4693&amp;slot=202&amp;checksum=1cf197a32a310902f5b52ffa668ac15f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:202_:flaggedcheckbox" name="q20803:202_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q202&id=4693"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:202_:sequencecheck" value="2"><div class="qtext"><p>Following carotid endarterectomy, a patient is noted to have an ipsilateral drooping of the corner of his mouth. Regarding this condition, which of the following statements is true?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:202_answer" disabled="disabled" value="0" id="q20803:202_answer0"><label for="q20803:202_answer0">a. it is likely related to an intraoperative embolic event</label> </div>
<div class="r1"><input type="radio" name="q20803:202_answer" disabled="disabled" value="1" id="q20803:202_answer1"><label for="q20803:202_answer1">b. it is usually due to injury to the marginal mandibular nerve</label> </div>
<div class="r0"><input type="radio" name="q20803:202_answer" disabled="disabled" value="2" id="q20803:202_answer2"><label for="q20803:202_answer2">c. it is often associated with ipsilateral tongue deviation</label> </div>
<div class="r1"><input type="radio" name="q20803:202_answer" disabled="disabled" value="3" id="q20803:202_answer3"><label for="q20803:202_answer3">d. it is usually permanent</label> </div>
<div class="r0"><input type="radio" name="q20803:202_answer" disabled="disabled" value="4" id="q20803:202_answer4"><label for="q20803:202_answer4">e. it is typically caused by a clamp injury</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:202_-submit" name="q20803:202_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Cranial nerve injuries occur in 5-20% of carotid endarterectomies. The hypoglossal nerve and vagus nerves are most frequently affected. Injury to the hypoglossal nerve results in ipsilateral tongue deviation. Vagus nerve injury is associated with unilateral vocal cord paralysis and hoarseness. Injury to the marginal mandibular branch of the facial nerve results in ipsilateral drooping of the corner of the mouth. This is typically the result of cephalad retraction on the mandible, rather than a clamp injury, and is usually transient. Isolated post-operative drooping of the corner of the mouth is a very rare presentation for stroke.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/7444729" target="_blank">Hertzer NR, Fledman BJ, Beven EG, Tucker HM. A prospective study of the incidence of injury to the cranial nerves during carotid endarterectomy. Surg Gynecol Obstet 1980;&nbsp;151:781-4. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9081129" target="_blank">Schauber MD, Fontenelle LJ, Solomon JW, Hanson TL. Cranial/cervical nerve dysfunction after carotid endarterectomy. J Vasc Surg 1997;&nbsp;25: 481-7. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/7444729" target="_blank"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/7125731" target="_blank">Evans WE, Medelowitz DS, Liapis C, Wolfe V<span>,&nbsp;</span>Florence CL<span>.</span>&nbsp;Motor speech deficit following carotid endarterectomy. Ann Surg 1982;&nbsp;196:461-4. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/7125731"><br></a></p>
<p>QID: 30351</p></div><div class="rightanswer">The correct answer is: it is usually due to injury to the marginal mandibular nerve</div></div></div></div></div><div id="q459" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">460</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4304"><input type="hidden" name="q20803:459_:flagged" value="0"><input type="hidden" value="qaid=911343&amp;qubaid=20803&amp;qid=5179&amp;slot=459&amp;checksum=b1c578981861f209c25e3014895b12b7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:459_:flaggedcheckbox" name="q20803:459_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q459&id=5179"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:459_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old woman develops heparin induced thrombocytopenia on postoperative day 8 following exploratory laparotomy for adhesive disease. She received prophylactic subcutaneous heparin following the procedure. Her postoperative course has been complicated by acute myocardial infarction, acute renal failure, prolonged ileus, and now, thrombocytopenia (platelets 48,000/uL) and associated deep venous thrombosis. Which of the following is the most appropriate treatment for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:459_answer" disabled="disabled" value="0" id="q20803:459_answer0"><label for="q20803:459_answer0">a. argatroban</label> </div>
<div class="r1"><input type="radio" name="q20803:459_answer" disabled="disabled" value="1" id="q20803:459_answer1"><label for="q20803:459_answer1">b. low molecular weight heparin</label> </div>
<div class="r0"><input type="radio" name="q20803:459_answer" disabled="disabled" value="2" id="q20803:459_answer2"><label for="q20803:459_answer2">c. fondaparinux</label> </div>
<div class="r1"><input type="radio" name="q20803:459_answer" disabled="disabled" value="3" id="q20803:459_answer3"><label for="q20803:459_answer3">d. lepirudin</label> </div>
<div class="r0"><input type="radio" name="q20803:459_answer" disabled="disabled" value="4" id="q20803:459_answer4"><label for="q20803:459_answer4">e. bivalirudin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:459_-submit" name="q20803:459_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient presents with typical-onset heparin-induced thrombocytopenia (HIT), which occurs 5-14 days following heparin exposure. A platelet decrease of &gt;50% baseline value or nadir of &lt;100,000/uL occurring days 5-9 following heparin exposure should prompt evaluation of HIT. In addition, new thrombosis or skin necrosis should raise the clinician's suspicion. Once clinical suspicion of HIT is established, serologic tests (PF4 antibodies or serotonin release assays) should be sent to confirm the diagnosis. Treatment includes eliminating heparin exposure to include heparin intravenous flushes and heparin coated catheters. Low molecular weight heparin has some cross reactivity with HIT antibodies. Direct thrombin inhibitors (argatroban, lepirudin, and bivalirudin) are approved for treatment of HIT. All three medications are titrated based on aPTT. There is no reversal agent for these medications; therefore, the drug half-life is very important when planning interventions (argatroban - 50 min, lepirudin - 80 min, and bivalirudin - 25 min). In addition, argatroban is eliminated via the hepatobiliary system and should not be used in patients with liver dysfunction. Both lepirudin and bivalirudin undergo renal execretion. Bivalirudin also undergoes enzymatic breakdown in serum (accounts for 80% of elimination). If utilizing bivalirudin for distal bypass surgery with a tourniquet, the concentration of bivalirudin in the distal bed will decrease rapidly secondary to enzymatic breakdown and should be used with caution. In this patient, argatroban is the best treatment option given her renal dysfunction. Fondaparinux is the only anti-Factor Xa agent available in the U.S.. Fondaparinux does not cross react with HIT antibodies; therefore, it should be safe in patients with HIT. It is not approved for treatment of acute HIT. If used in the treatment of HIT, it is better utilized to bridge patients to Warfarin once they are no longer hypercoagulable. Fondaparinux is also cleared by the kidneys.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/18574270" target="_blank">Warkentin TE, Greinacher A, Koster A, Lincoff AM<span>;&nbsp;</span><span class="highlight">American</span>&nbsp;<span class="highlight">College</span>&nbsp;of&nbsp;<span class="highlight">Chest</span>&nbsp;<span class="highlight">Physicians</span>. Treatment and Prevention of Heparin-induced Thrombocytopenia: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 2008; (133):340S-380S.&nbsp;<span class="highlight">Chest</span><span>&nbsp;2011 May;139(5):1261. Dosage error in article text.</span></a></p>
<p><span>QID: 30819</span></p></div><div class="rightanswer">The correct answer is: argatroban</div></div></div></div></div><div id="q206" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">461</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4313"><input type="hidden" name="q20803:206_:flagged" value="0"><input type="hidden" value="qaid=911090&amp;qubaid=20803&amp;qid=4698&amp;slot=206&amp;checksum=e04b20dd3f3ccba9811f2b79f837527c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:206_:flaggedcheckbox" name="q20803:206_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q206&id=4698"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:206_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old man presents with left subclavian artery occlusion. He has twice failed percutaneous treatment. While he denies upper extremity "claudication", he has dizziness and unsteadiness. The CT scan shows subacute posterior fossa infarcts. His cerebral angiogram shows concomitant left internal carotid stenosis of 80%. Which of the following is the best treatment option for this patient?</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:206_answer" disabled="disabled" value="0" id="q20803:206_answer0"><label for="q20803:206_answer0">a. left vertebral stent</label> </div>
<div class="r1"><input type="radio" name="q20803:206_answer" disabled="disabled" value="1" id="q20803:206_answer1"><label for="q20803:206_answer1">b. left vertebral transposition onto the left carotid with concomitant carotid endarterectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:206_answer" disabled="disabled" value="2" id="q20803:206_answer2"><label for="q20803:206_answer2">c. left carotid endarterectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:206_answer" disabled="disabled" value="3" id="q20803:206_answer3"><label for="q20803:206_answer3">d. left vertebral transposition onto the left common carotid</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:206_-submit" name="q20803:206_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>&nbsp;<img style="width: 194px; height: 284px;" src="./VESAP3_files/vertebral transposition.jpg" alt="vertebral transposition" width="616" height="716"></p>
<p>Direct transposition of the vertebral artery onto the cervical carotid artery for vertebral basilar ischemia is performed for revascularization of the &nbsp;V1 segment of the vertebral artery. In several studies it represents over a third of distal vertebral procedures. &nbsp;Berguer and colleagues performed 25 vertebral transpositions in their series of 100; the inflow vessels were the branches of the external carotid or internal carotid. In Koskas' review of 610 vertebral reconstructions, the distal internal carotid was endarterectomized at the same time. &nbsp;Proponents advocate the safety and ease of the operation as well as avoidance of the need for autologous or prosthetic conduit. Technical considerations include mobilization of the overlying vertebral veins and avoiding injury to the sympathetic ganglion.&nbsp;Type of open&nbsp;revascularization for vertebral lesions depends upon the location of the disease. Ostial lesions or inflow stenosis are treated with vertebral transposition or endarterectomy. Diseases of the more distal V2 and V3 lesions are treated with bypass with the either the branches of the external carotid or internal carotid as inflow sources.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/10743895" target="_blank">Edwards WH, Edwards WH Jr. Vertebral - carotid transposition. Semin Vasc Surg 2000; 13(1):70-3. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/10743895"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23518836" target="_blank">Shutze W, Gierman J, McQuade K, Pearl G<span>,&nbsp;</span>Smith B.&nbsp;Treatment of proximal vertebral artery disease. Vascular 2014; 22(2):85-92.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Koskas+F%2C+Kieffer+E%2C+Rancurel+G%2C+et+al.+Direct+transposition+of+the+distal+vertebral+artery+into+the+internal+carotid+artery.+Ann+Vasc+Surg+1995%3B+9(6)%3A515-524." target="_blank">Koskas F, Kieffer E, Rancurel G, Bahnini A<span>,&nbsp;</span>Ruotolo C<span>,&nbsp;</span>Illuminati G. Direct transposition of the distal vertebral artery into the internal carotid artery. Ann Vasc Surg 1995; 9(6):515-24. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9620137" target="_blank">Berguer R, Morasch MD, Kline RA. A review of 100 consecutive reconstructions of the distal vertebral artery for emboli and hemodynamic disease. J Vasc Surg 1998; 27(5):852-9. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Koskas+F%2C+Kieffer+E%2C+Rancurel+G%2C+et+al.+Direct+transposition+of+the+distal+vertebral+artery+into+the+internal+carotid+artery.+Ann+Vasc+Surg+1995%3B+9(6)%3A515-524." target="_blank"><br></a></p>
<p>QID: 30356</p></div><div class="rightanswer">The correct answer is: left vertebral transposition onto the left common carotid</div></div></div></div></div><div id="q550" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">462</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4322"><input type="hidden" name="q20803:550_:flagged" value="0"><input type="hidden" value="qaid=911434&amp;qubaid=20803&amp;qid=5287&amp;slot=550&amp;checksum=9f2c10a749274fc392c998b1b1968c9e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:550_:flaggedcheckbox" name="q20803:550_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q550&id=5287"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:550_:sequencecheck" value="2"><div class="qtext"><p>The tube current (mA) would need to be decreased by ______ to lower the radiation dose by one-half.</p>
<p>&nbsp;</p>
<p><strong><em>&nbsp;</em></strong></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:550_answer" disabled="disabled" value="0" id="q20803:550_answer0"><label for="q20803:550_answer0">A. one-fourth</label> </div>
<div class="r1"><input type="radio" name="q20803:550_answer" disabled="disabled" value="1" id="q20803:550_answer1"><label for="q20803:550_answer1">B. one-half</label> </div>
<div class="r0"><input type="radio" name="q20803:550_answer" disabled="disabled" value="2" id="q20803:550_answer2"><label for="q20803:550_answer2">C. two-thirds</label> </div>
<div class="r1"><input type="radio" name="q20803:550_answer" disabled="disabled" value="3" id="q20803:550_answer3"><label for="q20803:550_answer3">D. three-fourths</label> </div>
<div class="r0"><input type="radio" name="q20803:550_answer" disabled="disabled" value="4" id="q20803:550_answer4"><label for="q20803:550_answer4">E. one-third</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:550_-submit" name="q20803:550_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>In fluoroscopy, the principle parameters that contribute to radiation dose are tube current (mA), peak kilovoltage (kVp), and fluoroscopy time. Tube current is linearly related to radiation dose: thus, decreasing the tube current by 1/2 will decrease the radiation dose by 1/2. &nbsp;Tube current is not linearly related to kilovoltage and is dependent on body habitus, distance to image intensifier, and other factors. &nbsp; &nbsp;&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/14523191" target="_blank">Frush DP, Donnelly LF<span>,&nbsp;</span>Rosen NS. Computed tomography and radiation risks: What pediatric health care providers should know. Pediatrics 2003;112(4):951-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=RadioGraphics+2002%3B+22%3A1541-53." target="_blank">McNitt-Gray MF. AAPM/RSNA Physics tutorial for residents: Topics in CT: Radiation dose in CT. RadioGraphics 2002; 22:1541-53.</a></p>
<p>QID: 30958</p></div><div class="rightanswer">The correct answer is: one-half</div></div></div></div></div><div id="q131" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">463</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4331"><input type="hidden" name="q20803:131_:flagged" value="0"><input type="hidden" value="qaid=911015&amp;qubaid=20803&amp;qid=4748&amp;slot=131&amp;checksum=058cc73b8ceda4192ef295924c074181&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:131_:flaggedcheckbox" name="q20803:131_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q131&id=4748"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:131_:sequencecheck" value="2"><div class="qtext"><p>A 32-year-old man sustains a low-velocity penetrating gun shot wound (GSW) to the right upper chest just below the mid-clavicle. There is a moderate, unchanging hematoma. There is no secondary wound. He arrives intubated with a blood pressure (BP) of 95/50 and heart rate (HR) of 110 bpm. He was appropriate but resisting at the scene. No breath sounds are heard over the right chest; a chest tube produces 750 cc of blood and an air leak is present. Breath sounds return. CXR shows the pleural tube in good position, fragments associated with a comminuted clavicular fracture, and some residual pleural fluid. No pneumothorax is appreciated. After 2L of crystalloid his HR is 100 and BP 100/70. The right upper extremity is pulseless and cool with no Doppler signal in the right brachial artery. The left arm has palpable pulses throughout with capillary refill. No other injuries are appreciated.</p>
<p>Which of the following is the <strong>least</strong> appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:131_answer" disabled="disabled" value="0" id="q20803:131_answer0"><label for="q20803:131_answer0">a. transesophageal echocardiogram</label> </div>
<div class="r1"><input type="radio" name="q20803:131_answer" disabled="disabled" value="1" id="q20803:131_answer1"><label for="q20803:131_answer1">b. femoral access, innominate, subclavian selective arteriography</label> </div>
<div class="r0"><input type="radio" name="q20803:131_answer" disabled="disabled" value="2" id="q20803:131_answer2"><label for="q20803:131_answer2">c. urgent open exploration<span style="font-family: &#39;Calibri&#39;,&#39;sans-serif&#39;; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: &#39;Times New Roman&#39;; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><span style="font-family: &#39;Calibri&#39;,&#39;sans-serif&#39;; font-size: 12pt; mso-ascii-theme-font: minor-latin; mso-hansi-theme-font: minor-latin; mso-bidi-theme-font: minor-latin; mso-fareast-font-family: &#39;Times New Roman&#39;; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;"><br></span></span></label> </div>
<div class="r1"><input type="radio" name="q20803:131_answer" disabled="disabled" value="3" id="q20803:131_answer3"><label for="q20803:131_answer3">d. CTA of the chest, neck, and right upper extremity</label> </div>
<div class="r0"><input type="radio" name="q20803:131_answer" disabled="disabled" value="4" id="q20803:131_answer4"><label for="q20803:131_answer4">e. duplex ultrasound</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:131_-submit" name="q20803:131_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Hard signs of extremity vascular injury include acute ischemia, active pulsatile hemorrhage, expanding hematoma, palpable thrill, and audible bruit. These mandate rapid investigation and treatment of vascular injury. Softer signs, for which consideration of further assessment of arterial perfusion are necessary, include type of mechanism, nerve deficits, reduced pulses, objectified by extremity index below .9, and significant hemorrhage at the scene. These must be taken in context with the physical exam and scenario, and selective evaluation for arterial injury is usually undertaken. It is relatively clear that this patient has sustained a subclavian arterial injury with significant right upper extremity ischemia requiring correction.</p>
<p>While duplex is difficult in the axillosubclavian segment, and its applicability limited, particularly with hematoma, it is easily available in most trauma bays now and may be quickly performed at the bedside (attempting to confirm suspicion of reduced arterial flow) and generally doesn’t delay care in an urgent setting.</p>
<p>CTA of the chest, neck, and proximal right upper extremity arterial system in a relatively stable patient may allow for determination of vertebrobasilar and injury anatomy, thus evaluating for endovascular suitability and providing for operative planning, regardless of approach. Arteriography provides the same, and may allow for endovascular repair at the same setting, as well as proximal balloon occlusion control if open repair is required.</p>
<p>There is no need for&nbsp;transesophageal echocardiogram&nbsp;in this patient. Open operative exploration in this patient remains the&nbsp;traditional option.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Trauma+2011%3B71(5)%3AE114-121." target="_blank">Shalhub S, Starnes BW, Hatsukami TS, Karmy-Jones R, Tran NT. Repair of blunt thoracic arterial injuries: an evolution from open to endovascular approach. J Trauma 2011;71(5):E114-21.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Injury+2012%3B43%3A1785-92." target="_blank">DuBose JJ, Rajani R, Gilani R, Arthurs ZA, Morrison JJ, Clouse WD, et al. Endovascular management of axillo-subclavian arterial injury: a review of published experience. Injury 2012;43:1785-92.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B57%3A547-67." target="_blank">Sinha W, Patterson BO, Ma J, Holt PJ, Thompson MM, Carrell T, et al. Sytematic review and meta-analysis of open surgical and endovascular management of thoracic outlet vascular injuries. J Vasc Surg 2013;57:547-67.</a></p>
<p>QID: 30224</p></div><div class="rightanswer">The correct answer is: transesophageal echocardiogram</div></div></div></div></div><div id="q472" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">464</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4340"><input type="hidden" name="q20803:472_:flagged" value="0"><input type="hidden" value="qaid=911356&amp;qubaid=20803&amp;qid=5197&amp;slot=472&amp;checksum=29b682a6691fea24178ca79e63615eb2&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:472_:flaggedcheckbox" name="q20803:472_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q472&id=5197"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:472_:sequencecheck" value="2"><div class="qtext"><p>For serious foot infections in patients with diabetes, what empiric antibiotic regimen is recommended for treatment of specifically suspected organisms?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:472_answer" disabled="disabled" value="0" id="q20803:472_answer0"><label for="q20803:472_answer0">a. pseudomonas aeruginosa&nbsp;suspected: treat with piperacillin-tazobactam combination</label> </div>
<div class="r1"><input type="radio" name="q20803:472_answer" disabled="disabled" value="1" id="q20803:472_answer1"><label for="q20803:472_answer1">b. methcillin resistant&nbsp;Staphylcoccus aureus&nbsp;(MRSA) suspected: treat with ertapenem or moxifloxacin</label> </div>
<div class="r0"><input type="radio" name="q20803:472_answer" disabled="disabled" value="2" id="q20803:472_answer2"><label for="q20803:472_answer2">c. empiric therapy for skin and soft tissue infection: ceftaroline or telavancin</label> </div>
<div class="r1"><input type="radio" name="q20803:472_answer" disabled="disabled" value="3" id="q20803:472_answer3"><label for="q20803:472_answer3">d. methcillin sensitive&nbsp;Staphylcoccus aureus&nbsp;(MSSA) or&nbsp;Streptococcus&nbsp;species suspected: cephalexin or amoxicillin-clavulanate</label> </div>
<div class="r0"><input type="radio" name="q20803:472_answer" disabled="disabled" value="4" id="q20803:472_answer4"><label for="q20803:472_answer4">e. enterobacteriaceae&nbsp;suspected: treat with vancomycin or clindamycin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:472_-submit" name="q20803:472_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>While definitive antibiotic regimens can be selected after considering the results of culture and susceptibility tests from wound specimens, as well as the clinical response to the empiric antibiotic regimen, preliminary antibiotic selection should be based upon the suspected or most likely organisms.</p>
<p>Primary infection with Pseudomonas aeruginosa&nbsp;is unusual in serious diabetic foot infections, but Pseudomonas&nbsp;may be treated with the combination of piperacillin-tazobactam.</p>
<p>Drugs with activity against MRSA (eg, vancomycin, linezolid, daptomycin) should be used for patients who have a severe infection, current or prior infection or colonization with this organism elsewhere, or epidemiological risk factors for MRSA infection. These narrow-spectrum agents should be combined with other agents (eg, a fluoroquinolone) if a moderate or severe polymicrobial infection is suspected.</p>
<p>Similar agents of the same drug class can be substituted for suggested agents.</p>
<p>Enterobacteriaceae&nbsp;species include Escherichia, Enterobacter, and Klebsiella, which are susceptible to most second generation and later cephalosporins and most drugs that treat gram negative bacteria.&nbsp;Oral penicillins, such as cephalexin or amocillin-clavulanate, are not first-line therapy for serious diabetic foot infections.&nbsp;Ertapenem or moxifloxacin are not generally effective for MRSA.&nbsp;Ceftaroline and telavancin are antibiotics that have been approved for treatment of skin and soft tissue infections, but no studies have been done with these agents treating diabetic foot infections.</p>
<p>&nbsp;</p>
<h2><strong>Reference:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22619239" target="_blank">Lipsky BA, Berendt AR, Cornia PB, Pile JC, Peters EJ, Armstrong DG, et al. Executive summary: 2012 Infectious Diseases Society of America clinical practice&nbsp;guideline for the diagnosis and treatment of diabetic foot infections. Clin&nbsp;Infect Dis 2012; 54(12):e132-73.</a></p>
<p>QID: 30836</p></div><div class="rightanswer">The correct answer is: pseudomonas aeruginosa&nbsp;suspected: treat with piperacillin-tazobactam combination</div></div></div></div></div><div id="q172" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">465</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4349"><input type="hidden" name="q20803:172_:flagged" value="0"><input type="hidden" value="qaid=911056&amp;qubaid=20803&amp;qid=4674&amp;slot=172&amp;checksum=bfe0ea8ea85a52a59785ad5f0f2eaa55&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:172_:flaggedcheckbox" name="q20803:172_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q172&id=4674"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:172_:sequencecheck" value="2"><div class="qtext"><p>A 77-year-old woman underwent left carotid endarterectomy (CEA)&nbsp;one year ago that was complicated by a perioperative MI. She has been admitted for exacerbation of CHF in the past 6 months. She presents now with symptoms of left hemispheric TIA. Her left carotid duplex shows a PSV 330 cm/sec and EDV 145 cm/sec. Which of the following is both the probable cause of her symptoms <strong>and</strong> the appropriate treatment for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:172_answer" disabled="disabled" value="0" id="q20803:172_answer0"><label for="q20803:172_answer0">a. intimal flap from technical error during prior CEA; L carotid interposition graft</label> </div>
<div class="r1"><input type="radio" name="q20803:172_answer" disabled="disabled" value="1" id="q20803:172_answer1"><label for="q20803:172_answer1">b. recurrent atherosclerosis; repeat L CEA</label> </div>
<div class="r0"><input type="radio" name="q20803:172_answer" disabled="disabled" value="2" id="q20803:172_answer2"><label for="q20803:172_answer2">c. intimal hyperplasia after prior CEA; L carotid stent</label> </div>
<div class="r1"><input type="radio" name="q20803:172_answer" disabled="disabled" value="3" id="q20803:172_answer3"><label for="q20803:172_answer3">d. intimal hyperplasia after prior CEA; repeat L CEA</label> </div>
<div class="r0"><input type="radio" name="q20803:172_answer" disabled="disabled" value="4" id="q20803:172_answer4"><label for="q20803:172_answer4">e. recurrent atherosclerosis; L carotid interposition graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:172_-submit" name="q20803:172_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Recurrent carotid stenosis occurs in up to 20% of patients after CEA and is time-dependent regarding the cause of restenosis. Narrowing that occurs within ~2 years of the index procedure is usually due to intimal hyperplasia at the operative site. Recurrent carotid stenosis more than 2 years after CEA is most commonly from recurrent atherosclerosis. Technical errors resulting in ipsilateral hemispheric symptoms usually occur in the immediate post-operative period rather than remotely. Due to the histopathologic changes in the carotid artery after CEA, repeat endarterectomy may not be technically feasible. Open repair of recurrent carotid stenosis may require an interposition vein graft from the common carotid to the internal carotid artery distal to the site of stenosis. In addition, cranial nerve injury is significantly higher with repeat carotid sugery. Consistent with current Center for Medicare Services (CMS) guidelines for high-risk carotid surgery, treatment with a&nbsp;left carotid stent for this patient with symptomatic, recurrent high-grade (&gt;70%)&nbsp;stenosis would be appropriate.</p>
<p>Clinical series have shown that CAS in the setting of recurrent carotid stenosis after CEA is equivalent to redo CEA&nbsp;with regard to peri- and post-operative stroke/death rates, as well as stroke-free survival. Redo CEA, however, was associated with a significant increase in cranial nerve injuries (14% redo-CEA vs. 0% CAS). &nbsp;When compared to CAS for primary carotid atherosclerosis, CAS for recurrent carotid stenosis resulted in significantly lower peri-operative stroke/death/MI rates, as well as lower combined early and late stroke rates.&nbsp;Physician-specific and institution-specific outcomes should&nbsp;be considered in the selection of the optimal treatment (CAS vs. redo CEA) for recurrent carotid stenosis.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/472995" target="_blank">Hertzer&nbsp;NR,&nbsp;Martin</a><a href="http://www.ncbi.nlm.nih.gov/pubmed/472995" target="_blank">ez&nbsp;BD,&nbsp;Benjamin&nbsp;SP, Beven EG.&nbsp;Recurrent stenosis after carotid endarterectomy.&nbsp;Surg Gynecol Obstet 1979;&nbsp;149:360-4. </a><span style="COLOR: #000000"><a href="http://www.ncbi.nlm.nih.gov/pubmed/472995" target="_blank"><br></a></span></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9756575" target="_blank">Moore&nbsp;WS,&nbsp;Kempczinski&nbsp;RF,&nbsp;Nelson&nbsp;JJ, Toole JF.&nbsp;Recurrent carotid stenosis: results of this asymptomatic carotid atherosclerosis study.&nbsp;Stroke 1998;&nbsp;29:2018-25. <span style="COLOR: #000000"><br></span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20692794" target="_blank">AbuRahma AF, Abu-Halimah S, Hass SM, Nanjundappa A, Stone PA, Mousa A, et al.&nbsp;Carotid artery stenting outcomes are equivalent to carotid endarterectomy outcomes for patients with post-carotid endarterectomy stenosis.&nbsp;J Vasc Surg 2010. 52(5):1180-7. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19703753" target="_blank">AbuRahma AF,&nbsp;Abu-Halimah S,&nbsp;Bensenhaver J,&nbsp;Nanjundappa A,&nbsp;Stone PA,&nbsp;Dean LS, et al.&nbsp;Primary&nbsp;carotid&nbsp;artery&nbsp;stenting&nbsp;versus&nbsp;carotid&nbsp;artery&nbsp;stenting&nbsp;for postcarotid endarterectomy&nbsp;stenosis. J Vasc Surg 2009 50(5):1031-9.&nbsp;</a><a href="http://www.ncbi.nlm.nih.gov/pubmed/20692794" target="_blank"><br></a></p>
<p>QID: 30312</p></div><div class="rightanswer">The correct answer is: intimal hyperplasia after prior CEA; L carotid stent</div></div></div></div></div><div id="q142" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">466</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4358"><input type="hidden" name="q20803:142_:flagged" value="0"><input type="hidden" value="qaid=911026&amp;qubaid=20803&amp;qid=4760&amp;slot=142&amp;checksum=3a11a813326b9b8d1266b14ff2a6b6d4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:142_:flaggedcheckbox" name="q20803:142_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q142&id=4760"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:142_:sequencecheck" value="2"><div class="qtext"><p><img src="./VESAP3_files/VESAP Q-1.jpg" alt="Cull - 1 image" width="414" height="381"></p>
<p>A 66-year-old man presents 4 years after successful coronary artery bypass graft (CABG) with recurrent angina during light upper body workouts. On physical examination, his left arm blood pressure (BP) is 35 mm Hg lower than the right arm BP. A stress thallium test suggests reversible anterior wall myocardial ischemia. The patient’s arch aortogram is shown below. Which of the following is the best treatment option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:142_answer" disabled="disabled" value="0" id="q20803:142_answer0"><label for="q20803:142_answer0">a. prosthetic carotid subclavian bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:142_answer" disabled="disabled" value="1" id="q20803:142_answer1"><label for="q20803:142_answer1">b. coronary angioplasty with a drug-eluting stent</label> </div>
<div class="r0"><input type="radio" name="q20803:142_answer" disabled="disabled" value="2" id="q20803:142_answer2"><label for="q20803:142_answer2">c. subclavian to subclavian artery bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:142_answer" disabled="disabled" value="3" id="q20803:142_answer3"><label for="q20803:142_answer3">d. re-do CABG using vein or radial artery graft</label> </div>
<div class="r0"><input type="radio" name="q20803:142_answer" disabled="disabled" value="4" id="q20803:142_answer4"><label for="q20803:142_answer4">e. subclavian to carotid transposition</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:142_-submit" name="q20803:142_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The most probable etiology for this patient’s symptoms is coronary subclavian steal related to a subclavian stenosis or occlusion proximal to an internal mammary artery (IMA)-coronary artery bypass. The safest and most effective procedure for this would be a carotid-to-subclavian bypass, which could be performed without interrupting circulation through the left IMA bypass (or right IMA, if there is one) during the time of revascularization. Several studies have reported favorable outcomes with angioplasty and stenting to treat coronary-subclavian steal syndrome. Coronary angioplasty would not address the problem, regardless of the type of stent used. A&nbsp; subclavian-to-carotid transposition would require placement of a clamp proximal to the LIMA reconstruction and could result in myocardial ischemia during the clamp time. Re-doing a CABG and replacing the LIMA with another graft through a re-do sternotomy and mediastinal dissection would be effective, but would also be much more than this patient requires. A subclavian-subclavian bypass might relieve symptoms, but has an inferior patency rate; depending on the approach, it would either cross the sternotomy or increase the risk of local complications if performed through bilateral neck exposures.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cardiovasc+Intervent+Radiol+2006%3B+29(6)%3A348-53." target="_blank">Filippo F, Francesco M, Francesco R, Corrado A<span>,&nbsp;</span>Chiara M<span>,&nbsp;</span>Valentina C,&nbsp;et al. Percutaneous angioplasty and stenting of left subclavian artery lesionsfor the treatment of patients with concomitant vertebral and coronary subclavian steal syndrome. Cardiovasc Intervent Radiol&nbsp;2006; 29(6):348-53.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2004%3B+18(5)%3A566-71." target="_blank">Ferrara F, Meli F, Raimondi F, Milio G<span>,&nbsp;</span>Amato C<span>,&nbsp;</span>Cospite V,&nbsp;et al. Subclavian stenosis/occlusion in patients with subclavian steal syndrome and previous bypass of internal mammary artery: medical or surgical treatment? Ann Vasc Surg&nbsp;2004; 18(5):566-71.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chirurgia+2013%3B+108%3A264-7." target="_blank">Bindea D, Todoran A, Mihai T, Ober C<span>,&nbsp;</span>Iancu A. Coronary-subclavian steal syndrome treated with carotid to subclavian artery bypass. Chirurgia 2013; 108:264-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B+38%3A699-704." target="_blank">Westerband A, Rodriguez JA, Ramaiah VG, Diethrich EB<span>.</span>&nbsp;Endovascular therapy in prevention and management of coronary-subclavian steal. J Vasc Surg 2003; 38:699-704.</a></p>
<p>QID: 30236</p></div><div class="rightanswer">The correct answer is: prosthetic carotid subclavian bypass</div></div></div></div></div><div id="q74" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">467</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4367"><input type="hidden" name="q20803:74_:flagged" value="0"><input type="hidden" value="qaid=910958&amp;qubaid=20803&amp;qid=4986&amp;slot=74&amp;checksum=d4f4e94aff0f6004bf7bfc03555b7190&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:74_:flaggedcheckbox" name="q20803:74_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q74&id=4986"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:74_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding adventitial cystic disease of the popliteal artery is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:74_answer" disabled="disabled" value="0" id="q20803:74_answer0"><label for="q20803:74_answer0">a. found in males and females with equal frequency</label> </div>
<div class="r1"><input type="radio" name="q20803:74_answer" disabled="disabled" value="1" id="q20803:74_answer1"><label for="q20803:74_answer1">b. CT angiography is the preferred imaging modality</label> </div>
<div class="r0"><input type="radio" name="q20803:74_answer" disabled="disabled" value="2" id="q20803:74_answer2"><label for="q20803:74_answer2">c. is related to a defect in the fibrillin 1 gene</label> </div>
<div class="r1"><input type="radio" name="q20803:74_answer" disabled="disabled" value="3" id="q20803:74_answer3"><label for="q20803:74_answer3">d. dorsiflexion of the foot results in the loss of the ipsilateral pedal pulse</label> </div>
<div class="r0"><input type="radio" name="q20803:74_answer" disabled="disabled" value="4" id="q20803:74_answer4"><label for="q20803:74_answer4">e. usually presents with complete occlusion of the affected artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:74_-submit" name="q20803:74_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Advential cystic disease typically occurs in young to middle-aged healthy males (5:1) and generally involves the popliteal artery. Other reported sites include the external iliac and femoral arteries (15%). Patients most commonly present with progressive intermittent claudication. Initially the cyst results in stenosis of the affected artery as the cyst compresses the media, effectively narrowing the flow channel. Progression to complete occlusion of the artery is less common. Conventional angiography may demonstrate a so-called "scimitar" sign due to external compression of the arterial lumen (Figure A and B), but does not define the dimensions of the cyst itself. Pedal pulses that are present at rest may disappear with flexion of the knee (Ishikawa's sign). The etiology of adventitial cystic disease is unknown, but it has been postulated that the cysts arise from ectopic tissue related to the joint capsule or bursa. The treatment of adventitial cystic disease has not been well defined, as there have only been a few hundred reported cases. Most reports agree that simple aspiration and/or angioplasty alone are inadequte to achieve durable cure. A variety of techniques, including cyst excision, vein patch, and interposition grafting, either alone or in combination, have been reported to be successful in the mangement of adventitial cystic disease.</p>
<p>CT angiography has become the imaging modality of choice for defining popliteal pathology, such as popliteal aneurysm, popliteal entrapment, and adventitial cystic disease, because of its ability to demonstrate the cystic mass within the arterial wall as well as the residual lumen. Loss of distal pulses with dorsiflexion or plantar flexion of the foot is a sign of popliteal entrapment syndrome, not advential cystic disease. Defects in the fibrillin gene have been detected in patients with Marfan's Syndrome. <br><br><a href="./VESAP3_files/AssetProxy_116.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_116.jpg" alt="img" width="100" height="85" border="0" hspace="10" vspace="10"></a><br><br>Figure A. Femoral angiogram shows compression of the right popliteal artery by an adventitial cyst. Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery, 7th ed. Philadelphia, PA: Saunders Elsevier; 2010. Reproduced with permission.<br><br>Figure B. Lateral view of another patient shows anterior compression of the popliteal artery above the knee. Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery, 7th ed. Philadelphia, PA: Saunders Elsevier; 2010. Reproduced with permission.<br><br></p>
<h3>References:</h3>
<p>Forbes TL. Nonatheromatous popliteal artery disease. In: Cronenwett JL, Johnston KW, eds. Rutherford's Vascular Surgery. 7th ed. Philadelphia, PA: Saunders Elsevier; 2010:1721-34.</p>
<p>QID: 30115</p></div><div class="rightanswer">The correct answer is: CT angiography is the preferred imaging modality</div></div></div></div></div><div id="q354" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">468</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4376"><input type="hidden" name="q20803:354_:flagged" value="0"><input type="hidden" value="qaid=911238&amp;qubaid=20803&amp;qid=4417&amp;slot=354&amp;checksum=aa6d752cce493ed1c580518fd2046860&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:354_:flaggedcheckbox" name="q20803:354_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q354&id=4417"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:354_:sequencecheck" value="2"><div class="qtext"><p>Six months after endovascular aneurysm repair (EVAR), a 65 year old man &nbsp;presents with a three month history of constant abdominal and back pain that is unrelated to meals. He has lost more than 50 lbs. He has a history of left colectomy for colon cancer complicated by an anastomotic leak. He also has a history of congestive heart failure with an ejection fraction of 20% by echo. A CTA is obtained (Figure). Both the celiac and SMA are reported to have 50-70% stenoses unchanged from CT scans prior to EVAR. The next most appropriate step in management is:</p>
<p><a href="./VESAP3_files/Figure.jpg" target="images"><img src="./VESAP3_files/Figure.jpg" alt="Axial image from CTA showing celiac and SMA disease." width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:354_answer" disabled="disabled" value="0" id="q20803:354_answer0"><label for="q20803:354_answer0">a. Arteriogram and superior mesenteric artery stenting</label> </div>
<div class="r1"><input type="radio" name="q20803:354_answer" disabled="disabled" value="1" id="q20803:354_answer1"><label for="q20803:354_answer1">b. Evaluation for occult malignancy and other sources of abdominal pain with weight loss</label> </div>
<div class="r0"><input type="radio" name="q20803:354_answer" disabled="disabled" value="2" id="q20803:354_answer2"><label for="q20803:354_answer2">c. Laparoscopic/ robot-assisted median arcuate release</label> </div>
<div class="r1"><input type="radio" name="q20803:354_answer" disabled="disabled" value="3" id="q20803:354_answer3"><label for="q20803:354_answer3">d. Open abdominal aortic aneurysm repair via a retroperitoneal approach</label> </div>
<div class="r0"><input type="radio" name="q20803:354_answer" disabled="disabled" value="4" id="q20803:354_answer4"><label for="q20803:354_answer4">e. Antegrade aorta to superior mesenteric artery bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:354_-submit" name="q20803:354_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has abdominal pain and weight loss. The absence of a relationship with meals makes the diagnosis of chronic mesenteric ischemia unlikely. The endograft appears to be in good position and there is no endoleak making the aortic aneurysm an unlikely source of pain. Chronic mesenteric ischemia (CMI) is a syndrome with symptoms&nbsp;that frequently overlap with other clinical syndromes.&nbsp;While an exhaustive evaluation of every possible cause of abdominal pain and weight loss may result in inordinate delays in treatment, the mere presence of a <span style="text-decoration: underline;">&gt;</span> 70% stenosis&nbsp;of a mesenteric vessel with weight loss and abdominal pain is insufficient to cement the diagnosis and may subject the patient to&nbsp;inappropriate mesenteric revascularization.&nbsp;A thoughtful, efficient,&nbsp;and thorough evaluation for occult malignancy and other sources of abdominal pain and weight loss is advisable in those cases in which the history is atypical for chronic mesenteric ischemia.&nbsp;</p>
<p><strong>References</strong></p>
<p>1. Chandra A, and Quinones-Baldrich WJ.&nbsp; Chronic Mesenteric Ischemia:&nbsp; How to Select Patients for Invasive Treatment.&nbsp; Ann Vasc Surg 2013;27:113-122.</p>
<p>QID: 30622</p></div><div class="rightanswer">The correct answer is: Evaluation for occult malignancy and other sources of abdominal pain with weight loss</div></div></div></div></div><div id="q68" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">469</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4385"><input type="hidden" name="q20803:68_:flagged" value="0"><input type="hidden" value="qaid=910952&amp;qubaid=20803&amp;qid=4940&amp;slot=68&amp;checksum=65bdf9409e446d83e75001fd6fe414c6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:68_:flaggedcheckbox" name="q20803:68_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q68&id=4940"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:68_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements about distal bypass to the peroneal artery is most accurate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:68_answer" disabled="disabled" value="0" id="q20803:68_answer0"><label for="q20803:68_answer0">a. graft surveillance with duplex ultrasound is more difficult to perform than with a tibial bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:68_answer" disabled="disabled" value="1" id="q20803:68_answer1"><label for="q20803:68_answer1">b. it should not be performed in diabetic patients</label> </div>
<div class="r0"><input type="radio" name="q20803:68_answer" disabled="disabled" value="2" id="q20803:68_answer2"><label for="q20803:68_answer2">c. both medial exposure or fibulectomy with lateral exposure are acceptable approaches to the peroneal artery</label> </div>
<div class="r1"><input type="radio" name="q20803:68_answer" disabled="disabled" value="3" id="q20803:68_answer3"><label for="q20803:68_answer3">d. bypass to the proximal or middle third of the artery is a less desirable option than a pedal bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:68_answer" disabled="disabled" value="4" id="q20803:68_answer4"><label for="q20803:68_answer4">e. it is associated with significantly poorer graft patency than with a tibial bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:68_-submit" name="q20803:68_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>In patients with critical limb ischemia, the peroneal artery is often the only runoff vessel patent in the calf. Controversy has existed regarding whether a bypass to the proximal peroneal artery has as good an outcome in these patients without providing inline direct flow into the foot as a pedal bypass. In the presence of collaterals from the distal peroneal artery providing flow to the foot, a shorter bypass to the proximal peroneal artery is a good choice. Diabetics have a better or equivalent patency than nondiabetics after distal bypass. However, higher amputation rates in the presence of a patent graft attributable to small vessel disease and susceptibility to infection. Exposure of the distal peroneal artery is easier from the lateral leg than the medial side. Peroneal bypasses can be followed just like tibial bypasses and have similar patency rates.<br><br></p>
<h3>References:</h3>
<p>Mills JL. Infrainguinal bypass. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Elsevier Saunders, Philadelphia, PA; 2005:1154-1169.<br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1993%3B+18+(5)%3A881-8." target="_blank">Elliot BM, Robison JG, Brothers TE, Cross MA. Limitations of peroneal artery bypass grafting for limb salvage. J Vasc Surg; 1993; 18 (5):881-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1993%3B+17+(1)%3A97-105." target="_blank">Plecha EJ, Seabrook GR, Bandyk DF, Towne JB. Determinants of successful peroneal artery bypass. J Vasc Surg; 1993; 17 (1):97-105.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1994%3B+19+(6)%3A964-8." target="_blank">Raferty KB, Belkin M, Mackey WC, O'Donnell TF<span>.</span>&nbsp;Are peroneal artery bypass grafts hemodynamically inferior to other tibial artery bypass grafts? J Vasc Surg; 1994; 19 (6):964-8.</a></p>
<p>QID: 30106</p></div><div class="rightanswer">The correct answer is: both medial exposure or fibulectomy with lateral exposure are acceptable approaches to the peroneal artery</div></div></div></div></div><div id="q220" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">470</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4394"><input type="hidden" name="q20803:220_:flagged" value="0"><input type="hidden" value="qaid=911104&amp;qubaid=20803&amp;qid=4715&amp;slot=220&amp;checksum=c982263949f947d52c630601c89064e6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:220_:flaggedcheckbox" name="q20803:220_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q220&id=4715"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:220_:sequencecheck" value="2"><div class="qtext"><p>A 25-year-old woman sustains a single stab wound just above her sternal notch. Her&nbsp;heart rate&nbsp;is 115/min and her blood pressure is 70/55. An expanding hematoma is present in her lower neck and she is unable to move her right arm or leg. &nbsp;Which of the following is the most appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:220_answer" disabled="disabled" value="0" id="q20803:220_answer0"><label for="q20803:220_answer0">a. left supraclavicular incision, partial median sternotomy, and left anterolateral thoracotomy</label> </div>
<div class="r1"><input type="radio" name="q20803:220_answer" disabled="disabled" value="1" id="q20803:220_answer1"><label for="q20803:220_answer1">b. left anterolateral thoracotomy</label> </div>
<div class="r0"><input type="radio" name="q20803:220_answer" disabled="disabled" value="2" id="q20803:220_answer2"><label for="q20803:220_answer2">c. median sternotomy extending the incision anterior to the left sternocleidomastoid muscle</label> </div>
<div class="r1"><input type="radio" name="q20803:220_answer" disabled="disabled" value="3" id="q20803:220_answer3"><label for="q20803:220_answer3">d. arch angiogram with possible endovascular intervention</label> </div>
<div class="r0"><input type="radio" name="q20803:220_answer" disabled="disabled" value="4" id="q20803:220_answer4"><label for="q20803:220_answer4">e. CT angiogram of the neck</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:220_-submit" name="q20803:220_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The first decision to be made in a case like this is whether the patient is hemodynamically stable or unstable. If stable, further imaging (such as a CT angiogram) may be performed rapidly to help delineate an operative approach. However,&nbsp;in this case the patient is hemodynamically unstable with hypotension and an expanding hematoma. Therefore, she should be taken&nbsp;directly to the operating room. Given the neurologic deficit and significant bleeding, it is likely that this patient has sustained an injury to her left common carotid artery. The most appropriate incision to gain control and expose the injury is a median sternotomy with extension into the neck along the anterior border of the sternocleidomastoid muscle. A left anterolateral thoracotomy can be used to expose and repair injuries to the proximal left subclavian artery. Depending on the location of the subclavian artery injury, the left anterolateral thoracotomy incision can be extended to include a partial sternotomy and a supraclavicular incision ("trapdoor incision"). &nbsp;</p>
<p>For a&nbsp;hemodynamically stable patient with a Zone 1 injury, contrast angiography is helpful to identify the location of the injury and to plan the operative approach. Some zone 1 vascular injuries may be amenable to treatment using endovascular intervention. In some cases, proximal control of the vascular injury may be achieved with balloon occlusion prior to open repair. Ligation of the carotid arteries should be avoided unless it is the only alternative to exsanguination, as it has been associated with mortality &gt;45%. Up to 80% of patients with neurologic deficits who have repair of a carotid injury show improvement in neurologic symptoms.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21986686" target="_blank">O'Brien PJ,&nbsp;Cox MW. A modern approach to cervical vascular trauma.&nbsp;Perspect Vasc Surg Endovasc Ther 2011; 23(2):90-7.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/12891106" target="_blank">du Toit DF,&nbsp;van Schalkwyk GD,&nbsp;Wadee SA, Warren BL.&nbsp;Neurologic outcome after penetrating extracranial arterial trauma.J Vasc Surg&nbsp;2003;&nbsp;38(2):257-62.&nbsp;</a></p>
<p>QID: 30371</p></div><div class="rightanswer">The correct answer is: median sternotomy extending the incision anterior to the left sternocleidomastoid muscle</div></div></div></div></div><div id="q518" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">471</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4403"><input type="hidden" name="q20803:518_:flagged" value="0"><input type="hidden" value="qaid=911402&amp;qubaid=20803&amp;qid=5253&amp;slot=518&amp;checksum=3436e1b9023cbeca532776b73d9d7fc7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:518_:flaggedcheckbox" name="q20803:518_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q518&id=5253"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:518_:sequencecheck" value="2"><div class="qtext"><p>A radiation-induced injury, such as a skin burn or hair loss, that manifests itself days to weeks post-exposure is best classified as a which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:518_answer" disabled="disabled" value="0" id="q20803:518_answer0"><label for="q20803:518_answer0">a. stochastic effect</label> </div>
<div class="r1"><input type="radio" name="q20803:518_answer" disabled="disabled" value="1" id="q20803:518_answer1"><label for="q20803:518_answer1">b. deterministic effect</label> </div>
<div class="r0"><input type="radio" name="q20803:518_answer" disabled="disabled" value="2" id="q20803:518_answer2"><label for="q20803:518_answer2">c. decay effect</label> </div>
<div class="r1"><input type="radio" name="q20803:518_answer" disabled="disabled" value="3" id="q20803:518_answer3"><label for="q20803:518_answer3">d. teratogenic effect</label> </div>
<div class="r0"><input type="radio" name="q20803:518_answer" disabled="disabled" value="4" id="q20803:518_answer4"><label for="q20803:518_answer4">e. non-ionizing effect</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:518_-submit" name="q20803:518_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The effects of ionizing radiation such as X-rays and alpha or beta particles are classified as either having a deterministic effect on tissue, meaning that the effect is not seen if exposures are below a certain threshold, or having a stochastic effect, which can occur with any exposure (ie, there is no safe threshold below which the effect will not occur).&nbsp; Examples of deterministic effects are things such as early transient skin erythema that may occur as early as a few hours after exposure to as little as 2 Gray of radiation, or non-transient skin erythema that becomes evident days to weeks after exposure when doses are higher of around 6 Gray. Epilation of skin may be either transient or permanent and is another deterministic effect. Stochastic effects are random events that can occur at any level of exposure but whose probability of happening increases with increasing dosage. Cancer is the proto-typical stochastic effect. Decay is the process in which unstable isotopes lose energy when their nucleus emits particles of ionizing radiation. Non-ionizing radiation is energy that is not capable of removing electrons from an atom. Examples of non-ionizing radiation include radio waves and microwaves. Teratogenic effects are the appearance of developmental defects typically seen in a fetus exposed to some type of harmful substance.&nbsp; While radiation can be teratogenic, this is not the effect that produces skin burns or hair loss.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clinical+Radiology+2001%3B+56%3A+99-106." target="_blank">Johnson DR, Kyriou J, Morton EJ, Clifton A,&nbsp;Fitzgerald M,&nbsp;Macsweeney E. Radiation Protection in Interventional Radiology. Clinical Radiology 2001; 56: 99-106.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=RadioGraphics+1999%3B19%3A1289-1302" target="_blank">Parry RA, Glaze SA, Archer BR. The AAPM/RSNA Physics Tutorial for Residents. Typical Patient Radiation Doses in Diagnostic Radiology. RadioGraphics 1999; 19:1289-302.</a></p>
<p>QID: 30921</p></div><div class="rightanswer">The correct answer is: deterministic effect</div></div></div></div></div><div id="q303" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">472</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4412"><input type="hidden" name="q20803:303_:flagged" value="0"><input type="hidden" value="qaid=911187&amp;qubaid=20803&amp;qid=5061&amp;slot=303&amp;checksum=b1b84ef03c6b11c166526e13302d61ce&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:303_:flaggedcheckbox" name="q20803:303_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q303&id=5061"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:303_:sequencecheck" value="2"><div class="qtext"><p>A 40-year-old woman presents for evaluation of&nbsp;chronic swelling of the left lower extremity. Her past medical history is only significant for left femur fracture 3 years ago, from which she recovered uneventfully.&nbsp;Lower extremity&nbsp;duplex ultrasonography reveals the left superficial femoral artery and femoral vein. The duplex image shown below suggests which of the following?</p>
<p><a href="./VESAP3_files/12235.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/12235.jpg" alt="Img" width="135" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:303_answer" disabled="disabled" value="0" id="q20803:303_answer0"><label for="q20803:303_answer0">a. acute thrombosis of the femoral vein</label> </div>
<div class="r1"><input type="radio" name="q20803:303_answer" disabled="disabled" value="1" id="q20803:303_answer1"><label for="q20803:303_answer1">b. previous deep venous thrombosis</label> </div>
<div class="r0"><input type="radio" name="q20803:303_answer" disabled="disabled" value="2" id="q20803:303_answer2"><label for="q20803:303_answer2">c. an aneurysm of the superficial femoral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:303_answer" disabled="disabled" value="3" id="q20803:303_answer3"><label for="q20803:303_answer3">d. lymphedema in the peri-vascular tissue</label> </div>
<div class="r0"><input type="radio" name="q20803:303_answer" disabled="disabled" value="4" id="q20803:303_answer4"><label for="q20803:303_answer4">e. external compression of the femoral vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:303_-submit" name="q20803:303_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Acute venous thrombosis is marked by lack of flow within the venous lumen on color flow examination and failure of the vein to fully compress with probe compression. In addition, the vein is usually distended with very low-level echoes, all suggesting an acute thrombus. The image shown demonstrates chronic changes in the femoral vein that occur as late manifestations of venous thrombosis. The vein wall is thickened and highly echogenic; it has diminished caliber compared to the superficial femoral artery (not distended as in acute thrombosis, and flow is clearly present). Marked collateralization may also be present as a late finding associated with previous venous thrombosis, but it is not seen here. There is no evidence of external compression in the image. Lymphedema would not cause the venous duplex scan findings shown in the image. The superficial femoral artery diameter is not uniform, but the scale demonstrates a normal diameter.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1995%3B+21+(3)%3A472-6." target="_blank">Caprini JA, Arcelus JI, Hoffman KN, Size G<span>,&nbsp;</span>Laubach M<span>,&nbsp;</span>Traverso CI,&nbsp;et al. Venous duplex imaging follow-up of acute symptomatic deep vein thrombosis of the leg. J Vasc Surg 1995; 21 (3):472-6.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Hamper%20UM,%20Dejong%20MR,%20Scoutt%20LM.%20Ultrasound%20evaluation%20of%20the%20lower%20extremity%20veins.%20Radiol%20Clin%20North%20Am;%202007;%2045%20(3):525-547" target="_blank">Hamper UM, Dejong MR, Scoutt LM. Ultrasound evaluation of the lower extremity veins. Radiol Clin North Am 2007; 45 (3):525-47.</a><br><br>Ohgi S, Ito K, Tanaka K. Echogenic types of venous thrombi in the common femoral vein by ultrasonic B-mode imaging. J Vasc Surg 1991; 25 (4):253-8.</p>
<p>QID: 30523</p></div><div class="rightanswer">The correct answer is: previous deep venous thrombosis</div></div></div></div></div><div id="q227" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">473</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4421"><input type="hidden" name="q20803:227_:flagged" value="0"><input type="hidden" value="qaid=911111&amp;qubaid=20803&amp;qid=4958&amp;slot=227&amp;checksum=cd2ba8143e3fb67b2128ebc055425c8c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:227_:flaggedcheckbox" name="q20803:227_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q227&id=4958"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:227_:sequencecheck" value="2"><div class="qtext"><p>A 55-year-old woman with end-stage renal disease (ESRD) presents to the office in need of new permanent dialysis access. Her left arm has been previously used for dialysis and has no further options. She is currently being dialyzed via a left internal jugular long-term dialysis catheter. On physical examination of her right arm, she has prominent superficial venous collaterals, moderate edema, and palpable radial, ulnar, and brachial artery pulses. Which of the following is the best pre-operative test to optimize the placement an arteriovenous (AV) access in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:227_answer" disabled="disabled" value="0" id="q20803:227_answer0"><label for="q20803:227_answer0">a. upper extremity segmental pressures and pulse volume recordings</label> </div>
<div class="r1"><input type="radio" name="q20803:227_answer" disabled="disabled" value="1" id="q20803:227_answer1"><label for="q20803:227_answer1">b. upper extremity venogram</label> </div>
<div class="r0"><input type="radio" name="q20803:227_answer" disabled="disabled" value="2" id="q20803:227_answer2"><label for="q20803:227_answer2">c. upper extremity superficial venous duplex imaging</label> </div>
<div class="r1"><input type="radio" name="q20803:227_answer" disabled="disabled" value="3" id="q20803:227_answer3"><label for="q20803:227_answer3">d. upper extremity deep venous duplex imaging</label> </div>
<div class="r0"><input type="radio" name="q20803:227_answer" disabled="disabled" value="4" id="q20803:227_answer4"><label for="q20803:227_answer4">e. upper extremity arteriogram</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:227_-submit" name="q20803:227_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Central venous stenosis should be suspected if there are any prominent venous collaterals or edema, a differential in extremity diameter, any history of previous central venous catheters, or multiple previous accesses in the planned extremity to be used for access. If any of these abnormalities are identified, the patient should be further evaluated with either deep venous duplex or venography. Due to the position of the clavicle overlying the subclavian vein, deep venous duplex may be nondiagnostic in up to 10-20% of studies. Therefore, venography remains the gold standard; however, in pre-dialysis patients, the risk of contrast may be prohibitive. Given that this patient has a normal arterial exam, further arterial evaluation is unnecessary. <br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vas+Surg+1998%3B+28+(5)%3A869-75." target="_blank">Passman MA, Criado E, Farber MA, Risley GL<span>,&nbsp;</span>Burnham CB<span>,&nbsp;</span>Marston WA,&nbsp;et al. Efficacy of color flow duplex imaging for proximal upper extremity venous outflow obstruction in hemodialysis patients. J Vas Surg 1998; 28 (5):869-75.</a></p>
<p>QID: 30404</p></div><div class="rightanswer">The correct answer is: upper extremity venogram</div></div></div></div></div><div id="q367" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">474</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4430"><input type="hidden" name="q20803:367_:flagged" value="0"><input type="hidden" value="qaid=911251&amp;qubaid=20803&amp;qid=5119&amp;slot=367&amp;checksum=c26788027ac8be968d9efcd0f797c0fc&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:367_:flaggedcheckbox" name="q20803:367_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q367&id=5119"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:367_:sequencecheck" value="2"><div class="qtext"><p><span>An 83-year-old man with a history of peripheral atherosclerosis is in the ICU after being admitted with pneumonia. His course is complicated by cardiogenic hypotension requiring pressors and renal insufficiency requiring renal replacement therapy.&nbsp;During lucid moments, he complains of&nbsp;abdominal pain. Serum lactate levels are elevated and rising. Which of the following is the most probable diagnosis?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:367_answer" disabled="disabled" value="0" id="q20803:367_answer0"><label for="q20803:367_answer0">a. <span>superior mesenteric artery&nbsp;embolus</span></label> </div>
<div class="r1"><input type="radio" name="q20803:367_answer" disabled="disabled" value="1" id="q20803:367_answer1"><label for="q20803:367_answer1">b. <span>mesenteric venous thrombosis</span></label> </div>
<div class="r0"><input type="radio" name="q20803:367_answer" disabled="disabled" value="2" id="q20803:367_answer2"><label for="q20803:367_answer2">c. <span>non-occlusive mesenteric ischemia</span></label> </div>
<div class="r1"><input type="radio" name="q20803:367_answer" disabled="disabled" value="3" id="q20803:367_answer3"><label for="q20803:367_answer3">d. <span>chronic mesenteric ischemia</span></label> </div>
<div class="r0"><input type="radio" name="q20803:367_answer" disabled="disabled" value="4" id="q20803:367_answer4"><label for="q20803:367_answer4">e. <span>ischemic colitis</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:367_-submit" name="q20803:367_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Patients with non-occlusive mesenteric ischemia (NOMI) are usually elderly and critically ill with pre-existing atherosclerotic disease of the mesenteric vessels. The condition was first described in patients with advanced heart failure and low cardiac output. Patients with NOMI are typically encountered in the intensive care unit, are critically ill, and are often on vasopressors. &nbsp;Due to its frequent correlation with multiple organ dysfunction syndrome, NOMI has higher mortality than thromboembolic disease and is often under-recognized.</p>
<p>Diagnosis of NOMI can be challenging as patients are frequently critically ill and therefore cannot give a reliable history; physical exam is clouded by sedatives and paralytics used for ventilation.&nbsp;Symptom progression cannot be clearly ascertained.&nbsp;Despite advances in CTA, angiography is the most reliable diagnostic modality. Several angiographic findings have been described, including vasospasm of SMA, stensosis alternating with dilatation resulting in the characteristic “string of sausages” appearance, narrowing and tapering of mesenteric branches, and paucity of intramural vessels.</p>
<p>The treatment for NOMI is medical and supportive therapy. It is directed towards correcting the underlying cause, fluid resuscitation, optimization of cardiac output, correction of the low flow state, and elimination of vasopressors. Angiography with direct intrarterial infusion of papaverine in the SMA has been recommended but data supporting this treatment are anecdotal. The selection of agent (papaverine, nitroglycerin, prostaglandins), duration of infusion, dose and specific endovascular technique have not not been standardized. It is not clear that vasodilator infusion is effective if the underlying condition cannot be reversed. Heparin infusion to prevent catheter-related thrombosis should be considered. Laparotomy is reserved for progressive peritonitis due to &nbsp;bowel ischemia despite conservative measures.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11877691" target="_blank">Park WM, Gloviczki P, Cherry KJ,Jr, Hallett JW,Jr, Bower TC, Panneton JM, et al. Contemporary management of acute mesenteric ischemia: Factors associated with survival. J Vasc Surg&nbsp;2002;35(3):445-52.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Rofo+2012%3B184%3A805-9." target="_blank">Minko, Groesdonk H,&nbsp;Stroeder J,&nbsp;Miodek J,&nbsp;Graeber S,&nbsp;Bücker A,&nbsp;et al. A scoring system for the assessment of angiographic findings in non-occlusive mesenteric ischemia (NOMI). Rofo 2012;184:805-9.</a></p>
<p>QID: 30648</p></div><div class="rightanswer">The correct answer is: <span>non-occlusive mesenteric ischemia</span></div></div></div></div></div><div id="q178" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">475</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4439"><input type="hidden" name="q20803:178_:flagged" value="0"><input type="hidden" value="qaid=911062&amp;qubaid=20803&amp;qid=4682&amp;slot=178&amp;checksum=0c2e4122f14eb6af2a96f90e66951a0d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:178_:flaggedcheckbox" name="q20803:178_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q178&id=4682"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:178_:sequencecheck" value="2"><div class="qtext"><p>Which of the following methods is most reliable for determining adequate collateral cerebral perfusion during carotid endaterectomy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:178_answer" disabled="disabled" value="0" id="q20803:178_answer0"><label for="q20803:178_answer0">a. somatosensory evoked potential monitoring</label> </div>
<div class="r1"><input type="radio" name="q20803:178_answer" disabled="disabled" value="1" id="q20803:178_answer1"><label for="q20803:178_answer1">b. electroencephalographic (EEG)&nbsp;monitoring</label> </div>
<div class="r0"><input type="radio" name="q20803:178_answer" disabled="disabled" value="2" id="q20803:178_answer2"><label for="q20803:178_answer2">c. transcranial doppler</label> </div>
<div class="r1"><input type="radio" name="q20803:178_answer" disabled="disabled" value="3" id="q20803:178_answer3"><label for="q20803:178_answer3">d. awake neurologic monitoring</label> </div>
<div class="r0"><input type="radio" name="q20803:178_answer" disabled="disabled" value="4" id="q20803:178_answer4"><label for="q20803:178_answer4">e. stump pressure measurement</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:178_-submit" name="q20803:178_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Based upon awake monitoring studies, 80-90% of patients have adequate collateral perfusion with no change in neurologic status during carotid clamping. Other methods have been found to be less accurate. &nbsp;Several cases of false negatives with stump pressure have been documented. EEG monitoring has a higher rate of false positives, leading to an overestimate of patients who require shunts. Neurologic monitoring alone during awake regional anesthesia is&nbsp;a more reliable method of predicting the need for shunting. It is more accurate in identifying clinical hypoperfusion based on the development of hemispheric or global symptoms.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21906905" target="_blank">Aburahma AF, Albeir YM, Stone PA. Shunting during carotid endarterectomy. J Vasc Surg 2011; 54: 1502-10.</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/21906905"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19041130" target="_blank">GALA Trial Collaborative Group,&nbsp;Lewis SC,&nbsp;Warlow CP,&nbsp;Bodenham AR,&nbsp;Colam B,&nbsp;Rothwell PM, et al. General&nbsp;anesthesia versus local anesthesia&nbsp;for carotid surgery (GALA): a multicentre, randomised controlled&nbsp;trial. Lancet 2008; 372: 2132-42.</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/19041130"><br></a></p>
<p>QID: 30320</p></div><div class="rightanswer">The correct answer is: awake neurologic monitoring</div></div></div></div></div><div id="q446" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">476</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4448"><input type="hidden" name="q20803:446_:flagged" value="0"><input type="hidden" value="qaid=911330&amp;qubaid=20803&amp;qid=5163&amp;slot=446&amp;checksum=84ddc5ef3b3e531b82d36e1ef8936c36&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:446_:flaggedcheckbox" name="q20803:446_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q446&id=5163"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:446_:sequencecheck" value="2"><div class="qtext"><p>A 68-year-old man with thigh and buttock symptoms suspicious for claudication is referred to the noninvasive vascular lab for evaluation. Which of the following is <strong>not</strong>&nbsp;a contraindication to treadmill testing?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:446_answer" disabled="disabled" value="0" id="q20803:446_answer0"><label for="q20803:446_answer0">a. chest pain</label> </div>
<div class="r1"><input type="radio" name="q20803:446_answer" disabled="disabled" value="1" id="q20803:446_answer1"><label for="q20803:446_answer1">b. resting dyspnea</label> </div>
<div class="r0"><input type="radio" name="q20803:446_answer" disabled="disabled" value="2" id="q20803:446_answer2"><label for="q20803:446_answer2">c. a normal resting ankle-brachial index</label> </div>
<div class="r1"><input type="radio" name="q20803:446_answer" disabled="disabled" value="3" id="q20803:446_answer3"><label for="q20803:446_answer3">d. systolic blood pressure of 195 mm Hg</label> </div>
<div class="r0"><input type="radio" name="q20803:446_answer" disabled="disabled" value="4" id="q20803:446_answer4"><label for="q20803:446_answer4">e. aortic valvular stenosis with history of syncope</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:446_-submit" name="q20803:446_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Contraindications to exercise testing to diagnose claudication include uncontrolled hypertension, severe aortic stenosis, advanced stage congestive heart failure, or COPD. In some cases, strenuous exercise could precipitate cardiac or pulmonary symptoms. Importantly, however, if concomitant medical problems limit exercise capacity, treatment of claudication symptoms becomes a secondary concern.</p>
<p>Treadmill testing can be particularly helpful for patients with an isolated iliac artery stenosis who may have no pressure gradient across the stenosis at rest and a normal ankle-brachial index. In these patients, exercise will induce a decrease in the ankle brachial index (ABI) that can be detected in the immediate recovery period, thus confirming the diagnosis of peripheral arterial disease (PAD).</p>
<p>Cardiac monitoring may be used during exercise testing in the vascular laboratory, but it is not considered a practice standard.</p>
<p>The procedure requires an initial measurement of the ABI at rest. The patient is then asked to walk (typically on a treadmill at 3.2 km/h (2 mph), 10%-12% grade) until claudication pain occurs (or a maximum of 5 minutes), following which the ABI is again measured. A decrease in ABI of 15-20% would be diagnostic of PAD, whereas a normal post-exercise ABI rules out PAD. The highest reliability of treadmill assessment is attained with a graded protocol, employing a fixed speed and a graded increase in incline (approximately 2-3% every 2-3 minutes). Among the constant protocols, a 10% incline gives greater reliability than 0% incline.</p>
<p>Pain free walking distance (beginning of claudication pain), absolute claudication distance (the moment the test has to stop due to maximal pain), and post-exercise ABI should be recorded. The reliability of treadmill testing is highest when the absolute claudication distance is the primary outcome measure.</p>
<p>&nbsp;</p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17223489" target="_blank">Norgren L, Hiatt WR. Dormandy JA, Nehler MR<span>,&nbsp;</span>Harris KA<span>,&nbsp;</span>Fowkes FG,&nbsp;et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007; 45(1):S5-S67.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Reliability+of+treadmill+testing+in+peripheral+arterial+disease%3A+a+meta-regression+analysis." target="_blank">Nicolai, SPA, Viechtbauer, W, Kruidenier LM, Candel MJ<span>,&nbsp;</span>Prins MH<span>,&nbsp;</span>Teijink JA. Reliability of treadmill testing in peripheral arterial disease: A meta-regression analysis. J Vasc Surg; 2009; 50 (2):322-9.</a><br><br>Zierler RE, Sumner DS. Physiologic assessment of peripheral arterial disease. In: Rutherford RB, ed. Vascular Surgery. 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:197-222.</p>
<p>QID: 30803</p></div><div class="rightanswer">The correct answer is: a normal resting ankle-brachial index</div></div></div></div></div><div id="q461" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">477</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4457"><input type="hidden" name="q20803:461_:flagged" value="0"><input type="hidden" value="qaid=911345&amp;qubaid=20803&amp;qid=5181&amp;slot=461&amp;checksum=cab2b52dfd3cdce453d1fde11e1b045d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:461_:flaggedcheckbox" name="q20803:461_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q461&id=5181"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:461_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old man on warfarin for atrial fibrillation is scheduled for an elective open abdominal aortic aneurysm (AAA) repair. He has been on warfarin for 10 years without a clinical thromboembolic event.&nbsp;How should peri-operative anticoagulation be managed?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:461_answer" disabled="disabled" value="0" id="q20803:461_answer0"><label for="q20803:461_answer0">a. start aspirin pre-operatively and discontinue warfarin, without resumption</label> </div>
<div class="r1"><input type="radio" name="q20803:461_answer" disabled="disabled" value="1" id="q20803:461_answer1"><label for="q20803:461_answer1">b. stop warfarin 5 days prior to operation; admit to the hospital 1 day prior to operation and begin UFH and amiodarone for rate control; resume warfarin after surgery</label> </div>
<div class="r0"><input type="radio" name="q20803:461_answer" disabled="disabled" value="2" id="q20803:461_answer2"><label for="q20803:461_answer2">c. stop warfarin 5 days prior to operation; give full dose LMWH for 10 days after surgery and resume warfarin</label> </div>
<div class="r1"><input type="radio" name="q20803:461_answer" disabled="disabled" value="3" id="q20803:461_answer3"><label for="q20803:461_answer3">d. stop warfarin 5 days prior to operation, start intravenous unfractionated heparin when INR normalizes, and bridge with UFH for 10 days</label> </div>
<div class="r0"><input type="radio" name="q20803:461_answer" disabled="disabled" value="4" id="q20803:461_answer4"><label for="q20803:461_answer4">e. stop warfarin 5 days prior to operation; start low dose low molecular weight heparin (LMWH) after surgery and resume warfarin</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:461_-submit" name="q20803:461_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Management is based on consensus opinion, as few randomized controlled trials exist.</p>
<p>This patient is at low risk for arterial thromboembolic events, given his age is &lt; 75 years, he has no prior thromboembolic events, and he does not have diabetes. For this low-risk patient, the risk of postoperative bleeding with anticoagulation is greater than risk thromboembolism from chronic atrial fibrillation. Bleeding complications after open AAA repair could be serious.</p>
<p>Bridging with preoperative intravenous unfractionated heparin (UFH) or low molecular weight heparin (LMWH) is not required.&nbsp;Therapeutic dose post-operative LMWH for 10 days with warfarin resumption would be the correct approach for moderate to high-risk patients, including those with mechanical heart valves.&nbsp;Aspirin alone would probably not be harmful, but it offers little effective protection for patients with atrial fibrillation.&nbsp;Rate control itself would not be indicated for bridging therapy to prevent arterial thromboembolism.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Kearon%20C,%20Hirsh%20J.%20Management%20of%20anticoagulation%20before%20and%20after%20elective%20surgery.%20N%20Engl%20J%20Med;%201997;%20336%20(21):1506-1511" target="_blank">Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med 1997; 336 (21):1506-11.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Wysokinski%20WE,%20McBane%20RD,%20Daniels%20PR,%20et%20al.%20Periprocedural%20anticoagulation%20management%20of%20patients%20with%20nonvalvular%20atrial%20fibrillation.%20Mayo%20Clin%20Proc;%202008;%2083%20(6):639-645" target="_blank">Wysokinski WE, McBane RD, Daniels PR, Litin SC<span>,&nbsp;</span>Hodge DO<span>,&nbsp;</span>Dowling NF<span>,&nbsp;</span>Heit JA. Periprocedural anticoagulation management of patients with nonvalvular atrial fibrillation. Mayo Clin Proc 2008; 83 (6):639-45.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/18574269" target="_blank">Douketis JD, Berger PB, Dunn AS, Jaffer AK,&nbsp;Spyropoulos AC,&nbsp;Becker RC,&nbsp;et al. The perioperative management of antithrombotic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 8th ed. Chest 2008; 133 (6 Suppl):299S-339S.</a></p>
<p>QID: 30821</p></div><div class="rightanswer">The correct answer is: stop warfarin 5 days prior to operation; start low dose low molecular weight heparin (LMWH) after surgery and resume warfarin</div></div></div></div></div><div id="q194" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">478</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4466"><input type="hidden" name="q20803:194_:flagged" value="0"><input type="hidden" value="qaid=911078&amp;qubaid=20803&amp;qid=4564&amp;slot=194&amp;checksum=f2ab3d916ae4cf760f2915b51aad6a73&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:194_:flaggedcheckbox" name="q20803:194_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q194&id=4564"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:194_:sequencecheck" value="2"><div class="qtext"><p>A 75 year old man presents to his PCP complaining of dizziness and two syncopal events. He is found to have a BP of 112/79 on the left and 130/90 on the right. A carotid duplex was performed that demonstrates the picture shown below. The next step in his management should be:</p>
<p><img src="./VESAP3_files/Picture4(1).jpg" alt="" width="416" height="312"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:194_answer" disabled="disabled" value="0" id="q20803:194_answer0"><label for="q20803:194_answer0">a. EKG</label> </div>
<div class="r1"><input type="radio" name="q20803:194_answer" disabled="disabled" value="1" id="q20803:194_answer1"><label for="q20803:194_answer1">b. CT angiogram of the chest</label> </div>
<div class="r0"><input type="radio" name="q20803:194_answer" disabled="disabled" value="2" id="q20803:194_answer2"><label for="q20803:194_answer2">c. Echocardiogram</label> </div>
<div class="r1"><input type="radio" name="q20803:194_answer" disabled="disabled" value="3" id="q20803:194_answer3"><label for="q20803:194_answer3">d. MRI of the chest</label> </div>
<div class="r0"><input type="radio" name="q20803:194_answer" disabled="disabled" value="4" id="q20803:194_answer4"><label for="q20803:194_answer4">e. Chest X-ray</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:194_-submit" name="q20803:194_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient is demonstrating evidence of vertebrobasiliar insufficiency and steal syndrome. The BP differential between the arms suggests a possible subclavian artery lesion which is best interrogated by some type of vascular imaging. Diagnostic angiography is not offered as an answer choice but would certainly be indicated. MRI can be used to evaluate vascular lesions, although sites of stenosis represent areas where there is flow signal intensity loss. This can lead to overestimation of stenosis or even mislabeling of stenosis as occlusion.<sup>1</sup> CT angiography is noninvasive and quick, although heavy calcification can sometimes degrade the image.</p>
<p>&nbsp;</p>
<p>References:&nbsp;</p>
<p>1. Bash S, Villablanca JP, Jahan R, et al.&nbsp; Intracranial vascular stenosis and occlusive disease: Evaluation with CT angiography, MR angiography and digital subtraction angiography.&nbsp; AJMR Am&nbsp;J Neuroradiol 2005; 26: 1012-1021.&nbsp;&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/15891154">http://www.ncbi.nlm.nih.gov/pubmed/15891154</a></p>
<p>QID: 30341</p></div><div class="rightanswer">The correct answer is: CT angiogram of the chest</div></div></div></div></div><div id="q512" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">479</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4475"><input type="hidden" name="q20803:512_:flagged" value="0"><input type="hidden" value="qaid=911396&amp;qubaid=20803&amp;qid=5244&amp;slot=512&amp;checksum=8ecbc6af0e0c85ab22427217b71a0393&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:512_:flaggedcheckbox" name="q20803:512_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q512&id=5244"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:512_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old man returns to your clinic 1 month after endovascular repair of an 8 cm descending thoracic aortic aneurysm. The aneurysm repair went smoothly and was completed in less than an hour. He recovered well, especially considering that the aneurysm was detected during cardiac catheterization for an acute MI, which required multiple coronary stents. During routine physical exam, you notice an area of cutaneous erythema on a portion of his back larger than the surface area of your palm. His wife states that it has been there for about 2 weeks, without changing significantly. Which of the following would you tell the patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:512_answer" disabled="disabled" value="0" id="q20803:512_answer0"><label for="q20803:512_answer0">a. he may have a pressure-induced wound from lying in bed during his hospital stay</label> </div>
<div class="r1"><input type="radio" name="q20803:512_answer" disabled="disabled" value="1" id="q20803:512_answer1"><label for="q20803:512_answer1">b. he has a radiation-induced skin injury that needs to be monitored closely</label> </div>
<div class="r0"><input type="radio" name="q20803:512_answer" disabled="disabled" value="2" id="q20803:512_answer2"><label for="q20803:512_answer2">c. he needs antibiotics for a mild skin infection</label> </div>
<div class="r1"><input type="radio" name="q20803:512_answer" disabled="disabled" value="3" id="q20803:512_answer3"><label for="q20803:512_answer3">d. he appears to have had a local skin reaction, likely to an adhesive, operative skin prep, or other irritant</label> </div>
<div class="r0"><input type="radio" name="q20803:512_answer" disabled="disabled" value="4" id="q20803:512_answer4"><label for="q20803:512_answer4">e. he has an idiosyncratic skin reaction that will resolve spontaneously</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:512_-submit" name="q20803:512_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The patient hazards most often associated with exposure to x-ray radiation include increased risk of cancer and increased risk of genetic effects in exposed populations. These are generally quite small in the elderly vascular patient population, however, they are beyond reproductive years and carcinogenic effects typically surface many years after exposure (10-30 years for solid tumors, 10-15 years for leukemia). For vascular patients, a rare but significant hazard associated with use of fluoroscopy equipment is localized skin burns due exposure to the primary beam. The burn symptoms may require 1 to several weeks to develop, depending on the dose. A single minute of fluoroscopy is equivalent to about 10-15 plain x-rays, and lasting erythema and other cutaneous injury can be seen after 300 minutes of fluoroscopy at normal doses.</p>
<p>In this case, the thoracic aneurysm repair alone would be very unlikely to cause a radiation induced burn, but this patient also had a cardiac catheterization with multiple stents. Radiation is cumulative, and both procedures required radiation in the chest. Moreover, if the patient was inadvertently quite close to the emitter, radiation induced skin erythema may be induced with less fluoroscopy time than typical. Skin prep irritation, local infections, or pressure induced wounds would not typically develop in delayed fashion and remain relatively unchanged for 2 weeks. Routine fluoroscopy requires doses of approximately 300 rad (3 gray) to produce a visible reddening of the skin. Doses of approximately 1500 rad (15 gray) are required in order to produce serious burns with blistering. Doses on the order of 3000 rad (30 gray) may result in very serious burns which could require skin grafts or amputation.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=.+J+Interv+Cardiol%3B+2004%3B+17+(3)%3A131-142" target="_blank">Vlietstra RE, Wagner LK, Koenig T, Mettler F. Radiation burns as a severe complication of fluoroscopically guided cardiological interventions. J Interv Cardiol 2004; 17 (3):131-42.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+1995%3B+6+(6)%3A988-9." target="_blank">Wagner LK, Eifel P, Geise R. Effects of ionizing radiation. J Vasc Interv Radiol 1995; 6 (6):988-9.</a></p>
<p>QID: 30912</p></div><div class="rightanswer">The correct answer is: he has a radiation-induced skin injury that needs to be monitored closely</div></div></div></div></div><div id="q163" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">480</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4484"><input type="hidden" name="q20803:163_:flagged" value="0"><input type="hidden" value="qaid=911047&amp;qubaid=20803&amp;qid=4663&amp;slot=163&amp;checksum=09ac7a085a37a71432f982c221736407&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:163_:flaggedcheckbox" name="q20803:163_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q163&id=4663"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:163_:sequencecheck" value="2"><div class="qtext"><p>A 70-year-old man presents with an asymptomatic, 70% right internal carotid artery stenosis. Based on a published, randomized trial in a population of similar patients, which of the following is the estimated 5-year aggregate risk of ipsilateral stroke or death with medical management?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:163_answer" disabled="disabled" value="0" id="q20803:163_answer0"><label for="q20803:163_answer0">a. 1%</label> </div>
<div class="r1"><input type="radio" name="q20803:163_answer" disabled="disabled" value="1" id="q20803:163_answer1"><label for="q20803:163_answer1">b. 5%</label> </div>
<div class="r0"><input type="radio" name="q20803:163_answer" disabled="disabled" value="2" id="q20803:163_answer2"><label for="q20803:163_answer2">c. 11%</label> </div>
<div class="r1"><input type="radio" name="q20803:163_answer" disabled="disabled" value="3" id="q20803:163_answer3"><label for="q20803:163_answer3">d. 40%</label> </div>
<div class="r0"><input type="radio" name="q20803:163_answer" disabled="disabled" value="4" id="q20803:163_answer4"><label for="q20803:163_answer4">e. 17%</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:163_-submit" name="q20803:163_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The Asymptomatic Carotid Atherosclerosis (ACAS) Study randomized 1662 patients with a &gt; 60% asymptomatic carotid stenosis into a surgical (carotid endarterectomy) arm and a medical management arm (mainly aspirin therapy). After a mean of 2.7 years of follow up, the 5-year Kaplan-Meier projected risk for any stroke or death with medical management alone was 11%, compared to a 5.1% risk in those who underwent carotid endarterectomy. This large study concluded that all good, surgical risk patients with this type of carotid lesion be considered for carotid endarterectomy. It has been suggested that the current widespread use of statins, ACE inhibitors, and advanced antiplatelet drugs (eg clopidogrel) may have lowered the risk of stroke in asymptomatic patients with carotid stenosis. At the present time, carotid endarterectomy remains both indicated and the gold standard for stroke reduction in good surgical risk patients.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=The%20Executive%20Committee%20for%20the%20Asymptomatic%20Carotid%20Atherosclerosis%20(ACAS).%20Endarterectomy%20for%20asymptomatic%20carotid%20artery%20stenosis.%20JAMA;%201995;%20273%20(18):1421-1428" target="_blank">The Executive Committee for the Asymptomatic Carotid Atherosclerosis (ACAS). Endarterectomy for asymptomatic carotid artery stenosis. JAMA 1995; 273 (18):1421-8</a>.</p>
<p>QID: 30300</p></div><div class="rightanswer">The correct answer is: 11%</div></div></div></div></div><div id="q435" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">481</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4493"><input type="hidden" name="q20803:435_:flagged" value="0"><input type="hidden" value="qaid=911319&amp;qubaid=20803&amp;qid=4880&amp;slot=435&amp;checksum=4520b84e2c10cbb88648dc874a748538&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:435_:flaggedcheckbox" name="q20803:435_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q435&id=4880"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:435_:sequencecheck" value="2"><div class="qtext"><p>Three months ago, a 47-year-old man had an episode of left leg inflammation which was thought to be due to cellulitis and/or phlebitis.&nbsp;He remained ambulatory and was treated empirically with oral antibiotics, elastic compression, and analgesics.&nbsp;The inflammation resolved over the next 2 weeks, however, as it resolved the skin around the ankle and lower leg became progressively dark and discolored (blue-gray).&nbsp;</p>
<p>He recovered fully after 2 weeks and presents at this time for follow-up evaluation because of the persistent skin discoloration.&nbsp;On physical examination there is no swelling, and a venous ultrasound duplex scan does not demonstrate any evidence of venous obstruction or incompetence. The discoloration does not change with leg elevation or topical pressure.</p>
<p>Which of the following is the most likely cause of this skin discoloration shown below?</p>
<p><img src="./VESAP3_files/ROOKE-1.jpg" alt="" width="287" height="460"></p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:435_answer" disabled="disabled" value="0" id="q20803:435_answer0"><label for="q20803:435_answer0">a. occult trauma with bruising</label> </div>
<div class="r1"><input type="radio" name="q20803:435_answer" disabled="disabled" value="1" id="q20803:435_answer1"><label for="q20803:435_answer1">b. venous malformation</label> </div>
<div class="r0"><input type="radio" name="q20803:435_answer" disabled="disabled" value="2" id="q20803:435_answer2"><label for="q20803:435_answer2">c. antibiotic use</label> </div>
<div class="r1"><input type="radio" name="q20803:435_answer" disabled="disabled" value="3" id="q20803:435_answer3"><label for="q20803:435_answer3">d. chronic venous insufficiency not detected by ultrasound / duplex</label> </div>
<div class="r0"><input type="radio" name="q20803:435_answer" disabled="disabled" value="4" id="q20803:435_answer4"><label for="q20803:435_answer4">e. hemosiderin staining secondary to prolonged leg dependency</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:435_-submit" name="q20803:435_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This type of skin discoloration, which is often confused with the pigmentation caused by chronic venous disease, occasionally occurs after the use of tetracycline-type medications.&nbsp; In this case, the patient was given a tetracycline as treatment for presumed infectious cellulitis.&nbsp; The slate-colored discoloration induced by tetracycline-type drugs can fade over time, but residual discoloration may persist for months or even years.&nbsp; The hyperpigmentation is annoying but harmless. While prolonged lower extremity dependency can produce stasis-type discoloration even when the veins are patent and competent, this patient remained ambulatory. Venous disease severe enough to cause hyperpigmentation should easily be diagnosed with Duplex ultrasonography, and the ankle and foot are free of edema or other signs of chronic venous stasis.&nbsp; There is no reported history of trauma, and traumatic discoloration would not likely persist this long.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/3158284" target="_blank">Basler RS. Minocycline-related hyperpigmentation. Arch Dermatol 1985;121:606-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17261828" target="_blank"><span>Chatterjee S</span>.&nbsp; Hyperpigmentation associated with minocycline therapy.&nbsp;&nbsp;CMAJ 2007;176:321-2.</a></p>
<p>QID: 30761</p></div><div class="rightanswer">The correct answer is: antibiotic use</div></div></div></div></div><div id="q69" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">482</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4502"><input type="hidden" name="q20803:69_:flagged" value="0"><input type="hidden" value="qaid=910953&amp;qubaid=20803&amp;qid=4941&amp;slot=69&amp;checksum=f326291f7b2c4014d533a9a72cf22742&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:69_:flaggedcheckbox" name="q20803:69_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q69&id=4941"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:69_:sequencecheck" value="2"><div class="qtext"><p>Six months following femoral to the above-knee popliteal bypass with expanded polytetrafluoroethylene (ePTFE) for short-distance claudication, a 64-year-old woman presents with a 2-day history of nocturnal rest pain and a decline in her ankle-brachial index (ABI) of 0.3. Her initial post-operative ABI value was 0.9. She has a history of coronary artery bypass grafting (CABG) with greater saphenous vein (GSV) harvested from the same leg. Duplex scanning demonstrates occlusion of the graft. Which of the following is the best management option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:69_answer" disabled="disabled" value="0" id="q20803:69_answer0"><label for="q20803:69_answer0">a. thrombectomy of the graft only</label> </div>
<div class="r1"><input type="radio" name="q20803:69_answer" disabled="disabled" value="1" id="q20803:69_answer1"><label for="q20803:69_answer1">b. conservative management and exercise</label> </div>
<div class="r0"><input type="radio" name="q20803:69_answer" disabled="disabled" value="2" id="q20803:69_answer2"><label for="q20803:69_answer2">c. re-do bypass with contralateral GSV</label> </div>
<div class="r1"><input type="radio" name="q20803:69_answer" disabled="disabled" value="3" id="q20803:69_answer3"><label for="q20803:69_answer3">d. thrombolysis of the bypass graft</label> </div>
<div class="r0"><input type="radio" name="q20803:69_answer" disabled="disabled" value="4" id="q20803:69_answer4"><label for="q20803:69_answer4">e. subintimal re-canalization of a 20 cm occlusion of the native superficial femoral artery (SFA) followed by angioplasty and stenting</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:69_-submit" name="q20803:69_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Thrombolytic therapy to reopen this prosthetic bypass is the best option. The STILE trial observed that patients with acute arterial occlusion were most likely to benefit when treated within 2 weeks of the occlusion. This patient thrombosed her bypass graft 2 days ago, therefore she should be a good candidate. The TOPAS trial compared thrombolysis with urokinase to an operation for acute arterial occlusion, The amputation-free rates in the urokinase group were 71.8% at 6 months and 65% at 1 year, compared to 74.8% and 69.9%, respectively, in the operative group (<em>P&nbsp;</em>= NS). However, the rate of hemorrhagic complications was higher in the group undergoing thrombolysis. Graft thrombectomy can also be considered, but there is a high likelihood that a distal anastomotic narrowing secondary to intimal hyperplasia is present, which could be treated endovascularly after successful thrombolysis. Conservative management is not an option in this patient because of the onset of rest pain and need for palliation. A redo bypass with contralateral saphenous vein might be considered if thrombolytic therapy to reopen the occluded graft is not successful. Subintimal recanalization of a 20 cm occlusion may also be an option, but should be considered only after failure of the less invasive thrombolytic attempt. <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Surg%3B+1994%3B+220+(3)%3A251-66.+Discussion%3A+266-268." target="_blank">The STILE Investigators. Results of a prospective randomized trial evaluating surgery versus thrombolysis for ischemia of the lower extremity: the STILE trial. Ann Surg; 1994; 220 (3):251-66, discussion: 266-8.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med%3B+1998%3B+338+(16)%3A1105-11." target="_blank">Ouriel K, Veith FJ, Sasahara AA. A comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. N Engl J Med; 1998; 338 (16):1105-11.</a></p>
<p>QID: 30107</p></div><div class="rightanswer">The correct answer is: thrombolysis of the bypass graft</div></div></div></div></div><div id="q108" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">483</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4511"><input type="hidden" name="q20803:108_:flagged" value="0"><input type="hidden" value="qaid=910992&amp;qubaid=20803&amp;qid=4933&amp;slot=108&amp;checksum=ff4e6aef5d5b106055fef4fd52a9085e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:108_:flaggedcheckbox" name="q20803:108_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q108&id=4933"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:108_:sequencecheck" value="2"><div class="qtext"><p>Regarding the use of stents for the treatment of aortoiliac occlusive disease, which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:108_answer" disabled="disabled" value="0" id="q20803:108_answer0"><label for="q20803:108_answer0">a. stents in the aortoiliac system show no advantage compared to balloon angioplasty alone</label> </div>
<div class="r1"><input type="radio" name="q20803:108_answer" disabled="disabled" value="1" id="q20803:108_answer1"><label for="q20803:108_answer1">b. bare-metal stents can be more accurately deployed than covered stents</label> </div>
<div class="r0"><input type="radio" name="q20803:108_answer" disabled="disabled" value="2" id="q20803:108_answer2"><label for="q20803:108_answer2">c. covered stents have an improved outcome when compared to bare-metal stents when treating TASC C and D lesions of the aortoiliac system</label> </div>
<div class="r1"><input type="radio" name="q20803:108_answer" disabled="disabled" value="3" id="q20803:108_answer3"><label for="q20803:108_answer3">d. primary stenting in the aortoiliac system is only indicated for chronic total occlusions, not for stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:108_answer" disabled="disabled" value="4" id="q20803:108_answer4"><label for="q20803:108_answer4">e. covered stents have reduced rates of peri-procedural distal embolization</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:108_-submit" name="q20803:108_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The use of covered, balloon expandable stents was compared to bare metal stents in iliac arteries through the COBEST trial, a prospective, multicenter, randomized controlled study. Lesions treated with a covered stent were significantly less likely to develop restenosis than those treated with a bare metal stent. Subsequent occlusion was also less (but not significantly so) in the covered stent group. This was particularly notable in patients with TASC C and D lesions. Bare metal stents are similar in performance to covered stent grafts for TASC B lesions.</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B54(6)%3A+1561-70." target="_blank"> Mwipatayi BP, Thomas S, Wong J, Temple SE,&nbsp;Vijayan V,&nbsp;Jackson M,&nbsp;et al; COBEST Investigators. A comparison of covered versus bare expandable stents for the treatment of aortoiliac occlusive disease.&nbsp; J Vasc Surg 2011;54(6): 1561-70.</a></p>
<p>QID: 30162</p></div><div class="rightanswer">The correct answer is: covered stents have an improved outcome when compared to bare-metal stents when treating TASC C and D lesions of the aortoiliac system</div></div></div></div></div><div id="q26" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">484</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4520"><input type="hidden" name="q20803:26_:flagged" value="0"><input type="hidden" value="qaid=910910&amp;qubaid=20803&amp;qid=4636&amp;slot=26&amp;checksum=2e1bd0c50d7d5a21c4c766927999dc14&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:26_:flaggedcheckbox" name="q20803:26_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q26&id=4636"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:26_:sequencecheck" value="2"><div class="qtext"><p>A 76-year-old man with a history of systemic hypertension presents to the emergency room with back and chest pain. CT angiography shows a Type B dissection starting at the left subclavian artery extending down to the iliac arteries. All vessels are currently perfused, including all mesenteric, renal, and lower extremity arteries. Which of the following is the appropriate next step in the&nbsp;management&nbsp;of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:26_answer" disabled="disabled" value="0" id="q20803:26_answer0"><label for="q20803:26_answer0">a. intravenous ACE inhibitor</label> </div>
<div class="r1"><input type="radio" name="q20803:26_answer" disabled="disabled" value="1" id="q20803:26_answer1"><label for="q20803:26_answer1">b. intravenous nitroprusside</label> </div>
<div class="r0"><input type="radio" name="q20803:26_answer" disabled="disabled" value="2" id="q20803:26_answer2"><label for="q20803:26_answer2">c. intravenous calcium channel blocking agent</label> </div>
<div class="r1"><input type="radio" name="q20803:26_answer" disabled="disabled" value="3" id="q20803:26_answer3"><label for="q20803:26_answer3">d. intravenous diuretics</label> </div>
<div class="r0"><input type="radio" name="q20803:26_answer" disabled="disabled" value="4" id="q20803:26_answer4"><label for="q20803:26_answer4">e. intravenous beta-blockade</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:26_-submit" name="q20803:26_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The diagnosis of acute aortic dissection should prompt admission to the ICU for blood pressure monitoring and intravenous stabilization. The priorities of management should include amelioration of pain, hypertension, and minimizing the difference between systolic and diastolic blood pressure while maintaining visceral and peripheral perfusion. The treatment paradigm should begin with beta blockade, followed by afterload reduction. Afterload reduction first can lead to catecholamine release with an increase in left ventricular ejection function and subsequent death from a retrograde dissection (i.e. type A).</p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Henke%20PK,%20Williams%20DM,%20Upchurch%20GR,%20Jr,%20et%20al.%20Acute%20limb%20ischemia%20associated%20with%20type%20B%20aortic%20dissection:%20Clinical%20relevance%20and%20therapy.%20Surgery;%202006;%20140%20(4):532-539;%20discussion%20539-540" target="_blank">Henke PK, Williams DM, Upchurch GR, Jr, Proctor M, Cooper JV, Fang J, et al. Acute limb ischemia associated with type B aortic dissection: Clinical relevance and therapy. Surgery 2006; 140 (4):532-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Trimarchi%20S,%20Nienaber%20CA,%20Rampoldi%20V,%20et%20al.%20Role%20and%20results%20of%20surgery%20in%20acute%20type%20B%20aortic%20dissection:%20Insights%20from%20the%20international%20registry%20of%20acute%20aortic%20dissection%20(IRAD).%20Circulation;%202006;%20114%20(1%20Suppl):1357-1364" target="_blank">Trimarchi S, Nienaber CA, Rampoldi V, Myrmel T, Suzuki T, Bossone E, et al. Role and results of surgery in acute type B aortic dissection: Insights from the international registry of acute aortic dissection (IRAD). Circulation 2006; 114 (1 Suppl):1357-64.</a></p>
<p>QID: 30028</p></div><div class="rightanswer">The correct answer is: intravenous beta-blockade</div></div></div></div></div><div id="q49" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">485</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4529"><input type="hidden" name="q20803:49_:flagged" value="0"><input type="hidden" value="qaid=910933&amp;qubaid=20803&amp;qid=4303&amp;slot=49&amp;checksum=1938cebe9a77c84bbfc4ef7c4efe6531&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:49_:flaggedcheckbox" name="q20803:49_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q49&id=4303"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:49_:sequencecheck" value="2"><div class="qtext"><p>Which of the following risk factors have been identified&nbsp;to be&nbsp;NEGATIVELY ASSOCIATED with risk of abdominal aortic aneurysm (AAA) formation, expansion, and rupture?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:49_answer" disabled="disabled" value="0" id="q20803:49_answer0"><label for="q20803:49_answer0">a. Male sex.</label> </div>
<div class="r1"><input type="radio" name="q20803:49_answer" disabled="disabled" value="1" id="q20803:49_answer1"><label for="q20803:49_answer1">b. Family history of AAA.</label> </div>
<div class="r0"><input type="radio" name="q20803:49_answer" disabled="disabled" value="2" id="q20803:49_answer2"><label for="q20803:49_answer2">c. Advanced age.</label> </div>
<div class="r1"><input type="radio" name="q20803:49_answer" disabled="disabled" value="3" id="q20803:49_answer3"><label for="q20803:49_answer3">d. Smoking.</label> </div>
<div class="r0"><input type="radio" name="q20803:49_answer" disabled="disabled" value="4" id="q20803:49_answer4"><label for="q20803:49_answer4">e. Diabetes mellitus.</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:49_-submit" name="q20803:49_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Diabetes mellitus is not a risk factor for AAA formation, expansion, or rupture.</p>
<p>Risk factors have been assessed in patients at risk for the formation&nbsp;and expansion of infrarenal abdominal aortic aneurysms (AAAs). In a large VA study,&nbsp;73,451 veterans aged 50–79 were screened. The relative risk was five-fold higher in&nbsp;smokers than nonsmokers. Other significant risk factors included male gender (5.6 fold risk), age (1.7 fold risk per&nbsp;7-year increase), white race (2-fold risk), positive family history (2-fold&nbsp;risk), but the effect of diabetes was small and negative (0.5-fold risk).</p>
<p>Since that initial study in 1997, a variety of screening studies and&nbsp;prospective&nbsp;clinical follow-up studies have confirmed slower aneurysm enlargement, fewer&nbsp;repairs, and fewer ruptures in patients with diabetes.</p>
<p><strong>References</strong></p>
<p>Lederle FA. The strange relationship between diabetes and abdominal aortic&nbsp;aneurysm. Eur J Vasc Endovasc Surg. 2012 Mar;43(3):254-6. doi:&nbsp;10.1016/j.ejvs.2011.12.026. Epub 2012 Jan 9. PubMed PMID: 22237512.</p>
<p>Lederle FA, Johnson GR, Wilson SE, Chute EP, Littooy FN, Bandyk D, Krupski WC,&nbsp;Barone GW, Acher CW, Ballard DJ. Prevalence and associations of abdominal aortic aneurysm detected through screening. Aneurysm Detection and Management (ADAM)&nbsp;Veterans Affairs Cooperative Study Group. Ann Intern Med. 1997 Mar&nbsp;15;126(6):441-9. PubMed PMID: 9072929.&nbsp;</p>
<p>QID: 30053</p></div><div class="rightanswer">The correct answer is: Diabetes mellitus.</div></div></div></div></div><div id="q222" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">486</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4538"><input type="hidden" name="q20803:222_:flagged" value="0"><input type="hidden" value="qaid=911106&amp;qubaid=20803&amp;qid=4717&amp;slot=222&amp;checksum=881182e67492ff4a3cf3f9c84e287b5e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:222_:flaggedcheckbox" name="q20803:222_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q222&id=4717"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:222_:sequencecheck" value="2"><div class="qtext"><p>A 62-year-old man underwent a hemiarch repair for an acute Type A dissection. The initial dissection extended into his innominate and bilateral common carotid arteries and was not repaired in the acute setting. Postoperatively, he has 60% stenosis of bilateral common carotid arteries with thrombosed false lumens. He does not have any neurologic symptoms. Which of the following is the most appropriate management option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:222_answer" disabled="disabled" value="0" id="q20803:222_answer0"><label for="q20803:222_answer0">a. ascending aorta to bilateral carotid bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:222_answer" disabled="disabled" value="1" id="q20803:222_answer1"><label for="q20803:222_answer1">b. antiplatelet therapy</label> </div>
<div class="r0"><input type="radio" name="q20803:222_answer" disabled="disabled" value="2" id="q20803:222_answer2"><label for="q20803:222_answer2">c. bilateral subclavian-carotid bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:222_answer" disabled="disabled" value="3" id="q20803:222_answer3"><label for="q20803:222_answer3">d. replacement of left common carotid artery and innominate artery with PTFE</label> </div>
<div class="r0"><input type="radio" name="q20803:222_answer" disabled="disabled" value="4" id="q20803:222_answer4"><label for="q20803:222_answer4">e. bilateral common carotid artery stent placement</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:222_-submit" name="q20803:222_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The supraaortic trunks may be involved in acute Type A dissections. Type A dissections involving the carotid arteries have a higher rate of stroke at presentation than patients who do not have dissected carotid arteries. However, most reports&nbsp;show that after the acute event there is no difference in the rate of stroke for patients&nbsp;with the dissection&nbsp;extending into&nbsp;carotid arteries compared to those with the dissection confined to the arch.&nbsp;Therefore, medical (antiplatelet or anticoagulation) management&nbsp;is indicated for patients who are asymptomatic. The optimal medical therapy for carotid dissection is being&nbsp;investigated&nbsp;in the United Kingdom and Australia by the Cervical Artery Dissection in Stroke study (CADISS). Surgical repair of the dissected carotid arteries may be necessary for patients&nbsp;that experience&nbsp;TIAs or are otherwise symptomatic and who have failed medical therapy.</p>
<p>&nbsp;</p>
<h2>Reference:&nbsp;</h2>
<div><a href="http://www.ncbi.nlm.nih.gov/pubmed/23664277" target="_blank">Charlton-Ouw KM,&nbsp;Azizzadeh&nbsp;A,&nbsp;Sandhu HK,&nbsp;Sawal A,&nbsp;Leake SS,&nbsp;Miller CC 3rd, et al. Management of common carotid artery dissection due to extension from acute type A (DeBakey I) aortic dissection.&nbsp;J Vasc Surg&nbsp;2013; 58:910-6.</a></div>
<div>QID: 30373</div></div><div class="rightanswer">The correct answer is: antiplatelet therapy</div></div></div></div></div><div id="q324" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">487</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4547"><input type="hidden" name="q20803:324_:flagged" value="0"><input type="hidden" value="qaid=911208&amp;qubaid=20803&amp;qid=4855&amp;slot=324&amp;checksum=53fe497e53486ee511034a6600af7638&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:324_:flaggedcheckbox" name="q20803:324_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q324&id=4855"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:324_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements are TRUE regarding treadmill testing for the detection of peripheral vascular disease?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:324_answer" disabled="disabled" value="0" id="q20803:324_answer0"><label for="q20803:324_answer0">a. Patients with a 10mmHg drop at the ankle compared to the brachial pressures have a significant lesion that will benefit from revascularization</label> </div>
<div class="r1"><input type="radio" name="q20803:324_answer" disabled="disabled" value="1" id="q20803:324_answer1"><label for="q20803:324_answer1">b. Brachial pressures tend to decrease with exercise, especially in those patients with peripheral vascular disease</label> </div>
<div class="r0"><input type="radio" name="q20803:324_answer" disabled="disabled" value="2" id="q20803:324_answer2"><label for="q20803:324_answer2">c. Treadmill testing is a reliable test for the detection of infrapopliteal disease in patients with claudication</label> </div>
<div class="r1"><input type="radio" name="q20803:324_answer" disabled="disabled" value="3" id="q20803:324_answer3"><label for="q20803:324_answer3">d. Severe aortic stenosis is&nbsp;not a&nbsp;contraindication for&nbsp;treadmill testing to diagnose peripheral vascular disease</label> </div>
<div class="r0"><input type="radio" name="q20803:324_answer" disabled="disabled" value="4" id="q20803:324_answer4"><label for="q20803:324_answer4">e. Treadmill testing tends to be more positive in patients that have aortoiliac disease</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:324_-submit" name="q20803:324_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Treadmill testing is a physiologic test that can be used to distinguish true arterial claudication and pseudo claudication.&nbsp; As most patients with claudication have abnormal ankle brachial indices, this test is especially helpful if baseline ankle brachial indices are normal.&nbsp; In the standard treadmill test, resting supine ankle brachial pressures are first done.&nbsp; With the blood pressure cuffs left in place, the patient is asked to walk at a set speed (1.5- 2 miles per hour) on a treadmill at a fixed inclination (12 % grade) for 5-10 &nbsp;minutes or until forced to stop due to symptoms.&nbsp; The technologist takes note when the patient first complains of symptoms and the time until stopping is also noted.&nbsp; The patient is then asked to lie down and ankle brachial pressures are done every 1-2 minutes for 10 minutes or until baseline levels are reached.&nbsp; Brachial pressure tends to increase with exercise and this can be more pronounced in patients with peripheral vascular disease.&nbsp; Patients who have mild disease may have normal baseline pressures and then have a mild drop with exercise which returns to baseline within minutes.&nbsp; Patients with moderate disease may have abnormal baseline pressures and further decrease with exercise which does not return to baseline during the 10 minute testing period.&nbsp; Treadmill testing tends to be more positive in patients with aortoiliac disease as the aortoiliac vessels supply a large majority of the musculature of the lower extremities and the effect of a stenosis is greater.&nbsp; Exercise testing is not effective for infrapopliteal disease as the sural branches to the gastrocnemius muscle come off at or above this level.&nbsp;</p>
<p>Kohler, Sumner Vascular Laboratory: Arterial Physiologic Assessment; Rutherford Vascular Surgery 7<sup>th</sup> Edition</p>
<p>Gibbons&nbsp;RJ, Balady&nbsp;GJ, Bricker&nbsp;JT, Chaitman&nbsp;BR, Fletcher&nbsp;GF, Froelicher&nbsp;VF, et&nbsp;al.&nbsp;<strong>ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). </strong><em>J Am Coll Cardiol</em>. 2002;40((8):):1531–1540</p>
<p>QID: 30558</p></div><div class="rightanswer">The correct answer is: Treadmill testing tends to be more positive in patients that have aortoiliac disease</div></div></div></div></div><div id="q224" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">488</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4556"><input type="hidden" name="q20803:224_:flagged" value="0"><input type="hidden" value="qaid=911108&amp;qubaid=20803&amp;qid=4954&amp;slot=224&amp;checksum=8e8244d72c9a6fee0fbcbcc8bb9c043a&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:224_:flaggedcheckbox" name="q20803:224_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q224&id=4954"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:224_:sequencecheck" value="2"><div class="qtext"><p>As a result of the "Fistula First Breakthrough Initiative" (FFBI), what is the prevalence of autogenous access being used in the current hemodialysis population in the United States?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:224_answer" disabled="disabled" value="0" id="q20803:224_answer0"><label for="q20803:224_answer0">a. 60%</label> </div>
<div class="r1"><input type="radio" name="q20803:224_answer" disabled="disabled" value="1" id="q20803:224_answer1"><label for="q20803:224_answer1">b. 35%</label> </div>
<div class="r0"><input type="radio" name="q20803:224_answer" disabled="disabled" value="2" id="q20803:224_answer2"><label for="q20803:224_answer2">c. 5%</label> </div>
<div class="r1"><input type="radio" name="q20803:224_answer" disabled="disabled" value="3" id="q20803:224_answer3"><label for="q20803:224_answer3">d. 90%</label> </div>
<div class="r0"><input type="radio" name="q20803:224_answer" disabled="disabled" value="4" id="q20803:224_answer4"><label for="q20803:224_answer4">e. 10%</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:224_-submit" name="q20803:224_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The National Kidney Foundation-Dialysis Outcomes Quality Initiative (NKF-KDOQI) Clinical Practice Guidelines for Vascular Access were originally published in 1997 in an effort to increase the placement and prolong the use of autogenous arteriovenous (AV) access. The guidelines recommended that autogenous access should be constructed in at least 50% of all new AV access placements and that ultimately 40% of prevalent dialysis patients should have an autogenous AV access. As a response to these guidelines, the Centers for Medicare and Medicaid Services (CMS), the ESRD Network, and the Institute for Healthcare Improvement (IHI) formed the "Fistula First Breakthrough Initiative" (FFBI). Through the work of the FFBI, the national rate of autogenous access reached 40% prevalence by August 2005. The most recent data from April 2012 indicates that 60.6%&nbsp;of all renal patients&nbsp;obtain hemodialysis through autogenous arteriovenous access.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.kidney.org/professionals/KDOQI/guidelines.cfm" target="_blank">http://www.kidney.org/professionals/KDOQI/guidelines.cfm</a><br><br><a href="http://www.usrds.org/" target="_blank">http://www.usrds.org</a></p>
<p>QID: 30400</p></div><div class="rightanswer">The correct answer is: 60%</div></div></div></div></div><div id="q457" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">489</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4565"><input type="hidden" name="q20803:457_:flagged" value="0"><input type="hidden" value="qaid=911341&amp;qubaid=20803&amp;qid=5175&amp;slot=457&amp;checksum=6e9db4035796146d23d76aef0a045360&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:457_:flaggedcheckbox" name="q20803:457_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q457&id=5175"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:457_:sequencecheck" value="2"><div class="qtext"><p>Which secondary preventive measure has been shown to have the greatest effect reducing mortality following myocardial infarction?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:457_answer" disabled="disabled" value="0" id="q20803:457_answer0"><label for="q20803:457_answer0">a. aspirin</label> </div>
<div class="r1"><input type="radio" name="q20803:457_answer" disabled="disabled" value="1" id="q20803:457_answer1"><label for="q20803:457_answer1">b. beta blockers</label> </div>
<div class="r0"><input type="radio" name="q20803:457_answer" disabled="disabled" value="2" id="q20803:457_answer2"><label for="q20803:457_answer2">c. smoking cessation</label> </div>
<div class="r1"><input type="radio" name="q20803:457_answer" disabled="disabled" value="3" id="q20803:457_answer3"><label for="q20803:457_answer3">d. statins</label> </div>
<div class="r0"><input type="radio" name="q20803:457_answer" disabled="disabled" value="4" id="q20803:457_answer4"><label for="q20803:457_answer4">e. dipyridamole</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:457_-submit" name="q20803:457_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Mortality from coronary heart disease is reduced more through smoking cessation than by any other secondary preventative therapy, including statins or other cholesterol lowering drugs.&nbsp;Many of the pathophysiologic changes caused by smoking are reversed or improved by smoking cessation.</p>
<p>In a meta-analysis of cohort studies examining the effect of secondary preventative therapies in patients with myocardial infarction, smoking cessation had a far higher protective effect (odds ratio 0.54) than thrombolysis, aspirin and other antiplatelet agents, beta blockers, and statins (which have odds ratios of 0.75 to 0.88).</p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Erhardt%20L.%20Cigarette%20smoking:%20An%20undertreated%20risk%20factor%20for%20cardiovascular%20disease.%20Atherosclerosis;%202009;%20205%20():23-32" target="_blank">Erhardt L. Cigarette smoking: An undertreated risk factor for cardiovascular disease. Atherosclerosis; 2009; 205 ():23-32.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Intern+Med+2000%3B+160+()%3A939-44" target="_blank">Wilson K, Gibson N, Willan A, Cook D. Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. Arch Intern Med 2000; 160 (7):939-44.</a></p>
<p>QID: 30815</p></div><div class="rightanswer">The correct answer is: smoking cessation</div></div></div></div></div><div id="q212" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">490</span></h3><div class="state">Not answered</div><div class="grade">Points out of 6.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4574"><input type="hidden" name="q20803:212_:flagged" value="0"><input type="hidden" value="qaid=911096&amp;qubaid=20803&amp;qid=4704&amp;slot=212&amp;checksum=6af158830f272c9a816105197baeb9df&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:212_:flaggedcheckbox" name="q20803:212_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q212&id=4704"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:212_:sequencecheck" value="2"><div class="qtext"><p>A 59-year-old right handed woman presents with dizziness, blurred vision in both eyes, and ataxia when looking up while performing her daily living and driving activities. She denies upper extremity claudication and has no history of a transient ischemic attack or stroke. Her carotid duplex shows patent internal carotids and antegrade flow in her vertebral arteries. All of the following statements are true <strong>except</strong>:</p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:212_answer" disabled="disabled" value="0" id="q20803:212_answer0"><label for="q20803:212_answer0">a. dynamic compression of the vertebral artery has low risk of stroke</label> </div>
<div class="r1"><input type="radio" name="q20803:212_answer" disabled="disabled" value="1" id="q20803:212_answer1"><label for="q20803:212_answer1">b. distal vertebral reconstruction to the V3 segment is the best option</label> </div>
<div class="r0"><input type="radio" name="q20803:212_answer" disabled="disabled" value="2" id="q20803:212_answer2"><label for="q20803:212_answer2">c. atherosclerosis of the vertebral origin is the most common cause of repetitive postural symptoms</label> </div>
<div class="r1"><input type="radio" name="q20803:212_answer" disabled="disabled" value="3" id="q20803:212_answer3"><label for="q20803:212_answer3">d. dynamic vertebral angiography with head maneuvers would be diagnostic of vertebral compression at the skull base</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:212_-submit" name="q20803:212_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient presents with classic vertebral basilar ischemia (VBI). Possible symptoms include disequilibrium, ataxia, dizziness, vertigo, blurred vision, hemianopsia, diplopia, dysarthria, perioral numbness, and tinnitus. VBI may result from embolic or hemodynamic changes. Typically ostial lesions are atheromatous and less likely to be embolic. Complex stenotic lesions occuring in the transforaminal vertebral artery from C6-T1 are usually the culprit in embolic disease. Low flow or hemodynamic changes are initiated by orthostatic changes, alterations in cardiac output, and compression of the vertebral artery with neck maneuvers.&nbsp; Neck extension and/or rotation of the cervical spine can result in dynamic compression of the dominant&nbsp;vertebral artery resulting in transient and repetitive symptoms. Embolic lesions are likely to cause stroke while hemodynamic lesions rarely do.</p>
<p>Dynamic imaging with vertebral angiography and positional changes of the neck demonstrating compression of the vertebral artery is diagnostic. Proximal embolic lesions may be detected with noninvasive imaging such as MRA/CTA or arch and vertebral angiography. These patients also warrant extensive clinical workup to eliminate other disorders that may mimic VBI, including myxedema, hypertension, orthostatic hypotension, uncontrolled diabetes, and arrhythmias. Bypass to the uninvolved V3 segment may be curative.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9620137" target="_blank">Berguer R, Morasch MD, Kline RA. A review of 100 consecutive reconstructions of the distal veretebral artery for embolic and hemodynamic disease.&nbsp; J Vasc Surg 1998; 28:852-9. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/9620137"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/8746828" target="_blank">Koskas F, Kieffer E, Rancurel G, Bahnini A<span>,&nbsp;</span>Ruotolo C<span>,&nbsp;</span>Illuminati G.&nbsp; Direct transposition of the distal cervical vertebral artery into the internal carotid artery.&nbsp; Ann Vasc Surg 1995; 9:515-24.</a> <a href="http://www.ncbi.nlm.nih.gov/pubmed/8746828"><br></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/8268099" target="_blank">Kline R and Berguer R.&nbsp;Vertebral artery reconstruction.&nbsp; Ann Vasc Surg 1993; 7:497-9. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/8268099"><br></a></p>
<p>QID: 30362</p></div><div class="rightanswer">The correct answer is: atherosclerosis of the vertebral origin is the most common cause of repetitive postural symptoms</div></div></div></div></div><div id="q351" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">491</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4583"><input type="hidden" name="q20803:351_:flagged" value="0"><input type="hidden" value="qaid=911235&amp;qubaid=20803&amp;qid=5144&amp;slot=351&amp;checksum=5edab4d84aac001cc06257b566d8e71b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:351_:flaggedcheckbox" name="q20803:351_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q351&id=5144"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:351_:sequencecheck" value="2"><div class="qtext"><p>A patient presents with signs and symptoms of chronic mesenteric ischemia. You decide that a diagnostic arteriogram is indicated with possible endovascular therapy. Which of the statements regarding mesenteric arteriography is most <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:351_answer" disabled="disabled" value="0" id="q20803:351_answer0"><label for="q20803:351_answer0">a. absence of post-stenotic dilatation of the superior mesenteric artery excludes a significant stenosis of that artery</label> </div>
<div class="r1"><input type="radio" name="q20803:351_answer" disabled="disabled" value="1" id="q20803:351_answer1"><label for="q20803:351_answer1">b. after an anteroposterior aortogram is performed, the image intensifier is placed in 90 degree lateral position for imaging of the origin of the mesenteric arteries</label> </div>
<div class="r0"><input type="radio" name="q20803:351_answer" disabled="disabled" value="2" id="q20803:351_answer2"><label for="q20803:351_answer2">c. using femoral access, the length of the flush catheter for arteriography of the paravisceral aorta and visceral vessels is 120 cm</label> </div>
<div class="r1"><input type="radio" name="q20803:351_answer" disabled="disabled" value="3" id="q20803:351_answer3"><label for="q20803:351_answer3">d. cannulation of the celiac artery should be performed using brachial access, while cannulation of the superior mesenteric artery requires femoral access</label> </div>
<div class="r0"><input type="radio" name="q20803:351_answer" disabled="disabled" value="4" id="q20803:351_answer4"><label for="q20803:351_answer4">e. failure of the superior mesenteric artery to opacify during a celiac artery injection excludes a significant stenosis of the superior mesenteric artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:351_-submit" name="q20803:351_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Understanding the proper technique for performing any given arteriogram is crucial to the diagnosis and management of vascular disease. In this question, the arteriogram to be performed is a visceral angiogram. Typically, the length of catheter best suited for selective renal and visceral catheterization is 65-80 cm. A visceral angiogram is initiated by placing a multi-sidehole "flush" diagnostic catheter in the proximal paravisceral aorta for initial performance of an anteroposterior aortogram. The image intensifier is then placed in a full 90-degree lateral position and brought close to the patient's side. The arms are extended above the patient's head. The field is magnified and filtered, so that the catheter head is at the top of the field of view and the posterior portion of the vertebral column is excluded from the field. The superior mesenteric artery (SMA) and celiac artery arise from the anterior aspect of the aorta; thus, this lateral projection provides for the best view of the origin of these vessels for both diagnostic purposes and placement of stents, both of which are illustrated in the angiographic images below.<br><br><a href="./VESAP3_files/AssetProxy_048.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_048.jpg" alt="img" width="100" height="133" border="0" hspace="10" vspace="10"></a><a href="./VESAP3_files/AssetProxy_135.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_135.jpg" alt="img" width="156" height="132" border="0" hspace="10" vspace="10"></a><br><br>Although the presence of a post-stenotic dilatation and filling from collaterals (eg. via the gastroduodenal artery to the pancreaticoduodenal arcade to the middle colic artery and ultimately to the SMA) is indirect evidence of a significant stenosis, these findings are not absolute requirements to define a significant stenosis of the SMA. For instance, collaterals from the celiac artery to the SMA may have been interrupted by pancreatitis or prior surgery. Although access to the celiac artery or the SMA may be achieved from either a femoral or transbrachial approach, the transbrachial approach offers a more direct angle for cannulation since the angle of origin of the mesenteric arteries is more favorable for entry via this approach.<br><br></p>
<h2>References:</h2>
<p>Schneider PA. Endovascular Skills. 2nd ed. NY, NY: Marcell Dekker; 1998:151-2.<br><br>Pretus HA, Caridi J, Hawkins I, et al. Contrast angiography. In: Moore WS, Ahn SS, eds. Endovascular Surgery. Philadelphia, PA: WB Saunders; 2001:135-48.<br><br>Schneider PA. Endovascular Skills, 2nd ed. NY, NY: Marcell Dekker; 1998:99-100.</p>
<p>QID: 30618</p></div><div class="rightanswer">The correct answer is: after an anteroposterior aortogram is performed, the image intensifier is placed in 90 degree lateral position for imaging of the origin of the mesenteric arteries</div></div></div></div></div><div id="q391" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">492</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4592"><input type="hidden" name="q20803:391_:flagged" value="0"><input type="hidden" value="qaid=911275&amp;qubaid=20803&amp;qid=5042&amp;slot=391&amp;checksum=fc57d32f93e7561bd00e7105f4557a8e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:391_:flaggedcheckbox" name="q20803:391_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q391&id=5042"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:391_:sequencecheck" value="2"><div class="qtext"><p>In patients with postthrombotic chronic venous disease, the severity of venous claudication symptoms is most highly correlated with which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:391_answer" disabled="disabled" value="0" id="q20803:391_answer0"><label for="q20803:391_answer0">a. the magnitude of venous collaterals on ascending venography</label> </div>
<div class="r1"><input type="radio" name="q20803:391_answer" disabled="disabled" value="1" id="q20803:391_answer1"><label for="q20803:391_answer1">b. the presence and extent of venous obstruction</label> </div>
<div class="r0"><input type="radio" name="q20803:391_answer" disabled="disabled" value="2" id="q20803:391_answer2"><label for="q20803:391_answer2">c. the presence of great and small saphenous vein varicosities</label> </div>
<div class="r1"><input type="radio" name="q20803:391_answer" disabled="disabled" value="3" id="q20803:391_answer3"><label for="q20803:391_answer3">d. a decreased calf muscle pump ejection fraction as determined by air plethysmography</label> </div>
<div class="r0"><input type="radio" name="q20803:391_answer" disabled="disabled" value="4" id="q20803:391_answer4"><label for="q20803:391_answer4">e. the magnitude of valvular reflux, based on duplex exam with a reflux time &gt;1000 milliseconds</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:391_-submit" name="q20803:391_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Venous claudication is due to impaired outflow in the main venous system, most commonly the iliofemoral segments. Obstruction is the most important pathophysiologic finding. It is described by patients as a bursting sensation with ambulation. While both venous reflux and obstruction can occur after deep vein thrombosis (DVT), obstruction is associated with the greatest disability. While duplex demonstration of valvular reflux is the standard diagnostic test for identifying venous valve reflux, the magnitude of reflux does not correlate with symptoms or signs of chronic venous disease. Varicosities and collaterals often develop after DVT or other causes of venous obstruction, but neither is associated with more severe venous insufficiency.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Delis%20KT,%20Bountouroglou%20D,%20Mansfield%20AO.%20Venous%20claudication%20in%20iliofemoral%20thrombosis:%20Long-term%20effects%20on%20venous%20hemodynamics,%20clinical%20status,%20and%20quality%20of%20life.%20Ann%20Surg;%202004;%20239%20(1):118-126" target="_blank">Delis KT, Bountouroglou D, Mansfield AO. Venous claudication in iliofemoral thrombosis: Long-term effects on venous hemodynamics, clinical status, and quality of life. Ann Surg 2004; 239 (1):118-26.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B+46+(Suppl+S)%3AS%3A68S-83S." target="_blank">Meissner MH, Eklof B, Smith PC,&nbsp;Dalsing MC<span>,&nbsp;</span>DePalma RG<span>,&nbsp;</span>Gloviczki P<span>,&nbsp;</span>et al. Secondary chronic venous disorders. J Vasc Surg 2007; 46 (Suppl S):S:68S-83S.</a></p>
<p>QID: 30708</p></div><div class="rightanswer">The correct answer is: the presence and extent of venous obstruction</div></div></div></div></div><div id="q316" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">493</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4601"><input type="hidden" name="q20803:316_:flagged" value="0"><input type="hidden" value="qaid=911200&amp;qubaid=20803&amp;qid=5081&amp;slot=316&amp;checksum=e194ea107620f399a926c62df32c2dbe&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:316_:flaggedcheckbox" name="q20803:316_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q316&id=5081"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:316_:sequencecheck" value="2"><div class="qtext"><p>The images below were obtained from a carotid duplex examination of a 55-year-old woman with a remote history of TIA. The first image is a longitudinal gray-scale image of the internal carotid artery just beyond the bifurcation. Image 2 is a cross-sectional, color-coded image of the internal carotid artery. These images illustrate which of the following?</p>
<p><img src="./VESAP3_files/61.jpg" alt="" width="293" height="309"></p>
<p><img src="./VESAP3_files/62.jpg" alt="" width="292" height="337"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:316_answer" disabled="disabled" value="0" id="q20803:316_answer0"><label for="q20803:316_answer0">a. occlusion of the internal carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:316_answer" disabled="disabled" value="1" id="q20803:316_answer1"><label for="q20803:316_answer1">b. high-grade stenosis of the internal carotid artery</label> </div>
<div class="r0"><input type="radio" name="q20803:316_answer" disabled="disabled" value="2" id="q20803:316_answer2"><label for="q20803:316_answer2">c. fibromuscular dysplasia of the internal carotid artery</label> </div>
<div class="r1"><input type="radio" name="q20803:316_answer" disabled="disabled" value="3" id="q20803:316_answer3"><label for="q20803:316_answer3">d. an internal carotid artery dissection</label> </div>
<div class="r0"><input type="radio" name="q20803:316_answer" disabled="disabled" value="4" id="q20803:316_answer4"><label for="q20803:316_answer4">e. a normal carotid bifurcation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:316_-submit" name="q20803:316_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The images illustrate an internal carotid artery dissection. The dissection flap is visible within the lumen of the carotid in the gray-scale image (Image 1), and the carotid is depicted in cross section in image 2, with a sharp demarcation showing preservation of flow in the true lumen of the dissection (red color) and thrombosis of the false lumen (absence of color). If the false lumen remained patent, the velocity spectrum would demonstrate to and fro flow within the carotid, demonstrated by flow above and below the baseline. &nbsp;</p>
<p>If the internal carotid artery were occluded, there would be no color filling within the lumen as shown in image 2. The sharply demarcated region between flow and no flow as shown in image 2 is also inconsistent with a normal internal carotid artery. A judgment of stenosis of the carotid artery requires spectral analysis; stenosis is not normally quantified from a color image alone. Fibromuscular disease generally occurs more distally in the internal carotid artery and would demonstrate a so-called “string of beads”, best seen on a longitudinal color image.</p>
<p>QID: 30543</p></div><div class="rightanswer">The correct answer is: an internal carotid artery dissection</div></div></div></div></div><div id="q484" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">494</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4610"><input type="hidden" name="q20803:484_:flagged" value="0"><input type="hidden" value="qaid=911368&amp;qubaid=20803&amp;qid=5210&amp;slot=484&amp;checksum=9612476add03a9b70984eab61eae0bae&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:484_:flaggedcheckbox" name="q20803:484_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q484&id=5210"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:484_:sequencecheck" value="2"><div class="qtext"><p>The family history of a 41-year-old white woman with acute deep vein thrombosis is positive for venous thromboembolism in several first degree relatives. Which of the following laboratory tests is most likely to be abnormal?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:484_answer" disabled="disabled" value="0" id="q20803:484_answer0"><label for="q20803:484_answer0">a. prothrombin G20210A mutation</label> </div>
<div class="r1"><input type="radio" name="q20803:484_answer" disabled="disabled" value="1" id="q20803:484_answer1"><label for="q20803:484_answer1">b. antiphospholipid antibody</label> </div>
<div class="r0"><input type="radio" name="q20803:484_answer" disabled="disabled" value="2" id="q20803:484_answer2"><label for="q20803:484_answer2">c. JAK2 mutation</label> </div>
<div class="r1"><input type="radio" name="q20803:484_answer" disabled="disabled" value="3" id="q20803:484_answer3"><label for="q20803:484_answer3">d. prothrombin time (INR)</label> </div>
<div class="r0"><input type="radio" name="q20803:484_answer" disabled="disabled" value="4" id="q20803:484_answer4"><label for="q20803:484_answer4">e. assay for activated protein C resistance</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:484_-submit" name="q20803:484_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The positive family history suggests an inherited abnormality in coagulation function. The most common cause of inherited thrombophilia in Caucasians is the factor V Leiden mutation. Factor V Leiden results from a point mutation that causes a single amino acid substitution in factor V. This eliminates a cleavage site for activated protein C (APC), making the factor V molecule less susceptible to inactivation. Thus, the factor V Leiden mutation is also referred to as “APC resistance.”</p>
<p>Two types of tests can be used for factor V Leiden. The mutation is likely if a screening assay shows APC resistance, as the factor V Leiden mutation is the most common cause for APC resistance. The diagnosis is confirmed by genetic testing for the mutation, but genetic testing may also be used as a primary test. Also, with the reduced anticoagulant activity of APC with the factor V Leiden mutation, the activated partial thromboplastin time (aPTT) may be abnormally prolonged.</p>
<p>Hypercoagulability results from 2 effects: 1) a reduced anticoagulant effect resulting from a change in the factor V role as a cofactor in the degradation of other activated coagulation factors (Va and VIIIa); and 2) because of an increased factor Va procoagulant effect due to its slowed degradation. Prolonged presence of activated factor V Leiden results in continued thrombin generation.</p>
<p>The most common clinical manifestation of factor V Leiden is venous thromboembolism (VTE).&nbsp; The VTE risk is high for homozygotes (approximately 80-fold increased risk of deep vein thrombosis). Factor V Leiden also increases risk for cerebral, mesenteric, and portal vein thrombosis, but there is no similar increase in risk for thrombosis of arterial beds.</p>
<p>VTE risk is moderately increased for heterozygotes for the mutation (relative risk increased seven-fold). Heterozygosity for factor V Leiden, while a modest risk factor for a first DVT occurrence, does not appear to be associated with a substantially increased risk for recurrent DVT.</p>
<p>The clinical phenotypes of factor V Leiden heterozygotes are variable, and VTE risk is affected by the presence of concomitant risk factors for thrombosis. Of note, factor V Leiden is more common among patients with other thrombophilias, including deficiencies of protein C, protein S, and antithrombin; as well as the prothrombin gene mutation.</p>
<p>The JAK2 mutation is associated with myeloproliferative disorders and increased risk of mesenteric venous thrombosis.</p>
<p>A transition (guanine to adenine) at nucleotide 20210 in the 3' untranslated region of the prothrombin gene is a risk factor for thrombosis. Heterozygous carriers have 30% higher plasma prothrombin levels than normal individuals, but this genetic abnormality is less common than the factor V Leiden mutation.</p>
<p>Antiphospholipid syndromes (APS) are associated with&nbsp;autoimmune or rheumatic diseases or exposure to certain drugs or infectious agents, but a strong&nbsp;familial history is not typical.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest.+2012+Feb%3B141(2+Suppl)%3Ae419S-94S." target="_blank">Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb;141(2 Suppl):e419S-94S.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br+J+Haematol.+2010+Apr%3B149(2)%3A209-20." target="_blank">Baglin T, Gray E, Greaves M, Hunt BJ, Keeling D, Machin S, et al. Clinical guidelines for testing for heritable thrombophilia. Br J Haematol. 2010 Apr;149(2):209-20.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+2001%3B+344(16)%3A1222-31." target="_blank">Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med. 2001; 344(16):1222-31.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Intern+Med+1997%3B127(10)%3A895-903." target="_blank">Price DT, Ridker PM. Factor V Leiden mutation and the risks for thromboembolic&nbsp;disease: a clinical perspective. Ann Intern Med 1997;127(10):895-903.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Blood+1995%3B+85(6)%3A1504-8." target="_blank">Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995; 85(6):1504-8.</a></p>
<p>QID: 30849</p></div><div class="rightanswer">The correct answer is: assay for activated protein C resistance</div></div></div></div></div><div id="q245" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">495</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4619"><input type="hidden" name="q20803:245_:flagged" value="0"><input type="hidden" value="qaid=911129&amp;qubaid=20803&amp;qid=4978&amp;slot=245&amp;checksum=c9d978229aa99f029d7de3f2e7ff8b97&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:245_:flaggedcheckbox" name="q20803:245_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q245&id=4978"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:245_:sequencecheck" value="2"><div class="qtext"><p>Finish this sentence with the correct statement: The presence of pacemaker/defibrillator wires placed via subclavian vein puncture...</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:245_answer" disabled="disabled" value="0" id="q20803:245_answer0"><label for="q20803:245_answer0">a. mandates venography to ensure adequate venous outflow for ipsilateral hemoaccess</label> </div>
<div class="r1"><input type="radio" name="q20803:245_answer" disabled="disabled" value="1" id="q20803:245_answer1"><label for="q20803:245_answer1">b. should not cause a problem with ipsilateral hemoaccess as long as duplex scanning confirms patency of the subclavian vein</label> </div>
<div class="r0"><input type="radio" name="q20803:245_answer" disabled="disabled" value="2" id="q20803:245_answer2"><label for="q20803:245_answer2">c. is an absolute contraindication to ipsilateral hemoaccess placement</label> </div>
<div class="r1"><input type="radio" name="q20803:245_answer" disabled="disabled" value="3" id="q20803:245_answer3"><label for="q20803:245_answer3">d. requires that the device be removed prior to constructing ipsilateral hemodialysis access</label> </div>
<div class="r0"><input type="radio" name="q20803:245_answer" disabled="disabled" value="4" id="q20803:245_answer4"><label for="q20803:245_answer4">e. rarely causes significant venous outflow obstruction to an ipsilateral access fistula</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:245_-submit" name="q20803:245_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Pacemaker and defibrillator leads commonly result in fibrotic stenosis of the subclavian vein, and sometimes asymptomatic occlusion.&nbsp; While duplex imaging may demonstrate suggestive findings, it is not definitive, as the level of obstruction may be difficult to visualize within the thoracic cavity. Extracting pacemaker leads is no minor undertaking, as presumably the patient needs the device. Optimally the access should be placed contralateral to the location of the cardiac device. However, if that is not a good option, venography should be performed prior to or during the access construction so that any significant venous outflow lesion can be treated with angioplasty and adjunctive stenting to prevent venous hypertension, congestion, and inadequate dialysis. Caution should be observed when stenting in proximity to pacemaker or defibrillator leads since stent contact can be damaging to the leads.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17398386" target="_blank">Bakken AM, Protack CD, Saad WE, Lee DE, Waldman DL, Davies MG.&nbsp; Long-term outcomes of primary angioplasty and primary stenting of central venous stenosis in hemodialysis patients. J Vasc Surg&nbsp;2007;45:776-83.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2003%3B+17%3A526." target="_blank">Teruya TH, Abou-Zamzam AM Jr, Limm W, Wong L, Wong L. &nbsp;Symptomatic subclavian vein stenosis and occlusion in hemodialysis patients with transvenous pacemakers.&nbsp; Ann Vasc Surg&nbsp;2003; 17:526.</a></p>
<p>QID: 30428</p></div><div class="rightanswer">The correct answer is: mandates venography to ensure adequate venous outflow for ipsilateral hemoaccess</div></div></div></div></div><div id="q305" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">496</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4628"><input type="hidden" name="q20803:305_:flagged" value="0"><input type="hidden" value="qaid=911189&amp;qubaid=20803&amp;qid=5063&amp;slot=305&amp;checksum=84d79ecc0e8e1de81b67963038de8725&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:305_:flaggedcheckbox" name="q20803:305_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q305&id=5063"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:305_:sequencecheck" value="2"><div class="qtext"><p>A 67-year-old woman undergoes renal artery ultrasonography for evaluation of&nbsp;refractory hypertension and a mildly elevated creatinine. The study reveals&nbsp;an aortic peak systolic velocity of 72 cm/sec at the level of the renal arteries. The Duplex images shown below are from the proximal right renal artery (A) and the right renal artery in the parenchyma (B).&nbsp;These findings indicate which of the following?</p>
<p><a href="./VESAP3_files/12243.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/12243.jpg" alt="Img" width="66" height="100"></a><br>Abbreviations in this image are: RA = renal artery, PS = peak systolic velocity, ED = end diastolic velocity, RI = resistive index, Int.A. = intraparenchymal artery.&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:305_answer" disabled="disabled" value="0" id="q20803:305_answer0"><label for="q20803:305_answer0">a. high-grade renal artery stenosis by all measures</label> </div>
<div class="r1"><input type="radio" name="q20803:305_answer" disabled="disabled" value="1" id="q20803:305_answer1"><label for="q20803:305_answer1">b. no significant main renal artery stenosis but abnormal renal parenchyma</label> </div>
<div class="r0"><input type="radio" name="q20803:305_answer" disabled="disabled" value="2" id="q20803:305_answer2"><label for="q20803:305_answer2">c. indeterminate study relative to renal artery velocity due to high resistance</label> </div>
<div class="r1"><input type="radio" name="q20803:305_answer" disabled="disabled" value="3" id="q20803:305_answer3"><label for="q20803:305_answer3">d. renal artery stenosis by velocity but not by renal-aortic ratio</label> </div>
<div class="r0"><input type="radio" name="q20803:305_answer" disabled="disabled" value="4" id="q20803:305_answer4"><label for="q20803:305_answer4">e. abnormally low resistance suggesting possible renal AV malformation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:305_-submit" name="q20803:305_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This image reveals a maximum peak systolic velocity (PSV) of 122 cm/sec in the main right renal artery (RA). The calculated&nbsp;renal-aortic ratio (RAR) is 1.7 (RAR= highest RA PSV/aorta PSV). The most widely used criteria for establishing a significant stenosis (&gt;60%) in the main renal artery is the presence of RA PSV 180-200 cm/sec or a RAR of &gt; or = to 3.5.&nbsp;Thus, this patient does not have a significant renal artery stenosis based on the defined criterion.</p>
<p>The resistive index in the parenchyma (image B) is shown to be 0.81. Renal duplex scanning can provide an indication of renal parenchymal disease. The normal kidney has low parenchymal resistance and continuous flow to the end-organ even during diastole, as reflected in the end-diastolic velocity (EDV).&nbsp;As parenchymal resistance increases, EDV decreases. The most widely accepted measure of renal resistance is calculation of the parenchymal resistive index. Resistive index (RI) is calculated as follows: (PSV-EDV)/PSV. A normal RI, indicating healthy renal parenchyma, is a value &lt;0.8. This patient's renal duplex scan suggests increased parenchymal resistance with a calculated RI of 0.81 (for this index, higher numbers indicate greater resistance). Consequently, this patient demonstrates no significant main renal artery stenosis but an abnormal renal parenchymal resistance. Therefore, this patient's hypertension is likely due to underlying kidney disease rather than renal artery stenosis.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Taylor%20DC,%20Kettler%20MD,%20Moneta%20GL,%20et%20al.%20Duplex%20ultrasound%20and%20the%20diagnosis%20of%20renal%20artery%20stenosis:%20A%20prospective%20evaluation.%20J%20Vasc%20Surg;%201998;%207%20(2):363-369" target="_blank">Taylor DC, Kettler MD, Moneta GL, Kohler TR<span>,&nbsp;</span>Kazmers A<span>,&nbsp;</span>Beach KW<span>,&nbsp;</span>et al. Duplex ultrasound and the diagnosis of renal artery stenosis: A prospective evaluation. J Vasc Surg 1998; 7 (2):363-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med+2001%3B+344+(6)%3A410-7." target="_blank">Radermacher, J, Chavan A, Bleck, J, Vitzthum A,&nbsp;Stoess B,&nbsp;Gebel MJ,&nbsp;et al. Use of Doppler ultrasonography to predict the outcome of therapy for renal-artery stenosis. N Engl J Med 2001; 344 (6):410-7.</a></p>
<p>QID: 30525</p></div><div class="rightanswer">The correct answer is: no significant main renal artery stenosis but abnormal renal parenchyma</div></div></div></div></div><div id="q80" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">497</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4637"><input type="hidden" name="q20803:80_:flagged" value="0"><input type="hidden" value="qaid=910964&amp;qubaid=20803&amp;qid=4894&amp;slot=80&amp;checksum=044ed6ad711285620b89878bd9649b56&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:80_:flaggedcheckbox" name="q20803:80_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q80&id=4894"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:80_:sequencecheck" value="2"><div class="qtext"><p>A 72-year-old man with a history of atrial fibrillation is taken off of his anticoagulation in preparation for elective colonoscopy.&nbsp; On the day of his colonoscopy he describes 10 hours of right leg pain, pallor, coldness, and numbness.&nbsp; He has a palpable right femoral pulse and absent distal pulses. He undergoes urgent right femoral artery embolectomy with return of distal pulses. Postoperatively, he continues to complain of foot pain as well as numbness, primarily affecting the web space between his first and second toe.&nbsp;Which of the following structures is likely responsible for his persistent symptoms?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:80_answer" disabled="disabled" value="0" id="q20803:80_answer0"><label for="q20803:80_answer0">a. tibial nerve</label> </div>
<div class="r1"><input type="radio" name="q20803:80_answer" disabled="disabled" value="1" id="q20803:80_answer1"><label for="q20803:80_answer1">b. sciatic nerve</label> </div>
<div class="r0"><input type="radio" name="q20803:80_answer" disabled="disabled" value="2" id="q20803:80_answer2"><label for="q20803:80_answer2">c. sural nerve</label> </div>
<div class="r1"><input type="radio" name="q20803:80_answer" disabled="disabled" value="3" id="q20803:80_answer3"><label for="q20803:80_answer3">d. femoral nerve</label> </div>
<div class="r0"><input type="radio" name="q20803:80_answer" disabled="disabled" value="4" id="q20803:80_answer4"><label for="q20803:80_answer4">e. deep peroneal nerve</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:80_-submit" name="q20803:80_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has symptoms consistent with compartment syndrome secondary to reperfusion. The 4 compartments of the leg are the anterior, lateral, deep posterior, and superficial posterior compartments. Lower extremity compartment syndrome after revascularization of an acutely ischemic limb most frequently occurs in the anterior compartment, with the earliest symptoms resulting from compression of the deep peroneal nerve which lies within. Symptoms include numbness in the dorsal web space between the first and second toes, as well as “foot drop” from weakness in dorsiflexion.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Brit+Med+J+2002%3B+325(7364)%3A557-8." target="_blank">Pearse MF, Harry L, Nanchahal J. Acute compartment syndrome of the leg: fasciotomies must be performed early, but good surgical technique is important. Brit Med J 2002; 325(7364):557-8.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19527510" target="_blank">Kashuk JL, Moore EE,&nbsp;Pinski S,&nbsp;Johnson JL,&nbsp;Moore JB,&nbsp;Morgan S,&nbsp;et al. Lower extremity compartment syndrome in the acute care surgery paradigm: safety lessons learned. Patient Saf Surg 2009, 3:11.&nbsp;</a></p>
<p>Frank H. Netter. Atlas of Human Anatomy, 5th Edition. May 17, 2010.</p>
<p>QID: 30124</p></div><div class="rightanswer">The correct answer is: deep peroneal nerve</div></div></div></div></div><div id="q344" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">498</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4646"><input type="hidden" name="q20803:344_:flagged" value="0"><input type="hidden" value="qaid=911228&amp;qubaid=20803&amp;qid=5136&amp;slot=344&amp;checksum=837c3728f06b2467fdab39d69de6a290&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:344_:flaggedcheckbox" name="q20803:344_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q344&id=5136"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:344_:sequencecheck" value="2"><div class="qtext"><p>A 45-year-old woman is found to have a blood pressure of 160/94 mmHg on 2 anti-hypertensive medications. Her evaluation eventually leads to an arteriogram (image shown below). The etiology of the abnormalities in her renal artery is most likely which of the following?<br><br><a href="./VESAP3_files/AssetProxy_095.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_095.jpg" alt="img" width="100" height="92" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:344_answer" disabled="disabled" value="0" id="q20803:344_answer0"><label for="q20803:344_answer0">a. medial fibroplasia</label> </div>
<div class="r1"><input type="radio" name="q20803:344_answer" disabled="disabled" value="1" id="q20803:344_answer1"><label for="q20803:344_answer1">b. adventitial hyperplasia</label> </div>
<div class="r0"><input type="radio" name="q20803:344_answer" disabled="disabled" value="2" id="q20803:344_answer2"><label for="q20803:344_answer2">c. peri-medial fibroplasia</label> </div>
<div class="r1"><input type="radio" name="q20803:344_answer" disabled="disabled" value="3" id="q20803:344_answer3"><label for="q20803:344_answer3">d. medial hyperplasia</label> </div>
<div class="r0"><input type="radio" name="q20803:344_answer" disabled="disabled" value="4" id="q20803:344_answer4"><label for="q20803:344_answer4">e. intimal hyperplasia</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:344_-submit" name="q20803:344_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Medial fibroplasia is the most common form of fibromuscular dysplasia. The arteriogram demonstrates the typical string of beads appearance characteristic of medial fibroplasia, as well as an associated renal artery aneurysm. In medial fibroplasia, there are alternating areas of medial thinning and irregular thickened fibromuscular ridges containing collagen. Peri-medial fibroplasia is less common, involves the outer half of the media, and tends to have a smaller bead pattern angiographically. In contrast, intimal hyperplasia has concentric thickening and with an arteriographic appearance of a smooth narrowing. Medial hyperplasia also has a consistent hyperplastic pattern resulting in a smooth angiographic appearance. Adventitial hyperplasia is exceedingly rare and involves concentric thickening of the adventitial layer.<br><br></p>
<h2>References:</h2>
<p style="text-align: left;"><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Begelman%20SM,%20Olin%20JW.%20Fibromuscular%20dysplasia.%20Curr%20Opin%20Rheumatol;%202000;%2012%20(1):41-47" target="_blank">Begelman SM, Olin JW. Fibromuscular dysplasia. Curr Opin Rheumatol 2000; 12(1):41-7.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Slovut%20DP,%20Olin%20JW.%20Fibromuscular%20dysplasia.%20N%20Engl%20J%20Med;%202004;%20350%20(18):1862-1871" target="_blank">Slovut DP, Olin JW. Fibromuscular dysplasia. N Engl J Med 2004; 350(18):1862-71.</a></p>
<p style="text-align: left;">QID: 30610</p></div><div class="rightanswer">The correct answer is: medial fibroplasia</div></div></div></div></div><div id="q250" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">499</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4655"><input type="hidden" name="q20803:250_:flagged" value="0"><input type="hidden" value="qaid=911134&amp;qubaid=20803&amp;qid=4979&amp;slot=250&amp;checksum=23f04abc2d9ba7e88723f0a55e99dbbc&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:250_:flaggedcheckbox" name="q20803:250_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q250&id=4979"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:250_:sequencecheck" value="2"><div class="qtext"><p>A 35-year-old bodybuilder with glomerulonephritis is referred for new AV access construction. He has never been on hemodialysis before, he is right handed, and he's had no prior operations or procedures. On physical examination, he has bounding radial and ulnar pulses bilaterally with normal Allens' tests bilaterally. He has a clearly visible cephalic vein in both the forearm and upper arm bilaterally measuring approximately 4 mm at the wrist.&nbsp; Which of the following is the appropriate next step in the management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:250_answer" disabled="disabled" value="0" id="q20803:250_answer0"><label for="q20803:250_answer0">a. <p>create left brescia-cimino fistula (radio-cephalic)</p></label> </div>
<div class="r1"><input type="radio" name="q20803:250_answer" disabled="disabled" value="1" id="q20803:250_answer1"><label for="q20803:250_answer1">b. vein map both upper extremities</label> </div>
<div class="r0"><input type="radio" name="q20803:250_answer" disabled="disabled" value="2" id="q20803:250_answer2"><label for="q20803:250_answer2">c. <p>create&nbsp;right brescia-cimino fistula (radio-cephalic)</p></label> </div>
<div class="r1"><input type="radio" name="q20803:250_answer" disabled="disabled" value="3" id="q20803:250_answer3"><label for="q20803:250_answer3">d. vein map and arterial duplex of both upper extremities</label> </div>
<div class="r0"><input type="radio" name="q20803:250_answer" disabled="disabled" value="4" id="q20803:250_answer4"><label for="q20803:250_answer4">e. create left brachiocephalic fistula</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:250_-submit" name="q20803:250_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>There is no need for additional imaging studies on this bodybuilder. He has no underlying arterial abnormalities and he has clearly visible large veins. In a prospective, randomized study, physical exam alone (before access construction) was found to be sufficient in patients with adequately visualized vessels on physical exam. There is no support of routine use of duplex scanning for these patients. Duplex scanning offered no advantage in terms of early fistula outcome for forearm fistulas. Early success was 70% in this study. The same group did use preoperative ultrasound for those without visible vessels; they found an early success rate of 93% for upper arm fistulas with imaging.&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=World+J+Surg+2006%3B+30%3A1100-7." target="_blank">Nursal TZ, Oguzkurt L, Tercan F, Torer N, Noyan T, Karakayali H, et al. Is routine preoperative ultrasonagraphic mapping for arteriovenous fistula creation necessary in patients with favorable physical examination findings? Results of a randomized controlled trial. World J Surg 2006; 30:1100-7.</a></p>
<p><span>QID: 30434</span></p></div><div class="rightanswer">The correct answer is: <p>create left brescia-cimino fistula (radio-cephalic)</p></div></div></div></div></div><div id="q543" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">500</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4664"><input type="hidden" name="q20803:543_:flagged" value="0"><input type="hidden" value="qaid=911427&amp;qubaid=20803&amp;qid=5301&amp;slot=543&amp;checksum=f0437fa6a2be94c24dab51c0bfbc26d9&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:543_:flaggedcheckbox" name="q20803:543_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q543&id=5301"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:543_:sequencecheck" value="2"><div class="qtext"><p>&nbsp;Which of the following is the best option to decrease patient radiation skin dose?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:543_answer" disabled="disabled" value="0" id="q20803:543_answer0"><label for="q20803:543_answer0">a. maximize both the image&nbsp;detector&nbsp;to source distance and the patient to source distance</label> </div>
<div class="r1"><input type="radio" name="q20803:543_answer" disabled="disabled" value="1" id="q20803:543_answer1"><label for="q20803:543_answer1">b. maximize the image&nbsp;detector&nbsp;to source distance and minimize the patient to source distance</label> </div>
<div class="r0"><input type="radio" name="q20803:543_answer" disabled="disabled" value="2" id="q20803:543_answer2"><label for="q20803:543_answer2">c. minimize both the image&nbsp;detector&nbsp;to source distance and the patient to source distance&nbsp;</label> </div>
<div class="r1"><input type="radio" name="q20803:543_answer" disabled="disabled" value="3" id="q20803:543_answer3"><label for="q20803:543_answer3">d. minimize the image detector to source distance and maximize the source to patient distance&nbsp;</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:543_-submit" name="q20803:543_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Good operating practice to lower patient radiation dose during a fluoroscopic guided intervention includes maximizing&nbsp; the source to patient distance (keeping the fluoroscopic table as high as possible) and minimizing the source to image receptor distance (keeping the image receptor as close to the patient as possible). &nbsp;Modern fluoroscopy equipment operates in the automatic brightness control mode (ABC), whereby the peak kilovolts (kVp) and the miliamperes (mA) are adjusted by the machine to maintain a constant image brightness at the detector.&nbsp; When brightness is inadequate, the ABC automatically increases the mA or kVP, or both, to increase the x-ray penetration through the patient to provide appropriate image brightness, the net result is an increase in dose. &nbsp;When the source to target distance is increased by raising the table, the air kerma (kinetic energy released in the medium) at the patient drops below the air kerma at the reference point because radiation dose decreases with increasing distance from the x-ray source. Therefore, raising the table decreases skin dose at the patient.&nbsp; However, raising the table often concomitantly raises the image detector.&nbsp; Raising the image detector increases the air kerma at the reference point because increased machine output is needed to maintain a constant image brightness at the detector. Because air kerma at the patient decreases at a faster rate than air karma, the reference point increases, concurrently raising the table and detector results in a lower patient skin dose.&nbsp; Minimizing the patient to detector distance after the table is raised to the highest possible location is important to reduce exposure. &nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53(1)%3A+9S-14S." target="_blank">Killewich LA, Falls G, Mastracci TM, Brown KR. Factors Affecting Radiation Injury.&nbsp;J Vasc Surg 2011; 53(1): 9S-14S.</a></p>
<p>NCRP. Radiation Dose Management for Fluoroscopically Guided Interventional Medical Procedures, Report No. 168 (National Council on Radiation Protection and Measurements, Bethesda, Md, 2010). Report No. 168. Appendix D.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20959547" target="_blank">Miller DL, Balter S, Schueler BA, Wagner LK, Strauss KJ, Vano E. Clinical Radiation Management for Fluoroscopically Guided Interventional Procedures.&nbsp;Radiology&nbsp;2010: 257(2):321-2.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53(1)%3A+15S-21S." target="_blank">Brown KR, Rzucidlo E. Acute and Chronic Radiation Injury.&nbsp;J Vasc Surg&nbsp;2011; 53(1):15S-21S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2011%3B+53(1)%3A22S-27S." target="_blank">Mitchell EL, Furey P. Prevention of Radiation Injury from Medical Imaging.&nbsp;J Vasc Surg&nbsp;2011; 53(1):22S-27S.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B58(3)%3A715-21." target="_blank">Kirkwood ML, Arbique GM, Guild JB, Timaran C, Chung J, Anderson JA, et al. &nbsp;Surgeon Education Decreases Radiation Dose in Complex Endovascular Procedures and Improves Patient Safety.&nbsp;J Vasc Surg&nbsp;2013;58(3):715-21.</a></p>
<p>QID: 30949</p></div><div class="rightanswer">The correct answer is: minimize the image detector to source distance and maximize the source to patient distance&nbsp;</div></div></div></div></div><div id="q496" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">501</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4673"><input type="hidden" name="q20803:496_:flagged" value="0"><input type="hidden" value="qaid=911380&amp;qubaid=20803&amp;qid=5219&amp;slot=496&amp;checksum=bfade14dbf532a592780f014707430b7&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:496_:flaggedcheckbox" name="q20803:496_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q496&id=5219"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:496_:sequencecheck" value="2"><div class="qtext"><p>Protamine sulfate is commonly used in the care of vascular surgery patients.&nbsp; Which of the following statements regarding this medication is most <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:496_answer" disabled="disabled" value="0" id="q20803:496_answer0"><label for="q20803:496_answer0">a. protamine effectively reverses the anti-Xa activity of low molecular weight heparins, but incompletely neutralizes the anti-thrombin</label> </div>
<div class="r1"><input type="radio" name="q20803:496_answer" disabled="disabled" value="1" id="q20803:496_answer1"><label for="q20803:496_answer1">b. protamine is a heterogeneous mixture of polysaccharides derived from porcine intestinal mucosa</label> </div>
<div class="r0"><input type="radio" name="q20803:496_answer" disabled="disabled" value="2" id="q20803:496_answer2"><label for="q20803:496_answer2">c. protamine reverses the anticoagulant effect of dabigatran</label> </div>
<div class="r1"><input type="radio" name="q20803:496_answer" disabled="disabled" value="3" id="q20803:496_answer3"><label for="q20803:496_answer3">d. at high doses, protamine exhibits a paradoxical anticoagulant effect related to down-regulation of thrombin production</label> </div>
<div class="r0"><input type="radio" name="q20803:496_answer" disabled="disabled" value="4" id="q20803:496_answer4"><label for="q20803:496_answer4">e. hypotension associated with protamine administration can be severe, but is mitigated by rapid administration of the drug with a fluid bolus</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:496_-submit" name="q20803:496_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Protamine sulfate is an effective reversal agent for unfractionated heparin, commonly used in vascular surgery. It reverses the anticoagulant effects of heparin by ionic binding to heparin molecules. The heparin-protamine complex is then cleared by a complex mechanism that is not fully elucidated. In higher doses, protamine exerts a dose-dependent anticoagulant effect, likely related to down-regulation of thrombin production.&nbsp; This effect is not clinically significant at physiologic levels.</p>
<p>Severe adverse reactions associated with protamine administration include profound hypotension and anaphylaxis. The risks of adverse effects is reduced by slow infusion of the drug. Risk factors for adverse reactions include previous exposure to protamine, protamine-containing drugs such as NPH insulin, or a fish allergies, among others.</p>
<p>Although protamine is highly effective at reversing the anticoagulant effect of unfractionated heparin, it incompletely and ineffectively reverses the anti-Xa inhibition of low molecular weight heparins, making it much less useful in this regard. Protamine does not reverse the effects direct thrombin inhibitors, such as dabigatran.</p>
<p>Originally, protamine was derived from salmon sperm, but it is now manufactured using recombinant technology.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Blood+2009%3B+114(8)%3A1658-65." target="_blank">Ni Ainie F, Preston RJ, Jenkins PV, Nel HJ, Johnson JA, Smith OP, et al. Protamine sulfate down-regulates thrombin generation by inhibiting factor V activation. Blood 2009; 114(8):1658-65.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Transfus+Med+Rev.+2007+Jan%3B21(1)%3A37-48." target="_blank">Schulman S, Bijsterveld NR. Anticoagulants and their reversal. Transfus Med&nbsp;Rev. 2007 Jan;21(1):37-48.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Interact+Cardiovasc+Thorac+Surg+2003%3B+2(4)%3A424-6." target="_blank">McLaughlin KE, Dunning J. In patients post cardiac surgery do high doses of&nbsp;protamine cause increased bleeding? Interact Cardiovasc Thorac Surg 2003; 2(4):424-6</a>.&nbsp;</p>
<p>QID: 30863</p></div><div class="rightanswer">The correct answer is: at high doses, protamine exhibits a paradoxical anticoagulant effect related to down-regulation of thrombin production</div></div></div></div></div><div id="q549" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">502</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4682"><input type="hidden" name="q20803:549_:flagged" value="0"><input type="hidden" value="qaid=911433&amp;qubaid=20803&amp;qid=5286&amp;slot=549&amp;checksum=9b5b59fe074f59a39c2fb695e07426ff&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:549_:flaggedcheckbox" name="q20803:549_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q549&id=5286"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:549_:sequencecheck" value="2"><div class="qtext"><p>What is the minimum radiation dose at which a specific deterministic effect occurs called?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:549_answer" disabled="disabled" value="0" id="q20803:549_answer0"><label for="q20803:549_answer0">a. biologic dose</label> </div>
<div class="r1"><input type="radio" name="q20803:549_answer" disabled="disabled" value="1" id="q20803:549_answer1"><label for="q20803:549_answer1">b. dose area product</label> </div>
<div class="r0"><input type="radio" name="q20803:549_answer" disabled="disabled" value="2" id="q20803:549_answer2"><label for="q20803:549_answer2">c. cumulative dose</label> </div>
<div class="r1"><input type="radio" name="q20803:549_answer" disabled="disabled" value="3" id="q20803:549_answer3"><label for="q20803:549_answer3">d. threshold dose</label> </div>
<div class="r0"><input type="radio" name="q20803:549_answer" disabled="disabled" value="4" id="q20803:549_answer4"><label for="q20803:549_answer4">e. peak skin dose</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:549_-submit" name="q20803:549_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=VS+Radiation+Supplement+January+2011%3B+Radiation+Doses+in+Interventional+Radiology+JVIR+2003%3B14%3A711-27.">Miller DL,&nbsp;Balter S,&nbsp;Cole PE,&nbsp;Lu HT,&nbsp;Schueler BA,&nbsp;Geisinger M, et al.&nbsp;Radiation doses in interventional radiology procedures: the RAD-IR study: part I: overall measures of dose.<span>J Vasc Interv Radiol.</span><span>&nbsp;2003; 14(6):711-27.</span></a></p>
<p><span>QID: 30957</span></p></div><div class="rightanswer">The correct answer is: threshold dose</div></div></div></div></div><div id="q135" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">503</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4691"><input type="hidden" name="q20803:135_:flagged" value="0"><input type="hidden" value="qaid=911019&amp;qubaid=20803&amp;qid=4752&amp;slot=135&amp;checksum=4d5c7fd3c9ee2507e68d605e53355376&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:135_:flaggedcheckbox" name="q20803:135_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q135&id=4752"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:135_:sequencecheck" value="2"><div class="qtext"><p>A 34-year-old&nbsp;woman presents with a 6-month history of exercise induced right arm pain and weakness. She has minimal left hand and arm weakness, which is related to a right hemispheric stroke that occurred 2 years previously. She has smoked 1 pack of cigarettes daily for 12 years. On exam, her carotid arteries are tender bilaterally with diminished pulses. Radial pulses are absent bilaterally.&nbsp;CT angiogram&nbsp;shows stenotic and tapered subclavian arteries. Also, both common carotid arteries are&nbsp;occluded.&nbsp;Patency of the internal carotid arteries&nbsp;is maintained bilaterally by retrograde flow through the external carotid arteries. Erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels are elevated. Which of the following statements regarding treatment&nbsp;for this&nbsp;situation is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:135_answer" disabled="disabled" value="0" id="q20803:135_answer0"><label for="q20803:135_answer0">a. the long-term outcome of surgical management of the disease is not influenced by the presence of&nbsp;ongoing symptoms of systemic inflammation</label> </div>
<div class="r1"><input type="radio" name="q20803:135_answer" disabled="disabled" value="1" id="q20803:135_answer1"><label for="q20803:135_answer1">b. the most likely&nbsp;etiology for this patient's symptoms is early atherosclerotic disease</label> </div>
<div class="r0"><input type="radio" name="q20803:135_answer" disabled="disabled" value="2" id="q20803:135_answer2"><label for="q20803:135_answer2">c. immediate anatomic revascularization will provide the most favorable long-term outcomes and symptom relief</label> </div>
<div class="r1"><input type="radio" name="q20803:135_answer" disabled="disabled" value="3" id="q20803:135_answer3"><label for="q20803:135_answer3">d. studies have shown that endovascular intervention for this disease provides equivalent outcomes to direct surgical revascularization</label> </div>
<div class="r0"><input type="radio" name="q20803:135_answer" disabled="disabled" value="4" id="q20803:135_answer4"><label for="q20803:135_answer4">e. direct, anatomic revascularization of the brachiocephalic vessels should be considered, but only after serologic evidence of arterial inflammation is resolved</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:135_-submit" name="q20803:135_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Takayasu Arteritis is a large vessel immune vasculitis which may affect the aorta and its branches, the pulmonary artery, the coronary arteries, and the heart valves; the subclavian and carotid arteries are most commonly affected. Pathologically, it is characterized as a granulomatous panarteritis with a skip pattern. It has an unclear etiology, but is both positively and negatively associated with certain HLA haplotypes. It is rare, with the highest incidence occurring in those from East Asia, and more commonly affects women of childbearing age. Inflammation can lead to arterial stenosis and occlusion, most commonly valvular disease or aneurysm formation. Symptoms may be classic and directly related to organ and territory ischemia, as in angina, stroke, renovisceral insufficiency, or claudication. They may also reflect a more systemic effect of inflammation, such as with constitutional symptoms, fever, headaches, myalgia, and lightheadedness, or directly related to arterial inflammation such as here with carotodynia. Hypertension may be related to renal artery stenosis, arterial compliance changes, baroreceptor dysfunction, or aortic narrowing.&nbsp; Although no one laboratory finding is specific, ESR and CRP may be elevated in active inflammation. Suggestive findings on imaging can include thickened arterial walls on duplex, and MRA, CTA, standard arteriographic evidence of stenosis, occlusion, or aneurysm. A newer modality of imaging is <sup>18</sup>F-FDG-CT-PET with active increased uptake in arterial walls, suggesting active inflammation, and has been suggested as a potential monitor of disease. Therapy is initially medical with immunosuppressive agents and includes both steroidal and non-steroidal modalities. Revascularization may be needed urgently for standard critical indications, however, depending upon the series, between 15-70% of patients ultimately require arterial intervention. In general, the durability after reconstruction is related to steroid dependence and clinical activity of disease, with those able to undergo operation with complete clinical and laboratory disease quiescence requiring no steroids having best long term results. Reported restenosis rates of 20-40% with anastomotic aneurysm formation in 10-20% are not uncommon. Endovascular intervention, as opposed to open revascularization, remains controversial. Good results in focal stenoses without active disease are reported.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nat+Rev+Rheumatol.++2010%3B+6%3A+406-15" target="_blank">Mason, JT. Takayasu Arteritis-advances in diagnosis and management. Nat Rev Rheumatol.&nbsp; 2010; 6: 406-15.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23986869" target="_blank">Perera JH, Mason JT, Wolfe JH. Takayasu Arteritis: Criteria for Surgical Intervention Should Not Be Ignored. Int J Vasc Med 2013.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/22119246" target="_blank">Kim YW, Kim DI, Park YJ, Yang SS<span>,&nbsp;</span>Lee GY<span>,&nbsp;</span>Kim DK,&nbsp;et al. Surgical Bypass vs Endovascular Treatment for Patients with Supra-aortic Arterial Occlusive Disease Due to Takayasu Arteritis. J Vasc Surg 2012; 55:692-700.</a></p>
<p>QID: 30228</p></div><div class="rightanswer">The correct answer is: direct, anatomic revascularization of the brachiocephalic vessels should be considered, but only after serologic evidence of arterial inflammation is resolved</div></div></div></div></div><div id="q274" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">504</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4700"><input type="hidden" name="q20803:274_:flagged" value="0"><input type="hidden" value="qaid=911158&amp;qubaid=20803&amp;qid=5011&amp;slot=274&amp;checksum=5a7fe5ee19692a5d30e5f416baea45f3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:274_:flaggedcheckbox" name="q20803:274_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q274&id=5011"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:274_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statement regarding tunneled catheters for hemodialysis access is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:274_answer" disabled="disabled" value="0" id="q20803:274_answer0"><label for="q20803:274_answer0">a. the Fistula First Breakthrough Initiative has resulted in a significant reduction in the use of tunneled hemodialysis catheters</label> </div>
<div class="r1"><input type="radio" name="q20803:274_answer" disabled="disabled" value="1" id="q20803:274_answer1"><label for="q20803:274_answer1">b. subclavian vein access for tunneled hemodialysis catheters is preferred due to its low complication rate</label> </div>
<div class="r0"><input type="radio" name="q20803:274_answer" disabled="disabled" value="2" id="q20803:274_answer2"><label for="q20803:274_answer2">c. catheters should always be placed with ultrasound guidance to minimize inadvertent arterial cannulation</label> </div>
<div class="r1"><input type="radio" name="q20803:274_answer" disabled="disabled" value="3" id="q20803:274_answer3"><label for="q20803:274_answer3">d. tunneled dialysis catheters should be encouraged for long term dialysis access because of the ease of their placement</label> </div>
<div class="r0"><input type="radio" name="q20803:274_answer" disabled="disabled" value="4" id="q20803:274_answer4"><label for="q20803:274_answer4">e. catheter tip should be placed within the subclavian vein and confirmed by fluoroscopy for optimal flow</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:274_-submit" name="q20803:274_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Long-term use of dialysis catheters should be avoided because of complications such as infection, thrombosis, and central venous stenosis. Although the Fistula First Initiative has resulted in a significant increase in the number of arteriovenous fistulas, prolonged maturation rates for fistulas have resulted in the unintended consequence of failure to decrease catheter use. Internal jugular vein access for catheter placement is recommended. Use of the subclavian vein should be avoided because of the possibility of central venous stenosis, which can preclude the possibility of future upper extremity permanent access. Catheters should always be placed with ultrasound guidance to minimize insertion complications. Catheter tip placement should be in the right atrium for maximal flow rates and placement should be confirmed with fluoroscopy.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p>National Kidney Foundation KDOQI 2006 Vascular Access Guidelines.&nbsp; Am J Kidney Disease 2006;48(suppl 1):S177-322.</p>
<p><a href="http://www.fistulafirst.org/" target="_blank">Arteriovenous Fistula First Breakthrough Initiative.&nbsp;http://www.fistulafirst.org. Accessed: June 2, 2014.</a></p>
<p>QID: 30459</p></div><div class="rightanswer">The correct answer is: catheters should always be placed with ultrasound guidance to minimize inadvertent arterial cannulation</div></div></div></div></div><div id="q408" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">505</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4709"><input type="hidden" name="q20803:408_:flagged" value="0"><input type="hidden" value="qaid=911292&amp;qubaid=20803&amp;qid=4951&amp;slot=408&amp;checksum=485910ab960582dbda0027141c546333&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:408_:flaggedcheckbox" name="q20803:408_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q408&id=4951"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:408_:sequencecheck" value="2"><div class="qtext"><p>Neovascularization at the saphenofemoral junction following ligation and stripping of the great saphenous vein is a complex process. Which finding below best describes neovascularization?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:408_answer" disabled="disabled" value="0" id="q20803:408_answer0"><label for="q20803:408_answer0">a. multiple large channels</label> </div>
<div class="r1"><input type="radio" name="q20803:408_answer" disabled="disabled" value="1" id="q20803:408_answer1"><label for="q20803:408_answer1">b. simple color flow pattern on ultrasound</label> </div>
<div class="r0"><input type="radio" name="q20803:408_answer" disabled="disabled" value="2" id="q20803:408_answer2"><label for="q20803:408_answer2">c. primitive endothelial channels with disorganized adventitial and muscular layers</label> </div>
<div class="r1"><input type="radio" name="q20803:408_answer" disabled="disabled" value="3" id="q20803:408_answer3"><label for="q20803:408_answer3">d. single small channels</label> </div>
<div class="r0"><input type="radio" name="q20803:408_answer" disabled="disabled" value="4" id="q20803:408_answer4"><label for="q20803:408_answer4">e. channels directly connected with the common femoral vein</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:408_-submit" name="q20803:408_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Neovascular channels are an abnormal proliferation of blood vessels in tissues not normally containing them, which form a microvascular network. The neovascular network can have single large channels (38%) or multiple small channels (62%) (Fig 1, resin cast demonstrating multiple small channels emanating from a central large channel). These channels usually reflux and are connected to the stump of the previous saphenofemoral junction causing reflux in the femoral vein (Fig 2, surgical specimen of large channel resected from recurrent saphenofemoral junction). The neovascular channels are primitive with endothelial lining, a poorly defined muscular media and adventitia, and poorly defined or absent elastic fibers. The ultrasound findings can show small tortuous channels. On color flow duplex, they have a speckled mosaic appearance due to the many refluxing channels. <br><br><a href="./VESAP3_files/AssetProxy_019.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_019.jpg" alt="img" width="100" height="75" border="0" hspace="10" vspace="10"></a><br>Figure 1<br><br><a href="./VESAP3_files/AssetProxy_061.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_061.jpg" alt="img" width="100" height="79" border="0" hspace="10" vspace="10"></a><br>Figure 2<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Van%20Rij%20AM,%20Jones%20GT,%20Hill%20GB,%20Jiang%20P.%20Neovascularization%20and%20recurrent%20varicose%20veins:%20More%20histologic%20and%20ultrasound%20evidence.%20J%20Vasc%20Surg;%202004;%2040%20(2):296-302" target="_blank">Van Rij AM, Jones GT, Hill GB, Jiang P. Neovascularization and recurrent varicose veins: More histologic and ultrasound evidence. J Vasc Surg 2004; 40 (2):296-302.</a></p>
<p>QID: 30728</p></div><div class="rightanswer">The correct answer is: primitive endothelial channels with disorganized adventitial and muscular layers</div></div></div></div></div><div id="q490" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">506</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4718"><input type="hidden" name="q20803:490_:flagged" value="0"><input type="hidden" value="qaid=911374&amp;qubaid=20803&amp;qid=5228&amp;slot=490&amp;checksum=dbacd6003ada0454f9e092c092d49c22&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:490_:flaggedcheckbox" name="q20803:490_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q490&id=5228"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:490_:sequencecheck" value="2"><div class="qtext"><p>With regards to the use of smoking cessation pharmacotherapy, which of the following statements is&nbsp;<strong>true</strong><strong>?</strong></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:490_answer" disabled="disabled" value="0" id="q20803:490_answer0"><label for="q20803:490_answer0">A. <span style="color: #000000;">drowsiness is a common side effect for Buproprion SR</span></label> </div>
<div class="r1"><input type="radio" name="q20803:490_answer" disabled="disabled" value="1" id="q20803:490_answer1"><label for="q20803:490_answer1">B. <span style="color: #000000;">weight gain was found to be higher in the placebo group than in active treatment groups in randomized controlled trials of drugs to aid quitting</span></label> </div>
<div class="r0"><input type="radio" name="q20803:490_answer" disabled="disabled" value="2" id="q20803:490_answer2"><label for="q20803:490_answer2">C. <span style="color: #000000;">nicotine patch can be effective for patients with thromboangiitis obliterans (Buerger’s disease)</span></label> </div>
<div class="r1"><input type="radio" name="q20803:490_answer" disabled="disabled" value="3" id="q20803:490_answer3"><label for="q20803:490_answer3">D. <span style="color: #000000;">Buproprion SR (Zyban®) treatment should begin only after the patient has completely stopped smoking</span></label> </div>
<div class="r0"><input type="radio" name="q20803:490_answer" disabled="disabled" value="4" id="q20803:490_answer4"><label for="q20803:490_answer4">E. <span style="color: #000000;">Varenicline (Chantix®) side effects can include changes in behavior, agitation, depressed mood, and suicidal ideation</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:490_-submit" name="q20803:490_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Major first-line drugs to assist in smoking cessation are nicotine replacement therapies (nicotine patch, lozenge, gum, or spray), bupropion, and varenicline.</p>
<p>When beginning nicotine replacement, the patient has to stop smoking. Nicotine replacement is contraindicated in patients with thromboangiitis obliterans because it can worsen symptoms. A major randomized controlled trial compared placebo with buproprion and varenicline in identifying smoking cessation and side effects. Varenicline was found to be more effective in smoking cessation than buproprion. The most common side effect for varenicline was nausea, and for buproprion the most common side effect was insomnia. For both varenicline and bupriopion, the medication should be started 7 days prior to the patient’s planned stop date for smoking. With regards to weight gain, this side effect from smoking cessation was found to be equivalent in the placebo, varenicline, and bupriopion groups. However, a late post-marketing trial found that varenicline can cause behavior changes, and ,when this is prescribed, attention needs to be paid to following behavioral agitation, depressed mood, or suicidal ideation.&nbsp;&nbsp;&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=JAMA+2006%3B+296(1)%3A47-55." target="_blank">Gonzales D, Rennard SI, Nides M, Oncken C, Azoulay S, Billing CB, et al. Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs&nbsp;sustained-release bupropion and placebo for smoking cessation: a randomized&nbsp;controlled trial. JAMA 2006; 296(1):47-55.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=N+Engl+J+Med.+2000+Sep+21%3B343(12)%3A864-9." target="_blank">Olin JW. Thromboangiitis obliterans (Buerger's disease). N Engl J Med. 2000; 343(12):864-9.&nbsp;</a></p>
<p>QID: 30855</p></div><div class="rightanswer">The correct answer is: <span style="color: #000000;">Varenicline (Chantix®) side effects can include changes in behavior, agitation, depressed mood, and suicidal ideation</span></div></div></div></div></div><div id="q13" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">507</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4727"><input type="hidden" name="q20803:13_:flagged" value="0"><input type="hidden" value="qaid=910897&amp;qubaid=20803&amp;qid=4623&amp;slot=13&amp;checksum=0394baad19db93f2dd3eaaec357c6b6e&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:13_:flaggedcheckbox" name="q20803:13_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q13&id=4623"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:13_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is a&nbsp;risk factor for the development of spinal cord ischemia after thoracic aorta endovascular repair?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:13_answer" disabled="disabled" value="0" id="q20803:13_answer0"><label for="q20803:13_answer0">a. dominant right vertebral artery</label> </div>
<div class="r1"><input type="radio" name="q20803:13_answer" disabled="disabled" value="1" id="q20803:13_answer1"><label for="q20803:13_answer1">b. chronic Type B aortic dissection</label> </div>
<div class="r0"><input type="radio" name="q20803:13_answer" disabled="disabled" value="2" id="q20803:13_answer2"><label for="q20803:13_answer2">c. aortic atheromatous disease</label> </div>
<div class="r1"><input type="radio" name="q20803:13_answer" disabled="disabled" value="3" id="q20803:13_answer3"><label for="q20803:13_answer3">d. 4 or more pairs of patent intercostal arteries</label> </div>
<div class="r0"><input type="radio" name="q20803:13_answer" disabled="disabled" value="4" id="q20803:13_answer4"><label for="q20803:13_answer4">e. extent of thoracic aortic coverage</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:13_-submit" name="q20803:13_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Spinal cord ischemia (SCI) after thoracic aorta endovascular repair has been associated with a number of risk factors (e.g. extent of aortic coverage, history of previous abdominal aortic aneurysm repair, perioperative hypotension, and renal failure). One study analyzed the length of thoracic aorta covered using 3D CT angiogram reconstructions and found that&nbsp;SCI was significantly associated with coverage over 190 mm or 70% of the descending thoracic aorta. Despite a wide variety of thoracic aortic pathologies treated using endovascular techniques, there has not been an association with any one disease, nor has there been any evidence linking patent intercostal arteries to SCI. Atheromatous disease, especially involving the arch, is principally a concern for increased risk of intraoperative embolic stroke.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Feezor%20RJ,%20Martin%20TD,%20Hess%20PJ%20Jr,%20et%20al.%20Extent%20of%20aortic%20coverage%20and%20incidence%20of%20spinal%20cord%20ischemia%20after%20thoracic%20endovascular%20aneurysm%20repair.%20Ann%20Thorac%20Surg;%202008;%2086%20(6):1809-1814" target="_blank">Feezor RJ, Martin TD, Hess PJ Jr, Daniels MJ, Beaver TM, Klodell CT,et al. Extent of aortic coverage and incidence of spinal cord ischemia after thoracic endovascular aneurysm repair. Ann Thorac Surg 2008; 86 (6):1809-14.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Martin%20DJ,%20Martin%20TD,%20Hess%20PJ,%20et%20al.%20Spinal%20cord%20ischemia%20after%20TEVAR%20in%20patients%20with%20abdominal%20aortic%20aneurysms.%20J%20Vasc%20Surg;%202009;%2049%20(2):302-306" target="_blank">Martin DJ, Martin TD, Hess PJ, Daniels MJ, Freezor RJ, Lee WA. Spinal cord ischemia after TEVAR in patients with abdominal aortic aneurysms. J Vasc Surg 2009; 49 (2):302-6.</a></p>
<p>QID: 30014</p></div><div class="rightanswer">The correct answer is: extent of thoracic aortic coverage</div></div></div></div></div><div id="q319" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">508</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4736"><input type="hidden" name="q20803:319_:flagged" value="0"><input type="hidden" value="qaid=911203&amp;qubaid=20803&amp;qid=5084&amp;slot=319&amp;checksum=90189979e37c5ed38cee3c4a49eda982&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:319_:flaggedcheckbox" name="q20803:319_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q319&id=5084"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:319_:sequencecheck" value="2"><div class="qtext"><p>A 78-year-old woman is in the recovery area after undergoing a diagnostic coronary angiogram via a right common femoral artery approach. She has a small pulsatile mass near the puncture site on exam. What ultrasound findings would be favorable for ultrasound-guided thrombin injection?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:319_answer" disabled="disabled" value="0" id="q20803:319_answer0"><label for="q20803:319_answer0">a. multiple complex pseudoaneurysm originating off a wide neck</label> </div>
<div class="r1"><input type="radio" name="q20803:319_answer" disabled="disabled" value="1" id="q20803:319_answer1"><label for="q20803:319_answer1">b. a small (&lt;5mm) diameter long neck leading into the pseudoaneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:319_answer" disabled="disabled" value="2" id="q20803:319_answer2"><label for="q20803:319_answer2">c. multiple communicating pseudoaneurysms</label> </div>
<div class="r1"><input type="radio" name="q20803:319_answer" disabled="disabled" value="3" id="q20803:319_answer3"><label for="q20803:319_answer3">d. actively bleeding or ruptured pseudoaneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:319_answer" disabled="disabled" value="4" id="q20803:319_answer4"><label for="q20803:319_answer4">e. a broad-based neck at the base of the pseudoaneurysm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:319_-submit" name="q20803:319_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The incidence of iatrogenic psuedoaneurysm (false aneurysm) after arterial puncture ranges from 0.5-6%. Typical findings on physical exam include ecchymosis, a large hematoma, a pulsatile and painful mass, bruit, and weakness or paresthesia secondary to compression of adjacent nerves. Diagnosis of a pseudoaneurysm is made by ultrasound, CT angiography, or MR angiography or catheter-based angiography. Treatment options for pseudoaneurysm include ultrasound-guided compression, ultrasound-guided thrombin injection, endovascular exclusion with a covered stent, or coil embolization. The gold standard remains direct surgical repair. Findings on ultrasound that favor ultrasound-guided thrombin injection include a small- to medium-sized focal psuedoaneurysm with a small diameter long neck. Multiple complex pseudoaneurysms with large, short necks have a high rate of failure, and if treated have a high risk of distal embolization or thrombosis.&nbsp;</p>
<p>&nbsp;</p>
<p><img src="./VESAP3_files/Slide1(4).jpg" alt="Transverse view of a femoral pseudoaneurysm" width="537" height="403"></p>
<p>Image 1: Transverse view of a femoral artery pseudo aneurysm with color-doppler</p>
<p>&nbsp;</p>
<p><img src="./VESAP3_files/Rizvi Question #1 PSA image.jpg" alt="Transverse view demonstrating a long, narrow neck leading into the pseudo aneurysm" width="592" height="444"></p>
<p>Image 2: Transverse view of a long, narrow neck leading into the pseudoaneurysm. This anatomy is ideal for ultrasound-guided thrombin injection.</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Perspect+Vasc+Surg+Endovasc+Therapy%3B+2007%3B+19+(1)%3A58-64" target="_blank">Mansour MA, Gorsuch JM. Diagnosis and Management of Pseudoaneurysms. Perspect Vasc Surg Endovasc Therapy; 2007; 19 (1):58-64.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/18996260" target="_blank">Ahmad F, Turner SA, Torrie P, Gibson M. Iatrogenic femoral artery pseudoaneurysm- A review of current methods of diagnosis and treatment. Clinical Radiology; 2008; 63, 1310-6</a>.</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Surg+2002%3B+194%3AS53-7." target="_blank">Powell A, Benentani JF, Becker GJ, Katzen BT,&nbsp;Zemel G.&nbsp;Percutaneous ultrasound-guided thrombin injection for the treatment of pseudoaneurysms.&nbsp;J Am Coll Surg&nbsp;2002; 194:S53-7.</a></p>
<p>QID: 30553</p></div><div class="rightanswer">The correct answer is: a small (&lt;5mm) diameter long neck leading into the pseudoaneurysm</div></div></div></div></div><div id="q256" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">509</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4745"><input type="hidden" name="q20803:256_:flagged" value="0"><input type="hidden" value="qaid=911140&amp;qubaid=20803&amp;qid=4993&amp;slot=256&amp;checksum=1307c7a341bbbeec694e82acd40c4f51&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:256_:flaggedcheckbox" name="q20803:256_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q256&id=4993"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:256_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is the best placement location for a short-term dialysis catheter?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:256_answer" disabled="disabled" value="0" id="q20803:256_answer0"><label for="q20803:256_answer0">a. left internal jugular vein with catheter tip in the right atrium</label> </div>
<div class="r1"><input type="radio" name="q20803:256_answer" disabled="disabled" value="1" id="q20803:256_answer1"><label for="q20803:256_answer1">b. right femoral vein with catheter tip in the right common iliac vein</label> </div>
<div class="r0"><input type="radio" name="q20803:256_answer" disabled="disabled" value="2" id="q20803:256_answer2"><label for="q20803:256_answer2">c. right subclavian vein with cathter tip in the right atrium</label> </div>
<div class="r1"><input type="radio" name="q20803:256_answer" disabled="disabled" value="3" id="q20803:256_answer3"><label for="q20803:256_answer3">d. right internal jugular vein with catheter tip in the superior vena cava</label> </div>
<div class="r0"><input type="radio" name="q20803:256_answer" disabled="disabled" value="4" id="q20803:256_answer4"><label for="q20803:256_answer4">e. left femoral vein with catheter tip in the inferior vena cava</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:256_-submit" name="q20803:256_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Short-term dialysis catheters may be placed in the internal jugular, subclavian, and femoral veins. For best flow rates, the catheter tip should be placed in the superior vena cava just above the atrial caval junction. The subclavian vein should be avoided if at all possible to prevent subclavian venous stenosis and future complciations with permanent AV access. The femoral vein should be avoided if at all possible due to its higher rates of infection.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephrology+2003%3B+8(1)%3A16-20." target="_blank">Jefferys A,&nbsp; Chow J, Suranyi MG. Acute vascular access catheters for haemodialysis: Complications limiting technique survival.&nbsp; Nephrology 2003; 8(1):16-20.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephron+1990%3B+54(2)%3A154-61." target="_blank">Cimochoswki GE, Worley E, Rutherford WE, Sartain J, Blondin J, Harter H. Superiority of the internal jugular over the subclavian access for temporary dialysis. Nephron 1990; 54(2):154-61.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=andardized+surveilance+of+hemodialysis+vascular+access+infections%3A+18-month+experience+at+an+outpatient%2C+multifacility+hemodialysis+center.+Infect+Control+Hosp+Epidemiol+2003%3B+21(3)%3A200-3." target="_blank">Stevenson KB, Adcox MJ, Mallea MC, Narasimhan N, Wagnild J. Standardized surveilance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol 2003; 21(3):200-3.</a></p>
<p><span>QID: 30440</span></p></div><div class="rightanswer">The correct answer is: right internal jugular vein with catheter tip in the superior vena cava</div></div></div></div></div><div id="q541" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">510</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4754"><input type="hidden" name="q20803:541_:flagged" value="0"><input type="hidden" value="qaid=911425&amp;qubaid=20803&amp;qid=5300&amp;slot=541&amp;checksum=e7d63594e7194481d9c50db8d941126d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:541_:flaggedcheckbox" name="q20803:541_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q541&id=5300"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:541_:sequencecheck" value="2"><div class="qtext"><p>In which of the following scenarios is the radiation dose to the operator the HIGHEST?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:541_answer" disabled="disabled" value="0" id="q20803:541_answer0"><label for="q20803:541_answer0">a. on the right side of the patient and the projection is AP</label> </div>
<div class="r1"><input type="radio" name="q20803:541_answer" disabled="disabled" value="1" id="q20803:541_answer1"><label for="q20803:541_answer1">b. on the right side of the patient and the projection is 75 degrees LAO</label> </div>
<div class="r0"><input type="radio" name="q20803:541_answer" disabled="disabled" value="2" id="q20803:541_answer2"><label for="q20803:541_answer2">c. on the left side of the patient and the projection is 75 degrees LAO</label> </div>
<div class="r1"><input type="radio" name="q20803:541_answer" disabled="disabled" value="3" id="q20803:541_answer3"><label for="q20803:541_answer3">d. at the foot of the bed and the projection is 75 degrees RAO</label> </div>
<div class="r0"><input type="radio" name="q20803:541_answer" disabled="disabled" value="4" id="q20803:541_answer4"><label for="q20803:541_answer4">e. on the right side of the patient and the projection is in 75 degrees RAO</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:541_-submit" name="q20803:541_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Lifetime cumulative radiation exposure should not exceed 400 mSv. The annual dose for an interventionist performing 100 peripheral angiographic cases per year has been estimated at 40mSv to the hands and fingers and 30 mSv to the eye and head.&nbsp; Therefore during a typical career as a vascular surgeon, the total dose delivered can exceed the lifetime threshold doses for radiation exposure.&nbsp; That is why it is imperative that appropriate operating practices are employed.&nbsp; Radiation exposure during interventional procedures arises from 3 different methods of ionizing exposure: the primary x-ray beam, scattered x-rays and leakage x-ray. The primary beam is aimed at the patient and is in the direct line between the x-ray tube and the detector. &nbsp;Dose rates in this region are in the range of 5-20mGy/h. &nbsp;Operators with good practice avoid the primary beam and are exposed to mostly scatter and leakage radiation.&nbsp;&nbsp; Scattered x-rays are produced within the patient tissue when exposed to the primary beam. These x-rays travel in all directions originating from the patient. Scatter dose rates are typically 1-10 mGy/hour at the operator’s position. Leakage x-rays are emitted from the x-ray tube in areas other than the actual emitter.&nbsp; Equipment regulations limit the maximum leakage level to 1 mGy/h at 1 m from the x-ray tube. &nbsp;In lateral projections, the highest radiation area will be on the same side as the emitter. In one study evaluating operator radiation exposure during endovascular procedures, LAO angulation had much higher operator exposure than RAO angulation when the operator was standing to the right of the patient. Thus the greatest radiation exposure is observed when the emitter is on the same side as the operator.&nbsp; Consequently, it is critical in lateral angulated projections for the operator to stand on the detector side of the patient.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2012%3B55%3A799-805." target="_blank">Haqqani O, Agarwal P, Halin N, Iafrati M. Minimizing radiation exposure to the vascular surgeon. J Vasc Surg 2012;55:799-805.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Clin+Radiol+2001%3B56%3A99-106." target="_blank">Johnson DR, Kyriou J, Morton EJ, Clifton A, Fitzgerald M, Macsweeney E. Radiation protection in interventional radiology. Clin Radiol 2001;56:99-106.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Tech+Vasc+Interv+Radiol+2010%3B13%3A167-71." target="_blank">Schueler BA. Operator shielding: how and why. Tech Vasc Interv Radiol 2010;13:167-71.</a></p>
<p>QID: 30947</p></div><div class="rightanswer">The correct answer is: on the right side of the patient and the projection is 75 degrees LAO</div></div></div></div></div><div id="q527" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">511</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4763"><input type="hidden" name="q20803:527_:flagged" value="0"><input type="hidden" value="qaid=911411&amp;qubaid=20803&amp;qid=5263&amp;slot=527&amp;checksum=b83563e1ebfed93f4a7f9e5409883dc8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:527_:flaggedcheckbox" name="q20803:527_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q527&id=5263"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:527_:sequencecheck" value="2"><div class="qtext"><p>A second-year vascular surgery resident wants to reduce the risk of radiation-induced lens injuries, particularly cataracts. This is best accomplished by which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:527_answer" disabled="disabled" value="0" id="q20803:527_answer0"><label for="q20803:527_answer0">a. using continuous fluoroscopy</label> </div>
<div class="r1"><input type="radio" name="q20803:527_answer" disabled="disabled" value="1" id="q20803:527_answer1"><label for="q20803:527_answer1">b. utilizing left anterior oblique positioning</label> </div>
<div class="r0"><input type="radio" name="q20803:527_answer" disabled="disabled" value="2" id="q20803:527_answer2"><label for="q20803:527_answer2">c. avoiding an acute dose of &gt;0.150 Gy</label> </div>
<div class="r1"><input type="radio" name="q20803:527_answer" disabled="disabled" value="3" id="q20803:527_answer3"><label for="q20803:527_answer3">d. using plastic safety glasses</label> </div>
<div class="r0"><input type="radio" name="q20803:527_answer" disabled="disabled" value="4" id="q20803:527_answer4"><label for="q20803:527_answer4">e. avoiding a lens dose of 150 mSv/year</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:527_-submit" name="q20803:527_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span>Radiation injury to the lens can cause cataracts, particularly cortical or posterior subcapsular opacities. The latent period between exposure and cataract appearance is inversely related to dose. The minimal dose for opacity formation is ~ 1.3 Gy for acute exposures. In angiography procedures, eye-level dosimeters can measure 0.25 mSv/h- 3.2 mSv/h, but can reach up to 50 mSv/h during image acquisition. The use of lead eyewear reduces the eye dose to 2-3% of baseline dose. &nbsp;</span></p>
<p>&nbsp;</p>
<h2><span>References:</span></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiat+Res+2009%3B+172%3A1-9." target="_blank"><span>Ainsbury EA, Bouffler SD, Dörr W, Graw J, Muirhead CR, Edwards AA, et al. Radiation cataractogenesis: a review of recent studies. Radiat Res 2009; 172:1-9.&nbsp;</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiology+2008%3B+248%3A945-53." target="_blank">Vano E, Gonzalez L, Fernandez JM, Haskal ZJ. Eye lens exposure to radiation in interventional suites: caution is warranted. Radiology 2008; 248:945-53.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiat+Res+2001%3B+156%3A+460-6." target="_blank">Cucinotta FA, Manuel FK, Jones J, Iszard G, Murrey J, Djojonegro B, et al. Space radiation and cataracts in astronauts. Radiat Res 2001; 156: 460-6.&nbsp;</a></p>
<p>QID: 30931</p></div><div class="rightanswer">The correct answer is: avoiding a lens dose of 150 mSv/year</div></div></div></div></div><div id="q437" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">512</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4772"><input type="hidden" name="q20803:437_:flagged" value="0"><input type="hidden" value="qaid=911321&amp;qubaid=20803&amp;qid=4882&amp;slot=437&amp;checksum=a2a394d18aa6b6aaaa9d56d040f58b61&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:437_:flaggedcheckbox" name="q20803:437_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q437&id=4882"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:437_:sequencecheck" value="2"><div class="qtext"><p>A 52-year-old woman presents with concerns about “swollen legs.”&nbsp; Based on the appearance of her legs, which of the following is the most probable diagnosis?</p>
<p><img src="./VESAP3_files/ROOKE-6.jpg" alt="" width="288" height="514"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:437_answer" disabled="disabled" value="0" id="q20803:437_answer0"><label for="q20803:437_answer0">a. lipedema</label> </div>
<div class="r1"><input type="radio" name="q20803:437_answer" disabled="disabled" value="1" id="q20803:437_answer1"><label for="q20803:437_answer1">b. elephantiasis</label> </div>
<div class="r0"><input type="radio" name="q20803:437_answer" disabled="disabled" value="2" id="q20803:437_answer2"><label for="q20803:437_answer2">c. congestive heart failure</label> </div>
<div class="r1"><input type="radio" name="q20803:437_answer" disabled="disabled" value="3" id="q20803:437_answer3"><label for="q20803:437_answer3">d. chronic venous disease</label> </div>
<div class="r0"><input type="radio" name="q20803:437_answer" disabled="disabled" value="4" id="q20803:437_answer4"><label for="q20803:437_answer4">e. lymphedema</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:437_-submit" name="q20803:437_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Lipedema is a condition in which excessive adipose tissue is usually deposited in a symmetrical pattern in the legs. It most commonly affects women, and, unlike almost all other causes of lower leg enlargement, lipedema spares the feet. Conservative treatment is often unsuccessful; liposuction may be used when aggressive therapy is indicated. This patient's sparing of the feet and lack of the typical sequelae of venous disease eliminate CHF and venous disease as likely etiologies.</p>
<p>&nbsp;</p>
<h2>&nbsp;References:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Rehabil+Med.+2011+Dec%3B35(6)%3A922-7." target="_blank">Shin BW, Sim YJ, Jeong HJ, Kim GC. &nbsp;Lipedema, a rare disease.&nbsp; Ann Rehabil Med 2011; 35(6):922-7.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Med+Genet+A+2010%3B+152A(4)%3A970-6." target="_blank">Child AH, Gordon KD, Sharpe P, Brice G, Ostergaard P, Jeffery S, et al.&nbsp;Lipedema: an inherited condition.&nbsp; Am J Med Genet A 2010; 152A(4):970-6.</a></p>
<p>QID: 30763</p></div><div class="rightanswer">The correct answer is: lipedema</div></div></div></div></div><div id="q23" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">513</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4781"><input type="hidden" name="q20803:23_:flagged" value="0"><input type="hidden" value="qaid=910907&amp;qubaid=20803&amp;qid=4633&amp;slot=23&amp;checksum=8b2d6114444d8fd650c351c3131e5527&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:23_:flaggedcheckbox" name="q20803:23_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q23&id=4633"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:23_:sequencecheck" value="2"><div class="qtext"><p>A 74-year-old man is scheduled for endovascular repair of a 5.7 cm infrarenal abdominal aortic aneurysm (AAA). Preoperative computed tomographic (CT) scanning confirms an adequate proximal neck and distal landing zones. At operation, an aortic catheter is placed and the angiogram shown below is obtained. Which of the following is the appropriate next step in the&nbsp;management&nbsp;of this patient?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/20746.jpg" target="images"><img style="margin: 10px;" src="./VESAP3_files/20746.jpg" alt="Img" width="101" height="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:23_answer" disabled="disabled" value="0" id="q20803:23_answer0"><label for="q20803:23_answer0">a. endovascular repair using a modular bifurcated device</label> </div>
<div class="r1"><input type="radio" name="q20803:23_answer" disabled="disabled" value="1" id="q20803:23_answer1"><label for="q20803:23_answer1">b. endovascular repair using an aorto-uni-iliac device and femoral-femoral bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:23_answer" disabled="disabled" value="2" id="q20803:23_answer2"><label for="q20803:23_answer2">c. endovascular repair using a unibody bifurcated device</label> </div>
<div class="r1"><input type="radio" name="q20803:23_answer" disabled="disabled" value="3" id="q20803:23_answer3"><label for="q20803:23_answer3">d. terminating the endovascular repair</label> </div>
<div class="r0"><input type="radio" name="q20803:23_answer" disabled="disabled" value="4" id="q20803:23_answer4"><label for="q20803:23_answer4">e. endovascular repair using stacked aortic cuffs</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:23_-submit" name="q20803:23_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a large patent inferior mesenteric artery (IMA) and meandering mesenteric artery supplying the superior mesenteric artery (SMA). Any configuration of endovascular graft with successful exclusion of the aneurysm will occlude flow to this artery, resulting in catastrophic intestinal ischemia. The presence of an indispensable vessel within the segment to be excluded is a contraindication to endovascular repair until such time as branched grafts that permit their treatment become available. More common anatomic contraindications to endovascular repair include short proximal and distal landing zones, small diameter access vessels compromised by calcification and/or tortuosity, and proximal neck angulation. Endovascular repair should be aborted in this patient. Open repair with mesenteric revascularization, or revascularization of the SMA with IMA ligation followed by endovascular repair, should be performed.<br><br></p>
<h3>References:</h3>
<p>Buth J, Barris P. Endovascular treatment of aortic aneurysms. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Elsevier Saunders Philadelphia, Pa; 2005:1452-75.</p>
<p>QID: 30025</p></div><div class="rightanswer">The correct answer is: terminating the endovascular repair</div></div></div></div></div><div id="q395" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">514</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4790"><input type="hidden" name="q20803:395_:flagged" value="0"><input type="hidden" value="qaid=911279&amp;qubaid=20803&amp;qid=5046&amp;slot=395&amp;checksum=74169dda7b118d8d29a7e01c1c6accec&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:395_:flaggedcheckbox" name="q20803:395_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q395&id=5046"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:395_:sequencecheck" value="2"><div class="qtext"><p>A 64-year-old man presents with a 3-day history of pain and swelling in the popliteal fossa. D-dimer is positive and B-mode ultrasonography shows a cystic mass in the popliteal fossa. Which of the following is the most probable diagnosis?<br><br><a href="./VESAP3_files/AssetProxy_020.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_020.jpg" alt="img" width="100" height="43" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:395_answer" disabled="disabled" value="0" id="q20803:395_answer0"><label for="q20803:395_answer0">a. a popliteal angiosarcoma</label> </div>
<div class="r1"><input type="radio" name="q20803:395_answer" disabled="disabled" value="1" id="q20803:395_answer1"><label for="q20803:395_answer1">b. adventitial cystic disease of the popliteal artery</label> </div>
<div class="r0"><input type="radio" name="q20803:395_answer" disabled="disabled" value="2" id="q20803:395_answer2"><label for="q20803:395_answer2">c. a ruptured popliteal (Baker's) cyst</label> </div>
<div class="r1"><input type="radio" name="q20803:395_answer" disabled="disabled" value="3" id="q20803:395_answer3"><label for="q20803:395_answer3">d. a thrombosed popliteal artery aneurysm</label> </div>
<div class="r0"><input type="radio" name="q20803:395_answer" disabled="disabled" value="4" id="q20803:395_answer4"><label for="q20803:395_answer4">e. a thrombosed popliteal vein aneurysm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:395_-submit" name="q20803:395_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>A popliteal cyst (also called a Baker's cyst in honor of the British surgeon William Morrant Baker -1839-1896) is a benign cystic structure that arises from the joint capsule of the knee. It may remain asymptomatic (and undiagnosed) or it may cause pain in the popliteal fossa due to compression of adjacent structures. Rupture of a popliteal cyst releases a proteinaceous fluid into the soft tissues resulting in acute pain and swelling in the popliteal fossa; this may mimic deep vein thrombosis. In the ultrasound image shown, material is seen emerging from the knee joint and extending towards the subcutaneous space. It runs medial to the popliteal vessels, which are rarely affected by the cyst. D-dimer may be elevated due to soft tissue inflammation and is not diagnostic for deep vein thrombosis. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg%3B+1997%3B+25+(4)%3A658-62." target="_blank">Langsfeld M, Matteson B, Johnson W, Wascher D<span>,&nbsp;</span>Goodnough J<span>,&nbsp;</span>Weinstein E. Baker's cysts mimicking the symptoms of deep vein thrombosis: Diagnosis with venous duplex scanning. J Vasc Surg 1997; 25 (4):658-62.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Br+J+Surg+2004%3B+91+(10)%3A1313-8." target="_blank">Labropoulos N, Shifrin DA, Paxinos O. New insights into the development of popliteal cysts. Br J Surg 2004; 91 (10):1313-8.</a></p>
<p>QID: 30712</p></div><div class="rightanswer">The correct answer is: a ruptured popliteal (Baker's) cyst</div></div></div></div></div><div id="q200" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">515</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4799"><input type="hidden" name="q20803:200_:flagged" value="0"><input type="hidden" value="qaid=911084&amp;qubaid=20803&amp;qid=4691&amp;slot=200&amp;checksum=8eea909ff147e8f19afe43d96d3607be&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:200_:flaggedcheckbox" name="q20803:200_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q200&id=4691"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:200_:sequencecheck" value="2"><div class="qtext"><p>You perform an uncomplicated left CEA on a 62-year-old man for a symptomatic 70% left internal carotid artery stenosis. His symptoms were a TIA consisting of expressive aphasia and right arm weakness that lasted for 2 hours. He is neurologically intact immediately after surgery. His nurse calls 1 hour later to report a neurologic change; he has developed aphasia and is no longer moving his right arm or leg. Depending on the availability of resources, the next steps in the management of this patient could include any of the following <strong>except</strong>:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:200_answer" disabled="disabled" value="0" id="q20803:200_answer0"><label for="q20803:200_answer0">a. neurorescue with intra-arterial thrombolysis and/or mechanical thrombectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:200_answer" disabled="disabled" value="1" id="q20803:200_answer1"><label for="q20803:200_answer1">b. immediate return to the operating room for re-exploration</label> </div>
<div class="r0"><input type="radio" name="q20803:200_answer" disabled="disabled" value="2" id="q20803:200_answer2"><label for="q20803:200_answer2">c. systemic thrombolysis</label> </div>
<div class="r1"><input type="radio" name="q20803:200_answer" disabled="disabled" value="3" id="q20803:200_answer3"><label for="q20803:200_answer3">d. cerebral arteriogram</label> </div>
<div class="r0"><input type="radio" name="q20803:200_answer" disabled="disabled" value="4" id="q20803:200_answer4"><label for="q20803:200_answer4">e. carotid duplex examination</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:200_-submit" name="q20803:200_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The sole purpose of carotid endarterectomy is stroke prevention. Perioperative stroke is the most feared complication of carotid endarterectomy. In the past, immediate return to the operating room for surgical exploration was recommended for new-onset neurological symptoms in the recovery room.&nbsp;Alternative strategies may be appropriate in selected patients depending on local resources. If intraoperative imaging (angiography or duplex ultrasound) was used at the completion of the original procedure, the likelihood of a technical error is reduced. Emergency CT scan without contrast eliminates the possibility of intracranial hemorrhage. Contrast angiography in a hybrid operating rooms allows the surgeon to examine the endarterectomy site for correctible lesions. For example, an intimal flap can be expeditiously corrected with re-operation. Angiography also provides imaging of the proximal common carotid artery as well as the intracranial circulation. It also provides an opportunity for catheter-based neuro-rescue in the setting of major intracranial embolism (eg M1 or M2). Duplex ultrasound in the recovery may be an alternative to angiography, but it suffers from the technical challenges posed by the surgical wound/dressing and does not offer a therapeutic option. Systemic thrombolysis is contra-indicated in the setting of recent surgery.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/21889705" target="_blank">Ricotta JJ, Aburahma A, Ascher E, Eskandari M,&nbsp;Faries P,&nbsp;Lal BK,&nbsp;et al. Updated Society for Vascular Surgery guidelines for management of extracranial carotid disease. J Vasc Surg 2011; 54(3):832-6. <span style="color: #333333;"><br></span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/23281092" target="_blank">Brott TG, Halperin JL, Abbara S, Bacharach JM,&nbsp;Barr JD,&nbsp;Bush RL,&nbsp;et al.&nbsp;ASA/ACCF/AHA/AANN/AANS/ACR/ASNR/CNS/SAIP/SCAI/SIR/SNIS/SVM/SVS guideline on the management of patients with extracranial carotid and vertebral artery disease. Stroke 2011;&nbsp;1(81):e76-123.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/11387500" target="_blank">Chalela JA, Katzan I, Liebeskind DS, Rasmussen P,&nbsp;Zaidat O,&nbsp;Suarez JI,&nbsp;et al. Safety of intra-arterial thrombolysis in the postoperative period. Stroke 2001; 32(6):1365-9. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/23281092" target="_blank"><br></a></p>
<p>QID: 30349</p></div><div class="rightanswer">The correct answer is: systemic thrombolysis</div></div></div></div></div><div id="q332" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">516</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4808"><input type="hidden" name="q20803:332_:flagged" value="0"><input type="hidden" value="qaid=911216&amp;qubaid=20803&amp;qid=5097&amp;slot=332&amp;checksum=8c4d643325e2a536864e9fc0863f0443&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:332_:flaggedcheckbox" name="q20803:332_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q332&id=5097"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:332_:sequencecheck" value="2"><div class="qtext"><p>In this Doppler spectral waveform, which of the following adjustments can be made to stop the systolic peaks from going off the top of the velocity scale and being "cut off”?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/ZierleR Image 3.jpg" target="images"><img src="./VESAP3_files/ZierleR Image 3.jpg" alt="Zierler Image 3" width="100"></a></p>
<p>&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:332_answer" disabled="disabled" value="0" id="q20803:332_answer0"><label for="q20803:332_answer0">a. decrease the Doppler angle</label> </div>
<div class="r1"><input type="radio" name="q20803:332_answer" disabled="disabled" value="1" id="q20803:332_answer1"><label for="q20803:332_answer1">b. change to a higher frequency transducer</label> </div>
<div class="r0"><input type="radio" name="q20803:332_answer" disabled="disabled" value="2" id="q20803:332_answer2"><label for="q20803:332_answer2">c. increase the Doppler gain</label> </div>
<div class="r1"><input type="radio" name="q20803:332_answer" disabled="disabled" value="3" id="q20803:332_answer3"><label for="q20803:332_answer3">d. increase the pulse repetition frequency</label> </div>
<div class="r0"><input type="radio" name="q20803:332_answer" disabled="disabled" value="4" id="q20803:332_answer4"><label for="q20803:332_answer4">e. decrease the wall filter</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:332_-submit" name="q20803:332_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This pulsed Doppler spectral waveform shows aliasing. Pulsed wave Doppler instruments determine blood flow velocity by taking intermittent “samples” of the flow; the rate of this sampling is the pulse repetition frequency or PRF. The upper limit of the Doppler shift frequency that can be detected accurately by this process is called the Nyquist limit, which is commonly defined as PRF/2 or one-half of the PRF. Aliasing is an artifact of Doppler flow detection that occurs when the Doppler frequency shift exceeds the Nyquist limit. When aliasing occurs in a spectral waveform, the velocity information is displayed improperly and the systolic peaks are “cut off” at the top of the velocity scale and appear below the baseline as flow in the reverse direction. Increasing the PRF will increase the sampling rate of the pulsed Doppler and reduce or eliminate the aliasing artifact, so the systolic peaks of the waveforms will fit on the velocity scale. This can also be achieved by increasing the Doppler angle or using a lower frequency transducer. The Doppler gain and wall filter settings will not have any effect on aliasing.</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p>Kremkau FW. Chapter 6 Artifacts. In: Kremkau FW, Sonography Principles and Instruments, 8<sup>th</sup> ed. St. Louis: Elsevier Saunders; 2011:176-210.</p>
<p>QID: 30567</p></div><div class="rightanswer">The correct answer is: increase the pulse repetition frequency</div></div></div></div></div><div id="q270" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">517</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4817"><input type="hidden" name="q20803:270_:flagged" value="0"><input type="hidden" value="qaid=911154&amp;qubaid=20803&amp;qid=5007&amp;slot=270&amp;checksum=a22e9f2b5533bc91130e1f8ba6d597c5&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:270_:flaggedcheckbox" name="q20803:270_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q270&id=5007"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:270_:sequencecheck" value="2"><div class="qtext"><p>A 48-year-old, right-handed man with chronic end stage kidney disease is referred for hemodialysis access placement. On examination he has palpable brachial, radial, and ulnar pulses. His forearm cephalic vein is not visible on physical examination or duplex imaging. His forearm basilic vein is visible and measures 3.5 mm. Upper arm basilic and cephalic veins are patent and measure 3.5 to 4 mm in diameter. Which of the following is the best access option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:270_answer" disabled="disabled" value="0" id="q20803:270_answer0"><label for="q20803:270_answer0">a. left radiocephalic arteriovenous fistula</label> </div>
<div class="r1"><input type="radio" name="q20803:270_answer" disabled="disabled" value="1" id="q20803:270_answer1"><label for="q20803:270_answer1">b. left brachiocephalic arteriovenous fistula</label> </div>
<div class="r0"><input type="radio" name="q20803:270_answer" disabled="disabled" value="2" id="q20803:270_answer2"><label for="q20803:270_answer2">c. left forearm basilic vein transposition to the radial artery</label> </div>
<div class="r1"><input type="radio" name="q20803:270_answer" disabled="disabled" value="3" id="q20803:270_answer3"><label for="q20803:270_answer3">d. left upper arm basilic vein transposition</label> </div>
<div class="r0"><input type="radio" name="q20803:270_answer" disabled="disabled" value="4" id="q20803:270_answer4"><label for="q20803:270_answer4">e. prosthetic forearm loop access with PTFE</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:270_-submit" name="q20803:270_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Patients with stage 4 chronic kidney disease (GFR 15-29 mLmin/1.73 m<sup>2</sup>) should be evaluated for hemodialysis access placement. Autogenous access is preferred and should be performed well in advance of the need for hemodialysis. Access as far distal as possible in the nondominant arm is preferred. The cephalic vein, if available, is optimal because of its superficial position. The basilic vein will usually require transposition if used for an arteriovenous fistula in the forearm or upper arm. In this&nbsp;patient, the forearm basilic vein is of good caliber and pulses in the extremity are normal. Preferred access in this patient is a transposition of the forearm basilic vein to the radial artery, which keeps the access autogenous and distal.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B48%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M,&nbsp;Jennings WC,&nbsp;Padberg FT Jr,&nbsp;et al. The Society for Vascular Surgery:&nbsp; Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vasc Surg 2008;48:2S-25S.</a></p>
<div class="cit"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Son+HJ%2C+Min+SK%2C+Min+SI%2C+et+al.++Evaluation+of+the+efficacy+of+the+forearm+basilic+vein+transposition+arteriovenous+fistula." target="_blank">Son HJ, Min SK, Min SI, Park YJ,&nbsp;Ha J,&nbsp;Kim SJ. Evaluation of the efficacy of the forearm basilic vein transposition arteriovenous fistula.&nbsp;J Vasc Surg&nbsp;2010 Mar;51:667-72.</a></div>
<div class="cit">QID: 30455</div></div><div class="rightanswer">The correct answer is: left forearm basilic vein transposition to the radial artery</div></div></div></div></div><div id="q121" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">518</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4826"><input type="hidden" name="q20803:121_:flagged" value="0"><input type="hidden" value="qaid=911005&amp;qubaid=20803&amp;qid=4738&amp;slot=121&amp;checksum=fabe47afc7cfd99d7b43b1eb93ffe658&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:121_:flaggedcheckbox" name="q20803:121_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q121&id=4738"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:121_:sequencecheck" value="2"><div class="qtext"><p>A 32-year-old woman presents with pain, paresthesia, and weakness of her right hand. Her right brachial, radial, and ulnar pulses are absent, but her right axillary pulse is easily palpable. She undergoes brachial embolectomy and is&nbsp;anticoagulated. Transesophageal echocardiography shows normal wall motion and no evidence of a cardiac source for the embolus. On postoperative day 2 she develops recurrent ischemia of the right arm. A chest x-ray is obtained and show below. Which of the following is the appropriate next step in the management of this patient?</p>
<p><a href="./VESAP3_files/Cervical rib.jpg" target="images"><img src="./VESAP3_files/Cervical rib.jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:121_answer" disabled="disabled" value="0" id="q20803:121_answer0"><label for="q20803:121_answer0">a. repeat brachial thrombectomy and conversion to lepirudin for anticoagulation</label> </div>
<div class="r1"><input type="radio" name="q20803:121_answer" disabled="disabled" value="1" id="q20803:121_answer1"><label for="q20803:121_answer1">b. cervical sympathectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:121_answer" disabled="disabled" value="2" id="q20803:121_answer2"><label for="q20803:121_answer2">c. arterial thrombolysis</label> </div>
<div class="r1"><input type="radio" name="q20803:121_answer" disabled="disabled" value="3" id="q20803:121_answer3"><label for="q20803:121_answer3">d. venous duplex and closure of a patent foramen ovale</label> </div>
<div class="r0"><input type="radio" name="q20803:121_answer" disabled="disabled" value="4" id="q20803:121_answer4"><label for="q20803:121_answer4">e. obtain additional arterial diagnostic imaging</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:121_-submit" name="q20803:121_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The CXR demonstrates a cervical rib on side of the affected extremity. Additional imaging should be considered. This can include contrast angiography, CT angiography, or Duplex imaging. A bubble study is typically performed if no obvious cardiogenic source is identified to evaluate for paradoxical embolus. Arterial thrombolysis&nbsp;would not address the underlying anatomic cause for the distal ischemia and would be contraindicated 2 days after an open surgical intervention.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Med+Sci+Monit+2004%3B+10%3ACR521-3" target="_blank">Blum A, Reisner S, Farbstein Y.&nbsp;Transesophageal echocardiography (TEE) vs. transthoracic echocardiography (TTE) in assessing cardiovascular sources of emboli in patients with acute ischemic stroke. Med Sci Monit 2004; 10:CR521-3.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Vasc+Surg+2013%3B+27%3A1007-13." target="_blank">Marine L, Valdes F, Mertens R, Kramer A<span>,&nbsp;</span>Bergoeing M<span>,&nbsp;</span>Urbina J. Arterial thoracic outlet syndrome: a 32-year experience. Ann Vasc Surg 2013; 27:1007-13.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Pediatr+Radiol+2002%3B+32%3A22-4." target="_blank">Reid JR, Morrison SC, DiFiore JW. Thoracic outlet syndrome with subclavian aneurysm in a very young child: the complementary value of MRA and 3D-CT in diagnosis. Pediatr Radiol 2002; 32:22-4.</a></p>
<p>QID: 30214</p></div><div class="rightanswer">The correct answer is: obtain additional arterial diagnostic imaging</div></div></div></div></div><div id="q386" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">519</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4835"><input type="hidden" name="q20803:386_:flagged" value="0"><input type="hidden" value="qaid=911270&amp;qubaid=20803&amp;qid=5034&amp;slot=386&amp;checksum=6d7cb9521129d42ee54e25c5933c3280&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:386_:flaggedcheckbox" name="q20803:386_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q386&id=5034"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:386_:sequencecheck" value="2"><div class="qtext"><p>A 30-year-old man was referred for treatment of leg swelling and disfiguration, which has been getting progressively worse for a number years (images are shown below). Which of the following is the most probable diagnosis?</p>
<p><img style="margin-left: 10px; margin-right: 10px;" src="./VESAP3_files/AssetProxy_134.jpg" alt="Image" width="134" height="100"><img style="margin-left: 10px; margin-right: 10px;" src="./VESAP3_files/AssetProxy_297.jpg" alt="" width="75" height="100"><img style="margin-left: 10px; margin-right: 10px;" src="./VESAP3_files/AssetProxy_425.jpg" alt="" width="75" height="100"></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:386_answer" disabled="disabled" value="0" id="q20803:386_answer0"><label for="q20803:386_answer0">a. elephantiasis nostras verrucosa</label> </div>
<div class="r1"><input type="radio" name="q20803:386_answer" disabled="disabled" value="1" id="q20803:386_answer1"><label for="q20803:386_answer1">b. lymphangiosarcoma</label> </div>
<div class="r0"><input type="radio" name="q20803:386_answer" disabled="disabled" value="2" id="q20803:386_answer2"><label for="q20803:386_answer2">c. squamous carcinoma</label> </div>
<div class="r1"><input type="radio" name="q20803:386_answer" disabled="disabled" value="3" id="q20803:386_answer3"><label for="q20803:386_answer3">d. actinomycosis</label> </div>
<div class="r0"><input type="radio" name="q20803:386_answer" disabled="disabled" value="4" id="q20803:386_answer4"><label for="q20803:386_answer4">e. keloid</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:386_-submit" name="q20803:386_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has congenital lymphedema. He underwent a Charles reduction procedure consisting of excision of the skin and subcutaneous tissue of the lower leg followed by skin grafting as a child. He subsequently developed the hyperplastic epithelial condition referred to as elephantiasis nostras verrucosa (ENV) or "mossy foot" (as shown in the photos). ENV is a rare and dramatic consequence of chronic, non-filarial lymphedema. ENV is characterized by verrucous lesions, hyperkeratosis, pappilomatosis, limb enlargement, and woody fibrosis. Biopsy typically shows fibroblast proliferation and fibrosis. There is no ideal treatment for this devastating problem. The irregular surface is prone to superficial infection and may become malodorous and painful. In this case, as a last resort, the hyperplastic tissue was excised to the level of the deep fascia followed by skin grafting. Early recurrence is common because the underlying lymphatic problem remains.<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Clin+Derm+2008%3B+9+(3)%3A141-6." target="_blank">Sisto K, Khachemoune A. Elephantiasis nostras verrucosa: A review. Am J Clin Derm 2008; 9 (3):141-6.</a></p>
<p>QID: 30701</p></div><div class="rightanswer">The correct answer is: elephantiasis nostras verrucosa</div></div></div></div></div><div id="q73" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">520</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4844"><input type="hidden" name="q20803:73_:flagged" value="0"><input type="hidden" value="qaid=910957&amp;qubaid=20803&amp;qid=4987&amp;slot=73&amp;checksum=c153c7157107d52fab74b6713500aab3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:73_:flaggedcheckbox" name="q20803:73_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q73&id=4987"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:73_:sequencecheck" value="2"><div class="qtext"><p>A patient presents with blue, painful toes bilaterally and new onset renal failure after transfemoral diagnostic cardiac catheterization. Which of the following is the most probable diagnosis?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:73_answer" disabled="disabled" value="0" id="q20803:73_answer0"><label for="q20803:73_answer0">a. congestive heart failure</label> </div>
<div class="r1"><input type="radio" name="q20803:73_answer" disabled="disabled" value="1" id="q20803:73_answer1"><label for="q20803:73_answer1">b. femoral artery injury</label> </div>
<div class="r0"><input type="radio" name="q20803:73_answer" disabled="disabled" value="2" id="q20803:73_answer2"><label for="q20803:73_answer2">c. systemic sepsis</label> </div>
<div class="r1"><input type="radio" name="q20803:73_answer" disabled="disabled" value="3" id="q20803:73_answer3"><label for="q20803:73_answer3">d. contrast nephropathy</label> </div>
<div class="r0"><input type="radio" name="q20803:73_answer" disabled="disabled" value="4" id="q20803:73_answer4"><label for="q20803:73_answer4">e. cholesterol embolism syndrome</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:73_-submit" name="q20803:73_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This situation is classic for cholesterol embolism syndrome: the blue toes (both feet) and renal failure are both due to diffuse microscopic arteriolar occlusion by showers of cholesterol emboli (crystals of which can be seen on biopsy) induced by endovascular manipulation. Contrast nephropathy is a possible explanation for the deteriorating renal function but does not explain the ischemic toes. Edema caused by kidney failure or congestive heart failure would not be expected to produce discoloration of the toes. Catheterization-related femoral artery injury would not be expected to produce bilateral symptoms. The scenario presented includes nothing suggestive of sepsis.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Fukumoto+Y%2C+Tsutsui+H%2C+Tsuchihashi+M%2C+et+al.+Cholesterol+Embolism+Study+(CHEST)+Investigators." target="_blank">Fukumoto Y, Tsutsui H, Tsuchihashi M, Masumoto A<span>,&nbsp;</span>Takeshita A<span>;</span>&nbsp;Cholesterol Embolism Study (CHEST) Investigators. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: A prospective study. J Am Coll Cardio 2003; 42 (2):211-16.</a></p>
<p>QID: 30114</p></div><div class="rightanswer">The correct answer is: cholesterol embolism syndrome</div></div></div></div></div><div id="q413" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">521</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4853"><input type="hidden" name="q20803:413_:flagged" value="0"><input type="hidden" value="qaid=911297&amp;qubaid=20803&amp;qid=4786&amp;slot=413&amp;checksum=13bcb3121f39206a660275f99aba573f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:413_:flaggedcheckbox" name="q20803:413_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q413&id=4786"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:413_:sequencecheck" value="2"><div class="qtext"><p>A 45-year-old woman presents with extensive medial thigh superficial venous cording and associated erythema and tenderness. Duplex ultrasonography confirms superficial thrombophlebitis (5 cm in length) of her great saphenous vein at the level of the mid- and distal-thigh (&gt;3 cm distal to the saphenofemoral junction). Which of the following is the most appropriate initial treatment?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:413_answer" disabled="disabled" value="0" id="q20803:413_answer0"><label for="q20803:413_answer0">a. therapeutic anticoagulation with coumadin</label> </div>
<div class="r1"><input type="radio" name="q20803:413_answer" disabled="disabled" value="1" id="q20803:413_answer1"><label for="q20803:413_answer1">b. radiofrequency ablation</label> </div>
<div class="r0"><input type="radio" name="q20803:413_answer" disabled="disabled" value="2" id="q20803:413_answer2"><label for="q20803:413_answer2">c. non-steroidal anti-inflammatory agents (NSAIDs)</label> </div>
<div class="r1"><input type="radio" name="q20803:413_answer" disabled="disabled" value="3" id="q20803:413_answer3"><label for="q20803:413_answer3">d. warm compresses, ambulation, and compression</label> </div>
<div class="r0"><input type="radio" name="q20803:413_answer" disabled="disabled" value="4" id="q20803:413_answer4"><label for="q20803:413_answer4">e. prophylactic fondaparinux</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:413_-submit" name="q20803:413_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The inflammatory-thrombotic process of the superficial veins is termed superficial venous thrombosis (SVT).&nbsp; SVT is associated with a 6-53% risk of DVT and 0-10% risk of pulmonary embolism.&nbsp; While mild disease may still be managed simply with NSAIDs, compression, and warm compresses, patients with moderate disease, defined as SVT at least 5 cm in length and located at least 3cm distal to the saphenofemoral junction, should be managed more aggressively with either prophylactic low molecular weight heparin or fondaparinaux. This management is based on data from the The Superficial Thrombophlebitis Treated by Enoxaparin Study Group and, more recently, The CALISTO Study Group for the Treatment of Superficial-Vein Thrombosis in the Legs.&nbsp;<em>&nbsp;</em>Decousus et al assessed the safety and efficacy of fondaparinaux for SVT with an international, multi-center, randomized, double-blind, placebo-controlled trial that assessed 3002 patients with acute, symptomatic lower limb SVT involving a segment at least 5 cm in length located at least 3 cm distal to the SFJ.&nbsp;These patients were assigned to 45 days of treatment with fondaparinaux (2.5 mg administered subcutaneously daily), or placebo. The fondaparinaux group demonstrated an 85% lower rate of pulmonary embolism or DVT than the placebo group after 77 days, along with a significantly reduced rate of symptomatic SVT recurrence or SVT extension to the SFJ, all without increased major bleeding or serious adverse events. Therapeutic anticoagulation still applies to any patient that develops concomitant or subsequent deep venous thrombosis or PE. &nbsp;For patients who cannot tolerate anticoagulation, GSV disconnection and ligation at the SFJ remains appropriate.&nbsp; Surgical treatment with GSV ablation, along with phlebectomies of the involved branch varicosities, should be considered the optimal treatment for patients with symptomatic SVT and evidence of superficial venous insufficiency/reflux confirmed by Duplex ultrasound, which is usually performed after the phlebitis has resolved.&nbsp;</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Intern+Med+2003%3B+163%3A1657-63" target="_blank">Superficial Thrombophlebitis Treated By Enoxaparin Study Group. A pilot randomized double-blind comparison of a low-molecular-weight heparin, a nonsteroidal anti-inflammatory agent, and placebo in the treatment of superficial vein thrombosis. Arch Intern Med 2003;163:1657-63.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=New+Eng+J+Med+2010%3B+363%3A1222-32" target="_blank">Decousus H, Prandoni P, Mismetti P, Bauersachs RM<span>,&nbsp;</span>Boda Z<span>,&nbsp;</span>Brenner B,&nbsp;et al. Fondaparinux for the treatment of superficial-vein thrombosis in the legs. N Eng J Med 2010; 363:1222-32.</a></p>
<p>QID: 30733</p></div><div class="rightanswer">The correct answer is: prophylactic fondaparinux</div></div></div></div></div><div id="q385" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">522</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4862"><input type="hidden" name="q20803:385_:flagged" value="0"><input type="hidden" value="qaid=911269&amp;qubaid=20803&amp;qid=5100&amp;slot=385&amp;checksum=2fbba30b69a52f42d30f9640d313d479&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:385_:flaggedcheckbox" name="q20803:385_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q385&id=5100"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:385_:sequencecheck" value="2"><div class="qtext"><p>The use of an angiotensin converting enzyme inhibitor (ACEI), such as Captopril, in radionuclide renography has what effect on the glomerular filtration rate (GFR) of the suspected kidney?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:385_answer" disabled="disabled" value="0" id="q20803:385_answer0"><label for="q20803:385_answer0">a. improved GFR through constriction of efferent arterioles</label> </div>
<div class="r1"><input type="radio" name="q20803:385_answer" disabled="disabled" value="1" id="q20803:385_answer1"><label for="q20803:385_answer1">b. improved GFR through dilation of afferent arterioles</label> </div>
<div class="r0"><input type="radio" name="q20803:385_answer" disabled="disabled" value="2" id="q20803:385_answer2"><label for="q20803:385_answer2">c. diminished GFR through dilatation of efferent arterioles</label> </div>
<div class="r1"><input type="radio" name="q20803:385_answer" disabled="disabled" value="3" id="q20803:385_answer3"><label for="q20803:385_answer3">d. diminished GFR through constriction of afferent arterioles</label> </div>
<div class="r0"><input type="radio" name="q20803:385_answer" disabled="disabled" value="4" id="q20803:385_answer4"><label for="q20803:385_answer4">e. no change in GFR</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:385_-submit" name="q20803:385_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Angiotensin converting enzyme (ACE) inhibitor&nbsp;renography, more commonly known as captopril renography, combines renography with pharmacologic manipulation of the renin-angiotensin system. With critical unilateral renal artery disease, the affected kidney compensates for reduced glomerular perfusion by constricting efferent arterioles to maintain an adequate filtration pressure. Angiotensin II, which is excessive in hypoperfused kidneys, is the responsible agent for the intense vasoconstriction. After the pharmacologic blockade of ACE by Captopril, a decline in GFR is seen in the kidney, with&nbsp;a&nbsp;renal artery stenosis&nbsp;due to loss of compensatory efferent arteriolar constriction as angiotensin II levels fall. If the contralateral kidney is normal, renography may show a compensatory increase in&nbsp;excretory function from the normal kidney after ACE inhibition.</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Hypertension+1988%3B+12%3A411-9." target="_blank">Jonker GJ, de Zeeuw D, Huisman RM, Piers DB,&nbsp;Beekhuis H,&nbsp;van der Hem GK. Angiotensin converting enzyme inhibition improves diagnostic procedures for renovascular hypertension in dogs. Hypertension 1988; 12:411-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Acta+Radiol+2006%3B+47%3A764-74." target="_blank">Eklof H, Ahlstrom H, Magnusson A, Andersson LG,&nbsp;Andrén B,&nbsp;Hägg A,&nbsp;Bergqvist D,&nbsp;et al. A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. Acta Radiol 2006; 47:764-74.</a></p>
<p>QID: 30673</p></div><div class="rightanswer">The correct answer is: diminished GFR through dilatation of efferent arterioles</div></div></div></div></div><div id="q157" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">523</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4871"><input type="hidden" name="q20803:157_:flagged" value="0"><input type="hidden" value="qaid=911041&amp;qubaid=20803&amp;qid=4779&amp;slot=157&amp;checksum=5f7321acee3b2ecfabf7bcebe9fbdc07&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:157_:flaggedcheckbox" name="q20803:157_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q157&id=4779"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:157_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding upper extremity deep venous thrombosis is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:157_answer" disabled="disabled" value="0" id="q20803:157_answer0"><label for="q20803:157_answer0">a. pulmonary embolism occurs in less than 1% of patients</label> </div>
<div class="r1"><input type="radio" name="q20803:157_answer" disabled="disabled" value="1" id="q20803:157_answer1"><label for="q20803:157_answer1">b. associated central venous catheters may be retained if functional and clinically necessary</label> </div>
<div class="r0"><input type="radio" name="q20803:157_answer" disabled="disabled" value="2" id="q20803:157_answer2"><label for="q20803:157_answer2">c. recurrence is rare</label> </div>
<div class="r1"><input type="radio" name="q20803:157_answer" disabled="disabled" value="3" id="q20803:157_answer3"><label for="q20803:157_answer3">d. anticoagulation is not indicated in the absence of symptoms</label> </div>
<div class="r0"><input type="radio" name="q20803:157_answer" disabled="disabled" value="4" id="q20803:157_answer4"><label for="q20803:157_answer4">e. most often caused by compression at the costoclavicular junction</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:157_-submit" name="q20803:157_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Upper extremity deep venous thrombosis&nbsp;(UE DVT) represents about 10% of all DVT. It's occurrence is less frequent than DVT in the lower extremity because: the arms are more mobile than the legs in bedridden, hospitalized patients, the hydrostatic pressure in the upper extremity veins is less than that of the lower extremities, and the upper extremities lack a system where blood can pool, such as the soleal venous complex in the leg. Up to 75% of UE DVT occurs in patients with indwelling catheters, pacemakers, and malignancy.&nbsp; Central venous catheters are the most common cause of UE DVT. &nbsp;It has been estimated that pulmonary embolism occurs in up to 5% of cases. Recurrent &nbsp;DVT is a common manifestations of UE DVT occurring in 20% of cases. Central venous line associated UE DVT should be treated with 3 months of anticoagulation and removal of the line.&nbsp; However, if the central venous line is functional and necessary, current ACCP guidelines state that the line need not be removed.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Int+J+Crit+Illn+Inj+Sci+2012%3B+2%3A21-6." target="_blank">Saseedharan S, Bhargava S. Upper extremity deep venous thrombosis. Int J Crit Illn Inj Sci 2012; 2:21-6.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest+2012%3B+141(2+Suppl)%3Ae419S-94S." target="_blank">Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. &nbsp;Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141(2 Suppl):e419S-94S.&nbsp;</a></p>
<p>QID: 30251</p></div><div class="rightanswer">The correct answer is: associated central venous catheters may be retained if functional and clinically necessary</div></div></div></div></div><div id="q14" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">524</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4880"><input type="hidden" name="q20803:14_:flagged" value="0"><input type="hidden" value="qaid=910898&amp;qubaid=20803&amp;qid=4724&amp;slot=14&amp;checksum=00597885d413087ca65114a908f2ebef&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:14_:flaggedcheckbox" name="q20803:14_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q14&id=4724"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:14_:sequencecheck" value="2"><div class="qtext"><p>A 64-year-old man is evaluated in the emergency department for lethargy, fevers, and fatigue. He is 3-months status post open repair of a ruptured infrarenal aortic aneurysm. He denies abdominal or back pain, and is otherwise in his usual state of health. the emergency room CT scan obtained is shown below. Which of the following is the best treatment option for this patient?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images"><img src="./VESAP3_files/Treatment options for aortic graft infection.jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt"><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images">Select one:</a></div><div class="answer"><div class="r0"><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images"><input type="radio" name="q20803:14_answer" disabled="disabled" value="0" id="q20803:14_answer0"><label for="q20803:14_answer0">a. aortic ligation, simultaneous&nbsp;extra-anatomic bypass and complete graft excision, local debridement</label> </a></div><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images">
<div class="r1"><input type="radio" name="q20803:14_answer" disabled="disabled" value="1" id="q20803:14_answer1"><label for="q20803:14_answer1">b. aortic ligation, complete graft excision, local debridement</label> </div>
<div class="r0"><input type="radio" name="q20803:14_answer" disabled="disabled" value="2" id="q20803:14_answer2"><label for="q20803:14_answer2">c. surgical drainage, local debridement, placement of irrigating catheters</label> </div>
<div class="r1"><input type="radio" name="q20803:14_answer" disabled="disabled" value="3" id="q20803:14_answer3"><label for="q20803:14_answer3">d. aortic ligation, staged extra-anatomic bypass and complete graft excision, local debridement</label> </div>
<div class="r0"><input type="radio" name="q20803:14_answer" disabled="disabled" value="4" id="q20803:14_answer4"><label for="q20803:14_answer4">e. long-term broad spectrum antibiotics</label> </div>
</a></div></div><div class="im-controls"><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images"><input type="submit" id="q20803:14_-submit" name="q20803:14_-submit" value="Check" class="submit btn" disabled="disabled"></a></div></div><div class="outcome"><h4 class="accesshide"><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images">Feedback</a></h4><div class="feedback"><div class="specificfeedback"><p><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images">Your answer is incorrect.</a></p></div><div class="generalfeedback"><p><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images">Aortic graft infection is a grave complication of aortic surgery that is associated with an overall treatment-related mortality of 19%, and an overall survival of 56% at 5 years. The most common organism isolated from these infections is Staphlylococcus epidermidis (60%), as reported by Bandyck et al, during a 10-year review. Major amputation rates have been reported as high as 27%.</a></p><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images">
</a><p><a href="./VESAP3_files/Treatment options for aortic graft infection.jpg" target="images">No significant differences have been shown between patients treated with extra-anatomic bypass and subsequent graft removal versus both procedures being performed simultaneously.&nbsp; However, the staged group has been shown by O’hara et al to experience a lower rate of amputations as compared to the combined procedure. Subsequent axillofemoral graft infections were found to be as high as 22% and were associated with a markedly higher amputation rate, as compared to survivors who did not develop a graft infection.</a><a title="Yeager, 1990 #102" href="http://svsvesap.com/beta#_ENREF_2"><sup><br></sup></a></p>
<p>Graft excision without revascularization can be considered under limited circumstances, such as a previous end-side femoral anastomosis performed for claudication or a thrombosed graft&nbsp;without evidence of critical limb ischemia.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+1986%3B+3%3A725-31." target="_blank">O'Hara PJ, Hertzer NR, Beven EG, Krajewski LP. Surgical management of infected abdominal aortic grafts: review of a 25-year experience. J Vasc Surg&nbsp;1986; 3:725-31.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Am+J+Surg+1990%3B+159%3A466-9." target="_blank">Yeager RA, Moneta GL, Taylor LM Jr, Harris EJ Jr, McConnell DB, Porter JM. Improving survival and limb salvage in patients with aortic graft infection. Am J Surg&nbsp;1990; 159:466-9.</a></p>
<p>QID: 30015</p></div><div class="rightanswer">The correct answer is: aortic ligation, staged extra-anatomic bypass and complete graft excision, local debridement</div></div></div></div></div><div id="q430" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">525</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4889"><input type="hidden" name="q20803:430_:flagged" value="0"><input type="hidden" value="qaid=911314&amp;qubaid=20803&amp;qid=4874&amp;slot=430&amp;checksum=54f687ac6bd6e59bc52dc15e59db2d95&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:430_:flaggedcheckbox" name="q20803:430_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q430&id=4874"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:430_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements regarding plasminogen activators is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:430_answer" disabled="disabled" value="0" id="q20803:430_answer0"><label for="q20803:430_answer0">a. streptokinase and plasminogen form a complex, and it is this SK-plasminogen complex that breaks down other molecules of plasminogen to produce plasmin</label> </div>
<div class="r1"><input type="radio" name="q20803:430_answer" disabled="disabled" value="1" id="q20803:430_answer1"><label for="q20803:430_answer1">b. a-2 antiplasmin inhibits most of the plasminogen activators</label> </div>
<div class="r0"><input type="radio" name="q20803:430_answer" disabled="disabled" value="2" id="q20803:430_answer2"><label for="q20803:430_answer2">c. Glu-plasminogen is the thrombus bound form of plasminogen while Lys-plasminogen is free floating in plasma</label> </div>
<div class="r1"><input type="radio" name="q20803:430_answer" disabled="disabled" value="3" id="q20803:430_answer3"><label for="q20803:430_answer3">d. tenecteplase has the lowest affinity for thrombus bound plasminogen</label> </div>
<div class="r0"><input type="radio" name="q20803:430_answer" disabled="disabled" value="4" id="q20803:430_answer4"><label for="q20803:430_answer4">e. rt-PA has the shortest half-life (15 minutes) of all the commercially available plasminogen activators</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:430_-submit" name="q20803:430_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Plasminogen activators cleave plasminogen to produce plasmin. Plasmin is the active compound responsible for clot lysis. Currently, rt-PA has the shortest half life of the commercially available plasminogen activators, which is at 4-5 minutes. The other compounds range from approximately 14 minutes to 90 minutes. Tenecteplase has the highest affinity for thrombus bound plasminogen.</p>
<p>Plasminogen has two forms: Glu-plasminogen and Lys-plasminogen. Glu-plasminogen is found in the circulation and is stoichiometrically altered to Lys-plasminogen once it binds to fibrin. This structural change produces a higher affinity for binding to plasminogen activators and, in large part, is the basis for the intrathrombus delivery of plasminogen activators. Streptokinase is the only compound that must complex with plasminogen prior to having an ability to act on plasminogen to form plasmin.&nbsp; a-2 antiplasmin directly inhibits plasmin and not the plasminogen activator.&nbsp; Plasminogen activator inhibitors 1 and 2 are responsible for the direct inhibition of plasminogen activators.</p>
<p>&nbsp;</p>
<h2><strong>References:</strong></h2>
<p>Robbins KC. In:Comerota AJ, ed. Thrombolytic Therapy for Peripheral Vascular Disease. Philadelphia, PA: J.B. Lippincott; 1995:41-65.</p>
<p>Froehlich J, Stump DL. In:Comerota AJ, ed. Thrombolytic Therapy for Peripheral Vascular Disease. Philadelphia, PA: J.B. Lippincott; 1995:103-114.</p>
<p>QID: 30755</p></div><div class="rightanswer">The correct answer is: streptokinase and plasminogen form a complex, and it is this SK-plasminogen complex that breaks down other molecules of plasminogen to produce plasmin</div></div></div></div></div><div id="q552" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">526</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4898"><input type="hidden" name="q20803:552_:flagged" value="0"><input type="hidden" value="qaid=911436&amp;qubaid=20803&amp;qid=5290&amp;slot=552&amp;checksum=6d2d539737f8f6120d4777204425fb5d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:552_:flaggedcheckbox" name="q20803:552_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q552&id=5290"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:552_:sequencecheck" value="2"><div class="qtext"><p>Factors which can <strong>increase</strong>&nbsp;the radiation dose to the patient and personnel include which of the following?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:552_answer" disabled="disabled" value="0" id="q20803:552_answer0"><label for="q20803:552_answer0">A. using the last image hold feature</label> </div>
<div class="r1"><input type="radio" name="q20803:552_answer" disabled="disabled" value="1" id="q20803:552_answer1"><label for="q20803:552_answer1">B. using a 5-minute fluoroscopic warning buzzer</label> </div>
<div class="r0"><input type="radio" name="q20803:552_answer" disabled="disabled" value="2" id="q20803:552_answer2"><label for="q20803:552_answer2">C. employing pre-procedure planning</label> </div>
<div class="r1"><input type="radio" name="q20803:552_answer" disabled="disabled" value="3" id="q20803:552_answer3"><label for="q20803:552_answer3">D. using a lower frame rate during image acquisition</label> </div>
<div class="r0"><input type="radio" name="q20803:552_answer" disabled="disabled" value="4" id="q20803:552_answer4"><label for="q20803:552_answer4">E. exposing the patient while not viewing the image</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:552_-submit" name="q20803:552_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The concept of ALARA (“as low as reasonably achievable”) is a central concept in radiation safety and represents practice patterns designed to keep radiation dose to both the patient and healthcare personnel at a reasonable level while achieving the desired images.&nbsp; In endovascular procedures utilizing fluoroscopy, certain principles will result in reduction of radiation exposure to both the patient and the operator.&nbsp; For instance, most relevant anatomic features needed in an EVAR can be obtained from the pre operative CT scan, thus minimizing the fluoroscopic time during the actual procedure itself.&nbsp; Similarly, being aware of the total time of fluoroscopic exposure with 5-minute alarm intervals can limit the cumulative radiation dose.&nbsp; The use of “last image hold” feature can aid in target vessel cannulation without the need for further digital subtraction runs.&nbsp; Having your foot on the fluoroscope pedal while not actively looking at the image will increase radiation exposure not only to the patient but personnel within the angiographic suite.&nbsp;</p>
<p><em>&nbsp;</em></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol+2009%3B+20%3AS263-73." target="_blank">Stecker MS, Balter S<span>,&nbsp;</span>Towbin RB<span>,&nbsp;</span>Miller DL<span>,&nbsp;</span>Vañó E<span>,&nbsp;</span>Bartal G<span>,</span>&nbsp;et al. Guidelines for patient radiation dose management.&nbsp; J Vasc Interv Radiol 2009; 20:S263-73.</a>&nbsp;</p>
<p style="text-align: left;"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiographics+1999%3B19(4)%3A1037-55." target="_blank">Brateman L. Radiation safety considerations for diagnostic radiology personnel. Radiographics 1999;19(4):1037-55.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/20656429" target="_blank">Le Heron, Padovani R<span>,&nbsp;</span>Smith I<span>,&nbsp;</span>Czarwinski R<span>.</span>&nbsp;Radiation protection of medical staff.&nbsp; Eur J Radiol 2010; 76(1):20-3.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Radiol+Manage+1993+Winter%3B15(1)%3A22-30." target="_blank">Starchman DE, Hedrick WR. A practical guide for protecting personnel, pregnant personnel, and patients during diagnostic radiography and fluoroscopy. Radiol Manage 1993; 15(1):22-30.</a></p>
<p>QID: 30961</p></div><div class="rightanswer">The correct answer is: exposing the patient while not viewing the image</div></div></div></div></div><div id="q60" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">527</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4907"><input type="hidden" name="q20803:60_:flagged" value="0"><input type="hidden" value="qaid=910944&amp;qubaid=20803&amp;qid=4319&amp;slot=60&amp;checksum=5ef1304ecbd0324bbb4b5233472f4ad8&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:60_:flaggedcheckbox" name="q20803:60_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q60&id=4319"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:60_:sequencecheck" value="2"><div class="qtext"><p>Which of the following statements is correct&nbsp;with regard to unintentional renal artery occlusion during EVAR?&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:60_answer" disabled="disabled" value="0" id="q20803:60_answer0"><label for="q20803:60_answer0">a. Coverage of the renal arteries most commonly occurs during the initial endograft procedure because late cranial migration of modern endografts is extremely rare.</label> </div>
<div class="r1"><input type="radio" name="q20803:60_answer" disabled="disabled" value="1" id="q20803:60_answer1"><label for="q20803:60_answer1">b. If selective catheterization of the renal artery from either the femoral or brachial approach can be achieved, renal artery stenting may salvage an occluded renal artery.</label> </div>
<div class="r0"><input type="radio" name="q20803:60_answer" disabled="disabled" value="2" id="q20803:60_answer2"><label for="q20803:60_answer2">c. It is virtually always detected on completion angiography, at which point salvage maneuvers can be carried out.</label> </div>
<div class="r1"><input type="radio" name="q20803:60_answer" disabled="disabled" value="3" id="q20803:60_answer3"><label for="q20803:60_answer3">d. If there is significant impingement of graft fabric over the renal artery orifice, open renal artery bypass is the best strategy for renal revascularization when the complication is recognized intraoperatively.</label> </div>
<div class="r0"><input type="radio" name="q20803:60_answer" disabled="disabled" value="4" id="q20803:60_answer4"><label for="q20803:60_answer4">e. No attempt should be made to revascularize the kidney if the renal artery occlusion is recognized on routine postoperative imaging, as the period of warm ischemia time will have been so prolonged that no meaningful kidney function can be regained.</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:60_-submit" name="q20803:60_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><span style="font-family: Times New Roman;"><span style="font-size: medium;">Renal artery occlusion is a relatively rare complication of EVAR, occurring ~1% of cases, but can lead to significant patient morbidity.</span><sup><span style="font-size: small;">1</span></sup><span style="font-size: medium;">&nbsp; As surgeons attempt to repair increasingly short and angulated necks, it is likely that renal artery complications will increase.&nbsp; Most endografts even with active proximal fixation are vulnerable to upward displacement, especially during manipulation for implantation of the contralateral limb during the initial procedure.&nbsp; Renal artery occlusion may also occur from intraoperative plaque rupture and embolization.&nbsp; Immediate intraoperative rescue procedures include aspiration of embolized plaque or downward displacement of the endograft, either through inflation of a balloon at the proximal seal zone and exerting downward traction or passing a wire or wire/catheter combination over the bifurcation, snaring from the contralateral groin and then exerting downward traction on either one or both ends of the wire.</span><sup><span style="font-size: small;">2,3</span></sup><span style="font-size: medium;"> &nbsp;Alternate maneuvers include cannulation of the renal artery either from the femoral or brachial approach and using a stent to push down the fabric occluding the renal orifice.&nbsp; Extension of a covered stent as a snorkel may be required if there is significant impingement of fabric on the renal artery orifice.</span><sup><span style="font-size: small;">4</span></sup><span style="font-size: medium;">&nbsp; Renal artery occlusion is only recognized intraoperatively approximately 50% of the time, possibly secondary to residual anticoagulation at the time of the completion angiography.</span><sup><span style="font-size: small;">2</span></sup><span style="font-size: medium;">&nbsp; Patients may present with renovascular hypertension secondary to delayed renal artery occlusion.</span><sup><span style="font-size: small;">5</span></sup><span style="font-size: medium;">&nbsp; Aneurysm sac remodeling and the fact that there is significant craniocaudal movement of the renal arteries with respect to the aorta may lead to delayed renal artery occlusion, especially in patients with suprarenal fixation, fenestrated, or snorkeled endografts.&nbsp; Delayed revascularization either via stent placement or open renal artery bypass may result in patients regaining renal function, especially if the kidney receives collateral flow from the periureteral, adrenal, and peripelvic vessels.</span><sup><span style="font-size: small;">6</span></sup><span style="font-size: medium;">&nbsp; Potentially salvageable kidneys have normal size and show parenchymal enhancement on contrast CT imaging.</span><sup><span style="font-size: small;">4,5</span></sup><span style="font-size: medium;">&nbsp; </span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Greenberg, R.K., Chuter, T.A., Lawrence-Brown, M., Haulon, S. &amp; Nolte, L. Analysis of renal function after aneurysm repair with a device using suprarenal fixation (Zenith AAA Endovascular Graft) in contrast to open surgical repair. <em>J Vasc Surg</em> <strong>39</strong>, 1219-1228 (2004).</span></span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Lin, P.H., Bush, R.L. &amp; Lumsden, A.B. Endovascular rescue of a maldeployed aortic stent-graft causing renal artery occlusion: technical considerations. <em>Vasc Endovascular Surg</em> <strong>38</strong>, 69-73 (2004).</span></span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Grande, W. &amp; Stavropoulos, S.W. Treatment of complications following endovascular repair of abdominal aortic aneurysms. <em>Semin Intervent Radiol</em> <strong>23</strong>, 156-164 (2006).</span></span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Adu, J., Cheshire, N.J., Riga, C.V., Hamady, M. &amp; Bicknell, C.D. Strategies to tackle unrecognized bilateral renal artery occlusion after endovascular aneurysm repair. <em>Ann Vasc Surg</em> <strong>26</strong>, 1127 e1121-1127 (2012).</span></span></span></p>
<p><span style="font-family: Calibri;"><span style="font-size: medium;"><span style="color: #000000;">5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hedayati, N., Lin, P.H., Lumsden, A.B. &amp; Zhou, W. Prolonged renal artery occlusion after endovascular aneurysm repair: endovascular rescue and renal function salvage. <em>J Vasc Surg</em> <strong>47</strong>, 446-449 (2008).</span></span></span></p>
<p><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Calibri;">6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hamish, M.<em>, et al.</em> Delayed hepato-spleno-renal bypass for renal salvage following malposition of an infrarenal aortic stent-graft. <em>J Endovasc Ther</em> <strong>17</strong>, 326-331 (2010).</span></span></span></p>
<p><span style="font-size: medium;"><span style="color: #000000;"><span style="font-family: Calibri;">QID: 30069</span></span></span></p></div><div class="rightanswer">The correct answer is: If selective catheterization of the renal artery from either the femoral or brachial approach can be achieved, renal artery stenting may salvage an occluded renal artery.</div></div></div></div></div><div id="q347" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">528</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4916"><input type="hidden" name="q20803:347_:flagged" value="0"><input type="hidden" value="qaid=911231&amp;qubaid=20803&amp;qid=5140&amp;slot=347&amp;checksum=c3faf22dc2f2846dd6adfe64a11826c6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:347_:flaggedcheckbox" name="q20803:347_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q347&id=5140"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:347_:sequencecheck" value="2"><div class="qtext"><p>A 67-year-old man with a known 5.5 cm abdominal aortic aneurysm underwent CT arteriography in preparation for his endovascular aneurysm repair (EVAR). The aorta and access vessels appear amenable to the planned endovascular repair. On the CT scan, the patient was found to have single renal arteries on both sides with a moderate stenosis of approximately 60% on the left. His past medical history was notable for hypertension, which was well controlled on a diuretic and an ACE inhibitor. His baseline serum creatinine was 0.8 mg/dL. Which of the following is the most appropriate treatment for this patient who has combined aortic aneurysmal and atherosclerotic renal artery occlusive disease?<br><br><a href="./VESAP3_files/AssetProxy_068.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_068.jpg" alt="img" width="100" height="85" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:347_answer" disabled="disabled" value="0" id="q20803:347_answer0"><label for="q20803:347_answer0">a. endovascular aneurysm repair alone</label> </div>
<div class="r1"><input type="radio" name="q20803:347_answer" disabled="disabled" value="1" id="q20803:347_answer1"><label for="q20803:347_answer1">b. staged left renal artery bypass, followed by open aortic aneurysm repair</label> </div>
<div class="r0"><input type="radio" name="q20803:347_answer" disabled="disabled" value="2" id="q20803:347_answer2"><label for="q20803:347_answer2">c. left renal artery stenting with a balloon-expandable stent at the time of endovascular repair with the renal artery stent placed after the complete deployment of endovascular stent graft</label> </div>
<div class="r1"><input type="radio" name="q20803:347_answer" disabled="disabled" value="3" id="q20803:347_answer3"><label for="q20803:347_answer3">d. left renal artery stenting with a balloon-expandable stent at the time of endovascular repair with the renal artery stent placed immediately prior to the deployment of the main body of the endovascular stent graft</label> </div>
<div class="r0"><input type="radio" name="q20803:347_answer" disabled="disabled" value="4" id="q20803:347_answer4"><label for="q20803:347_answer4">e. open aortic aneurysm repair with a left renal bypass using saphenous vein originating from the main body of the infrarenal graft</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:347_-submit" name="q20803:347_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>The natural history of atherosclerotic renal artery occlusive disease appears to be relatively benign and not necessarily associated with anatomic progression in terms of the degree of stenosis or progression to occlusion. Recent studies have reported rates of anatomic progression ranging from 8-31%, with progression to occlusion occurring in 0-7% of cases. More importantly, the anatomic progression has not been consistently associated with a decline in renal function or progression in the severity of the hypertension. In their analysis from the Cardiovascular Health Study cohort, Pearce et al reported an association between the presence of atherosclerotic renal artery occlusive disease and the longitudinal increases in blood pressure and serum creatinine. However, similar associations were not detected for the anatomic progression of the baseline occlusive disease. Given this relatively benign natural history, "prophylactic" intervention does not appear to be justified for patients with atherosclerotic renal artery occlusive disease with normal renal function and well controlled hypertension. Repair of the 5.5 cm abdominal aortic aneurysm alone appears to be the best treatment choice.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Edwards%20MD,%20Corriere%20MA.%20Contemporary%20management%20of%20atherosclerotic%20renovascular%20disease.%20J%20Vasc%20Surg;%202009;%2050%20(5):1197-1210" target="_blank">Edwards MD, Corriere MA. Contemporary management of atherosclerotic renovascular disease. J Vasc Surg 2009; 50(5):1197-1210.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2006%3B+44(5)%3A955-62." target="_blank">Pearce JD, Craven BL, Craven TE, Piercy KT,&nbsp;Stafford JM,&nbsp;Edwards MS,&nbsp;et al. Progression of atherosclerotic renovascular disease: A prospective population-based study. J Vasc Surg 2006; 44(5):955-62.</a></p>
<p>QID: 30614</p></div><div class="rightanswer">The correct answer is: endovascular aneurysm repair alone</div></div></div></div></div><div id="q372" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">529</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4925"><input type="hidden" name="q20803:372_:flagged" value="0"><input type="hidden" value="qaid=911256&amp;qubaid=20803&amp;qid=5112&amp;slot=372&amp;checksum=f8b557d293e5b908e75f2bda8b2af27b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:372_:flaggedcheckbox" name="q20803:372_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q372&id=5112"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:372_:sequencecheck" value="2"><div class="qtext"><p><span>A 65-year-old man presents with acute onset of severe abdominal pain of 6 hours duration. His past medical history is significant for hypertension, diabetes,&nbsp;and atrial fibrillation. Abdominal exam shows diffuse tenderness without frank peritonitis. Which of the following is the most probable diagnosis?</span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:372_answer" disabled="disabled" value="0" id="q20803:372_answer0"><label for="q20803:372_answer0">a. <span>superior mesenteric artery (SMA) embolus</span></label> </div>
<div class="r1"><input type="radio" name="q20803:372_answer" disabled="disabled" value="1" id="q20803:372_answer1"><label for="q20803:372_answer1">b. <span>median arcuate ligament syndrome</span></label> </div>
<div class="r0"><input type="radio" name="q20803:372_answer" disabled="disabled" value="2" id="q20803:372_answer2"><label for="q20803:372_answer2">c. mesenteric venous thrombosis</label> </div>
<div class="r1"><input type="radio" name="q20803:372_answer" disabled="disabled" value="3" id="q20803:372_answer3"><label for="q20803:372_answer3">d. <span>spontaneous SMA dissection</span></label> </div>
<div class="r0"><input type="radio" name="q20803:372_answer" disabled="disabled" value="4" id="q20803:372_answer4"><label for="q20803:372_answer4">e. <span>atherosclerotic occlusion of&nbsp;the SMA</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:372_-submit" name="q20803:372_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient presents with typical symptoms and signs of early acute mesenteric ischemia. Single vessel involvement, typically the SMA, is the most common pattern for emboli to the mesenteric arteries. An embolus typically lodges just distal to the middle colic branch of the SMA, sparing several proximal jejunal branches.&nbsp;The inferior mesenteric artery is seldom the site at which an embolus will become lodged. Only small emboli can enter this vessel because of its smaller lumen, and they typically lodge at the site of division of the inferior mesenteric artery into the left colic and sigmoidal arteries. In those cases, collateral flow from the middle colic and middle hemorrhoidal arteries will usually maintain the perfusion of the left colon. Median arcuate ligament accounts for a minority of cases of chronic mesenteric ischemia, not acute mesenteric ischemia. Mesenteric venous thrombosis is characterized by vague abdominal pain and indolent onset.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arch+Surg+1999%3B+134%3A328-30." target="_blank">Mansour MA. Management of acute mesenteric ischemia.&nbsp;Arch Surg&nbsp;1999; 134:328-30.</a></p>
<p id="yui_3_13_0_2_1388339419131_90"><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B46%3A467-74." target="_blank">Kougias P, Lau D, El Sayed HF, Zhou W, Huynh TT, Lin PH. Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia.&nbsp;J Vasc Surg&nbsp;2007;46:467-74.</a></p>
<p>QID: 30656</p></div><div class="rightanswer">The correct answer is: <span>superior mesenteric artery (SMA) embolus</span></div></div></div></div></div><div id="q9" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">530</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4934"><input type="hidden" name="q20803:9_:flagged" value="0"><input type="hidden" value="qaid=910893&amp;qubaid=20803&amp;qid=4618&amp;slot=9&amp;checksum=07d3b8bb17181fcab53786c9794b0d98&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:9_:flaggedcheckbox" name="q20803:9_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q9&id=4618"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:9_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old&nbsp;white man&nbsp;with a past medical history of hypertension, hypercholesterolemia, and smoking presents with a popliteal artery aneurysm. What is the prevalence of an associated abdominal aortic aneurysm (AAA) in this setting?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:9_answer" disabled="disabled" value="0" id="q20803:9_answer0"><label for="q20803:9_answer0">a. 10%</label> </div>
<div class="r1"><input type="radio" name="q20803:9_answer" disabled="disabled" value="1" id="q20803:9_answer1"><label for="q20803:9_answer1">b. 25%</label> </div>
<div class="r0"><input type="radio" name="q20803:9_answer" disabled="disabled" value="2" id="q20803:9_answer2"><label for="q20803:9_answer2">c. 50%</label> </div>
<div class="r1"><input type="radio" name="q20803:9_answer" disabled="disabled" value="3" id="q20803:9_answer3"><label for="q20803:9_answer3">d. 5%</label> </div>
<div class="r0"><input type="radio" name="q20803:9_answer" disabled="disabled" value="4" id="q20803:9_answer4"><label for="q20803:9_answer4">e. 85%</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:9_-submit" name="q20803:9_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Knowledge of associated vascular disorders is vital to providing optimal patient care and the prioritization thereof. Given the prevalence of obesity in the population today, abdominal aortic aneurysms large enough to be at risk of rupture can easily go undetected on physical exam. An abdominal AAA may be present in up to 62% of patients with a popliteal aneurysm and 85% of patients with a femoral artery aneurysm. In contrast, patients with an AAA have only a 14% incidence of either a femoral or popliteal artery aneurysm. Given the strength of these associations, all patients with femoral or popliteal aneurysms should undergo abdominal imaging to evaluate for an AAA.<br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Diwan%20A%2C%20Sarkar%20R%2C%20Stanley%20JC%2C%20et%20al.%20Incidence%20of%20femoral%20and%20popliteal%20artery%20aneurysms%20in%20patients%20with%20abdominal%20aortic%20aneurysms.%20J%20Vasc%20Surg%3B%202000%3B%2031%20%285%29%3A863-869" target="_blank">Diwan A, Sarkar R, Stanley JC, Zelenock GB, Wakefield TW. Incidence of femoral and popliteal artery aneurysms in patients with abdominal aortic aneurysms. J Vasc Surg 2000; 31 (5):863-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Graham%20LM%2C%20Zelenock%20GB%2C%20Whitehouse%20WM%2C%20et%20al.%20Clinical%20significance%20of%20arteriosclerotic%20femoral%20artery%20aneurysms.%20Arch%20Surg%3B%201980%3B%20115%20%284%29%3A502-507" target="_blank">Graham LM, Zelenock GB, Whitehouse WM Jr, Erlandson EE, Dent TL, Lindenauer SM,&nbsp;et al. Clinical significance of arteriosclerotic femoral artery aneurysms. Arch Surg 1980; 115 (4):502-7.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Whitehouse%20WM%2C%20Wakefield%20TW%2C%20Graham%20LM.%20Limb%20threatening%20potential%20of%20arteriosclerotic%20popliteal%20artery%20aneurysms.%20Surgery%3B%201983%3B%2093%20%285%29%3A694-699" target="_blank">Whitehouse WM, Wakefield TW, Graham LM. Limb threatening potential of arteriosclerotic popliteal artery aneurysms. Surgery 1983; 93 (5):694-9.</a></p>
<p>QID: 30009</p></div><div class="rightanswer">The correct answer is: 50%</div></div></div></div></div><div id="q126" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">531</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4943"><input type="hidden" name="q20803:126_:flagged" value="0"><input type="hidden" value="qaid=911010&amp;qubaid=20803&amp;qid=4743&amp;slot=126&amp;checksum=7f401c1010147020540ac7630668529c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:126_:flaggedcheckbox" name="q20803:126_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q126&id=4743"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:126_:sequencecheck" value="2"><div class="qtext"><p>A 75-year-old woman underwent successful renal artery stent placement from the left axillary artery. After 3 hours in the recovery room she developed numbness and tingling in her left hand. Her vital signs were stable, the left radial pulse was palpable, and motor function was intact. There was no palpable hematoma at the access site. Which of the following is the most appropriate next step in the management of this patient?&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:126_answer" disabled="disabled" value="0" id="q20803:126_answer0"><label for="q20803:126_answer0">a. arterial duplex evaluation of the left upper extremity</label> </div>
<div class="r1"><input type="radio" name="q20803:126_answer" disabled="disabled" value="1" id="q20803:126_answer1"><label for="q20803:126_answer1">b. aortic arch and left upper extremity arteriogram using a femoral approach</label> </div>
<div class="r0"><input type="radio" name="q20803:126_answer" disabled="disabled" value="2" id="q20803:126_answer2"><label for="q20803:126_answer2">c. serial neurologic examinations</label> </div>
<div class="r1"><input type="radio" name="q20803:126_answer" disabled="disabled" value="3" id="q20803:126_answer3"><label for="q20803:126_answer3">d. urgent left upper extremity surgical decompression</label> </div>
<div class="r0"><input type="radio" name="q20803:126_answer" disabled="disabled" value="4" id="q20803:126_answer4"><label for="q20803:126_answer4">e. MRI of the brain and spinal cord</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:126_-submit" name="q20803:126_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The axillary artery and brachial plexus travel together in the axillary sheath. Bleeding from an axillary artery access site can result in a hematoma that tracks along this inelastic sheath. When compression of the nerve develops, a sensory deficit is usually noted first. This can rapidly progress to motor loss as the hematoma expands. The median and ulnar nerves travel the longest distance within the sheath and the median nerve is the most commonly injured. Complete recovery of neurologic function is more likely when compression is relieved expeditiously. A high index of suspicion is required when evaluating patients with an axillary sheath hematoma because the extent of hematoma on physical exam can be unimpressive. Additionally, diagnostic tests will likely delay treatment without benefit to the patient, potentially resulting in a worse neurologic outcome. In particular, duplex ultrasound may not detect small but clinically important axillary sheath hematomas, and a negative ultrasound should not delay prompt surgical decompression in the face of persistent neurological symptoms.</p>
<p>&nbsp;</p>
<h2>Reference:&nbsp;</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=PMID%3A+21514101" target="_blank">Tran DD, Andersen CA. Axillary sheath hematomas causing neurologic complications following arterial access. Ann Vasc Surg. 2011; 25:697.&nbsp;</a></p>
<p>QID: 30219</p></div><div class="rightanswer">The correct answer is: urgent left upper extremity surgical decompression</div></div></div></div></div><div id="q238" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">532</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4952"><input type="hidden" name="q20803:238_:flagged" value="0"><input type="hidden" value="qaid=911122&amp;qubaid=20803&amp;qid=4967&amp;slot=238&amp;checksum=ba0e5597a607753bf0fb43379cc53cc4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:238_:flaggedcheckbox" name="q20803:238_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q238&id=4967"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:238_:sequencecheck" value="2"><div class="qtext"><p>A 72-year-old, right arm dominant man presents to the emergency department from dialysis with a thrombosed left autogenous radial-cephalic wrist direct access. The arteriovenous (AV) access was placed 2 years ago; it was noted to be working well until 2 weeks ago. On physical examination of his left arm, he has no thrill or bruit in his AV access outflow, no edema. He has&nbsp;palpable radial, ulnar, and brachial artery pulses. Which of the following is the most probable cause of AV access thrombosis in this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:238_answer" disabled="disabled" value="0" id="q20803:238_answer0"><label for="q20803:238_answer0">a. stenosis of the venous outflow</label> </div>
<div class="r1"><input type="radio" name="q20803:238_answer" disabled="disabled" value="1" id="q20803:238_answer1"><label for="q20803:238_answer1">b. poor arterial inflow</label> </div>
<div class="r0"><input type="radio" name="q20803:238_answer" disabled="disabled" value="2" id="q20803:238_answer2"><label for="q20803:238_answer2">c. tehnical defect at the arteriovenous anastomosis</label> </div>
<div class="r1"><input type="radio" name="q20803:238_answer" disabled="disabled" value="3" id="q20803:238_answer3"><label for="q20803:238_answer3">d. central venous stenosis</label> </div>
<div class="r0"><input type="radio" name="q20803:238_answer" disabled="disabled" value="4" id="q20803:238_answer4"><label for="q20803:238_answer4">e. hypercoagulability</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:238_-submit" name="q20803:238_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Thrombosis of an autogenous radial-cephalic wrist direct access at this time point that had previously been functioning well is most commonly due to intimal hyperplasia. This&nbsp;can occur anywhere in the venous&nbsp;outflow tract. Central venous stenosis related to central venous catheters is the second common cause of late AV access failure. Since this patient had no arm edema, no central lines for over 2 years, and a normal pulse examination, the most probable cause is intimal hyperplasia of the outflow tract.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Padberg%20FT,%20Calligaro%20KD,%20Sidawy%20AN.%20Complications%20of%20arteriovenous%20hemodialysis%20access:%20Recognition%20and%20management.%20J%20Vas%20Surg;%202008;%2048%20(S):55S-80S" target="_blank">Padberg FT, Calligaro KD, Sidawy AN. Complications of arteriovenous hemodialysis access: Recognition and management. J Vas Surg 2008; 48 (S):55S-80S.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Sidawy%20AN,%20Spergel%20LM,%20Besarb%20A,%20et%20al.%20The%20Society%20for%20Vascular%20Surgery:%20Clinical%20practice%20guidelines%20for%20the%20surgical%20placement%20and%20maintenance%20of%20arteriovenous%20hemodialysis%20access.[all]&cmd=correctspelling" target="_blank">Sidawy AN, Spergel LM, Besarb A, Allon M<span>,&nbsp;</span>Jennings WC<span>,&nbsp;</span>Padberg FT Jr<span>,&nbsp;</span>et al. The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access. J Vas Surg 2008; 48 (5S):2S-25S.</a></p>
<p>QID: 30416</p></div><div class="rightanswer">The correct answer is: stenosis of the venous outflow</div></div></div></div></div><div id="q361" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">533</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4961"><input type="hidden" name="q20803:361_:flagged" value="0"><input type="hidden" value="qaid=911245&amp;qubaid=20803&amp;qid=5157&amp;slot=361&amp;checksum=ea968a5a0dca274347ffe3c7b16b8501&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:361_:flaggedcheckbox" name="q20803:361_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q361&id=5157"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:361_:sequencecheck" value="2"><div class="qtext"><p>Which of the following is the most appropriate management of acute mesenteric ischemia caused by a superior mesenteric artery (SMA) embolus?&nbsp;</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:361_answer" disabled="disabled" value="0" id="q20803:361_answer0"><label for="q20803:361_answer0">a. antegrade SMA bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:361_answer" disabled="disabled" value="1" id="q20803:361_answer1"><label for="q20803:361_answer1">b. embolectomy&nbsp;via a longitudinal SMA arteriotomy</label> </div>
<div class="r0"><input type="radio" name="q20803:361_answer" disabled="disabled" value="2" id="q20803:361_answer2"><label for="q20803:361_answer2">c. embolectomy&nbsp;via a transverse SMA arteriotomy</label> </div>
<div class="r1"><input type="radio" name="q20803:361_answer" disabled="disabled" value="3" id="q20803:361_answer3"><label for="q20803:361_answer3">d. systemic anticoagulation and laparotomy for peritonitis</label> </div>
<div class="r0"><input type="radio" name="q20803:361_answer" disabled="disabled" value="4" id="q20803:361_answer4"><label for="q20803:361_answer4">e. pharmaco-mechanical thrombectomy of the SMA</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:361_-submit" name="q20803:361_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Acute mesenteric ischemia results from a sudden diminution in&nbsp;intestinal blood flow to a level that is insufficient to maintain viability of the affected bowel. Etiologies can be&nbsp;categorized as either arterial or venous causes. Arterial&nbsp;causes&nbsp;may be sub-divided into occlusive and non-occlusive etiologies.&nbsp;The most common&nbsp;etiologies for&nbsp;acute&nbsp;mesenteric arterial occlusion include in situ thrombosis of a&nbsp;mesenteric artery with&nbsp;atherosclerotic arterial occlusive disease versus&nbsp;arterial embolization to a mesenteric artery.&nbsp;In most cases (70%) of acute mesenteric ischemia, the superior mesenteric artery (SMA) is the site of acute arterial inflow obstruction. Non-occlusive&nbsp;mesenteric ischemia is&nbsp;typically&nbsp;related to vasoconstriction in response to a low flow state, such as&nbsp;congestive heart failure. Lastly, venous obstruction&nbsp;of the superior mesenteric vein (SMV) may also&nbsp;cause acute mesenteric ischemia. Hypercoagulable states and&nbsp;acute pancreatitis are the two most common conditions associated with SMV thrombosis.&nbsp;&nbsp;</p>
<p>The goal of therapy in acute mesenteric ischemia&nbsp;is expeditious restoration of intestinal blood flow.&nbsp;The SMA is the most common site of mesenteric emboli, which is due to its relatively large caliber and acute angle of origin. The&nbsp;typical location for an SMA embolus to lodge is&nbsp;4-10 cm distal to the SMA&nbsp;origin, distal to the take off of the middle colic artery where the artery begins to narrow. An embolus in this location will produce a characteristic pattern of ischemia involving the mid and distal jejunum, ileum, and right colon. The proximal jejunum is often&nbsp;spared because the embolus&nbsp;lodges distal to several proximal jejunal branches off of the SMA. The transverse colon is&nbsp;usually&nbsp;spared because the middle colic artery&nbsp;remains patent. The left colon and rectum are&nbsp;supplied largely by the inferior mesenteric artery, so these&nbsp;portions&nbsp;are also spared.&nbsp;&nbsp;</p>
<p>Once acute mesenteric ischemia is suspected, systemic anticoagulation should be instituted with a goal of expeditious revascularization. Open surgical management includes exposure of the SMA in the root of the mesentery, inferior to the pancreas and transverse colon. For an embolectomy, a transverse arteriotomy in the SMA permits rapid passage of Fogarty embolectomy catheters proximally (and distally if necessary) to extract the embolus and associated thrombus. The advantage of the transverse arteriotomy is that it can be closed primarily, while a longitudinal arteriotomy requires a patch closure to minimize narrowing of the SMA. Due to arterial occlusive disease,&nbsp;SMA bypass should be reserved for cases of acute mesenteric ischemia.</p>
<p>Anecdotal reports have described the use of&nbsp;pharmaco-mechanical thrombectomy and catheter directed intra-arterial thrombolysis to treat SMA embolism.&nbsp;The obvious downside of this approach is that it will not obviate the need for laparotomy for most patients since the bowel will require inspection and possible resection. If these approaches are used, it is important to reestablish mesenteric perfusion prior to leaving the operating room or arteriography suite to avoid further risk of bowel necrosis. In general, these&nbsp;approaches are probably most appropriate for patients without signs of bowel infarction who present early after the onset of&nbsp;abdominal pain.&nbsp;In most patients with acute mesenteric ischemia there is sufficient concern for bowel viability that a laparotomy is indicated for inspection of the bowel, so SMA embolectomy can be accomplished at the same setting.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9146714" target="_blank">McKinsey JF, Gewertz BL.&nbsp;Acute mesenteric ischemia.&nbsp;Surg Clin North Am 1997;77(2):307-18.</a>&nbsp;</p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Vascular+2012%3B20%3A166-9." target="_blank"><span class="cit-auth cit-auth-type-author">Ballehaninna UK, </span><span class="cit-auth cit-auth-type-author">Hingorani A</span><span class="cit-auth cit-auth-type-author">, Ascher E, Shiferson A, Marks N, Aboian E, et al.&nbsp;</span>&nbsp;<span class="cit-auth cit-auth-type-author">Acute superior mesenteric artery embolism: reperfusion with AngioJet hydrodynamic suction thrombectomy and pharmacologic thrombolysis&nbsp;with the EKOS catheter.&nbsp;Vascular 2012; 20:166-9.&nbsp;</span></a></p>
<p><span class="cit-auth cit-auth-type-author">QID: 30633</span></p></div><div class="rightanswer">The correct answer is: embolectomy&nbsp;via a transverse SMA arteriotomy</div></div></div></div></div><div id="q160" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">534</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4970"><input type="hidden" name="q20803:160_:flagged" value="0"><input type="hidden" value="qaid=911044&amp;qubaid=20803&amp;qid=4775&amp;slot=160&amp;checksum=0b881f0964e8e58e8fc5b1d297243269&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:160_:flaggedcheckbox" name="q20803:160_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q160&id=4775"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:160_:sequencecheck" value="2"><div class="qtext"><p>A 60-year-old woman is seen in the recovery area for right hand ischemia after cardiac catheterization via the radial artery. With regards to this scenario, which of the following statements is most accurate?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:160_answer" disabled="disabled" value="0" id="q20803:160_answer0"><label for="q20803:160_answer0">a. a single arcade of collaterals provides communication between the radial and ulnar arteries contributing to the incidence of symptomatic radial artery occlusion</label> </div>
<div class="r1"><input type="radio" name="q20803:160_answer" disabled="disabled" value="1" id="q20803:160_answer1"><label for="q20803:160_answer1">b. occlusion of the radial artery after catheterization requires thrombectomy in most cases</label> </div>
<div class="r0"><input type="radio" name="q20803:160_answer" disabled="disabled" value="2" id="q20803:160_answer2"><label for="q20803:160_answer2">c. pain syndromes are more common after radial artery access than after femoral artery access</label> </div>
<div class="r1"><input type="radio" name="q20803:160_answer" disabled="disabled" value="3" id="q20803:160_answer3"><label for="q20803:160_answer3">d. access vessel diameter eliminates the option of stenting for percutaneous coronary intervention from a radial artery approach</label> </div>
<div class="r0"><input type="radio" name="q20803:160_answer" disabled="disabled" value="4" id="q20803:160_answer4"><label for="q20803:160_answer4">e. bleeding complications are significantly reduced with the radial artery approach in comparison to femoral artery access</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:160_-submit" name="q20803:160_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The radial artery approach has become increasingly utilized for cardiac catheterizations. The reasons for this include improved patient comfort with earlier ambulation and discharge, as well as fewer complications (bleeding, false aneurysms, neuropathic pain syndromes) than with a femoral approach. With the advent of .14 compatible systems, a full complement of interventional options are available for cardiac intervention with this technique. Thrombosis of the radial artery is noted in up to 12% of patients after radial artery cannulation but has rarely resulted in symptomatic ischemia or the need for associated intervention. Presumably, this is partly due to appropriate patient selection with the pre-procedure confirmation of patent ulnar arteries and intact superficial and/or deep palmar arcades that provide adequate supplemental perfusion if the radial artery occludes.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cardiovasc+Interv+2011%3B+77(4)%3A530-6." target="_blank">Babunashvili A, Dundua D. Recanalization and reuse of early occluded radial</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cardiovasc+Interv+2011%3B+77(4)%3A530-6." target="_blank">artery within 6 days after previous transradial diagnostic procedure. Catheter</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Cardiovasc+Interv+2011%3B+77(4)%3A530-6." target="_blank">Cardiovasc Interv 2011; 77(4):530-6.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+2011%3B+377(9775)%3A1409-20." target="_blank">Jolly SS, Yusuf S, Cairns J, Niemelä K, Xavier D, Widimsky P, et al.&nbsp;&nbsp;Radial versus femoral access for&nbsp;coronary angiography and intervention in patients with acute coronary syndromes</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Lancet+2011%3B+377(9775)%3A1409-20." target="_blank">(RIVAL): a randomised, parallel group, multicentre trial. Lancet 2011; 377(9775):1409-20.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+2010%3B+55(20)%3A2187-95." target="_blank">Rao SV, Cohen MG, Kandzari DE, Bertrand OF, Gilchrist IC. The transracial</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+2010%3B+55(20)%3A2187-95." target="_blank">approach to percutaneous coronary intervention: historical perspective, current</a>&nbsp;<a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Am+Coll+Cardiol+2010%3B+55(20)%3A2187-95." target="_blank">concepts, and future directions. J Am Coll Cardiol 2010; 55(20):2187-95.</a></p>
<p>QID: 30254</p></div><div class="rightanswer">The correct answer is: bleeding complications are significantly reduced with the radial artery approach in comparison to femoral artery access</div></div></div></div></div><div id="q277" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">535</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4979"><input type="hidden" name="q20803:277_:flagged" value="0"><input type="hidden" value="qaid=911161&amp;qubaid=20803&amp;qid=1858&amp;slot=277&amp;checksum=e18721949403de49c5bfa34513727143&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:277_:flaggedcheckbox" name="q20803:277_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q277&id=1858"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:277_:sequencecheck" value="2"><div class="qtext"><p>A 45-year-old woman with end stage renal disease is scheduled for elective placement of a radiocephalic arteriovenous autogenous access for hemodialysis. Administration of clopidogrel beginning on postoperative day one would be expected to</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:277_answer" disabled="disabled" value="0" id="q20803:277_answer0"><label for="q20803:277_answer0">a. Increase the risk of pseudoaneurysms</label> </div>
<div class="r1"><input type="radio" name="q20803:277_answer" disabled="disabled" value="1" id="q20803:277_answer1"><label for="q20803:277_answer1">b. Decrease the risk of early thrombosis</label> </div>
<div class="r0"><input type="radio" name="q20803:277_answer" disabled="disabled" value="2" id="q20803:277_answer2"><label for="q20803:277_answer2">c. Decrease the need for additional hospitalization</label> </div>
<div class="r1"><input type="radio" name="q20803:277_answer" disabled="disabled" value="3" id="q20803:277_answer3"><label for="q20803:277_answer3">d. Increase the likelihood of suitability for hemodialysis</label> </div>
<div class="r0"><input type="radio" name="q20803:277_answer" disabled="disabled" value="4" id="q20803:277_answer4"><label for="q20803:277_answer4">e. Increase the risk of major bleeding</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:277_-submit" name="q20803:277_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Access-related complications represent the major reason for hospitalization in dialysis patients, and thrombotic occlusion is the major cause of access failure. Short-term use of antiplatelet agents such as aspirin, sulfinpyrazone, or ticlopidine in the perioperative period has been associated with lower rates of early fistula thrombosis (1). However, previous studies were generally underpowered, and most did not show a statistically significant difference between treatment and placebo groups. In a recent multicenter study of 877 patients undergoing new upper extremity arteriovenous fistulas, half were randomized to clopidogrel (300 mg loading does followed by 75 mg/day) or placebo within one day of surgery and continued for six weeks (2). Although the frequency of early fistula thrombosis was lower in the clopidogrel group (12.2% vs. 19.5% placebo group, P = .018), there was no difference in the proportion of fistulas that became suitable for dialysis. Likewise, there were no differences in the frequency or severity of bleeding events, technical complications, or frequency of hospitalization.</p>
<p>&nbsp;</p>
<p>References</p>
<p>1. Kaufman JS. Antithrombotic agents and the prevention of access thrombosis. Semin Dial 2000; 13: 40-46.</p>
<p>2. Dember LM, Beck GJ, Allon M, Delmez JA, et al. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis. JAMA 2008; 299 (18): 2164-2171.</p>
<p>QID: 30462</p></div><div class="rightanswer">The correct answer is: Decrease the risk of early thrombosis</div></div></div></div></div><div id="q98" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">536</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4988"><input type="hidden" name="q20803:98_:flagged" value="0"><input type="hidden" value="qaid=910982&amp;qubaid=20803&amp;qid=4919&amp;slot=98&amp;checksum=cba8b28b16fa0b0b0b1bab6e1f2c39b3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:98_:flaggedcheckbox" name="q20803:98_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q98&id=4919"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:98_:sequencecheck" value="2"><div class="qtext"><p><span>A 7-year-old boy presents with a left leg 2.5 cm shorter than his right 11 months after sustaining an iatrogenic left femoral artery injury that was managed with an autogenous interposition graft. Which of the following statements regarding this boy's condition is&nbsp;<strong>true</strong><strong>?</strong></span></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:98_answer" disabled="disabled" value="0" id="q20803:98_answer0"><label for="q20803:98_answer0">a. <span>routine follow-up should include bi-annual angiograms</span></label> </div>
<div class="r1"><input type="radio" name="q20803:98_answer" disabled="disabled" value="1" id="q20803:98_answer1"><label for="q20803:98_answer1">b. <span>the frequency of this condition is 12-25%</span></label> </div>
<div class="r0"><input type="radio" name="q20803:98_answer" disabled="disabled" value="2" id="q20803:98_answer2"><label for="q20803:98_answer2">c. <span>revascularization is indicated in symptomatic extremity arterial insufficiency in growing children</span></label> </div>
<div class="r1"><input type="radio" name="q20803:98_answer" disabled="disabled" value="3" id="q20803:98_answer3"><label for="q20803:98_answer3">d. <span>early revascularization restores limb length by 1 year post surgery</span></label> </div>
<div class="r0"><input type="radio" name="q20803:98_answer" disabled="disabled" value="4" id="q20803:98_answer4"><label for="q20803:98_answer4">e. <span>operative revascularization is only indicated in asymptomatic children who are still growing</span></label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:98_-submit" name="q20803:98_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Long-term follow-up in pediatric patients with femoral artery injuries notes a 33-50% rate of ipsilateral limb shortening. Growing children require an aggressive approach when managing arterial insufficiency to prevent limb-length discrepancy. The diagnosis of limb-length discrepancy involves extremity plain x-ray films and measurement of bone length, given that external measurements are inaccurate. Symptomatic arterial insufficiency (gait disturbances, claudication, changes in ABI) require investigation and intervention. Revascularization is indicated for symptomatic extremity arterial insufficiency in a growing child or adolescent. However, the revascularization does not always lead to the reversal or amelioration of the limb-length discrepancy.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/985076" target="_blank">Whitehouse WM, Coran AG, Stanley JC, Kuhns LR, Weintraub WH, Fry WJ. Pediatric vascular trauma. Manifestations, management, and sequelae of extremity arterial injury in patients undergoing surgical treatment. Arch Surg 1976;111(11):1269–75.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ann+Surg+1983%3B198(4)%3A430%E2%80%9342." target="_blank">Flanigan DP, Keifer TJ, Schuler JJ, Ryan TJ, Castronuovo JJ. Experience with iatrogenic pediatric vascular injuries. Incidence, etiology, management, and results. Ann Surg 1983;198(4):430–42.</a></p>
<p>Heinzerling N, Sato T. Pediatric Vascular Injuries. Clinical Review of Vascular Trauma. Dua et al. Springer-Verlag Berlin Heidelberg&nbsp;2014.</p>
<p>QID: 30149</p></div><div class="rightanswer">The correct answer is: <span>revascularization is indicated in symptomatic extremity arterial insufficiency in growing children</span></div></div></div></div></div><div id="q251" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">537</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_4997"><input type="hidden" name="q20803:251_:flagged" value="0"><input type="hidden" value="qaid=911135&amp;qubaid=20803&amp;qid=4980&amp;slot=251&amp;checksum=afa79e01f5bf460058eabf5338fe8e7c&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:251_:flaggedcheckbox" name="q20803:251_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q251&id=4980"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:251_:sequencecheck" value="2"><div class="qtext"><p>A thin, 65-year-old woman presents for managment of AV access. She had a left forearm&nbsp;brachial artery&nbsp;- brachial vein&nbsp;AV graft&nbsp;two years ago, which is now functioning poorly. The access has undergone multiple salvage attempts and angiography reveals it to be unsalvageable. She has normal pulses in the brachial, radial, and ulnar arteries bilaterally. Which of the following is the next step in access construction?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:251_answer" disabled="disabled" value="0" id="q20803:251_answer0"><label for="q20803:251_answer0">a. wait until the access fails, and then place a new access after vein mapping the patient</label> </div>
<div class="r1"><input type="radio" name="q20803:251_answer" disabled="disabled" value="1" id="q20803:251_answer1"><label for="q20803:251_answer1">b. plan AV access in the right arm</label> </div>
<div class="r0"><input type="radio" name="q20803:251_answer" disabled="disabled" value="2" id="q20803:251_answer2"><label for="q20803:251_answer2">c. place AV fistula in the left upper arm</label> </div>
<div class="r1"><input type="radio" name="q20803:251_answer" disabled="disabled" value="3" id="q20803:251_answer3"><label for="q20803:251_answer3">d. vein map both upper extremities to assess for possible autogenous AV access sites, and then proceed with access placement</label> </div>
<div class="r0"><input type="radio" name="q20803:251_answer" disabled="disabled" value="4" id="q20803:251_answer4"><label for="q20803:251_answer4">e. place a new AV graft in the left upper arm</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:251_-submit" name="q20803:251_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Most dialysis patients whose access is failing will have one or more sites suitable for autogenous AV fistula placement. Vessel mapping is critical in the evaluation of failing AV grafts to determine what options are available for the patient. Placing a fistula and allowing it to mature while the old access is still functioning is superior to allowing it to fail and placing a central venous catheter emergently and then having to continue with the catheter until access maturation.&nbsp;</p>
<p>&nbsp;</p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Seminars+in+Dialysis+2008%3B+21(5)%3A474-82." target="_blank">Slayden GC.&nbsp; Spergel L.&nbsp; Jennings WC.&nbsp;Secondary arteriovenous fistulas: converting prosthetic AV grafts to autogenous dialysis access. Semin Dial2008; 21(5):474-82.</a></p>
<p><span>QID: 30435</span></p></div><div class="rightanswer">The correct answer is: vein map both upper extremities to assess for possible autogenous AV access sites, and then proceed with access placement</div></div></div></div></div><div id="q138" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">538</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5006"><input type="hidden" name="q20803:138_:flagged" value="0"><input type="hidden" value="qaid=911022&amp;qubaid=20803&amp;qid=4755&amp;slot=138&amp;checksum=193edf6c3930d3bea33b4754ff0f7fb4&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:138_:flaggedcheckbox" name="q20803:138_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q138&id=4755"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:138_:sequencecheck" value="2"><div class="qtext"><p><span>A 52-year-old man with a history of end stage renal disease (ESRD) presents for evaluation of painful skin lesions on the fingers of both hands. They have been present for several months and he denies any history of injury, trauma, or substance abuse. The lesions are black and tender (see figure below), and he has a similar ulcer on his penis. Bilateral radial and ulnar pulses are palpable bilaterally, and non-invasive upper extremity arterial studies demonstrate non-compressible vessels. &nbsp;Which of the following tests would be most likely to specifically inform diagnosis and treatment?</span></p>
<p><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images"><img src="./VESAP3_files/calciphylaxis of fingers.jpg" alt="calciphylaxis of fingers" width="100"></a></p></div><div class="ablock"><div class="prompt"><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images">Select one:</a></div><div class="answer"><div class="r0"><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images"><input type="radio" name="q20803:138_answer" disabled="disabled" value="0" id="q20803:138_answer0"><label for="q20803:138_answer0">a. Erythrocyte sedimentation rate</label> </a></div><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images">
<div class="r1"><input type="radio" name="q20803:138_answer" disabled="disabled" value="1" id="q20803:138_answer1"><label for="q20803:138_answer1">b. D-dimer</label> </div>
<div class="r0"><input type="radio" name="q20803:138_answer" disabled="disabled" value="2" id="q20803:138_answer2"><label for="q20803:138_answer2">c. C-reactive protein</label> </div>
<div class="r1"><input type="radio" name="q20803:138_answer" disabled="disabled" value="3" id="q20803:138_answer3"><label for="q20803:138_answer3">d. Hemoglobin A1C</label> </div>
<div class="r0"><input type="radio" name="q20803:138_answer" disabled="disabled" value="4" id="q20803:138_answer4"><label for="q20803:138_answer4">e. Parathyroid hormone</label> </div>
</a></div></div><div class="im-controls"><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images"><input type="submit" id="q20803:138_-submit" name="q20803:138_-submit" value="Check" class="submit btn" disabled="disabled"></a></div></div><div class="outcome"><h4 class="accesshide"><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images">Feedback</a></h4><div class="feedback"><div class="specificfeedback"><p><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images">Your answer is incorrect.</a></p></div><div class="generalfeedback"><p><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images">Calciphylaxis is associated with tender skin lesions that progress to necrotic ulcers; it is also more common among patients with ESRD on chronic hemodialysis. The lesions most commonly appear on the extremities (see picture). &nbsp;Calciphylaxis is typically characterized by abnormal calcium and phosphate metabolism, which results in vascular wall calcification of small arterioles and venules leading to thrombosis and skin necrosis. Peripheral pulses may be normal despite the severity of skin necrosis. Definitive diagnosis is made by clinical history and skin biopsy, which demonstrates the classic findings of arterial calcification. &nbsp; Among patients with calciphylaxis, who have abnormal calcium metabolism and/or hyperparathyroidism, medications (such as phosphate binders, sodium thiosulfate, or Cinacalcet) and/or parathyroidectomy may improve wound healing and short-term mortality.&nbsp; Less commonly, calciphylaxis may also occur in the absence of kidney disease; other risk factors include liver disease and corticosteroid use.</a></p><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images">
<p><img src="./VESAP3_files/calciphylaxis.png" alt="calciphylaxis" width="367" height="408"></p>
<p align="center">&nbsp;</p>
<p style="text-align: left;" align="center">&nbsp;</p>
<h2 style="text-align: left;" align="center">References:&nbsp;</h2>
</a><p><a href="./VESAP3_files/calciphylaxis of fingers.jpg" target="images"></a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surg+Clin+N+Am.+2010%3B90(6)%3A1161" target="_blank">Panuncialman J, Falanga V. Unusual Causes of Cutaneous Ulceration. Surg Clin North Am 2010; 90(6):1161-80.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Diethelm+AG.+Therapy+for+calciphylaxis%3A+An+outcome+analysis." target="_blank">Arch-Ferrer JE, Beenken SW, Rue LW, Bland KI, Diethelm AG. Therapy for calciphylaxis: An outcome analysis. Surgery 2003;134(6):941-4.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Dermatol+Ther+2011%3B+24(2)%3A256-62" target="_blank">Ng AT, Peng DH. Calciphylaxis. Dermatol Ther 2011; 24(2):256-62.</a></p>
<p>QID: 30231</p></div><div class="rightanswer">The correct answer is: Parathyroid hormone</div></div></div></div></div><div id="q275" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">539</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5015"><input type="hidden" name="q20803:275_:flagged" value="0"><input type="hidden" value="qaid=911159&amp;qubaid=20803&amp;qid=5012&amp;slot=275&amp;checksum=2263faf4f3b565085b2bf2fbd6d919d3&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:275_:flaggedcheckbox" name="q20803:275_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q275&id=5012"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:275_:sequencecheck" value="2"><div class="qtext"><p>Regarding use of the proximal radial artery as an inflow site for hemodialysis access, which of the following statements is <strong>true</strong>?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:275_answer" disabled="disabled" value="0" id="q20803:275_answer0"><label for="q20803:275_answer0">a. autogenous arteriovenous accesses based on the proximal radial artery have inferior primary patency rates when compared to upper arm prosthetic arteriovenous grafts</label> </div>
<div class="r1"><input type="radio" name="q20803:275_answer" disabled="disabled" value="1" id="q20803:275_answer1"><label for="q20803:275_answer1">b. autogenous arteriovenous accesses with inflow from the proximal radial artery have an increased risk of ischemic complications when compared with brachial artery based autogenous accesses</label> </div>
<div class="r0"><input type="radio" name="q20803:275_answer" disabled="disabled" value="2" id="q20803:275_answer2"><label for="q20803:275_answer2">c. proximal radial artery inflow is contraindicated in patients with calcification of the radial and ulnar arteries at the wrist</label> </div>
<div class="r1"><input type="radio" name="q20803:275_answer" disabled="disabled" value="3" id="q20803:275_answer3"><label for="q20803:275_answer3">d. proximal radial artery inflow can result in bidirectional flow by disruption of venous valves in the forearm cephalic vein</label> </div>
<div class="r0"><input type="radio" name="q20803:275_answer" disabled="disabled" value="4" id="q20803:275_answer4"><label for="q20803:275_answer4">e. proximal radial artery inflow is a poor choice for prosthetic arteriovenous access</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:275_-submit" name="q20803:275_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The proximal radial artery can provide excellent&nbsp;inflow for autogenous and prosthetic arteriovenous accesses. This option can be used in diabetics even in the presence of extensive calcification of the distal radial and ulnar arteries at the wrist. Bidirectional flow into the forearm can be established by disruption of valves in the forearm cephalic vein.&nbsp; Ischemic complications are minimized with proximal radial artery inflow when compared to use of the brachial artery for inflow.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/12831925" target="_blank">Bruns SD, Jennings WC. Proximal radial artery as inflow site for native arteriovenous fistula.&nbsp; J Am Coll Surg 2003;197:58-63.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B48%3A2S-25S." target="_blank">Sidawy AN, Spergel LM, Besarab A, Allon M,&nbsp;Jennings WC,&nbsp;Padberg FT Jr,&nbsp;et al.: The Society for Vascular Surgery: Clinical practice guidelines for the surgical placement and maintenance of arteriovenous hemodialysis access.&nbsp; J Vasc Surg 2008; 48:2S-25S.</a></p>
<p>QID: 30460</p>
<p>&nbsp;</p></div><div class="rightanswer">The correct answer is: proximal radial artery inflow can result in bidirectional flow by disruption of venous valves in the forearm cephalic vein</div></div></div></div></div><div id="q352" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">540</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5024"><input type="hidden" name="q20803:352_:flagged" value="0"><input type="hidden" value="qaid=911236&amp;qubaid=20803&amp;qid=5145&amp;slot=352&amp;checksum=32e05d33d964c8410a0a3cf8375004ef&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:352_:flaggedcheckbox" name="q20803:352_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q352&id=5145"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:352_:sequencecheck" value="2"><div class="qtext"><p>A 43-year-old woman presents with 3-drug, refractory hypertension. Renal artery duplex scanning suggests bilateral renal artery stenoses. She undergoes arteriography, with a representative image shown below. Similar pathology was demonstrated on the contralateral side. Which of the following is the most appropriate treatment option for this patient?<br><br><a href="./VESAP3_files/AssetProxy_156.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_156.jpg" alt="img" width="100" height="93" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:352_answer" disabled="disabled" value="0" id="q20803:352_answer0"><label for="q20803:352_answer0">a. unilateral renal artery stenting, followed by contralateral stenting 6 weeks later</label> </div>
<div class="r1"><input type="radio" name="q20803:352_answer" disabled="disabled" value="1" id="q20803:352_answer1"><label for="q20803:352_answer1">b. concomitant bilateral renal artery balloon expandable stenting</label> </div>
<div class="r0"><input type="radio" name="q20803:352_answer" disabled="disabled" value="2" id="q20803:352_answer2"><label for="q20803:352_answer2">c. bilateral aorto-renal artery bypass grafting with greater saphenous vein</label> </div>
<div class="r1"><input type="radio" name="q20803:352_answer" disabled="disabled" value="3" id="q20803:352_answer3"><label for="q20803:352_answer3">d. bilateral renal artery balloon angioplasty</label> </div>
<div class="r0"><input type="radio" name="q20803:352_answer" disabled="disabled" value="4" id="q20803:352_answer4"><label for="q20803:352_answer4">e. antiplatelet therapy alone with repeat duplex in 6 months</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:352_-submit" name="q20803:352_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Renal artery fibromuscular dysplasia (FMD) is responsible for a minority of renovascular hypertension cases. The medial fibroplasia variant is the most common pathology. This variant is characterized angiographically by web-like stenoses alternating with mural microaneuryms, creating a so-called "string-of-beads". Typically, renal artery FMD responds to angioplasty alone, and stents are not only unnecessary, but lead to a higher incidence of restenosis. A recognized risk of angioplasty, however, is the creation of a local dissection that could require a stent. In a series of 29 patients with FMD, reported by Davies and colleagues, 13% of arteries treated with angioplasty required secondary stenting for technical failures or flow-limiting dissections. The outcomes for endovascular therapy of FMD are generally superior to those obtained for atherosclerosis. Davies observed an improvement or cure of blood pressure in 72% of patients. In that study, Davies found that "predictors of long-term clinical benefit were duration of hypertension &lt; 8 years, creatinine &lt; 1.5 mg/dL, ipsilateral kidney size &gt; 9 cm, functional status of the contralateral kidney, a fasting blood glucose &lt; 110 mg/dL, triglycerides &lt; 150 mg/dL, and high-density lipoprotein &gt; 50 mg/dL". Interestingly, statin use or age &lt;50 years were not predictors of a favorable clinical response in Davies' series. While staging the two renal artery interventions is an option, there is no clear benefit to this approach; also, another procedure would be required. Aorto-renal bypass is another option, but would require a much more invasive procedure. With extension of the FMD into the branch renal arteries, an ex vivo repair may be required if surgical revascularization is pursued. Antiplatelet therapy alone will not resolve the hypertension; thus, it is not an appropriate option for a young patient with reasonable options for intervention. <br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Davies%20MG,%20Saad%20WE,%20Peden%20EK,%20et%20al.%20The%20long-term%20outcomes%20of%20percutaneous%20therapy%20for%20renal%20artery%20fibromuscular%20dysplasia.%20J%20Vasc%20Surg;%202008;%2048%20(4):865-871" target="_blank">Davies MG, Saad WE, Peden EK, Mohiuddin IT<span>,&nbsp;</span>Naoum JJ<span>,&nbsp;</span>Lumsden AB. The long-term outcomes of percutaneous therapy for renal artery fibromuscular dysplasia. J Vasc Surg 2008; 48(4):865-71.</a><br><br>Stanley JC, Wakefield TW. Arterial fibrodysplasia. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders; 2005:431-47.</p>
<p>QID: 30619</p></div><div class="rightanswer">The correct answer is: bilateral renal artery balloon angioplasty</div></div></div></div></div><div id="q393" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">541</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5033"><input type="hidden" name="q20803:393_:flagged" value="0"><input type="hidden" value="qaid=911277&amp;qubaid=20803&amp;qid=5044&amp;slot=393&amp;checksum=08b895493c78ca3c6388aff821afc646&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:393_:flaggedcheckbox" name="q20803:393_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q393&id=5044"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:393_:sequencecheck" value="2"><div class="qtext"><p>An ultrasound exam was performed in the standing position to assess the lower extremity veins of a woman who presented with burning sensation, telangiectasias, and prominent superficial veins. According to the duration of the retrograde flow (valve closure time), which of the following veins has reflux?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:393_answer" disabled="disabled" value="0" id="q20803:393_answer0"><label for="q20803:393_answer0">a. popliteal vein: 400 ms</label> </div>
<div class="r1"><input type="radio" name="q20803:393_answer" disabled="disabled" value="1" id="q20803:393_answer1"><label for="q20803:393_answer1">b. posterior tibial vein: 400 ms</label> </div>
<div class="r0"><input type="radio" name="q20803:393_answer" disabled="disabled" value="2" id="q20803:393_answer2"><label for="q20803:393_answer2">c. great saphenous vein in the thigh: 300 ms</label> </div>
<div class="r1"><input type="radio" name="q20803:393_answer" disabled="disabled" value="3" id="q20803:393_answer3"><label for="q20803:393_answer3">d. small saphenous vein: 750 ms</label> </div>
<div class="r0"><input type="radio" name="q20803:393_answer" disabled="disabled" value="4" id="q20803:393_answer4"><label for="q20803:393_answer4">e. great saphenous vein in the calf: 450 ms</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:393_-submit" name="q20803:393_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Reflux in the superficial veins has been defined as a retrograde flow of &gt;500 ms. The same value is used for the deep calf veins (muscular and axial) and for the deep femoral vein. The cut-off value for reflux in the common femoral, femoral, and popliteal veins has been reported to be 1000 ms in one study and &gt;500 ms in other reports. The duplex ultrasound test is performed in the standing position since the supine position can result in more false negative examinations. All would agree that valve closure times &lt;500 ms are normal.<br><br></p>
<h2>Reference:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2003%3B+38+(4)%3A793-98." target="_blank">Labropoulos N, Tiongson J, Pryor L, Tassiopoulos AK<span>,&nbsp;</span>Kang SS<span>,&nbsp;</span>Ashraf Mansour M<span>,&nbsp;</span>et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg 2003; 38 (4):793-98.</a></p>
<p>QID: 30710</p></div><div class="rightanswer">The correct answer is: small saphenous vein: 750 ms</div></div></div></div></div><div id="q190" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">542</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5042"><input type="hidden" name="q20803:190_:flagged" value="0"><input type="hidden" value="qaid=911074&amp;qubaid=20803&amp;qid=4558&amp;slot=190&amp;checksum=284063cb60975cd2c5a3c1db04e55a35&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:190_:flaggedcheckbox" name="q20803:190_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q190&id=4558"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:190_:sequencecheck" value="2"><div class="qtext"><p>A 55 year old woman with a 50 pack-year smoking history presents to the emergency room complaining of a sudden onset of right arm pain, paralysis and numbness as well as transient left arm weakness. She reports that over the last year, her right arm has become fatigued when she is styling her hair, and her blood pressure is always lower on the right.&nbsp; On exam, her right hand is cyanotic and cool, and only Doppler signals are detectable in the brachial, radial and ulnar arteries. She has a weakly palpable carotid pulse on the right. On the left, the carotid, brachial, radial and ulnar pulses are strongly palpable. CT angiogram of the chest demonstrates calcified origins of the great vessels, a homogenous filling defect in the innominate artery extending into the origins of the right common carotid and subclavian arteries, and a dominant left vertebral artery.&nbsp;&nbsp; By the time the CT scan is completed, the patient’s arm symptoms have improved significantly.&nbsp; The best management for this patient is:</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:190_answer" disabled="disabled" value="0" id="q20803:190_answer0"><label for="q20803:190_answer0">a. Heparinization, brachial artery cutdown, retrograde thrombectomy of the innominate artery using an over-the-wire balloon under fluoroscopy</label> </div>
<div class="r1"><input type="radio" name="q20803:190_answer" disabled="disabled" value="1" id="q20803:190_answer1"><label for="q20803:190_answer1">b. Heparinization and observation&nbsp;</label> </div>
<div class="r0"><input type="radio" name="q20803:190_answer" disabled="disabled" value="2" id="q20803:190_answer2"><label for="q20803:190_answer2">c. Heparinization, retrograde thrombectomy through the right brachial and carotid arteries, retrograde stenting of the origin of the innominate artery</label> </div>
<div class="r1"><input type="radio" name="q20803:190_answer" disabled="disabled" value="3" id="q20803:190_answer3"><label for="q20803:190_answer3">d. Heparinization, placement of an infusion catheter into the right subclavian artery from a femoral approach, initiation of lysis followed by stenting of the innominate artery origin the following day</label> </div>
<div class="r0"><input type="radio" name="q20803:190_answer" disabled="disabled" value="4" id="q20803:190_answer4"><label for="q20803:190_answer4">e. Heparinization, retrograde thrombectomy of the innominate and right common carotid artery, and right carotid subclavian bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:190_-submit" name="q20803:190_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The patient presents with a TIA and arm ischemia secondary to clot that has developed in the innominate artery, likely from inflow disease. In a recent meta-analysis evaluating results of endarterectomy with angioplasty and stenting of proximal common carotid or innominate artery tandem &nbsp;lesion, the technical success rate was 97%.&nbsp; Thirty day mortality and stroke rates were 0.7 and 1.5%, respectively. In this case, the clot extends to the origins of the right common carotid and subclavian arteries.&nbsp; Any management strategy must be cognizant of the risk of embolization and stroke during manipulation. Thus, retrograde thrombectomy through the brachial and carotid arteries maintains control of the proximal carotid artery during any manipulation, is expeditious and would be appropriate in this setting. Right carotid subclavian bypass after thrombectomy is not correct because her history and CT suggests inflow disease at the origin of the innominate artery, which needs to be addressed before bypass.&nbsp; Over the wire thrombectomy as described does not allow for control of the common carotid artery on the right during manipulation. Similarly, a femoral approach with placement of the infusion catheter in the right subclavian artery does not address embolization risk to the common carotid artery. &nbsp;It is not uncommon for symptoms of arm ischemia to improve after the initial embolic or thrombotic event to the upper extremity vessels. However, symptom improvement does not justify non-operative management in the setting of acute arm ischemia from embolus, unless the patient’s clinical status is not stable for other reasons.</p>
<p>&nbsp;</p>
<p>References:</p>
<p>1. Sfyroeras GS, Karathanos C, Antoniou GA, et al. A meta-analysis of combined endarterectomy and proximal balloon angioplasty for tandem disease of the arch vessels and carotid bifurcation. J Vasc Surg 2011; 54(2):534-40. <a href="http://www.ncbi.nlm.nih.gov/pubmed/21684709">http://www.ncbi.nlm.nih.gov/pubmed/21684709</a></p>
<p>QID: 30335</p></div><div class="rightanswer">The correct answer is: Heparinization, retrograde thrombectomy through the right brachial and carotid arteries, retrograde stenting of the origin of the innominate artery</div></div></div></div></div><div id="q252" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">543</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5051"><input type="hidden" name="q20803:252_:flagged" value="0"><input type="hidden" value="qaid=911136&amp;qubaid=20803&amp;qid=1933&amp;slot=252&amp;checksum=3efaf7080c336570c1a223d9a7ecb8bc&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:252_:flaggedcheckbox" name="q20803:252_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q252&id=1933"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:252_:sequencecheck" value="2"><div class="qtext">A 78 year old, mildly obese Caucasian male presents for progressive CKD.&nbsp; He is expected to need hemodialysis within the next 6 months.&nbsp; He has DM, CAD, and has undergone CABG with saphenous harvest bilaterally in the past.&nbsp; He is right handed.&nbsp; He gives a history of severe, short distance claudication bilaterally at less than 1/2 block.&nbsp; He denies rest pain.&nbsp; He has no visible veins in his upper extremities on visual evaluation.&nbsp; He also complains of upper extremity pain with use bilaterally, worse on the left side.&nbsp; He does not have any tissue loss in the upper or lower extremities. He has 2+ femoral pulses bilaterally, and 1+ brachial pulses, with no pedal pulses.&nbsp; Blood pressure is 160/80 on the right and 130/70 on the left. The radial and ulnar pulses are not palpable bilaterally.&nbsp;&nbsp; The next step in assessment should include:</div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:252_answer" disabled="disabled" value="0" id="q20803:252_answer0"><label for="q20803:252_answer0">a. Placement of a permacath for permanent dialysis with no plan for other av access placement</label> </div>
<div class="r1"><input type="radio" name="q20803:252_answer" disabled="disabled" value="1" id="q20803:252_answer1"><label for="q20803:252_answer1">b. Vein map and arterial duplex of both upper extremities prior to planning access creation</label> </div>
<div class="r0"><input type="radio" name="q20803:252_answer" disabled="disabled" value="2" id="q20803:252_answer2"><label for="q20803:252_answer2">c. Vein map of both upper extremities, and then proceed with fistula creation</label> </div>
<div class="r1"><input type="radio" name="q20803:252_answer" disabled="disabled" value="3" id="q20803:252_answer3"><label for="q20803:252_answer3">d. Arteriogram of both upper extremities, and then proceeding with AV fistula placement</label> </div>
<div class="r0"><input type="radio" name="q20803:252_answer" disabled="disabled" value="4" id="q20803:252_answer4"><label for="q20803:252_answer4">e. Vein map of both lower extremities for possible access creation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:252_-submit" name="q20803:252_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This elderly, diabetic patient with PAD merits both arterial and venous assessment prior to any access creation.</p>
<p>Routine preoperative vascular ultrasound improves patency and use of arteriovenous fistulas for hemodialysis: a randomized trial, Ferring M.&nbsp; Claridge M.&nbsp; Smith SA.&nbsp; Wilmink T. Clinical Journal of The American Society of Nephrology: CJASN.&nbsp; 5(12):2236-44, 2010 Dec.</p>
<p>Vascular ultrasound for the pre-operative evaluation prior to arteriovenous fistula formation for haemodialysis: review of the evidence.&nbsp; Ferring M.&nbsp; Henderson J.&nbsp; Wilmink A.&nbsp; Smith S., Nephrology Dialysis Transplantation.&nbsp; 23(6):1809-15, 2008 Jun.</p>
<p><span>QID: 30436</span></p></div><div class="rightanswer">The correct answer is: Vein map and arterial duplex of both upper extremities prior to planning access creation</div></div></div></div></div><div id="q219" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">544</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5060"><input type="hidden" name="q20803:219_:flagged" value="0"><input type="hidden" value="qaid=911103&amp;qubaid=20803&amp;qid=4714&amp;slot=219&amp;checksum=6e909e4e27cbed82c414a66e57a88d3b&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:219_:flaggedcheckbox" name="q20803:219_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q219&id=4714"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:219_:sequencecheck" value="2"><div class="qtext"><p>A 61-year-old woman has a 5-minute episode of left hand and leg weakness but then it resolves completely. She also complains of right arm claudication. A CT angiogram demonstrates a 90% innominate artery stenosis extending into the right subclavian and proximal right common carotid artery. There is no significant stenosis of the right internal carotid artery. Which of the following is the most appropriate management option for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:219_answer" disabled="disabled" value="0" id="q20803:219_answer0"><label for="q20803:219_answer0">a. aorta to innominate artery bypass</label> </div>
<div class="r1"><input type="radio" name="q20803:219_answer" disabled="disabled" value="1" id="q20803:219_answer1"><label for="q20803:219_answer1">b. observation</label> </div>
<div class="r0"><input type="radio" name="q20803:219_answer" disabled="disabled" value="2" id="q20803:219_answer2"><label for="q20803:219_answer2">c. innominate artery endarterectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:219_answer" disabled="disabled" value="3" id="q20803:219_answer3"><label for="q20803:219_answer3">d. right carotid-subclavian bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:219_answer" disabled="disabled" value="4" id="q20803:219_answer4"><label for="q20803:219_answer4">e. aorta to right subclavian and common carotid artery bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:219_-submit" name="q20803:219_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Surgical reconstruction of the supra-aortic vessels can be an effective treatment for good risk patients with symptomatic occlusive disease of the arch vessels. This patient's presentation&nbsp;indicates that the occlusive disease in the common carotid and subclavian arteries&nbsp;are causing symptoms; thus, observation is not warranted. Neither endarterectomy of the innominate artery nor aorto-innominate artery bypass would effectively treat occlusive disease extending into the carotid and subclavian arteries. A right carotid-subclavian bypass is not indicated. A bifurcated graft or creation of a&nbsp;branched graft can be used to treat this patient's disease. Ligation of the proximal diseased&nbsp;arteries will prevent continued embolization from the plaque in the proximal common carotid artery. Alternatively, the distal anastomoses may be end to end.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9950982" target="_blank">Berguer R, Morasch MD, Kline RA, Kazmers A, Friedland MS.&nbsp;Cervical&nbsp;reconstruction&nbsp;of the&nbsp;supra-aortic&nbsp;trunks: a 16-year experience.&nbsp;J Vasc Surg&nbsp;1999; 29:239-46.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9142155" target="_blank">Ligush J Jr, Criado E, Keagy BA. Innominate artery&nbsp;occlusive disease: management with central reconstructive techniques.&nbsp;Surgery 1997; 121(5):556-62.</a></p>
<p>QID: 30370</p></div><div class="rightanswer">The correct answer is: aorta to right subclavian and common carotid artery bypass</div></div></div></div></div><div id="q134" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">545</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5069"><input type="hidden" name="q20803:134_:flagged" value="0"><input type="hidden" value="qaid=911018&amp;qubaid=20803&amp;qid=4751&amp;slot=134&amp;checksum=e6632adeec3de42083dbe61904a396a0&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:134_:flaggedcheckbox" name="q20803:134_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q134&id=4751"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:134_:sequencecheck" value="2"><div class="qtext"><p>A 57-year-old woman presents with a 4-week history of progressive right forearm and hand pain. Her right arm is cool and pale from the elbow distally. Hand strength seems preserved. While the left arm pulses are normal, the right brachial and wrist pulses are not palpable. She has no history of arrhythmias, palpitations, or cardiac conditions; the electrocardiogram (ECG) is unremarkable. A CT angiography (CTA) was obtained and reconstruction is shown below. Which of the following is the most appropriate procedure for this patient's condition?</p>
<p><a href="./VESAP3_files/CTA UE.png" target="images"><img src="./VESAP3_files/CTA UE.png" alt="CTA UE" width="100"></a></p>

<p><a href="./VESAP3_files/CTA UE 2.jpg" target="images"><img src="./VESAP3_files/CTA UE 2.jpg" alt="CTA UE 2" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:134_answer" disabled="disabled" value="0" id="q20803:134_answer0"><label for="q20803:134_answer0">a. open brachial thrombectomy, followed with 1<sup>st</sup>rib resection, thoracic outlet decompression, and subclavian-axillary bypass/aneurysmectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:134_answer" disabled="disabled" value="1" id="q20803:134_answer1"><label for="q20803:134_answer1">b. carotid-axillary bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:134_answer" disabled="disabled" value="2" id="q20803:134_answer2"><label for="q20803:134_answer2">c. axillo-axillary bypass with proximal and distal ligation of aneurysm</label> </div>
<div class="r1"><input type="radio" name="q20803:134_answer" disabled="disabled" value="3" id="q20803:134_answer3"><label for="q20803:134_answer3">d. covered stent of subclavian artery aneurysm alone</label> </div>
<div class="r0"><input type="radio" name="q20803:134_answer" disabled="disabled" value="4" id="q20803:134_answer4"><label for="q20803:134_answer4">e. catheter-directed thrombolysis of right subclavian artery and subsequent observation</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:134_-submit" name="q20803:134_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The spectrum of arterial thoracic outlet compression has been organized by Scher. The key component to the treatment of arterial TOS with subclavian artery aneurysm is decompression of the costoclavicular space/thoracic outlet, removal of embolic source, and revascularization of the upper extremity. Decompression consists of at least first rib and accessory rib/osseous abnormality resection, and some recommend concomitant scalene muscle resection. Arterial reconstruction can be accomplished with either autogenous or prosthetic conduits and may require a combined supraclavicular and infraclavicular approach. &nbsp;If presentation is acute limb ischemia due to thromboembolism with patent axillosubclavian system (Scher III), then thrombectomy followed by decompression and arterial reconstruction is appropriate. Thrombolysis alone in this case provides incomplete treatment, and subclavian catheter positioning would be inadequate. Further, this patient, as most arterial TOS patients, has had symptoms and likely emboli for a duration, which does not favor a catheter-directed thrombolytic approach. Occasionally, a patient with significant chronic, organized embolic burden may require distal arm revascularization in addition to subclavian aneurysm reconstruction. Covered stenting of the subclavian artery, as well as open extraanatomic revascularizations of the upper extremity, do not completely treat the described pathology.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Staging+of+arterial+complications+of+cervical+rib%3A+guidelines+for+surgical+management" target="_blank">Scher LA, Veith FJ, Haimovichi H, Samson RH,&nbsp;Ascer E,&nbsp;Gupta SK,&nbsp;et al. Staging of arterial complications of cervical rib: guidelines for surgical management. Surgery 1984; 95:664-9.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Surgical+treatment+of+thoracic+outlet+compression+syndromes.++II.+Supraclavicular+exploration+and+vascular+reconstruction" target="_blank">Thompson RW, Petrinec D, Toursarkissian B. Surgical treatment of thoracic outlet compression syndromes. II. Supraclavicular exploration and vascular reconstruction. Ann Vasc Surg 1997;11:442-51.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/9161397" target="_blank">Nehler MR, Taylor LM, Moneta GL, Porter JM. Upper extremity ischemia from subclavian artery aneurysm caused by bony abnormalities of the thoracic outlet. Arch Surg 1997;132:527-32.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Arterial+thoracic+outlet+syndrome%3A+a+32-year+experience." target="_blank">Marine L, Valdes F, Mertens R,<span>&nbsp;</span>Kramer A<span>,&nbsp;</span>Bergoeing M<span>,&nbsp;</span>Urbina J. Arterial thoracic outlet syndrome: a 32-year experience. Ann Vasc Surg 2013; 27:1007-13.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2013%3B57%3A771-5." target="_blank">Chang KZ, Likes K, Davis, Demos J<span>,&nbsp;</span>Freischlag JA. The significance of cervical ribs in thoracic outlet syndrome. J Vasc Surg 2013;57:771-5.</a></p>
<p>QID: 30227</p></div><div class="rightanswer">The correct answer is: open brachial thrombectomy, followed with 1<sup>st</sup>rib resection, thoracic outlet decompression, and subclavian-axillary bypass/aneurysmectomy</div></div></div></div></div><div id="q85" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">546</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5078"><input type="hidden" name="q20803:85_:flagged" value="0"><input type="hidden" value="qaid=910969&amp;qubaid=20803&amp;qid=4899&amp;slot=85&amp;checksum=acbedccd8219e180f1b2e41939f9f796&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:85_:flaggedcheckbox" name="q20803:85_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q85&id=4899"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:85_:sequencecheck" value="2"><div class="qtext"><p>A 23-year-old man involved in a motorcycle accident presents to the trauma bay with multiple lacerations and the injury shown in the image below. His right foot is cold and pulseless but has some intact motor and sensory ability. His left leg is uninjured. His primary and secondary survey are otherwise unremarkable. He has stable vital signs, with a GCS of 15. He is taken to the operating room for a below-ankle bypass. Based on published data, which of the following statements is&nbsp;<strong>true</strong>?</p>
<p><a href="./VESAP3_files/4(4).jpg" target="images"><img src="./VESAP3_files/4(4).jpg" alt="" width="100"></a></p></div><div class="ablock"><div class="prompt"><a href="./VESAP3_files/4(4).jpg" target="images">Select one:</a></div><div class="answer"><div class="r0"><a href="./VESAP3_files/4(4).jpg" target="images"><input type="radio" name="q20803:85_answer" disabled="disabled" value="0" id="q20803:85_answer0"><label for="q20803:85_answer0">a. the overall 1-year foot salvage rate for isolated vascular injury is about 90%</label> </a></div><a href="./VESAP3_files/4(4).jpg" target="images">
<div class="r1"><input type="radio" name="q20803:85_answer" disabled="disabled" value="1" id="q20803:85_answer1"><label for="q20803:85_answer1">b. polytetrafluoroethylene grafts have a 50% 1-year secondary patency rate</label> </div>
<div class="r0"><input type="radio" name="q20803:85_answer" disabled="disabled" value="2" id="q20803:85_answer2"><label for="q20803:85_answer2">c. smoking is an independent risk factor for prolonged wound healing</label> </div>
<div class="r1"><input type="radio" name="q20803:85_answer" disabled="disabled" value="3" id="q20803:85_answer3"><label for="q20803:85_answer3">d. the use of a reversed saphenous vein graft consistently has better outcomes over a 3-year period compared to in-situ vein bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:85_answer" disabled="disabled" value="4" id="q20803:85_answer4"><label for="q20803:85_answer4">e. the 1-year primary patency with reversed saphenous vein is about 70%</label> </div>
</a></div></div><div class="im-controls"><a href="./VESAP3_files/4(4).jpg" target="images"><input type="submit" id="q20803:85_-submit" name="q20803:85_-submit" value="Check" class="submit btn" disabled="disabled"></a></div></div><div class="outcome"><h4 class="accesshide"><a href="./VESAP3_files/4(4).jpg" target="images">Feedback</a></h4><div class="feedback"><div class="specificfeedback"><p><a href="./VESAP3_files/4(4).jpg" target="images">Your answer is incorrect.</a></p></div><div class="generalfeedback"><p><a href="./VESAP3_files/4(4).jpg" target="images">Ankle and below-ankle grafts have similar 1-year primary patency rates to above knee and below knee bypasses, regardless of whether reversed saphenous vein or in-situ vein is used. There is no significant difference in patency between reversed saphenous vein and in-situ vein bypass. However, given the injury shown, an in-situ bypass would not be possible.</a></p><a href="./VESAP3_files/4(4).jpg" target="images">
<p>One-year primary patency with reversed saphenous vein graft is over 80%. Overall foot salvage at 1 year is 93%. While it is true that PTFE grafts have approximately a 50% secondary patency rate, that number is quoted for infrapopliteal grafts; the use of PTFE as a conduit for ankle bypass is rare and outcome data unknown. Wound healing is impaired by the presence of diabetes mellitus. In addition, the presence of renal failure and ischemic tissue loss predicts readmission to the hospital.</p>
<p>&nbsp;</p>
<h2>References:</h2>
</a><p><a href="./VESAP3_files/4(4).jpg" target="images"></a><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg++2006%3B+43%3A498-503" target="_blank">Albers M, Romiti M, Brochado-Neto FC, De Luccia N<span>,&nbsp;</span>Pereira CA<span>.</span>&nbsp;Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg&nbsp; 2006; 43:498-503.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg++2000%3B+32%3A1-12." target="_blank">Wixon CL, Mills JL, Westerband A, Hughes JD<span>,&nbsp;</span>Ihnat DM<span>.</span>&nbsp;An economic appraisal of lower extremity bypass graft maintenance. J Vasc Surg 2000; 32:1-12.</a></p>
<p>QID: 30129</p></div><div class="rightanswer">The correct answer is: the overall 1-year foot salvage rate for isolated vascular injury is about 90%</div></div></div></div></div><div id="q493" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">547</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5087"><input type="hidden" name="q20803:493_:flagged" value="0"><input type="hidden" value="qaid=911377&amp;qubaid=20803&amp;qid=5222&amp;slot=493&amp;checksum=aa3ef148f17fbd331ce4c47ccfe23ff6&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:493_:flaggedcheckbox" name="q20803:493_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q493&id=5222"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:493_:sequencecheck" value="2"><div class="qtext"><p>A 30-year-old man returns to the emergency department with acute onset of shortness of breath 2 days after hospital&nbsp;discharge. His prior hospitalization was for treatment of&nbsp;injuries sustained during a motor vehicle collision, including non-operative management of a subdural hemorrhage, exploratory laparotomy, and open-repair of a tibial fracture.</p>
<p>He appears anxious and in obvious distress: blood pressure 89/55 mm Hg, heart rate 110 bpm, respiratory rate 30/min, and pulse oximetry 92% on room air. A CT angiogram confirms a saddle pulmonary embolus. Troponin I and B-type natriuretic levels are both abnormally elevated.</p>
<p>Which of the following treatment strategies is expected to yield the best survival?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:493_answer" disabled="disabled" value="0" id="q20803:493_answer0"><label for="q20803:493_answer0">a. catheter-based intervention in conjunction with systemic anticoagulation</label> </div>
<div class="r1"><input type="radio" name="q20803:493_answer" disabled="disabled" value="1" id="q20803:493_answer1"><label for="q20803:493_answer1">b. avoidance of open surgical thrombectomy</label> </div>
<div class="r0"><input type="radio" name="q20803:493_answer" disabled="disabled" value="2" id="q20803:493_answer2"><label for="q20803:493_answer2">c. intravenous (systemic) fibrinolysis,&nbsp;initiated&nbsp;with a bolus of alteplase 100 mg</label> </div>
<div class="r1"><input type="radio" name="q20803:493_answer" disabled="disabled" value="3" id="q20803:493_answer3"><label for="q20803:493_answer3">d. anticoagulation with low-molecular weight heparin or a direct thrombin inhibitor</label> </div>
<div class="r0"><input type="radio" name="q20803:493_answer" disabled="disabled" value="4" id="q20803:493_answer4"><label for="q20803:493_answer4">e. anticoagulation with unfractionated heparin and immediate placement of an IVC filter</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:493_-submit" name="q20803:493_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>This patient has a massive pulmonary embolism (PE). The AHA consensus statement defines massive pulmonary embolus as sustained hypotension with a systolic blood pressure &lt;90 mm Hg for 15 minutes or the need for inotropic support, not related to another medical condition. This patient has both serologic evidence of heart strain and myocardial necrosis, based on the elevated B-type natriuretic peptide and troponin I, respectively.</p>
<p>Although systemic fibrinolysis should be strongly considered in patients with massive PE, recent head injury with intracranial hemorrhage is a contraindication, and recent surgery (within 3 weeks) is a relative contraindication.&nbsp; Although anticoagulation should be initiated in the setting of acute PE, it is insufficient in the context of massive PE.</p>
<p>Catheter-based interventions such as aspiration or rheolytic thrombectomy can be performed when systemic fibrinolysis is contraindicated. When catheter-based interventions are not available, open surgical thrombectomy should be considered.&nbsp; Despite past reports of prohibitive operative mortality rates, contemporary data suggest an acceptably low mortality risk, with a 4-year survival rate of 96%. In patients with poor cardiopulmonary reserve, in whom an additional embolism may be fatal, it is reasonable to consider IVC filter placement.&nbsp; Registry data suggest a decreased mortality rate in this subset of patients with massive PE.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation.+2011+Apr+26%3B123(16)%3A1788-830." target="_blank">Jaff MR, McMurtry MS, Archer SL, Cushman M, Goldenberg N, Goldhaber SZ, et al. Management of massive and submissive pulmonary&nbsp;embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary &nbsp;hypertension: a scientific statement from the American Heart Association.&nbsp;Circulation 2011; 123(16):1788-830. Erratum in: Circulation. 2012 Aug 14;126(7):e104. Circulation. 2012;125(11):e495.&nbsp;</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Chest+2012%3B141(2+Suppl)%3A7S-47S." target="_blank">Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ; American College&nbsp;of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel.&nbsp;Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed:&nbsp;American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.&nbsp;Chest 2012;141(2 Suppl):7S-47S. Erratum in:&nbsp;Chest. 2012 Dec;142(6):1698. Dosage error in article text. Chest. 2012&nbsp;Apr;141(4):1129. Dosage error in article text.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Semin+Respir+Crit+Care+Med.+2012+Apr%3B33(2)%3A176-85." target="_blank">Imberti D, Maraldi C, Gallerani M. Interventional approaches in VTE treatment&nbsp;(vena cava filters, catheter-guided thrombolysis, thrombosuction). Semin Respir&nbsp;Crit Care Med. 2012; 33(2):176-85.&nbsp;</a></p>
<p>QID: 30860</p></div><div class="rightanswer">The correct answer is: catheter-based intervention in conjunction with systemic anticoagulation</div></div></div></div></div><div id="q210" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">548</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5096"><input type="hidden" name="q20803:210_:flagged" value="0"><input type="hidden" value="qaid=911094&amp;qubaid=20803&amp;qid=4702&amp;slot=210&amp;checksum=40352b80fe12ade7782c696274041149&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:210_:flaggedcheckbox" name="q20803:210_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q210&id=4702"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:210_:sequencecheck" value="2"><div class="qtext"><p>A 34-year-old right handed woman presents with a headache and a sudden onset of neck pain following a chiropractic manipulation of her neck for stress. She is intact neurologically. A CT scan of her head and neck demonstrated a left vertebral artery dissection in the V2-V3 segment without evidence of intracranial hemorrhage. At this time, which of the following is the appropriate management of care for this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:210_answer" disabled="disabled" value="0" id="q20803:210_answer0"><label for="q20803:210_answer0">a. coil occlusion to prevent embolization</label> </div>
<div class="r1"><input type="radio" name="q20803:210_answer" disabled="disabled" value="1" id="q20803:210_answer1"><label for="q20803:210_answer1">b. carotid to distal vertebral artery bypass with saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:210_answer" disabled="disabled" value="2" id="q20803:210_answer2"><label for="q20803:210_answer2">c. observation and anticoagulation</label> </div>
<div class="r1"><input type="radio" name="q20803:210_answer" disabled="disabled" value="3" id="q20803:210_answer3"><label for="q20803:210_answer3">d. vertebral angiography with balloon angioplasty and stenting of the vertebral artery</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:210_-submit" name="q20803:210_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p><img src="./VESAP3_files/vert dissection_2.jpg edit.jpg" alt="" width="206" height="351"></p>
<p>- Image of left vertebral artery dissection with corresponding dilation of distal vertebral artery</p>
<p>Spontaneous vertebral artery dissection is uncommon, but it is also disabling and under diagnosed. It is the most common cause of brainstem ischemia and lateral medullary syndrome in young adults. Clinical presentation can be as benign as an occipital headache and/or neck pain, as well as posterior circulation ischemia. Dissection typically occurs in the distal one third of the vessel where mechanical traction and stretch is maximal and often precipitated by mechanical manipulation. The dissection can progress to intraluminal thrombosis due to compression of the true lumen. The dissection can also extend distally and obstruct flow, compress cranial nerves, and&nbsp;result in subarachnoid hemorrhage. The symptoms on presentation are typically neck or occipital pain, and, in a matter of hours, progress to brainstem ischemia. Atraumatic or spontaneous dissections can occur as a result of hypertension or fibromuscular dysplasia (FMD). Those associated with FMD are typically proximal and occur bilaterally.</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Ahn+SS%2C+Kim+BM%2C+Suh+SH%2C+et+al.++Spontaneous+symptomatic+intracranial+vertebrobasilar+dissection%3A+Initial+and+follow+up+imaging+findins.++Radiology+2012%3B+264%3A196-202." target="_blank">Ahn SS, Kim BM, Suh SH, Kim DJ<span>,&nbsp;</span>Kim DI<span>,&nbsp;</span>Shin YS,&nbsp;et al. Spontaneous symptomatic intracranial vertebrobasilar dissection: Initial and follow up imaging findins. Radiology 2012; 264:196-202.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/16960096" target="_blank">Arnold M, Bousser MG, Fahrni G, Fischer U<span>,&nbsp;</span>Georgiadis D<span>,&nbsp;</span>Gandjour J,&nbsp;et al.&nbsp;Vertebral artery dissection:Presenting findings and predictors of outcom.&nbsp; Stroke 2006; 37:2499-2503. </a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/3368081" target="_blank">Hart, RG. Vertebral artery dissection. Neurology 1988; 38:987-9. </a><a href="http://www.ncbi.nlm.nih.gov/pubmed/16960096" target="_blank"><br></a></p>
<p>QID: 30360</p></div><div class="rightanswer">The correct answer is: observation and anticoagulation</div></div></div></div></div><div id="q243" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">549</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5105"><input type="hidden" name="q20803:243_:flagged" value="0"><input type="hidden" value="qaid=911127&amp;qubaid=20803&amp;qid=4975&amp;slot=243&amp;checksum=40f30f258697f722b5aa9b3bd5950685&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:243_:flaggedcheckbox" name="q20803:243_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q243&id=4975"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:243_:sequencecheck" value="2"><div class="qtext"><p>&nbsp;A 47-year-old woman with end stage renal disease secondary to diabetic nephropathy underwent&nbsp; construction of a brachiocephalic arteriovenous fistula in her non-dominant right arm 3 weeks ago. Pre-operative duplex assessment showed no significant arterial disease on the right side and a 4-5 mm cephalic vein caliber. She has been dialyzing via a tunneled central catheter in the right internal jugular vein since initiating dialysis 2 months ago. She has noted coolness, numbness, and intermittent pain over all 5 digits of the right hand since the surgery, with symptoms exacerbated by dialysis treatments. Her radial pulse is present but diminished, there is normal hand motor function, and no cutaneous breakdown. Which of the following is the most appropriate next step in the evaluation and management of this patient?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:243_answer" disabled="disabled" value="0" id="q20803:243_answer0"><label for="q20803:243_answer0">a. duplex imaging of the fistula and arterial inflow</label> </div>
<div class="r1"><input type="radio" name="q20803:243_answer" disabled="disabled" value="1" id="q20803:243_answer1"><label for="q20803:243_answer1">b. immediate fistula ligation</label> </div>
<div class="r0"><input type="radio" name="q20803:243_answer" disabled="disabled" value="2" id="q20803:243_answer2"><label for="q20803:243_answer2">c. upper extremity arteriography</label> </div>
<div class="r1"><input type="radio" name="q20803:243_answer" disabled="disabled" value="3" id="q20803:243_answer3"><label for="q20803:243_answer3">d. EMG and nerve conduction studies</label> </div>
<div class="r0"><input type="radio" name="q20803:243_answer" disabled="disabled" value="4" id="q20803:243_answer4"><label for="q20803:243_answer4">e. physiologic testing with and without fistula compression</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:243_-submit" name="q20803:243_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>The patient describes classical symptoms of arterial steal, which occur in 4-10% of patients with hemoaccess. While other conditions, such as neuropathy or causalgia, can also occur in these patients, the severity of the symptoms in this case warrants a definitive diagnosis. Immediate sacrifice of the fistula would leave the patient with fewer long-term access options and would not be justifiable. While duplex mapping may reveal an inflow stenosis, most patients with steal have no such lesion and its specificity for establishing the diagnosis is less than plethysmography. Likewise, arteriography may reveal retrograde flow at the arterial anastomosis, but not in all cases; it is present frequently in the absence of steal. The optimal study to establish the diagnosis of arterial steal is digital plethysmography with and without compression of the fistula. Once the diagnosis and its severitiy is established, a treatment algorithm can be applied.&nbsp;</p>
<p>&nbsp;</p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Nephrol+Dial+Transplant+2003%3B+18%3A2387%E2%80%9390." target="_blank">Lazarides MK, Staramos DN, Kopadis G, Maltezos C, Tzilalis VD, Georgiadis GS. Onset of arterial ‘steal’ following proximal angioaccess: Immediate and delayed types. Nephrol Dial Transplant&nbsp;2003; 18:2387–90.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Access+2008%3B+9%3A155-66." target="_blank"><span style="line-height: 1.5;">Malik J, Tuka V<span style="line-height: 1.5;">, </span>Kasalova Z<span style="line-height: 1.5;">, </span>Chytilova E<span style="line-height: 1.5;">, </span>Slavikova M<span style="line-height: 1.5;">, </span>Clagett P</span>,&nbsp;et al.&nbsp;<span style="line-height: 1.5;">Understanding the dialysis access steal syndrome. A review of the etiologies, diagnosis, prevention and treatment strategies.&nbsp;J Vasc Access</span><span style="line-height: 1.5;">&nbsp;2008; 9:155-66.</span></a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Rocha+A%2C+Silva+F%2C+Queiros+J%2C+Malheiro+J%2C+Cabrita+A.+Predictors+of+steal+syndrome+in+hemodialysis+patients.+Hemodialysis+International+2012%3A539-44" target="_blank">Rocha A, Silva F, Queiros J, Malheiro J, Cabrita A. Predictors of steal syndrome in hemodialysis patients.&nbsp;Hemodial Int&nbsp;2012; 16:539-44.</a></p>
<p>QID: 30424</p></div><div class="rightanswer">The correct answer is: physiologic testing with and without fistula compression</div></div></div></div></div><div id="q4" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">550</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5114"><input type="hidden" name="q20803:4_:flagged" value="0"><input type="hidden" value="qaid=910888&amp;qubaid=20803&amp;qid=4613&amp;slot=4&amp;checksum=87a7d943c66d9865a269d6fabd0fba4d&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:4_:flaggedcheckbox" name="q20803:4_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q4&id=4613"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:4_:sequencecheck" value="2"><div class="qtext"><p>A 65-year-old&nbsp;man presents with severe claudication and postprandial abdominal pain.&nbsp;He had an aortobifemoral bypass 8 years previously&nbsp;for claudication. He has weakly palpable femoral pulses and bilateral ankle brachial indices (ABI) of 0.4. An image from the current arteriogram is shown below. Which of the following is the&nbsp;most appropriate&nbsp;management option?</p>
<p><br><a href="./VESAP3_files/AssetProxy_082.jpg" target="images"><img title="img" src="./VESAP3_files/AssetProxy_082.jpg" alt="img" width="100" height="107" border="0" hspace="10" vspace="10"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:4_answer" disabled="disabled" value="0" id="q20803:4_answer0"><label for="q20803:4_answer0">a. aortic angioplasty and stenting</label> </div>
<div class="r1"><input type="radio" name="q20803:4_answer" disabled="disabled" value="1" id="q20803:4_answer1"><label for="q20803:4_answer1">b. axillary-bi-femoral bypass</label> </div>
<div class="r0"><input type="radio" name="q20803:4_answer" disabled="disabled" value="2" id="q20803:4_answer2"><label for="q20803:4_answer2">c. open aortic endarterectomy</label> </div>
<div class="r1"><input type="radio" name="q20803:4_answer" disabled="disabled" value="3" id="q20803:4_answer3"><label for="q20803:4_answer3">d. observation only</label> </div>
<div class="r0"><input type="radio" name="q20803:4_answer" disabled="disabled" value="4" id="q20803:4_answer4"><label for="q20803:4_answer4">e. thoraco-bi-femoral bypass</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:4_-submit" name="q20803:4_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>This patient has a heavily calcified atherosclerotic lesion in the visceral aortic segment. This is causing severe bilateral lower extremity claudication, as well as&nbsp;chronic mesenteric ischemia; both have indications for treatment. While thoraco-&nbsp;or axillary-bi-femoral bypass grafting will address the disabling claudication, neither&nbsp;will remedy the chronic mesenteric ischemia. Endovascular management&nbsp;is also risky, as the&nbsp;chance of visceral or distal embolization, as well as&nbsp;dissection-associated occlusion of the visceral vessels, would be high. Optimal management is aortic endarterectomy.<br><br></p>
<h3>Reference:</h3>
<p><a href="http://www.expertconsultbook.com/" target="_blank">Krupski WC, Messina LM, Stoney RJ. Endarterectomy. In: Rutherford RB, ed. Vascular Surgery, 6th ed. Philadelphia, PA: Elsevier Saunders 2005:679-88.</a></p>
<p>&nbsp;</p>
<p>QID: 30004</p></div><div class="rightanswer">The correct answer is: open aortic endarterectomy</div></div></div></div></div><div id="q463" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">551</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5123"><input type="hidden" name="q20803:463_:flagged" value="0"><input type="hidden" value="qaid=911347&amp;qubaid=20803&amp;qid=5183&amp;slot=463&amp;checksum=5bd29f574d6cb84e4612f6bccd3df244&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:463_:flaggedcheckbox" name="q20803:463_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q463&id=5183"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:463_:sequencecheck" value="2"><div class="qtext"><p>A 67-year-old woman with history of coronary disease undergoes elective carotid endarterectomy. She was maintained on both her beta-blocker and aspirin. Post-operatively, she develops chest pain while monitored in the intensive care unit. An electrocardiogram (ECG) obtained shows ST segment elevation and laboratory studies demonstrate significant troponin&nbsp;elevation.&nbsp;Which of the following management options offers the best balance of safety and treatment efficacy in patients with recent carotid surgery?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:463_answer" disabled="disabled" value="0" id="q20803:463_answer0"><label for="q20803:463_answer0">a. increase beta blocker dose, as long as heart rate remains 60 bpm or greater</label> </div>
<div class="r1"><input type="radio" name="q20803:463_answer" disabled="disabled" value="1" id="q20803:463_answer1"><label for="q20803:463_answer1">b. morphine for pain control and nitroglycerine titrated by blood pressure response</label> </div>
<div class="r0"><input type="radio" name="q20803:463_answer" disabled="disabled" value="2" id="q20803:463_answer2"><label for="q20803:463_answer2">c. percutaneous coronary intervention</label> </div>
<div class="r1"><input type="radio" name="q20803:463_answer" disabled="disabled" value="3" id="q20803:463_answer3"><label for="q20803:463_answer3">d. intravenous glycoprotein IIb/IIIa inhibitor infusion</label> </div>
<div class="r0"><input type="radio" name="q20803:463_answer" disabled="disabled" value="4" id="q20803:463_answer4"><label for="q20803:463_answer4">e. add clopidogrel to her aspirin therapy</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:463_-submit" name="q20803:463_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>Concomitant carotid and coronary disease, with severe atherosclerosis damaging both arterial systems, is a current and frequent clinical problem. Indeed, prospective studies have shown that 8-14% of coronary artery bypass graft patients have significant carotid stenosis, where it has been estimated that up to 28% of patients undergoing exploration for CEA have severe correctable coronary disease. Furthermore, coronary artery disease is the leading cause of both early and late mortality after CEA. Thus, an understanding of the management of myocardial infarction (MI) is essential.</p>
<p>In patients with post-operative MI, the initial diagnosis is made by obtaining serum markers (such as troponin) and ECG. Risk stratification based on&nbsp;the ECG findings and serum markers guides&nbsp;therapy. In patients with non-ST elevation MI, therapy usually consists of aspirin, clopidogrel, IIb/IIIa inhibitor, and heparin alone or in combination.</p>
<p>Patients with ST-segment elevation MI (STEMI) and elevated serum biomarkers should undergo immediate cardiac catheterization and catheter-directed therapy. <br><br></p>
<h3>References:</h3>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Vesely%20MR,%20Kelemen%20MD.%20Cardiac%20risk%20assessment:%20Matching%20intensity%20of%20therapy%20to%20risk.%20Cardiol%20Clin;%202006;%2024%20(1):67-78" target="_blank">Vesely MR, Kelemen MD. Cardiac risk assessment: Matching intensity of therapy to risk. Cardiol Clin 2006; 24 (1):67-78.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Miller%20KL,%20Pollack%20CV%20Jr,%20Peterson%20ED.%20Moving%20from%20evidence%20to%20practice%20in%20the%20care%20of%20patients%20who%20have%20acute%20coronary%20syndrome.%20Cardiol%20Clin;%202006;%2024%20(1):87-102" target="_blank">Miller KL, Pollack CV Jr, Peterson ED. Moving from evidence to practice in the care of patients who have acute coronary syndrome. Cardiol Clin 2006; 24 (1):87-102.</a></p>
<p>QID: 30823</p></div><div class="rightanswer">The correct answer is: percutaneous coronary intervention</div></div></div></div></div><div id="q424" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">552</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5132"><input type="hidden" name="q20803:424_:flagged" value="0"><input type="hidden" value="qaid=911308&amp;qubaid=20803&amp;qid=4868&amp;slot=424&amp;checksum=71464990472be7ed2c5d2ce2d631155f&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:424_:flaggedcheckbox" name="q20803:424_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q424&id=4868"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:424_:sequencecheck" value="2"><div class="qtext"><p>A 32-year-old man is seen with painful varicose veins and edema in his right lower extremity. He has a history of reddish markings on the right lower extremity, as shown in the image below. The prominent symptomatic varicosisties are primarily on the lateral thigh and calf, and all appear to connect to a prominent subcutaneous vein running up the lateral thigh (as pictured in the attached ultrasound image). This vein demonstrates high velocity reflux with compression and release, and can be followed up to the lateral iliac crest where it dives deep to enter the retroperitoneal space. The deep veins are patent and do not appear to be hypoplastic. Which of the following treatments is most likely to correct the patient's symptoms?</p>
<p>&nbsp;</p>
<p><a href="./VESAP3_files/right leg appearance.jpg" target="images"><img src="./VESAP3_files/right leg appearance.jpg" alt="right leg appearance" width="100"></a></p>
<p><a href="./VESAP3_files/lateral leg ultrasound.jpg" target="images"><img src="./VESAP3_files/lateral leg ultrasound.jpg" alt="lateral thigh ultrasound" width="100"></a></p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:424_answer" disabled="disabled" value="0" id="q20803:424_answer0"><label for="q20803:424_answer0">a. phlebectomy of the prominent lateral varicose veins</label> </div>
<div class="r1"><input type="radio" name="q20803:424_answer" disabled="disabled" value="1" id="q20803:424_answer1"><label for="q20803:424_answer1">b. endovenous ablation of the right small saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:424_answer" disabled="disabled" value="2" id="q20803:424_answer2"><label for="q20803:424_answer2">c. right iliac vein recanalization and stenting</label> </div>
<div class="r1"><input type="radio" name="q20803:424_answer" disabled="disabled" value="3" id="q20803:424_answer3"><label for="q20803:424_answer3">d. endovenous ablation of the right great saphenous vein</label> </div>
<div class="r0"><input type="radio" name="q20803:424_answer" disabled="disabled" value="4" id="q20803:424_answer4"><label for="q20803:424_answer4">e. endovenous ablation of the lateral subcutaneous vein pictured in the ultrasound image</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:424_-submit" name="q20803:424_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="specificfeedback"><p>Your answer is incorrect.</p></div><div class="generalfeedback"><p>Klippel-Trenaunay syndrome is classically described as a triad of tissue hypertrophy, varicose veins, and port wine stain. A variety of venous anomalies are found in these patients, including hypoplasia of the deep venous system, persistence of the sciatic vein, and enlarged superficial lateral leg veins. Patients who develop significant symptoms related to an enlarged refluxing lateral vein may be considered for intervention, but only if the deep system is confirmed to be intact and of adequate capacity to drain the limb. Phlebectomy alone may result in temporary symptomatic improvement, but would have a high recurrence rate if the refluxing source vein is not eliminated. If the lateral subcutaneous vein is not too tortuous it may be treated with endovenous ablation or with surgical stripping, if ablation is not possible.</p>
<p>&nbsp;</p>
<h2>&nbsp;<strong>References:</strong></h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2008%3B47%3A1339-45." target="_blank">Frasier K, Giangola G, Rosen R, Ginat DT. Endovascular radiofrequency ablation: A novel treatment of venous insufficiency in Klippel-Trenaunay patients. J Vasc Surg 2008; 47:1339-45.</a></p>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/17275246" target="_blank">Delis KT, Gloviczki P, Wennberg PW, Rooke TW, Driscoll DJ. Hemodynamic impairment, venous segmental disease, and clinical severity scoring in limbs with Klippel-Trenaunay syndrome. J Vasc Surg 2007;45:561-7.</a></p>
<p>QID: 30749</p></div><div class="rightanswer">The correct answer is: endovenous ablation of the lateral subcutaneous vein pictured in the ultrasound image</div></div></div></div></div><div id="q509" class="que multichoice interactive notanswered"><div class="info"><h3 class="no">Question <span class="qno">553</span></h3><div class="state">Not answered</div><div class="grade">Points out of 1.00</div><div class="questionflag editable" aria-atomic="true" aria-relevant="text" aria-live="assertive" id="yui_3_15_0_3_1445544180031_5141"><input type="hidden" name="q20803:509_:flagged" value="0"><input type="hidden" value="qaid=911393&amp;qubaid=20803&amp;qid=5240&amp;slot=509&amp;checksum=a1239924d6c03f0c47f0061f26f34337&amp;sesskey=yaTBuJMiS2&amp;newstate=" class="questionflagpostdata">
<input type="hidden" class="questionflagvalue" id="q20803:509_:flaggedcheckbox" name="q20803:509_:flagged" value="0"><input type="image" class="questionflagimage" src="./VESAP3_files/unflagged" title="Flag this question for future reference" alt="Not flagged"><span class="questionflagtext" title="Flag this question for future reference">Flag question</span></div><div class="editquestion"><a href="http://svsvesap.com/question/question.php?cmid=78&returnurl=%2Fmod%2Fquiz%2Freview.php%3Fattempt%3D18301%26showall%3D1%23q509&id=5240"><img class="iconsmall" alt="Edit" title="Edit" src="./VESAP3_files/edit">Edit question</a></div></div><div class="content"><div class="formulation"><h4 class="accesshide">Question stem</h4><input type="hidden" name="q20803:509_:sequencecheck" value="2"><div class="qtext"><p>Which of the following will reduce the radiation exposure to the patient during fluoroscopy?</p></div><div class="ablock"><div class="prompt">Select one:</div><div class="answer"><div class="r0"><input type="radio" name="q20803:509_answer" disabled="disabled" value="0" id="q20803:509_answer0"><label for="q20803:509_answer0">a. moving the patient closer to the tube</label> </div>
<div class="r1"><input type="radio" name="q20803:509_answer" disabled="disabled" value="1" id="q20803:509_answer1"><label for="q20803:509_answer1">b. magnification of the image</label> </div>
<div class="r0"><input type="radio" name="q20803:509_answer" disabled="disabled" value="2" id="q20803:509_answer2"><label for="q20803:509_answer2">c. use of a more rapid frame rate</label> </div>
<div class="r1"><input type="radio" name="q20803:509_answer" disabled="disabled" value="3" id="q20803:509_answer3"><label for="q20803:509_answer3">d. increasing the distance from the patient to the image intensifier</label> </div>
<div class="r0"><input type="radio" name="q20803:509_answer" disabled="disabled" value="4" id="q20803:509_answer4"><label for="q20803:509_answer4">e. collimation of the image</label> </div>
</div></div><div class="im-controls"><input type="submit" id="q20803:509_-submit" name="q20803:509_-submit" value="Check" class="submit btn" disabled="disabled"></div></div><div class="outcome"><h4 class="accesshide">Feedback</h4><div class="feedback"><div class="generalfeedback"><p>In the current age of increasing use of radiation-based imaging, protection of the patient and practitioner from radiation cannot be overemphasized. During fluoroscopic imaging, several maneuvers can be performed to reduce the amount of scatter and the overall dose of radiation that the patient receives. Decreasing the frame rate provides a significant decrease in the overall radiation exposure during fluoroscopy, but it will decrease the image quality. Decreasing the dose of radiation does just that, but also at the expense of image quality. Collimation narrows the beam of radiation and the portion of the patient imaged, and thus decreases the volume of tissue that is exposed. When magnification is performed, the input field size is decreased, which results in decreased brightness. Many systems have automatic brightness stabilizers that respond by increasing the X-ray dose to maintain a constant image brightness, thus increasing the overall dose of radiation. This is especially true in older systems with image intensifiers where 2x magnification can quadruple the radiation dose. Newer digital flat panel systems typically increase dose only 25-50% for a similar magnification, but higher magnification still increases the dose to the patient.<br><br></p>
<h2>References:</h2>
<p><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Surg+2007%3B+46+(3)%3A455-9." target="_blank">Ho P, Cheng SW, Wu PM, Ting AC<span>,&nbsp;</span>Poon JT<span>,&nbsp;</span>Cheng CK,&nbsp;et al. Ionizing radiation absorption of vascular surgeons during endovascular procedures. J Vasc Surg 2007; 46 (3):455-9.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=J+Vasc+Interv+Radiol%3B+2009%3B+20+(7+Suppl)%3AS263-73." target="_blank">Stecker MS, Balter S, Towbin RB, Miller DL<span>,&nbsp;</span>Vañó E<span>,&nbsp;</span>Bartal G<span>,&nbsp;</span>et al. Guidelines for patient radiation dose management. J Vasc Interv Radiol 2009; 20 (7 Suppl):S263-73.</a><br><br><a href="http://www.ncbi.nlm.nih.gov/pubmed/?term=Circulation%3B+2005%3B+111+(4)%3A511-32." target="_blank">Hirshfeld JW, Jr., Balter S, Brinker JA, Kern MJ<span>,&nbsp;</span>Klein LW<span>,&nbsp;</span>Lindsay BD,&nbsp;et al. ACCF/AHA/HRS/SCAI clinical competence statement on physician knowledge to optimize patient safety and image quality in fluoroscopically guided invasive cardiovascular procedures: A report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training. Circulation 2005; 111 (4):511-32.</a></p>
<p>QID: 30908</p></div><div class="rightanswer">The correct answer is: collimation of the image</div></div></div></div></div></div>
